data_2cjk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2cjk _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 44.0 m . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.543 0.211 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -72.43 138.44 47.12 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 121.573 0.701 . . . . 0.0 112.215 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.547 ' N ' ' O ' ' A' ' 205' ' ' LEU . 82.1 mmm -116.08 150.63 37.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.653 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.541 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 4.8 t80 -103.57 128.57 50.8 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.544 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 16.2 mm -115.26 127.72 72.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -132.31 163.63 23.96 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.511 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.43 29.78 59.44 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.352 -0.927 . . . . 0.0 112.269 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.423 ' HA ' HD21 ' A' ' 166' ' ' LEU . 76.4 mt -86.84 140.63 29.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.744 0.307 . . . . 0.0 111.164 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.486 ' HB2' ' HG3' ' A' ' 226' ' ' LYS . 22.2 t30 -66.13 133.68 51.21 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 -52.09 -38.47 57.39 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.99 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -62.97 -26.85 69.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.5 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 51.5 m -54.07 139.86 33.59 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.542 0.687 . . . . 0.0 111.383 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 28.5 m -119.39 151.5 38.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.7 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.737 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 98.5 mt-10 -55.33 -36.3 66.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.854 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -58.3 -43.81 88.26 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 120.602 -0.439 . . . . 0.0 109.861 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -65.45 -37.3 86.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.498 ' HB3' ' CD1' ' A' ' 188' ' ' LEU . 1.0 OUTLIER -55.43 -62.37 1.72 Allowed 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.332 178.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.481 ' O ' ' N ' ' A' ' 180' ' ' GLY . 67.2 ttp85 -57.19 -41.04 78.58 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.912 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.08 -40.23 94.35 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.742 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.587 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 62.7 t80 -61.98 -48.07 81.99 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.637 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.447 ' CG ' HD23 ' A' ' 205' ' ' LEU . 88.8 m-85 -87.93 0.0 56.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.395 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -61.2 -28.84 69.79 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.595 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -38.67 78.58 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.803 0.811 . . . . 0.0 110.04 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -67.63 -30.03 69.49 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.62 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 159.46 -132.83 3.13 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.238 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 52.8 m -119.92 139.62 52.15 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.435 HG12 ' HG3' ' A' ' 176' ' ' ARG . 3.4 m -100.81 122.8 53.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.489 -0.485 . . . . 0.0 110.502 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.3 t -73.22 -46.92 47.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.288 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -145.73 121.7 10.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.016 0.436 . . . . 0.0 111.455 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.498 ' CD1' ' HB3' ' A' ' 175' ' ' LEU . 0.0 OUTLIER -118.6 139.69 51.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.572 179.462 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.588 ' O ' ' CA ' ' A' ' 203' ' ' GLY . 8.7 tptt -133.01 83.38 2.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.841 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.737 ' HB ' ' HG2' ' A' ' 172' ' ' GLU . 12.0 tt -60.45 -22.64 26.02 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-O 121.146 0.498 . . . . 0.0 109.77 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.504 ' CE ' ' CE2' ' A' ' 204' ' ' PHE . 0.0 OUTLIER 73.13 55.38 0.12 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.486 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.63 152.07 46.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.467 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 1.5 t0 -124.16 75.85 59.77 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.23 -25.43 80.06 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.462 2.108 . . . . 0.0 112.308 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.74 -66.52 0.6 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.806 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 70.9 p -68.65 -24.83 64.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.195 0.521 . . . . 0.0 110.281 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.59 -3.35 68.27 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.431 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.484 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 6.3 ttp180 -130.35 124.37 32.1 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.971 0.415 . . . . 0.0 111.268 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.1 m -64.41 156.14 30.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.779 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.657 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 5.4 mpt_? -57.07 -33.91 67.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.083 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 93.17 3.37 65.42 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.668 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.657 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 40.4 p90 -144.62 154.8 43.19 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.588 ' CA ' ' O ' ' A' ' 189' ' ' LYS . . . -151.18 169.11 30.84 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 119.373 -1.394 . . . . 0.0 113.273 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.541 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 98.0 m-85 -106.54 120.47 42.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.188 0.518 . . . . 0.0 109.674 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 161' ' ' MET . 55.3 tp -108.39 125.56 51.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.955 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 50.2 m -118.55 143.56 46.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.312 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 74.3 m-85 -120.81 144.33 48.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.394 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.18 -34.8 77.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.943 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -110.87 119.51 45.89 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.787 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -56.55 -22.05 41.29 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.673 2.249 . . . . 0.0 113.139 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.7 m -57.14 -37.35 71.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.577 0.227 . . . . 0.0 111.558 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.412 ' HA ' ' OE2' ' A' ' 215' ' ' GLU . 21.6 m -59.33 -35.81 74.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.816 0.341 . . . . 0.0 110.745 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.16 -42.3 92.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.243 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -59.22 -41.92 89.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.869 0.366 . . . . 0.0 111.179 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.412 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 15.3 pt-20 -76.34 -29.17 57.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.82 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.798 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 77.1 t -60.05 -41.54 86.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.441 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.9 m -72.17 -30.02 34.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -59.12 -37.67 77.75 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.704 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 43.4 m -91.86 142.27 27.75 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 63.7 tt0 -66.19 -41.68 89.9 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.666 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.798 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 79.3 m-70 81.65 111.2 0.07 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 20.5 mm -119.24 113.38 41.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 175.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.8 tt -120.67 124.63 45.67 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.937 0.399 . . . . 0.0 111.736 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 52.67 43.0 31.77 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.47 8.35 87.63 Favored Glycine 0 CA--C 1.516 0.141 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.345 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.486 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 2.4 mmmm -120.11 164.61 15.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.68 0.276 . . . . 0.0 110.532 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.9 p -117.52 135.99 56.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.087 0.47 . . . . 0.0 110.263 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.461 HG13 ' HD3' ' A' ' 230' ' ' PRO . 37.4 pt -126.96 160.47 35.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.61 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -127.83 79.22 74.01 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.158 0.504 . . . . 0.0 110.744 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.559 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 52.3 Cg_exo -58.78 124.06 14.91 Favored 'Trans proline' 0 CA--C 1.528 0.185 0 C-N-CA 122.934 2.423 . . . . 0.0 111.454 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 8.9 mtmm -133.58 157.18 46.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.915 0.388 . . . . 0.0 111.454 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 35.6 tpt85 -57.6 136.06 56.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.407 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.29 144.44 56.95 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.947 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 11.5 mt -111.06 125.25 31.0 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.67 143.44 46.69 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 121.82 1.68 . . . . 0.0 110.707 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -57.62 -39.86 77.86 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -62.27 -46.19 89.91 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.295 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.78 -38.16 76.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.578 0.704 . . . . 0.0 109.762 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -59.27 -40.96 87.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.027 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -61.61 -40.53 95.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.896 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -61.21 -34.59 75.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.46 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 19.1 p -80.71 161.93 24.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.535 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -147.46 175.77 26.64 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.178 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.488 ' CE ' ' CD2' ' A' ' 288' ' ' PHE . 49.1 tptt -131.08 129.94 42.56 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.627 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -119.74 161.12 19.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.377 0.608 . . . . 0.0 111.116 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.41 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 86.6 t80 -103.96 135.99 44.45 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.451 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.535 HG21 HG12 ' A' ' 315' ' ' ILE . 7.5 p -129.48 144.55 37.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.563 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.64 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -129.8 176.87 18.45 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.82 32.73 26.13 Favored Glycine 0 C--N 1.32 -0.333 0 C-N-CA 119.895 -1.145 . . . . 0.0 112.211 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.487 ' CD1' ' HA2' ' A' ' 287' ' ' GLY . 69.3 mt -107.86 130.89 59.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -143.0 -163.12 9.6 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.438 -0.886 . . . . 0.0 113.39 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -52.32 147.69 27.88 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.934 2.423 . . . . 0.0 112.463 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 50.1 t0 74.16 -3.7 2.47 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.672 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' A' ' 258' ' ' GLU . 11.3 p -60.93 -38.58 79.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.1 OUTLIER 54.56 115.25 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.403 -179.452 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.21 -34.42 69.27 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 121.664 1.576 . . . . 0.0 111.998 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -61.75 -43.31 99.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.682 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 254' ' ' VAL . 84.3 tt0 -65.86 -35.66 81.28 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.281 0.563 . . . . 0.0 110.548 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.611 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 13.9 t80 -58.65 -45.16 89.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.594 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.38 -41.96 93.17 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.3 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.493 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.3 pt-20 -73.65 -30.8 63.14 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.01 0.433 . . . . 0.0 110.506 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.51 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 8.5 t80 -61.16 -53.23 59.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.224 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.557 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 4.3 m-85 -70.0 -23.5 63.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.888 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.481 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 70.8 p -58.41 -25.61 62.34 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.734 0.302 . . . . 0.0 111.541 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -55.38 -34.51 64.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.242 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.644 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 11.2 p90 -117.05 45.12 1.94 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.259 0.552 . . . . 0.0 111.434 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.502 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 152.44 147.69 4.66 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.745 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 49.8 m -59.41 -37.99 79.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 111.348 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.533 HD12 ' CB ' ' A' ' 263' ' ' PHE . 70.4 mt 67.55 86.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.873 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.548 ' CD1' ' HB3' ' A' ' 292' ' ' ASP . 34.0 mm -58.56 -38.94 73.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.9 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -155.98 150.34 25.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.095 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -153.2 132.38 12.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.087 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -149.93 163.04 39.13 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 275' ' ' MET . 1.6 mm? -95.83 7.77 45.4 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.643 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.436 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 86.0 mtp 71.02 -80.28 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.14 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 283' ' ' SER . 0.1 OUTLIER 37.95 49.42 1.17 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 178.694 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.28 -45.04 84.47 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.386 -0.525 . . . . 0.0 110.661 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -108.02 3.42 24.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.09 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.467 ' OD1' ' HB2' ' A' ' 276' ' ' LEU . 83.3 m-20 51.28 38.13 20.57 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 63.6 p -111.17 0.18 16.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.924 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.62 -30.73 0.26 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 119.409 -1.377 . . . . 0.0 114.334 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.489 ' HB2' ' HA ' ' A' ' 276' ' ' LEU . 94.9 mt-30 -57.46 -31.15 65.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.33 0.565 . . . . 0.0 110.641 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.564 ' HB3' ' HB3' ' A' ' 276' ' ' LEU . 95.4 p -59.32 -26.0 64.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.393 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -127.3 154.87 44.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.315 0.578 . . . . 0.0 111.389 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.52 -50.49 0.98 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.727 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.41 ' CD2' ' HE1' ' A' ' 246' ' ' PHE . 22.4 p90 -145.16 165.07 29.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.862 0.331 . . . . 0.0 110.748 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.487 ' HA2' ' CD1' ' A' ' 250' ' ' ILE . . . -137.24 163.68 25.36 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.421 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.488 ' CD2' ' CE ' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -122.4 124.96 44.85 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.278 0.231 . . . . 0.0 110.8 179.489 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.627 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 43.4 t -127.12 139.9 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.009 0.433 . . . . 0.0 112.032 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.422 ' OG1' ' CD ' ' A' ' 244' ' ' LYS . 34.8 m -114.69 137.87 51.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.858 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.502 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 37.8 m-85 -117.43 140.11 50.02 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.548 ' HB3' ' CD1' ' A' ' 270' ' ' ILE . 29.2 p-10 -61.53 -33.79 74.43 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.236 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' SER . . . . . 0.424 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 31.1 t -124.16 139.06 54.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.423 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.82 -31.73 73.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.61 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -56.12 -37.24 69.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.97 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.92 -36.65 79.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.957 0.408 . . . . 0.0 110.352 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 82.0 t -61.1 -40.87 87.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.143 0.497 . . . . 0.0 110.194 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -59.47 -36.61 76.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.407 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -56.84 -42.91 80.5 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.085 0.469 . . . . 0.0 111.046 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.644 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 0.3 OUTLIER -75.71 -30.22 21.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.667 179.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 80.9 m -56.43 -45.87 80.55 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -64.15 -34.31 77.76 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -100.54 70.58 1.47 Allowed 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.204 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.583 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 7.6 tptt -53.81 -43.74 69.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.239 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.583 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.9 m-85 -113.55 126.0 54.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.302 0.572 . . . . 0.0 110.899 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.498 HD11 ' CZ3' ' A' ' 266' ' ' TRP . 25.8 mt -117.68 139.17 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.192 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -79.54 102.39 8.81 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.519 ' CE2' ' HD3' ' A' ' 309' ' ' LYS . 5.7 t80 -107.4 -72.57 0.72 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.385 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.519 ' HD3' ' CE2' ' A' ' 308' ' ' PHE . 3.7 mmmt -100.15 26.28 6.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.346 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 63.03 41.56 8.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.697 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 312' ' ' LYS . 94.6 mtt180 -150.78 7.86 0.56 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.151 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 311' ' ' ARG . 24.0 mmtm 56.71 138.53 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.537 0.684 . . . . 0.0 112.129 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.64 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 36.3 pt -120.81 148.01 24.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.221 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -104.32 127.35 51.96 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.535 HG12 HG21 ' A' ' 247' ' ' VAL . 86.8 mt -118.19 130.86 72.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.324 0.583 . . . . 0.0 112.074 -178.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -132.51 142.84 49.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.526 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 69.3 mtt85 -53.11 149.13 7.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.641 0.258 . . . . 0.0 110.378 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.27 141.88 28.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.91 0.386 . . . . 0.0 111.116 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.313 -179.488 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 37.4 m . . . . . 0 CA--C 1.531 0.25 0 CA-C-O 120.625 0.25 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -56.15 141.25 41.41 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.288 0.566 . . . . 0.0 111.621 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.483 ' CG ' HG22 ' A' ' 213' ' ' VAL . 93.8 mtp -115.83 156.04 26.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.435 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.621 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 3.5 t80 -105.16 129.57 53.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.894 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.581 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 16.0 mm -116.98 131.37 69.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.478 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -134.48 164.08 24.62 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.411 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.2 25.32 66.51 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.368 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.419 ' HA ' HD21 ' A' ' 166' ' ' LEU . 75.6 mt -86.88 143.05 27.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.734 0.302 . . . . 0.0 110.949 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -61.12 133.23 55.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -52.32 -28.18 18.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.703 0.287 . . . . 0.0 111.013 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 50.2 p30 -83.81 8.5 14.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.16 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 88.8 m -70.77 140.23 51.24 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.351 0.596 . . . . 0.0 110.164 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 27.9 m -114.97 144.38 43.68 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.566 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.644 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 98.3 mt-10 -55.73 -35.42 66.13 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.865 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.796 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 92.1 m-20 -57.1 -40.46 77.05 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -65.15 -38.69 91.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.11 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.448 HD21 ' CD2' ' A' ' 179' ' ' PHE . 3.6 mt -63.22 -48.32 78.76 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.796 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -71.63 -34.11 69.52 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.033 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -62.08 -38.57 89.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.581 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 63.8 t80 -80.25 -61.86 1.85 Allowed 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.942 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.449 ' CD2' HD13 ' A' ' 205' ' ' LEU . 72.6 m-85 -66.62 -21.47 66.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.314 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -50.56 -27.97 13.85 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.512 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 1.7 tmtt? -55.15 -43.14 73.92 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.864 -0.668 . . . . 0.0 110.062 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.429 ' CE2' ' HA ' ' A' ' 216' ' ' VAL . 46.0 m-85 -71.08 -33.94 70.69 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.454 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.414 ' O ' ' HA3' ' A' ' 180' ' ' GLY . . . -177.38 179.99 47.89 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.334 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 54.1 m -62.89 -33.85 76.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.805 0.336 . . . . 0.0 111.68 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.556 ' CG1' ' O ' ' A' ' 185' ' ' VAL . 0.5 OUTLIER 64.99 102.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 121.205 0.526 . . . . 0.0 109.654 -178.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.429 ' CG2' ' CA ' ' A' ' 208' ' ' GLU . 43.9 p -67.29 -37.68 83.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.965 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 206' ' ' SER . 20.1 t70 -160.81 160.77 31.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.427 ' CD1' ' CB ' ' A' ' 175' ' ' LEU . 0.1 OUTLIER -158.43 144.13 16.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.055 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.507 ' CG ' ' HB2' ' A' ' 204' ' ' PHE . 0.0 OUTLIER -131.71 113.56 13.7 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.644 ' HB ' ' HG2' ' A' ' 172' ' ' GLU . 2.0 tt -93.05 11.1 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.498 ' HE2' ' HA3' ' A' ' 203' ' ' GLY . 0.0 OUTLIER 67.21 -71.09 0.1 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.763 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.7 ' HA ' ' HA ' ' A' ' 199' ' ' SER . 20.0 ttmm 59.81 133.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.095 0.474 . . . . 0.0 111.261 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 88.2 m-20 -120.73 87.78 42.74 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.893 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.59 -24.71 37.83 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.342 2.028 . . . . 0.0 112.306 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -75.46 -75.63 0.17 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.402 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 62.8 p -70.36 -24.43 62.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.051 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 91.26 9.8 63.0 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.992 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 17.9 ttp85 -96.15 133.01 40.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.213 0.53 . . . . 0.0 111.827 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.7 ' HA ' ' HA ' ' A' ' 192' ' ' LYS . 75.4 m -85.83 10.22 14.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.132 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.487 ' HG3' ' CB ' ' A' ' 191' ' ' MET . 40.2 mmt180 74.94 -41.88 0.48 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 199' ' ' SER . . . 92.95 6.01 63.77 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.331 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.581 ' HB2' ' O ' ' A' ' 163' ' ' ILE . 33.9 p90 -147.37 155.48 42.01 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.498 ' HA3' ' HE2' ' A' ' 191' ' ' MET . . . -154.92 166.65 32.53 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.148 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.621 ' CE2' ' CD1' ' A' ' 162' ' ' PHE . 91.1 m-85 -109.92 128.39 55.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.655 0.264 . . . . 0.0 110.416 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.449 HD13 ' CD2' ' A' ' 179' ' ' PHE . 63.3 mt -104.99 140.5 38.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.837 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 33.1 t -123.21 130.69 53.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.347 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 94.7 m-85 -117.25 138.33 51.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.001 0.429 . . . . 0.0 111.538 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.429 ' CA ' ' CG2' ' A' ' 186' ' ' THR . 84.4 tt0 -61.48 -34.62 75.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.095 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -113.36 120.49 39.8 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.955 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . 0.492 ' O ' HG11 ' A' ' 213' ' ' VAL . 49.6 Cg_exo -56.17 -22.29 39.46 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.537 2.158 . . . . 0.0 112.989 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.6 m -56.61 -37.91 71.33 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.688 0.28 . . . . 0.0 111.291 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 22.4 m -59.68 -35.69 74.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 0.0 110.284 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.492 HG11 ' O ' ' A' ' 210' ' ' PRO . 0.4 OUTLIER -59.48 -40.51 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.721 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.477 ' N ' HG11 ' A' ' 213' ' ' VAL . 92.4 m-20 -62.57 -41.88 99.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.432 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -77.68 -34.08 53.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.997 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.765 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 84.0 t -62.62 -47.09 94.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 CA-C-O 121.104 0.478 . . . . 0.0 110.522 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.22 -34.09 67.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -57.99 -37.43 74.23 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.685 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 38.5 m -96.0 141.73 29.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.724 0.297 . . . . 0.0 111.619 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 228' ' ' ILE . 63.6 tt0 -67.05 -41.53 86.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.765 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 47.0 m-70 77.61 122.3 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 21.0 mm -116.38 110.65 32.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 175.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.1 tt -121.77 125.91 47.64 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.228 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 53.92 41.56 32.0 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 76.5 12.86 83.98 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.551 -0.833 . . . . 0.0 114.162 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -126.13 156.48 40.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.482 0.641 . . . . 0.0 111.764 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 33.7 m -107.82 136.52 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.298 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 220' ' ' GLN . 34.3 pt -126.78 162.76 30.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.012 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -129.02 79.18 75.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.046 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.703 ' HG3' ' CD2' ' A' ' 221' ' ' HIS . 9.6 Cg_endo -54.21 133.48 55.85 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.417 2.078 . . . . 0.0 111.681 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -137.65 147.78 45.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.619 0.247 . . . . 0.0 110.774 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -56.28 137.53 52.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 111.391 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.75 148.87 51.35 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.114 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . 0.413 ' CG2' ' HD2' ' A' ' 235' ' ' PRO . 5.6 mt -114.27 142.84 28.68 Favored Pre-proline 0 N--CA 1.464 0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.581 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.413 ' HD2' ' CG2' ' A' ' 234' ' ' ILE . 37.3 Cg_exo -56.94 138.88 88.0 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 121.763 1.642 . . . . 0.0 110.732 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -60.06 -40.4 89.32 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.608 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 56.7 p30 -64.67 -40.8 96.06 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.573 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.608 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 97.3 mt-10 -71.47 -35.93 71.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.579 0.704 . . . . 0.0 109.363 177.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -58.42 -42.01 86.3 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.752 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -63.53 -40.09 96.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.057 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -60.06 -36.45 77.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.708 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.443 ' CG2' ' CD1' ' A' ' 270' ' ' ILE . 17.2 p -78.84 160.63 27.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.532 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -142.11 169.26 25.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.424 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -134.79 136.07 42.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.54 0.21 . . . . 0.0 110.839 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.4 ' CD1' ' CG2' ' A' ' 315' ' ' ILE . 9.6 pt -120.29 156.6 23.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.127 0.489 . . . . 0.0 111.53 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 315' ' ' ILE . 78.9 t80 -94.41 131.44 40.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.15 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.615 ' CG2' ' CZ ' ' A' ' 263' ' ' PHE . 25.1 t -124.47 135.9 62.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.396 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.561 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -132.57 178.32 18.16 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.71 26.35 46.44 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.037 -1.078 . . . . 0.0 112.268 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 32.0 pt -118.44 154.79 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 121.04 0.448 . . . . 0.0 111.339 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.49 ' O ' ' CG1' ' A' ' 254' ' ' VAL . . . -127.43 176.01 18.02 Favored Glycine 0 C--O 1.226 -0.344 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.972 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . 0.415 ' HD3' ' HG3' ' A' ' 284' ' ' ARG . 54.1 Cg_exo -51.69 -28.61 30.3 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 121.92 1.746 . . . . 0.0 111.304 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -61.32 -30.53 70.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.177 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.535 ' O ' ' O ' ' A' ' 255' ' ' ARG . 7.8 p -47.54 -38.59 6.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.819 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.0 OUTLIER 56.34 125.68 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.281 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.47 -35.8 86.28 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 121.787 1.658 . . . . 0.0 112.656 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -63.56 -47.76 80.21 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.524 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 85.0 tt0 -68.07 -37.05 80.83 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.126 0.488 . . . . 0.0 111.15 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.504 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 27.4 t80 -58.88 -45.68 89.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.061 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -66.84 -40.98 88.11 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.944 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 258' ' ' GLU . 19.5 pt-20 -70.26 -34.09 72.39 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.882 0.372 . . . . 0.0 110.491 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.603 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 83.7 t80 -60.4 -54.33 46.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.454 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.69 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 26.9 m-85 -69.22 -28.39 66.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.67 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.476 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 22.7 t -57.05 -29.67 63.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.455 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 262' ' ' PHE . 19.9 pt20 -53.26 -36.09 60.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.822 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.69 ' CZ2' ' CD2' ' A' ' 263' ' ' PHE . 12.5 p90 -115.19 40.99 2.53 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.915 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.44 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 170.91 -179.01 43.08 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.465 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.404 ' CG2' ' HB3' ' A' ' 292' ' ' ASP . 0.0 OUTLIER -104.81 0.75 28.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.77 0.319 . . . . 0.0 110.345 179.045 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.58 HD12 ' CB ' ' A' ' 263' ' ' PHE . 75.5 mt 28.91 97.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.623 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 72.5 mt -60.44 -45.47 96.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.581 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -164.83 94.02 0.66 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.404 ' CB ' HG22 ' A' ' 269' ' ' ILE . . . -99.09 136.4 39.1 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -142.16 154.52 44.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.624 0.726 . . . . 0.0 112.745 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.612 ' O ' ' HB2' ' A' ' 275' ' ' MET . 35.7 tp -64.68 -37.38 87.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.648 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.612 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 95.8 mmm 93.32 114.75 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.518 -178.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 28.5 mt -111.15 141.9 44.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.421 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.671 ' HB3' ' HA2' ' A' ' 281' ' ' GLY . 59.8 t0 -144.52 88.01 1.9 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.156 0.503 . . . . 0.0 110.405 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? 64.6 37.13 8.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.568 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 51.84 44.23 29.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.961 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 1.6 t 169.66 46.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.911 0.386 . . . . 0.0 110.729 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . 0.671 ' HA2' ' HB3' ' A' ' 277' ' ' ASP . . . -136.43 -111.82 1.13 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.313 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.5 ' OE1' ' HB3' ' A' ' 275' ' ' MET . 91.9 mt-30 -56.9 -24.99 56.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.027 -0.587 . . . . 0.0 111.101 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 275' ' ' MET . 16.8 m -49.52 -31.9 11.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.086 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.415 ' HG3' ' HD3' ' A' ' 252' ' ' PRO . 70.7 ttp85 -116.36 136.98 52.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.161 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.16 -57.03 0.44 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.799 -0.715 . . . . 0.0 114.071 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -141.62 167.98 20.86 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.555 0.677 . . . . 0.0 112.02 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -134.45 156.02 22.21 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.238 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.478 ' HB2' ' HG2' ' A' ' 275' ' ' MET . 0.1 OUTLIER -111.97 129.85 56.05 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.709 0.29 . . . . 0.0 111.722 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.504 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 38.4 t -122.39 135.04 63.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 111.496 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 52.0 m -118.48 135.64 54.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.44 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 38.7 m-85 -116.87 134.99 54.08 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.623 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 54.4 t0 -59.43 -36.08 75.22 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.5 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 50.5 m -120.77 143.92 48.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.266 0.555 . . . . 0.0 111.436 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.63 -30.61 71.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.158 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -56.47 -38.9 72.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.278 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.8 88.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.074 0.464 . . . . 0.0 110.299 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 71.6 t -62.2 -42.99 97.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.707 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -60.57 -37.72 82.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.125 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -58.59 -43.81 89.62 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.662 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 0.4 OUTLIER -74.34 -34.38 36.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.953 0.406 . . . . 0.0 111.045 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 97.8 m -58.24 -44.69 88.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.193 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -62.22 -40.12 95.08 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.312 0.577 . . . . 0.0 109.91 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -63.81 -32.67 74.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.369 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.681 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 22.5 tptm 67.47 -74.89 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.629 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.681 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.5 m-30 -109.06 131.85 54.67 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.127 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.433 ' CD1' HG22 ' A' ' 300' ' ' VAL . 1.7 mt -121.07 138.08 52.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.48 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.414 ' OD1' ' CE ' ' A' ' 312' ' ' LYS . 86.9 m-20 -67.55 138.46 56.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.603 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 2.2 t80 -140.62 -107.98 0.15 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.209 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.419 ' NZ ' ' CZ ' ' A' ' 308' ' ' PHE . 2.6 mmpt? -58.92 -38.54 79.18 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.834 0.35 . . . . 0.0 111.862 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 309' ' ' LYS . 58.3 t0 176.7 -29.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.227 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 88.2 mmt-85 -113.66 160.32 18.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.607 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.609 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 37.0 mmtm -66.65 140.67 57.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.092 0.472 . . . . 0.0 111.567 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.561 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 34.5 pt -110.45 133.75 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . 0.547 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 84.2 mt-10 -96.04 131.49 42.38 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.798 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 246' ' ' PHE . 68.6 mt -120.3 123.92 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.068 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -130.41 154.81 47.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.983 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -56.12 151.53 12.11 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -48.29 142.98 5.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.975 0.417 . . . . 0.0 110.866 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.731 -178.601 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.3 m . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.835 0.35 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.48 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 6.3 tptt -56.85 136.37 55.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.47 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.445 ' N ' ' O ' ' A' ' 205' ' ' LEU . 90.3 mtp -125.74 155.88 40.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.303 0.573 . . . . 0.0 112.016 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.549 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 3.1 t80 -105.22 130.88 53.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.376 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.506 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 22.4 mm -117.4 128.89 74.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.556 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -122.43 157.15 17.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.968 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.68 54.52 5.91 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.218 -0.992 . . . . 0.0 112.27 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.504 ' O ' ' OG1' ' A' ' 170' ' ' THR . 69.4 mt -83.55 3.47 32.34 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.498 ' HB2' ' HG3' ' A' ' 226' ' ' LYS . 36.9 t30 58.27 39.95 25.12 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.842 -0.536 . . . . 0.0 110.109 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.428 ' HA ' ' OG ' ' A' ' 199' ' ' SER . 8.8 m0 33.32 35.05 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.075 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -175.72 22.48 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.504 ' OG1' ' O ' ' A' ' 166' ' ' LEU . 95.1 m -59.84 -34.65 73.38 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 122.137 -0.352 . . . . 0.0 111.795 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.0 OUTLIER 62.33 131.23 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -178.196 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 188' ' ' LEU . 96.5 mt-10 -59.02 -34.95 72.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.633 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.596 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.9 m-20 -57.04 -40.77 77.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.886 0.374 . . . . 0.0 111.386 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 170' ' ' THR . 85.9 m-20 -63.12 -36.19 82.77 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.472 HD21 ' CD2' ' A' ' 179' ' ' PHE . 6.3 mt -59.93 -42.25 93.57 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.596 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -65.29 -38.82 91.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.016 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.436 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 75.8 mm-40 -70.82 -44.11 67.21 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.043 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.558 ' O ' ' HD3' ' A' ' 181' ' ' LYS . 58.4 t80 -65.28 -44.56 87.59 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.223 0.535 . . . . 0.0 111.435 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.472 ' CD2' HD21 ' A' ' 175' ' ' LEU . 88.5 m-85 -94.86 -1.82 51.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.206 -0.907 . . . . 0.0 112.452 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -61.54 -26.97 67.25 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.312 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.558 ' HD3' ' O ' ' A' ' 178' ' ' TYR . 0.8 OUTLIER -56.11 -39.76 72.69 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.032 0.92 . . . . 0.0 111.002 -179.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -67.51 -27.86 67.34 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.711 -1.586 . . . . 0.0 112.012 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 159.64 -123.15 1.2 Allowed Glycine 0 CA--C 1.507 -0.432 0 C-N-CA 120.678 -0.773 . . . . 0.0 111.674 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.488 ' O ' ' HD1' ' A' ' 207' ' ' PHE . 28.3 p -119.88 160.0 23.55 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.447 HG23 ' CD2' ' A' ' 188' ' ' LEU . 8.1 p -122.67 130.25 74.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.332 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.459 ' CG2' ' HA ' ' A' ' 208' ' ' GLU . 50.9 p -77.12 -38.86 51.22 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -155.29 150.98 27.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.472 0.653 . . . . 0.0 112.564 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 172' ' ' GLU . 0.2 OUTLIER -122.06 130.88 53.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.454 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 9.5 tptp -136.41 120.54 17.77 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.518 HG23 ' HG3' ' A' ' 192' ' ' LYS . 6.4 mt -130.28 130.63 65.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.771 176.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.541 ' SD ' ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -90.38 122.26 33.09 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.53 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.518 ' HG3' HG23 ' A' ' 190' ' ' ILE . 58.9 mttm -126.76 156.46 41.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.752 0.31 . . . . 0.0 111.496 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.649 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 7.7 t70 -122.19 80.24 44.12 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.378 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.41 -25.88 50.53 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.429 2.086 . . . . 0.0 112.57 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -72.19 -67.44 0.54 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.916 0.389 . . . . 0.0 111.235 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 61.4 p -71.63 -22.12 61.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.629 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 84.21 18.2 63.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.378 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.649 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 2.1 ttt-85 -122.98 144.24 49.38 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 120.92 0.39 . . . . 0.0 111.273 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.428 ' OG ' ' HA ' ' A' ' 168' ' ' TRP . 90.1 p -110.38 157.61 19.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.979 0.419 . . . . 0.0 111.039 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.541 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 1.5 mpt_? -53.53 -32.43 50.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.502 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.419 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 94.42 -0.09 65.51 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.352 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.541 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 23.9 p90 -139.15 154.86 48.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.222 0.534 . . . . 0.0 110.873 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.525 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -140.42 162.2 26.52 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.23 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.549 ' CE2' ' CD1' ' A' ' 162' ' ' PHE . 95.6 m-85 -106.21 127.46 53.24 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.979 0.418 . . . . 0.0 109.982 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.512 HD23 ' CZ ' ' A' ' 207' ' ' PHE . 2.0 tt -107.23 128.03 54.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.807 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.51 ' N ' HD22 ' A' ' 205' ' ' LEU . 11.9 t -117.0 132.45 56.7 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.494 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.512 ' CZ ' HD23 ' A' ' 205' ' ' LEU . 72.5 m-85 -117.5 141.55 48.22 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.459 ' HA ' ' CG2' ' A' ' 186' ' ' THR . 47.0 tp10 -63.07 -36.08 82.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.6 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.24 116.57 51.0 Favored Pre-proline 0 CA--C 1.529 0.141 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.624 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.97 -26.02 65.86 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.346 2.031 . . . . 0.0 112.584 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 21.4 m -57.98 -37.28 73.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.26 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.416 ' HA ' ' OE2' ' A' ' 215' ' ' GLU . 23.5 m -59.08 -35.61 73.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.942 0.401 . . . . 0.0 110.399 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.492 HG13 ' HD3' ' A' ' 232' ' ' ARG . 86.0 t -61.68 -42.32 93.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.022 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -59.6 -41.63 90.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.131 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.416 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 18.7 pt-20 -75.1 -31.49 61.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.818 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.776 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 77.7 t -60.99 -44.69 98.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.278 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.1 m -76.23 -29.24 19.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.028 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -58.31 -33.04 69.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.667 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 88.5 m -111.53 145.49 38.99 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -76.87 145.12 38.53 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.776 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 63.7 m-70 -120.57 134.05 55.32 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -176.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.438 ' CD1' HG22 ' A' ' 227' ' ' VAL . 28.3 mm -119.61 113.64 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.1 tt -121.66 126.77 49.8 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.74 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 56.4 t0 52.75 37.38 23.62 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 93.47 -24.67 24.49 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.839 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.498 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 30.9 mmtp -97.58 170.96 8.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.841 0.353 . . . . 0.0 111.324 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.438 HG22 ' CD1' ' A' ' 222' ' ' ILE . 11.7 p -120.89 139.97 46.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.927 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.435 HG13 ' HD3' ' A' ' 230' ' ' PRO . 36.0 pt -123.64 159.86 27.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.097 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -125.25 81.39 63.64 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.172 0.51 . . . . 0.0 110.834 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.513 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 51.0 Cg_exo -57.83 129.05 31.47 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.966 2.444 . . . . 0.0 111.551 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -140.74 155.94 46.32 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.571 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.492 ' HD3' HG13 ' A' ' 213' ' ' VAL . 52.5 mmm-85 -56.08 140.11 44.85 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.515 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.35 147.43 52.58 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.886 0.374 . . . . 0.0 111.506 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 35.7 mt -118.48 125.73 27.64 Favored Pre-proline 0 C--N 1.333 -0.132 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.155 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.445 ' HG2' ' CB ' ' A' ' 238' ' ' GLU . 9.8 Cg_endo -54.3 146.13 52.16 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 121.461 1.44 . . . . 0.0 110.072 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -55.98 -40.25 73.01 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.48 -44.13 95.27 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.897 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.445 ' CB ' ' HG2' ' A' ' 235' ' ' PRO . 84.3 tt0 -67.43 -38.14 84.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.038 0.447 . . . . 0.0 110.645 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -58.95 -40.71 85.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.998 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -60.38 -40.38 90.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.082 0.468 . . . . 0.0 110.661 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -61.52 -36.58 80.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.267 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 291' ' ' TYR . 69.5 p -31.31 -75.57 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 80.61 47.77 6.6 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.918 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 16.8 tttp -58.77 138.54 57.09 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 122.449 0.299 . . . . 0.0 110.785 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.41 161.52 21.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -96.03 131.24 42.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.82 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.647 HG12 HG12 ' A' ' 315' ' ' ILE . 59.9 t -124.02 139.97 48.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.482 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.66 -174.32 13.79 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . 0.456 ' O ' ' CG2' ' A' ' 313' ' ' ILE . . . 79.98 57.14 3.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 119.765 -1.207 . . . . 0.0 112.882 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 31.6 mm -104.41 129.41 56.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.438 ' O ' ' CG1' ' A' ' 254' ' ' VAL . . . -107.81 169.25 14.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.004 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.39 141.54 89.35 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.454 2.103 . . . . 0.0 112.622 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 55.76 42.45 29.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.254 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.51 ' O ' ' HB2' ' A' ' 258' ' ' GLU . 2.5 m -73.15 -35.79 48.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.675 0.274 . . . . 0.0 110.916 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.21 124.29 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.09 -28.68 51.94 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 121.867 1.711 . . . . 0.0 111.9 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -60.75 -42.94 98.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.015 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 96.7 mt-10 -66.21 -39.4 89.58 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.925 0.393 . . . . 0.0 111.128 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.578 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 37.1 t80 -64.9 -46.75 80.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.385 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.47 -40.58 95.97 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.717 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.471 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 21.1 pt-20 -76.3 -29.71 57.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 110.391 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.602 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 18.3 t80 -61.53 -57.2 13.08 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.944 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.578 ' CZ ' ' CG2' ' A' ' 247' ' ' VAL . 7.4 m-85 -67.41 -27.22 66.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.106 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.586 ' N ' HD13 ' A' ' 269' ' ' ILE . 34.8 m -54.53 -27.24 36.89 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -46.77 -38.21 9.74 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.348 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.664 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 19.9 p90 -126.66 42.66 3.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.09 0.471 . . . . 0.0 111.269 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 264' ' ' SER . . . 162.71 154.17 7.49 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.756 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.9 m -61.27 -35.6 77.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.888 0.375 . . . . 0.0 111.593 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.586 HD13 ' N ' ' A' ' 264' ' ' SER . 2.5 mt 69.39 80.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.633 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.513 ' CD1' ' HB3' ' A' ' 292' ' ' ASP . 34.4 mm -59.85 -41.75 86.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.51 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -157.86 86.48 0.91 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -105.23 130.59 53.34 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -147.39 155.82 42.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.334 0.588 . . . . 0.0 112.506 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.575 ' O ' ' HB2' ' A' ' 275' ' ' MET . 34.5 tp -65.08 -36.98 86.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.825 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.575 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 95.7 mmm 81.24 119.92 0.05 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.329 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 25.4 mt -127.03 129.03 47.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.598 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -62.24 -39.57 93.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.616 0.722 . . . . 0.0 109.599 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -161.77 -46.94 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.907 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -131.19 -79.93 0.53 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.653 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 68.7 p -116.3 13.36 15.57 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.891 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -49.87 -81.54 0.05 OUTLIER Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.419 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 286' ' ' PHE . 68.8 mm-40 -83.97 6.38 22.12 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 122.781 0.433 . . . . 0.0 110.791 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.422 ' O ' ' CD2' ' A' ' 274' ' ' LEU . 22.8 t -56.95 -31.57 65.13 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.233 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 20.9 ptp180 -130.27 158.17 40.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.399 0.618 . . . . 0.0 111.902 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.68 -34.79 5.39 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.048 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 18.1 p90 -155.27 164.28 39.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 117.286 0.543 . . . . 0.0 111.768 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -135.13 150.92 20.32 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.121 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.487 ' CD2' ' CE ' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -112.26 125.61 54.35 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.859 -0.201 . . . . 0.0 111.483 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.578 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 60.5 t -130.22 137.43 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 27.8 m -119.32 137.54 53.64 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 242' ' ' THR . 43.7 m-85 -114.44 142.25 46.61 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.513 ' HB3' ' CD1' ' A' ' 270' ' ' ILE . 27.7 p-10 -62.63 -33.9 75.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.03 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' SER . . . . . 0.421 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 50.9 m -123.46 144.49 49.49 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.308 0.575 . . . . 0.0 111.719 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.4 -28.86 68.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.209 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 296' ' ' ALA . 52.4 p30 -60.27 -33.3 72.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.661 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.566 ' N ' ' OD1' ' A' ' 295' ' ' ASP . . . -61.33 -36.85 81.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.083 0.468 . . . . 0.0 110.368 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 300' ' ' VAL . 83.2 t -62.06 -42.51 95.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.089 0.471 . . . . 0.0 110.442 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -61.43 -38.09 85.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.624 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -59.39 -43.77 92.88 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.942 0.401 . . . . 0.0 111.73 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.664 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 0.7 OUTLIER -72.16 -34.91 51.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.368 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 85.5 m -59.07 -45.65 90.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.164 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -62.63 -39.17 92.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.253 0.549 . . . . 0.0 110.089 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -62.53 -32.9 73.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.744 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.63 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 7.1 tptt 69.2 -72.76 0.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.659 ' HB3' ' HB3' ' A' ' 312' ' ' LYS . 3.8 m-30 -114.76 142.62 46.28 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.576 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.536 HD13 ' CH2' ' A' ' 266' ' ' TRP . 6.8 mt -120.11 133.73 65.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -75.37 80.65 2.44 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.183 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.602 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 11.7 t80 -76.9 -57.68 3.71 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.775 0.798 . . . . 0.0 109.869 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.444 ' HE3' ' CE2' ' A' ' 308' ' ' PHE . 9.3 mmpt? -109.87 -165.04 0.97 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.453 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -55.2 -23.45 22.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.758 0.313 . . . . 0.0 110.478 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -118.59 159.68 23.15 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.014 0.435 . . . . 0.0 111.558 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.659 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 78.5 mttt -76.58 147.96 37.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.818 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 23.4 pt -118.16 151.4 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . 0.6 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 81.9 mt-10 -106.6 135.72 47.63 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.259 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.647 HG12 HG12 ' A' ' 247' ' ' VAL . 72.1 mt -120.51 126.91 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 120.927 0.394 . . . . 0.0 110.977 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm -128.43 154.54 45.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.147 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 40.9 ptt85 -55.47 147.91 16.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.352 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.97 139.57 58.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.143 0.497 . . . . 0.0 111.407 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.173 179.575 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 121.274 0.559 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.421 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 68.1 tttt -69.58 140.3 53.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.506 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.447 ' N ' ' O ' ' A' ' 205' ' ' LEU . 86.4 mmm -115.03 147.95 39.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.78 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.635 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 5.6 t80 -108.71 130.97 55.36 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.583 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 16.6 mm -111.65 127.82 68.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.465 ' O ' ' HB ' ' A' ' 228' ' ' ILE . . . -133.85 165.34 24.28 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.795 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.74 28.68 60.62 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.254 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 201' ' ' GLY . 66.1 mt -86.99 139.62 30.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.883 0.373 . . . . 0.0 110.744 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.546 ' O ' ' N ' ' A' ' 169' ' ' ASP . 30.3 t30 -65.48 136.39 56.38 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.479 ' CD1' ' O ' ' A' ' 199' ' ' SER . 6.2 m0 -60.27 75.95 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 167' ' ' ASN . 58.4 t0 178.28 -22.31 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.656 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 88.8 m -65.07 138.53 58.38 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.182 0.515 . . . . 0.0 111.038 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 p -115.96 166.37 12.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.923 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 188' ' ' LEU . 53.1 mp0 -58.34 -28.91 65.52 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.765 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.1 m-20 -58.07 -43.46 86.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.846 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -65.99 -38.41 88.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.607 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.486 HD21 ' CE2' ' A' ' 179' ' ' PHE . 4.7 mt -61.65 -42.71 99.27 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.765 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -66.04 -38.22 87.82 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.798 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.439 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 97.1 mt-10 -69.55 -43.43 72.96 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.124 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.522 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 56.2 t80 -67.22 -48.66 67.16 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.477 0.656 . . . . 0.0 111.603 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.559 ' CG ' ' CD1' ' A' ' 205' ' ' LEU . 94.9 m-85 -91.75 -1.59 57.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.128 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -57.95 -29.15 61.71 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.22 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.817 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -57.05 -40.49 76.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.19 -0.505 . . . . 0.0 110.841 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.817 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 78.1 m-85 -70.34 -34.97 73.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.122 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 178.74 -173.88 46.12 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 119.938 -1.125 . . . . 0.0 113.652 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.6 m -62.38 -30.69 71.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.13 -0.535 . . . . 0.0 111.178 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.638 ' CG1' ' O ' ' A' ' 185' ' ' VAL . 0.4 OUTLIER 67.47 89.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -177.399 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.461 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -56.13 -49.32 74.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.517 -177.073 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -142.45 137.68 30.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.28 0.562 . . . . 0.0 112.409 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 172' ' ' GLU . 0.2 OUTLIER -115.08 133.03 56.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.524 179.115 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 15.3 tptt -133.78 122.61 23.54 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 172' ' ' GLU . 4.7 mt -128.58 130.41 68.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.757 176.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.574 ' CE ' ' HA3' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -93.01 126.44 38.09 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -126.08 152.85 45.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.972 0.415 . . . . 0.0 111.933 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.625 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 4.6 m-20 -122.72 68.87 33.62 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.885 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.9 -24.99 80.56 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.925 2.417 . . . . 0.0 113.098 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -60.98 -47.38 86.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.929 0.395 . . . . 0.0 111.265 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 55.2 p -96.83 -4.04 41.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.235 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 76.68 24.97 66.12 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.619 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.625 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 5.9 tpt180 -121.83 159.84 25.91 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.479 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 97.8 p -128.32 154.16 46.23 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.21 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.555 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 4.9 mpt_? -55.76 -35.63 66.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.362 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 166' ' ' LEU . . . 86.8 5.06 81.81 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.59 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.583 ' HB2' ' O ' ' A' ' 163' ' ' ILE . 39.6 p90 -144.93 157.31 44.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.864 0.364 . . . . 0.0 110.647 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.574 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -150.45 166.45 30.15 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.015 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 162' ' ' PHE . 95.4 m-85 -105.92 127.19 52.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.16 0.505 . . . . 0.0 109.89 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.586 HD23 ' CZ ' ' A' ' 207' ' ' PHE . 6.3 tt -108.45 130.45 55.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.942 -178.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.474 ' N ' HD22 ' A' ' 205' ' ' LEU . 54.9 m -120.84 140.3 51.95 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.724 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.586 ' CZ ' HD23 ' A' ' 205' ' ' LEU . 84.9 m-85 -121.05 142.74 49.54 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.395 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.461 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.5 tt0 -63.36 -35.38 80.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.195 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.42 119.27 47.18 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.92 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -56.84 -28.21 75.83 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.609 2.206 . . . . 0.0 113.102 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.6 m -58.67 -35.42 72.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.383 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.407 ' OG ' ' CG ' ' A' ' 207' ' ' PHE . 87.2 p -61.13 -30.15 70.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.92 0.391 . . . . 0.0 110.725 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.71 -39.2 83.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.167 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -56.38 -41.85 76.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.847 0.356 . . . . 0.0 111.238 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.36 -34.77 77.99 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.774 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 94.2 t -63.06 -45.3 99.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.073 0.463 . . . . 0.0 111.31 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 52.8 t -70.09 -43.42 79.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -59.39 -35.99 74.99 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.429 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 61.9 m -98.05 143.73 28.3 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -76.13 147.61 38.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.774 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 35.8 m-70 -126.31 132.38 51.65 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 226' ' ' LYS . 68.3 mt -122.2 115.24 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.3 tt -121.78 127.11 50.26 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.515 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 54.45 42.52 31.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.999 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 73.91 18.32 79.59 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.005 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 222' ' ' ILE . 0.5 OUTLIER -128.21 153.46 46.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.801 0.301 . . . . 0.0 110.893 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.13 130.34 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.983 0.42 . . . . 0.0 110.259 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 164' ' ' GLY . 34.5 pt -127.19 159.54 37.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.796 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -128.27 79.73 73.52 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.217 0.532 . . . . 0.0 111.037 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.481 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 37.3 Cg_exo -60.36 126.97 21.44 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 123.176 2.584 . . . . 0.0 111.687 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 12.4 mtmm -132.7 156.55 46.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.846 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -58.92 136.46 57.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.935 0.398 . . . . 0.0 111.608 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.99 143.9 56.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.089 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.76 124.57 30.26 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.803 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.402 ' HG2' ' CG ' ' A' ' 238' ' ' GLU . 10.4 Cg_endo -53.93 151.06 28.14 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 121.987 1.791 . . . . 0.0 110.643 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -54.29 -37.21 64.51 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -60.25 -43.53 96.03 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.964 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.402 ' CG ' ' HG2' ' A' ' 235' ' ' PRO . 97.7 mt-10 -72.6 -38.66 67.77 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.313 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -60.86 -39.38 88.95 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.844 0.354 . . . . 0.0 110.691 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -62.69 -40.35 96.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.171 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -60.19 -38.18 82.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.811 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 25.7 p -82.55 161.46 22.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.009 0.433 . . . . 0.0 111.55 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -154.02 114.79 0.64 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.961 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.459 ' NZ ' ' CE2' ' A' ' 288' ' ' PHE . 19.8 ttpp -85.77 134.33 33.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.645 0.259 . . . . 0.0 111.134 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.63 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -118.42 163.24 15.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.479 0.657 . . . . 0.0 111.407 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.446 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 91.8 t80 -103.41 137.44 41.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.765 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.524 HG12 ' CE1' ' A' ' 259' ' ' PHE . 10.8 p -131.35 146.87 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.878 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.511 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -129.83 172.09 20.15 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 84.65 28.74 31.5 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.086 -1.054 . . . . 0.0 112.508 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.438 HD12 ' CE1' ' A' ' 259' ' ' PHE . 68.1 mt -110.52 133.0 57.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.819 0.342 . . . . 0.0 110.575 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -123.03 172.2 15.88 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.392 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . 0.408 ' HG3' ' NE ' ' A' ' 284' ' ' ARG . 51.6 Cg_exo -53.78 -31.06 59.88 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.054 1.836 . . . . 0.0 111.667 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -60.15 -36.58 77.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.156 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 258' ' ' GLU . 25.5 t -58.13 -45.1 88.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.486 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 254' ' ' VAL . 2.0 mmm180 60.97 141.84 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.28 -28.31 52.04 Favored 'Trans proline' 0 CA--C 1.528 0.189 0 C-N-CA 122.033 1.822 . . . . 0.0 112.919 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -61.69 -45.96 91.74 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 97.6 mt-10 -69.05 -38.39 79.09 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.171 0.51 . . . . 0.0 111.691 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.665 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 20.3 t80 -61.23 -47.19 87.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.805 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.21 -41.84 94.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.601 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.402 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.8 pt-20 -75.05 -34.09 61.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.919 0.39 . . . . 0.0 111.211 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.534 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 16.4 t80 -62.2 -55.0 32.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.063 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.528 ' HA ' ' CZ3' ' A' ' 266' ' ' TRP . 4.5 m-85 -67.92 -23.62 65.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.074 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.465 ' CA ' HD13 ' A' ' 269' ' ' ILE . 23.2 t -55.91 -31.38 62.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.818 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -53.64 -35.79 61.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.644 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.644 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 11.3 p90 -115.89 48.69 1.19 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.363 0.601 . . . . 0.0 111.148 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.569 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 148.39 146.18 4.29 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.671 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.409 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 45.2 m -59.41 -37.47 78.1 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.519 HD12 ' CB ' ' A' ' 263' ' ' PHE . 74.2 mt 69.7 83.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.417 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.48 ' CD1' ' HB2' ' A' ' 292' ' ' ASP . 32.1 mm -57.25 -43.59 82.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.543 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -161.63 93.1 0.9 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -103.32 134.65 46.34 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 178.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -143.63 155.47 44.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.467 0.651 . . . . 0.0 112.331 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.587 ' O ' ' HB2' ' A' ' 275' ' ' MET . 32.7 tp -64.3 -38.41 90.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.364 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.587 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 93.6 mmm 95.0 115.48 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.466 0.706 . . . . 0.0 110.966 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 29.7 mt -120.42 116.68 25.94 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.931 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -64.05 -38.98 93.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.778 0.799 . . . . 0.0 109.179 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -150.39 -49.38 0.13 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.583 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 280' ' ' THR . 35.5 p-10 -150.38 -54.32 0.15 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.874 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.4 ' N ' ' OD1' ' A' ' 279' ' ' ASP . 64.4 p -126.49 14.17 7.63 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -56.74 -80.93 0.07 OUTLIER Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.64 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 286' ' ' PHE . 78.4 mm-40 -83.38 3.21 32.75 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.562 0.345 . . . . 0.0 110.532 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.442 ' HB2' HD22 ' A' ' 274' ' ' LEU . 86.4 p -61.35 -26.31 67.73 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.619 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.408 ' NE ' ' HG3' ' A' ' 252' ' ' PRO . 98.2 mtt180 -119.38 146.4 45.37 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.145 0.497 . . . . 0.0 111.85 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.95 -43.39 1.8 Allowed Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.505 -0.77 . . . . 0.0 114.327 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 23.2 p90 -149.29 165.13 32.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.914 0.857 . . . . 0.0 112.732 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.465 ' O ' HG11 ' A' ' 247' ' ' VAL . . . -135.12 161.13 24.56 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.752 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.459 ' CE2' ' NZ ' ' A' ' 244' ' ' LYS . 0.2 OUTLIER -118.05 126.95 53.28 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.498 0.185 . . . . 0.0 111.498 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.665 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 60.1 t -124.87 136.02 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.017 0.436 . . . . 0.0 111.685 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 50.4 m -114.72 134.65 54.92 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.569 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 30.4 m-85 -114.74 137.01 52.44 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.48 ' HB2' ' CD1' ' A' ' 270' ' ' ILE . 52.5 t0 -56.73 -36.14 69.37 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.027 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 31.0 t -122.33 139.35 53.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.498 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . 0.458 ' O ' HG11 ' A' ' 297' ' ' VAL . . . -64.27 -30.05 71.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.985 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -54.96 -35.08 63.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.491 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.37 79.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.616 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 294' ' ' ALA . 7.0 p -59.2 -37.66 69.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.824 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . 0.437 ' N ' HG11 ' A' ' 297' ' ' VAL . 56.0 t0 -62.37 -37.7 86.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.305 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -58.65 -43.23 89.73 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.636 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.644 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 0.9 OUTLIER -70.58 -35.52 61.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.696 -179.127 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . 0.418 ' N ' HG11 ' A' ' 300' ' ' VAL . 75.2 m -60.28 -44.04 95.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.86 0.362 . . . . 0.0 110.579 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.69 -33.93 74.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.189 0.518 . . . . 0.0 110.175 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.623 ' O ' ' N ' ' A' ' 305' ' ' PHE . 80.6 m-20 -85.66 5.36 32.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.943 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.669 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 13.4 tptt 37.62 -81.57 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.719 0.407 . . . . 0.0 111.03 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.669 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 2.7 m-30 -108.52 143.86 36.95 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.856 0.36 . . . . 0.0 110.23 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.593 HD11 ' CZ3' ' A' ' 266' ' ' TRP . 25.3 mt -118.0 138.04 49.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.142 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.544 ' OD1' ' O ' ' A' ' 307' ' ' ASP . 51.0 p30 -75.34 114.36 13.78 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.017 0.437 . . . . 0.0 109.951 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.534 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 1.9 t80 -106.16 -109.37 0.29 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.435 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 1.5 mmpt? -59.38 -37.24 77.45 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.933 0.397 . . . . 0.0 111.896 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -179.6 -27.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.889 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 60.5 mtp85 -112.67 153.85 27.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.989 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.446 ' CG ' ' HB3' ' A' ' 305' ' ' PHE . 2.1 tptm -72.17 139.89 48.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.975 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 35.9 pt -115.46 152.09 17.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.884 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -100.71 132.17 46.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.017 0.437 . . . . 0.0 110.908 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.46 HG12 HG21 ' A' ' 247' ' ' VAL . 74.5 mt -120.35 128.45 75.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.819 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -132.85 147.18 52.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.916 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -50.97 149.65 3.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.712 0.291 . . . . 0.0 110.435 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.36 141.6 35.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.07 0.462 . . . . 0.0 111.417 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.992 -179.816 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 20.0 p . . . . . 0 CA--C 1.531 0.217 0 CA-C-O 120.489 0.185 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -64.33 139.59 58.78 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.908 0.385 . . . . 0.0 110.682 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.621 ' O ' ' HA ' ' A' ' 204' ' ' PHE . 91.2 mtp -115.61 151.1 35.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.827 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.603 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 3.5 t80 -104.88 127.44 52.71 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.452 ' O ' ' CB ' ' A' ' 202' ' ' PHE . 13.4 mt -121.68 127.12 75.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.797 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 202' ' ' PHE . . . -117.9 149.03 18.57 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.43 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.51 36.26 39.0 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.458 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.592 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 74.5 mt -59.1 -34.33 71.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.682 ' O ' ' N ' ' A' ' 169' ' ' ASP . 26.4 t30 101.8 37.34 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.481 ' CZ3' ' NH2' ' A' ' 198' ' ' ARG . 9.3 m0 40.91 -68.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.382 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.682 ' N ' ' O ' ' A' ' 167' ' ' ASN . 92.5 m-20 -55.37 -30.0 59.52 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.629 ' O ' ' ND2' ' A' ' 174' ' ' ASN . 86.7 m -44.39 -36.03 2.66 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.0 OUTLIER 54.88 165.06 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.726 -0.609 . . . . 0.0 110.969 -179.154 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.469 ' HG3' HG13 ' A' ' 190' ' ' ILE . 53.7 mp0 -63.49 -35.79 81.62 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 174' ' ' ASN . 54.4 p30 -61.68 -39.2 90.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.629 ' ND2' ' O ' ' A' ' 170' ' ' THR . 63.9 m-80 -64.7 -37.6 88.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.465 HD23 HG21 ' A' ' 170' ' ' THR . 3.6 mm? -62.85 -39.9 95.81 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 120.919 0.39 . . . . 0.0 111.192 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 180' ' ' GLY . 69.9 ttp85 -56.53 -41.89 77.54 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.08 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -68.28 -43.6 77.38 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.346 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.477 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 61.4 t80 -65.14 -46.38 81.18 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.87 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.481 ' CG ' ' CD1' ' A' ' 205' ' ' LEU . 78.3 m-85 -91.64 -3.66 56.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.072 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -60.42 -31.15 73.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.294 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.477 ' HD3' ' O ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -57.69 -41.15 81.05 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.512 0.673 . . . . 0.0 110.841 -179.136 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -67.08 -33.44 75.5 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.14 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.64 -177.2 47.11 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.91 -1.138 . . . . 0.0 113.354 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 44.2 m -61.6 -31.56 71.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.289 -0.456 . . . . 0.0 110.72 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.491 ' CG1' ' O ' ' A' ' 185' ' ' VAL . 0.9 OUTLIER 65.19 95.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -178.031 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.469 ' O ' ' OD1' ' A' ' 187' ' ' ASP . 2.3 t -63.55 -45.57 89.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.084 -178.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 186' ' ' THR . 91.5 m-20 -141.65 153.86 44.99 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.426 ' CD2' HG12 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -129.55 129.77 44.89 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.312 178.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 19.4 tptt -136.48 116.73 13.54 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.469 HG13 ' HG3' ' A' ' 172' ' ' GLU . 86.0 mt -127.64 131.0 70.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.728 174.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.503 ' SD ' ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -78.23 99.07 6.11 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.76 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 41.8 pttt -89.36 153.02 21.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.048 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 1.3 m-20 -124.72 78.77 63.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.251 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.77 -24.69 64.96 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.41 2.073 . . . . 0.0 112.132 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.01 -74.65 0.18 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.456 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.1 p -68.2 -27.72 66.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.578 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.38 7.88 64.84 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.696 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.493 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 0.8 OUTLIER -122.87 121.48 36.32 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 117.651 0.725 . . . . 0.0 111.313 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 56.6 m -75.64 161.06 29.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.684 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.543 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -55.45 -33.46 63.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.858 178.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 96.3 -5.24 65.21 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.014 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.543 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 35.5 p90 -134.2 154.34 51.3 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.456 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -146.38 167.71 27.95 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.12 -1.038 . . . . 0.0 112.412 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.621 ' HA ' ' O ' ' A' ' 161' ' ' MET . 89.1 m-85 -108.59 125.83 52.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.526 HD23 ' CZ ' ' A' ' 207' ' ' PHE . 7.4 tt -109.13 131.84 54.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.161 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.43 ' N ' HD22 ' A' ' 205' ' ' LEU . 22.8 t -120.71 135.86 55.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.9 0.381 . . . . 0.0 111.8 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.526 ' CZ ' HD23 ' A' ' 205' ' ' LEU . 87.2 m-85 -116.69 143.65 45.39 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.681 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -60.94 -34.57 74.92 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -114.23 115.73 44.91 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.211 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.74 -23.56 41.96 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.547 2.165 . . . . 0.0 113.171 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.566 ' O ' ' OE1' ' A' ' 215' ' ' GLU . 23.3 t -57.79 -38.15 74.97 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.499 ' HA ' ' OE1' ' A' ' 215' ' ' GLU . 24.0 m -56.97 -34.37 68.01 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.911 0.386 . . . . 0.0 110.314 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.462 HG13 ' HD3' ' A' ' 232' ' ' ARG . 85.0 t -60.35 -39.26 80.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.312 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.432 ' O ' ' HG3' ' A' ' 218' ' ' LYS . 92.9 m-20 -57.37 -41.2 79.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.403 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.566 ' OE1' ' O ' ' A' ' 211' ' ' SER . 47.6 mp0 -65.44 -35.74 81.82 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.076 0.465 . . . . 0.0 111.788 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.753 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 85.5 t -59.96 -44.01 93.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.964 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 22.3 m -73.24 -35.51 47.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 214' ' ' ASP . 56.0 mtmt -60.09 -30.31 69.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 79.3 m -110.98 144.76 39.57 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -78.8 145.02 34.55 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.753 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 44.2 m-70 -120.96 129.51 53.46 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 68.3 mt -121.98 113.25 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.0 tt -122.23 124.06 42.93 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.163 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 53.29 42.48 32.08 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.85 9.2 87.01 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.719 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -123.66 150.41 44.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.897 0.379 . . . . 0.0 111.32 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.24 132.83 52.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.377 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.409 HG13 ' HD3' ' A' ' 230' ' ' PRO . 34.7 pt -123.82 159.13 29.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.517 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.74 82.05 64.49 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.425 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.588 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 73.4 Cg_exo -55.23 130.82 42.71 Favored 'Trans proline' 0 CA--C 1.528 0.195 0 C-N-CA 122.998 2.465 . . . . 0.0 112.189 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt -139.75 144.16 37.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.579 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.462 ' HD3' HG13 ' A' ' 213' ' ' VAL . 56.1 mmm-85 -52.58 142.71 17.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.015 0.436 . . . . 0.0 111.051 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.03 143.62 52.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.654 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -115.44 123.31 31.67 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.536 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.451 ' HD2' ' OE1' ' A' ' 238' ' ' GLU . 78.2 Cg_exo -50.36 148.7 14.08 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 121.908 1.738 . . . . 0.0 110.996 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -53.7 -39.89 65.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.592 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 54.5 p30 -64.42 -37.57 87.99 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.914 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.592 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 94.9 mt-10 -68.23 -36.38 79.39 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.264 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -60.01 -37.29 79.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.911 0.386 . . . . 0.0 110.342 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -60.4 -39.43 87.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.631 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -60.5 -36.21 77.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.117 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 20.6 p -89.09 162.92 15.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.445 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.27 167.3 24.75 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.907 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.552 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 6.6 tptm -133.69 133.31 41.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.796 0.298 . . . . 0.0 110.591 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.438 HD11 HG13 ' A' ' 300' ' ' VAL . 5.7 pt -123.87 157.15 30.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.345 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.429 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 88.9 t80 -97.27 131.0 44.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.926 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.626 ' CG2' ' CZ ' ' A' ' 263' ' ' PHE . 26.7 t -123.58 137.37 57.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.883 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.501 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -127.22 173.95 18.42 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.278 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 81.35 34.75 25.17 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.062 -1.066 . . . . 0.0 111.628 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.402 ' CG2' ' CG2' ' A' ' 254' ' ' VAL . 64.2 mt -110.52 130.82 63.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.698 0.285 . . . . 0.0 110.65 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.47 ' O ' ' CG2' ' A' ' 254' ' ' VAL . . . -165.12 -107.54 0.2 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.184 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -62.2 137.7 67.72 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.522 2.148 . . . . 0.0 113.465 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 52.03 42.85 30.66 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.266 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 251' ' ' GLY . 18.8 m -121.68 27.17 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.437 ' HB2' ' OE1' ' A' ' 258' ' ' GLU . 3.2 mmt180 -41.62 155.91 0.22 Allowed Pre-proline 0 N--CA 1.462 0.163 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -50.93 -28.01 22.63 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.011 1.808 . . . . 0.0 112.177 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -61.81 -47.15 86.41 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.004 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.465 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 54.8 mp0 -69.76 -40.17 76.26 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.85 0.357 . . . . 0.0 111.431 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.511 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 48.8 t80 -65.05 -46.69 80.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.117 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.33 -40.87 96.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.965 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.465 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.8 pt-20 -74.55 -32.6 62.49 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.974 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.735 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 78.3 t80 -59.93 -58.41 8.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.225 0.536 . . . . 0.0 111.713 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.683 ' CD1' ' HD2' ' A' ' 262' ' ' PHE . 33.0 m-85 -66.78 -24.62 66.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.828 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.491 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 34.6 t -55.7 -24.21 33.23 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -47.01 -38.76 11.34 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.063 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.645 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 23.0 p90 -132.34 53.6 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.086 0.47 . . . . 0.0 111.574 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.526 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 153.34 148.89 5.02 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.937 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.427 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 56.7 m -59.88 -37.09 78.35 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.514 HD12 ' CB ' ' A' ' 263' ' ' PHE . 72.1 mt 69.74 78.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.223 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.489 HG12 ' CA ' ' A' ' 292' ' ' ASP . 33.6 mm -59.0 -44.51 91.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.961 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 270' ' ' ILE . 75.8 m-20 -153.51 86.99 1.22 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -103.27 135.99 43.88 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -141.66 151.1 42.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.498 0.665 . . . . 0.0 112.125 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.556 ' CD2' ' HB2' ' A' ' 283' ' ' SER . 37.1 tp -67.14 -34.89 78.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.625 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.612 ' HE1' ' HB2' ' A' ' 288' ' ' PHE . 2.9 ttm 86.46 145.8 0.06 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.008 0.523 . . . . 0.0 110.624 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.555 ' CB ' ' HA ' ' A' ' 280' ' ' THR . 0.5 OUTLIER 174.41 87.18 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 120.641 0.258 . . . . 0.0 111.048 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.01 -42.16 89.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.868 0.366 . . . . 0.0 110.656 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . 0.446 ' O ' ' OD1' ' A' ' 279' ' ' ASP . 50.5 mttt -139.51 133.88 31.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.666 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 278' ' ' LYS . 44.1 p30 30.12 44.51 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.555 ' HA ' ' CB ' ' A' ' 276' ' ' LEU . 1.3 p 70.23 29.52 3.66 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 278' ' ' LYS . . . -66.29 -58.72 8.25 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.246 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 286' ' ' PHE . 97.4 mm-40 -64.04 -29.85 70.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.834 0.35 . . . . 0.0 111.353 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.556 ' HB2' ' CD2' ' A' ' 274' ' ' LEU . 87.0 p -56.55 -27.82 58.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.712 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -87.3 126.9 35.13 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.02 0.438 . . . . 0.0 111.537 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.14 -37.1 3.52 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 114.989 0.755 . . . . 0.0 114.989 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.545 ' CE2' ' CE ' ' A' ' 275' ' ' MET . 12.3 p90 -147.23 162.6 38.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.415 1.107 . . . . 0.0 112.733 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -143.25 163.91 27.36 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 121.102 -0.57 . . . . 0.0 113.264 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.612 ' HB2' ' HE1' ' A' ' 275' ' ' MET . 0.3 OUTLIER -113.5 132.38 55.7 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.511 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 42.6 t -123.74 136.09 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 35.8 m -118.39 136.99 53.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.509 178.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.526 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 30.7 m-85 -120.65 140.56 51.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.489 ' CA ' HG12 ' A' ' 270' ' ' ILE . 51.3 t0 -57.88 -36.28 72.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.307 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 93.7 p -125.86 149.19 48.86 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.331 0.586 . . . . 0.0 111.784 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.96 -29.68 69.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.18 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -56.16 -38.23 70.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.333 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.405 ' O ' ' CD1' ' A' ' 266' ' ' TRP . . . -61.38 -37.51 83.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.055 0.455 . . . . 0.0 110.468 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 77.1 t -61.91 -44.62 99.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.713 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -61.82 -37.6 85.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.346 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -58.42 -43.4 88.66 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.645 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 0.5 OUTLIER -73.18 -32.04 36.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.915 0.388 . . . . 0.0 111.152 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 91.6 m -54.97 -44.55 74.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.046 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -62.76 -40.07 96.12 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.003 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.44 ' O ' ' N ' ' A' ' 305' ' ' PHE . 86.1 m-20 -63.98 -36.22 83.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.518 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.648 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 19.1 tptm 66.57 -67.84 0.15 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.792 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.648 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 20.9 m-85 -115.87 136.24 53.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.235 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.501 ' CG2' ' HZ ' ' A' ' 262' ' ' PHE . 30.0 mt -121.55 137.97 53.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.965 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 307' ' ' ASP . 52.6 p30 -78.99 85.46 4.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.977 0.417 . . . . 0.0 111.199 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.735 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 4.1 t80 -79.36 -71.78 0.43 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.478 ' HE3' ' CE1' ' A' ' 308' ' ' PHE . 8.1 mmpt? -104.56 -145.56 0.38 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.151 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.483 ' OD1' ' HG3' ' A' ' 311' ' ' ARG . 54.5 p30 -81.59 2.48 29.07 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.13 0.49 . . . . 0.0 109.952 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.483 ' HG3' ' OD1' ' A' ' 310' ' ' ASP . 94.0 mtt-85 -126.24 149.16 49.27 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.577 ' HG2' ' HB3' ' A' ' 305' ' ' PHE . 11.3 tttp -80.02 137.2 36.76 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 21.7 pt -105.01 135.85 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.82 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . 0.421 ' HB2' ' CE2' ' A' ' 305' ' ' PHE . 84.6 tt0 -102.15 130.31 48.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.812 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.484 HD12 ' CZ ' ' A' ' 263' ' ' PHE . 67.5 mt -119.34 128.54 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-O 121.024 0.44 . . . . 0.0 111.125 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -130.91 144.19 51.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.253 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -51.85 138.05 24.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.93 0.395 . . . . 0.0 110.424 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 244' ' ' LYS . . . -64.68 145.27 56.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.004 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.614 179.129 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 20.5 m . . . . . 0 CA--C 1.529 0.155 0 N-CA-C 111.544 0.201 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -64.45 137.46 57.89 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.428 0.632 . . . . 0.0 111.458 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 205' ' ' LEU . 85.2 mmm -117.2 151.79 36.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.215 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.569 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 5.9 t80 -106.13 129.31 54.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 203' ' ' GLY . 12.9 mm -116.45 127.61 74.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -130.45 163.97 23.05 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.492 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.88 28.58 64.55 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.809 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 74.3 mt -86.7 142.15 28.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.782 0.325 . . . . 0.0 111.604 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -64.65 135.42 55.91 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.482 ' CD1' ' O ' ' A' ' 199' ' ' SER . 4.7 m0 -52.06 -31.52 30.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.688 0.28 . . . . 0.0 111.003 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -91.17 5.41 49.17 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.614 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.52 ' O ' ' O ' ' A' ' 171' ' ' THR . 86.1 m -58.04 -40.43 80.88 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.52 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.1 OUTLIER 53.16 157.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.189 0.519 . . . . 0.0 110.1 -177.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.5 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 97.4 mt-10 -62.41 -26.78 68.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.704 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.645 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 93.0 m-20 -53.53 -42.85 67.87 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.464 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -68.09 -38.0 81.85 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.4 HD21 ' CD2' ' A' ' 179' ' ' PHE . 5.1 mt -59.69 -47.6 85.0 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.645 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -68.02 -37.2 81.11 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.194 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.41 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 48.5 tp10 -67.76 -45.51 74.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.866 0.365 . . . . 0.0 110.421 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.654 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 72.2 t80 -67.17 -48.28 68.44 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.767 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.47 ' CB ' HD12 ' A' ' 205' ' ' LEU . 81.3 m-85 -88.73 -4.52 58.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.185 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -58.67 -32.02 68.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.199 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -41.5 89.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.707 0.765 . . . . 0.0 109.988 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -68.55 -34.24 75.5 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.89 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -179.12 -176.84 47.21 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.247 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.509 ' O ' HG21 ' A' ' 185' ' ' VAL . 49.0 m -63.3 -30.09 71.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.518 -0.341 . . . . 0.0 111.559 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.652 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 0.6 OUTLIER 64.85 83.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 122.355 1.074 . . . . 0.0 108.478 -177.309 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.476 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -53.13 -47.74 68.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.723 -177.097 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 186' ' ' THR . 92.2 m-20 -138.95 156.08 47.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.213 0.53 . . . . 0.0 112.391 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.77 136.78 46.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.876 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.574 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 7.8 tptt -142.79 66.05 1.33 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.584 0.231 . . . . 0.0 111.415 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.511 ' O ' ' O ' ' A' ' 202' ' ' PHE . 8.7 tt -61.82 -19.16 20.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.59 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.658 ' CE ' ' HA3' ' A' ' 203' ' ' GLY . 10.8 mtm 64.07 131.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.741 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.519 ' HG3' ' HD3' ' A' ' 194' ' ' PRO . 6.2 pttt -132.2 156.49 46.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.958 0.408 . . . . 0.0 111.805 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 10.7 t0 -125.65 74.63 69.94 Favored Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.901 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.519 ' HD3' ' HG3' ' A' ' 192' ' ' LYS . 19.9 Cg_endo -59.98 -27.67 85.43 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.616 2.211 . . . . 0.0 112.788 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -66.81 -59.12 3.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.952 0.406 . . . . 0.0 111.366 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 65.8 p -74.27 -18.43 60.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.417 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 89.7 9.19 66.66 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.134 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 25.1 mmt85 -120.95 -179.22 3.95 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.294 0.569 . . . . 0.0 111.859 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.482 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 51.0 m -119.93 152.64 37.11 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.969 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.475 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 5.9 mpt_? -51.35 -34.87 35.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.833 0.349 . . . . 0.0 110.745 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 87.81 2.57 81.32 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.419 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.511 ' O ' ' O ' ' A' ' 190' ' ' ILE . 14.8 p90 -139.37 153.74 47.71 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.658 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -145.06 155.97 26.72 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.062 -1.066 . . . . 0.0 112.413 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.569 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 97.4 m-85 -102.88 123.37 46.4 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 161' ' ' MET . 1.6 tt -106.37 127.81 53.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.168 -177.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 186' ' ' THR . 34.5 t -115.8 133.62 55.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.765 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.436 ' CZ ' HD23 ' A' ' 205' ' ' LEU . 95.7 m-85 -116.18 136.4 53.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.408 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.476 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.5 tt0 -61.54 -33.76 74.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.136 0.493 . . . . 0.0 109.75 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -110.09 120.4 44.63 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.802 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.91 -23.06 49.17 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.522 2.148 . . . . 0.0 113.073 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.1 m -57.12 -36.76 71.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.543 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.456 ' HA ' ' OE2' ' A' ' 215' ' ' GLU . 23.0 m -58.85 -36.45 74.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.698 0.285 . . . . 0.0 110.938 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 73.4 t -62.12 -42.88 96.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.231 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -60.11 -41.76 93.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.314 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.456 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 19.3 pt-20 -73.94 -28.51 61.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.903 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.712 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 70.3 t -59.89 -42.7 90.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.638 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.2 m -73.87 -27.38 22.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -58.54 -31.38 67.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.74 0.305 . . . . 0.0 111.488 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.59 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 67.3 m -108.29 142.41 38.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.818 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 14.1 pt20 -68.51 -40.71 80.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.463 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.712 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 61.0 m-70 81.97 118.52 0.05 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 72.8 mt -114.26 106.47 20.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.9 tt -122.62 121.39 36.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.82 0.343 . . . . 0.0 110.781 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 50.14 40.31 21.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.53 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.79 11.21 84.88 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.503 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 31.6 mmtm -113.4 139.48 48.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 117.233 0.517 . . . . 0.0 111.595 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.81 ' O ' ' O ' ' A' ' 228' ' ' ILE . 17.2 m -73.61 -30.45 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.999 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.81 ' O ' ' O ' ' A' ' 227' ' ' VAL . 17.0 pt 34.42 136.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -123.7 80.87 55.22 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.171 0.51 . . . . 0.0 111.258 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.478 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 46.9 Cg_exo -59.13 126.15 20.16 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.151 2.567 . . . . 0.0 112.202 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt -134.25 153.67 51.72 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.432 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -56.06 145.29 26.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.995 0.426 . . . . 0.0 111.767 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.85 146.76 54.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.054 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . 0.416 HG13 ' OE1' ' A' ' 238' ' ' GLU . 3.2 tt -108.25 137.14 19.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.318 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.439 ' HG2' ' HG3' ' A' ' 238' ' ' GLU . 13.0 Cg_endo -55.93 143.19 83.16 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.826 1.684 . . . . 0.0 110.709 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -54.53 -36.61 64.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.739 0.304 . . . . 0.0 111.25 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.31 -41.49 84.61 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.439 ' HG3' ' HG2' ' A' ' 235' ' ' PRO . 97.4 mt-10 -68.14 -35.88 78.8 Favored 'General case' 0 C--O 1.23 0.07 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.484 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -60.82 -36.76 79.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.045 0.45 . . . . 0.0 111.039 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -58.66 -38.86 79.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.533 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 242' ' ' THR . 75.2 mmtt -87.47 -76.9 0.36 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.51 ' O ' ' O ' ' A' ' 241' ' ' LYS . 76.9 p 34.66 -165.68 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -162.97 55.62 0.29 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.728 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.532 ' CE ' ' CD2' ' A' ' 288' ' ' PHE . 7.9 tptt -73.7 121.17 20.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.692 0.282 . . . . 0.0 110.399 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.68 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -130.01 164.58 32.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.176 0.512 . . . . 0.0 110.848 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -104.91 136.57 44.16 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.316 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.506 HG12 ' CE1' ' A' ' 259' ' ' PHE . 15.0 p -130.7 144.83 36.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.719 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.642 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -130.37 170.14 21.02 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.93 21.52 35.89 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 119.889 -1.148 . . . . 0.0 112.377 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 67.0 mt -106.52 128.9 60.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.467 ' HA3' ' CA ' ' A' ' 284' ' ' ARG . . . -166.09 -115.28 0.32 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.329 -0.938 . . . . 0.0 113.272 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.43 138.63 86.86 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.334 2.023 . . . . 0.0 113.506 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 54.02 44.45 29.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.34 -0.845 . . . . 0.0 113.215 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.592 ' O ' ' HB2' ' A' ' 258' ' ' GLU . 8.8 m -109.49 -54.23 5.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.443 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 254' ' ' VAL . 13.2 mmt180 60.85 135.98 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -54.82 -31.9 74.61 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.192 1.928 . . . . 0.0 113.418 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -60.12 -45.08 94.22 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.792 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.649 ' HA ' ' HB3' ' A' ' 261' ' ' GLU . 58.6 mp0 -68.52 -33.69 74.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.828 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.604 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 13.2 t80 -61.93 -52.73 62.85 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.897 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.77 -37.14 86.24 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.649 ' HB3' ' HA ' ' A' ' 258' ' ' GLU . 81.7 tt0 -61.41 -37.74 84.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 113.824 -1.534 . . . . 0.0 111.717 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.596 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 84.3 t80 -68.93 -54.72 13.9 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.549 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 7.3 m-85 -66.04 -25.22 66.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.208 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.604 ' N ' HD13 ' A' ' 269' ' ' ILE . 86.5 p -56.32 -23.06 34.59 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -52.29 -39.68 60.82 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.298 -1.319 . . . . 0.0 113.072 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.662 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 43.9 p90 -120.87 58.33 0.95 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.543 0.687 . . . . 0.0 112.268 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 122.32 153.9 8.98 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.012 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.7 m -72.49 132.18 43.51 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.604 HD13 ' N ' ' A' ' 264' ' ' SER . 74.9 mt -93.98 126.14 46.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.711 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.619 HG21 ' HB ' ' A' ' 290' ' ' THR . 10.5 tt -65.55 -36.25 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.281 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 270' ' ' ILE . 51.2 p30 171.79 73.71 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.894 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.404 ' CB ' HG22 ' A' ' 269' ' ' ILE . . . -67.76 142.53 56.21 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.408 0.147 . . . . 0.0 111.01 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -144.03 152.16 40.64 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.581 ' O ' ' HB2' ' A' ' 275' ' ' MET . 22.3 tp -65.89 -35.87 81.85 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.087 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.581 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 93.1 mmm 99.5 -13.66 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.925 0.89 . . . . 0.0 112.574 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' A' ' 281' ' ' GLY . 0.0 OUTLIER -64.59 50.44 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.407 ' O ' ' CG2' ' A' ' 227' ' ' VAL . 21.8 t70 -59.0 -40.51 85.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.075 0.464 . . . . 0.0 110.592 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . 0.434 ' O ' ' HB3' ' A' ' 279' ' ' ASP . 37.1 mtpt -59.79 -26.92 66.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.326 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 278' ' ' LYS . 54.3 t0 80.44 38.62 0.09 Allowed 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.096 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.62 -61.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.061 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 276' ' ' LEU . . . -82.49 164.28 43.39 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.396 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 59.36 41.65 19.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.883 0.373 . . . . 0.0 110.12 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 29.8 t -127.45 142.14 51.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.896 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.467 ' CA ' ' HA3' ' A' ' 251' ' ' GLY . 60.6 mtm180 45.85 25.49 0.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.671 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -119.53 -62.85 0.27 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.039 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -139.23 164.9 28.6 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.479 ' O ' HG11 ' A' ' 247' ' ' VAL . . . -130.39 156.54 21.63 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 119.927 -1.13 . . . . 0.0 113.625 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.532 ' CD2' ' CE ' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -119.3 123.08 43.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.729 -0.236 . . . . 0.0 110.465 179.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.68 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 57.4 t -123.91 137.37 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.195 0.521 . . . . 0.0 112.105 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.619 ' HB ' HG21 ' A' ' 270' ' ' ILE . 20.8 m -120.41 138.33 53.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.407 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -114.91 138.96 50.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.145 0.498 . . . . 0.0 111.776 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 293' ' ' SER . 53.0 p30 -62.42 -30.47 71.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.928 178.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' SER . . . . . 0.55 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 51.0 m -119.76 142.65 48.36 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 121.18 0.514 . . . . 0.0 111.3 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.6 -31.83 72.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.72 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.48 -37.12 69.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.618 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.422 ' O ' ' HD1' ' A' ' 266' ' ' TRP . . . -61.15 -38.01 84.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.416 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 79.9 t -60.99 -40.01 84.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.933 0.397 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -58.08 -36.89 73.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.937 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -56.78 -43.75 81.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.987 0.422 . . . . 0.0 111.704 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.662 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 0.3 OUTLIER -76.1 -30.07 20.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.815 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 84.9 m -55.91 -45.29 78.72 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.77 -34.76 79.1 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.08 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -102.15 79.89 1.92 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.602 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.606 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 11.9 tptt -55.74 -44.59 77.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.048 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.606 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 8.5 m-85 -117.06 126.73 53.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.514 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.519 HD13 ' CH2' ' A' ' 266' ' ' TRP . 2.4 mt -121.37 139.38 48.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.228 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -78.76 113.32 16.74 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.376 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.596 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 7.0 t80 -112.3 -77.28 0.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.928 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.402 ' HG3' HG11 ' A' ' 254' ' ' VAL . 6.4 mmpt? -97.41 -167.29 1.51 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.967 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -51.84 -29.78 20.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.839 0.352 . . . . 0.0 110.486 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -105.42 144.59 31.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.05 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.532 ' HE2' ' HB3' ' A' ' 305' ' ' PHE . 10.3 tptt -70.74 142.04 51.45 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.642 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 28.8 pt -109.64 141.2 25.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.034 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . 0.509 ' HG3' ' CE1' ' A' ' 305' ' ' PHE . 85.6 tt0 -101.59 131.82 47.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.813 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.423 ' CD1' HG23 ' A' ' 300' ' ' VAL . 71.3 mt -119.91 128.29 75.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.108 0.48 . . . . 0.0 111.766 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.411 ' HE3' ' OE2' ' A' ' 314' ' ' GLU . 38.1 mttp -127.89 156.06 43.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.83 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -60.46 148.46 37.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -53.95 137.46 39.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.19 0.519 . . . . 0.0 111.611 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.649 179.927 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.965 0.412 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.455 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 79.4 tttt -87.69 134.62 33.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.88 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 5.0 tpp -120.39 147.37 45.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.648 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.626 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 5.0 t80 -100.19 129.35 46.2 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.494 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 21.8 mm -116.79 128.37 74.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.792 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -130.67 165.93 22.65 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.198 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.9 27.75 62.01 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.571 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.405 HD22 HD11 ' A' ' 228' ' ' ILE . 80.9 mt -87.41 144.28 26.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.737 0.303 . . . . 0.0 111.714 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -66.92 133.77 50.68 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.542 ' HD1' ' O ' ' A' ' 199' ' ' SER . 5.0 m-90 -50.23 -34.77 24.1 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.298 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -63.73 -20.63 65.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.5 m -50.83 139.24 17.28 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.786 0.803 . . . . 0.0 111.89 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 32.6 m -120.51 148.38 43.91 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.778 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.524 ' HG3' ' HB ' ' A' ' 190' ' ' ILE . 96.2 mt-10 -56.63 -34.84 67.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.606 0.241 . . . . 0.0 110.544 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.632 ' OD1' ' N ' ' A' ' 174' ' ' ASN . 54.9 p30 -61.46 -38.04 85.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.576 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.632 ' N ' ' OD1' ' A' ' 173' ' ' ASP . 84.0 m-20 -65.56 -36.13 82.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.159 0.504 . . . . 0.0 110.526 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.42 -48.6 68.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.273 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.495 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -64.18 -37.0 85.88 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.107 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.416 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 84.4 tt0 -65.92 -44.13 86.05 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.722 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.478 ' OH ' ' HB3' ' A' ' 221' ' ' HIS . 73.2 t80 -64.88 -46.59 81.14 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.144 0.497 . . . . 0.0 111.429 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.424 ' CG ' ' CD2' ' A' ' 205' ' ' LEU . 91.5 m-85 -91.18 1.67 56.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.255 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -60.73 -28.69 68.52 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.381 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.98 -38.05 78.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.705 0.764 . . . . 0.0 110.445 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.405 ' CD2' HG21 ' A' ' 216' ' ' VAL . 47.9 m-85 -67.31 -29.62 69.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.526 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 153.76 -124.31 1.55 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.892 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 56.8 m -117.16 139.01 51.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.432 HG22 ' CD1' ' A' ' 188' ' ' LEU . 4.8 m -109.56 126.2 66.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.685 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 206' ' ' SER . 43.9 p -75.1 -31.89 61.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.58 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.451 ' O ' HD11 ' A' ' 205' ' ' LEU . 51.5 t0 -150.6 150.01 30.63 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.451 ' CD1' ' N ' ' A' ' 188' ' ' LEU . 0.0 OUTLIER -141.49 81.45 1.78 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.013 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.548 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 8.4 tptp -79.41 119.43 22.43 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.524 ' HB ' ' HG3' ' A' ' 172' ' ' GLU . 74.0 mt -127.26 112.42 28.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 174.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.627 ' HB2' ' HD3' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -61.37 -34.43 75.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.2 -177.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.47 ' O ' ' O ' ' A' ' 191' ' ' MET . 52.2 tttm 49.6 162.79 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.438 ' N ' ' HG2' ' A' ' 192' ' ' LYS . 5.2 t70 -112.18 100.27 48.85 Favored Pre-proline 0 N--CA 1.463 0.206 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.347 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.8 -29.15 85.0 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.325 2.016 . . . . 0.0 113.165 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -78.96 -88.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.6 p -70.79 -27.11 63.66 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 193' ' ' ASP . . . 97.66 -8.28 63.78 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.204 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 199' ' ' SER . 33.3 mtm-85 -124.65 133.38 53.25 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.242 0.544 . . . . 0.0 111.849 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.56 ' O ' ' HB3' ' A' ' 200' ' ' ARG . 36.2 t 162.22 -177.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.071 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.751 ' HG2' ' H ' ' A' ' 202' ' ' PHE . 58.2 ttp85 68.52 -95.42 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.24 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 85.11 9.53 80.06 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.386 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.751 ' H ' ' HG2' ' A' ' 200' ' ' ARG . 34.5 p90 -146.14 153.53 40.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -148.65 166.59 29.22 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 119.858 -1.163 . . . . 0.0 112.209 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.626 ' CE2' ' CD1' ' A' ' 162' ' ' PHE . 89.9 m-85 -108.75 122.53 47.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.016 0.436 . . . . 0.0 110.023 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.49 ' CD2' ' CZ ' ' A' ' 207' ' ' PHE . 0.7 OUTLIER -114.75 129.55 56.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.493 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.464 ' O ' ' N ' ' A' ' 186' ' ' THR . 58.5 m -115.18 143.08 45.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.251 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.49 ' CZ ' ' CD2' ' A' ' 205' ' ' LEU . 92.5 m-85 -117.74 138.09 52.26 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.431 ' N ' ' CG2' ' A' ' 186' ' ' THR . 84.5 tt0 -63.68 -35.59 81.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.892 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.17 116.34 56.93 Favored Pre-proline 0 C--N 1.333 -0.123 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.388 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . 0.435 ' O ' HG11 ' A' ' 213' ' ' VAL . 46.4 Cg_exo -56.13 -25.01 52.71 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.241 1.96 . . . . 0.0 112.829 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.7 m -58.84 -36.25 74.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.65 0.262 . . . . 0.0 111.47 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.417 ' OG ' ' CG ' ' A' ' 207' ' ' PHE . 89.7 p -62.53 -32.7 73.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.453 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.488 HG11 ' N ' ' A' ' 214' ' ' ASP . 3.0 p -62.66 -37.2 78.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.892 0.377 . . . . 0.0 110.754 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.488 ' N ' HG11 ' A' ' 213' ' ' VAL . 54.9 t0 -61.99 -42.98 99.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.589 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 212' ' ' SER . 4.5 pt-20 -74.06 -32.34 63.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.904 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.826 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 92.7 t -63.61 -44.63 98.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.073 0.463 . . . . 0.0 110.894 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 59.1 t -68.02 -46.14 82.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 214' ' ' ASP . 47.0 mmtm -61.11 -34.51 75.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.403 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 49.2 m -88.37 144.03 26.65 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -79.74 141.41 36.37 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.826 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 55.2 m-70 -121.15 130.77 53.88 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -176.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 226' ' ' LYS . 69.0 mt -123.63 112.31 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.264 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.7 tt -119.12 127.23 53.17 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.139 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 55.05 42.46 30.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.314 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 77.62 10.95 85.91 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.56 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 222' ' ' ILE . 6.3 mptt -126.67 153.76 44.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.976 0.388 . . . . 0.0 110.753 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 43.4 t -102.25 132.8 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.917 0.389 . . . . 0.0 110.859 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.405 HD11 HD22 ' A' ' 166' ' ' LEU . 30.8 pt -125.27 159.62 32.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.377 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -126.86 82.86 66.89 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 121.13 0.49 . . . . 0.0 110.981 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.532 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 56.0 Cg_exo -56.73 128.57 30.55 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.195 2.597 . . . . 0.0 112.15 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.405 ' HE2' ' OD1' ' A' ' 271' ' ' ASP . 10.2 mtmp? -133.98 157.26 46.51 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.665 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 40.1 tpt85 -58.74 135.08 57.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.987 0.423 . . . . 0.0 111.165 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.435 ' HB1' ' HB3' ' A' ' 160' ' ' LYS . . . -65.81 145.85 55.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.088 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . 0.501 ' CG2' ' HB2' ' A' ' 238' ' ' GLU . 6.1 mt -117.96 120.46 32.57 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.561 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.553 ' HB2' ' OE1' ' A' ' 238' ' ' GLU . 34.5 Cg_exo -53.89 152.69 22.38 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 121.548 1.499 . . . . 0.0 110.634 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 52.3 mmm-85 -54.23 -35.63 62.65 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.32 -40.74 82.86 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.553 ' OE1' ' HB2' ' A' ' 235' ' ' PRO . 55.3 mp0 -65.85 -35.82 81.73 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.587 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -59.35 -39.81 84.38 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.598 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -64.14 -45.19 89.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.053 0.454 . . . . 0.0 110.185 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -65.09 -40.08 94.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.649 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.41 HG23 ' HA ' ' A' ' 292' ' ' ASP . 24.8 p -83.69 161.42 21.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.129 -178.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.53 166.27 25.88 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.34 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.485 ' HE3' ' CE2' ' A' ' 288' ' ' PHE . 4.6 ttpt -137.45 135.61 37.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.075 0.437 . . . . 0.0 111.233 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.433 ' CD1' ' CG2' ' A' ' 315' ' ' ILE . 7.4 pt -120.05 159.83 20.98 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 121.176 0.512 . . . . 0.0 110.933 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -99.52 129.62 45.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.675 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 44.0 t -119.83 137.32 54.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.349 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.482 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.05 167.72 18.38 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.564 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 94.48 8.58 59.64 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.197 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.459 HG21 ' CG2' ' A' ' 254' ' ' VAL . 27.8 mm -56.8 -39.89 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 120.762 0.315 . . . . 0.0 110.581 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 250' ' ' ILE . . . 27.56 -145.36 0.01 OUTLIER Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.677 -0.692 . . . . 0.0 114.419 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.9 169.25 11.89 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.338 2.692 . . . . 0.0 113.533 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 60.46 43.47 13.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.313 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.459 ' CG2' HG21 ' A' ' 250' ' ' ILE . 26.8 m -133.8 156.88 41.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.924 0.392 . . . . 0.0 110.991 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.92 155.12 74.84 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.778 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -57.01 -40.3 85.01 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 121.532 1.488 . . . . 0.0 110.851 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.52 -42.62 98.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.773 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 262' ' ' PHE . 74.6 mm-40 -65.43 -41.34 93.64 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.491 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.478 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 43.1 t80 -66.91 -48.96 67.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.722 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -64.65 -40.89 96.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.774 0.321 . . . . 0.0 111.058 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.406 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.1 pt-20 -74.69 -30.72 61.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.892 0.377 . . . . 0.0 110.548 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.669 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 91.4 t80 -57.38 -44.65 84.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.172 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.634 ' HA ' ' CZ3' ' A' ' 266' ' ' TRP . 86.7 m-85 -92.7 -2.22 56.22 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 267' ' ' GLY . 47.2 t -60.09 -30.16 69.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -56.36 -39.8 73.46 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.44 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.634 ' CZ3' ' HA ' ' A' ' 263' ' ' PHE . 17.3 m-90 -60.42 -39.23 86.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.085 0.469 . . . . 0.0 110.811 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 264' ' ' SER . . . -173.71 -172.55 39.18 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.663 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 90.7 m -58.34 -37.18 74.64 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.49 HG12 ' CE1' ' A' ' 291' ' ' TYR . 49.2 mt 61.7 86.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.566 ' CD1' ' HB3' ' A' ' 292' ' ' ASP . 31.4 mm -55.09 -44.5 74.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.405 ' OD1' ' HE2' ' A' ' 231' ' ' LYS . 24.2 t70 -159.66 92.48 1.04 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -104.86 133.98 48.75 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -144.68 154.94 43.3 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.576 ' O ' ' HB2' ' A' ' 275' ' ' MET . 31.8 tp -66.19 -37.83 86.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.23 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.576 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 93.2 mmm 84.21 138.08 0.06 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.199 -178.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.449 ' CD1' ' HA ' ' A' ' 279' ' ' ASP . 0.2 OUTLIER 173.59 89.78 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.841 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 278' ' ' LYS . 55.4 p30 -64.16 -39.86 94.92 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.688 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . 0.615 ' N ' ' OD1' ' A' ' 277' ' ' ASP . 60.1 mttm -101.11 7.98 43.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.978 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.449 ' HA ' ' CD1' ' A' ' 276' ' ' LEU . 51.2 t0 78.94 -13.69 0.94 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.857 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 46.4 p -139.43 12.13 2.55 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -94.58 -74.63 1.25 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.761 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 286' ' ' PHE . 80.1 mm-40 -60.1 -32.47 71.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.049 0.452 . . . . 0.0 111.232 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 33.1 t -61.66 -4.7 1.52 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.911 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -49.94 -38.2 35.4 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 178.91 19.17 0.03 OUTLIER Glycine 0 CA--C 1.524 0.604 0 C-N-CA 118.717 -1.706 . . . . 0.0 115.847 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.424 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 24.9 p90 -137.93 160.53 39.07 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.755 1.278 . . . . 0.0 111.022 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -139.36 157.27 24.97 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.319 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.485 ' CE2' ' HE3' ' A' ' 244' ' ' LYS . 0.6 OUTLIER -111.13 129.18 56.01 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.582 0.353 . . . . 0.0 110.919 179.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.478 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 42.3 t -122.76 133.14 69.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.712 0.292 . . . . 0.0 111.16 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 52.5 m -119.61 138.02 53.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.379 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.49 ' CE1' HG12 ' A' ' 269' ' ' ILE . 47.8 m-85 -120.45 143.42 48.5 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.611 ' OD1' ' N ' ' A' ' 293' ' ' SER . 52.9 p30 -63.56 -32.65 74.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.499 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' SER . . . . . 0.611 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 98.2 p -127.06 149.34 49.96 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 121.26 0.552 . . . . 0.0 111.806 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -68.35 -32.76 73.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.092 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -56.25 -39.6 72.83 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.658 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -63.88 -34.72 78.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.173 0.511 . . . . 0.0 110.591 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 78.1 t -63.14 -42.1 95.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.664 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -60.55 -42.01 95.72 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -64.33 -45.86 86.01 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.457 ' HB ' ' CD1' ' A' ' 266' ' ' TRP . 7.5 p -70.62 -40.65 77.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 95.1 m -67.69 -40.11 84.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.737 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -56.85 -39.91 75.15 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.872 0.368 . . . . 0.0 111.022 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.502 ' HB3' ' CD1' ' A' ' 306' ' ' ILE . 44.5 t-20 -60.2 -33.34 72.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.736 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.649 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 6.7 tptm 75.24 -62.56 0.44 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.336 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.649 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 24.4 m-85 -116.07 132.78 56.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.236 0.541 . . . . 0.0 111.994 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.639 ' O ' HG12 ' A' ' 313' ' ' ILE . 20.7 mm -121.22 140.85 44.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.002 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.412 ' OD1' ' NZ ' ' A' ' 312' ' ' LYS . 94.6 m-20 -78.82 130.0 35.22 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.669 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 1.8 t80 -118.23 -127.06 0.28 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.451 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.479 ' HD3' ' CE1' ' A' ' 308' ' ' PHE . 0.0 OUTLIER -60.21 -36.05 76.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.194 0.521 . . . . 0.0 110.563 -179.091 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -177.43 -35.78 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.218 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -86.59 144.93 26.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.423 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.495 ' HE3' ' HB3' ' A' ' 305' ' ' PHE . 3.0 tptt -74.26 136.6 42.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.639 HG12 ' O ' ' A' ' 306' ' ' ILE . 30.8 pt -112.56 143.57 22.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.298 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -102.41 138.63 39.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.433 ' CG2' ' CD1' ' A' ' 245' ' ' ILE . 15.2 mm -112.37 127.14 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -136.53 137.02 39.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.479 0.181 . . . . 0.0 110.988 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -55.51 146.82 19.21 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.37 135.49 26.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.284 0.564 . . . . 0.0 111.245 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.431 -179.784 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.786 0.327 . . . . 0.0 110.42 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.422 ' HG2' ' HB2' ' A' ' 233' ' ' ALA . 75.6 tttt -100.08 141.59 32.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.205 0.526 . . . . 0.0 111.829 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.503 ' N ' ' O ' ' A' ' 205' ' ' LEU . 82.4 mmm -124.02 145.86 48.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.649 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.65 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 3.6 t80 -105.5 127.52 53.06 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.503 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 18.2 mt -122.28 130.11 74.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.445 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -128.73 163.98 22.0 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.747 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.51 47.31 28.42 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 119.829 -1.177 . . . . 0.0 111.481 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.423 ' HB3' ' CB ' ' A' ' 170' ' ' THR . 45.2 mt -83.63 9.67 11.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.464 ' HB2' ' HG3' ' A' ' 226' ' ' LYS . 49.4 t30 62.81 43.61 6.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.023 0.44 . . . . 0.0 110.195 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 6.0 m0 39.15 39.45 0.41 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.267 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.446 ' C ' ' H ' ' A' ' 171' ' ' THR . 59.8 t0 -162.44 -111.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.263 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.617 ' O ' ' O ' ' A' ' 171' ' ' THR . 77.0 m 63.26 -40.97 0.2 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.617 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.5 OUTLIER 47.74 155.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.553 0.692 . . . . 0.0 111.374 -179.296 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.457 ' HG3' ' HB ' ' A' ' 190' ' ' ILE . 96.3 mt-10 -62.5 -31.98 72.83 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.659 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -64.0 -61.53 2.22 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.551 ' HB2' ' O ' ' A' ' 170' ' ' THR . 85.9 m-20 -62.57 -37.19 85.23 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.226 0.536 . . . . 0.0 110.016 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.433 ' HB2' ' CG2' ' A' ' 170' ' ' THR . 52.3 tp -61.86 -42.97 99.69 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.359 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 -61.65 -42.52 99.02 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.169 0.509 . . . . 0.0 110.173 177.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -66.82 -40.31 88.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.224 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.496 ' OH ' ' HB3' ' A' ' 221' ' ' HIS . 50.6 t80 -59.91 -45.26 93.12 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.163 0.506 . . . . 0.0 110.898 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.491 ' CB ' HD23 ' A' ' 205' ' ' LEU . 97.5 m-85 -95.46 -0.99 51.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.072 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.27 -30.85 64.98 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.008 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.441 ' HD3' ' O ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -58.34 -41.78 85.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.534 0.683 . . . . 0.0 110.644 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -67.39 -35.35 79.13 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.613 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -179.42 -177.19 47.61 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 119.719 -1.229 . . . . 0.0 113.483 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.489 ' O ' HG21 ' A' ' 185' ' ' VAL . 46.7 m -63.11 -30.69 71.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.029 -0.586 . . . . 0.0 110.995 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.619 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 0.6 OUTLIER 64.38 91.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.857 0.837 . . . . 0.0 108.954 -177.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.7 t -58.49 -44.48 89.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.581 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -135.59 149.31 49.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.49 0.662 . . . . 0.0 112.687 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.83 127.62 45.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.099 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.517 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 13.0 tptt -135.95 120.78 18.55 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.457 ' HB ' ' HG3' ' A' ' 172' ' ' GLU . 0.8 OUTLIER -130.35 132.0 65.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.83 176.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.68 ' HB2' ' HD2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -99.23 156.49 16.95 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.432 -179.156 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.486 ' HG3' ' HD3' ' A' ' 194' ' ' PRO . 13.4 pttt -132.23 161.93 32.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.641 0.258 . . . . 0.0 110.881 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.539 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 1.0 OUTLIER -125.49 75.65 69.36 Favored Pre-proline 0 C--O 1.232 0.144 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.189 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.486 ' HD3' ' HG3' ' A' ' 192' ' ' LYS . 26.8 Cg_exo -61.77 -25.46 78.63 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.504 2.136 . . . . 0.0 112.019 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.45 -71.16 0.36 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.882 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 58.5 p -66.9 -28.71 68.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.072 0.463 . . . . 0.0 110.458 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 89.53 6.8 70.08 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.209 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.539 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 3.3 tpt180 -123.6 124.08 42.01 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.291 0.546 . . . . 0.0 110.632 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.464 ' HB3' ' NH1' ' A' ' 200' ' ' ARG . 54.8 m -62.31 147.9 46.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.164 0.507 . . . . 0.0 112.047 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.68 ' HD2' ' HB2' ' A' ' 191' ' ' MET . 0.0 OUTLIER -60.62 -35.59 76.54 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.849 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 91.89 7.59 64.26 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 114.973 0.749 . . . . 0.0 114.973 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.563 ' H ' ' HG2' ' A' ' 200' ' ' ARG . 36.6 p90 -141.12 153.91 45.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.23 0.538 . . . . 0.0 111.371 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.507 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -142.51 161.61 27.35 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.606 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.65 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 97.7 m-85 -105.75 124.56 49.77 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 161' ' ' MET . 44.2 tp -111.01 127.37 55.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.321 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 49.9 m -117.81 142.05 47.73 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.786 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.447 ' CZ ' ' CD2' ' A' ' 205' ' ' LEU . 93.5 m-85 -120.73 146.16 46.76 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.063 0.458 . . . . 0.0 111.707 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.72 -34.95 79.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.752 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 0.6 OUTLIER -118.54 135.91 23.85 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.934 -179.308 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . 0.475 ' O ' ' CG1' ' A' ' 213' ' ' VAL . 39.6 Cg_exo -60.53 -26.36 82.66 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.846 2.364 . . . . 0.0 113.286 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 31.4 m -58.08 -38.45 76.4 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.188 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 22.9 m -61.41 -37.88 85.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.809 0.338 . . . . 0.0 111.069 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.547 HG11 ' N ' ' A' ' 214' ' ' ASP . 3.0 p -61.43 -35.87 69.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.466 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.547 ' N ' HG11 ' A' ' 213' ' ' VAL . 92.6 m-20 -60.79 -43.54 97.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.793 0.33 . . . . 0.0 111.375 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.29 -34.64 77.82 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.788 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 98.4 t -60.58 -43.47 94.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 20.9 m -83.51 -37.8 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 214' ' ' ASP . 25.7 mttm -60.51 -32.77 71.77 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.405 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 48.3 m -99.49 144.91 28.04 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -76.84 145.41 38.4 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.788 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 74.2 m-70 -121.87 128.15 51.29 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -176.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 70.9 mt -128.41 89.07 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.429 ' HA ' ' CE2' ' A' ' 178' ' ' TYR . 6.8 tt -67.36 -38.68 85.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -163.8 50.32 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.005 0.431 . . . . 0.0 111.353 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 91.28 2.44 70.82 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.661 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.464 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 10.7 mmtp -116.58 152.25 34.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 41.6 t -105.12 131.62 53.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.132 0.491 . . . . 0.0 110.932 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.448 HG13 ' HD3' ' A' ' 230' ' ' PRO . 36.8 pt -123.66 159.82 28.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.113 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -126.93 79.82 72.12 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-O 121.127 0.489 . . . . 0.0 111.125 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.607 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 52.0 Cg_exo -57.93 124.02 15.02 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.649 2.233 . . . . 0.0 111.107 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.428 ' N ' ' HE2' ' A' ' 161' ' ' MET . 4.0 ttpm? -134.88 149.08 50.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.639 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.428 ' CZ ' HG12 ' A' ' 213' ' ' VAL . 24.5 mmt85 -52.5 141.16 20.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.9 0.381 . . . . 0.0 110.769 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.422 ' HB2' ' HG2' ' A' ' 160' ' ' LYS . . . -64.98 148.52 51.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.982 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 65.3 mt -109.64 128.58 25.15 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.407 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.89 141.0 57.13 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 121.623 1.548 . . . . 0.0 110.802 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 57.4 mmm-85 -57.37 -39.66 76.51 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.382 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.07 -43.19 99.28 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.018 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.72 -37.25 79.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.088 0.471 . . . . 0.0 110.552 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -60.1 -40.69 90.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.92 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -60.59 -39.8 89.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.811 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -60.78 -32.7 72.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.411 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.488 ' CG2' HD13 ' A' ' 270' ' ' ILE . 11.3 p -77.91 161.98 27.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.129 0.49 . . . . 0.0 111.818 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -146.55 115.25 0.78 Allowed Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.86 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.443 ' CD ' ' OG1' ' A' ' 290' ' ' THR . 46.3 tptt -82.44 130.61 35.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.519 0.2 . . . . 0.0 110.918 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.666 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -120.97 159.79 22.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.249 0.547 . . . . 0.0 110.758 179.199 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.52 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 91.9 t80 -103.26 137.52 41.28 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.061 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.503 HG12 ' CE1' ' A' ' 259' ' ' PHE . 7.2 p -130.46 143.98 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.818 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.612 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -131.92 165.47 23.44 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 94.43 13.42 53.97 Favored Glycine 0 C--N 1.321 -0.264 0 C-N-CA 119.952 -1.118 . . . . 0.0 112.333 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.535 ' CD1' ' HA2' ' A' ' 287' ' ' GLY . 36.4 pt -117.9 155.69 19.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.771 0.32 . . . . 0.0 110.93 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 284' ' ' ARG . . . 178.2 -134.69 2.46 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.292 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.67 -28.03 63.91 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.973 1.782 . . . . 0.0 111.179 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.03 -31.99 70.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.374 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.514 ' CG1' ' HB ' ' A' ' 250' ' ' ILE . 7.9 p -122.55 143.23 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.668 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.8 mmm-85 -102.39 163.12 18.29 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.08 -40.39 81.74 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 121.483 1.455 . . . . 0.0 112.003 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -64.37 -46.32 83.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.847 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.405 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 84.1 tt0 -65.59 -39.79 91.97 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-O 120.913 0.387 . . . . 0.0 111.881 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.61 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 26.3 t80 -61.66 -45.91 92.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.011 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -64.53 -42.17 95.91 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.478 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.405 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.7 pt-20 -74.1 -30.78 62.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.187 0.518 . . . . 0.0 110.432 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.545 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 5.7 t80 -60.45 -56.53 20.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.817 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.588 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 4.6 m-85 -64.64 -23.46 67.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.041 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.484 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 22.7 t -55.12 -30.55 59.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.941 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -52.72 -35.33 55.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.096 -0.242 . . . . 0.0 111.398 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.658 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 7.4 p90 -117.55 45.27 1.96 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 121.16 0.505 . . . . 0.0 111.593 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.512 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 152.48 146.79 4.43 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.857 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 46.2 m -59.32 -38.21 79.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.769 0.319 . . . . 0.0 111.358 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.582 HD12 ' CB ' ' A' ' 263' ' ' PHE . 75.3 mt 68.0 82.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.487 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 71.2 mt -58.35 -40.52 78.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.4 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 290' ' ' THR . 58.0 t0 -149.83 142.48 24.54 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.992 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -158.08 136.97 11.4 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.623 0.249 . . . . 0.0 111.046 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -148.69 154.04 39.09 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.143 0.497 . . . . 0.0 112.018 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.568 ' O ' ' HB2' ' A' ' 275' ' ' MET . 31.9 tp -66.02 -37.01 84.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.859 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.568 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 92.2 mmm 86.95 126.55 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.471 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.503 ' HB3' ' OG ' ' A' ' 283' ' ' SER . 0.0 OUTLIER -154.66 138.68 16.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 111.134 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -81.7 -132.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -56.6 -35.01 67.76 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 122.115 -0.366 . . . . 0.0 110.547 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 276' ' ' LEU . 93.2 m-20 -135.58 -101.46 0.22 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.583 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 63.7 p -111.04 16.78 20.97 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -42.09 -79.85 0.05 OUTLIER Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.564 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.424 ' HB2' ' C ' ' A' ' 275' ' ' MET . 90.3 mm-40 -59.29 -33.16 70.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.082 0.468 . . . . 0.0 110.011 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.592 ' O ' ' HG2' ' A' ' 284' ' ' ARG . 58.8 m -64.56 171.84 3.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.529 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.592 ' HG2' ' O ' ' A' ' 283' ' ' SER . 42.2 ptt85 49.55 46.68 23.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.305 0.574 . . . . 0.0 110.398 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -167.87 -67.78 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.455 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.52 ' CD2' ' HE1' ' A' ' 246' ' ' PHE . 35.7 p90 -139.29 167.0 23.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.731 0.301 . . . . 0.0 111.212 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.535 ' HA2' ' CD1' ' A' ' 250' ' ' ILE . . . -133.88 164.29 24.43 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.702 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.443 ' CD2' ' CE ' ' A' ' 244' ' ' LYS . 0.2 OUTLIER -118.5 126.8 52.79 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.442 -0.379 . . . . 0.0 110.822 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.666 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 46.6 t -127.53 139.7 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.443 ' OG1' ' CD ' ' A' ' 244' ' ' LYS . 32.5 m -116.66 137.69 52.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.408 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.512 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 40.2 m-85 -117.95 140.49 49.66 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 293' ' ' SER . 54.0 p30 -62.1 -32.14 72.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.285 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' SER . . . . . 0.591 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 29.7 t -124.46 139.43 53.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.209 0.528 . . . . 0.0 111.508 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.81 -30.93 71.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.177 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -56.48 -37.66 70.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.202 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -61.31 -36.86 81.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 0.0 110.736 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 95.0 t -61.17 -43.11 95.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.029 0.442 . . . . 0.0 110.501 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -61.77 -36.5 81.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.719 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -57.18 -42.8 81.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.826 0.346 . . . . 0.0 111.917 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.658 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 1.2 p -68.94 -33.53 59.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.397 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 76.3 m -57.49 -44.28 84.79 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.998 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.77 -38.82 89.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.232 0.539 . . . . 0.0 109.93 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.6 m-20 -61.12 -33.38 73.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.999 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.603 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 52.4 tptt 67.4 -70.4 0.12 Allowed 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -177.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.603 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.0 m-30 -115.56 148.46 39.54 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.755 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.457 ' CG2' ' CZ ' ' A' ' 262' ' ' PHE . 5.7 mm -115.18 137.56 48.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -78.19 46.36 0.6 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.03 0.443 . . . . 0.0 110.36 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.545 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 7.3 t80 -56.95 -65.48 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -101.28 20.92 14.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.506 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 58.99 35.77 24.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.527 0.68 . . . . 0.0 109.293 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -139.07 0.95 1.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.614 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.422 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 98.4 mttt 64.78 123.25 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.242 0.544 . . . . 0.0 112.004 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.612 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 34.4 pt -116.46 146.46 20.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.281 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -100.71 130.78 46.79 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.785 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.453 HG12 ' CG2' ' A' ' 247' ' ' VAL . 72.3 mt -121.26 131.4 73.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.594 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 8.0 tptp -131.71 144.61 51.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.643 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -57.71 144.52 37.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.936 0.398 . . . . 0.0 110.805 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.08 147.17 40.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.375 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.055 -179.762 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 14.0 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.79 0.329 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -56.72 143.79 35.16 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.236 0.541 . . . . 0.0 111.452 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.546 ' N ' ' O ' ' A' ' 205' ' ' LEU . 84.0 mmm -116.21 149.64 38.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.792 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.716 ' HB3' ' HG2' ' A' ' 231' ' ' LYS . 4.2 t80 -104.1 128.87 51.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.501 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 15.9 mm -113.88 127.09 71.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.486 ' O ' ' HB ' ' A' ' 228' ' ' ILE . . . -131.95 166.8 23.04 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.537 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.89 33.54 45.79 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.353 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 61.4 mt -80.74 146.55 30.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 169' ' ' ASP . 43.8 t30 -79.85 59.48 3.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.712 0.291 . . . . 0.0 111.421 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.423 ' CD1' ' O ' ' A' ' 199' ' ' SER . 12.2 m0 28.92 37.83 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.502 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 167' ' ' ASN . 54.8 t0 -163.14 20.08 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.442 ' CG2' HD12 ' A' ' 190' ' ' ILE . 59.9 m -76.26 136.55 39.66 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.861 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 30.8 m -114.46 144.47 43.28 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.23 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 54.5 mp0 -56.43 -36.55 69.11 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.404 -0.519 . . . . 0.0 109.878 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -65.65 -48.62 71.52 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.795 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -66.37 -41.7 89.06 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.584 0.706 . . . . 0.0 109.976 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 63.9 tp -64.19 -41.62 97.01 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.173 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -62.87 -45.23 93.51 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.267 0.556 . . . . 0.0 110.167 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -66.85 -38.13 85.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.871 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.594 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 52.4 t80 -57.9 -46.05 85.52 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.223 0.535 . . . . 0.0 110.87 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.509 ' CG ' HD23 ' A' ' 205' ' ' LEU . 96.1 m-85 -93.66 1.26 56.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.647 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -59.28 -28.43 64.38 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.23 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -39.14 79.24 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.759 0.79 . . . . 0.0 110.503 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -67.53 -31.81 72.16 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.045 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 161.72 -133.27 3.09 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.283 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.0 m -119.28 140.16 50.74 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 207' ' ' PHE . 2.8 m -102.36 126.68 56.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.405 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.481 ' CG2' ' HA ' ' A' ' 208' ' ' GLU . 51.8 p -69.92 -37.91 76.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.291 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 186' ' ' THR . 90.9 m-20 -143.74 155.68 44.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.195 0.521 . . . . 0.0 112.029 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.406 HD22 HG23 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -133.79 126.41 30.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.567 179.335 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 15.2 tptt -134.6 119.67 18.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.345 0.593 . . . . 0.0 112.225 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.442 HD12 ' CG2' ' A' ' 170' ' ' THR . 0.8 OUTLIER -125.49 129.61 72.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.022 176.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.659 ' CE ' ' HA3' ' A' ' 203' ' ' GLY . 3.1 mtm -96.23 134.56 39.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.191 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -128.48 155.56 44.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.852 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 6.0 m-20 -123.21 73.15 48.35 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.509 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.72 -28.75 88.05 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.718 2.279 . . . . 0.0 113.131 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -64.86 -57.86 7.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 0.0 110.95 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 55.9 p -78.74 -15.02 58.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.224 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 80.16 24.28 59.72 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.573 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.536 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 1.9 tpt180 -124.22 175.61 6.93 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 120.687 0.279 . . . . 0.0 110.509 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.423 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 32.6 t -126.4 147.4 49.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.609 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 36.6 mmt180 -54.48 -35.07 62.69 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.23 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 90.2 3.34 72.83 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.532 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.609 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 26.3 p90 -139.8 157.5 45.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.777 0.323 . . . . 0.0 110.653 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.659 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -147.0 160.07 28.17 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.935 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.576 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 98.1 m-85 -105.6 124.27 49.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.361 0.6 . . . . 0.0 109.971 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 161' ' ' MET . 60.2 tp -111.51 125.73 54.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.367 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 23.9 t -118.86 136.91 53.78 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.684 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 68.3 m-85 -119.84 143.8 47.7 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.668 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.481 ' HA ' ' CG2' ' A' ' 186' ' ' THR . 84.5 tt0 -63.95 -34.85 78.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.941 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.81 115.54 55.25 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.764 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.25 -21.1 34.56 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.591 2.194 . . . . 0.0 112.87 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.9 m -56.73 -36.3 69.56 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.406 ' O ' ' CG2' ' A' ' 216' ' ' VAL . 22.4 m -58.39 -35.1 71.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.935 0.398 . . . . 0.0 110.296 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 75.1 t -60.39 -42.28 90.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.95 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -58.98 -41.98 88.86 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.899 0.381 . . . . 0.0 110.837 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.405 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 20.3 pt-20 -76.89 -30.62 56.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.752 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.86 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 77.6 t -60.22 -41.32 86.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.418 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.0 m -71.53 -31.99 44.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -59.93 -38.8 83.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.723 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 35.0 m -85.13 143.16 29.0 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 63.3 tt0 -66.0 -40.96 91.6 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.935 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.86 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 85.2 m-70 78.84 97.81 0.06 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 72.2 mt -117.07 107.66 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.436 ' HG ' ' CD2' ' A' ' 178' ' ' TYR . 3.6 tt -97.66 -74.13 0.59 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -90.78 14.86 12.4 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 101.99 -6.78 54.38 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.226 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.418 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -99.69 -172.59 2.27 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.632 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 15.0 p -120.03 135.91 58.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.241 0.543 . . . . 0.0 111.159 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' A' ' 164' ' ' GLY . 36.0 pt -124.98 156.66 33.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.199 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -127.84 78.51 75.0 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.207 0.527 . . . . 0.0 111.289 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.577 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 74.4 Cg_exo -55.39 131.21 44.89 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.844 2.363 . . . . 0.0 111.299 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.716 ' HG2' ' HB3' ' A' ' 162' ' ' PHE . 0.5 OUTLIER -136.78 170.3 16.31 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -70.82 140.09 51.11 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.125 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.58 143.8 56.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.763 0.316 . . . . 0.0 111.184 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 28.6 mt -111.44 121.91 38.94 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.015 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.51 144.14 52.76 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.836 1.691 . . . . 0.0 110.986 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -56.81 -39.11 73.56 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.486 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -61.3 -46.53 89.91 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.115 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -68.85 -37.22 78.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.358 0.599 . . . . 0.0 109.737 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -58.5 -43.46 89.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.742 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -65.14 -40.26 94.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.408 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -60.11 -37.77 81.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.218 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.4 HG23 ' HA ' ' A' ' 292' ' ' ASP . 19.9 p -81.39 161.71 23.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.167 0.508 . . . . 0.0 111.987 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.56 163.72 25.18 Favored Glycine 0 C--N 1.332 0.338 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.424 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.402 ' NZ ' ' CD2' ' A' ' 288' ' ' PHE . 11.8 tttm -138.07 137.76 38.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.141 0.471 . . . . 0.0 110.719 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.656 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -123.06 164.21 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.688 0.756 . . . . 0.0 112.538 -179.245 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.515 ' HB3' ' O ' ' A' ' 317' ' ' ARG . 86.0 t80 -105.1 138.62 41.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.565 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.461 ' CG2' HG12 ' A' ' 315' ' ' ILE . 7.4 p -127.45 133.75 67.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -105.48 -4.04 40.51 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.586 -0.816 . . . . 0.0 114.178 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . 0.45 ' HA2' ' CB ' ' A' ' 313' ' ' ILE . . . -115.82 115.72 3.46 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.72 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.545 ' O ' HG23 ' A' ' 254' ' ' VAL . 24.5 mm -94.22 -78.42 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.475 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.437 ' O ' HG22 ' A' ' 254' ' ' VAL . . . 119.21 162.29 11.96 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.075 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.69 128.25 22.85 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.143 1.896 . . . . 0.0 112.719 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 51.47 42.18 29.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.65 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.693 ' O ' ' HB3' ' A' ' 258' ' ' GLU . 6.4 t -63.91 -44.26 97.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.404 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.4 OUTLIER 61.51 134.86 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.43 -31.01 66.46 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 121.946 1.764 . . . . 0.0 112.706 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -63.99 -48.63 75.63 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.693 ' HB3' ' O ' ' A' ' 254' ' ' VAL . 42.8 tp10 -64.6 -38.15 90.0 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.044 0.45 . . . . 0.0 111.054 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.59 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 44.8 t80 -59.49 -44.19 93.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.165 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.434 ' O ' ' CD1' ' A' ' 269' ' ' ILE . 97.2 mt-10 -65.34 -40.58 93.84 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.557 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -77.72 -30.63 51.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.21 0.529 . . . . 0.0 110.466 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.528 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 5.5 t80 -61.9 -54.87 35.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.436 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.535 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 4.3 m-85 -65.17 -23.82 67.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.553 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.484 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 23.5 t -54.82 -25.47 28.66 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -46.45 -37.34 7.62 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.41 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.706 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 23.2 p90 -129.83 54.45 1.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.052 0.453 . . . . 0.0 111.472 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 264' ' ' SER . . . 149.11 146.52 4.34 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.803 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.434 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 53.1 m -59.26 -37.51 77.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.758 0.313 . . . . 0.0 111.354 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.514 HD12 ' CB ' ' A' ' 263' ' ' PHE . 74.8 mt 71.55 85.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.848 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.539 ' CD1' ' HB3' ' A' ' 292' ' ' ASP . 34.8 mm -59.36 -35.51 58.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.198 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -137.97 -104.76 0.18 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.079 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 289' ' ' VAL . . . 80.36 113.93 0.06 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.934 0.397 . . . . 0.0 112.016 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -141.99 155.83 45.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.317 0.579 . . . . 0.0 111.382 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.534 ' O ' ' HB2' ' A' ' 275' ' ' MET . 22.9 tp -63.63 -36.49 83.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.421 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.534 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 95.8 mmm 76.96 123.37 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.674 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.475 ' HG ' ' HB3' ' A' ' 283' ' ' SER . 5.1 mp -128.35 125.81 39.45 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.42 ' H ' ' H ' ' A' ' 282' ' ' GLN . 55.9 t0 -62.67 -40.75 98.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.594 0.712 . . . . 0.0 109.697 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -162.12 -73.7 0.05 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.781 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -94.56 -75.75 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.484 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 73.3 p -129.33 13.57 6.08 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.357 -0.383 . . . . 0.0 112.015 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -44.99 -91.01 0.01 OUTLIER Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.037 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.42 ' H ' ' H ' ' A' ' 277' ' ' ASP . 98.7 mt-30 -60.26 -25.65 65.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.167 -0.517 . . . . 0.0 111.599 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.482 ' HA ' ' HG ' ' A' ' 274' ' ' LEU . 63.5 p -51.89 -27.32 12.42 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.73 0.3 . . . . 0.0 110.938 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -122.5 139.07 54.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.911 0.386 . . . . 0.0 110.557 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.63 -53.52 0.58 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.25 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.42 ' CD2' ' HE1' ' A' ' 246' ' ' PHE . 33.3 p90 -142.56 166.27 25.13 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 117.425 0.612 . . . . 0.0 111.708 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.408 ' O ' ' CG1' ' A' ' 247' ' ' VAL . . . -134.42 157.36 22.89 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.259 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.531 ' HB2' ' HG2' ' A' ' 275' ' ' MET . 0.2 OUTLIER -118.16 125.24 49.82 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.868 -0.195 . . . . 0.0 111.171 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.656 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 53.3 t -128.4 137.57 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.036 0.445 . . . . 0.0 112.151 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 54.8 m -117.02 136.69 52.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.311 178.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.464 ' CD1' ' HA2' ' A' ' 267' ' ' GLY . 47.5 m-85 -118.03 142.6 47.21 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 293' ' ' SER . 54.7 p30 -62.13 -31.58 72.07 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.108 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' SER . . . . . 0.613 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 27.6 t -124.67 139.54 53.77 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.161 0.505 . . . . 0.0 111.963 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.91 -31.58 72.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.946 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -55.46 -36.54 66.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.966 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.64 -34.86 74.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.649 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 84.6 t -59.55 -43.73 91.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.148 0.499 . . . . 0.0 110.309 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -62.43 -36.36 82.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.693 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 89.7 mtt-85 -57.12 -43.91 82.8 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.002 0.429 . . . . 0.0 111.976 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.706 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 1.3 p -68.77 -32.28 54.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.356 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . 0.413 ' N ' HG11 ' A' ' 300' ' ' VAL . 76.2 m -57.13 -43.74 82.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.207 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -60.45 -41.27 93.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.218 0.532 . . . . 0.0 110.186 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.416 ' O ' ' N ' ' A' ' 305' ' ' PHE . 88.3 m-20 -61.81 -33.53 74.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.399 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.615 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 7.9 tptm 67.05 -73.5 0.08 Allowed 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -178.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.615 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.5 m-30 -115.82 147.63 40.79 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.43 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.487 ' CD1' ' CH2' ' A' ' 266' ' ' TRP . 37.6 mt -119.92 129.51 75.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -59.48 -35.43 74.1 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.438 0.637 . . . . 0.0 111.005 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 1.3 t80 49.88 -124.86 2.11 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.299 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 310' ' ' ASP . 2.0 mmpt? -59.57 -37.51 78.67 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.931 0.396 . . . . 0.0 110.997 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 309' ' ' LYS . 23.3 t70 170.35 -0.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.26 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -122.12 152.39 39.94 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.785 0.326 . . . . 0.0 110.2 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 79.7 mttt -77.78 129.38 35.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.078 0.466 . . . . 0.0 111.222 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 305' ' ' PHE . 26.8 pt -115.3 143.33 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.375 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . 0.561 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 85.6 mt-10 -100.91 133.25 45.67 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.471 -0.492 . . . . 0.0 109.897 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.461 HG12 ' CG2' ' A' ' 247' ' ' VAL . 82.4 mt -122.21 126.07 73.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.144 0.497 . . . . 0.0 111.898 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -133.05 -170.45 2.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.456 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.515 ' O ' ' HB3' ' A' ' 246' ' ' PHE . 74.7 mtp180 -57.34 146.8 27.74 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.728 0.299 . . . . 0.0 110.623 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 244' ' ' LYS . . . -60.86 -23.16 64.93 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 . . . . . 0 C--N 1.327 -0.378 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.297 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 CA--C 1.529 0.148 0 CA-C-O 120.727 0.298 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.542 ' HE2' ' HB3' ' A' ' 204' ' ' PHE . 15.4 tptm -56.27 140.06 46.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.453 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.484 ' N ' ' O ' ' A' ' 205' ' ' LEU . 86.1 mmm -118.15 150.0 40.11 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.075 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.61 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 4.3 t80 -106.79 130.17 54.54 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.523 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 17.2 mm -115.41 121.81 67.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.024 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -126.44 164.8 19.89 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.441 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.79 27.13 65.5 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.547 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 201' ' ' GLY . 71.0 mt -87.63 142.21 28.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.901 0.381 . . . . 0.0 111.349 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -67.23 134.16 51.12 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 199' ' ' SER . 4.7 m-90 -52.15 -36.77 52.4 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.999 -0.281 . . . . 0.0 111.404 -178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -60.23 -31.47 70.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.689 0.281 . . . . 0.0 111.359 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 79.6 m -58.3 140.18 53.82 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.335 0.588 . . . . 0.0 111.971 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.5 p -118.36 167.76 11.26 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.495 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.511 ' HG3' ' HB ' ' A' ' 190' ' ' ILE . 96.1 mt-10 -58.91 -33.26 70.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -60.43 -41.23 93.57 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -61.63 -41.71 97.87 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.538 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.519 HD21 ' CE2' ' A' ' 179' ' ' PHE . 3.9 mt -65.56 -42.94 91.25 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.703 178.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.428 ' HG3' HG13 ' A' ' 185' ' ' VAL . 70.7 ttp85 -60.9 -44.51 97.03 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.735 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -67.86 -39.16 83.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.619 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 67.0 t80 -70.89 -62.1 1.52 Allowed 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.308 0.575 . . . . 0.0 111.41 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.519 ' CE2' HD21 ' A' ' 175' ' ' LEU . 67.4 m-85 -70.52 -24.21 62.78 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.516 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 183' ' ' GLY . . . -51.29 -27.03 14.89 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.672 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.5 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -56.2 -43.96 79.02 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.405 0.682 . . . . 0.0 110.99 178.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -71.51 -34.4 70.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.727 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 180' ' ' GLY . . . -164.62 -173.8 33.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.147 -1.025 . . . . 0.0 113.258 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.581 ' O ' ' CG1' ' A' ' 185' ' ' VAL . 51.0 m -59.22 -35.05 72.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.425 0.155 . . . . 0.0 110.782 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.634 HG11 ' O ' ' A' ' 185' ' ' VAL . 1.0 OUTLIER 78.67 69.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 CA-C-O 122.631 1.205 . . . . 0.0 108.749 -178.231 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.67 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 5.7 m -52.34 -42.55 63.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.08 -1.418 . . . . 0.0 112.801 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -148.35 141.49 25.0 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.415 ' CD2' ' CG2' ' A' ' 185' ' ' VAL . 0.2 OUTLIER -121.22 131.21 54.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.562 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 8.5 tptp -136.23 121.05 18.57 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.511 ' HB ' ' HG3' ' A' ' 172' ' ' GLU . 4.3 mt -127.05 132.45 69.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.663 176.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.554 ' CE ' ' HA3' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -92.15 125.11 36.7 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.969 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 199' ' ' SER . 4.1 mtmp? -126.7 155.04 43.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.895 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 9.1 t70 -97.22 108.8 46.48 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.693 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.69 -26.18 81.35 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.549 2.166 . . . . 0.0 112.958 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.68 -86.64 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 51.8 p -71.66 -21.52 61.8 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 193' ' ' ASP . . . 93.12 4.88 64.37 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.119 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.479 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 11.0 tpt180 -74.93 143.05 43.9 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.481 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 23.6 t -103.32 148.77 25.45 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.746 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.622 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 15.0 mmm180 -53.18 -30.6 38.26 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 166' ' ' LEU . . . 95.93 -0.87 62.82 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.86 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.622 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 25.4 p90 -136.62 156.4 48.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.875 0.369 . . . . 0.0 110.299 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.554 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -142.87 162.5 27.44 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.982 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.61 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 97.8 m-85 -105.06 125.3 50.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.363 0.602 . . . . 0.0 109.521 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.489 HD23 ' CG ' ' A' ' 179' ' ' PHE . 46.8 tp -106.7 130.3 54.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.041 -177.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 28.0 t -124.3 135.13 53.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.883 0.373 . . . . 0.0 111.979 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.476 ' CZ ' HD23 ' A' ' 205' ' ' LEU . 95.4 m-85 -119.48 140.05 51.09 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.782 178.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.67 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.3 tt0 -60.58 -34.47 74.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.026 0.441 . . . . 0.0 110.087 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.5 119.48 49.3 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.499 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.59 -20.55 27.66 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.516 2.144 . . . . 0.0 112.801 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 85.1 p -59.97 -31.07 69.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.667 0.27 . . . . 0.0 111.234 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.41 ' O ' ' CG2' ' A' ' 216' ' ' VAL . 23.0 m -59.44 -36.06 75.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.603 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 70.5 t -61.61 -43.52 97.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.305 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -59.81 -42.03 92.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.01 0.433 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.02 -31.9 61.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.77 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.79 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 66.0 t -60.76 -42.27 91.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 120.662 0.267 . . . . 0.0 110.983 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.411 HG21 ' N ' ' A' ' 218' ' ' LYS . 24.3 m -73.15 -27.55 24.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.411 ' N ' HG21 ' A' ' 217' ' ' VAL . 23.3 tptp -58.72 -35.5 72.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.659 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.694 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 57.4 m -100.13 141.52 32.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.852 0.358 . . . . 0.0 111.863 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.418 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 59.7 tp60 -66.09 -40.64 90.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.737 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.79 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 64.8 m-70 79.31 116.49 0.06 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 24.6 mm -116.4 107.4 22.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.2 tt -121.32 122.96 41.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.789 0.328 . . . . 0.0 110.177 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 51.73 40.17 26.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.148 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 73.64 20.32 79.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.342 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -115.21 136.23 53.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.329 0.565 . . . . 0.0 111.506 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.756 ' O ' ' O ' ' A' ' 228' ' ' ILE . 9.5 p -62.04 -35.89 71.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.096 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.756 ' O ' ' O ' ' A' ' 227' ' ' VAL . 9.0 pt 30.9 128.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.513 0.725 . . . . 0.0 112.68 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -123.29 84.56 51.94 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 121.056 0.455 . . . . 0.0 111.315 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.503 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 50.7 Cg_exo -56.05 135.34 69.31 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.912 2.408 . . . . 0.0 111.986 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -136.88 157.3 47.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.909 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -55.93 133.45 51.53 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.747 0.308 . . . . 0.0 110.852 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.45 ' HB1' ' HB3' ' A' ' 160' ' ' LYS . . . -72.91 148.05 44.71 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -122.13 125.58 26.56 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.674 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.424 ' HG2' ' CG ' ' A' ' 238' ' ' GLU . 9.4 Cg_endo -51.84 145.62 31.2 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 121.791 1.66 . . . . 0.0 111.14 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.416 ' O ' ' HD2' ' A' ' 236' ' ' ARG . 6.2 tmm_? -54.66 -39.25 67.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.78 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 55.3 p30 -61.42 -38.51 87.39 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.702 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.586 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 97.9 mt-10 -68.17 -34.13 75.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.995 0.426 . . . . 0.0 110.381 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -59.61 -38.28 80.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.281 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.93 -40.47 93.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.627 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -61.69 -34.94 76.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.162 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 22.4 p -83.41 162.23 21.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.572 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -146.47 112.71 0.63 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.847 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 17.5 ttpp -88.72 134.27 33.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.893 0.378 . . . . 0.0 111.194 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.667 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -117.46 164.02 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.537 0.684 . . . . 0.0 111.43 -179.247 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.469 ' HD2' ' HG2' ' A' ' 316' ' ' LYS . 93.5 t80 -101.85 136.34 41.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.518 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.511 HG12 ' CE1' ' A' ' 259' ' ' PHE . 12.5 p -131.57 146.37 33.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.314 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.644 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -131.66 169.43 21.94 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 89.92 17.82 52.77 Favored Glycine 0 N--CA 1.454 -0.147 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.727 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.489 HG21 ' CB ' ' A' ' 254' ' ' VAL . 23.3 mm -54.96 -43.84 70.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.841 0.353 . . . . 0.0 110.792 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 50.51 174.12 0.01 OUTLIER Glycine 0 CA--C 1.521 0.451 0 CA-C-N 116.074 -0.512 . . . . 0.0 114.086 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.09 154.68 65.83 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.62 2.88 . . . . 0.0 113.616 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 57.62 41.67 25.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.919 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.644 ' O ' ' HB2' ' A' ' 258' ' ' GLU . 2.4 p -85.79 -40.69 14.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.542 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.6 OUTLIER 60.05 118.97 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.92 -33.78 63.48 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 121.743 1.629 . . . . 0.0 112.426 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -61.51 -41.74 97.77 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.998 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.644 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 98.3 mt-10 -66.16 -36.15 82.36 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.627 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.625 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 16.5 t80 -63.86 -50.11 70.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.782 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.67 -37.03 86.18 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.587 ' HB3' ' HA ' ' A' ' 258' ' ' GLU . 78.5 tt0 -63.03 -37.9 89.04 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.646 -1.616 . . . . 0.0 111.883 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.556 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 86.4 t80 -67.78 -55.08 14.41 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.582 ' HB3' ' OH ' ' A' ' 291' ' ' TYR . 10.0 m-85 -66.45 -25.29 66.66 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.471 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 35.1 t -55.29 -31.31 61.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.689 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -56.15 -36.48 68.33 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.291 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.637 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 9.0 p90 -117.57 51.79 1.02 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.44 0.638 . . . . 0.0 111.16 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.509 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 148.3 148.03 4.66 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.508 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.427 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 11.8 t -64.06 -35.8 81.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 110.928 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.565 HD12 ' CB ' ' A' ' 263' ' ' PHE . 79.3 mt 71.66 83.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.223 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.5 ' CD1' ' HB2' ' A' ' 292' ' ' ASP . 36.0 mm -58.98 -38.58 74.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.984 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -149.46 150.91 33.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.185 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -170.59 122.31 0.62 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.577 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -142.85 152.3 42.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.22 0.533 . . . . 0.0 111.861 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.526 ' O ' ' HB2' ' A' ' 275' ' ' MET . 29.2 tp -64.23 -37.82 88.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.901 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.526 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 91.8 mmm 101.59 102.87 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.441 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 23.9 mt -108.05 139.02 43.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.521 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.58 ' HB3' ' HA2' ' A' ' 281' ' ' GLY . 59.9 t0 -145.39 93.31 2.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.092 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt 65.38 39.18 5.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.873 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' A' ' 280' ' ' THR . 57.4 t0 46.31 41.75 9.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.782 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 279' ' ' ASP . 2.0 t 171.2 50.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.911 0.386 . . . . 0.0 110.709 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 277' ' ' ASP . . . -131.49 -112.11 1.42 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.448 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 275' ' ' MET . 78.8 mm-40 -57.9 -28.36 64.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.415 -0.392 . . . . 0.0 110.431 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 275' ' ' MET . 86.3 p -57.69 -22.64 47.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.215 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -52.73 -36.63 57.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.92 0.39 . . . . 0.0 110.749 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 286' ' ' PHE . . . -166.61 -176.62 37.86 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.091 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.558 ' O ' ' O ' ' A' ' 285' ' ' GLY . 3.1 p90 48.54 155.13 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.175 0.512 . . . . 0.0 112.075 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.462 ' O ' HG11 ' A' ' 247' ' ' VAL . . . -139.25 164.41 25.9 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.153 -1.022 . . . . 0.0 113.783 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.452 ' CE2' ' NZ ' ' A' ' 244' ' ' LYS . 0.4 OUTLIER -119.73 125.6 49.04 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.669 0.388 . . . . 0.0 110.949 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.667 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 48.9 t -127.45 137.07 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.003 0.43 . . . . 0.0 111.748 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 44.4 m -113.55 135.8 53.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.605 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.582 ' OH ' ' HB3' ' A' ' 263' ' ' PHE . 34.5 m-85 -117.15 137.21 52.47 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.5 ' HB2' ' CD1' ' A' ' 270' ' ' ILE . 50.5 t0 -58.84 -35.65 73.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.558 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 30.5 t -119.99 140.18 51.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.28 0.562 . . . . 0.0 111.887 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . 0.412 ' O ' ' CG1' ' A' ' 297' ' ' VAL . . . -63.66 -30.64 71.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.526 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -55.74 -35.12 65.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.029 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.26 90.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.539 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.542 HG11 ' N ' ' A' ' 298' ' ' ASP . 9.5 p -61.16 -37.14 76.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.001 0.429 . . . . 0.0 110.735 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . 0.542 ' N ' HG11 ' A' ' 297' ' ' VAL . 88.5 m-20 -63.94 -38.18 90.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.527 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -59.16 -43.37 92.08 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.906 0.384 . . . . 0.0 111.943 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.637 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 0.9 OUTLIER -72.58 -36.68 54.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.638 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 74.5 m -59.23 -42.93 92.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.833 0.349 . . . . 0.0 110.447 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -61.78 -34.17 75.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.215 0.531 . . . . 0.0 110.013 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.65 ' O ' ' N ' ' A' ' 305' ' ' PHE . 80.6 m-20 -87.04 4.9 40.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.213 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.628 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 19.9 tptm 41.85 -80.85 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.605 0.24 . . . . 0.0 110.4 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.65 ' N ' ' O ' ' A' ' 303' ' ' ASN . 2.2 m-30 -107.58 141.26 39.33 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.507 HD13 ' CZ3' ' A' ' 266' ' ' TRP . 1.0 OUTLIER -116.58 134.47 59.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.531 ' O ' ' HE1' ' A' ' 262' ' ' PHE . 89.0 m-20 -70.67 124.59 24.63 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.556 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 2.0 t80 -112.0 -109.89 0.35 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.479 ' HE2' ' OE1' ' A' ' 258' ' ' GLU . 1.2 mmmp? -60.15 -37.42 80.07 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.743 0.306 . . . . 0.0 111.386 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.406 ' CG ' ' O ' ' A' ' 309' ' ' LYS . 32.5 m-20 -177.96 -27.39 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.219 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -113.13 160.81 17.82 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.951 0.405 . . . . 0.0 110.841 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.576 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 43.9 mttt -71.67 143.63 49.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.351 0.596 . . . . 0.0 112.114 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.644 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 31.6 pt -118.93 147.87 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . 0.529 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 87.4 mt-10 -101.05 129.73 46.95 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.515 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.503 ' CD1' HG23 ' A' ' 300' ' ' VAL . 74.7 mt -123.31 127.61 74.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.207 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.469 ' HG2' ' HD2' ' A' ' 246' ' ' PHE . 3.4 ptpt -135.2 163.62 29.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.601 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 45.8 ptt85 -59.03 148.84 29.37 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.45 133.19 55.56 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.79 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.964 -179.61 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.8 p . . . . . 0 CA--C 1.53 0.21 0 CA-C-O 120.512 0.196 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.437 ' HE2' ' HB3' ' A' ' 204' ' ' PHE . 5.3 tptm -69.56 131.6 44.94 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.601 ' O ' ' HA ' ' A' ' 204' ' ' PHE . 93.3 mmm -120.67 143.57 48.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.877 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.567 ' CE1' ' CZ ' ' A' ' 204' ' ' PHE . 2.7 t80 -108.29 125.74 52.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 0.3 OUTLIER -120.88 127.86 75.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.615 -179.446 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -121.49 153.34 16.7 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.318 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.44 29.08 64.49 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.151 -1.023 . . . . 0.0 110.994 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.626 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 69.1 mt -59.06 -33.3 70.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.728 ' O ' ' N ' ' A' ' 169' ' ' ASP . 21.1 t30 107.63 37.19 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.977 0.511 . . . . 0.0 110.669 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.44 ' CD1' ' O ' ' A' ' 199' ' ' SER . 5.1 m0 45.99 -59.7 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.728 ' N ' ' O ' ' A' ' 167' ' ' ASN . 89.4 m-20 -83.4 19.73 1.48 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.605 ' OG1' ' HB3' ' A' ' 166' ' ' LEU . 57.6 m -51.88 -36.08 47.35 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.502 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.0 OUTLIER 58.26 139.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.157 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.628 ' O ' ' HD3' ' A' ' 176' ' ' ARG . 58.1 mp0 -60.39 -36.25 77.65 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -58.8 -40.9 85.42 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.598 ' HB2' ' O ' ' A' ' 170' ' ' THR . 82.8 m-20 -61.69 -36.63 81.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 179' ' ' PHE . 7.0 mt -55.74 -51.31 67.79 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.628 ' HD3' ' O ' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -67.93 -30.36 69.66 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.298 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -58.42 -39.35 79.52 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.37 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.64 ' OH ' ' CG ' ' A' ' 221' ' ' HIS . 0.0 OUTLIER -96.04 -55.52 2.95 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.25 179.199 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.627 ' CE2' ' CE2' ' A' ' 178' ' ' TYR . 72.5 m-85 -60.14 -27.15 66.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.397 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.42 -23.58 9.35 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.199 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.801 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -54.05 -40.46 67.13 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.992 0.425 . . . . 0.0 110.714 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.801 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 53.8 m-85 -69.85 -32.21 70.48 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.275 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 164.81 -130.19 2.13 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.262 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 49.1 m -120.96 140.28 52.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.414 ' CG2' ' HG ' ' A' ' 188' ' ' LEU . 0.2 OUTLIER -92.88 120.65 42.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.257 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.5 t -71.61 -45.53 61.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.348 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -149.9 109.51 4.02 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.477 ' CD2' ' HD2' ' A' ' 176' ' ' ARG . 0.1 OUTLIER -102.65 150.16 23.71 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.341 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 204' ' ' PHE . 18.9 tptt -133.69 124.53 26.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.94 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.503 ' HB ' ' HG3' ' A' ' 172' ' ' GLU . 1.0 OUTLIER -123.0 134.31 66.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.571 ' HB2' ' HB2' ' A' ' 200' ' ' ARG . 10.0 mmt -86.93 135.16 33.4 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -131.79 138.75 48.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.736 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 7.4 t0 -121.72 75.7 36.56 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.594 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -60.47 -25.81 81.38 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.521 2.147 . . . . 0.0 111.998 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -71.83 -67.9 0.5 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.255 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 49.2 p -68.95 -26.98 65.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.112 0.482 . . . . 0.0 110.079 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.93 4.09 67.48 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.585 -0.734 . . . . 0.0 113.09 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.465 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 6.0 tpt180 -127.13 121.85 32.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.239 0.52 . . . . 0.0 110.329 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 191' ' ' MET . 66.5 p -71.91 160.56 32.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.919 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.571 ' HB2' ' HB2' ' A' ' 191' ' ' MET . 23.9 mmm180 -58.3 -34.34 70.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.861 0.362 . . . . 0.0 110.093 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 94.39 -0.98 66.33 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.526 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.565 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 38.7 p90 -137.96 159.04 43.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.934 0.397 . . . . 0.0 110.426 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 189' ' ' LYS . . . -153.21 171.33 32.16 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.028 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.601 ' HA ' ' O ' ' A' ' 161' ' ' MET . 73.0 m-85 -110.2 125.3 52.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.833 0.349 . . . . 0.0 110.756 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.536 ' O ' ' HB2' ' A' ' 161' ' ' MET . 23.5 tp -110.1 132.18 54.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.401 ' O ' HG21 ' A' ' 185' ' ' VAL . 45.7 m -121.48 145.69 47.68 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.182 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.48 ' CE2' ' CG2' ' A' ' 216' ' ' VAL . 96.9 m-85 -121.4 147.59 45.52 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.862 0.363 . . . . 0.0 111.826 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.44 -35.7 80.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.328 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.45 119.19 53.63 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.603 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.15 -29.73 76.36 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.32 2.013 . . . . 0.0 112.636 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.3 t -59.54 -37.46 78.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 0.0 110.858 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 24.0 m -59.25 -34.87 72.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.047 0.451 . . . . 0.0 110.5 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 70.8 t -61.1 -42.74 94.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.211 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -59.55 -43.4 93.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.921 0.391 . . . . 0.0 111.046 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.411 ' HB3' ' CE2' ' A' ' 182' ' ' TYR . 98.4 mt-10 -69.38 -35.38 75.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.368 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.549 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 99.0 t -60.91 -46.42 96.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.899 0.38 . . . . 0.0 110.829 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 14.8 p -75.44 -40.01 41.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -59.11 -36.96 76.08 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 29.9 m -96.37 144.61 26.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.156 0.503 . . . . 0.0 112.077 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -92.09 125.24 36.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.851 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.64 ' CG ' ' OH ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -130.58 155.89 45.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.177 0.513 . . . . 0.0 111.39 -178.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.431 ' CG2' ' O ' ' A' ' 226' ' ' LYS . 73.5 mt -122.12 125.76 73.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.297 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.516 ' HG ' ' CE2' ' A' ' 178' ' ' TYR . 3.8 mt -103.26 125.36 49.88 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.927 0.394 . . . . 0.0 111.607 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 52.58 41.16 31.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.29 2.18 87.06 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.897 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.431 ' O ' ' CG2' ' A' ' 222' ' ' ILE . 21.8 mmtt -107.18 137.96 44.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.3 0.55 . . . . 0.0 111.131 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 10.1 p -80.49 125.08 39.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.138 0.494 . . . . 0.0 111.094 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.401 ' CD1' HD13 ' A' ' 223' ' ' LEU . 34.4 pt -126.38 156.34 36.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.95 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -131.05 83.38 60.91 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.384 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.503 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 72.8 Cg_exo -52.76 130.73 38.53 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.606 2.204 . . . . 0.0 112.061 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -136.72 144.29 43.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.0 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.432 ' HD2' ' N ' ' A' ' 233' ' ' ALA . 3.8 tmm_? -54.61 140.53 34.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.993 0.425 . . . . 0.0 111.188 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.432 ' N ' ' HD2' ' A' ' 232' ' ' ARG . . . -59.74 149.17 31.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.184 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 3.5 tt -112.62 134.98 21.53 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.019 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.14 144.27 99.45 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.587 1.525 . . . . 0.0 109.547 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.3 mmt180 -55.84 -36.57 67.66 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.745 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -60.97 -43.03 99.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.388 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -68.43 -37.52 80.36 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.115 0.483 . . . . 0.0 110.719 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -59.11 -43.58 91.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.908 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -65.46 -39.1 91.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.718 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -59.49 -39.24 83.11 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 21.1 p -90.64 161.23 15.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.178 0.513 . . . . 0.0 112.005 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.36 166.56 25.76 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.626 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 289' ' ' VAL . 39.7 ttpt -136.85 132.31 34.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.864 0.332 . . . . 0.0 111.338 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.656 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -115.74 163.76 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-O 121.282 0.563 . . . . 0.0 111.028 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.428 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 89.0 t80 -100.23 137.38 38.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.67 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.509 HG21 HG12 ' A' ' 315' ' ' ILE . 7.9 p -129.78 145.39 35.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.963 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.587 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.07 166.85 18.66 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 178.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.49 15.7 56.5 Favored Glycine 0 N--CA 1.454 -0.131 0 C-N-CA 120.015 -1.088 . . . . 0.0 112.533 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.538 ' CD1' ' CE1' ' A' ' 259' ' ' PHE . 69.8 mt -110.66 131.99 60.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.516 0.198 . . . . 0.0 110.595 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.416 ' O ' ' CG1' ' A' ' 254' ' ' VAL . . . -167.98 -116.29 0.36 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.239 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.82 142.13 98.63 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.623 2.216 . . . . 0.0 113.294 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . 0.416 ' O ' ' NZ ' ' A' ' 309' ' ' LYS . 85.5 m-20 54.98 43.58 29.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.351 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 255' ' ' ARG . 7.1 p -108.31 -50.87 7.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.239 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 254' ' ' VAL . 7.7 mpt_? 59.07 132.01 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.224 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.5 -27.97 52.49 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.154 1.903 . . . . 0.0 112.911 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -60.72 -48.09 83.37 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.584 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 61.0 mp0 -69.3 -36.98 77.58 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.538 ' CE1' ' CD1' ' A' ' 250' ' ' ILE . 18.6 t80 -61.8 -49.52 75.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.649 0.262 . . . . 0.0 110.679 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 264' ' ' SER . 84.4 tt0 -64.15 -37.73 88.5 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.438 ' HB3' ' HA ' ' A' ' 258' ' ' GLU . 43.0 tp10 -62.62 -39.28 93.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.669 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.66 ' HD2' ' CD1' ' A' ' 263' ' ' PHE . 89.8 t80 -64.87 -58.52 5.95 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.668 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 33.4 m-85 -69.7 -23.24 63.4 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.499 ' N ' HD13 ' A' ' 269' ' ' ILE . 30.4 t -56.57 -32.33 65.1 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -54.71 -34.23 62.1 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.668 ' CZ2' ' CD2' ' A' ' 263' ' ' PHE . 8.5 p90 -119.86 56.53 0.95 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.255 0.55 . . . . 0.0 112.073 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.572 ' HA2' ' CD1' ' A' ' 291' ' ' TYR . . . 160.65 -31.74 0.37 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.786 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.42 ' CB ' ' O ' ' A' ' 267' ' ' GLY . 0.5 OUTLIER 85.34 2.82 0.65 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.777 0.431 . . . . 0.0 111.544 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.511 ' CD1' ' HB2' ' A' ' 263' ' ' PHE . 76.4 mt 30.13 108.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.623 ' CD1' ' HB3' ' A' ' 292' ' ' ASP . 32.0 mm -68.49 -36.01 72.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.486 175.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -137.45 -88.42 0.27 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.42 ' CB ' HG22 ' A' ' 269' ' ' ILE . . . 61.17 123.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.948 0.404 . . . . 0.0 111.548 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -141.37 154.92 45.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.031 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.62 ' O ' ' HB2' ' A' ' 275' ' ' MET . 20.0 tp -62.74 -37.58 87.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.259 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.747 ' HB2' ' HB3' ' A' ' 282' ' ' GLN . 93.8 mmm 93.83 176.71 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.848 0.717 . . . . 0.0 109.857 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -179.43 78.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.621 0.248 . . . . 0.0 111.053 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -84.37 109.66 18.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.935 0.398 . . . . 0.0 110.241 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 59.6 mttp 57.12 35.43 26.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.685 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 53.82 44.26 29.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.74 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 1.7 t 174.98 35.16 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.726 0.298 . . . . 0.0 111.585 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -99.46 -73.33 1.07 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.696 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.747 ' HB3' ' HB2' ' A' ' 275' ' ' MET . 5.0 pp0? -59.69 -30.96 69.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.43 ' N ' ' CD ' ' A' ' 282' ' ' GLN . 85.0 p -56.85 -22.96 40.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.555 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -56.52 -33.34 65.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.249 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 250' ' ' ILE . . . 144.98 28.08 0.1 OUTLIER Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.116 -1.04 . . . . 0.0 114.733 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.525 ' CE1' ' HA ' ' A' ' 282' ' ' GLN . 17.6 p90 -141.82 165.75 26.61 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.416 1.108 . . . . 0.0 112.19 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -143.98 165.65 27.27 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.774 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.423 ' CE2' ' HE3' ' A' ' 244' ' ' LYS . 0.4 OUTLIER -116.48 127.11 54.27 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.221 0.208 . . . . 0.0 111.252 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.656 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 21.5 t -122.32 135.68 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.88 0.371 . . . . 0.0 111.924 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 52.6 m -113.84 136.02 53.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.402 178.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.572 ' CD1' ' HA2' ' A' ' 267' ' ' GLY . 31.3 m-85 -120.1 143.15 48.31 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.65 ' OD1' ' N ' ' A' ' 293' ' ' SER . 52.9 p30 -62.34 -33.97 75.74 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.329 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' SER . . . . . 0.65 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 50.8 m -127.04 145.18 50.81 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.147 0.499 . . . . 0.0 111.746 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.05 -30.69 71.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.933 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -56.61 -37.04 70.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.421 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.44 -35.46 75.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.384 . . . . 0.0 110.803 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 96.7 t -61.36 -44.05 97.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.155 0.502 . . . . 0.0 110.527 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.75 -36.8 84.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.129 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -57.55 -43.51 84.51 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.64 ' CG2' ' CZ2' ' A' ' 266' ' ' TRP . 0.7 OUTLIER -72.2 -32.25 42.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.919 0.39 . . . . 0.0 110.973 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 81.6 m -56.29 -44.74 80.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.269 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -62.42 -40.2 95.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.271 0.558 . . . . 0.0 110.054 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -63.4 -34.47 77.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.419 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.641 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 15.9 tptm 66.11 -72.7 0.08 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.803 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.641 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 16.3 m-85 -111.17 127.79 55.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.334 0.588 . . . . 0.0 111.682 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.41 HG23 ' CZ ' ' A' ' 262' ' ' PHE . 1.4 mt -118.22 138.99 47.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.584 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.425 ' OD1' ' CE ' ' A' ' 312' ' ' LYS . 73.4 m-20 -76.47 110.98 11.46 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.323 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.658 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 6.0 t80 -108.11 -70.16 0.82 Allowed 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.601 0.715 . . . . 0.0 110.063 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.469 ' HD3' ' CE2' ' A' ' 308' ' ' PHE . 0.0 OUTLIER -106.91 -158.5 0.66 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.169 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -54.88 -32.88 61.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.818 0.342 . . . . 0.0 110.789 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -113.85 153.16 29.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.012 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.425 ' CE ' ' OD1' ' A' ' 307' ' ' ASP . 18.8 mmtp -67.18 152.46 45.71 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.043 0.449 . . . . 0.0 111.008 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.587 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 27.7 pt -114.1 132.22 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -95.2 131.45 41.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.509 HG12 HG21 ' A' ' 247' ' ' VAL . 74.4 mt -118.76 125.26 74.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.429 0.633 . . . . 0.0 112.488 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -132.8 155.65 48.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.908 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -55.3 144.96 23.18 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . 0.574 ' O ' ' CB ' ' A' ' 319' ' ' GLU . . . -94.67 131.62 40.27 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . 0.574 ' CB ' ' O ' ' A' ' 318' ' ' ALA . 4.4 tm-20 . . . . . 0 N--CA 1.467 0.39 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.984 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.463 0.197 0 CA-C-O 120.813 0.34 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.446 ' HG2' ' CB ' ' A' ' 233' ' ' ALA . 74.5 tttt -129.99 142.13 50.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.062 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.45 ' N ' ' O ' ' A' ' 205' ' ' LEU . 87.4 mmm -118.84 148.69 42.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.451 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.576 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 4.2 t80 -107.03 129.05 54.86 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 7.7 mm -116.64 125.05 73.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.783 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 228' ' ' ILE . . . -125.63 158.79 20.04 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 178.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.43 33.37 53.11 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.194 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 83.0 mt -59.38 -18.63 40.42 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.785 ' O ' ' N ' ' A' ' 169' ' ' ASP . 58.2 t30 73.5 41.97 0.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -177.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 9.5 m0 41.32 -55.65 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.858 -1.064 . . . . 0.0 113.823 178.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.785 ' N ' ' O ' ' A' ' 167' ' ' ASN . 52.9 p30 -58.02 -31.2 66.74 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.521 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 86.2 m -65.56 138.11 57.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.248 0.547 . . . . 0.0 111.293 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 9.3 p -117.64 166.93 11.82 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.345 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.488 ' N ' ' CD1' ' A' ' 190' ' ' ILE . 20.8 pt-20 -60.73 -25.78 66.69 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.65 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 90.6 m-20 -61.37 -43.69 98.44 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.133 0.492 . . . . 0.0 110.095 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -67.36 -37.65 83.53 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.861 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.464 HD21 ' CD2' ' A' ' 179' ' ' PHE . 3.3 mt -58.43 -43.73 88.86 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.65 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -67.02 -36.72 82.75 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.295 179.202 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.417 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 48.6 tp10 -64.56 -40.91 96.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.065 0.46 . . . . 0.0 110.411 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.626 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 59.4 t80 -74.93 -61.68 1.8 Allowed 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.604 0.716 . . . . 0.0 111.111 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.464 ' CD2' HD21 ' A' ' 175' ' ' LEU . 80.1 m-85 -70.68 -15.7 62.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.514 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.71 -27.76 20.67 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.243 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.804 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -57.5 -41.93 81.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.107 0.479 . . . . 0.0 110.431 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.804 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 68.6 m-85 -70.39 -35.56 73.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.841 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -177.09 -176.65 45.39 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.464 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.518 ' O ' HG21 ' A' ' 185' ' ' VAL . 44.2 m -64.53 -30.75 71.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.123 -0.538 . . . . 0.0 111.476 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.631 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 0.6 OUTLIER 65.54 90.14 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 121.854 0.835 . . . . 0.0 108.91 -177.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.0 t -59.23 -44.02 92.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.915 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -139.72 136.26 34.01 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.58 133.04 56.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.316 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 9.1 tptp -134.01 120.95 20.91 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.488 ' CD1' ' N ' ' A' ' 172' ' ' GLU . 0.4 OUTLIER -128.24 134.08 65.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.361 176.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.533 ' CE ' ' HA3' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -90.47 140.03 30.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.746 -179.078 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -133.31 168.48 18.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.919 0.39 . . . . 0.0 111.377 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 7.4 m-20 -117.7 93.92 44.77 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.383 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.53 -24.64 29.46 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.335 2.024 . . . . 0.0 112.693 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -75.55 -83.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.673 0.273 . . . . 0.0 111.449 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 63.2 p -71.77 -24.13 61.7 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.443 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 92.47 7.15 63.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.772 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 4.2 tpt180 -82.22 154.25 25.52 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.946 0.403 . . . . 0.0 110.781 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 28.3 t -105.69 146.84 29.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.718 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.628 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 34.2 mmt180 -54.33 -30.89 52.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.894 0.378 . . . . 0.0 110.296 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 97.25 -2.02 60.96 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.237 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.628 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 39.7 p90 -139.4 155.57 47.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.058 0.456 . . . . 0.0 110.387 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.533 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -148.31 169.28 28.97 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.664 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.576 ' CE2' ' CD1' ' A' ' 162' ' ' PHE . 95.9 m-85 -107.84 125.76 51.83 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.083 0.468 . . . . 0.0 109.945 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.552 HD23 ' CZ ' ' A' ' 207' ' ' PHE . 6.0 tt -108.42 128.56 54.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.577 -178.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.449 ' N ' HD22 ' A' ' 205' ' ' LEU . 49.9 m -120.34 142.53 49.05 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.331 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.552 ' CZ ' HD23 ' A' ' 205' ' ' LEU . 84.8 m-85 -119.14 141.21 49.02 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.712 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.06 -35.51 80.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.166 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -108.17 117.37 55.04 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.756 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . 0.409 ' O ' ' CG1' ' A' ' 213' ' ' VAL . 45.5 Cg_exo -56.74 -26.38 65.6 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.563 2.175 . . . . 0.0 113.276 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 85.7 p -61.78 -32.35 72.61 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.325 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 24.7 m -60.31 -35.5 75.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.809 0.338 . . . . 0.0 110.706 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.444 HG11 ' N ' ' A' ' 214' ' ' ASP . 2.6 p -58.85 -35.34 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.981 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.444 ' N ' HG11 ' A' ' 213' ' ' VAL . 20.4 t70 -59.06 -44.63 91.86 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.008 0.432 . . . . 0.0 110.73 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -68.25 -33.07 73.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.58 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.945 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 99.0 t -58.97 -40.68 81.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.261 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.402 HG21 ' N ' ' A' ' 218' ' ' LYS . 24.2 m -77.73 -29.85 16.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.16 -0.616 . . . . 0.0 112.062 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.402 ' N ' HG21 ' A' ' 217' ' ' VAL . 27.8 tptp -60.15 -38.78 84.17 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.779 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 60.4 m -91.48 146.59 23.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.761 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -67.13 -42.0 85.19 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.529 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.945 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 57.8 m-70 74.95 96.04 0.07 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 72.3 mt -113.53 115.81 50.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.6 tt -123.77 126.07 45.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.008 0.433 . . . . 0.0 111.148 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 54.63 42.45 31.25 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 91.0 -30.95 5.88 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.612 -0.804 . . . . 0.0 114.33 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -103.13 155.82 18.14 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 11.9 p -102.81 124.48 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 164' ' ' GLY . 17.8 pt -84.94 -26.9 6.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -177.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 23.7 t70 52.37 70.58 1.81 Allowed Pre-proline 0 C--N 1.318 -0.802 0 CA-C-O 121.532 0.682 . . . . 0.0 110.802 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.657 ' HD2' ' CD2' ' A' ' 221' ' ' HIS . 43.6 Cg_exo -58.83 136.39 73.32 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.942 3.095 . . . . 0.0 112.122 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.408 ' N ' ' HE2' ' A' ' 161' ' ' MET . 14.1 ttpt -138.35 150.11 46.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.351 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -48.35 147.17 2.45 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 110.789 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.446 ' CB ' ' HG2' ' A' ' 160' ' ' LYS . . . -98.0 145.0 26.94 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.209 0.528 . . . . 0.0 112.199 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -110.9 126.22 29.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.13 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.565 ' HB2' ' OE1' ' A' ' 238' ' ' GLU . 36.8 Cg_exo -54.49 152.54 26.29 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.492 1.462 . . . . 0.0 110.549 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -52.32 -37.83 56.96 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -57.88 -43.57 86.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.565 ' OE1' ' HB2' ' A' ' 235' ' ' PRO . 58.9 mp0 -67.9 -36.99 81.17 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.705 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -59.98 -38.15 81.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.988 0.423 . . . . 0.0 110.732 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -61.2 -37.21 82.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.543 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -88.44 4.26 47.07 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.429 HG23 ' HA ' ' A' ' 292' ' ' ASP . 16.7 p -121.33 160.86 23.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.052 0.453 . . . . 0.0 112.021 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.27 167.52 25.18 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.606 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.578 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 78.2 tttt -136.57 137.21 39.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.209 0.505 . . . . 0.0 110.905 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.409 HD11 ' CG2' ' A' ' 315' ' ' ILE . 7.1 pt -120.31 157.54 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.39 0.614 . . . . 0.0 112.126 -178.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.422 ' CE1' ' CD2' ' A' ' 286' ' ' PHE . 81.0 t80 -94.78 130.34 41.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.96 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.693 HG12 HG12 ' A' ' 315' ' ' ILE . 57.2 t -124.6 133.17 70.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.643 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.697 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -119.98 166.96 13.51 Favored Glycine 0 C--O 1.225 -0.445 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 313' ' ' ILE . . . 94.54 13.36 53.98 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.132 -1.033 . . . . 0.0 112.103 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.489 ' CD1' ' CE1' ' A' ' 259' ' ' PHE . 67.4 mt -108.84 130.61 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 120.812 0.339 . . . . 0.0 110.491 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.478 ' O ' ' CG2' ' A' ' 254' ' ' VAL . . . -165.27 -119.11 0.46 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.544 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.38 144.08 96.77 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 122.313 2.009 . . . . 0.0 113.137 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 57.34 45.68 19.67 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.572 ' O ' ' HB2' ' A' ' 258' ' ' GLU . 16.1 m -118.33 -50.89 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.388 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 62.83 130.25 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.195 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.68 -28.62 47.6 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 121.98 1.787 . . . . 0.0 112.194 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 12.7 tptp -60.6 -44.14 96.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.142 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.572 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 79.3 mm-40 -66.91 -39.77 87.48 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.84 0.352 . . . . 0.0 111.085 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.599 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 30.5 t80 -63.25 -48.01 80.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.537 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.427 ' O ' ' CD1' ' A' ' 269' ' ' ILE . 84.3 tt0 -64.46 -42.74 95.76 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.36 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -76.7 -28.85 56.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.83 0.348 . . . . 0.0 110.81 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.513 ' CD2' ' CD1' ' A' ' 263' ' ' PHE . 12.8 t80 -60.66 -55.59 31.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.169 0.509 . . . . 0.0 111.39 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.64 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 10.4 m-85 -69.64 -22.45 63.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.994 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.493 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 27.8 t -57.22 -30.94 65.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.892 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -54.04 -36.11 62.71 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.678 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 7.3 p90 -117.76 41.36 2.88 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.763 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.494 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 159.92 147.93 5.07 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.985 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.412 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 52.5 m -59.52 -36.85 76.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 0.0 111.285 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.541 HD12 ' CB ' ' A' ' 263' ' ' PHE . 69.8 mt 68.81 78.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.395 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.545 ' O ' ' OD1' ' A' ' 271' ' ' ASP . 32.1 mm -58.91 -45.59 91.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.449 -0.5 . . . . 0.0 112.094 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.545 ' OD1' ' O ' ' A' ' 270' ' ' ILE . 83.4 m-20 -151.26 90.7 1.61 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -106.03 132.62 51.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.528 0.204 . . . . 0.0 110.506 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -145.61 151.61 38.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.285 0.564 . . . . 0.0 111.885 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.588 ' O ' ' HB2' ' A' ' 275' ' ' MET . 26.3 tp -66.05 -36.57 83.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.713 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.588 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 96.0 mmm 84.13 114.28 0.05 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.513 -178.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.435 ' HG ' ' HB3' ' A' ' 283' ' ' SER . 5.1 mp -122.39 138.58 54.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.744 0.306 . . . . 0.0 111.418 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.454 ' HB2' ' HA2' ' A' ' 281' ' ' GLY . 85.0 m-20 -129.4 100.39 5.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.084 0.469 . . . . 0.0 110.679 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 63.48 35.99 11.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.17 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 51.45 43.82 29.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.75 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 169.86 47.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.041 0.448 . . . . 0.0 110.753 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . 0.454 ' HA2' ' HB2' ' A' ' 277' ' ' ASP . . . -139.53 -105.38 0.64 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.135 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.441 ' OE1' ' HB3' ' A' ' 275' ' ' MET . 96.5 mt-30 -56.85 -27.04 59.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.209 -0.496 . . . . 0.0 111.525 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 275' ' ' MET . 83.3 p -53.18 -24.63 11.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.95 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -118.58 136.89 53.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.652 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 105.96 -57.95 0.46 Allowed Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.573 -0.823 . . . . 0.0 114.242 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 247' ' ' VAL . 32.5 p90 -140.72 166.77 23.84 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.757 0.779 . . . . 0.0 112.652 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -135.93 154.83 22.04 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.461 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.578 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -110.22 129.89 55.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.747 0.308 . . . . 0.0 111.711 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.599 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 55.1 t -124.48 134.84 65.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.978 0.418 . . . . 0.0 111.901 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 63.0 m -115.48 135.75 53.79 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.494 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 38.9 m-85 -117.04 139.51 50.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.491 ' CA ' HG12 ' A' ' 270' ' ' ILE . 51.1 t0 -58.22 -36.53 73.28 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.421 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 49.1 m -123.66 144.2 49.78 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.318 0.58 . . . . 0.0 112.053 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.92 -30.61 71.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.693 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -56.26 -37.53 69.91 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.005 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -61.21 -36.65 80.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.011 0.434 . . . . 0.0 110.403 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.428 ' O ' HG11 ' A' ' 300' ' ' VAL . 75.1 t -61.74 -42.82 95.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.234 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -61.5 -37.68 84.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.53 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -59.06 -44.09 91.8 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.678 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 0.8 OUTLIER -71.9 -33.04 46.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.175 -179.654 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 89.0 m -57.88 -45.6 86.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.142 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -61.09 -41.46 96.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.254 0.549 . . . . 0.0 110.018 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -61.91 -33.05 73.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.211 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.624 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 31.8 tptt 68.16 -74.21 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -178.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.624 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.0 m-30 -113.31 141.55 46.88 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.424 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.514 ' CD1' ' CH2' ' A' ' 266' ' ' TRP . 34.6 mt -116.98 136.65 53.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -75.09 79.82 2.25 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.367 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 9.1 t80 -83.17 -105.7 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.978 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 310' ' ' ASP . 4.2 mmpt? -60.71 -34.96 75.17 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 309' ' ' LYS . 52.2 p30 137.78 0.17 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.997 0.919 . . . . 0.0 111.142 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 312' ' ' LYS . 73.3 mtt85 -98.18 4.44 48.96 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.432 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 95.1 mttt 65.04 54.07 1.29 Allowed 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.109 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.697 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 20.3 pt -50.14 99.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.777 0.799 . . . . 0.0 110.784 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . 0.566 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 92.4 mt-10 -60.91 139.53 57.97 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.19 -178.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.693 HG12 HG12 ' A' ' 247' ' ' VAL . 63.2 mt -121.65 128.14 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.009 0.433 . . . . 0.0 111.065 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -133.85 142.78 47.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.112 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 21.7 ttp-105 -50.8 146.74 5.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.699 0.285 . . . . 0.0 110.624 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.23 143.51 27.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.402 . . . . 0.0 111.131 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.358 -179.394 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.469 0.478 0 CA-C-O 120.846 0.355 . . . . 0.0 111.881 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.463 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 21.8 tttt -96.2 137.5 35.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.499 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.615 ' HE1' ' HB ' ' A' ' 216' ' ' VAL . 8.5 tpp -114.36 145.4 41.87 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.637 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 6.8 t80 -102.85 131.85 49.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.925 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.595 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 17.5 mm -116.63 132.37 66.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.354 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.439 ' O ' ' CG2' ' A' ' 228' ' ' ILE . . . -123.59 156.64 17.9 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.294 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.31 34.95 44.2 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.407 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.499 ' CD1' ' HA ' ' A' ' 202' ' ' PHE . 4.4 mp -92.62 141.75 28.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.638 0.256 . . . . 0.0 110.732 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.16 135.44 57.72 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.546 ' CD1' ' O ' ' A' ' 199' ' ' SER . 4.3 m0 -53.91 -33.66 57.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.794 0.331 . . . . 0.0 110.754 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -93.22 9.72 34.91 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.422 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 171' ' ' THR . 98.5 m -56.98 -40.54 76.72 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.1 OUTLIER 54.32 162.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -177.322 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.5 ' O ' ' HD3' ' A' ' 176' ' ' ARG . 57.2 mp0 -62.73 -28.56 70.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.113 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.544 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 92.6 m-20 -55.47 -43.44 75.53 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -67.46 -36.95 82.17 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.504 HD21 ' CD2' ' A' ' 179' ' ' PHE . 6.1 mt -56.38 -48.39 76.97 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.544 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -68.42 -30.36 69.24 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.333 179.15 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -56.89 -39.4 74.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.577 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.661 ' OH ' ' CD2' ' A' ' 221' ' ' HIS . 0.0 OUTLIER -96.37 -59.47 1.82 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.967 0.413 . . . . 0.0 110.092 178.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.625 ' CE2' ' CE2' ' A' ' 178' ' ' TYR . 70.9 m-85 -59.87 -31.95 70.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.544 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.13 -25.37 7.75 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.11 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.798 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -56.41 -41.19 75.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.775 0.321 . . . . 0.0 111.487 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.798 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 69.8 m-85 -70.56 -35.74 73.25 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -174.66 -177.54 43.87 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.475 -1.345 . . . . 0.0 114.195 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 61.1 m -62.73 -34.38 77.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.699 -0.75 . . . . 0.0 111.867 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 185' ' ' VAL . 0.5 OUTLIER 67.15 106.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 206' ' ' SER . 43.3 p -64.78 -36.79 85.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.983 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -154.01 150.65 28.49 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.4 HD13 ' CD1' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -118.47 133.66 55.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.348 179.188 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 10.5 tptt -133.48 119.09 19.13 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.484 HD13 ' HA ' ' A' ' 172' ' ' GLU . 0.8 OUTLIER -128.58 137.66 56.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.034 177.506 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.549 ' HB2' ' HB2' ' A' ' 200' ' ' ARG . 0.3 OUTLIER -96.19 127.53 42.28 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.857 -179.525 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -131.95 155.52 47.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.983 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.601 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 15.2 t0 -120.55 80.82 31.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.442 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.09 -24.85 42.49 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.52 2.147 . . . . 0.0 112.642 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.79 -70.52 0.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.867 0.365 . . . . 0.0 111.111 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 49.4 p -73.08 -20.56 60.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.812 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 84.87 19.72 59.06 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.53 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.601 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 8.3 tpt180 -115.6 151.92 34.05 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 120.756 0.312 . . . . 0.0 110.466 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.546 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 49.1 m -117.34 153.4 33.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.904 0.383 . . . . 0.0 110.809 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.641 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 30.5 mmt180 -54.34 -34.5 61.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 110.961 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 166' ' ' LEU . . . 90.71 5.61 68.59 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.231 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.641 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 22.5 p90 -140.36 158.92 43.29 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.881 0.372 . . . . 0.0 110.641 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.454 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -143.02 162.9 27.47 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.402 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.637 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 95.8 m-85 -109.68 129.59 55.59 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.867 0.365 . . . . 0.0 110.199 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.492 HD13 ' CE2' ' A' ' 179' ' ' PHE . 61.1 mt -104.54 141.21 36.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.778 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 186' ' ' THR . 18.0 t -127.94 128.37 44.98 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.447 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 98.1 m-85 -120.41 143.08 48.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.14 0.495 . . . . 0.0 112.073 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.402 ' N ' ' CG2' ' A' ' 186' ' ' THR . 47.3 tp10 -62.14 -34.37 76.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.063 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -110.83 116.23 52.29 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.4 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.7 -30.59 76.31 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.454 2.103 . . . . 0.0 113.064 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.418 ' O ' ' OD1' ' A' ' 214' ' ' ASP . 25.6 m -59.39 -35.51 74.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.626 0.25 . . . . 0.0 110.926 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 24.8 m -57.01 -34.61 68.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.131 0.491 . . . . 0.0 109.898 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.402 ' CG1' ' CD ' ' A' ' 232' ' ' ARG . 83.5 t -63.49 -38.4 82.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.678 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.695 ' OD1' ' N ' ' A' ' 215' ' ' GLU . 36.4 p30 -60.35 -39.4 87.0 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.746 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.695 ' N ' ' OD1' ' A' ' 214' ' ' ASP . 97.8 mt-10 -70.95 -35.52 72.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.527 0.68 . . . . 0.0 110.714 177.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.723 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 93.9 t -60.44 -36.88 72.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.528 -178.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.432 ' HB ' ' HE3' ' A' ' 161' ' ' MET . 6.5 p -87.21 -54.22 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -60.44 -36.74 78.93 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 215' ' ' GLU . 62.0 m -58.26 -37.75 75.58 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 63.86 110.56 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -177.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.723 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 0.0 OUTLIER -137.98 175.13 9.86 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -176.037 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 227' ' ' VAL . 17.8 mm -115.36 120.25 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.75 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 18.8 tp -69.64 -43.81 71.89 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.644 -0.423 . . . . 0.0 112.017 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -177.36 69.68 0.02 OUTLIER 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.741 0.305 . . . . 0.0 111.774 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 95.21 -8.09 69.54 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.467 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -124.08 157.76 33.81 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 117.036 0.418 . . . . 0.0 111.584 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.5 ' HA ' HD11 ' A' ' 222' ' ' ILE . 44.3 t -93.88 126.95 46.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.165 0.507 . . . . 0.0 110.26 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 164' ' ' GLY . 31.6 pt -126.87 155.98 37.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.048 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 8.7 p30 -132.15 81.57 61.15 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 121.191 0.519 . . . . 0.0 110.421 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.429 ' HD3' HG13 ' A' ' 228' ' ' ILE . 92.8 Cg_exo -47.51 127.02 13.05 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.72 2.28 . . . . 0.0 111.345 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -132.45 144.96 50.83 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.684 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.402 ' CD ' ' CG1' ' A' ' 213' ' ' VAL . 57.3 mmm-85 -50.06 143.1 8.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.202 0.525 . . . . 0.0 111.269 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.62 150.08 48.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.787 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . 0.41 ' HB ' ' NE2' ' A' ' 239' ' ' GLN . 34.4 mt -117.44 140.4 27.32 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.935 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.46 ' HD2' ' OE1' ' A' ' 238' ' ' GLU . 45.0 Cg_exo -55.26 139.84 81.27 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 121.758 1.639 . . . . 0.0 111.229 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.44 ' O ' ' HD3' ' A' ' 236' ' ' ARG . 3.2 tmt_? -56.83 -41.12 77.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.728 0.299 . . . . 0.0 111.123 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -60.01 -39.35 85.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.368 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.46 ' OE1' ' HD2' ' A' ' 235' ' ' PRO . 94.8 mt-10 -63.66 -32.62 74.16 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.701 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.41 ' NE2' ' HB ' ' A' ' 234' ' ' ILE . 98.9 mm-40 -58.24 -38.52 77.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.998 0.428 . . . . 0.0 110.213 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -61.06 -42.33 98.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.223 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -63.15 -36.0 82.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.461 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 21.0 p -83.26 161.44 21.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.155 0.502 . . . . 0.0 111.897 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.94 169.99 25.07 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.609 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.539 ' CE ' ' CD2' ' A' ' 288' ' ' PHE . 46.9 tptt -134.71 130.36 36.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.861 0.331 . . . . 0.0 110.706 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.433 HD11 ' CG2' ' A' ' 315' ' ' ILE . 5.5 pt -123.5 154.84 29.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 121.11 0.481 . . . . 0.0 110.65 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.431 ' CE1' ' CD2' ' A' ' 286' ' ' PHE . 92.9 t80 -97.28 133.37 42.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.651 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.654 ' CG2' ' CZ ' ' A' ' 263' ' ' PHE . 21.4 t -121.42 139.36 48.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.032 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.598 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -129.02 171.93 19.77 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.18 36.9 16.56 Favored Glycine 0 C--N 1.323 -0.181 0 C-N-CA 120.071 -1.061 . . . . 0.0 111.901 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.48 ' CD1' ' HA2' ' A' ' 287' ' ' GLY . 69.8 mt -111.66 132.32 60.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.598 0.237 . . . . 0.0 110.81 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.511 ' O ' ' CG2' ' A' ' 254' ' ' VAL . . . -158.16 -119.59 0.57 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.246 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.63 140.58 95.45 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.38 2.053 . . . . 0.0 113.482 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 54.15 44.06 29.74 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.402 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 251' ' ' GLY . 22.4 m -121.04 27.77 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.533 ' HG3' ' HD2' ' A' ' 256' ' ' PRO . 0.2 OUTLIER -39.96 155.12 0.18 Allowed Pre-proline 0 N--CA 1.465 0.304 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.533 ' HD2' ' HG3' ' A' ' 255' ' ' ARG . 7.5 Cg_endo -50.19 -29.47 22.77 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.051 1.834 . . . . 0.0 112.128 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -62.05 -45.72 92.31 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.036 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -68.29 -42.11 79.97 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.101 0.477 . . . . 0.0 111.066 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.468 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 35.3 t80 -66.13 -47.2 74.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.294 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.43 ' O ' HD11 ' A' ' 269' ' ' ILE . 84.4 tt0 -64.9 -41.37 95.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.333 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -75.01 -31.98 61.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.613 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.637 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 83.4 t80 -59.51 -55.61 32.42 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.732 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 25.3 m-85 -66.85 -30.65 70.88 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.648 ' N ' HD13 ' A' ' 269' ' ' ILE . 16.5 m -56.01 -27.43 52.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.758 0.313 . . . . 0.0 111.194 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -51.89 -38.04 54.66 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.732 ' CZ2' ' CD2' ' A' ' 263' ' ' PHE . 19.9 p90 -110.84 48.08 0.94 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.586 0.708 . . . . 0.0 111.954 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 133.28 149.08 6.04 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.313 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 53.4 m -69.76 131.85 45.18 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.648 HD13 ' N ' ' A' ' 264' ' ' SER . 49.6 mt -94.44 135.92 27.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.005 0.431 . . . . 0.0 111.395 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.515 HG12 ' N ' ' A' ' 292' ' ' ASP . 27.3 mm -92.38 -75.09 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.49 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 272' ' ' ALA . 90.4 m-20 -93.0 -75.51 0.49 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.469 ' O ' ' O ' ' A' ' 271' ' ' ASP . . . 42.79 108.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -140.64 157.73 45.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.222 0.534 . . . . 0.0 111.68 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.57 ' O ' ' HB2' ' A' ' 275' ' ' MET . 25.9 tp -62.17 -37.39 85.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.537 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.57 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 84.9 mtp 86.27 128.26 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.95 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.571 ' HA ' ' O ' ' A' ' 281' ' ' GLY . 31.9 mt -130.14 120.9 25.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.853 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 278' ' ' LYS . 55.1 t0 -61.0 -41.75 97.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.213 0.53 . . . . 0.0 110.192 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 277' ' ' ASP . 98.8 mttt -165.28 59.09 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.975 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 58.17 44.62 18.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.739 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 1.5 t -178.66 -34.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.401 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 276' ' ' LEU . . . -83.39 178.48 52.71 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.436 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.47 ' OE1' ' HB3' ' A' ' 275' ' ' MET . 98.1 mt-30 42.9 21.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 94.0 p -80.54 -30.82 37.1 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -134.36 154.04 51.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.362 0.601 . . . . 0.0 112.463 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.13 -40.94 2.27 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.041 -0.981 . . . . 0.0 114.422 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.45 ' HE2' ' SD ' ' A' ' 275' ' ' MET . 12.4 p90 -149.0 165.55 31.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.792 0.796 . . . . 0.0 111.556 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.48 ' HA2' ' CD1' ' A' ' 250' ' ' ILE . . . -138.99 153.79 22.94 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.975 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.539 ' CD2' ' CE ' ' A' ' 244' ' ' LYS . 0.3 OUTLIER -109.59 127.38 54.47 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.594 0.358 . . . . 0.0 110.364 179.255 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.502 HG22 ' CD2' ' A' ' 263' ' ' PHE . 38.5 t -125.32 135.45 63.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.453 ' OG1' ' CD ' ' A' ' 244' ' ' LYS . 47.5 m -120.27 136.52 54.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.313 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.407 ' OH ' ' O ' ' A' ' 263' ' ' PHE . 40.5 m-85 -116.21 138.4 51.32 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.515 ' N ' HG12 ' A' ' 270' ' ' ILE . 51.4 t0 -57.3 -36.35 70.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.507 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 50.6 m -122.37 145.04 48.64 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.247 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.83 -27.84 68.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.649 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -55.56 -38.42 69.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.626 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.44 -37.38 85.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.977 0.417 . . . . 0.0 110.901 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 73.1 t -62.71 -43.66 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.258 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -61.58 -38.66 88.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.29 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -59.51 -43.32 93.41 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.691 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 1.2 p -70.92 -33.04 50.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.466 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . 0.411 ' N ' HG11 ' A' ' 300' ' ' VAL . 81.6 m -57.5 -45.63 84.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.278 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -61.76 -42.2 98.68 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.207 0.527 . . . . 0.0 110.364 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.9 m-20 -63.04 -35.25 79.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.607 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.642 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 16.2 tptm 67.58 -67.79 0.17 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.642 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 16.1 m-85 -114.97 133.35 56.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.166 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.515 HD13 ' CH2' ' A' ' 266' ' ' TRP . 14.8 mt -121.45 140.17 46.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.92 178.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.54 ' OD1' ' O ' ' A' ' 307' ' ' ASP . 50.7 p30 -77.1 110.21 11.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.224 0.535 . . . . 0.0 110.884 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.637 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 7.9 t80 -110.21 -79.65 0.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.543 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.449 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 6.7 mmpt? -97.89 -162.4 0.95 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.505 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -52.76 -28.97 24.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.759 0.314 . . . . 0.0 110.456 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -109.99 152.66 25.61 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.522 ' HG2' ' HB3' ' A' ' 305' ' ' PHE . 14.2 tttp -75.29 139.99 42.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.527 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.598 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 27.4 pt -105.49 136.63 38.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.236 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . 0.437 ' HB2' ' CE2' ' A' ' 305' ' ' PHE . 84.5 tt0 -101.25 131.32 47.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.651 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.502 HD11 HG23 ' A' ' 300' ' ' VAL . 66.0 mt -119.48 127.51 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-O 121.052 0.454 . . . . 0.0 111.2 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -131.34 144.7 51.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.482 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -49.62 146.19 4.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.017 0.437 . . . . 0.0 111.065 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.32 147.36 36.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.632 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.938 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.4 m . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 120.698 0.285 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 205' ' ' LEU . 37.6 ttpt -89.49 136.59 32.94 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.099 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.556 ' HB3' ' O ' ' A' ' 231' ' ' LYS . 29.0 mtm -124.86 164.14 20.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.147 0.499 . . . . 0.0 111.239 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.578 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 1.8 t80 -98.49 130.01 45.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.302 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 202' ' ' PHE . 47.0 mt -119.28 127.73 75.84 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.67 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.705 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.431 ' O ' ' CG2' ' A' ' 228' ' ' ILE . . . -127.27 165.63 20.35 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.73 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.13 34.71 40.66 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.962 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 73.9 mt -59.25 -22.89 61.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.443 ' CB ' ' HG3' ' A' ' 226' ' ' LYS . 51.8 t30 75.59 39.61 0.33 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.198 0.523 . . . . 0.0 109.751 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 20.4 m0 33.53 35.22 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.143 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -153.94 8.2 0.35 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' A' ' 166' ' ' LEU . 55.4 m -78.71 137.16 37.65 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.372 0.606 . . . . 0.0 110.392 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 30.5 m -116.42 145.02 43.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.825 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.444 ' HA ' HD13 ' A' ' 190' ' ' ILE . 55.4 mp0 -55.66 -36.46 67.1 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.146 -0.621 . . . . 0.0 109.646 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' A' ' 176' ' ' ARG . 89.6 m-20 -65.43 -48.29 73.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.973 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -67.25 -40.8 86.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.609 0.718 . . . . 0.0 110.158 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 65.8 tp -64.68 -41.42 96.06 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.107 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 173' ' ' ASP . 41.2 ptt85 -69.66 -40.03 76.68 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.395 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 173' ' ' ASP . 75.4 mm-40 -65.12 -37.86 88.8 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.037 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.462 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 65.2 t80 -61.72 -54.53 41.33 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.416 0.627 . . . . 0.0 110.135 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -73.58 -21.83 60.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.703 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.41 -26.54 22.86 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.222 -0.99 . . . . 0.0 110.847 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.507 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -54.91 -41.49 71.03 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 123.752 0.821 . . . . 0.0 111.072 179.211 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -69.02 -32.59 72.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.099 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 174.94 -125.34 1.08 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.306 -0.95 . . . . 0.0 112.702 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 57.1 m -117.44 143.33 46.13 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 206' ' ' SER . 15.0 p -109.8 135.07 49.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.715 0.293 . . . . 0.0 110.238 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.437 HG21 ' CB ' ' A' ' 206' ' ' SER . 0.5 OUTLIER -95.79 -47.58 6.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.928 -179.18 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -136.6 132.19 34.76 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.281 0.562 . . . . 0.0 112.488 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.474 ' HG ' ' HB3' ' A' ' 176' ' ' ARG . 0.3 OUTLIER -116.22 129.72 56.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.58 179.278 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 11.7 tptt -137.03 116.07 12.41 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 172' ' ' GLU . 55.1 mt -126.74 126.26 68.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.989 176.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.547 ' SD ' ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -86.03 114.95 23.31 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.404 ' HG3' HG23 ' A' ' 190' ' ' ILE . 69.5 mttt -117.84 153.35 33.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.856 0.36 . . . . 0.0 111.458 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.591 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 3.1 t0 -124.79 74.11 64.19 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.31 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.77 -28.7 83.17 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.54 2.16 . . . . 0.0 112.905 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -66.74 -58.72 4.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.057 0.456 . . . . 0.0 111.108 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.2 p -75.16 -18.6 60.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.341 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 86.29 12.17 70.87 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.802 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.591 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 88.7 mtt-85 -122.32 177.16 5.5 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-O 120.87 0.367 . . . . 0.0 111.974 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 86.0 p -139.7 160.85 38.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.37 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.53 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 39.5 mmt180 -55.47 -31.96 62.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.989 0.423 . . . . 0.0 110.081 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.457 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 92.87 6.57 63.46 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.378 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.547 ' CE1' ' SD ' ' A' ' 191' ' ' MET . 26.2 p90 -146.56 154.33 41.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.153 0.501 . . . . 0.0 111.102 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.529 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -142.88 159.2 27.34 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.88 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.578 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 90.5 m-85 -106.83 123.66 48.48 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.502 HD23 ' CE1' ' A' ' 207' ' ' PHE . 7.3 tt -115.07 131.48 56.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.394 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.464 ' O ' HG21 ' A' ' 185' ' ' VAL . 38.8 t -116.31 135.67 53.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.015 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.502 ' CE1' HD23 ' A' ' 205' ' ' LEU . 75.5 m-85 -111.92 135.49 52.48 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.29 -35.33 78.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.464 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -109.77 115.16 55.86 Favored Pre-proline 0 C--O 1.231 0.119 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.695 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -56.2 -23.08 43.33 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.519 2.146 . . . . 0.0 112.862 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.1 t -57.66 -38.32 74.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.78 0.324 . . . . 0.0 111.113 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.457 ' O ' ' CG2' ' A' ' 216' ' ' VAL . 22.9 m -59.64 -36.56 76.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.595 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 83.0 t -60.48 -42.75 92.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.921 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -59.49 -41.45 89.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.88 0.371 . . . . 0.0 110.805 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.442 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 17.4 pt-20 -78.34 -36.41 46.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.726 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.845 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 93.8 t -63.5 -46.31 95.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 CA-C-O 120.924 0.393 . . . . 0.0 110.422 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 8.0 p -62.01 -36.62 75.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -59.97 -38.7 83.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.706 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 31.4 m -87.66 142.39 27.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.918 0.389 . . . . 0.0 111.847 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 228' ' ' ILE . 60.1 tp60 -66.23 -40.89 90.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.455 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.845 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 58.2 m-70 74.55 105.73 0.07 Allowed 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 75.3 mt -112.28 108.02 24.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.5 tt -117.0 125.99 52.21 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.948 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 55.76 41.19 30.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.03 8.29 87.41 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.95 -0.643 . . . . 0.0 114.643 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.443 ' HG3' ' CB ' ' A' ' 167' ' ' ASN . 42.2 mmtm -127.2 153.76 45.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.55 0.675 . . . . 0.0 111.961 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 34.2 m -100.06 136.93 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.64 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 220' ' ' GLN . 31.1 pt -123.75 161.85 25.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.083 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -124.95 80.3 63.79 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.119 0.485 . . . . 0.0 111.756 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.651 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 31.3 Cg_exo -63.92 76.31 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.399 2.733 . . . . 0.0 112.043 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.556 ' O ' ' HB3' ' A' ' 161' ' ' MET . 9.9 mtmt -95.5 159.42 15.01 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.117 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.458 ' HA ' ' HG2' ' A' ' 161' ' ' MET . 16.5 tpt180 -57.41 136.91 56.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.068 0.461 . . . . 0.0 111.578 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.31 145.71 55.0 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.49 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 13.9 mt -110.31 120.47 44.15 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.946 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.97 147.76 50.78 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.04 1.827 . . . . 0.0 111.309 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.401 ' HD3' ' NE2' ' A' ' 239' ' ' GLN . 25.2 mmt180 -55.86 -36.71 67.88 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -57.68 -43.19 84.89 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.003 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.447 ' O ' HG22 ' A' ' 242' ' ' THR . 97.6 mt-10 -71.92 -39.66 69.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.084 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.455 ' HA ' HG22 ' A' ' 242' ' ' THR . 27.1 mt-30 -61.18 -36.94 81.22 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.472 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -59.68 -37.31 78.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.999 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -86.41 -0.48 56.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 239' ' ' GLN . 27.3 p -87.85 162.54 16.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.081 0.467 . . . . 0.0 111.689 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -158.33 91.83 0.12 Allowed Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.767 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.587 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 77.5 tttt -79.2 132.42 36.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.764 0.316 . . . . 0.0 110.644 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.634 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -117.45 162.62 15.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.735 0.779 . . . . 0.0 112.254 -178.368 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.407 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 81.9 t80 -103.0 133.97 47.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.817 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.633 ' O ' ' HB2' ' A' ' 286' ' ' PHE . 8.2 p -128.15 135.05 63.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.351 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 286' ' ' PHE . . . -123.96 12.03 8.2 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.349 -0.929 . . . . 0.0 113.694 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . 0.515 ' HA2' ' HB ' ' A' ' 313' ' ' ILE . . . -97.78 15.76 61.35 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.725 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.477 ' CD1' ' HA2' ' A' ' 287' ' ' GLY . 31.7 pt -120.9 155.56 24.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.489 0.662 . . . . 0.0 112.597 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.452 ' O ' ' CG2' ' A' ' 254' ' ' VAL . . . -137.73 177.17 20.14 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.086 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.15 -26.96 44.39 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 121.981 1.787 . . . . 0.0 111.702 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.13 -35.1 72.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.592 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 251' ' ' GLY . 20.5 m -65.85 -28.1 43.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.74 127.35 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.07 -32.38 79.18 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.213 1.942 . . . . 0.0 113.126 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -61.15 -47.16 87.51 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.239 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 84.1 tt0 -66.67 -36.35 82.31 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.241 0.543 . . . . 0.0 110.944 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.627 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 31.3 t80 -59.5 -45.06 92.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.449 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.7 -40.32 92.16 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.321 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 258' ' ' GLU . 20.8 pt-20 -76.33 -30.64 57.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.08 0.467 . . . . 0.0 110.604 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.572 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 11.6 t80 -63.94 -55.56 21.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.057 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.571 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 4.2 m-85 -66.72 -24.66 66.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.547 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.495 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 71.2 p -60.08 -24.78 64.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.537 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -54.89 -35.76 64.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.467 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.655 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 13.0 p90 -114.39 35.43 4.21 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.073 0.463 . . . . 0.0 111.604 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 264' ' ' SER . . . 164.31 149.03 5.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.641 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 44.5 m -59.91 -36.07 76.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.944 0.402 . . . . 0.0 110.92 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.534 HD12 ' CB ' ' A' ' 263' ' ' PHE . 66.0 mt 64.82 90.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.161 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.599 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 80.5 mt -56.65 -42.47 76.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.201 178.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.451 ' OD2' ' CE ' ' A' ' 231' ' ' LYS . 61.9 t0 -168.69 100.88 0.4 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -98.73 136.72 38.37 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -143.02 155.43 44.64 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.651 ' O ' ' HB2' ' A' ' 275' ' ' MET . 30.6 tp -65.94 -35.45 80.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.176 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.651 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 86.7 mmm 105.58 -79.41 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.168 0.987 . . . . 0.0 112.234 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.434 ' HG ' ' HA ' ' A' ' 280' ' ' THR . 6.5 mp 59.14 65.92 1.12 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.461 0.172 . . . . 0.0 111.017 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.71 -41.31 81.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.383 0.611 . . . . 0.0 109.598 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' A' ' 280' ' ' THR . 55.8 mttp -142.0 114.87 8.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.966 177.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 60.59 -65.44 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.034 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 278' ' ' LYS . 0.3 OUTLIER 170.94 18.7 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -58.07 -38.58 89.94 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.691 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 286' ' ' PHE . 96.1 mm-40 -60.96 -36.37 79.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.259 0.552 . . . . 0.0 110.349 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.454 ' HB2' HD22 ' A' ' 274' ' ' LEU . 36.8 t -60.58 -23.77 64.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.54 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -48.05 -33.4 7.99 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -144.6 -18.52 0.19 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 119.083 -1.532 . . . . 0.0 115.755 -178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.633 ' HB2' ' O ' ' A' ' 247' ' ' VAL . 26.3 p90 -136.61 165.17 26.51 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.132 1.466 . . . . 0.0 113.269 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.477 ' HA2' ' CD1' ' A' ' 250' ' ' ILE . . . -141.62 163.57 26.84 Favored Glycine 0 CA--C 1.52 0.393 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.516 178.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.587 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -116.89 130.22 56.57 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.446 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.634 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 61.2 t -125.94 136.19 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.351 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 53.0 m -114.02 135.92 53.48 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.475 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 49.3 m-85 -115.76 136.35 53.14 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.599 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 21.8 t70 -59.18 -34.82 72.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.535 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 51.0 m -119.69 143.22 47.86 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.375 0.607 . . . . 0.0 111.763 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.55 -31.2 71.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.161 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 296' ' ' ALA . 53.5 p30 -60.8 -33.69 73.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.46 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.574 ' N ' ' OD1' ' A' ' 295' ' ' ASP . . . -62.16 -37.94 87.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.919 0.39 . . . . 0.0 110.65 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.48 -42.07 92.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.031 0.443 . . . . 0.0 110.61 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -59.52 -37.17 77.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.592 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -58.35 -43.63 88.42 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.053 0.454 . . . . 0.0 111.821 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.655 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 1.0 OUTLIER -70.2 -34.4 58.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.456 -179.35 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . 0.424 ' N ' HG11 ' A' ' 300' ' ' VAL . 79.7 m -59.64 -47.24 86.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.333 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.19 -39.29 94.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.187 0.517 . . . . 0.0 110.419 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.1 m-20 -62.12 -34.75 76.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.772 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.65 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 23.2 tptm 65.39 -73.95 0.06 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.65 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 5.1 m-30 -108.87 134.51 51.45 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.888 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.58 HD11 ' CZ3' ' A' ' 266' ' ' TRP . 14.9 mt -116.52 137.84 49.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.073 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.421 ' OD1' ' CE ' ' A' ' 312' ' ' LYS . 73.0 m-20 -75.99 87.53 2.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.68 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.572 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 7.8 t80 -97.76 -71.76 0.67 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.385 0.612 . . . . 0.0 110.655 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -96.69 -164.24 1.13 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.344 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 311' ' ' ARG . 55.8 p30 -59.21 -21.8 60.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.702 0.287 . . . . 0.0 110.792 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.426 ' N ' ' OD1' ' A' ' 310' ' ' ASP . 24.9 mmm180 -120.67 157.62 29.2 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.615 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.579 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 24.8 mmtm -72.5 154.02 41.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.634 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.515 ' HB ' ' HA2' ' A' ' 249' ' ' GLY . 35.3 pt -117.46 148.86 19.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.118 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -106.48 130.17 54.32 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.432 HD11 HD13 ' A' ' 306' ' ' ILE . 81.7 mt -120.94 129.64 75.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.169 0.509 . . . . 0.0 112.231 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -128.99 153.24 47.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.545 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -63.54 144.43 57.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.73 0.3 . . . . 0.0 110.718 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.53 144.68 46.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.629 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 . . . . . 0 C--N 1.331 -0.206 0 CA-C-O 120.811 0.339 . . . . 0.0 111.501 -179.493 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.7 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.715 0.293 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.442 ' HB3' ' HB1' ' A' ' 233' ' ' ALA . 80.9 tttt -64.46 138.74 58.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.423 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.413 ' CE ' ' CG1' ' A' ' 216' ' ' VAL . 89.8 mtp -127.27 157.87 38.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.283 0.563 . . . . 0.0 111.909 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.535 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 1.3 t80 -103.29 129.94 50.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.882 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.447 ' O ' ' CB ' ' A' ' 202' ' ' PHE . 21.8 mm -114.07 129.34 70.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.357 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -128.58 163.09 22.14 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.821 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.4 38.37 33.62 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.888 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 75.7 mt -59.52 -25.45 64.5 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.423 ' HB2' ' HD2' ' A' ' 226' ' ' LYS . 38.7 t-20 72.52 41.02 0.6 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.973 0.416 . . . . 0.0 110.278 -178.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.439 ' CD2' ' HD2' ' A' ' 198' ' ' ARG . 23.5 m0 29.84 38.37 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.33 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 167' ' ' ASN . 58.4 t0 -156.54 28.43 0.33 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.798 0.332 . . . . 0.0 111.462 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.0 m -121.44 141.64 50.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 111.002 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.421 ' O ' ' CD2' ' A' ' 175' ' ' LEU . 15.8 p -117.35 163.09 16.87 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.635 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.493 ' HG3' ' HB ' ' A' ' 190' ' ' ILE . 96.1 mt-10 -57.82 -33.24 68.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.514 ' O ' ' HG2' ' A' ' 176' ' ' ARG . 21.8 t70 -64.02 -41.34 97.47 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.974 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -63.54 -38.79 92.49 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.421 ' CD2' ' O ' ' A' ' 171' ' ' THR . 3.7 mm? -61.41 -40.32 93.96 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 173' ' ' ASP . 0.1 OUTLIER -61.77 -37.38 84.09 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.683 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.47 -37.39 87.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.022 0.439 . . . . 0.0 110.073 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.655 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 64.0 t80 -78.86 -64.72 1.12 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.44 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.481 ' CG ' ' CD1' ' A' ' 205' ' ' LEU . 78.0 m-85 -68.06 -20.76 64.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.385 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -50.79 -29.04 18.21 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.615 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.81 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -58.86 -41.23 86.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.2 0.524 . . . . 0.0 110.298 179.239 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.81 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 71.3 m-85 -71.04 -33.95 70.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.882 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -172.19 -172.91 38.49 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.881 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 33.9 p -72.72 -11.81 60.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.77 0.319 . . . . 0.0 110.875 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.608 ' CG1' ' O ' ' A' ' 185' ' ' VAL . 1.1 t 52.2 87.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -177.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 3.3 m -56.69 -43.47 80.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.696 -176.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -150.3 140.93 22.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.244 0.545 . . . . 0.0 112.311 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 172' ' ' GLU . 0.2 OUTLIER -116.31 134.4 54.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.055 179.001 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 0.3 OUTLIER -131.81 123.6 27.92 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.382 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.493 ' HB ' ' HG3' ' A' ' 172' ' ' GLU . 2.4 mt -125.07 128.09 72.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.396 176.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.446 ' HE2' ' HA3' ' A' ' 203' ' ' GLY . 3.1 mpp? -103.77 141.98 35.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.966 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 199' ' ' SER . 1.8 pttt -131.36 177.04 7.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.047 0.451 . . . . 0.0 111.56 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.612 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 74.3 m-20 -119.27 83.08 24.5 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.751 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.6 -26.3 54.44 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.269 1.979 . . . . 0.0 112.096 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.42 -67.4 0.63 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.295 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 56.1 p -70.71 -22.41 62.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.543 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 83.61 21.34 58.24 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.024 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.612 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 16.8 tpp85 -125.43 136.61 53.58 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 121.168 0.509 . . . . 0.0 111.934 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 192' ' ' LYS . 46.8 m -63.38 151.71 40.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.72 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.548 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 26.2 mmm180 -58.38 -32.2 68.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.943 0.401 . . . . 0.0 110.628 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.445 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 95.24 0.17 63.48 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.772 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.548 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 36.5 p90 -144.13 159.7 42.18 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.988 0.423 . . . . 0.0 111.067 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.446 ' HA3' ' HE2' ' A' ' 191' ' ' MET . . . -148.1 169.25 28.83 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.556 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 189' ' ' LYS . 96.3 m-85 -110.07 129.19 55.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.092 0.472 . . . . 0.0 110.359 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.635 HD23 ' CZ ' ' A' ' 207' ' ' PHE . 3.6 tt -108.78 132.7 53.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.404 -177.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.475 ' N ' HD22 ' A' ' 205' ' ' LEU . 33.1 t -122.22 131.61 54.02 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.305 178.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.635 ' CZ ' HD23 ' A' ' 205' ' ' LEU . 88.4 m-85 -118.23 136.92 53.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.057 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.589 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.4 tt0 -61.66 -35.14 77.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.053 0.454 . . . . 0.0 110.304 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -109.6 119.21 48.58 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.733 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.64 -26.6 73.36 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.413 2.075 . . . . 0.0 112.839 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.0 m -58.02 -36.44 72.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.567 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 23.5 m -58.16 -34.07 69.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.964 0.411 . . . . 0.0 110.593 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 78.0 t -61.0 -39.51 82.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.279 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 218' ' ' LYS . 21.6 t70 -56.0 -42.39 76.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.743 0.306 . . . . 0.0 111.178 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -66.9 -33.61 75.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.071 178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.775 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 92.7 t -59.13 -42.85 87.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.734 -178.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 20.3 m -72.79 -32.52 40.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.31 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 214' ' ' ASP . 45.0 mmtt -60.57 -34.24 73.87 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.616 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 52.7 m -99.05 138.78 35.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.836 0.35 . . . . 0.0 111.534 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 57.8 tp60 -65.91 -41.64 91.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.078 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.775 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 64.2 m-70 83.04 115.0 0.06 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 178.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 21.5 mm -117.66 109.35 27.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 175.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.5 tt -122.39 130.48 53.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.061 0.458 . . . . 0.0 111.63 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 57.8 t0 52.84 33.61 14.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.682 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 83.14 5.68 88.84 Favored Glycine 0 CA--C 1.517 0.163 0 C-N-CA 120.588 -0.815 . . . . 0.0 114.665 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.423 ' HD2' ' HB2' ' A' ' 167' ' ' ASN . 36.8 ttmt -133.32 131.96 40.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.816 0.808 . . . . 0.0 111.612 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 19.6 m -67.83 136.03 27.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.574 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.405 HG13 ' HD3' ' A' ' 230' ' ' PRO . 35.6 pt -122.59 157.95 27.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.223 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -127.76 80.06 72.6 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.008 0.432 . . . . 0.0 111.92 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.539 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 47.7 Cg_exo -59.56 136.84 73.87 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 123.188 2.592 . . . . 0.0 111.542 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -138.46 154.54 48.85 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.715 -0.221 . . . . 0.0 110.721 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -57.57 136.97 56.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 0.0 111.319 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.442 ' HB1' ' HB3' ' A' ' 160' ' ' LYS . . . -72.36 146.47 47.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.605 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . 0.431 ' CD1' ' HG2' ' A' ' 239' ' ' GLN . 1.2 pt -134.04 108.48 11.59 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.783 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 234' ' ' ILE . 1.6 Cg_endo -46.87 154.78 0.98 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.105 1.87 . . . . 0.0 110.884 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -51.47 -40.93 60.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.601 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 54.6 p30 -64.68 -38.74 92.01 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.215 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.601 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 96.8 mt-10 -70.48 -35.04 73.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.612 0.244 . . . . 0.0 111.181 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.431 ' HG2' ' CD1' ' A' ' 234' ' ' ILE . 26.6 mt-30 -59.21 -39.59 83.16 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.021 0.439 . . . . 0.0 110.0 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -62.71 -42.75 99.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.369 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -64.12 -39.65 94.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.542 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 291' ' ' TYR . 53.1 p -68.48 -38.22 80.82 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.879 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 61.54 142.41 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.016 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.534 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 6.8 tptm -131.66 131.04 42.84 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.437 HG12 ' HB ' ' A' ' 289' ' ' VAL . 8.4 pt -120.23 154.32 23.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.482 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.498 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 88.3 t80 -100.91 132.24 46.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.838 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.613 ' CG2' ' CZ ' ' A' ' 263' ' ' PHE . 20.6 t -120.4 128.46 76.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.028 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -121.65 -7.34 8.16 Favored Glycine 0 C--N 1.329 0.163 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.441 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . 0.488 ' HA2' ' CB ' ' A' ' 313' ' ' ILE . . . -81.25 9.56 53.66 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.17 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.467 ' HB ' HG23 ' A' ' 254' ' ' VAL . 41.3 pt -111.7 133.68 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 116.968 0.384 . . . . 0.0 111.229 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.412 ' N ' HG23 ' A' ' 254' ' ' VAL . . . 159.18 -49.43 0.4 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.693 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.96 -33.57 89.54 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.446 2.097 . . . . 0.0 112.72 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -162.68 64.03 0.2 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.077 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.467 HG23 ' HB ' ' A' ' 250' ' ' ILE . 27.6 m -131.36 156.22 42.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.529 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.68 156.43 79.51 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.449 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.57 -40.14 86.52 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 121.521 1.481 . . . . 0.0 111.562 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.24 -42.99 99.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.289 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' A' ' 262' ' ' PHE . 97.7 mt-10 -68.04 -41.07 82.62 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.95 0.405 . . . . 0.0 111.276 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.508 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 82.8 t80 -65.13 -47.84 75.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.12 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 264' ' ' SER . 84.4 tt0 -64.17 -42.03 96.89 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.094 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -76.39 -30.71 57.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.022 0.439 . . . . 0.0 111.085 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.617 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 5.5 t80 -61.83 -64.82 0.81 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.019 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.661 ' CD2' ' CH2' ' A' ' 266' ' ' TRP . 32.8 m-85 -62.64 -27.51 69.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.064 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.484 ' N ' HD13 ' A' ' 269' ' ' ILE . 33.3 t -56.38 -28.53 59.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.087 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -53.13 -34.7 57.92 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.678 ' CZ2' ' CG2' ' A' ' 300' ' ' VAL . 14.4 p90 -116.71 54.5 0.85 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.907 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.51 ' HA2' ' CD1' ' A' ' 291' ' ' TYR . . . 153.06 -12.77 0.61 Allowed Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.775 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.567 ' O ' ' O ' ' A' ' 269' ' ' ILE . 0.5 OUTLIER 66.95 -1.84 1.29 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.567 ' O ' ' O ' ' A' ' 268' ' ' THR . 77.4 mt 33.54 115.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 75.7 mt -60.4 -42.06 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.06 176.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -166.16 97.47 0.61 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.424 ' N ' HG23 ' A' ' 269' ' ' ILE . . . -104.82 142.72 34.22 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -140.07 150.59 44.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.444 0.64 . . . . 0.0 112.141 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.573 ' O ' ' HB2' ' A' ' 275' ' ' MET . 43.5 tp -66.49 -37.54 85.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.713 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.573 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 91.9 mmm 90.73 111.16 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.424 0.69 . . . . 0.0 111.147 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 6.2 mp -118.46 124.11 46.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.704 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -62.41 -39.06 92.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.87 0.843 . . . . 0.0 109.045 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -161.09 -106.97 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.083 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -62.34 -37.2 84.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.014 0.435 . . . . 0.0 110.054 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 1.2 t 171.66 68.82 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.75 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -93.19 -75.35 1.3 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.094 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 286' ' ' PHE . 96.0 mm-40 -57.54 -30.7 65.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.171 0.51 . . . . 0.0 110.034 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.461 ' HB2' ' CD2' ' A' ' 274' ' ' LEU . 76.5 p -64.18 163.2 13.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.465 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 284' ' ' ARG . 59.4 ttp180 69.69 6.26 5.63 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.252 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -130.92 -48.02 0.12 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.65 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 40.6 p90 -148.67 166.77 27.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.542 0.211 . . . . 0.0 111.029 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -136.72 157.06 23.5 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.263 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.534 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.9 OUTLIER -109.75 129.84 55.58 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.748 0.419 . . . . 0.0 110.552 179.47 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.508 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 48.5 t -126.16 134.22 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.468 ' OG1' ' CD ' ' A' ' 244' ' ' LYS . 30.5 m -123.01 139.44 54.08 Favored 'General case' 0 C--O 1.23 0.063 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.51 ' CD1' ' HA2' ' A' ' 267' ' ' GLY . 51.0 m-85 -117.5 140.32 49.77 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.609 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 21.4 t70 -56.34 -34.86 67.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.599 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 51.1 m -119.86 142.74 48.39 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.948 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.47 -32.05 73.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.045 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -56.21 -36.5 68.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.467 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.06 -37.07 78.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.408 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.79 -44.13 98.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.037 0.446 . . . . 0.0 110.405 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -63.2 -37.48 87.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.1 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -58.38 -43.14 88.37 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.678 ' CG2' ' CZ2' ' A' ' 266' ' ' TRP . 0.4 OUTLIER -73.45 -32.82 38.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.923 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 83.9 m -57.21 -44.39 83.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -60.43 -40.26 90.42 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.329 0.585 . . . . 0.0 109.812 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -60.41 -32.48 71.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.407 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.612 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 22.0 tptt 69.88 -68.2 0.21 Allowed 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.612 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.0 m-30 -115.5 149.72 37.66 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.445 178.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.511 ' CG2' ' HZ ' ' A' ' 262' ' ' PHE . 23.7 mm -117.23 140.18 41.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.742 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -80.28 39.74 0.46 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.961 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.617 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 6.2 t80 -48.24 -68.4 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.465 ' HD3' ' CZ ' ' A' ' 308' ' ' PHE . 16.9 mmmt -105.6 19.41 20.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.811 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 53.6 t0 69.25 9.69 7.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.732 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -109.88 2.02 19.57 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.037 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.407 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 22.6 mttm 62.2 121.55 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.017 0.437 . . . . 0.0 111.714 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 305' ' ' PHE . 31.6 pt -116.28 147.09 19.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.444 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . 0.558 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 84.7 mt-10 -103.93 132.19 50.43 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.847 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.518 HD12 ' CZ ' ' A' ' 263' ' ' PHE . 63.2 mt -120.35 127.98 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.589 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -126.7 148.39 49.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.716 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -55.53 148.3 15.96 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.03 140.92 36.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.139 0.495 . . . . 0.0 111.394 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.63 -179.916 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 4.0 m . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.565 ' HE2' ' HB3' ' A' ' 204' ' ' PHE . 8.5 tptm -63.25 134.07 55.27 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.76 0.314 . . . . 0.0 110.342 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.518 ' O ' ' HA ' ' A' ' 204' ' ' PHE . 89.8 mmm -123.4 147.28 47.26 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.62 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 3.4 t80 -109.56 126.05 53.17 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.526 HD12 ' CZ ' ' A' ' 179' ' ' PHE . 3.7 mt -121.96 130.16 74.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.112 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 202' ' ' PHE . . . -125.05 156.04 18.84 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.038 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.85 33.34 57.81 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.707 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.607 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 69.7 mt -58.68 -32.45 69.14 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.645 ' O ' ' N ' ' A' ' 169' ' ' ASP . 45.4 t30 110.49 31.22 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.283 0.633 . . . . 0.0 110.99 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.455 ' CG ' ' HD2' ' A' ' 198' ' ' ARG . 6.5 m0 53.04 -49.25 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.645 ' N ' ' O ' ' A' ' 167' ' ' ASN . 50.3 p30 -82.27 9.27 9.16 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 166' ' ' LEU . 85.7 m -68.99 137.81 54.02 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.203 0.525 . . . . 0.0 109.975 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 30.6 m -112.14 148.33 34.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.387 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.481 ' HG3' ' HB ' ' A' ' 190' ' ' ILE . 55.6 mp0 -54.56 -37.51 65.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.538 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 89.5 m-20 -63.2 -40.12 96.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.946 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -61.6 -36.69 81.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.302 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.476 HD21 ' CD2' ' A' ' 179' ' ' PHE . 5.8 mt -55.34 -49.38 72.37 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.538 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -67.05 -31.94 72.8 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.482 179.073 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.43 -39.0 78.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.695 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.636 ' CE2' ' CE2' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -94.08 -55.62 3.14 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.113 179.288 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.636 ' CE2' ' CE2' ' A' ' 178' ' ' TYR . 64.0 m-85 -60.72 -28.95 69.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.874 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.93 -23.28 10.86 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.169 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.796 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -54.52 -40.52 68.69 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.882 0.373 . . . . 0.0 111.14 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.796 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 55.5 m-85 -69.32 -31.67 70.29 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.243 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 166.97 -134.41 3.26 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.871 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 57.7 m -117.64 136.89 53.01 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.576 HG21 ' CD1' ' A' ' 207' ' ' PHE . 0.9 OUTLIER -95.0 127.79 46.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.613 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.45 ' CG2' ' HA ' ' A' ' 208' ' ' GLU . 54.0 p -70.18 -35.94 74.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.397 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -148.86 145.24 27.39 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.446 HD13 HD11 ' A' ' 175' ' ' LEU . 0.2 OUTLIER -116.45 129.06 56.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.749 178.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.539 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 7.3 tppt? -138.59 111.36 7.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.481 ' HB ' ' HG3' ' A' ' 172' ' ' GLU . 82.3 mt -125.68 123.13 63.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 174.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.588 ' O ' ' O ' ' A' ' 192' ' ' LYS . 0.0 OUTLIER -59.9 -37.61 79.93 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.084 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.588 ' O ' ' O ' ' A' ' 191' ' ' MET . 26.7 tttt 49.18 149.68 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.268 0.556 . . . . 0.0 112.008 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 9.9 t0 -128.3 78.48 75.52 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.366 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.74 -24.17 61.96 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.408 2.072 . . . . 0.0 112.011 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -73.82 -72.0 0.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.572 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 48.4 p -69.03 -26.21 64.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.624 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.66 7.01 65.22 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.707 -0.759 . . . . 0.0 113.241 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 20.9 tpp180 -124.38 125.78 44.87 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-N 117.267 0.534 . . . . 0.0 111.181 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.1 t -70.27 156.99 38.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.63 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.643 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 83.8 mmt-85 -55.55 -31.75 62.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.705 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 95.78 0.49 62.28 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.675 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.643 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 42.6 p90 -142.47 154.41 44.51 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.41 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -150.45 170.66 30.36 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.666 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.62 ' CE2' ' CD1' ' A' ' 162' ' ' PHE . 89.5 m-85 -107.91 125.55 51.62 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.109 0.481 . . . . 0.0 109.963 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.515 ' HB2' HD13 ' A' ' 163' ' ' ILE . 16.8 tp -112.61 131.19 55.74 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.197 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.409 ' OG ' ' HD2' ' A' ' 160' ' ' LYS . 49.1 m -120.1 140.39 51.12 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.723 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.576 ' CD1' HG21 ' A' ' 185' ' ' VAL . 78.4 m-85 -121.65 141.88 50.69 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.567 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.45 ' HA ' ' CG2' ' A' ' 186' ' ' THR . 84.5 tt0 -64.45 -34.75 78.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.245 178.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -110.76 115.58 53.27 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.926 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . 0.4 ' O ' ' HB ' ' A' ' 213' ' ' VAL . 52.5 Cg_exo -56.25 -25.78 57.83 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.582 2.188 . . . . 0.0 113.033 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.2 m -58.06 -37.42 74.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.0 110.555 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 25.0 m -59.97 -34.76 73.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.244 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 210' ' ' PRO . 71.2 t -60.39 -41.0 85.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.214 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -57.4 -44.86 84.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.051 0.453 . . . . 0.0 110.487 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.58 -33.77 73.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.384 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.855 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 74.9 t -59.65 -40.59 82.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.692 -178.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.3 m -88.87 -38.68 11.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -178.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -60.14 -34.73 73.95 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.495 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 32.2 m -93.37 146.28 23.86 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.438 ' NE2' ' CG2' ' A' ' 227' ' ' VAL . 54.0 tp60 -79.76 140.76 36.8 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.855 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 41.8 m-70 -125.85 139.41 53.51 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -176.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 67.7 mt -125.52 114.61 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.347 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.423 ' HG ' ' CD2' ' A' ' 178' ' ' TYR . 1.0 OUTLIER -82.22 -50.83 8.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.04 0.448 . . . . 0.0 111.99 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -142.86 43.68 1.58 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.788 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 96.17 -0.65 62.22 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.978 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.436 ' CG ' ' OD1' ' A' ' 167' ' ' ASN . 12.2 mmmm -99.36 169.49 9.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.663 0.268 . . . . 0.0 110.352 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.438 ' CG2' ' NE2' ' A' ' 220' ' ' GLN . 14.6 p -118.33 132.91 66.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.948 0.404 . . . . 0.0 110.125 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.436 HG13 ' HD3' ' A' ' 230' ' ' PRO . 35.9 pt -129.41 161.13 39.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.949 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -129.63 81.01 70.64 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.0 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.517 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 78.1 Cg_exo -54.97 129.48 35.56 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.958 2.438 . . . . 0.0 112.782 -178.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -132.86 154.58 50.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.423 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.589 ' HD3' ' N ' ' A' ' 233' ' ' ALA . 1.5 tmt_? -63.5 135.08 56.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.902 0.382 . . . . 0.0 110.759 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.589 ' N ' ' HD3' ' A' ' 232' ' ' ARG . . . -63.91 145.77 55.24 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.286 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -109.92 130.67 22.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.479 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.436 ' HG2' ' HB2' ' A' ' 238' ' ' GLU . 9.6 Cg_endo -53.45 138.84 65.87 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 121.772 1.648 . . . . 0.0 110.85 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -56.56 -40.39 75.08 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.16 -45.6 92.53 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.496 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.436 ' HB2' ' HG2' ' A' ' 235' ' ' PRO . 97.1 mt-10 -71.61 -37.32 70.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.599 0.714 . . . . 0.0 109.842 178.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -59.5 -39.48 83.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.979 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -59.51 -39.28 83.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.037 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -60.35 -35.3 75.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.54 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.401 ' CG2' ' CD1' ' A' ' 270' ' ' ILE . 19.3 p -84.08 162.21 20.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.991 0.424 . . . . 0.0 111.65 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -154.27 118.54 0.87 Allowed Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.13 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.448 ' NZ ' ' CE2' ' A' ' 288' ' ' PHE . 18.2 ttpp -88.49 135.93 33.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.732 0.301 . . . . 0.0 111.127 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.641 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -119.51 164.6 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.358 0.599 . . . . 0.0 111.781 -179.012 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.439 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 88.2 t80 -101.27 136.98 40.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.156 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.502 HG12 ' CE1' ' A' ' 259' ' ' PHE . 9.2 p -129.72 145.13 36.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.107 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.55 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -131.84 165.36 23.44 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 97.31 -2.69 61.25 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.986 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.471 HD12 ' CE1' ' A' ' 259' ' ' PHE . 43.7 pt -117.64 137.92 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-O 121.172 0.511 . . . . 0.0 111.604 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -174.18 -89.26 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.488 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.66 132.57 43.58 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.455 2.103 . . . . 0.0 112.984 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 51.17 40.17 25.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.818 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.676 ' O ' ' HB2' ' A' ' 258' ' ' GLU . 29.8 m -105.84 -35.49 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.049 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 254' ' ' VAL . 13.4 mmm180 57.39 132.63 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.76 -30.22 66.09 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.892 1.728 . . . . 0.0 112.35 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 39.0 tttm -61.28 -44.14 97.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.604 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.676 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 98.0 mt-10 -67.0 -39.87 87.22 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.164 0.506 . . . . 0.0 110.599 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.659 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 15.7 t80 -62.55 -45.49 92.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.029 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 257' ' ' LYS . 20.3 pt-20 -69.23 -41.16 77.39 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.795 0.331 . . . . 0.0 111.021 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.405 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.7 pt-20 -74.26 -29.76 61.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.288 0.566 . . . . 0.0 110.157 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.533 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 5.8 t80 -60.94 -57.28 13.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.884 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.583 ' CB ' HD12 ' A' ' 269' ' ' ILE . 3.7 m-85 -65.18 -23.44 67.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.355 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.468 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 27.2 t -53.97 -30.14 45.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.616 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -53.39 -34.75 58.92 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.105 -0.238 . . . . 0.0 111.116 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.753 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 7.4 p90 -119.0 46.02 1.96 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.21 0.529 . . . . 0.0 111.74 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.484 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 156.31 152.92 6.41 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.916 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 43.0 p -70.28 -25.53 63.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.041 0.448 . . . . 0.0 110.748 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.583 HD12 ' CB ' ' A' ' 263' ' ' PHE . 76.9 mt 54.55 96.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.111 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.568 HG13 ' CA ' ' A' ' 292' ' ' ASP . 79.3 mt -59.18 -40.61 81.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.207 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 50.3 p30 -169.77 156.55 6.42 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.496 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -155.07 145.32 21.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.866 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -145.45 150.71 36.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.11 0.481 . . . . 0.0 111.852 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.583 ' O ' ' HB2' ' A' ' 275' ' ' MET . 24.7 tp -66.17 -39.75 89.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.229 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.583 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 94.8 mmm 98.2 151.85 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.495 0.718 . . . . 0.0 109.659 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 282' ' ' GLN . 0.3 OUTLIER -162.04 84.44 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.562 0.22 . . . . 0.0 111.427 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -85.89 110.84 19.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.912 0.386 . . . . 0.0 110.621 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 40.8 mttm 55.95 30.69 16.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 51.51 43.95 29.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.135 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 1.6 t -165.83 -41.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.717 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -55.0 -37.49 62.9 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.475 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.562 ' HG2' ' HB2' ' A' ' 275' ' ' MET . 3.4 tp-100 -109.41 132.51 54.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.747 0.308 . . . . 0.0 111.494 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 282' ' ' GLN . 27.5 p 148.89 -18.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.059 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 51.1 ttt85 -56.46 -37.97 71.03 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.226 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 250' ' ' ILE . . . 144.59 43.08 0.05 OUTLIER Glycine 0 CA--C 1.522 0.503 0 C-N-CA 119.984 -1.103 . . . . 0.0 114.147 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.49 ' CE1' ' OE1' ' A' ' 282' ' ' GLN . 15.5 p90 -140.28 167.47 22.06 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 117.483 0.641 . . . . 0.0 110.409 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.408 ' O ' HG11 ' A' ' 247' ' ' VAL . . . -147.51 169.28 28.43 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.579 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.448 ' CE2' ' NZ ' ' A' ' 244' ' ' LYS . 0.3 OUTLIER -122.42 124.16 42.99 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 122.346 0.258 . . . . 0.0 111.053 179.429 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.659 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 61.2 t -127.67 138.07 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.033 0.445 . . . . 0.0 112.142 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 44.4 m -116.04 137.09 52.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.241 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.484 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 41.7 m-85 -115.1 135.19 54.47 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.568 ' CA ' HG13 ' A' ' 270' ' ' ILE . 55.1 t0 -59.01 -35.37 73.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.652 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 30.5 t -118.35 139.31 51.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.207 0.527 . . . . 0.0 111.61 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . 0.469 ' O ' HG11 ' A' ' 297' ' ' VAL . . . -64.08 -31.89 73.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.02 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -57.06 -35.61 69.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.299 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.2 -37.33 77.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.705 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.469 HG11 ' O ' ' A' ' 294' ' ' ALA . 6.2 p -58.73 -38.21 70.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.005 0.431 . . . . 0.0 110.662 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . 0.448 ' N ' HG11 ' A' ' 297' ' ' VAL . 21.7 t70 -63.3 -37.43 87.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.181 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -58.23 -41.13 83.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.893 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.753 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 2.3 p -65.12 -33.68 65.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.066 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 74.5 m -56.92 -39.75 75.06 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -62.77 -35.5 80.03 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.924 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.595 ' OD1' ' O ' ' A' ' 300' ' ' VAL . 22.9 p30 -101.2 42.76 1.1 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.008 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.611 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 18.7 tptm -16.08 -65.07 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.915 0.388 . . . . 0.0 110.432 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.619 ' HB3' ' HB3' ' A' ' 312' ' ' LYS . 4.1 m-30 -110.22 142.36 41.89 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.433 ' CD1' ' CG ' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -117.01 130.23 72.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.732 179.681 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -73.18 71.55 1.18 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.533 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 2.9 t80 -62.47 -105.6 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.344 -177.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.454 ' HG2' ' CD2' ' A' ' 308' ' ' PHE . 12.6 mmmm -61.83 -37.17 83.46 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.054 0.454 . . . . 0.0 111.316 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 309' ' ' LYS . 60.3 t0 175.8 -25.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.791 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -111.8 159.43 18.31 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.199 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 42.4 mttp -72.99 140.48 47.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.333 0.587 . . . . 0.0 111.905 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 305' ' ' PHE . 36.3 pt -119.0 152.79 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.615 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -107.54 131.48 54.29 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.617 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.412 HG12 HG21 ' A' ' 247' ' ' VAL . 74.1 mt -119.85 129.71 75.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.38 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 22.9 tttm -133.08 144.37 49.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.5 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -54.1 144.99 18.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.721 0.296 . . . . 0.0 110.314 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.67 140.14 55.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 111.073 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.932 -179.851 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 51.7 t . . . . . 0 C--O 1.23 0.056 0 CA-C-O 121.005 0.431 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.472 ' CG ' ' CB ' ' A' ' 233' ' ' ALA . 6.5 tptt -135.07 142.73 46.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.584 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.627 ' HB2' ' HB2' ' A' ' 205' ' ' LEU . 87.0 mmm -122.21 147.01 46.72 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.58 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 1.6 t80 -108.81 125.6 52.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.036 177.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 202' ' ' PHE . 20.9 mm -118.04 129.71 74.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -127.06 162.73 21.12 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.007 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.67 36.12 38.58 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.745 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 70.7 mt -59.61 -24.55 63.91 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 72.48 43.78 0.45 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.136 0.494 . . . . 0.0 110.505 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 21.1 m0 31.39 39.38 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.429 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -160.54 46.57 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.353 . . . . 0.0 111.304 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 90.4 m -123.96 139.92 53.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.019 0.438 . . . . 0.0 110.899 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 33.5 p -119.93 160.07 23.44 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.393 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 55.8 mp0 -61.98 -30.54 71.0 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.797 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 88.8 m-20 -61.03 -42.89 99.33 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.907 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -65.93 -38.54 88.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.121 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.458 HD21 ' CD2' ' A' ' 179' ' ' PHE . 10.6 mt -61.87 -42.47 99.09 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.797 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -65.78 -38.82 90.06 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.893 179.329 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.435 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 84.5 tt0 -70.89 -45.01 65.09 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.134 0.492 . . . . 0.0 110.457 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.971 ' OH ' ' HB2' ' A' ' 221' ' ' HIS . 19.0 t80 -63.17 -45.14 93.2 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.28 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.458 ' CD2' HD21 ' A' ' 175' ' ' LEU . 96.0 m-85 -98.04 2.02 48.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.34 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -58.51 -28.1 61.89 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.358 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.489 ' CD ' ' H ' ' A' ' 181' ' ' LYS . 0.6 OUTLIER -56.72 -42.73 79.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.959 0.885 . . . . 0.0 110.328 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -70.99 -35.19 72.0 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 113.781 -1.554 . . . . 0.0 112.75 -177.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 177.55 -174.37 46.87 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 119.679 -1.248 . . . . 0.0 113.741 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.8 m -63.82 -28.55 69.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.042 -0.579 . . . . 0.0 111.241 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.642 ' CG1' ' O ' ' A' ' 185' ' ' VAL . 0.4 OUTLIER 64.3 87.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -176.775 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -54.77 -46.15 74.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.033 -176.661 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 186' ' ' THR . 90.8 m-20 -139.25 152.36 47.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.226 0.536 . . . . 0.0 112.012 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.407 HD12 ' CD2' ' A' ' 205' ' ' LEU . 0.2 OUTLIER -125.55 129.08 49.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.505 179.452 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 22.8 tptt -132.33 119.26 20.5 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.488 0.661 . . . . 0.0 112.643 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 1.9 mt -128.83 131.95 67.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.662 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.622 ' SD ' ' CE2' ' A' ' 202' ' ' PHE . 0.8 OUTLIER -88.77 127.32 35.6 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -133.24 162.74 30.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.979 0.418 . . . . 0.0 111.593 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 32.3 m-20 -124.81 84.37 58.33 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.348 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.34 -25.42 39.06 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.241 1.961 . . . . 0.0 112.362 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.88 -71.29 0.36 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.9 0.381 . . . . 0.0 111.313 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.4 p -71.8 -21.56 61.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.178 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 80.36 26.76 54.02 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.32 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.588 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 15.8 ttp180 -119.78 149.95 41.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.26 0.552 . . . . 0.0 112.372 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.8 t -108.71 148.41 30.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.593 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.604 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 59.8 mmt-85 -53.35 -29.92 36.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.758 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.497 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 97.56 2.16 58.81 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.137 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.622 ' CE2' ' SD ' ' A' ' 191' ' ' MET . 25.6 p90 -142.96 155.35 44.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.937 0.398 . . . . 0.0 110.819 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.505 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -142.94 161.73 27.52 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.768 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.612 ' HA ' ' O ' ' A' ' 161' ' ' MET . 89.7 m-85 -111.65 130.55 55.73 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.827 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.627 ' HB2' ' HB2' ' A' ' 161' ' ' MET . 44.8 mt -109.35 141.67 41.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.974 0.416 . . . . 0.0 111.667 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 33.1 t -127.15 131.15 50.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.346 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -119.15 140.58 49.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.814 0.34 . . . . 0.0 111.562 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.501 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.3 tt0 -60.87 -34.63 74.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.089 0.471 . . . . 0.0 110.089 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.1 114.08 51.44 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.395 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.74 -26.83 58.58 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.389 2.059 . . . . 0.0 113.005 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.2 m -58.61 -36.17 73.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.775 0.321 . . . . 0.0 111.153 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 21.9 m -58.63 -35.04 71.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.049 0.452 . . . . 0.0 110.66 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.417 HG12 ' HD3' ' A' ' 232' ' ' ARG . 54.6 t -60.94 -38.67 79.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.784 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -54.2 -42.82 70.16 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.347 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.469 ' O ' ' OG1' ' A' ' 219' ' ' THR . 73.5 mm-40 -69.69 -34.34 73.8 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.539 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 98.3 t -60.64 -44.77 97.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.967 0.413 . . . . 0.0 111.346 -178.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.403 HG23 ' HE3' ' A' ' 161' ' ' MET . 41.9 t -76.77 -51.68 18.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 7.8 tptm -61.17 -40.5 94.14 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 215' ' ' GLU . 88.7 m -59.0 -38.27 78.81 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 219' ' ' THR . 63.7 tt0 60.69 111.7 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -177.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.971 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -139.92 167.12 22.84 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -176.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.402 ' CG1' ' HA ' ' A' ' 227' ' ' VAL . 3.6 mp -118.0 126.05 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.207 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.491 ' HG ' ' CD2' ' A' ' 178' ' ' TYR . 7.5 tt -119.0 132.21 56.05 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.157 0.503 . . . . 0.0 111.744 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.403 ' HB2' HD22 ' A' ' 223' ' ' LEU . 19.5 t70 63.81 28.82 14.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.093 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 94.11 -14.3 65.58 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.542 -0.837 . . . . 0.0 115.037 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -113.49 137.54 51.41 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 117.953 0.877 . . . . 0.0 112.338 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.402 ' HA ' ' CG1' ' A' ' 222' ' ' ILE . 33.7 m -64.77 128.27 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.282 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.454 HG13 ' HD3' ' A' ' 230' ' ' PRO . 37.6 pt -124.28 155.1 31.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.045 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.1 76.69 78.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.295 0.569 . . . . 0.0 110.619 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.503 ' HG2' ' NE2' ' A' ' 221' ' ' HIS . 80.2 Cg_exo -53.0 128.67 29.86 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.12 2.547 . . . . 0.0 111.537 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.438 ' N ' ' HE2' ' A' ' 161' ' ' MET . 6.3 ttpm? -139.03 148.3 43.22 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.317 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.417 ' HD3' HG12 ' A' ' 213' ' ' VAL . 15.2 mmt85 -48.97 138.76 11.14 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.12 0.485 . . . . 0.0 111.523 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.472 ' CB ' ' CG ' ' A' ' 160' ' ' LYS . . . -75.72 146.07 40.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.98 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.84 129.1 24.8 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.417 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.04 149.15 21.8 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 121.915 1.744 . . . . 0.0 110.911 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 52.6 mmm-85 -54.62 -40.44 68.93 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.671 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -64.57 -40.32 95.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.596 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -65.51 -36.39 83.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.6 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -60.14 -37.59 80.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.991 0.424 . . . . 0.0 110.521 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -60.07 -38.62 83.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.129 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -59.68 -35.58 74.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.665 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 20.7 p -87.13 161.86 17.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.005 0.431 . . . . 0.0 111.666 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -142.87 113.91 0.82 Allowed Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.722 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 33.0 ttpt -85.33 140.75 30.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.96 0.409 . . . . 0.0 111.599 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.611 HG12 ' HB ' ' A' ' 289' ' ' VAL . 10.1 pt -118.36 160.52 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.488 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 315' ' ' ILE . 84.6 t80 -99.63 132.46 44.96 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.523 HG22 HG12 ' A' ' 315' ' ' ILE . 14.0 p -128.55 145.34 35.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.647 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.41 166.11 19.32 Favored Glycine 0 C--O 1.226 -0.378 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.92 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 78.41 30.81 48.33 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.262 -0.971 . . . . 0.0 111.799 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.655 ' O ' ' HB ' ' A' ' 254' ' ' VAL . 34.7 mm -55.27 -46.61 78.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 81.47 126.41 0.81 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.024 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -56.49 -29.56 78.71 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.604 2.202 . . . . 0.0 113.332 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -91.64 10.66 27.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.391 . . . . 0.0 111.388 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.655 ' HB ' ' O ' ' A' ' 250' ' ' ILE . 13.0 p -56.24 -40.9 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.403 ' N ' HG12 ' A' ' 254' ' ' VAL . 11.2 tpp85 63.59 116.08 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -176.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -50.29 -30.4 26.23 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 121.994 1.796 . . . . 0.0 112.561 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -60.51 -42.13 95.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.315 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 77.5 mm-40 -68.24 -39.66 82.21 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.049 0.452 . . . . 0.0 111.556 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.519 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 40.6 t80 -62.63 -47.01 85.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.782 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.19 -42.43 93.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.694 0.283 . . . . 0.0 111.556 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -78.18 -31.16 49.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.806 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.505 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 15.1 t80 -60.66 -57.1 14.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.153 0.501 . . . . 0.0 111.698 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.708 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 16.9 m-85 -66.38 -23.8 66.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.715 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.477 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 25.2 t -56.64 -30.51 63.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.527 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -53.55 -36.62 62.04 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.788 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 9.2 p90 -116.82 42.76 2.41 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.119 0.485 . . . . 0.0 111.51 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.545 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 156.97 148.42 5.09 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.824 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.423 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 50.1 m -59.85 -36.92 77.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.729 0.3 . . . . 0.0 111.72 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.507 HD12 ' CB ' ' A' ' 263' ' ' PHE . 69.9 mt 69.86 77.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.394 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.502 HG12 ' CA ' ' A' ' 292' ' ' ASP . 35.4 mm -59.84 -40.97 84.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.806 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -154.28 86.71 1.16 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -101.85 131.26 48.29 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -143.66 152.57 41.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.504 0.668 . . . . 0.0 112.712 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.699 ' O ' ' HB2' ' A' ' 275' ' ' MET . 21.1 tp -68.43 -31.57 70.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.783 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.699 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 10.3 mmm 92.86 -86.61 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.001 0.92 . . . . 0.0 112.721 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.527 ' HA ' ' HB3' ' A' ' 282' ' ' GLN . 5.9 mp 62.27 145.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.227 0.537 . . . . 0.0 111.268 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 51.6 p30 -113.08 -132.24 0.33 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.388 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -55.99 -32.45 63.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -149.81 -108.0 0.07 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.736 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.418 ' O ' ' OG ' ' A' ' 283' ' ' SER . 64.4 p -108.4 20.08 19.04 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -52.44 -39.3 52.3 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 119.645 -1.264 . . . . 0.0 111.975 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.527 ' HB3' ' HA ' ' A' ' 276' ' ' LEU . 13.1 tm0? -64.98 -32.83 74.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.039 0.447 . . . . 0.0 111.424 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 280' ' ' THR . 48.0 p -57.2 -10.08 1.14 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.777 -178.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -50.4 -36.95 35.16 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 121.406 -0.118 . . . . 0.0 110.908 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 151.57 26.72 0.05 OUTLIER Glycine 0 CA--C 1.524 0.601 0 C-N-CA 119.423 -1.37 . . . . 0.0 115.567 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.545 ' HA ' ' HA3' ' A' ' 248' ' ' GLY . 13.4 p90 -138.78 157.01 46.87 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.722 1.261 . . . . 0.0 111.184 178.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -148.26 166.02 29.02 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.777 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.405 ' CE2' ' HE3' ' A' ' 244' ' ' LYS . 2.0 m-30 -113.52 130.03 56.43 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.611 ' HB ' HG12 ' A' ' 245' ' ' ILE . 40.8 t -125.57 133.34 69.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.849 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 52.2 m -114.79 135.38 54.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.545 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 24.5 m-85 -120.02 139.34 52.65 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.502 ' CA ' HG12 ' A' ' 270' ' ' ILE . 53.0 t0 -58.82 -36.93 75.31 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.763 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 99.8 p -123.12 147.73 46.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.406 0.622 . . . . 0.0 111.715 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.43 -30.55 70.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.439 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -55.56 -40.36 71.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.332 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -65.18 -37.58 87.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.792 0.329 . . . . 0.0 110.413 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 69.4 t -62.08 -49.07 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 CA-C-O 121.179 0.514 . . . . 0.0 109.738 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -66.68 -35.5 80.29 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.874 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.57 ' HD3' ' HB2' ' A' ' 266' ' ' TRP . 62.3 ttt-85 -56.19 -45.77 79.68 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.083 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.788 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 2.1 p -71.84 -35.35 54.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.964 0.411 . . . . 0.0 111.214 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 74.0 m -59.07 -40.74 86.12 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.701 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -57.57 -34.66 69.44 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.312 0.577 . . . . 0.0 109.843 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 305' ' ' PHE . 81.6 m-20 -83.85 4.77 27.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.686 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.678 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 30.7 tptt 44.04 -82.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.323 0.249 . . . . 0.0 110.575 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.701 ' HB3' ' HB3' ' A' ' 312' ' ' LYS . 3.1 m-30 -105.31 135.92 45.8 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.12 0.486 . . . . 0.0 110.269 178.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.448 ' CD1' HG22 ' A' ' 300' ' ' VAL . 0.9 OUTLIER -115.01 134.92 56.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.661 178.653 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -69.36 130.36 42.35 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.807 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 17.7 t80 -150.25 -72.56 0.17 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.89 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.442 ' HE3' ' CE2' ' A' ' 308' ' ' PHE . 4.0 mmpt? -91.96 -176.53 4.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.261 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -50.14 -30.57 11.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.911 0.386 . . . . 0.0 110.384 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -117.56 152.74 34.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.903 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.701 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 62.6 mttp -62.18 148.77 43.52 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.115 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 28.4 pt -107.81 138.63 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . 0.6 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 81.9 mt-10 -104.55 132.89 50.28 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.523 HG12 HG22 ' A' ' 247' ' ' VAL . 82.6 mt -119.31 128.55 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 121.394 0.616 . . . . 0.0 111.744 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -131.25 146.07 52.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.838 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -49.79 145.46 5.31 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.234 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.45 142.5 43.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.138 0.494 . . . . 0.0 111.463 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.477 179.806 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 121.115 0.483 . . . . 0.0 110.039 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.444 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 6.7 tptm -117.92 135.65 53.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.639 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.478 ' HB2' ' HB2' ' A' ' 205' ' ' LEU . 89.0 mmm -117.72 145.19 44.62 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.628 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 3.3 t80 -110.43 130.79 55.48 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.477 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.754 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 19.9 mm -116.87 127.68 74.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.578 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.486 ' O ' ' HB ' ' A' ' 228' ' ' ILE . . . -128.81 161.52 22.42 Favored Glycine 0 CA--C 1.505 -0.562 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.518 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.59 27.69 58.7 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.96 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 201' ' ' GLY . 72.9 mt -86.45 140.44 29.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.636 0.255 . . . . 0.0 111.176 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -63.63 135.42 56.75 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.513 ' CE2' ' HD2' ' A' ' 198' ' ' ARG . 4.1 m-90 -53.6 143.21 20.61 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.176 -0.609 . . . . 0.0 109.906 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 168' ' ' TRP . 53.7 t0 74.21 36.53 0.66 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.742 -177.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 171' ' ' THR . 90.0 m -59.98 -34.67 73.62 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.17 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.0 OUTLIER 59.66 127.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -178.519 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.498 ' HA ' HD13 ' A' ' 190' ' ' ILE . 55.1 mp0 -58.15 -31.62 67.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.361 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.579 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.9 m-20 -55.46 -41.22 72.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.761 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 170' ' ' THR . 85.7 m-20 -64.83 -37.63 88.26 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.517 HD21 ' CD2' ' A' ' 179' ' ' PHE . 4.8 mt -60.51 -45.41 93.91 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.579 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -67.68 -34.84 77.71 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.363 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.29 -37.96 89.28 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.028 0.442 . . . . 0.0 109.851 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.43 ' OH ' ' HB3' ' A' ' 221' ' ' HIS . 67.3 t80 -80.58 -61.47 1.96 Allowed 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.437 0.637 . . . . 0.0 110.936 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.517 ' CD2' HD21 ' A' ' 175' ' ' LEU . 72.2 m-85 -66.04 -25.68 67.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.776 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.25 -26.11 12.82 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.241 -0.98 . . . . 0.0 110.738 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.524 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 0.1 OUTLIER -54.29 -46.05 72.67 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.511 0.724 . . . . 0.0 111.02 179.007 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -70.31 -35.33 73.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.701 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 171.36 -169.89 42.86 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.19 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 48.1 m -84.0 138.48 33.08 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 206' ' ' SER . 7.1 p -102.34 124.37 56.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.501 ' O ' ' OD1' ' A' ' 187' ' ' ASP . 69.4 p -69.63 -40.6 76.46 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.792 0.33 . . . . 0.0 111.136 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.501 ' OD1' ' O ' ' A' ' 186' ' ' THR . 86.3 m-20 -149.11 161.99 40.87 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.342 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.422 HD22 HD11 ' A' ' 175' ' ' LEU . 0.0 OUTLIER -138.4 144.23 40.13 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.207 -178.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.512 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 11.2 tptt -140.5 121.57 14.69 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 178.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.498 HD13 ' HA ' ' A' ' 172' ' ' GLU . 11.4 mt -124.56 130.82 73.39 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.796 176.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.581 ' HB2' ' HB2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -86.2 109.12 18.69 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.228 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -121.4 148.11 44.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.733 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 10.7 t0 -123.76 77.46 56.83 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -56.73 -23.25 48.71 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.678 2.252 . . . . 0.0 112.758 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.66 -74.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.53 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.1 p -69.75 -26.05 64.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.03 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.87 -2.97 67.04 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.389 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.513 ' HD2' ' CE2' ' A' ' 168' ' ' TRP . 9.8 tpp85 -129.41 137.0 50.66 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.73 -167.22 1.94 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.391 0.615 . . . . 0.0 112.48 -178.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.928 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 66.8 mmt-85 -53.52 -38.49 63.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.474 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 166' ' ' LEU . . . 81.2 18.05 70.28 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.955 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.928 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 32.2 p90 -139.52 159.81 41.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.669 0.271 . . . . 0.0 110.534 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.474 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -142.51 160.07 27.28 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.948 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.628 ' CE2' ' CD1' ' A' ' 162' ' ' PHE . 97.5 m-85 -108.37 129.05 55.26 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 161' ' ' MET . 65.7 mt -108.31 142.05 39.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.939 0.399 . . . . 0.0 111.969 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.479 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 33.8 t -125.01 128.2 48.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.314 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -117.02 138.93 51.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.95 0.405 . . . . 0.0 111.975 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.433 ' CA ' ' CG2' ' A' ' 186' ' ' THR . 84.4 tt0 -62.81 -34.52 77.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.727 178.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.92 117.48 53.72 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.509 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.04 -21.13 33.14 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.639 2.226 . . . . 0.0 113.296 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.7 m -57.31 -39.02 74.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.617 0.246 . . . . 0.0 111.553 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.455 ' HA ' ' OE2' ' A' ' 215' ' ' GLU . 21.2 m -60.82 -37.53 82.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.818 0.342 . . . . 0.0 110.696 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.51 -43.81 97.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.376 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -61.47 -41.43 97.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.931 0.396 . . . . 0.0 111.045 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.455 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 21.7 pt-20 -76.76 -29.44 56.11 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.836 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 79.5 t -61.85 -43.89 98.03 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-O 121.027 0.442 . . . . 0.0 110.639 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 50.1 t -71.87 -45.53 64.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -60.15 -38.76 84.12 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.475 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 35.5 m -81.72 144.28 31.24 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -80.21 138.67 36.88 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.836 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 41.0 m-70 -122.34 132.16 54.25 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -176.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.402 HD11 ' O ' ' A' ' 221' ' ' HIS . 29.1 mm -122.24 110.56 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.7 tt -122.4 126.72 48.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.926 0.393 . . . . 0.0 111.061 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 55.4 41.81 30.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.226 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 74.32 14.03 81.06 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.707 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -125.73 152.63 45.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.981 0.39 . . . . 0.0 111.721 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 27.5 m -99.89 130.64 48.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.312 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' A' ' 164' ' ' GLY . 33.6 pt -126.04 158.44 35.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.396 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.57 80.48 71.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.159 0.504 . . . . 0.0 110.786 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.556 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 61.8 Cg_exo -56.66 127.97 28.1 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 123.07 2.513 . . . . 0.0 112.096 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 8.8 mtmm -133.13 156.06 48.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.008 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -60.14 137.18 58.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.769 0.318 . . . . 0.0 110.98 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.414 ' CB ' ' CG ' ' A' ' 160' ' ' LYS . . . -64.34 144.52 57.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.269 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.41 137.03 27.1 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.645 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.48 ' HD2' ' OE1' ' A' ' 238' ' ' GLU . 34.8 Cg_exo -56.26 145.05 79.43 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 121.923 1.749 . . . . 0.0 110.727 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -55.38 -40.97 71.99 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.931 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -61.72 -41.76 98.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.436 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.48 ' OE1' ' HD2' ' A' ' 235' ' ' PRO . 94.4 mt-10 -66.14 -35.25 79.99 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.906 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -59.98 -37.0 78.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.07 0.462 . . . . 0.0 110.259 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -59.79 -38.17 81.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.975 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -58.66 -37.98 77.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.193 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 19.2 p -84.8 161.98 19.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.114 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.04 161.74 24.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.809 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.485 ' HD2' ' CE2' ' A' ' 288' ' ' PHE . 7.6 ttpm? -138.7 131.99 30.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.812 0.306 . . . . 0.0 111.182 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.639 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -120.9 162.52 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 121.409 0.623 . . . . 0.0 112.23 -178.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.5 ' HB3' ' O ' ' A' ' 316' ' ' LYS . 85.1 t80 -104.19 138.22 40.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.746 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.596 HG12 HD13 ' A' ' 250' ' ' ILE . 9.2 p -131.99 147.61 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.538 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -125.99 165.18 19.28 Favored Glycine 0 C--O 1.226 -0.389 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 178.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 85.59 14.66 67.56 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.586 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.596 HD13 HG12 ' A' ' 247' ' ' VAL . 35.8 mm -54.95 -45.7 76.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.54 ' O ' ' CG1' ' A' ' 254' ' ' VAL . . . 59.44 129.77 0.01 OUTLIER Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.961 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.93 -27.11 52.23 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.326 2.017 . . . . 0.0 113.137 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -59.25 -33.97 71.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.919 0.39 . . . . 0.0 111.427 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.54 ' CG1' ' O ' ' A' ' 251' ' ' GLY . 7.1 p -50.5 -39.55 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 68.11 126.65 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -175.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.457 ' HB3' ' HG ' ' A' ' 274' ' ' LEU . 8.9 Cg_endo -51.08 -26.62 19.56 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 121.904 1.736 . . . . 0.0 112.827 -177.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -62.01 -45.5 93.34 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 78.2 mm-40 -66.38 -38.41 87.48 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.633 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 40.6 t80 -60.88 -45.56 94.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.166 -178.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.49 -43.4 97.37 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.594 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -78.12 -28.52 48.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.013 0.435 . . . . 0.0 111.012 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.597 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 4.3 t80 -59.12 -58.61 7.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.918 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.68 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 5.8 m-85 -63.51 -23.63 67.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.218 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.464 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 23.1 t -55.13 -29.82 58.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.842 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -52.35 -35.47 51.17 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.361 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.68 ' CZ2' ' CD2' ' A' ' 263' ' ' PHE . 9.0 p90 -116.13 41.72 2.53 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.215 0.531 . . . . 0.0 111.526 179.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.506 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 159.39 157.12 8.38 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.81 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 4.5 t -73.45 -25.19 60.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.339 . . . . 0.0 111.011 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.543 HD12 ' CB ' ' A' ' 263' ' ' PHE . 75.1 mt 58.11 124.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.768 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 292' ' ' ASP . 25.3 mm -93.2 -74.45 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.14 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -92.09 -72.54 0.59 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.793 0.33 . . . . 0.0 111.738 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' A' ' 289' ' ' VAL . . . 46.56 101.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.353 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . 0.466 ' HG3' ' HG2' ' A' ' 275' ' ' MET . 14.1 pt20 -143.17 158.22 43.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.115 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.591 ' HB3' ' CD ' ' A' ' 282' ' ' GLN . 42.6 mt -63.78 -33.98 76.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.181 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.682 ' O ' ' HB3' ' A' ' 282' ' ' GLN . 8.0 mtm 68.11 71.13 0.32 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.634 0.254 . . . . 0.0 110.96 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.473 HD22 ' HG2' ' A' ' 282' ' ' GLN . 9.7 mt -76.4 126.64 31.36 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.129 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -58.93 -38.17 78.37 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.888 0.852 . . . . 0.0 108.726 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -157.34 -101.05 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 113.993 -1.458 . . . . 0.0 108.026 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.459 ' O ' ' CG2' ' A' ' 280' ' ' THR . 89.5 m-20 -62.77 -39.08 93.06 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.574 178.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.459 ' CG2' ' O ' ' A' ' 279' ' ' ASP . 0.5 OUTLIER 170.77 50.07 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.005 -179.729 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -56.16 -38.38 76.79 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.092 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.682 ' HB3' ' O ' ' A' ' 275' ' ' MET . 4.8 pp0? -61.81 -30.07 70.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.197 0.522 . . . . 0.0 111.632 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 52.2 p -54.55 -14.18 1.21 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.626 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -51.33 -36.64 43.7 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 121.332 -0.147 . . . . 0.0 110.775 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 157.37 23.75 0.03 OUTLIER Glycine 0 CA--C 1.526 0.721 0 C-N-CA 119.596 -1.288 . . . . 0.0 115.379 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.44 ' HA ' ' HA3' ' A' ' 248' ' ' GLY . 2.0 p90 -138.43 163.17 32.59 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.672 1.236 . . . . 0.0 111.073 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.468 ' CA ' HG13 ' A' ' 250' ' ' ILE . . . -142.17 159.83 27.11 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.525 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.496 ' CD2' ' SD ' ' A' ' 275' ' ' MET . 0.1 OUTLIER -122.41 124.17 43.02 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.639 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 52.4 t -125.89 136.19 61.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.083 0.468 . . . . 0.0 111.501 178.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 55.7 m -116.44 136.24 53.16 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.506 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 42.8 m-85 -114.1 136.92 52.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.355 0.598 . . . . 0.0 112.398 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.486 ' HB2' ' CD1' ' A' ' 270' ' ' ILE . 51.7 t0 -57.09 -36.11 70.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.638 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 50.4 m -121.97 145.2 48.35 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.337 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . 0.471 ' O ' HG11 ' A' ' 297' ' ' VAL . . . -65.77 -28.99 69.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.531 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -54.68 -35.62 63.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.872 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.45 -39.26 83.03 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.471 HG11 ' O ' ' A' ' 294' ' ' ALA . 7.3 p -60.0 -37.51 72.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.974 0.416 . . . . 0.0 111.331 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . 0.461 ' N ' HG11 ' A' ' 297' ' ' VAL . 91.0 m-20 -61.98 -39.31 91.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.846 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -61.08 -43.83 98.29 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.635 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 0.9 OUTLIER -69.38 -34.1 60.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.32 -179.322 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 89.5 m -57.77 -45.28 86.18 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.062 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -62.23 -39.72 93.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.213 0.53 . . . . 0.0 109.883 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.6 m-20 -62.38 -33.64 75.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.123 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.614 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 22.6 tptm 68.47 -69.06 0.16 Allowed 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -177.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.614 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.4 m-30 -116.28 151.11 36.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.121 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.424 HG22 ' CZ ' ' A' ' 262' ' ' PHE . 8.4 mm -116.53 136.35 53.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.502 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -79.93 65.12 4.98 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.597 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 3.9 t80 -65.86 -63.44 1.09 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.444 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 5.5 mmpt? -105.91 38.79 1.92 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.376 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 61.47 34.24 18.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -175.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -151.01 163.96 37.52 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 113.167 -1.833 . . . . 0.0 107.351 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 68.5 mttt -97.15 136.26 37.92 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.514 0.673 . . . . 0.0 112.711 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 305' ' ' PHE . 36.3 pt -117.62 150.95 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . 0.531 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 87.7 mt-10 -106.06 133.35 50.91 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.86 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.483 ' CD1' ' CZ ' ' A' ' 263' ' ' PHE . 74.3 mt -122.59 129.32 75.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.227 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.5 ' O ' ' HB3' ' A' ' 246' ' ' PHE . 8.8 tptt -133.94 141.22 47.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.717 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -53.69 150.56 7.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.669 0.271 . . . . 0.0 110.332 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -49.69 142.86 7.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.948 0.404 . . . . 0.0 111.232 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.718 -179.06 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 43.5 t . . . . . 0 CA--C 1.529 0.144 0 CA-C-O 120.755 0.312 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -138.94 137.41 36.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.099 0.475 . . . . 0.0 111.198 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.648 ' O ' ' HA ' ' A' ' 204' ' ' PHE . 94.6 mmm -113.56 148.07 36.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.26 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.583 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 2.9 t80 -104.06 127.79 51.64 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 203' ' ' GLY . 20.3 mm -116.71 129.1 73.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.734 0.302 . . . . 0.0 111.364 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -133.33 163.27 24.36 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 178.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.84 36.63 52.37 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.981 -1.104 . . . . 0.0 112.024 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.36 -26.73 65.33 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 52.2 t30 69.67 40.38 1.38 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -177.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 15.4 m0 30.9 38.5 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 114.636 -1.166 . . . . 0.0 112.76 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -164.34 13.56 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.569 ' O ' ' O ' ' A' ' 171' ' ' THR . 63.1 m -60.74 -38.17 84.24 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.569 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.1 OUTLIER 51.92 135.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.178 0.514 . . . . 0.0 111.591 -179.432 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.527 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 97.8 mt-10 -61.15 -33.77 73.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.028 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 177' ' ' GLU . 91.5 m-20 -59.37 -44.49 92.71 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.629 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 170' ' ' THR . 81.9 m-20 -77.16 -42.23 38.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.376 0.608 . . . . 0.0 110.735 178.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.427 ' HB2' ' CG2' ' A' ' 170' ' ' THR . 41.1 tp -66.63 -48.75 68.46 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.419 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 68.0 ttp85 -63.13 -44.42 95.63 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.806 0.336 . . . . 0.0 111.015 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 173' ' ' ASP . 98.3 mt-10 -67.03 -37.29 83.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.476 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.647 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 69.5 t80 -61.16 -48.21 82.64 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.1 0.476 . . . . 0.0 110.864 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -82.76 -12.06 57.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.885 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.17 -29.85 53.33 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 177.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.499 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 0.3 OUTLIER -56.48 -45.27 81.01 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.307 -0.947 . . . . 0.0 110.764 178.761 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -70.64 -33.66 71.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.331 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -173.38 -179.7 44.22 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.26 -0.971 . . . . 0.0 113.166 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 46.6 m -63.07 -31.09 72.15 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.534 ' CG1' ' O ' ' A' ' 185' ' ' VAL . 1.2 t 63.95 85.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -177.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -59.22 -50.98 71.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.019 -178.005 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 206' ' ' SER . 60.7 t0 -147.49 105.87 3.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.171 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.469 ' O ' ' CD1' ' A' ' 188' ' ' LEU . 0.0 OUTLIER -97.93 144.44 27.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.903 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.492 ' O ' ' CA ' ' A' ' 203' ' ' GLY . 30.7 tptt -127.26 128.68 46.41 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.627 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.549 ' O ' ' O ' ' A' ' 191' ' ' MET . 1.5 tt -117.82 -10.35 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.845 -0.162 . . . . 0.0 111.428 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.707 ' CE ' ' HA3' ' A' ' 203' ' ' GLY . 17.0 mtm 51.44 150.18 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.987 0.422 . . . . 0.0 111.543 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.402 ' HG3' ' HD3' ' A' ' 194' ' ' PRO . 7.5 ptmt -134.5 163.66 29.21 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.095 0.474 . . . . 0.0 112.223 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.642 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 1.3 t70 -124.23 76.55 60.64 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.619 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.402 ' HD3' ' HG3' ' A' ' 192' ' ' LYS . 38.8 Cg_exo -58.03 -25.46 70.66 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.711 2.274 . . . . 0.0 112.98 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -68.94 -66.66 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.32 . . . . 0.0 111.588 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.0 p -71.98 -20.31 61.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.772 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 88.07 12.88 65.1 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.369 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.642 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 55.5 mtt180 -118.47 167.75 11.3 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 121.094 0.473 . . . . 0.0 112.253 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.9 t -69.71 152.19 44.95 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.254 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.866 ' HG3' ' CE1' ' A' ' 202' ' ' PHE . 15.2 tpt180 -52.68 -32.02 40.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.977 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 98.1 -4.11 60.57 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.485 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.866 ' CE1' ' HG3' ' A' ' 200' ' ' ARG . 12.1 p90 -151.41 159.45 44.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.707 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -152.71 150.43 22.22 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.274 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.648 ' HA ' ' O ' ' A' ' 161' ' ' MET . 94.8 m-85 -106.78 125.63 51.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.081 0.44 . . . . 0.0 109.82 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 161' ' ' MET . 46.6 mt -103.1 138.92 39.3 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.911 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 23.2 t -123.17 132.77 54.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.119 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.513 ' CE1' ' CG2' ' A' ' 185' ' ' VAL . 96.9 m-85 -117.89 140.55 49.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 111.695 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.424 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.2 tt0 -60.66 -34.12 73.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.198 0.523 . . . . 0.0 109.673 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.2 115.17 50.36 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.609 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.62 -21.76 32.81 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.665 2.244 . . . . 0.0 113.22 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.5 m -56.86 -35.7 69.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.726 0.298 . . . . 0.0 111.307 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.428 ' O ' ' CG2' ' A' ' 216' ' ' VAL . 32.3 m -58.49 -36.96 74.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.851 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 63.0 t -60.83 -42.02 90.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.179 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.402 ' O ' HG11 ' A' ' 217' ' ' VAL . 94.6 m-20 -59.29 -40.64 86.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.877 0.37 . . . . 0.0 111.177 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.81 -27.38 36.59 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.634 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 53.1 t -62.07 -45.77 97.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 CA-C-O 120.773 0.32 . . . . 0.0 111.693 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.402 HG11 ' O ' ' A' ' 214' ' ' ASP . 8.3 p -60.01 -36.55 68.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -60.96 -35.87 77.89 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.753 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 29.6 m -80.66 143.27 33.19 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 93.1 mt-30 -65.97 -36.83 84.37 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.753 ' CD2' ' O ' ' A' ' 219' ' ' THR . 82.4 m-70 78.4 44.33 0.07 Allowed 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 75.4 mt -75.38 82.2 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.441 HD13 ' CG ' ' A' ' 178' ' ' TYR . 7.2 tt -82.52 -75.47 0.31 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -176.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 49.2 p30 -94.67 13.22 25.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.582 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 95.17 7.4 59.56 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.052 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.12 137.0 52.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.405 ' O ' HG11 ' A' ' 227' ' ' VAL . 5.6 p -69.73 126.17 29.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.277 0.56 . . . . 0.0 111.773 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.463 HG13 ' HD3' ' A' ' 230' ' ' PRO . 34.5 pt -124.84 157.52 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.329 178.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.8 77.21 76.6 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.202 0.525 . . . . 0.0 112.4 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.634 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 35.0 Cg_exo -63.55 84.98 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 123.087 2.524 . . . . 0.0 111.653 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -100.73 157.13 16.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.825 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 37.7 tpt85 -60.27 137.04 58.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.935 0.397 . . . . 0.0 111.574 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -59.91 145.79 44.58 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.06 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 9.7 mt -109.51 124.36 34.05 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.282 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.69 143.44 57.87 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 121.802 1.668 . . . . 0.0 110.753 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 32.5 mmm180 -57.53 -39.27 76.2 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.695 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 55.2 p30 -63.88 -41.69 97.67 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.978 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.613 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 97.5 mt-10 -73.43 -37.92 65.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.558 0.694 . . . . 0.0 109.703 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -60.41 -39.98 89.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.314 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -59.52 -40.24 86.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.211 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -61.13 -35.05 76.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.148 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 16.3 p -82.87 161.39 21.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.392 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -149.03 173.02 29.05 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.193 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.514 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 6.9 tptm -135.01 131.7 37.41 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.711 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -121.48 162.24 20.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.348 0.594 . . . . 0.0 111.011 179.486 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -104.6 136.56 43.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.35 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.476 HG11 ' O ' ' A' ' 287' ' ' GLY . 14.7 p -131.49 147.87 32.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.421 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -129.11 166.59 21.46 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.404 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 84.2 22.79 53.8 Favored Glycine 0 C--N 1.328 0.107 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.476 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.525 ' O ' ' O ' ' A' ' 251' ' ' GLY . 43.0 mm -54.97 -48.99 74.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 250' ' ' ILE . . . 57.88 129.64 0.01 OUTLIER Glycine 0 CA--C 1.525 0.679 0 C-N-CA 119.807 -1.187 . . . . 0.0 111.436 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . 0.484 ' HD3' ' HG3' ' A' ' 284' ' ' ARG . 52.0 Cg_exo -54.04 -24.92 34.49 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.165 1.91 . . . . 0.0 112.907 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -57.84 -36.49 72.37 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.563 ' O ' ' HB2' ' A' ' 258' ' ' GLU . 16.2 m -65.98 -36.76 78.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 62.35 153.32 0.11 Allowed Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -56.54 -31.12 85.39 Favored 'Trans proline' 0 CA--C 1.527 0.154 0 C-N-CA 122.39 2.06 . . . . 0.0 113.478 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -64.12 -49.0 73.9 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.563 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 97.8 mt-10 -66.22 -35.57 80.78 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.938 0.399 . . . . 0.0 112.029 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.565 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 35.5 t80 -59.62 -45.34 92.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.471 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -64.73 -40.58 95.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.455 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 258' ' ' GLU . 20.5 pt-20 -75.79 -33.5 60.16 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.7 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.577 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 83.8 t80 -58.9 -56.78 17.84 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.652 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 18.6 m-85 -65.83 -24.61 66.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.326 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.48 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 24.9 t -56.21 -31.14 63.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.55 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -53.99 -36.15 62.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.526 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.652 ' CZ2' ' CD2' ' A' ' 263' ' ' PHE . 6.9 p90 -119.18 50.58 1.21 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.49 0.662 . . . . 0.0 111.213 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.565 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 148.86 145.85 4.21 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.634 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.428 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 41.1 m -59.74 -38.1 80.77 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.567 HD12 ' CB ' ' A' ' 263' ' ' PHE . 76.9 mt 70.72 84.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.533 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.601 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 66.5 mt -59.69 -38.72 77.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.836 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -131.99 -84.89 0.49 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 289' ' ' VAL . . . 61.68 113.08 0.02 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.705 0.288 . . . . 0.0 110.867 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -139.29 155.23 47.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.362 0.601 . . . . 0.0 112.07 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.545 ' O ' ' HB2' ' A' ' 275' ' ' MET . 35.5 tp -65.05 -35.19 80.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.251 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.545 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 95.7 mmm 76.66 12.81 2.41 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.425 ' HB3' HD22 ' A' ' 274' ' ' LEU . 0.9 OUTLIER -56.64 119.09 5.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.215 0.531 . . . . 0.0 111.334 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 279' ' ' ASP . 58.3 t0 -88.79 119.0 28.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.852 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 62.9 -75.31 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.273 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 277' ' ' ASP . 51.6 t0 -142.53 98.75 3.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.781 0.324 . . . . 0.0 111.648 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 2.8 p 44.62 50.54 8.38 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -84.48 -74.7 1.23 Allowed Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.028 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 286' ' ' PHE . 92.4 mm-40 -60.94 -32.02 71.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.243 0.544 . . . . 0.0 109.814 179.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.541 ' O ' ' HB3' ' A' ' 284' ' ' ARG . 54.1 p -63.17 168.27 4.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.45 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.541 ' HB3' ' O ' ' A' ' 283' ' ' SER . 39.1 ttt85 81.03 -41.39 0.16 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.826 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -94.94 -52.16 1.82 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.225 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.507 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 29.0 p90 -143.45 167.7 21.57 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.193 0.521 . . . . 0.0 112.209 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.476 ' O ' HG11 ' A' ' 247' ' ' VAL . . . -137.13 158.39 24.28 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.141 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.514 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.7 OUTLIER -115.34 127.44 55.42 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.734 -0.274 . . . . 0.0 111.207 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.711 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 21.8 t -124.2 136.38 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.799 0.333 . . . . 0.0 111.69 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 33.6 m -115.68 136.22 53.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.659 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.565 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 31.5 m-85 -118.33 139.21 51.69 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.601 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 55.8 p30 -62.56 -32.22 73.15 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.663 179.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' SER . . . . . 0.573 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 99.0 p -122.23 145.81 47.86 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.27 0.557 . . . . 0.0 111.556 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.98 -33.63 75.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.169 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -57.31 -37.39 72.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.361 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.59 82.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.914 0.387 . . . . 0.0 110.915 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 83.3 t -62.23 -42.42 95.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.981 0.42 . . . . 0.0 110.96 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -60.94 -36.62 79.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.356 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -56.98 -43.31 81.56 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.649 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 1.3 p -69.15 -34.55 63.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.656 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 80.8 m -58.01 -45.92 86.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.473 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -62.68 -39.54 94.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.252 0.549 . . . . 0.0 110.258 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -63.36 -31.99 73.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.955 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.665 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 38.4 tptt 67.81 -75.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.665 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.9 m-30 -111.16 135.57 51.49 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.702 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.521 HD13 ' CZ3' ' A' ' 266' ' ' TRP . 1.0 OUTLIER -118.55 137.41 52.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.192 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -79.08 112.64 16.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.965 0.412 . . . . 0.0 110.287 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 1.3 t80 -91.99 -89.22 0.19 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.809 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.47 ' HD3' ' CE1' ' A' ' 308' ' ' PHE . 0.0 OUTLIER -92.41 -74.86 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.939 0.399 . . . . 0.0 110.981 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -131.78 -15.79 3.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.259 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -122.02 157.36 31.53 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.518 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -79.04 143.34 35.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.935 0.398 . . . . 0.0 111.093 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 29.9 pt -115.3 147.81 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . 0.562 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 84.1 mt-10 -104.78 133.3 49.83 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.651 -0.42 . . . . 0.0 109.982 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.506 ' CD1' HG23 ' A' ' 300' ' ' VAL . 73.5 mt -122.55 127.95 75.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.069 0.461 . . . . 0.0 111.253 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -126.01 155.05 42.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.725 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 70.0 ttp85 -58.87 146.12 38.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.718 0.294 . . . . 0.0 110.378 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.71 145.26 24.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.076 0.465 . . . . 0.0 111.442 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.549 -179.928 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 45.8 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.959 0.409 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -129.66 141.36 50.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.574 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 95.1 mmm -118.08 146.38 44.15 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.536 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 6.7 t80 -106.09 127.55 53.26 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 202' ' ' PHE . 11.1 mm -115.37 117.45 55.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.249 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 202' ' ' PHE . . . -91.54 178.86 41.53 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.813 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 164' ' ' GLY . . . 26.69 80.11 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 114.387 0.515 . . . . 0.0 114.387 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.481 ' O ' ' HB ' ' A' ' 170' ' ' THR . 58.8 mt -85.76 2.13 46.81 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.881 ' O ' ' N ' ' A' ' 169' ' ' ASP . 41.7 t-20 61.04 41.39 13.96 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 16.9 m0 34.49 -55.97 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.053 0.941 . . . . 0.0 113.522 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.881 ' N ' ' O ' ' A' ' 167' ' ' ASN . 93.1 m-20 -53.21 -34.84 58.74 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 166' ' ' LEU . 55.8 m -62.95 139.43 58.75 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.189 0.518 . . . . 0.0 111.206 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 10.5 p -116.12 167.43 11.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.324 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.474 ' HA ' HD13 ' A' ' 190' ' ' ILE . 21.2 pt-20 -59.85 -27.08 66.35 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.482 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 89.6 m-20 -62.07 -43.01 99.76 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.044 0.449 . . . . 0.0 110.3 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -67.05 -36.66 82.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.766 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.418 HD21 ' CD2' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -53.63 -49.82 67.04 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -179.025 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 180' ' ' GLY . 0.0 OUTLIER -65.29 -33.45 76.01 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.623 178.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -62.02 -41.36 97.99 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.255 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.451 ' OH ' ' HB3' ' A' ' 221' ' ' HIS . 64.0 t80 -75.74 -60.0 2.51 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.628 0.727 . . . . 0.0 111.003 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.452 ' CG ' HD23 ' A' ' 205' ' ' LEU . 80.8 m-85 -69.0 -21.1 64.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.652 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.95 -25.53 16.82 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.687 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.799 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -55.7 -40.72 72.78 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.0 0.428 . . . . 0.0 110.795 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.799 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 64.6 m-85 -69.96 -32.49 70.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.43 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 167.08 -133.11 2.8 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.831 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.4 m -119.93 139.06 53.02 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.477 HG21 ' O ' ' A' ' 206' ' ' SER . 0.8 OUTLIER -91.22 117.63 34.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.2 t -66.7 -43.77 83.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.138 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -156.28 98.34 1.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.34 142.1 27.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.499 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.595 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 49.1 tptt -130.92 128.0 39.62 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 172' ' ' GLU . 1.4 mt -122.54 129.53 75.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.623 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.519 ' N ' ' SD ' ' A' ' 191' ' ' MET . 2.6 mpp? -92.6 135.08 34.39 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -131.91 168.67 17.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.163 0.506 . . . . 0.0 112.168 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 0.6 OUTLIER -125.43 85.24 58.84 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.742 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.77 -24.57 47.28 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.305 2.003 . . . . 0.0 112.313 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -73.37 -70.66 0.35 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.372 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 55.0 p -71.49 -21.08 61.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.019 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 84.18 19.57 60.58 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.376 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.577 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 79.7 mtt180 -120.43 163.59 17.67 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.6 m -111.95 154.5 25.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.104 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.692 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 14.3 mmp_? -51.35 -29.43 15.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.476 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 98.08 -1.84 59.47 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.706 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.692 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 36.4 p90 -140.86 158.64 43.66 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.326 -0.437 . . . . 0.0 110.448 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.447 ' HA3' ' HE2' ' A' ' 191' ' ' MET . . . -142.92 161.99 27.49 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.595 ' HB2' ' HB3' ' A' ' 189' ' ' LYS . 94.8 m-85 -104.68 122.16 45.08 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.455 ' CD2' ' CZ ' ' A' ' 207' ' ' PHE . 63.1 tp -109.75 126.34 53.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.813 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.477 ' O ' HG21 ' A' ' 185' ' ' VAL . 29.4 t -118.31 139.05 51.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.973 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.455 ' CZ ' ' CD2' ' A' ' 205' ' ' LEU . 82.1 m-85 -119.4 146.51 45.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.95 0.405 . . . . 0.0 111.497 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.55 -36.12 82.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.616 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -111.07 121.81 39.62 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.363 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -56.33 -27.17 65.85 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.491 2.127 . . . . 0.0 112.923 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.0 t -58.35 -36.34 73.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.768 0.318 . . . . 0.0 110.713 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 22.8 m -58.83 -35.21 72.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.28 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.47 -40.89 87.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.887 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -58.21 -43.57 87.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.783 0.325 . . . . 0.0 110.769 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.27 -34.83 75.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.132 0.492 . . . . 0.0 111.197 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.9 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 79.9 t -60.85 -43.02 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.785 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.1 m -86.52 -31.84 6.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -59.64 -35.26 74.06 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.472 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 74.4 m -100.59 147.01 26.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -78.96 139.24 38.28 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.9 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 44.0 m-70 -120.63 129.26 53.64 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -176.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 68.6 mt -122.44 115.4 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.1 tt -117.94 127.25 53.66 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.758 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 58.9 t0 52.87 36.34 21.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.959 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.06 13.86 82.9 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.731 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -126.48 156.39 40.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.994 0.397 . . . . 0.0 111.626 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 44.0 t -99.94 129.61 50.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.801 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.488 HG13 ' HD3' ' A' ' 230' ' ' PRO . 29.0 pt -109.3 -30.95 2.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 48.09 76.66 0.53 Allowed Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 121.246 0.546 . . . . 0.0 110.855 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.488 ' HD3' HG13 ' A' ' 228' ' ' ILE . 34.9 Cg_exo -59.8 135.58 64.58 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 123.234 2.622 . . . . 0.0 112.117 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 162' ' ' PHE . 5.5 ttpt -136.73 142.08 43.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.184 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -51.78 142.02 15.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.974 0.416 . . . . 0.0 111.355 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.96 143.13 54.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.21 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.17 128.33 26.0 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.668 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.9 149.79 25.11 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.061 1.841 . . . . 0.0 110.858 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -53.25 -41.96 65.99 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.772 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -63.2 -40.79 98.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.971 0.415 . . . . 0.0 110.459 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -66.05 -36.94 84.58 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.649 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.47 -37.95 82.64 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.861 0.362 . . . . 0.0 110.568 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -60.23 -40.05 88.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.975 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -60.57 -35.12 75.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.289 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.402 ' CG2' ' CD1' ' A' ' 270' ' ' ILE . 18.3 p -83.22 162.44 21.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.521 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -155.98 108.02 0.35 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.21 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 7.3 ttpm? -81.34 136.18 35.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.656 0.265 . . . . 0.0 110.935 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.606 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -119.39 162.87 17.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.498 0.666 . . . . 0.0 111.832 -179.139 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -101.72 137.07 40.52 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.066 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.518 HG11 ' O ' ' A' ' 287' ' ' GLY . 11.7 p -131.11 145.45 35.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.934 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.644 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -130.5 164.67 22.93 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 98.1 -1.61 59.33 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.129 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.454 ' CD1' ' CD1' ' A' ' 259' ' ' PHE . 41.1 pt -116.62 139.49 43.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 117.192 0.496 . . . . 0.0 110.636 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.404 ' N ' HG12 ' A' ' 254' ' ' VAL . . . 177.77 -103.05 0.17 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 119.599 -1.286 . . . . 0.0 114.495 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -53.15 -25.99 31.58 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.822 2.348 . . . . 0.0 113.173 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -131.99 95.02 3.59 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.522 ' O ' ' HB2' ' A' ' 258' ' ' GLU . 0.5 OUTLIER -178.19 -46.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.152 -179.276 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 28.1 mmt180 68.37 128.02 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -177.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.38 -29.03 37.44 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.012 1.808 . . . . 0.0 112.809 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -61.72 -43.3 99.13 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.574 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 97.0 mt-10 -67.74 -35.52 78.88 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 111.368 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.653 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 19.2 t80 -59.15 -49.09 79.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.459 -178.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.74 -37.7 88.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -63.71 -40.1 95.94 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.828 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.656 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 84.0 t80 -65.41 -55.12 19.82 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.589 ' CB ' HD12 ' A' ' 269' ' ' ILE . 9.3 m-85 -65.19 -27.24 68.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.791 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.483 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 33.4 t -54.48 -26.97 34.46 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -50.17 -38.12 38.11 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.794 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.709 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 24.3 p90 -127.42 54.24 1.68 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.267 0.556 . . . . 0.0 111.18 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.485 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 151.48 153.28 6.14 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.432 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 32.8 p -71.43 -23.0 61.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.899 0.38 . . . . 0.0 111.14 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.589 HD12 ' CB ' ' A' ' 263' ' ' PHE . 77.8 mt 55.53 99.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.589 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.617 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 73.4 mt -58.47 -40.84 79.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.174 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -174.92 106.06 0.1 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.516 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -100.7 135.59 41.9 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.469 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -146.01 161.99 38.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.325 0.583 . . . . 0.0 112.546 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.605 ' O ' ' HB2' ' A' ' 275' ' ' MET . 56.7 mt -88.71 3.67 50.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.694 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.605 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 90.4 mtp 81.65 -49.53 0.24 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.584 0.354 . . . . 0.0 111.767 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 47.2 56.94 6.24 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -77.65 114.48 16.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.083 0.468 . . . . 0.0 110.276 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . 0.425 ' O ' ' HG2' ' A' ' 278' ' ' LYS . 80.4 tttt 44.34 25.97 0.15 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.836 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 53.19 44.82 29.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.372 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 1.7 t -171.53 -37.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.908 0.385 . . . . 0.0 111.294 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -54.42 -27.99 42.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.948 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.579 ' O ' ' CB ' ' A' ' 283' ' ' SER . 4.8 pp0? -137.07 162.79 32.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.601 0.239 . . . . 0.0 111.583 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.579 ' CB ' ' O ' ' A' ' 282' ' ' GLN . 83.2 p 121.91 -8.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 O-C-N 124.226 0.954 . . . . 0.0 110.385 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 67.6 mtt85 -57.36 -33.62 67.97 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.617 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 250' ' ' ILE . . . 158.28 35.38 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.618 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -144.36 165.18 28.65 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.524 0.662 . . . . 0.0 110.997 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.518 ' O ' HG11 ' A' ' 247' ' ' VAL . . . -145.98 166.18 27.99 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.069 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.45 ' CE2' ' CE ' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -120.43 122.11 40.0 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 122.892 -0.181 . . . . 0.0 111.27 179.576 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.653 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 57.6 t -123.84 137.67 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.049 0.452 . . . . 0.0 111.58 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 48.7 m -115.38 135.98 53.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.638 178.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.485 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 41.1 m-85 -114.95 136.94 52.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.15 0.5 . . . . 0.0 112.007 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.617 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 31.9 p-10 -62.38 -33.25 74.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.19 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' SER . . . . . 0.427 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 28.6 t -123.15 140.06 53.41 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.636 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.33 -30.96 72.0 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.067 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.4 -38.18 68.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.211 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.457 ' O ' ' HD1' ' A' ' 266' ' ' TRP . . . -62.19 -37.04 83.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.907 0.384 . . . . 0.0 110.478 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 81.3 t -61.89 -42.24 93.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.201 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.99 -36.7 77.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.147 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -57.25 -43.9 83.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.911 0.386 . . . . 0.0 112.027 -178.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.709 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 1.0 OUTLIER -69.86 -33.6 56.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.632 -179.141 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . 0.401 ' N ' HG11 ' A' ' 300' ' ' VAL . 76.8 m -57.44 -45.37 84.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.416 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -61.94 -41.42 97.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.25 0.547 . . . . 0.0 110.55 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -62.8 -32.5 73.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.433 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.657 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 10.6 tptm 67.94 -75.96 0.06 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -177.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.657 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.3 m-30 -110.52 136.1 50.16 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.473 HD13 ' CZ3' ' A' ' 266' ' ' TRP . 1.1 mt -117.05 136.95 52.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.506 ' OD1' ' O ' ' A' ' 307' ' ' ASP . 52.4 p30 -72.83 96.94 2.15 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.146 0.498 . . . . 0.0 111.705 -178.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.656 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 6.2 t80 -102.27 -75.16 0.61 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.345 0.593 . . . . 0.0 110.375 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.44 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 10.2 mmpt? -95.14 -167.9 1.71 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.152 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -52.04 -27.72 14.71 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.836 0.35 . . . . 0.0 110.753 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -116.67 160.48 20.67 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.414 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.497 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 71.4 mttt -71.85 147.82 46.77 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.53 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.644 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 28.6 pt -115.37 144.47 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . 0.594 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 83.4 mt-10 -104.29 134.52 47.38 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.059 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.494 ' CD1' HG23 ' A' ' 300' ' ' VAL . 73.5 mt -122.35 126.25 73.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.072 0.463 . . . . 0.0 111.466 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -129.96 155.42 46.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.776 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -55.46 148.42 15.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.794 0.33 . . . . 0.0 110.494 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.03 145.85 24.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.995 0.426 . . . . 0.0 111.409 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.952 -179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 10.5 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.912 0.387 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -62.03 139.91 58.4 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.457 0.646 . . . . 0.0 111.74 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.491 ' N ' ' O ' ' A' ' 205' ' ' LEU . 92.7 mmm -121.08 149.13 43.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.617 -179.045 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.596 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 8.4 t80 -105.92 129.42 54.07 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.496 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 14.9 mm -114.76 127.51 72.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.835 -178.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.485 ' O ' ' HB ' ' A' ' 228' ' ' ILE . . . -130.09 162.25 23.07 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.908 179.216 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.6 27.39 63.29 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 119.861 -1.161 . . . . 0.0 111.691 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.401 HD22 ' CG2' ' A' ' 228' ' ' ILE . 84.6 mt -85.1 140.32 31.06 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 120.802 0.335 . . . . 0.0 111.414 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -63.07 136.75 57.98 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.431 ' CD2' ' HD2' ' A' ' 198' ' ' ARG . 3.9 m0 -51.9 -28.23 15.58 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.811 0.339 . . . . 0.0 110.882 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -92.4 9.04 35.89 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.564 178.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.581 ' O ' ' HB2' ' A' ' 174' ' ' ASN . 89.6 m -56.24 -37.2 69.41 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.566 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.7 OUTLIER 53.64 145.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.247 0.546 . . . . 0.0 110.794 -178.38 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.517 ' HG2' HG13 ' A' ' 190' ' ' ILE . 97.3 mt-10 -61.45 -33.15 73.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.766 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.539 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 92.6 m-20 -57.38 -41.26 79.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.872 -178.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.581 ' HB2' ' O ' ' A' ' 170' ' ' THR . 83.2 m-20 -64.49 -35.71 81.83 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.456 HD11 HD13 ' A' ' 188' ' ' LEU . 2.4 mt -54.02 -51.15 64.9 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.539 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -63.58 -36.76 84.85 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.935 179.605 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -66.4 -44.8 82.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.085 0.469 . . . . 0.0 110.34 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.624 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 62.4 t80 -66.33 -47.32 73.88 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.922 179.207 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.466 ' CG ' HD23 ' A' ' 205' ' ' LEU . 86.4 m-85 -91.39 -1.77 57.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.108 -178.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -61.89 -28.86 70.94 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.486 179.012 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -37.41 74.71 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.715 0.769 . . . . 0.0 110.797 -178.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -66.72 -30.69 70.98 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.062 -178.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 163.97 -126.64 1.55 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.195 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 57.3 m -119.23 141.46 48.89 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.494 HG22 ' CD2' ' A' ' 188' ' ' LEU . 13.8 p -106.69 128.73 61.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.586 -0.445 . . . . 0.0 109.972 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.412 HG21 ' CB ' ' A' ' 206' ' ' SER . 1.2 t -84.49 -43.49 14.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.535 -178.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -138.68 136.18 35.58 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -178.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.494 ' CD2' HG22 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -116.07 128.76 55.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.091 179.008 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 8.9 tptt -140.29 113.69 8.56 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.517 HG13 ' HG2' ' A' ' 172' ' ' GLU . 79.4 mt -126.77 126.62 68.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 174.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.662 ' HB2' ' HB2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -81.31 77.25 8.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.235 0.541 . . . . 0.0 110.644 -178.587 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -73.06 141.66 47.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.258 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 10.2 m-20 -92.36 100.55 3.82 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 193' ' ' ASP . 27.9 Cg_endo -62.06 -27.07 78.84 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.523 2.149 . . . . 0.0 112.796 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -75.34 -76.3 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.707 -179.484 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 57.9 p -69.99 -22.5 63.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 80.54 24.62 58.37 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.234 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.517 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 16.4 tpp85 -113.07 129.73 56.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.971 0.415 . . . . 0.0 111.395 -179.552 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.8 m -66.48 151.35 47.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.097 0.475 . . . . 0.0 111.288 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.766 ' HG3' ' CE1' ' A' ' 202' ' ' PHE . 17.3 tpt85 -59.55 -29.34 67.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.48 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 102.35 -9.75 56.14 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.722 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.766 ' CE1' ' HG3' ' A' ' 200' ' ' ARG . 21.0 p90 -144.24 155.3 43.81 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.445 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -144.79 164.13 27.86 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.828 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.596 ' CE2' ' CD1' ' A' ' 162' ' ' PHE . 96.5 m-85 -105.17 123.49 47.92 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.058 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 161' ' ' MET . 58.2 tp -108.02 125.52 51.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.442 -178.124 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.444 ' O ' HG21 ' A' ' 185' ' ' VAL . 27.3 t -118.29 134.51 54.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.671 0.272 . . . . 0.0 110.983 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.464 ' CZ ' ' CD2' ' A' ' 205' ' ' LEU . 88.5 m-85 -115.42 138.67 50.76 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 120.963 0.411 . . . . 0.0 112.012 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -62.04 -35.03 77.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.842 178.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.84 117.51 53.76 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.631 179.515 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -56.79 -22.88 47.22 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.512 2.142 . . . . 0.0 112.875 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.3 t -57.37 -36.74 71.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.407 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.456 ' HA ' ' OE2' ' A' ' 215' ' ' GLU . 22.0 m -58.88 -35.64 73.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.809 0.337 . . . . 0.0 110.733 179.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.47 -42.33 93.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -59.57 -42.2 91.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.33 . . . . 0.0 111.003 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.456 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 15.2 pt-20 -74.58 -29.26 61.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.669 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.814 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 75.3 t -61.97 -42.95 96.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.129 0.49 . . . . 0.0 110.346 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.77 -40.31 88.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -58.61 -38.7 78.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.679 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 39.5 m -82.39 140.2 33.61 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.071 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 60.7 tp60 -66.23 -40.01 89.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.539 178.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.814 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 85.9 m-70 82.34 97.68 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 178.134 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 72.1 mt -115.34 109.54 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 176.232 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.9 tt -116.54 128.05 55.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.935 0.397 . . . . 0.0 111.593 -178.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 22.4 t70 49.02 38.41 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.405 179.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 83.46 7.44 86.37 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.526 178.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.438 ' HD3' ' HE2' ' A' ' 278' ' ' LYS . 35.4 mmtp -120.49 152.09 38.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.778 0.323 . . . . 0.0 111.398 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 41.3 t -104.93 132.8 50.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.489 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 164' ' ' GLY . 38.8 pt -123.73 159.72 28.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.193 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -125.19 77.85 67.35 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.307 0.575 . . . . 0.0 111.081 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.575 ' HD2' ' CD2' ' A' ' 221' ' ' HIS . 50.5 Cg_exo -59.1 123.86 14.38 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.4 2.733 . . . . 0.0 111.735 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.42 ' NZ ' ' OD2' ' A' ' 271' ' ' ASP . 9.1 mtmm -134.05 153.44 51.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.793 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -56.26 138.06 51.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.042 0.449 . . . . 0.0 111.77 -179.438 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.03 145.13 56.43 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.591 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 2.5 mt -114.21 135.76 22.19 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.589 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.428 ' HG2' ' HB3' ' A' ' 238' ' ' GLU . 10.8 Cg_endo -55.6 139.2 82.59 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.814 1.676 . . . . 0.0 111.099 179.247 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -57.0 -41.33 78.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -61.09 -45.62 93.99 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.494 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.428 ' HB3' ' HG2' ' A' ' 235' ' ' PRO . 84.2 tt0 -70.2 -38.51 75.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.673 0.749 . . . . 0.0 109.569 178.093 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -59.53 -39.83 85.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.289 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.19 -40.88 91.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.35 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.404 ' HE3' ' HA ' ' A' ' 238' ' ' GLU . 10.5 mtmp? -61.98 -35.39 78.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.684 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 18.2 p -84.18 162.51 20.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.221 0.534 . . . . 0.0 111.826 -178.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -165.34 172.85 41.03 Favored Glycine 0 C--O 1.226 -0.383 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.448 179.228 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.543 ' HE2' ' CE2' ' A' ' 288' ' ' PHE . 14.0 pttm -135.99 151.36 49.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.384 0.592 . . . . 0.0 111.603 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.601 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -118.82 165.58 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 121.457 0.646 . . . . 0.0 111.916 -178.395 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.422 ' CE1' ' CD2' ' A' ' 286' ' ' PHE . 82.5 t80 -99.93 133.74 43.86 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.407 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 287' ' ' GLY . 13.1 p -131.16 143.57 40.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.758 179.305 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 313' ' ' ILE . . . -126.85 169.43 18.78 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.288 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.22 15.84 56.69 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.161 -1.018 . . . . 0.0 112.456 -179.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.463 ' CD1' ' CE1' ' A' ' 259' ' ' PHE . 65.3 mt -110.78 131.15 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 120.961 0.41 . . . . 0.0 110.971 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.45 ' O ' ' CG2' ' A' ' 254' ' ' VAL . . . -174.04 -101.73 0.15 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.324 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.79 139.34 56.99 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.273 1.982 . . . . 0.0 113.01 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 55.15 45.45 25.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 178.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.497 ' O ' ' O ' ' A' ' 255' ' ' ARG . 15.4 m -125.39 -48.52 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.232 178.455 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.56 ' HB3' ' OE1' ' A' ' 258' ' ' GLU . 2.4 tpp85 57.09 136.51 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.214 0 CA-C-O 120.833 0.349 . . . . 0.0 110.17 -179.365 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.14 -26.91 53.21 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.518 2.146 . . . . 0.0 113.466 -178.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -59.8 -48.01 83.41 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.698 -179.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.56 ' OE1' ' HB3' ' A' ' 255' ' ' ARG . 58.8 mp0 -67.97 -35.56 78.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.029 0.442 . . . . 0.0 111.246 179.119 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.624 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 29.8 t80 -60.67 -45.31 94.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.914 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.59 -39.41 91.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.154 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.1 pt-20 -75.75 -30.51 59.21 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.742 0.306 . . . . 0.0 110.773 179.495 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.708 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 79.0 t80 -58.18 -57.48 12.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.136 0.493 . . . . 0.0 111.924 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.726 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 30.9 m-85 -68.28 -21.66 64.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.611 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.502 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 34.0 t -55.35 -25.27 34.02 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.043 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -47.82 -38.6 16.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.705 178.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.726 ' CZ2' ' CD2' ' A' ' 263' ' ' PHE . 24.3 p90 -132.15 55.79 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.237 0.541 . . . . 0.0 111.444 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.452 ' HA2' ' CD1' ' A' ' 291' ' ' TYR . . . 151.59 145.29 4.1 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.652 179.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 52.8 m -58.68 -36.38 74.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.847 0.356 . . . . 0.0 111.133 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.531 HD12 ' CB ' ' A' ' 263' ' ' PHE . 73.8 mt 67.74 86.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.177 -178.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.578 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 78.9 mt -55.98 -44.6 78.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.798 179.377 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.42 ' OD2' ' NZ ' ' A' ' 231' ' ' LYS . 59.5 t0 -166.89 105.02 0.58 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.703 0.287 . . . . 0.0 111.667 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -100.19 136.84 39.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.701 179.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -139.46 145.45 38.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.114 0.483 . . . . 0.0 111.9 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 275' ' ' MET . 23.3 tp -67.39 -38.07 84.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.351 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.535 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 92.5 mmm 101.87 115.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.937 0.895 . . . . 0.0 109.52 -178.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 281' ' ' GLY . 29.7 mt -123.39 140.8 52.64 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.204 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.541 ' HB3' ' HA2' ' A' ' 281' ' ' GLY . 59.4 t0 -157.66 93.72 1.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.053 177.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . 0.438 ' HE2' ' HD3' ' A' ' 226' ' ' LYS . 11.2 mmtt 69.41 48.13 0.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.205 0.526 . . . . 0.0 110.189 -177.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 60.0 t0 67.14 -70.68 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.719 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 59.5 p -69.32 -14.13 62.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.436 -179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . 0.541 ' HA2' ' HB3' ' A' ' 277' ' ' ASP . . . -55.12 126.48 38.91 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.866 -178.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.421 ' CB ' ' CB ' ' A' ' 275' ' ' MET . 58.2 mm-40 41.25 36.79 0.52 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.996 -0.602 . . . . 0.0 110.87 178.641 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 90.8 p -126.57 157.88 37.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.859 -179.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.445 ' O ' ' HG2' ' A' ' 284' ' ' ARG . 72.0 ttt180 58.16 39.78 25.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.118 0.485 . . . . 0.0 109.808 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -160.46 -68.83 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.945 -179.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 247' ' ' VAL . 29.7 p90 -136.82 166.85 22.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.967 0.413 . . . . 0.0 111.462 -178.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.506 ' O ' HG11 ' A' ' 247' ' ' VAL . . . -135.27 158.15 23.48 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.883 179.012 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.543 ' CE2' ' HE2' ' A' ' 244' ' ' LYS . 0.2 OUTLIER -115.13 127.95 55.89 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 122.254 0.222 . . . . 0.0 110.624 179.419 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.624 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 48.2 t -121.21 135.18 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.689 178.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 48.8 m -111.38 136.36 50.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.537 178.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.652 ' OH ' ' HB3' ' A' ' 263' ' ' PHE . 39.2 m-85 -116.08 138.69 51.02 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.371 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.578 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 21.7 t70 -57.82 -34.04 69.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.56 178.091 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 28.9 t -119.06 137.41 53.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.351 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.83 -29.76 70.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.1 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -56.05 -37.05 68.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.419 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 266' ' ' TRP . . . -60.2 -35.84 76.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.908 0.385 . . . . 0.0 110.811 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 71.2 t -60.57 -44.3 96.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.988 0.423 . . . . 0.0 110.658 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -63.43 -37.23 86.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.071 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -58.16 -42.74 86.62 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.657 ' CG2' ' CZ2' ' A' ' 266' ' ' TRP . 1.2 p -68.99 -33.7 60.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.797 0.332 . . . . 0.0 111.603 -179.405 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 72.6 m -55.2 -42.24 73.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.106 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -61.83 -37.35 84.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.085 0.469 . . . . 0.0 110.529 179.399 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.55 ' OD1' ' C ' ' A' ' 305' ' ' PHE . 0.0 OUTLIER -62.96 -35.99 81.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.654 -179.795 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.66 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 45.1 tptt 70.69 -71.86 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.457 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.667 ' CE2' ' HG2' ' A' ' 314' ' ' GLU . 32.7 m-85 -119.89 130.08 54.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.733 178.856 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.474 HG12 ' OD1' ' A' ' 303' ' ' ASN . 39.8 mt -113.11 136.42 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -78.04 95.22 4.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.0 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.708 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 4.9 t80 -87.36 -85.43 0.17 Allowed 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.991 179.451 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.566 ' O ' ' HB2' ' A' ' 310' ' ' ASP . 12.1 mmmt -94.91 4.5 53.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.566 ' HB2' ' O ' ' A' ' 309' ' ' LYS . 83.5 m-20 107.68 -31.34 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.04 0.936 . . . . 0.0 110.499 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' A' ' 312' ' ' LYS . 28.9 tpt180 -57.43 -35.46 70.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.945 179.337 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.548 ' HG3' ' HB3' ' A' ' 305' ' ' PHE . 16.4 tptt 96.12 71.6 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.537 -179.349 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.687 ' O ' HG13 ' A' ' 313' ' ' ILE . 29.9 pt -57.2 98.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.624 0.726 . . . . 0.0 110.173 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . 0.667 ' HG2' ' CE2' ' A' ' 305' ' ' PHE . 77.0 mt-10 -61.85 138.04 58.31 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.463 HG12 HG21 ' A' ' 247' ' ' VAL . 72.3 mt -121.93 128.54 75.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 19.4 mtpt -131.61 150.98 51.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.7 178.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -58.13 144.77 39.2 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.467 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . 0.402 ' O ' ' CG ' ' A' ' 319' ' ' GLU . . . -65.06 143.63 57.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.972 0.415 . . . . 0.0 111.244 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 318' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.285 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 26.3 m . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.539 0.209 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -74.36 139.25 43.97 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.168 0.509 . . . . 0.0 111.58 -179.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.406 ' HB2' ' HB3' ' A' ' 205' ' ' LEU . 87.3 mmm -112.52 149.32 32.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.504 -179.304 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.533 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 4.6 t80 -103.08 129.19 49.83 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 17.8 mm -116.8 125.91 73.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.943 -179.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -120.91 155.97 16.18 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 178.404 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.57 41.53 35.6 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 119.971 -1.109 . . . . 0.0 111.8 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.514 HD11 HD12 ' A' ' 190' ' ' ILE . 75.0 mt -58.81 -28.18 65.76 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.774 ' O ' ' N ' ' A' ' 169' ' ' ASP . 52.5 t30 71.98 45.41 0.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -177.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.424 ' CZ3' ' NH2' ' A' ' 198' ' ' ARG . 10.9 m0 23.36 -62.62 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.534 1.134 . . . . 0.0 113.911 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.774 ' N ' ' O ' ' A' ' 167' ' ' ASN . 92.3 m-20 -53.91 -33.82 57.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.142 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 166' ' ' LEU . 87.9 m -52.92 -39.31 62.69 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.593 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 169' ' ' ASP . 0.1 OUTLIER 55.44 166.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.073 0.464 . . . . 0.0 109.822 -177.846 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.522 ' HA ' HD13 ' A' ' 190' ' ' ILE . 21.0 pt-20 -67.76 -23.0 65.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.399 -179.42 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.569 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.8 m-20 -58.68 -44.29 90.17 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.459 -178.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.411 ' HB2' ' CG2' ' A' ' 170' ' ' THR . 83.9 m-20 -68.11 -35.33 77.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.677 0.275 . . . . 0.0 111.542 179.27 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.5 mt -55.91 -44.8 78.63 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.19 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.569 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -64.37 -38.77 92.2 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.978 179.312 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.42 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 75.6 mm-40 -69.41 -42.49 75.01 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.573 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 53.8 t80 -64.96 -47.59 77.06 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.421 0.629 . . . . 0.0 111.565 179.471 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.446 ' CG ' HD23 ' A' ' 205' ' ' LEU . 82.4 m-85 -92.42 -1.04 57.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.224 -178.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -58.45 -31.16 66.08 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.205 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -41.18 90.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.543 0.687 . . . . 0.0 110.576 -179.322 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -68.34 -33.89 75.1 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.209 -178.301 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.44 -174.62 44.85 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.862 -179.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 54.5 m -63.48 -28.29 69.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.777 0.322 . . . . 0.0 111.319 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 185' ' ' VAL . 1.2 t 64.86 82.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -176.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.615 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 3.1 m -56.72 -42.87 79.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.414 -176.473 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -148.34 144.62 27.67 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.411 ' CD2' HG12 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -115.4 134.7 54.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.571 178.577 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 11.1 tptt -141.39 67.13 1.35 Allowed 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.522 HD13 ' HA ' ' A' ' 172' ' ' GLU . 3.3 mt -66.43 -9.93 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 121.104 0.478 . . . . 0.0 110.377 177.359 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.573 ' HE3' ' O ' ' A' ' 202' ' ' PHE . 1.8 mpp? 74.53 -56.62 0.63 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.588 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' A' ' 191' ' ' MET . 8.0 mtmp? 56.43 152.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.077 0.465 . . . . 0.0 111.597 179.392 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.691 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 0.7 OUTLIER -126.08 78.58 70.35 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.519 -179.762 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -56.51 -25.41 58.26 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 121.988 1.792 . . . . 0.0 111.706 179.442 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.77 -67.16 0.66 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.66 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.5 p -67.25 -26.83 66.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.507 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 93.14 0.77 67.66 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.818 -0.706 . . . . 0.0 113.151 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.691 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 1.5 tpt180 -127.41 125.94 41.53 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 117.162 0.481 . . . . 0.0 110.743 179.708 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 192' ' ' LYS . 42.8 m -58.11 155.46 11.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.161 0.505 . . . . 0.0 111.59 -179.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.534 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 40.3 mmt180 -55.68 -30.46 61.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.666 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 97.82 0.16 59.06 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.853 -178.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.573 ' O ' ' HE3' ' A' ' 191' ' ' MET . 28.2 p90 -148.36 159.18 44.27 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 189' ' ' LYS . . . -147.04 163.75 28.63 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.09 -1.052 . . . . 0.0 111.548 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.537 ' HB2' ' HB3' ' A' ' 189' ' ' LYS . 99.0 m-85 -104.63 122.16 45.06 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.446 HD23 ' CG ' ' A' ' 179' ' ' PHE . 53.5 tp -102.77 127.1 50.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.209 -177.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 186' ' ' THR . 51.8 m -119.7 139.88 51.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.453 -179.573 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.507 ' CE1' HG21 ' A' ' 185' ' ' VAL . 94.9 m-85 -122.6 139.68 53.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.578 178.455 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.615 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.5 tt0 -59.98 -33.83 72.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.924 0.392 . . . . 0.0 110.114 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 13.3 mtmm -114.51 122.91 33.19 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.008 179.383 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -56.78 -20.44 35.44 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.744 2.296 . . . . 0.0 113.023 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.9 m -56.48 -36.93 69.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.694 0.283 . . . . 0.0 111.306 -179.269 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.445 ' HA ' ' OE2' ' A' ' 215' ' ' GLU . 22.4 m -59.18 -35.87 74.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.798 0.333 . . . . 0.0 110.764 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 83.2 t -61.56 -42.5 94.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.069 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -59.58 -42.4 92.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.744 0.306 . . . . 0.0 111.091 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.445 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 14.8 pt-20 -74.38 -29.41 61.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.596 179.454 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.729 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 64.6 t -59.77 -42.37 88.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.064 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 24.2 m -72.5 -26.95 24.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -58.63 -31.69 68.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.458 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.615 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 68.7 m -108.42 140.01 42.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.893 0.378 . . . . 0.0 111.605 -179.129 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 63.4 tt0 -65.53 -40.74 93.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.64 179.079 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.729 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 71.7 m-70 84.47 110.74 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 178.352 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 20.3 mm -116.66 114.05 44.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 175.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.8 tt -122.58 122.3 38.54 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.469 -178.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 51.5 42.39 29.36 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 178.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.07 8.26 87.95 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.562 -0.827 . . . . 0.0 113.443 178.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.417 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 35.5 mmtp -121.5 155.37 35.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.753 0.311 . . . . 0.0 111.008 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 32.8 m -110.5 134.94 51.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.04 0.447 . . . . 0.0 110.349 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.453 HG13 ' HD3' ' A' ' 230' ' ' PRO . 36.5 pt -124.32 158.63 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.866 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -126.74 79.2 72.28 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 121.16 0.505 . . . . 0.0 111.175 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.54 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 51.1 Cg_exo -58.98 120.87 9.01 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.739 2.293 . . . . 0.0 110.669 179.232 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -134.1 146.97 50.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.686 0.279 . . . . 0.0 111.712 -179.065 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.55 ' HD2' ' N ' ' A' ' 232' ' ' ARG . 0.0 OUTLIER -49.4 134.91 18.38 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.986 0.422 . . . . 0.0 110.989 -179.557 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.45 145.66 55.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.915 -179.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . 0.404 ' CG2' ' HD2' ' A' ' 235' ' ' PRO . 1.2 mt -118.13 137.55 24.65 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.167 179.223 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 238' ' ' GLU . 9.5 Cg_endo -54.28 141.03 72.11 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 121.8 1.666 . . . . 0.0 110.97 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -55.76 -41.76 74.45 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -178.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -60.83 -41.79 96.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.782 0.325 . . . . 0.0 111.047 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.41 ' HB2' ' HG2' ' A' ' 235' ' ' PRO . 84.5 tt0 -64.75 -36.59 84.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.601 179.394 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -60.0 -38.83 83.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.704 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -61.12 -39.42 89.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.207 0.527 . . . . 0.0 110.394 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -60.97 -31.4 70.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.347 179.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.493 ' CG2' HD13 ' A' ' 270' ' ' ILE . 10.4 p -75.31 161.44 29.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.911 -178.136 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.69 112.72 0.85 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.086 179.53 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.602 ' HE3' ' CD2' ' A' ' 288' ' ' PHE . 5.3 tptp -85.8 129.2 34.89 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -179.629 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.629 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -120.84 160.71 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.474 0.654 . . . . 0.0 111.865 -179.55 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 286' ' ' PHE . 76.2 t80 -104.31 137.45 42.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.951 179.416 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.548 HG21 HG12 ' A' ' 315' ' ' ILE . 7.2 p -128.68 147.17 33.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.644 -179.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.664 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -128.7 166.96 21.01 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.026 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 81.02 42.19 9.76 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.804 -179.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.419 HD13 ' N ' ' A' ' 287' ' ' GLY . 27.3 mm -55.65 -36.29 41.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.849 0.357 . . . . 0.0 111.295 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 60.79 169.02 0.5 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.868 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.26 144.66 81.59 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.032 2.488 . . . . 0.0 113.674 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 55.11 42.47 30.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.936 178.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.615 ' O ' ' O ' ' A' ' 255' ' ' ARG . 12.5 p -63.72 -38.3 81.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.996 178.612 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.615 ' O ' ' O ' ' A' ' 254' ' ' VAL . 4.5 mpt_? 50.31 126.29 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.43 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.48 -28.28 44.13 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.077 1.852 . . . . 0.0 112.668 -178.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -61.17 -47.79 84.55 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.614 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.495 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 53.0 mp0 -69.44 -39.62 77.69 Favored 'General case' 0 C--O 1.224 -0.261 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.576 ' CZ ' HG21 ' A' ' 289' ' ' VAL . 27.4 t80 -61.37 -47.25 86.68 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.21 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.58 -43.11 90.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.736 0.303 . . . . 0.0 111.295 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.495 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.8 pt-20 -76.47 -28.86 56.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.129 0.49 . . . . 0.0 110.877 179.444 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.66 ' CZ ' ' HB2' ' A' ' 308' ' ' PHE . 11.6 t80 -61.93 -56.48 18.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.13 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.598 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 5.2 m-85 -67.67 -27.56 66.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.069 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.487 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 80.1 p -56.44 -23.97 42.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.736 0.303 . . . . 0.0 111.113 -178.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -56.68 -35.94 69.01 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.669 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 19.4 p90 -111.66 48.99 0.92 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -179.648 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 133.43 150.39 6.31 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.184 178.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.4 m -70.3 131.68 44.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.566 HD12 ' CB ' ' A' ' 263' ' ' PHE . 74.5 mt -102.9 118.65 50.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.84 -178.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.668 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 72.7 mt -69.51 -39.4 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 120.289 -0.565 . . . . 0.0 112.236 179.359 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -136.38 -87.44 0.32 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 289' ' ' VAL . . . 65.14 110.42 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.709 0.29 . . . . 0.0 110.886 -178.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . 0.419 ' O ' ' NE2' ' A' ' 282' ' ' GLN . 21.6 pt20 -141.23 158.67 43.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.253 0.549 . . . . 0.0 111.853 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.65 ' O ' ' HB2' ' A' ' 275' ' ' MET . 28.6 tp -66.1 -26.86 67.66 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.09 -179.608 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.65 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 66.8 mmm 82.51 -80.91 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.457 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 274' ' ' LEU . 5.2 mp 55.53 72.25 0.5 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.16 -178.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.451 ' HB3' ' HA2' ' A' ' 281' ' ' GLY . 60.2 t0 -79.91 113.56 18.16 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.001 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 18.6 mttt 69.76 -59.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.358 -178.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 280' ' ' THR . 53.7 p30 -178.1 -31.12 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 179.133 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 280' ' ' THR . . . . . 0.53 ' N ' ' OD1' ' A' ' 279' ' ' ASP . 68.2 p -109.46 10.89 25.22 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.493 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 277' ' ' ASP . . . -91.37 99.07 2.52 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.209 -0.995 . . . . 0.0 113.149 -179.525 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.681 ' HB2' ' CZ ' ' A' ' 286' ' ' PHE . 38.2 tt0 75.38 -8.1 1.65 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.89 0.476 . . . . 0.0 112.18 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 21.9 m -57.77 -38.46 75.46 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -137.79 142.59 40.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.31 178.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.05 -46.46 1.71 Allowed Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.484 -0.865 . . . . 0.0 114.399 178.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.681 ' CZ ' ' HB2' ' A' ' 282' ' ' GLN . 23.7 p90 -140.24 168.38 19.93 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.224 1.012 . . . . 0.0 113.076 -179.162 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.501 ' CA ' HG11 ' A' ' 247' ' ' VAL . . . -138.03 174.35 21.95 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.173 179.164 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.602 ' CD2' ' HE3' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -137.17 123.33 20.44 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.294 0.547 . . . . 0.0 111.44 -179.948 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.629 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 56.8 t -126.44 137.6 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.008 0.432 . . . . 0.0 111.815 178.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.468 ' OG1' ' CD ' ' A' ' 244' ' ' LYS . 32.6 m -110.73 136.45 49.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.7 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.436 ' OH ' ' O ' ' A' ' 263' ' ' PHE . 31.0 m-85 -117.96 136.1 53.72 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.668 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 55.7 t0 -59.05 -36.18 74.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.254 178.6 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 49.9 m -121.53 143.88 49.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.471 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . 0.438 ' O ' HG11 ' A' ' 297' ' ' VAL . . . -66.57 -28.72 68.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.389 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -56.01 -36.59 68.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.824 -179.126 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.71 91.46 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.487 HG11 ' N ' ' A' ' 298' ' ' ASP . 6.2 p -59.62 -36.96 68.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.219 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . 0.487 ' N ' HG11 ' A' ' 297' ' ' VAL . 89.6 m-20 -62.18 -38.41 88.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.346 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -59.87 -43.41 94.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.894 -178.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.669 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 0.8 OUTLIER -69.4 -34.84 64.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.375 -179.334 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . 0.402 ' N ' HG11 ' A' ' 300' ' ' VAL . 80.2 m -59.33 -46.6 88.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.155 -179.569 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -62.49 -38.83 91.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.199 0.523 . . . . 0.0 109.965 179.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.401 ' O ' ' N ' ' A' ' 305' ' ' PHE . 88.5 m-20 -61.55 -32.36 72.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.257 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.618 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 18.8 tptm 69.24 -69.55 0.16 Allowed 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.618 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.7 m-30 -113.95 143.0 45.43 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.758 178.063 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.474 ' CG2' ' CZ ' ' A' ' 262' ' ' PHE . 6.9 mm -111.94 136.35 48.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -72.41 83.69 1.08 Allowed 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.198 -179.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.66 ' HB2' ' CZ ' ' A' ' 262' ' ' PHE . 4.9 t80 -105.9 142.84 34.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.556 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.513 ' HG2' ' CD2' ' A' ' 308' ' ' PHE . 18.8 mmmt 46.34 -135.89 0.79 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.116 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -96.74 9.77 40.74 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -178.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -151.05 165.82 32.63 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.453 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 53.0 mttt -78.86 143.46 35.94 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.76 179.159 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.664 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 33.7 pt -121.1 153.76 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.088 179.185 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . 0.596 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 84.0 mt-10 -110.16 134.98 51.65 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.414 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.548 HG12 HG21 ' A' ' 247' ' ' VAL . 76.7 mt -122.28 128.61 75.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.268 0.556 . . . . 0.0 112.17 -179.287 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -128.4 156.66 42.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.113 179.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -54.68 146.97 15.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.64 0.257 . . . . 0.0 110.363 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . 0.457 ' HA ' ' HB2' ' A' ' 246' ' ' PHE . . . -54.26 -98.28 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.042 -179.273 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 318' ' ' ALA . 56.3 mm-40 . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.416 0.151 . . . . 0.0 111.351 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.403 ' O ' HG23 ' A' ' 213' ' ' VAL . 8.2 m . . . . . 0 CA--C 1.529 0.173 0 CA-C-O 120.806 0.336 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.488 ' HE2' ' CD2' ' A' ' 204' ' ' PHE . 74.2 tttt -56.74 139.69 49.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.179 0.514 . . . . 0.0 111.896 -178.607 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.541 ' HB2' ' HB2' ' A' ' 205' ' ' LEU . 94.7 mmm -121.94 150.46 41.98 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.896 -178.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.711 ' CE1' ' CZ ' ' A' ' 204' ' ' PHE . 1.5 t80 -108.42 129.64 55.25 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.262 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.573 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 24.4 mm -116.83 131.04 70.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.253 -179.221 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 228' ' ' ILE . . . -130.17 166.2 22.25 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 178.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.78 32.54 59.02 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.937 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 65.2 mt -59.57 -23.43 62.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -179.234 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 169' ' ' ASP . 33.3 t-20 70.3 37.29 1.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -177.549 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.522 ' CZ2' ' HD2' ' A' ' 198' ' ' ARG . 18.6 m0 37.12 17.95 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.28 -1.327 . . . . 0.0 113.829 179.453 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 167' ' ' ASN . 93.3 m-20 -139.28 10.04 2.52 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.552 ' O ' ' O ' ' A' ' 171' ' ' THR . 95.1 m -57.24 -38.52 73.94 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.465 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.552 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.2 OUTLIER 54.78 142.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.108 0.48 . . . . 0.0 110.459 -178.344 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.483 ' CG ' ' HB ' ' A' ' 190' ' ' ILE . 97.2 mt-10 -61.63 -34.96 76.58 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.554 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 60.1 t0 -57.28 -42.45 81.7 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.601 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 170' ' ' THR . 82.9 m-20 -64.13 -37.8 88.76 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.022 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 179' ' ' PHE . 11.0 mt -56.76 -50.5 72.09 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.229 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.554 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -67.46 -34.71 77.74 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.429 179.506 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -59.44 -38.91 81.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.395 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.622 ' CE2' ' CE2' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -94.69 -55.71 3.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.676 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.622 ' CE2' ' CE2' ' A' ' 178' ' ' TYR . 72.0 m-85 -60.62 -29.55 69.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.28 179.145 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.63 -24.13 23.62 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.904 179.073 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.777 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -55.71 -38.75 70.14 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.896 0.379 . . . . 0.0 111.483 -179.632 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.777 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 59.2 m-85 -68.1 -30.78 70.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.516 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 166.9 -129.33 1.9 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.092 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 59.7 m -117.4 141.78 47.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.227 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.453 ' CG2' ' O ' ' A' ' 206' ' ' SER . 10.5 p -104.41 125.44 59.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.409 ' CG2' ' N ' ' A' ' 208' ' ' GLU . 43.4 p -70.75 -35.48 72.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.605 -178.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -154.14 149.75 27.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.338 0.59 . . . . 0.0 112.253 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.421 HD13 ' CD1' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -118.63 130.14 55.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.476 179.689 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 35.5 tptt -128.57 118.87 23.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.211 0.529 . . . . 0.0 111.341 179.391 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.483 ' HB ' ' CG ' ' A' ' 172' ' ' GLU . 0.3 OUTLIER -124.44 138.48 53.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.696 177.676 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.664 ' HB2' ' HB3' ' A' ' 200' ' ' ARG . 15.1 mmt -86.29 135.08 33.68 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.901 -179.213 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -139.25 134.67 32.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.052 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 0.8 OUTLIER -123.31 78.02 53.29 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.676 -179.939 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.63 -27.9 72.32 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.252 1.968 . . . . 0.0 112.117 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -71.82 -63.01 1.22 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.083 0.468 . . . . 0.0 111.036 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 55.2 p -72.88 -18.83 61.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.512 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 79.6 28.9 50.45 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.36 -179.776 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.544 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 7.8 ttp180 -124.91 141.81 51.88 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 121.048 0.452 . . . . 0.0 111.854 -179.399 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 191' ' ' MET . 22.6 p -84.73 8.23 17.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.649 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.773 ' HG3' ' CE1' ' A' ' 202' ' ' PHE . 11.4 tpt180 76.48 -42.64 0.44 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.065 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.53 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 96.37 4.73 59.48 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.851 -0.69 . . . . 0.0 114.219 178.311 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.773 ' CE1' ' HG3' ' A' ' 200' ' ' ARG . 36.6 p90 -149.54 159.13 44.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.257 0.551 . . . . 0.0 112.106 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -151.66 170.88 31.16 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.418 179.577 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.711 ' CZ ' ' CE1' ' A' ' 162' ' ' PHE . 78.9 m-85 -114.98 134.94 54.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.025 0.441 . . . . 0.0 112.058 -179.558 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 161' ' ' MET . 59.5 mt -107.73 139.65 41.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.349 179.112 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.453 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 20.1 t -123.24 126.97 47.93 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -114.64 135.18 54.43 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.409 ' N ' ' CG2' ' A' ' 186' ' ' THR . 84.5 tt0 -63.35 -35.56 80.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.153 178.583 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.69 117.39 54.26 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.879 179.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.78 -28.09 74.65 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.58 2.187 . . . . 0.0 113.041 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 20.4 m -59.02 -39.65 82.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.796 0.331 . . . . 0.0 110.724 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 23.8 m -61.42 -35.58 77.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.222 0.534 . . . . 0.0 110.095 178.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 159' ' ' CYS . 96.7 t -62.19 -41.74 92.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.392 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 218' ' ' LYS . 92.4 m-20 -58.62 -43.61 89.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.305 -179.345 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -70.02 -34.35 73.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.855 0.36 . . . . 0.0 111.708 178.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.603 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 87.0 t -60.35 -44.36 95.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.18 -178.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.428 HG13 ' NE ' ' A' ' 232' ' ' ARG . 10.4 p -80.75 -44.84 21.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 214' ' ' ASP . 15.0 mtpt -59.21 -34.19 71.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 27.5 m -96.46 143.65 27.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.135 0.493 . . . . 0.0 111.745 -178.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -93.3 125.28 37.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.902 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.603 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 0.0 OUTLIER -131.79 152.34 51.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.201 -179.028 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 70.7 mt -121.91 128.41 75.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.871 179.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.45 HD12 HD22 ' A' ' 175' ' ' LEU . 4.7 mt -88.1 -72.78 0.51 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -93.07 14.15 18.7 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.143 -178.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 100.19 -0.32 56.0 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.987 -178.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -112.22 132.58 54.84 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 34.3 m -59.01 120.05 4.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.498 -179.325 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.723 HG13 ' HD3' ' A' ' 230' ' ' PRO . 31.1 pt -97.47 -33.0 4.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.298 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 47.57 73.72 0.94 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.079 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.723 ' HD3' HG13 ' A' ' 228' ' ' ILE . 31.0 Cg_endo -60.54 135.01 58.07 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.736 2.291 . . . . 0.0 112.143 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -128.53 151.99 48.81 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.547 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.428 ' NE ' HG13 ' A' ' 217' ' ' VAL . 1.9 mpt_? -59.47 143.45 49.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.206 0.527 . . . . 0.0 112.233 -178.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.451 ' HB1' ' HB3' ' A' ' 160' ' ' LYS . . . -74.95 150.14 39.16 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.613 179.611 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . 0.4 ' CD1' ' HG2' ' A' ' 239' ' ' GLN . 0.1 OUTLIER -124.89 133.49 24.84 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.287 178.873 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.534 ' HD2' ' OE1' ' A' ' 238' ' ' GLU . 44.0 Cg_exo -54.96 145.64 61.81 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 121.775 1.65 . . . . 0.0 110.092 178.321 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 48.7 tpt85 -54.55 -40.53 68.79 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.565 -178.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.599 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 53.4 p30 -65.24 -37.31 86.84 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.371 179.414 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.599 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 93.1 mt-10 -68.29 -34.85 76.92 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.008 179.393 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.4 ' HG2' ' CD1' ' A' ' 234' ' ' ILE . 97.4 mt-30 -58.89 -38.62 79.28 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.045 0.45 . . . . 0.0 109.901 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -61.51 -39.08 89.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.048 178.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -60.05 -34.76 73.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.393 179.529 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.425 ' CG2' ' CD1' ' A' ' 270' ' ' ILE . 12.1 p -105.38 162.96 12.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.407 -178.607 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.22 168.62 25.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.519 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 289' ' ' VAL . 7.2 ttpm? -134.31 139.6 45.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.431 0.158 . . . . 0.0 110.678 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.48 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.1 OUTLIER -118.71 157.53 20.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 121.13 0.491 . . . . 0.0 111.465 -179.361 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -102.8 128.37 49.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.645 178.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 314' ' ' GLU . 41.5 t -124.55 131.27 72.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.885 0.374 . . . . 0.0 111.44 179.303 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.654 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -105.45 174.19 20.94 Favored Glycine 0 C--O 1.225 -0.411 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.907 179.219 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 285' ' ' GLY . . . 82.86 16.22 70.79 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.933 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.574 ' CD1' ' CE1' ' A' ' 259' ' ' PHE . 64.0 mt -116.13 132.66 65.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.94 0.4 . . . . 0.0 111.519 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -168.02 -116.3 0.36 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.666 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.89 143.53 99.58 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.616 2.211 . . . . 0.0 113.389 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 55.34 41.81 30.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.953 178.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.597 ' O ' ' O ' ' A' ' 255' ' ' ARG . 16.6 m -118.8 -1.84 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.369 178.099 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.597 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.2 OUTLIER 37.61 111.91 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.431 0 O-C-N 123.365 0.415 . . . . 0.0 111.804 -179.851 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.19 -39.72 51.82 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.542 1.495 . . . . 0.0 111.492 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -62.6 -40.99 98.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.014 0.435 . . . . 0.0 109.959 178.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.491 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 85.0 tt0 -65.11 -37.47 87.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.822 179.502 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.574 ' CE1' ' CD1' ' A' ' 250' ' ' ILE . 35.1 t80 -60.51 -45.46 93.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.643 179.076 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.1 -42.01 97.08 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.491 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.3 pt-20 -74.73 -30.23 61.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.015 0.436 . . . . 0.0 110.362 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.569 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 88.1 t80 -58.78 -46.56 87.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.885 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.624 ' HA ' ' CZ3' ' A' ' 266' ' ' TRP . 34.8 m-85 -88.09 -7.12 57.44 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.745 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.442 ' CA ' HD13 ' A' ' 269' ' ' ILE . 81.6 p -62.6 -26.28 68.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.039 0.447 . . . . 0.0 111.107 -179.668 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -57.16 -38.41 73.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.911 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.624 ' CZ3' ' HA ' ' A' ' 263' ' ' PHE . 11.6 m-90 -59.26 -38.35 79.89 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.342 0.591 . . . . 0.0 111.199 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 264' ' ' SER . . . 174.83 -159.77 28.51 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.069 -178.757 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 51.3 m -79.57 130.73 35.65 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.143 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.531 HG12 ' CE1' ' A' ' 291' ' ' TYR . 72.2 mt -106.59 118.32 54.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.635 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 69.5 mt -61.17 -52.46 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 120.089 -0.645 . . . . 0.0 112.288 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 270' ' ' ILE . 72.9 m-20 -162.97 68.9 0.22 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -73.87 135.71 43.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -139.63 149.43 43.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.451 0.643 . . . . 0.0 111.969 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.563 ' O ' ' HB2' ' A' ' 275' ' ' MET . 22.6 tp -65.14 -37.91 88.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.855 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.651 ' HB2' ' HG3' ' A' ' 282' ' ' GLN . 93.6 mmm 84.62 148.59 0.07 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.14 0.576 . . . . 0.0 109.899 -178.293 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.488 ' HA ' ' HB3' ' A' ' 282' ' ' GLN . 5.5 mp -158.57 133.34 8.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.632 0.253 . . . . 0.0 110.734 179.453 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -74.82 -134.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.129 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . 0.41 ' O ' ' OD1' ' A' ' 279' ' ' ASP . 86.4 mttt -58.78 -37.14 75.65 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 278' ' ' LYS . 95.9 m-20 -140.34 -85.07 0.22 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.762 179.125 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 57.8 p -116.04 24.31 11.54 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.711 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -51.88 -41.92 52.55 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.805 -179.08 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.651 ' HG3' ' HB2' ' A' ' 275' ' ' MET . 0.9 OUTLIER -64.52 -34.74 78.94 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.972 0.415 . . . . 0.0 111.493 178.991 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 39.4 t -49.59 -15.14 0.14 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.244 -177.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -51.18 -36.87 43.36 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.098 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 249' ' ' GLY . . . 154.2 31.09 0.03 OUTLIER Glycine 0 CA--C 1.528 0.888 0 C-N-CA 118.828 -1.653 . . . . 0.0 116.636 178.419 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.441 ' O ' ' OE1' ' A' ' 282' ' ' GLN . 12.7 p90 -143.89 160.6 40.51 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.51 1.655 . . . . 0.0 111.962 178.322 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -147.2 163.34 28.68 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.952 179.286 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.422 ' CE2' ' HE3' ' A' ' 244' ' ' LYS . 1.4 m-30 -113.68 128.07 56.28 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.493 HG21 ' CZ ' ' A' ' 259' ' ' PHE . 39.8 t -121.52 132.67 70.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.527 0.203 . . . . 0.0 110.462 177.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 49.7 m -120.26 136.51 54.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.642 0.258 . . . . 0.0 110.42 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.531 ' CE1' HG12 ' A' ' 269' ' ' ILE . 45.7 m-85 -119.23 134.98 54.91 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.635 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 55.0 t0 -60.52 -34.84 74.68 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.649 178.07 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 23.3 t -117.32 140.79 49.12 Favored 'General case' 0 N--CA 1.46 0.047 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.066 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.53 -28.36 69.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.873 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 296' ' ' ALA . 53.8 p30 -59.26 -35.87 74.49 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.53 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.575 ' N ' ' OD1' ' A' ' 295' ' ' ASP . . . -64.29 -33.83 76.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.979 0.419 . . . . 0.0 110.335 179.215 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 72.2 t -62.55 -43.44 98.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.196 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -61.35 -42.58 98.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.751 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -64.49 -42.81 95.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.151 0.501 . . . . 0.0 112.116 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.531 HG11 ' N ' ' A' ' 301' ' ' CYS . 1.4 p -66.59 -36.23 76.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.618 -178.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . 0.531 ' N ' HG11 ' A' ' 300' ' ' VAL . 75.1 m -71.3 -42.41 68.69 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.565 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -57.76 -39.46 77.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.811 0.339 . . . . 0.0 111.697 -178.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -57.84 -30.85 66.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.557 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.671 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 7.4 tptt 70.13 -71.8 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.55 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.671 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.8 m-30 -111.68 138.16 48.61 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.042 0.448 . . . . 0.0 110.949 178.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.495 HG23 ' CZ ' ' A' ' 262' ' ' PHE . 21.9 mm -117.97 137.33 52.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.522 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -75.51 86.35 2.62 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.996 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.569 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 5.1 t80 -110.24 129.04 55.8 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.44 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.694 ' HD2' ' N ' ' A' ' 309' ' ' LYS . 0.0 OUTLIER 59.01 40.33 22.39 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.751 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 53.98 37.5 26.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.514 0.673 . . . . 0.0 109.274 -178.014 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -148.59 162.51 39.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.93 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.627 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 30.6 mttt -93.89 133.69 37.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.232 0.539 . . . . 0.0 111.509 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.654 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 32.2 pt -118.06 144.17 26.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.196 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . 0.51 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 89.1 mt-10 -101.55 142.13 33.38 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.731 -178.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.477 HD11 ' CG2' ' A' ' 300' ' ' VAL . 69.6 mt -118.71 126.51 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 121.095 0.474 . . . . 0.0 111.496 -179.514 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -137.64 137.4 38.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.846 179.34 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -48.66 144.67 4.17 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.566 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.92 143.81 30.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.008 0.432 . . . . 0.0 111.259 -179.083 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.245 -179.824 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.8 p . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.918 0.389 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.499 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 5.3 tptm -67.55 138.49 56.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.031 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.666 ' O ' ' HA ' ' A' ' 204' ' ' PHE . 90.0 mtp -129.46 160.0 34.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.077 0.465 . . . . 0.0 111.906 -179.659 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.564 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 1.6 t80 -107.63 129.54 54.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.771 178.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.485 ' O ' ' CB ' ' A' ' 202' ' ' PHE . 20.4 mm -118.49 130.62 73.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 121.263 -0.175 . . . . 0.0 111.205 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -128.53 158.37 21.71 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.726 178.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.23 36.61 34.4 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.586 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 68.3 mt -59.79 -26.03 65.4 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.446 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 169' ' ' ASP . 54.3 t30 74.11 39.88 0.48 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.93 0.395 . . . . 0.0 110.207 -178.188 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.429 ' CE2' ' HD2' ' A' ' 198' ' ' ARG . 9.6 m0 30.65 30.06 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.638 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 167' ' ' ASN . 89.6 m-20 -130.97 5.8 4.57 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 23.6 m -82.73 133.76 35.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 110.348 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.547 ' O ' ' HB2' ' A' ' 172' ' ' GLU . 5.3 p -109.49 14.69 23.43 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.104 -179.409 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.69 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 95.5 mt-10 77.67 -30.28 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -177.619 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.662 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 90.1 m-20 -62.92 -41.0 99.31 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 121.114 0.483 . . . . 0.0 111.486 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.432 ' O ' ' CB ' ' A' ' 178' ' ' TYR . 85.1 m-20 -61.53 -38.0 85.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.685 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.436 HD21 ' CE2' ' A' ' 179' ' ' PHE . 18.9 mt -62.81 -41.93 99.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -178.247 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.662 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -68.83 -42.73 76.77 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.752 179.955 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.509 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 84.2 tt0 -72.64 -44.38 61.97 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.031 0.443 . . . . 0.0 110.811 179.014 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.606 ' OH ' ' CB ' ' A' ' 221' ' ' HIS . 43.1 t80 -62.62 -44.39 96.41 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.575 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.436 ' CE2' HD21 ' A' ' 175' ' ' LEU . 95.3 m-85 -97.8 -0.27 45.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.061 -178.531 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -59.32 -29.75 66.61 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.822 178.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.493 ' CD ' ' H ' ' A' ' 181' ' ' LYS . 0.5 OUTLIER -57.34 -42.29 81.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 122.093 0.949 . . . . 0.0 110.356 -179.897 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -69.65 -34.1 73.53 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.702 -1.59 . . . . 0.0 112.492 -177.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -175.39 -173.43 41.14 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 119.46 -1.353 . . . . 0.0 114.187 -179.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.532 ' O ' ' CG1' ' A' ' 185' ' ' VAL . 51.7 m -61.74 -26.53 68.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.533 -0.833 . . . . 0.0 112.05 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.545 HG11 ' O ' ' A' ' 185' ' ' VAL . 8.0 p 51.31 73.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.831 0.824 . . . . 0.0 109.427 -177.292 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.4 t -54.23 -46.36 72.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.62 -1.173 . . . . 0.0 113.275 -177.584 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -137.45 157.33 46.8 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.587 0.708 . . . . 0.0 112.849 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.43 ' CD1' HD11 ' A' ' 175' ' ' LEU . 0.2 OUTLIER -127.32 130.87 50.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.429 179.599 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 20.0 tptt -134.26 120.58 20.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 179.676 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.69 ' HB ' ' HG2' ' A' ' 172' ' ' GLU . 1.0 OUTLIER -127.88 134.61 64.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.139 176.868 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.591 ' N ' ' SD ' ' A' ' 191' ' ' MET . 0.0 OUTLIER -92.8 135.95 33.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.456 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -127.93 150.94 49.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.608 -178.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.634 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 17.8 m-20 -119.76 78.11 22.2 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.665 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.94 -26.41 74.47 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.11 1.874 . . . . 0.0 111.701 179.176 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.29 -66.55 0.71 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.444 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.8 p -67.58 -27.51 66.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.125 179.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 90.6 6.14 68.29 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.411 179.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.634 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 6.2 ttp85 -128.82 129.48 45.68 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 117.519 0.66 . . . . 0.0 111.816 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.5 t -66.37 155.46 37.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.807 -179.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.672 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 1.1 mpt_? -53.95 -34.03 58.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.131 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.474 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 93.82 1.85 65.29 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.842 -179.103 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.672 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 33.6 p90 -139.54 156.6 46.8 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.953 0.406 . . . . 0.0 110.919 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.515 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -144.31 158.92 27.63 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.819 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.666 ' HA ' ' O ' ' A' ' 161' ' ' MET . 90.5 m-85 -108.7 130.0 55.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 117.082 0.441 . . . . 0.0 110.463 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 161' ' ' MET . 64.2 mt -106.68 138.06 43.55 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.861 0.362 . . . . 0.0 111.943 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 49.0 m -121.29 136.2 55.0 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -123.36 145.29 48.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.748 0.309 . . . . 0.0 111.108 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.45 -34.36 76.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.952 178.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.7 115.34 51.39 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.336 179.161 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.37 -24.34 51.43 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.643 2.228 . . . . 0.0 113.61 -179.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 85.4 p -60.82 -31.42 70.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.586 0.232 . . . . 0.0 111.444 -179.405 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 19.5 m -59.68 -36.11 75.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.912 0.387 . . . . 0.0 110.771 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 85.8 t -62.13 -41.95 93.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.435 -179.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -59.26 -41.38 88.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.66 -179.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -76.79 -34.55 57.97 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.581 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 76.4 t -62.23 -46.31 96.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.25 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 13.3 p -68.24 -45.53 82.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.022 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 27.0 mttp -61.31 -36.19 79.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.405 ' O ' ' O ' ' A' ' 220' ' ' GLN . 47.9 m -59.11 -38.78 80.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.783 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.405 ' O ' ' O ' ' A' ' 219' ' ' THR . 63.9 tt0 60.67 107.26 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -177.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.606 ' CB ' ' OH ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -136.92 167.63 21.12 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -176.568 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.404 ' CG1' ' HA ' ' A' ' 227' ' ' VAL . 3.0 mt -125.58 118.8 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.321 176.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.452 ' CD2' ' OD1' ' A' ' 224' ' ' ASP . 8.4 tt -91.16 -54.27 4.01 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -177.468 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.452 ' OD1' ' CD2' ' A' ' 223' ' ' LEU . 97.4 m-20 -101.14 16.13 26.44 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.056 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 98.92 -1.86 58.06 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.568 -178.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.466 ' CG ' ' HB2' ' A' ' 167' ' ' ASN . 32.8 mmtp -110.76 139.23 46.24 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.105 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.404 ' HA ' ' CG1' ' A' ' 222' ' ' ILE . 16.1 m -64.29 123.99 18.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.903 -179.457 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 221' ' ' HIS . 34.0 pt -120.78 151.21 23.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.624 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -128.54 80.4 72.57 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 121.073 0.463 . . . . 0.0 111.502 -179.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.504 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 72.4 Cg_exo -53.01 126.31 21.07 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.43 2.087 . . . . 0.0 110.583 179.208 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -131.9 149.52 52.42 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.725 -178.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 14.1 ttp-105 -64.27 133.64 53.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.281 179.24 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . 0.405 ' HB1' ' HB3' ' A' ' 160' ' ' LYS . . . -56.86 145.18 30.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.85 0.357 . . . . 0.0 111.033 -179.413 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 5.1 mt -108.67 125.08 32.56 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.487 -179.412 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' A' ' 239' ' ' GLN . 52.5 Cg_exo -51.54 152.16 12.85 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.077 1.851 . . . . 0.0 110.503 178.88 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.457 ' HD3' ' OE1' ' A' ' 239' ' ' GLN . 31.2 mmt180 -55.89 -40.26 72.74 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.148 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -63.8 -46.35 85.58 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.17 179.12 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.29 -35.2 73.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.301 0.572 . . . . 0.0 109.923 178.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 235' ' ' PRO . 61.1 tt0 -58.25 -42.27 86.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.183 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -63.08 -40.31 97.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.327 0.584 . . . . 0.0 110.011 178.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 242' ' ' THR . 24.2 mttp -62.63 -34.05 76.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.384 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 291' ' ' TYR . 68.2 p -29.08 -81.26 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -178.179 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 76.71 46.28 11.59 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.96 179.204 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 7.9 ttpm? -59.73 136.21 57.92 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.552 HD12 ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -123.31 161.2 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.771 0.796 . . . . 0.0 112.919 -179.307 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -99.2 135.92 39.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.866 179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.471 HG12 ' CE1' ' A' ' 259' ' ' PHE . 9.6 p -129.92 144.03 39.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.238 0.542 . . . . 0.0 111.601 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.628 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.75 171.55 18.42 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.87 16.93 58.91 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.045 -1.074 . . . . 0.0 111.994 -179.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.496 ' CD1' ' CE1' ' A' ' 259' ' ' PHE . 68.7 mt -110.52 129.33 65.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 254' ' ' VAL . . . -169.75 -99.08 0.12 Allowed Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.135 -179.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . 0.406 ' HD3' ' HA2' ' A' ' 251' ' ' GLY . 32.1 Cg_exo -60.02 136.37 68.96 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.399 2.066 . . . . 0.0 113.255 -179.238 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 51.72 43.01 30.25 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.245 178.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.493 HG23 ' N ' ' A' ' 251' ' ' GLY . 14.8 m -127.0 45.4 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 254' ' ' VAL . 0.1 OUTLIER -40.77 151.67 0.26 Allowed Pre-proline 0 N--CA 1.462 0.155 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.859 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.411 ' N ' HD13 ' A' ' 274' ' ' LEU . 11.1 Cg_endo -55.28 -28.02 60.21 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 121.982 1.788 . . . . 0.0 112.381 -178.308 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -61.44 -44.62 96.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.293 179.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.49 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 55.6 mp0 -67.43 -38.7 84.95 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.902 0.382 . . . . 0.0 111.716 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.647 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 31.6 t80 -64.72 -47.52 77.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.534 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.46 -41.55 98.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.832 0.348 . . . . 0.0 110.626 179.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.49 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.5 pt-20 -75.39 -28.84 59.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.424 178.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.594 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 3.7 t80 -62.57 -56.87 13.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.607 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.622 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 7.0 m-85 -65.89 -21.42 66.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.064 -179.384 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.462 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 67.5 p -57.87 -20.12 34.28 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.742 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -47.67 -38.43 14.94 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.059 178.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.719 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 23.5 p90 -131.17 44.0 3.01 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 264' ' ' SER . . . 161.47 150.03 5.8 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.164 179.137 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.4 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 55.7 m -59.98 -34.83 73.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.876 0.369 . . . . 0.0 111.005 179.443 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.551 HD12 ' CB ' ' A' ' 263' ' ' PHE . 79.0 mt 68.44 112.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.075 -178.804 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.533 ' CG2' ' HB ' ' A' ' 290' ' ' THR . 14.7 tt -61.04 -29.43 45.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.916 0.388 . . . . 0.0 110.359 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 272' ' ' ALA . 55.8 t0 -176.9 -48.53 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.533 179.433 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.491 ' O ' ' O ' ' A' ' 271' ' ' ASP . . . 52.13 122.11 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.879 0.371 . . . . 0.0 111.755 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -141.34 155.19 45.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.394 0.616 . . . . 0.0 112.43 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.566 ' O ' ' HB2' ' A' ' 275' ' ' MET . 64.0 mt -66.41 -31.79 72.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.212 178.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.566 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 94.2 mmm 102.1 -80.8 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.643 0.777 . . . . 0.0 110.397 -178.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.502 ' HA ' ' O ' ' A' ' 281' ' ' GLY . 0.1 OUTLIER 38.57 64.74 0.71 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.345 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -56.57 -39.81 74.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.943 0.402 . . . . 0.0 110.747 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 17.2 mtpt -95.07 9.56 39.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.39 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.2 t70 60.56 42.25 14.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.143 0.497 . . . . 0.0 110.386 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.26 -67.26 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.346 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 276' ' ' LEU . . . -83.19 175.56 52.8 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.467 179.201 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 64.05 45.06 4.31 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.013 0.435 . . . . 0.0 110.88 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 10.3 p -167.98 -40.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.033 179.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' A' ' 250' ' ' ILE . 41.2 ttm180 -55.2 -31.34 61.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.933 179.299 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -105.77 -39.18 2.23 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.746 -0.74 . . . . 0.0 114.571 -178.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -136.6 167.24 21.77 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.001 0.9 . . . . 0.0 112.828 -178.17 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.422 ' O ' HG11 ' A' ' 247' ' ' VAL . . . -132.44 159.14 23.29 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.187 178.685 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.4 ' HB2' ' CG ' ' A' ' 275' ' ' MET . 0.1 OUTLIER -119.21 124.6 47.16 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 122.734 -0.274 . . . . 0.0 111.612 -179.502 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.647 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 57.4 t -128.98 135.72 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 178.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 26.5 m -122.4 139.9 53.31 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.358 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.59 ' O ' ' HA ' ' A' ' 242' ' ' THR . 74.5 m-85 -113.35 137.32 51.69 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 293' ' ' SER . 54.1 p30 -63.35 -30.14 71.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.295 178.55 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 293' ' ' SER . . . . . 0.537 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 99.1 p -115.55 144.1 44.37 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.272 0.558 . . . . 0.0 111.362 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . 0.497 ' O ' HG11 ' A' ' 297' ' ' VAL . . . -69.03 -33.32 73.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.348 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -57.04 -36.9 71.03 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.79 -39.09 87.59 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.497 HG11 ' O ' ' A' ' 294' ' ' ALA . 8.7 p -59.68 -37.83 72.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.437 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . 0.46 ' N ' HG11 ' A' ' 297' ' ' VAL . 55.7 t0 -62.79 -39.03 92.97 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -179.142 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -60.56 -43.29 97.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.719 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 0.9 OUTLIER -67.71 -34.18 66.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.671 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 77.4 m -57.82 -45.88 85.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.497 -179.166 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -61.59 -40.47 94.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.205 0.526 . . . . 0.0 110.704 179.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -60.52 -33.25 72.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.18 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.645 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 47.8 tptt 68.52 -73.21 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -177.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.645 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.6 m-30 -114.42 144.25 43.62 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.276 178.43 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.519 ' CD1' ' CH2' ' A' ' 266' ' ' TRP . 24.4 mt -118.89 133.4 65.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.639 178.204 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -76.84 75.69 3.46 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.594 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 5.2 t80 -72.8 -52.03 16.61 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.553 0.692 . . . . 0.0 110.927 -179.196 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.446 ' HD3' ' CE1' ' A' ' 308' ' ' PHE . 23.6 mmmt -128.39 -151.78 0.49 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.191 -179.147 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -58.08 -26.48 62.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.386 179.198 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -121.29 159.69 25.48 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.109 0.481 . . . . 0.0 112.237 -178.149 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.517 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 49.2 mttt -75.78 149.04 38.03 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.167 179.508 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.628 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 36.8 pt -117.84 149.52 20.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.311 178.466 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . 0.584 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 83.0 mt-10 -110.79 132.13 54.46 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.584 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.482 HD11 HD13 ' A' ' 306' ' ' ILE . 79.7 mt -121.05 126.9 75.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.14 0.495 . . . . 0.0 111.685 -179.487 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -126.09 150.31 48.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.133 179.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 95.1 mtm-85 -55.83 144.13 28.87 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.264 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 244' ' ' LYS . . . -61.66 142.66 57.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.983 0.42 . . . . 0.0 111.34 -179.337 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.128 179.551 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.087 0.47 . . . . 0.0 109.949 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.464 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 74.9 tttt -127.01 139.1 53.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.851 -179.505 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.499 ' HB2' ' HB2' ' A' ' 205' ' ' LEU . 93.2 mmm -116.29 147.56 41.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.42 -178.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.574 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 2.9 t80 -104.74 130.22 52.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.446 -0.797 . . . . 0.0 108.912 178.314 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.468 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 21.8 mm -117.42 130.84 71.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.312 -179.217 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.499 ' O ' ' CG2' ' A' ' 228' ' ' ILE . . . -128.5 162.81 22.12 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 178.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.46 36.43 34.05 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.14 -1.029 . . . . 0.0 111.992 -179.717 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.479 ' HB3' ' OG1' ' A' ' 170' ' ' THR . 50.7 mt -60.68 -26.12 66.86 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -178.774 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.445 ' HB2' ' HG3' ' A' ' 226' ' ' LYS . 42.0 t30 71.38 40.76 0.81 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -176.902 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 8.2 m0 31.4 41.76 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.948 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -174.84 21.89 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 179.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.522 ' O ' ' O ' ' A' ' 171' ' ' THR . 98.1 m -61.62 -38.19 86.72 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.522 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.0 OUTLIER 57.82 130.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -177.657 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.434 ' HA ' HD13 ' A' ' 190' ' ' ILE . 21.6 pt-20 -58.77 -29.49 66.82 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -178.29 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.502 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.1 m-20 -60.06 -40.67 90.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.71 0.29 . . . . 0.0 111.582 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 170' ' ' THR . 83.1 m-20 -64.91 -37.17 86.75 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -179.138 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.478 HD21 ' CE2' ' A' ' 179' ' ' PHE . 7.2 mt -55.8 -47.78 76.53 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.502 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -65.1 -33.03 75.06 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.068 179.269 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -62.23 -39.02 91.41 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.672 -179.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.66 ' O ' ' HD3' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -94.59 -45.91 7.18 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-O 120.723 0.297 . . . . 0.0 110.755 179.614 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.649 ' CE2' ' CE2' ' A' ' 178' ' ' TYR . 75.0 m-85 -72.93 -13.96 61.36 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 179.074 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.69 -26.45 24.79 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.27 -0.49 . . . . 0.0 113.564 -179.297 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.66 ' HD3' ' O ' ' A' ' 178' ' ' TYR . 0.5 OUTLIER -56.47 -41.95 77.39 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.909 0.861 . . . . 0.0 110.796 -179.719 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -69.72 -35.15 74.78 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.054 -1.43 . . . . 0.0 112.927 -177.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 174.93 -175.08 47.02 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.352 -1.404 . . . . 0.0 114.171 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.543 ' O ' ' CG1' ' A' ' 185' ' ' VAL . 54.1 m -63.11 -25.11 68.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.573 -0.814 . . . . 0.0 111.659 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.553 HG11 ' O ' ' A' ' 185' ' ' VAL . 7.9 p 52.75 79.66 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 CA-C-O 121.962 0.887 . . . . 0.0 109.091 -177.006 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -47.19 -50.95 19.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.664 -177.175 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 206' ' ' SER . 22.9 t70 -146.02 124.52 12.42 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.504 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.434 ' CD2' ' HD2' ' A' ' 176' ' ' ARG . 0.0 OUTLIER -108.97 153.87 22.97 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.708 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.569 ' HG3' ' SD ' ' A' ' 191' ' ' MET . 11.8 tptt -138.07 125.24 21.57 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -177.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 190' ' ' ILE . . . . . 0.449 HD13 HD13 ' A' ' 175' ' ' LEU . 5.6 mt -123.67 126.55 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.564 175.58 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 191' ' ' MET . . . . . 0.569 ' SD ' ' HG3' ' A' ' 189' ' ' LYS . 2.6 mpp? -94.6 57.98 2.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.295 -179.489 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 34.2 tttm -63.9 149.49 47.02 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.81 -179.033 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' A' ' 198' ' ' ARG . 2.1 t0 -120.4 75.85 24.88 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.594 -179.48 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.14 -23.88 75.09 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.59 2.193 . . . . 0.0 112.767 179.608 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -68.28 -73.85 0.14 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.883 -179.041 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.7 p -68.05 -25.54 65.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.704 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 93.95 -0.23 66.76 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.591 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.509 ' O ' ' HB3' ' A' ' 193' ' ' ASP . 0.8 OUTLIER -127.29 131.9 50.42 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.71 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.442 ' OG ' ' NH1' ' A' ' 200' ' ' ARG . 13.3 t -110.5 155.37 22.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.552 0.692 . . . . 0.0 112.799 -178.009 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.61 ' HB2' ' CE2' ' A' ' 202' ' ' PHE . 0.5 OUTLIER -45.01 -32.21 1.58 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.731 -179.801 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.504 ' H ' ' HD3' ' A' ' 200' ' ' ARG . . . 90.11 22.17 36.33 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.59 -0.814 . . . . 0.0 114.849 178.607 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.61 ' CE2' ' HB2' ' A' ' 200' ' ' ARG . 41.5 p90 -150.83 152.66 34.06 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 117.503 0.652 . . . . 0.0 111.008 178.773 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.448 ' HA3' ' HE3' ' A' ' 191' ' ' MET . . . -138.54 161.69 25.75 Favored Glycine 0 C--O 1.228 -0.265 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.355 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.574 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 85.3 m-85 -110.73 126.0 54.1 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.9 -179.836 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 161' ' ' MET . 53.9 mt -107.73 142.01 38.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.687 0.28 . . . . 0.0 110.8 179.811 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 187' ' ' ASP . 26.3 t -124.65 130.12 51.82 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.614 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -114.76 135.75 53.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.94 0.4 . . . . 0.0 111.31 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.43 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.4 tt0 -60.23 -34.23 73.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.473 179.204 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.62 116.96 56.79 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.823 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.85 -29.5 81.7 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.515 2.143 . . . . 0.0 113.189 -179.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.7 m -59.15 -37.91 78.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.786 0.327 . . . . 0.0 110.853 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 23.3 m -59.83 -34.42 73.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.194 0.521 . . . . 0.0 110.31 179.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.426 ' CG1' ' HG3' ' A' ' 232' ' ' ARG . 78.1 t -60.38 -41.24 86.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.094 -179.658 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -57.82 -43.95 86.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.026 0.441 . . . . 0.0 110.754 -179.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.429 ' O ' ' OG1' ' A' ' 219' ' ' THR . 97.6 mt-10 -69.7 -33.36 72.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.044 178.674 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.649 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 96.8 t -60.39 -43.07 93.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.589 -178.512 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 9.0 p -84.23 -49.5 16.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.121 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -59.93 -39.68 86.3 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.424 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 215' ' ' GLU . 70.5 m -59.19 -38.89 80.94 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.329 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.408 ' O ' ' O ' ' A' ' 219' ' ' THR . 63.1 tt0 62.1 114.67 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.03 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.649 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 0.0 OUTLIER -134.2 169.03 17.79 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -176.707 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.473 HD13 ' CG2' ' A' ' 227' ' ' VAL . 16.1 mm -117.62 128.39 74.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.839 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.408 HD11 ' CE2' ' A' ' 178' ' ' TYR . 8.5 tt -117.3 126.0 52.0 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.708 179.366 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 53.53 41.89 32.02 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 178.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 90.35 -23.88 19.5 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.412 -0.899 . . . . 0.0 114.337 177.444 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.445 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 34.7 mmtp -95.66 151.21 19.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.202 0.501 . . . . 0.0 111.405 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.473 ' CG2' HD13 ' A' ' 222' ' ' ILE . 26.3 t -92.28 128.76 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.769 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.499 ' CG2' ' O ' ' A' ' 164' ' ' GLY . 28.3 pt -125.67 154.98 34.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.253 -179.341 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.58 78.21 75.86 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.121 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 230' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 162' ' ' PHE . 9.4 Cg_endo -52.28 131.59 40.51 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.636 2.224 . . . . 0.0 111.775 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 162' ' ' PHE . 5.4 ttpm? -136.21 139.73 43.01 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.731 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.426 ' HG3' ' CG1' ' A' ' 213' ' ' VAL . 0.9 OUTLIER -50.82 141.98 12.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.088 0.471 . . . . 0.0 111.743 -179.494 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.45 144.44 55.92 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.391 179.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -107.68 135.81 19.73 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 121.353 -0.139 . . . . 0.0 110.902 179.761 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.91 139.95 85.03 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 121.789 1.659 . . . . 0.0 110.623 178.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -58.52 -37.55 75.86 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -60.18 -48.29 82.36 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.711 -179.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -73.04 -41.33 64.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.567 0.699 . . . . 0.0 110.168 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -60.36 -37.06 79.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.505 -179.479 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -56.25 -37.42 69.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.613 -179.368 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 242' ' ' THR . 39.8 mttm -82.62 -74.09 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.468 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 241' ' ' LYS . 33.5 p 38.62 -168.01 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.087 0.47 . . . . 0.0 112.215 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -168.08 49.75 0.23 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.353 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 15.3 tttp -72.82 128.72 36.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.76 0.314 . . . . 0.0 110.532 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.52 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -125.02 162.94 26.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -179.409 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.42 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 87.4 t80 -101.45 134.15 44.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.647 -1.161 . . . . 0.0 111.181 179.566 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 286' ' ' PHE . 14.0 p -127.79 136.38 60.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.687 179.006 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -125.04 4.66 8.38 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.747 -178.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . 0.512 ' HA2' ' CB ' ' A' ' 313' ' ' ILE . . . -88.14 9.16 76.0 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.744 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.541 HD12 ' CE1' ' A' ' 259' ' ' PHE . 31.9 pt -120.61 154.75 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 121.004 0.43 . . . . 0.0 111.521 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -167.51 -142.58 3.5 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.839 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.07 -19.71 34.25 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.55 2.167 . . . . 0.0 112.449 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -82.9 3.18 30.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.81 -179.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.421 HG23 ' HB ' ' A' ' 250' ' ' ILE . 19.1 m -126.77 157.04 38.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.718 0.294 . . . . 0.0 110.792 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.0 mmt85 -111.65 154.94 43.75 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.102 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.49 -43.01 55.23 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 121.793 1.662 . . . . 0.0 111.797 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 261' ' ' GLU . 35.3 mttp -63.14 -43.14 99.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.129 179.349 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.536 ' HA ' ' HB3' ' A' ' 261' ' ' GLU . 76.3 mm-40 -66.53 -36.87 83.75 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.576 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.591 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 25.2 t80 -63.67 -52.37 61.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.21 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -64.11 -37.25 86.76 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.536 ' HB3' ' HA ' ' A' ' 258' ' ' GLU . 72.7 tt0 -61.88 -38.03 86.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.876 -1.511 . . . . 0.0 111.968 178.213 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.719 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 71.6 t80 -69.61 -56.52 7.06 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -179.445 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.679 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 18.9 m-85 -65.2 -24.08 67.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.932 -179.377 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.457 ' CA ' HD13 ' A' ' 269' ' ' ILE . 86.1 p -59.48 -25.91 64.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.376 -179.312 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -57.54 -36.89 72.22 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 266' ' ' TRP . . . . . 0.679 ' CZ2' ' CD2' ' A' ' 263' ' ' PHE . 11.9 p90 -115.18 39.81 2.82 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.113 0.482 . . . . 0.0 111.765 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.505 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 157.51 146.74 4.58 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.709 178.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.407 ' HB ' ' OD2' ' A' ' 292' ' ' ASP . 59.8 m -58.94 -37.49 76.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.754 0.311 . . . . 0.0 111.27 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.558 HD12 ' CB ' ' A' ' 263' ' ' PHE . 73.9 mt 69.3 90.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.099 -179.202 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.624 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 75.0 mt -54.97 -44.76 75.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.932 179.009 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 290' ' ' THR . 54.0 t0 -156.49 146.76 21.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.824 179.079 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -154.69 141.37 18.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.348 178.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -146.61 155.83 42.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.505 0.669 . . . . 0.0 112.378 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 274' ' ' LEU . . . . . 0.449 ' CD2' ' HB2' ' A' ' 283' ' ' SER . 27.0 tp -64.44 -33.9 76.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.426 179.382 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 275' ' ' MET . . . . . 0.556 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 72.9 mmm 69.48 80.74 0.18 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 -178.478 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 283' ' ' SER . 0.2 OUTLIER -119.38 126.67 51.94 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.34 179.578 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.421 ' HB2' ' HG2' ' A' ' 282' ' ' GLN . 60.0 t0 -86.63 118.71 26.22 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.128 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 278' ' ' LYS . . . . . 0.435 ' CE ' ' HE2' ' A' ' 226' ' ' LYS . 26.9 mmtp 59.22 -150.23 0.44 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.602 -0.439 . . . . 0.0 109.911 -178.358 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.2 -38.73 68.75 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.222 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 14.4 t -168.42 114.37 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.906 0.384 . . . . 0.0 111.448 179.282 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -145.4 -90.91 0.11 Allowed Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.207 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 286' ' ' PHE . 97.3 mm-40 -56.39 -31.26 63.69 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.934 0.494 . . . . 0.0 111.946 -179.084 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 275' ' ' MET . 91.8 p -72.76 -4.71 33.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.562 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -51.9 -34.64 42.25 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 250' ' ' ILE . . . -156.22 9.51 0.29 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 119.318 -1.42 . . . . 0.0 115.398 -179.094 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 16.4 p90 -145.87 164.65 31.28 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.976 1.388 . . . . 0.0 112.084 179.12 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.436 ' HA2' ' CD1' ' A' ' 250' ' ' ILE . . . -140.1 164.68 26.13 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.254 179.126 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.464 ' CD2' ' CE ' ' A' ' 244' ' ' LYS . 0.2 OUTLIER -119.4 128.54 54.14 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.367 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.591 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 44.1 t -128.31 138.27 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.813 0.34 . . . . 0.0 111.524 178.289 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 36.2 m -117.34 136.41 53.15 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 291' ' ' TYR . . . . . 0.505 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 39.7 m-85 -115.31 136.01 53.55 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.416 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.624 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 55.3 p30 -64.79 -32.93 74.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.724 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 293' ' ' SER . . . . . 0.57 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 51.0 m -121.98 144.42 48.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.312 0.577 . . . . 0.0 112.237 -178.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . 0.475 ' O ' ' CG1' ' A' ' 297' ' ' VAL . . . -66.23 -32.06 73.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.075 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -56.61 -38.19 71.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.098 -179.717 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -64.42 -41.59 96.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.767 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.571 HG11 ' N ' ' A' ' 298' ' ' ASP . 9.7 p -59.83 -37.05 69.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.014 0.435 . . . . 0.0 111.479 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 298' ' ' ASP . . . . . 0.571 ' N ' HG11 ' A' ' 297' ' ' VAL . 90.1 m-20 -61.75 -37.26 83.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.717 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -58.88 -44.13 91.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.677 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 0.7 OUTLIER -73.41 -35.87 47.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.927 0.394 . . . . 0.0 111.274 -179.642 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 79.3 m -58.53 -46.14 87.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.032 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -63.6 -40.62 97.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.225 0.536 . . . . 0.0 110.192 179.198 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.416 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.4 m-20 -64.3 -35.6 81.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.865 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.64 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 35.5 tptt 67.76 -67.37 0.19 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.168 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.64 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 17.5 m-85 -113.98 131.84 56.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.929 179.148 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 306' ' ' ILE . . . . . 0.511 HD13 ' CZ3' ' A' ' 266' ' ' TRP . 1.3 mt -122.18 138.69 51.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.127 178.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.494 ' OD1' ' CD ' ' A' ' 312' ' ' LYS . 94.0 m-20 -73.89 119.21 17.79 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.422 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.719 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 9.4 t80 -119.75 -76.07 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.417 0.627 . . . . 0.0 109.948 178.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.455 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 6.4 mmpt? -97.72 -163.39 1.04 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.513 178.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -52.93 -31.31 39.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.785 0.326 . . . . 0.0 110.742 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -112.15 153.62 26.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.106 0.479 . . . . 0.0 111.351 -179.369 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.579 ' CG ' ' HB3' ' A' ' 305' ' ' PHE . 19.7 tptt -70.77 143.96 51.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.541 -179.091 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.512 ' CB ' ' HA2' ' A' ' 249' ' ' GLY . 26.4 pt -111.31 141.38 26.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.799 179.218 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -101.48 131.69 47.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.716 179.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 315' ' ' ILE . . . . . 0.52 HD11 ' CE2' ' A' ' 263' ' ' PHE . 72.2 mt -119.92 129.57 75.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.156 0.503 . . . . 0.0 111.421 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 30.5 tttp -131.6 141.49 49.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.162 -179.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -54.55 137.75 42.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 0.0 110.581 -179.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.72 140.73 56.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.332 -179.269 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.191 179.089 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 52.3 pttt . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.313 0.102 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.69 -34.3 74.14 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.6 0.238 . . . . 0.0 111.57 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 22.4 m -57.98 -35.53 71.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 110.937 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 44.0 m -89.24 4.68 47.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.168 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -72.43 138.44 47.12 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 121.573 0.701 . . . . 0.0 112.215 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.547 ' N ' ' O ' ' A' ' 205' ' ' LEU . 82.1 mmm -116.08 150.63 37.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.653 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.601 ' CE2' ' N9 ' ' B' ' 6' ' ' ' A' . 4.8 t80 -103.57 128.57 50.8 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.544 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 16.2 mm -115.26 127.72 72.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.678 ' HA2' ' C6 ' ' B' ' 5' ' ' ' U' . . . -132.31 163.63 23.96 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.511 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.43 29.78 59.44 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.352 -0.927 . . . . 0.0 112.269 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.48 ' O ' ' C8 ' ' B' ' 4' ' ' ' A' . 76.4 mt -86.84 140.63 29.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.744 0.307 . . . . 0.0 111.164 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.486 ' HB2' ' HG3' ' A' ' 226' ' ' LYS . 22.2 t30 -66.13 133.68 51.21 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.612 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 4.1 m-90 -52.09 -38.47 57.39 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.99 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -62.97 -26.85 69.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.5 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 51.5 m -54.07 139.86 33.59 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.542 0.687 . . . . 0.0 111.383 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 28.5 m -119.39 151.5 38.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.7 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.737 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 98.5 mt-10 -55.33 -36.3 66.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.854 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -58.3 -43.81 88.26 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 120.602 -0.439 . . . . 0.0 109.861 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -65.45 -37.3 86.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.498 ' HB3' ' CD1' ' A' ' 188' ' ' LEU . 1.0 OUTLIER -55.43 -62.37 1.72 Allowed 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.332 178.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.481 ' O ' ' N ' ' A' ' 180' ' ' GLY . 67.2 ttp85 -57.19 -41.04 78.58 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.912 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.08 -40.23 94.35 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.742 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.587 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 62.7 t80 -61.98 -48.07 81.99 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.637 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.447 ' CG ' HD23 ' A' ' 205' ' ' LEU . 88.8 m-85 -87.93 0.0 56.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.395 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -61.2 -28.84 69.79 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.595 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -38.67 78.58 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.803 0.811 . . . . 0.0 110.04 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -67.63 -30.03 69.49 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.62 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 159.46 -132.83 3.13 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.238 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 52.8 m -119.92 139.62 52.15 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.435 HG12 ' HG3' ' A' ' 176' ' ' ARG . 3.4 m -100.81 122.8 53.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.489 -0.485 . . . . 0.0 110.502 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.3 t -73.22 -46.92 47.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.288 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -145.73 121.7 10.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.016 0.436 . . . . 0.0 111.455 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.498 ' CD1' ' HB3' ' A' ' 175' ' ' LEU . 0.0 OUTLIER -118.6 139.69 51.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.572 179.462 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.588 ' O ' ' CA ' ' A' ' 203' ' ' GLY . 8.7 tptt -133.01 83.38 2.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.841 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.737 ' HB ' ' HG2' ' A' ' 172' ' ' GLU . 12.0 tt -60.45 -22.64 26.02 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-O 121.146 0.498 . . . . 0.0 109.77 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.504 ' CE ' ' CE2' ' A' ' 204' ' ' PHE . 0.0 OUTLIER 73.13 55.38 0.12 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.486 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.63 152.07 46.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.467 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 1.5 t0 -124.16 75.85 59.77 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.23 -25.43 80.06 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.462 2.108 . . . . 0.0 112.308 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.74 -66.52 0.6 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.806 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 70.9 p -68.65 -24.83 64.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.195 0.521 . . . . 0.0 110.281 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.59 -3.35 68.27 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.431 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.484 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 6.3 ttp180 -130.35 124.37 32.1 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.971 0.415 . . . . 0.0 111.268 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.1 m -64.41 156.14 30.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.779 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.657 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 5.4 mpt_? -57.07 -33.91 67.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.083 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.594 ' HA2' " O2'" ' B' ' 4' ' ' ' A' . . . 93.17 3.37 65.42 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.668 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.657 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 40.4 p90 -144.62 154.8 43.19 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.588 ' CA ' ' O ' ' A' ' 189' ' ' LYS . . . -151.18 169.11 30.84 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 119.373 -1.394 . . . . 0.0 113.273 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.85 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 98.0 m-85 -106.54 120.47 42.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.188 0.518 . . . . 0.0 109.674 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 161' ' ' MET . 55.3 tp -108.39 125.56 51.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.955 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 50.2 m -118.55 143.56 46.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.312 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 74.3 m-85 -120.81 144.33 48.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.394 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.18 -34.8 77.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.943 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -110.87 119.51 45.89 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.787 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -56.55 -22.05 41.29 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.673 2.249 . . . . 0.0 113.139 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.7 m -57.14 -37.35 71.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.577 0.227 . . . . 0.0 111.558 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.412 ' HA ' ' OE2' ' A' ' 215' ' ' GLU . 21.6 m -59.33 -35.81 74.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.816 0.341 . . . . 0.0 110.745 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.16 -42.3 92.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.243 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -59.22 -41.92 89.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.869 0.366 . . . . 0.0 111.179 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.412 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 15.3 pt-20 -76.34 -29.17 57.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.82 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.798 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 77.1 t -60.05 -41.54 86.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.441 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.9 m -72.17 -30.02 34.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -59.12 -37.67 77.75 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.704 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 43.4 m -91.86 142.27 27.75 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 63.7 tt0 -66.19 -41.68 89.9 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.666 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.798 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 79.3 m-70 81.65 111.2 0.07 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 20.5 mm -119.24 113.38 41.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 175.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.8 tt -120.67 124.63 45.67 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.937 0.399 . . . . 0.0 111.736 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 52.67 43.0 31.77 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.47 8.35 87.63 Favored Glycine 0 CA--C 1.516 0.141 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.345 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.486 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 2.4 mmmm -120.11 164.61 15.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.68 0.276 . . . . 0.0 110.532 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.9 p -117.52 135.99 56.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.087 0.47 . . . . 0.0 110.263 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.461 HG13 ' HD3' ' A' ' 230' ' ' PRO . 37.4 pt -126.96 160.47 35.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.61 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -127.83 79.22 74.01 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.158 0.504 . . . . 0.0 110.744 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.559 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 52.3 Cg_exo -58.78 124.06 14.91 Favored 'Trans proline' 0 CA--C 1.528 0.185 0 C-N-CA 122.934 2.423 . . . . 0.0 111.454 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 8.9 mtmm -133.58 157.18 46.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.915 0.388 . . . . 0.0 111.454 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 35.6 tpt85 -57.6 136.06 56.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.407 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.29 144.44 56.95 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.947 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.519 ' CD1' ' C6 ' ' B' ' 6' ' ' ' A' . 11.5 mt -111.06 125.25 31.0 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.67 143.44 46.69 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 121.82 1.68 . . . . 0.0 110.707 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -57.62 -39.86 77.86 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -62.27 -46.19 89.91 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.295 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.78 -38.16 76.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.578 0.704 . . . . 0.0 109.762 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.443 ' NE2' " O2'" ' B' ' 6' ' ' ' A' . 43.4 tt0 -59.27 -40.96 87.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.027 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -61.61 -40.53 95.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.896 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -61.21 -34.59 75.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.46 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 19.1 p -80.71 161.93 24.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.535 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -147.46 175.77 26.64 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.178 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.488 ' CE ' ' CD2' ' A' ' 288' ' ' PHE . 49.1 tptt -131.08 129.94 42.56 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.627 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -119.74 161.12 19.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.377 0.608 . . . . 0.0 111.116 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.524 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 86.6 t80 -103.96 135.99 44.45 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.451 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.535 HG21 HG12 ' A' ' 315' ' ' ILE . 7.5 p -129.48 144.55 37.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.563 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.64 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -129.8 176.87 18.45 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.82 32.73 26.13 Favored Glycine 0 C--N 1.32 -0.333 0 C-N-CA 119.895 -1.145 . . . . 0.0 112.211 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.487 ' CD1' ' HA2' ' A' ' 287' ' ' GLY . 69.3 mt -107.86 130.89 59.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -143.0 -163.12 9.6 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.438 -0.886 . . . . 0.0 113.39 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -52.32 147.69 27.88 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.934 2.423 . . . . 0.0 112.463 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 50.1 t0 74.16 -3.7 2.47 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.672 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' A' ' 258' ' ' GLU . 11.3 p -60.93 -38.58 79.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.1 OUTLIER 54.56 115.25 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.403 -179.452 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.21 -34.42 69.27 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 121.664 1.576 . . . . 0.0 111.998 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -61.75 -43.31 99.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.682 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 254' ' ' VAL . 84.3 tt0 -65.86 -35.66 81.28 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.281 0.563 . . . . 0.0 110.548 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.611 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 13.9 t80 -58.65 -45.16 89.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.594 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.38 -41.96 93.17 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.3 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.493 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.3 pt-20 -73.65 -30.8 63.14 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.01 0.433 . . . . 0.0 110.506 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.51 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 8.5 t80 -61.16 -53.23 59.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.224 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.557 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 4.3 m-85 -70.0 -23.5 63.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.888 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.481 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 70.8 p -58.41 -25.61 62.34 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.734 0.302 . . . . 0.0 111.541 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -55.38 -34.51 64.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.242 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.644 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 11.2 p90 -117.05 45.12 1.94 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.259 0.552 . . . . 0.0 111.434 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.502 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 152.44 147.69 4.66 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.745 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 49.8 m -59.41 -37.99 79.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 111.348 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.533 HD12 ' CB ' ' A' ' 263' ' ' PHE . 70.4 mt 67.55 86.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.873 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.548 ' CD1' ' HB3' ' A' ' 292' ' ' ASP . 34.0 mm -58.56 -38.94 73.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.9 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -155.98 150.34 25.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.095 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -153.2 132.38 12.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.087 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -149.93 163.04 39.13 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 275' ' ' MET . 1.6 mm? -95.83 7.77 45.4 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.643 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.436 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 86.0 mtp 71.02 -80.28 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.14 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 283' ' ' SER . 0.1 OUTLIER 37.95 49.42 1.17 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 178.694 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.445 ' HB2' ' OP1' ' B' ' 4' ' ' ' A' . 22.0 t70 -57.28 -45.04 84.47 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.386 -0.525 . . . . 0.0 110.661 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -108.02 3.42 24.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.09 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.467 ' OD1' ' HB2' ' A' ' 276' ' ' LEU . 83.3 m-20 51.28 38.13 20.57 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 63.6 p -111.17 0.18 16.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.924 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.62 -30.73 0.26 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 119.409 -1.377 . . . . 0.0 114.334 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.489 ' HB2' ' HA ' ' A' ' 276' ' ' LEU . 94.9 mt-30 -57.46 -31.15 65.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.33 0.565 . . . . 0.0 110.641 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.564 ' HB3' ' HB3' ' A' ' 276' ' ' LEU . 95.4 p -59.32 -26.0 64.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.393 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -127.3 154.87 44.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.315 0.578 . . . . 0.0 111.389 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.52 -50.49 0.98 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.727 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.439 ' CE1' H5'' ' B' ' 2' ' ' ' A' . 22.4 p90 -145.16 165.07 29.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.862 0.331 . . . . 0.0 110.748 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.487 ' HA2' ' CD1' ' A' ' 250' ' ' ILE . . . -137.24 163.68 25.36 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.421 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.488 ' CD2' ' CE ' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -122.4 124.96 44.85 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.278 0.231 . . . . 0.0 110.8 179.489 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.627 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 43.4 t -127.12 139.9 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.009 0.433 . . . . 0.0 112.032 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.422 ' OG1' ' CD ' ' A' ' 244' ' ' LYS . 34.8 m -114.69 137.87 51.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.858 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.502 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 37.8 m-85 -117.43 140.11 50.02 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.548 ' HB3' ' CD1' ' A' ' 270' ' ' ILE . 29.2 p-10 -61.53 -33.79 74.43 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.236 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.424 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 31.1 t -124.16 139.06 54.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.423 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.82 -31.73 73.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.61 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -56.12 -37.24 69.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.97 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.92 -36.65 79.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.957 0.408 . . . . 0.0 110.352 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 82.0 t -61.1 -40.87 87.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.143 0.497 . . . . 0.0 110.194 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -59.47 -36.61 76.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.407 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -56.84 -42.91 80.5 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.085 0.469 . . . . 0.0 111.046 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.644 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 0.3 OUTLIER -75.71 -30.22 21.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.667 179.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 80.9 m -56.43 -45.87 80.55 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -64.15 -34.31 77.76 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -100.54 70.58 1.47 Allowed 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.204 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.583 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 7.6 tptt -53.81 -43.74 69.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.239 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.583 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.9 m-85 -113.55 126.0 54.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.302 0.572 . . . . 0.0 110.899 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.498 HD11 ' CZ3' ' A' ' 266' ' ' TRP . 25.8 mt -117.68 139.17 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.192 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -79.54 102.39 8.81 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.519 ' CE2' ' HD3' ' A' ' 309' ' ' LYS . 5.7 t80 -107.4 -72.57 0.72 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.385 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.519 ' HD3' ' CE2' ' A' ' 308' ' ' PHE . 3.7 mmmt -100.15 26.28 6.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.346 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 63.03 41.56 8.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.697 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 312' ' ' LYS . 94.6 mtt180 -150.78 7.86 0.56 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.151 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 311' ' ' ARG . 24.0 mmtm 56.71 138.53 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.537 0.684 . . . . 0.0 112.129 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.64 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 36.3 pt -120.81 148.01 24.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.221 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -104.32 127.35 51.96 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.535 HG12 HG21 ' A' ' 247' ' ' VAL . 86.8 mt -118.19 130.86 72.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.324 0.583 . . . . 0.0 112.074 -178.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -132.51 142.84 49.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.526 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 69.3 mtt85 -53.11 149.13 7.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.641 0.258 . . . . 0.0 110.378 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.27 141.88 28.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.91 0.386 . . . . 0.0 111.116 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -137.17 160.29 66.43 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.313 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.45 146.58 94.58 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.711 2.274 . . . . 0.0 112.124 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.0 -34.97 70.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.789 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.396 -179.943 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.433 ' O2 ' " O4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.429 -0.67 0 C3'-C2'-O2' 111.205 -0.722 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.524 ' C5 ' ' CE1' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.945 0 C3'-C2'-O2' 111.423 -0.647 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.535 ' O2 ' ' P ' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -1.022 0 C3'-C2'-C1' 100.76 -0.823 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.612 ' C2 ' ' CZ3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.426 -0.848 0 C4'-C3'-C2' 103.749 1.049 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.876 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.75 0 C4'-C3'-C2' 103.66 0.96 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.876 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.976 0 C3'-C2'-O2' 111.004 -0.792 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.85 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.955 0 C3'-C2'-O2' 111.289 -0.693 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.937 0 C3'-C2'-O2' 111.251 -0.706 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.2 tptt . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.776 0.322 . . . . 0.0 111.324 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -111.97 154.13 25.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.27 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 93.7 p -62.3 -23.61 66.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.087 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 37.4 m -50.33 -24.29 2.88 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.502 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -56.15 141.25 41.41 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.288 0.566 . . . . 0.0 111.621 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.483 ' CG ' HG22 ' A' ' 213' ' ' VAL . 93.8 mtp -115.83 156.04 26.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.435 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.621 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 3.5 t80 -105.16 129.57 53.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.894 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.581 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 16.0 mm -116.98 131.37 69.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.478 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.658 ' HA2' ' C6 ' ' B' ' 5' ' ' ' U' . . . -134.48 164.08 24.62 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.411 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.2 25.32 66.51 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.368 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.487 ' O ' ' C8 ' ' B' ' 4' ' ' ' A' . 75.6 mt -86.88 143.05 27.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.734 0.302 . . . . 0.0 110.949 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.417 ' OD1' ' N6 ' ' B' ' 4' ' ' ' A' . 39.8 t-20 -61.12 133.23 55.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.581 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 4.8 m0 -52.32 -28.18 18.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.703 0.287 . . . . 0.0 111.013 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 50.2 p30 -83.81 8.5 14.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.16 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 88.8 m -70.77 140.23 51.24 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.351 0.596 . . . . 0.0 110.164 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 27.9 m -114.97 144.38 43.68 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.566 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.644 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 98.3 mt-10 -55.73 -35.42 66.13 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.865 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.796 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 92.1 m-20 -57.1 -40.46 77.05 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -65.15 -38.69 91.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.11 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.448 HD21 ' CD2' ' A' ' 179' ' ' PHE . 3.6 mt -63.22 -48.32 78.76 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.796 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -71.63 -34.11 69.52 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.033 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -62.08 -38.57 89.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.581 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 63.8 t80 -80.25 -61.86 1.85 Allowed 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.942 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.449 ' CD2' HD13 ' A' ' 205' ' ' LEU . 72.6 m-85 -66.62 -21.47 66.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.314 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -50.56 -27.97 13.85 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.512 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 1.7 tmtt? -55.15 -43.14 73.92 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.864 -0.668 . . . . 0.0 110.062 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.429 ' CE2' ' HA ' ' A' ' 216' ' ' VAL . 46.0 m-85 -71.08 -33.94 70.69 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.454 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.414 ' O ' ' HA3' ' A' ' 180' ' ' GLY . . . -177.38 179.99 47.89 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.334 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 54.1 m -62.89 -33.85 76.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.805 0.336 . . . . 0.0 111.68 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.556 ' CG1' ' O ' ' A' ' 185' ' ' VAL . 0.5 OUTLIER 64.99 102.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 121.205 0.526 . . . . 0.0 109.654 -178.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.429 ' CG2' ' CA ' ' A' ' 208' ' ' GLU . 43.9 p -67.29 -37.68 83.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.965 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 206' ' ' SER . 20.1 t70 -160.81 160.77 31.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.427 ' CD1' ' CB ' ' A' ' 175' ' ' LEU . 0.1 OUTLIER -158.43 144.13 16.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.055 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.507 ' CG ' ' HB2' ' A' ' 204' ' ' PHE . 0.0 OUTLIER -131.71 113.56 13.7 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.644 ' HB ' ' HG2' ' A' ' 172' ' ' GLU . 2.0 tt -93.05 11.1 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.517 ' CG ' " H1'" ' B' ' 7' ' ' ' U' . 0.0 OUTLIER 67.21 -71.09 0.1 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.763 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.7 ' HA ' ' HA ' ' A' ' 199' ' ' SER . 20.0 ttmm 59.81 133.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.095 0.474 . . . . 0.0 111.261 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 88.2 m-20 -120.73 87.78 42.74 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.893 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.59 -24.71 37.83 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.342 2.028 . . . . 0.0 112.306 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -75.46 -75.63 0.17 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.402 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 62.8 p -70.36 -24.43 62.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.051 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 91.26 9.8 63.0 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.992 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 17.9 ttp85 -96.15 133.01 40.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.213 0.53 . . . . 0.0 111.827 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.7 ' HA ' ' HA ' ' A' ' 192' ' ' LYS . 75.4 m -85.83 10.22 14.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.132 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.487 ' HG3' ' CB ' ' A' ' 191' ' ' MET . 40.2 mmt180 74.94 -41.88 0.48 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.583 ' HA2' " O2'" ' B' ' 4' ' ' ' A' . . . 92.95 6.01 63.77 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.331 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.581 ' HB2' ' O ' ' A' ' 163' ' ' ILE . 33.9 p90 -147.37 155.48 42.01 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.498 ' HA3' ' HE2' ' A' ' 191' ' ' MET . . . -154.92 166.65 32.53 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.148 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.656 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 91.1 m-85 -109.92 128.39 55.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.655 0.264 . . . . 0.0 110.416 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.449 HD13 ' CD2' ' A' ' 179' ' ' PHE . 63.3 mt -104.99 140.5 38.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.837 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 33.1 t -123.21 130.69 53.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.347 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 94.7 m-85 -117.25 138.33 51.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.001 0.429 . . . . 0.0 111.538 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.429 ' CA ' ' CG2' ' A' ' 186' ' ' THR . 84.4 tt0 -61.48 -34.62 75.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.095 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -113.36 120.49 39.8 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.955 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.492 ' O ' HG11 ' A' ' 213' ' ' VAL . 49.6 Cg_exo -56.17 -22.29 39.46 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.537 2.158 . . . . 0.0 112.989 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.6 m -56.61 -37.91 71.33 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.688 0.28 . . . . 0.0 111.291 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 22.4 m -59.68 -35.69 74.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 0.0 110.284 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.492 HG11 ' O ' ' A' ' 210' ' ' PRO . 0.4 OUTLIER -59.48 -40.51 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.721 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.477 ' N ' HG11 ' A' ' 213' ' ' VAL . 92.4 m-20 -62.57 -41.88 99.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.432 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -77.68 -34.08 53.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.997 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.765 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 84.0 t -62.62 -47.09 94.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 CA-C-O 121.104 0.478 . . . . 0.0 110.522 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.22 -34.09 67.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -57.99 -37.43 74.23 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.685 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 38.5 m -96.0 141.73 29.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.724 0.297 . . . . 0.0 111.619 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 228' ' ' ILE . 63.6 tt0 -67.05 -41.53 86.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.765 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 47.0 m-70 77.61 122.3 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 21.0 mm -116.38 110.65 32.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 175.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.1 tt -121.77 125.91 47.64 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.228 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 53.92 41.56 32.0 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 76.5 12.86 83.98 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.551 -0.833 . . . . 0.0 114.162 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -126.13 156.48 40.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.482 0.641 . . . . 0.0 111.764 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 33.7 m -107.82 136.52 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.298 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 220' ' ' GLN . 34.3 pt -126.78 162.76 30.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.012 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -129.02 79.18 75.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.046 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.703 ' HG3' ' CD2' ' A' ' 221' ' ' HIS . 9.6 Cg_endo -54.21 133.48 55.85 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.417 2.078 . . . . 0.0 111.681 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.589 ' HE2' ' H62' ' B' ' 6' ' ' ' A' . 4.3 ttpm? -137.65 147.78 45.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.619 0.247 . . . . 0.0 110.774 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -56.28 137.53 52.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 111.391 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.75 148.87 51.35 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.114 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.555 HG13 ' N6 ' ' B' ' 6' ' ' ' A' . 5.6 mt -114.27 142.84 28.68 Favored Pre-proline 0 N--CA 1.464 0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.581 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.413 ' HD2' ' CG2' ' A' ' 234' ' ' ILE . 37.3 Cg_exo -56.94 138.88 88.0 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 121.763 1.642 . . . . 0.0 110.732 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -60.06 -40.4 89.32 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.608 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 56.7 p30 -64.67 -40.8 96.06 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.573 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.608 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 97.3 mt-10 -71.47 -35.93 71.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.579 0.704 . . . . 0.0 109.363 177.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.421 ' NE2' " O2'" ' B' ' 6' ' ' ' A' . 43.0 tt0 -58.42 -42.01 86.3 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.752 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -63.53 -40.09 96.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.057 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -60.06 -36.45 77.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.708 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.443 ' CG2' ' CD1' ' A' ' 270' ' ' ILE . 17.2 p -78.84 160.63 27.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.532 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -142.11 169.26 25.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.424 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -134.79 136.07 42.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.54 0.21 . . . . 0.0 110.839 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.4 ' CD1' ' CG2' ' A' ' 315' ' ' ILE . 9.6 pt -120.29 156.6 23.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.127 0.489 . . . . 0.0 111.53 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.514 ' CG ' ' C6 ' ' B' ' 2' ' ' ' A' . 78.9 t80 -94.41 131.44 40.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.15 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.615 ' CG2' ' CZ ' ' A' ' 263' ' ' PHE . 25.1 t -124.47 135.9 62.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.396 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.561 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -132.57 178.32 18.16 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.71 26.35 46.44 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.037 -1.078 . . . . 0.0 112.268 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 32.0 pt -118.44 154.79 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 121.04 0.448 . . . . 0.0 111.339 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.49 ' O ' ' CG1' ' A' ' 254' ' ' VAL . . . -127.43 176.01 18.02 Favored Glycine 0 C--O 1.226 -0.344 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.972 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . 0.415 ' HD3' ' HG3' ' A' ' 284' ' ' ARG . 54.1 Cg_exo -51.69 -28.61 30.3 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 121.92 1.746 . . . . 0.0 111.304 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -61.32 -30.53 70.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.177 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.535 ' O ' ' O ' ' A' ' 255' ' ' ARG . 7.8 p -47.54 -38.59 6.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.819 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.0 OUTLIER 56.34 125.68 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.281 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.47 -35.8 86.28 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 121.787 1.658 . . . . 0.0 112.656 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -63.56 -47.76 80.21 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.524 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 85.0 tt0 -68.07 -37.05 80.83 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.126 0.488 . . . . 0.0 111.15 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.504 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 27.4 t80 -58.88 -45.68 89.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.061 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -66.84 -40.98 88.11 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.944 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 258' ' ' GLU . 19.5 pt-20 -70.26 -34.09 72.39 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.882 0.372 . . . . 0.0 110.491 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.603 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 83.7 t80 -60.4 -54.33 46.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.454 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.69 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 26.9 m-85 -69.22 -28.39 66.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.67 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.476 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 22.7 t -57.05 -29.67 63.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.455 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 262' ' ' PHE . 19.9 pt20 -53.26 -36.09 60.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.822 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.69 ' CZ2' ' CD2' ' A' ' 263' ' ' PHE . 12.5 p90 -115.19 40.99 2.53 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.915 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.44 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 170.91 -179.01 43.08 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.465 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.404 ' CG2' ' HB3' ' A' ' 292' ' ' ASP . 0.0 OUTLIER -104.81 0.75 28.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.77 0.319 . . . . 0.0 110.345 179.045 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.58 HD12 ' CB ' ' A' ' 263' ' ' PHE . 75.5 mt 28.91 97.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.623 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 72.5 mt -60.44 -45.47 96.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.581 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -164.83 94.02 0.66 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.404 ' CB ' HG22 ' A' ' 269' ' ' ILE . . . -99.09 136.4 39.1 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -142.16 154.52 44.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.624 0.726 . . . . 0.0 112.745 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.612 ' O ' ' HB2' ' A' ' 275' ' ' MET . 35.7 tp -64.68 -37.38 87.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.648 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.612 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 95.8 mmm 93.32 114.75 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.518 -178.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 28.5 mt -111.15 141.9 44.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.421 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.671 ' HB3' ' HA2' ' A' ' 281' ' ' GLY . 59.8 t0 -144.52 88.01 1.9 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.156 0.503 . . . . 0.0 110.405 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? 64.6 37.13 8.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.568 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 51.84 44.23 29.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.961 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 1.6 t 169.66 46.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.911 0.386 . . . . 0.0 110.729 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . 0.671 ' HA2' ' HB3' ' A' ' 277' ' ' ASP . . . -136.43 -111.82 1.13 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.313 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.5 ' OE1' ' HB3' ' A' ' 275' ' ' MET . 91.9 mt-30 -56.9 -24.99 56.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.027 -0.587 . . . . 0.0 111.101 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 275' ' ' MET . 16.8 m -49.52 -31.9 11.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.086 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.415 ' HG3' ' HD3' ' A' ' 252' ' ' PRO . 70.7 ttp85 -116.36 136.98 52.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.161 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.16 -57.03 0.44 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.799 -0.715 . . . . 0.0 114.071 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.434 ' CE1' H5'' ' B' ' 2' ' ' ' A' . 35.1 p90 -141.62 167.98 20.86 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.555 0.677 . . . . 0.0 112.02 -178.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -134.45 156.02 22.21 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.238 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.478 ' HB2' ' HG2' ' A' ' 275' ' ' MET . 0.1 OUTLIER -111.97 129.85 56.05 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.709 0.29 . . . . 0.0 111.722 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.504 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 38.4 t -122.39 135.04 63.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 111.496 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 52.0 m -118.48 135.64 54.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.44 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 38.7 m-85 -116.87 134.99 54.08 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.623 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 54.4 t0 -59.43 -36.08 75.22 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.5 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 50.5 m -120.77 143.92 48.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.266 0.555 . . . . 0.0 111.436 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.63 -30.61 71.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.158 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -56.47 -38.9 72.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.278 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.8 88.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.074 0.464 . . . . 0.0 110.299 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 71.6 t -62.2 -42.99 97.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.707 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -60.57 -37.72 82.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.125 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -58.59 -43.81 89.62 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.662 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 0.4 OUTLIER -74.34 -34.38 36.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.953 0.406 . . . . 0.0 111.045 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 97.8 m -58.24 -44.69 88.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.193 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -62.22 -40.12 95.08 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.312 0.577 . . . . 0.0 109.91 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -63.81 -32.67 74.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.369 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.681 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 22.5 tptm 67.47 -74.89 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.629 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.681 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.5 m-30 -109.06 131.85 54.67 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.127 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.433 ' CD1' HG22 ' A' ' 300' ' ' VAL . 1.7 mt -121.07 138.08 52.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.48 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.414 ' OD1' ' CE ' ' A' ' 312' ' ' LYS . 86.9 m-20 -67.55 138.46 56.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.603 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 2.2 t80 -140.62 -107.98 0.15 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.209 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.419 ' NZ ' ' CZ ' ' A' ' 308' ' ' PHE . 2.6 mmpt? -58.92 -38.54 79.18 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.834 0.35 . . . . 0.0 111.862 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 309' ' ' LYS . 58.3 t0 176.7 -29.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.227 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 88.2 mmt-85 -113.66 160.32 18.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.607 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.609 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 37.0 mmtm -66.65 140.67 57.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.092 0.472 . . . . 0.0 111.567 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.561 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 34.5 pt -110.45 133.75 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . 0.547 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 84.2 mt-10 -96.04 131.49 42.38 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.798 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 246' ' ' PHE . 68.6 mt -120.3 123.92 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.068 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -130.41 154.81 47.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.983 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -56.12 151.53 12.11 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -48.29 142.98 5.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.975 0.417 . . . . 0.0 110.866 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -124.31 168.38 13.11 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.731 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.68 152.01 29.54 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.792 2.328 . . . . 0.0 111.801 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -55.86 -34.99 65.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.877 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 84.1 t60 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.293 -0.86 . . . . 0.0 110.868 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.706 0 C3'-C2'-O2' 111.206 -0.722 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.514 ' C6 ' ' CG ' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.918 0 C3'-C2'-O2' 111.286 -0.695 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.483 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.951 0 C3'-C2'-O2' 111.402 -0.655 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.583 " O2'" ' HA2' ' A' ' 201' ' ' GLY . . . . . . . . 0 O5'--C5' 1.425 -0.944 0 C4'-C3'-C2' 103.861 1.161 . 0.01 2u . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.658 ' C6 ' ' HA2' ' A' ' 164' ' ' GLY . . . . . . . . 0 O5'--C5' 1.424 -0.992 0 C4'-C3'-C2' 103.658 0.958 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.634 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.892 0 C3'-C2'-O2' 111.186 -0.729 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.656 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.939 0 C4'-C3'-C2' 103.686 0.986 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.893 0 C3'-C2'-O2' 111.249 -0.707 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.6 pttp . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.642 0.258 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -58.62 -37.11 75.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.018 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 69.3 m -150.5 8.61 0.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.917 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.3 m -60.59 -26.36 66.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.835 0.35 . . . . 0.0 110.844 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.48 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 6.3 tptt -56.85 136.37 55.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.47 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.445 ' N ' ' O ' ' A' ' 205' ' ' LEU . 90.3 mtp -125.74 155.88 40.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.303 0.573 . . . . 0.0 112.016 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.596 ' CD2' ' C5 ' ' B' ' 6' ' ' ' A' . 3.1 t80 -105.22 130.88 53.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.376 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.506 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 22.4 mm -117.4 128.89 74.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.556 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.48 ' HA2' ' C6 ' ' B' ' 5' ' ' ' U' . . . -122.43 157.15 17.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.968 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.68 54.52 5.91 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.218 -0.992 . . . . 0.0 112.27 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.504 ' O ' ' OG1' ' A' ' 170' ' ' THR . 69.4 mt -83.55 3.47 32.34 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.653 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 36.9 t30 58.27 39.95 25.12 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.842 -0.536 . . . . 0.0 110.109 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.57 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 8.8 m0 33.32 35.05 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.075 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -175.72 22.48 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.504 ' OG1' ' O ' ' A' ' 166' ' ' LEU . 95.1 m -59.84 -34.65 73.38 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 122.137 -0.352 . . . . 0.0 111.795 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.0 OUTLIER 62.33 131.23 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -178.196 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 188' ' ' LEU . 96.5 mt-10 -59.02 -34.95 72.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.633 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.596 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.9 m-20 -57.04 -40.77 77.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.886 0.374 . . . . 0.0 111.386 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 170' ' ' THR . 85.9 m-20 -63.12 -36.19 82.77 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.472 HD21 ' CD2' ' A' ' 179' ' ' PHE . 6.3 mt -59.93 -42.25 93.57 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.596 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -65.29 -38.82 91.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.016 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.436 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 75.8 mm-40 -70.82 -44.11 67.21 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.043 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.558 ' O ' ' HD3' ' A' ' 181' ' ' LYS . 58.4 t80 -65.28 -44.56 87.59 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.223 0.535 . . . . 0.0 111.435 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.472 ' CD2' HD21 ' A' ' 175' ' ' LEU . 88.5 m-85 -94.86 -1.82 51.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.206 -0.907 . . . . 0.0 112.452 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -61.54 -26.97 67.25 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.312 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.558 ' HD3' ' O ' ' A' ' 178' ' ' TYR . 0.8 OUTLIER -56.11 -39.76 72.69 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.032 0.92 . . . . 0.0 111.002 -179.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -67.51 -27.86 67.34 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.711 -1.586 . . . . 0.0 112.012 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 159.64 -123.15 1.2 Allowed Glycine 0 CA--C 1.507 -0.432 0 C-N-CA 120.678 -0.773 . . . . 0.0 111.674 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.488 ' O ' ' HD1' ' A' ' 207' ' ' PHE . 28.3 p -119.88 160.0 23.55 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.447 HG23 ' CD2' ' A' ' 188' ' ' LEU . 8.1 p -122.67 130.25 74.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.332 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.459 ' CG2' ' HA ' ' A' ' 208' ' ' GLU . 50.9 p -77.12 -38.86 51.22 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -155.29 150.98 27.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.472 0.653 . . . . 0.0 112.564 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 172' ' ' GLU . 0.2 OUTLIER -122.06 130.88 53.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.454 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 9.5 tptp -136.41 120.54 17.77 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.518 HG23 ' HG3' ' A' ' 192' ' ' LYS . 6.4 mt -130.28 130.63 65.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.771 176.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.541 ' SD ' ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -90.38 122.26 33.09 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.53 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.518 ' HG3' HG23 ' A' ' 190' ' ' ILE . 58.9 mttm -126.76 156.46 41.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.752 0.31 . . . . 0.0 111.496 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.649 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 7.7 t70 -122.19 80.24 44.12 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.378 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.41 -25.88 50.53 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.429 2.086 . . . . 0.0 112.57 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -72.19 -67.44 0.54 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.916 0.389 . . . . 0.0 111.235 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 61.4 p -71.63 -22.12 61.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.629 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 84.21 18.2 63.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.378 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.649 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 2.1 ttt-85 -122.98 144.24 49.38 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 120.92 0.39 . . . . 0.0 111.273 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.428 ' OG ' ' HA ' ' A' ' 168' ' ' TRP . 90.1 p -110.38 157.61 19.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.979 0.419 . . . . 0.0 111.039 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.541 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 1.5 mpt_? -53.53 -32.43 50.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.502 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.419 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 94.42 -0.09 65.51 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.352 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.541 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 23.9 p90 -139.15 154.86 48.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.222 0.534 . . . . 0.0 110.873 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.525 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -140.42 162.2 26.52 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.23 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.701 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 95.6 m-85 -106.21 127.46 53.24 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.979 0.418 . . . . 0.0 109.982 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.512 HD23 ' CZ ' ' A' ' 207' ' ' PHE . 2.0 tt -107.23 128.03 54.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.807 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.51 ' N ' HD22 ' A' ' 205' ' ' LEU . 11.9 t -117.0 132.45 56.7 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.494 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.512 ' CZ ' HD23 ' A' ' 205' ' ' LEU . 72.5 m-85 -117.5 141.55 48.22 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.459 ' HA ' ' CG2' ' A' ' 186' ' ' THR . 47.0 tp10 -63.07 -36.08 82.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.6 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.24 116.57 51.0 Favored Pre-proline 0 CA--C 1.529 0.141 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.624 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.97 -26.02 65.86 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.346 2.031 . . . . 0.0 112.584 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 21.4 m -57.98 -37.28 73.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.26 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.416 ' HA ' ' OE2' ' A' ' 215' ' ' GLU . 23.5 m -59.08 -35.61 73.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.942 0.401 . . . . 0.0 110.399 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.492 HG13 ' HD3' ' A' ' 232' ' ' ARG . 86.0 t -61.68 -42.32 93.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.022 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -59.6 -41.63 90.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.131 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.416 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 18.7 pt-20 -75.1 -31.49 61.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.818 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.776 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 77.7 t -60.99 -44.69 98.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.278 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.1 m -76.23 -29.24 19.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.028 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -58.31 -33.04 69.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.667 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 88.5 m -111.53 145.49 38.99 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -76.87 145.12 38.53 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.776 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 63.7 m-70 -120.57 134.05 55.32 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -176.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.438 ' CD1' HG22 ' A' ' 227' ' ' VAL . 28.3 mm -119.61 113.64 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.1 tt -121.66 126.77 49.8 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.74 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 56.4 t0 52.75 37.38 23.62 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 93.47 -24.67 24.49 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.839 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.498 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 30.9 mmtp -97.58 170.96 8.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.841 0.353 . . . . 0.0 111.324 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.438 HG22 ' CD1' ' A' ' 222' ' ' ILE . 11.7 p -120.89 139.97 46.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.927 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.435 HG13 ' HD3' ' A' ' 230' ' ' PRO . 36.0 pt -123.64 159.86 27.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.097 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -125.25 81.39 63.64 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.172 0.51 . . . . 0.0 110.834 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.513 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 51.0 Cg_exo -57.83 129.05 31.47 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.966 2.444 . . . . 0.0 111.551 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.584 ' HE2' ' H62' ' B' ' 6' ' ' ' A' . 3.3 ttpm? -140.74 155.94 46.32 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.571 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.492 ' HD3' HG13 ' A' ' 213' ' ' VAL . 52.5 mmm-85 -56.08 140.11 44.85 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.515 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.35 147.43 52.58 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.886 0.374 . . . . 0.0 111.506 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.536 HG13 ' N6 ' ' B' ' 6' ' ' ' A' . 35.7 mt -118.48 125.73 27.64 Favored Pre-proline 0 C--N 1.333 -0.132 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.155 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.445 ' HG2' ' CB ' ' A' ' 238' ' ' GLU . 9.8 Cg_endo -54.3 146.13 52.16 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 121.461 1.44 . . . . 0.0 110.072 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -55.98 -40.25 73.01 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.48 -44.13 95.27 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.897 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.445 ' CB ' ' HG2' ' A' ' 235' ' ' PRO . 84.3 tt0 -67.43 -38.14 84.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.038 0.447 . . . . 0.0 110.645 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -58.95 -40.71 85.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.998 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -60.38 -40.38 90.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.082 0.468 . . . . 0.0 110.661 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -61.52 -36.58 80.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.267 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 291' ' ' TYR . 69.5 p -31.31 -75.57 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 80.61 47.77 6.6 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.918 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 16.8 tttp -58.77 138.54 57.09 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 122.449 0.299 . . . . 0.0 110.785 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.41 161.52 21.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.527 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 75.2 t80 -96.03 131.24 42.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.82 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.647 HG12 HG12 ' A' ' 315' ' ' ILE . 59.9 t -124.02 139.97 48.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.482 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.66 -174.32 13.79 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . 0.456 ' O ' ' CG2' ' A' ' 313' ' ' ILE . . . 79.98 57.14 3.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 119.765 -1.207 . . . . 0.0 112.882 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 31.6 mm -104.41 129.41 56.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.438 ' O ' ' CG1' ' A' ' 254' ' ' VAL . . . -107.81 169.25 14.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.004 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.39 141.54 89.35 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.454 2.103 . . . . 0.0 112.622 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 55.76 42.45 29.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.254 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.51 ' O ' ' HB2' ' A' ' 258' ' ' GLU . 2.5 m -73.15 -35.79 48.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.675 0.274 . . . . 0.0 110.916 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.21 124.29 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.09 -28.68 51.94 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 121.867 1.711 . . . . 0.0 111.9 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -60.75 -42.94 98.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.015 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 96.7 mt-10 -66.21 -39.4 89.58 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.925 0.393 . . . . 0.0 111.128 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.578 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 37.1 t80 -64.9 -46.75 80.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.385 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.47 -40.58 95.97 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.717 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.471 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 21.1 pt-20 -76.3 -29.71 57.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 110.391 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.602 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 18.3 t80 -61.53 -57.2 13.08 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.944 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.578 ' CZ ' ' CG2' ' A' ' 247' ' ' VAL . 7.4 m-85 -67.41 -27.22 66.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.106 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.586 ' N ' HD13 ' A' ' 269' ' ' ILE . 34.8 m -54.53 -27.24 36.89 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -46.77 -38.21 9.74 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.348 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.664 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 19.9 p90 -126.66 42.66 3.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.09 0.471 . . . . 0.0 111.269 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 264' ' ' SER . . . 162.71 154.17 7.49 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.756 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.9 m -61.27 -35.6 77.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.888 0.375 . . . . 0.0 111.593 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.586 HD13 ' N ' ' A' ' 264' ' ' SER . 2.5 mt 69.39 80.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.633 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.513 ' CD1' ' HB3' ' A' ' 292' ' ' ASP . 34.4 mm -59.85 -41.75 86.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.51 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -157.86 86.48 0.91 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -105.23 130.59 53.34 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -147.39 155.82 42.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.334 0.588 . . . . 0.0 112.506 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.575 ' O ' ' HB2' ' A' ' 275' ' ' MET . 34.5 tp -65.08 -36.98 86.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.825 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.575 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 95.7 mmm 81.24 119.92 0.05 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.329 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 25.4 mt -127.03 129.03 47.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.598 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -62.24 -39.57 93.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.616 0.722 . . . . 0.0 109.599 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -161.77 -46.94 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.907 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -131.19 -79.93 0.53 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.653 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 68.7 p -116.3 13.36 15.57 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.891 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -49.87 -81.54 0.05 OUTLIER Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.419 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.706 ' OE1' " H5'" ' B' ' 2' ' ' ' A' . 68.8 mm-40 -83.97 6.38 22.12 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 122.781 0.433 . . . . 0.0 110.791 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.422 ' O ' ' CD2' ' A' ' 274' ' ' LEU . 22.8 t -56.95 -31.57 65.13 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.233 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 20.9 ptp180 -130.27 158.17 40.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.399 0.618 . . . . 0.0 111.902 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.68 -34.79 5.39 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.048 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 18.1 p90 -155.27 164.28 39.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 117.286 0.543 . . . . 0.0 111.768 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -135.13 150.92 20.32 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.121 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.487 ' CD2' ' CE ' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -112.26 125.61 54.35 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.859 -0.201 . . . . 0.0 111.483 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.578 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 60.5 t -130.22 137.43 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 27.8 m -119.32 137.54 53.64 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 242' ' ' THR . 43.7 m-85 -114.44 142.25 46.61 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.513 ' HB3' ' CD1' ' A' ' 270' ' ' ILE . 27.7 p-10 -62.63 -33.9 75.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.03 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.421 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 50.9 m -123.46 144.49 49.49 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.308 0.575 . . . . 0.0 111.719 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.4 -28.86 68.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.209 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 296' ' ' ALA . 52.4 p30 -60.27 -33.3 72.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.661 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.566 ' N ' ' OD1' ' A' ' 295' ' ' ASP . . . -61.33 -36.85 81.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.083 0.468 . . . . 0.0 110.368 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 300' ' ' VAL . 83.2 t -62.06 -42.51 95.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.089 0.471 . . . . 0.0 110.442 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -61.43 -38.09 85.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.624 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -59.39 -43.77 92.88 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.942 0.401 . . . . 0.0 111.73 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.664 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 0.7 OUTLIER -72.16 -34.91 51.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.368 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 85.5 m -59.07 -45.65 90.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.164 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -62.63 -39.17 92.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.253 0.549 . . . . 0.0 110.089 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -62.53 -32.9 73.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.744 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.63 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 7.1 tptt 69.2 -72.76 0.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.659 ' HB3' ' HB3' ' A' ' 312' ' ' LYS . 3.8 m-30 -114.76 142.62 46.28 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.576 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.536 HD13 ' CH2' ' A' ' 266' ' ' TRP . 6.8 mt -120.11 133.73 65.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -75.37 80.65 2.44 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.183 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.602 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 11.7 t80 -76.9 -57.68 3.71 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.775 0.798 . . . . 0.0 109.869 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.444 ' HE3' ' CE2' ' A' ' 308' ' ' PHE . 9.3 mmpt? -109.87 -165.04 0.97 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.453 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -55.2 -23.45 22.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.758 0.313 . . . . 0.0 110.478 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -118.59 159.68 23.15 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.014 0.435 . . . . 0.0 111.558 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.659 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 78.5 mttt -76.58 147.96 37.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.818 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 23.4 pt -118.16 151.4 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . 0.6 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 81.9 mt-10 -106.6 135.72 47.63 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.259 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.647 HG12 HG12 ' A' ' 247' ' ' VAL . 72.1 mt -120.51 126.91 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 120.927 0.394 . . . . 0.0 110.977 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm -128.43 154.54 45.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.147 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 40.9 ptt85 -55.47 147.91 16.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.352 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.97 139.57 58.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.143 0.497 . . . . 0.0 111.407 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -129.93 77.93 75.83 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.173 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.43 ' HA ' ' O4 ' ' B' ' 3' ' ' ' U' . 10.2 Cg_endo -54.15 132.9 52.82 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.038 1.825 . . . . 0.0 111.959 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -61.13 -34.69 75.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.82 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.05 179.879 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.672 0 C1'-C2'-O2' 108.51 -0.697 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.706 " H5'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.934 0 C3'-C2'-O2' 111.521 -0.613 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.43 ' O4 ' ' HA ' ' A' ' 320' ' ' PRO . . . . . . . . 0 O5'--C5' 1.424 -1.003 0 C3'-C2'-O2' 111.219 -0.718 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.653 ' N7 ' ' HA ' ' A' ' 167' ' ' ASN . . . . . . . . 0 O5'--C5' 1.425 -0.94 0 C4'-C3'-C2' 103.742 1.042 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.642 H5'' " H3'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.79 0 C5'-C4'-O4' 107.806 -0.996 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.612 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.94 0 C1'-C2'-O2' 108.54 -0.687 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.701 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.968 0 C3'-C2'-O2' 111.182 -0.73 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -1.003 0 C3'-C2'-O2' 111.281 -0.696 . 0.0 OUTLIER '7D dist 2u wannabe' 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.489 ' HG3' ' H ' ' A' ' 158' ' ' SER . 15.0 pttm . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.407 0.146 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -60.68 -34.13 73.88 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.847 0.356 . . . . 0.0 111.516 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.489 ' H ' ' HG3' ' A' ' 156' ' ' LYS . 86.2 p -62.28 -24.23 67.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.36 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER 62.76 59.6 1.4 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.274 0.559 . . . . 0.0 110.173 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.421 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 68.1 tttt -69.58 140.3 53.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.506 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.447 ' N ' ' O ' ' A' ' 205' ' ' LEU . 86.4 mmm -115.03 147.95 39.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.78 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.635 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 5.6 t80 -108.71 130.97 55.36 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.583 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 16.6 mm -111.65 127.82 68.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.667 ' HA2' ' C6 ' ' B' ' 5' ' ' ' U' . . . -133.85 165.34 24.28 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.795 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.74 28.68 60.62 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.254 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 201' ' ' GLY . 66.1 mt -86.99 139.62 30.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.883 0.373 . . . . 0.0 110.744 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.546 ' O ' ' N ' ' A' ' 169' ' ' ASP . 30.3 t30 -65.48 136.39 56.38 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.577 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 6.2 m0 -60.27 75.95 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 167' ' ' ASN . 58.4 t0 178.28 -22.31 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.656 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 88.8 m -65.07 138.53 58.38 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.182 0.515 . . . . 0.0 111.038 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 p -115.96 166.37 12.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.923 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 188' ' ' LEU . 53.1 mp0 -58.34 -28.91 65.52 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.765 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.1 m-20 -58.07 -43.46 86.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.846 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -65.99 -38.41 88.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.607 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.486 HD21 ' CE2' ' A' ' 179' ' ' PHE . 4.7 mt -61.65 -42.71 99.27 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.765 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -66.04 -38.22 87.82 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.798 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.439 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 97.1 mt-10 -69.55 -43.43 72.96 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.124 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.522 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 56.2 t80 -67.22 -48.66 67.16 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.477 0.656 . . . . 0.0 111.603 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.559 ' CG ' ' CD1' ' A' ' 205' ' ' LEU . 94.9 m-85 -91.75 -1.59 57.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.128 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -57.95 -29.15 61.71 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.22 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.817 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -57.05 -40.49 76.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.19 -0.505 . . . . 0.0 110.841 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.817 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 78.1 m-85 -70.34 -34.97 73.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.122 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 178.74 -173.88 46.12 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 119.938 -1.125 . . . . 0.0 113.652 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.6 m -62.38 -30.69 71.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.13 -0.535 . . . . 0.0 111.178 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.638 ' CG1' ' O ' ' A' ' 185' ' ' VAL . 0.4 OUTLIER 67.47 89.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -177.399 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.461 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -56.13 -49.32 74.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.517 -177.073 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -142.45 137.68 30.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.28 0.562 . . . . 0.0 112.409 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 172' ' ' GLU . 0.2 OUTLIER -115.08 133.03 56.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.524 179.115 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 15.3 tptt -133.78 122.61 23.54 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 172' ' ' GLU . 4.7 mt -128.58 130.41 68.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.757 176.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.574 ' CE ' ' HA3' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -93.01 126.44 38.09 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -126.08 152.85 45.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.972 0.415 . . . . 0.0 111.933 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.625 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 4.6 m-20 -122.72 68.87 33.62 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.885 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.9 -24.99 80.56 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.925 2.417 . . . . 0.0 113.098 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -60.98 -47.38 86.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.929 0.395 . . . . 0.0 111.265 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 55.2 p -96.83 -4.04 41.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.235 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 76.68 24.97 66.12 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.619 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.625 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 5.9 tpt180 -121.83 159.84 25.91 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.479 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 97.8 p -128.32 154.16 46.23 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.21 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.555 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 4.9 mpt_? -55.76 -35.63 66.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.362 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 166' ' ' LEU . . . 86.8 5.06 81.81 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.59 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.583 ' HB2' ' O ' ' A' ' 163' ' ' ILE . 39.6 p90 -144.93 157.31 44.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.864 0.364 . . . . 0.0 110.647 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.574 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -150.45 166.45 30.15 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.015 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.747 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 95.4 m-85 -105.92 127.19 52.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.16 0.505 . . . . 0.0 109.89 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.586 HD23 ' CZ ' ' A' ' 207' ' ' PHE . 6.3 tt -108.45 130.45 55.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.942 -178.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.474 ' N ' HD22 ' A' ' 205' ' ' LEU . 54.9 m -120.84 140.3 51.95 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.724 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.586 ' CZ ' HD23 ' A' ' 205' ' ' LEU . 84.9 m-85 -121.05 142.74 49.54 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.395 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.461 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.5 tt0 -63.36 -35.38 80.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.195 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.42 119.27 47.18 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.92 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -56.84 -28.21 75.83 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.609 2.206 . . . . 0.0 113.102 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.6 m -58.67 -35.42 72.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.383 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.407 ' OG ' ' CG ' ' A' ' 207' ' ' PHE . 87.2 p -61.13 -30.15 70.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.92 0.391 . . . . 0.0 110.725 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.71 -39.2 83.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.167 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -56.38 -41.85 76.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.847 0.356 . . . . 0.0 111.238 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.36 -34.77 77.99 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.774 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 94.2 t -63.06 -45.3 99.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.073 0.463 . . . . 0.0 111.31 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 52.8 t -70.09 -43.42 79.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -59.39 -35.99 74.99 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.429 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 61.9 m -98.05 143.73 28.3 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -76.13 147.61 38.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.774 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 35.8 m-70 -126.31 132.38 51.65 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 226' ' ' LYS . 68.3 mt -122.2 115.24 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.3 tt -121.78 127.11 50.26 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.515 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 54.45 42.52 31.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.999 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 73.91 18.32 79.59 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.005 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 222' ' ' ILE . 0.5 OUTLIER -128.21 153.46 46.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.801 0.301 . . . . 0.0 110.893 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.13 130.34 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.983 0.42 . . . . 0.0 110.259 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 164' ' ' GLY . 34.5 pt -127.19 159.54 37.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.796 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -128.27 79.73 73.52 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.217 0.532 . . . . 0.0 111.037 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.481 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 37.3 Cg_exo -60.36 126.97 21.44 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 123.176 2.584 . . . . 0.0 111.687 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 12.4 mtmm -132.7 156.55 46.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.846 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -58.92 136.46 57.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.935 0.398 . . . . 0.0 111.608 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.99 143.9 56.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.089 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.579 ' CG1' ' C6 ' ' B' ' 6' ' ' ' A' . 0.0 OUTLIER -114.76 124.57 30.26 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.803 179.195 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.402 ' HG2' ' CG ' ' A' ' 238' ' ' GLU . 10.4 Cg_endo -53.93 151.06 28.14 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 121.987 1.791 . . . . 0.0 110.643 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.436 ' NH2' " H5'" ' B' ' 7' ' ' ' U' . 21.0 mmt180 -54.29 -37.21 64.51 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -60.25 -43.53 96.03 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.964 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.402 ' CG ' ' HG2' ' A' ' 235' ' ' PRO . 97.7 mt-10 -72.6 -38.66 67.77 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.313 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -60.86 -39.38 88.95 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.844 0.354 . . . . 0.0 110.691 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -62.69 -40.35 96.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.171 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -60.19 -38.18 82.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.811 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 25.7 p -82.55 161.46 22.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.009 0.433 . . . . 0.0 111.55 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -154.02 114.79 0.64 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.961 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.459 ' NZ ' ' CE2' ' A' ' 288' ' ' PHE . 19.8 ttpp -85.77 134.33 33.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.645 0.259 . . . . 0.0 111.134 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.63 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -118.42 163.24 15.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.479 0.657 . . . . 0.0 111.407 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.526 ' CG ' ' C6 ' ' B' ' 2' ' ' ' A' . 91.8 t80 -103.41 137.44 41.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.765 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.524 HG12 ' CE1' ' A' ' 259' ' ' PHE . 10.8 p -131.35 146.87 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.878 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.511 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -129.83 172.09 20.15 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 84.65 28.74 31.5 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.086 -1.054 . . . . 0.0 112.508 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.438 HD12 ' CE1' ' A' ' 259' ' ' PHE . 68.1 mt -110.52 133.0 57.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.819 0.342 . . . . 0.0 110.575 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -123.03 172.2 15.88 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.392 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . 0.408 ' HG3' ' NE ' ' A' ' 284' ' ' ARG . 51.6 Cg_exo -53.78 -31.06 59.88 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.054 1.836 . . . . 0.0 111.667 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -60.15 -36.58 77.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.156 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 258' ' ' GLU . 25.5 t -58.13 -45.1 88.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.486 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 254' ' ' VAL . 2.0 mmm180 60.97 141.84 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.28 -28.31 52.04 Favored 'Trans proline' 0 CA--C 1.528 0.189 0 C-N-CA 122.033 1.822 . . . . 0.0 112.919 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -61.69 -45.96 91.74 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 97.6 mt-10 -69.05 -38.39 79.09 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.171 0.51 . . . . 0.0 111.691 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.665 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 20.3 t80 -61.23 -47.19 87.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.805 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.21 -41.84 94.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.601 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.402 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.8 pt-20 -75.05 -34.09 61.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.919 0.39 . . . . 0.0 111.211 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.534 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 16.4 t80 -62.2 -55.0 32.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.063 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.528 ' HA ' ' CZ3' ' A' ' 266' ' ' TRP . 4.5 m-85 -67.92 -23.62 65.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.074 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.465 ' CA ' HD13 ' A' ' 269' ' ' ILE . 23.2 t -55.91 -31.38 62.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.818 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -53.64 -35.79 61.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.644 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.644 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 11.3 p90 -115.89 48.69 1.19 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.363 0.601 . . . . 0.0 111.148 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.569 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 148.39 146.18 4.29 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.671 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.409 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 45.2 m -59.41 -37.47 78.1 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.519 HD12 ' CB ' ' A' ' 263' ' ' PHE . 74.2 mt 69.7 83.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.417 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.48 ' CD1' ' HB2' ' A' ' 292' ' ' ASP . 32.1 mm -57.25 -43.59 82.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.543 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -161.63 93.1 0.9 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -103.32 134.65 46.34 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 178.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -143.63 155.47 44.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.467 0.651 . . . . 0.0 112.331 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.587 ' O ' ' HB2' ' A' ' 275' ' ' MET . 32.7 tp -64.3 -38.41 90.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.364 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.587 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 93.6 mmm 95.0 115.48 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.466 0.706 . . . . 0.0 110.966 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 29.7 mt -120.42 116.68 25.94 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.931 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -64.05 -38.98 93.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.778 0.799 . . . . 0.0 109.179 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -150.39 -49.38 0.13 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.583 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 280' ' ' THR . 35.5 p-10 -150.38 -54.32 0.15 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.874 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.4 ' N ' ' OD1' ' A' ' 279' ' ' ASP . 64.4 p -126.49 14.17 7.63 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -56.74 -80.93 0.07 OUTLIER Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.64 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.99 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 78.4 mm-40 -83.38 3.21 32.75 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.562 0.345 . . . . 0.0 110.532 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.442 ' HB2' HD22 ' A' ' 274' ' ' LEU . 86.4 p -61.35 -26.31 67.73 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.619 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.408 ' NE ' ' HG3' ' A' ' 252' ' ' PRO . 98.2 mtt180 -119.38 146.4 45.37 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.145 0.497 . . . . 0.0 111.85 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.95 -43.39 1.8 Allowed Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.505 -0.77 . . . . 0.0 114.327 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 23.2 p90 -149.29 165.13 32.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.914 0.857 . . . . 0.0 112.732 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.465 ' O ' HG11 ' A' ' 247' ' ' VAL . . . -135.12 161.13 24.56 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.752 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.459 ' CE2' ' NZ ' ' A' ' 244' ' ' LYS . 0.2 OUTLIER -118.05 126.95 53.28 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.498 0.185 . . . . 0.0 111.498 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.665 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 60.1 t -124.87 136.02 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.017 0.436 . . . . 0.0 111.685 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 50.4 m -114.72 134.65 54.92 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.569 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 30.4 m-85 -114.74 137.01 52.44 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.48 ' HB2' ' CD1' ' A' ' 270' ' ' ILE . 52.5 t0 -56.73 -36.14 69.37 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.027 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 31.0 t -122.33 139.35 53.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.498 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . 0.458 ' O ' HG11 ' A' ' 297' ' ' VAL . . . -64.27 -30.05 71.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.985 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -54.96 -35.08 63.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.491 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.37 79.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.616 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 294' ' ' ALA . 7.0 p -59.2 -37.66 69.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.824 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . 0.437 ' N ' HG11 ' A' ' 297' ' ' VAL . 56.0 t0 -62.37 -37.7 86.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.305 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -58.65 -43.23 89.73 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.636 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.644 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 0.9 OUTLIER -70.58 -35.52 61.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.696 -179.127 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . 0.418 ' N ' HG11 ' A' ' 300' ' ' VAL . 75.2 m -60.28 -44.04 95.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.86 0.362 . . . . 0.0 110.579 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.69 -33.93 74.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.189 0.518 . . . . 0.0 110.175 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.623 ' O ' ' N ' ' A' ' 305' ' ' PHE . 80.6 m-20 -85.66 5.36 32.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.943 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.669 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 13.4 tptt 37.62 -81.57 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.719 0.407 . . . . 0.0 111.03 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.669 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 2.7 m-30 -108.52 143.86 36.95 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.856 0.36 . . . . 0.0 110.23 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.593 HD11 ' CZ3' ' A' ' 266' ' ' TRP . 25.3 mt -118.0 138.04 49.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.142 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.544 ' OD1' ' O ' ' A' ' 307' ' ' ASP . 51.0 p30 -75.34 114.36 13.78 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.017 0.437 . . . . 0.0 109.951 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.534 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 1.9 t80 -106.16 -109.37 0.29 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.435 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 1.5 mmpt? -59.38 -37.24 77.45 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.933 0.397 . . . . 0.0 111.896 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -179.6 -27.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.889 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 60.5 mtp85 -112.67 153.85 27.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.989 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.446 ' CG ' ' HB3' ' A' ' 305' ' ' PHE . 2.1 tptm -72.17 139.89 48.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.975 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 35.9 pt -115.46 152.09 17.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.884 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -100.71 132.17 46.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.017 0.437 . . . . 0.0 110.908 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.46 HG12 HG21 ' A' ' 247' ' ' VAL . 74.5 mt -120.35 128.45 75.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.819 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -132.85 147.18 52.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.916 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -50.97 149.65 3.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.712 0.291 . . . . 0.0 110.435 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.36 141.6 35.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.07 0.462 . . . . 0.0 111.417 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -113.51 118.17 43.85 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.992 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.33 -20.98 34.54 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.272 1.981 . . . . 0.0 112.03 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.454 ' O ' ' CG ' ' A' ' 322' ' ' HIS . 17.9 mmm180 65.27 -71.0 0.08 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.0 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . 0.454 ' CG ' ' O ' ' A' ' 321' ' ' ARG . 2.3 m80 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.749 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.695 0 C3'-C2'-O2' 111.261 -0.703 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.99 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.953 0 C3'-C2'-O2' 111.371 -0.665 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.413 " H1'" ' CE ' ' A' ' 275' ' ' MET . . . . . . . . 0 O5'--C5' 1.425 -0.944 0 C3'-C2'-O2' 111.24 -0.71 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.577 ' C2 ' ' CZ3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.425 -0.913 0 C4'-C3'-C2' 103.69 0.99 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 1.0 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.85 0 C4'-C3'-C2' 103.73 1.03 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 1.0 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.971 0 C3'-C2'-O2' 111.242 -0.71 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.747 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.423 -1.058 0 C3'-C2'-O2' 111.304 -0.688 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.959 0 C1'-C2'-O2' 108.535 -0.688 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 42.3 tttt . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.869 0.366 . . . . 0.0 111.336 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 60.8 mp0 -61.85 -33.29 73.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.017 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.3 m -119.83 146.96 45.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.003 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 20.0 p 178.55 -26.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.322 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -64.33 139.59 58.78 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.908 0.385 . . . . 0.0 110.682 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.621 ' O ' ' HA ' ' A' ' 204' ' ' PHE . 91.2 mtp -115.61 151.1 35.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.827 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.603 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 3.5 t80 -104.88 127.44 52.71 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.452 ' O ' ' CB ' ' A' ' 202' ' ' PHE . 13.4 mt -121.68 127.12 75.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.797 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.457 ' HA2' ' C6 ' ' B' ' 5' ' ' ' U' . . . -117.9 149.03 18.57 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.43 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.51 36.26 39.0 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.458 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.592 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 74.5 mt -59.1 -34.33 71.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.682 ' O ' ' N ' ' A' ' 169' ' ' ASP . 26.4 t30 101.8 37.34 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.638 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 9.3 m0 40.91 -68.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.382 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.682 ' N ' ' O ' ' A' ' 167' ' ' ASN . 92.5 m-20 -55.37 -30.0 59.52 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.629 ' O ' ' ND2' ' A' ' 174' ' ' ASN . 86.7 m -44.39 -36.03 2.66 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.0 OUTLIER 54.88 165.06 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.726 -0.609 . . . . 0.0 110.969 -179.154 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.469 ' HG3' HG13 ' A' ' 190' ' ' ILE . 53.7 mp0 -63.49 -35.79 81.62 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 174' ' ' ASN . 54.4 p30 -61.68 -39.2 90.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.629 ' ND2' ' O ' ' A' ' 170' ' ' THR . 63.9 m-80 -64.7 -37.6 88.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.465 HD23 HG21 ' A' ' 170' ' ' THR . 3.6 mm? -62.85 -39.9 95.81 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 120.919 0.39 . . . . 0.0 111.192 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 180' ' ' GLY . 69.9 ttp85 -56.53 -41.89 77.54 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.08 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -68.28 -43.6 77.38 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.346 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.477 ' O ' ' HD3' ' A' ' 181' ' ' LYS . 61.4 t80 -65.14 -46.38 81.18 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.87 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.481 ' CG ' ' CD1' ' A' ' 205' ' ' LEU . 78.3 m-85 -91.64 -3.66 56.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.072 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -60.42 -31.15 73.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.294 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.477 ' HD3' ' O ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -57.69 -41.15 81.05 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.512 0.673 . . . . 0.0 110.841 -179.136 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -67.08 -33.44 75.5 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.14 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.64 -177.2 47.11 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.91 -1.138 . . . . 0.0 113.354 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 44.2 m -61.6 -31.56 71.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.289 -0.456 . . . . 0.0 110.72 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.491 ' CG1' ' O ' ' A' ' 185' ' ' VAL . 0.9 OUTLIER 65.19 95.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -178.031 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.469 ' O ' ' OD1' ' A' ' 187' ' ' ASP . 2.3 t -63.55 -45.57 89.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.084 -178.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 186' ' ' THR . 91.5 m-20 -141.65 153.86 44.99 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.426 ' CD2' HG12 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -129.55 129.77 44.89 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.312 178.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 19.4 tptt -136.48 116.73 13.54 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.469 HG13 ' HG3' ' A' ' 172' ' ' GLU . 86.0 mt -127.64 131.0 70.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.728 174.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.503 ' SD ' ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -78.23 99.07 6.11 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.76 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 41.8 pttt -89.36 153.02 21.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.048 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 1.3 m-20 -124.72 78.77 63.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.251 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.77 -24.69 64.96 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.41 2.073 . . . . 0.0 112.132 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.01 -74.65 0.18 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.456 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.1 p -68.2 -27.72 66.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.578 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.38 7.88 64.84 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.696 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.493 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 0.8 OUTLIER -122.87 121.48 36.32 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 117.651 0.725 . . . . 0.0 111.313 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 56.6 m -75.64 161.06 29.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.684 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.543 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -55.45 -33.46 63.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.858 178.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.54 ' HA2' " O2'" ' B' ' 4' ' ' ' A' . . . 96.3 -5.24 65.21 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.014 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.578 ' CD2' " H4'" ' B' ' 5' ' ' ' U' . 35.5 p90 -134.2 154.34 51.3 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.456 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -146.38 167.71 27.95 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.12 -1.038 . . . . 0.0 112.412 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.719 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 89.1 m-85 -108.59 125.83 52.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.526 HD23 ' CZ ' ' A' ' 207' ' ' PHE . 7.4 tt -109.13 131.84 54.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.161 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.43 ' N ' HD22 ' A' ' 205' ' ' LEU . 22.8 t -120.71 135.86 55.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.9 0.381 . . . . 0.0 111.8 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.526 ' CZ ' HD23 ' A' ' 205' ' ' LEU . 87.2 m-85 -116.69 143.65 45.39 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.681 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -60.94 -34.57 74.92 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -114.23 115.73 44.91 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.211 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.74 -23.56 41.96 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.547 2.165 . . . . 0.0 113.171 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.566 ' O ' ' OE1' ' A' ' 215' ' ' GLU . 23.3 t -57.79 -38.15 74.97 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.499 ' HA ' ' OE1' ' A' ' 215' ' ' GLU . 24.0 m -56.97 -34.37 68.01 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.911 0.386 . . . . 0.0 110.314 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.462 HG13 ' HD3' ' A' ' 232' ' ' ARG . 85.0 t -60.35 -39.26 80.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.312 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.432 ' O ' ' HG3' ' A' ' 218' ' ' LYS . 92.9 m-20 -57.37 -41.2 79.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.403 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.566 ' OE1' ' O ' ' A' ' 211' ' ' SER . 47.6 mp0 -65.44 -35.74 81.82 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.076 0.465 . . . . 0.0 111.788 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.753 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 85.5 t -59.96 -44.01 93.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.964 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 22.3 m -73.24 -35.51 47.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 214' ' ' ASP . 56.0 mtmt -60.09 -30.31 69.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 79.3 m -110.98 144.76 39.57 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -78.8 145.02 34.55 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.753 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 44.2 m-70 -120.96 129.51 53.46 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 68.3 mt -121.98 113.25 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.0 tt -122.23 124.06 42.93 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.163 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 53.29 42.48 32.08 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.85 9.2 87.01 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.719 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.523 ' NZ ' ' C6 ' ' B' ' 4' ' ' ' A' . 34.3 mmtp -123.66 150.41 44.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.897 0.379 . . . . 0.0 111.32 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.24 132.83 52.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.377 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.409 HG13 ' HD3' ' A' ' 230' ' ' PRO . 34.7 pt -123.82 159.13 29.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.517 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.74 82.05 64.49 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.425 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.588 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 73.4 Cg_exo -55.23 130.82 42.71 Favored 'Trans proline' 0 CA--C 1.528 0.195 0 C-N-CA 122.998 2.465 . . . . 0.0 112.189 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.528 ' CE ' ' H62' ' B' ' 6' ' ' ' A' . 9.5 ttpt -139.75 144.16 37.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.579 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.462 ' HD3' HG13 ' A' ' 213' ' ' VAL . 56.1 mmm-85 -52.58 142.71 17.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.015 0.436 . . . . 0.0 111.051 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.03 143.62 52.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.654 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.516 ' CD1' ' C6 ' ' B' ' 6' ' ' ' A' . 0.3 OUTLIER -115.44 123.31 31.67 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.536 179.117 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.451 ' HD2' ' OE1' ' A' ' 238' ' ' GLU . 78.2 Cg_exo -50.36 148.7 14.08 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 121.908 1.738 . . . . 0.0 110.996 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -53.7 -39.89 65.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.592 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 54.5 p30 -64.42 -37.57 87.99 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.914 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.592 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 94.9 mt-10 -68.23 -36.38 79.39 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.264 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -60.01 -37.29 79.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.911 0.386 . . . . 0.0 110.342 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -60.4 -39.43 87.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.631 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -60.5 -36.21 77.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.117 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 20.6 p -89.09 162.92 15.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.445 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.27 167.3 24.75 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.907 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.552 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 6.6 tptm -133.69 133.31 41.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.796 0.298 . . . . 0.0 110.591 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.438 HD11 HG13 ' A' ' 300' ' ' VAL . 5.7 pt -123.87 157.15 30.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.345 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.523 ' CZ ' ' N7 ' ' B' ' 2' ' ' ' A' . 88.9 t80 -97.27 131.0 44.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.926 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.626 ' CG2' ' CZ ' ' A' ' 263' ' ' PHE . 26.7 t -123.58 137.37 57.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.883 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.501 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -127.22 173.95 18.42 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.278 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 81.35 34.75 25.17 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.062 -1.066 . . . . 0.0 111.628 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.402 ' CG2' ' CG2' ' A' ' 254' ' ' VAL . 64.2 mt -110.52 130.82 63.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.698 0.285 . . . . 0.0 110.65 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.47 ' O ' ' CG2' ' A' ' 254' ' ' VAL . . . -165.12 -107.54 0.2 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.184 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -62.2 137.7 67.72 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.522 2.148 . . . . 0.0 113.465 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 52.03 42.85 30.66 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.266 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 251' ' ' GLY . 18.8 m -121.68 27.17 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.437 ' HB2' ' OE1' ' A' ' 258' ' ' GLU . 3.2 mmt180 -41.62 155.91 0.22 Allowed Pre-proline 0 N--CA 1.462 0.163 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -50.93 -28.01 22.63 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.011 1.808 . . . . 0.0 112.177 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -61.81 -47.15 86.41 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.004 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.465 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 54.8 mp0 -69.76 -40.17 76.26 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.85 0.357 . . . . 0.0 111.431 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.511 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 48.8 t80 -65.05 -46.69 80.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.117 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.33 -40.87 96.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.965 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.465 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.8 pt-20 -74.55 -32.6 62.49 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.974 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.735 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 78.3 t80 -59.93 -58.41 8.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.225 0.536 . . . . 0.0 111.713 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.683 ' CD1' ' HD2' ' A' ' 262' ' ' PHE . 33.0 m-85 -66.78 -24.62 66.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.828 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.491 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 34.6 t -55.7 -24.21 33.23 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -47.01 -38.76 11.34 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.063 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.645 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 23.0 p90 -132.34 53.6 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.086 0.47 . . . . 0.0 111.574 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.526 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 153.34 148.89 5.02 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.937 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.427 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 56.7 m -59.88 -37.09 78.35 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.514 HD12 ' CB ' ' A' ' 263' ' ' PHE . 72.1 mt 69.74 78.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.223 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.489 HG12 ' CA ' ' A' ' 292' ' ' ASP . 33.6 mm -59.0 -44.51 91.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.961 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 270' ' ' ILE . 75.8 m-20 -153.51 86.99 1.22 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -103.27 135.99 43.88 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -141.66 151.1 42.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.498 0.665 . . . . 0.0 112.125 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.556 ' CD2' ' HB2' ' A' ' 283' ' ' SER . 37.1 tp -67.14 -34.89 78.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.625 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.612 ' HE1' ' HB2' ' A' ' 288' ' ' PHE . 2.9 ttm 86.46 145.8 0.06 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.008 0.523 . . . . 0.0 110.624 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.555 ' CB ' ' HA ' ' A' ' 280' ' ' THR . 0.5 OUTLIER 174.41 87.18 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 120.641 0.258 . . . . 0.0 111.048 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.01 -42.16 89.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.868 0.366 . . . . 0.0 110.656 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . 0.446 ' O ' ' OD1' ' A' ' 279' ' ' ASP . 50.5 mttt -139.51 133.88 31.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.666 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 278' ' ' LYS . 44.1 p30 30.12 44.51 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.555 ' HA ' ' CB ' ' A' ' 276' ' ' LEU . 1.3 p 70.23 29.52 3.66 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 278' ' ' LYS . . . -66.29 -58.72 8.25 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.246 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.909 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 97.4 mm-40 -64.04 -29.85 70.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.834 0.35 . . . . 0.0 111.353 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.556 ' HB2' ' CD2' ' A' ' 274' ' ' LEU . 87.0 p -56.55 -27.82 58.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.712 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -87.3 126.9 35.13 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.02 0.438 . . . . 0.0 111.537 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.14 -37.1 3.52 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 114.989 0.755 . . . . 0.0 114.989 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.545 ' CE2' ' CE ' ' A' ' 275' ' ' MET . 12.3 p90 -147.23 162.6 38.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.415 1.107 . . . . 0.0 112.733 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -143.25 163.91 27.36 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 121.102 -0.57 . . . . 0.0 113.264 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.612 ' HB2' ' HE1' ' A' ' 275' ' ' MET . 0.3 OUTLIER -113.5 132.38 55.7 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.511 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 42.6 t -123.74 136.09 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 35.8 m -118.39 136.99 53.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.509 178.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.526 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 30.7 m-85 -120.65 140.56 51.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.489 ' CA ' HG12 ' A' ' 270' ' ' ILE . 51.3 t0 -57.88 -36.28 72.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.307 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 93.7 p -125.86 149.19 48.86 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.331 0.586 . . . . 0.0 111.784 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.96 -29.68 69.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.18 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -56.16 -38.23 70.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.333 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.405 ' O ' ' CD1' ' A' ' 266' ' ' TRP . . . -61.38 -37.51 83.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.055 0.455 . . . . 0.0 110.468 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 77.1 t -61.91 -44.62 99.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.713 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -61.82 -37.6 85.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.346 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -58.42 -43.4 88.66 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.645 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 0.5 OUTLIER -73.18 -32.04 36.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.915 0.388 . . . . 0.0 111.152 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 91.6 m -54.97 -44.55 74.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.046 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -62.76 -40.07 96.12 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.003 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.44 ' O ' ' N ' ' A' ' 305' ' ' PHE . 86.1 m-20 -63.98 -36.22 83.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.518 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.648 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 19.1 tptm 66.57 -67.84 0.15 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.792 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.648 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 20.9 m-85 -115.87 136.24 53.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.235 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.501 ' CG2' ' HZ ' ' A' ' 262' ' ' PHE . 30.0 mt -121.55 137.97 53.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.965 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 307' ' ' ASP . 52.6 p30 -78.99 85.46 4.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.977 0.417 . . . . 0.0 111.199 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.735 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 4.1 t80 -79.36 -71.78 0.43 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.478 ' HE3' ' CE1' ' A' ' 308' ' ' PHE . 8.1 mmpt? -104.56 -145.56 0.38 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.151 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.483 ' OD1' ' HG3' ' A' ' 311' ' ' ARG . 54.5 p30 -81.59 2.48 29.07 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.13 0.49 . . . . 0.0 109.952 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.483 ' HG3' ' OD1' ' A' ' 310' ' ' ASP . 94.0 mtt-85 -126.24 149.16 49.27 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.577 ' HG2' ' HB3' ' A' ' 305' ' ' PHE . 11.3 tttp -80.02 137.2 36.76 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 21.7 pt -105.01 135.85 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.82 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . 0.421 ' HB2' ' CE2' ' A' ' 305' ' ' PHE . 84.6 tt0 -102.15 130.31 48.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.812 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.484 HD12 ' CZ ' ' A' ' 263' ' ' PHE . 67.5 mt -119.34 128.54 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-O 121.024 0.44 . . . . 0.0 111.125 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -130.91 144.19 51.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.253 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -51.85 138.05 24.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.93 0.395 . . . . 0.0 110.424 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 244' ' ' LYS . . . -64.68 145.27 56.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.004 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -114.62 146.44 35.98 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.614 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.47 134.18 62.71 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 121.957 1.772 . . . . 0.0 111.981 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -58.34 -37.91 76.1 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.966 0.412 . . . . 0.0 110.965 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.899 -179.898 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.41 HO2' ' P ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.429 -0.671 0 C3'-C2'-O2' 111.256 -0.705 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.909 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.424 -1.001 0 C1'-C2'-O2' 108.599 -0.667 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -1.015 0 C4'-C3'-C2' 103.756 1.056 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.638 ' C2 ' ' CZ3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.425 -0.929 0 C4'-C3'-C2' 103.993 1.293 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.786 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.826 0 C5'-C4'-O4' 107.973 -0.877 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.786 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.927 0 C3'-C2'-C1' 100.832 -0.742 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.719 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.914 0 C3'-C2'-C1' 100.861 -0.71 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . 0.561 ' N3 ' " H2'" ' B' ' 8' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.944 0 C3'-C2'-O2' 111.221 -0.717 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.9 pttp . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.9 0.381 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.87 145.37 35.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.691 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.5 m -116.17 146.06 42.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.087 0.47 . . . . 0.0 111.038 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 20.5 m -90.01 8.9 30.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.544 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -64.45 137.46 57.89 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.428 0.632 . . . . 0.0 111.458 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 205' ' ' LEU . 85.2 mmm -117.2 151.79 36.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.215 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.581 ' CE2' ' N9 ' ' B' ' 6' ' ' ' A' . 5.9 t80 -106.13 129.31 54.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 203' ' ' GLY . 12.9 mm -116.45 127.61 74.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.707 ' HA2' ' C6 ' ' B' ' 5' ' ' ' U' . . . -130.45 163.97 23.05 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.492 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.88 28.58 64.55 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.809 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.463 ' O ' ' C8 ' ' B' ' 4' ' ' ' A' . 74.3 mt -86.7 142.15 28.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.782 0.325 . . . . 0.0 111.604 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -64.65 135.42 55.91 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.581 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 4.7 m0 -52.06 -31.52 30.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.688 0.28 . . . . 0.0 111.003 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -91.17 5.41 49.17 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.614 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.52 ' O ' ' O ' ' A' ' 171' ' ' THR . 86.1 m -58.04 -40.43 80.88 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.52 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.1 OUTLIER 53.16 157.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.189 0.519 . . . . 0.0 110.1 -177.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.5 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 97.4 mt-10 -62.41 -26.78 68.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.704 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.645 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 93.0 m-20 -53.53 -42.85 67.87 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.464 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -68.09 -38.0 81.85 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.4 HD21 ' CD2' ' A' ' 179' ' ' PHE . 5.1 mt -59.69 -47.6 85.0 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.645 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -68.02 -37.2 81.11 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.194 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.41 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 48.5 tp10 -67.76 -45.51 74.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.866 0.365 . . . . 0.0 110.421 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.654 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 72.2 t80 -67.17 -48.28 68.44 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.767 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.47 ' CB ' HD12 ' A' ' 205' ' ' LEU . 81.3 m-85 -88.73 -4.52 58.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.185 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -58.67 -32.02 68.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.199 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -41.5 89.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.707 0.765 . . . . 0.0 109.988 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -68.55 -34.24 75.5 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.89 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -179.12 -176.84 47.21 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.247 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.509 ' O ' HG21 ' A' ' 185' ' ' VAL . 49.0 m -63.3 -30.09 71.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.518 -0.341 . . . . 0.0 111.559 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.652 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 0.6 OUTLIER 64.85 83.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 122.355 1.074 . . . . 0.0 108.478 -177.309 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.476 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -53.13 -47.74 68.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.723 -177.097 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 186' ' ' THR . 92.2 m-20 -138.95 156.08 47.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.213 0.53 . . . . 0.0 112.391 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.77 136.78 46.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.876 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.574 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 7.8 tptt -142.79 66.05 1.33 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.584 0.231 . . . . 0.0 111.415 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.511 ' O ' ' O ' ' A' ' 202' ' ' PHE . 8.7 tt -61.82 -19.16 20.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.59 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.658 ' CE ' ' HA3' ' A' ' 203' ' ' GLY . 10.8 mtm 64.07 131.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.741 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.519 ' HG3' ' HD3' ' A' ' 194' ' ' PRO . 6.2 pttt -132.2 156.49 46.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.958 0.408 . . . . 0.0 111.805 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 10.7 t0 -125.65 74.63 69.94 Favored Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.901 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.519 ' HD3' ' HG3' ' A' ' 192' ' ' LYS . 19.9 Cg_endo -59.98 -27.67 85.43 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.616 2.211 . . . . 0.0 112.788 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -66.81 -59.12 3.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.952 0.406 . . . . 0.0 111.366 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 65.8 p -74.27 -18.43 60.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.417 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 89.7 9.19 66.66 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.134 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 25.1 mmt85 -120.95 -179.22 3.95 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.294 0.569 . . . . 0.0 111.859 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.482 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 51.0 m -119.93 152.64 37.11 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.969 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.475 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 5.9 mpt_? -51.35 -34.87 35.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.833 0.349 . . . . 0.0 110.745 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.733 ' HA2' " O2'" ' B' ' 4' ' ' ' A' . . . 87.81 2.57 81.32 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.419 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.511 ' O ' ' O ' ' A' ' 190' ' ' ILE . 14.8 p90 -139.37 153.74 47.71 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.658 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -145.06 155.97 26.72 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.062 -1.066 . . . . 0.0 112.413 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.691 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 97.4 m-85 -102.88 123.37 46.4 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 161' ' ' MET . 1.6 tt -106.37 127.81 53.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.168 -177.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 186' ' ' THR . 34.5 t -115.8 133.62 55.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.765 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.436 ' CZ ' HD23 ' A' ' 205' ' ' LEU . 95.7 m-85 -116.18 136.4 53.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.408 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.476 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.5 tt0 -61.54 -33.76 74.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.136 0.493 . . . . 0.0 109.75 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -110.09 120.4 44.63 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.802 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.91 -23.06 49.17 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.522 2.148 . . . . 0.0 113.073 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.1 m -57.12 -36.76 71.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.543 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.456 ' HA ' ' OE2' ' A' ' 215' ' ' GLU . 23.0 m -58.85 -36.45 74.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.698 0.285 . . . . 0.0 110.938 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 73.4 t -62.12 -42.88 96.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.231 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -60.11 -41.76 93.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.314 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.456 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 19.3 pt-20 -73.94 -28.51 61.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.903 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.712 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 70.3 t -59.89 -42.7 90.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.638 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.2 m -73.87 -27.38 22.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -58.54 -31.38 67.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.74 0.305 . . . . 0.0 111.488 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.59 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 67.3 m -108.29 142.41 38.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.818 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 14.1 pt20 -68.51 -40.71 80.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.463 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.712 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 61.0 m-70 81.97 118.52 0.05 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 72.8 mt -114.26 106.47 20.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.9 tt -122.62 121.39 36.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.82 0.343 . . . . 0.0 110.781 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 50.14 40.31 21.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.53 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.79 11.21 84.88 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.503 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 31.6 mmtm -113.4 139.48 48.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 117.233 0.517 . . . . 0.0 111.595 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.81 ' O ' ' O ' ' A' ' 228' ' ' ILE . 17.2 m -73.61 -30.45 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.999 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.81 ' O ' ' O ' ' A' ' 227' ' ' VAL . 17.0 pt 34.42 136.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -123.7 80.87 55.22 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.171 0.51 . . . . 0.0 111.258 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.478 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 46.9 Cg_exo -59.13 126.15 20.16 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.151 2.567 . . . . 0.0 112.202 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt -134.25 153.67 51.72 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.432 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -56.06 145.29 26.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.995 0.426 . . . . 0.0 111.767 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.85 146.76 54.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.054 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.489 ' CG2' ' C2 ' ' B' ' 6' ' ' ' A' . 3.2 tt -108.25 137.14 19.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.318 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.439 ' HG2' ' HG3' ' A' ' 238' ' ' GLU . 13.0 Cg_endo -55.93 143.19 83.16 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.826 1.684 . . . . 0.0 110.709 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -54.53 -36.61 64.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.739 0.304 . . . . 0.0 111.25 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.31 -41.49 84.61 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.439 ' HG3' ' HG2' ' A' ' 235' ' ' PRO . 97.4 mt-10 -68.14 -35.88 78.8 Favored 'General case' 0 C--O 1.23 0.07 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.484 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.448 ' NE2' HO2' ' B' ' 6' ' ' ' A' . 97.3 mt-30 -60.82 -36.76 79.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.045 0.45 . . . . 0.0 111.039 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -58.66 -38.86 79.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.533 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 242' ' ' THR . 75.2 mmtt -87.47 -76.9 0.36 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.51 ' O ' ' O ' ' A' ' 241' ' ' LYS . 76.9 p 34.66 -165.68 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -162.97 55.62 0.29 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.728 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.532 ' CE ' ' CD2' ' A' ' 288' ' ' PHE . 7.9 tptt -73.7 121.17 20.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.692 0.282 . . . . 0.0 110.399 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.68 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -130.01 164.58 32.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.176 0.512 . . . . 0.0 110.848 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -104.91 136.57 44.16 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.316 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.506 HG12 ' CE1' ' A' ' 259' ' ' PHE . 15.0 p -130.7 144.83 36.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.719 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.642 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -130.37 170.14 21.02 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.93 21.52 35.89 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 119.889 -1.148 . . . . 0.0 112.377 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 67.0 mt -106.52 128.9 60.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.467 ' HA3' ' CA ' ' A' ' 284' ' ' ARG . . . -166.09 -115.28 0.32 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.329 -0.938 . . . . 0.0 113.272 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.43 138.63 86.86 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.334 2.023 . . . . 0.0 113.506 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 54.02 44.45 29.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.34 -0.845 . . . . 0.0 113.215 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.592 ' O ' ' HB2' ' A' ' 258' ' ' GLU . 8.8 m -109.49 -54.23 5.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.443 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 254' ' ' VAL . 13.2 mmt180 60.85 135.98 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -54.82 -31.9 74.61 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.192 1.928 . . . . 0.0 113.418 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -60.12 -45.08 94.22 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.792 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.649 ' HA ' ' HB3' ' A' ' 261' ' ' GLU . 58.6 mp0 -68.52 -33.69 74.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.828 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.604 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 13.2 t80 -61.93 -52.73 62.85 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.897 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.77 -37.14 86.24 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.649 ' HB3' ' HA ' ' A' ' 258' ' ' GLU . 81.7 tt0 -61.41 -37.74 84.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 113.824 -1.534 . . . . 0.0 111.717 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.596 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 84.3 t80 -68.93 -54.72 13.9 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.549 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 7.3 m-85 -66.04 -25.22 66.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.208 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.604 ' N ' HD13 ' A' ' 269' ' ' ILE . 86.5 p -56.32 -23.06 34.59 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -52.29 -39.68 60.82 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.298 -1.319 . . . . 0.0 113.072 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.662 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 43.9 p90 -120.87 58.33 0.95 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.543 0.687 . . . . 0.0 112.268 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 122.32 153.9 8.98 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.012 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.7 m -72.49 132.18 43.51 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.604 HD13 ' N ' ' A' ' 264' ' ' SER . 74.9 mt -93.98 126.14 46.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.711 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.619 HG21 ' HB ' ' A' ' 290' ' ' THR . 10.5 tt -65.55 -36.25 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.281 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 270' ' ' ILE . 51.2 p30 171.79 73.71 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.894 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.404 ' CB ' HG22 ' A' ' 269' ' ' ILE . . . -67.76 142.53 56.21 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.408 0.147 . . . . 0.0 111.01 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -144.03 152.16 40.64 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.581 ' O ' ' HB2' ' A' ' 275' ' ' MET . 22.3 tp -65.89 -35.87 81.85 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.087 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.581 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 93.1 mmm 99.5 -13.66 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.925 0.89 . . . . 0.0 112.574 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.487 ' HA ' ' O ' ' A' ' 281' ' ' GLY . 0.0 OUTLIER -64.59 50.44 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.407 ' O ' ' CG2' ' A' ' 227' ' ' VAL . 21.8 t70 -59.0 -40.51 85.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.075 0.464 . . . . 0.0 110.592 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . 0.434 ' O ' ' HB3' ' A' ' 279' ' ' ASP . 37.1 mtpt -59.79 -26.92 66.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.326 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 278' ' ' LYS . 54.3 t0 80.44 38.62 0.09 Allowed 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.096 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.62 -61.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.061 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 276' ' ' LEU . . . -82.49 164.28 43.39 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.396 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 59.36 41.65 19.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.883 0.373 . . . . 0.0 110.12 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 29.8 t -127.45 142.14 51.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.896 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.467 ' CA ' ' HA3' ' A' ' 251' ' ' GLY . 60.6 mtm180 45.85 25.49 0.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.671 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -119.53 -62.85 0.27 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.039 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.473 ' CZ ' " C4'" ' B' ' 2' ' ' ' A' . 41.6 p90 -139.23 164.9 28.6 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.479 ' O ' HG11 ' A' ' 247' ' ' VAL . . . -130.39 156.54 21.63 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 119.927 -1.13 . . . . 0.0 113.625 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.532 ' CD2' ' CE ' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -119.3 123.08 43.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.729 -0.236 . . . . 0.0 110.465 179.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.68 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 57.4 t -123.91 137.37 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.195 0.521 . . . . 0.0 112.105 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.619 ' HB ' HG21 ' A' ' 270' ' ' ILE . 20.8 m -120.41 138.33 53.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.407 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -114.91 138.96 50.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.145 0.498 . . . . 0.0 111.776 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 293' ' ' SER . 53.0 p30 -62.42 -30.47 71.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.928 178.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.55 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 51.0 m -119.76 142.65 48.36 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 121.18 0.514 . . . . 0.0 111.3 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.6 -31.83 72.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.72 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.48 -37.12 69.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.618 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.422 ' O ' ' HD1' ' A' ' 266' ' ' TRP . . . -61.15 -38.01 84.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.416 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 79.9 t -60.99 -40.01 84.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.933 0.397 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -58.08 -36.89 73.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.937 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -56.78 -43.75 81.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.987 0.422 . . . . 0.0 111.704 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.662 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 0.3 OUTLIER -76.1 -30.07 20.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.815 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 84.9 m -55.91 -45.29 78.72 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.77 -34.76 79.1 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.08 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -102.15 79.89 1.92 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.602 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.606 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 11.9 tptt -55.74 -44.59 77.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.048 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.606 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 8.5 m-85 -117.06 126.73 53.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.514 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.519 HD13 ' CH2' ' A' ' 266' ' ' TRP . 2.4 mt -121.37 139.38 48.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.228 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -78.76 113.32 16.74 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.376 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.596 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 7.0 t80 -112.3 -77.28 0.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.928 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.402 ' HG3' HG11 ' A' ' 254' ' ' VAL . 6.4 mmpt? -97.41 -167.29 1.51 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.967 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -51.84 -29.78 20.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.839 0.352 . . . . 0.0 110.486 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -105.42 144.59 31.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.05 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.532 ' HE2' ' HB3' ' A' ' 305' ' ' PHE . 10.3 tptt -70.74 142.04 51.45 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.642 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 28.8 pt -109.64 141.2 25.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.034 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . 0.509 ' HG3' ' CE1' ' A' ' 305' ' ' PHE . 85.6 tt0 -101.59 131.82 47.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.813 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.423 ' CD1' HG23 ' A' ' 300' ' ' VAL . 71.3 mt -119.91 128.29 75.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.108 0.48 . . . . 0.0 111.766 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.411 ' HE3' ' OE2' ' A' ' 314' ' ' GLU . 38.1 mttp -127.89 156.06 43.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.83 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -60.46 148.46 37.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -53.95 137.46 39.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.19 0.519 . . . . 0.0 111.611 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -133.27 81.06 56.99 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.649 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.25 137.65 71.22 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.187 1.925 . . . . 0.0 112.002 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -59.66 -35.42 74.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.106 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 79.5 m80 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.928 -179.893 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.722 0 C3'-C2'-O2' 111.244 -0.709 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.473 " C4'" ' CZ ' ' A' ' 286' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.972 0 C3'-C2'-O2' 111.208 -0.721 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.54 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.964 0 C3'-C2'-C1' 100.855 -0.716 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.733 " O2'" ' HA2' ' A' ' 201' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.853 0 C4'-C3'-C2' 103.957 1.257 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.902 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.818 0 C4'-C3'-C2' 103.573 0.873 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.902 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.893 0 C4'-C3'-C2' 103.547 0.847 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.691 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.423 -1.068 0 C3'-C2'-O2' 111.416 -0.65 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . 0.794 " H2'" ' N3 ' ' B' ' 8' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.423 -1.032 0 O4'-C1'-C2' 107.485 0.775 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 27.7 tptp . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.655 0.264 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 158' ' ' SER . 84.5 tt0 -104.26 136.33 44.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.975 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 157' ' ' GLU . 2.2 m 48.91 174.15 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.616 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.96 77.83 1.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.694 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.455 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 79.4 tttt -87.69 134.62 33.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.88 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 5.0 tpp -120.39 147.37 45.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.648 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.626 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 5.0 t80 -100.19 129.35 46.2 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.494 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 21.8 mm -116.79 128.37 74.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.792 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.649 ' HA2' ' C6 ' ' B' ' 5' ' ' ' U' . . . -130.67 165.93 22.65 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.198 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.9 27.75 62.01 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.571 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.46 ' O ' ' C8 ' ' B' ' 4' ' ' ' A' . 80.9 mt -87.41 144.28 26.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.737 0.303 . . . . 0.0 111.714 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.473 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 9.4 t30 -66.92 133.77 50.68 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.587 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 5.0 m-90 -50.23 -34.77 24.1 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.298 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -63.73 -20.63 65.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.5 m -50.83 139.24 17.28 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.786 0.803 . . . . 0.0 111.89 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 32.6 m -120.51 148.38 43.91 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.778 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.524 ' HG3' ' HB ' ' A' ' 190' ' ' ILE . 96.2 mt-10 -56.63 -34.84 67.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.606 0.241 . . . . 0.0 110.544 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.632 ' OD1' ' N ' ' A' ' 174' ' ' ASN . 54.9 p30 -61.46 -38.04 85.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.576 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.632 ' N ' ' OD1' ' A' ' 173' ' ' ASP . 84.0 m-20 -65.56 -36.13 82.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.159 0.504 . . . . 0.0 110.526 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.42 -48.6 68.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.273 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.495 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -64.18 -37.0 85.88 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.107 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.416 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 84.4 tt0 -65.92 -44.13 86.05 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.722 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.478 ' OH ' ' HB3' ' A' ' 221' ' ' HIS . 73.2 t80 -64.88 -46.59 81.14 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.144 0.497 . . . . 0.0 111.429 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.424 ' CG ' ' CD2' ' A' ' 205' ' ' LEU . 91.5 m-85 -91.18 1.67 56.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.255 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -60.73 -28.69 68.52 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.381 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.98 -38.05 78.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.705 0.764 . . . . 0.0 110.445 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.405 ' CD2' HG21 ' A' ' 216' ' ' VAL . 47.9 m-85 -67.31 -29.62 69.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.526 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 153.76 -124.31 1.55 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.892 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 56.8 m -117.16 139.01 51.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.432 HG22 ' CD1' ' A' ' 188' ' ' LEU . 4.8 m -109.56 126.2 66.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.685 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 206' ' ' SER . 43.9 p -75.1 -31.89 61.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.58 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.451 ' O ' HD11 ' A' ' 205' ' ' LEU . 51.5 t0 -150.6 150.01 30.63 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.451 ' CD1' ' N ' ' A' ' 188' ' ' LEU . 0.0 OUTLIER -141.49 81.45 1.78 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.013 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.548 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 8.4 tptp -79.41 119.43 22.43 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.524 ' HB ' ' HG3' ' A' ' 172' ' ' GLU . 74.0 mt -127.26 112.42 28.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 174.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.633 ' SD ' " H1'" ' B' ' 7' ' ' ' U' . 0.0 OUTLIER -61.37 -34.43 75.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.2 -177.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.47 ' O ' ' O ' ' A' ' 191' ' ' MET . 52.2 tttm 49.6 162.79 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.438 ' N ' ' HG2' ' A' ' 192' ' ' LYS . 5.2 t70 -112.18 100.27 48.85 Favored Pre-proline 0 N--CA 1.463 0.206 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.347 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.8 -29.15 85.0 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.325 2.016 . . . . 0.0 113.165 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -78.96 -88.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.6 p -70.79 -27.11 63.66 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 193' ' ' ASP . . . 97.66 -8.28 63.78 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.204 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 199' ' ' SER . 33.3 mtm-85 -124.65 133.38 53.25 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.242 0.544 . . . . 0.0 111.849 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.56 ' O ' ' HB3' ' A' ' 200' ' ' ARG . 36.2 t 162.22 -177.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.071 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.751 ' HG2' ' H ' ' A' ' 202' ' ' PHE . 58.2 ttp85 68.52 -95.42 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.24 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.536 ' HA2' " O2'" ' B' ' 4' ' ' ' A' . . . 85.11 9.53 80.06 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.386 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.751 ' H ' ' HG2' ' A' ' 200' ' ' ARG . 34.5 p90 -146.14 153.53 40.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -148.65 166.59 29.22 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 119.858 -1.163 . . . . 0.0 112.209 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.802 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 89.9 m-85 -108.75 122.53 47.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.016 0.436 . . . . 0.0 110.023 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.49 ' CD2' ' CZ ' ' A' ' 207' ' ' PHE . 0.7 OUTLIER -114.75 129.55 56.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.493 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.464 ' O ' ' N ' ' A' ' 186' ' ' THR . 58.5 m -115.18 143.08 45.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.251 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.49 ' CZ ' ' CD2' ' A' ' 205' ' ' LEU . 92.5 m-85 -117.74 138.09 52.26 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.431 ' N ' ' CG2' ' A' ' 186' ' ' THR . 84.5 tt0 -63.68 -35.59 81.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.892 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.17 116.34 56.93 Favored Pre-proline 0 C--N 1.333 -0.123 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.388 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.435 ' O ' HG11 ' A' ' 213' ' ' VAL . 46.4 Cg_exo -56.13 -25.01 52.71 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.241 1.96 . . . . 0.0 112.829 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.7 m -58.84 -36.25 74.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.65 0.262 . . . . 0.0 111.47 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.417 ' OG ' ' CG ' ' A' ' 207' ' ' PHE . 89.7 p -62.53 -32.7 73.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.453 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.488 HG11 ' N ' ' A' ' 214' ' ' ASP . 3.0 p -62.66 -37.2 78.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.892 0.377 . . . . 0.0 110.754 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.488 ' N ' HG11 ' A' ' 213' ' ' VAL . 54.9 t0 -61.99 -42.98 99.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.589 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 212' ' ' SER . 4.5 pt-20 -74.06 -32.34 63.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.904 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.826 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 92.7 t -63.61 -44.63 98.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.073 0.463 . . . . 0.0 110.894 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 59.1 t -68.02 -46.14 82.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 214' ' ' ASP . 47.0 mmtm -61.11 -34.51 75.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.403 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 49.2 m -88.37 144.03 26.65 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -79.74 141.41 36.37 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.826 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 55.2 m-70 -121.15 130.77 53.88 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -176.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 226' ' ' LYS . 69.0 mt -123.63 112.31 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.264 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.7 tt -119.12 127.23 53.17 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.139 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 55.05 42.46 30.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.314 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 77.62 10.95 85.91 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.56 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 222' ' ' ILE . 6.3 mptt -126.67 153.76 44.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.976 0.388 . . . . 0.0 110.753 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 43.4 t -102.25 132.8 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.917 0.389 . . . . 0.0 110.859 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.405 HD11 HD22 ' A' ' 166' ' ' LEU . 30.8 pt -125.27 159.62 32.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.377 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -126.86 82.86 66.89 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 121.13 0.49 . . . . 0.0 110.981 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.532 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 56.0 Cg_exo -56.73 128.57 30.55 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.195 2.597 . . . . 0.0 112.15 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.68 ' HE3' ' O4 ' ' B' ' 5' ' ' ' U' . 10.2 mtmp? -133.98 157.26 46.51 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.665 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 40.1 tpt85 -58.74 135.08 57.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.987 0.423 . . . . 0.0 111.165 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.435 ' HB1' ' HB3' ' A' ' 160' ' ' LYS . . . -65.81 145.85 55.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.088 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.516 ' CD1' ' C6 ' ' B' ' 6' ' ' ' A' . 6.1 mt -117.96 120.46 32.57 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.561 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.553 ' HB2' ' OE1' ' A' ' 238' ' ' GLU . 34.5 Cg_exo -53.89 152.69 22.38 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 121.548 1.499 . . . . 0.0 110.634 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 52.3 mmm-85 -54.23 -35.63 62.65 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.32 -40.74 82.86 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.553 ' OE1' ' HB2' ' A' ' 235' ' ' PRO . 55.3 mp0 -65.85 -35.82 81.73 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.587 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -59.35 -39.81 84.38 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.598 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -64.14 -45.19 89.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.053 0.454 . . . . 0.0 110.185 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -65.09 -40.08 94.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.649 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.41 HG23 ' HA ' ' A' ' 292' ' ' ASP . 24.8 p -83.69 161.42 21.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.129 -178.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.53 166.27 25.88 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.34 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.485 ' HE3' ' CE2' ' A' ' 288' ' ' PHE . 4.6 ttpt -137.45 135.61 37.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.075 0.437 . . . . 0.0 111.233 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.433 ' CD1' ' CG2' ' A' ' 315' ' ' ILE . 7.4 pt -120.05 159.83 20.98 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 121.176 0.512 . . . . 0.0 110.933 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.55 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 90.0 t80 -99.52 129.62 45.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.675 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 44.0 t -119.83 137.32 54.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.349 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.482 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.05 167.72 18.38 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.564 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 94.48 8.58 59.64 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.197 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.459 HG21 ' CG2' ' A' ' 254' ' ' VAL . 27.8 mm -56.8 -39.89 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 120.762 0.315 . . . . 0.0 110.581 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 250' ' ' ILE . . . 27.56 -145.36 0.01 OUTLIER Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.677 -0.692 . . . . 0.0 114.419 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.9 169.25 11.89 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.338 2.692 . . . . 0.0 113.533 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 60.46 43.47 13.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.313 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.459 ' CG2' HG21 ' A' ' 250' ' ' ILE . 26.8 m -133.8 156.88 41.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.924 0.392 . . . . 0.0 110.991 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.92 155.12 74.84 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.778 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -57.01 -40.3 85.01 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 121.532 1.488 . . . . 0.0 110.851 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.52 -42.62 98.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.773 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 262' ' ' PHE . 74.6 mm-40 -65.43 -41.34 93.64 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.491 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.478 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 43.1 t80 -66.91 -48.96 67.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.722 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -64.65 -40.89 96.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.774 0.321 . . . . 0.0 111.058 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.406 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.1 pt-20 -74.69 -30.72 61.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.892 0.377 . . . . 0.0 110.548 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.669 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 91.4 t80 -57.38 -44.65 84.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.172 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.634 ' HA ' ' CZ3' ' A' ' 266' ' ' TRP . 86.7 m-85 -92.7 -2.22 56.22 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 267' ' ' GLY . 47.2 t -60.09 -30.16 69.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -56.36 -39.8 73.46 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.44 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.634 ' CZ3' ' HA ' ' A' ' 263' ' ' PHE . 17.3 m-90 -60.42 -39.23 86.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.085 0.469 . . . . 0.0 110.811 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 264' ' ' SER . . . -173.71 -172.55 39.18 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.663 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 90.7 m -58.34 -37.18 74.64 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.49 HG12 ' CE1' ' A' ' 291' ' ' TYR . 49.2 mt 61.7 86.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.566 ' CD1' ' HB3' ' A' ' 292' ' ' ASP . 31.4 mm -55.09 -44.5 74.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.405 ' OD1' ' HE2' ' A' ' 231' ' ' LYS . 24.2 t70 -159.66 92.48 1.04 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -104.86 133.98 48.75 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -144.68 154.94 43.3 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.576 ' O ' ' HB2' ' A' ' 275' ' ' MET . 31.8 tp -66.19 -37.83 86.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.23 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.576 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 93.2 mmm 84.21 138.08 0.06 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.199 -178.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.449 ' CD1' ' HA ' ' A' ' 279' ' ' ASP . 0.2 OUTLIER 173.59 89.78 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.841 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 278' ' ' LYS . 55.4 p30 -64.16 -39.86 94.92 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.688 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . 0.615 ' N ' ' OD1' ' A' ' 277' ' ' ASP . 60.1 mttm -101.11 7.98 43.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.978 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.449 ' HA ' ' CD1' ' A' ' 276' ' ' LEU . 51.2 t0 78.94 -13.69 0.94 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.857 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 46.4 p -139.43 12.13 2.55 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -94.58 -74.63 1.25 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.761 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.975 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 80.1 mm-40 -60.1 -32.47 71.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.049 0.452 . . . . 0.0 111.232 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 33.1 t -61.66 -4.7 1.52 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.911 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -49.94 -38.2 35.4 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 178.91 19.17 0.03 OUTLIER Glycine 0 CA--C 1.524 0.604 0 C-N-CA 118.717 -1.706 . . . . 0.0 115.847 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.451 ' CZ ' " H4'" ' B' ' 2' ' ' ' A' . 24.9 p90 -137.93 160.53 39.07 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.755 1.278 . . . . 0.0 111.022 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -139.36 157.27 24.97 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.319 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.485 ' CE2' ' HE3' ' A' ' 244' ' ' LYS . 0.6 OUTLIER -111.13 129.18 56.01 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.582 0.353 . . . . 0.0 110.919 179.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.478 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 42.3 t -122.76 133.14 69.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.712 0.292 . . . . 0.0 111.16 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 52.5 m -119.61 138.02 53.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.379 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.49 ' CE1' HG12 ' A' ' 269' ' ' ILE . 47.8 m-85 -120.45 143.42 48.5 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.611 ' OD1' ' N ' ' A' ' 293' ' ' SER . 52.9 p30 -63.56 -32.65 74.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.499 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.611 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 98.2 p -127.06 149.34 49.96 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 121.26 0.552 . . . . 0.0 111.806 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -68.35 -32.76 73.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.092 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -56.25 -39.6 72.83 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.658 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -63.88 -34.72 78.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.173 0.511 . . . . 0.0 110.591 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 78.1 t -63.14 -42.1 95.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.664 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -60.55 -42.01 95.72 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -64.33 -45.86 86.01 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.457 ' HB ' ' CD1' ' A' ' 266' ' ' TRP . 7.5 p -70.62 -40.65 77.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 95.1 m -67.69 -40.11 84.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.737 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -56.85 -39.91 75.15 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.872 0.368 . . . . 0.0 111.022 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.502 ' HB3' ' CD1' ' A' ' 306' ' ' ILE . 44.5 t-20 -60.2 -33.34 72.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.736 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.649 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 6.7 tptm 75.24 -62.56 0.44 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.336 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.649 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 24.4 m-85 -116.07 132.78 56.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.236 0.541 . . . . 0.0 111.994 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.639 ' O ' HG12 ' A' ' 313' ' ' ILE . 20.7 mm -121.22 140.85 44.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.002 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.412 ' OD1' ' NZ ' ' A' ' 312' ' ' LYS . 94.6 m-20 -78.82 130.0 35.22 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.669 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 1.8 t80 -118.23 -127.06 0.28 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.451 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.479 ' HD3' ' CE1' ' A' ' 308' ' ' PHE . 0.0 OUTLIER -60.21 -36.05 76.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.194 0.521 . . . . 0.0 110.563 -179.091 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -177.43 -35.78 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.218 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -86.59 144.93 26.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.423 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.495 ' HE3' ' HB3' ' A' ' 305' ' ' PHE . 3.0 tptt -74.26 136.6 42.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.639 HG12 ' O ' ' A' ' 306' ' ' ILE . 30.8 pt -112.56 143.57 22.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.298 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -102.41 138.63 39.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.433 ' CG2' ' CD1' ' A' ' 245' ' ' ILE . 15.2 mm -112.37 127.14 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -136.53 137.02 39.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.479 0.181 . . . . 0.0 110.988 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -55.51 146.82 19.21 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.37 135.49 26.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.284 0.564 . . . . 0.0 111.245 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -132.37 84.62 51.21 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.431 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.51 137.69 32.24 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 121.762 1.641 . . . . 0.0 111.696 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -58.01 -34.93 70.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.302 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 83.7 t60 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.843 -179.815 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.46 " O2'" ' N7 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.728 0 C3'-C2'-O2' 111.181 -0.731 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.975 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.952 0 C1'-C2'-O2' 108.571 -0.676 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.498 " H4'" ' HG3' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.424 -1.024 0 C3'-C2'-O2' 111.163 -0.737 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.587 ' C5 ' ' CE3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.425 -0.921 0 C4'-C3'-C2' 103.906 1.206 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.78 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.819 0 C4'-C3'-C2' 103.621 0.921 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.78 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.0 0 C4'-C3'-C2' 103.463 0.763 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.802 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.897 0 C3'-C2'-C1' 100.796 -0.782 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.937 0 O4'-C1'-C2' 107.431 0.736 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.835 0.35 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.32 -33.15 69.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.077 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.5 p -67.94 160.5 28.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.99 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.58 97.2 4.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.42 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.422 ' HG2' ' HB2' ' A' ' 233' ' ' ALA . 75.6 tttt -100.08 141.59 32.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.205 0.526 . . . . 0.0 111.829 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.503 ' N ' ' O ' ' A' ' 205' ' ' LEU . 82.4 mmm -124.02 145.86 48.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.649 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.65 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 3.6 t80 -105.5 127.52 53.06 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.503 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 18.2 mt -122.28 130.11 74.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.445 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.426 ' HA2' ' C6 ' ' B' ' 5' ' ' ' U' . . . -128.73 163.98 22.0 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.747 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.51 47.31 28.42 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 119.829 -1.177 . . . . 0.0 111.481 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.423 ' HB3' ' CB ' ' A' ' 170' ' ' THR . 45.2 mt -83.63 9.67 11.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.511 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 49.4 t30 62.81 43.61 6.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.023 0.44 . . . . 0.0 110.195 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.537 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 6.0 m0 39.15 39.45 0.41 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.267 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.446 ' C ' ' H ' ' A' ' 171' ' ' THR . 59.8 t0 -162.44 -111.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.263 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.617 ' O ' ' O ' ' A' ' 171' ' ' THR . 77.0 m 63.26 -40.97 0.2 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.617 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.5 OUTLIER 47.74 155.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.553 0.692 . . . . 0.0 111.374 -179.296 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.457 ' HG3' ' HB ' ' A' ' 190' ' ' ILE . 96.3 mt-10 -62.5 -31.98 72.83 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.659 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -64.0 -61.53 2.22 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.551 ' HB2' ' O ' ' A' ' 170' ' ' THR . 85.9 m-20 -62.57 -37.19 85.23 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.226 0.536 . . . . 0.0 110.016 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.433 ' HB2' ' CG2' ' A' ' 170' ' ' THR . 52.3 tp -61.86 -42.97 99.69 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.359 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 -61.65 -42.52 99.02 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.169 0.509 . . . . 0.0 110.173 177.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -66.82 -40.31 88.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.224 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.496 ' OH ' ' HB3' ' A' ' 221' ' ' HIS . 50.6 t80 -59.91 -45.26 93.12 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.163 0.506 . . . . 0.0 110.898 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.491 ' CB ' HD23 ' A' ' 205' ' ' LEU . 97.5 m-85 -95.46 -0.99 51.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.072 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.27 -30.85 64.98 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.008 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.441 ' HD3' ' O ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -58.34 -41.78 85.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.534 0.683 . . . . 0.0 110.644 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -67.39 -35.35 79.13 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.613 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -179.42 -177.19 47.61 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 119.719 -1.229 . . . . 0.0 113.483 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.489 ' O ' HG21 ' A' ' 185' ' ' VAL . 46.7 m -63.11 -30.69 71.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.029 -0.586 . . . . 0.0 110.995 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.619 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 0.6 OUTLIER 64.38 91.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.857 0.837 . . . . 0.0 108.954 -177.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.7 t -58.49 -44.48 89.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.581 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -135.59 149.31 49.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.49 0.662 . . . . 0.0 112.687 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.83 127.62 45.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.099 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.517 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 13.0 tptt -135.95 120.78 18.55 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.457 ' HB ' ' HG3' ' A' ' 172' ' ' GLU . 0.8 OUTLIER -130.35 132.0 65.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.83 176.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.68 ' HB2' ' HD2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -99.23 156.49 16.95 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.432 -179.156 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.486 ' HG3' ' HD3' ' A' ' 194' ' ' PRO . 13.4 pttt -132.23 161.93 32.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.641 0.258 . . . . 0.0 110.881 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.539 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 1.0 OUTLIER -125.49 75.65 69.36 Favored Pre-proline 0 C--O 1.232 0.144 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.189 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.486 ' HD3' ' HG3' ' A' ' 192' ' ' LYS . 26.8 Cg_exo -61.77 -25.46 78.63 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.504 2.136 . . . . 0.0 112.019 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.45 -71.16 0.36 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.882 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 58.5 p -66.9 -28.71 68.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.072 0.463 . . . . 0.0 110.458 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 89.53 6.8 70.08 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.209 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.539 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 3.3 tpt180 -123.6 124.08 42.01 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.291 0.546 . . . . 0.0 110.632 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.464 ' HB3' ' NH1' ' A' ' 200' ' ' ARG . 54.8 m -62.31 147.9 46.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.164 0.507 . . . . 0.0 112.047 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.68 ' HD2' ' HB2' ' A' ' 191' ' ' MET . 0.0 OUTLIER -60.62 -35.59 76.54 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.849 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 91.89 7.59 64.26 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 114.973 0.749 . . . . 0.0 114.973 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.569 ' CD1' " H4'" ' B' ' 5' ' ' ' U' . 36.6 p90 -141.12 153.91 45.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.23 0.538 . . . . 0.0 111.371 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.507 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -142.51 161.61 27.35 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.606 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.795 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 97.7 m-85 -105.75 124.56 49.77 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 161' ' ' MET . 44.2 tp -111.01 127.37 55.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.321 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 49.9 m -117.81 142.05 47.73 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.786 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.447 ' CZ ' ' CD2' ' A' ' 205' ' ' LEU . 93.5 m-85 -120.73 146.16 46.76 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.063 0.458 . . . . 0.0 111.707 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.72 -34.95 79.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.752 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 0.6 OUTLIER -118.54 135.91 23.85 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.934 -179.308 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.475 ' O ' ' CG1' ' A' ' 213' ' ' VAL . 39.6 Cg_exo -60.53 -26.36 82.66 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.846 2.364 . . . . 0.0 113.286 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 31.4 m -58.08 -38.45 76.4 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.188 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 22.9 m -61.41 -37.88 85.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.809 0.338 . . . . 0.0 111.069 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.547 HG11 ' N ' ' A' ' 214' ' ' ASP . 3.0 p -61.43 -35.87 69.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.466 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.547 ' N ' HG11 ' A' ' 213' ' ' VAL . 92.6 m-20 -60.79 -43.54 97.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.793 0.33 . . . . 0.0 111.375 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.29 -34.64 77.82 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.788 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 98.4 t -60.58 -43.47 94.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 20.9 m -83.51 -37.8 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 214' ' ' ASP . 25.7 mttm -60.51 -32.77 71.77 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.405 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 48.3 m -99.49 144.91 28.04 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -76.84 145.41 38.4 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.788 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 74.2 m-70 -121.87 128.15 51.29 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -176.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 70.9 mt -128.41 89.07 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.429 ' HA ' ' CE2' ' A' ' 178' ' ' TYR . 6.8 tt -67.36 -38.68 85.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -163.8 50.32 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.005 0.431 . . . . 0.0 111.353 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 91.28 2.44 70.82 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.661 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.464 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 10.7 mmtp -116.58 152.25 34.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 41.6 t -105.12 131.62 53.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.132 0.491 . . . . 0.0 110.932 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.448 HG13 ' HD3' ' A' ' 230' ' ' PRO . 36.8 pt -123.66 159.82 28.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.113 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -126.93 79.82 72.12 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-O 121.127 0.489 . . . . 0.0 111.125 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.607 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 52.0 Cg_exo -57.93 124.02 15.02 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.649 2.233 . . . . 0.0 111.107 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.516 ' HE2' ' H62' ' B' ' 6' ' ' ' A' . 4.0 ttpm? -134.88 149.08 50.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.639 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.428 ' CZ ' HG12 ' A' ' 213' ' ' VAL . 24.5 mmt85 -52.5 141.16 20.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.9 0.381 . . . . 0.0 110.769 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.422 ' HB2' ' HG2' ' A' ' 160' ' ' LYS . . . -64.98 148.52 51.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.982 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.51 HG13 ' N6 ' ' B' ' 6' ' ' ' A' . 65.3 mt -109.64 128.58 25.15 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.407 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.89 141.0 57.13 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 121.623 1.548 . . . . 0.0 110.802 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 57.4 mmm-85 -57.37 -39.66 76.51 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.382 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.07 -43.19 99.28 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.018 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.72 -37.25 79.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.088 0.471 . . . . 0.0 110.552 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -60.1 -40.69 90.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.92 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -60.59 -39.8 89.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.811 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -60.78 -32.7 72.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.411 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.488 ' CG2' HD13 ' A' ' 270' ' ' ILE . 11.3 p -77.91 161.98 27.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.129 0.49 . . . . 0.0 111.818 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -146.55 115.25 0.78 Allowed Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.86 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.443 ' CD ' ' OG1' ' A' ' 290' ' ' THR . 46.3 tptt -82.44 130.61 35.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.519 0.2 . . . . 0.0 110.918 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.666 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -120.97 159.79 22.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.249 0.547 . . . . 0.0 110.758 179.199 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.55 ' CG ' ' C6 ' ' B' ' 2' ' ' ' A' . 91.9 t80 -103.26 137.52 41.28 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.061 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.503 HG12 ' CE1' ' A' ' 259' ' ' PHE . 7.2 p -130.46 143.98 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.818 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.612 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -131.92 165.47 23.44 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 94.43 13.42 53.97 Favored Glycine 0 C--N 1.321 -0.264 0 C-N-CA 119.952 -1.118 . . . . 0.0 112.333 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.535 ' CD1' ' HA2' ' A' ' 287' ' ' GLY . 36.4 pt -117.9 155.69 19.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.771 0.32 . . . . 0.0 110.93 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 284' ' ' ARG . . . 178.2 -134.69 2.46 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.292 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.67 -28.03 63.91 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.973 1.782 . . . . 0.0 111.179 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.03 -31.99 70.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.374 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.514 ' CG1' ' HB ' ' A' ' 250' ' ' ILE . 7.9 p -122.55 143.23 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.668 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.8 mmm-85 -102.39 163.12 18.29 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.08 -40.39 81.74 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 121.483 1.455 . . . . 0.0 112.003 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -64.37 -46.32 83.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.847 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.405 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 84.1 tt0 -65.59 -39.79 91.97 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-O 120.913 0.387 . . . . 0.0 111.881 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.61 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 26.3 t80 -61.66 -45.91 92.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.011 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -64.53 -42.17 95.91 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.478 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.405 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.7 pt-20 -74.1 -30.78 62.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.187 0.518 . . . . 0.0 110.432 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.545 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 5.7 t80 -60.45 -56.53 20.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.817 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.588 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 4.6 m-85 -64.64 -23.46 67.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.041 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.484 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 22.7 t -55.12 -30.55 59.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.941 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -52.72 -35.33 55.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.096 -0.242 . . . . 0.0 111.398 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.658 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 7.4 p90 -117.55 45.27 1.96 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 121.16 0.505 . . . . 0.0 111.593 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.512 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 152.48 146.79 4.43 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.857 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 46.2 m -59.32 -38.21 79.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.769 0.319 . . . . 0.0 111.358 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.582 HD12 ' CB ' ' A' ' 263' ' ' PHE . 75.3 mt 68.0 82.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.487 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 71.2 mt -58.35 -40.52 78.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.4 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 290' ' ' THR . 58.0 t0 -149.83 142.48 24.54 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.992 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -158.08 136.97 11.4 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.623 0.249 . . . . 0.0 111.046 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -148.69 154.04 39.09 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.143 0.497 . . . . 0.0 112.018 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.568 ' O ' ' HB2' ' A' ' 275' ' ' MET . 31.9 tp -66.02 -37.01 84.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.859 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.568 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 92.2 mmm 86.95 126.55 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.471 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.503 ' HB3' ' OG ' ' A' ' 283' ' ' SER . 0.0 OUTLIER -154.66 138.68 16.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 111.134 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -81.7 -132.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -56.6 -35.01 67.76 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 122.115 -0.366 . . . . 0.0 110.547 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 276' ' ' LEU . 93.2 m-20 -135.58 -101.46 0.22 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.583 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 63.7 p -111.04 16.78 20.97 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -42.09 -79.85 0.05 OUTLIER Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.564 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.519 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 90.3 mm-40 -59.29 -33.16 70.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.082 0.468 . . . . 0.0 110.011 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.592 ' O ' ' HG2' ' A' ' 284' ' ' ARG . 58.8 m -64.56 171.84 3.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.529 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.592 ' HG2' ' O ' ' A' ' 283' ' ' SER . 42.2 ptt85 49.55 46.68 23.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.305 0.574 . . . . 0.0 110.398 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -167.87 -67.78 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.455 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.52 ' CD2' ' HE1' ' A' ' 246' ' ' PHE . 35.7 p90 -139.29 167.0 23.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.731 0.301 . . . . 0.0 111.212 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.535 ' HA2' ' CD1' ' A' ' 250' ' ' ILE . . . -133.88 164.29 24.43 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.702 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.443 ' CD2' ' CE ' ' A' ' 244' ' ' LYS . 0.2 OUTLIER -118.5 126.8 52.79 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.442 -0.379 . . . . 0.0 110.822 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.666 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 46.6 t -127.53 139.7 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.443 ' OG1' ' CD ' ' A' ' 244' ' ' LYS . 32.5 m -116.66 137.69 52.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.408 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.512 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 40.2 m-85 -117.95 140.49 49.66 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 293' ' ' SER . 54.0 p30 -62.1 -32.14 72.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.285 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.591 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 29.7 t -124.46 139.43 53.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.209 0.528 . . . . 0.0 111.508 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.81 -30.93 71.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.177 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -56.48 -37.66 70.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.202 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -61.31 -36.86 81.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 0.0 110.736 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 95.0 t -61.17 -43.11 95.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.029 0.442 . . . . 0.0 110.501 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -61.77 -36.5 81.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.719 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -57.18 -42.8 81.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.826 0.346 . . . . 0.0 111.917 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.658 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 1.2 p -68.94 -33.53 59.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.397 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 76.3 m -57.49 -44.28 84.79 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.998 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.77 -38.82 89.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.232 0.539 . . . . 0.0 109.93 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.6 m-20 -61.12 -33.38 73.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.999 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.603 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 52.4 tptt 67.4 -70.4 0.12 Allowed 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -177.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.603 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.0 m-30 -115.56 148.46 39.54 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.755 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.457 ' CG2' ' CZ ' ' A' ' 262' ' ' PHE . 5.7 mm -115.18 137.56 48.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -78.19 46.36 0.6 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.03 0.443 . . . . 0.0 110.36 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.545 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 7.3 t80 -56.95 -65.48 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -101.28 20.92 14.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.506 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 58.99 35.77 24.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.527 0.68 . . . . 0.0 109.293 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -139.07 0.95 1.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.614 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.422 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 98.4 mttt 64.78 123.25 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.242 0.544 . . . . 0.0 112.004 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.612 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 34.4 pt -116.46 146.46 20.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.281 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -100.71 130.78 46.79 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.785 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.453 HG12 ' CG2' ' A' ' 247' ' ' VAL . 72.3 mt -121.26 131.4 73.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.594 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 8.0 tptp -131.71 144.61 51.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.643 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -57.71 144.52 37.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.936 0.398 . . . . 0.0 110.805 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.08 147.17 40.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.375 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -110.09 151.15 42.33 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.055 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.566 ' O ' ' CB ' ' A' ' 321' ' ' ARG . 20.4 Cg_endo -60.27 -24.17 76.49 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.7 2.266 . . . . 0.0 112.402 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.566 ' CB ' ' O ' ' A' ' 320' ' ' PRO . 52.5 mmm-85 111.55 125.5 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.931 0.892 . . . . 0.0 110.514 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.904 -179.845 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.43 -0.644 0 C3'-C2'-O2' 111.241 -0.71 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.55 ' C6 ' ' CG ' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.935 0 C3'-C2'-O2' 111.306 -0.688 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.501 " C3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -1.018 0 C1'-C2'-O2' 108.61 -0.663 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.537 ' C5 ' ' CE3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.425 -0.948 0 C4'-C3'-C2' 103.906 1.206 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.999 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.89 0 C5'-C4'-O4' 108.032 -0.835 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.999 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.972 0 C3'-C2'-O2' 111.304 -0.688 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.795 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.423 -1.037 0 C3'-C2'-O2' 111.213 -0.72 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.979 0 C3'-C2'-O2' 111.16 -0.738 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.432 ' HG2' ' HG2' ' A' ' 157' ' ' GLU . 70.5 tttt . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.632 0.253 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.432 ' HG2' ' HG2' ' A' ' 156' ' ' LYS . 75.3 mm-40 60.24 -79.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.238 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 156' ' ' LYS . 10.1 t 53.74 18.51 1.55 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.574 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 14.0 m -59.45 -27.73 66.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.79 0.329 . . . . 0.0 111.029 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -56.72 143.79 35.16 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.236 0.541 . . . . 0.0 111.452 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.546 ' N ' ' O ' ' A' ' 205' ' ' LEU . 84.0 mmm -116.21 149.64 38.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.792 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.716 ' HB3' ' HG2' ' A' ' 231' ' ' LYS . 4.2 t80 -104.1 128.87 51.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.501 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 15.9 mm -113.88 127.09 71.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.655 ' HA2' ' C6 ' ' B' ' 5' ' ' ' U' . . . -131.95 166.8 23.04 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.537 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.89 33.54 45.79 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.353 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.614 ' O ' ' C8 ' ' B' ' 4' ' ' ' A' . 61.4 mt -80.74 146.55 30.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 169' ' ' ASP . 43.8 t30 -79.85 59.48 3.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.712 0.291 . . . . 0.0 111.421 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.538 ' CG ' ' C8 ' ' B' ' 4' ' ' ' A' . 12.2 m0 28.92 37.83 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.502 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 167' ' ' ASN . 54.8 t0 -163.14 20.08 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.442 ' CG2' HD12 ' A' ' 190' ' ' ILE . 59.9 m -76.26 136.55 39.66 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.861 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 30.8 m -114.46 144.47 43.28 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.23 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 54.5 mp0 -56.43 -36.55 69.11 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.404 -0.519 . . . . 0.0 109.878 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -65.65 -48.62 71.52 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.795 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -66.37 -41.7 89.06 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.584 0.706 . . . . 0.0 109.976 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 63.9 tp -64.19 -41.62 97.01 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.173 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -62.87 -45.23 93.51 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.267 0.556 . . . . 0.0 110.167 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -66.85 -38.13 85.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.871 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.594 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 52.4 t80 -57.9 -46.05 85.52 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.223 0.535 . . . . 0.0 110.87 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.509 ' CG ' HD23 ' A' ' 205' ' ' LEU . 96.1 m-85 -93.66 1.26 56.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.647 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -59.28 -28.43 64.38 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.23 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -39.14 79.24 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.759 0.79 . . . . 0.0 110.503 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -67.53 -31.81 72.16 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.045 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 161.72 -133.27 3.09 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.283 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.0 m -119.28 140.16 50.74 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 207' ' ' PHE . 2.8 m -102.36 126.68 56.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.405 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.481 ' CG2' ' HA ' ' A' ' 208' ' ' GLU . 51.8 p -69.92 -37.91 76.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.291 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 186' ' ' THR . 90.9 m-20 -143.74 155.68 44.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.195 0.521 . . . . 0.0 112.029 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.406 HD22 HG23 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -133.79 126.41 30.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.567 179.335 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 15.2 tptt -134.6 119.67 18.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.345 0.593 . . . . 0.0 112.225 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.442 HD12 ' CG2' ' A' ' 170' ' ' THR . 0.8 OUTLIER -125.49 129.61 72.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.022 176.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.659 ' CE ' ' HA3' ' A' ' 203' ' ' GLY . 3.1 mtm -96.23 134.56 39.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.191 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -128.48 155.56 44.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.852 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 6.0 m-20 -123.21 73.15 48.35 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.509 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.72 -28.75 88.05 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.718 2.279 . . . . 0.0 113.131 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -64.86 -57.86 7.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 0.0 110.95 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 55.9 p -78.74 -15.02 58.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.224 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 80.16 24.28 59.72 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.573 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.536 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 1.9 tpt180 -124.22 175.61 6.93 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 120.687 0.279 . . . . 0.0 110.509 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.423 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 32.6 t -126.4 147.4 49.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.609 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 36.6 mmt180 -54.48 -35.07 62.69 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.23 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.594 ' HA2' " O2'" ' B' ' 4' ' ' ' A' . . . 90.2 3.34 72.83 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.532 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.609 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 26.3 p90 -139.8 157.5 45.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.777 0.323 . . . . 0.0 110.653 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.659 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -147.0 160.07 28.17 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.935 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.811 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 98.1 m-85 -105.6 124.27 49.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.361 0.6 . . . . 0.0 109.971 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 161' ' ' MET . 60.2 tp -111.51 125.73 54.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.367 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 23.9 t -118.86 136.91 53.78 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.684 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 68.3 m-85 -119.84 143.8 47.7 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.668 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.481 ' HA ' ' CG2' ' A' ' 186' ' ' THR . 84.5 tt0 -63.95 -34.85 78.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.941 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.81 115.54 55.25 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.764 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.25 -21.1 34.56 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.591 2.194 . . . . 0.0 112.87 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.9 m -56.73 -36.3 69.56 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.406 ' O ' ' CG2' ' A' ' 216' ' ' VAL . 22.4 m -58.39 -35.1 71.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.935 0.398 . . . . 0.0 110.296 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 75.1 t -60.39 -42.28 90.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.95 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -58.98 -41.98 88.86 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.899 0.381 . . . . 0.0 110.837 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.405 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 20.3 pt-20 -76.89 -30.62 56.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.752 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.86 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 77.6 t -60.22 -41.32 86.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.418 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.0 m -71.53 -31.99 44.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -59.93 -38.8 83.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.723 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 35.0 m -85.13 143.16 29.0 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 63.3 tt0 -66.0 -40.96 91.6 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.935 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.86 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 85.2 m-70 78.84 97.81 0.06 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 72.2 mt -117.07 107.66 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.436 ' HG ' ' CD2' ' A' ' 178' ' ' TYR . 3.6 tt -97.66 -74.13 0.59 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -90.78 14.86 12.4 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 101.99 -6.78 54.38 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.226 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.418 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -99.69 -172.59 2.27 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.632 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 15.0 p -120.03 135.91 58.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.241 0.543 . . . . 0.0 111.159 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' A' ' 164' ' ' GLY . 36.0 pt -124.98 156.66 33.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.199 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.468 ' O ' ' O4 ' ' B' ' 5' ' ' ' U' . 25.9 t0 -127.84 78.51 75.0 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.207 0.527 . . . . 0.0 111.289 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.577 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 74.4 Cg_exo -55.39 131.21 44.89 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.844 2.363 . . . . 0.0 111.299 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.716 ' HG2' ' HB3' ' A' ' 162' ' ' PHE . 0.5 OUTLIER -136.78 170.3 16.31 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -70.82 140.09 51.11 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.125 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.58 143.8 56.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.763 0.316 . . . . 0.0 111.184 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.509 ' CD1' ' C6 ' ' B' ' 6' ' ' ' A' . 28.6 mt -111.44 121.91 38.94 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.015 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.51 144.14 52.76 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.836 1.691 . . . . 0.0 110.986 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -56.81 -39.11 73.56 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.486 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -61.3 -46.53 89.91 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.115 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -68.85 -37.22 78.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.358 0.599 . . . . 0.0 109.737 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.411 ' NE2' " O2'" ' B' ' 6' ' ' ' A' . 47.7 tt0 -58.5 -43.46 89.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.742 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -65.14 -40.26 94.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.408 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -60.11 -37.77 81.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.218 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.4 HG23 ' HA ' ' A' ' 292' ' ' ASP . 19.9 p -81.39 161.71 23.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.167 0.508 . . . . 0.0 111.987 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.56 163.72 25.18 Favored Glycine 0 C--N 1.332 0.338 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.424 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.402 ' NZ ' ' CD2' ' A' ' 288' ' ' PHE . 11.8 tttm -138.07 137.76 38.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.141 0.471 . . . . 0.0 110.719 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.656 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -123.06 164.21 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.688 0.756 . . . . 0.0 112.538 -179.245 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.559 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 86.0 t80 -105.1 138.62 41.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.565 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.461 ' CG2' HG12 ' A' ' 315' ' ' ILE . 7.4 p -127.45 133.75 67.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -105.48 -4.04 40.51 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.586 -0.816 . . . . 0.0 114.178 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . 0.45 ' HA2' ' CB ' ' A' ' 313' ' ' ILE . . . -115.82 115.72 3.46 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.72 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.545 ' O ' HG23 ' A' ' 254' ' ' VAL . 24.5 mm -94.22 -78.42 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.475 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.437 ' O ' HG22 ' A' ' 254' ' ' VAL . . . 119.21 162.29 11.96 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.075 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.69 128.25 22.85 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.143 1.896 . . . . 0.0 112.719 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 51.47 42.18 29.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.65 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.693 ' O ' ' HB3' ' A' ' 258' ' ' GLU . 6.4 t -63.91 -44.26 97.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.404 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.4 OUTLIER 61.51 134.86 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.43 -31.01 66.46 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 121.946 1.764 . . . . 0.0 112.706 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -63.99 -48.63 75.63 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.693 ' HB3' ' O ' ' A' ' 254' ' ' VAL . 42.8 tp10 -64.6 -38.15 90.0 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.044 0.45 . . . . 0.0 111.054 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.59 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 44.8 t80 -59.49 -44.19 93.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.165 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.434 ' O ' ' CD1' ' A' ' 269' ' ' ILE . 97.2 mt-10 -65.34 -40.58 93.84 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.557 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -77.72 -30.63 51.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.21 0.529 . . . . 0.0 110.466 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.528 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 5.5 t80 -61.9 -54.87 35.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.436 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.535 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 4.3 m-85 -65.17 -23.82 67.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.553 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.484 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 23.5 t -54.82 -25.47 28.66 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -46.45 -37.34 7.62 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.41 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.706 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 23.2 p90 -129.83 54.45 1.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.052 0.453 . . . . 0.0 111.472 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 264' ' ' SER . . . 149.11 146.52 4.34 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.803 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.434 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 53.1 m -59.26 -37.51 77.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.758 0.313 . . . . 0.0 111.354 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.514 HD12 ' CB ' ' A' ' 263' ' ' PHE . 74.8 mt 71.55 85.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.848 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.539 ' CD1' ' HB3' ' A' ' 292' ' ' ASP . 34.8 mm -59.36 -35.51 58.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.198 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -137.97 -104.76 0.18 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.079 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 289' ' ' VAL . . . 80.36 113.93 0.06 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.934 0.397 . . . . 0.0 112.016 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -141.99 155.83 45.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.317 0.579 . . . . 0.0 111.382 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.534 ' O ' ' HB2' ' A' ' 275' ' ' MET . 22.9 tp -63.63 -36.49 83.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.421 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.534 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 95.8 mmm 76.96 123.37 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.674 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.475 ' HG ' ' HB3' ' A' ' 283' ' ' SER . 5.1 mp -128.35 125.81 39.45 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.42 ' H ' ' H ' ' A' ' 282' ' ' GLN . 55.9 t0 -62.67 -40.75 98.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.594 0.712 . . . . 0.0 109.697 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -162.12 -73.7 0.05 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.781 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -94.56 -75.75 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.484 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 73.3 p -129.33 13.57 6.08 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.357 -0.383 . . . . 0.0 112.015 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -44.99 -91.01 0.01 OUTLIER Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.037 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.42 ' H ' ' H ' ' A' ' 277' ' ' ASP . 98.7 mt-30 -60.26 -25.65 65.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.167 -0.517 . . . . 0.0 111.599 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.482 ' HA ' ' HG ' ' A' ' 274' ' ' LEU . 63.5 p -51.89 -27.32 12.42 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.73 0.3 . . . . 0.0 110.938 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -122.5 139.07 54.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.911 0.386 . . . . 0.0 110.557 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.63 -53.52 0.58 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.25 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.56 ' CE1' " C4'" ' B' ' 2' ' ' ' A' . 33.3 p90 -142.56 166.27 25.13 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 117.425 0.612 . . . . 0.0 111.708 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.408 ' O ' ' CG1' ' A' ' 247' ' ' VAL . . . -134.42 157.36 22.89 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.259 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.531 ' HB2' ' HG2' ' A' ' 275' ' ' MET . 0.2 OUTLIER -118.16 125.24 49.82 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.868 -0.195 . . . . 0.0 111.171 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.656 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 53.3 t -128.4 137.57 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.036 0.445 . . . . 0.0 112.151 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 54.8 m -117.02 136.69 52.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.311 178.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.464 ' CD1' ' HA2' ' A' ' 267' ' ' GLY . 47.5 m-85 -118.03 142.6 47.21 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 293' ' ' SER . 54.7 p30 -62.13 -31.58 72.07 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.108 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.613 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 27.6 t -124.67 139.54 53.77 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.161 0.505 . . . . 0.0 111.963 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.91 -31.58 72.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.946 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -55.46 -36.54 66.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.966 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.64 -34.86 74.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.649 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 84.6 t -59.55 -43.73 91.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.148 0.499 . . . . 0.0 110.309 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -62.43 -36.36 82.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.693 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 89.7 mtt-85 -57.12 -43.91 82.8 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.002 0.429 . . . . 0.0 111.976 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.706 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 1.3 p -68.77 -32.28 54.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.356 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . 0.413 ' N ' HG11 ' A' ' 300' ' ' VAL . 76.2 m -57.13 -43.74 82.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.207 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -60.45 -41.27 93.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.218 0.532 . . . . 0.0 110.186 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.416 ' O ' ' N ' ' A' ' 305' ' ' PHE . 88.3 m-20 -61.81 -33.53 74.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.399 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.615 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 7.9 tptm 67.05 -73.5 0.08 Allowed 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -178.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.615 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.5 m-30 -115.82 147.63 40.79 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.43 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.487 ' CD1' ' CH2' ' A' ' 266' ' ' TRP . 37.6 mt -119.92 129.51 75.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -59.48 -35.43 74.1 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.438 0.637 . . . . 0.0 111.005 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 1.3 t80 49.88 -124.86 2.11 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.299 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 310' ' ' ASP . 2.0 mmpt? -59.57 -37.51 78.67 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.931 0.396 . . . . 0.0 110.997 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 309' ' ' LYS . 23.3 t70 170.35 -0.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.26 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -122.12 152.39 39.94 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.785 0.326 . . . . 0.0 110.2 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 79.7 mttt -77.78 129.38 35.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.078 0.466 . . . . 0.0 111.222 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 305' ' ' PHE . 26.8 pt -115.3 143.33 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.375 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . 0.561 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 85.6 mt-10 -100.91 133.25 45.67 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.471 -0.492 . . . . 0.0 109.897 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.461 HG12 ' CG2' ' A' ' 247' ' ' VAL . 82.4 mt -122.21 126.07 73.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.144 0.497 . . . . 0.0 111.898 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -133.05 -170.45 2.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.456 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.515 ' O ' ' HB3' ' A' ' 246' ' ' PHE . 74.7 mtp180 -57.34 146.8 27.74 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.728 0.299 . . . . 0.0 110.623 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . 0.888 ' O ' ' H2 ' ' B' ' 2' ' ' ' A' . . . -60.86 -23.16 64.93 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . 0.491 ' CB ' ' CD ' ' A' ' 320' ' ' PRO . 24.6 tt0 -111.61 -72.99 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 319' ' ' GLU . 9.9 Cg_endo -54.16 138.15 71.19 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 121.769 1.646 . . . . 0.0 112.377 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.478 ' HA ' ' N6 ' ' B' ' 2' ' ' ' A' . 27.0 mmt85 -59.44 -35.27 73.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.121 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 77.5 m80 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.18 -0.914 . . . . 0.0 111.078 -179.818 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.43 -0.635 0 C3'-C2'-O2' 111.258 -0.704 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.888 ' H2 ' ' O ' ' A' ' 318' ' ' ALA . . . . . . . . 0 O5'--C5' 1.425 -0.949 0 C1'-C2'-O2' 108.747 -0.618 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.613 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -1.009 0 C3'-C2'-O2' 111.305 -0.688 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.614 ' C8 ' ' O ' ' A' ' 166' ' ' LEU . . . . . . . . 0 O5'--C5' 1.426 -0.897 0 C4'-C3'-C2' 103.887 1.187 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.655 ' C6 ' ' HA2' ' A' ' 164' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.843 0 C5'-C4'-O4' 108.171 -0.735 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.616 ' N9 ' ' CE2' ' A' ' 162' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.926 0 C4'-C3'-C2' 103.389 0.689 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.811 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.972 0 C4'-C3'-C2' 103.541 0.841 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . 0.7 " H2'" ' N3 ' ' B' ' 8' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.896 0 C3'-C2'-O2' 111.175 -0.733 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 79.5 tttt . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.864 0.364 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.72 -33.5 68.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.008 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.4 m -57.47 -34.85 69.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.127 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.6 p -55.0 -21.73 12.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.273 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.542 ' HE2' ' HB3' ' A' ' 204' ' ' PHE . 15.4 tptm -56.27 140.06 46.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.453 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.484 ' N ' ' O ' ' A' ' 205' ' ' LEU . 86.1 mmm -118.15 150.0 40.11 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.075 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.613 ' CE2' ' N9 ' ' B' ' 6' ' ' ' A' . 4.3 t80 -106.79 130.17 54.54 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.523 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 17.2 mm -115.41 121.81 67.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.024 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.661 ' HA2' ' C6 ' ' B' ' 5' ' ' ' U' . . . -126.44 164.8 19.89 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.441 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.79 27.13 65.5 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.547 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.419 ' O ' ' C8 ' ' B' ' 4' ' ' ' A' . 71.0 mt -87.63 142.21 28.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.901 0.381 . . . . 0.0 111.349 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.402 ' OD1' ' N6 ' ' B' ' 4' ' ' ' A' . 9.5 t30 -67.23 134.16 51.12 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.569 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 4.7 m-90 -52.15 -36.77 52.4 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.999 -0.281 . . . . 0.0 111.404 -178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -60.23 -31.47 70.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.689 0.281 . . . . 0.0 111.359 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 79.6 m -58.3 140.18 53.82 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.335 0.588 . . . . 0.0 111.971 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.5 p -118.36 167.76 11.26 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.495 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.511 ' HG3' ' HB ' ' A' ' 190' ' ' ILE . 96.1 mt-10 -58.91 -33.26 70.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -60.43 -41.23 93.57 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -61.63 -41.71 97.87 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.538 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.519 HD21 ' CE2' ' A' ' 179' ' ' PHE . 3.9 mt -65.56 -42.94 91.25 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.703 178.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.428 ' HG3' HG13 ' A' ' 185' ' ' VAL . 70.7 ttp85 -60.9 -44.51 97.03 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.735 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -67.86 -39.16 83.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.619 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 67.0 t80 -70.89 -62.1 1.52 Allowed 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.308 0.575 . . . . 0.0 111.41 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.519 ' CE2' HD21 ' A' ' 175' ' ' LEU . 67.4 m-85 -70.52 -24.21 62.78 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.516 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 183' ' ' GLY . . . -51.29 -27.03 14.89 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.672 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.5 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -56.2 -43.96 79.02 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.405 0.682 . . . . 0.0 110.99 178.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -71.51 -34.4 70.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.727 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 180' ' ' GLY . . . -164.62 -173.8 33.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.147 -1.025 . . . . 0.0 113.258 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.581 ' O ' ' CG1' ' A' ' 185' ' ' VAL . 51.0 m -59.22 -35.05 72.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.425 0.155 . . . . 0.0 110.782 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.634 HG11 ' O ' ' A' ' 185' ' ' VAL . 1.0 OUTLIER 78.67 69.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 CA-C-O 122.631 1.205 . . . . 0.0 108.749 -178.231 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.67 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 5.7 m -52.34 -42.55 63.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.08 -1.418 . . . . 0.0 112.801 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -148.35 141.49 25.0 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.415 ' CD2' ' CG2' ' A' ' 185' ' ' VAL . 0.2 OUTLIER -121.22 131.21 54.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.562 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 8.5 tptp -136.23 121.05 18.57 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.511 ' HB ' ' HG3' ' A' ' 172' ' ' GLU . 4.3 mt -127.05 132.45 69.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.663 176.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.554 ' CE ' ' HA3' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -92.15 125.11 36.7 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.969 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 199' ' ' SER . 4.1 mtmp? -126.7 155.04 43.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.895 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 9.1 t70 -97.22 108.8 46.48 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.693 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.69 -26.18 81.35 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.549 2.166 . . . . 0.0 112.958 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.68 -86.64 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 51.8 p -71.66 -21.52 61.8 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 193' ' ' ASP . . . 93.12 4.88 64.37 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.119 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.479 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 11.0 tpt180 -74.93 143.05 43.9 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.481 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 23.6 t -103.32 148.77 25.45 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.746 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.622 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 15.0 mmm180 -53.18 -30.6 38.26 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.747 ' HA2' " O2'" ' B' ' 4' ' ' ' A' . . . 95.93 -0.87 62.82 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.86 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.69 ' CD1' " H4'" ' B' ' 5' ' ' ' U' . 25.4 p90 -136.62 156.4 48.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.875 0.369 . . . . 0.0 110.299 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.554 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -142.87 162.5 27.44 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.982 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.742 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 97.8 m-85 -105.06 125.3 50.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.363 0.602 . . . . 0.0 109.521 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.489 HD23 ' CG ' ' A' ' 179' ' ' PHE . 46.8 tp -106.7 130.3 54.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.041 -177.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 28.0 t -124.3 135.13 53.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.883 0.373 . . . . 0.0 111.979 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.476 ' CZ ' HD23 ' A' ' 205' ' ' LEU . 95.4 m-85 -119.48 140.05 51.09 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.782 178.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.67 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.3 tt0 -60.58 -34.47 74.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.026 0.441 . . . . 0.0 110.087 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.5 119.48 49.3 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.499 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.59 -20.55 27.66 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.516 2.144 . . . . 0.0 112.801 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 85.1 p -59.97 -31.07 69.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.667 0.27 . . . . 0.0 111.234 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.41 ' O ' ' CG2' ' A' ' 216' ' ' VAL . 23.0 m -59.44 -36.06 75.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.603 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 70.5 t -61.61 -43.52 97.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.305 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -59.81 -42.03 92.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.01 0.433 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.02 -31.9 61.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.77 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.79 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 66.0 t -60.76 -42.27 91.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 120.662 0.267 . . . . 0.0 110.983 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.411 HG21 ' N ' ' A' ' 218' ' ' LYS . 24.3 m -73.15 -27.55 24.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.411 ' N ' HG21 ' A' ' 217' ' ' VAL . 23.3 tptp -58.72 -35.5 72.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.659 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.694 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 57.4 m -100.13 141.52 32.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.852 0.358 . . . . 0.0 111.863 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.418 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 59.7 tp60 -66.09 -40.64 90.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.737 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.79 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 64.8 m-70 79.31 116.49 0.06 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 24.6 mm -116.4 107.4 22.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.2 tt -121.32 122.96 41.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.789 0.328 . . . . 0.0 110.177 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 51.73 40.17 26.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.148 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 73.64 20.32 79.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.342 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -115.21 136.23 53.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.329 0.565 . . . . 0.0 111.506 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.756 ' O ' ' O ' ' A' ' 228' ' ' ILE . 9.5 p -62.04 -35.89 71.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.096 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.756 ' O ' ' O ' ' A' ' 227' ' ' VAL . 9.0 pt 30.9 128.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.513 0.725 . . . . 0.0 112.68 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -123.29 84.56 51.94 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 121.056 0.455 . . . . 0.0 111.315 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.503 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 50.7 Cg_exo -56.05 135.34 69.31 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.912 2.408 . . . . 0.0 111.986 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -136.88 157.3 47.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.909 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -55.93 133.45 51.53 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.747 0.308 . . . . 0.0 110.852 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.45 ' HB1' ' HB3' ' A' ' 160' ' ' LYS . . . -72.91 148.05 44.71 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.514 ' CD1' ' C6 ' ' B' ' 6' ' ' ' A' . 0.7 OUTLIER -122.13 125.58 26.56 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.674 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.424 ' HG2' ' CG ' ' A' ' 238' ' ' GLU . 9.4 Cg_endo -51.84 145.62 31.2 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 121.791 1.66 . . . . 0.0 111.14 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.416 ' O ' ' HD2' ' A' ' 236' ' ' ARG . 6.2 tmm_? -54.66 -39.25 67.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.78 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 55.3 p30 -61.42 -38.51 87.39 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.702 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.586 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 97.9 mt-10 -68.17 -34.13 75.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.995 0.426 . . . . 0.0 110.381 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -59.61 -38.28 80.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.281 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.93 -40.47 93.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.627 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -61.69 -34.94 76.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.162 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 22.4 p -83.41 162.23 21.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.572 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -146.47 112.71 0.63 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.847 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 17.5 ttpp -88.72 134.27 33.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.893 0.378 . . . . 0.0 111.194 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.667 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -117.46 164.02 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.537 0.684 . . . . 0.0 111.43 -179.247 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.581 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 93.5 t80 -101.85 136.34 41.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.518 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.511 HG12 ' CE1' ' A' ' 259' ' ' PHE . 12.5 p -131.57 146.37 33.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.314 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.644 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -131.66 169.43 21.94 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 89.92 17.82 52.77 Favored Glycine 0 N--CA 1.454 -0.147 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.727 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.489 HG21 ' CB ' ' A' ' 254' ' ' VAL . 23.3 mm -54.96 -43.84 70.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.841 0.353 . . . . 0.0 110.792 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 50.51 174.12 0.01 OUTLIER Glycine 0 CA--C 1.521 0.451 0 CA-C-N 116.074 -0.512 . . . . 0.0 114.086 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.09 154.68 65.83 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.62 2.88 . . . . 0.0 113.616 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 57.62 41.67 25.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.919 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.644 ' O ' ' HB2' ' A' ' 258' ' ' GLU . 2.4 p -85.79 -40.69 14.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.542 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.6 OUTLIER 60.05 118.97 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.92 -33.78 63.48 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 121.743 1.629 . . . . 0.0 112.426 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -61.51 -41.74 97.77 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.998 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.644 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 98.3 mt-10 -66.16 -36.15 82.36 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.627 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.625 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 16.5 t80 -63.86 -50.11 70.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.782 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.67 -37.03 86.18 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.587 ' HB3' ' HA ' ' A' ' 258' ' ' GLU . 78.5 tt0 -63.03 -37.9 89.04 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.646 -1.616 . . . . 0.0 111.883 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.556 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 86.4 t80 -67.78 -55.08 14.41 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.582 ' HB3' ' OH ' ' A' ' 291' ' ' TYR . 10.0 m-85 -66.45 -25.29 66.66 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.471 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 35.1 t -55.29 -31.31 61.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.689 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -56.15 -36.48 68.33 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.291 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.637 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 9.0 p90 -117.57 51.79 1.02 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.44 0.638 . . . . 0.0 111.16 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.509 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 148.3 148.03 4.66 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.508 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.427 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 11.8 t -64.06 -35.8 81.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 110.928 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.565 HD12 ' CB ' ' A' ' 263' ' ' PHE . 79.3 mt 71.66 83.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.223 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.5 ' CD1' ' HB2' ' A' ' 292' ' ' ASP . 36.0 mm -58.98 -38.58 74.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.984 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -149.46 150.91 33.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.185 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -170.59 122.31 0.62 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.577 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -142.85 152.3 42.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.22 0.533 . . . . 0.0 111.861 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.526 ' O ' ' HB2' ' A' ' 275' ' ' MET . 29.2 tp -64.23 -37.82 88.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.901 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.526 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 91.8 mmm 101.59 102.87 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.441 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 23.9 mt -108.05 139.02 43.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.521 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.58 ' HB3' ' HA2' ' A' ' 281' ' ' GLY . 59.9 t0 -145.39 93.31 2.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.092 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt 65.38 39.18 5.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.873 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' A' ' 280' ' ' THR . 57.4 t0 46.31 41.75 9.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.782 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 279' ' ' ASP . 2.0 t 171.2 50.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.911 0.386 . . . . 0.0 110.709 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 277' ' ' ASP . . . -131.49 -112.11 1.42 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.448 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 1.038 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 78.8 mm-40 -57.9 -28.36 64.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.415 -0.392 . . . . 0.0 110.431 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 275' ' ' MET . 86.3 p -57.69 -22.64 47.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.215 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -52.73 -36.63 57.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.92 0.39 . . . . 0.0 110.749 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 286' ' ' PHE . . . -166.61 -176.62 37.86 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.091 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.558 ' O ' ' O ' ' A' ' 285' ' ' GLY . 3.1 p90 48.54 155.13 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.175 0.512 . . . . 0.0 112.075 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.462 ' O ' HG11 ' A' ' 247' ' ' VAL . . . -139.25 164.41 25.9 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.153 -1.022 . . . . 0.0 113.783 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.452 ' CE2' ' NZ ' ' A' ' 244' ' ' LYS . 0.4 OUTLIER -119.73 125.6 49.04 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.669 0.388 . . . . 0.0 110.949 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.667 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 48.9 t -127.45 137.07 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.003 0.43 . . . . 0.0 111.748 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 44.4 m -113.55 135.8 53.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.605 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.582 ' OH ' ' HB3' ' A' ' 263' ' ' PHE . 34.5 m-85 -117.15 137.21 52.47 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.5 ' HB2' ' CD1' ' A' ' 270' ' ' ILE . 50.5 t0 -58.84 -35.65 73.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.558 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 30.5 t -119.99 140.18 51.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.28 0.562 . . . . 0.0 111.887 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . 0.412 ' O ' ' CG1' ' A' ' 297' ' ' VAL . . . -63.66 -30.64 71.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.526 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -55.74 -35.12 65.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.029 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.26 90.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.539 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.542 HG11 ' N ' ' A' ' 298' ' ' ASP . 9.5 p -61.16 -37.14 76.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.001 0.429 . . . . 0.0 110.735 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . 0.542 ' N ' HG11 ' A' ' 297' ' ' VAL . 88.5 m-20 -63.94 -38.18 90.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.527 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -59.16 -43.37 92.08 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.906 0.384 . . . . 0.0 111.943 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.637 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 0.9 OUTLIER -72.58 -36.68 54.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.638 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 74.5 m -59.23 -42.93 92.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.833 0.349 . . . . 0.0 110.447 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -61.78 -34.17 75.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.215 0.531 . . . . 0.0 110.013 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.65 ' O ' ' N ' ' A' ' 305' ' ' PHE . 80.6 m-20 -87.04 4.9 40.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.213 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.628 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 19.9 tptm 41.85 -80.85 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.605 0.24 . . . . 0.0 110.4 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.65 ' N ' ' O ' ' A' ' 303' ' ' ASN . 2.2 m-30 -107.58 141.26 39.33 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.507 HD13 ' CZ3' ' A' ' 266' ' ' TRP . 1.0 OUTLIER -116.58 134.47 59.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.531 ' O ' ' HE1' ' A' ' 262' ' ' PHE . 89.0 m-20 -70.67 124.59 24.63 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.556 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 2.0 t80 -112.0 -109.89 0.35 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.479 ' HE2' ' OE1' ' A' ' 258' ' ' GLU . 1.2 mmmp? -60.15 -37.42 80.07 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.743 0.306 . . . . 0.0 111.386 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.406 ' CG ' ' O ' ' A' ' 309' ' ' LYS . 32.5 m-20 -177.96 -27.39 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.219 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -113.13 160.81 17.82 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.951 0.405 . . . . 0.0 110.841 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.576 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 43.9 mttt -71.67 143.63 49.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.351 0.596 . . . . 0.0 112.114 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.644 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 31.6 pt -118.93 147.87 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . 0.529 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 87.4 mt-10 -101.05 129.73 46.95 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.515 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.503 ' CD1' HG23 ' A' ' 300' ' ' VAL . 74.7 mt -123.31 127.61 74.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.207 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.469 ' HG2' ' HD2' ' A' ' 246' ' ' PHE . 3.4 ptpt -135.2 163.62 29.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.601 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 45.8 ptt85 -59.03 148.84 29.37 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.45 133.19 55.56 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.79 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -137.62 82.93 26.17 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.964 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.43 129.15 32.3 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 121.571 1.514 . . . . 0.0 111.474 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.435 ' HG3' HO2' ' B' ' 2' ' ' ' A' . 25.6 mmt85 -60.88 -34.9 75.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.209 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.873 -179.891 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.433 ' N3 ' ' HA2' ' A' ' 248' ' ' GLY . . . . . . . . 0 O5'--C5' 1.428 -0.726 0 C3'-C2'-O2' 111.357 -0.67 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 1.038 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.951 0 C3'-C2'-O2' 111.199 -0.724 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.551 HO2' ' P ' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.956 0 C3'-C2'-C1' 100.735 -0.85 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.747 " O2'" ' HA2' ' A' ' 201' ' ' GLY . . . . . . . . 0 O5'--C5' 1.425 -0.96 0 C4'-C3'-C2' 104.091 1.391 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.927 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.796 0 C4'-C3'-C2' 103.742 1.042 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.927 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.038 0 C3'-C2'-O2' 111.239 -0.711 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.742 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -1.011 0 C1'-C2'-O2' 108.514 -0.695 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . 0.439 ' N3 ' " C2'" ' B' ' 8' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -1.016 0 C3'-C2'-O2' 111.272 -0.699 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 60.7 mttp . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.831 0.348 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -58.02 142.97 44.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.882 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.1 m -120.86 147.72 45.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.125 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.8 p -83.99 6.28 22.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.385 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.437 ' HE2' ' HB3' ' A' ' 204' ' ' PHE . 5.3 tptm -69.56 131.6 44.94 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.601 ' O ' ' HA ' ' A' ' 204' ' ' PHE . 93.3 mmm -120.67 143.57 48.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.877 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.607 ' CD2' ' C4 ' ' B' ' 6' ' ' ' A' . 2.7 t80 -108.29 125.74 52.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 0.3 OUTLIER -120.88 127.86 75.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.615 -179.446 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.467 ' HA2' ' C6 ' ' B' ' 5' ' ' ' U' . . . -121.49 153.34 16.7 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.318 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.44 29.08 64.49 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.151 -1.023 . . . . 0.0 110.994 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.626 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 69.1 mt -59.06 -33.3 70.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.728 ' O ' ' N ' ' A' ' 169' ' ' ASP . 21.1 t30 107.63 37.19 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.977 0.511 . . . . 0.0 110.669 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.612 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 5.1 m0 45.99 -59.7 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.728 ' N ' ' O ' ' A' ' 167' ' ' ASN . 89.4 m-20 -83.4 19.73 1.48 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.605 ' OG1' ' HB3' ' A' ' 166' ' ' LEU . 57.6 m -51.88 -36.08 47.35 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.502 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.0 OUTLIER 58.26 139.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.157 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.628 ' O ' ' HD3' ' A' ' 176' ' ' ARG . 58.1 mp0 -60.39 -36.25 77.65 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -58.8 -40.9 85.42 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.598 ' HB2' ' O ' ' A' ' 170' ' ' THR . 82.8 m-20 -61.69 -36.63 81.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 179' ' ' PHE . 7.0 mt -55.74 -51.31 67.79 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.628 ' HD3' ' O ' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -67.93 -30.36 69.66 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.298 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -58.42 -39.35 79.52 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.37 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.64 ' OH ' ' CG ' ' A' ' 221' ' ' HIS . 0.0 OUTLIER -96.04 -55.52 2.95 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.25 179.199 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.627 ' CE2' ' CE2' ' A' ' 178' ' ' TYR . 72.5 m-85 -60.14 -27.15 66.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.397 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.42 -23.58 9.35 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.199 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.801 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -54.05 -40.46 67.13 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.992 0.425 . . . . 0.0 110.714 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.801 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 53.8 m-85 -69.85 -32.21 70.48 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.275 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 164.81 -130.19 2.13 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.262 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 49.1 m -120.96 140.28 52.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.414 ' CG2' ' HG ' ' A' ' 188' ' ' LEU . 0.2 OUTLIER -92.88 120.65 42.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.257 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.5 t -71.61 -45.53 61.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.348 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -149.9 109.51 4.02 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.477 ' CD2' ' HD2' ' A' ' 176' ' ' ARG . 0.1 OUTLIER -102.65 150.16 23.71 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.341 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 204' ' ' PHE . 18.9 tptt -133.69 124.53 26.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.94 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.503 ' HB ' ' HG3' ' A' ' 172' ' ' GLU . 1.0 OUTLIER -123.0 134.31 66.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.571 ' HB2' ' HB2' ' A' ' 200' ' ' ARG . 10.0 mmt -86.93 135.16 33.4 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -131.79 138.75 48.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.736 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 7.4 t0 -121.72 75.7 36.56 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.594 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -60.47 -25.81 81.38 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.521 2.147 . . . . 0.0 111.998 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -71.83 -67.9 0.5 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.255 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 49.2 p -68.95 -26.98 65.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.112 0.482 . . . . 0.0 110.079 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.93 4.09 67.48 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.585 -0.734 . . . . 0.0 113.09 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.465 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 6.0 tpt180 -127.13 121.85 32.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.239 0.52 . . . . 0.0 110.329 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 191' ' ' MET . 66.5 p -71.91 160.56 32.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.919 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.571 ' HB2' ' HB2' ' A' ' 191' ' ' MET . 23.9 mmm180 -58.3 -34.34 70.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.861 0.362 . . . . 0.0 110.093 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.481 ' HA2' " O2'" ' B' ' 4' ' ' ' A' . . . 94.39 -0.98 66.33 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.526 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.615 ' CD2' " H4'" ' B' ' 5' ' ' ' U' . 38.7 p90 -137.96 159.04 43.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.934 0.397 . . . . 0.0 110.426 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 189' ' ' LYS . . . -153.21 171.33 32.16 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.028 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.749 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 73.0 m-85 -110.2 125.3 52.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.833 0.349 . . . . 0.0 110.756 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.536 ' O ' ' HB2' ' A' ' 161' ' ' MET . 23.5 tp -110.1 132.18 54.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.401 ' O ' HG21 ' A' ' 185' ' ' VAL . 45.7 m -121.48 145.69 47.68 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.182 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.48 ' CE2' ' CG2' ' A' ' 216' ' ' VAL . 96.9 m-85 -121.4 147.59 45.52 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.862 0.363 . . . . 0.0 111.826 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.44 -35.7 80.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.328 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.45 119.19 53.63 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.603 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.15 -29.73 76.36 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.32 2.013 . . . . 0.0 112.636 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.3 t -59.54 -37.46 78.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 0.0 110.858 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 24.0 m -59.25 -34.87 72.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.047 0.451 . . . . 0.0 110.5 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 70.8 t -61.1 -42.74 94.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.211 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -59.55 -43.4 93.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.921 0.391 . . . . 0.0 111.046 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.411 ' HB3' ' CE2' ' A' ' 182' ' ' TYR . 98.4 mt-10 -69.38 -35.38 75.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.368 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.549 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 99.0 t -60.91 -46.42 96.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.899 0.38 . . . . 0.0 110.829 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 14.8 p -75.44 -40.01 41.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -59.11 -36.96 76.08 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 29.9 m -96.37 144.61 26.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.156 0.503 . . . . 0.0 112.077 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -92.09 125.24 36.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.851 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.64 ' CG ' ' OH ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -130.58 155.89 45.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.177 0.513 . . . . 0.0 111.39 -178.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.431 ' CG2' ' O ' ' A' ' 226' ' ' LYS . 73.5 mt -122.12 125.76 73.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.297 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.516 ' HG ' ' CE2' ' A' ' 178' ' ' TYR . 3.8 mt -103.26 125.36 49.88 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.927 0.394 . . . . 0.0 111.607 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 52.58 41.16 31.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.29 2.18 87.06 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.897 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.431 ' O ' ' CG2' ' A' ' 222' ' ' ILE . 21.8 mmtt -107.18 137.96 44.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.3 0.55 . . . . 0.0 111.131 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 10.1 p -80.49 125.08 39.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.138 0.494 . . . . 0.0 111.094 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.401 ' CD1' HD13 ' A' ' 223' ' ' LEU . 34.4 pt -126.38 156.34 36.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.95 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -131.05 83.38 60.91 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.384 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.503 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 72.8 Cg_exo -52.76 130.73 38.53 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.606 2.204 . . . . 0.0 112.061 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.523 ' CE ' ' H61' ' B' ' 6' ' ' ' A' . 6.3 ttpt -136.72 144.29 43.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.0 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.432 ' HD2' ' N ' ' A' ' 233' ' ' ALA . 3.8 tmm_? -54.61 140.53 34.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.993 0.425 . . . . 0.0 111.188 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.432 ' N ' ' HD2' ' A' ' 232' ' ' ARG . . . -59.74 149.17 31.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.184 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.542 HG23 ' C6 ' ' B' ' 6' ' ' ' A' . 3.5 tt -112.62 134.98 21.53 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.019 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.14 144.27 99.45 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.587 1.525 . . . . 0.0 109.547 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.3 mmt180 -55.84 -36.57 67.66 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.745 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -60.97 -43.03 99.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.388 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -68.43 -37.52 80.36 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.115 0.483 . . . . 0.0 110.719 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -59.11 -43.58 91.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.908 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -65.46 -39.1 91.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.718 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -59.49 -39.24 83.11 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 21.1 p -90.64 161.23 15.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.178 0.513 . . . . 0.0 112.005 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.36 166.56 25.76 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.626 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 289' ' ' VAL . 39.7 ttpt -136.85 132.31 34.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.864 0.332 . . . . 0.0 111.338 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.656 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -115.74 163.76 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-O 121.282 0.563 . . . . 0.0 111.028 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.555 ' CD1' ' C5 ' ' B' ' 2' ' ' ' A' . 89.0 t80 -100.23 137.38 38.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.67 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.509 HG21 HG12 ' A' ' 315' ' ' ILE . 7.9 p -129.78 145.39 35.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.963 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.587 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.07 166.85 18.66 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 178.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.49 15.7 56.5 Favored Glycine 0 N--CA 1.454 -0.131 0 C-N-CA 120.015 -1.088 . . . . 0.0 112.533 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.538 ' CD1' ' CE1' ' A' ' 259' ' ' PHE . 69.8 mt -110.66 131.99 60.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.516 0.198 . . . . 0.0 110.595 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.416 ' O ' ' CG1' ' A' ' 254' ' ' VAL . . . -167.98 -116.29 0.36 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.239 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.82 142.13 98.63 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.623 2.216 . . . . 0.0 113.294 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.416 ' O ' ' NZ ' ' A' ' 309' ' ' LYS . 85.5 m-20 54.98 43.58 29.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.351 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 255' ' ' ARG . 7.1 p -108.31 -50.87 7.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.239 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.475 ' O ' ' O ' ' A' ' 254' ' ' VAL . 7.7 mpt_? 59.07 132.01 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.224 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.5 -27.97 52.49 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.154 1.903 . . . . 0.0 112.911 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -60.72 -48.09 83.37 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.584 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 61.0 mp0 -69.3 -36.98 77.58 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.538 ' CE1' ' CD1' ' A' ' 250' ' ' ILE . 18.6 t80 -61.8 -49.52 75.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.649 0.262 . . . . 0.0 110.679 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 264' ' ' SER . 84.4 tt0 -64.15 -37.73 88.5 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.438 ' HB3' ' HA ' ' A' ' 258' ' ' GLU . 43.0 tp10 -62.62 -39.28 93.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.669 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.66 ' HD2' ' CD1' ' A' ' 263' ' ' PHE . 89.8 t80 -64.87 -58.52 5.95 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.668 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 33.4 m-85 -69.7 -23.24 63.4 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.499 ' N ' HD13 ' A' ' 269' ' ' ILE . 30.4 t -56.57 -32.33 65.1 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -54.71 -34.23 62.1 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.668 ' CZ2' ' CD2' ' A' ' 263' ' ' PHE . 8.5 p90 -119.86 56.53 0.95 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.255 0.55 . . . . 0.0 112.073 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.572 ' HA2' ' CD1' ' A' ' 291' ' ' TYR . . . 160.65 -31.74 0.37 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.786 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.42 ' CB ' ' O ' ' A' ' 267' ' ' GLY . 0.5 OUTLIER 85.34 2.82 0.65 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.777 0.431 . . . . 0.0 111.544 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.511 ' CD1' ' HB2' ' A' ' 263' ' ' PHE . 76.4 mt 30.13 108.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.623 ' CD1' ' HB3' ' A' ' 292' ' ' ASP . 32.0 mm -68.49 -36.01 72.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.486 175.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -137.45 -88.42 0.27 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.42 ' CB ' HG22 ' A' ' 269' ' ' ILE . . . 61.17 123.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.948 0.404 . . . . 0.0 111.548 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -141.37 154.92 45.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.031 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.62 ' O ' ' HB2' ' A' ' 275' ' ' MET . 20.0 tp -62.74 -37.58 87.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.259 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.747 ' HB2' ' HB3' ' A' ' 282' ' ' GLN . 93.8 mmm 93.83 176.71 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.848 0.717 . . . . 0.0 109.857 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -179.43 78.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.621 0.248 . . . . 0.0 111.053 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -84.37 109.66 18.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.935 0.398 . . . . 0.0 110.241 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 59.6 mttp 57.12 35.43 26.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.685 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 53.82 44.26 29.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.74 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 1.7 t 174.98 35.16 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.726 0.298 . . . . 0.0 111.585 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -99.46 -73.33 1.07 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.696 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.747 ' HB3' ' HB2' ' A' ' 275' ' ' MET . 5.0 pp0? -59.69 -30.96 69.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.43 ' N ' ' CD ' ' A' ' 282' ' ' GLN . 85.0 p -56.85 -22.96 40.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.555 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -56.52 -33.34 65.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.249 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 250' ' ' ILE . . . 144.98 28.08 0.1 OUTLIER Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.116 -1.04 . . . . 0.0 114.733 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.535 ' CE1' " C4'" ' B' ' 2' ' ' ' A' . 17.6 p90 -141.82 165.75 26.61 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.416 1.108 . . . . 0.0 112.19 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -143.98 165.65 27.27 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.774 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.423 ' CE2' ' HE3' ' A' ' 244' ' ' LYS . 0.4 OUTLIER -116.48 127.11 54.27 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.221 0.208 . . . . 0.0 111.252 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.656 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 21.5 t -122.32 135.68 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.88 0.371 . . . . 0.0 111.924 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 52.6 m -113.84 136.02 53.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.402 178.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.572 ' CD1' ' HA2' ' A' ' 267' ' ' GLY . 31.3 m-85 -120.1 143.15 48.31 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.65 ' OD1' ' N ' ' A' ' 293' ' ' SER . 52.9 p30 -62.34 -33.97 75.74 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.329 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.65 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 50.8 m -127.04 145.18 50.81 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.147 0.499 . . . . 0.0 111.746 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.05 -30.69 71.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.933 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -56.61 -37.04 70.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.421 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.44 -35.46 75.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.384 . . . . 0.0 110.803 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 96.7 t -61.36 -44.05 97.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.155 0.502 . . . . 0.0 110.527 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.75 -36.8 84.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.129 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -57.55 -43.51 84.51 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.64 ' CG2' ' CZ2' ' A' ' 266' ' ' TRP . 0.7 OUTLIER -72.2 -32.25 42.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.919 0.39 . . . . 0.0 110.973 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 81.6 m -56.29 -44.74 80.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.269 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -62.42 -40.2 95.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.271 0.558 . . . . 0.0 110.054 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -63.4 -34.47 77.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.419 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.641 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 15.9 tptm 66.11 -72.7 0.08 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.803 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.641 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 16.3 m-85 -111.17 127.79 55.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.334 0.588 . . . . 0.0 111.682 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.41 HG23 ' CZ ' ' A' ' 262' ' ' PHE . 1.4 mt -118.22 138.99 47.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.584 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.425 ' OD1' ' CE ' ' A' ' 312' ' ' LYS . 73.4 m-20 -76.47 110.98 11.46 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.323 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.658 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 6.0 t80 -108.11 -70.16 0.82 Allowed 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.601 0.715 . . . . 0.0 110.063 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.469 ' HD3' ' CE2' ' A' ' 308' ' ' PHE . 0.0 OUTLIER -106.91 -158.5 0.66 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.169 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -54.88 -32.88 61.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.818 0.342 . . . . 0.0 110.789 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -113.85 153.16 29.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.012 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.425 ' CE ' ' OD1' ' A' ' 307' ' ' ASP . 18.8 mmtp -67.18 152.46 45.71 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.043 0.449 . . . . 0.0 111.008 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.587 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 27.7 pt -114.1 132.22 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -95.2 131.45 41.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.509 HG12 HG21 ' A' ' 247' ' ' VAL . 74.4 mt -118.76 125.26 74.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.429 0.633 . . . . 0.0 112.488 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -132.8 155.65 48.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.908 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -55.3 144.96 23.18 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . 0.574 ' O ' ' CB ' ' A' ' 319' ' ' GLU . . . -94.67 131.62 40.27 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . 0.586 ' HB3' ' HD3' ' A' ' 320' ' ' PRO . 4.4 tm-20 106.74 -53.9 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.39 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.984 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 319' ' ' GLU . 32.5 Cg_exo -57.24 -27.44 74.95 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 121.688 1.592 . . . . 0.0 111.71 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.57 45.03 27.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.698 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . 0.451 ' CD2' ' O ' ' A' ' 320' ' ' PRO . 93.4 m-70 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.779 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.717 0 C3'-C2'-O2' 111.215 -0.719 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.555 ' C5 ' ' CD1' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.939 0 C3'-C2'-O2' 111.362 -0.668 . 0.077 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.539 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.997 0 C3'-C2'-O2' 111.34 -0.676 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.612 ' C2 ' ' CZ3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.423 -1.042 0 C3'-C2'-O2' 110.793 -0.864 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.964 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.843 0 C4'-C3'-C2' 103.672 0.972 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.964 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.917 0 C4'-C3'-C2' 103.579 0.879 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.749 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.931 0 C3'-C2'-O2' 111.312 -0.685 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.894 0 C3'-C2'-O2' 111.24 -0.71 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.695 0.284 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 60.5 mp0 -61.91 -34.04 75.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.214 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.4 p -127.65 154.11 45.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.09 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.2 p 166.64 43.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.683 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.446 ' HG2' ' CB ' ' A' ' 233' ' ' ALA . 74.5 tttt -129.99 142.13 50.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.062 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.45 ' N ' ' O ' ' A' ' 205' ' ' LEU . 87.4 mmm -118.84 148.69 42.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.451 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.594 ' CE2' ' N9 ' ' B' ' 6' ' ' ' A' . 4.2 t80 -107.03 129.05 54.86 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 7.7 mm -116.64 125.05 73.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.783 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 228' ' ' ILE . . . -125.63 158.79 20.04 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 178.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.43 33.37 53.11 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.194 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 83.0 mt -59.38 -18.63 40.42 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.785 ' O ' ' N ' ' A' ' 169' ' ' ASP . 58.2 t30 73.5 41.97 0.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -177.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.611 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 9.5 m0 41.32 -55.65 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.858 -1.064 . . . . 0.0 113.823 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.785 ' N ' ' O ' ' A' ' 167' ' ' ASN . 52.9 p30 -58.02 -31.2 66.74 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.521 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 86.2 m -65.56 138.11 57.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.248 0.547 . . . . 0.0 111.293 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 9.3 p -117.64 166.93 11.82 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.345 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.488 ' N ' ' CD1' ' A' ' 190' ' ' ILE . 20.8 pt-20 -60.73 -25.78 66.69 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.65 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 90.6 m-20 -61.37 -43.69 98.44 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.133 0.492 . . . . 0.0 110.095 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -67.36 -37.65 83.53 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.861 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.464 HD21 ' CD2' ' A' ' 179' ' ' PHE . 3.3 mt -58.43 -43.73 88.86 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.65 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -67.02 -36.72 82.75 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.295 179.202 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.417 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 48.6 tp10 -64.56 -40.91 96.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.065 0.46 . . . . 0.0 110.411 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.626 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 59.4 t80 -74.93 -61.68 1.8 Allowed 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.604 0.716 . . . . 0.0 111.111 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.464 ' CD2' HD21 ' A' ' 175' ' ' LEU . 80.1 m-85 -70.68 -15.7 62.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.514 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.71 -27.76 20.67 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.243 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.804 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -57.5 -41.93 81.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.107 0.479 . . . . 0.0 110.431 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.804 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 68.6 m-85 -70.39 -35.56 73.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.841 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -177.09 -176.65 45.39 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.464 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.518 ' O ' HG21 ' A' ' 185' ' ' VAL . 44.2 m -64.53 -30.75 71.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.123 -0.538 . . . . 0.0 111.476 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.631 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 0.6 OUTLIER 65.54 90.14 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 121.854 0.835 . . . . 0.0 108.91 -177.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.0 t -59.23 -44.02 92.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.915 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -139.72 136.26 34.01 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.58 133.04 56.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.316 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 9.1 tptp -134.01 120.95 20.91 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.488 ' CD1' ' N ' ' A' ' 172' ' ' GLU . 0.4 OUTLIER -128.24 134.08 65.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.361 176.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.533 ' CE ' ' HA3' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -90.47 140.03 30.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.746 -179.078 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -133.31 168.48 18.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.919 0.39 . . . . 0.0 111.377 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 7.4 m-20 -117.7 93.92 44.77 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.383 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.53 -24.64 29.46 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.335 2.024 . . . . 0.0 112.693 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -75.55 -83.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.673 0.273 . . . . 0.0 111.449 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 63.2 p -71.77 -24.13 61.7 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.443 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 92.47 7.15 63.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.772 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 4.2 tpt180 -82.22 154.25 25.52 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.946 0.403 . . . . 0.0 110.781 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 28.3 t -105.69 146.84 29.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.718 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.628 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 34.2 mmt180 -54.33 -30.89 52.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.894 0.378 . . . . 0.0 110.296 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.565 ' HA2' " O2'" ' B' ' 4' ' ' ' A' . . . 97.25 -2.02 60.96 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.237 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.628 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 39.7 p90 -139.4 155.57 47.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.058 0.456 . . . . 0.0 110.387 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.533 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -148.31 169.28 28.97 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.664 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.785 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 95.9 m-85 -107.84 125.76 51.83 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.083 0.468 . . . . 0.0 109.945 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.552 HD23 ' CZ ' ' A' ' 207' ' ' PHE . 6.0 tt -108.42 128.56 54.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.577 -178.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.449 ' N ' HD22 ' A' ' 205' ' ' LEU . 49.9 m -120.34 142.53 49.05 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.331 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.552 ' CZ ' HD23 ' A' ' 205' ' ' LEU . 84.8 m-85 -119.14 141.21 49.02 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.712 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.06 -35.51 80.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.166 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -108.17 117.37 55.04 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.756 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.409 ' O ' ' CG1' ' A' ' 213' ' ' VAL . 45.5 Cg_exo -56.74 -26.38 65.6 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.563 2.175 . . . . 0.0 113.276 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 85.7 p -61.78 -32.35 72.61 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.325 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 24.7 m -60.31 -35.5 75.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.809 0.338 . . . . 0.0 110.706 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.444 HG11 ' N ' ' A' ' 214' ' ' ASP . 2.6 p -58.85 -35.34 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.981 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.444 ' N ' HG11 ' A' ' 213' ' ' VAL . 20.4 t70 -59.06 -44.63 91.86 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.008 0.432 . . . . 0.0 110.73 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -68.25 -33.07 73.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.58 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.945 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 99.0 t -58.97 -40.68 81.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.261 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.402 HG21 ' N ' ' A' ' 218' ' ' LYS . 24.2 m -77.73 -29.85 16.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.16 -0.616 . . . . 0.0 112.062 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.402 ' N ' HG21 ' A' ' 217' ' ' VAL . 27.8 tptp -60.15 -38.78 84.17 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.779 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 60.4 m -91.48 146.59 23.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.761 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -67.13 -42.0 85.19 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.529 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.945 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 57.8 m-70 74.95 96.04 0.07 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 72.3 mt -113.53 115.81 50.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.6 tt -123.77 126.07 45.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.008 0.433 . . . . 0.0 111.148 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 54.63 42.45 31.25 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 91.0 -30.95 5.88 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.612 -0.804 . . . . 0.0 114.33 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -103.13 155.82 18.14 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 11.9 p -102.81 124.48 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 164' ' ' GLY . 17.8 pt -84.94 -26.9 6.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -177.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 23.7 t70 52.37 70.58 1.81 Allowed Pre-proline 0 C--N 1.318 -0.802 0 CA-C-O 121.532 0.682 . . . . 0.0 110.802 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.657 ' HD2' ' CD2' ' A' ' 221' ' ' HIS . 43.6 Cg_exo -58.83 136.39 73.32 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.942 3.095 . . . . 0.0 112.122 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.408 ' N ' ' HE2' ' A' ' 161' ' ' MET . 14.1 ttpt -138.35 150.11 46.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.351 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -48.35 147.17 2.45 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 110.789 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.446 ' CB ' ' HG2' ' A' ' 160' ' ' LYS . . . -98.0 145.0 26.94 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.209 0.528 . . . . 0.0 112.199 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.456 HD13 ' C6 ' ' B' ' 6' ' ' ' A' . 0.7 OUTLIER -110.9 126.22 29.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.13 179.3 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.565 ' HB2' ' OE1' ' A' ' 238' ' ' GLU . 36.8 Cg_exo -54.49 152.54 26.29 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.492 1.462 . . . . 0.0 110.549 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -52.32 -37.83 56.96 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -57.88 -43.57 86.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.565 ' OE1' ' HB2' ' A' ' 235' ' ' PRO . 58.9 mp0 -67.9 -36.99 81.17 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.705 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -59.98 -38.15 81.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.988 0.423 . . . . 0.0 110.732 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -61.2 -37.21 82.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.543 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -88.44 4.26 47.07 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.429 HG23 ' HA ' ' A' ' 292' ' ' ASP . 16.7 p -121.33 160.86 23.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.052 0.453 . . . . 0.0 112.021 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.27 167.52 25.18 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.606 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.578 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 78.2 tttt -136.57 137.21 39.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.209 0.505 . . . . 0.0 110.905 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.409 HD11 ' CG2' ' A' ' 315' ' ' ILE . 7.1 pt -120.31 157.54 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.39 0.614 . . . . 0.0 112.126 -178.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.521 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 81.0 t80 -94.78 130.34 41.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.96 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.693 HG12 HG12 ' A' ' 315' ' ' ILE . 57.2 t -124.6 133.17 70.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.643 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.697 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -119.98 166.96 13.51 Favored Glycine 0 C--O 1.225 -0.445 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 313' ' ' ILE . . . 94.54 13.36 53.98 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.132 -1.033 . . . . 0.0 112.103 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.489 ' CD1' ' CE1' ' A' ' 259' ' ' PHE . 67.4 mt -108.84 130.61 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 120.812 0.339 . . . . 0.0 110.491 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.478 ' O ' ' CG2' ' A' ' 254' ' ' VAL . . . -165.27 -119.11 0.46 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.544 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.38 144.08 96.77 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 122.313 2.009 . . . . 0.0 113.137 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 57.34 45.68 19.67 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.572 ' O ' ' HB2' ' A' ' 258' ' ' GLU . 16.1 m -118.33 -50.89 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.388 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 62.83 130.25 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.195 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.68 -28.62 47.6 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 121.98 1.787 . . . . 0.0 112.194 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 12.7 tptp -60.6 -44.14 96.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.142 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.572 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 79.3 mm-40 -66.91 -39.77 87.48 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.84 0.352 . . . . 0.0 111.085 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.599 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 30.5 t80 -63.25 -48.01 80.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.537 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.427 ' O ' ' CD1' ' A' ' 269' ' ' ILE . 84.3 tt0 -64.46 -42.74 95.76 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.36 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -76.7 -28.85 56.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.83 0.348 . . . . 0.0 110.81 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.513 ' CD2' ' CD1' ' A' ' 263' ' ' PHE . 12.8 t80 -60.66 -55.59 31.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.169 0.509 . . . . 0.0 111.39 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.64 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 10.4 m-85 -69.64 -22.45 63.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.994 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.493 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 27.8 t -57.22 -30.94 65.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.892 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -54.04 -36.11 62.71 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.678 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 7.3 p90 -117.76 41.36 2.88 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.763 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.494 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 159.92 147.93 5.07 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.985 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.412 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 52.5 m -59.52 -36.85 76.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 0.0 111.285 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.541 HD12 ' CB ' ' A' ' 263' ' ' PHE . 69.8 mt 68.81 78.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.395 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.545 ' O ' ' OD1' ' A' ' 271' ' ' ASP . 32.1 mm -58.91 -45.59 91.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.449 -0.5 . . . . 0.0 112.094 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.545 ' OD1' ' O ' ' A' ' 270' ' ' ILE . 83.4 m-20 -151.26 90.7 1.61 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -106.03 132.62 51.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.528 0.204 . . . . 0.0 110.506 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -145.61 151.61 38.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.285 0.564 . . . . 0.0 111.885 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.588 ' O ' ' HB2' ' A' ' 275' ' ' MET . 26.3 tp -66.05 -36.57 83.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.713 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.588 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 96.0 mmm 84.13 114.28 0.05 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.513 -178.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.435 ' HG ' ' HB3' ' A' ' 283' ' ' SER . 5.1 mp -122.39 138.58 54.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.744 0.306 . . . . 0.0 111.418 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.454 ' HB2' ' HA2' ' A' ' 281' ' ' GLY . 85.0 m-20 -129.4 100.39 5.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.084 0.469 . . . . 0.0 110.679 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 63.48 35.99 11.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.17 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 51.45 43.82 29.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.75 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 169.86 47.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.041 0.448 . . . . 0.0 110.753 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . 0.454 ' HA2' ' HB2' ' A' ' 277' ' ' ASP . . . -139.53 -105.38 0.64 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.135 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.441 ' OE1' ' HB3' ' A' ' 275' ' ' MET . 96.5 mt-30 -56.85 -27.04 59.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.209 -0.496 . . . . 0.0 111.525 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 275' ' ' MET . 83.3 p -53.18 -24.63 11.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.95 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -118.58 136.89 53.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.652 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 105.96 -57.95 0.46 Allowed Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.573 -0.823 . . . . 0.0 114.242 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.461 ' CZ ' " O4'" ' B' ' 2' ' ' ' A' . 32.5 p90 -140.72 166.77 23.84 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.757 0.779 . . . . 0.0 112.652 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -135.93 154.83 22.04 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.461 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.578 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -110.22 129.89 55.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.747 0.308 . . . . 0.0 111.711 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.599 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 55.1 t -124.48 134.84 65.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.978 0.418 . . . . 0.0 111.901 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 63.0 m -115.48 135.75 53.79 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.494 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 38.9 m-85 -117.04 139.51 50.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.491 ' CA ' HG12 ' A' ' 270' ' ' ILE . 51.1 t0 -58.22 -36.53 73.28 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.421 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 49.1 m -123.66 144.2 49.78 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.318 0.58 . . . . 0.0 112.053 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.92 -30.61 71.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.693 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -56.26 -37.53 69.91 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.005 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -61.21 -36.65 80.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.011 0.434 . . . . 0.0 110.403 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.428 ' O ' HG11 ' A' ' 300' ' ' VAL . 75.1 t -61.74 -42.82 95.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.234 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -61.5 -37.68 84.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.53 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -59.06 -44.09 91.8 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.678 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 0.8 OUTLIER -71.9 -33.04 46.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.175 -179.654 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 89.0 m -57.88 -45.6 86.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.142 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -61.09 -41.46 96.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.254 0.549 . . . . 0.0 110.018 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -61.91 -33.05 73.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.211 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.624 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 31.8 tptt 68.16 -74.21 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -178.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.624 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.0 m-30 -113.31 141.55 46.88 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.424 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.514 ' CD1' ' CH2' ' A' ' 266' ' ' TRP . 34.6 mt -116.98 136.65 53.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -75.09 79.82 2.25 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.367 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 9.1 t80 -83.17 -105.7 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.978 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 310' ' ' ASP . 4.2 mmpt? -60.71 -34.96 75.17 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 309' ' ' LYS . 52.2 p30 137.78 0.17 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.997 0.919 . . . . 0.0 111.142 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 312' ' ' LYS . 73.3 mtt85 -98.18 4.44 48.96 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.432 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 95.1 mttt 65.04 54.07 1.29 Allowed 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.109 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.697 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 20.3 pt -50.14 99.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.777 0.799 . . . . 0.0 110.784 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . 0.566 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 92.4 mt-10 -60.91 139.53 57.97 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.19 -178.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.693 HG12 HG12 ' A' ' 247' ' ' VAL . 63.2 mt -121.65 128.14 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.009 0.433 . . . . 0.0 111.065 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -133.85 142.78 47.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.112 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 21.7 ttp-105 -50.8 146.74 5.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.699 0.285 . . . . 0.0 110.624 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.23 143.51 27.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.402 . . . . 0.0 111.131 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -99.43 123.88 46.66 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.358 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -55.77 -21.35 32.15 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.54 2.16 . . . . 0.0 112.129 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.478 ' NH1' ' C4 ' ' B' ' 3' ' ' ' U' . 0.0 OUTLIER 76.92 0.72 3.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.092 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 68.6 m80 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.767 179.744 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.735 0 C3'-C2'-O2' 111.235 -0.712 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.521 ' C5 ' ' CE1' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.957 0 C3'-C2'-O2' 111.273 -0.699 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.478 ' C4 ' ' NH1' ' A' ' 321' ' ' ARG . . . . . . . . 0 O5'--C5' 1.423 -1.052 0 C3'-C2'-O2' 111.488 -0.625 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.724 ' N7 ' ' HA ' ' A' ' 167' ' ' ASN . . . . . . . . 0 O5'--C5' 1.426 -0.905 0 C4'-C3'-C2' 103.706 1.006 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.594 " H4'" ' CD1' ' A' ' 202' ' ' PHE . . . . . . . . 0 O5'--C5' 1.428 -0.756 0 C4'-C3'-C2' 103.67 0.97 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.594 ' N9 ' ' CE2' ' A' ' 162' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -1.008 0 C4'-C3'-C2' 103.567 0.867 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.785 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -1.027 0 C3'-C2'-O2' 111.128 -0.749 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . 0.479 H5'' " O2'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.96 0 C3'-C2'-O2' 111.143 -0.744 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 26.1 pttm . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.65 0.262 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -108.97 148.59 30.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.776 0.322 . . . . 0.0 110.909 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 86.5 p -62.71 -29.1 70.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.26 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.5 p 34.69 35.01 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.881 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.463 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 21.8 tttt -96.2 137.5 35.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.499 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.615 ' HE1' ' HB ' ' A' ' 216' ' ' VAL . 8.5 tpp -114.36 145.4 41.87 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.637 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 6.8 t80 -102.85 131.85 49.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.925 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.595 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 17.5 mm -116.63 132.37 66.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.354 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.583 ' HA2' ' C6 ' ' B' ' 5' ' ' ' U' . . . -123.59 156.64 17.9 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.294 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.31 34.95 44.2 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.407 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.499 ' CD1' ' HA ' ' A' ' 202' ' ' PHE . 4.4 mp -92.62 141.75 28.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.638 0.256 . . . . 0.0 110.732 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.555 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 0.6 OUTLIER -60.16 135.44 57.72 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.198 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.626 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 4.3 m0 -53.91 -33.66 57.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.794 0.331 . . . . 0.0 110.754 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -93.22 9.72 34.91 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.422 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 171' ' ' THR . 98.5 m -56.98 -40.54 76.72 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.1 OUTLIER 54.32 162.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -177.322 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.5 ' O ' ' HD3' ' A' ' 176' ' ' ARG . 57.2 mp0 -62.73 -28.56 70.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.113 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.544 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 92.6 m-20 -55.47 -43.44 75.53 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -67.46 -36.95 82.17 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.504 HD21 ' CD2' ' A' ' 179' ' ' PHE . 6.1 mt -56.38 -48.39 76.97 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.544 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -68.42 -30.36 69.24 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.333 179.15 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -56.89 -39.4 74.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.577 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.661 ' OH ' ' CD2' ' A' ' 221' ' ' HIS . 0.0 OUTLIER -96.37 -59.47 1.82 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.967 0.413 . . . . 0.0 110.092 178.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.625 ' CE2' ' CE2' ' A' ' 178' ' ' TYR . 70.9 m-85 -59.87 -31.95 70.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.544 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.13 -25.37 7.75 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.11 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.798 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -56.41 -41.19 75.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.775 0.321 . . . . 0.0 111.487 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.798 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 69.8 m-85 -70.56 -35.74 73.25 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -174.66 -177.54 43.87 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.475 -1.345 . . . . 0.0 114.195 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 61.1 m -62.73 -34.38 77.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.699 -0.75 . . . . 0.0 111.867 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 185' ' ' VAL . 0.5 OUTLIER 67.15 106.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 206' ' ' SER . 43.3 p -64.78 -36.79 85.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.983 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -154.01 150.65 28.49 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.4 HD13 ' CD1' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -118.47 133.66 55.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.348 179.188 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 10.5 tptt -133.48 119.09 19.13 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.484 HD13 ' HA ' ' A' ' 172' ' ' GLU . 0.8 OUTLIER -128.58 137.66 56.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.034 177.506 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.555 ' CG ' " H1'" ' B' ' 7' ' ' ' U' . 0.3 OUTLIER -96.19 127.53 42.28 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.857 -179.525 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -131.95 155.52 47.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.983 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.601 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 15.2 t0 -120.55 80.82 31.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.442 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.09 -24.85 42.49 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.52 2.147 . . . . 0.0 112.642 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.79 -70.52 0.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.867 0.365 . . . . 0.0 111.111 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 49.4 p -73.08 -20.56 60.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.812 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 84.87 19.72 59.06 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.53 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.601 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 8.3 tpt180 -115.6 151.92 34.05 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 120.756 0.312 . . . . 0.0 110.466 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.546 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 49.1 m -117.34 153.4 33.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.904 0.383 . . . . 0.0 110.809 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.641 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 30.5 mmt180 -54.34 -34.5 61.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 110.961 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.51 ' HA2' " O2'" ' B' ' 4' ' ' ' A' . . . 90.71 5.61 68.59 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.231 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.641 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 22.5 p90 -140.36 158.92 43.29 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.881 0.372 . . . . 0.0 110.641 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.454 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -143.02 162.9 27.47 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.402 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.637 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 95.8 m-85 -109.68 129.59 55.59 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.867 0.365 . . . . 0.0 110.199 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.492 HD13 ' CE2' ' A' ' 179' ' ' PHE . 61.1 mt -104.54 141.21 36.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.778 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 186' ' ' THR . 18.0 t -127.94 128.37 44.98 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.447 ' HA ' ' HA ' ' A' ' 185' ' ' VAL . 98.1 m-85 -120.41 143.08 48.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.14 0.495 . . . . 0.0 112.073 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.402 ' N ' ' CG2' ' A' ' 186' ' ' THR . 47.3 tp10 -62.14 -34.37 76.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.063 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -110.83 116.23 52.29 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.4 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.7 -30.59 76.31 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.454 2.103 . . . . 0.0 113.064 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.418 ' O ' ' OD1' ' A' ' 214' ' ' ASP . 25.6 m -59.39 -35.51 74.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.626 0.25 . . . . 0.0 110.926 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 24.8 m -57.01 -34.61 68.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.131 0.491 . . . . 0.0 109.898 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.402 ' CG1' ' CD ' ' A' ' 232' ' ' ARG . 83.5 t -63.49 -38.4 82.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.678 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.695 ' OD1' ' N ' ' A' ' 215' ' ' GLU . 36.4 p30 -60.35 -39.4 87.0 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.746 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.695 ' N ' ' OD1' ' A' ' 214' ' ' ASP . 97.8 mt-10 -70.95 -35.52 72.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.527 0.68 . . . . 0.0 110.714 177.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.723 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 93.9 t -60.44 -36.88 72.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.528 -178.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.432 ' HB ' ' HE3' ' A' ' 161' ' ' MET . 6.5 p -87.21 -54.22 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -60.44 -36.74 78.93 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 215' ' ' GLU . 62.0 m -58.26 -37.75 75.58 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 63.86 110.56 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -177.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.723 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 0.0 OUTLIER -137.98 175.13 9.86 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -176.037 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 227' ' ' VAL . 17.8 mm -115.36 120.25 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.75 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 18.8 tp -69.64 -43.81 71.89 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.644 -0.423 . . . . 0.0 112.017 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -177.36 69.68 0.02 OUTLIER 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.741 0.305 . . . . 0.0 111.774 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 95.21 -8.09 69.54 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.467 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -124.08 157.76 33.81 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 117.036 0.418 . . . . 0.0 111.584 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.5 ' HA ' HD11 ' A' ' 222' ' ' ILE . 44.3 t -93.88 126.95 46.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.165 0.507 . . . . 0.0 110.26 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 164' ' ' GLY . 31.6 pt -126.87 155.98 37.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.048 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 8.7 p30 -132.15 81.57 61.15 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 121.191 0.519 . . . . 0.0 110.421 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.429 ' HD3' HG13 ' A' ' 228' ' ' ILE . 92.8 Cg_exo -47.51 127.02 13.05 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.72 2.28 . . . . 0.0 111.345 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.444 ' CE ' ' H61' ' B' ' 6' ' ' ' A' . 5.6 ttpt -132.45 144.96 50.83 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.684 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.402 ' CD ' ' CG1' ' A' ' 213' ' ' VAL . 57.3 mmm-85 -50.06 143.1 8.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.202 0.525 . . . . 0.0 111.269 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.62 150.08 48.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.787 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.502 ' CD1' ' C6 ' ' B' ' 6' ' ' ' A' . 34.4 mt -117.44 140.4 27.32 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.935 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.46 ' HD2' ' OE1' ' A' ' 238' ' ' GLU . 45.0 Cg_exo -55.26 139.84 81.27 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 121.758 1.639 . . . . 0.0 111.229 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 236' ' ' ARG . 3.2 tmt_? -56.83 -41.12 77.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.728 0.299 . . . . 0.0 111.123 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -60.01 -39.35 85.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.368 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.46 ' OE1' ' HD2' ' A' ' 235' ' ' PRO . 94.8 mt-10 -63.66 -32.62 74.16 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.701 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.41 ' NE2' ' HB ' ' A' ' 234' ' ' ILE . 98.9 mm-40 -58.24 -38.52 77.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.998 0.428 . . . . 0.0 110.213 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -61.06 -42.33 98.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.223 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -63.15 -36.0 82.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.461 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 21.0 p -83.26 161.44 21.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.155 0.502 . . . . 0.0 111.897 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.94 169.99 25.07 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.609 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.539 ' CE ' ' CD2' ' A' ' 288' ' ' PHE . 46.9 tptt -134.71 130.36 36.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.861 0.331 . . . . 0.0 110.706 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.433 HD11 ' CG2' ' A' ' 315' ' ' ILE . 5.5 pt -123.5 154.84 29.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 121.11 0.481 . . . . 0.0 110.65 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.556 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 92.9 t80 -97.28 133.37 42.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.651 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.654 ' CG2' ' CZ ' ' A' ' 263' ' ' PHE . 21.4 t -121.42 139.36 48.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.032 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.598 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -129.02 171.93 19.77 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.18 36.9 16.56 Favored Glycine 0 C--N 1.323 -0.181 0 C-N-CA 120.071 -1.061 . . . . 0.0 111.901 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.48 ' CD1' ' HA2' ' A' ' 287' ' ' GLY . 69.8 mt -111.66 132.32 60.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.598 0.237 . . . . 0.0 110.81 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.511 ' O ' ' CG2' ' A' ' 254' ' ' VAL . . . -158.16 -119.59 0.57 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.246 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.63 140.58 95.45 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.38 2.053 . . . . 0.0 113.482 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 54.15 44.06 29.74 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.402 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 251' ' ' GLY . 22.4 m -121.04 27.77 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.533 ' HG3' ' HD2' ' A' ' 256' ' ' PRO . 0.2 OUTLIER -39.96 155.12 0.18 Allowed Pre-proline 0 N--CA 1.465 0.304 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.533 ' HD2' ' HG3' ' A' ' 255' ' ' ARG . 7.5 Cg_endo -50.19 -29.47 22.77 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.051 1.834 . . . . 0.0 112.128 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -62.05 -45.72 92.31 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.036 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -68.29 -42.11 79.97 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.101 0.477 . . . . 0.0 111.066 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.468 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 35.3 t80 -66.13 -47.2 74.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.294 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.43 ' O ' HD11 ' A' ' 269' ' ' ILE . 84.4 tt0 -64.9 -41.37 95.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.333 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -75.01 -31.98 61.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.613 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.637 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 83.4 t80 -59.51 -55.61 32.42 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.732 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 25.3 m-85 -66.85 -30.65 70.88 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.648 ' N ' HD13 ' A' ' 269' ' ' ILE . 16.5 m -56.01 -27.43 52.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.758 0.313 . . . . 0.0 111.194 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -51.89 -38.04 54.66 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.732 ' CZ2' ' CD2' ' A' ' 263' ' ' PHE . 19.9 p90 -110.84 48.08 0.94 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.586 0.708 . . . . 0.0 111.954 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 133.28 149.08 6.04 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.313 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 53.4 m -69.76 131.85 45.18 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.648 HD13 ' N ' ' A' ' 264' ' ' SER . 49.6 mt -94.44 135.92 27.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.005 0.431 . . . . 0.0 111.395 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.515 HG12 ' N ' ' A' ' 292' ' ' ASP . 27.3 mm -92.38 -75.09 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.49 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 272' ' ' ALA . 90.4 m-20 -93.0 -75.51 0.49 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.469 ' O ' ' O ' ' A' ' 271' ' ' ASP . . . 42.79 108.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -140.64 157.73 45.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.222 0.534 . . . . 0.0 111.68 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.57 ' O ' ' HB2' ' A' ' 275' ' ' MET . 25.9 tp -62.17 -37.39 85.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.537 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.57 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 84.9 mtp 86.27 128.26 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.95 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.571 ' HA ' ' O ' ' A' ' 281' ' ' GLY . 31.9 mt -130.14 120.9 25.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.853 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 278' ' ' LYS . 55.1 t0 -61.0 -41.75 97.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.213 0.53 . . . . 0.0 110.192 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 277' ' ' ASP . 98.8 mttt -165.28 59.09 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.975 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 58.17 44.62 18.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.739 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 1.5 t -178.66 -34.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.401 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 276' ' ' LEU . . . -83.39 178.48 52.71 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.436 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.491 ' NE2' " O3'" ' B' ' 2' ' ' ' A' . 98.1 mt-30 42.9 21.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 94.0 p -80.54 -30.82 37.1 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -134.36 154.04 51.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.362 0.601 . . . . 0.0 112.463 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.13 -40.94 2.27 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.041 -0.981 . . . . 0.0 114.422 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.491 ' CZ ' " O4'" ' B' ' 2' ' ' ' A' . 12.4 p90 -149.0 165.55 31.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.792 0.796 . . . . 0.0 111.556 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.48 ' HA2' ' CD1' ' A' ' 250' ' ' ILE . . . -138.99 153.79 22.94 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.975 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.539 ' CD2' ' CE ' ' A' ' 244' ' ' LYS . 0.3 OUTLIER -109.59 127.38 54.47 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.594 0.358 . . . . 0.0 110.364 179.255 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.502 HG22 ' CD2' ' A' ' 263' ' ' PHE . 38.5 t -125.32 135.45 63.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.453 ' OG1' ' CD ' ' A' ' 244' ' ' LYS . 47.5 m -120.27 136.52 54.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.313 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.407 ' OH ' ' O ' ' A' ' 263' ' ' PHE . 40.5 m-85 -116.21 138.4 51.32 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.515 ' N ' HG12 ' A' ' 270' ' ' ILE . 51.4 t0 -57.3 -36.35 70.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.507 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 50.6 m -122.37 145.04 48.64 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.247 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.83 -27.84 68.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.649 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -55.56 -38.42 69.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.626 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.44 -37.38 85.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.977 0.417 . . . . 0.0 110.901 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 73.1 t -62.71 -43.66 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.258 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -61.58 -38.66 88.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.29 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -59.51 -43.32 93.41 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.691 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 1.2 p -70.92 -33.04 50.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.466 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . 0.411 ' N ' HG11 ' A' ' 300' ' ' VAL . 81.6 m -57.5 -45.63 84.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.278 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -61.76 -42.2 98.68 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.207 0.527 . . . . 0.0 110.364 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.9 m-20 -63.04 -35.25 79.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.607 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.642 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 16.2 tptm 67.58 -67.79 0.17 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.642 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 16.1 m-85 -114.97 133.35 56.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.166 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.515 HD13 ' CH2' ' A' ' 266' ' ' TRP . 14.8 mt -121.45 140.17 46.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.92 178.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.54 ' O ' ' OD1' ' A' ' 307' ' ' ASP . 50.7 p30 -77.1 110.21 11.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.224 0.535 . . . . 0.0 110.884 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.637 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 7.9 t80 -110.21 -79.65 0.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.543 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.449 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 6.7 mmpt? -97.89 -162.4 0.95 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.505 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -52.76 -28.97 24.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.759 0.314 . . . . 0.0 110.456 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -109.99 152.66 25.61 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.522 ' HG2' ' HB3' ' A' ' 305' ' ' PHE . 14.2 tttp -75.29 139.99 42.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.527 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.598 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 27.4 pt -105.49 136.63 38.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.236 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . 0.437 ' HB2' ' CE2' ' A' ' 305' ' ' PHE . 84.5 tt0 -101.25 131.32 47.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.651 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.502 HD11 HG23 ' A' ' 300' ' ' VAL . 66.0 mt -119.48 127.51 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-O 121.052 0.454 . . . . 0.0 111.2 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -131.34 144.7 51.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.482 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -49.62 146.19 4.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.017 0.437 . . . . 0.0 111.065 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.32 147.36 36.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.632 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.01 152.68 46.81 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.938 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.29 -26.19 80.97 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.512 2.141 . . . . 0.0 112.341 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 32.9 mmm180 35.23 53.22 0.71 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.857 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.962 179.941 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.724 0 C3'-C2'-O2' 111.318 -0.684 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.556 ' C5 ' ' CE1' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.974 0 C3'-C2'-O2' 111.454 -0.637 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.567 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.968 0 C3'-C2'-O2' 111.333 -0.678 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.626 ' C2 ' ' CZ3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.425 -0.94 0 C4'-C3'-C2' 103.876 1.176 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.899 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.788 0 C4'-C3'-C2' 103.709 1.009 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.899 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.895 0 C3'-C2'-O2' 111.265 -0.702 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.63 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.912 0 O4'-C1'-N19 109.482 1.282 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . 0.571 ' P ' " O2'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.427 -0.788 0 O4'-C1'-C2' 107.474 0.767 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 52.6 tttp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.864 0.364 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 57.09 22.09 7.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.166 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.6 m -120.14 147.58 44.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.698 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.4 m 47.62 25.3 0.64 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.23 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 205' ' ' LEU . 37.6 ttpt -89.49 136.59 32.94 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.099 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.556 ' HB3' ' O ' ' A' ' 231' ' ' LYS . 29.0 mtm -124.86 164.14 20.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.147 0.499 . . . . 0.0 111.239 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.602 ' CD2' ' C4 ' ' B' ' 6' ' ' ' A' . 1.8 t80 -98.49 130.01 45.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.302 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 202' ' ' PHE . 47.0 mt -119.28 127.73 75.84 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.67 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.705 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.476 ' HA2' ' C6 ' ' B' ' 5' ' ' ' U' . . . -127.27 165.63 20.35 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.73 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.13 34.71 40.66 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.962 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 73.9 mt -59.25 -22.89 61.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.548 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 51.8 t30 75.59 39.61 0.33 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.198 0.523 . . . . 0.0 109.751 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.559 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 20.4 m0 33.53 35.22 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.143 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -153.94 8.2 0.35 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' A' ' 166' ' ' LEU . 55.4 m -78.71 137.16 37.65 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.372 0.606 . . . . 0.0 110.392 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 30.5 m -116.42 145.02 43.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.825 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.444 ' HA ' HD13 ' A' ' 190' ' ' ILE . 55.4 mp0 -55.66 -36.46 67.1 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.146 -0.621 . . . . 0.0 109.646 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' A' ' 176' ' ' ARG . 89.6 m-20 -65.43 -48.29 73.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.973 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -67.25 -40.8 86.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.609 0.718 . . . . 0.0 110.158 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 65.8 tp -64.68 -41.42 96.06 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.107 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 173' ' ' ASP . 41.2 ptt85 -69.66 -40.03 76.68 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.395 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 173' ' ' ASP . 75.4 mm-40 -65.12 -37.86 88.8 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.037 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.462 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 65.2 t80 -61.72 -54.53 41.33 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.416 0.627 . . . . 0.0 110.135 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -73.58 -21.83 60.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.703 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.41 -26.54 22.86 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.222 -0.99 . . . . 0.0 110.847 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.507 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -54.91 -41.49 71.03 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 123.752 0.821 . . . . 0.0 111.072 179.211 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -69.02 -32.59 72.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.099 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 174.94 -125.34 1.08 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.306 -0.95 . . . . 0.0 112.702 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 57.1 m -117.44 143.33 46.13 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 206' ' ' SER . 15.0 p -109.8 135.07 49.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.715 0.293 . . . . 0.0 110.238 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.437 HG21 ' CB ' ' A' ' 206' ' ' SER . 0.5 OUTLIER -95.79 -47.58 6.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.928 -179.18 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -136.6 132.19 34.76 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.281 0.562 . . . . 0.0 112.488 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.474 ' HG ' ' HB3' ' A' ' 176' ' ' ARG . 0.3 OUTLIER -116.22 129.72 56.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.58 179.278 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 11.7 tptt -137.03 116.07 12.41 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 172' ' ' GLU . 55.1 mt -126.74 126.26 68.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.989 176.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.547 ' SD ' ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -86.03 114.95 23.31 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.404 ' HG3' HG23 ' A' ' 190' ' ' ILE . 69.5 mttt -117.84 153.35 33.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.856 0.36 . . . . 0.0 111.458 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.591 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 3.1 t0 -124.79 74.11 64.19 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.31 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.77 -28.7 83.17 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.54 2.16 . . . . 0.0 112.905 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -66.74 -58.72 4.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.057 0.456 . . . . 0.0 111.108 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.2 p -75.16 -18.6 60.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.341 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 86.29 12.17 70.87 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.802 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.591 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 88.7 mtt-85 -122.32 177.16 5.5 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-O 120.87 0.367 . . . . 0.0 111.974 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 86.0 p -139.7 160.85 38.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.37 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.53 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 39.5 mmt180 -55.47 -31.96 62.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.989 0.423 . . . . 0.0 110.081 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.458 ' HA2' " O2'" ' B' ' 4' ' ' ' A' . . . 92.87 6.57 63.46 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.378 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.547 ' CE1' ' SD ' ' A' ' 191' ' ' MET . 26.2 p90 -146.56 154.33 41.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.153 0.501 . . . . 0.0 111.102 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.529 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -142.88 159.2 27.34 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.88 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.744 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 90.5 m-85 -106.83 123.66 48.48 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.502 HD23 ' CE1' ' A' ' 207' ' ' PHE . 7.3 tt -115.07 131.48 56.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.394 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.464 ' O ' HG21 ' A' ' 185' ' ' VAL . 38.8 t -116.31 135.67 53.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.015 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.502 ' CE1' HD23 ' A' ' 205' ' ' LEU . 75.5 m-85 -111.92 135.49 52.48 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.29 -35.33 78.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.464 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -109.77 115.16 55.86 Favored Pre-proline 0 C--O 1.231 0.119 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.695 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -56.2 -23.08 43.33 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.519 2.146 . . . . 0.0 112.862 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.1 t -57.66 -38.32 74.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.78 0.324 . . . . 0.0 111.113 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.457 ' O ' ' CG2' ' A' ' 216' ' ' VAL . 22.9 m -59.64 -36.56 76.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.595 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 83.0 t -60.48 -42.75 92.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.921 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -59.49 -41.45 89.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.88 0.371 . . . . 0.0 110.805 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.442 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 17.4 pt-20 -78.34 -36.41 46.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.726 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.845 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 93.8 t -63.5 -46.31 95.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 CA-C-O 120.924 0.393 . . . . 0.0 110.422 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 8.0 p -62.01 -36.62 75.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -59.97 -38.7 83.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.706 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 31.4 m -87.66 142.39 27.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.918 0.389 . . . . 0.0 111.847 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 228' ' ' ILE . 60.1 tp60 -66.23 -40.89 90.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.455 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.845 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 58.2 m-70 74.55 105.73 0.07 Allowed 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 75.3 mt -112.28 108.02 24.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.5 tt -117.0 125.99 52.21 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.948 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 55.76 41.19 30.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.03 8.29 87.41 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.95 -0.643 . . . . 0.0 114.643 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.443 ' HG3' ' CB ' ' A' ' 167' ' ' ASN . 42.2 mmtm -127.2 153.76 45.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.55 0.675 . . . . 0.0 111.961 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 34.2 m -100.06 136.93 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.64 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 220' ' ' GLN . 31.1 pt -123.75 161.85 25.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.083 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -124.95 80.3 63.79 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.119 0.485 . . . . 0.0 111.756 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.651 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 31.3 Cg_exo -63.92 76.31 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.399 2.733 . . . . 0.0 112.043 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.556 ' O ' ' HB3' ' A' ' 161' ' ' MET . 9.9 mtmt -95.5 159.42 15.01 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.117 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.458 ' HA ' ' HG2' ' A' ' 161' ' ' MET . 16.5 tpt180 -57.41 136.91 56.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.068 0.461 . . . . 0.0 111.578 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.31 145.71 55.0 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.49 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.497 HG13 ' N6 ' ' B' ' 6' ' ' ' A' . 13.9 mt -110.31 120.47 44.15 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.946 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.97 147.76 50.78 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.04 1.827 . . . . 0.0 111.309 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.409 ' NH2' " H5'" ' B' ' 7' ' ' ' U' . 25.2 mmt180 -55.86 -36.71 67.88 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -57.68 -43.19 84.89 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.003 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.447 ' O ' HG22 ' A' ' 242' ' ' THR . 97.6 mt-10 -71.92 -39.66 69.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.084 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.455 ' HA ' HG22 ' A' ' 242' ' ' THR . 27.1 mt-30 -61.18 -36.94 81.22 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.472 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -59.68 -37.31 78.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.999 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -86.41 -0.48 56.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 239' ' ' GLN . 27.3 p -87.85 162.54 16.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.081 0.467 . . . . 0.0 111.689 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -158.33 91.83 0.12 Allowed Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.767 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.587 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 77.5 tttt -79.2 132.42 36.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.764 0.316 . . . . 0.0 110.644 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.634 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -117.45 162.62 15.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.735 0.779 . . . . 0.0 112.254 -178.368 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.427 ' CG ' ' C6 ' ' B' ' 2' ' ' ' A' . 81.9 t80 -103.0 133.97 47.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.817 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.633 ' O ' ' HB2' ' A' ' 286' ' ' PHE . 8.2 p -128.15 135.05 63.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.351 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 286' ' ' PHE . . . -123.96 12.03 8.2 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.349 -0.929 . . . . 0.0 113.694 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . 0.515 ' HA2' ' HB ' ' A' ' 313' ' ' ILE . . . -97.78 15.76 61.35 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.725 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.477 ' CD1' ' HA2' ' A' ' 287' ' ' GLY . 31.7 pt -120.9 155.56 24.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.489 0.662 . . . . 0.0 112.597 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.452 ' O ' ' CG2' ' A' ' 254' ' ' VAL . . . -137.73 177.17 20.14 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.086 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.15 -26.96 44.39 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 121.981 1.787 . . . . 0.0 111.702 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.13 -35.1 72.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.592 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 251' ' ' GLY . 20.5 m -65.85 -28.1 43.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.74 127.35 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.07 -32.38 79.18 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.213 1.942 . . . . 0.0 113.126 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -61.15 -47.16 87.51 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.239 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 84.1 tt0 -66.67 -36.35 82.31 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.241 0.543 . . . . 0.0 110.944 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.627 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 31.3 t80 -59.5 -45.06 92.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.449 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.7 -40.32 92.16 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.321 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 258' ' ' GLU . 20.8 pt-20 -76.33 -30.64 57.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.08 0.467 . . . . 0.0 110.604 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.572 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 11.6 t80 -63.94 -55.56 21.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.057 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.571 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 4.2 m-85 -66.72 -24.66 66.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.547 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.495 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 71.2 p -60.08 -24.78 64.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.537 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -54.89 -35.76 64.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.467 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.655 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 13.0 p90 -114.39 35.43 4.21 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.073 0.463 . . . . 0.0 111.604 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 264' ' ' SER . . . 164.31 149.03 5.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.641 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 44.5 m -59.91 -36.07 76.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.944 0.402 . . . . 0.0 110.92 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.534 HD12 ' CB ' ' A' ' 263' ' ' PHE . 66.0 mt 64.82 90.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.161 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.599 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 80.5 mt -56.65 -42.47 76.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.201 178.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.451 ' OD2' ' CE ' ' A' ' 231' ' ' LYS . 61.9 t0 -168.69 100.88 0.4 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -98.73 136.72 38.37 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -143.02 155.43 44.64 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.651 ' O ' ' HB2' ' A' ' 275' ' ' MET . 30.6 tp -65.94 -35.45 80.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.176 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.651 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 86.7 mmm 105.58 -79.41 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.168 0.987 . . . . 0.0 112.234 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.434 ' HG ' ' HA ' ' A' ' 280' ' ' THR . 6.5 mp 59.14 65.92 1.12 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.461 0.172 . . . . 0.0 111.017 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.404 ' HA ' ' OP2' ' B' ' 4' ' ' ' A' . 22.0 t70 -57.71 -41.31 81.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.383 0.611 . . . . 0.0 109.598 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' A' ' 280' ' ' THR . 55.8 mttp -142.0 114.87 8.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.966 177.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 60.59 -65.44 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.034 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 278' ' ' LYS . 0.3 OUTLIER 170.94 18.7 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -58.07 -38.58 89.94 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.691 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.9 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 96.1 mm-40 -60.96 -36.37 79.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.259 0.552 . . . . 0.0 110.349 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.454 ' HB2' HD22 ' A' ' 274' ' ' LEU . 36.8 t -60.58 -23.77 64.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.54 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -48.05 -33.4 7.99 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -144.6 -18.52 0.19 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 119.083 -1.532 . . . . 0.0 115.755 -178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.633 ' HB2' ' O ' ' A' ' 247' ' ' VAL . 26.3 p90 -136.61 165.17 26.51 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.132 1.466 . . . . 0.0 113.269 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.477 ' HA2' ' CD1' ' A' ' 250' ' ' ILE . . . -141.62 163.57 26.84 Favored Glycine 0 CA--C 1.52 0.393 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.516 178.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.587 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -116.89 130.22 56.57 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.446 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.634 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 61.2 t -125.94 136.19 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.351 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 53.0 m -114.02 135.92 53.48 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.475 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 49.3 m-85 -115.76 136.35 53.14 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.599 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 21.8 t70 -59.18 -34.82 72.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.535 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 51.0 m -119.69 143.22 47.86 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.375 0.607 . . . . 0.0 111.763 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.55 -31.2 71.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.161 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 296' ' ' ALA . 53.5 p30 -60.8 -33.69 73.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.46 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.574 ' N ' ' OD1' ' A' ' 295' ' ' ASP . . . -62.16 -37.94 87.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.919 0.39 . . . . 0.0 110.65 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.48 -42.07 92.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.031 0.443 . . . . 0.0 110.61 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -59.52 -37.17 77.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.592 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -58.35 -43.63 88.42 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.053 0.454 . . . . 0.0 111.821 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.655 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 1.0 OUTLIER -70.2 -34.4 58.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.456 -179.35 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . 0.424 ' N ' HG11 ' A' ' 300' ' ' VAL . 79.7 m -59.64 -47.24 86.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.333 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.19 -39.29 94.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.187 0.517 . . . . 0.0 110.419 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.1 m-20 -62.12 -34.75 76.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.772 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.65 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 23.2 tptm 65.39 -73.95 0.06 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.65 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 5.1 m-30 -108.87 134.51 51.45 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.888 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.58 HD11 ' CZ3' ' A' ' 266' ' ' TRP . 14.9 mt -116.52 137.84 49.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.073 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.421 ' OD1' ' CE ' ' A' ' 312' ' ' LYS . 73.0 m-20 -75.99 87.53 2.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.68 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.572 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 7.8 t80 -97.76 -71.76 0.67 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.385 0.612 . . . . 0.0 110.655 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -96.69 -164.24 1.13 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.344 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 311' ' ' ARG . 55.8 p30 -59.21 -21.8 60.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.702 0.287 . . . . 0.0 110.792 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.426 ' N ' ' OD1' ' A' ' 310' ' ' ASP . 24.9 mmm180 -120.67 157.62 29.2 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.615 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.579 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 24.8 mmtm -72.5 154.02 41.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.634 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.515 ' HB ' ' HA2' ' A' ' 249' ' ' GLY . 35.3 pt -117.46 148.86 19.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.118 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -106.48 130.17 54.32 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.432 HD11 HD13 ' A' ' 306' ' ' ILE . 81.7 mt -120.94 129.64 75.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.169 0.509 . . . . 0.0 112.231 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -128.99 153.24 47.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.545 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -63.54 144.43 57.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.73 0.3 . . . . 0.0 110.718 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.53 144.68 46.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.629 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -122.73 159.65 52.38 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.811 0.339 . . . . 0.0 111.501 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.76 -23.01 64.51 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.842 2.362 . . . . 0.0 112.68 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 41.05 97.26 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.969 0.414 . . . . 0.0 111.74 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 84.5 t60 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.034 179.875 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.43 -0.643 0 C3'-C2'-O2' 111.273 -0.699 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.9 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.921 0 C3'-C2'-O2' 111.307 -0.687 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.504 " H1'" ' CE ' ' A' ' 275' ' ' MET . . . . . . . . 0 O5'--C5' 1.423 -1.084 0 C3'-C2'-O2' 111.3 -0.69 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.559 ' C2 ' ' CZ3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.426 -0.895 0 C4'-C3'-C2' 103.903 1.203 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.556 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.782 0 C3'-C2'-O2' 110.927 -0.818 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.602 ' C4 ' ' CD2' ' A' ' 162' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.925 0 C3'-C2'-C1' 100.899 -0.668 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.744 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.984 0 C4'-C3'-C2' 103.614 0.914 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . 0.799 " H2'" ' N3 ' ' B' ' 8' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.998 0 C3'-C2'-O2' 111.203 -0.723 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.762 0.315 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -61.69 -32.35 72.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.792 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.9 m -57.38 -33.65 68.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.971 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.7 m -56.26 -33.49 65.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.721 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.442 ' HB3' ' HB1' ' A' ' 233' ' ' ALA . 80.9 tttt -64.46 138.74 58.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.423 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.413 ' CE ' ' CG1' ' A' ' 216' ' ' VAL . 89.8 mtp -127.27 157.87 38.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.283 0.563 . . . . 0.0 111.909 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.568 ' CE2' ' N9 ' ' B' ' 6' ' ' ' A' . 1.3 t80 -103.29 129.94 50.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.882 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.447 ' O ' ' CB ' ' A' ' 202' ' ' PHE . 21.8 mm -114.07 129.34 70.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.357 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.526 ' HA2' ' C6 ' ' B' ' 5' ' ' ' U' . . . -128.58 163.09 22.14 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.821 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.4 38.37 33.62 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.888 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 75.7 mt -59.52 -25.45 64.5 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.595 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 38.7 t-20 72.52 41.02 0.6 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.973 0.416 . . . . 0.0 110.278 -178.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.58 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 23.5 m0 29.84 38.37 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.33 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 167' ' ' ASN . 58.4 t0 -156.54 28.43 0.33 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.798 0.332 . . . . 0.0 111.462 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.0 m -121.44 141.64 50.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 111.002 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.421 ' O ' ' CD2' ' A' ' 175' ' ' LEU . 15.8 p -117.35 163.09 16.87 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.635 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.493 ' HG3' ' HB ' ' A' ' 190' ' ' ILE . 96.1 mt-10 -57.82 -33.24 68.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.514 ' O ' ' HG2' ' A' ' 176' ' ' ARG . 21.8 t70 -64.02 -41.34 97.47 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.974 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -63.54 -38.79 92.49 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.421 ' CD2' ' O ' ' A' ' 171' ' ' THR . 3.7 mm? -61.41 -40.32 93.96 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 173' ' ' ASP . 0.1 OUTLIER -61.77 -37.38 84.09 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.683 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.47 -37.39 87.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.022 0.439 . . . . 0.0 110.073 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.655 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 64.0 t80 -78.86 -64.72 1.12 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.44 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.481 ' CG ' ' CD1' ' A' ' 205' ' ' LEU . 78.0 m-85 -68.06 -20.76 64.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.385 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -50.79 -29.04 18.21 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.615 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.81 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -58.86 -41.23 86.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.2 0.524 . . . . 0.0 110.298 179.239 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.81 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 71.3 m-85 -71.04 -33.95 70.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.882 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -172.19 -172.91 38.49 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.881 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 33.9 p -72.72 -11.81 60.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.77 0.319 . . . . 0.0 110.875 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.608 ' CG1' ' O ' ' A' ' 185' ' ' VAL . 1.1 t 52.2 87.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -177.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 3.3 m -56.69 -43.47 80.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.696 -176.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -150.3 140.93 22.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.244 0.545 . . . . 0.0 112.311 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 172' ' ' GLU . 0.2 OUTLIER -116.31 134.4 54.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.055 179.001 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 0.3 OUTLIER -131.81 123.6 27.92 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.382 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.493 ' HB ' ' HG3' ' A' ' 172' ' ' GLU . 2.4 mt -125.07 128.09 72.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.396 176.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.749 ' HG2' " H1'" ' B' ' 7' ' ' ' U' . 3.1 mpp? -103.77 141.98 35.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.966 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 199' ' ' SER . 1.8 pttt -131.36 177.04 7.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.047 0.451 . . . . 0.0 111.56 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.612 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 74.3 m-20 -119.27 83.08 24.5 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.751 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.6 -26.3 54.44 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.269 1.979 . . . . 0.0 112.096 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.42 -67.4 0.63 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.295 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 56.1 p -70.71 -22.41 62.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.543 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 83.61 21.34 58.24 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.024 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.612 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 16.8 tpp85 -125.43 136.61 53.58 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 121.168 0.509 . . . . 0.0 111.934 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 192' ' ' LYS . 46.8 m -63.38 151.71 40.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.72 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.548 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 26.2 mmm180 -58.38 -32.2 68.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.943 0.401 . . . . 0.0 110.628 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.599 ' HA2' " O2'" ' B' ' 4' ' ' ' A' . . . 95.24 0.17 63.48 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.772 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.55 ' CD1' " H4'" ' B' ' 5' ' ' ' U' . 36.5 p90 -144.13 159.7 42.18 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.988 0.423 . . . . 0.0 111.067 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.446 ' HA3' ' HE2' ' A' ' 191' ' ' MET . . . -148.1 169.25 28.83 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.556 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.74 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 96.3 m-85 -110.07 129.19 55.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.092 0.472 . . . . 0.0 110.359 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.635 HD23 ' CZ ' ' A' ' 207' ' ' PHE . 3.6 tt -108.78 132.7 53.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.404 -177.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.475 ' N ' HD22 ' A' ' 205' ' ' LEU . 33.1 t -122.22 131.61 54.02 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.305 178.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.635 ' CZ ' HD23 ' A' ' 205' ' ' LEU . 88.4 m-85 -118.23 136.92 53.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.057 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.589 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.4 tt0 -61.66 -35.14 77.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.053 0.454 . . . . 0.0 110.304 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -109.6 119.21 48.58 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.733 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.64 -26.6 73.36 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.413 2.075 . . . . 0.0 112.839 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.0 m -58.02 -36.44 72.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.567 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 23.5 m -58.16 -34.07 69.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.964 0.411 . . . . 0.0 110.593 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 78.0 t -61.0 -39.51 82.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.279 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 218' ' ' LYS . 21.6 t70 -56.0 -42.39 76.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.743 0.306 . . . . 0.0 111.178 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -66.9 -33.61 75.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.071 178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.775 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 92.7 t -59.13 -42.85 87.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.734 -178.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 20.3 m -72.79 -32.52 40.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.31 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 214' ' ' ASP . 45.0 mmtt -60.57 -34.24 73.87 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.616 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 52.7 m -99.05 138.78 35.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.836 0.35 . . . . 0.0 111.534 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 57.8 tp60 -65.91 -41.64 91.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.078 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.775 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 64.2 m-70 83.04 115.0 0.06 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 178.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 21.5 mm -117.66 109.35 27.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 175.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.5 tt -122.39 130.48 53.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.061 0.458 . . . . 0.0 111.63 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 57.8 t0 52.84 33.61 14.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.682 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 83.14 5.68 88.84 Favored Glycine 0 CA--C 1.517 0.163 0 C-N-CA 120.588 -0.815 . . . . 0.0 114.665 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.437 ' NZ ' ' C6 ' ' B' ' 4' ' ' ' A' . 36.8 ttmt -133.32 131.96 40.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.816 0.808 . . . . 0.0 111.612 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 19.6 m -67.83 136.03 27.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.574 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.405 HG13 ' HD3' ' A' ' 230' ' ' PRO . 35.6 pt -122.59 157.95 27.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.223 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.577 ' O ' ' O4 ' ' B' ' 5' ' ' ' U' . 1.1 m-20 -127.76 80.06 72.6 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.008 0.432 . . . . 0.0 111.92 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.539 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 47.7 Cg_exo -59.56 136.84 73.87 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 123.188 2.592 . . . . 0.0 111.542 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.616 ' HE2' ' H61' ' B' ' 6' ' ' ' A' . 7.2 ttpm? -138.46 154.54 48.85 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.715 -0.221 . . . . 0.0 110.721 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -57.57 136.97 56.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 0.0 111.319 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.442 ' HB1' ' HB3' ' A' ' 160' ' ' LYS . . . -72.36 146.47 47.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.605 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.552 ' CG1' ' C6 ' ' B' ' 6' ' ' ' A' . 1.2 pt -134.04 108.48 11.59 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.783 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 234' ' ' ILE . 1.6 Cg_endo -46.87 154.78 0.98 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.105 1.87 . . . . 0.0 110.884 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -51.47 -40.93 60.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.601 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 54.6 p30 -64.68 -38.74 92.01 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.215 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.601 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 96.8 mt-10 -70.48 -35.04 73.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.612 0.244 . . . . 0.0 111.181 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.431 ' HG2' ' CD1' ' A' ' 234' ' ' ILE . 26.6 mt-30 -59.21 -39.59 83.16 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.021 0.439 . . . . 0.0 110.0 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -62.71 -42.75 99.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.369 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -64.12 -39.65 94.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.542 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 291' ' ' TYR . 53.1 p -68.48 -38.22 80.82 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.879 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 61.54 142.41 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.016 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.534 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 6.8 tptm -131.66 131.04 42.84 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.437 HG12 ' HB ' ' A' ' 289' ' ' VAL . 8.4 pt -120.23 154.32 23.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.482 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.551 ' CZ ' ' N7 ' ' B' ' 2' ' ' ' A' . 88.3 t80 -100.91 132.24 46.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.838 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.613 ' CG2' ' CZ ' ' A' ' 263' ' ' PHE . 20.6 t -120.4 128.46 76.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.028 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -121.65 -7.34 8.16 Favored Glycine 0 C--N 1.329 0.163 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.441 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . 0.488 ' HA2' ' CB ' ' A' ' 313' ' ' ILE . . . -81.25 9.56 53.66 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.17 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.467 ' HB ' HG23 ' A' ' 254' ' ' VAL . 41.3 pt -111.7 133.68 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 116.968 0.384 . . . . 0.0 111.229 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.412 ' N ' HG23 ' A' ' 254' ' ' VAL . . . 159.18 -49.43 0.4 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.693 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.96 -33.57 89.54 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.446 2.097 . . . . 0.0 112.72 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -162.68 64.03 0.2 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.077 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.467 HG23 ' HB ' ' A' ' 250' ' ' ILE . 27.6 m -131.36 156.22 42.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.529 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.68 156.43 79.51 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.449 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.57 -40.14 86.52 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 121.521 1.481 . . . . 0.0 111.562 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.24 -42.99 99.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.289 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' A' ' 262' ' ' PHE . 97.7 mt-10 -68.04 -41.07 82.62 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.95 0.405 . . . . 0.0 111.276 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.508 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 82.8 t80 -65.13 -47.84 75.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.12 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 264' ' ' SER . 84.4 tt0 -64.17 -42.03 96.89 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.094 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -76.39 -30.71 57.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.022 0.439 . . . . 0.0 111.085 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.617 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 5.5 t80 -61.83 -64.82 0.81 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.019 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.661 ' CD2' ' CH2' ' A' ' 266' ' ' TRP . 32.8 m-85 -62.64 -27.51 69.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.064 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.484 ' N ' HD13 ' A' ' 269' ' ' ILE . 33.3 t -56.38 -28.53 59.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.087 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -53.13 -34.7 57.92 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.678 ' CZ2' ' CG2' ' A' ' 300' ' ' VAL . 14.4 p90 -116.71 54.5 0.85 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.907 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.51 ' HA2' ' CD1' ' A' ' 291' ' ' TYR . . . 153.06 -12.77 0.61 Allowed Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.775 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.567 ' O ' ' O ' ' A' ' 269' ' ' ILE . 0.5 OUTLIER 66.95 -1.84 1.29 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.567 ' O ' ' O ' ' A' ' 268' ' ' THR . 77.4 mt 33.54 115.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 75.7 mt -60.4 -42.06 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.06 176.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -166.16 97.47 0.61 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.424 ' N ' HG23 ' A' ' 269' ' ' ILE . . . -104.82 142.72 34.22 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -140.07 150.59 44.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.444 0.64 . . . . 0.0 112.141 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.573 ' O ' ' HB2' ' A' ' 275' ' ' MET . 43.5 tp -66.49 -37.54 85.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.713 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.573 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 91.9 mmm 90.73 111.16 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.424 0.69 . . . . 0.0 111.147 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 6.2 mp -118.46 124.11 46.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.704 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -62.41 -39.06 92.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.87 0.843 . . . . 0.0 109.045 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -161.09 -106.97 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.083 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -62.34 -37.2 84.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.014 0.435 . . . . 0.0 110.054 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 1.2 t 171.66 68.82 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.75 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -93.19 -75.35 1.3 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.094 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.811 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 96.0 mm-40 -57.54 -30.7 65.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.171 0.51 . . . . 0.0 110.034 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.461 ' HB2' ' CD2' ' A' ' 274' ' ' LEU . 76.5 p -64.18 163.2 13.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.465 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 284' ' ' ARG . 59.4 ttp180 69.69 6.26 5.63 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.252 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -130.92 -48.02 0.12 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.65 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 40.6 p90 -148.67 166.77 27.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.542 0.211 . . . . 0.0 111.029 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -136.72 157.06 23.5 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.263 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.534 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.9 OUTLIER -109.75 129.84 55.58 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.748 0.419 . . . . 0.0 110.552 179.47 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.508 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 48.5 t -126.16 134.22 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.468 ' OG1' ' CD ' ' A' ' 244' ' ' LYS . 30.5 m -123.01 139.44 54.08 Favored 'General case' 0 C--O 1.23 0.063 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.51 ' CD1' ' HA2' ' A' ' 267' ' ' GLY . 51.0 m-85 -117.5 140.32 49.77 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.609 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 21.4 t70 -56.34 -34.86 67.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.599 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 51.1 m -119.86 142.74 48.39 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.948 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.47 -32.05 73.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.045 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -56.21 -36.5 68.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.467 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.06 -37.07 78.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.408 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.79 -44.13 98.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.037 0.446 . . . . 0.0 110.405 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -63.2 -37.48 87.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.1 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -58.38 -43.14 88.37 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.678 ' CG2' ' CZ2' ' A' ' 266' ' ' TRP . 0.4 OUTLIER -73.45 -32.82 38.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.923 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 83.9 m -57.21 -44.39 83.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -60.43 -40.26 90.42 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.329 0.585 . . . . 0.0 109.812 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -60.41 -32.48 71.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.407 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.612 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 22.0 tptt 69.88 -68.2 0.21 Allowed 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.612 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.0 m-30 -115.5 149.72 37.66 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.445 178.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.511 ' CG2' ' HZ ' ' A' ' 262' ' ' PHE . 23.7 mm -117.23 140.18 41.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.742 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -80.28 39.74 0.46 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.961 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.617 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 6.2 t80 -48.24 -68.4 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.465 ' HD3' ' CZ ' ' A' ' 308' ' ' PHE . 16.9 mmmt -105.6 19.41 20.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.811 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 53.6 t0 69.25 9.69 7.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.732 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -109.88 2.02 19.57 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.037 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.407 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 22.6 mttm 62.2 121.55 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.017 0.437 . . . . 0.0 111.714 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 305' ' ' PHE . 31.6 pt -116.28 147.09 19.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.444 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . 0.558 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 84.7 mt-10 -103.93 132.19 50.43 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.847 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.518 HD12 ' CZ ' ' A' ' 263' ' ' PHE . 63.2 mt -120.35 127.98 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.589 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -126.7 148.39 49.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.716 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -55.53 148.3 15.96 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.03 140.92 36.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.139 0.495 . . . . 0.0 111.394 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -117.39 111.03 40.3 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.63 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -49.99 102.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.906 1.737 . . . . 0.0 111.885 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -57.97 -38.1 75.42 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.15 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 85.1 t60 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.873 -179.759 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.676 0 C3'-C2'-O2' 111.178 -0.732 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.811 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.967 0 O4'-C1'-C2' 107.474 0.767 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.718 ' O2 ' " H3'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.023 0 C3'-C2'-O2' 111.36 -0.669 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.599 " O2'" ' HA2' ' A' ' 201' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.882 0 C4'-C3'-C2' 104.05 1.35 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.797 " O2'" ' P ' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.883 0 C3'-C2'-C1' 100.321 -1.31 OUTLIER-EPSILON 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.797 ' P ' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.957 0 C4'-C3'-C2' 103.464 0.764 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.749 " H1'" ' HG2' ' A' ' 191' ' ' MET . . . . . . . . 0 O5'--C5' 1.425 -0.92 0 C1'-C2'-O2' 108.509 -0.697 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . 0.42 ' OP2' ' CZ ' ' A' ' 200' ' ' ARG . . . . . . . . 0 O5'--C5' 1.424 -0.983 0 C3'-C2'-O2' 111.219 -0.718 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 65.2 mttp . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.636 0.255 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.534 ' HG3' ' H ' ' A' ' 159' ' ' CYS . 43.7 tp10 -101.55 138.54 38.41 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.786 0.327 . . . . 0.0 110.543 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 53.7 p -80.31 -2.52 45.64 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.198 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.534 ' H ' ' HG3' ' A' ' 157' ' ' GLU . 4.0 m -85.07 13.45 6.14 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.565 ' HE2' ' HB3' ' A' ' 204' ' ' PHE . 8.5 tptm -63.25 134.07 55.27 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.76 0.314 . . . . 0.0 110.342 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.518 ' O ' ' HA ' ' A' ' 204' ' ' PHE . 89.8 mmm -123.4 147.28 47.26 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.62 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 3.4 t80 -109.56 126.05 53.17 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.526 HD12 ' CZ ' ' A' ' 179' ' ' PHE . 3.7 mt -121.96 130.16 74.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.112 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.456 ' HA2' ' C6 ' ' B' ' 5' ' ' ' U' . . . -125.05 156.04 18.84 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.038 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.85 33.34 57.81 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.707 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.607 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 69.7 mt -58.68 -32.45 69.14 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.645 ' O ' ' N ' ' A' ' 169' ' ' ASP . 45.4 t30 110.49 31.22 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.283 0.633 . . . . 0.0 110.99 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.571 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 6.5 m0 53.04 -49.25 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.645 ' N ' ' O ' ' A' ' 167' ' ' ASN . 50.3 p30 -82.27 9.27 9.16 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 166' ' ' LEU . 85.7 m -68.99 137.81 54.02 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.203 0.525 . . . . 0.0 109.975 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 30.6 m -112.14 148.33 34.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.387 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.481 ' HG3' ' HB ' ' A' ' 190' ' ' ILE . 55.6 mp0 -54.56 -37.51 65.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.538 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 89.5 m-20 -63.2 -40.12 96.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.946 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -61.6 -36.69 81.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.302 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.476 HD21 ' CD2' ' A' ' 179' ' ' PHE . 5.8 mt -55.34 -49.38 72.37 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.538 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -67.05 -31.94 72.8 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.482 179.073 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.43 -39.0 78.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.695 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.636 ' CE2' ' CE2' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -94.08 -55.62 3.14 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.113 179.288 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.636 ' CE2' ' CE2' ' A' ' 178' ' ' TYR . 64.0 m-85 -60.72 -28.95 69.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.874 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.93 -23.28 10.86 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.169 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.796 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -54.52 -40.52 68.69 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.882 0.373 . . . . 0.0 111.14 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.796 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 55.5 m-85 -69.32 -31.67 70.29 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.243 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 166.97 -134.41 3.26 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.871 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 57.7 m -117.64 136.89 53.01 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.576 HG21 ' CD1' ' A' ' 207' ' ' PHE . 0.9 OUTLIER -95.0 127.79 46.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.613 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.45 ' CG2' ' HA ' ' A' ' 208' ' ' GLU . 54.0 p -70.18 -35.94 74.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.397 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -148.86 145.24 27.39 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.446 HD13 HD11 ' A' ' 175' ' ' LEU . 0.2 OUTLIER -116.45 129.06 56.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.749 178.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.539 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 7.3 tppt? -138.59 111.36 7.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.481 ' HB ' ' HG3' ' A' ' 172' ' ' GLU . 82.3 mt -125.68 123.13 63.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 174.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.588 ' O ' ' O ' ' A' ' 192' ' ' LYS . 0.0 OUTLIER -59.9 -37.61 79.93 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.084 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.588 ' O ' ' O ' ' A' ' 191' ' ' MET . 26.7 tttt 49.18 149.68 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.268 0.556 . . . . 0.0 112.008 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 9.9 t0 -128.3 78.48 75.52 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.366 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.74 -24.17 61.96 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.408 2.072 . . . . 0.0 112.011 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -73.82 -72.0 0.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.572 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 48.4 p -69.03 -26.21 64.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.624 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.66 7.01 65.22 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.707 -0.759 . . . . 0.0 113.241 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 20.9 tpp180 -124.38 125.78 44.87 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-N 117.267 0.534 . . . . 0.0 111.181 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.1 t -70.27 156.99 38.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.63 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.643 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 83.8 mmt-85 -55.55 -31.75 62.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.705 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.434 ' HA2' " O2'" ' B' ' 4' ' ' ' A' . . . 95.78 0.49 62.28 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.675 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.643 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 42.6 p90 -142.47 154.41 44.51 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.41 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -150.45 170.66 30.36 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.666 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.848 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 89.5 m-85 -107.91 125.55 51.62 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.109 0.481 . . . . 0.0 109.963 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.515 ' HB2' HD13 ' A' ' 163' ' ' ILE . 16.8 tp -112.61 131.19 55.74 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.197 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.409 ' OG ' ' HD2' ' A' ' 160' ' ' LYS . 49.1 m -120.1 140.39 51.12 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.723 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.576 ' CD1' HG21 ' A' ' 185' ' ' VAL . 78.4 m-85 -121.65 141.88 50.69 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.567 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.45 ' HA ' ' CG2' ' A' ' 186' ' ' THR . 84.5 tt0 -64.45 -34.75 78.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.245 178.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -110.76 115.58 53.27 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.926 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.4 ' O ' ' HB ' ' A' ' 213' ' ' VAL . 52.5 Cg_exo -56.25 -25.78 57.83 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.582 2.188 . . . . 0.0 113.033 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.2 m -58.06 -37.42 74.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.0 110.555 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 25.0 m -59.97 -34.76 73.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.244 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 210' ' ' PRO . 71.2 t -60.39 -41.0 85.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.214 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -57.4 -44.86 84.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.051 0.453 . . . . 0.0 110.487 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.58 -33.77 73.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.384 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.855 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 74.9 t -59.65 -40.59 82.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.692 -178.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.3 m -88.87 -38.68 11.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -178.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -60.14 -34.73 73.95 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.495 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 32.2 m -93.37 146.28 23.86 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.438 ' NE2' ' CG2' ' A' ' 227' ' ' VAL . 54.0 tp60 -79.76 140.76 36.8 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.855 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 41.8 m-70 -125.85 139.41 53.51 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -176.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 67.7 mt -125.52 114.61 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.347 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.423 ' HG ' ' CD2' ' A' ' 178' ' ' TYR . 1.0 OUTLIER -82.22 -50.83 8.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.04 0.448 . . . . 0.0 111.99 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -142.86 43.68 1.58 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.788 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 96.17 -0.65 62.22 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.978 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.436 ' CG ' ' OD1' ' A' ' 167' ' ' ASN . 12.2 mmmm -99.36 169.49 9.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.663 0.268 . . . . 0.0 110.352 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.438 ' CG2' ' NE2' ' A' ' 220' ' ' GLN . 14.6 p -118.33 132.91 66.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.948 0.404 . . . . 0.0 110.125 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.436 HG13 ' HD3' ' A' ' 230' ' ' PRO . 35.9 pt -129.41 161.13 39.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.949 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -129.63 81.01 70.64 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.0 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.517 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 78.1 Cg_exo -54.97 129.48 35.56 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.958 2.438 . . . . 0.0 112.782 -178.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.412 ' HE2' ' O4 ' ' B' ' 5' ' ' ' U' . 9.8 mtmm -132.86 154.58 50.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.423 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.589 ' HD3' ' N ' ' A' ' 233' ' ' ALA . 1.5 tmt_? -63.5 135.08 56.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.902 0.382 . . . . 0.0 110.759 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.589 ' N ' ' HD3' ' A' ' 232' ' ' ARG . . . -63.91 145.77 55.24 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.286 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.505 ' CD1' ' C6 ' ' B' ' 6' ' ' ' A' . 0.8 OUTLIER -109.92 130.67 22.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.479 179.498 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.436 ' HG2' ' HB2' ' A' ' 238' ' ' GLU . 9.6 Cg_endo -53.45 138.84 65.87 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 121.772 1.648 . . . . 0.0 110.85 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -56.56 -40.39 75.08 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.16 -45.6 92.53 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.496 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.436 ' HB2' ' HG2' ' A' ' 235' ' ' PRO . 97.1 mt-10 -71.61 -37.32 70.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.599 0.714 . . . . 0.0 109.842 178.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.438 ' NE2' " O2'" ' B' ' 6' ' ' ' A' . 45.3 tt0 -59.5 -39.48 83.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.979 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -59.51 -39.28 83.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.037 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -60.35 -35.3 75.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.54 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.401 ' CG2' ' CD1' ' A' ' 270' ' ' ILE . 19.3 p -84.08 162.21 20.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.991 0.424 . . . . 0.0 111.65 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -154.27 118.54 0.87 Allowed Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.13 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.448 ' NZ ' ' CE2' ' A' ' 288' ' ' PHE . 18.2 ttpp -88.49 135.93 33.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.732 0.301 . . . . 0.0 111.127 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.641 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -119.51 164.6 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.358 0.599 . . . . 0.0 111.781 -179.012 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.54 ' CZ ' ' N7 ' ' B' ' 2' ' ' ' A' . 88.2 t80 -101.27 136.98 40.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.156 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.502 HG12 ' CE1' ' A' ' 259' ' ' PHE . 9.2 p -129.72 145.13 36.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.107 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.55 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -131.84 165.36 23.44 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 97.31 -2.69 61.25 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.986 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.471 HD12 ' CE1' ' A' ' 259' ' ' PHE . 43.7 pt -117.64 137.92 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-O 121.172 0.511 . . . . 0.0 111.604 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -174.18 -89.26 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.488 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.66 132.57 43.58 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.455 2.103 . . . . 0.0 112.984 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 51.17 40.17 25.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.818 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.676 ' O ' ' HB2' ' A' ' 258' ' ' GLU . 29.8 m -105.84 -35.49 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.049 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 254' ' ' VAL . 13.4 mmm180 57.39 132.63 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.76 -30.22 66.09 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.892 1.728 . . . . 0.0 112.35 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 39.0 tttm -61.28 -44.14 97.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.604 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.676 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 98.0 mt-10 -67.0 -39.87 87.22 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.164 0.506 . . . . 0.0 110.599 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.659 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 15.7 t80 -62.55 -45.49 92.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.029 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 257' ' ' LYS . 20.3 pt-20 -69.23 -41.16 77.39 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.795 0.331 . . . . 0.0 111.021 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.405 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.7 pt-20 -74.26 -29.76 61.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.288 0.566 . . . . 0.0 110.157 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.533 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 5.8 t80 -60.94 -57.28 13.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.884 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.583 ' CB ' HD12 ' A' ' 269' ' ' ILE . 3.7 m-85 -65.18 -23.44 67.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.355 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.468 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 27.2 t -53.97 -30.14 45.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.616 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -53.39 -34.75 58.92 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.105 -0.238 . . . . 0.0 111.116 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.753 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 7.4 p90 -119.0 46.02 1.96 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.21 0.529 . . . . 0.0 111.74 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.484 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 156.31 152.92 6.41 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.916 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 43.0 p -70.28 -25.53 63.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.041 0.448 . . . . 0.0 110.748 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.583 HD12 ' CB ' ' A' ' 263' ' ' PHE . 76.9 mt 54.55 96.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.111 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.568 HG13 ' CA ' ' A' ' 292' ' ' ASP . 79.3 mt -59.18 -40.61 81.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.207 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 50.3 p30 -169.77 156.55 6.42 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.496 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -155.07 145.32 21.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.866 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -145.45 150.71 36.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.11 0.481 . . . . 0.0 111.852 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.583 ' O ' ' HB2' ' A' ' 275' ' ' MET . 24.7 tp -66.17 -39.75 89.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.229 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.583 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 94.8 mmm 98.2 151.85 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.495 0.718 . . . . 0.0 109.659 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 282' ' ' GLN . 0.3 OUTLIER -162.04 84.44 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.562 0.22 . . . . 0.0 111.427 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -85.89 110.84 19.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.912 0.386 . . . . 0.0 110.621 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 40.8 mttm 55.95 30.69 16.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 51.51 43.95 29.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.135 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 1.6 t -165.83 -41.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.717 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -55.0 -37.49 62.9 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.475 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.562 ' HG2' ' HB2' ' A' ' 275' ' ' MET . 3.4 tp-100 -109.41 132.51 54.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.747 0.308 . . . . 0.0 111.494 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 282' ' ' GLN . 27.5 p 148.89 -18.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.059 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 51.1 ttt85 -56.46 -37.97 71.03 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.226 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 250' ' ' ILE . . . 144.59 43.08 0.05 OUTLIER Glycine 0 CA--C 1.522 0.503 0 C-N-CA 119.984 -1.103 . . . . 0.0 114.147 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.51 ' CE1' " H4'" ' B' ' 2' ' ' ' A' . 15.5 p90 -140.28 167.47 22.06 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 117.483 0.641 . . . . 0.0 110.409 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.408 ' O ' HG11 ' A' ' 247' ' ' VAL . . . -147.51 169.28 28.43 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.579 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.448 ' CE2' ' NZ ' ' A' ' 244' ' ' LYS . 0.3 OUTLIER -122.42 124.16 42.99 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 122.346 0.258 . . . . 0.0 111.053 179.429 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.659 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 61.2 t -127.67 138.07 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.033 0.445 . . . . 0.0 112.142 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 44.4 m -116.04 137.09 52.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.241 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.484 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 41.7 m-85 -115.1 135.19 54.47 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.568 ' CA ' HG13 ' A' ' 270' ' ' ILE . 55.1 t0 -59.01 -35.37 73.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.652 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 30.5 t -118.35 139.31 51.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.207 0.527 . . . . 0.0 111.61 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . 0.469 ' O ' HG11 ' A' ' 297' ' ' VAL . . . -64.08 -31.89 73.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.02 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -57.06 -35.61 69.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.299 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.2 -37.33 77.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.705 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.469 HG11 ' O ' ' A' ' 294' ' ' ALA . 6.2 p -58.73 -38.21 70.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.005 0.431 . . . . 0.0 110.662 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . 0.448 ' N ' HG11 ' A' ' 297' ' ' VAL . 21.7 t70 -63.3 -37.43 87.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.181 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -58.23 -41.13 83.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.893 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.753 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 2.3 p -65.12 -33.68 65.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.066 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 74.5 m -56.92 -39.75 75.06 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -62.77 -35.5 80.03 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.924 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.595 ' OD1' ' O ' ' A' ' 300' ' ' VAL . 22.9 p30 -101.2 42.76 1.1 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.008 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.611 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 18.7 tptm -16.08 -65.07 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.915 0.388 . . . . 0.0 110.432 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.619 ' HB3' ' HB3' ' A' ' 312' ' ' LYS . 4.1 m-30 -110.22 142.36 41.89 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.433 ' CD1' ' CG ' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -117.01 130.23 72.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.732 179.681 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -73.18 71.55 1.18 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.533 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 2.9 t80 -62.47 -105.6 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.344 -177.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.454 ' HG2' ' CD2' ' A' ' 308' ' ' PHE . 12.6 mmmm -61.83 -37.17 83.46 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.054 0.454 . . . . 0.0 111.316 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 309' ' ' LYS . 60.3 t0 175.8 -25.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.791 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -111.8 159.43 18.31 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.199 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 42.4 mttp -72.99 140.48 47.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.333 0.587 . . . . 0.0 111.905 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 305' ' ' PHE . 36.3 pt -119.0 152.79 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.615 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -107.54 131.48 54.29 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.617 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.412 HG12 HG21 ' A' ' 247' ' ' VAL . 74.1 mt -119.85 129.71 75.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.38 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 22.9 tttm -133.08 144.37 49.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.5 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -54.1 144.99 18.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.721 0.296 . . . . 0.0 110.314 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.67 140.14 55.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 111.073 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -87.46 143.3 33.94 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.932 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.64 -19.86 47.57 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.472 2.114 . . . . 0.0 111.763 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.487 ' HD3' ' C5 ' ' B' ' 3' ' ' ' U' . 1.9 ttt-85 41.63 92.98 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.687 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 54.5 p-80 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.909 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.754 0 C3'-C2'-O2' 111.243 -0.709 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.54 ' N7 ' ' CZ ' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.989 0 C3'-C2'-O2' 111.382 -0.661 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.532 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.423 -1.036 0 C3'-C2'-O2' 111.227 -0.715 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.571 ' C2 ' ' CZ3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.425 -0.909 0 C4'-C3'-C2' 103.782 1.082 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.908 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.857 0 C3'-C2'-O2' 110.962 -0.806 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.908 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.005 0 C3'-C2'-O2' 111.122 -0.751 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.848 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.987 0 C4'-C3'-C2' 103.694 0.994 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . 0.683 ' N3 ' " H2'" ' B' ' 8' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.954 0 C3'-C2'-O2' 111.257 -0.704 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 97.0 mttt . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.822 0.344 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 60.1 mp0 -61.48 -33.87 74.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.575 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.7 p 28.89 94.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.651 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 51.7 t -124.85 92.63 3.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.214 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.472 ' CG ' ' CB ' ' A' ' 233' ' ' ALA . 6.5 tptt -135.07 142.73 46.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.584 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.627 ' HB2' ' HB2' ' A' ' 205' ' ' LEU . 87.0 mmm -122.21 147.01 46.72 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.619 ' CE2' ' N9 ' ' B' ' 6' ' ' ' A' . 1.6 t80 -108.81 125.6 52.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.036 177.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 202' ' ' PHE . 20.9 mm -118.04 129.71 74.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.525 ' HA2' ' C6 ' ' B' ' 5' ' ' ' U' . . . -127.06 162.73 21.12 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.007 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.67 36.12 38.58 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.745 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 70.7 mt -59.61 -24.55 63.91 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.557 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 42.2 t-20 72.48 43.78 0.45 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.136 0.494 . . . . 0.0 110.505 -178.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.572 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 21.1 m0 31.39 39.38 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.429 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -160.54 46.57 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.353 . . . . 0.0 111.304 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 90.4 m -123.96 139.92 53.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.019 0.438 . . . . 0.0 110.899 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 33.5 p -119.93 160.07 23.44 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.393 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 55.8 mp0 -61.98 -30.54 71.0 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.797 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 88.8 m-20 -61.03 -42.89 99.33 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.907 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -65.93 -38.54 88.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.121 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.458 HD21 ' CD2' ' A' ' 179' ' ' PHE . 10.6 mt -61.87 -42.47 99.09 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.797 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -65.78 -38.82 90.06 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.893 179.329 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.435 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 84.5 tt0 -70.89 -45.01 65.09 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.134 0.492 . . . . 0.0 110.457 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.971 ' OH ' ' HB2' ' A' ' 221' ' ' HIS . 19.0 t80 -63.17 -45.14 93.2 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.28 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.458 ' CD2' HD21 ' A' ' 175' ' ' LEU . 96.0 m-85 -98.04 2.02 48.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.34 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -58.51 -28.1 61.89 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.358 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.489 ' CD ' ' H ' ' A' ' 181' ' ' LYS . 0.6 OUTLIER -56.72 -42.73 79.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.959 0.885 . . . . 0.0 110.328 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -70.99 -35.19 72.0 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 113.781 -1.554 . . . . 0.0 112.75 -177.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 177.55 -174.37 46.87 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 119.679 -1.248 . . . . 0.0 113.741 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.8 m -63.82 -28.55 69.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.042 -0.579 . . . . 0.0 111.241 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.642 ' CG1' ' O ' ' A' ' 185' ' ' VAL . 0.4 OUTLIER 64.3 87.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -176.775 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -54.77 -46.15 74.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.033 -176.661 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 186' ' ' THR . 90.8 m-20 -139.25 152.36 47.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.226 0.536 . . . . 0.0 112.012 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.407 HD12 ' CD2' ' A' ' 205' ' ' LEU . 0.2 OUTLIER -125.55 129.08 49.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.505 179.452 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.483 ' HE2' ' C2 ' ' B' ' 7' ' ' ' U' . 22.8 tptt -132.33 119.26 20.5 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.488 0.661 . . . . 0.0 112.643 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 1.9 mt -128.83 131.95 67.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.662 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.622 ' SD ' ' CE2' ' A' ' 202' ' ' PHE . 0.8 OUTLIER -88.77 127.32 35.6 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -133.24 162.74 30.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.979 0.418 . . . . 0.0 111.593 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 32.3 m-20 -124.81 84.37 58.33 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.348 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.34 -25.42 39.06 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.241 1.961 . . . . 0.0 112.362 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.88 -71.29 0.36 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.9 0.381 . . . . 0.0 111.313 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.4 p -71.8 -21.56 61.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.178 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 80.36 26.76 54.02 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.32 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.588 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 15.8 ttp180 -119.78 149.95 41.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.26 0.552 . . . . 0.0 112.372 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.8 t -108.71 148.41 30.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.593 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.604 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 59.8 mmt-85 -53.35 -29.92 36.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.758 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.573 ' HA2' " O2'" ' B' ' 4' ' ' ' A' . . . 97.56 2.16 58.81 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.137 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.622 ' CE2' ' SD ' ' A' ' 191' ' ' MET . 25.6 p90 -142.96 155.35 44.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.937 0.398 . . . . 0.0 110.819 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.505 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -142.94 161.73 27.52 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.768 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.672 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 89.7 m-85 -111.65 130.55 55.73 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.827 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.627 ' HB2' ' HB2' ' A' ' 161' ' ' MET . 44.8 mt -109.35 141.67 41.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.974 0.416 . . . . 0.0 111.667 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 33.1 t -127.15 131.15 50.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.346 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -119.15 140.58 49.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.814 0.34 . . . . 0.0 111.562 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.501 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.3 tt0 -60.87 -34.63 74.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.089 0.471 . . . . 0.0 110.089 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.1 114.08 51.44 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.395 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.74 -26.83 58.58 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.389 2.059 . . . . 0.0 113.005 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.2 m -58.61 -36.17 73.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.775 0.321 . . . . 0.0 111.153 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 21.9 m -58.63 -35.04 71.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.049 0.452 . . . . 0.0 110.66 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.417 HG12 ' HD3' ' A' ' 232' ' ' ARG . 54.6 t -60.94 -38.67 79.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.784 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -54.2 -42.82 70.16 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.347 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.469 ' O ' ' OG1' ' A' ' 219' ' ' THR . 73.5 mm-40 -69.69 -34.34 73.8 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.539 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 98.3 t -60.64 -44.77 97.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.967 0.413 . . . . 0.0 111.346 -178.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.403 HG23 ' HE3' ' A' ' 161' ' ' MET . 41.9 t -76.77 -51.68 18.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 7.8 tptm -61.17 -40.5 94.14 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 215' ' ' GLU . 88.7 m -59.0 -38.27 78.81 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 219' ' ' THR . 63.7 tt0 60.69 111.7 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -177.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.971 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -139.92 167.12 22.84 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -176.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.402 ' CG1' ' HA ' ' A' ' 227' ' ' VAL . 3.6 mp -118.0 126.05 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.207 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.491 ' HG ' ' CD2' ' A' ' 178' ' ' TYR . 7.5 tt -119.0 132.21 56.05 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.157 0.503 . . . . 0.0 111.744 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.403 ' HB2' HD22 ' A' ' 223' ' ' LEU . 19.5 t70 63.81 28.82 14.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.093 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 94.11 -14.3 65.58 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.542 -0.837 . . . . 0.0 115.037 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -113.49 137.54 51.41 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 117.953 0.877 . . . . 0.0 112.338 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.402 ' HA ' ' CG1' ' A' ' 222' ' ' ILE . 33.7 m -64.77 128.27 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.282 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.454 HG13 ' HD3' ' A' ' 230' ' ' PRO . 37.6 pt -124.28 155.1 31.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.045 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.1 76.69 78.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.295 0.569 . . . . 0.0 110.619 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.503 ' HG2' ' NE2' ' A' ' 221' ' ' HIS . 80.2 Cg_exo -53.0 128.67 29.86 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.12 2.547 . . . . 0.0 111.537 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.438 ' N ' ' HE2' ' A' ' 161' ' ' MET . 6.3 ttpm? -139.03 148.3 43.22 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.317 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.417 ' HD3' HG12 ' A' ' 213' ' ' VAL . 15.2 mmt85 -48.97 138.76 11.14 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.12 0.485 . . . . 0.0 111.523 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.613 ' HA ' ' N1 ' ' B' ' 6' ' ' ' A' . . . -75.72 146.07 40.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.98 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.515 ' CG1' ' C6 ' ' B' ' 6' ' ' ' A' . 0.0 OUTLIER -112.84 129.1 24.8 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.417 179.286 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.04 149.15 21.8 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 121.915 1.744 . . . . 0.0 110.911 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 52.6 mmm-85 -54.62 -40.44 68.93 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.671 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -64.57 -40.32 95.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.596 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -65.51 -36.39 83.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.6 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -60.14 -37.59 80.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.991 0.424 . . . . 0.0 110.521 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -60.07 -38.62 83.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.129 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -59.68 -35.58 74.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.665 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 20.7 p -87.13 161.86 17.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.005 0.431 . . . . 0.0 111.666 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -142.87 113.91 0.82 Allowed Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.722 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 33.0 ttpt -85.33 140.75 30.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.96 0.409 . . . . 0.0 111.599 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.611 HG12 ' HB ' ' A' ' 289' ' ' VAL . 10.1 pt -118.36 160.52 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.488 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.544 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 84.6 t80 -99.63 132.46 44.96 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.523 HG22 HG12 ' A' ' 315' ' ' ILE . 14.0 p -128.55 145.34 35.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.647 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.41 166.11 19.32 Favored Glycine 0 C--O 1.226 -0.378 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.92 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 78.41 30.81 48.33 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.262 -0.971 . . . . 0.0 111.799 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.655 ' O ' ' HB ' ' A' ' 254' ' ' VAL . 34.7 mm -55.27 -46.61 78.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 81.47 126.41 0.81 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.024 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -56.49 -29.56 78.71 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.604 2.202 . . . . 0.0 113.332 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -91.64 10.66 27.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.391 . . . . 0.0 111.388 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.655 ' HB ' ' O ' ' A' ' 250' ' ' ILE . 13.0 p -56.24 -40.9 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.403 ' N ' HG12 ' A' ' 254' ' ' VAL . 11.2 tpp85 63.59 116.08 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -176.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -50.29 -30.4 26.23 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 121.994 1.796 . . . . 0.0 112.561 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -60.51 -42.13 95.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.315 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 77.5 mm-40 -68.24 -39.66 82.21 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.049 0.452 . . . . 0.0 111.556 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.519 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 40.6 t80 -62.63 -47.01 85.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.782 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.19 -42.43 93.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.694 0.283 . . . . 0.0 111.556 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -78.18 -31.16 49.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.806 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.505 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 15.1 t80 -60.66 -57.1 14.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.153 0.501 . . . . 0.0 111.698 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.708 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 16.9 m-85 -66.38 -23.8 66.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.715 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.477 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 25.2 t -56.64 -30.51 63.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.527 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -53.55 -36.62 62.04 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.788 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 9.2 p90 -116.82 42.76 2.41 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.119 0.485 . . . . 0.0 111.51 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.545 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 156.97 148.42 5.09 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.824 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.423 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 50.1 m -59.85 -36.92 77.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.729 0.3 . . . . 0.0 111.72 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.507 HD12 ' CB ' ' A' ' 263' ' ' PHE . 69.9 mt 69.86 77.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.394 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.502 HG12 ' CA ' ' A' ' 292' ' ' ASP . 35.4 mm -59.84 -40.97 84.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.806 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -154.28 86.71 1.16 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -101.85 131.26 48.29 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -143.66 152.57 41.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.504 0.668 . . . . 0.0 112.712 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.699 ' O ' ' HB2' ' A' ' 275' ' ' MET . 21.1 tp -68.43 -31.57 70.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.783 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.699 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 10.3 mmm 92.86 -86.61 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.001 0.92 . . . . 0.0 112.721 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.527 ' HA ' ' HB3' ' A' ' 282' ' ' GLN . 5.9 mp 62.27 145.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.227 0.537 . . . . 0.0 111.268 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.438 ' HA ' ' OP1' ' B' ' 4' ' ' ' A' . 51.6 p30 -113.08 -132.24 0.33 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.388 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -55.99 -32.45 63.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -149.81 -108.0 0.07 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.736 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.418 ' O ' ' OG ' ' A' ' 283' ' ' SER . 64.4 p -108.4 20.08 19.04 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -52.44 -39.3 52.3 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 119.645 -1.264 . . . . 0.0 111.975 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.527 ' HB3' ' HA ' ' A' ' 276' ' ' LEU . 13.1 tm0? -64.98 -32.83 74.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.039 0.447 . . . . 0.0 111.424 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 280' ' ' THR . 48.0 p -57.2 -10.08 1.14 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.777 -178.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -50.4 -36.95 35.16 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 121.406 -0.118 . . . . 0.0 110.908 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 151.57 26.72 0.05 OUTLIER Glycine 0 CA--C 1.524 0.601 0 C-N-CA 119.423 -1.37 . . . . 0.0 115.567 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.545 ' HA ' ' HA3' ' A' ' 248' ' ' GLY . 13.4 p90 -138.78 157.01 46.87 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.722 1.261 . . . . 0.0 111.184 178.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -148.26 166.02 29.02 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.777 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.405 ' CE2' ' HE3' ' A' ' 244' ' ' LYS . 2.0 m-30 -113.52 130.03 56.43 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.611 ' HB ' HG12 ' A' ' 245' ' ' ILE . 40.8 t -125.57 133.34 69.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.849 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 52.2 m -114.79 135.38 54.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.545 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 24.5 m-85 -120.02 139.34 52.65 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.502 ' CA ' HG12 ' A' ' 270' ' ' ILE . 53.0 t0 -58.82 -36.93 75.31 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.763 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 99.8 p -123.12 147.73 46.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.406 0.622 . . . . 0.0 111.715 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.43 -30.55 70.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.439 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -55.56 -40.36 71.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.332 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -65.18 -37.58 87.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.792 0.329 . . . . 0.0 110.413 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 69.4 t -62.08 -49.07 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 CA-C-O 121.179 0.514 . . . . 0.0 109.738 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -66.68 -35.5 80.29 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.874 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.57 ' HD3' ' HB2' ' A' ' 266' ' ' TRP . 62.3 ttt-85 -56.19 -45.77 79.68 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.083 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.788 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 2.1 p -71.84 -35.35 54.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.964 0.411 . . . . 0.0 111.214 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 74.0 m -59.07 -40.74 86.12 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.701 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -57.57 -34.66 69.44 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.312 0.577 . . . . 0.0 109.843 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 305' ' ' PHE . 81.6 m-20 -83.85 4.77 27.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.686 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.678 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 30.7 tptt 44.04 -82.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.323 0.249 . . . . 0.0 110.575 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.701 ' HB3' ' HB3' ' A' ' 312' ' ' LYS . 3.1 m-30 -105.31 135.92 45.8 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.12 0.486 . . . . 0.0 110.269 178.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.448 ' CD1' HG22 ' A' ' 300' ' ' VAL . 0.9 OUTLIER -115.01 134.92 56.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.661 178.653 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -69.36 130.36 42.35 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.807 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 17.7 t80 -150.25 -72.56 0.17 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.89 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.442 ' HE3' ' CE2' ' A' ' 308' ' ' PHE . 4.0 mmpt? -91.96 -176.53 4.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.261 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -50.14 -30.57 11.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.911 0.386 . . . . 0.0 110.384 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -117.56 152.74 34.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.903 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.701 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 62.6 mttp -62.18 148.77 43.52 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.115 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 28.4 pt -107.81 138.63 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . 0.6 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 81.9 mt-10 -104.55 132.89 50.28 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.523 HG12 HG22 ' A' ' 247' ' ' VAL . 82.6 mt -119.31 128.55 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 121.394 0.616 . . . . 0.0 111.744 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -131.25 146.07 52.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.838 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -49.79 145.46 5.31 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.234 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.45 142.5 43.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.138 0.494 . . . . 0.0 111.463 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -126.83 82.18 67.99 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.477 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.57 143.27 28.69 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.231 1.954 . . . . 0.0 111.969 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.416 ' NH2' " H5'" ' B' ' 3' ' ' ' U' . 20.5 mmt85 -56.74 -34.98 68.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.824 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.839 179.974 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.739 0 C3'-C2'-O2' 111.167 -0.736 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.544 ' C5 ' ' CE1' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.962 0 C1'-C2'-O2' 108.463 -0.712 . 0.51 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.482 " C3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.998 0 C4'-C3'-C2' 103.614 0.914 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.573 " O2'" ' HA2' ' A' ' 201' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.883 0 C4'-C3'-C2' 103.923 1.223 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.552 " H1'" ' CE2' ' A' ' 162' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.89 0 O4'-C1'-N19 109.123 0.923 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.619 ' N9 ' ' CE2' ' A' ' 162' ' ' PHE . . . . . . . . 0 O5'--C5' 1.423 -1.067 0 C3'-C2'-O2' 111.311 -0.686 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.672 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -1.03 0 C3'-C2'-O2' 111.226 -0.715 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.96 0 C3'-C2'-O2' 111.236 -0.712 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 48.3 tttp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.766 0.317 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 158' ' ' SER . 75.8 mm-40 -111.12 154.6 24.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 157' ' ' GLU . 3.9 m 90.39 93.47 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.003 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.74 109.01 7.78 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.115 0.483 . . . . 0.0 110.039 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.444 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 6.7 tptm -117.92 135.65 53.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.639 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.478 ' HB2' ' HB2' ' A' ' 205' ' ' LEU . 89.0 mmm -117.72 145.19 44.62 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.628 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 3.3 t80 -110.43 130.79 55.48 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.477 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.754 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 19.9 mm -116.87 127.68 74.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.578 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.658 ' HA2' ' C6 ' ' B' ' 5' ' ' ' U' . . . -128.81 161.52 22.42 Favored Glycine 0 CA--C 1.505 -0.562 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.518 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.44 ' HA3' " C5'" ' B' ' 4' ' ' ' A' . . . 77.59 27.69 58.7 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.96 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.513 ' O ' ' C8 ' ' B' ' 4' ' ' ' A' . 72.9 mt -86.45 140.44 29.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.636 0.255 . . . . 0.0 111.176 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.493 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 18.2 t30 -63.63 135.42 56.75 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.576 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 4.1 m-90 -53.6 143.21 20.61 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.176 -0.609 . . . . 0.0 109.906 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 168' ' ' TRP . 53.7 t0 74.21 36.53 0.66 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.742 -177.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 171' ' ' THR . 90.0 m -59.98 -34.67 73.62 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.17 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.0 OUTLIER 59.66 127.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -178.519 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.498 ' HA ' HD13 ' A' ' 190' ' ' ILE . 55.1 mp0 -58.15 -31.62 67.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.361 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.579 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.9 m-20 -55.46 -41.22 72.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.761 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 170' ' ' THR . 85.7 m-20 -64.83 -37.63 88.26 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.517 HD21 ' CD2' ' A' ' 179' ' ' PHE . 4.8 mt -60.51 -45.41 93.91 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.579 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -67.68 -34.84 77.71 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.363 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.29 -37.96 89.28 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.028 0.442 . . . . 0.0 109.851 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.43 ' OH ' ' HB3' ' A' ' 221' ' ' HIS . 67.3 t80 -80.58 -61.47 1.96 Allowed 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.437 0.637 . . . . 0.0 110.936 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.517 ' CD2' HD21 ' A' ' 175' ' ' LEU . 72.2 m-85 -66.04 -25.68 67.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.776 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.25 -26.11 12.82 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.241 -0.98 . . . . 0.0 110.738 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.524 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 0.1 OUTLIER -54.29 -46.05 72.67 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.511 0.724 . . . . 0.0 111.02 179.007 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -70.31 -35.33 73.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.701 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 171.36 -169.89 42.86 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.19 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 48.1 m -84.0 138.48 33.08 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 206' ' ' SER . 7.1 p -102.34 124.37 56.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.501 ' O ' ' OD1' ' A' ' 187' ' ' ASP . 69.4 p -69.63 -40.6 76.46 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.792 0.33 . . . . 0.0 111.136 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.501 ' OD1' ' O ' ' A' ' 186' ' ' THR . 86.3 m-20 -149.11 161.99 40.87 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.342 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.422 HD22 HD11 ' A' ' 175' ' ' LEU . 0.0 OUTLIER -138.4 144.23 40.13 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.207 -178.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.512 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 11.2 tptt -140.5 121.57 14.69 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 178.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.498 HD13 ' HA ' ' A' ' 172' ' ' GLU . 11.4 mt -124.56 130.82 73.39 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.796 176.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.581 ' HB2' ' HB2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -86.2 109.12 18.69 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.228 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -121.4 148.11 44.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.733 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 10.7 t0 -123.76 77.46 56.83 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -56.73 -23.25 48.71 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.678 2.252 . . . . 0.0 112.758 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.66 -74.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.53 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.1 p -69.75 -26.05 64.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.03 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.87 -2.97 67.04 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.389 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.513 ' HD2' ' CE2' ' A' ' 168' ' ' TRP . 9.8 tpp85 -129.41 137.0 50.66 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.73 -167.22 1.94 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.391 0.615 . . . . 0.0 112.48 -178.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.928 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 66.8 mmt-85 -53.52 -38.49 63.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.474 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 166' ' ' LEU . . . 81.2 18.05 70.28 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.955 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.928 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 32.2 p90 -139.52 159.81 41.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.669 0.271 . . . . 0.0 110.534 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.474 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -142.51 160.07 27.28 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.948 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.69 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 97.5 m-85 -108.37 129.05 55.26 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 161' ' ' MET . 65.7 mt -108.31 142.05 39.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.939 0.399 . . . . 0.0 111.969 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.479 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 33.8 t -125.01 128.2 48.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.314 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -117.02 138.93 51.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.95 0.405 . . . . 0.0 111.975 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.433 ' CA ' ' CG2' ' A' ' 186' ' ' THR . 84.4 tt0 -62.81 -34.52 77.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.727 178.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.92 117.48 53.72 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.509 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.04 -21.13 33.14 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.639 2.226 . . . . 0.0 113.296 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.7 m -57.31 -39.02 74.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.617 0.246 . . . . 0.0 111.553 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.455 ' HA ' ' OE2' ' A' ' 215' ' ' GLU . 21.2 m -60.82 -37.53 82.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.818 0.342 . . . . 0.0 110.696 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.51 -43.81 97.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.376 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -61.47 -41.43 97.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.931 0.396 . . . . 0.0 111.045 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.455 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 21.7 pt-20 -76.76 -29.44 56.11 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.836 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 79.5 t -61.85 -43.89 98.03 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-O 121.027 0.442 . . . . 0.0 110.639 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 50.1 t -71.87 -45.53 64.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -60.15 -38.76 84.12 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.475 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 35.5 m -81.72 144.28 31.24 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -80.21 138.67 36.88 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.836 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 41.0 m-70 -122.34 132.16 54.25 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -176.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.402 HD11 ' O ' ' A' ' 221' ' ' HIS . 29.1 mm -122.24 110.56 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.7 tt -122.4 126.72 48.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.926 0.393 . . . . 0.0 111.061 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 55.4 41.81 30.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.226 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 74.32 14.03 81.06 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.707 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.444 ' NZ ' ' N6 ' ' B' ' 4' ' ' ' A' . 35.8 mmtp -125.73 152.63 45.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.981 0.39 . . . . 0.0 111.721 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 27.5 m -99.89 130.64 48.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.312 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' A' ' 164' ' ' GLY . 33.6 pt -126.04 158.44 35.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.396 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.57 80.48 71.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.159 0.504 . . . . 0.0 110.786 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.556 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 61.8 Cg_exo -56.66 127.97 28.1 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 123.07 2.513 . . . . 0.0 112.096 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.407 ' HE2' ' O4 ' ' B' ' 5' ' ' ' U' . 8.8 mtmm -133.13 156.06 48.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.008 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -60.14 137.18 58.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.769 0.318 . . . . 0.0 110.98 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.511 ' HA ' ' N1 ' ' B' ' 6' ' ' ' A' . . . -64.34 144.52 57.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.269 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.515 ' CD1' ' C6 ' ' B' ' 6' ' ' ' A' . 0.1 OUTLIER -122.41 137.03 27.1 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.645 179.304 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.48 ' HD2' ' OE1' ' A' ' 238' ' ' GLU . 34.8 Cg_exo -56.26 145.05 79.43 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 121.923 1.749 . . . . 0.0 110.727 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -55.38 -40.97 71.99 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.931 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -61.72 -41.76 98.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.436 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.48 ' OE1' ' HD2' ' A' ' 235' ' ' PRO . 94.4 mt-10 -66.14 -35.25 79.99 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.906 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -59.98 -37.0 78.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.07 0.462 . . . . 0.0 110.259 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -59.79 -38.17 81.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.975 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -58.66 -37.98 77.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.193 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 19.2 p -84.8 161.98 19.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.114 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.04 161.74 24.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.809 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.485 ' HD2' ' CE2' ' A' ' 288' ' ' PHE . 7.6 ttpm? -138.7 131.99 30.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.812 0.306 . . . . 0.0 111.182 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.639 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -120.9 162.52 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 121.409 0.623 . . . . 0.0 112.23 -178.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.539 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 85.1 t80 -104.19 138.22 40.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.746 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.596 HG12 HD13 ' A' ' 250' ' ' ILE . 9.2 p -131.99 147.61 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.538 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -125.99 165.18 19.28 Favored Glycine 0 C--O 1.226 -0.389 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 178.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 85.59 14.66 67.56 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.586 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.596 HD13 HG12 ' A' ' 247' ' ' VAL . 35.8 mm -54.95 -45.7 76.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.54 ' O ' ' CG1' ' A' ' 254' ' ' VAL . . . 59.44 129.77 0.01 OUTLIER Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.961 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.93 -27.11 52.23 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.326 2.017 . . . . 0.0 113.137 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -59.25 -33.97 71.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.919 0.39 . . . . 0.0 111.427 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.54 ' CG1' ' O ' ' A' ' 251' ' ' GLY . 7.1 p -50.5 -39.55 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 68.11 126.65 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -175.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.457 ' HB3' ' HG ' ' A' ' 274' ' ' LEU . 8.9 Cg_endo -51.08 -26.62 19.56 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 121.904 1.736 . . . . 0.0 112.827 -177.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -62.01 -45.5 93.34 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 78.2 mm-40 -66.38 -38.41 87.48 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.633 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 40.6 t80 -60.88 -45.56 94.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.166 -178.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.49 -43.4 97.37 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.594 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -78.12 -28.52 48.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.013 0.435 . . . . 0.0 111.012 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.597 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 4.3 t80 -59.12 -58.61 7.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.918 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.68 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 5.8 m-85 -63.51 -23.63 67.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.218 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.464 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 23.1 t -55.13 -29.82 58.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.842 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -52.35 -35.47 51.17 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.361 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.68 ' CZ2' ' CD2' ' A' ' 263' ' ' PHE . 9.0 p90 -116.13 41.72 2.53 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.215 0.531 . . . . 0.0 111.526 179.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.506 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 159.39 157.12 8.38 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.81 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 4.5 t -73.45 -25.19 60.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.339 . . . . 0.0 111.011 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.543 HD12 ' CB ' ' A' ' 263' ' ' PHE . 75.1 mt 58.11 124.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.768 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 292' ' ' ASP . 25.3 mm -93.2 -74.45 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.14 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -92.09 -72.54 0.59 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.793 0.33 . . . . 0.0 111.738 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' A' ' 289' ' ' VAL . . . 46.56 101.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.353 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . 0.466 ' HG3' ' HG2' ' A' ' 275' ' ' MET . 14.1 pt20 -143.17 158.22 43.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.115 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.591 ' HB3' ' CD ' ' A' ' 282' ' ' GLN . 42.6 mt -63.78 -33.98 76.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.181 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.682 ' O ' ' HB3' ' A' ' 282' ' ' GLN . 8.0 mtm 68.11 71.13 0.32 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.634 0.254 . . . . 0.0 110.96 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.473 HD22 ' HG2' ' A' ' 282' ' ' GLN . 9.7 mt -76.4 126.64 31.36 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.129 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -58.93 -38.17 78.37 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.888 0.852 . . . . 0.0 108.726 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -157.34 -101.05 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 113.993 -1.458 . . . . 0.0 108.026 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.459 ' O ' ' CG2' ' A' ' 280' ' ' THR . 89.5 m-20 -62.77 -39.08 93.06 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.574 178.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.459 ' CG2' ' O ' ' A' ' 279' ' ' ASP . 0.5 OUTLIER 170.77 50.07 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.005 -179.729 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -56.16 -38.38 76.79 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.092 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.682 ' HB3' ' O ' ' A' ' 275' ' ' MET . 4.8 pp0? -61.81 -30.07 70.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.197 0.522 . . . . 0.0 111.632 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 52.2 p -54.55 -14.18 1.21 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.626 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -51.33 -36.64 43.7 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 121.332 -0.147 . . . . 0.0 110.775 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 157.37 23.75 0.03 OUTLIER Glycine 0 CA--C 1.526 0.721 0 C-N-CA 119.596 -1.288 . . . . 0.0 115.379 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.534 ' CE1' " H4'" ' B' ' 2' ' ' ' A' . 2.0 p90 -138.43 163.17 32.59 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.672 1.236 . . . . 0.0 111.073 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.468 ' CA ' HG13 ' A' ' 250' ' ' ILE . . . -142.17 159.83 27.11 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.525 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.496 ' CD2' ' SD ' ' A' ' 275' ' ' MET . 0.1 OUTLIER -122.41 124.17 43.02 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.639 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 52.4 t -125.89 136.19 61.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.083 0.468 . . . . 0.0 111.501 178.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 55.7 m -116.44 136.24 53.16 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.506 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 42.8 m-85 -114.1 136.92 52.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.355 0.598 . . . . 0.0 112.398 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.486 ' HB2' ' CD1' ' A' ' 270' ' ' ILE . 51.7 t0 -57.09 -36.11 70.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.638 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 50.4 m -121.97 145.2 48.35 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.337 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . 0.471 ' O ' HG11 ' A' ' 297' ' ' VAL . . . -65.77 -28.99 69.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.531 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -54.68 -35.62 63.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.872 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.45 -39.26 83.03 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.471 HG11 ' O ' ' A' ' 294' ' ' ALA . 7.3 p -60.0 -37.51 72.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.974 0.416 . . . . 0.0 111.331 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . 0.461 ' N ' HG11 ' A' ' 297' ' ' VAL . 91.0 m-20 -61.98 -39.31 91.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.846 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -61.08 -43.83 98.29 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.635 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 0.9 OUTLIER -69.38 -34.1 60.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.32 -179.322 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 89.5 m -57.77 -45.28 86.18 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.062 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -62.23 -39.72 93.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.213 0.53 . . . . 0.0 109.883 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.6 m-20 -62.38 -33.64 75.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.123 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.614 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 22.6 tptm 68.47 -69.06 0.16 Allowed 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -177.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.614 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.4 m-30 -116.28 151.11 36.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.121 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.424 HG22 ' CZ ' ' A' ' 262' ' ' PHE . 8.4 mm -116.53 136.35 53.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.502 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -79.93 65.12 4.98 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.597 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 3.9 t80 -65.86 -63.44 1.09 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.444 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 5.5 mmpt? -105.91 38.79 1.92 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.376 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 61.47 34.24 18.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -175.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -151.01 163.96 37.52 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 113.167 -1.833 . . . . 0.0 107.351 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 68.5 mttt -97.15 136.26 37.92 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.514 0.673 . . . . 0.0 112.711 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 305' ' ' PHE . 36.3 pt -117.62 150.95 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . 0.531 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 87.7 mt-10 -106.06 133.35 50.91 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.86 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.483 ' CD1' ' CZ ' ' A' ' 263' ' ' PHE . 74.3 mt -122.59 129.32 75.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.227 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.5 ' O ' ' HB3' ' A' ' 246' ' ' PHE . 8.8 tptt -133.94 141.22 47.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.717 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -53.69 150.56 7.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.669 0.271 . . . . 0.0 110.332 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -49.69 142.86 7.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.948 0.404 . . . . 0.0 111.232 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -96.61 149.82 36.26 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.718 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.424 ' O ' ' HB2' ' A' ' 321' ' ' ARG . 36.7 Cg_exo -59.66 -18.77 49.69 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.952 2.435 . . . . 0.0 112.439 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 320' ' ' PRO . 51.0 mmm-85 70.27 -61.03 0.47 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.964 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.884 179.857 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.758 0 C3'-C2'-O2' 111.285 -0.695 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.539 ' C5 ' ' CE1' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.869 0 C3'-C2'-O2' 111.231 -0.714 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.554 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.423 -1.047 0 C1'-C2'-O2' 108.294 -0.769 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.576 ' C5 ' ' CE3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.426 -0.9 0 C4'-C3'-C2' 103.861 1.161 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.957 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.791 0 C4'-C3'-C2' 103.758 1.058 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.957 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.999 0 C3'-C2'-O2' 111.247 -0.708 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.69 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.996 0 C1'-C2'-O2' 108.524 -0.692 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . 0.513 ' P ' " O2'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.01 0 C3'-C2'-O2' 111.308 -0.687 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.928 0.394 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -62.05 -31.27 71.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.058 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 86.6 p -60.13 -26.49 66.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.39 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 43.5 t -133.66 95.76 3.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.755 0.312 . . . . 0.0 111.246 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -138.94 137.41 36.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.099 0.475 . . . . 0.0 111.198 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.648 ' O ' ' HA ' ' A' ' 204' ' ' PHE . 94.6 mmm -113.56 148.07 36.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.26 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.626 ' CE2' ' N9 ' ' B' ' 6' ' ' ' A' . 2.9 t80 -104.06 127.79 51.64 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 203' ' ' GLY . 20.3 mm -116.71 129.1 73.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.734 0.302 . . . . 0.0 111.364 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.543 ' HA2' ' C6 ' ' B' ' 5' ' ' ' U' . . . -133.33 163.27 24.36 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 178.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.84 36.63 52.37 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.981 -1.104 . . . . 0.0 112.024 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.36 -26.73 65.33 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.677 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 52.2 t30 69.67 40.38 1.38 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -177.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.63 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 15.4 m0 30.9 38.5 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 114.636 -1.166 . . . . 0.0 112.76 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -164.34 13.56 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.569 ' O ' ' O ' ' A' ' 171' ' ' THR . 63.1 m -60.74 -38.17 84.24 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.569 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.1 OUTLIER 51.92 135.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.178 0.514 . . . . 0.0 111.591 -179.432 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.527 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 97.8 mt-10 -61.15 -33.77 73.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.028 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 177' ' ' GLU . 91.5 m-20 -59.37 -44.49 92.71 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.629 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 170' ' ' THR . 81.9 m-20 -77.16 -42.23 38.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.376 0.608 . . . . 0.0 110.735 178.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.427 ' HB2' ' CG2' ' A' ' 170' ' ' THR . 41.1 tp -66.63 -48.75 68.46 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.419 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 68.0 ttp85 -63.13 -44.42 95.63 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.806 0.336 . . . . 0.0 111.015 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 173' ' ' ASP . 98.3 mt-10 -67.03 -37.29 83.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.476 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.647 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 69.5 t80 -61.16 -48.21 82.64 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.1 0.476 . . . . 0.0 110.864 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -82.76 -12.06 57.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.885 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.17 -29.85 53.33 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 177.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.499 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 0.3 OUTLIER -56.48 -45.27 81.01 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.307 -0.947 . . . . 0.0 110.764 178.761 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -70.64 -33.66 71.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.331 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -173.38 -179.7 44.22 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.26 -0.971 . . . . 0.0 113.166 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 46.6 m -63.07 -31.09 72.15 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.534 ' CG1' ' O ' ' A' ' 185' ' ' VAL . 1.2 t 63.95 85.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -177.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -59.22 -50.98 71.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.019 -178.005 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 206' ' ' SER . 60.7 t0 -147.49 105.87 3.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.171 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.469 ' O ' ' CD1' ' A' ' 188' ' ' LEU . 0.0 OUTLIER -97.93 144.44 27.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.903 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.492 ' O ' ' CA ' ' A' ' 203' ' ' GLY . 30.7 tptt -127.26 128.68 46.41 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.627 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.549 ' O ' ' O ' ' A' ' 191' ' ' MET . 1.5 tt -117.82 -10.35 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.845 -0.162 . . . . 0.0 111.428 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.707 ' CE ' ' HA3' ' A' ' 203' ' ' GLY . 17.0 mtm 51.44 150.18 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.987 0.422 . . . . 0.0 111.543 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.402 ' HG3' ' HD3' ' A' ' 194' ' ' PRO . 7.5 ptmt -134.5 163.66 29.21 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.095 0.474 . . . . 0.0 112.223 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.642 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 1.3 t70 -124.23 76.55 60.64 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.619 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.402 ' HD3' ' HG3' ' A' ' 192' ' ' LYS . 38.8 Cg_exo -58.03 -25.46 70.66 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.711 2.274 . . . . 0.0 112.98 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -68.94 -66.66 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.32 . . . . 0.0 111.588 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.0 p -71.98 -20.31 61.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.772 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 88.07 12.88 65.1 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.369 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.642 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 55.5 mtt180 -118.47 167.75 11.3 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 121.094 0.473 . . . . 0.0 112.253 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.9 t -69.71 152.19 44.95 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.254 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.866 ' HG3' ' CE1' ' A' ' 202' ' ' PHE . 15.2 tpt180 -52.68 -32.02 40.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.977 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.463 ' HA2' " O2'" ' B' ' 4' ' ' ' A' . . . 98.1 -4.11 60.57 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.485 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.866 ' CE1' ' HG3' ' A' ' 200' ' ' ARG . 12.1 p90 -151.41 159.45 44.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.707 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -152.71 150.43 22.22 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.274 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.717 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 94.8 m-85 -106.78 125.63 51.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.081 0.44 . . . . 0.0 109.82 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 161' ' ' MET . 46.6 mt -103.1 138.92 39.3 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.911 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 23.2 t -123.17 132.77 54.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.119 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.513 ' CE1' ' CG2' ' A' ' 185' ' ' VAL . 96.9 m-85 -117.89 140.55 49.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 111.695 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.424 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.2 tt0 -60.66 -34.12 73.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.198 0.523 . . . . 0.0 109.673 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.2 115.17 50.36 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.609 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.62 -21.76 32.81 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.665 2.244 . . . . 0.0 113.22 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.5 m -56.86 -35.7 69.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.726 0.298 . . . . 0.0 111.307 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.428 ' O ' ' CG2' ' A' ' 216' ' ' VAL . 32.3 m -58.49 -36.96 74.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.851 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 63.0 t -60.83 -42.02 90.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.179 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.402 ' O ' HG11 ' A' ' 217' ' ' VAL . 94.6 m-20 -59.29 -40.64 86.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.877 0.37 . . . . 0.0 111.177 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.81 -27.38 36.59 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.634 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 53.1 t -62.07 -45.77 97.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 CA-C-O 120.773 0.32 . . . . 0.0 111.693 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.402 HG11 ' O ' ' A' ' 214' ' ' ASP . 8.3 p -60.01 -36.55 68.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -60.96 -35.87 77.89 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.753 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 29.6 m -80.66 143.27 33.19 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 93.1 mt-30 -65.97 -36.83 84.37 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.753 ' CD2' ' O ' ' A' ' 219' ' ' THR . 82.4 m-70 78.4 44.33 0.07 Allowed 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 75.4 mt -75.38 82.2 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.441 HD13 ' CG ' ' A' ' 178' ' ' TYR . 7.2 tt -82.52 -75.47 0.31 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -176.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 49.2 p30 -94.67 13.22 25.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.582 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 95.17 7.4 59.56 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.052 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.12 137.0 52.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.405 ' O ' HG11 ' A' ' 227' ' ' VAL . 5.6 p -69.73 126.17 29.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.277 0.56 . . . . 0.0 111.773 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.463 HG13 ' HD3' ' A' ' 230' ' ' PRO . 34.5 pt -124.84 157.52 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.329 178.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.446 ' O ' ' O4 ' ' B' ' 5' ' ' ' U' . 0.3 OUTLIER -127.8 77.21 76.6 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.202 0.525 . . . . 0.0 112.4 -179.096 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.634 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 35.0 Cg_exo -63.55 84.98 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 123.087 2.524 . . . . 0.0 111.653 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -100.73 157.13 16.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.825 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 37.7 tpt85 -60.27 137.04 58.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.935 0.397 . . . . 0.0 111.574 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.5 ' HA ' ' N1 ' ' B' ' 6' ' ' ' A' . . . -59.91 145.79 44.58 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.06 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.561 HG13 ' N6 ' ' B' ' 6' ' ' ' A' . 9.7 mt -109.51 124.36 34.05 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.282 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.69 143.44 57.87 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 121.802 1.668 . . . . 0.0 110.753 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 32.5 mmm180 -57.53 -39.27 76.2 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.695 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 55.2 p30 -63.88 -41.69 97.67 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.978 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.613 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 97.5 mt-10 -73.43 -37.92 65.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.558 0.694 . . . . 0.0 109.703 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.563 ' NE2' " O2'" ' B' ' 6' ' ' ' A' . 61.1 tt0 -60.41 -39.98 89.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.314 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -59.52 -40.24 86.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.211 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -61.13 -35.05 76.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.148 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 16.3 p -82.87 161.39 21.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.392 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -149.03 173.02 29.05 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.193 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.514 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 6.9 tptm -135.01 131.7 37.41 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.711 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -121.48 162.24 20.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.348 0.594 . . . . 0.0 111.011 179.486 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -104.6 136.56 43.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.35 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.476 HG11 ' O ' ' A' ' 287' ' ' GLY . 14.7 p -131.49 147.87 32.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.421 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -129.11 166.59 21.46 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.404 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 84.2 22.79 53.8 Favored Glycine 0 C--N 1.328 0.107 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.476 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.525 ' O ' ' O ' ' A' ' 251' ' ' GLY . 43.0 mm -54.97 -48.99 74.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 250' ' ' ILE . . . 57.88 129.64 0.01 OUTLIER Glycine 0 CA--C 1.525 0.679 0 C-N-CA 119.807 -1.187 . . . . 0.0 111.436 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . 0.484 ' HD3' ' HG3' ' A' ' 284' ' ' ARG . 52.0 Cg_exo -54.04 -24.92 34.49 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.165 1.91 . . . . 0.0 112.907 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -57.84 -36.49 72.37 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.563 ' O ' ' HB2' ' A' ' 258' ' ' GLU . 16.2 m -65.98 -36.76 78.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 62.35 153.32 0.11 Allowed Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -56.54 -31.12 85.39 Favored 'Trans proline' 0 CA--C 1.527 0.154 0 C-N-CA 122.39 2.06 . . . . 0.0 113.478 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -64.12 -49.0 73.9 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.563 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 97.8 mt-10 -66.22 -35.57 80.78 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.938 0.399 . . . . 0.0 112.029 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.565 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 35.5 t80 -59.62 -45.34 92.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.471 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -64.73 -40.58 95.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.455 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 258' ' ' GLU . 20.5 pt-20 -75.79 -33.5 60.16 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.7 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.577 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 83.8 t80 -58.9 -56.78 17.84 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.652 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 18.6 m-85 -65.83 -24.61 66.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.326 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.48 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 24.9 t -56.21 -31.14 63.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.55 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -53.99 -36.15 62.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.526 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.652 ' CZ2' ' CD2' ' A' ' 263' ' ' PHE . 6.9 p90 -119.18 50.58 1.21 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.49 0.662 . . . . 0.0 111.213 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.565 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 148.86 145.85 4.21 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.634 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.428 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 41.1 m -59.74 -38.1 80.77 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.567 HD12 ' CB ' ' A' ' 263' ' ' PHE . 76.9 mt 70.72 84.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.533 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.601 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 66.5 mt -59.69 -38.72 77.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.836 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -131.99 -84.89 0.49 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 289' ' ' VAL . . . 61.68 113.08 0.02 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.705 0.288 . . . . 0.0 110.867 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -139.29 155.23 47.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.362 0.601 . . . . 0.0 112.07 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.545 ' O ' ' HB2' ' A' ' 275' ' ' MET . 35.5 tp -65.05 -35.19 80.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.251 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.545 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 95.7 mmm 76.66 12.81 2.41 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.425 ' HB3' HD22 ' A' ' 274' ' ' LEU . 0.9 OUTLIER -56.64 119.09 5.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.215 0.531 . . . . 0.0 111.334 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 279' ' ' ASP . 58.3 t0 -88.79 119.0 28.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.852 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 62.9 -75.31 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.273 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 277' ' ' ASP . 51.6 t0 -142.53 98.75 3.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.781 0.324 . . . . 0.0 111.648 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 2.8 p 44.62 50.54 8.38 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -84.48 -74.7 1.23 Allowed Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.028 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.953 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 92.4 mm-40 -60.94 -32.02 71.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.243 0.544 . . . . 0.0 109.814 179.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.541 ' O ' ' HB3' ' A' ' 284' ' ' ARG . 54.1 p -63.17 168.27 4.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.45 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.541 ' HB3' ' O ' ' A' ' 283' ' ' SER . 39.1 ttt85 81.03 -41.39 0.16 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.826 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -94.94 -52.16 1.82 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.225 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.513 ' CZ ' " O4'" ' B' ' 2' ' ' ' A' . 29.0 p90 -143.45 167.7 21.57 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.193 0.521 . . . . 0.0 112.209 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.476 ' O ' HG11 ' A' ' 247' ' ' VAL . . . -137.13 158.39 24.28 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.141 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.514 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.7 OUTLIER -115.34 127.44 55.42 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.734 -0.274 . . . . 0.0 111.207 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.711 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 21.8 t -124.2 136.38 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.799 0.333 . . . . 0.0 111.69 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 33.6 m -115.68 136.22 53.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.659 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.565 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 31.5 m-85 -118.33 139.21 51.69 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.601 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 55.8 p30 -62.56 -32.22 73.15 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.663 179.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.573 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 99.0 p -122.23 145.81 47.86 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.27 0.557 . . . . 0.0 111.556 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.98 -33.63 75.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.169 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -57.31 -37.39 72.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.361 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.59 82.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.914 0.387 . . . . 0.0 110.915 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 83.3 t -62.23 -42.42 95.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.981 0.42 . . . . 0.0 110.96 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -60.94 -36.62 79.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.356 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -56.98 -43.31 81.56 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.649 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 1.3 p -69.15 -34.55 63.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.656 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 80.8 m -58.01 -45.92 86.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.473 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -62.68 -39.54 94.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.252 0.549 . . . . 0.0 110.258 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -63.36 -31.99 73.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.955 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.665 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 38.4 tptt 67.81 -75.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.665 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.9 m-30 -111.16 135.57 51.49 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.702 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.521 HD13 ' CZ3' ' A' ' 266' ' ' TRP . 1.0 OUTLIER -118.55 137.41 52.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.192 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -79.08 112.64 16.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.965 0.412 . . . . 0.0 110.287 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 1.3 t80 -91.99 -89.22 0.19 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.809 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.47 ' HD3' ' CE1' ' A' ' 308' ' ' PHE . 0.0 OUTLIER -92.41 -74.86 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.939 0.399 . . . . 0.0 110.981 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -131.78 -15.79 3.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.259 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -122.02 157.36 31.53 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.518 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -79.04 143.34 35.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.935 0.398 . . . . 0.0 111.093 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 29.9 pt -115.3 147.81 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . 0.562 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 84.1 mt-10 -104.78 133.3 49.83 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.651 -0.42 . . . . 0.0 109.982 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.506 ' CD1' HG23 ' A' ' 300' ' ' VAL . 73.5 mt -122.55 127.95 75.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.069 0.461 . . . . 0.0 111.253 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -126.01 155.05 42.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.725 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 70.0 ttp85 -58.87 146.12 38.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.718 0.294 . . . . 0.0 110.378 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.71 145.26 24.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.076 0.465 . . . . 0.0 111.442 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -124.24 86.19 54.67 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.549 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.436 ' HA ' ' O4 ' ' B' ' 3' ' ' ' U' . 72.8 Cg_exo -49.37 142.02 23.52 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.353 2.035 . . . . 0.0 112.261 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -57.86 -35.29 70.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.19 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 77.6 m80 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.842 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.698 0 C3'-C2'-O2' 111.247 -0.708 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.953 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.946 0 C3'-C2'-O2' 111.284 -0.695 . 0.211 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.457 ' C5 ' ' HZ ' ' A' ' 288' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -1.027 0 C3'-C2'-O2' 111.254 -0.705 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.677 ' N7 ' ' HA ' ' A' ' 167' ' ' ASN . . . . . . . . 0 O5'--C5' 1.425 -0.927 0 C4'-C3'-C2' 103.786 1.086 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.543 ' C6 ' ' HA2' ' A' ' 164' ' ' GLY . . . . . . . . 0 O5'--C5' 1.425 -0.932 0 N19-C1'-C2' 114.789 0.868 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.626 ' N9 ' ' CE2' ' A' ' 162' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.968 0 C4'-C3'-C2' 103.737 1.037 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.717 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.954 0 C4'-C3'-C2' 103.421 0.721 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . 0.457 ' P ' " O2'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.922 0 C3'-C2'-O2' 111.326 -0.681 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.7 tttt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.794 0.33 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -103.46 138.89 39.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.652 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.9 p -127.75 154.62 45.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.945 0.403 . . . . 0.0 111.222 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 45.8 t -175.12 61.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.457 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -129.66 141.36 50.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.574 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 95.1 mmm -118.08 146.38 44.15 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.635 ' CE2' ' C8 ' ' B' ' 6' ' ' ' A' . 6.7 t80 -106.09 127.55 53.26 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 202' ' ' PHE . 11.1 mm -115.37 117.45 55.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.249 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 202' ' ' PHE . . . -91.54 178.86 41.53 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.813 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 164' ' ' GLY . . . 26.69 80.11 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 114.387 0.515 . . . . 0.0 114.387 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.481 ' O ' ' HB ' ' A' ' 170' ' ' THR . 58.8 mt -85.76 2.13 46.81 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.881 ' O ' ' N ' ' A' ' 169' ' ' ASP . 41.7 t-20 61.04 41.39 13.96 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.573 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 16.9 m0 34.49 -55.97 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.053 0.941 . . . . 0.0 113.522 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.881 ' N ' ' O ' ' A' ' 167' ' ' ASN . 93.1 m-20 -53.21 -34.84 58.74 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 166' ' ' LEU . 55.8 m -62.95 139.43 58.75 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.189 0.518 . . . . 0.0 111.206 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 10.5 p -116.12 167.43 11.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.324 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.474 ' HA ' HD13 ' A' ' 190' ' ' ILE . 21.2 pt-20 -59.85 -27.08 66.35 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.482 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 89.6 m-20 -62.07 -43.01 99.76 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.044 0.449 . . . . 0.0 110.3 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -67.05 -36.66 82.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.766 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.418 HD21 ' CD2' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -53.63 -49.82 67.04 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -179.025 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 180' ' ' GLY . 0.0 OUTLIER -65.29 -33.45 76.01 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.623 178.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -62.02 -41.36 97.99 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.255 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.451 ' OH ' ' HB3' ' A' ' 221' ' ' HIS . 64.0 t80 -75.74 -60.0 2.51 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.628 0.727 . . . . 0.0 111.003 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.452 ' CG ' HD23 ' A' ' 205' ' ' LEU . 80.8 m-85 -69.0 -21.1 64.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.652 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.95 -25.53 16.82 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.687 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.799 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -55.7 -40.72 72.78 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.0 0.428 . . . . 0.0 110.795 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.799 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 64.6 m-85 -69.96 -32.49 70.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.43 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 167.08 -133.11 2.8 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.831 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.4 m -119.93 139.06 53.02 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.477 HG21 ' O ' ' A' ' 206' ' ' SER . 0.8 OUTLIER -91.22 117.63 34.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.2 t -66.7 -43.77 83.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.138 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -156.28 98.34 1.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.34 142.1 27.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.499 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.595 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 49.1 tptt -130.92 128.0 39.62 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 172' ' ' GLU . 1.4 mt -122.54 129.53 75.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.623 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.563 ' HG2' " H1'" ' B' ' 7' ' ' ' U' . 2.6 mpp? -92.6 135.08 34.39 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -131.91 168.67 17.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.163 0.506 . . . . 0.0 112.168 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 0.6 OUTLIER -125.43 85.24 58.84 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.742 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.77 -24.57 47.28 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.305 2.003 . . . . 0.0 112.313 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -73.37 -70.66 0.35 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.372 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 55.0 p -71.49 -21.08 61.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.019 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 84.18 19.57 60.58 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.376 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.577 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 79.7 mtt180 -120.43 163.59 17.67 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.6 m -111.95 154.5 25.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.104 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.692 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 14.3 mmp_? -51.35 -29.43 15.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.476 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.51 ' HA2' " C2'" ' B' ' 4' ' ' ' A' . . . 98.08 -1.84 59.47 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.706 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.692 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 36.4 p90 -140.86 158.64 43.66 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.326 -0.437 . . . . 0.0 110.448 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.447 ' HA3' ' HE2' ' A' ' 191' ' ' MET . . . -142.92 161.99 27.49 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.674 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 94.8 m-85 -104.68 122.16 45.08 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.455 ' CD2' ' CZ ' ' A' ' 207' ' ' PHE . 63.1 tp -109.75 126.34 53.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.813 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.477 ' O ' HG21 ' A' ' 185' ' ' VAL . 29.4 t -118.31 139.05 51.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.973 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.455 ' CZ ' ' CD2' ' A' ' 205' ' ' LEU . 82.1 m-85 -119.4 146.51 45.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.95 0.405 . . . . 0.0 111.497 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.55 -36.12 82.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.616 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -111.07 121.81 39.62 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.363 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -56.33 -27.17 65.85 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.491 2.127 . . . . 0.0 112.923 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.0 t -58.35 -36.34 73.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.768 0.318 . . . . 0.0 110.713 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 22.8 m -58.83 -35.21 72.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.28 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.47 -40.89 87.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.887 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -58.21 -43.57 87.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.783 0.325 . . . . 0.0 110.769 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.27 -34.83 75.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.132 0.492 . . . . 0.0 111.197 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.9 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 79.9 t -60.85 -43.02 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.785 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.1 m -86.52 -31.84 6.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -59.64 -35.26 74.06 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.472 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 74.4 m -100.59 147.01 26.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -78.96 139.24 38.28 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.9 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 44.0 m-70 -120.63 129.26 53.64 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -176.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 68.6 mt -122.44 115.4 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.1 tt -117.94 127.25 53.66 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.758 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 58.9 t0 52.87 36.34 21.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.959 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.06 13.86 82.9 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.731 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -126.48 156.39 40.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.994 0.397 . . . . 0.0 111.626 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 44.0 t -99.94 129.61 50.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.801 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.488 HG13 ' HD3' ' A' ' 230' ' ' PRO . 29.0 pt -109.3 -30.95 2.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 48.09 76.66 0.53 Allowed Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 121.246 0.546 . . . . 0.0 110.855 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.488 ' HD3' HG13 ' A' ' 228' ' ' ILE . 34.9 Cg_exo -59.8 135.58 64.58 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 123.234 2.622 . . . . 0.0 112.117 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.554 ' HE2' ' H62' ' B' ' 6' ' ' ' A' . 5.5 ttpt -136.73 142.08 43.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.184 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -51.78 142.02 15.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.974 0.416 . . . . 0.0 111.355 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.96 143.13 54.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.21 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.545 ' CG1' ' C6 ' ' B' ' 6' ' ' ' A' . 0.1 OUTLIER -119.17 128.33 26.0 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.668 179.233 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.9 149.79 25.11 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.061 1.841 . . . . 0.0 110.858 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -53.25 -41.96 65.99 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.772 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -63.2 -40.79 98.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.971 0.415 . . . . 0.0 110.459 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -66.05 -36.94 84.58 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.649 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.47 -37.95 82.64 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.861 0.362 . . . . 0.0 110.568 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -60.23 -40.05 88.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.975 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -60.57 -35.12 75.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.289 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.402 ' CG2' ' CD1' ' A' ' 270' ' ' ILE . 18.3 p -83.22 162.44 21.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.521 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -155.98 108.02 0.35 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.21 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 7.3 ttpm? -81.34 136.18 35.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.656 0.265 . . . . 0.0 110.935 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.606 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -119.39 162.87 17.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.498 0.666 . . . . 0.0 111.832 -179.139 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.515 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 91.2 t80 -101.72 137.07 40.52 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.066 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.518 HG11 ' O ' ' A' ' 287' ' ' GLY . 11.7 p -131.11 145.45 35.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.934 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.644 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -130.5 164.67 22.93 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 98.1 -1.61 59.33 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.129 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.454 ' CD1' ' CD1' ' A' ' 259' ' ' PHE . 41.1 pt -116.62 139.49 43.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 117.192 0.496 . . . . 0.0 110.636 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.404 ' N ' HG12 ' A' ' 254' ' ' VAL . . . 177.77 -103.05 0.17 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 119.599 -1.286 . . . . 0.0 114.495 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -53.15 -25.99 31.58 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.822 2.348 . . . . 0.0 113.173 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -131.99 95.02 3.59 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.522 ' O ' ' HB2' ' A' ' 258' ' ' GLU . 0.5 OUTLIER -178.19 -46.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.152 -179.276 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 28.1 mmt180 68.37 128.02 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -177.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.38 -29.03 37.44 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.012 1.808 . . . . 0.0 112.809 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -61.72 -43.3 99.13 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.574 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 97.0 mt-10 -67.74 -35.52 78.88 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 111.368 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.653 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 19.2 t80 -59.15 -49.09 79.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.459 -178.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.74 -37.7 88.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -63.71 -40.1 95.94 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.828 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.656 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 84.0 t80 -65.41 -55.12 19.82 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.589 ' CB ' HD12 ' A' ' 269' ' ' ILE . 9.3 m-85 -65.19 -27.24 68.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.791 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.483 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 33.4 t -54.48 -26.97 34.46 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -50.17 -38.12 38.11 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.794 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.709 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 24.3 p90 -127.42 54.24 1.68 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.267 0.556 . . . . 0.0 111.18 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.485 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 151.48 153.28 6.14 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.432 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 32.8 p -71.43 -23.0 61.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.899 0.38 . . . . 0.0 111.14 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.589 HD12 ' CB ' ' A' ' 263' ' ' PHE . 77.8 mt 55.53 99.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.589 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.617 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 73.4 mt -58.47 -40.84 79.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.174 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -174.92 106.06 0.1 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.516 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -100.7 135.59 41.9 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.469 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -146.01 161.99 38.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.325 0.583 . . . . 0.0 112.546 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.605 ' O ' ' HB2' ' A' ' 275' ' ' MET . 56.7 mt -88.71 3.67 50.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.694 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.605 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 90.4 mtp 81.65 -49.53 0.24 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.584 0.354 . . . . 0.0 111.767 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 47.2 56.94 6.24 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -77.65 114.48 16.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.083 0.468 . . . . 0.0 110.276 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . 0.425 ' O ' ' HG2' ' A' ' 278' ' ' LYS . 80.4 tttt 44.34 25.97 0.15 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.836 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 53.19 44.82 29.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.372 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 1.7 t -171.53 -37.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.908 0.385 . . . . 0.0 111.294 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -54.42 -27.99 42.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.948 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.579 ' O ' ' CB ' ' A' ' 283' ' ' SER . 4.8 pp0? -137.07 162.79 32.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.601 0.239 . . . . 0.0 111.583 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.579 ' CB ' ' O ' ' A' ' 282' ' ' GLN . 83.2 p 121.91 -8.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 O-C-N 124.226 0.954 . . . . 0.0 110.385 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 67.6 mtt85 -57.36 -33.62 67.97 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.617 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 250' ' ' ILE . . . 158.28 35.38 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.618 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.474 ' CE1' " H5'" ' B' ' 2' ' ' ' A' . 7.5 p90 -144.36 165.18 28.65 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.524 0.662 . . . . 0.0 110.997 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.518 ' O ' HG11 ' A' ' 247' ' ' VAL . . . -145.98 166.18 27.99 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.069 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.45 ' CE2' ' CE ' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -120.43 122.11 40.0 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 122.892 -0.181 . . . . 0.0 111.27 179.576 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.653 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 57.6 t -123.84 137.67 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.049 0.452 . . . . 0.0 111.58 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 48.7 m -115.38 135.98 53.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.638 178.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.485 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 41.1 m-85 -114.95 136.94 52.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.15 0.5 . . . . 0.0 112.007 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.617 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 31.9 p-10 -62.38 -33.25 74.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.19 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.427 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 28.6 t -123.15 140.06 53.41 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.636 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.33 -30.96 72.0 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.067 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.4 -38.18 68.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.211 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.457 ' O ' ' HD1' ' A' ' 266' ' ' TRP . . . -62.19 -37.04 83.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.907 0.384 . . . . 0.0 110.478 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 81.3 t -61.89 -42.24 93.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.201 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.99 -36.7 77.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.147 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -57.25 -43.9 83.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.911 0.386 . . . . 0.0 112.027 -178.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.709 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 1.0 OUTLIER -69.86 -33.6 56.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.632 -179.141 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . 0.401 ' N ' HG11 ' A' ' 300' ' ' VAL . 76.8 m -57.44 -45.37 84.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.416 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -61.94 -41.42 97.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.25 0.547 . . . . 0.0 110.55 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -62.8 -32.5 73.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.433 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.657 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 10.6 tptm 67.94 -75.96 0.06 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -177.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.657 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.3 m-30 -110.52 136.1 50.16 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.473 HD13 ' CZ3' ' A' ' 266' ' ' TRP . 1.1 mt -117.05 136.95 52.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.506 ' OD1' ' O ' ' A' ' 307' ' ' ASP . 52.4 p30 -72.83 96.94 2.15 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.146 0.498 . . . . 0.0 111.705 -178.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.656 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 6.2 t80 -102.27 -75.16 0.61 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.345 0.593 . . . . 0.0 110.375 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.44 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 10.2 mmpt? -95.14 -167.9 1.71 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.152 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -52.04 -27.72 14.71 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.836 0.35 . . . . 0.0 110.753 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -116.67 160.48 20.67 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.414 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.497 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 71.4 mttt -71.85 147.82 46.77 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.53 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.644 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 28.6 pt -115.37 144.47 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . 0.594 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 83.4 mt-10 -104.29 134.52 47.38 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.059 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.494 ' CD1' HG23 ' A' ' 300' ' ' VAL . 73.5 mt -122.35 126.25 73.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.072 0.463 . . . . 0.0 111.466 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -129.96 155.42 46.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.776 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -55.46 148.42 15.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.794 0.33 . . . . 0.0 110.494 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.03 145.85 24.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.995 0.426 . . . . 0.0 111.409 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.1 101.49 53.91 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.952 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.535 ' O ' ' HB2' ' A' ' 321' ' ' ARG . 53.0 Cg_exo -54.96 -20.26 22.44 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.517 2.145 . . . . 0.0 112.354 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 320' ' ' PRO . 50.2 mmm-85 93.44 -0.0 0.09 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.282 0.633 . . . . 0.0 111.169 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.107 179.753 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.657 0 C3'-C2'-O2' 111.256 -0.705 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.515 ' C5 ' ' CE1' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.98 0 C3'-C2'-O2' 111.313 -0.685 . 0.01 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.707 " O2'" " H3'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.01 0 C3'-C2'-O2' 111.292 -0.692 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.573 ' C2 ' ' CZ3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.424 -0.984 0 O4'-C1'-C2' 107.773 0.981 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.707 " H3'" " O2'" ' B' ' 3' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.427 -0.832 0 C5'-C4'-O4' 107.741 -1.042 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.65 ' OP2' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.861 0 C3'-C2'-O2' 111.297 -0.691 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.674 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -1.026 0 C4'-C3'-C2' 103.444 0.744 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . 0.755 " H2'" ' N3 ' ' B' ' 8' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -1.017 0 C3'-C2'-O2' 111.204 -0.723 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 52.2 tttp . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.722 0.296 . . . . 0.0 111.392 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -59.47 -33.62 71.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.321 -179.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.5 m -56.89 -36.06 69.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.94 0.4 . . . . 0.0 110.785 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 10.5 m -60.1 -29.42 68.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.421 179.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -62.03 139.91 58.4 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.457 0.646 . . . . 0.0 111.74 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.491 ' N ' ' O ' ' A' ' 205' ' ' LEU . 92.7 mmm -121.08 149.13 43.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.617 -179.045 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.596 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 8.4 t80 -105.92 129.42 54.07 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.496 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 14.9 mm -114.76 127.51 72.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.835 -178.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.719 ' HA2' ' C6 ' ' B' ' 5' ' ' ' U' . . . -130.09 162.25 23.07 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.908 179.216 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.517 ' HA3' H5'' ' B' ' 4' ' ' ' A' . . . 75.6 27.39 63.29 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 119.861 -1.161 . . . . 0.0 111.691 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.505 ' O ' ' C8 ' ' B' ' 4' ' ' ' A' . 84.6 mt -85.1 140.32 31.06 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 120.802 0.335 . . . . 0.0 111.414 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.432 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 2.1 t-20 -63.07 136.75 57.98 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.423 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.61 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 3.9 m0 -51.9 -28.23 15.58 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.811 0.339 . . . . 0.0 110.882 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -92.4 9.04 35.89 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.564 178.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.581 ' O ' ' HB2' ' A' ' 174' ' ' ASN . 89.6 m -56.24 -37.2 69.41 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.566 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.7 OUTLIER 53.64 145.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.247 0.546 . . . . 0.0 110.794 -178.38 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.517 ' HG2' HG13 ' A' ' 190' ' ' ILE . 97.3 mt-10 -61.45 -33.15 73.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.766 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.539 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 92.6 m-20 -57.38 -41.26 79.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.872 -178.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.581 ' HB2' ' O ' ' A' ' 170' ' ' THR . 83.2 m-20 -64.49 -35.71 81.83 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.456 HD11 HD13 ' A' ' 188' ' ' LEU . 2.4 mt -54.02 -51.15 64.9 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.539 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -63.58 -36.76 84.85 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.935 179.605 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -66.4 -44.8 82.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.085 0.469 . . . . 0.0 110.34 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.624 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 62.4 t80 -66.33 -47.32 73.88 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.922 179.207 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.466 ' CG ' HD23 ' A' ' 205' ' ' LEU . 86.4 m-85 -91.39 -1.77 57.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.108 -178.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -61.89 -28.86 70.94 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.486 179.012 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -37.41 74.71 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.715 0.769 . . . . 0.0 110.797 -178.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -66.72 -30.69 70.98 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.062 -178.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 163.97 -126.64 1.55 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.195 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 57.3 m -119.23 141.46 48.89 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.494 HG22 ' CD2' ' A' ' 188' ' ' LEU . 13.8 p -106.69 128.73 61.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.586 -0.445 . . . . 0.0 109.972 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.412 HG21 ' CB ' ' A' ' 206' ' ' SER . 1.2 t -84.49 -43.49 14.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.535 -178.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -138.68 136.18 35.58 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -178.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.494 ' CD2' HG22 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -116.07 128.76 55.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.091 179.008 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 8.9 tptt -140.29 113.69 8.56 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.517 HG13 ' HG2' ' A' ' 172' ' ' GLU . 79.4 mt -126.77 126.62 68.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 174.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.662 ' HB2' ' HB2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -81.31 77.25 8.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.235 0.541 . . . . 0.0 110.644 -178.587 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -73.06 141.66 47.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.258 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 10.2 m-20 -92.36 100.55 3.82 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 193' ' ' ASP . 27.9 Cg_endo -62.06 -27.07 78.84 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.523 2.149 . . . . 0.0 112.796 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -75.34 -76.3 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.707 -179.484 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 57.9 p -69.99 -22.5 63.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 80.54 24.62 58.37 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.234 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.517 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 16.4 tpp85 -113.07 129.73 56.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.971 0.415 . . . . 0.0 111.395 -179.552 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.8 m -66.48 151.35 47.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.097 0.475 . . . . 0.0 111.288 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.766 ' HG3' ' CE1' ' A' ' 202' ' ' PHE . 17.3 tpt85 -59.55 -29.34 67.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.48 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.654 ' HA2' " O2'" ' B' ' 4' ' ' ' A' . . . 102.35 -9.75 56.14 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.722 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.766 ' CE1' ' HG3' ' A' ' 200' ' ' ARG . 21.0 p90 -144.24 155.3 43.81 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.445 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -144.79 164.13 27.86 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.828 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.74 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 96.5 m-85 -105.17 123.49 47.92 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.058 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 161' ' ' MET . 58.2 tp -108.02 125.52 51.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.442 -178.124 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.444 ' O ' HG21 ' A' ' 185' ' ' VAL . 27.3 t -118.29 134.51 54.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.671 0.272 . . . . 0.0 110.983 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.464 ' CZ ' ' CD2' ' A' ' 205' ' ' LEU . 88.5 m-85 -115.42 138.67 50.76 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 120.963 0.411 . . . . 0.0 112.012 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -62.04 -35.03 77.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.842 178.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.84 117.51 53.76 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.631 179.515 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -56.79 -22.88 47.22 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.512 2.142 . . . . 0.0 112.875 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.3 t -57.37 -36.74 71.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.407 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.456 ' HA ' ' OE2' ' A' ' 215' ' ' GLU . 22.0 m -58.88 -35.64 73.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.809 0.337 . . . . 0.0 110.733 179.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.47 -42.33 93.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -59.57 -42.2 91.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.33 . . . . 0.0 111.003 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.456 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 15.2 pt-20 -74.58 -29.26 61.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.669 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.814 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 75.3 t -61.97 -42.95 96.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.129 0.49 . . . . 0.0 110.346 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.77 -40.31 88.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -58.61 -38.7 78.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.679 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 39.5 m -82.39 140.2 33.61 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.071 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 60.7 tp60 -66.23 -40.01 89.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.539 178.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.814 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 85.9 m-70 82.34 97.68 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 178.134 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 72.1 mt -115.34 109.54 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 176.232 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.9 tt -116.54 128.05 55.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.935 0.397 . . . . 0.0 111.593 -178.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 22.4 t70 49.02 38.41 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.405 179.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 83.46 7.44 86.37 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.526 178.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.438 ' HD3' ' HE2' ' A' ' 278' ' ' LYS . 35.4 mmtp -120.49 152.09 38.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.778 0.323 . . . . 0.0 111.398 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 41.3 t -104.93 132.8 50.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.489 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 164' ' ' GLY . 38.8 pt -123.73 159.72 28.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.193 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -125.19 77.85 67.35 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.307 0.575 . . . . 0.0 111.081 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.575 ' HD2' ' CD2' ' A' ' 221' ' ' HIS . 50.5 Cg_exo -59.1 123.86 14.38 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.4 2.733 . . . . 0.0 111.735 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.42 ' NZ ' ' OD2' ' A' ' 271' ' ' ASP . 9.1 mtmm -134.05 153.44 51.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.793 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -56.26 138.06 51.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.042 0.449 . . . . 0.0 111.77 -179.438 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.03 145.13 56.43 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.591 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.506 ' CD1' ' C6 ' ' B' ' 6' ' ' ' A' . 2.5 mt -114.21 135.76 22.19 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.589 179.279 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.428 ' HG2' ' HB3' ' A' ' 238' ' ' GLU . 10.8 Cg_endo -55.6 139.2 82.59 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.814 1.676 . . . . 0.0 111.099 179.247 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -57.0 -41.33 78.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -61.09 -45.62 93.99 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.494 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.428 ' HB3' ' HG2' ' A' ' 235' ' ' PRO . 84.2 tt0 -70.2 -38.51 75.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.673 0.749 . . . . 0.0 109.569 178.093 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.437 ' NE2' " O2'" ' B' ' 6' ' ' ' A' . 45.2 tt0 -59.53 -39.83 85.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.289 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.19 -40.88 91.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.35 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.404 ' HE3' ' HA ' ' A' ' 238' ' ' GLU . 10.5 mtmp? -61.98 -35.39 78.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.684 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 18.2 p -84.18 162.51 20.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.221 0.534 . . . . 0.0 111.826 -178.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -165.34 172.85 41.03 Favored Glycine 0 C--O 1.226 -0.383 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.448 179.228 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.543 ' HE2' ' CE2' ' A' ' 288' ' ' PHE . 14.0 pttm -135.99 151.36 49.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.384 0.592 . . . . 0.0 111.603 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.601 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -118.82 165.58 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 121.457 0.646 . . . . 0.0 111.916 -178.395 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.462 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 82.5 t80 -99.93 133.74 43.86 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.407 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 287' ' ' GLY . 13.1 p -131.16 143.57 40.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.758 179.305 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 313' ' ' ILE . . . -126.85 169.43 18.78 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.288 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.22 15.84 56.69 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.161 -1.018 . . . . 0.0 112.456 -179.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.463 ' CD1' ' CE1' ' A' ' 259' ' ' PHE . 65.3 mt -110.78 131.15 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 120.961 0.41 . . . . 0.0 110.971 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.45 ' O ' ' CG2' ' A' ' 254' ' ' VAL . . . -174.04 -101.73 0.15 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.324 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.79 139.34 56.99 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.273 1.982 . . . . 0.0 113.01 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 55.15 45.45 25.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 178.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.497 ' O ' ' O ' ' A' ' 255' ' ' ARG . 15.4 m -125.39 -48.52 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.232 178.455 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.56 ' HB3' ' OE1' ' A' ' 258' ' ' GLU . 2.4 tpp85 57.09 136.51 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.214 0 CA-C-O 120.833 0.349 . . . . 0.0 110.17 -179.365 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.14 -26.91 53.21 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.518 2.146 . . . . 0.0 113.466 -178.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -59.8 -48.01 83.41 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.698 -179.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.56 ' OE1' ' HB3' ' A' ' 255' ' ' ARG . 58.8 mp0 -67.97 -35.56 78.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.029 0.442 . . . . 0.0 111.246 179.119 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.624 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 29.8 t80 -60.67 -45.31 94.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.914 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.59 -39.41 91.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.154 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.1 pt-20 -75.75 -30.51 59.21 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.742 0.306 . . . . 0.0 110.773 179.495 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.708 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 79.0 t80 -58.18 -57.48 12.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.136 0.493 . . . . 0.0 111.924 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.726 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 30.9 m-85 -68.28 -21.66 64.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.611 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.502 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 34.0 t -55.35 -25.27 34.02 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.043 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -47.82 -38.6 16.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.705 178.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.726 ' CZ2' ' CD2' ' A' ' 263' ' ' PHE . 24.3 p90 -132.15 55.79 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.237 0.541 . . . . 0.0 111.444 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.452 ' HA2' ' CD1' ' A' ' 291' ' ' TYR . . . 151.59 145.29 4.1 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.652 179.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 52.8 m -58.68 -36.38 74.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.847 0.356 . . . . 0.0 111.133 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.531 HD12 ' CB ' ' A' ' 263' ' ' PHE . 73.8 mt 67.74 86.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.177 -178.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.578 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 78.9 mt -55.98 -44.6 78.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.798 179.377 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.42 ' OD2' ' NZ ' ' A' ' 231' ' ' LYS . 59.5 t0 -166.89 105.02 0.58 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.703 0.287 . . . . 0.0 111.667 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -100.19 136.84 39.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.701 179.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -139.46 145.45 38.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.114 0.483 . . . . 0.0 111.9 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 275' ' ' MET . 23.3 tp -67.39 -38.07 84.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.351 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.535 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 92.5 mmm 101.87 115.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.937 0.895 . . . . 0.0 109.52 -178.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 281' ' ' GLY . 29.7 mt -123.39 140.8 52.64 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.204 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.541 ' HB3' ' HA2' ' A' ' 281' ' ' GLY . 59.4 t0 -157.66 93.72 1.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.053 177.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . 0.438 ' HE2' ' HD3' ' A' ' 226' ' ' LYS . 11.2 mmtt 69.41 48.13 0.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.205 0.526 . . . . 0.0 110.189 -177.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 60.0 t0 67.14 -70.68 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.719 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 59.5 p -69.32 -14.13 62.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.436 -179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . 0.541 ' HA2' ' HB3' ' A' ' 277' ' ' ASP . . . -55.12 126.48 38.91 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.866 -178.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.979 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 58.2 mm-40 41.25 36.79 0.52 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.996 -0.602 . . . . 0.0 110.87 178.641 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 90.8 p -126.57 157.88 37.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.859 -179.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 284' ' ' ARG . 72.0 ttt180 58.16 39.78 25.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.118 0.485 . . . . 0.0 109.808 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -160.46 -68.83 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.945 -179.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.517 ' CE1' " C4'" ' B' ' 2' ' ' ' A' . 29.7 p90 -136.82 166.85 22.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.967 0.413 . . . . 0.0 111.462 -178.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.506 ' O ' HG11 ' A' ' 247' ' ' VAL . . . -135.27 158.15 23.48 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.883 179.012 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.543 ' CE2' ' HE2' ' A' ' 244' ' ' LYS . 0.2 OUTLIER -115.13 127.95 55.89 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 122.254 0.222 . . . . 0.0 110.624 179.419 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.624 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 48.2 t -121.21 135.18 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.689 178.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 48.8 m -111.38 136.36 50.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.537 178.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.652 ' OH ' ' HB3' ' A' ' 263' ' ' PHE . 39.2 m-85 -116.08 138.69 51.02 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.371 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.578 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 21.7 t70 -57.82 -34.04 69.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.56 178.091 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 28.9 t -119.06 137.41 53.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.351 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.83 -29.76 70.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.1 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -56.05 -37.05 68.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.419 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 266' ' ' TRP . . . -60.2 -35.84 76.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.908 0.385 . . . . 0.0 110.811 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 71.2 t -60.57 -44.3 96.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.988 0.423 . . . . 0.0 110.658 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -63.43 -37.23 86.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.071 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -58.16 -42.74 86.62 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.657 ' CG2' ' CZ2' ' A' ' 266' ' ' TRP . 1.2 p -68.99 -33.7 60.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.797 0.332 . . . . 0.0 111.603 -179.405 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 72.6 m -55.2 -42.24 73.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.106 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -61.83 -37.35 84.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.085 0.469 . . . . 0.0 110.529 179.399 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.55 ' OD1' ' C ' ' A' ' 305' ' ' PHE . 0.0 OUTLIER -62.96 -35.99 81.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.654 -179.795 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.66 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 45.1 tptt 70.69 -71.86 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.457 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.667 ' CE2' ' HG2' ' A' ' 314' ' ' GLU . 32.7 m-85 -119.89 130.08 54.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.733 178.856 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.474 HG12 ' OD1' ' A' ' 303' ' ' ASN . 39.8 mt -113.11 136.42 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -78.04 95.22 4.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.0 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.708 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 4.9 t80 -87.36 -85.43 0.17 Allowed 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.991 179.451 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.566 ' O ' ' HB2' ' A' ' 310' ' ' ASP . 12.1 mmmt -94.91 4.5 53.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.566 ' HB2' ' O ' ' A' ' 309' ' ' LYS . 83.5 m-20 107.68 -31.34 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.04 0.936 . . . . 0.0 110.499 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' A' ' 312' ' ' LYS . 28.9 tpt180 -57.43 -35.46 70.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.945 179.337 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.548 ' HG3' ' HB3' ' A' ' 305' ' ' PHE . 16.4 tptt 96.12 71.6 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.537 -179.349 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.687 HG13 ' O ' ' A' ' 313' ' ' ILE . 29.9 pt -57.2 98.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.624 0.726 . . . . 0.0 110.173 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . 0.667 ' HG2' ' CE2' ' A' ' 305' ' ' PHE . 77.0 mt-10 -61.85 138.04 58.31 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.463 HG12 HG21 ' A' ' 247' ' ' VAL . 72.3 mt -121.93 128.54 75.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 19.4 mtpt -131.61 150.98 51.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.7 178.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -58.13 144.77 39.2 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.467 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . 0.402 ' O ' ' CG ' ' A' ' 319' ' ' GLU . . . -65.06 143.63 57.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.972 0.415 . . . . 0.0 111.244 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . 0.43 ' O ' ' C2 ' ' B' ' 2' ' ' ' A' . 0.9 OUTLIER 177.52 137.32 0.22 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.285 -179.85 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -55.98 126.75 23.43 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 121.541 1.494 . . . . 0.0 111.026 179.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.428 ' CB ' " O2'" ' B' ' 2' ' ' ' A' . 38.1 tpt85 -58.84 -37.82 77.32 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 120.931 0.396 . . . . 0.0 111.103 -179.387 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 77.1 m80 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.938 -179.861 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.692 0 C3'-C2'-O2' 111.214 -0.719 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.979 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.942 0 C3'-C2'-O2' 110.883 -0.834 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.521 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.423 -1.068 0 C3'-C2'-O2' 111.349 -0.673 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.654 " O2'" ' HA2' ' A' ' 201' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.888 0 C4'-C3'-C2' 104.034 1.334 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.719 ' C6 ' ' HA2' ' A' ' 164' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.783 0 O4'-C1'-N19 109.166 0.966 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.591 ' N9 ' ' CE2' ' A' ' 162' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -1.001 0 C4'-C3'-C2' 103.646 0.946 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.74 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.963 0 C3'-C2'-O2' 111.101 -0.758 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . 0.412 ' OP1' ' NH2' ' A' ' 200' ' ' ARG . . . . . . . . 0 O5'--C5' 1.425 -0.968 0 C3'-C2'-O2' 111.242 -0.71 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.864 0.364 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 60.4 mp0 -61.84 -34.22 75.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.0 t -126.09 142.27 51.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.103 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 26.3 m -86.64 0.35 54.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.041 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -74.36 139.25 43.97 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.168 0.509 . . . . 0.0 111.58 -179.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.406 ' HB2' ' HB3' ' A' ' 205' ' ' LEU . 87.3 mmm -112.52 149.32 32.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.504 -179.304 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.58 ' CE2' ' N9 ' ' B' ' 6' ' ' ' A' . 4.6 t80 -103.08 129.19 49.83 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 17.8 mm -116.8 125.91 73.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.943 -179.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.553 ' HA2' ' C6 ' ' B' ' 5' ' ' ' U' . . . -120.91 155.97 16.18 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 178.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.57 41.53 35.6 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 119.971 -1.109 . . . . 0.0 111.8 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.514 HD11 HD12 ' A' ' 190' ' ' ILE . 75.0 mt -58.81 -28.18 65.76 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.774 ' O ' ' N ' ' A' ' 169' ' ' ASP . 52.5 t30 71.98 45.41 0.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -177.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.655 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 10.9 m0 23.36 -62.62 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.534 1.134 . . . . 0.0 113.911 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.774 ' N ' ' O ' ' A' ' 167' ' ' ASN . 92.3 m-20 -53.91 -33.82 57.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.142 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 166' ' ' LEU . 87.9 m -52.92 -39.31 62.69 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.593 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 169' ' ' ASP . 0.1 OUTLIER 55.44 166.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.073 0.464 . . . . 0.0 109.822 -177.846 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.522 ' HA ' HD13 ' A' ' 190' ' ' ILE . 21.0 pt-20 -67.76 -23.0 65.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.399 -179.42 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.569 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.8 m-20 -58.68 -44.29 90.17 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.459 -178.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.411 ' HB2' ' CG2' ' A' ' 170' ' ' THR . 83.9 m-20 -68.11 -35.33 77.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.677 0.275 . . . . 0.0 111.542 179.27 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 1.5 mt -55.91 -44.8 78.63 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.19 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.569 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -64.37 -38.77 92.2 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.978 179.312 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.42 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 75.6 mm-40 -69.41 -42.49 75.01 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.573 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 53.8 t80 -64.96 -47.59 77.06 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.421 0.629 . . . . 0.0 111.565 179.471 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.446 ' CG ' HD23 ' A' ' 205' ' ' LEU . 82.4 m-85 -92.42 -1.04 57.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.224 -178.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -58.45 -31.16 66.08 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.205 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -41.18 90.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.543 0.687 . . . . 0.0 110.576 -179.322 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -68.34 -33.89 75.1 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.209 -178.301 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.44 -174.62 44.85 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.862 -179.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 54.5 m -63.48 -28.29 69.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.777 0.322 . . . . 0.0 111.319 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 185' ' ' VAL . 1.2 t 64.86 82.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -176.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.615 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 3.1 m -56.72 -42.87 79.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.414 -176.473 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -148.34 144.62 27.67 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.411 ' CD2' HG12 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -115.4 134.7 54.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.571 178.577 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 11.1 tptt -141.39 67.13 1.35 Allowed 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.522 HD13 ' HA ' ' A' ' 172' ' ' GLU . 3.3 mt -66.43 -9.93 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 121.104 0.478 . . . . 0.0 110.377 177.359 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.573 ' HE3' ' O ' ' A' ' 202' ' ' PHE . 1.8 mpp? 74.53 -56.62 0.63 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.588 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' A' ' 191' ' ' MET . 8.0 mtmp? 56.43 152.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.077 0.465 . . . . 0.0 111.597 179.392 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.691 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 0.7 OUTLIER -126.08 78.58 70.35 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.519 -179.762 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -56.51 -25.41 58.26 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 121.988 1.792 . . . . 0.0 111.706 179.442 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.77 -67.16 0.66 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.66 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.5 p -67.25 -26.83 66.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.507 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 93.14 0.77 67.66 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.818 -0.706 . . . . 0.0 113.151 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.691 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 1.5 tpt180 -127.41 125.94 41.53 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 117.162 0.481 . . . . 0.0 110.743 179.708 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 192' ' ' LYS . 42.8 m -58.11 155.46 11.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.161 0.505 . . . . 0.0 111.59 -179.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.534 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 40.3 mmt180 -55.68 -30.46 61.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.666 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.641 ' HA2' " O2'" ' B' ' 4' ' ' ' A' . . . 97.82 0.16 59.06 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.853 -178.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.602 ' CD1' " H4'" ' B' ' 5' ' ' ' U' . 28.2 p90 -148.36 159.18 44.27 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 189' ' ' LYS . . . -147.04 163.75 28.63 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.09 -1.052 . . . . 0.0 111.548 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.742 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 99.0 m-85 -104.63 122.16 45.06 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.446 HD23 ' CG ' ' A' ' 179' ' ' PHE . 53.5 tp -102.77 127.1 50.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.209 -177.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 186' ' ' THR . 51.8 m -119.7 139.88 51.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.453 -179.573 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.507 ' CE1' HG21 ' A' ' 185' ' ' VAL . 94.9 m-85 -122.6 139.68 53.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.578 178.455 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.615 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.5 tt0 -59.98 -33.83 72.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.924 0.392 . . . . 0.0 110.114 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 13.3 mtmm -114.51 122.91 33.19 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.008 179.383 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -56.78 -20.44 35.44 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.744 2.296 . . . . 0.0 113.023 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.9 m -56.48 -36.93 69.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.694 0.283 . . . . 0.0 111.306 -179.269 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.445 ' HA ' ' OE2' ' A' ' 215' ' ' GLU . 22.4 m -59.18 -35.87 74.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.798 0.333 . . . . 0.0 110.764 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 83.2 t -61.56 -42.5 94.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.069 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -59.58 -42.4 92.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.744 0.306 . . . . 0.0 111.091 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.445 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 14.8 pt-20 -74.38 -29.41 61.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.596 179.454 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.729 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 64.6 t -59.77 -42.37 88.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.064 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 24.2 m -72.5 -26.95 24.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -58.63 -31.69 68.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.458 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.615 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 68.7 m -108.42 140.01 42.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.893 0.378 . . . . 0.0 111.605 -179.129 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 63.4 tt0 -65.53 -40.74 93.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.64 179.079 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.729 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 71.7 m-70 84.47 110.74 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 178.352 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 20.3 mm -116.66 114.05 44.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 175.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.8 tt -122.58 122.3 38.54 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.469 -178.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 51.5 42.39 29.36 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 178.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.07 8.26 87.95 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.562 -0.827 . . . . 0.0 113.443 178.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.417 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 35.5 mmtp -121.5 155.37 35.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.753 0.311 . . . . 0.0 111.008 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 32.8 m -110.5 134.94 51.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.04 0.447 . . . . 0.0 110.349 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.453 HG13 ' HD3' ' A' ' 230' ' ' PRO . 36.5 pt -124.32 158.63 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.866 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -126.74 79.2 72.28 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 121.16 0.505 . . . . 0.0 111.175 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.54 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 51.1 Cg_exo -58.98 120.87 9.01 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.739 2.293 . . . . 0.0 110.669 179.232 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.53 ' HD3' ' O4 ' ' B' ' 5' ' ' ' U' . 28.7 mtpt -134.1 146.97 50.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.686 0.279 . . . . 0.0 111.712 -179.065 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.55 ' HD2' ' N ' ' A' ' 232' ' ' ARG . 0.0 OUTLIER -49.4 134.91 18.38 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.986 0.422 . . . . 0.0 110.989 -179.557 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.42 ' HA ' ' N1 ' ' B' ' 6' ' ' ' A' . . . -65.45 145.66 55.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.915 -179.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.498 ' CD1' ' C6 ' ' B' ' 6' ' ' ' A' . 1.2 mt -118.13 137.55 24.65 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.167 179.223 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 238' ' ' GLU . 9.5 Cg_endo -54.28 141.03 72.11 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 121.8 1.666 . . . . 0.0 110.97 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -55.76 -41.76 74.45 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -178.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -60.83 -41.79 96.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.782 0.325 . . . . 0.0 111.047 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.41 ' HB2' ' HG2' ' A' ' 235' ' ' PRO . 84.5 tt0 -64.75 -36.59 84.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.601 179.394 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.408 ' NE2' ' N3 ' ' B' ' 6' ' ' ' A' . 94.8 mt-30 -60.0 -38.83 83.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.704 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -61.12 -39.42 89.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.207 0.527 . . . . 0.0 110.394 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -60.97 -31.4 70.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.347 179.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.493 ' CG2' HD13 ' A' ' 270' ' ' ILE . 10.4 p -75.31 161.44 29.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.911 -178.136 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.69 112.72 0.85 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.086 179.53 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.602 ' HE3' ' CD2' ' A' ' 288' ' ' PHE . 5.3 tptp -85.8 129.2 34.89 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -179.629 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.629 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -120.84 160.71 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.474 0.654 . . . . 0.0 111.865 -179.55 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.491 ' CE1' ' C4 ' ' B' ' 2' ' ' ' A' . 76.2 t80 -104.31 137.45 42.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.951 179.416 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.548 HG21 HG12 ' A' ' 315' ' ' ILE . 7.2 p -128.68 147.17 33.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.644 -179.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.664 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -128.7 166.96 21.01 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.026 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 81.02 42.19 9.76 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.804 -179.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.419 HD13 ' N ' ' A' ' 287' ' ' GLY . 27.3 mm -55.65 -36.29 41.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.849 0.357 . . . . 0.0 111.295 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 60.79 169.02 0.5 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.868 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.26 144.66 81.59 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.032 2.488 . . . . 0.0 113.674 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 55.11 42.47 30.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.936 178.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.615 ' O ' ' O ' ' A' ' 255' ' ' ARG . 12.5 p -63.72 -38.3 81.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.996 178.612 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.615 ' O ' ' O ' ' A' ' 254' ' ' VAL . 4.5 mpt_? 50.31 126.29 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.43 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.48 -28.28 44.13 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.077 1.852 . . . . 0.0 112.668 -178.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -61.17 -47.79 84.55 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.614 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.495 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 53.0 mp0 -69.44 -39.62 77.69 Favored 'General case' 0 C--O 1.224 -0.261 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.576 ' CZ ' HG21 ' A' ' 289' ' ' VAL . 27.4 t80 -61.37 -47.25 86.68 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.21 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.58 -43.11 90.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.736 0.303 . . . . 0.0 111.295 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.495 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.8 pt-20 -76.47 -28.86 56.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.129 0.49 . . . . 0.0 110.877 179.444 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.66 ' CZ ' ' HB2' ' A' ' 308' ' ' PHE . 11.6 t80 -61.93 -56.48 18.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.13 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.598 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 5.2 m-85 -67.67 -27.56 66.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.069 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.487 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 80.1 p -56.44 -23.97 42.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.736 0.303 . . . . 0.0 111.113 -178.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -56.68 -35.94 69.01 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.669 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 19.4 p90 -111.66 48.99 0.92 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -179.648 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 133.43 150.39 6.31 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.184 178.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.4 m -70.3 131.68 44.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.566 HD12 ' CB ' ' A' ' 263' ' ' PHE . 74.5 mt -102.9 118.65 50.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.84 -178.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.668 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 72.7 mt -69.51 -39.4 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 120.289 -0.565 . . . . 0.0 112.236 179.359 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -136.38 -87.44 0.32 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 289' ' ' VAL . . . 65.14 110.42 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.709 0.29 . . . . 0.0 110.886 -178.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . 0.419 ' O ' ' NE2' ' A' ' 282' ' ' GLN . 21.6 pt20 -141.23 158.67 43.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.253 0.549 . . . . 0.0 111.853 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.65 ' O ' ' HB2' ' A' ' 275' ' ' MET . 28.6 tp -66.1 -26.86 67.66 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.09 -179.608 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.65 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 66.8 mmm 82.51 -80.91 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.457 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 274' ' ' LEU . 5.2 mp 55.53 72.25 0.5 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.16 -178.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.451 ' HB3' ' HA2' ' A' ' 281' ' ' GLY . 60.2 t0 -79.91 113.56 18.16 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.001 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 18.6 mttt 69.76 -59.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.358 -178.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 280' ' ' THR . 53.7 p30 -178.1 -31.12 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 179.133 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 280' ' ' THR . . . . . 0.53 ' N ' ' OD1' ' A' ' 279' ' ' ASP . 68.2 p -109.46 10.89 25.22 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.493 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 277' ' ' ASP . . . -91.37 99.07 2.52 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.209 -0.995 . . . . 0.0 113.149 -179.525 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.681 ' HB2' ' CZ ' ' A' ' 286' ' ' PHE . 38.2 tt0 75.38 -8.1 1.65 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.89 0.476 . . . . 0.0 112.18 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 21.9 m -57.77 -38.46 75.46 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -137.79 142.59 40.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.31 178.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.05 -46.46 1.71 Allowed Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.484 -0.865 . . . . 0.0 114.399 178.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.681 ' CZ ' ' HB2' ' A' ' 282' ' ' GLN . 23.7 p90 -140.24 168.38 19.93 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.224 1.012 . . . . 0.0 113.076 -179.162 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.501 ' CA ' HG11 ' A' ' 247' ' ' VAL . . . -138.03 174.35 21.95 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.173 179.164 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.602 ' CD2' ' HE3' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -137.17 123.33 20.44 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.294 0.547 . . . . 0.0 111.44 -179.948 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.629 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 56.8 t -126.44 137.6 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.008 0.432 . . . . 0.0 111.815 178.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.468 ' OG1' ' CD ' ' A' ' 244' ' ' LYS . 32.6 m -110.73 136.45 49.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.7 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.436 ' OH ' ' O ' ' A' ' 263' ' ' PHE . 31.0 m-85 -117.96 136.1 53.72 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.668 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 55.7 t0 -59.05 -36.18 74.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.254 178.6 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 49.9 m -121.53 143.88 49.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.471 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . 0.438 ' O ' HG11 ' A' ' 297' ' ' VAL . . . -66.57 -28.72 68.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.389 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -56.01 -36.59 68.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.824 -179.126 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.71 91.46 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.487 HG11 ' N ' ' A' ' 298' ' ' ASP . 6.2 p -59.62 -36.96 68.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.219 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . 0.487 ' N ' HG11 ' A' ' 297' ' ' VAL . 89.6 m-20 -62.18 -38.41 88.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.346 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -59.87 -43.41 94.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.894 -178.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.669 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 0.8 OUTLIER -69.4 -34.84 64.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.375 -179.334 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . 0.402 ' N ' HG11 ' A' ' 300' ' ' VAL . 80.2 m -59.33 -46.6 88.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.155 -179.569 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -62.49 -38.83 91.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.199 0.523 . . . . 0.0 109.965 179.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.401 ' O ' ' N ' ' A' ' 305' ' ' PHE . 88.5 m-20 -61.55 -32.36 72.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.257 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.618 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 18.8 tptm 69.24 -69.55 0.16 Allowed 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.618 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.7 m-30 -113.95 143.0 45.43 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.758 178.063 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.474 ' CG2' ' CZ ' ' A' ' 262' ' ' PHE . 6.9 mm -111.94 136.35 48.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -72.41 83.69 1.08 Allowed 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.198 -179.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.66 ' HB2' ' CZ ' ' A' ' 262' ' ' PHE . 4.9 t80 -105.9 142.84 34.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.556 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.513 ' HG2' ' CD2' ' A' ' 308' ' ' PHE . 18.8 mmmt 46.34 -135.89 0.79 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.116 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -96.74 9.77 40.74 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -178.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -151.05 165.82 32.63 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.453 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 53.0 mttt -78.86 143.46 35.94 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.76 179.159 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.664 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 33.7 pt -121.1 153.76 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.088 179.185 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . 0.596 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 84.0 mt-10 -110.16 134.98 51.65 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.414 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.548 HG12 HG21 ' A' ' 247' ' ' VAL . 76.7 mt -122.28 128.61 75.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.268 0.556 . . . . 0.0 112.17 -179.287 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -128.4 156.66 42.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.113 179.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -54.68 146.97 15.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.64 0.257 . . . . 0.0 110.363 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . 0.57 ' O ' ' N1 ' ' B' ' 2' ' ' ' A' . . . -54.26 -98.28 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.042 -179.273 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 318' ' ' ALA . 56.3 mm-40 69.38 102.4 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.416 0.151 . . . . 0.0 111.351 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.97 143.66 99.6 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.232 1.954 . . . . 0.0 111.842 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -58.08 -34.88 70.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.052 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 77.4 m80 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.916 179.973 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.697 0 C3'-C2'-O2' 111.206 -0.722 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.57 ' N1 ' ' O ' ' A' ' 318' ' ' ALA . . . . . . . . 0 O5'--C5' 1.425 -0.939 0 C1'-C2'-O2' 108.559 -0.68 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.599 " O3'" ' HE3' ' A' ' 275' ' ' MET . . . . . . . . 0 O5'--C5' 1.423 -1.043 0 C1'-C2'-O2' 108.379 -0.74 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.689 ' N7 ' ' HA ' ' A' ' 167' ' ' ASN . . . . . . . . 0 O5'--C5' 1.426 -0.875 0 C4'-C3'-C2' 103.801 1.101 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.708 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.729 0 C5'-C4'-O4' 107.771 -1.021 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.708 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.916 0 C3'-C2'-O2' 111.08 -0.766 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.742 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.89 0 C4'-C3'-C2' 103.543 0.843 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . 0.801 " H3'" ' N3 ' ' B' ' 8' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.997 0 O4'-C1'-C2' 107.384 0.703 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.4 tttt . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.89 0.376 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.445 ' OE2' ' HG2' ' A' ' 232' ' ' ARG . 47.9 tp10 -105.81 145.29 31.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.906 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.2 m -116.71 144.69 44.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.109 0.481 . . . . 0.0 111.292 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.403 ' O ' HG23 ' A' ' 213' ' ' VAL . 8.2 m -65.29 -29.75 70.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.56 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.488 ' HE2' ' CD2' ' A' ' 204' ' ' PHE . 74.2 tttt -56.74 139.69 49.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.179 0.514 . . . . 0.0 111.896 -178.607 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.541 ' HB2' ' HB2' ' A' ' 205' ' ' LEU . 94.7 mmm -121.94 150.46 41.98 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.896 -178.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.711 ' CE1' ' CZ ' ' A' ' 204' ' ' PHE . 1.5 t80 -108.42 129.64 55.25 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.262 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.573 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 24.4 mm -116.83 131.04 70.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.253 -179.221 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 228' ' ' ILE . . . -130.17 166.2 22.25 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 178.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.78 32.54 59.02 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.937 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 65.2 mt -59.57 -23.43 62.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -179.234 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.604 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 33.3 t-20 70.3 37.29 1.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -177.549 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.625 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 18.6 m0 37.12 17.95 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.28 -1.327 . . . . 0.0 113.829 179.453 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 167' ' ' ASN . 93.3 m-20 -139.28 10.04 2.52 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.552 ' O ' ' O ' ' A' ' 171' ' ' THR . 95.1 m -57.24 -38.52 73.94 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.465 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.552 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.2 OUTLIER 54.78 142.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.108 0.48 . . . . 0.0 110.459 -178.344 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.483 ' CG ' ' HB ' ' A' ' 190' ' ' ILE . 97.2 mt-10 -61.63 -34.96 76.58 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.554 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 60.1 t0 -57.28 -42.45 81.7 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.601 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 170' ' ' THR . 82.9 m-20 -64.13 -37.8 88.76 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.022 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 179' ' ' PHE . 11.0 mt -56.76 -50.5 72.09 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.229 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.554 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -67.46 -34.71 77.74 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.429 179.506 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -59.44 -38.91 81.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.395 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.622 ' CE2' ' CE2' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -94.69 -55.71 3.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.676 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.622 ' CE2' ' CE2' ' A' ' 178' ' ' TYR . 72.0 m-85 -60.62 -29.55 69.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.28 179.145 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.63 -24.13 23.62 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.904 179.073 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.777 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -55.71 -38.75 70.14 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.896 0.379 . . . . 0.0 111.483 -179.632 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.777 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 59.2 m-85 -68.1 -30.78 70.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.516 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 166.9 -129.33 1.9 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.092 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 59.7 m -117.4 141.78 47.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.227 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.453 ' CG2' ' O ' ' A' ' 206' ' ' SER . 10.5 p -104.41 125.44 59.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.409 ' CG2' ' N ' ' A' ' 208' ' ' GLU . 43.4 p -70.75 -35.48 72.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.605 -178.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -154.14 149.75 27.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.338 0.59 . . . . 0.0 112.253 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.421 HD13 ' CD1' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -118.63 130.14 55.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.476 179.689 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 35.5 tptt -128.57 118.87 23.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.211 0.529 . . . . 0.0 111.341 179.391 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.483 ' HB ' ' CG ' ' A' ' 172' ' ' GLU . 0.3 OUTLIER -124.44 138.48 53.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.696 177.676 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.664 ' HB2' ' HB3' ' A' ' 200' ' ' ARG . 15.1 mmt -86.29 135.08 33.68 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.901 -179.213 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -139.25 134.67 32.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.052 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 0.8 OUTLIER -123.31 78.02 53.29 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.676 -179.939 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.63 -27.9 72.32 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.252 1.968 . . . . 0.0 112.117 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -71.82 -63.01 1.22 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.083 0.468 . . . . 0.0 111.036 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 55.2 p -72.88 -18.83 61.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.512 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 79.6 28.9 50.45 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.36 -179.776 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.544 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 7.8 ttp180 -124.91 141.81 51.88 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 121.048 0.452 . . . . 0.0 111.854 -179.399 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 191' ' ' MET . 22.6 p -84.73 8.23 17.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.649 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.773 ' HG3' ' CE1' ' A' ' 202' ' ' PHE . 11.4 tpt180 76.48 -42.64 0.44 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.065 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.53 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 96.37 4.73 59.48 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.851 -0.69 . . . . 0.0 114.219 178.311 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.773 ' CE1' ' HG3' ' A' ' 200' ' ' ARG . 36.6 p90 -149.54 159.13 44.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.257 0.551 . . . . 0.0 112.106 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -151.66 170.88 31.16 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.418 179.577 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.745 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 78.9 m-85 -114.98 134.94 54.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.025 0.441 . . . . 0.0 112.058 -179.558 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 161' ' ' MET . 59.5 mt -107.73 139.65 41.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.349 179.112 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.453 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 20.1 t -123.24 126.97 47.93 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -114.64 135.18 54.43 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.409 ' N ' ' CG2' ' A' ' 186' ' ' THR . 84.5 tt0 -63.35 -35.56 80.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.153 178.583 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.69 117.39 54.26 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.879 179.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.78 -28.09 74.65 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.58 2.187 . . . . 0.0 113.041 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 20.4 m -59.02 -39.65 82.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.796 0.331 . . . . 0.0 110.724 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 23.8 m -61.42 -35.58 77.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.222 0.534 . . . . 0.0 110.095 178.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 159' ' ' CYS . 96.7 t -62.19 -41.74 92.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.392 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 218' ' ' LYS . 92.4 m-20 -58.62 -43.61 89.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.305 -179.345 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -70.02 -34.35 73.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.855 0.36 . . . . 0.0 111.708 178.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.603 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 87.0 t -60.35 -44.36 95.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.18 -178.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.428 HG13 ' NE ' ' A' ' 232' ' ' ARG . 10.4 p -80.75 -44.84 21.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 214' ' ' ASP . 15.0 mtpt -59.21 -34.19 71.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 27.5 m -96.46 143.65 27.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.135 0.493 . . . . 0.0 111.745 -178.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -93.3 125.28 37.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.902 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.603 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 0.0 OUTLIER -131.79 152.34 51.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.201 -179.028 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 70.7 mt -121.91 128.41 75.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.871 179.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.45 HD12 HD22 ' A' ' 175' ' ' LEU . 4.7 mt -88.1 -72.78 0.51 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -93.07 14.15 18.7 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.143 -178.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 100.19 -0.32 56.0 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.987 -178.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -112.22 132.58 54.84 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 34.3 m -59.01 120.05 4.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.498 -179.325 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.723 HG13 ' HD3' ' A' ' 230' ' ' PRO . 31.1 pt -97.47 -33.0 4.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.298 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 47.57 73.72 0.94 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.079 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.723 ' HD3' HG13 ' A' ' 228' ' ' ILE . 31.0 Cg_endo -60.54 135.01 58.07 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.736 2.291 . . . . 0.0 112.143 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.427 ' HE2' ' O4 ' ' B' ' 5' ' ' ' U' . 16.3 mtmm -128.53 151.99 48.81 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.547 179.047 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.445 ' HG2' ' OE2' ' A' ' 157' ' ' GLU . 1.9 mpt_? -59.47 143.45 49.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.206 0.527 . . . . 0.0 112.233 -178.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.464 ' HA ' ' N1 ' ' B' ' 6' ' ' ' A' . . . -74.95 150.14 39.16 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.613 179.611 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.531 ' CG1' ' C6 ' ' B' ' 6' ' ' ' A' . 0.1 OUTLIER -124.89 133.49 24.84 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.287 178.873 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.534 ' HD2' ' OE1' ' A' ' 238' ' ' GLU . 44.0 Cg_exo -54.96 145.64 61.81 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 121.775 1.65 . . . . 0.0 110.092 178.321 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 48.7 tpt85 -54.55 -40.53 68.79 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.565 -178.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.599 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 53.4 p30 -65.24 -37.31 86.84 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.371 179.414 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.599 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 93.1 mt-10 -68.29 -34.85 76.92 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.008 179.393 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.4 ' HG2' ' CD1' ' A' ' 234' ' ' ILE . 97.4 mt-30 -58.89 -38.62 79.28 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.045 0.45 . . . . 0.0 109.901 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -61.51 -39.08 89.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.048 178.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -60.05 -34.76 73.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.393 179.529 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.425 ' CG2' ' CD1' ' A' ' 270' ' ' ILE . 12.1 p -105.38 162.96 12.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.407 -178.607 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.22 168.62 25.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.519 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 289' ' ' VAL . 7.2 ttpm? -134.31 139.6 45.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.431 0.158 . . . . 0.0 110.678 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.48 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.1 OUTLIER -118.71 157.53 20.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 121.13 0.491 . . . . 0.0 111.465 -179.361 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.555 ' CE1' ' C4 ' ' B' ' 2' ' ' ' A' . 88.1 t80 -102.8 128.37 49.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.645 178.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 314' ' ' GLU . 41.5 t -124.55 131.27 72.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.885 0.374 . . . . 0.0 111.44 179.303 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.654 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -105.45 174.19 20.94 Favored Glycine 0 C--O 1.225 -0.411 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.907 179.219 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 285' ' ' GLY . . . 82.86 16.22 70.79 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.933 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.574 ' CD1' ' CE1' ' A' ' 259' ' ' PHE . 64.0 mt -116.13 132.66 65.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.94 0.4 . . . . 0.0 111.519 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -168.02 -116.3 0.36 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.666 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.89 143.53 99.58 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.616 2.211 . . . . 0.0 113.389 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 55.34 41.81 30.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.953 178.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.597 ' O ' ' O ' ' A' ' 255' ' ' ARG . 16.6 m -118.8 -1.84 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.369 178.099 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.597 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.2 OUTLIER 37.61 111.91 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.431 0 O-C-N 123.365 0.415 . . . . 0.0 111.804 -179.851 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.19 -39.72 51.82 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.542 1.495 . . . . 0.0 111.492 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -62.6 -40.99 98.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.014 0.435 . . . . 0.0 109.959 178.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.491 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 85.0 tt0 -65.11 -37.47 87.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.822 179.502 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.574 ' CE1' ' CD1' ' A' ' 250' ' ' ILE . 35.1 t80 -60.51 -45.46 93.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.643 179.076 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.1 -42.01 97.08 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.491 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.3 pt-20 -74.73 -30.23 61.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.015 0.436 . . . . 0.0 110.362 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.569 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 88.1 t80 -58.78 -46.56 87.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.885 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.624 ' HA ' ' CZ3' ' A' ' 266' ' ' TRP . 34.8 m-85 -88.09 -7.12 57.44 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.745 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.442 ' CA ' HD13 ' A' ' 269' ' ' ILE . 81.6 p -62.6 -26.28 68.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.039 0.447 . . . . 0.0 111.107 -179.668 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -57.16 -38.41 73.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.911 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.624 ' CZ3' ' HA ' ' A' ' 263' ' ' PHE . 11.6 m-90 -59.26 -38.35 79.89 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.342 0.591 . . . . 0.0 111.199 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 264' ' ' SER . . . 174.83 -159.77 28.51 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.069 -178.757 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 51.3 m -79.57 130.73 35.65 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.143 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.531 HG12 ' CE1' ' A' ' 291' ' ' TYR . 72.2 mt -106.59 118.32 54.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.635 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 69.5 mt -61.17 -52.46 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 120.089 -0.645 . . . . 0.0 112.288 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 270' ' ' ILE . 72.9 m-20 -162.97 68.9 0.22 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -73.87 135.71 43.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -139.63 149.43 43.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.451 0.643 . . . . 0.0 111.969 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.563 ' O ' ' HB2' ' A' ' 275' ' ' MET . 22.6 tp -65.14 -37.91 88.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.855 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.651 ' HB2' ' HG3' ' A' ' 282' ' ' GLN . 93.6 mmm 84.62 148.59 0.07 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.14 0.576 . . . . 0.0 109.899 -178.293 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.488 ' HA ' ' HB3' ' A' ' 282' ' ' GLN . 5.5 mp -158.57 133.34 8.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.632 0.253 . . . . 0.0 110.734 179.453 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -74.82 -134.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.129 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . 0.41 ' O ' ' OD1' ' A' ' 279' ' ' ASP . 86.4 mttt -58.78 -37.14 75.65 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 278' ' ' LYS . 95.9 m-20 -140.34 -85.07 0.22 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.762 179.125 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 57.8 p -116.04 24.31 11.54 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.711 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -51.88 -41.92 52.55 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.805 -179.08 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.651 ' HG3' ' HB2' ' A' ' 275' ' ' MET . 0.9 OUTLIER -64.52 -34.74 78.94 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.972 0.415 . . . . 0.0 111.493 178.991 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 39.4 t -49.59 -15.14 0.14 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.244 -177.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.409 ' NH2' ' OP1' ' B' ' 2' ' ' ' A' . 59.2 ttp180 -51.18 -36.87 43.36 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.098 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 249' ' ' GLY . . . 154.2 31.09 0.03 OUTLIER Glycine 0 CA--C 1.528 0.888 0 C-N-CA 118.828 -1.653 . . . . 0.0 116.636 178.419 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.526 ' CE1' " H4'" ' B' ' 2' ' ' ' A' . 12.7 p90 -143.89 160.6 40.51 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.51 1.655 . . . . 0.0 111.962 178.322 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -147.2 163.34 28.68 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.952 179.286 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.422 ' CE2' ' HE3' ' A' ' 244' ' ' LYS . 1.4 m-30 -113.68 128.07 56.28 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.493 HG21 ' CZ ' ' A' ' 259' ' ' PHE . 39.8 t -121.52 132.67 70.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.527 0.203 . . . . 0.0 110.462 177.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 49.7 m -120.26 136.51 54.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.642 0.258 . . . . 0.0 110.42 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.531 ' CE1' HG12 ' A' ' 269' ' ' ILE . 45.7 m-85 -119.23 134.98 54.91 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.635 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 55.0 t0 -60.52 -34.84 74.68 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.649 178.07 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 23.3 t -117.32 140.79 49.12 Favored 'General case' 0 N--CA 1.46 0.047 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.066 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.53 -28.36 69.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.873 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 296' ' ' ALA . 53.8 p30 -59.26 -35.87 74.49 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.53 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.575 ' N ' ' OD1' ' A' ' 295' ' ' ASP . . . -64.29 -33.83 76.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.979 0.419 . . . . 0.0 110.335 179.215 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 72.2 t -62.55 -43.44 98.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.196 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -61.35 -42.58 98.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.751 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -64.49 -42.81 95.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.151 0.501 . . . . 0.0 112.116 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.531 HG11 ' N ' ' A' ' 301' ' ' CYS . 1.4 p -66.59 -36.23 76.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.618 -178.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . 0.531 ' N ' HG11 ' A' ' 300' ' ' VAL . 75.1 m -71.3 -42.41 68.69 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.565 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -57.76 -39.46 77.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.811 0.339 . . . . 0.0 111.697 -178.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -57.84 -30.85 66.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.557 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.671 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 7.4 tptt 70.13 -71.8 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.55 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.671 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.8 m-30 -111.68 138.16 48.61 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.042 0.448 . . . . 0.0 110.949 178.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.495 HG23 ' CZ ' ' A' ' 262' ' ' PHE . 21.9 mm -117.97 137.33 52.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.522 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -75.51 86.35 2.62 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.996 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.569 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 5.1 t80 -110.24 129.04 55.8 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.44 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.694 ' HD2' ' N ' ' A' ' 309' ' ' LYS . 0.0 OUTLIER 59.01 40.33 22.39 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.751 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 53.98 37.5 26.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.514 0.673 . . . . 0.0 109.274 -178.014 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -148.59 162.51 39.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.93 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.627 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 30.6 mttt -93.89 133.69 37.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.232 0.539 . . . . 0.0 111.509 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.654 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 32.2 pt -118.06 144.17 26.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.196 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . 0.51 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 89.1 mt-10 -101.55 142.13 33.38 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.731 -178.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.477 HD11 ' CG2' ' A' ' 300' ' ' VAL . 69.6 mt -118.71 126.51 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 121.095 0.474 . . . . 0.0 111.496 -179.514 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -137.64 137.4 38.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.846 179.34 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -48.66 144.67 4.17 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.566 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.92 143.81 30.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.008 0.432 . . . . 0.0 111.259 -179.083 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . 0.437 ' HG3' ' HD2' ' A' ' 320' ' ' PRO . 1.9 tt0 -123.65 143.69 42.45 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.245 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.437 ' HD2' ' HG3' ' A' ' 319' ' ' GLU . 13.7 Cg_endo -56.53 139.61 87.9 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.119 1.879 . . . . 0.0 111.59 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 46.5 tpt85 -57.01 -37.63 71.96 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.881 0.372 . . . . 0.0 110.998 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 83.7 t60 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.864 179.913 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.454 " O3'" ' H8 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.728 0 C3'-C2'-O2' 111.246 -0.708 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.555 ' C4 ' ' CE1' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.917 0 C3'-C2'-O2' 111.195 -0.726 . 0.0 OUTLIER '7D dist 0b' 0.0 . . . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.539 ' H6 ' " O2'" ' B' ' 2' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.99 0 C1'-C2'-O2' 108.453 -0.716 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.625 ' C5 ' ' CE3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.426 -0.861 0 C4'-C3'-C2' 103.792 1.092 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.795 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.787 0 C4'-C3'-C2' 103.709 1.009 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.795 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.031 0 C4'-C3'-C2' 103.637 0.937 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.745 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.421 -1.16 0 C5'-C4'-O4' 107.003 -1.569 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.97 0 C3'-C2'-O2' 111.284 -0.695 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 88.3 mttt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.9 0.381 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 61.31 19.23 9.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.258 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 24.0 m -57.97 -36.02 71.99 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.831 0.348 . . . . 0.0 110.883 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.8 p -60.78 -30.84 70.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.714 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.499 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 5.3 tptm -67.55 138.49 56.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.031 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.666 ' O ' ' HA ' ' A' ' 204' ' ' PHE . 90.0 mtp -129.46 160.0 34.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.077 0.465 . . . . 0.0 111.906 -179.659 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.564 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 1.6 t80 -107.63 129.54 54.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.771 178.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.485 ' O ' ' CB ' ' A' ' 202' ' ' PHE . 20.4 mm -118.49 130.62 73.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 121.263 -0.175 . . . . 0.0 111.205 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.47 ' HA2' ' C6 ' ' B' ' 5' ' ' ' U' . . . -128.53 158.37 21.71 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.726 178.889 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.23 36.61 34.4 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.586 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 68.3 mt -59.79 -26.03 65.4 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.446 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.738 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 54.3 t30 74.11 39.88 0.48 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.93 0.395 . . . . 0.0 110.207 -178.188 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.648 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 9.6 m0 30.65 30.06 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.638 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 167' ' ' ASN . 89.6 m-20 -130.97 5.8 4.57 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 23.6 m -82.73 133.76 35.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 110.348 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.547 ' O ' ' HB2' ' A' ' 172' ' ' GLU . 5.3 p -109.49 14.69 23.43 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.104 -179.409 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.69 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 95.5 mt-10 77.67 -30.28 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -177.619 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.662 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 90.1 m-20 -62.92 -41.0 99.31 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 121.114 0.483 . . . . 0.0 111.486 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.432 ' O ' ' CB ' ' A' ' 178' ' ' TYR . 85.1 m-20 -61.53 -38.0 85.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.685 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.436 HD21 ' CE2' ' A' ' 179' ' ' PHE . 18.9 mt -62.81 -41.93 99.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -178.247 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.662 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -68.83 -42.73 76.77 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.752 179.955 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.509 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 84.2 tt0 -72.64 -44.38 61.97 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.031 0.443 . . . . 0.0 110.811 179.014 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.606 ' OH ' ' CB ' ' A' ' 221' ' ' HIS . 43.1 t80 -62.62 -44.39 96.41 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.575 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.436 ' CE2' HD21 ' A' ' 175' ' ' LEU . 95.3 m-85 -97.8 -0.27 45.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.061 -178.531 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -59.32 -29.75 66.61 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.822 178.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.493 ' CD ' ' H ' ' A' ' 181' ' ' LYS . 0.5 OUTLIER -57.34 -42.29 81.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 122.093 0.949 . . . . 0.0 110.356 -179.897 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -69.65 -34.1 73.53 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.702 -1.59 . . . . 0.0 112.492 -177.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -175.39 -173.43 41.14 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 119.46 -1.353 . . . . 0.0 114.187 -179.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.532 ' O ' ' CG1' ' A' ' 185' ' ' VAL . 51.7 m -61.74 -26.53 68.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.533 -0.833 . . . . 0.0 112.05 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.545 HG11 ' O ' ' A' ' 185' ' ' VAL . 8.0 p 51.31 73.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.831 0.824 . . . . 0.0 109.427 -177.292 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.4 t -54.23 -46.36 72.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.62 -1.173 . . . . 0.0 113.275 -177.584 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -137.45 157.33 46.8 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.587 0.708 . . . . 0.0 112.849 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.43 ' CD1' HD11 ' A' ' 175' ' ' LEU . 0.2 OUTLIER -127.32 130.87 50.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.429 179.599 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 20.0 tptt -134.26 120.58 20.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 179.676 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.69 ' HB ' ' HG2' ' A' ' 172' ' ' GLU . 1.0 OUTLIER -127.88 134.61 64.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.139 176.868 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.591 ' N ' ' SD ' ' A' ' 191' ' ' MET . 0.0 OUTLIER -92.8 135.95 33.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.456 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -127.93 150.94 49.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.608 -178.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.634 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 17.8 m-20 -119.76 78.11 22.2 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.665 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.94 -26.41 74.47 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.11 1.874 . . . . 0.0 111.701 179.176 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.29 -66.55 0.71 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.444 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.8 p -67.58 -27.51 66.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.125 179.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 90.6 6.14 68.29 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.411 179.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.634 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 6.2 ttp85 -128.82 129.48 45.68 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 117.519 0.66 . . . . 0.0 111.816 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.5 t -66.37 155.46 37.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.807 -179.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.672 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 1.1 mpt_? -53.95 -34.03 58.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.131 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.474 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 93.82 1.85 65.29 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.842 -179.103 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.672 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 33.6 p90 -139.54 156.6 46.8 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.953 0.406 . . . . 0.0 110.919 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.515 ' HA3' ' CE ' ' A' ' 191' ' ' MET . . . -144.31 158.92 27.63 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.819 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.666 ' HA ' ' O ' ' A' ' 161' ' ' MET . 90.5 m-85 -108.7 130.0 55.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 117.082 0.441 . . . . 0.0 110.463 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 161' ' ' MET . 64.2 mt -106.68 138.06 43.55 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.861 0.362 . . . . 0.0 111.943 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 49.0 m -121.29 136.2 55.0 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -123.36 145.29 48.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.748 0.309 . . . . 0.0 111.108 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.45 -34.36 76.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.952 178.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.7 115.34 51.39 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.336 179.161 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.37 -24.34 51.43 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.643 2.228 . . . . 0.0 113.61 -179.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 85.4 p -60.82 -31.42 70.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.586 0.232 . . . . 0.0 111.444 -179.405 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 19.5 m -59.68 -36.11 75.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.912 0.387 . . . . 0.0 110.771 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 85.8 t -62.13 -41.95 93.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.435 -179.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -59.26 -41.38 88.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.66 -179.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -76.79 -34.55 57.97 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.581 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 76.4 t -62.23 -46.31 96.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.25 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 13.3 p -68.24 -45.53 82.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.022 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 27.0 mttp -61.31 -36.19 79.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.405 ' O ' ' O ' ' A' ' 220' ' ' GLN . 47.9 m -59.11 -38.78 80.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.783 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.405 ' O ' ' O ' ' A' ' 219' ' ' THR . 63.9 tt0 60.67 107.26 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -177.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.606 ' CB ' ' OH ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -136.92 167.63 21.12 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -176.568 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.404 ' CG1' ' HA ' ' A' ' 227' ' ' VAL . 3.0 mt -125.58 118.8 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.321 176.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.452 ' CD2' ' OD1' ' A' ' 224' ' ' ASP . 8.4 tt -91.16 -54.27 4.01 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -177.468 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.452 ' OD1' ' CD2' ' A' ' 223' ' ' LEU . 97.4 m-20 -101.14 16.13 26.44 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.056 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 98.92 -1.86 58.06 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.568 -178.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.466 ' CG ' ' HB2' ' A' ' 167' ' ' ASN . 32.8 mmtp -110.76 139.23 46.24 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.105 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.404 ' HA ' ' CG1' ' A' ' 222' ' ' ILE . 16.1 m -64.29 123.99 18.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.903 -179.457 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 221' ' ' HIS . 34.0 pt -120.78 151.21 23.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.624 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -128.54 80.4 72.57 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 121.073 0.463 . . . . 0.0 111.502 -179.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.504 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 72.4 Cg_exo -53.01 126.31 21.07 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.43 2.087 . . . . 0.0 110.583 179.208 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.528 ' HD2' ' H61' ' B' ' 6' ' ' ' A' . 1.2 ttmm -131.9 149.52 52.42 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.725 -178.487 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 14.1 ttp-105 -64.27 133.64 53.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.281 179.24 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.498 ' HA ' ' N1 ' ' B' ' 6' ' ' ' A' . . . -56.86 145.18 30.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.85 0.357 . . . . 0.0 111.033 -179.413 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.428 ' CD1' ' C6 ' ' B' ' 6' ' ' ' A' . 5.1 mt -108.67 125.08 32.56 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.487 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' A' ' 239' ' ' GLN . 52.5 Cg_exo -51.54 152.16 12.85 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.077 1.851 . . . . 0.0 110.503 178.88 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.457 ' HD3' ' OE1' ' A' ' 239' ' ' GLN . 31.2 mmt180 -55.89 -40.26 72.74 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.148 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -63.8 -46.35 85.58 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.17 179.12 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.29 -35.2 73.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.301 0.572 . . . . 0.0 109.923 178.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 235' ' ' PRO . 61.1 tt0 -58.25 -42.27 86.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.183 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -63.08 -40.31 97.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.327 0.584 . . . . 0.0 110.011 178.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 242' ' ' THR . 24.2 mttp -62.63 -34.05 76.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.384 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 291' ' ' TYR . 68.2 p -29.08 -81.26 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -178.179 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 76.71 46.28 11.59 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.96 179.204 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 7.9 ttpm? -59.73 136.21 57.92 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.552 HD12 ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -123.31 161.2 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.771 0.796 . . . . 0.0 112.919 -179.307 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.505 ' CD1' ' C5 ' ' B' ' 2' ' ' ' A' . 91.8 t80 -99.2 135.92 39.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.866 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.471 HG12 ' CE1' ' A' ' 259' ' ' PHE . 9.6 p -129.92 144.03 39.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.238 0.542 . . . . 0.0 111.601 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.628 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.75 171.55 18.42 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.87 16.93 58.91 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.045 -1.074 . . . . 0.0 111.994 -179.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.496 ' CD1' ' CE1' ' A' ' 259' ' ' PHE . 68.7 mt -110.52 129.33 65.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 254' ' ' VAL . . . -169.75 -99.08 0.12 Allowed Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.135 -179.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . 0.406 ' HD3' ' HA2' ' A' ' 251' ' ' GLY . 32.1 Cg_exo -60.02 136.37 68.96 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.399 2.066 . . . . 0.0 113.255 -179.238 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 51.72 43.01 30.25 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.245 178.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.493 HG23 ' N ' ' A' ' 251' ' ' GLY . 14.8 m -127.0 45.4 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 254' ' ' VAL . 0.1 OUTLIER -40.77 151.67 0.26 Allowed Pre-proline 0 N--CA 1.462 0.155 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.859 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.411 ' N ' HD13 ' A' ' 274' ' ' LEU . 11.1 Cg_endo -55.28 -28.02 60.21 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 121.982 1.788 . . . . 0.0 112.381 -178.308 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -61.44 -44.62 96.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.293 179.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.49 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 55.6 mp0 -67.43 -38.7 84.95 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.902 0.382 . . . . 0.0 111.716 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.647 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 31.6 t80 -64.72 -47.52 77.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.534 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.46 -41.55 98.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.832 0.348 . . . . 0.0 110.626 179.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.49 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.5 pt-20 -75.39 -28.84 59.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.424 178.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.594 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 3.7 t80 -62.57 -56.87 13.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.607 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.622 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 7.0 m-85 -65.89 -21.42 66.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.064 -179.384 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.462 ' N ' ' CD1' ' A' ' 269' ' ' ILE . 67.5 p -57.87 -20.12 34.28 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.742 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -47.67 -38.43 14.94 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.059 178.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.719 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 23.5 p90 -131.17 44.0 3.01 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 264' ' ' SER . . . 161.47 150.03 5.8 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.164 179.137 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.4 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 55.7 m -59.98 -34.83 73.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.876 0.369 . . . . 0.0 111.005 179.443 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.551 HD12 ' CB ' ' A' ' 263' ' ' PHE . 79.0 mt 68.44 112.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.075 -178.804 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.533 ' CG2' ' HB ' ' A' ' 290' ' ' THR . 14.7 tt -61.04 -29.43 45.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.916 0.388 . . . . 0.0 110.359 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 272' ' ' ALA . 55.8 t0 -176.9 -48.53 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.533 179.433 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.491 ' O ' ' O ' ' A' ' 271' ' ' ASP . . . 52.13 122.11 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.879 0.371 . . . . 0.0 111.755 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -141.34 155.19 45.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.394 0.616 . . . . 0.0 112.43 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.566 ' O ' ' HB2' ' A' ' 275' ' ' MET . 64.0 mt -66.41 -31.79 72.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.212 178.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.566 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 94.2 mmm 102.1 -80.8 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.643 0.777 . . . . 0.0 110.397 -178.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.502 ' HA ' ' O ' ' A' ' 281' ' ' GLY . 0.1 OUTLIER 38.57 64.74 0.71 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.345 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -56.57 -39.81 74.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.943 0.402 . . . . 0.0 110.747 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 17.2 mtpt -95.07 9.56 39.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.39 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.2 t70 60.56 42.25 14.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.143 0.497 . . . . 0.0 110.386 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.26 -67.26 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.346 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 276' ' ' LEU . . . -83.19 175.56 52.8 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.467 179.201 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.912 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 94.0 mm-40 64.05 45.06 4.31 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.013 0.435 . . . . 0.0 110.88 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 10.3 p -167.98 -40.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.033 179.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' A' ' 250' ' ' ILE . 41.2 ttm180 -55.2 -31.34 61.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.933 179.299 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -105.77 -39.18 2.23 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.746 -0.74 . . . . 0.0 114.571 -178.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.491 ' CE1' " C4'" ' B' ' 2' ' ' ' A' . 27.3 p90 -136.6 167.24 21.77 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.001 0.9 . . . . 0.0 112.828 -178.17 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.422 ' O ' HG11 ' A' ' 247' ' ' VAL . . . -132.44 159.14 23.29 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.187 178.685 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.4 ' HB2' ' CG ' ' A' ' 275' ' ' MET . 0.1 OUTLIER -119.21 124.6 47.16 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 122.734 -0.274 . . . . 0.0 111.612 -179.502 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.647 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 57.4 t -128.98 135.72 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 178.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 26.5 m -122.4 139.9 53.31 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.358 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.59 ' O ' ' HA ' ' A' ' 242' ' ' THR . 74.5 m-85 -113.35 137.32 51.69 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 293' ' ' SER . 54.1 p30 -63.35 -30.14 71.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.295 178.55 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.537 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 99.1 p -115.55 144.1 44.37 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.272 0.558 . . . . 0.0 111.362 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . 0.497 ' O ' HG11 ' A' ' 297' ' ' VAL . . . -69.03 -33.32 73.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.348 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -57.04 -36.9 71.03 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.79 -39.09 87.59 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.497 HG11 ' O ' ' A' ' 294' ' ' ALA . 8.7 p -59.68 -37.83 72.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.437 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . 0.46 ' N ' HG11 ' A' ' 297' ' ' VAL . 55.7 t0 -62.79 -39.03 92.97 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -179.142 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -60.56 -43.29 97.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.719 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 0.9 OUTLIER -67.71 -34.18 66.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.671 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 77.4 m -57.82 -45.88 85.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.497 -179.166 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -61.59 -40.47 94.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.205 0.526 . . . . 0.0 110.704 179.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -60.52 -33.25 72.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.18 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.645 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 47.8 tptt 68.52 -73.21 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -177.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.645 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.6 m-30 -114.42 144.25 43.62 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.276 178.43 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.519 ' CD1' ' CH2' ' A' ' 266' ' ' TRP . 24.4 mt -118.89 133.4 65.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.639 178.204 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -76.84 75.69 3.46 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.594 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 5.2 t80 -72.8 -52.03 16.61 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.553 0.692 . . . . 0.0 110.927 -179.196 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.446 ' HD3' ' CE1' ' A' ' 308' ' ' PHE . 23.6 mmmt -128.39 -151.78 0.49 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.191 -179.147 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -58.08 -26.48 62.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.386 179.198 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -121.29 159.69 25.48 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.109 0.481 . . . . 0.0 112.237 -178.149 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.517 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 49.2 mttt -75.78 149.04 38.03 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.167 179.508 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.628 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 36.8 pt -117.84 149.52 20.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.311 178.466 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . 0.584 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 83.0 mt-10 -110.79 132.13 54.46 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.584 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.482 HD11 HD13 ' A' ' 306' ' ' ILE . 79.7 mt -121.05 126.9 75.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.14 0.495 . . . . 0.0 111.685 -179.487 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -126.09 150.31 48.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.133 179.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 95.1 mtm-85 -55.83 144.13 28.87 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.264 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 244' ' ' LYS . . . -61.66 142.66 57.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.983 0.42 . . . . 0.0 111.34 -179.337 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -109.62 136.94 20.25 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.128 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.38 130.98 42.99 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 121.823 1.682 . . . . 0.0 111.438 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 44.6 tpt85 -58.52 -37.72 76.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 84.0 t60 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.925 -179.96 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.756 0 C3'-C2'-O2' 111.229 -0.714 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.912 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.947 0 C3'-C2'-O2' 111.331 -0.679 . 0.18 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.595 ' O2 ' " H3'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.983 0 C1'-C2'-O2' 108.572 -0.676 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.738 ' N7 ' ' HA ' ' A' ' 167' ' ' ASN . . . . . . . . 0 O5'--C5' 1.427 -0.829 0 C4'-C3'-C2' 103.998 1.298 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.743 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.429 -0.662 0 O4'-C1'-N19 109.036 0.836 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.743 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.939 0 C4'-C3'-O3' 113.176 0.991 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.634 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.985 0 C4'-C3'-C2' 103.461 0.761 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.95 0 C3'-C2'-O2' 111.262 -0.703 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.991 0.424 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -61.6 -32.34 72.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.791 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.1 t -116.2 145.22 43.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.956 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.67 91.27 3.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.949 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.464 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 74.9 tttt -127.01 139.1 53.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.851 -179.505 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.499 ' HB2' ' HB2' ' A' ' 205' ' ' LEU . 93.2 mmm -116.29 147.56 41.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.42 -178.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.682 ' CE2' ' C8 ' ' B' ' 6' ' ' ' A' . 2.9 t80 -104.74 130.22 52.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.446 -0.797 . . . . 0.0 108.912 178.314 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.468 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 21.8 mm -117.42 130.84 71.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.312 -179.217 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.499 ' O ' ' CG2' ' A' ' 228' ' ' ILE . . . -128.5 162.81 22.12 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 178.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.46 36.43 34.05 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.14 -1.029 . . . . 0.0 111.992 -179.717 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.479 ' HB3' ' OG1' ' A' ' 170' ' ' THR . 50.7 mt -60.68 -26.12 66.86 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -178.774 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.763 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 42.0 t30 71.38 40.76 0.81 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -176.902 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.603 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 8.2 m0 31.4 41.76 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.948 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -174.84 21.89 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 179.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.522 ' O ' ' O ' ' A' ' 171' ' ' THR . 98.1 m -61.62 -38.19 86.72 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.522 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.0 OUTLIER 57.82 130.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -177.657 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.434 ' HA ' HD13 ' A' ' 190' ' ' ILE . 21.6 pt-20 -58.77 -29.49 66.82 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -178.29 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.502 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.1 m-20 -60.06 -40.67 90.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.71 0.29 . . . . 0.0 111.582 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 170' ' ' THR . 83.1 m-20 -64.91 -37.17 86.75 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -179.138 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.478 HD21 ' CE2' ' A' ' 179' ' ' PHE . 7.2 mt -55.8 -47.78 76.53 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.502 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -65.1 -33.03 75.06 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.068 179.269 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -62.23 -39.02 91.41 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.672 -179.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.66 ' O ' ' HD3' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -94.59 -45.91 7.18 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-O 120.723 0.297 . . . . 0.0 110.755 179.614 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.649 ' CE2' ' CE2' ' A' ' 178' ' ' TYR . 75.0 m-85 -72.93 -13.96 61.36 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 179.074 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.69 -26.45 24.79 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.27 -0.49 . . . . 0.0 113.564 -179.297 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.66 ' HD3' ' O ' ' A' ' 178' ' ' TYR . 0.5 OUTLIER -56.47 -41.95 77.39 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.909 0.861 . . . . 0.0 110.796 -179.719 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -69.72 -35.15 74.78 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.054 -1.43 . . . . 0.0 112.927 -177.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 174.93 -175.08 47.02 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.352 -1.404 . . . . 0.0 114.171 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.543 ' O ' ' CG1' ' A' ' 185' ' ' VAL . 54.1 m -63.11 -25.11 68.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.573 -0.814 . . . . 0.0 111.659 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.553 HG11 ' O ' ' A' ' 185' ' ' VAL . 7.9 p 52.75 79.66 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 CA-C-O 121.962 0.887 . . . . 0.0 109.091 -177.006 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -47.19 -50.95 19.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.664 -177.175 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 206' ' ' SER . 22.9 t70 -146.02 124.52 12.42 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.504 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.434 ' CD2' ' HD2' ' A' ' 176' ' ' ARG . 0.0 OUTLIER -108.97 153.87 22.97 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.708 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.569 ' HG3' ' SD ' ' A' ' 191' ' ' MET . 11.8 tptt -138.07 125.24 21.57 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -177.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . 0.449 HD13 HD13 ' A' ' 175' ' ' LEU . 5.6 mt -123.67 126.55 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.564 175.58 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 191' ' ' MET . . . . . 0.569 ' SD ' ' HG3' ' A' ' 189' ' ' LYS . 2.6 mpp? -94.6 57.98 2.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.295 -179.489 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 34.2 tttm -63.9 149.49 47.02 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.81 -179.033 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' A' ' 198' ' ' ARG . 2.1 t0 -120.4 75.85 24.88 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.594 -179.48 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.14 -23.88 75.09 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.59 2.193 . . . . 0.0 112.767 179.608 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -68.28 -73.85 0.14 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.883 -179.041 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.7 p -68.05 -25.54 65.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.704 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 93.95 -0.23 66.76 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.591 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.509 ' O ' ' HB3' ' A' ' 193' ' ' ASP . 0.8 OUTLIER -127.29 131.9 50.42 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.71 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.442 ' OG ' ' NH1' ' A' ' 200' ' ' ARG . 13.3 t -110.5 155.37 22.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.552 0.692 . . . . 0.0 112.799 -178.009 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.61 ' HB2' ' CE2' ' A' ' 202' ' ' PHE . 0.5 OUTLIER -45.01 -32.21 1.58 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.731 -179.801 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.524 ' HA2' " H2'" ' B' ' 4' ' ' ' A' . . . 90.11 22.17 36.33 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.59 -0.814 . . . . 0.0 114.849 178.607 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.61 ' CE2' ' HB2' ' A' ' 200' ' ' ARG . 41.5 p90 -150.83 152.66 34.06 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 117.503 0.652 . . . . 0.0 111.008 178.773 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.448 ' HA3' ' HE3' ' A' ' 191' ' ' MET . . . -138.54 161.69 25.75 Favored Glycine 0 C--O 1.228 -0.265 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.355 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.713 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 85.3 m-85 -110.73 126.0 54.1 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.9 -179.836 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 161' ' ' MET . 53.9 mt -107.73 142.01 38.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.687 0.28 . . . . 0.0 110.8 179.811 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 187' ' ' ASP . 26.3 t -124.65 130.12 51.82 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.614 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -114.76 135.75 53.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.94 0.4 . . . . 0.0 111.31 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.43 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.4 tt0 -60.23 -34.23 73.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.473 179.204 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.62 116.96 56.79 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.823 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.85 -29.5 81.7 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.515 2.143 . . . . 0.0 113.189 -179.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.7 m -59.15 -37.91 78.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.786 0.327 . . . . 0.0 110.853 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 23.3 m -59.83 -34.42 73.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.194 0.521 . . . . 0.0 110.31 179.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.426 ' CG1' ' HG3' ' A' ' 232' ' ' ARG . 78.1 t -60.38 -41.24 86.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.094 -179.658 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -57.82 -43.95 86.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.026 0.441 . . . . 0.0 110.754 -179.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.429 ' O ' ' OG1' ' A' ' 219' ' ' THR . 97.6 mt-10 -69.7 -33.36 72.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.044 178.674 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.649 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 96.8 t -60.39 -43.07 93.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.589 -178.512 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 9.0 p -84.23 -49.5 16.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.121 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -59.93 -39.68 86.3 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.424 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 215' ' ' GLU . 70.5 m -59.19 -38.89 80.94 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.329 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.408 ' O ' ' O ' ' A' ' 219' ' ' THR . 63.1 tt0 62.1 114.67 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.03 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.649 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 0.0 OUTLIER -134.2 169.03 17.79 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -176.707 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.473 HD13 ' CG2' ' A' ' 227' ' ' VAL . 16.1 mm -117.62 128.39 74.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.839 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.408 HD11 ' CE2' ' A' ' 178' ' ' TYR . 8.5 tt -117.3 126.0 52.0 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.708 179.366 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 53.53 41.89 32.02 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 178.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 90.35 -23.88 19.5 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.412 -0.899 . . . . 0.0 114.337 177.444 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.445 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 34.7 mmtp -95.66 151.21 19.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.202 0.501 . . . . 0.0 111.405 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.473 ' CG2' HD13 ' A' ' 222' ' ' ILE . 26.3 t -92.28 128.76 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.769 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.499 ' CG2' ' O ' ' A' ' 164' ' ' GLY . 28.3 pt -125.67 154.98 34.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.253 -179.341 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.58 78.21 75.86 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.121 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 230' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 162' ' ' PHE . 9.4 Cg_endo -52.28 131.59 40.51 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.636 2.224 . . . . 0.0 111.775 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 162' ' ' PHE . 5.4 ttpm? -136.21 139.73 43.01 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.731 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.426 ' HG3' ' CG1' ' A' ' 213' ' ' VAL . 0.9 OUTLIER -50.82 141.98 12.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.088 0.471 . . . . 0.0 111.743 -179.494 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.514 ' HA ' ' N1 ' ' B' ' 6' ' ' ' A' . . . -62.45 144.44 55.92 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.391 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . 0.591 HG13 ' N6 ' ' B' ' 6' ' ' ' A' . 0.4 OUTLIER -107.68 135.81 19.73 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 121.353 -0.139 . . . . 0.0 110.902 179.761 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.91 139.95 85.03 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 121.789 1.659 . . . . 0.0 110.623 178.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -58.52 -37.55 75.86 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -60.18 -48.29 82.36 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.711 -179.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -73.04 -41.33 64.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.567 0.699 . . . . 0.0 110.168 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.499 ' NE2' " O2'" ' B' ' 6' ' ' ' A' . 61.1 tt0 -60.36 -37.06 79.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.505 -179.479 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -56.25 -37.42 69.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.613 -179.368 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 242' ' ' THR . 39.8 mttm -82.62 -74.09 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.468 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 241' ' ' LYS . 33.5 p 38.62 -168.01 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.087 0.47 . . . . 0.0 112.215 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -168.08 49.75 0.23 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.353 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 15.3 tttp -72.82 128.72 36.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.76 0.314 . . . . 0.0 110.532 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.52 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -125.02 162.94 26.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -179.409 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.42 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 87.4 t80 -101.45 134.15 44.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.647 -1.161 . . . . 0.0 111.181 179.566 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 286' ' ' PHE . 14.0 p -127.79 136.38 60.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.687 179.006 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -125.04 4.66 8.38 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.747 -178.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . 0.512 ' HA2' ' CB ' ' A' ' 313' ' ' ILE . . . -88.14 9.16 76.0 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.744 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.541 HD12 ' CE1' ' A' ' 259' ' ' PHE . 31.9 pt -120.61 154.75 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 121.004 0.43 . . . . 0.0 111.521 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -167.51 -142.58 3.5 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.839 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.07 -19.71 34.25 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.55 2.167 . . . . 0.0 112.449 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -82.9 3.18 30.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.81 -179.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.421 HG23 ' HB ' ' A' ' 250' ' ' ILE . 19.1 m -126.77 157.04 38.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.718 0.294 . . . . 0.0 110.792 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.0 mmt85 -111.65 154.94 43.75 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.102 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.49 -43.01 55.23 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 121.793 1.662 . . . . 0.0 111.797 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 261' ' ' GLU . 35.3 mttp -63.14 -43.14 99.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.129 179.349 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.536 ' HA ' ' HB3' ' A' ' 261' ' ' GLU . 76.3 mm-40 -66.53 -36.87 83.75 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.576 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.591 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 25.2 t80 -63.67 -52.37 61.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.21 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -64.11 -37.25 86.76 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.536 ' HB3' ' HA ' ' A' ' 258' ' ' GLU . 72.7 tt0 -61.88 -38.03 86.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.876 -1.511 . . . . 0.0 111.968 178.213 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.719 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 71.6 t80 -69.61 -56.52 7.06 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -179.445 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.679 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 18.9 m-85 -65.2 -24.08 67.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.932 -179.377 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.457 ' CA ' HD13 ' A' ' 269' ' ' ILE . 86.1 p -59.48 -25.91 64.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.376 -179.312 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -57.54 -36.89 72.22 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 266' ' ' TRP . . . . . 0.679 ' CZ2' ' CD2' ' A' ' 263' ' ' PHE . 11.9 p90 -115.18 39.81 2.82 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.113 0.482 . . . . 0.0 111.765 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.505 ' HA2' ' CE1' ' A' ' 291' ' ' TYR . . . 157.51 146.74 4.58 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.709 178.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.407 ' HB ' ' OD2' ' A' ' 292' ' ' ASP . 59.8 m -58.94 -37.49 76.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.754 0.311 . . . . 0.0 111.27 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.558 HD12 ' CB ' ' A' ' 263' ' ' PHE . 73.9 mt 69.3 90.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.099 -179.202 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.624 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 75.0 mt -54.97 -44.76 75.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.932 179.009 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 290' ' ' THR . 54.0 t0 -156.49 146.76 21.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.824 179.079 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -154.69 141.37 18.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.348 178.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -146.61 155.83 42.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.505 0.669 . . . . 0.0 112.378 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . 0.449 ' CD2' ' HB2' ' A' ' 283' ' ' SER . 27.0 tp -64.44 -33.9 76.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.426 179.382 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 275' ' ' MET . . . . . 0.575 ' CE ' " H1'" ' B' ' 3' ' ' ' U' . 72.9 mmm 69.48 80.74 0.18 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 -178.478 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 283' ' ' SER . 0.2 OUTLIER -119.38 126.67 51.94 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.34 179.578 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.421 ' HB2' ' HG2' ' A' ' 282' ' ' GLN . 60.0 t0 -86.63 118.71 26.22 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.128 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 278' ' ' LYS . . . . . 0.435 ' CE ' ' HE2' ' A' ' 226' ' ' LYS . 26.9 mmtp 59.22 -150.23 0.44 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.602 -0.439 . . . . 0.0 109.911 -178.358 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.2 -38.73 68.75 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.222 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 14.4 t -168.42 114.37 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.906 0.384 . . . . 0.0 111.448 179.282 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -145.4 -90.91 0.11 Allowed Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.207 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.951 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 97.3 mm-40 -56.39 -31.26 63.69 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.934 0.494 . . . . 0.0 111.946 -179.084 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 275' ' ' MET . 91.8 p -72.76 -4.71 33.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.562 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -51.9 -34.64 42.25 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 250' ' ' ILE . . . -156.22 9.51 0.29 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 119.318 -1.42 . . . . 0.0 115.398 -179.094 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 16.4 p90 -145.87 164.65 31.28 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.976 1.388 . . . . 0.0 112.084 179.12 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.436 ' HA2' ' CD1' ' A' ' 250' ' ' ILE . . . -140.1 164.68 26.13 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.254 179.126 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.464 ' CD2' ' CE ' ' A' ' 244' ' ' LYS . 0.2 OUTLIER -119.4 128.54 54.14 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.367 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.591 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 44.1 t -128.31 138.27 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.813 0.34 . . . . 0.0 111.524 178.289 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 36.2 m -117.34 136.41 53.15 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.505 ' CE1' ' HA2' ' A' ' 267' ' ' GLY . 39.7 m-85 -115.31 136.01 53.55 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.416 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.624 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 55.3 p30 -64.79 -32.93 74.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.724 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.57 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 51.0 m -121.98 144.42 48.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.312 0.577 . . . . 0.0 112.237 -178.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . 0.475 ' O ' ' CG1' ' A' ' 297' ' ' VAL . . . -66.23 -32.06 73.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.075 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -56.61 -38.19 71.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.098 -179.717 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -64.42 -41.59 96.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.767 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.571 HG11 ' N ' ' A' ' 298' ' ' ASP . 9.7 p -59.83 -37.05 69.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.014 0.435 . . . . 0.0 111.479 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 298' ' ' ASP . . . . . 0.571 ' N ' HG11 ' A' ' 297' ' ' VAL . 90.1 m-20 -61.75 -37.26 83.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.717 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -58.88 -44.13 91.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.677 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 0.7 OUTLIER -73.41 -35.87 47.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.927 0.394 . . . . 0.0 111.274 -179.642 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 79.3 m -58.53 -46.14 87.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.032 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -63.6 -40.62 97.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.225 0.536 . . . . 0.0 110.192 179.198 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.416 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.4 m-20 -64.3 -35.6 81.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.865 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.64 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 35.5 tptt 67.76 -67.37 0.19 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.168 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.64 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 17.5 m-85 -113.98 131.84 56.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.929 179.148 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 306' ' ' ILE . . . . . 0.511 HD13 ' CZ3' ' A' ' 266' ' ' TRP . 1.3 mt -122.18 138.69 51.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.127 178.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.494 ' OD1' ' CD ' ' A' ' 312' ' ' LYS . 94.0 m-20 -73.89 119.21 17.79 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.422 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.719 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 9.4 t80 -119.75 -76.07 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.417 0.627 . . . . 0.0 109.948 178.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.455 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 6.4 mmpt? -97.72 -163.39 1.04 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.513 178.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -52.93 -31.31 39.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.785 0.326 . . . . 0.0 110.742 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -112.15 153.62 26.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.106 0.479 . . . . 0.0 111.351 -179.369 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.579 ' CG ' ' HB3' ' A' ' 305' ' ' PHE . 19.7 tptt -70.77 143.96 51.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.541 -179.091 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.512 ' CB ' ' HA2' ' A' ' 249' ' ' GLY . 26.4 pt -111.31 141.38 26.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.799 179.218 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -101.48 131.69 47.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.716 179.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 315' ' ' ILE . . . . . 0.52 HD11 ' CE2' ' A' ' 263' ' ' PHE . 72.2 mt -119.92 129.57 75.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.156 0.503 . . . . 0.0 111.421 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 30.5 tttp -131.6 141.49 49.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.162 -179.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -54.55 137.75 42.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 0.0 110.581 -179.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.72 140.73 56.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.332 -179.269 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -75.42 152.5 85.66 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.191 179.089 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.7 -23.83 42.94 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.25 1.967 . . . . 0.0 111.712 179.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.468 ' HG3' ' O4 ' ' B' ' 3' ' ' ' U' . 31.6 mmm180 38.09 40.58 0.32 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.482 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.895 -179.683 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.725 0 C3'-C2'-O2' 111.32 -0.683 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.951 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.424 -1.008 0 C3'-C2'-O2' 111.274 -0.698 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.575 " H1'" ' CE ' ' A' ' 275' ' ' MET . . . . . . . . 0 O5'--C5' 1.424 -1.028 0 C3'-C2'-O2' 111.117 -0.753 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.763 " H3'" H5'' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.998 0 O4'-C1'-C2' 107.771 0.979 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.763 H5'' " H3'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.731 0 C4'-C3'-C2' 103.548 0.848 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.682 ' C8 ' ' CE2' ' A' ' 162' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.961 0 C4'-C3'-C2' 103.574 0.874 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.713 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -1.0 0 C3'-C2'-O2' 111.341 -0.675 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.984 0 C3'-C2'-O2' 111.26 -0.703 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 44.0 m . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.543 0.211 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -72.43 138.44 47.12 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 121.573 0.701 . . . . 0.0 112.215 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.832 ' SD ' HG13 ' A' ' 213' ' ' VAL . 82.1 mmm -116.08 150.63 37.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.653 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.541 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 4.8 t80 -103.57 128.57 50.8 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.61 ' CG2' HD21 ' A' ' 166' ' ' LEU . 16.2 mm -115.26 127.72 72.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -132.31 163.63 23.96 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.511 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.43 29.78 59.44 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.352 -0.927 . . . . 0.0 112.269 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.946 HD23 HG21 ' A' ' 228' ' ' ILE . 76.4 mt -86.84 140.63 29.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.744 0.307 . . . . 0.0 111.164 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.51 ' HB2' ' HG3' ' A' ' 226' ' ' LYS . 7.8 t-20 -66.13 133.68 51.21 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 -52.09 -38.47 57.39 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.99 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -62.97 -26.85 69.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.5 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 51.5 m -54.07 139.86 33.59 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.542 0.687 . . . . 0.0 111.383 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 28.5 m -119.39 151.5 38.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.7 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.791 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 98.5 mt-10 -55.33 -36.3 66.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.854 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -58.3 -43.81 88.26 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 120.602 -0.439 . . . . 0.0 109.861 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -65.45 -37.3 86.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.622 HD13 HD12 ' A' ' 188' ' ' LEU . 1.0 OUTLIER -55.43 -62.37 1.72 Allowed 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.332 178.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.481 ' O ' ' N ' ' A' ' 180' ' ' GLY . 67.2 ttp85 -57.19 -41.04 78.58 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.912 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.08 -40.23 94.35 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.742 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.551 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 62.7 t80 -61.98 -48.07 81.99 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.637 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.566 ' CD2' HD23 ' A' ' 175' ' ' LEU . 88.8 m-85 -87.93 0.0 56.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.395 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -61.2 -28.84 69.79 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.595 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.443 ' CD ' ' H ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -58.64 -38.67 78.58 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.803 0.811 . . . . 0.0 110.04 -179.049 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -67.63 -30.03 69.49 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.62 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 159.46 -132.83 3.13 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.238 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 52.8 m -119.92 139.62 52.15 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.914 HG12 ' CE1' ' A' ' 207' ' ' PHE . 3.4 m -100.81 122.8 53.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.489 -0.485 . . . . 0.0 110.502 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.3 t -73.22 -46.92 47.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.288 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -145.73 121.7 10.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.016 0.436 . . . . 0.0 111.455 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -118.6 139.69 51.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.572 179.462 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.588 ' O ' ' CA ' ' A' ' 203' ' ' GLY . 8.7 tptt -133.01 83.38 2.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.841 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.791 ' HB ' ' HG2' ' A' ' 172' ' ' GLU . 12.0 tt -60.45 -22.64 26.02 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-O 121.146 0.498 . . . . 0.0 109.77 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.635 ' HE1' ' HA2' ' A' ' 203' ' ' GLY . 0.0 OUTLIER 73.13 55.38 0.12 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.486 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.63 152.07 46.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.467 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 1.5 t0 -124.16 75.85 59.77 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.23 -25.43 80.06 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.462 2.108 . . . . 0.0 112.308 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.74 -66.52 0.6 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.806 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 70.9 p -68.65 -24.83 64.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.195 0.521 . . . . 0.0 110.281 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.59 -3.35 68.27 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.431 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.484 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 6.3 ttp180 -130.35 124.37 32.1 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.971 0.415 . . . . 0.0 111.268 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.1 m -64.41 156.14 30.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.779 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.667 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 5.4 mpt_? -57.07 -33.91 67.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.083 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 93.17 3.37 65.42 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.668 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.667 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 40.4 p90 -144.62 154.8 43.19 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.635 ' HA2' ' HE1' ' A' ' 191' ' ' MET . . . -151.18 169.11 30.84 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 119.373 -1.394 . . . . 0.0 113.273 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.541 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 98.0 m-85 -106.54 120.47 42.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.188 0.518 . . . . 0.0 109.674 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.618 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 55.3 tp -108.39 125.56 51.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.955 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 50.2 m -118.55 143.56 46.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.312 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.914 ' CE1' HG12 ' A' ' 185' ' ' VAL . 74.3 m-85 -120.81 144.33 48.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.394 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.18 -34.8 77.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.943 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -110.87 119.51 45.89 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.787 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -56.55 -22.05 41.29 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.673 2.249 . . . . 0.0 113.139 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.7 m -57.14 -37.35 71.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.577 0.227 . . . . 0.0 111.558 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.939 ' O ' HG23 ' A' ' 216' ' ' VAL . 21.6 m -59.33 -35.81 74.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.816 0.341 . . . . 0.0 110.745 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.832 HG13 ' SD ' ' A' ' 161' ' ' MET . 78.1 t -61.16 -42.3 92.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.243 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.406 ' O ' HG22 ' A' ' 217' ' ' VAL . 54.0 t0 -59.22 -41.92 89.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.869 0.366 . . . . 0.0 111.179 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.42 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 15.3 pt-20 -76.34 -29.17 57.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.82 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.939 HG23 ' O ' ' A' ' 212' ' ' SER . 77.1 t -60.05 -41.54 86.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.441 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 214' ' ' ASP . 21.9 m -72.17 -30.02 34.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -59.12 -37.67 77.75 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.704 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 43.4 m -91.86 142.27 27.75 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 63.7 tt0 -66.19 -41.68 89.9 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.666 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.798 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 79.3 m-70 81.65 111.2 0.07 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.482 HD13 ' O ' ' A' ' 221' ' ' HIS . 20.5 mm -119.24 113.38 41.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.8 tt -120.67 124.63 45.67 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.937 0.399 . . . . 0.0 111.736 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 52.67 43.0 31.77 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.47 8.35 87.63 Favored Glycine 0 CA--C 1.516 0.141 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.345 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.51 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 2.4 mmmm -120.11 164.61 15.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.68 0.276 . . . . 0.0 110.532 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.9 p -117.52 135.99 56.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.087 0.47 . . . . 0.0 110.263 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.946 HG21 HD23 ' A' ' 166' ' ' LEU . 37.4 pt -126.96 160.47 35.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.61 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -127.83 79.22 74.01 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.158 0.504 . . . . 0.0 110.744 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.559 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 52.3 Cg_exo -58.78 124.06 14.91 Favored 'Trans proline' 0 CA--C 1.528 0.185 0 C-N-CA 122.934 2.423 . . . . 0.0 111.454 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 8.9 mtmm -133.58 157.18 46.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.915 0.388 . . . . 0.0 111.454 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 35.6 tpt85 -57.6 136.06 56.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.407 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.29 144.44 56.95 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.947 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 11.5 mt -111.06 125.25 31.0 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.67 143.44 46.69 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 121.82 1.68 . . . . 0.0 110.707 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -57.62 -39.86 77.86 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -62.27 -46.19 89.91 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.295 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.456 ' O ' HG23 ' A' ' 242' ' ' THR . 84.4 tt0 -69.78 -38.16 76.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.578 0.704 . . . . 0.0 109.762 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -59.27 -40.96 87.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.027 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -61.61 -40.53 95.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.896 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -61.21 -34.59 75.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.46 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.729 HG22 ' HA ' ' A' ' 292' ' ' ASP . 19.1 p -80.71 161.93 24.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.535 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -147.46 175.77 26.64 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.178 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.517 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 49.1 tptt -131.08 129.94 42.56 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.648 HD13 ' O ' ' A' ' 245' ' ' ILE . 0.0 OUTLIER -119.74 161.12 19.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.377 0.608 . . . . 0.0 111.116 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.408 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 86.6 t80 -103.96 135.99 44.45 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.451 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 287' ' ' GLY . 7.5 p -129.48 144.55 37.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.563 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.65 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -129.8 176.87 18.45 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.82 32.73 26.13 Favored Glycine 0 C--N 1.32 -0.333 0 C-N-CA 119.895 -1.145 . . . . 0.0 112.211 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 1.023 HG23 HG21 ' A' ' 254' ' ' VAL . 69.3 mt -107.86 130.89 59.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -143.0 -163.12 9.6 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.438 -0.886 . . . . 0.0 113.39 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -52.32 147.69 27.88 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.934 2.423 . . . . 0.0 112.463 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 50.1 t0 74.16 -3.7 2.47 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.672 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 1.023 HG21 HG23 ' A' ' 250' ' ' ILE . 11.3 p -60.93 -38.58 79.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.1 OUTLIER 54.56 115.25 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.403 -179.452 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.21 -34.42 69.27 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 121.664 1.576 . . . . 0.0 111.998 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -61.75 -43.31 99.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.682 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.519 ' HB3' ' O ' ' A' ' 254' ' ' VAL . 84.3 tt0 -65.86 -35.66 81.28 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.281 0.563 . . . . 0.0 110.548 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.63 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 13.9 t80 -58.65 -45.16 89.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.594 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.414 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.4 tt0 -65.38 -41.96 93.17 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.3 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 258' ' ' GLU . 20.3 pt-20 -73.65 -30.8 63.14 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.01 0.433 . . . . 0.0 110.506 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.511 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 8.5 t80 -61.16 -53.23 59.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.224 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.688 ' CD2' HG21 ' A' ' 289' ' ' VAL . 4.3 m-85 -70.0 -23.5 63.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.888 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.637 ' N ' HD11 ' A' ' 269' ' ' ILE . 70.8 p -58.41 -25.61 62.34 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.734 0.302 . . . . 0.0 111.541 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -55.38 -34.51 64.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.242 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.687 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 11.2 p90 -117.05 45.12 1.94 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.259 0.552 . . . . 0.0 111.434 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.504 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 152.44 147.69 4.66 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.745 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 49.8 m -59.41 -37.99 79.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 111.348 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.68 HD11 ' C ' ' A' ' 263' ' ' PHE . 70.4 mt 67.55 86.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.873 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 292' ' ' ASP . 34.0 mm -58.56 -38.94 73.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.9 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -155.98 150.34 25.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.095 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -153.2 132.38 12.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.087 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -149.93 163.04 39.13 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 275' ' ' MET . 1.6 mm? -95.83 7.77 45.4 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.643 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.887 ' O ' HD12 ' A' ' 276' ' ' LEU . 86.0 mtp 71.02 -80.28 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.14 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.887 HD12 ' O ' ' A' ' 275' ' ' MET . 0.1 OUTLIER 37.95 49.42 1.17 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 178.694 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.28 -45.04 84.47 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.386 -0.525 . . . . 0.0 110.661 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.512 ' O ' HG23 ' A' ' 280' ' ' THR . 61.4 mttp -108.02 3.42 24.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.09 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.484 ' OD1' ' HB2' ' A' ' 276' ' ' LEU . 83.3 m-20 51.28 38.13 20.57 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 278' ' ' LYS . 63.6 p -111.17 0.18 16.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.924 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.62 -30.73 0.26 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 119.409 -1.377 . . . . 0.0 114.334 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.528 ' HB2' ' HA ' ' A' ' 276' ' ' LEU . 94.9 mt-30 -57.46 -31.15 65.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.33 0.565 . . . . 0.0 110.641 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.714 ' CB ' HD23 ' A' ' 276' ' ' LEU . 95.4 p -59.32 -26.0 64.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.393 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -127.3 154.87 44.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.315 0.578 . . . . 0.0 111.389 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.52 -50.49 0.98 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.727 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.52 ' C ' HD12 ' A' ' 250' ' ' ILE . 22.4 p90 -145.16 165.07 29.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.862 0.331 . . . . 0.0 110.748 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.682 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -137.24 163.68 25.36 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.421 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.517 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -122.4 124.96 44.85 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.278 0.231 . . . . 0.0 110.8 179.489 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.688 HG21 ' CD2' ' A' ' 263' ' ' PHE . 43.4 t -127.12 139.9 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.009 0.433 . . . . 0.0 112.032 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.422 ' OG1' ' CD ' ' A' ' 244' ' ' LYS . 34.8 m -114.69 137.87 51.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.858 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.504 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 37.8 m-85 -117.43 140.11 50.02 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.729 ' HA ' HG22 ' A' ' 242' ' ' THR . 29.2 p-10 -61.53 -33.79 74.43 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.236 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' SER . . . . . 0.424 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 31.1 t -124.16 139.06 54.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.423 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.82 -31.73 73.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.61 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -56.12 -37.24 69.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.97 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -60.92 -36.65 79.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.957 0.408 . . . . 0.0 110.352 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 300' ' ' VAL . 82.0 t -61.1 -40.87 87.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.143 0.497 . . . . 0.0 110.194 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -59.47 -36.61 76.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.407 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -56.84 -42.91 80.5 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.085 0.469 . . . . 0.0 111.046 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.809 HG23 HD11 ' A' ' 306' ' ' ILE . 0.3 OUTLIER -75.71 -30.22 21.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.667 179.586 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 80.9 m -56.43 -45.87 80.55 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -64.15 -34.31 77.76 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -100.54 70.58 1.47 Allowed 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.204 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.609 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 7.6 tptt -53.81 -43.74 69.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.239 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.609 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.9 m-85 -113.55 126.0 54.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.302 0.572 . . . . 0.0 110.899 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.809 HD11 HG23 ' A' ' 300' ' ' VAL . 25.8 mt -117.68 139.17 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.192 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -79.54 102.39 8.81 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.595 ' HE2' HG23 ' A' ' 254' ' ' VAL . 5.7 t80 -107.4 -72.57 0.72 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.385 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.528 ' HD3' ' CE2' ' A' ' 308' ' ' PHE . 3.7 mmmt -100.15 26.28 6.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.346 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 63.03 41.56 8.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.697 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 312' ' ' LYS . 94.6 mtt180 -150.78 7.86 0.56 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.151 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 311' ' ' ARG . 24.0 mmtm 56.71 138.53 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.537 0.684 . . . . 0.0 112.129 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.65 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 36.3 pt -120.81 148.01 24.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.221 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' GLU . . . . . 0.408 ' CG ' ' HE3' ' A' ' 304' ' ' LYS . 84.9 tt0 -104.32 127.35 51.96 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 0.608 HG12 HG23 ' A' ' 247' ' ' VAL . 86.8 mt -118.19 130.86 72.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.324 0.583 . . . . 0.0 112.074 -178.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -132.51 142.84 49.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.526 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 69.3 mtt85 -53.11 149.13 7.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.641 0.258 . . . . 0.0 110.378 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 244' ' ' LYS . . . -54.27 141.88 28.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.91 0.386 . . . . 0.0 111.116 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.313 -179.488 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 37.4 m . . . . . 0 CA--C 1.531 0.25 0 CA-C-O 120.625 0.25 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -56.15 141.25 41.41 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.288 0.566 . . . . 0.0 111.621 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.671 ' CG ' HG23 ' A' ' 213' ' ' VAL . 93.8 mtp -115.83 156.04 26.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.435 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.621 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 3.5 t80 -105.16 129.57 53.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.894 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.638 HG23 HD12 ' A' ' 228' ' ' ILE . 16.0 mm -116.98 131.37 69.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.478 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -134.48 164.08 24.62 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.411 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.2 25.32 66.51 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.368 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.981 HD23 HG21 ' A' ' 228' ' ' ILE . 75.6 mt -86.88 143.05 27.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.734 0.302 . . . . 0.0 110.949 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -61.12 133.23 55.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -52.32 -28.18 18.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.703 0.287 . . . . 0.0 111.013 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 50.2 p30 -83.81 8.5 14.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.16 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 88.8 m -70.77 140.23 51.24 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.351 0.596 . . . . 0.0 110.164 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 173' ' ' ASP . 27.9 m -114.97 144.38 43.68 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.566 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.948 ' HB3' HD21 ' A' ' 188' ' ' LEU . 98.3 mt-10 -55.73 -35.42 66.13 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.865 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.795 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 92.1 m-20 -57.1 -40.46 77.05 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -65.15 -38.69 91.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.11 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.722 HD22 HD21 ' A' ' 205' ' ' LEU . 3.6 mt -63.22 -48.32 78.76 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.795 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -71.63 -34.11 69.52 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.033 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -62.08 -38.57 89.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.536 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 63.8 t80 -80.25 -61.86 1.85 Allowed 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.942 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.575 ' CE2' HD23 ' A' ' 175' ' ' LEU . 72.6 m-85 -66.62 -21.47 66.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.314 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -50.56 -27.97 13.85 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.512 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 1.7 tmtt? -55.15 -43.14 73.92 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.864 -0.668 . . . . 0.0 110.062 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.467 ' CG ' HG22 ' A' ' 216' ' ' VAL . 46.0 m-85 -71.08 -33.94 70.69 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.454 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.419 ' O ' ' HA2' ' A' ' 180' ' ' GLY . . . -177.38 179.99 47.89 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.334 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 54.1 m -62.89 -33.85 76.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.805 0.336 . . . . 0.0 111.68 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.818 HG23 ' CE1' ' A' ' 207' ' ' PHE . 0.5 OUTLIER 64.99 102.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 121.205 0.526 . . . . 0.0 109.654 -178.184 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.75 HG23 ' N ' ' A' ' 208' ' ' GLU . 43.9 p -67.29 -37.68 83.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.965 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 206' ' ' SER . 20.1 t70 -160.81 160.77 31.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.948 HD21 ' HB3' ' A' ' 172' ' ' GLU . 0.1 OUTLIER -158.43 144.13 16.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.055 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.518 ' CG ' ' HB2' ' A' ' 204' ' ' PHE . 0.0 OUTLIER -131.71 113.56 13.7 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.724 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.696 ' HB ' ' HG2' ' A' ' 172' ' ' GLU . 2.0 tt -93.05 11.1 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.515 ' CB ' ' HG3' ' A' ' 200' ' ' ARG . 0.0 OUTLIER 67.21 -71.09 0.1 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.763 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.724 ' HA ' ' HA ' ' A' ' 199' ' ' SER . 20.0 ttmm 59.81 133.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.095 0.474 . . . . 0.0 111.261 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 88.2 m-20 -120.73 87.78 42.74 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.893 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.59 -24.71 37.83 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.342 2.028 . . . . 0.0 112.306 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -75.46 -75.63 0.17 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.402 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 62.8 p -70.36 -24.43 62.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.051 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 91.26 9.8 63.0 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.992 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 17.9 ttp85 -96.15 133.01 40.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.213 0.53 . . . . 0.0 111.827 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.724 ' HA ' ' HA ' ' A' ' 192' ' ' LYS . 75.4 m -85.83 10.22 14.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.132 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.515 ' HG3' ' CB ' ' A' ' 191' ' ' MET . 40.2 mmt180 74.94 -41.88 0.48 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 166' ' ' LEU . . . 92.95 6.01 63.77 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.331 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.613 ' HB2' ' O ' ' A' ' 163' ' ' ILE . 33.9 p90 -147.37 155.48 42.01 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.441 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -154.92 166.65 32.53 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.148 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.621 ' CE2' ' CD1' ' A' ' 162' ' ' PHE . 91.1 m-85 -109.92 128.39 55.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.655 0.264 . . . . 0.0 110.416 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.722 HD21 HD22 ' A' ' 175' ' ' LEU . 63.3 mt -104.99 140.5 38.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.837 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 33.1 t -123.21 130.69 53.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.347 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.818 ' CE1' HG23 ' A' ' 185' ' ' VAL . 94.7 m-85 -117.25 138.33 51.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.001 0.429 . . . . 0.0 111.538 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.75 ' N ' HG23 ' A' ' 186' ' ' THR . 84.4 tt0 -61.48 -34.62 75.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.095 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -113.36 120.49 39.8 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.955 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 0.755 ' O ' HG12 ' A' ' 213' ' ' VAL . 49.6 Cg_exo -56.17 -22.29 39.46 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.537 2.158 . . . . 0.0 112.989 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.6 m -56.61 -37.91 71.33 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.688 0.28 . . . . 0.0 111.291 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.867 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.4 m -59.68 -35.69 74.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 0.0 110.284 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 210' ' ' PRO . 0.4 OUTLIER -59.48 -40.51 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.721 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -62.57 -41.88 99.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.432 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.401 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 10.1 pt-20 -77.68 -34.08 53.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.997 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 212' ' ' SER . 84.0 t -62.62 -47.09 94.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 CA-C-O 121.104 0.478 . . . . 0.0 110.522 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.22 -34.09 67.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -57.99 -37.43 74.23 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.685 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 38.5 m -96.0 141.73 29.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.724 0.297 . . . . 0.0 111.619 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 228' ' ' ILE . 63.6 tt0 -67.05 -41.53 86.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.765 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 47.0 m-70 77.61 122.3 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.996 HD12 HG12 ' A' ' 227' ' ' VAL . 21.0 mm -116.38 110.65 32.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 175.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.494 HD23 ' CG ' ' A' ' 224' ' ' ASP . 7.1 tt -121.77 125.91 47.64 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.228 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.494 ' CG ' HD23 ' A' ' 223' ' ' LEU . 86.7 m-20 53.92 41.56 32.0 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 76.5 12.86 83.98 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.551 -0.833 . . . . 0.0 114.162 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -126.13 156.48 40.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.482 0.641 . . . . 0.0 111.764 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.996 HG12 HD12 ' A' ' 222' ' ' ILE . 33.7 m -107.82 136.52 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.298 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.981 HG21 HD23 ' A' ' 166' ' ' LEU . 34.3 pt -126.78 162.76 30.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.012 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -129.02 79.18 75.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.046 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.732 ' HG3' ' CD2' ' A' ' 221' ' ' HIS . 9.6 Cg_endo -54.21 133.48 55.85 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.417 2.078 . . . . 0.0 111.681 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -137.65 147.78 45.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.619 0.247 . . . . 0.0 110.774 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -56.28 137.53 52.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 111.391 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.75 148.87 51.35 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.114 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.465 HG22 ' HD2' ' A' ' 235' ' ' PRO . 5.6 mt -114.27 142.84 28.68 Favored Pre-proline 0 N--CA 1.464 0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.581 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.465 ' HD2' HG22 ' A' ' 234' ' ' ILE . 37.3 Cg_exo -56.94 138.88 88.0 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 121.763 1.642 . . . . 0.0 110.732 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -60.06 -40.4 89.32 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.608 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 56.7 p30 -64.67 -40.8 96.06 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.573 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.608 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 97.3 mt-10 -71.47 -35.93 71.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.579 0.704 . . . . 0.0 109.363 177.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -58.42 -42.01 86.3 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.752 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -63.53 -40.09 96.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.057 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -60.06 -36.45 77.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.708 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.722 HG21 ' CD1' ' A' ' 270' ' ' ILE . 17.2 p -78.84 160.63 27.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.532 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -142.11 169.26 25.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.424 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 7.9 ttpm? -134.79 136.07 42.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.54 0.21 . . . . 0.0 110.839 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.835 HD12 HG21 ' A' ' 315' ' ' ILE . 9.6 pt -120.29 156.6 23.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.127 0.489 . . . . 0.0 111.53 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 315' ' ' ILE . 78.9 t80 -94.41 131.44 40.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.15 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.851 HG21 ' CZ ' ' A' ' 263' ' ' PHE . 25.1 t -124.47 135.9 62.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.396 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.558 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -132.57 178.32 18.16 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.71 26.35 46.44 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.037 -1.078 . . . . 0.0 112.268 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.65 HD11 ' C ' ' A' ' 286' ' ' PHE . 32.0 pt -118.44 154.79 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 121.04 0.448 . . . . 0.0 111.339 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.763 ' O ' HG12 ' A' ' 254' ' ' VAL . . . -127.43 176.01 18.02 Favored Glycine 0 C--O 1.226 -0.344 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.972 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' PRO . . . . . 0.419 ' HD3' ' HG3' ' A' ' 284' ' ' ARG . 54.1 Cg_exo -51.69 -28.61 30.3 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 121.92 1.746 . . . . 0.0 111.304 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -61.32 -30.53 70.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.177 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.763 HG12 ' O ' ' A' ' 251' ' ' GLY . 7.8 p -47.54 -38.59 6.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.819 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.0 OUTLIER 56.34 125.68 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.281 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.47 -35.8 86.28 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 121.787 1.658 . . . . 0.0 112.656 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -63.56 -47.76 80.21 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 85.0 tt0 -68.07 -37.05 80.83 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.126 0.488 . . . . 0.0 111.15 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.504 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 27.4 t80 -58.88 -45.68 89.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.061 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.426 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.4 tt0 -66.84 -40.98 88.11 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.944 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' A' ' 258' ' ' GLU . 19.5 pt-20 -70.26 -34.09 72.39 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.882 0.372 . . . . 0.0 110.491 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.603 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 83.7 t80 -60.4 -54.33 46.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.454 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.851 ' CZ ' HG21 ' A' ' 247' ' ' VAL . 26.9 m-85 -69.22 -28.39 66.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.67 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.651 ' N ' HD11 ' A' ' 269' ' ' ILE . 22.7 t -57.05 -29.67 63.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.455 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 262' ' ' PHE . 7.1 pt20 -53.26 -36.09 60.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.822 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.814 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 12.5 p90 -115.19 40.99 2.53 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.915 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 170.91 -179.01 43.08 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.465 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.518 HG23 ' HB3' ' A' ' 292' ' ' ASP . 0.0 OUTLIER -104.81 0.75 28.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.77 0.319 . . . . 0.0 110.345 179.045 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.651 HD11 ' N ' ' A' ' 264' ' ' SER . 75.5 mt 28.91 97.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.722 ' CD1' HG21 ' A' ' 242' ' ' THR . 72.5 mt -60.44 -45.47 96.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.581 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -164.83 94.02 0.66 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -99.09 136.4 39.1 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -142.16 154.52 44.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.624 0.726 . . . . 0.0 112.745 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.794 HD21 ' O ' ' A' ' 283' ' ' SER . 35.7 tp -64.68 -37.38 87.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.648 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.611 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 95.8 mmm 93.32 114.75 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.518 -178.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.415 HD22 ' OG ' ' A' ' 283' ' ' SER . 28.5 mt -111.15 141.9 44.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.421 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.681 ' HB3' ' HA3' ' A' ' 281' ' ' GLY . 59.8 t0 -144.52 88.01 1.9 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.156 0.503 . . . . 0.0 110.405 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.704 ' O ' HG22 ' A' ' 280' ' ' THR . 3.5 mtmp? 64.6 37.13 8.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.568 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.461 ' O ' ' HB ' ' A' ' 280' ' ' THR . 86.0 m-20 51.84 44.23 29.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.961 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.704 HG22 ' O ' ' A' ' 278' ' ' LYS . 1.6 t 169.66 46.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.911 0.386 . . . . 0.0 110.729 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' GLY . . . . . 0.681 ' HA3' ' HB3' ' A' ' 277' ' ' ASP . . . -136.43 -111.82 1.13 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.313 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.51 ' OE1' ' HB3' ' A' ' 275' ' ' MET . 91.9 mt-30 -56.9 -24.99 56.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.027 -0.587 . . . . 0.0 111.101 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.794 ' O ' HD21 ' A' ' 274' ' ' LEU . 16.8 m -49.52 -31.9 11.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.086 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.419 ' HG3' ' HD3' ' A' ' 252' ' ' PRO . 70.7 ttp85 -116.36 136.98 52.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.161 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.16 -57.03 0.44 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.799 -0.715 . . . . 0.0 114.071 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.65 ' C ' HD11 ' A' ' 250' ' ' ILE . 35.1 p90 -141.62 167.98 20.86 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.555 0.677 . . . . 0.0 112.02 -178.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.448 ' N ' HD11 ' A' ' 250' ' ' ILE . . . -134.45 156.02 22.21 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.238 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.515 ' HB2' ' HG2' ' A' ' 275' ' ' MET . 0.1 OUTLIER -111.97 129.85 56.05 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.709 0.29 . . . . 0.0 111.722 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.54 HG21 ' CG ' ' A' ' 263' ' ' PHE . 38.4 t -122.39 135.04 63.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 111.496 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 52.0 m -118.48 135.64 54.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.444 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 38.7 m-85 -116.87 134.99 54.08 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.633 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 54.4 t0 -59.43 -36.08 75.22 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.5 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 50.5 m -120.77 143.92 48.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.266 0.555 . . . . 0.0 111.436 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.63 -30.61 71.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.158 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -56.47 -38.9 72.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.278 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.8 88.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.074 0.464 . . . . 0.0 110.299 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.702 HG13 HG21 ' A' ' 245' ' ' ILE . 71.6 t -62.2 -42.99 97.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.707 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -60.57 -37.72 82.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.125 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -58.59 -43.81 89.62 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.814 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 0.4 OUTLIER -74.34 -34.38 36.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.953 0.406 . . . . 0.0 111.045 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 97.8 m -58.24 -44.69 88.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.193 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -62.22 -40.12 95.08 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.312 0.577 . . . . 0.0 109.91 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -63.81 -32.67 74.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.369 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.707 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 22.5 tptm 67.47 -74.89 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.629 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.707 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.5 m-30 -109.06 131.85 54.67 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.127 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.66 HD11 HG23 ' A' ' 300' ' ' VAL . 1.7 mt -121.07 138.08 52.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.48 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.414 ' OD1' ' CE ' ' A' ' 312' ' ' LYS . 86.9 m-20 -67.55 138.46 56.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.603 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 2.2 t80 -140.62 -107.98 0.15 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.209 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 310' ' ' ASP . 2.6 mmpt? -58.92 -38.54 79.18 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.834 0.35 . . . . 0.0 111.862 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 309' ' ' LYS . 58.3 t0 176.7 -29.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.227 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 88.2 mmt-85 -113.66 160.32 18.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.607 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 37.0 mmtm -66.65 140.67 57.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.092 0.472 . . . . 0.0 111.567 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.558 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 34.5 pt -110.45 133.75 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' GLU . . . . . 0.548 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 84.2 mt-10 -96.04 131.49 42.38 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.798 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 0.835 HG21 HD12 ' A' ' 245' ' ' ILE . 68.6 mt -120.3 123.92 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.068 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -130.41 154.81 47.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.983 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -56.12 151.53 12.11 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -48.29 142.98 5.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.975 0.417 . . . . 0.0 110.866 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.731 -178.601 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.3 m . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.835 0.35 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.511 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 6.3 tptt -56.85 136.37 55.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.47 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.68 ' SD ' HG13 ' A' ' 213' ' ' VAL . 90.3 mtp -125.74 155.88 40.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.303 0.573 . . . . 0.0 112.016 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.549 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 3.1 t80 -105.22 130.88 53.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.376 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.828 HG23 HD12 ' A' ' 228' ' ' ILE . 22.4 mm -117.4 128.89 74.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.556 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.525 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -122.43 157.15 17.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.968 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.565 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 74.68 54.52 5.91 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.218 -0.992 . . . . 0.0 112.27 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.532 HD11 ' N ' ' A' ' 203' ' ' GLY . 69.4 mt -83.55 3.47 32.34 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.514 ' HB2' ' HG3' ' A' ' 226' ' ' LYS . 36.9 t30 58.27 39.95 25.12 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.842 -0.536 . . . . 0.0 110.109 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.435 ' HA ' ' OG ' ' A' ' 199' ' ' SER . 8.8 m0 33.32 35.05 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.075 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -175.72 22.48 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.504 ' OG1' ' O ' ' A' ' 166' ' ' LEU . 95.1 m -59.84 -34.65 73.38 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 122.137 -0.352 . . . . 0.0 111.795 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.0 OUTLIER 62.33 131.23 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -178.196 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.63 ' N ' HD12 ' A' ' 190' ' ' ILE . 96.5 mt-10 -59.02 -34.95 72.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.633 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.638 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.9 m-20 -57.04 -40.77 77.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.886 0.374 . . . . 0.0 111.386 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 170' ' ' THR . 9.7 m120 -63.12 -36.19 82.77 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.742 ' CB ' HD11 ' A' ' 188' ' ' LEU . 6.3 mt -59.93 -42.25 93.57 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.638 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -65.29 -38.82 91.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.016 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.447 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 75.8 mm-40 -70.82 -44.11 67.21 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.043 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.556 ' O ' ' HD3' ' A' ' 181' ' ' LYS . 58.4 t80 -65.28 -44.56 87.59 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.223 0.535 . . . . 0.0 111.435 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.609 ' CE2' HD23 ' A' ' 175' ' ' LEU . 88.5 m-85 -94.86 -1.82 51.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.206 -0.907 . . . . 0.0 112.452 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -61.54 -26.97 67.25 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.312 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.621 ' H ' ' CD ' ' A' ' 181' ' ' LYS . 0.8 OUTLIER -56.11 -39.76 72.69 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.032 0.92 . . . . 0.0 111.002 -179.259 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -67.51 -27.86 67.34 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.711 -1.586 . . . . 0.0 112.012 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 159.64 -123.15 1.2 Allowed Glycine 0 CA--C 1.507 -0.432 0 C-N-CA 120.678 -0.773 . . . . 0.0 111.674 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.492 ' O ' ' HD1' ' A' ' 207' ' ' PHE . 28.3 p -119.88 160.0 23.55 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 206' ' ' SER . 8.1 p -122.67 130.25 74.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.332 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.769 HG23 ' N ' ' A' ' 208' ' ' GLU . 50.9 p -77.12 -38.86 51.22 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -155.29 150.98 27.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.472 0.653 . . . . 0.0 112.564 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.742 HD11 ' CB ' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -122.06 130.88 53.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.454 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 9.5 tptp -136.41 120.54 17.77 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.63 HD12 ' N ' ' A' ' 172' ' ' GLU . 6.4 mt -130.28 130.63 65.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.771 176.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.541 ' SD ' ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -90.38 122.26 33.09 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.53 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.56 ' HG3' HG22 ' A' ' 190' ' ' ILE . 58.9 mttm -126.76 156.46 41.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.752 0.31 . . . . 0.0 111.496 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.649 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 7.7 t70 -122.19 80.24 44.12 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.378 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.41 -25.88 50.53 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.429 2.086 . . . . 0.0 112.57 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -72.19 -67.44 0.54 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.916 0.389 . . . . 0.0 111.235 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 61.4 p -71.63 -22.12 61.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.629 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 84.21 18.2 63.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.378 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.649 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 2.1 ttt-85 -122.98 144.24 49.38 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 120.92 0.39 . . . . 0.0 111.273 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.435 ' OG ' ' HA ' ' A' ' 168' ' ' TRP . 90.1 p -110.38 157.61 19.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.979 0.419 . . . . 0.0 111.039 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.557 ' HD2' ' N ' ' A' ' 200' ' ' ARG . 1.5 mpt_? -53.53 -32.43 50.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.502 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.435 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 94.42 -0.09 65.51 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.352 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.554 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 23.9 p90 -139.15 154.86 48.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.222 0.534 . . . . 0.0 110.873 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.532 ' N ' HD11 ' A' ' 166' ' ' LEU . . . -140.42 162.2 26.52 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.23 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.549 ' CE2' ' CD1' ' A' ' 162' ' ' PHE . 95.6 m-85 -106.21 127.46 53.24 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.979 0.418 . . . . 0.0 109.982 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.664 HD23 ' N ' ' A' ' 206' ' ' SER . 2.0 tt -107.23 128.03 54.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.807 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.664 ' N ' HD23 ' A' ' 205' ' ' LEU . 11.9 t -117.0 132.45 56.7 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.494 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 205' ' ' LEU . 72.5 m-85 -117.5 141.55 48.22 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.769 ' N ' HG23 ' A' ' 186' ' ' THR . 47.0 tp10 -63.07 -36.08 82.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.6 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.24 116.57 51.0 Favored Pre-proline 0 CA--C 1.529 0.141 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.624 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.97 -26.02 65.86 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.346 2.031 . . . . 0.0 112.584 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 21.4 m -57.98 -37.28 73.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.26 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.915 ' O ' HG23 ' A' ' 216' ' ' VAL . 23.5 m -59.08 -35.61 73.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.942 0.401 . . . . 0.0 110.399 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.68 HG13 ' SD ' ' A' ' 161' ' ' MET . 86.0 t -61.68 -42.32 93.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.022 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -59.6 -41.63 90.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.131 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.43 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 18.7 pt-20 -75.1 -31.49 61.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.818 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 212' ' ' SER . 77.7 t -60.99 -44.69 98.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.278 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 230' ' ' PRO . 21.1 m -76.23 -29.24 19.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.028 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -58.31 -33.04 69.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.667 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 88.5 m -111.53 145.49 38.99 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -76.87 145.12 38.53 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.776 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 63.7 m-70 -120.57 134.05 55.32 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -176.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.61 HD13 HG23 ' A' ' 227' ' ' VAL . 28.3 mm -119.61 113.64 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.1 tt -121.66 126.77 49.8 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.74 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 56.4 t0 52.75 37.38 23.62 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 93.47 -24.67 24.49 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.839 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.514 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 30.9 mmtp -97.58 170.96 8.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.841 0.353 . . . . 0.0 111.324 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.61 HG23 HD13 ' A' ' 222' ' ' ILE . 11.7 p -120.89 139.97 46.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.927 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.828 HD12 HG23 ' A' ' 163' ' ' ILE . 36.0 pt -123.64 159.86 27.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.097 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -125.25 81.39 63.64 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.172 0.51 . . . . 0.0 110.834 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.724 ' O ' HG12 ' A' ' 217' ' ' VAL . 51.0 Cg_exo -57.83 129.05 31.47 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.966 2.444 . . . . 0.0 111.551 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -140.74 155.94 46.32 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.571 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.595 ' CD ' HG11 ' A' ' 213' ' ' VAL . 52.5 mmm-85 -56.08 140.11 44.85 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.515 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.35 147.43 52.58 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.886 0.374 . . . . 0.0 111.506 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 35.7 mt -118.48 125.73 27.64 Favored Pre-proline 0 C--N 1.333 -0.132 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.155 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.451 ' HG2' ' CB ' ' A' ' 238' ' ' GLU . 9.8 Cg_endo -54.3 146.13 52.16 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 121.461 1.44 . . . . 0.0 110.072 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -55.98 -40.25 73.01 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.48 -44.13 95.27 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.897 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.451 ' CB ' ' HG2' ' A' ' 235' ' ' PRO . 84.3 tt0 -67.43 -38.14 84.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.038 0.447 . . . . 0.0 110.645 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.416 ' O ' HG23 ' A' ' 242' ' ' THR . 59.8 tp60 -58.95 -40.71 85.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.998 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -60.38 -40.38 90.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.082 0.468 . . . . 0.0 110.661 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -61.52 -36.58 80.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.267 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 291' ' ' TYR . 69.5 p -31.31 -75.57 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 80.61 47.77 6.6 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.918 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 16.8 tttp -58.77 138.54 57.09 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 122.449 0.299 . . . . 0.0 110.785 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.474 HG21 HG13 ' A' ' 297' ' ' VAL . 0.2 OUTLIER -121.41 161.52 21.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.855 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -96.03 131.24 42.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.82 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.848 HG21 ' CE2' ' A' ' 263' ' ' PHE . 59.9 t -124.02 139.97 48.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.494 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.66 -174.32 13.79 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.456 ' O ' ' CG2' ' A' ' 313' ' ' ILE . . . 79.98 57.14 3.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 119.765 -1.207 . . . . 0.0 112.882 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.578 ' CG2' HG21 ' A' ' 254' ' ' VAL . 31.6 mm -104.41 129.41 56.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.919 ' O ' HG13 ' A' ' 254' ' ' VAL . . . -107.81 169.25 14.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.004 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.39 141.54 89.35 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.454 2.103 . . . . 0.0 112.622 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 55.76 42.45 29.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.254 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.919 HG13 ' O ' ' A' ' 251' ' ' GLY . 2.5 m -73.15 -35.79 48.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.675 0.274 . . . . 0.0 110.916 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.21 124.29 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.09 -28.68 51.94 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 121.867 1.711 . . . . 0.0 111.9 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -60.75 -42.94 98.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.015 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 96.7 mt-10 -66.21 -39.4 89.58 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.925 0.393 . . . . 0.0 111.128 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.699 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 37.1 t80 -64.9 -46.75 80.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.385 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.528 ' O ' HD12 ' A' ' 269' ' ' ILE . 96.8 mt-10 -64.47 -40.58 95.97 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.717 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 21.1 pt-20 -76.3 -29.71 57.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 110.391 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.722 ' HE2' HD11 ' A' ' 313' ' ' ILE . 18.3 t80 -61.53 -57.2 13.08 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.944 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.903 ' CB ' HD11 ' A' ' 269' ' ' ILE . 7.4 m-85 -67.41 -27.22 66.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.106 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 267' ' ' GLY . 34.8 m -54.53 -27.24 36.89 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -46.77 -38.21 9.74 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.348 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.72 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 19.9 p90 -126.66 42.66 3.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.09 0.471 . . . . 0.0 111.269 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 264' ' ' SER . . . 162.71 154.17 7.49 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.756 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.407 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 50.9 m -61.27 -35.6 77.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.888 0.375 . . . . 0.0 111.593 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.903 HD11 ' CB ' ' A' ' 263' ' ' PHE . 2.5 mt 69.39 80.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.633 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.618 HD11 ' HB3' ' A' ' 292' ' ' ASP . 34.4 mm -59.85 -41.75 86.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.51 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -157.86 86.48 0.91 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.559 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -105.23 130.59 53.34 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -147.39 155.82 42.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.334 0.588 . . . . 0.0 112.506 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.726 HD21 ' O ' ' A' ' 283' ' ' SER . 34.5 tp -65.08 -36.98 86.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.825 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.69 ' O ' HD23 ' A' ' 276' ' ' LEU . 95.7 mmm 81.24 119.92 0.05 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.329 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.728 HD22 ' HB2' ' A' ' 283' ' ' SER . 25.4 mt -127.03 129.03 47.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.598 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -62.24 -39.57 93.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.616 0.722 . . . . 0.0 109.599 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -161.77 -46.94 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.907 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.465 ' O ' HD13 ' A' ' 276' ' ' LEU . 91.9 m-20 -131.19 -79.93 0.53 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.653 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.435 ' HA ' ' HB2' ' A' ' 283' ' ' SER . 68.7 p -116.3 13.36 15.57 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.891 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -49.87 -81.54 0.05 OUTLIER Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.419 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.757 HE21 ' HE1' ' A' ' 286' ' ' PHE . 17.9 mm100 -83.97 6.38 22.12 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 122.781 0.433 . . . . 0.0 110.791 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.728 ' HB2' HD22 ' A' ' 276' ' ' LEU . 22.8 t -56.95 -31.57 65.13 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.233 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 20.9 ptp180 -130.27 158.17 40.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.399 0.618 . . . . 0.0 111.902 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.68 -34.79 5.39 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.048 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.757 ' HE1' HE21 ' A' ' 282' ' ' GLN . 18.1 p90 -155.27 164.28 39.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 117.286 0.543 . . . . 0.0 111.768 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -135.13 150.92 20.32 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.121 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.511 ' HB2' ' HG2' ' A' ' 275' ' ' MET . 0.1 OUTLIER -112.26 125.61 54.35 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.859 -0.201 . . . . 0.0 111.483 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.699 HG23 ' CZ ' ' A' ' 259' ' ' PHE . 60.5 t -130.22 137.43 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 27.8 m -119.32 137.54 53.64 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.578 ' O ' ' HA ' ' A' ' 242' ' ' THR . 43.7 m-85 -114.44 142.25 46.61 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.618 ' HB3' HD11 ' A' ' 270' ' ' ILE . 27.7 p-10 -62.63 -33.9 75.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.03 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' SER . . . . . 0.421 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 50.9 m -123.46 144.49 49.49 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.308 0.575 . . . . 0.0 111.719 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.4 -28.86 68.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.209 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 296' ' ' ALA . 52.4 p30 -60.27 -33.3 72.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.661 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.566 ' N ' ' OD1' ' A' ' 295' ' ' ASP . . . -61.33 -36.85 81.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.083 0.468 . . . . 0.0 110.368 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 300' ' ' VAL . 83.2 t -62.06 -42.51 95.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.089 0.471 . . . . 0.0 110.442 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -61.43 -38.09 85.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.624 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -59.39 -43.77 92.88 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.942 0.401 . . . . 0.0 111.73 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.995 HG23 HD11 ' A' ' 306' ' ' ILE . 0.7 OUTLIER -72.16 -34.91 51.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.368 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 85.5 m -59.07 -45.65 90.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.164 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -62.63 -39.17 92.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.253 0.549 . . . . 0.0 110.089 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -62.53 -32.9 73.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.744 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.655 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 7.1 tptt 69.2 -72.76 0.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.67 ' HB3' ' HB3' ' A' ' 312' ' ' LYS . 3.8 m-30 -114.76 142.62 46.28 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.576 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.995 HD11 HG23 ' A' ' 300' ' ' VAL . 6.8 mt -120.11 133.73 65.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -75.37 80.65 2.44 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.183 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.608 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 11.7 t80 -76.9 -57.68 3.71 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.775 0.798 . . . . 0.0 109.869 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.459 ' HE3' ' CE2' ' A' ' 308' ' ' PHE . 9.3 mmpt? -109.87 -165.04 0.97 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.453 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -55.2 -23.45 22.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.758 0.313 . . . . 0.0 110.478 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -118.59 159.68 23.15 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.014 0.435 . . . . 0.0 111.558 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.67 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 78.5 mttt -76.58 147.96 37.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.818 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.722 HD11 ' HE2' ' A' ' 262' ' ' PHE . 23.4 pt -118.16 151.4 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' GLU . . . . . 0.604 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 81.9 mt-10 -106.6 135.72 47.63 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.259 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 0.79 HG23 HG22 ' A' ' 247' ' ' VAL . 72.1 mt -120.51 126.91 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 120.927 0.394 . . . . 0.0 110.977 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm -128.43 154.54 45.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.147 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 40.9 ptt85 -55.47 147.91 16.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.352 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.97 139.57 58.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.143 0.497 . . . . 0.0 111.407 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.173 179.575 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.606 ' SG ' HG21 ' A' ' 213' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 121.274 0.559 . . . . 0.0 110.173 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 68.1 tttt -69.58 140.3 53.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.506 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.827 ' SD ' HG13 ' A' ' 213' ' ' VAL . 86.4 mmm -115.03 147.95 39.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.78 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.635 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 5.6 t80 -108.71 130.97 55.36 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.614 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 16.6 mm -111.65 127.82 68.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 228' ' ' ILE . . . -133.85 165.34 24.28 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.795 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.453 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 75.74 28.68 60.62 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.254 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.964 HD23 HG21 ' A' ' 228' ' ' ILE . 66.1 mt -86.99 139.62 30.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.883 0.373 . . . . 0.0 110.744 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.546 ' O ' ' N ' ' A' ' 169' ' ' ASP . 30.3 t30 -65.48 136.39 56.38 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.635 ' HD1' ' HG ' ' A' ' 199' ' ' SER . 6.2 m0 -60.27 75.95 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 167' ' ' ASN . 58.4 t0 178.28 -22.31 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.656 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 88.8 m -65.07 138.53 58.38 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.182 0.515 . . . . 0.0 111.038 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.505 ' C ' HD12 ' A' ' 190' ' ' ILE . 7.4 p -115.96 166.37 12.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.923 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.7 ' N ' HD12 ' A' ' 190' ' ' ILE . 53.1 mp0 -58.34 -28.91 65.52 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.813 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.1 m-20 -58.07 -43.46 86.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.846 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -65.99 -38.41 88.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.607 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.668 HD12 HD11 ' A' ' 190' ' ' ILE . 4.7 mt -61.65 -42.71 99.27 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.813 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -66.04 -38.22 87.82 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.798 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.45 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 97.1 mt-10 -69.55 -43.43 72.96 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.124 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.485 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 56.2 t80 -67.22 -48.66 67.16 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.477 0.656 . . . . 0.0 111.603 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.663 ' CB ' HD11 ' A' ' 205' ' ' LEU . 94.9 m-85 -91.75 -1.59 57.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.128 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -57.95 -29.15 61.71 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.22 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.844 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -57.05 -40.49 76.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.19 -0.505 . . . . 0.0 110.841 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.844 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 78.1 m-85 -70.34 -34.97 73.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.122 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 178.74 -173.88 46.12 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 119.938 -1.125 . . . . 0.0 113.652 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.6 m -62.38 -30.69 71.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.13 -0.535 . . . . 0.0 111.178 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.638 ' CG1' ' O ' ' A' ' 185' ' ' VAL . 0.4 OUTLIER 67.47 89.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -177.399 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.461 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -56.13 -49.32 74.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.517 -177.073 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -142.45 137.68 30.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.28 0.562 . . . . 0.0 112.409 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.66 HD11 ' HB3' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -115.08 133.03 56.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.524 179.115 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 15.3 tptt -133.78 122.61 23.54 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.7 HD12 ' N ' ' A' ' 172' ' ' GLU . 4.7 mt -128.58 130.41 68.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.757 176.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.585 ' CE ' ' HA2' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -93.01 126.44 38.09 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.444 ' HG3' HG22 ' A' ' 190' ' ' ILE . 12.6 mtpt -126.08 152.85 45.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.972 0.415 . . . . 0.0 111.933 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.615 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 4.6 m-20 -122.72 68.87 33.62 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.885 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.9 -24.99 80.56 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.925 2.417 . . . . 0.0 113.098 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -60.98 -47.38 86.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.929 0.395 . . . . 0.0 111.265 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 55.2 p -96.83 -4.04 41.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.235 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 76.68 24.97 66.12 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.619 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.615 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 5.9 tpt180 -121.83 159.84 25.91 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.635 ' HG ' ' HD1' ' A' ' 168' ' ' TRP . 97.8 p -128.32 154.16 46.23 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.21 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.556 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 4.9 mpt_? -55.76 -35.63 66.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.362 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 166' ' ' LEU . . . 86.8 5.06 81.81 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.59 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.614 ' HB2' ' O ' ' A' ' 163' ' ' ILE . 39.6 p90 -144.93 157.31 44.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.864 0.364 . . . . 0.0 110.647 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.585 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -150.45 166.45 30.15 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.015 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 162' ' ' PHE . 95.4 m-85 -105.92 127.19 52.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.16 0.505 . . . . 0.0 109.89 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.663 HD11 ' CB ' ' A' ' 179' ' ' PHE . 6.3 tt -108.45 130.45 55.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.942 -178.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.586 ' N ' HD23 ' A' ' 205' ' ' LEU . 54.9 m -120.84 140.3 51.95 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.724 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.648 ' CE2' HD22 ' A' ' 205' ' ' LEU . 84.9 m-85 -121.05 142.74 49.54 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.395 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.461 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.5 tt0 -63.36 -35.38 80.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.195 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.42 119.27 47.18 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.92 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -56.84 -28.21 75.83 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.609 2.206 . . . . 0.0 113.102 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.6 m -58.67 -35.42 72.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.383 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.407 ' OG ' ' CG ' ' A' ' 207' ' ' PHE . 87.2 p -61.13 -30.15 70.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.92 0.391 . . . . 0.0 110.725 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.827 HG13 ' SD ' ' A' ' 161' ' ' MET . 70.1 t -62.71 -39.2 83.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.167 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -56.38 -41.85 76.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.847 0.356 . . . . 0.0 111.238 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.42 ' HB2' ' HD2' ' A' ' 182' ' ' TYR . 97.1 mt-10 -67.36 -34.77 77.99 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.774 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 94.2 t -63.06 -45.3 99.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.073 0.463 . . . . 0.0 111.31 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 52.8 t -70.09 -43.42 79.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -59.39 -35.99 74.99 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.429 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 61.9 m -98.05 143.73 28.3 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -76.13 147.61 38.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.774 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 35.8 m-70 -126.31 132.38 51.65 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 226' ' ' LYS . 68.3 mt -122.2 115.24 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.505 HD23 ' CG ' ' A' ' 224' ' ' ASP . 7.3 tt -121.78 127.11 50.26 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.515 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.505 ' CG ' HD23 ' A' ' 223' ' ' LEU . 85.6 m-20 54.45 42.52 31.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.999 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 73.91 18.32 79.59 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.005 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 222' ' ' ILE . 0.5 OUTLIER -128.21 153.46 46.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.801 0.301 . . . . 0.0 110.893 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.13 130.34 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.983 0.42 . . . . 0.0 110.259 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.964 HG21 HD23 ' A' ' 166' ' ' LEU . 34.5 pt -127.19 159.54 37.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.796 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -128.27 79.73 73.52 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.217 0.532 . . . . 0.0 111.037 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.483 ' HB2' HG12 ' A' ' 216' ' ' VAL . 37.3 Cg_exo -60.36 126.97 21.44 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 123.176 2.584 . . . . 0.0 111.687 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 12.4 mtmm -132.7 156.55 46.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.846 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -58.92 136.46 57.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.935 0.398 . . . . 0.0 111.608 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -66.99 143.9 56.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.089 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.457 ' O ' ' NE2' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -114.76 124.57 30.26 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.803 179.195 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.418 ' HG2' ' CG ' ' A' ' 238' ' ' GLU . 10.4 Cg_endo -53.93 151.06 28.14 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 121.987 1.791 . . . . 0.0 110.643 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -54.29 -37.21 64.51 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -60.25 -43.53 96.03 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.964 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.418 ' CG ' ' HG2' ' A' ' 235' ' ' PRO . 97.7 mt-10 -72.6 -38.66 67.77 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.313 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.457 ' NE2' ' O ' ' A' ' 234' ' ' ILE . 87.8 mt-30 -60.86 -39.38 88.95 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.844 0.354 . . . . 0.0 110.691 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -62.69 -40.35 96.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.171 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -60.19 -38.18 82.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.811 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 25.7 p -82.55 161.46 22.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.009 0.433 . . . . 0.0 111.55 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -154.02 114.79 0.64 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.961 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.459 ' NZ ' ' CE2' ' A' ' 288' ' ' PHE . 19.8 ttpp -85.77 134.33 33.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.645 0.259 . . . . 0.0 111.134 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.698 HG21 HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -118.42 163.24 15.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.479 0.657 . . . . 0.0 111.407 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.449 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 91.8 t80 -103.41 137.44 41.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.765 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.847 HG11 ' CE1' ' A' ' 259' ' ' PHE . 10.8 p -131.35 146.87 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.878 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.523 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -129.83 172.09 20.15 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 84.65 28.74 31.5 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.086 -1.054 . . . . 0.0 112.508 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.528 HG23 HG11 ' A' ' 254' ' ' VAL . 68.1 mt -110.52 133.0 57.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.819 0.342 . . . . 0.0 110.575 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.4 ' O ' ' HB ' ' A' ' 254' ' ' VAL . . . -123.03 172.2 15.88 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.392 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' PRO . . . . . 0.437 ' HG3' ' NE ' ' A' ' 284' ' ' ARG . 51.6 Cg_exo -53.78 -31.06 59.88 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.054 1.836 . . . . 0.0 111.667 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -60.15 -36.58 77.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.156 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.528 HG11 HG23 ' A' ' 250' ' ' ILE . 25.5 t -58.13 -45.1 88.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.486 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 254' ' ' VAL . 2.0 mmm180 60.97 141.84 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.28 -28.31 52.04 Favored 'Trans proline' 0 CA--C 1.528 0.189 0 C-N-CA 122.033 1.822 . . . . 0.0 112.919 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -61.69 -45.96 91.74 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 97.6 mt-10 -69.05 -38.39 79.09 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.171 0.51 . . . . 0.0 111.691 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.847 ' CE1' HG11 ' A' ' 247' ' ' VAL . 20.3 t80 -61.23 -47.19 87.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.805 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.439 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.4 tt0 -65.21 -41.84 94.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.601 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.8 pt-20 -75.05 -34.09 61.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.919 0.39 . . . . 0.0 111.211 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.671 ' HE2' HD11 ' A' ' 313' ' ' ILE . 16.4 t80 -62.2 -55.0 32.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.063 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.837 ' CD2' HG21 ' A' ' 289' ' ' VAL . 4.5 m-85 -67.92 -23.62 65.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.074 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.654 ' N ' HD11 ' A' ' 269' ' ' ILE . 23.2 t -55.91 -31.38 62.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.818 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -53.64 -35.79 61.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.644 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.647 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 11.3 p90 -115.89 48.69 1.19 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.363 0.601 . . . . 0.0 111.148 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.574 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 148.39 146.18 4.29 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.671 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.425 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 45.2 m -59.41 -37.47 78.1 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.654 HD11 ' N ' ' A' ' 264' ' ' SER . 74.2 mt 69.7 83.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.417 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.509 HD11 ' CG ' ' A' ' 292' ' ' ASP . 32.1 mm -57.25 -43.59 82.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.543 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -161.63 93.1 0.9 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.576 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -103.32 134.65 46.34 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -143.63 155.47 44.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.467 0.651 . . . . 0.0 112.331 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.747 HD21 ' O ' ' A' ' 283' ' ' SER . 32.7 tp -64.3 -38.41 90.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.364 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.588 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 93.6 mmm 95.0 115.48 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.466 0.706 . . . . 0.0 110.966 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 275' ' ' MET . 29.7 mt -120.42 116.68 25.94 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.931 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -64.05 -38.98 93.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.778 0.799 . . . . 0.0 109.179 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -150.39 -49.38 0.13 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.583 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 280' ' ' THR . 35.5 p-10 -150.38 -54.32 0.15 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.874 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.4 ' N ' ' OD1' ' A' ' 279' ' ' ASP . 64.4 p -126.49 14.17 7.63 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -56.74 -80.93 0.07 OUTLIER Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.64 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 286' ' ' PHE . 78.4 mm-40 -83.38 3.21 32.75 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.562 0.345 . . . . 0.0 110.532 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.747 ' O ' HD21 ' A' ' 274' ' ' LEU . 86.4 p -61.35 -26.31 67.73 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.619 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.437 ' NE ' ' HG3' ' A' ' 252' ' ' PRO . 98.2 mtt180 -119.38 146.4 45.37 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.145 0.497 . . . . 0.0 111.85 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.95 -43.39 1.8 Allowed Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.505 -0.77 . . . . 0.0 114.327 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 23.2 p90 -149.29 165.13 32.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.914 0.857 . . . . 0.0 112.732 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.65 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -135.12 161.13 24.56 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.752 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.459 ' CE2' ' NZ ' ' A' ' 244' ' ' LYS . 0.2 OUTLIER -118.05 126.95 53.28 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.498 0.185 . . . . 0.0 111.498 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.837 HG21 ' CD2' ' A' ' 263' ' ' PHE . 60.1 t -124.87 136.02 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.017 0.436 . . . . 0.0 111.685 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 50.4 m -114.72 134.65 54.92 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.574 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 30.4 m-85 -114.74 137.01 52.44 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.509 ' CG ' HD11 ' A' ' 270' ' ' ILE . 52.5 t0 -56.73 -36.14 69.37 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.027 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 31.0 t -122.33 139.35 53.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.498 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.913 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -64.27 -30.05 71.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.985 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -54.96 -35.08 63.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.491 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -59.09 -38.37 79.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.616 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.913 HG12 ' O ' ' A' ' 294' ' ' ALA . 7.0 p -59.2 -37.66 69.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.824 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -62.37 -37.7 86.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.305 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -58.65 -43.23 89.73 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.636 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.974 HG23 HD11 ' A' ' 306' ' ' ILE . 0.9 OUTLIER -70.58 -35.52 61.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.696 -179.127 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 75.2 m -60.28 -44.04 95.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.86 0.362 . . . . 0.0 110.579 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.69 -33.93 74.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.189 0.518 . . . . 0.0 110.175 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.623 ' O ' ' N ' ' A' ' 305' ' ' PHE . 80.6 m-20 -85.66 5.36 32.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.943 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.694 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 13.4 tptt 37.62 -81.57 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.719 0.407 . . . . 0.0 111.03 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.694 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 2.7 m-30 -108.52 143.86 36.95 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.856 0.36 . . . . 0.0 110.23 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.974 HD11 HG23 ' A' ' 300' ' ' VAL . 25.3 mt -118.0 138.04 49.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.142 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.544 ' O ' ' OD1' ' A' ' 307' ' ' ASP . 51.0 p30 -75.34 114.36 13.78 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.017 0.437 . . . . 0.0 109.951 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.538 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 1.9 t80 -106.16 -109.37 0.29 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.457 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 1.5 mmpt? -59.38 -37.24 77.45 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.933 0.397 . . . . 0.0 111.896 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -179.6 -27.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.889 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 60.5 mtp85 -112.67 153.85 27.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.989 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.475 ' HG3' ' HB3' ' A' ' 305' ' ' PHE . 2.1 tptm -72.17 139.89 48.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.975 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.671 HD11 ' HE2' ' A' ' 262' ' ' PHE . 35.9 pt -115.46 152.09 17.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.884 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -100.71 132.17 46.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.017 0.437 . . . . 0.0 110.908 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 0.675 HG12 HG23 ' A' ' 247' ' ' VAL . 74.5 mt -120.35 128.45 75.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.819 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -132.85 147.18 52.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.916 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -50.97 149.65 3.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.712 0.291 . . . . 0.0 110.435 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 244' ' ' LYS . . . -55.36 141.6 35.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.07 0.462 . . . . 0.0 111.417 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.992 -179.816 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 20.0 p . . . . . 0 CA--C 1.531 0.217 0 CA-C-O 120.489 0.185 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -64.33 139.59 58.78 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.908 0.385 . . . . 0.0 110.682 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.662 ' O ' ' HA ' ' A' ' 204' ' ' PHE . 91.2 mtp -115.61 151.1 35.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.827 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.603 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 3.5 t80 -104.88 127.44 52.71 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.714 HG23 HD12 ' A' ' 228' ' ' ILE . 13.4 mt -121.68 127.12 75.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.797 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 202' ' ' PHE . . . -117.9 149.03 18.57 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.43 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.51 36.26 39.0 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.458 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.632 HD22 HD11 ' A' ' 175' ' ' LEU . 74.5 mt -59.1 -34.33 71.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.682 ' O ' ' N ' ' A' ' 169' ' ' ASP . 26.4 t30 101.8 37.34 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.481 ' CZ3' ' NH2' ' A' ' 198' ' ' ARG . 9.3 m0 40.91 -68.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.382 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.682 ' N ' ' O ' ' A' ' 167' ' ' ASN . 92.5 m-20 -55.37 -30.0 59.52 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.629 ' O ' ' ND2' ' A' ' 174' ' ' ASN . 86.7 m -44.39 -36.03 2.66 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.581 ' C ' HD12 ' A' ' 190' ' ' ILE . 0.0 OUTLIER 54.88 165.06 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.726 -0.609 . . . . 0.0 110.969 -179.154 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.732 ' N ' HD12 ' A' ' 190' ' ' ILE . 53.7 mp0 -63.49 -35.79 81.62 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 174' ' ' ASN . 54.4 p30 -61.68 -39.2 90.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.629 ' ND2' ' O ' ' A' ' 170' ' ' THR . 63.9 m-80 -64.7 -37.6 88.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.632 HD11 HD22 ' A' ' 166' ' ' LEU . 3.6 mm? -62.85 -39.9 95.81 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 120.919 0.39 . . . . 0.0 111.192 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 180' ' ' GLY . 69.9 ttp85 -56.53 -41.89 77.54 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.08 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -68.28 -43.6 77.38 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.346 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.455 ' O ' ' HD3' ' A' ' 181' ' ' LYS . 61.4 t80 -65.14 -46.38 81.18 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.87 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.627 ' CB ' HD11 ' A' ' 205' ' ' LEU . 78.3 m-85 -91.64 -3.66 56.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.072 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -60.42 -31.15 73.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.294 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.455 ' HD3' ' O ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -57.69 -41.15 81.05 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.512 0.673 . . . . 0.0 110.841 -179.136 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -67.08 -33.44 75.5 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.14 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.64 -177.2 47.11 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.91 -1.138 . . . . 0.0 113.354 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 44.2 m -61.6 -31.56 71.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.289 -0.456 . . . . 0.0 110.72 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.852 HG23 ' CE1' ' A' ' 207' ' ' PHE . 0.9 OUTLIER 65.19 95.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -178.031 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.469 ' O ' ' OD1' ' A' ' 187' ' ' ASP . 2.3 t -63.55 -45.57 89.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.084 -178.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 186' ' ' THR . 91.5 m-20 -141.65 153.86 44.99 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.475 HD23 HG11 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -129.55 129.77 44.89 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.312 178.632 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 19.4 tptt -136.48 116.73 13.54 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.732 HD12 ' N ' ' A' ' 172' ' ' GLU . 86.0 mt -127.64 131.0 70.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.728 174.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.503 ' SD ' ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -78.23 99.07 6.11 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.76 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 41.8 pttt -89.36 153.02 21.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.048 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 1.3 m-20 -124.72 78.77 63.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.251 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.77 -24.69 64.96 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.41 2.073 . . . . 0.0 112.132 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.01 -74.65 0.18 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.456 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.1 p -68.2 -27.72 66.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.578 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.38 7.88 64.84 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.696 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 0.8 OUTLIER -122.87 121.48 36.32 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 117.651 0.725 . . . . 0.0 111.313 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 56.6 m -75.64 161.06 29.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.684 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.552 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -55.45 -33.46 63.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.858 178.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 96.3 -5.24 65.21 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.014 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 35.5 p90 -134.2 154.34 51.3 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.462 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -146.38 167.71 27.95 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.12 -1.038 . . . . 0.0 112.412 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.662 ' HA ' ' O ' ' A' ' 161' ' ' MET . 89.1 m-85 -108.59 125.83 52.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.677 HD21 HG22 ' A' ' 185' ' ' VAL . 7.4 tt -109.13 131.84 54.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.161 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.509 ' N ' HD23 ' A' ' 205' ' ' LEU . 22.8 t -120.71 135.86 55.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.9 0.381 . . . . 0.0 111.8 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.852 ' CE1' HG23 ' A' ' 185' ' ' VAL . 87.2 m-85 -116.69 143.65 45.39 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.681 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -60.94 -34.57 74.92 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -114.23 115.73 44.91 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.211 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.74 -23.56 41.96 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.547 2.165 . . . . 0.0 113.171 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.566 ' O ' ' OE1' ' A' ' 215' ' ' GLU . 23.3 t -57.79 -38.15 74.97 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.498 ' HA ' ' OE1' ' A' ' 215' ' ' GLU . 24.0 m -56.97 -34.37 68.01 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.911 0.386 . . . . 0.0 110.314 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.724 HG11 ' CD ' ' A' ' 232' ' ' ARG . 85.0 t -60.35 -39.26 80.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.312 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 218' ' ' LYS . 92.9 m-20 -57.37 -41.2 79.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.403 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.566 ' OE1' ' O ' ' A' ' 211' ' ' SER . 47.6 mp0 -65.44 -35.74 81.82 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.076 0.465 . . . . 0.0 111.788 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.753 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 85.5 t -59.96 -44.01 93.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.964 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 214' ' ' ASP . 22.3 m -73.24 -35.51 47.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 214' ' ' ASP . 56.0 mtmt -60.09 -30.31 69.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 79.3 m -110.98 144.76 39.57 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -78.8 145.02 34.55 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.753 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 44.2 m-70 -120.96 129.51 53.46 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.469 HG12 HG22 ' A' ' 227' ' ' VAL . 68.3 mt -121.98 113.25 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 176.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.55 ' CD1' HD13 ' A' ' 175' ' ' LEU . 6.0 tt -122.23 124.06 42.93 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.163 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 53.29 42.48 32.08 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.85 9.2 87.01 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.719 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -123.66 150.41 44.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.897 0.379 . . . . 0.0 111.32 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.469 HG22 HG12 ' A' ' 222' ' ' ILE . 40.0 t -106.24 132.83 52.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.377 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.714 HD12 HG23 ' A' ' 163' ' ' ILE . 34.7 pt -123.82 159.13 29.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.517 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.74 82.05 64.49 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.425 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.599 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 73.4 Cg_exo -55.23 130.82 42.71 Favored 'Trans proline' 0 CA--C 1.528 0.195 0 C-N-CA 122.998 2.465 . . . . 0.0 112.189 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt -139.75 144.16 37.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.579 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.724 ' CD ' HG11 ' A' ' 213' ' ' VAL . 56.1 mmm-85 -52.58 142.71 17.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.015 0.436 . . . . 0.0 111.051 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.03 143.62 52.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.654 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.633 HG22 ' HB2' ' A' ' 238' ' ' GLU . 0.3 OUTLIER -115.44 123.31 31.67 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.536 179.117 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.47 ' HD2' ' OE1' ' A' ' 238' ' ' GLU . 78.2 Cg_exo -50.36 148.7 14.08 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 121.908 1.738 . . . . 0.0 110.996 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -53.7 -39.89 65.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.592 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 54.5 p30 -64.42 -37.57 87.99 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.914 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.633 ' HB2' HG22 ' A' ' 234' ' ' ILE . 94.9 mt-10 -68.23 -36.38 79.39 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.264 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -60.01 -37.29 79.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.911 0.386 . . . . 0.0 110.342 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -60.4 -39.43 87.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.631 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -60.5 -36.21 77.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.117 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 20.6 p -89.09 162.92 15.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.445 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.27 167.3 24.75 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.907 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.558 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 6.6 tptm -133.69 133.31 41.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.796 0.298 . . . . 0.0 110.591 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.634 HD12 HG21 ' A' ' 315' ' ' ILE . 5.7 pt -123.87 157.15 30.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.345 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.435 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 88.9 t80 -97.27 131.0 44.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.926 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.821 HG21 ' CZ ' ' A' ' 263' ' ' PHE . 26.7 t -123.58 137.37 57.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.883 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.494 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -127.22 173.95 18.42 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.278 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 81.35 34.75 25.17 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.062 -1.066 . . . . 0.0 111.628 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.833 HG22 HG21 ' A' ' 254' ' ' VAL . 64.2 mt -110.52 130.82 63.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.698 0.285 . . . . 0.0 110.65 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.872 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -165.12 -107.54 0.2 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.184 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' PRO . . . . . 0.472 ' O ' HG13 ' A' ' 254' ' ' VAL . 25.1 Cg_endo -62.2 137.7 67.72 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.522 2.148 . . . . 0.0 113.465 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 52.03 42.85 30.66 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.266 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 251' ' ' GLY . 18.8 m -121.68 27.17 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.439 ' HB2' ' OE1' ' A' ' 258' ' ' GLU . 3.2 mmt180 -41.62 155.91 0.22 Allowed Pre-proline 0 N--CA 1.462 0.163 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -50.93 -28.01 22.63 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.011 1.808 . . . . 0.0 112.177 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -61.81 -47.15 86.41 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.004 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.475 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 54.8 mp0 -69.76 -40.17 76.26 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.85 0.357 . . . . 0.0 111.431 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.511 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 48.8 t80 -65.05 -46.69 80.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.117 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.33 -40.87 96.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.965 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.8 pt-20 -74.55 -32.6 62.49 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.974 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.735 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 78.3 t80 -59.93 -58.41 8.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.225 0.536 . . . . 0.0 111.713 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.821 ' CZ ' HG21 ' A' ' 247' ' ' VAL . 33.0 m-85 -66.78 -24.62 66.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.828 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.711 ' N ' HD11 ' A' ' 269' ' ' ILE . 34.6 t -55.7 -24.21 33.23 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -47.01 -38.76 11.34 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.063 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.797 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 23.0 p90 -132.34 53.6 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.086 0.47 . . . . 0.0 111.574 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.526 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 153.34 148.89 5.02 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.937 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.44 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 56.7 m -59.88 -37.09 78.35 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.711 HD11 ' N ' ' A' ' 264' ' ' SER . 72.1 mt 69.74 78.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.223 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 292' ' ' ASP . 33.6 mm -59.0 -44.51 91.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.961 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 270' ' ' ILE . 75.8 m-20 -153.51 86.99 1.22 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.58 ' HB2' HG23 ' A' ' 269' ' ' ILE . . . -103.27 135.99 43.88 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -141.66 151.1 42.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.498 0.665 . . . . 0.0 112.125 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.575 ' CD2' ' HB2' ' A' ' 283' ' ' SER . 37.1 tp -67.14 -34.89 78.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.625 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.613 ' HE2' ' HB2' ' A' ' 288' ' ' PHE . 2.9 ttm 86.46 145.8 0.06 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.008 0.523 . . . . 0.0 110.624 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.581 ' CB ' ' HA ' ' A' ' 280' ' ' THR . 0.5 OUTLIER 174.41 87.18 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 120.641 0.258 . . . . 0.0 111.048 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.01 -42.16 89.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.868 0.366 . . . . 0.0 110.656 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.446 ' O ' ' OD1' ' A' ' 279' ' ' ASP . 50.5 mttt -139.51 133.88 31.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.666 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.474 ' C ' HG23 ' A' ' 280' ' ' THR . 44.1 p30 30.12 44.51 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.581 ' HA ' ' CB ' ' A' ' 276' ' ' LEU . 1.3 p 70.23 29.52 3.66 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 278' ' ' LYS . . . -66.29 -58.72 8.25 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.246 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 286' ' ' PHE . 97.4 mm-40 -64.04 -29.85 70.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.834 0.35 . . . . 0.0 111.353 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.575 ' HB2' ' CD2' ' A' ' 274' ' ' LEU . 87.0 p -56.55 -27.82 58.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.712 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -87.3 126.9 35.13 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.02 0.438 . . . . 0.0 111.537 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.14 -37.1 3.52 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 114.989 0.755 . . . . 0.0 114.989 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.545 ' CE2' ' CE ' ' A' ' 275' ' ' MET . 12.3 p90 -147.23 162.6 38.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.415 1.107 . . . . 0.0 112.733 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.704 ' N ' HD12 ' A' ' 250' ' ' ILE . . . -143.25 163.91 27.36 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 121.102 -0.57 . . . . 0.0 113.264 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.613 ' HB2' ' HE2' ' A' ' 275' ' ' MET . 0.3 OUTLIER -113.5 132.38 55.7 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.511 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 42.6 t -123.74 136.09 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 35.8 m -118.39 136.99 53.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.509 178.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.526 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 30.7 m-85 -120.65 140.56 51.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.514 ' HB2' HD11 ' A' ' 270' ' ' ILE . 51.3 t0 -57.88 -36.28 72.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.307 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 93.7 p -125.86 149.19 48.86 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.331 0.586 . . . . 0.0 111.784 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.96 -29.68 69.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.18 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -56.16 -38.23 70.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.333 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.498 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -61.38 -37.51 83.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.055 0.455 . . . . 0.0 110.468 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.556 HG13 ' CG2' ' A' ' 245' ' ' ILE . 77.1 t -61.91 -44.62 99.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.713 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -61.82 -37.6 85.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.346 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -58.42 -43.4 88.66 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.917 HG23 HD11 ' A' ' 306' ' ' ILE . 0.5 OUTLIER -73.18 -32.04 36.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.915 0.388 . . . . 0.0 111.152 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 91.6 m -54.97 -44.55 74.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.046 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -62.76 -40.07 96.12 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.003 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.44 ' O ' ' N ' ' A' ' 305' ' ' PHE . 86.1 m-20 -63.98 -36.22 83.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.518 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.681 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 19.1 tptm 66.57 -67.84 0.15 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.792 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.681 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 20.9 m-85 -115.87 136.24 53.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.235 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.917 HD11 HG23 ' A' ' 300' ' ' VAL . 30.0 mt -121.55 137.97 53.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.965 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 307' ' ' ASP . 52.6 p30 -78.99 85.46 4.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.977 0.417 . . . . 0.0 111.199 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.735 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 4.1 t80 -79.36 -71.78 0.43 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.5 ' HE3' ' CE1' ' A' ' 308' ' ' PHE . 8.1 mmpt? -104.56 -145.56 0.38 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.151 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.493 ' OD1' ' HG3' ' A' ' 311' ' ' ARG . 54.5 p30 -81.59 2.48 29.07 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.13 0.49 . . . . 0.0 109.952 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.493 ' HG3' ' OD1' ' A' ' 310' ' ' ASP . 94.0 mtt-85 -126.24 149.16 49.27 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.588 ' HG2' ' HB3' ' A' ' 305' ' ' PHE . 11.3 tttp -80.02 137.2 36.76 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.654 HD11 ' CE2' ' A' ' 262' ' ' PHE . 21.7 pt -105.01 135.85 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.82 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' GLU . . . . . 0.417 ' HB2' ' CE2' ' A' ' 305' ' ' PHE . 84.6 tt0 -102.15 130.31 48.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.812 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 0.638 HD13 ' CE2' ' A' ' 263' ' ' PHE . 67.5 mt -119.34 128.54 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-O 121.024 0.44 . . . . 0.0 111.125 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -130.91 144.19 51.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.253 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -51.85 138.05 24.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.93 0.395 . . . . 0.0 110.424 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 244' ' ' LYS . . . -64.68 145.27 56.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.004 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.614 179.129 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 20.5 m . . . . . 0 CA--C 1.529 0.155 0 N-CA-C 111.544 0.201 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.483 ' HE3' ' HB1' ' A' ' 233' ' ' ALA . 36.6 ttpt -64.45 137.46 57.89 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.428 0.632 . . . . 0.0 111.458 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.825 ' SD ' HG13 ' A' ' 213' ' ' VAL . 85.2 mmm -117.2 151.79 36.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.215 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.569 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 5.9 t80 -106.13 129.31 54.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.678 ' CG2' HD21 ' A' ' 166' ' ' LEU . 12.9 mm -116.45 127.61 74.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -130.45 163.97 23.05 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.492 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 73.88 28.58 64.55 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.809 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.678 HD21 ' CG2' ' A' ' 163' ' ' ILE . 74.3 mt -86.7 142.15 28.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.782 0.325 . . . . 0.0 111.604 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -64.65 135.42 55.91 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.482 ' CD1' ' O ' ' A' ' 199' ' ' SER . 4.7 m0 -52.06 -31.52 30.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.688 0.28 . . . . 0.0 111.003 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -91.17 5.41 49.17 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.614 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.52 ' O ' ' O ' ' A' ' 171' ' ' THR . 86.1 m -58.04 -40.43 80.88 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.558 ' C ' HD12 ' A' ' 190' ' ' ILE . 0.1 OUTLIER 53.16 157.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.189 0.519 . . . . 0.0 110.1 -177.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.54 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 97.4 mt-10 -62.41 -26.78 68.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.704 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.685 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 93.0 m-20 -53.53 -42.85 67.87 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.464 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -68.09 -38.0 81.85 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.526 HD23 ' CE2' ' A' ' 179' ' ' PHE . 5.1 mt -59.69 -47.6 85.0 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.685 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -68.02 -37.2 81.11 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.194 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.417 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 48.5 tp10 -67.76 -45.51 74.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.866 0.365 . . . . 0.0 110.421 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.607 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 72.2 t80 -67.17 -48.28 68.44 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.767 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.535 ' CB ' HD11 ' A' ' 205' ' ' LEU . 81.3 m-85 -88.73 -4.52 58.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.185 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -58.67 -32.02 68.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.199 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -41.5 89.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.707 0.765 . . . . 0.0 109.988 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -68.55 -34.24 75.5 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.89 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -179.12 -176.84 47.21 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.247 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.521 ' O ' HG22 ' A' ' 185' ' ' VAL . 49.0 m -63.3 -30.09 71.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.518 -0.341 . . . . 0.0 111.559 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.652 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 0.6 OUTLIER 64.85 83.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 122.355 1.074 . . . . 0.0 108.478 -177.309 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.476 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -53.13 -47.74 68.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.723 -177.097 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 186' ' ' THR . 92.2 m-20 -138.95 156.08 47.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.213 0.53 . . . . 0.0 112.391 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -132.77 136.78 46.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.876 179.252 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.587 ' O ' ' HA2' ' A' ' 203' ' ' GLY . 7.8 tptt -142.79 66.05 1.33 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.584 0.231 . . . . 0.0 111.415 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.561 ' HA ' ' HA3' ' A' ' 203' ' ' GLY . 8.7 tt -61.82 -19.16 20.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.59 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.67 ' CE ' ' HA2' ' A' ' 203' ' ' GLY . 10.8 mtm 64.07 131.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.741 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.55 ' HG3' ' HD3' ' A' ' 194' ' ' PRO . 6.2 pttt -132.2 156.49 46.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.958 0.408 . . . . 0.0 111.805 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 10.7 t0 -125.65 74.63 69.94 Favored Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.901 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.55 ' HD3' ' HG3' ' A' ' 192' ' ' LYS . 19.9 Cg_endo -59.98 -27.67 85.43 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.616 2.211 . . . . 0.0 112.788 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -66.81 -59.12 3.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.952 0.406 . . . . 0.0 111.366 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 65.8 p -74.27 -18.43 60.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.417 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 89.7 9.19 66.66 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.134 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 25.1 mmt85 -120.95 -179.22 3.95 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.294 0.569 . . . . 0.0 111.859 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.482 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 51.0 m -119.93 152.64 37.11 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.969 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.472 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 5.9 mpt_? -51.35 -34.87 35.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.833 0.349 . . . . 0.0 110.745 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 87.81 2.57 81.32 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.419 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.651 ' O ' ' HE3' ' A' ' 191' ' ' MET . 14.8 p90 -139.37 153.74 47.71 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.67 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -145.06 155.97 26.72 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.062 -1.066 . . . . 0.0 112.413 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.569 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 97.4 m-85 -102.88 123.37 46.4 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.691 HD23 ' N ' ' A' ' 206' ' ' SER . 1.6 tt -106.37 127.81 53.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.168 -177.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.691 ' N ' HD23 ' A' ' 205' ' ' LEU . 34.5 t -115.8 133.62 55.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.765 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.606 ' CE2' HD22 ' A' ' 205' ' ' LEU . 95.7 m-85 -116.18 136.4 53.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.408 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.476 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.5 tt0 -61.54 -33.76 74.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.136 0.493 . . . . 0.0 109.75 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -110.09 120.4 44.63 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.802 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.91 -23.06 49.17 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.522 2.148 . . . . 0.0 113.073 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.1 m -57.12 -36.76 71.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.543 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.915 ' O ' HG23 ' A' ' 216' ' ' VAL . 23.0 m -58.85 -36.45 74.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.698 0.285 . . . . 0.0 110.938 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.825 HG13 ' SD ' ' A' ' 161' ' ' MET . 73.4 t -62.12 -42.88 96.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.231 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -60.11 -41.76 93.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.314 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.465 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 19.3 pt-20 -73.94 -28.51 61.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.903 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 212' ' ' SER . 70.3 t -59.89 -42.7 90.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.638 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.2 m -73.87 -27.38 22.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -58.54 -31.38 67.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.74 0.305 . . . . 0.0 111.488 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.59 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 67.3 m -108.29 142.41 38.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.818 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.409 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 14.1 pt20 -68.51 -40.71 80.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.463 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.712 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 61.0 m-70 81.97 118.52 0.05 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 72.8 mt -114.26 106.47 20.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.497 HD21 HG23 ' A' ' 170' ' ' THR . 6.9 tt -122.62 121.39 36.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.82 0.343 . . . . 0.0 110.781 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 50.14 40.31 21.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.53 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.79 11.21 84.88 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.503 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 31.6 mmtm -113.4 139.48 48.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 117.233 0.517 . . . . 0.0 111.595 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.81 ' O ' ' O ' ' A' ' 228' ' ' ILE . 17.2 m -73.61 -30.45 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.999 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.81 ' O ' ' O ' ' A' ' 227' ' ' VAL . 17.0 pt 34.42 136.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -123.7 80.87 55.22 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.171 0.51 . . . . 0.0 111.258 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.471 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 46.9 Cg_exo -59.13 126.15 20.16 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.151 2.567 . . . . 0.0 112.202 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt -134.25 153.67 51.72 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.432 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -56.06 145.29 26.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.995 0.426 . . . . 0.0 111.767 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.483 ' HB1' ' HE3' ' A' ' 160' ' ' LYS . . . -64.85 146.76 54.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.054 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.604 HD11 ' CB ' ' A' ' 238' ' ' GLU . 3.2 tt -108.25 137.14 19.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.318 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.452 ' HG2' ' HG3' ' A' ' 238' ' ' GLU . 13.0 Cg_endo -55.93 143.19 83.16 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.826 1.684 . . . . 0.0 110.709 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -54.53 -36.61 64.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.739 0.304 . . . . 0.0 111.25 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.31 -41.49 84.61 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 242' ' ' THR . 97.4 mt-10 -68.14 -35.88 78.8 Favored 'General case' 0 C--O 1.23 0.07 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.484 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -60.82 -36.76 79.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.045 0.45 . . . . 0.0 111.039 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -58.66 -38.86 79.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.533 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 242' ' ' THR . 75.2 mmtt -87.47 -76.9 0.36 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 238' ' ' GLU . 76.9 p 34.66 -165.68 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -162.97 55.62 0.29 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.728 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.532 ' CE ' ' CD2' ' A' ' 288' ' ' PHE . 7.9 tptt -73.7 121.17 20.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.692 0.282 . . . . 0.0 110.399 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.7 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -130.01 164.58 32.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.176 0.512 . . . . 0.0 110.848 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -104.91 136.57 44.16 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.316 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.85 HG11 ' CE1' ' A' ' 259' ' ' PHE . 15.0 p -130.7 144.83 36.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.719 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.643 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -130.37 170.14 21.02 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.93 21.52 35.89 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 119.889 -1.148 . . . . 0.0 112.377 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 287' ' ' GLY . 67.0 mt -106.52 128.9 60.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.874 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -166.09 -115.28 0.32 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.329 -0.938 . . . . 0.0 113.272 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.43 138.63 86.86 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.334 2.023 . . . . 0.0 113.506 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 54.02 44.45 29.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.34 -0.845 . . . . 0.0 113.215 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.874 HG22 ' O ' ' A' ' 251' ' ' GLY . 8.8 m -109.49 -54.23 5.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.443 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.477 ' N ' HG23 ' A' ' 254' ' ' VAL . 13.2 mmt180 60.85 135.98 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -54.82 -31.9 74.61 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.192 1.928 . . . . 0.0 113.418 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -60.12 -45.08 94.22 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.792 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.682 ' HA ' ' HB3' ' A' ' 261' ' ' GLU . 58.6 mp0 -68.52 -33.69 74.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.828 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.85 ' CE1' HG11 ' A' ' 247' ' ' VAL . 13.2 t80 -61.93 -52.73 62.85 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.897 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.664 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.3 tt0 -63.77 -37.14 86.24 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.682 ' HB3' ' HA ' ' A' ' 258' ' ' GLU . 81.7 tt0 -61.41 -37.74 84.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 113.824 -1.534 . . . . 0.0 111.717 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.882 ' CE2' HD11 ' A' ' 313' ' ' ILE . 84.3 t80 -68.93 -54.72 13.9 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.782 ' CB ' HD11 ' A' ' 269' ' ' ILE . 7.3 m-85 -66.04 -25.22 66.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.208 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 86.5 p -56.32 -23.06 34.59 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -52.29 -39.68 60.82 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.298 -1.319 . . . . 0.0 113.072 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.665 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 43.9 p90 -120.87 58.33 0.95 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.543 0.687 . . . . 0.0 112.268 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.422 ' HA3' ' HB1' ' A' ' 296' ' ' ALA . . . 122.32 153.9 8.98 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.012 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.7 m -72.49 132.18 43.51 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.782 HD11 ' CB ' ' A' ' 263' ' ' PHE . 74.9 mt -93.98 126.14 46.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.711 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.772 HG22 ' HB ' ' A' ' 290' ' ' THR . 10.5 tt -65.55 -36.25 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.281 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 270' ' ' ILE . 51.2 p30 171.79 73.71 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.894 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.573 ' HB2' HG21 ' A' ' 269' ' ' ILE . . . -67.76 142.53 56.21 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.408 0.147 . . . . 0.0 111.01 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -144.03 152.16 40.64 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.84 HD23 ' HG ' ' A' ' 276' ' ' LEU . 22.3 tp -65.89 -35.87 81.85 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.087 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.582 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 93.1 mmm 99.5 -13.66 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.925 0.89 . . . . 0.0 112.574 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.84 ' HG ' HD23 ' A' ' 274' ' ' LEU . 0.0 OUTLIER -64.59 50.44 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.489 ' O ' HG22 ' A' ' 227' ' ' VAL . 21.8 t70 -59.0 -40.51 85.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.075 0.464 . . . . 0.0 110.592 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 279' ' ' ASP . 37.1 mtpt -59.79 -26.92 66.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.326 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 278' ' ' LYS . 54.3 t0 80.44 38.62 0.09 Allowed 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.096 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 281' ' ' GLY . 0.1 OUTLIER -166.62 -61.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.061 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 281' ' ' GLY . . . . . 0.557 ' H ' HG23 ' A' ' 280' ' ' THR . . . -82.49 164.28 43.39 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.396 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.405 ' OE1' ' HB3' ' A' ' 275' ' ' MET . 48.3 mt-30 59.36 41.65 19.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.883 0.373 . . . . 0.0 110.12 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.492 ' HA ' HD21 ' A' ' 274' ' ' LEU . 29.8 t -127.45 142.14 51.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.896 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.477 ' CA ' ' HA2' ' A' ' 251' ' ' GLY . 60.6 mtm180 45.85 25.49 0.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.671 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -119.53 -62.85 0.27 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.039 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -139.23 164.9 28.6 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.805 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -130.39 156.54 21.63 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 119.927 -1.13 . . . . 0.0 113.625 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.532 ' CD2' ' CE ' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -119.3 123.08 43.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.729 -0.236 . . . . 0.0 110.465 179.364 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.815 HG23 ' CZ ' ' A' ' 259' ' ' PHE . 57.4 t -123.91 137.37 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.195 0.521 . . . . 0.0 112.105 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.772 ' HB ' HG22 ' A' ' 270' ' ' ILE . 20.8 m -120.41 138.33 53.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.407 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -114.91 138.96 50.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.145 0.498 . . . . 0.0 111.776 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 293' ' ' SER . 53.0 p30 -62.42 -30.47 71.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.928 178.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' SER . . . . . 0.55 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 51.0 m -119.76 142.65 48.36 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 121.18 0.514 . . . . 0.0 111.3 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.6 -31.83 72.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.72 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.48 -37.12 69.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.618 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.434 ' O ' ' HD1' ' A' ' 266' ' ' TRP . . . -61.15 -38.01 84.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.416 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 79.9 t -60.99 -40.01 84.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.933 0.397 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -58.08 -36.89 73.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.937 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -56.78 -43.75 81.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.987 0.422 . . . . 0.0 111.704 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.817 HG23 HD11 ' A' ' 306' ' ' ILE . 0.3 OUTLIER -76.1 -30.07 20.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.815 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 84.9 m -55.91 -45.29 78.72 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.77 -34.76 79.1 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.08 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -102.15 79.89 1.92 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.602 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.633 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 11.9 tptt -55.74 -44.59 77.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.048 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.633 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 8.5 m-85 -117.06 126.73 53.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.514 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.817 HD11 HG23 ' A' ' 300' ' ' VAL . 2.4 mt -121.37 139.38 48.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.228 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -78.76 113.32 16.74 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.376 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.601 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 7.0 t80 -112.3 -77.28 0.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.928 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.412 ' HG3' HG12 ' A' ' 254' ' ' VAL . 6.4 mmpt? -97.41 -167.29 1.51 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.967 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -51.84 -29.78 20.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.839 0.352 . . . . 0.0 110.486 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -105.42 144.59 31.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.05 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.578 ' HE2' ' HB3' ' A' ' 305' ' ' PHE . 10.3 tptt -70.74 142.04 51.45 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.882 HD11 ' CE2' ' A' ' 262' ' ' PHE . 28.8 pt -109.64 141.2 25.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.034 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' GLU . . . . . 0.506 ' HG3' ' CE1' ' A' ' 305' ' ' PHE . 85.6 tt0 -101.59 131.82 47.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.813 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 0.781 HG12 HG23 ' A' ' 247' ' ' VAL . 71.3 mt -119.91 128.29 75.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.108 0.48 . . . . 0.0 111.766 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.415 ' HE3' ' OE2' ' A' ' 314' ' ' GLU . 38.1 mttp -127.89 156.06 43.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.83 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -60.46 148.46 37.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -53.95 137.46 39.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.19 0.519 . . . . 0.0 111.611 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.649 179.927 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.965 0.412 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.47 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 79.4 tttt -87.69 134.62 33.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.88 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.415 ' N ' ' O ' ' A' ' 205' ' ' LEU . 5.0 tpp -120.39 147.37 45.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.648 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.626 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 5.0 t80 -100.19 129.35 46.2 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.807 HG23 HD12 ' A' ' 228' ' ' ILE . 21.8 mm -116.79 128.37 74.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.792 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -130.67 165.93 22.65 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.198 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.9 27.75 62.01 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.571 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.964 HD23 HG21 ' A' ' 228' ' ' ILE . 80.9 mt -87.41 144.28 26.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.737 0.303 . . . . 0.0 111.714 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -66.92 133.77 50.68 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.545 ' HD1' ' O ' ' A' ' 199' ' ' SER . 5.0 m-90 -50.23 -34.77 24.1 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.298 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -63.73 -20.63 65.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.5 m -50.83 139.24 17.28 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.786 0.803 . . . . 0.0 111.89 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.515 ' C ' HD12 ' A' ' 190' ' ' ILE . 32.6 m -120.51 148.38 43.91 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.778 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.887 ' N ' HD12 ' A' ' 190' ' ' ILE . 96.2 mt-10 -56.63 -34.84 67.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.606 0.241 . . . . 0.0 110.544 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.632 ' OD1' ' N ' ' A' ' 174' ' ' ASN . 54.9 p30 -61.46 -38.04 85.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.576 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.632 ' N ' ' OD1' ' A' ' 173' ' ' ASP . 84.0 m-20 -65.56 -36.13 82.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.159 0.504 . . . . 0.0 110.526 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.543 HD12 HD11 ' A' ' 190' ' ' ILE . 0.4 OUTLIER -53.42 -48.6 68.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.273 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.544 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -64.18 -37.0 85.88 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.107 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.425 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 84.4 tt0 -65.92 -44.13 86.05 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.722 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.48 ' OH ' ' HB3' ' A' ' 221' ' ' HIS . 73.2 t80 -64.88 -46.59 81.14 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.144 0.497 . . . . 0.0 111.429 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.485 ' HE1' HG13 ' A' ' 216' ' ' VAL . 91.5 m-85 -91.18 1.67 56.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.255 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -60.73 -28.69 68.52 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.381 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.465 ' CD ' ' H ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -58.98 -38.05 78.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.705 0.764 . . . . 0.0 110.445 -179.01 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.418 ' CE2' ' HA ' ' A' ' 216' ' ' VAL . 47.9 m-85 -67.31 -29.62 69.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.526 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 153.76 -124.31 1.55 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.892 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 56.8 m -117.16 139.01 51.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.95 HG12 ' CE1' ' A' ' 207' ' ' PHE . 4.8 m -109.56 126.2 66.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.685 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.81 HG23 ' N ' ' A' ' 208' ' ' GLU . 43.9 p -75.1 -31.89 61.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.58 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.851 ' C ' HD13 ' A' ' 188' ' ' LEU . 51.5 t0 -150.6 150.01 30.63 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.851 HD13 ' C ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -141.49 81.45 1.78 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.013 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.576 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 8.4 tptp -79.41 119.43 22.43 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.887 HD12 ' N ' ' A' ' 172' ' ' GLU . 74.0 mt -127.26 112.42 28.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 174.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.634 ' HB2' ' HD3' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -61.37 -34.43 75.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.2 -177.245 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.47 ' O ' ' O ' ' A' ' 191' ' ' MET . 52.2 tttm 49.6 162.79 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.455 ' N ' ' HG2' ' A' ' 192' ' ' LYS . 5.2 t70 -112.18 100.27 48.85 Favored Pre-proline 0 N--CA 1.463 0.206 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.347 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.8 -29.15 85.0 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.325 2.016 . . . . 0.0 113.165 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -78.96 -88.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.6 p -70.79 -27.11 63.66 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 193' ' ' ASP . . . 97.66 -8.28 63.78 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.204 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 199' ' ' SER . 33.3 mtm-85 -124.65 133.38 53.25 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.242 0.544 . . . . 0.0 111.849 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.575 ' O ' ' HB3' ' A' ' 200' ' ' ARG . 36.2 t 162.22 -177.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.071 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.833 ' HG2' ' H ' ' A' ' 202' ' ' PHE . 58.2 ttp85 68.52 -95.42 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.24 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 85.11 9.53 80.06 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.386 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.833 ' H ' ' HG2' ' A' ' 200' ' ' ARG . 34.5 p90 -146.14 153.53 40.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -148.65 166.59 29.22 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 119.858 -1.163 . . . . 0.0 112.209 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.626 ' CE2' ' CD1' ' A' ' 162' ' ' PHE . 89.9 m-85 -108.75 122.53 47.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.016 0.436 . . . . 0.0 110.023 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.948 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 0.7 OUTLIER -114.75 129.55 56.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.493 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.792 ' N ' HD12 ' A' ' 205' ' ' LEU . 58.5 m -115.18 143.08 45.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.251 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.95 ' CE1' HG12 ' A' ' 185' ' ' VAL . 92.5 m-85 -117.74 138.09 52.26 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.81 ' N ' HG23 ' A' ' 186' ' ' THR . 84.5 tt0 -63.68 -35.59 81.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.892 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.17 116.34 56.93 Favored Pre-proline 0 C--N 1.333 -0.123 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.388 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 0.914 ' O ' HG12 ' A' ' 213' ' ' VAL . 46.4 Cg_exo -56.13 -25.01 52.71 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.241 1.96 . . . . 0.0 112.829 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.7 m -58.84 -36.25 74.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.65 0.262 . . . . 0.0 111.47 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.758 ' O ' HG23 ' A' ' 216' ' ' VAL . 89.7 p -62.53 -32.7 73.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.453 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.914 HG12 ' O ' ' A' ' 210' ' ' PRO . 3.0 p -62.66 -37.2 78.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.892 0.377 . . . . 0.0 110.754 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 218' ' ' LYS . 54.9 t0 -61.99 -42.98 99.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.589 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 212' ' ' SER . 4.5 pt-20 -74.06 -32.34 63.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.904 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.826 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 92.7 t -63.61 -44.63 98.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.073 0.463 . . . . 0.0 110.894 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 213' ' ' VAL . 59.1 t -68.02 -46.14 82.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 214' ' ' ASP . 47.0 mmtm -61.11 -34.51 75.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.403 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 49.2 m -88.37 144.03 26.65 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -79.74 141.41 36.37 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.826 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 55.2 m-70 -121.15 130.77 53.88 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -176.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.565 HG12 HG22 ' A' ' 227' ' ' VAL . 69.0 mt -123.63 112.31 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.264 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.559 HD23 ' CG ' ' A' ' 224' ' ' ASP . 6.7 tt -119.12 127.23 53.17 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.139 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.559 ' CG ' HD23 ' A' ' 223' ' ' LEU . 86.0 m-20 55.05 42.46 30.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.314 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 77.62 10.95 85.91 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.56 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 222' ' ' ILE . 6.3 mptt -126.67 153.76 44.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.976 0.388 . . . . 0.0 110.753 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.565 HG22 HG12 ' A' ' 222' ' ' ILE . 43.4 t -102.25 132.8 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.917 0.389 . . . . 0.0 110.859 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.964 HG21 HD23 ' A' ' 166' ' ' LEU . 30.8 pt -125.27 159.62 32.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.377 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -126.86 82.86 66.89 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 121.13 0.49 . . . . 0.0 110.981 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.537 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 56.0 Cg_exo -56.73 128.57 30.55 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.195 2.597 . . . . 0.0 112.15 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -133.98 157.26 46.51 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.665 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 40.1 tpt85 -58.74 135.08 57.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.987 0.423 . . . . 0.0 111.165 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -65.81 145.85 55.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.088 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.795 HG22 ' HB2' ' A' ' 238' ' ' GLU . 6.1 mt -117.96 120.46 32.57 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.561 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.545 ' HB2' ' OE1' ' A' ' 238' ' ' GLU . 34.5 Cg_exo -53.89 152.69 22.38 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 121.548 1.499 . . . . 0.0 110.634 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 52.3 mmm-85 -54.23 -35.63 62.65 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.32 -40.74 82.86 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.795 ' HB2' HG22 ' A' ' 234' ' ' ILE . 55.3 mp0 -65.85 -35.82 81.73 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.587 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -59.35 -39.81 84.38 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.598 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -64.14 -45.19 89.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.053 0.454 . . . . 0.0 110.185 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -65.09 -40.08 94.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.649 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.742 HG23 ' O ' ' A' ' 238' ' ' GLU . 24.8 p -83.69 161.42 21.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.129 -178.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.53 166.27 25.88 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.34 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.496 ' HE3' ' CE2' ' A' ' 288' ' ' PHE . 4.6 ttpt -137.45 135.61 37.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.075 0.437 . . . . 0.0 111.233 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.956 HD12 ' CG2' ' A' ' 315' ' ' ILE . 7.4 pt -120.05 159.83 20.98 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 121.176 0.512 . . . . 0.0 110.933 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -99.52 129.62 45.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.675 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.458 HG22 HD12 ' A' ' 315' ' ' ILE . 44.0 t -119.83 137.32 54.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.349 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.05 167.72 18.38 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.564 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 94.48 8.58 59.64 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.197 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.965 HG22 HG21 ' A' ' 254' ' ' VAL . 27.8 mm -56.8 -39.89 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 120.762 0.315 . . . . 0.0 110.581 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 250' ' ' ILE . . . 27.56 -145.36 0.01 OUTLIER Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.677 -0.692 . . . . 0.0 114.419 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.9 169.25 11.89 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.338 2.692 . . . . 0.0 113.533 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 60.46 43.47 13.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.313 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.965 HG21 HG22 ' A' ' 250' ' ' ILE . 26.8 m -133.8 156.88 41.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.924 0.392 . . . . 0.0 110.991 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.92 155.12 74.84 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.778 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -57.01 -40.3 85.01 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 121.532 1.488 . . . . 0.0 110.851 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.52 -42.62 98.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.773 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 262' ' ' PHE . 74.6 mm-40 -65.43 -41.34 93.64 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.491 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.478 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 43.1 t80 -66.91 -48.96 67.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.722 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -64.65 -40.89 96.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.774 0.321 . . . . 0.0 111.058 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.1 pt-20 -74.69 -30.72 61.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.892 0.377 . . . . 0.0 110.548 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.669 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 91.4 t80 -57.38 -44.65 84.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.172 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.659 ' HZ ' HD12 ' A' ' 313' ' ' ILE . 86.7 m-85 -92.7 -2.22 56.22 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 267' ' ' GLY . 47.2 t -60.09 -30.16 69.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -56.36 -39.8 73.46 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.44 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.699 ' HH2' HG21 ' A' ' 306' ' ' ILE . 17.3 m-90 -60.42 -39.23 86.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.085 0.469 . . . . 0.0 110.811 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 264' ' ' SER . . . -173.71 -172.55 39.18 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.663 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 90.7 m -58.34 -37.18 74.64 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.625 HD11 ' C ' ' A' ' 263' ' ' PHE . 49.2 mt 61.7 86.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.65 HD11 ' HB3' ' A' ' 292' ' ' ASP . 31.4 mm -55.09 -44.5 74.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -159.66 92.48 1.04 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -104.86 133.98 48.75 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -144.68 154.94 43.3 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.812 ' CD1' HG21 ' A' ' 250' ' ' ILE . 31.8 tp -66.19 -37.83 86.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.23 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.625 ' O ' HD23 ' A' ' 276' ' ' LEU . 93.2 mmm 84.21 138.08 0.06 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.199 -178.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 275' ' ' MET . 0.2 OUTLIER 173.59 89.78 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.841 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 278' ' ' LYS . 55.4 p30 -64.16 -39.86 94.92 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.688 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.615 ' N ' ' OD1' ' A' ' 277' ' ' ASP . 60.1 mttm -101.11 7.98 43.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.978 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.461 ' HA ' ' CD1' ' A' ' 276' ' ' LEU . 51.2 t0 78.94 -13.69 0.94 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.857 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 46.4 p -139.43 12.13 2.55 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -94.58 -74.63 1.25 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.761 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 286' ' ' PHE . 80.1 mm-40 -60.1 -32.47 71.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.049 0.452 . . . . 0.0 111.232 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.697 ' OG ' HD21 ' A' ' 274' ' ' LEU . 33.1 t -61.66 -4.7 1.52 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.911 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -49.94 -38.2 35.4 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 178.91 19.17 0.03 OUTLIER Glycine 0 CA--C 1.524 0.604 0 C-N-CA 118.717 -1.706 . . . . 0.0 115.847 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 24.9 p90 -137.93 160.53 39.07 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.755 1.278 . . . . 0.0 111.022 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -139.36 157.27 24.97 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.319 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.496 ' CE2' ' HE3' ' A' ' 244' ' ' LYS . 0.6 OUTLIER -111.13 129.18 56.01 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.582 0.353 . . . . 0.0 110.919 179.574 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.492 ' O ' ' HG3' ' A' ' 244' ' ' LYS . 42.3 t -122.76 133.14 69.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.712 0.292 . . . . 0.0 111.16 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 52.5 m -119.61 138.02 53.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.379 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.515 ' CE1' HG12 ' A' ' 269' ' ' ILE . 47.8 m-85 -120.45 143.42 48.5 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.65 ' HB3' HD11 ' A' ' 270' ' ' ILE . 52.9 p30 -63.56 -32.65 74.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.499 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 293' ' ' SER . . . . . 0.611 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 98.2 p -127.06 149.34 49.96 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 121.26 0.552 . . . . 0.0 111.806 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -68.35 -32.76 73.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.092 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -56.25 -39.6 72.83 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.658 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -63.88 -34.72 78.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.173 0.511 . . . . 0.0 110.591 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.753 HG13 ' CG2' ' A' ' 245' ' ' ILE . 78.1 t -63.14 -42.1 95.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.664 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -60.55 -42.01 95.72 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -64.33 -45.86 86.01 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.85 HG22 HG13 ' A' ' 315' ' ' ILE . 7.5 p -70.62 -40.65 77.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 95.1 m -67.69 -40.11 84.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.737 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -56.85 -39.91 75.15 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.872 0.368 . . . . 0.0 111.022 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.777 ' HB3' HD11 ' A' ' 306' ' ' ILE . 0.3 OUTLIER -60.2 -33.34 72.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.736 179.308 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.681 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 6.7 tptm 75.24 -62.56 0.44 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.336 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.681 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 24.4 m-85 -116.07 132.78 56.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.236 0.541 . . . . 0.0 111.994 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.777 HD11 ' HB3' ' A' ' 303' ' ' ASN . 20.7 mm -121.22 140.85 44.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.002 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -78.82 130.0 35.22 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.669 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 1.8 t80 -118.23 -127.06 0.28 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.451 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.5 ' HD3' ' CE1' ' A' ' 308' ' ' PHE . 0.0 OUTLIER -60.21 -36.05 76.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.194 0.521 . . . . 0.0 110.563 -179.091 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -177.43 -35.78 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.218 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -86.59 144.93 26.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.423 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.53 ' HE3' ' HB3' ' A' ' 305' ' ' PHE . 3.0 tptt -74.26 136.6 42.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 306' ' ' ILE . 30.8 pt -112.56 143.57 22.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.298 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -102.41 138.63 39.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 0.956 ' CG2' HD12 ' A' ' 245' ' ' ILE . 15.2 mm -112.37 127.14 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -136.53 137.02 39.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.479 0.181 . . . . 0.0 110.988 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -55.51 146.82 19.21 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 244' ' ' LYS . . . -51.37 135.49 26.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.284 0.564 . . . . 0.0 111.245 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.431 -179.784 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.786 0.327 . . . . 0.0 110.42 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.64 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 75.6 tttt -100.08 141.59 32.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.205 0.526 . . . . 0.0 111.829 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.506 ' N ' ' O ' ' A' ' 205' ' ' LEU . 82.4 mmm -124.02 145.86 48.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.649 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.65 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 3.6 t80 -105.5 127.52 53.06 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.672 HG22 HD21 ' A' ' 166' ' ' LEU . 18.2 mt -122.28 130.11 74.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.445 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.408 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -128.73 163.98 22.0 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.747 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.524 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 72.51 47.31 28.42 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 119.829 -1.177 . . . . 0.0 111.481 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.76 HD12 HH21 ' A' ' 200' ' ' ARG . 45.2 mt -83.63 9.67 11.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.473 ' HB2' ' HG3' ' A' ' 226' ' ' LYS . 49.4 t30 62.81 43.61 6.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.023 0.44 . . . . 0.0 110.195 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 6.0 m0 39.15 39.45 0.41 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.267 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 171' ' ' THR . 59.8 t0 -162.44 -111.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.263 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.779 HG22 ' HB2' ' A' ' 175' ' ' LEU . 77.0 m 63.26 -40.97 0.2 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.617 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.5 OUTLIER 47.74 155.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.553 0.692 . . . . 0.0 111.374 -179.296 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.528 ' N ' HD12 ' A' ' 190' ' ' ILE . 96.3 mt-10 -62.5 -31.98 72.83 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.659 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -64.0 -61.53 2.22 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.563 ' HB2' ' O ' ' A' ' 170' ' ' THR . 85.9 m-20 -62.57 -37.19 85.23 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.226 0.536 . . . . 0.0 110.016 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.779 ' HB2' HG22 ' A' ' 170' ' ' THR . 52.3 tp -61.86 -42.97 99.69 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.359 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 -61.65 -42.52 99.02 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.169 0.509 . . . . 0.0 110.173 177.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -66.82 -40.31 88.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.224 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.496 ' OH ' ' HB3' ' A' ' 221' ' ' HIS . 50.6 t80 -59.91 -45.26 93.12 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.163 0.506 . . . . 0.0 110.898 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.406 ' HB3' HD21 ' A' ' 205' ' ' LEU . 97.5 m-85 -95.46 -0.99 51.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.072 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.27 -30.85 64.98 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.008 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.426 ' HD3' ' O ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -58.34 -41.78 85.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.534 0.683 . . . . 0.0 110.644 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -67.39 -35.35 79.13 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.613 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -179.42 -177.19 47.61 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 119.719 -1.229 . . . . 0.0 113.483 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.52 ' C ' HG13 ' A' ' 185' ' ' VAL . 46.7 m -63.11 -30.69 71.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.029 -0.586 . . . . 0.0 110.995 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.619 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 0.6 OUTLIER 64.38 91.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.857 0.837 . . . . 0.0 108.954 -177.797 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.7 t -58.49 -44.48 89.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.581 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 206' ' ' SER . 89.0 m-20 -135.59 149.31 49.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.49 0.662 . . . . 0.0 112.687 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.522 ' CD1' HD23 ' A' ' 175' ' ' LEU . 0.2 OUTLIER -126.83 127.62 45.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.099 179.144 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.539 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 13.0 tptt -135.95 120.78 18.55 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.528 HD12 ' N ' ' A' ' 172' ' ' GLU . 0.8 OUTLIER -130.35 132.0 65.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.83 176.671 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.695 ' HB2' ' HD2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -99.23 156.49 16.95 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.432 -179.156 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.492 ' HG3' ' HD3' ' A' ' 194' ' ' PRO . 13.4 pttt -132.23 161.93 32.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.641 0.258 . . . . 0.0 110.881 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 1.0 OUTLIER -125.49 75.65 69.36 Favored Pre-proline 0 C--O 1.232 0.144 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.189 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.492 ' HD3' ' HG3' ' A' ' 192' ' ' LYS . 26.8 Cg_exo -61.77 -25.46 78.63 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.504 2.136 . . . . 0.0 112.019 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.45 -71.16 0.36 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.882 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 58.5 p -66.9 -28.71 68.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.072 0.463 . . . . 0.0 110.458 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 89.53 6.8 70.08 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.209 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 3.3 tpt180 -123.6 124.08 42.01 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.291 0.546 . . . . 0.0 110.632 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.472 ' HB3' ' NH1' ' A' ' 200' ' ' ARG . 54.8 m -62.31 147.9 46.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.164 0.507 . . . . 0.0 112.047 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.76 HH21 HD12 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -60.62 -35.59 76.54 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.849 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 91.89 7.59 64.26 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 114.973 0.749 . . . . 0.0 114.973 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.622 ' H ' ' HG2' ' A' ' 200' ' ' ARG . 36.6 p90 -141.12 153.91 45.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.23 0.538 . . . . 0.0 111.371 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.515 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -142.51 161.61 27.35 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.606 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.65 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 97.7 m-85 -105.75 124.56 49.77 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.626 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 44.2 tp -111.01 127.37 55.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.321 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' A' ' 187' ' ' ASP . 49.9 m -117.81 142.05 47.73 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.786 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.626 ' CZ ' HD21 ' A' ' 205' ' ' LEU . 93.5 m-85 -120.73 146.16 46.76 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.063 0.458 . . . . 0.0 111.707 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.72 -34.95 79.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.752 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 0.6 OUTLIER -118.54 135.91 23.85 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.934 -179.308 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 0.998 ' O ' HG12 ' A' ' 213' ' ' VAL . 39.6 Cg_exo -60.53 -26.36 82.66 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.846 2.364 . . . . 0.0 113.286 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 31.4 m -58.08 -38.45 76.4 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.188 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.63 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.9 m -61.41 -37.88 85.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.809 0.338 . . . . 0.0 111.069 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.998 HG12 ' O ' ' A' ' 210' ' ' PRO . 3.0 p -61.43 -35.87 69.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.466 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.431 ' O ' ' HG3' ' A' ' 218' ' ' LYS . 92.6 m-20 -60.79 -43.54 97.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.793 0.33 . . . . 0.0 111.375 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.29 -34.64 77.82 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.788 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 98.4 t -60.58 -43.47 94.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 230' ' ' PRO . 20.9 m -83.51 -37.8 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 214' ' ' ASP . 25.7 mttm -60.51 -32.77 71.77 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.405 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 48.3 m -99.49 144.91 28.04 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -76.84 145.41 38.4 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.788 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 74.2 m-70 -121.87 128.15 51.29 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -176.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 70.9 mt -128.41 89.07 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.436 ' CD1' HG23 ' A' ' 170' ' ' THR . 6.8 tt -67.36 -38.68 85.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -163.8 50.32 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.005 0.431 . . . . 0.0 111.353 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 91.28 2.44 70.82 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.661 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.473 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 10.7 mmtp -116.58 152.25 34.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 41.6 t -105.12 131.62 53.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.132 0.491 . . . . 0.0 110.932 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.587 HD12 HG23 ' A' ' 163' ' ' ILE . 36.8 pt -123.66 159.82 28.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.113 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -126.93 79.82 72.12 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-O 121.127 0.489 . . . . 0.0 111.125 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.613 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 52.0 Cg_exo -57.93 124.02 15.02 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.649 2.233 . . . . 0.0 111.107 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.46 ' N ' ' HE3' ' A' ' 161' ' ' MET . 4.0 ttpm? -134.88 149.08 50.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.639 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -52.5 141.16 20.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.9 0.381 . . . . 0.0 110.769 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.64 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -64.98 148.52 51.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.982 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 65.3 mt -109.64 128.58 25.15 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.407 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.89 141.0 57.13 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 121.623 1.548 . . . . 0.0 110.802 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 57.4 mmm-85 -57.37 -39.66 76.51 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.382 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.07 -43.19 99.28 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.018 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.481 ' O ' HG23 ' A' ' 242' ' ' THR . 97.0 mt-10 -68.72 -37.25 79.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.088 0.471 . . . . 0.0 110.552 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -60.1 -40.69 90.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.92 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -60.59 -39.8 89.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.811 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -60.78 -32.7 72.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.411 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.791 HG22 HD12 ' A' ' 270' ' ' ILE . 11.3 p -77.91 161.98 27.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.129 0.49 . . . . 0.0 111.818 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -146.55 115.25 0.78 Allowed Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.86 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.472 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 46.3 tptt -82.44 130.61 35.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.519 0.2 . . . . 0.0 110.918 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.684 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -120.97 159.79 22.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.249 0.547 . . . . 0.0 110.758 179.199 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.526 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 91.9 t80 -103.26 137.52 41.28 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.061 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.837 HG23 HG12 ' A' ' 315' ' ' ILE . 7.2 p -130.46 143.98 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.818 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.626 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -131.92 165.47 23.44 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 94.43 13.42 53.97 Favored Glycine 0 C--N 1.321 -0.264 0 C-N-CA 119.952 -1.118 . . . . 0.0 112.333 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.833 HD11 ' CA ' ' A' ' 287' ' ' GLY . 36.4 pt -117.9 155.69 19.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.771 0.32 . . . . 0.0 110.93 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.666 ' H ' HG12 ' A' ' 254' ' ' VAL . . . 178.2 -134.69 2.46 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.292 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.67 -28.03 63.91 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.973 1.782 . . . . 0.0 111.179 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.03 -31.99 70.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.374 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.772 HG11 ' HB ' ' A' ' 250' ' ' ILE . 7.9 p -122.55 143.23 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.668 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.8 mmm-85 -102.39 163.12 18.29 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.08 -40.39 81.74 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 121.483 1.455 . . . . 0.0 112.003 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -64.37 -46.32 83.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.847 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.432 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 84.1 tt0 -65.59 -39.79 91.97 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-O 120.913 0.387 . . . . 0.0 111.881 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.643 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 26.3 t80 -61.66 -45.91 92.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.011 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -64.53 -42.17 95.91 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.478 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.432 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.7 pt-20 -74.1 -30.78 62.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.187 0.518 . . . . 0.0 110.432 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.709 ' CZ ' HG21 ' A' ' 306' ' ' ILE . 5.7 t80 -60.45 -56.53 20.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.817 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.679 ' C ' HD11 ' A' ' 269' ' ' ILE . 4.6 m-85 -64.64 -23.46 67.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.041 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.686 ' N ' HD11 ' A' ' 269' ' ' ILE . 22.7 t -55.12 -30.55 59.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.941 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -52.72 -35.33 55.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.096 -0.242 . . . . 0.0 111.398 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.665 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 7.4 p90 -117.55 45.27 1.96 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 121.16 0.505 . . . . 0.0 111.593 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.516 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 152.48 146.79 4.43 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.857 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.406 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 46.2 m -59.32 -38.21 79.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.769 0.319 . . . . 0.0 111.358 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.686 HD11 ' N ' ' A' ' 264' ' ' SER . 75.3 mt 68.0 82.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.487 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.791 HD12 HG22 ' A' ' 242' ' ' THR . 71.2 mt -58.35 -40.52 78.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.4 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 290' ' ' THR . 58.0 t0 -149.83 142.48 24.54 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.992 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.44 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -158.08 136.97 11.4 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.623 0.249 . . . . 0.0 111.046 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' GLN . . . . . 0.402 ' HG3' ' SD ' ' A' ' 275' ' ' MET . 9.2 pt20 -148.69 154.04 39.09 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.143 0.497 . . . . 0.0 112.018 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.569 ' O ' ' HB2' ' A' ' 275' ' ' MET . 31.9 tp -66.02 -37.01 84.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.859 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.569 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 92.2 mmm 86.95 126.55 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.471 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.51 ' HB3' ' OG ' ' A' ' 283' ' ' SER . 0.0 OUTLIER -154.66 138.68 16.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 111.134 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -81.7 -132.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -56.6 -35.01 67.76 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 122.115 -0.366 . . . . 0.0 110.547 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 276' ' ' LEU . 93.2 m-20 -135.58 -101.46 0.22 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.583 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 63.7 p -111.04 16.78 20.97 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -42.09 -79.85 0.05 OUTLIER Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.564 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.448 ' HB2' ' C ' ' A' ' 275' ' ' MET . 90.3 mm-40 -59.29 -33.16 70.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.082 0.468 . . . . 0.0 110.011 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.623 ' O ' ' HG2' ' A' ' 284' ' ' ARG . 58.8 m -64.56 171.84 3.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.529 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 283' ' ' SER . 42.2 ptt85 49.55 46.68 23.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.305 0.574 . . . . 0.0 110.398 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -167.87 -67.78 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.455 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.526 ' CD2' ' HE1' ' A' ' 246' ' ' PHE . 35.7 p90 -139.29 167.0 23.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.731 0.301 . . . . 0.0 111.212 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.833 ' CA ' HD11 ' A' ' 250' ' ' ILE . . . -133.88 164.29 24.43 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.702 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.472 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.2 OUTLIER -118.5 126.8 52.79 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.442 -0.379 . . . . 0.0 110.822 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.684 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 46.6 t -127.53 139.7 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.443 ' OG1' ' CD ' ' A' ' 244' ' ' LYS . 32.5 m -116.66 137.69 52.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.408 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.516 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 40.2 m-85 -117.95 140.49 49.66 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 293' ' ' SER . 54.0 p30 -62.1 -32.14 72.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.285 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' SER . . . . . 0.591 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 29.7 t -124.46 139.43 53.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.209 0.528 . . . . 0.0 111.508 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.81 -30.93 71.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.177 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -56.48 -37.66 70.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.202 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -61.31 -36.86 81.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 0.0 110.736 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.576 ' O ' HG12 ' A' ' 300' ' ' VAL . 95.0 t -61.17 -43.11 95.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.029 0.442 . . . . 0.0 110.501 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -61.77 -36.5 81.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.719 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -57.18 -42.8 81.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.826 0.346 . . . . 0.0 111.917 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.665 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 1.2 p -68.94 -33.53 59.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.397 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 76.3 m -57.49 -44.28 84.79 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.998 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.77 -38.82 89.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.232 0.539 . . . . 0.0 109.93 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.6 m-20 -61.12 -33.38 73.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.999 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.628 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 52.4 tptt 67.4 -70.4 0.12 Allowed 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -177.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.628 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.0 m-30 -115.56 148.46 39.54 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.755 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.709 HG21 ' CZ ' ' A' ' 262' ' ' PHE . 5.7 mm -115.18 137.56 48.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -78.19 46.36 0.6 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.03 0.443 . . . . 0.0 110.36 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.546 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 7.3 t80 -56.95 -65.48 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.402 ' HE2' ' C ' ' A' ' 308' ' ' PHE . 4.4 mmpt? -101.28 20.92 14.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.506 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 58.99 35.77 24.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.527 0.68 . . . . 0.0 109.293 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -139.07 0.95 1.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.614 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.441 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 98.4 mttt 64.78 123.25 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.242 0.544 . . . . 0.0 112.004 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.626 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 34.4 pt -116.46 146.46 20.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.281 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -100.71 130.78 46.79 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.785 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 0.837 HG12 HG23 ' A' ' 247' ' ' VAL . 72.3 mt -121.26 131.4 73.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.594 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 246' ' ' PHE . 8.0 tptp -131.71 144.61 51.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.643 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -57.71 144.52 37.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.936 0.398 . . . . 0.0 110.805 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.08 147.17 40.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.375 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.055 -179.762 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 14.0 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.79 0.329 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -56.72 143.79 35.16 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.236 0.541 . . . . 0.0 111.452 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.823 ' SD ' HG13 ' A' ' 213' ' ' VAL . 84.0 mmm -116.21 149.64 38.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.792 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.762 ' HB3' ' HG2' ' A' ' 231' ' ' LYS . 4.2 t80 -104.1 128.87 51.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.543 HG22 HD21 ' A' ' 166' ' ' LEU . 15.9 mm -113.88 127.09 71.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.482 ' O ' ' HB ' ' A' ' 228' ' ' ILE . . . -131.95 166.8 23.04 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.537 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.459 ' C ' HG22 ' A' ' 228' ' ' ILE . . . 76.89 33.54 45.79 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.353 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.543 HD21 HG22 ' A' ' 163' ' ' ILE . 61.4 mt -80.74 146.55 30.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 169' ' ' ASP . 43.8 t30 -79.85 59.48 3.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.712 0.291 . . . . 0.0 111.421 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.423 ' CD1' ' O ' ' A' ' 199' ' ' SER . 12.2 m0 28.92 37.83 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.502 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 167' ' ' ASN . 54.8 t0 -163.14 20.08 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.799 HG22 HD11 ' A' ' 190' ' ' ILE . 59.9 m -76.26 136.55 39.66 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.861 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 173' ' ' ASP . 30.8 m -114.46 144.47 43.28 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.23 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.553 ' N ' HD12 ' A' ' 190' ' ' ILE . 54.5 mp0 -56.43 -36.55 69.11 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.404 -0.519 . . . . 0.0 109.878 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.408 ' H ' HG22 ' A' ' 171' ' ' THR . 89.4 m-20 -65.65 -48.62 71.52 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.795 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -66.37 -41.7 89.06 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.584 0.706 . . . . 0.0 109.976 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.744 HD23 ' CD1' ' A' ' 188' ' ' LEU . 63.9 tp -64.19 -41.62 97.01 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.173 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -62.87 -45.23 93.51 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.267 0.556 . . . . 0.0 110.167 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -66.85 -38.13 85.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.871 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.566 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 52.4 t80 -57.9 -46.05 85.52 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.223 0.535 . . . . 0.0 110.87 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.462 ' CD2' ' HD1' ' A' ' 178' ' ' TYR . 96.1 m-85 -93.66 1.26 56.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.647 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -59.28 -28.43 64.38 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.23 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.443 ' CD ' ' H ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -58.51 -39.14 79.24 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.759 0.79 . . . . 0.0 110.503 -179.11 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -67.53 -31.81 72.16 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.045 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 161.72 -133.27 3.09 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.283 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.0 m -119.28 140.16 50.74 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.955 HG21 HD23 ' A' ' 188' ' ' LEU . 2.8 m -102.36 126.68 56.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.405 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.749 HG23 ' N ' ' A' ' 208' ' ' GLU . 51.8 p -69.92 -37.91 76.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.291 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 186' ' ' THR . 90.9 m-20 -143.74 155.68 44.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.195 0.521 . . . . 0.0 112.029 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.955 HD23 HG21 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -133.79 126.41 30.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.567 179.335 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 15.2 tptt -134.6 119.67 18.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.345 0.593 . . . . 0.0 112.225 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.799 HD11 HG22 ' A' ' 170' ' ' THR . 0.8 OUTLIER -125.49 129.61 72.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.022 176.919 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.667 ' CE ' ' HA2' ' A' ' 203' ' ' GLY . 3.1 mtm -96.23 134.56 39.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.191 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -128.48 155.56 44.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.852 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.524 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 6.0 m-20 -123.21 73.15 48.35 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.509 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.72 -28.75 88.05 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.718 2.279 . . . . 0.0 113.131 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -64.86 -57.86 7.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 0.0 110.95 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 55.9 p -78.74 -15.02 58.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.224 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 80.16 24.28 59.72 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.573 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 1.9 tpt180 -124.22 175.61 6.93 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 120.687 0.279 . . . . 0.0 110.509 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.423 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 32.6 t -126.4 147.4 49.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.626 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 36.6 mmt180 -54.48 -35.07 62.69 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.23 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.401 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 90.2 3.34 72.83 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.532 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.626 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 26.3 p90 -139.8 157.5 45.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.777 0.323 . . . . 0.0 110.653 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.667 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -147.0 160.07 28.17 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.935 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.576 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 98.1 m-85 -105.6 124.27 49.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.361 0.6 . . . . 0.0 109.971 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.663 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 60.2 tp -111.51 125.73 54.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.367 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 23.9 t -118.86 136.91 53.78 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.684 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.893 ' CE1' HG12 ' A' ' 185' ' ' VAL . 68.3 m-85 -119.84 143.8 47.7 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.668 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.749 ' N ' HG23 ' A' ' 186' ' ' THR . 84.5 tt0 -63.95 -34.85 78.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.941 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.81 115.54 55.25 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.764 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.25 -21.1 34.56 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.591 2.194 . . . . 0.0 112.87 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.9 m -56.73 -36.3 69.56 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.946 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.4 m -58.39 -35.1 71.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.935 0.398 . . . . 0.0 110.296 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.823 HG13 ' SD ' ' A' ' 161' ' ' MET . 75.1 t -60.39 -42.28 90.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.95 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.41 ' O ' HG22 ' A' ' 217' ' ' VAL . 22.0 t70 -58.98 -41.98 88.86 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.899 0.381 . . . . 0.0 110.837 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.415 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 20.3 pt-20 -76.89 -30.62 56.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.752 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.946 HG23 ' O ' ' A' ' 212' ' ' SER . 77.6 t -60.22 -41.32 86.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.418 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 214' ' ' ASP . 21.0 m -71.53 -31.99 44.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -59.93 -38.8 83.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.723 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 35.0 m -85.13 143.16 29.0 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 63.3 tt0 -66.0 -40.96 91.6 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.935 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.86 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 85.2 m-70 78.84 97.81 0.06 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 72.2 mt -117.07 107.66 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.443 ' HG ' ' CD2' ' A' ' 178' ' ' TYR . 3.6 tt -97.66 -74.13 0.59 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.401 ' OD1' HD23 ' A' ' 223' ' ' LEU . 92.6 m-20 -90.78 14.86 12.4 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 101.99 -6.78 54.38 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.226 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.406 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -99.69 -172.59 2.27 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.632 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 15.0 p -120.03 135.91 58.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.241 0.543 . . . . 0.0 111.159 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.493 HD11 ' HB3' ' A' ' 221' ' ' HIS . 36.0 pt -124.98 156.66 33.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.199 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -127.84 78.51 75.0 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.207 0.527 . . . . 0.0 111.289 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.581 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 74.4 Cg_exo -55.39 131.21 44.89 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.844 2.363 . . . . 0.0 111.299 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.762 ' HG2' ' HB3' ' A' ' 162' ' ' PHE . 0.5 OUTLIER -136.78 170.3 16.31 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -70.82 140.09 51.11 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.125 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.58 143.8 56.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.763 0.316 . . . . 0.0 111.184 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 28.6 mt -111.44 121.91 38.94 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.015 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.51 144.14 52.76 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.836 1.691 . . . . 0.0 110.986 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -56.81 -39.11 73.56 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.486 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -61.3 -46.53 89.91 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.115 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 242' ' ' THR . 84.6 tt0 -68.85 -37.22 78.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.358 0.599 . . . . 0.0 109.737 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -58.5 -43.46 89.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.742 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -65.14 -40.26 94.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.408 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -60.11 -37.77 81.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.218 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 238' ' ' GLU . 19.9 p -81.39 161.71 23.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.167 0.508 . . . . 0.0 111.987 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.56 163.72 25.18 Favored Glycine 0 C--N 1.332 0.338 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.424 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.651 ' C ' ' HB2' ' A' ' 318' ' ' ALA . 11.8 tttm -138.07 137.76 38.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.141 0.471 . . . . 0.0 110.719 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.701 HD13 ' O ' ' A' ' 245' ' ' ILE . 0.0 OUTLIER -123.06 164.21 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.688 0.756 . . . . 0.0 112.538 -179.245 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.545 ' HB3' ' O ' ' A' ' 317' ' ' ARG . 86.0 t80 -105.1 138.62 41.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.565 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.638 HG12 ' O ' ' A' ' 287' ' ' GLY . 7.4 p -127.45 133.75 67.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -105.48 -4.04 40.51 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.586 -0.816 . . . . 0.0 114.178 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 313' ' ' ILE . . . -115.82 115.72 3.46 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.72 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.606 ' O ' HG21 ' A' ' 254' ' ' VAL . 24.5 mm -94.22 -78.42 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.475 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 119.21 162.29 11.96 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.075 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.69 128.25 22.85 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.143 1.896 . . . . 0.0 112.719 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 51.47 42.18 29.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.65 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.722 ' O ' ' HB3' ' A' ' 258' ' ' GLU . 6.4 t -63.91 -44.26 97.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.404 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.4 OUTLIER 61.51 134.86 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.43 -31.01 66.46 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 121.946 1.764 . . . . 0.0 112.706 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -63.99 -48.63 75.63 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.722 ' HB3' ' O ' ' A' ' 254' ' ' VAL . 42.8 tp10 -64.6 -38.15 90.0 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.044 0.45 . . . . 0.0 111.054 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.616 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 44.8 t80 -59.49 -44.19 93.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.165 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.464 ' O ' HD12 ' A' ' 269' ' ' ILE . 97.2 mt-10 -65.34 -40.58 93.84 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.557 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 264' ' ' SER . 20.6 pt-20 -77.72 -30.63 51.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.21 0.529 . . . . 0.0 110.466 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.711 ' CZ ' HG21 ' A' ' 306' ' ' ILE . 5.5 t80 -61.9 -54.87 35.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.436 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.85 ' CD2' HG21 ' A' ' 289' ' ' VAL . 4.3 m-85 -65.17 -23.82 67.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.553 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.704 ' N ' HD11 ' A' ' 269' ' ' ILE . 23.5 t -54.82 -25.47 28.66 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -46.45 -37.34 7.62 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.41 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.713 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 23.2 p90 -129.83 54.45 1.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.052 0.453 . . . . 0.0 111.472 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 264' ' ' SER . . . 149.11 146.52 4.34 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.803 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.449 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 53.1 m -59.26 -37.51 77.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.758 0.313 . . . . 0.0 111.354 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.704 HD11 ' N ' ' A' ' 264' ' ' SER . 74.8 mt 71.55 85.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.848 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.594 HD11 ' HB3' ' A' ' 292' ' ' ASP . 34.8 mm -59.36 -35.51 58.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.198 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.58 ' O ' ' HB3' ' A' ' 272' ' ' ALA . 61.6 t0 -137.97 -104.76 0.18 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.079 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.608 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . 80.36 113.93 0.06 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.934 0.397 . . . . 0.0 112.016 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -141.99 155.83 45.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.317 0.579 . . . . 0.0 111.382 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.541 ' O ' ' HB2' ' A' ' 275' ' ' MET . 22.9 tp -63.63 -36.49 83.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.421 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.569 ' HG2' ' HB2' ' A' ' 288' ' ' PHE . 95.8 mmm 76.96 123.37 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.674 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.504 ' HG ' ' HB3' ' A' ' 283' ' ' SER . 5.1 mp -128.35 125.81 39.45 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.497 ' H ' ' H ' ' A' ' 282' ' ' GLN . 55.9 t0 -62.67 -40.75 98.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.594 0.712 . . . . 0.0 109.697 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -162.12 -73.7 0.05 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.781 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.408 ' O ' HD23 ' A' ' 276' ' ' LEU . 60.8 t0 -94.56 -75.75 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.484 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 73.3 p -129.33 13.57 6.08 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.357 -0.383 . . . . 0.0 112.015 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -44.99 -91.01 0.01 OUTLIER Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.037 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.497 ' H ' ' H ' ' A' ' 277' ' ' ASP . 98.7 mt-30 -60.26 -25.65 65.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.167 -0.517 . . . . 0.0 111.599 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.51 ' O ' HD21 ' A' ' 274' ' ' LEU . 63.5 p -51.89 -27.32 12.42 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.73 0.3 . . . . 0.0 110.938 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -122.5 139.07 54.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.911 0.386 . . . . 0.0 110.557 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.63 -53.52 0.58 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.25 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.571 ' C ' HD11 ' A' ' 250' ' ' ILE . 33.3 p90 -142.56 166.27 25.13 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 117.425 0.612 . . . . 0.0 111.708 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.638 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -134.42 157.36 22.89 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.259 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.569 ' HB2' ' HG2' ' A' ' 275' ' ' MET . 0.2 OUTLIER -118.16 125.24 49.82 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.868 -0.195 . . . . 0.0 111.171 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.85 HG21 ' CD2' ' A' ' 263' ' ' PHE . 53.3 t -128.4 137.57 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.036 0.445 . . . . 0.0 112.151 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 54.8 m -117.02 136.69 52.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.311 178.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.47 ' CD1' ' HA3' ' A' ' 267' ' ' GLY . 47.5 m-85 -118.03 142.6 47.21 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 293' ' ' SER . 54.7 p30 -62.13 -31.58 72.07 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.108 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' SER . . . . . 0.613 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 27.6 t -124.67 139.54 53.77 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.161 0.505 . . . . 0.0 111.963 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.91 -31.58 72.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.946 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -55.46 -36.54 66.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.966 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -60.64 -34.86 74.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.649 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.589 ' O ' HG12 ' A' ' 300' ' ' VAL . 84.6 t -59.55 -43.73 91.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.148 0.499 . . . . 0.0 110.309 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -62.43 -36.36 82.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.693 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 89.7 mtt-85 -57.12 -43.91 82.8 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.002 0.429 . . . . 0.0 111.976 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.713 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 1.3 p -68.77 -32.28 54.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.356 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 76.2 m -57.13 -43.74 82.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.207 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -60.45 -41.27 93.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.218 0.532 . . . . 0.0 110.186 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.416 ' O ' ' N ' ' A' ' 305' ' ' PHE . 88.3 m-20 -61.81 -33.53 74.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.399 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.639 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 7.9 tptm 67.05 -73.5 0.08 Allowed 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -178.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.639 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.5 m-30 -115.82 147.63 40.79 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.43 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.711 HG21 ' CZ ' ' A' ' 262' ' ' PHE . 37.6 mt -119.92 129.51 75.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -59.48 -35.43 74.1 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.438 0.637 . . . . 0.0 111.005 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.529 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 1.3 t80 49.88 -124.86 2.11 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.299 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.526 ' HE3' ' CE1' ' A' ' 308' ' ' PHE . 2.0 mmpt? -59.57 -37.51 78.67 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.931 0.396 . . . . 0.0 110.997 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 309' ' ' LYS . 23.3 t70 170.35 -0.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.26 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -122.12 152.39 39.94 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.785 0.326 . . . . 0.0 110.2 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 79.7 mttt -77.78 129.38 35.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.078 0.466 . . . . 0.0 111.222 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 305' ' ' PHE . 26.8 pt -115.3 143.33 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.375 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' GLU . . . . . 0.571 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 85.6 mt-10 -100.91 133.25 45.67 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.471 -0.492 . . . . 0.0 109.897 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 0.631 HG12 HG23 ' A' ' 247' ' ' VAL . 82.4 mt -122.21 126.07 73.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.144 0.497 . . . . 0.0 111.898 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -133.05 -170.45 2.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.456 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.545 ' O ' ' HB3' ' A' ' 246' ' ' PHE . 74.7 mtp180 -57.34 146.8 27.74 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.728 0.299 . . . . 0.0 110.623 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.651 ' HB2' ' C ' ' A' ' 244' ' ' LYS . . . -60.86 -23.16 64.93 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 . . . . . 0 C--N 1.327 -0.378 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.297 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 CA--C 1.529 0.148 0 CA-C-O 120.727 0.298 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.57 ' HE2' ' HB3' ' A' ' 204' ' ' PHE . 15.4 tptm -56.27 140.06 46.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.453 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.797 ' SD ' HG13 ' A' ' 213' ' ' VAL . 86.1 mmm -118.15 150.0 40.11 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.075 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.61 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 4.3 t80 -106.79 130.17 54.54 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.683 ' CG2' HD21 ' A' ' 166' ' ' LEU . 17.2 mm -115.41 121.81 67.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.024 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -126.44 164.8 19.89 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.441 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.725 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 74.79 27.13 65.5 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.547 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.683 HD21 ' CG2' ' A' ' 163' ' ' ILE . 71.0 mt -87.63 142.21 28.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.901 0.381 . . . . 0.0 111.349 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -67.23 134.16 51.12 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 199' ' ' SER . 4.7 m-90 -52.15 -36.77 52.4 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.999 -0.281 . . . . 0.0 111.404 -178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -60.23 -31.47 70.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.689 0.281 . . . . 0.0 111.359 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.466 HG23 ' HB3' ' A' ' 174' ' ' ASN . 79.6 m -58.3 140.18 53.82 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.335 0.588 . . . . 0.0 111.971 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.42 ' C ' HD12 ' A' ' 190' ' ' ILE . 1.5 p -118.36 167.76 11.26 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.495 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.822 ' N ' HD12 ' A' ' 190' ' ' ILE . 96.1 mt-10 -58.91 -33.26 70.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -60.43 -41.23 93.57 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.466 ' HB3' HG23 ' A' ' 170' ' ' THR . 0.4 OUTLIER -61.63 -41.71 97.87 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.538 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.717 HD12 HD11 ' A' ' 190' ' ' ILE . 3.9 mt -65.56 -42.94 91.25 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.703 178.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.938 ' HG3' HG11 ' A' ' 185' ' ' VAL . 70.7 ttp85 -60.9 -44.51 97.03 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.735 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -67.86 -39.16 83.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.573 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 67.0 t80 -70.89 -62.1 1.52 Allowed 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.308 0.575 . . . . 0.0 111.41 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.538 ' CE2' HD23 ' A' ' 175' ' ' LEU . 67.4 m-85 -70.52 -24.21 62.78 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.516 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 183' ' ' GLY . . . -51.29 -27.03 14.89 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.672 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.5 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -56.2 -43.96 79.02 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.405 0.682 . . . . 0.0 110.99 178.866 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -71.51 -34.4 70.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.727 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 180' ' ' GLY . . . -164.62 -173.8 33.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.147 -1.025 . . . . 0.0 113.258 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.956 ' O ' HG12 ' A' ' 185' ' ' VAL . 51.0 m -59.22 -35.05 72.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.425 0.155 . . . . 0.0 110.782 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.956 HG12 ' O ' ' A' ' 184' ' ' THR . 1.0 OUTLIER 78.67 69.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 CA-C-O 122.631 1.205 . . . . 0.0 108.749 -178.231 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.67 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 5.7 m -52.34 -42.55 63.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.08 -1.418 . . . . 0.0 112.801 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.418 ' HB3' ' HB3' ' A' ' 206' ' ' SER . 54.5 t0 -148.35 141.49 25.0 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.71 HD11 ' HB3' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -121.22 131.21 54.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.562 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 8.5 tptp -136.23 121.05 18.57 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.822 HD12 ' N ' ' A' ' 172' ' ' GLU . 4.3 mt -127.05 132.45 69.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.663 176.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.574 ' HB2' ' CG ' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -92.15 125.11 36.7 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.969 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 199' ' ' SER . 4.1 mtmp? -126.7 155.04 43.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.895 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 9.1 t70 -97.22 108.8 46.48 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.693 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.69 -26.18 81.35 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.549 2.166 . . . . 0.0 112.958 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.412 ' HB3' ' OD1' ' A' ' 193' ' ' ASP . . . -74.68 -86.64 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 51.8 p -71.66 -21.52 61.8 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 193' ' ' ASP . . . 93.12 4.88 64.37 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.119 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.479 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 11.0 tpt180 -74.93 143.05 43.9 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.481 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 23.6 t -103.32 148.77 25.45 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.746 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.645 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 15.0 mmm180 -53.18 -30.6 38.26 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 166' ' ' LEU . . . 95.93 -0.87 62.82 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.86 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.645 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 25.4 p90 -136.62 156.4 48.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.875 0.369 . . . . 0.0 110.299 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.563 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -142.87 162.5 27.44 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.982 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.61 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 97.8 m-85 -105.06 125.3 50.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.363 0.602 . . . . 0.0 109.521 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.658 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 46.8 tp -106.7 130.3 54.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.041 -177.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' A' ' 187' ' ' ASP . 28.0 t -124.3 135.13 53.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.883 0.373 . . . . 0.0 111.979 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.658 ' CZ ' HD21 ' A' ' 205' ' ' LEU . 95.4 m-85 -119.48 140.05 51.09 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.782 178.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.67 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.3 tt0 -60.58 -34.47 74.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.026 0.441 . . . . 0.0 110.087 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.5 119.48 49.3 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.499 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.59 -20.55 27.66 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.516 2.144 . . . . 0.0 112.801 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 85.1 p -59.97 -31.07 69.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.667 0.27 . . . . 0.0 111.234 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.932 ' O ' HG23 ' A' ' 216' ' ' VAL . 23.0 m -59.44 -36.06 75.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.603 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.797 HG13 ' SD ' ' A' ' 161' ' ' MET . 70.5 t -61.61 -43.52 97.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.305 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -59.81 -42.03 92.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.01 0.433 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.02 -31.9 61.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.77 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 212' ' ' SER . 66.0 t -60.76 -42.27 91.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 120.662 0.267 . . . . 0.0 110.983 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 24.3 m -73.15 -27.55 24.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -58.72 -35.5 72.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.659 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.694 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 57.4 m -100.13 141.52 32.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.852 0.358 . . . . 0.0 111.863 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 59.7 tp60 -66.09 -40.64 90.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.737 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.79 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 64.8 m-70 79.31 116.49 0.06 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 24.6 mm -116.4 107.4 22.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.2 tt -121.32 122.96 41.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.789 0.328 . . . . 0.0 110.177 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 51.73 40.17 26.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.148 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 73.64 20.32 79.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.342 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -115.21 136.23 53.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.329 0.565 . . . . 0.0 111.506 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.756 ' O ' ' O ' ' A' ' 228' ' ' ILE . 9.5 p -62.04 -35.89 71.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.096 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.756 ' O ' ' O ' ' A' ' 227' ' ' VAL . 9.0 pt 30.9 128.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.513 0.725 . . . . 0.0 112.68 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -123.29 84.56 51.94 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 121.056 0.455 . . . . 0.0 111.315 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.498 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 50.7 Cg_exo -56.05 135.34 69.31 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.912 2.408 . . . . 0.0 111.986 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -136.88 157.3 47.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.909 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -55.93 133.45 51.53 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.747 0.308 . . . . 0.0 110.852 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 160' ' ' LYS . . . -72.91 148.05 44.71 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -122.13 125.58 26.56 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.674 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.444 ' HG2' ' CG ' ' A' ' 238' ' ' GLU . 9.4 Cg_endo -51.84 145.62 31.2 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 121.791 1.66 . . . . 0.0 111.14 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 236' ' ' ARG . 6.2 tmm_? -54.66 -39.25 67.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.78 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 55.3 p30 -61.42 -38.51 87.39 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.702 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.586 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 97.9 mt-10 -68.17 -34.13 75.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.995 0.426 . . . . 0.0 110.381 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -59.61 -38.28 80.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.281 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.93 -40.47 93.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.627 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -61.69 -34.94 76.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.162 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 22.4 p -83.41 162.23 21.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.572 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -146.47 112.71 0.63 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.847 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 17.5 ttpp -88.72 134.27 33.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.893 0.378 . . . . 0.0 111.194 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.686 HG21 HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -117.46 164.02 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.537 0.684 . . . . 0.0 111.43 -179.247 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.486 ' HD2' ' HG2' ' A' ' 316' ' ' LYS . 93.5 t80 -101.85 136.34 41.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.518 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.821 HG11 ' CE1' ' A' ' 259' ' ' PHE . 12.5 p -131.57 146.37 33.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.314 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.646 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -131.66 169.43 21.94 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 89.92 17.82 52.77 Favored Glycine 0 N--CA 1.454 -0.147 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.727 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.91 HG23 HG21 ' A' ' 254' ' ' VAL . 23.3 mm -54.96 -43.84 70.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.841 0.353 . . . . 0.0 110.792 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 50.51 174.12 0.01 OUTLIER Glycine 0 CA--C 1.521 0.451 0 CA-C-N 116.074 -0.512 . . . . 0.0 114.086 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.09 154.68 65.83 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.62 2.88 . . . . 0.0 113.616 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 57.62 41.67 25.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.919 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.91 HG21 HG23 ' A' ' 250' ' ' ILE . 2.4 p -85.79 -40.69 14.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.542 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.6 OUTLIER 60.05 118.97 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.595 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.92 -33.78 63.48 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 121.743 1.629 . . . . 0.0 112.426 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -61.51 -41.74 97.77 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.998 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.656 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 98.3 mt-10 -66.16 -36.15 82.36 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.627 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.821 ' CE1' HG11 ' A' ' 247' ' ' VAL . 16.5 t80 -63.86 -50.11 70.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.782 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.725 ' HG2' ' HB3' ' A' ' 272' ' ' ALA . 97.2 mt-10 -64.67 -37.03 86.18 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.605 ' HB3' ' HA ' ' A' ' 258' ' ' GLU . 78.5 tt0 -63.03 -37.9 89.04 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.646 -1.616 . . . . 0.0 111.883 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.815 ' CE2' HD11 ' A' ' 313' ' ' ILE . 86.4 t80 -67.78 -55.08 14.41 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.683 ' CE2' HD11 ' A' ' 245' ' ' ILE . 10.0 m-85 -66.45 -25.29 66.66 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.727 ' N ' HD11 ' A' ' 269' ' ' ILE . 35.1 t -55.29 -31.31 61.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.689 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -56.15 -36.48 68.33 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.291 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.664 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 9.0 p90 -117.57 51.79 1.02 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.44 0.638 . . . . 0.0 111.16 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.512 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 148.3 148.03 4.66 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.508 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.444 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 11.8 t -64.06 -35.8 81.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 110.928 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.727 HD11 ' N ' ' A' ' 264' ' ' SER . 79.3 mt 71.66 83.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.223 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.507 HG12 ' CA ' ' A' ' 292' ' ' ASP . 36.0 mm -58.98 -38.58 74.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.984 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -149.46 150.91 33.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.185 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.725 ' HB3' ' HG2' ' A' ' 260' ' ' GLU . . . -170.59 122.31 0.62 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.577 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -142.85 152.3 42.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.22 0.533 . . . . 0.0 111.861 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.81 HD11 HG21 ' A' ' 250' ' ' ILE . 29.2 tp -64.23 -37.82 88.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.901 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.524 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 91.8 mmm 101.59 102.87 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.441 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.412 ' CD2' ' HB3' ' A' ' 283' ' ' SER . 23.9 mt -108.05 139.02 43.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.521 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.605 ' HB3' ' HA3' ' A' ' 281' ' ' GLY . 59.9 t0 -145.39 93.31 2.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.092 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.855 ' O ' HG22 ' A' ' 280' ' ' THR . 40.8 mtpt 65.38 39.18 5.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.873 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.468 ' O ' ' HB ' ' A' ' 280' ' ' THR . 57.4 t0 46.31 41.75 9.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.782 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.855 HG22 ' O ' ' A' ' 278' ' ' LYS . 2.0 t 171.2 50.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.911 0.386 . . . . 0.0 110.709 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' GLY . . . . . 0.605 ' HA3' ' HB3' ' A' ' 277' ' ' ASP . . . -131.49 -112.11 1.42 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.448 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 275' ' ' MET . 78.8 mm-40 -57.9 -28.36 64.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.415 -0.392 . . . . 0.0 110.431 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.412 ' HB3' ' CD2' ' A' ' 276' ' ' LEU . 86.3 p -57.69 -22.64 47.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.215 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -52.73 -36.63 57.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.92 0.39 . . . . 0.0 110.749 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 286' ' ' PHE . . . -166.61 -176.62 37.86 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.091 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.558 ' O ' ' O ' ' A' ' 285' ' ' GLY . 3.1 p90 48.54 155.13 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.175 0.512 . . . . 0.0 112.075 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.69 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -139.25 164.41 25.9 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.153 -1.022 . . . . 0.0 113.783 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.452 ' CE2' ' NZ ' ' A' ' 244' ' ' LYS . 0.4 OUTLIER -119.73 125.6 49.04 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.669 0.388 . . . . 0.0 110.949 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.684 HG23 ' CZ ' ' A' ' 259' ' ' PHE . 48.9 t -127.45 137.07 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.003 0.43 . . . . 0.0 111.748 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 44.4 m -113.55 135.8 53.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.605 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.584 ' OH ' ' HB3' ' A' ' 263' ' ' PHE . 34.5 m-85 -117.15 137.21 52.47 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.507 ' CA ' HG12 ' A' ' 270' ' ' ILE . 50.5 t0 -58.84 -35.65 73.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.558 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 30.5 t -119.99 140.18 51.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.28 0.562 . . . . 0.0 111.887 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.962 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -63.66 -30.64 71.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.526 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -55.74 -35.12 65.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.029 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.26 90.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.539 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.962 HG12 ' O ' ' A' ' 294' ' ' ALA . 9.5 p -61.16 -37.14 76.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.001 0.429 . . . . 0.0 110.735 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.94 -38.18 90.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.527 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -59.16 -43.37 92.08 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.906 0.384 . . . . 0.0 111.943 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.752 HG23 HD11 ' A' ' 306' ' ' ILE . 0.9 OUTLIER -72.58 -36.68 54.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.638 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 74.5 m -59.23 -42.93 92.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.833 0.349 . . . . 0.0 110.447 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -61.78 -34.17 75.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.215 0.531 . . . . 0.0 110.013 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.65 ' O ' ' N ' ' A' ' 305' ' ' PHE . 80.6 m-20 -87.04 4.9 40.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.213 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.656 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 19.9 tptm 41.85 -80.85 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.605 0.24 . . . . 0.0 110.4 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.656 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 2.2 m-30 -107.58 141.26 39.33 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.752 HD11 HG23 ' A' ' 300' ' ' VAL . 1.0 OUTLIER -116.58 134.47 59.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.538 ' O ' ' HE1' ' A' ' 262' ' ' PHE . 89.0 m-20 -70.67 124.59 24.63 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.556 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 2.0 t80 -112.0 -109.89 0.35 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.501 ' HE2' ' OE1' ' A' ' 258' ' ' GLU . 1.2 mmmp? -60.15 -37.42 80.07 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.743 0.306 . . . . 0.0 111.386 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.406 ' CG ' ' O ' ' A' ' 309' ' ' LYS . 32.5 m-20 -177.96 -27.39 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.219 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -113.13 160.81 17.82 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.951 0.405 . . . . 0.0 110.841 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 43.9 mttt -71.67 143.63 49.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.351 0.596 . . . . 0.0 112.114 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.815 HD11 ' CE2' ' A' ' 262' ' ' PHE . 31.6 pt -118.93 147.87 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' GLU . . . . . 0.532 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 87.4 mt-10 -101.05 129.73 46.95 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.515 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 0.763 HG12 HG23 ' A' ' 247' ' ' VAL . 74.7 mt -123.31 127.61 74.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.207 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.486 ' HG2' ' HD2' ' A' ' 246' ' ' PHE . 3.4 ptpt -135.2 163.62 29.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.601 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 45.8 ptt85 -59.03 148.84 29.37 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.45 133.19 55.56 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.79 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.964 -179.61 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.718 ' HA ' HG21 ' A' ' 213' ' ' VAL . 7.8 p . . . . . 0 CA--C 1.53 0.21 0 CA-C-O 120.512 0.196 . . . . 0.0 111.385 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.586 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 5.3 tptm -69.56 131.6 44.94 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.825 ' SD ' HG13 ' A' ' 213' ' ' VAL . 93.3 mmm -120.67 143.57 48.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.877 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.567 ' CE1' ' CZ ' ' A' ' 204' ' ' PHE . 2.7 t80 -108.29 125.74 52.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.921 ' HB ' HD21 ' A' ' 166' ' ' LEU . 0.3 OUTLIER -120.88 127.86 75.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.615 -179.446 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.597 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -121.49 153.34 16.7 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.318 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.464 ' C ' HG22 ' A' ' 228' ' ' ILE . . . 73.44 29.08 64.49 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.151 -1.023 . . . . 0.0 110.994 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.921 HD21 ' HB ' ' A' ' 163' ' ' ILE . 69.1 mt -59.06 -33.3 70.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.728 ' O ' ' N ' ' A' ' 169' ' ' ASP . 21.1 t30 107.63 37.19 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.977 0.511 . . . . 0.0 110.669 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.574 ' HD1' ' HG ' ' A' ' 199' ' ' SER . 5.1 m0 45.99 -59.7 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.728 ' N ' ' O ' ' A' ' 167' ' ' ASN . 89.4 m-20 -83.4 19.73 1.48 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.627 ' OG1' ' HB3' ' A' ' 166' ' ' LEU . 57.6 m -51.88 -36.08 47.35 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.502 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.0 OUTLIER 58.26 139.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.157 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.661 ' O ' ' HD3' ' A' ' 176' ' ' ARG . 58.1 mp0 -60.39 -36.25 77.65 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -58.8 -40.9 85.42 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.596 ' HB2' ' O ' ' A' ' 170' ' ' THR . 9.4 m120 -61.69 -36.63 81.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.695 HD23 ' CE2' ' A' ' 179' ' ' PHE . 7.0 mt -55.74 -51.31 67.79 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.661 ' HD3' ' O ' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -67.93 -30.36 69.66 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.298 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -58.42 -39.35 79.52 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.37 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.64 ' OH ' ' CG ' ' A' ' 221' ' ' HIS . 0.0 OUTLIER -96.04 -55.52 2.95 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.25 179.199 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.695 ' CE2' HD23 ' A' ' 175' ' ' LEU . 72.5 m-85 -60.14 -27.15 66.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.397 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.42 -23.58 9.35 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.199 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.827 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -54.05 -40.46 67.13 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.992 0.425 . . . . 0.0 110.714 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.827 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 53.8 m-85 -69.85 -32.21 70.48 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.275 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 164.81 -130.19 2.13 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.262 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 49.1 m -120.96 140.28 52.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.659 HG21 HD23 ' A' ' 188' ' ' LEU . 0.2 OUTLIER -92.88 120.65 42.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.257 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.5 t -71.61 -45.53 61.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.348 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -149.9 109.51 4.02 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.659 HD23 HG21 ' A' ' 185' ' ' VAL . 0.1 OUTLIER -102.65 150.16 23.71 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.341 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 204' ' ' PHE . 18.9 tptt -133.69 124.53 26.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.94 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.582 HD12 ' CA ' ' A' ' 172' ' ' GLU . 1.0 OUTLIER -123.0 134.31 66.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.928 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.582 ' HB2' ' HB2' ' A' ' 200' ' ' ARG . 10.0 mmt -86.93 135.16 33.4 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -131.79 138.75 48.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.736 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 7.4 t0 -121.72 75.7 36.56 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.594 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -60.47 -25.81 81.38 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.521 2.147 . . . . 0.0 111.998 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -71.83 -67.9 0.5 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.255 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 49.2 p -68.95 -26.98 65.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.112 0.482 . . . . 0.0 110.079 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.93 4.09 67.48 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.585 -0.734 . . . . 0.0 113.09 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.465 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 6.0 tpt180 -127.13 121.85 32.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.239 0.52 . . . . 0.0 110.329 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.574 ' HG ' ' HD1' ' A' ' 168' ' ' TRP . 66.5 p -71.91 160.56 32.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.919 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.585 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 23.9 mmm180 -58.3 -34.34 70.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.861 0.362 . . . . 0.0 110.093 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 94.39 -0.98 66.33 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.526 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.585 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 38.7 p90 -137.96 159.04 43.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.934 0.397 . . . . 0.0 110.426 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 189' ' ' LYS . . . -153.21 171.33 32.16 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.028 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.636 ' HA ' ' O ' ' A' ' 161' ' ' MET . 73.0 m-85 -110.2 125.3 52.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.833 0.349 . . . . 0.0 110.756 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.771 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 23.5 tp -110.1 132.18 54.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.427 ' O ' HG23 ' A' ' 185' ' ' VAL . 45.7 m -121.48 145.69 47.68 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.182 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 1.007 ' CE2' HG21 ' A' ' 216' ' ' VAL . 96.9 m-85 -121.4 147.59 45.52 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.862 0.363 . . . . 0.0 111.826 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.44 -35.7 80.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.328 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.45 119.19 53.63 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.603 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.15 -29.73 76.36 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.32 2.013 . . . . 0.0 112.636 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.3 t -59.54 -37.46 78.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 0.0 110.858 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.844 ' O ' HG23 ' A' ' 216' ' ' VAL . 24.0 m -59.25 -34.87 72.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.047 0.451 . . . . 0.0 110.5 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.825 HG13 ' SD ' ' A' ' 161' ' ' MET . 70.8 t -61.1 -42.74 94.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.211 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -59.55 -43.4 93.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.921 0.391 . . . . 0.0 111.046 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.429 ' HB3' ' CE2' ' A' ' 182' ' ' TYR . 98.4 mt-10 -69.38 -35.38 75.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.368 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 1.007 HG21 ' CE2' ' A' ' 207' ' ' PHE . 99.0 t -60.91 -46.42 96.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.899 0.38 . . . . 0.0 110.829 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 230' ' ' PRO . 14.8 p -75.44 -40.01 41.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -59.11 -36.96 76.08 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 29.9 m -96.37 144.61 26.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.156 0.503 . . . . 0.0 112.077 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -92.09 125.24 36.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.851 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.64 ' CG ' ' OH ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -130.58 155.89 45.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.177 0.513 . . . . 0.0 111.39 -178.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 226' ' ' LYS . 73.5 mt -122.12 125.76 73.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.297 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.648 HD12 HD13 ' A' ' 228' ' ' ILE . 3.8 mt -103.26 125.36 49.88 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.927 0.394 . . . . 0.0 111.607 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 52.58 41.16 31.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.29 2.18 87.06 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.897 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.763 ' O ' HG23 ' A' ' 222' ' ' ILE . 21.8 mmtt -107.18 137.96 44.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.3 0.55 . . . . 0.0 111.131 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.414 HG13 ' O ' ' A' ' 227' ' ' VAL . 10.1 p -80.49 125.08 39.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.138 0.494 . . . . 0.0 111.094 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.807 HD12 ' CG2' ' A' ' 163' ' ' ILE . 34.4 pt -126.38 156.34 36.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.95 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -131.05 83.38 60.91 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.384 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.726 ' O ' HG23 ' A' ' 217' ' ' VAL . 72.8 Cg_exo -52.76 130.73 38.53 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.606 2.204 . . . . 0.0 112.061 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -136.72 144.29 43.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.0 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.431 ' HD2' ' N ' ' A' ' 233' ' ' ALA . 3.8 tmm_? -54.61 140.53 34.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.993 0.425 . . . . 0.0 111.188 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -59.74 149.17 31.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.184 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.466 HG21 ' OE1' ' A' ' 239' ' ' GLN . 3.5 tt -112.62 134.98 21.53 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.019 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.425 ' HG2' ' HB2' ' A' ' 238' ' ' GLU . 18.1 Cg_endo -59.14 144.27 99.45 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.587 1.525 . . . . 0.0 109.547 177.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.3 mmt180 -55.84 -36.57 67.66 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.745 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -60.97 -43.03 99.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.388 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.425 ' HB2' ' HG2' ' A' ' 235' ' ' PRO . 85.0 tt0 -68.43 -37.52 80.36 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.115 0.483 . . . . 0.0 110.719 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.466 ' OE1' HG21 ' A' ' 234' ' ' ILE . 57.7 tp60 -59.11 -43.58 91.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.908 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -65.46 -39.1 91.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.718 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -59.49 -39.24 83.11 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 21.1 p -90.64 161.23 15.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.178 0.513 . . . . 0.0 112.005 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.36 166.56 25.76 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.626 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.535 ' HG3' ' O ' ' A' ' 289' ' ' VAL . 39.7 ttpt -136.85 132.31 34.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.864 0.332 . . . . 0.0 111.338 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.674 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -115.74 163.76 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-O 121.282 0.563 . . . . 0.0 111.028 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.478 ' N ' ' HB2' ' A' ' 318' ' ' ALA . 89.0 t80 -100.23 137.38 38.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.67 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.683 HG12 ' O ' ' A' ' 287' ' ' GLY . 7.9 p -129.78 145.39 35.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.963 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.594 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.07 166.85 18.66 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.49 15.7 56.5 Favored Glycine 0 N--CA 1.454 -0.131 0 C-N-CA 120.015 -1.088 . . . . 0.0 112.533 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.839 HG23 HG21 ' A' ' 254' ' ' VAL . 69.8 mt -110.66 131.99 60.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.516 0.198 . . . . 0.0 110.595 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.685 ' O ' HG12 ' A' ' 254' ' ' VAL . . . -167.98 -116.29 0.36 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.239 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.82 142.13 98.63 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.623 2.216 . . . . 0.0 113.294 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 54.98 43.58 29.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.351 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.839 HG21 HG23 ' A' ' 250' ' ' ILE . 7.1 p -108.31 -50.87 7.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.239 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.525 ' N ' HG13 ' A' ' 254' ' ' VAL . 7.7 mpt_? 59.07 132.01 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.224 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.5 -27.97 52.49 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.154 1.903 . . . . 0.0 112.911 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -60.72 -48.09 83.37 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.584 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 261' ' ' GLU . 61.0 mp0 -69.3 -36.98 77.58 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.669 ' CE1' HG11 ' A' ' 247' ' ' VAL . 18.6 t80 -61.8 -49.52 75.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.649 0.262 . . . . 0.0 110.679 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.826 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.4 tt0 -64.15 -37.73 88.5 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 258' ' ' GLU . 43.0 tp10 -62.62 -39.28 93.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.669 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.846 ' CE2' HD11 ' A' ' 313' ' ' ILE . 89.8 t80 -64.87 -58.52 5.95 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 1.022 ' HB2' HD11 ' A' ' 269' ' ' ILE . 33.4 m-85 -69.7 -23.24 63.4 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 260' ' ' GLU . 30.4 t -56.57 -32.33 65.1 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -54.71 -34.23 62.1 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.8 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 8.5 p90 -119.86 56.53 0.95 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.255 0.55 . . . . 0.0 112.073 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.585 ' HA3' ' CD1' ' A' ' 291' ' ' TYR . . . 160.65 -31.74 0.37 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.786 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.574 HG22 ' O ' ' A' ' 267' ' ' GLY . 0.5 OUTLIER 85.34 2.82 0.65 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.777 0.431 . . . . 0.0 111.544 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 1.022 HD11 ' HB2' ' A' ' 263' ' ' PHE . 76.4 mt 30.13 108.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.747 HD11 ' HB3' ' A' ' 292' ' ' ASP . 32.0 mm -68.49 -36.01 72.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.486 175.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -137.45 -88.42 0.27 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.636 ' HB3' HG21 ' A' ' 269' ' ' ILE . . . 61.17 123.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.948 0.404 . . . . 0.0 111.548 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -141.37 154.92 45.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.031 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.623 ' O ' ' HB2' ' A' ' 275' ' ' MET . 20.0 tp -62.74 -37.58 87.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.259 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.775 ' HB2' ' HB3' ' A' ' 282' ' ' GLN . 93.8 mmm 93.83 176.71 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.848 0.717 . . . . 0.0 109.857 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.744 HD22 ' O ' ' A' ' 275' ' ' MET . 0.0 OUTLIER -179.43 78.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.621 0.248 . . . . 0.0 111.053 -179.816 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -84.37 109.66 18.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.935 0.398 . . . . 0.0 110.241 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.669 ' O ' HG22 ' A' ' 280' ' ' THR . 59.6 mttp 57.12 35.43 26.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.685 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.425 ' O ' ' HB ' ' A' ' 280' ' ' THR . 85.6 m-20 53.82 44.26 29.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.74 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.669 HG22 ' O ' ' A' ' 278' ' ' LYS . 1.7 t 174.98 35.16 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.726 0.298 . . . . 0.0 111.585 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -99.46 -73.33 1.07 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.696 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.775 ' HB3' ' HB2' ' A' ' 275' ' ' MET . 5.0 pp0? -59.69 -30.96 69.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.43 ' N ' ' CD ' ' A' ' 282' ' ' GLN . 85.0 p -56.85 -22.96 40.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.555 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -56.52 -33.34 65.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.249 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 250' ' ' ILE . . . 144.98 28.08 0.1 OUTLIER Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.116 -1.04 . . . . 0.0 114.733 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.537 ' CE1' ' HA ' ' A' ' 282' ' ' GLN . 17.6 p90 -141.82 165.75 26.61 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.416 1.108 . . . . 0.0 112.19 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.683 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -143.98 165.65 27.27 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.774 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.41 ' CE2' ' HE3' ' A' ' 244' ' ' LYS . 0.4 OUTLIER -116.48 127.11 54.27 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.221 0.208 . . . . 0.0 111.252 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.674 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 21.5 t -122.32 135.68 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.88 0.371 . . . . 0.0 111.924 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 52.6 m -113.84 136.02 53.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.402 178.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.585 ' CD1' ' HA3' ' A' ' 267' ' ' GLY . 31.3 m-85 -120.1 143.15 48.31 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.747 ' HB3' HD11 ' A' ' 270' ' ' ILE . 52.9 p30 -62.34 -33.97 75.74 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.329 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 293' ' ' SER . . . . . 0.65 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 50.8 m -127.04 145.18 50.81 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.147 0.499 . . . . 0.0 111.746 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.05 -30.69 71.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.933 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -56.61 -37.04 70.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.421 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.67 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -60.44 -35.46 75.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.384 . . . . 0.0 110.803 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.571 HG22 ' CG2' ' A' ' 245' ' ' ILE . 96.7 t -61.36 -44.05 97.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.155 0.502 . . . . 0.0 110.527 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.75 -36.8 84.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.129 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -57.55 -43.51 84.51 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.8 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 0.7 OUTLIER -72.2 -32.25 42.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.919 0.39 . . . . 0.0 110.973 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 81.6 m -56.29 -44.74 80.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.269 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -62.42 -40.2 95.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.271 0.558 . . . . 0.0 110.054 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -63.4 -34.47 77.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.419 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.675 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 15.9 tptm 66.11 -72.7 0.08 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.803 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.675 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 16.3 m-85 -111.17 127.79 55.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.334 0.588 . . . . 0.0 111.682 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.72 HD11 HG23 ' A' ' 300' ' ' VAL . 1.4 mt -118.22 138.99 47.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.584 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.425 ' OD1' ' CE ' ' A' ' 312' ' ' LYS . 73.4 m-20 -76.47 110.98 11.46 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.323 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.658 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 6.0 t80 -108.11 -70.16 0.82 Allowed 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.601 0.715 . . . . 0.0 110.063 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.474 ' HD3' ' CE2' ' A' ' 308' ' ' PHE . 0.0 OUTLIER -106.91 -158.5 0.66 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.169 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -54.88 -32.88 61.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.818 0.342 . . . . 0.0 110.789 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -113.85 153.16 29.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.012 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.425 ' CE ' ' OD1' ' A' ' 307' ' ' ASP . 18.8 mmtp -67.18 152.46 45.71 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.043 0.449 . . . . 0.0 111.008 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.846 HD11 ' CE2' ' A' ' 262' ' ' PHE . 27.7 pt -114.1 132.22 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -95.2 131.45 41.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 0.638 HD13 ' CE2' ' A' ' 263' ' ' PHE . 74.4 mt -118.76 125.26 74.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.429 0.633 . . . . 0.0 112.488 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -132.8 155.65 48.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.908 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -55.3 144.96 23.18 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.574 ' O ' ' CB ' ' A' ' 319' ' ' GLU . . . -94.67 131.62 40.27 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 319' ' ' GLU . . . . . 0.574 ' CB ' ' O ' ' A' ' 318' ' ' ALA . 4.4 tm-20 . . . . . 0 N--CA 1.467 0.39 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.984 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.463 0.197 0 CA-C-O 120.813 0.34 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.433 ' HG2' ' CB ' ' A' ' 233' ' ' ALA . 74.5 tttt -129.99 142.13 50.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.062 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.586 ' HE2' HG11 ' A' ' 216' ' ' VAL . 87.4 mmm -118.84 148.69 42.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.451 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.576 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 4.2 t80 -107.03 129.05 54.86 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.958 HG23 HD12 ' A' ' 228' ' ' ILE . 7.7 mm -116.64 125.05 73.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.783 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 228' ' ' ILE . . . -125.63 158.79 20.04 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 178.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.43 33.37 53.11 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.194 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 83.0 mt -59.38 -18.63 40.42 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.785 ' O ' ' N ' ' A' ' 169' ' ' ASP . 58.2 t30 73.5 41.97 0.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -177.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 9.5 m0 41.32 -55.65 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.858 -1.064 . . . . 0.0 113.823 178.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.785 ' N ' ' O ' ' A' ' 167' ' ' ASN . 52.9 p30 -58.02 -31.2 66.74 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.521 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 86.2 m -65.56 138.11 57.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.248 0.547 . . . . 0.0 111.293 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.445 ' C ' HD12 ' A' ' 190' ' ' ILE . 9.3 p -117.64 166.93 11.82 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.345 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.928 ' N ' HD12 ' A' ' 190' ' ' ILE . 20.8 pt-20 -60.73 -25.78 66.69 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.676 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 90.6 m-20 -61.37 -43.69 98.44 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.133 0.492 . . . . 0.0 110.095 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -67.36 -37.65 83.53 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.861 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.581 HD23 ' CE2' ' A' ' 179' ' ' PHE . 3.3 mt -58.43 -43.73 88.86 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.676 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -67.02 -36.72 82.75 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.295 179.202 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.433 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 48.6 tp10 -64.56 -40.91 96.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.065 0.46 . . . . 0.0 110.411 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 59.4 t80 -74.93 -61.68 1.8 Allowed 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.604 0.716 . . . . 0.0 111.111 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.88 ' HZ ' HD11 ' A' ' 228' ' ' ILE . 80.1 m-85 -70.68 -15.7 62.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.514 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.71 -27.76 20.67 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.243 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.828 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -57.5 -41.93 81.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.107 0.479 . . . . 0.0 110.431 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.828 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 68.6 m-85 -70.39 -35.56 73.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.841 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -177.09 -176.65 45.39 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.464 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.521 ' C ' HG13 ' A' ' 185' ' ' VAL . 44.2 m -64.53 -30.75 71.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.123 -0.538 . . . . 0.0 111.476 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.631 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 0.6 OUTLIER 65.54 90.14 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 121.854 0.835 . . . . 0.0 108.91 -177.526 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.0 t -59.23 -44.02 92.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.915 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -139.72 136.26 34.01 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.464 HD23 ' CG2' ' A' ' 185' ' ' VAL . 0.3 OUTLIER -117.58 133.04 56.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.316 178.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.567 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 9.1 tptp -134.01 120.95 20.91 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.928 HD12 ' N ' ' A' ' 172' ' ' GLU . 0.4 OUTLIER -128.24 134.08 65.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.361 176.662 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.543 ' CE ' ' HA2' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -90.47 140.03 30.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.746 -179.078 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -133.31 168.48 18.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.919 0.39 . . . . 0.0 111.377 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 7.4 m-20 -117.7 93.92 44.77 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.383 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.53 -24.64 29.46 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.335 2.024 . . . . 0.0 112.693 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -75.55 -83.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.673 0.273 . . . . 0.0 111.449 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 63.2 p -71.77 -24.13 61.7 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.443 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 92.47 7.15 63.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.772 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 4.2 tpt180 -82.22 154.25 25.52 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.946 0.403 . . . . 0.0 110.781 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 28.3 t -105.69 146.84 29.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.718 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.648 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 34.2 mmt180 -54.33 -30.89 52.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.894 0.378 . . . . 0.0 110.296 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.418 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 97.25 -2.02 60.96 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.237 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.648 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 39.7 p90 -139.4 155.57 47.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.058 0.456 . . . . 0.0 110.387 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.543 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -148.31 169.28 28.97 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.664 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.576 ' CE2' ' CD1' ' A' ' 162' ' ' PHE . 95.9 m-85 -107.84 125.76 51.83 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.083 0.468 . . . . 0.0 109.945 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.627 HD22 ' CE2' ' A' ' 207' ' ' PHE . 6.0 tt -108.42 128.56 54.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.577 -178.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.547 ' N ' HD23 ' A' ' 205' ' ' LEU . 49.9 m -120.34 142.53 49.05 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.331 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.649 ' CE2' HG21 ' A' ' 216' ' ' VAL . 84.8 m-85 -119.14 141.21 49.02 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.712 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.06 -35.51 80.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.166 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -108.17 117.37 55.04 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.756 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 0.885 ' O ' HG12 ' A' ' 213' ' ' VAL . 45.5 Cg_exo -56.74 -26.38 65.6 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.563 2.175 . . . . 0.0 113.276 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 85.7 p -61.78 -32.35 72.61 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.325 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.62 ' O ' HG23 ' A' ' 216' ' ' VAL . 24.7 m -60.31 -35.5 75.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.809 0.338 . . . . 0.0 110.706 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.885 HG12 ' O ' ' A' ' 210' ' ' PRO . 2.6 p -58.85 -35.34 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.981 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.454 ' O ' HG22 ' A' ' 217' ' ' VAL . 20.4 t70 -59.06 -44.63 91.86 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.008 0.432 . . . . 0.0 110.73 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -68.25 -33.07 73.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.58 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.945 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 99.0 t -58.97 -40.68 81.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.261 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 214' ' ' ASP . 24.2 m -77.73 -29.85 16.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.16 -0.616 . . . . 0.0 112.062 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -60.15 -38.78 84.17 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.779 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 60.4 m -91.48 146.59 23.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.761 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.498 ' HG2' HG21 ' A' ' 227' ' ' VAL . 63.4 tt0 -67.13 -42.0 85.19 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.529 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.945 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 57.8 m-70 74.95 96.04 0.07 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 72.3 mt -113.53 115.81 50.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.492 HD23 ' CG ' ' A' ' 224' ' ' ASP . 6.6 tt -123.77 126.07 45.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.008 0.433 . . . . 0.0 111.148 -178.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.492 ' CG ' HD23 ' A' ' 223' ' ' LEU . 86.6 m-20 54.63 42.45 31.25 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 91.0 -30.95 5.88 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.612 -0.804 . . . . 0.0 114.33 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -103.13 155.82 18.14 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 221' ' ' HIS . 11.9 p -102.81 124.48 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.958 HD12 HG23 ' A' ' 163' ' ' ILE . 17.8 pt -84.94 -26.9 6.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -177.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 23.7 t70 52.37 70.58 1.81 Allowed Pre-proline 0 C--N 1.318 -0.802 0 CA-C-O 121.532 0.682 . . . . 0.0 110.802 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.677 ' HD2' ' CD2' ' A' ' 221' ' ' HIS . 43.6 Cg_exo -58.83 136.39 73.32 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.942 3.095 . . . . 0.0 112.122 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.406 ' N ' ' HE3' ' A' ' 161' ' ' MET . 14.1 ttpt -138.35 150.11 46.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.351 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -48.35 147.17 2.45 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 110.789 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.433 ' CB ' ' HG2' ' A' ' 160' ' ' LYS . . . -98.0 145.0 26.94 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.209 0.528 . . . . 0.0 112.199 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.853 HD11 ' OD2' ' A' ' 271' ' ' ASP . 0.7 OUTLIER -110.9 126.22 29.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.13 179.3 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.561 ' HB2' ' OE1' ' A' ' 238' ' ' GLU . 36.8 Cg_exo -54.49 152.54 26.29 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.492 1.462 . . . . 0.0 110.549 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -52.32 -37.83 56.96 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -57.88 -43.57 86.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.886 ' O ' HG23 ' A' ' 242' ' ' THR . 58.9 mp0 -67.9 -36.99 81.17 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.705 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -59.98 -38.15 81.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.988 0.423 . . . . 0.0 110.732 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -61.2 -37.21 82.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.543 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -88.44 4.26 47.07 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.886 HG23 ' O ' ' A' ' 238' ' ' GLU . 16.7 p -121.33 160.86 23.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.052 0.453 . . . . 0.0 112.021 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.27 167.52 25.18 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.606 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.575 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 78.2 tttt -136.57 137.21 39.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.209 0.505 . . . . 0.0 110.905 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.62 HD12 ' CG2' ' A' ' 315' ' ' ILE . 7.1 pt -120.31 157.54 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.39 0.614 . . . . 0.0 112.126 -178.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.422 ' CE1' ' CD2' ' A' ' 286' ' ' PHE . 81.0 t80 -94.78 130.34 41.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.96 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.981 HG21 ' CZ ' ' A' ' 263' ' ' PHE . 57.2 t -124.6 133.17 70.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.643 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.701 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -119.98 166.96 13.51 Favored Glycine 0 C--O 1.225 -0.445 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.746 ' O ' HG22 ' A' ' 313' ' ' ILE . . . 94.54 13.36 53.98 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.132 -1.033 . . . . 0.0 112.103 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.556 HG23 HG11 ' A' ' 254' ' ' VAL . 67.4 mt -108.84 130.61 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 120.812 0.339 . . . . 0.0 110.491 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.827 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -165.27 -119.11 0.46 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.544 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.38 144.08 96.77 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 122.313 2.009 . . . . 0.0 113.137 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 57.34 45.68 19.67 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.827 HG22 ' O ' ' A' ' 251' ' ' GLY . 16.1 m -118.33 -50.89 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.388 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.521 ' N ' HG23 ' A' ' 254' ' ' VAL . 9.8 mmt180 62.83 130.25 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.195 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.68 -28.62 47.6 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 121.98 1.787 . . . . 0.0 112.194 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 12.7 tptp -60.6 -44.14 96.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.142 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.578 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 79.3 mm-40 -66.91 -39.77 87.48 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.84 0.352 . . . . 0.0 111.085 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.599 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 30.5 t80 -63.25 -48.01 80.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.537 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.427 ' O ' ' CD1' ' A' ' 269' ' ' ILE . 84.3 tt0 -64.46 -42.74 95.76 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.36 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.406 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.9 pt-20 -76.7 -28.85 56.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.83 0.348 . . . . 0.0 110.81 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.874 ' CE2' HD11 ' A' ' 313' ' ' ILE . 12.8 t80 -60.66 -55.59 31.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.169 0.509 . . . . 0.0 111.39 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.981 ' CZ ' HG21 ' A' ' 247' ' ' VAL . 10.4 m-85 -69.64 -22.45 63.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.994 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.707 ' N ' HD11 ' A' ' 269' ' ' ILE . 27.8 t -57.22 -30.94 65.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.892 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -54.04 -36.11 62.71 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.754 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 7.3 p90 -117.76 41.36 2.88 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.763 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.496 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 159.92 147.93 5.07 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.985 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.423 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 52.5 m -59.52 -36.85 76.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 0.0 111.285 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.707 HD11 ' N ' ' A' ' 264' ' ' SER . 69.8 mt 68.81 78.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.395 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.545 ' O ' ' OD1' ' A' ' 271' ' ' ASP . 32.1 mm -58.91 -45.59 91.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.449 -0.5 . . . . 0.0 112.094 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.853 ' OD2' HD11 ' A' ' 234' ' ' ILE . 83.4 m-20 -151.26 90.7 1.61 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.583 ' HB2' HG23 ' A' ' 269' ' ' ILE . . . -106.03 132.62 51.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.528 0.204 . . . . 0.0 110.506 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -145.61 151.61 38.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.285 0.564 . . . . 0.0 111.885 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.59 ' O ' ' HB2' ' A' ' 275' ' ' MET . 26.3 tp -66.05 -36.57 83.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.713 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.59 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 96.0 mmm 84.13 114.28 0.05 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.513 -178.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.484 HD12 ' N ' ' A' ' 276' ' ' LEU . 5.1 mp -122.39 138.58 54.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.744 0.306 . . . . 0.0 111.418 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.469 ' HB2' ' HA3' ' A' ' 281' ' ' GLY . 85.0 m-20 -129.4 100.39 5.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.084 0.469 . . . . 0.0 110.679 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.738 ' O ' HG22 ' A' ' 280' ' ' THR . 94.3 mttt 63.48 35.99 11.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.17 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.429 ' O ' ' HB ' ' A' ' 280' ' ' THR . 85.8 m-20 51.45 43.82 29.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.75 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 278' ' ' LYS . 0.9 OUTLIER 169.86 47.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.041 0.448 . . . . 0.0 110.753 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 281' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' A' ' 277' ' ' ASP . . . -139.53 -105.38 0.64 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.135 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.448 ' OE1' ' HB3' ' A' ' 275' ' ' MET . 96.5 mt-30 -56.85 -27.04 59.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.209 -0.496 . . . . 0.0 111.525 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.561 ' O ' HD21 ' A' ' 274' ' ' LEU . 83.3 p -53.18 -24.63 11.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.95 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -118.58 136.89 53.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.652 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 105.96 -57.95 0.46 Allowed Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.573 -0.823 . . . . 0.0 114.242 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 247' ' ' VAL . 32.5 p90 -140.72 166.77 23.84 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.757 0.779 . . . . 0.0 112.652 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -135.93 154.83 22.04 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.461 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.575 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -110.22 129.89 55.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.747 0.308 . . . . 0.0 111.711 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.67 HG21 ' CD2' ' A' ' 263' ' ' PHE . 55.1 t -124.48 134.84 65.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.978 0.418 . . . . 0.0 111.901 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 63.0 m -115.48 135.75 53.79 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.496 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 38.9 m-85 -117.04 139.51 50.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.511 ' CA ' HG12 ' A' ' 270' ' ' ILE . 51.1 t0 -58.22 -36.53 73.28 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.421 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 49.1 m -123.66 144.2 49.78 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.318 0.58 . . . . 0.0 112.053 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.92 -30.61 71.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.693 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -56.26 -37.53 69.91 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.005 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -61.21 -36.65 80.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.011 0.434 . . . . 0.0 110.403 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.583 HG13 HG21 ' A' ' 245' ' ' ILE . 75.1 t -61.74 -42.82 95.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.234 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -61.5 -37.68 84.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.53 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -59.06 -44.09 91.8 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.965 HG23 HD11 ' A' ' 306' ' ' ILE . 0.8 OUTLIER -71.9 -33.04 46.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.175 -179.654 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 89.0 m -57.88 -45.6 86.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.142 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -61.09 -41.46 96.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.254 0.549 . . . . 0.0 110.018 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -61.91 -33.05 73.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.211 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.648 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 31.8 tptt 68.16 -74.21 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -178.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.648 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.0 m-30 -113.31 141.55 46.88 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.424 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.965 HD11 HG23 ' A' ' 300' ' ' VAL . 34.6 mt -116.98 136.65 53.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -75.09 79.82 2.25 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.367 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.531 ' CD2' HD13 ' A' ' 313' ' ' ILE . 9.1 t80 -83.17 -105.7 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.978 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 310' ' ' ASP . 4.2 mmpt? -60.71 -34.96 75.17 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 309' ' ' LYS . 52.2 p30 137.78 0.17 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.997 0.919 . . . . 0.0 111.142 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 312' ' ' LYS . 73.3 mtt85 -98.18 4.44 48.96 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.451 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 95.1 mttt 65.04 54.07 1.29 Allowed 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.109 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.874 HD11 ' CE2' ' A' ' 262' ' ' PHE . 20.3 pt -50.14 99.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.777 0.799 . . . . 0.0 110.784 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 314' ' ' GLU . . . . . 0.567 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 92.4 mt-10 -60.91 139.53 57.97 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.19 -178.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 0.772 HG23 HG22 ' A' ' 247' ' ' VAL . 63.2 mt -121.65 128.14 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.009 0.433 . . . . 0.0 111.065 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -133.85 142.78 47.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.112 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 21.7 ttp-105 -50.8 146.74 5.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.699 0.285 . . . . 0.0 110.624 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.23 143.51 27.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.402 . . . . 0.0 111.131 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.358 -179.394 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.469 0.478 0 CA-C-O 120.846 0.355 . . . . 0.0 111.881 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.484 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 21.8 tttt -96.2 137.5 35.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.499 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.64 ' HE2' ' HB ' ' A' ' 216' ' ' VAL . 8.5 tpp -114.36 145.4 41.87 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.637 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 6.8 t80 -102.85 131.85 49.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.925 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.112 HG22 HD11 ' A' ' 166' ' ' LEU . 17.5 mm -116.63 132.37 66.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.354 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.582 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -123.59 156.64 17.9 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.294 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.31 34.95 44.2 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.407 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 1.112 HD11 HG22 ' A' ' 163' ' ' ILE . 4.4 mp -92.62 141.75 28.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.638 0.256 . . . . 0.0 110.732 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.16 135.44 57.72 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.546 ' CD1' ' O ' ' A' ' 199' ' ' SER . 4.3 m0 -53.91 -33.66 57.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.794 0.331 . . . . 0.0 110.754 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -93.22 9.72 34.91 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.422 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' THR . . . . . 1.131 HG21 HD21 ' A' ' 223' ' ' LEU . 98.5 m -56.98 -40.54 76.72 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.49 HG23 ' C ' ' A' ' 170' ' ' THR . 0.1 OUTLIER 54.32 162.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -177.322 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.532 ' O ' ' HD3' ' A' ' 176' ' ' ARG . 57.2 mp0 -62.73 -28.56 70.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.113 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.575 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 92.6 m-20 -55.47 -43.44 75.53 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -67.46 -36.95 82.17 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 1.009 HD22 HD21 ' A' ' 205' ' ' LEU . 6.1 mt -56.38 -48.39 76.97 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.575 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -68.42 -30.36 69.24 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.333 179.15 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -56.89 -39.4 74.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.577 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.792 ' HD2' HD12 ' A' ' 223' ' ' LEU . 0.0 OUTLIER -96.37 -59.47 1.82 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.967 0.413 . . . . 0.0 110.092 178.965 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.635 ' CE2' HD23 ' A' ' 175' ' ' LEU . 70.9 m-85 -59.87 -31.95 70.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.544 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.13 -25.37 7.75 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.11 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.825 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -56.41 -41.19 75.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.775 0.321 . . . . 0.0 111.487 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.825 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 69.8 m-85 -70.56 -35.74 73.25 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -174.66 -177.54 43.87 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.475 -1.345 . . . . 0.0 114.195 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 61.1 m -62.73 -34.38 77.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.699 -0.75 . . . . 0.0 111.867 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.848 HG23 ' CE1' ' A' ' 207' ' ' PHE . 0.5 OUTLIER 67.15 106.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.645 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.76 HG23 ' N ' ' A' ' 208' ' ' GLU . 43.3 p -64.78 -36.79 85.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.983 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -154.01 150.65 28.49 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.473 HD23 HG11 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -118.47 133.66 55.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.348 179.188 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 10.5 tptt -133.48 119.09 19.13 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 172' ' ' GLU . 0.8 OUTLIER -128.58 137.66 56.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.034 177.506 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.566 ' HB2' ' HB2' ' A' ' 200' ' ' ARG . 0.3 OUTLIER -96.19 127.53 42.28 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.857 -179.525 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -131.95 155.52 47.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.983 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.601 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 15.2 t0 -120.55 80.82 31.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.442 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.09 -24.85 42.49 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.52 2.147 . . . . 0.0 112.642 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.79 -70.52 0.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.867 0.365 . . . . 0.0 111.111 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 49.4 p -73.08 -20.56 60.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.812 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 84.87 19.72 59.06 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.53 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.601 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 8.3 tpt180 -115.6 151.92 34.05 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 120.756 0.312 . . . . 0.0 110.466 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.546 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 49.1 m -117.34 153.4 33.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.904 0.383 . . . . 0.0 110.809 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.653 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 30.5 mmt180 -54.34 -34.5 61.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 110.961 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 166' ' ' LEU . . . 90.71 5.61 68.59 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.231 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.962 ' HA ' HD13 ' A' ' 166' ' ' LEU . 22.5 p90 -140.36 158.92 43.29 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.881 0.372 . . . . 0.0 110.641 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.456 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -143.02 162.9 27.47 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.402 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.637 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 95.8 m-85 -109.68 129.59 55.59 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.867 0.365 . . . . 0.0 110.199 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 1.009 HD21 HD22 ' A' ' 175' ' ' LEU . 61.1 mt -104.54 141.21 36.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.778 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 186' ' ' THR . 18.0 t -127.94 128.37 44.98 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.848 ' CE1' HG23 ' A' ' 185' ' ' VAL . 98.1 m-85 -120.41 143.08 48.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.14 0.495 . . . . 0.0 112.073 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.76 ' N ' HG23 ' A' ' 186' ' ' THR . 47.3 tp10 -62.14 -34.37 76.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.063 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -110.83 116.23 52.29 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.4 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.7 -30.59 76.31 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.454 2.103 . . . . 0.0 113.064 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.418 ' O ' ' OD1' ' A' ' 214' ' ' ASP . 25.6 m -59.39 -35.51 74.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.626 0.25 . . . . 0.0 110.926 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.821 ' O ' HG23 ' A' ' 216' ' ' VAL . 24.8 m -57.01 -34.61 68.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.131 0.491 . . . . 0.0 109.898 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.51 HG11 ' CD ' ' A' ' 232' ' ' ARG . 83.5 t -63.49 -38.4 82.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.678 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.695 ' OD1' ' N ' ' A' ' 215' ' ' GLU . 36.4 p30 -60.35 -39.4 87.0 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.746 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.695 ' N ' ' OD1' ' A' ' 214' ' ' ASP . 97.8 mt-10 -70.95 -35.52 72.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.527 0.68 . . . . 0.0 110.714 177.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 212' ' ' SER . 93.9 t -60.44 -36.88 72.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.528 -178.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 230' ' ' PRO . 6.5 p -87.21 -54.22 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.493 ' N ' HG13 ' A' ' 217' ' ' VAL . 26.2 mttt -60.44 -36.74 78.93 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.424 ' HB ' ' CE1' ' A' ' 221' ' ' HIS . 62.0 m -58.26 -37.75 75.58 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 63.86 110.56 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -177.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.723 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 0.0 OUTLIER -137.98 175.13 9.86 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -176.037 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.861 HG23 ' O ' ' A' ' 226' ' ' LYS . 17.8 mm -115.36 120.25 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.75 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 1.131 HD21 HG21 ' A' ' 170' ' ' THR . 18.8 tp -69.64 -43.81 71.89 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.644 -0.423 . . . . 0.0 112.017 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -177.36 69.68 0.02 OUTLIER 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.741 0.305 . . . . 0.0 111.774 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 95.21 -8.09 69.54 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.467 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.861 ' O ' HG23 ' A' ' 222' ' ' ILE . 76.2 mttt -124.08 157.76 33.81 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 117.036 0.418 . . . . 0.0 111.584 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.91 HG21 ' OD2' ' A' ' 279' ' ' ASP . 44.3 t -93.88 126.95 46.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.165 0.507 . . . . 0.0 110.26 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.63 HD13 ' HB2' ' A' ' 223' ' ' LEU . 31.6 pt -126.87 155.98 37.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.048 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 8.7 p30 -132.15 81.57 61.15 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 121.191 0.519 . . . . 0.0 110.421 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.771 ' O ' HG23 ' A' ' 217' ' ' VAL . 92.8 Cg_exo -47.51 127.02 13.05 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.72 2.28 . . . . 0.0 111.345 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -132.45 144.96 50.83 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.684 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.51 ' CD ' HG11 ' A' ' 213' ' ' VAL . 57.3 mmm-85 -50.06 143.1 8.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.202 0.525 . . . . 0.0 111.269 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -68.62 150.08 48.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.787 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 34.4 mt -117.44 140.4 27.32 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.935 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.475 ' HD2' ' OE1' ' A' ' 238' ' ' GLU . 45.0 Cg_exo -55.26 139.84 81.27 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 121.758 1.639 . . . . 0.0 111.229 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.449 ' O ' ' HD3' ' A' ' 236' ' ' ARG . 3.2 tmt_? -56.83 -41.12 77.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.728 0.299 . . . . 0.0 111.123 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -60.01 -39.35 85.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.368 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.503 ' O ' HG23 ' A' ' 242' ' ' THR . 94.8 mt-10 -63.66 -32.62 74.16 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.701 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 30.9 mm100 -58.24 -38.52 77.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.998 0.428 . . . . 0.0 110.213 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -61.06 -42.33 98.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.223 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -63.15 -36.0 82.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.461 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 238' ' ' GLU . 21.0 p -83.26 161.44 21.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.155 0.502 . . . . 0.0 111.897 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.94 169.99 25.07 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.609 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.539 ' CE ' ' CD2' ' A' ' 288' ' ' PHE . 46.9 tptt -134.71 130.36 36.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.861 0.331 . . . . 0.0 110.706 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.656 HD12 HG21 ' A' ' 315' ' ' ILE . 5.5 pt -123.5 154.84 29.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 121.11 0.481 . . . . 0.0 110.65 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.431 ' CE1' ' CD2' ' A' ' 286' ' ' PHE . 92.9 t80 -97.28 133.37 42.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.651 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.752 HG21 ' CZ ' ' A' ' 263' ' ' PHE . 21.4 t -121.42 139.36 48.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.032 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.595 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -129.02 171.93 19.77 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.18 36.9 16.56 Favored Glycine 0 C--N 1.323 -0.181 0 C-N-CA 120.071 -1.061 . . . . 0.0 111.901 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.866 HG22 HG21 ' A' ' 254' ' ' VAL . 69.8 mt -111.66 132.32 60.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.598 0.237 . . . . 0.0 110.81 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.862 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -158.16 -119.59 0.57 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.246 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.63 140.58 95.45 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.38 2.053 . . . . 0.0 113.482 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 54.15 44.06 29.74 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.402 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.866 HG21 HG22 ' A' ' 250' ' ' ILE . 22.4 m -121.04 27.77 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.529 ' HG3' ' HD2' ' A' ' 256' ' ' PRO . 0.2 OUTLIER -39.96 155.12 0.18 Allowed Pre-proline 0 N--CA 1.465 0.304 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.529 ' HD2' ' HG3' ' A' ' 255' ' ' ARG . 7.5 Cg_endo -50.19 -29.47 22.77 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.051 1.834 . . . . 0.0 112.128 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -62.05 -45.72 92.31 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.036 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -68.29 -42.11 79.97 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.101 0.477 . . . . 0.0 111.066 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.468 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 35.3 t80 -66.13 -47.2 74.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.294 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.733 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.4 tt0 -64.9 -41.37 95.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.333 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -75.01 -31.98 61.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.613 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.685 ' CE2' HD11 ' A' ' 313' ' ' ILE . 83.4 t80 -59.51 -55.61 32.42 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.818 ' CB ' HD11 ' A' ' 269' ' ' ILE . 25.3 m-85 -66.85 -30.65 70.88 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.537 ' HA ' HG13 ' A' ' 269' ' ' ILE . 16.5 m -56.01 -27.43 52.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.758 0.313 . . . . 0.0 111.194 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -51.89 -38.04 54.66 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.745 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 19.9 p90 -110.84 48.08 0.94 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.586 0.708 . . . . 0.0 111.954 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 133.28 149.08 6.04 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.313 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 53.4 m -69.76 131.85 45.18 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.818 HD11 ' CB ' ' A' ' 263' ' ' PHE . 49.6 mt -94.44 135.92 27.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.005 0.431 . . . . 0.0 111.395 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' A' ' 292' ' ' ASP . 27.3 mm -92.38 -75.09 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.49 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 272' ' ' ALA . 90.4 m-20 -93.0 -75.51 0.49 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.489 ' HB3' HG21 ' A' ' 269' ' ' ILE . . . 42.79 108.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -140.64 157.73 45.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.222 0.534 . . . . 0.0 111.68 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.573 ' O ' ' HB2' ' A' ' 275' ' ' MET . 25.9 tp -62.17 -37.39 85.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.537 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.709 ' O ' HD23 ' A' ' 276' ' ' LEU . 84.9 mtp 86.27 128.26 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.95 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 275' ' ' MET . 31.9 mt -130.14 120.9 25.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.853 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.444 ' O ' ' HG3' ' A' ' 278' ' ' LYS . 55.1 t0 -61.0 -41.75 97.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.213 0.53 . . . . 0.0 110.192 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.542 ' O ' HG22 ' A' ' 280' ' ' THR . 98.8 mttt -165.28 59.09 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.975 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.91 ' OD2' HG21 ' A' ' 227' ' ' VAL . 83.7 m-20 58.17 44.62 18.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.739 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 278' ' ' LYS . 1.5 t -178.66 -34.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.401 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 276' ' ' LEU . . . -83.39 178.48 52.71 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.436 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.486 ' OE1' ' HB3' ' A' ' 275' ' ' MET . 98.1 mt-30 42.9 21.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.483 ' O ' HD21 ' A' ' 274' ' ' LEU . 94.0 p -80.54 -30.82 37.1 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -134.36 154.04 51.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.362 0.601 . . . . 0.0 112.463 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.13 -40.94 2.27 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.041 -0.981 . . . . 0.0 114.422 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.664 ' C ' HD12 ' A' ' 250' ' ' ILE . 12.4 p90 -149.0 165.55 31.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.792 0.796 . . . . 0.0 111.556 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.788 ' N ' HD12 ' A' ' 250' ' ' ILE . . . -138.99 153.79 22.94 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.975 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.539 ' CD2' ' CE ' ' A' ' 244' ' ' LYS . 0.3 OUTLIER -109.59 127.38 54.47 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.594 0.358 . . . . 0.0 110.364 179.255 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.556 HG21 ' CG ' ' A' ' 263' ' ' PHE . 38.5 t -125.32 135.45 63.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.453 ' OG1' ' CD ' ' A' ' 244' ' ' LYS . 47.5 m -120.27 136.52 54.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.313 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.407 ' OH ' ' O ' ' A' ' 263' ' ' PHE . 40.5 m-85 -116.21 138.4 51.32 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.617 ' HB2' HD11 ' A' ' 270' ' ' ILE . 51.4 t0 -57.3 -36.35 70.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.507 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 50.6 m -122.37 145.04 48.64 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.247 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.83 -27.84 68.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.649 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -55.56 -38.42 69.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.626 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.44 -37.38 85.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.977 0.417 . . . . 0.0 110.901 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.566 HG13 ' CG2' ' A' ' 245' ' ' ILE . 73.1 t -62.71 -43.66 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.258 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -61.58 -38.66 88.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.29 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -59.51 -43.32 93.41 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.895 HG23 HD11 ' A' ' 306' ' ' ILE . 1.2 p -70.92 -33.04 50.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.466 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 81.6 m -57.5 -45.63 84.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.278 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -61.76 -42.2 98.68 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.207 0.527 . . . . 0.0 110.364 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.9 m-20 -63.04 -35.25 79.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.607 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.677 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 16.2 tptm 67.58 -67.79 0.17 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.677 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 16.1 m-85 -114.97 133.35 56.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.166 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.895 HD11 HG23 ' A' ' 300' ' ' VAL . 14.8 mt -121.45 140.17 46.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.92 178.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.54 ' OD1' ' O ' ' A' ' 307' ' ' ASP . 50.7 p30 -77.1 110.21 11.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.224 0.535 . . . . 0.0 110.884 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.637 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 7.9 t80 -110.21 -79.65 0.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.543 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.463 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 6.7 mmpt? -97.89 -162.4 0.95 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.505 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -52.76 -28.97 24.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.759 0.314 . . . . 0.0 110.456 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -109.99 152.66 25.61 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.534 ' HG2' ' HB3' ' A' ' 305' ' ' PHE . 14.2 tttp -75.29 139.99 42.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.527 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.685 HD11 ' CE2' ' A' ' 262' ' ' PHE . 27.4 pt -105.49 136.63 38.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.236 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 314' ' ' GLU . . . . . 0.434 ' HB2' ' CE2' ' A' ' 305' ' ' PHE . 84.5 tt0 -101.25 131.32 47.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.651 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 0.683 HD13 ' CE2' ' A' ' 263' ' ' PHE . 66.0 mt -119.48 127.51 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-O 121.052 0.454 . . . . 0.0 111.2 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -131.34 144.7 51.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.482 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -49.62 146.19 4.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.017 0.437 . . . . 0.0 111.065 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.32 147.36 36.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.632 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.938 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.4 m . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 120.698 0.285 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 205' ' ' LEU . 37.6 ttpt -89.49 136.59 32.94 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.099 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.805 ' SD ' HG13 ' A' ' 213' ' ' VAL . 29.0 mtm -124.86 164.14 20.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.147 0.499 . . . . 0.0 111.239 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.578 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 1.8 t80 -98.49 130.01 45.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.302 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.805 HG23 HD12 ' A' ' 228' ' ' ILE . 47.0 mt -119.28 127.73 75.84 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.67 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.705 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.645 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -127.27 165.63 20.35 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.73 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.13 34.71 40.66 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.962 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.556 HD22 HG21 ' A' ' 170' ' ' THR . 73.9 mt -59.25 -22.89 61.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.474 ' CB ' ' HG3' ' A' ' 226' ' ' LYS . 51.8 t30 75.59 39.61 0.33 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.198 0.523 . . . . 0.0 109.751 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 20.4 m0 33.53 35.22 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.143 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -153.94 8.2 0.35 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.556 HG21 HD22 ' A' ' 166' ' ' LEU . 55.4 m -78.71 137.16 37.65 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.372 0.606 . . . . 0.0 110.392 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.52 HG23 ' HZ1' ' A' ' 192' ' ' LYS . 30.5 m -116.42 145.02 43.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.825 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.554 ' N ' HD12 ' A' ' 190' ' ' ILE . 55.4 mp0 -55.66 -36.46 67.1 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.146 -0.621 . . . . 0.0 109.646 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.541 ' O ' ' HG2' ' A' ' 176' ' ' ARG . 89.6 m-20 -65.43 -48.29 73.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.973 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -67.25 -40.8 86.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.609 0.718 . . . . 0.0 110.158 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.835 HD22 HD11 ' A' ' 190' ' ' ILE . 65.8 tp -64.68 -41.42 96.06 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.107 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.541 ' HG2' ' O ' ' A' ' 173' ' ' ASP . 41.2 ptt85 -69.66 -40.03 76.68 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.395 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 173' ' ' ASP . 75.4 mm-40 -65.12 -37.86 88.8 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.037 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.439 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 65.2 t80 -61.72 -54.53 41.33 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.416 0.627 . . . . 0.0 110.135 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.607 ' HZ ' HD11 ' A' ' 228' ' ' ILE . 86.6 m-85 -73.58 -21.83 60.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.703 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.41 -26.54 22.86 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.222 -0.99 . . . . 0.0 110.847 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.507 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -54.91 -41.49 71.03 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 123.752 0.821 . . . . 0.0 111.072 179.211 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -69.02 -32.59 72.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.099 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 174.94 -125.34 1.08 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.306 -0.95 . . . . 0.0 112.702 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 57.1 m -117.44 143.33 46.13 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.903 HG21 ' CD2' ' A' ' 188' ' ' LEU . 15.0 p -109.8 135.07 49.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.715 0.293 . . . . 0.0 110.238 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.452 HG23 ' CB ' ' A' ' 206' ' ' SER . 0.5 OUTLIER -95.79 -47.58 6.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.928 -179.18 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.418 ' HB3' ' HB3' ' A' ' 206' ' ' SER . 59.6 t0 -136.6 132.19 34.76 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.281 0.562 . . . . 0.0 112.488 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.903 ' CD2' HG21 ' A' ' 185' ' ' VAL . 0.3 OUTLIER -116.22 129.72 56.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.58 179.278 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 11.7 tptt -137.03 116.07 12.41 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.835 HD11 HD22 ' A' ' 175' ' ' LEU . 55.1 mt -126.74 126.26 68.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.989 176.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.547 ' SD ' ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -86.03 114.95 23.31 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.52 ' HZ1' HG23 ' A' ' 171' ' ' THR . 69.5 mttt -117.84 153.35 33.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.856 0.36 . . . . 0.0 111.458 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.591 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 3.1 t0 -124.79 74.11 64.19 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.31 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.77 -28.7 83.17 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.54 2.16 . . . . 0.0 112.905 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -66.74 -58.72 4.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.057 0.456 . . . . 0.0 111.108 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.2 p -75.16 -18.6 60.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.341 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 86.29 12.17 70.87 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.802 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.591 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 88.7 mtt-85 -122.32 177.16 5.5 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-O 120.87 0.367 . . . . 0.0 111.974 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 86.0 p -139.7 160.85 38.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.37 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.546 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 39.5 mmt180 -55.47 -31.96 62.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.989 0.423 . . . . 0.0 110.081 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.474 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 92.87 6.57 63.46 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.378 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.547 ' CE1' ' SD ' ' A' ' 191' ' ' MET . 26.2 p90 -146.56 154.33 41.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.153 0.501 . . . . 0.0 111.102 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.535 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -142.88 159.2 27.34 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.88 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.578 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 90.5 m-85 -106.83 123.66 48.48 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.629 HD22 ' CE2' ' A' ' 207' ' ' PHE . 7.3 tt -115.07 131.48 56.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.394 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.498 ' N ' HD23 ' A' ' 205' ' ' LEU . 38.8 t -116.31 135.67 53.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.015 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.629 ' CE2' HD22 ' A' ' 205' ' ' LEU . 75.5 m-85 -111.92 135.49 52.48 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.29 -35.33 78.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.464 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -109.77 115.16 55.86 Favored Pre-proline 0 C--O 1.231 0.119 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.695 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -56.2 -23.08 43.33 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.519 2.146 . . . . 0.0 112.862 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.1 t -57.66 -38.32 74.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.78 0.324 . . . . 0.0 111.113 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.94 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.9 m -59.64 -36.56 76.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.595 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.805 HG13 ' SD ' ' A' ' 161' ' ' MET . 83.0 t -60.48 -42.75 92.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.921 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.407 ' O ' HG12 ' A' ' 217' ' ' VAL . 55.5 t0 -59.49 -41.45 89.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.88 0.371 . . . . 0.0 110.805 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.449 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 17.4 pt-20 -78.34 -36.41 46.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.726 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.94 HG23 ' O ' ' A' ' 212' ' ' SER . 93.8 t -63.5 -46.31 95.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 CA-C-O 120.924 0.393 . . . . 0.0 110.422 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 214' ' ' ASP . 8.0 p -62.01 -36.62 75.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -59.97 -38.7 83.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.706 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 31.4 m -87.66 142.39 27.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.918 0.389 . . . . 0.0 111.847 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 228' ' ' ILE . 60.1 tp60 -66.23 -40.89 90.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.455 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.845 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 58.2 m-70 74.55 105.73 0.07 Allowed 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.615 HG12 HG12 ' A' ' 227' ' ' VAL . 75.3 mt -112.28 108.02 24.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.5 tt -117.0 125.99 52.21 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.948 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 55.76 41.19 30.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.03 8.29 87.41 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.95 -0.643 . . . . 0.0 114.643 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.474 ' HG3' ' CB ' ' A' ' 167' ' ' ASN . 42.2 mmtm -127.2 153.76 45.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.55 0.675 . . . . 0.0 111.961 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.615 HG12 HG12 ' A' ' 222' ' ' ILE . 34.2 m -100.06 136.93 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.64 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.805 HD12 HG23 ' A' ' 163' ' ' ILE . 31.1 pt -123.75 161.85 25.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.083 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -124.95 80.3 63.79 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.119 0.485 . . . . 0.0 111.756 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.653 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 31.3 Cg_exo -63.92 76.31 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.399 2.733 . . . . 0.0 112.043 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 161' ' ' MET . 9.9 mtmt -95.5 159.42 15.01 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.117 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.458 ' HA ' ' HG2' ' A' ' 161' ' ' MET . 16.5 tpt180 -57.41 136.91 56.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.068 0.461 . . . . 0.0 111.578 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.31 145.71 55.0 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.49 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 13.9 mt -110.31 120.47 44.15 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.946 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.402 ' HG2' ' CG ' ' A' ' 238' ' ' GLU . 11.3 Cg_endo -54.97 147.76 50.78 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.04 1.827 . . . . 0.0 111.309 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -55.86 -36.71 67.88 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -57.68 -43.19 84.89 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.003 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.684 ' O ' HG23 ' A' ' 242' ' ' THR . 97.6 mt-10 -71.92 -39.66 69.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.084 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -61.18 -36.94 81.22 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.472 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -59.68 -37.31 78.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.999 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -86.41 -0.48 56.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 238' ' ' GLU . 27.3 p -87.85 162.54 16.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.081 0.467 . . . . 0.0 111.689 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -158.33 91.83 0.12 Allowed Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.767 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.584 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 77.5 tttt -79.2 132.42 36.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.764 0.316 . . . . 0.0 110.644 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.68 HD13 ' O ' ' A' ' 245' ' ' ILE . 0.0 OUTLIER -117.45 162.62 15.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.735 0.779 . . . . 0.0 112.254 -178.368 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.408 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 81.9 t80 -103.0 133.97 47.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.817 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.652 ' O ' ' HB2' ' A' ' 286' ' ' PHE . 8.2 p -128.15 135.05 63.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.351 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -123.96 12.03 8.2 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.349 -0.929 . . . . 0.0 113.694 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 313' ' ' ILE . . . -97.78 15.76 61.35 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.725 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.988 HD11 ' HA3' ' A' ' 287' ' ' GLY . 31.7 pt -120.9 155.56 24.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.489 0.662 . . . . 0.0 112.597 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.996 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -137.73 177.17 20.14 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.086 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.15 -26.96 44.39 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 121.981 1.787 . . . . 0.0 111.702 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.13 -35.1 72.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.592 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.996 HG22 ' O ' ' A' ' 251' ' ' GLY . 20.5 m -65.85 -28.1 43.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.74 127.35 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.07 -32.38 79.18 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.213 1.942 . . . . 0.0 113.126 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -61.15 -47.16 87.51 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.239 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 84.1 tt0 -66.67 -36.35 82.31 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.241 0.543 . . . . 0.0 110.944 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.72 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 31.3 t80 -59.5 -45.06 92.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.449 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.7 -40.32 92.16 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.321 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 258' ' ' GLU . 20.8 pt-20 -76.33 -30.64 57.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.08 0.467 . . . . 0.0 110.604 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.576 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 11.6 t80 -63.94 -55.56 21.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.057 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.832 ' CD2' HG21 ' A' ' 289' ' ' VAL . 4.2 m-85 -66.72 -24.66 66.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.547 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.634 ' N ' HD11 ' A' ' 269' ' ' ILE . 71.2 p -60.08 -24.78 64.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.537 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -54.89 -35.76 64.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.467 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.667 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 13.0 p90 -114.39 35.43 4.21 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.073 0.463 . . . . 0.0 111.604 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 264' ' ' SER . . . 164.31 149.03 5.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.641 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 44.5 m -59.91 -36.07 76.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.944 0.402 . . . . 0.0 110.92 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.651 HD11 ' C ' ' A' ' 263' ' ' PHE . 66.0 mt 64.82 90.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.161 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.611 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 80.5 mt -56.65 -42.47 76.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.201 178.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.451 ' OD2' ' CE ' ' A' ' 231' ' ' LYS . 61.9 t0 -168.69 100.88 0.4 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.745 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -98.73 136.72 38.37 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -143.02 155.43 44.64 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 1.073 HD23 HD11 ' A' ' 276' ' ' LEU . 30.6 tp -65.94 -35.45 80.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.176 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.657 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 86.7 mmm 105.58 -79.41 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.168 0.987 . . . . 0.0 112.234 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 1.073 HD11 HD23 ' A' ' 274' ' ' LEU . 6.5 mp 59.14 65.92 1.12 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.461 0.172 . . . . 0.0 111.017 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.71 -41.31 81.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.383 0.611 . . . . 0.0 109.598 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' A' ' 280' ' ' THR . 55.8 mttp -142.0 114.87 8.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.966 177.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.68 ' O ' HD23 ' A' ' 276' ' ' LEU . 87.8 m-20 60.59 -65.44 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.034 -179.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 278' ' ' LYS . 0.3 OUTLIER 170.94 18.7 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -58.07 -38.58 89.94 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.691 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 286' ' ' PHE . 96.1 mm-40 -60.96 -36.37 79.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.259 0.552 . . . . 0.0 110.349 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.819 ' OG ' HD21 ' A' ' 274' ' ' LEU . 36.8 t -60.58 -23.77 64.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.54 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -48.05 -33.4 7.99 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -144.6 -18.52 0.19 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 119.083 -1.532 . . . . 0.0 115.755 -178.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.652 ' HB2' ' O ' ' A' ' 247' ' ' VAL . 26.3 p90 -136.61 165.17 26.51 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.132 1.466 . . . . 0.0 113.269 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.988 ' HA3' HD11 ' A' ' 250' ' ' ILE . . . -141.62 163.57 26.84 Favored Glycine 0 CA--C 1.52 0.393 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.516 178.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.584 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -116.89 130.22 56.57 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.446 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.832 HG21 ' CD2' ' A' ' 263' ' ' PHE . 61.2 t -125.94 136.19 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.351 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 53.0 m -114.02 135.92 53.48 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.472 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 49.3 m-85 -115.76 136.35 53.14 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.611 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 21.8 t70 -59.18 -34.82 72.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.535 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 51.0 m -119.69 143.22 47.86 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.375 0.607 . . . . 0.0 111.763 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.55 -31.2 71.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.161 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 296' ' ' ALA . 53.5 p30 -60.8 -33.69 73.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.46 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.574 ' N ' ' OD1' ' A' ' 295' ' ' ASP . . . -62.16 -37.94 87.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.919 0.39 . . . . 0.0 110.65 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.593 ' O ' HG12 ' A' ' 300' ' ' VAL . 75.2 t -61.48 -42.07 92.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.031 0.443 . . . . 0.0 110.61 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -59.52 -37.17 77.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.592 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -58.35 -43.63 88.42 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.053 0.454 . . . . 0.0 111.821 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 1.008 HG23 HD11 ' A' ' 306' ' ' ILE . 1.0 OUTLIER -70.2 -34.4 58.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.456 -179.35 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 79.7 m -59.64 -47.24 86.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.333 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.19 -39.29 94.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.187 0.517 . . . . 0.0 110.419 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.1 m-20 -62.12 -34.75 76.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.772 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.675 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 23.2 tptm 65.39 -73.95 0.06 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.675 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 5.1 m-30 -108.87 134.51 51.45 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.888 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 1.008 HD11 HG23 ' A' ' 300' ' ' VAL . 14.9 mt -116.52 137.84 49.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.073 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.421 ' OD1' ' CE ' ' A' ' 312' ' ' LYS . 73.0 m-20 -75.99 87.53 2.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.68 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 7.8 t80 -97.76 -71.76 0.67 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.385 0.612 . . . . 0.0 110.655 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.629 ' HD2' HG12 ' A' ' 254' ' ' VAL . 4.6 mmpt? -96.69 -164.24 1.13 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.344 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.431 ' OD1' ' HG2' ' A' ' 311' ' ' ARG . 55.8 p30 -59.21 -21.8 60.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.702 0.287 . . . . 0.0 110.792 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.431 ' HG2' ' OD1' ' A' ' 310' ' ' ASP . 24.9 mmm180 -120.67 157.62 29.2 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.615 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.599 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 24.8 mmtm -72.5 154.02 41.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.634 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 249' ' ' GLY . 35.3 pt -117.46 148.86 19.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.118 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -106.48 130.17 54.32 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 0.628 HG12 HG23 ' A' ' 247' ' ' VAL . 81.7 mt -120.94 129.64 75.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.169 0.509 . . . . 0.0 112.231 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -128.99 153.24 47.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.545 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -63.54 144.43 57.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.73 0.3 . . . . 0.0 110.718 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.53 144.68 46.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.629 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 . . . . . 0 C--N 1.331 -0.206 0 CA-C-O 120.811 0.339 . . . . 0.0 111.501 -179.493 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.7 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.715 0.293 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.447 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 80.9 tttt -64.46 138.74 58.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.423 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.542 ' CE ' HG11 ' A' ' 216' ' ' VAL . 89.8 mtp -127.27 157.87 38.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.283 0.563 . . . . 0.0 111.909 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.535 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 1.3 t80 -103.29 129.94 50.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.882 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 21.8 mm -114.07 129.34 70.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.357 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -128.58 163.09 22.14 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.821 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.527 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 76.4 38.37 33.62 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.888 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 75.7 mt -59.52 -25.45 64.5 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.414 ' O ' ' N ' ' A' ' 169' ' ' ASP . 38.7 t-20 72.52 41.02 0.6 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.973 0.416 . . . . 0.0 110.278 -178.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.452 ' CD2' ' HD2' ' A' ' 198' ' ' ARG . 23.5 m0 29.84 38.37 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.33 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 167' ' ' ASN . 58.4 t0 -156.54 28.43 0.33 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.798 0.332 . . . . 0.0 111.462 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.513 HG22 ' CD2' ' A' ' 175' ' ' LEU . 61.0 m -121.44 141.64 50.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 111.002 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.57 ' C ' HD12 ' A' ' 190' ' ' ILE . 15.8 p -117.35 163.09 16.87 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.635 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.779 ' N ' HD12 ' A' ' 190' ' ' ILE . 96.1 mt-10 -57.82 -33.24 68.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.515 ' O ' ' HG2' ' A' ' 176' ' ' ARG . 21.8 t70 -64.02 -41.34 97.47 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.974 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -63.54 -38.79 92.49 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.6 HD12 ' HE2' ' A' ' 179' ' ' PHE . 3.7 mm? -61.41 -40.32 93.96 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 173' ' ' ASP . 0.1 OUTLIER -61.77 -37.38 84.09 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.683 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.47 -37.39 87.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.022 0.439 . . . . 0.0 110.073 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.606 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 64.0 t80 -78.86 -64.72 1.12 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.44 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.6 ' HE2' HD12 ' A' ' 175' ' ' LEU . 78.0 m-85 -68.06 -20.76 64.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.385 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -50.79 -29.04 18.21 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.615 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.837 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -58.86 -41.23 86.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.2 0.524 . . . . 0.0 110.298 179.239 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.837 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 71.3 m-85 -71.04 -33.95 70.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.882 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -172.19 -172.91 38.49 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.881 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 33.9 p -72.72 -11.81 60.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.77 0.319 . . . . 0.0 110.875 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.65 ' O ' HG12 ' A' ' 185' ' ' VAL . 1.1 t 52.2 87.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -177.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 3.3 m -56.69 -43.47 80.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.696 -176.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -150.3 140.93 22.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.244 0.545 . . . . 0.0 112.311 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.554 HD23 ' CG1' ' A' ' 185' ' ' VAL . 0.2 OUTLIER -116.31 134.4 54.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.055 179.001 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 0.3 OUTLIER -131.81 123.6 27.92 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.382 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.779 HD12 ' N ' ' A' ' 172' ' ' GLU . 2.4 mt -125.07 128.09 72.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.396 176.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.496 ' HE1' ' HA2' ' A' ' 203' ' ' GLY . 3.1 mpp? -103.77 141.98 35.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.966 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 199' ' ' SER . 1.8 pttt -131.36 177.04 7.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.047 0.451 . . . . 0.0 111.56 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 74.3 m-20 -119.27 83.08 24.5 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.751 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.6 -26.3 54.44 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.269 1.979 . . . . 0.0 112.096 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.42 -67.4 0.63 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.295 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 56.1 p -70.71 -22.41 62.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.543 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 83.61 21.34 58.24 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.024 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.596 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 16.8 tpp85 -125.43 136.61 53.58 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 121.168 0.509 . . . . 0.0 111.934 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 192' ' ' LYS . 46.8 m -63.38 151.71 40.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.72 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.564 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 26.2 mmm180 -58.38 -32.2 68.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.943 0.401 . . . . 0.0 110.628 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.46 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 95.24 0.17 63.48 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.772 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 36.5 p90 -144.13 159.7 42.18 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.988 0.423 . . . . 0.0 111.067 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.496 ' HA2' ' HE1' ' A' ' 191' ' ' MET . . . -148.1 169.25 28.83 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.556 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.569 ' HB2' ' HB3' ' A' ' 189' ' ' LYS . 96.3 m-85 -110.07 129.19 55.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.092 0.472 . . . . 0.0 110.359 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.803 HD23 ' N ' ' A' ' 206' ' ' SER . 3.6 tt -108.78 132.7 53.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.404 -177.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.803 ' N ' HD23 ' A' ' 205' ' ' LEU . 33.1 t -122.22 131.61 54.02 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.305 178.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 205' ' ' LEU . 88.4 m-85 -118.23 136.92 53.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.057 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.589 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.4 tt0 -61.66 -35.14 77.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.053 0.454 . . . . 0.0 110.304 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -109.6 119.21 48.58 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.733 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.64 -26.6 73.36 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.413 2.075 . . . . 0.0 112.839 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.0 m -58.02 -36.44 72.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.567 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.447 ' O ' HG23 ' A' ' 216' ' ' VAL . 23.5 m -58.16 -34.07 69.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.964 0.411 . . . . 0.0 110.593 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.538 HG13 ' SD ' ' A' ' 161' ' ' MET . 78.0 t -61.0 -39.51 82.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.279 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.457 ' O ' HG22 ' A' ' 217' ' ' VAL . 21.6 t70 -56.0 -42.39 76.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.743 0.306 . . . . 0.0 111.178 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 182' ' ' TYR . 96.4 mt-10 -66.9 -33.61 75.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.071 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.775 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 92.7 t -59.13 -42.85 87.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.734 -178.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 214' ' ' ASP . 20.3 m -72.79 -32.52 40.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.31 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 214' ' ' ASP . 45.0 mmtt -60.57 -34.24 73.87 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.616 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 52.7 m -99.05 138.78 35.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.836 0.35 . . . . 0.0 111.534 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 57.8 tp60 -65.91 -41.64 91.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.078 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.775 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 64.2 m-70 83.04 115.0 0.06 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 178.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.901 HD12 HG12 ' A' ' 227' ' ' VAL . 21.5 mm -117.66 109.35 27.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 175.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.5 tt -122.39 130.48 53.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.061 0.458 . . . . 0.0 111.63 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 57.8 t0 52.84 33.61 14.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.682 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 83.14 5.68 88.84 Favored Glycine 0 CA--C 1.517 0.163 0 C-N-CA 120.588 -0.815 . . . . 0.0 114.665 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.402 ' HD2' ' HB2' ' A' ' 167' ' ' ASN . 36.8 ttmt -133.32 131.96 40.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.816 0.808 . . . . 0.0 111.612 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.901 HG12 HD12 ' A' ' 222' ' ' ILE . 19.6 m -67.83 136.03 27.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.574 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 165' ' ' GLY . 35.6 pt -122.59 157.95 27.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.223 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -127.76 80.06 72.6 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.008 0.432 . . . . 0.0 111.92 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.539 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 47.7 Cg_exo -59.56 136.84 73.87 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 123.188 2.592 . . . . 0.0 111.542 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -138.46 154.54 48.85 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.715 -0.221 . . . . 0.0 110.721 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -57.57 136.97 56.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 0.0 111.319 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -72.36 146.47 47.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.605 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.771 HD12 ' HG2' ' A' ' 239' ' ' GLN . 1.2 pt -134.04 108.48 11.59 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.783 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 234' ' ' ILE . 1.6 Cg_endo -46.87 154.78 0.98 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.105 1.87 . . . . 0.0 110.884 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -51.47 -40.93 60.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.601 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 54.6 p30 -64.68 -38.74 92.01 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.215 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.601 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 96.8 mt-10 -70.48 -35.04 73.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.612 0.244 . . . . 0.0 111.181 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.771 ' HG2' HD12 ' A' ' 234' ' ' ILE . 84.2 mt-30 -59.21 -39.59 83.16 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.021 0.439 . . . . 0.0 110.0 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -62.71 -42.75 99.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.369 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -64.12 -39.65 94.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.542 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 238' ' ' GLU . 53.1 p -68.48 -38.22 80.82 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.879 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 61.54 142.41 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.016 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.543 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 6.8 tptm -131.66 131.04 42.84 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.952 HD12 HG21 ' A' ' 315' ' ' ILE . 8.4 pt -120.23 154.32 23.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.482 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.503 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 88.3 t80 -100.91 132.24 46.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.838 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.826 HG21 ' CZ ' ' A' ' 263' ' ' PHE . 20.6 t -120.4 128.46 76.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.028 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -121.65 -7.34 8.16 Favored Glycine 0 C--N 1.329 0.163 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.441 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.544 ' O ' HG22 ' A' ' 313' ' ' ILE . . . -81.25 9.56 53.66 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.17 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.743 HD11 ' HA3' ' A' ' 287' ' ' GLY . 41.3 pt -111.7 133.68 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 116.968 0.384 . . . . 0.0 111.229 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 159.18 -49.43 0.4 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.693 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.96 -33.57 89.54 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.446 2.097 . . . . 0.0 112.72 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -162.68 64.03 0.2 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.077 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.526 HG21 ' HB ' ' A' ' 250' ' ' ILE . 27.6 m -131.36 156.22 42.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.529 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.68 156.43 79.51 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.449 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.57 -40.14 86.52 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 121.521 1.481 . . . . 0.0 111.562 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.24 -42.99 99.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.289 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' A' ' 262' ' ' PHE . 97.7 mt-10 -68.04 -41.07 82.62 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.95 0.405 . . . . 0.0 111.276 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.675 ' CE1' HD13 ' A' ' 250' ' ' ILE . 82.8 t80 -65.13 -47.84 75.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.12 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 264' ' ' SER . 84.4 tt0 -64.17 -42.03 96.89 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.094 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -76.39 -30.71 57.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.022 0.439 . . . . 0.0 111.085 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.694 ' CZ ' HG21 ' A' ' 306' ' ' ILE . 5.5 t80 -61.83 -64.82 0.81 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.019 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.995 ' CB ' HD11 ' A' ' 269' ' ' ILE . 32.8 m-85 -62.64 -27.51 69.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.064 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.455 ' OG ' ' HA ' ' A' ' 268' ' ' THR . 33.3 t -56.38 -28.53 59.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.087 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -53.13 -34.7 57.92 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.803 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 14.4 p90 -116.71 54.5 0.85 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.907 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.519 ' O ' HG22 ' A' ' 268' ' ' THR . . . 153.06 -12.77 0.61 Allowed Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.775 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.567 ' O ' ' O ' ' A' ' 269' ' ' ILE . 0.5 OUTLIER 66.95 -1.84 1.29 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.995 HD11 ' CB ' ' A' ' 263' ' ' PHE . 77.4 mt 33.54 115.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.622 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 75.7 mt -60.4 -42.06 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.06 176.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -166.16 97.47 0.61 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.927 ' HB2' HG21 ' A' ' 269' ' ' ILE . . . -104.82 142.72 34.22 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -140.07 150.59 44.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.444 0.64 . . . . 0.0 112.141 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.576 ' O ' ' HB2' ' A' ' 275' ' ' MET . 43.5 tp -66.49 -37.54 85.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.713 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.576 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 91.9 mmm 90.73 111.16 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.424 0.69 . . . . 0.0 111.147 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 276' ' ' LEU . 6.2 mp -118.46 124.11 46.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.704 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -62.41 -39.06 92.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.87 0.843 . . . . 0.0 109.045 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -161.09 -106.97 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.083 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -62.34 -37.2 84.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.014 0.435 . . . . 0.0 110.054 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 1.2 t 171.66 68.82 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.75 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -93.19 -75.35 1.3 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.094 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 286' ' ' PHE . 96.0 mm-40 -57.54 -30.7 65.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.171 0.51 . . . . 0.0 110.034 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.485 ' HB2' ' CD2' ' A' ' 274' ' ' LEU . 76.5 p -64.18 163.2 13.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.465 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 284' ' ' ARG . 59.4 ttp180 69.69 6.26 5.63 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.252 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -130.92 -48.02 0.12 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.65 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 40.6 p90 -148.67 166.77 27.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.542 0.211 . . . . 0.0 111.029 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.743 ' HA3' HD11 ' A' ' 250' ' ' ILE . . . -136.72 157.06 23.5 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.263 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.543 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.9 OUTLIER -109.75 129.84 55.58 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.748 0.419 . . . . 0.0 110.552 179.47 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.508 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 48.5 t -126.16 134.22 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.801 ' O ' HG23 ' A' ' 269' ' ' ILE . 30.5 m -123.01 139.44 54.08 Favored 'General case' 0 C--O 1.23 0.063 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 242' ' ' THR . 51.0 m-85 -117.5 140.32 49.77 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.622 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 21.4 t70 -56.34 -34.86 67.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.599 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 51.1 m -119.86 142.74 48.39 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.948 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.47 -32.05 73.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.045 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -56.21 -36.5 68.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.467 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -60.06 -37.07 78.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.408 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.692 HG13 ' CG2' ' A' ' 245' ' ' ILE . 71.4 t -61.79 -44.13 98.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.037 0.446 . . . . 0.0 110.405 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -63.2 -37.48 87.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.1 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -58.38 -43.14 88.37 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.803 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 0.4 OUTLIER -73.45 -32.82 38.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.923 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 83.9 m -57.21 -44.39 83.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -60.43 -40.26 90.42 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.329 0.585 . . . . 0.0 109.812 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 305' ' ' PHE . 88.0 m-20 -60.41 -32.48 71.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.407 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.635 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 22.0 tptt 69.88 -68.2 0.21 Allowed 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.635 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.0 m-30 -115.5 149.72 37.66 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.445 178.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.694 HG21 ' CZ ' ' A' ' 262' ' ' PHE . 23.7 mm -117.23 140.18 41.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.742 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -80.28 39.74 0.46 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.961 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.62 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 6.2 t80 -48.24 -68.4 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.478 ' HD3' ' CZ ' ' A' ' 308' ' ' PHE . 16.9 mmmt -105.6 19.41 20.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.811 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 53.6 t0 69.25 9.69 7.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.732 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -109.88 2.02 19.57 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.037 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.423 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 22.6 mttm 62.2 121.55 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.017 0.437 . . . . 0.0 111.714 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 249' ' ' GLY . 31.6 pt -116.28 147.09 19.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.444 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 314' ' ' GLU . . . . . 0.564 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 84.7 mt-10 -103.93 132.19 50.43 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.847 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 0.952 HG21 HD12 ' A' ' 245' ' ' ILE . 63.2 mt -120.35 127.98 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.589 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -126.7 148.39 49.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.716 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -55.53 148.3 15.96 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.03 140.92 36.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.139 0.495 . . . . 0.0 111.394 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.63 -179.916 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 4.0 m . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.667 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 8.5 tptm -63.25 134.07 55.27 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.76 0.314 . . . . 0.0 110.342 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.785 ' SD ' HG13 ' A' ' 213' ' ' VAL . 89.8 mmm -123.4 147.28 47.26 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.62 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 3.4 t80 -109.56 126.05 53.17 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.823 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 3.7 mt -121.96 130.16 74.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.112 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.509 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -125.05 156.04 18.84 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.038 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.85 33.34 57.81 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.707 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.607 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 69.7 mt -58.68 -32.45 69.14 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.645 ' O ' ' N ' ' A' ' 169' ' ' ASP . 45.4 t30 110.49 31.22 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.283 0.633 . . . . 0.0 110.99 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.473 ' CG ' ' HD2' ' A' ' 198' ' ' ARG . 6.5 m0 53.04 -49.25 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.645 ' N ' ' O ' ' A' ' 167' ' ' ASN . 50.3 p30 -82.27 9.27 9.16 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 166' ' ' LEU . 85.7 m -68.99 137.81 54.02 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.203 0.525 . . . . 0.0 109.975 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 30.6 m -112.14 148.33 34.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.387 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.662 ' N ' HD12 ' A' ' 190' ' ' ILE . 55.6 mp0 -54.56 -37.51 65.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.555 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 89.5 m-20 -63.2 -40.12 96.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.946 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -61.6 -36.69 81.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.302 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.673 HD23 ' CE2' ' A' ' 179' ' ' PHE . 5.8 mt -55.34 -49.38 72.37 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.555 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -67.05 -31.94 72.8 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.482 179.073 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.43 -39.0 78.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.695 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.636 ' CE2' ' CE2' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -94.08 -55.62 3.14 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.113 179.288 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.823 ' CZ ' HD13 ' A' ' 163' ' ' ILE . 64.0 m-85 -60.72 -28.95 69.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.874 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.93 -23.28 10.86 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.169 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.82 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -54.52 -40.52 68.69 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.882 0.373 . . . . 0.0 111.14 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.82 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 55.5 m-85 -69.32 -31.67 70.29 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.243 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 166.97 -134.41 3.26 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.871 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 57.7 m -117.64 136.89 53.01 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.887 HG23 ' CE1' ' A' ' 207' ' ' PHE . 0.9 OUTLIER -95.0 127.79 46.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.613 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.746 HG23 ' N ' ' A' ' 208' ' ' GLU . 54.0 p -70.18 -35.94 74.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.397 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -148.86 145.24 27.39 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.879 HD22 HG11 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -116.45 129.06 56.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.749 178.915 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.565 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 7.3 tppt? -138.59 111.36 7.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 172' ' ' GLU . 82.3 mt -125.68 123.13 63.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 174.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.588 ' O ' ' O ' ' A' ' 192' ' ' LYS . 0.0 OUTLIER -59.9 -37.61 79.93 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.084 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.588 ' O ' ' O ' ' A' ' 191' ' ' MET . 26.7 tttt 49.18 149.68 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.268 0.556 . . . . 0.0 112.008 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 9.9 t0 -128.3 78.48 75.52 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.366 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.74 -24.17 61.96 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.408 2.072 . . . . 0.0 112.011 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -73.82 -72.0 0.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.572 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 48.4 p -69.03 -26.21 64.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.624 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.66 7.01 65.22 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.707 -0.759 . . . . 0.0 113.241 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 20.9 tpp180 -124.38 125.78 44.87 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-N 117.267 0.534 . . . . 0.0 111.181 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.1 t -70.27 156.99 38.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.63 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.663 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 83.8 mmt-85 -55.55 -31.75 62.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.705 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 95.78 0.49 62.28 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.675 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.663 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 42.6 p90 -142.47 154.41 44.51 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.418 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -150.45 170.66 30.36 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.666 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.62 ' CE2' ' CD1' ' A' ' 162' ' ' PHE . 89.5 m-85 -107.91 125.55 51.62 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.109 0.481 . . . . 0.0 109.963 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.669 HD11 HG21 ' A' ' 185' ' ' VAL . 16.8 tp -112.61 131.19 55.74 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.197 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.577 ' O ' HG22 ' A' ' 185' ' ' VAL . 49.1 m -120.1 140.39 51.12 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.723 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.887 ' CE1' HG23 ' A' ' 185' ' ' VAL . 78.4 m-85 -121.65 141.88 50.69 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.567 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.746 ' N ' HG23 ' A' ' 186' ' ' THR . 84.5 tt0 -64.45 -34.75 78.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.245 178.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -110.76 115.58 53.27 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.926 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 0.406 ' O ' ' HB ' ' A' ' 213' ' ' VAL . 52.5 Cg_exo -56.25 -25.78 57.83 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.582 2.188 . . . . 0.0 113.033 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.2 m -58.06 -37.42 74.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.0 110.555 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.887 ' O ' HG23 ' A' ' 216' ' ' VAL . 25.0 m -59.97 -34.76 73.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.244 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.785 HG13 ' SD ' ' A' ' 161' ' ' MET . 71.2 t -60.39 -41.0 85.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.214 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -57.4 -44.86 84.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.051 0.453 . . . . 0.0 110.487 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.58 -33.77 73.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.384 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 212' ' ' SER . 74.9 t -59.65 -40.59 82.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.692 -178.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 230' ' ' PRO . 21.3 m -88.87 -38.68 11.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -178.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -60.14 -34.73 73.95 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.495 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 32.2 m -93.37 146.28 23.86 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -79.76 140.76 36.8 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.855 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 41.8 m-70 -125.85 139.41 53.51 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -176.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.593 HG22 ' H ' ' A' ' 225' ' ' GLY . 67.7 mt -125.52 114.61 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.347 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.434 ' HG ' ' CD2' ' A' ' 178' ' ' TYR . 1.0 OUTLIER -82.22 -50.83 8.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.04 0.448 . . . . 0.0 111.99 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -142.86 43.68 1.58 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.788 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.593 ' H ' HG22 ' A' ' 222' ' ' ILE . . . 96.17 -0.65 62.22 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.978 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.436 ' CG ' ' OD1' ' A' ' 167' ' ' ASN . 12.2 mmmm -99.36 169.49 9.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.663 0.268 . . . . 0.0 110.352 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 14.6 p -118.33 132.91 66.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.948 0.404 . . . . 0.0 110.125 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.642 HD12 ' CG2' ' A' ' 163' ' ' ILE . 35.9 pt -129.41 161.13 39.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.949 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -129.63 81.01 70.64 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.0 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.746 ' O ' HG12 ' A' ' 217' ' ' VAL . 78.1 Cg_exo -54.97 129.48 35.56 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.958 2.438 . . . . 0.0 112.782 -178.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -132.86 154.58 50.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.423 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.604 ' HD3' ' N ' ' A' ' 233' ' ' ALA . 1.5 tmt_? -63.5 135.08 56.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.902 0.382 . . . . 0.0 110.759 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.667 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -63.91 145.77 55.24 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.286 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -109.92 130.67 22.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.479 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.43 ' HG2' ' HB2' ' A' ' 238' ' ' GLU . 9.6 Cg_endo -53.45 138.84 65.87 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 121.772 1.648 . . . . 0.0 110.85 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -56.56 -40.39 75.08 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.16 -45.6 92.53 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.496 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.43 ' HB2' ' HG2' ' A' ' 235' ' ' PRO . 97.1 mt-10 -71.61 -37.32 70.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.599 0.714 . . . . 0.0 109.842 178.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -59.5 -39.48 83.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.979 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -59.51 -39.28 83.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.037 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -60.35 -35.3 75.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.54 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.528 HG21 ' CD1' ' A' ' 270' ' ' ILE . 19.3 p -84.08 162.21 20.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.991 0.424 . . . . 0.0 111.65 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -154.27 118.54 0.87 Allowed Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.13 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 18.2 ttpp -88.49 135.93 33.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.732 0.301 . . . . 0.0 111.127 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.73 HG21 HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -119.51 164.6 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.358 0.599 . . . . 0.0 111.781 -179.012 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.439 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 88.2 t80 -101.27 136.98 40.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.156 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.853 HG23 HG12 ' A' ' 315' ' ' ILE . 9.2 p -129.72 145.13 36.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.107 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.56 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -131.84 165.36 23.44 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 97.31 -2.69 61.25 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.986 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.79 HD11 ' HA3' ' A' ' 287' ' ' GLY . 43.7 pt -117.64 137.92 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-O 121.172 0.511 . . . . 0.0 111.604 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.868 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -174.18 -89.26 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.488 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.66 132.57 43.58 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.455 2.103 . . . . 0.0 112.984 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 51.17 40.17 25.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.818 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 251' ' ' GLY . 29.8 m -105.84 -35.49 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.049 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 254' ' ' VAL . 13.4 mmm180 57.39 132.63 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.76 -30.22 66.09 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.892 1.728 . . . . 0.0 112.35 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 39.0 tttm -61.28 -44.14 97.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.604 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.681 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 98.0 mt-10 -67.0 -39.87 87.22 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.164 0.506 . . . . 0.0 110.599 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.78 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 15.7 t80 -62.55 -45.49 92.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.029 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 257' ' ' LYS . 20.3 pt-20 -69.23 -41.16 77.39 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.795 0.331 . . . . 0.0 111.021 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.412 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.7 pt-20 -74.26 -29.76 61.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.288 0.566 . . . . 0.0 110.157 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.571 ' CZ ' HD11 ' A' ' 313' ' ' ILE . 5.8 t80 -60.94 -57.28 13.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.884 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.701 ' CD2' HG21 ' A' ' 289' ' ' VAL . 3.7 m-85 -65.18 -23.44 67.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.355 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.653 ' N ' HD11 ' A' ' 269' ' ' ILE . 27.2 t -53.97 -30.14 45.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.616 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -53.39 -34.75 58.92 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.105 -0.238 . . . . 0.0 111.116 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.757 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 7.4 p90 -119.0 46.02 1.96 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.21 0.529 . . . . 0.0 111.74 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.486 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 156.31 152.92 6.41 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.916 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 43.0 p -70.28 -25.53 63.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.041 0.448 . . . . 0.0 110.748 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.653 HD11 ' N ' ' A' ' 264' ' ' SER . 76.9 mt 54.55 96.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.111 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.576 HG13 ' CA ' ' A' ' 292' ' ' ASP . 79.3 mt -59.18 -40.61 81.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.207 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 50.3 p30 -169.77 156.55 6.42 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.496 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -155.07 145.32 21.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.866 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -145.45 150.71 36.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.11 0.481 . . . . 0.0 111.852 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.59 ' O ' ' HB2' ' A' ' 275' ' ' MET . 24.7 tp -66.17 -39.75 89.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.229 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.922 ' O ' HD12 ' A' ' 276' ' ' LEU . 94.8 mmm 98.2 151.85 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.495 0.718 . . . . 0.0 109.659 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.922 HD12 ' O ' ' A' ' 275' ' ' MET . 0.3 OUTLIER -162.04 84.44 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.562 0.22 . . . . 0.0 111.427 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -85.89 110.84 19.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.912 0.386 . . . . 0.0 110.621 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.635 ' O ' HG22 ' A' ' 280' ' ' THR . 40.8 mttm 55.95 30.69 16.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.91 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 51.51 43.95 29.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.135 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.635 HG22 ' O ' ' A' ' 278' ' ' LYS . 1.6 t -165.83 -41.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.717 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -55.0 -37.49 62.9 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.475 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.571 ' HG2' ' HB2' ' A' ' 275' ' ' MET . 3.4 tp-100 -109.41 132.51 54.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.747 0.308 . . . . 0.0 111.494 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 282' ' ' GLN . 27.5 p 148.89 -18.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.059 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 51.1 ttt85 -56.46 -37.97 71.03 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.226 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 250' ' ' ILE . . . 144.59 43.08 0.05 OUTLIER Glycine 0 CA--C 1.522 0.503 0 C-N-CA 119.984 -1.103 . . . . 0.0 114.147 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.49 ' CE1' ' OE1' ' A' ' 282' ' ' GLN . 15.5 p90 -140.28 167.47 22.06 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 117.483 0.641 . . . . 0.0 110.409 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.79 ' HA3' HD11 ' A' ' 250' ' ' ILE . . . -147.51 169.28 28.43 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.579 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.445 ' CE2' ' NZ ' ' A' ' 244' ' ' LYS . 0.3 OUTLIER -122.42 124.16 42.99 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 122.346 0.258 . . . . 0.0 111.053 179.429 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.78 HG23 ' CZ ' ' A' ' 259' ' ' PHE . 61.2 t -127.67 138.07 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.033 0.445 . . . . 0.0 112.142 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 44.4 m -116.04 137.09 52.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.241 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.486 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 41.7 m-85 -115.1 135.19 54.47 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.576 ' CA ' HG13 ' A' ' 270' ' ' ILE . 55.1 t0 -59.01 -35.37 73.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.652 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 30.5 t -118.35 139.31 51.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.207 0.527 . . . . 0.0 111.61 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.914 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -64.08 -31.89 73.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.02 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -57.06 -35.61 69.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.299 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.2 -37.33 77.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.705 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.914 HG12 ' O ' ' A' ' 294' ' ' ALA . 6.2 p -58.73 -38.21 70.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.005 0.431 . . . . 0.0 110.662 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -63.3 -37.43 87.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.181 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 302' ' ' GLN . 92.8 mtt-85 -58.23 -41.13 83.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.893 -178.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.757 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 2.3 p -65.12 -33.68 65.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.066 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 74.5 m -56.92 -39.75 75.06 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' GLN . . . . . 0.409 ' HB3' ' O ' ' A' ' 299' ' ' ARG . 50.6 tp60 -62.77 -35.5 80.03 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.924 177.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.756 ' ND2' HD12 ' A' ' 306' ' ' ILE . 22.9 p30 -101.2 42.76 1.1 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.008 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.638 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 18.7 tptm -16.08 -65.07 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.915 0.388 . . . . 0.0 110.432 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.638 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.1 m-30 -110.22 142.36 41.89 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.756 HD12 ' ND2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -117.01 130.23 72.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.732 179.681 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -73.18 71.55 1.18 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.535 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 2.9 t80 -62.47 -105.6 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.344 -177.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.46 ' HD2' ' CE1' ' A' ' 308' ' ' PHE . 12.6 mmmm -61.83 -37.17 83.46 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.054 0.454 . . . . 0.0 111.316 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 309' ' ' LYS . 60.3 t0 175.8 -25.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.791 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -111.8 159.43 18.31 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.199 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.628 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 42.4 mttp -72.99 140.48 47.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.333 0.587 . . . . 0.0 111.905 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 305' ' ' PHE . 36.3 pt -119.0 152.79 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.615 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -107.54 131.48 54.29 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.617 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 0.853 HG12 HG23 ' A' ' 247' ' ' VAL . 74.1 mt -119.85 129.71 75.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.38 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 22.9 tttm -133.08 144.37 49.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.5 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -54.1 144.99 18.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.721 0.296 . . . . 0.0 110.314 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.67 140.14 55.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 111.073 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.932 -179.851 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 51.7 t . . . . . 0 C--O 1.23 0.056 0 CA-C-O 121.005 0.431 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.864 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 6.5 tptt -135.07 142.73 46.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.584 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.794 ' SD ' HG13 ' A' ' 213' ' ' VAL . 87.0 mmm -122.21 147.01 46.72 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.58 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 1.6 t80 -108.81 125.6 52.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.036 177.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 202' ' ' PHE . 20.9 mm -118.04 129.71 74.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.613 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -127.06 162.73 21.12 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.007 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.67 36.12 38.58 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.745 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.543 HD22 HG21 ' A' ' 170' ' ' THR . 70.7 mt -59.61 -24.55 63.91 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 72.48 43.78 0.45 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.136 0.494 . . . . 0.0 110.505 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 21.1 m0 31.39 39.38 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.429 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -160.54 46.57 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.353 . . . . 0.0 111.304 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.543 HG21 HD22 ' A' ' 166' ' ' LEU . 90.4 m -123.96 139.92 53.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.019 0.438 . . . . 0.0 110.899 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 33.5 p -119.93 160.07 23.44 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.393 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.535 ' N ' HD12 ' A' ' 190' ' ' ILE . 55.8 mp0 -61.98 -30.54 71.0 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.844 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 88.8 m-20 -61.03 -42.89 99.33 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.907 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -65.93 -38.54 88.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.121 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.979 HD22 HD21 ' A' ' 205' ' ' LEU . 10.6 mt -61.87 -42.47 99.09 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.844 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -65.78 -38.82 90.06 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.893 179.329 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.45 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 84.5 tt0 -70.89 -45.01 65.09 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.134 0.492 . . . . 0.0 110.457 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.984 ' OH ' ' HB2' ' A' ' 221' ' ' HIS . 19.0 t80 -63.17 -45.14 93.2 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.28 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.606 ' CE2' HD23 ' A' ' 175' ' ' LEU . 96.0 m-85 -98.04 2.02 48.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.34 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -58.51 -28.1 61.89 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.358 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.566 ' H ' ' CD ' ' A' ' 181' ' ' LYS . 0.6 OUTLIER -56.72 -42.73 79.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.959 0.885 . . . . 0.0 110.328 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -70.99 -35.19 72.0 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 113.781 -1.554 . . . . 0.0 112.75 -177.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 177.55 -174.37 46.87 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 119.679 -1.248 . . . . 0.0 113.741 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.8 m -63.82 -28.55 69.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.042 -0.579 . . . . 0.0 111.241 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.642 ' CG1' ' O ' ' A' ' 185' ' ' VAL . 0.4 OUTLIER 64.3 87.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -176.775 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -54.77 -46.15 74.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.033 -176.661 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 186' ' ' THR . 90.8 m-20 -139.25 152.36 47.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.226 0.536 . . . . 0.0 112.012 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.701 HD11 ' CB ' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -125.55 129.08 49.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.505 179.452 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 22.8 tptt -132.33 119.26 20.5 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.488 0.661 . . . . 0.0 112.643 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.535 HD12 ' N ' ' A' ' 172' ' ' GLU . 1.9 mt -128.83 131.95 67.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.662 177.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.622 ' SD ' ' CE2' ' A' ' 202' ' ' PHE . 0.8 OUTLIER -88.77 127.32 35.6 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -133.24 162.74 30.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.979 0.418 . . . . 0.0 111.593 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.578 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 32.3 m-20 -124.81 84.37 58.33 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.348 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.34 -25.42 39.06 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.241 1.961 . . . . 0.0 112.362 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.88 -71.29 0.36 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.9 0.381 . . . . 0.0 111.313 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.4 p -71.8 -21.56 61.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.178 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 80.36 26.76 54.02 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.32 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.578 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 15.8 ttp180 -119.78 149.95 41.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.26 0.552 . . . . 0.0 112.372 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.8 t -108.71 148.41 30.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.593 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.626 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 59.8 mmt-85 -53.35 -29.92 36.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.758 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.514 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 97.56 2.16 58.81 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.137 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.626 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 25.6 p90 -142.96 155.35 44.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.937 0.398 . . . . 0.0 110.819 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.507 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -142.94 161.73 27.52 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.768 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.639 ' HA ' ' O ' ' A' ' 161' ' ' MET . 89.7 m-85 -111.65 130.55 55.73 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.827 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.979 HD21 HD22 ' A' ' 175' ' ' LEU . 44.8 mt -109.35 141.67 41.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.974 0.416 . . . . 0.0 111.667 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 33.1 t -127.15 131.15 50.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.346 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.583 ' CE1' HG23 ' A' ' 185' ' ' VAL . 99.1 m-85 -119.15 140.58 49.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.814 0.34 . . . . 0.0 111.562 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.501 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.3 tt0 -60.87 -34.63 74.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.089 0.471 . . . . 0.0 110.089 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.1 114.08 51.44 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.395 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.74 -26.83 58.58 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.389 2.059 . . . . 0.0 113.005 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.2 m -58.61 -36.17 73.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.775 0.321 . . . . 0.0 111.153 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.422 ' O ' HG23 ' A' ' 216' ' ' VAL . 21.9 m -58.63 -35.04 71.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.049 0.452 . . . . 0.0 110.66 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.794 HG13 ' SD ' ' A' ' 161' ' ' MET . 54.6 t -60.94 -38.67 79.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.784 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -54.2 -42.82 70.16 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.347 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -69.69 -34.34 73.8 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.71 HG12 ' HB2' ' A' ' 230' ' ' PRO . 98.3 t -60.64 -44.77 97.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.967 0.413 . . . . 0.0 111.346 -178.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.597 HG22 ' HE1' ' A' ' 161' ' ' MET . 41.9 t -76.77 -51.68 18.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 7.8 tptm -61.17 -40.5 94.14 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 220' ' ' GLN . 88.7 m -59.0 -38.27 78.81 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 219' ' ' THR . 63.7 tt0 60.69 111.7 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -177.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.984 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -139.92 167.12 22.84 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -176.839 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.814 HG23 ' C ' ' A' ' 226' ' ' LYS . 3.6 mp -118.0 126.05 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.207 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.757 HD12 ' CG ' ' A' ' 178' ' ' TYR . 7.5 tt -119.0 132.21 56.05 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.157 0.503 . . . . 0.0 111.744 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.516 ' HB2' HD23 ' A' ' 223' ' ' LEU . 19.5 t70 63.81 28.82 14.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.093 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 94.11 -14.3 65.58 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.542 -0.837 . . . . 0.0 115.037 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.814 ' C ' HG23 ' A' ' 222' ' ' ILE . 66.6 mttt -113.49 137.54 51.41 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 117.953 0.877 . . . . 0.0 112.338 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.809 HG12 HG12 ' A' ' 222' ' ' ILE . 33.7 m -64.77 128.27 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.282 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.613 HG22 ' O ' ' A' ' 164' ' ' GLY . 37.6 pt -124.28 155.1 31.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.045 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.1 76.69 78.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.295 0.569 . . . . 0.0 110.619 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.71 ' HB2' HG12 ' A' ' 216' ' ' VAL . 80.2 Cg_exo -53.0 128.67 29.86 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.12 2.547 . . . . 0.0 111.537 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -139.03 148.3 43.22 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.317 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.692 ' HE ' HG11 ' A' ' 213' ' ' VAL . 15.2 mmt85 -48.97 138.76 11.14 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.12 0.485 . . . . 0.0 111.523 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.864 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -75.72 146.07 40.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.98 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.84 129.1 24.8 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.417 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.04 149.15 21.8 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 121.915 1.744 . . . . 0.0 110.911 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 52.6 mmm-85 -54.62 -40.44 68.93 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.671 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -64.57 -40.32 95.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.596 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -65.51 -36.39 83.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.6 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -60.14 -37.59 80.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.991 0.424 . . . . 0.0 110.521 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -60.07 -38.62 83.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.129 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -59.68 -35.58 74.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.665 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.454 HG22 ' HA ' ' A' ' 292' ' ' ASP . 20.7 p -87.13 161.86 17.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.005 0.431 . . . . 0.0 111.666 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -142.87 113.91 0.82 Allowed Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.722 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 33.0 ttpt -85.33 140.75 30.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.96 0.409 . . . . 0.0 111.599 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 1.059 HD12 HG21 ' A' ' 315' ' ' ILE . 10.1 pt -118.36 160.52 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.488 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 315' ' ' ILE . 84.6 t80 -99.63 132.46 44.96 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 287' ' ' GLY . 14.0 p -128.55 145.34 35.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.639 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.41 166.11 19.32 Favored Glycine 0 C--O 1.226 -0.378 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.92 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 78.41 30.81 48.33 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.262 -0.971 . . . . 0.0 111.799 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.698 HD11 HG13 ' A' ' 247' ' ' VAL . 34.7 mm -55.27 -46.61 78.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 81.47 126.41 0.81 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.024 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -56.49 -29.56 78.71 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.604 2.202 . . . . 0.0 113.332 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -91.64 10.66 27.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.391 . . . . 0.0 111.388 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.67 ' HB ' ' O ' ' A' ' 250' ' ' ILE . 13.0 p -56.24 -40.9 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.524 ' N ' HG13 ' A' ' 254' ' ' VAL . 11.2 tpp85 63.59 116.08 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -176.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -50.29 -30.4 26.23 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 121.994 1.796 . . . . 0.0 112.561 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -60.51 -42.13 95.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.315 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 77.5 mm-40 -68.24 -39.66 82.21 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.049 0.452 . . . . 0.0 111.556 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.561 ' CZ ' HG22 ' A' ' 289' ' ' VAL . 40.6 t80 -62.63 -47.01 85.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.782 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.19 -42.43 93.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.694 0.283 . . . . 0.0 111.556 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -78.18 -31.16 49.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.806 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.506 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 15.1 t80 -60.66 -57.1 14.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.153 0.501 . . . . 0.0 111.698 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.708 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 16.9 m-85 -66.38 -23.8 66.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.715 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.703 ' N ' HD11 ' A' ' 269' ' ' ILE . 25.2 t -56.64 -30.51 63.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.527 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -53.55 -36.62 62.04 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.855 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 9.2 p90 -116.82 42.76 2.41 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.119 0.485 . . . . 0.0 111.51 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.546 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 156.97 148.42 5.09 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.824 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.437 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 50.1 m -59.85 -36.92 77.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.729 0.3 . . . . 0.0 111.72 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.703 HD11 ' N ' ' A' ' 264' ' ' SER . 69.9 mt 69.86 77.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.394 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.522 HG12 ' CA ' ' A' ' 292' ' ' ASP . 35.4 mm -59.84 -40.97 84.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.806 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -154.28 86.71 1.16 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.586 ' HB2' HG23 ' A' ' 269' ' ' ILE . . . -101.85 131.26 48.29 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -143.66 152.57 41.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.504 0.668 . . . . 0.0 112.712 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 1.023 HD23 HD11 ' A' ' 276' ' ' LEU . 21.1 tp -68.43 -31.57 70.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.783 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.718 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 10.3 mmm 92.86 -86.61 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.001 0.92 . . . . 0.0 112.721 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 1.023 HD11 HD23 ' A' ' 274' ' ' LEU . 5.9 mp 62.27 145.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.227 0.537 . . . . 0.0 111.268 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 51.6 p30 -113.08 -132.24 0.33 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.388 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -55.99 -32.45 63.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.51 ' OD1' HG23 ' A' ' 280' ' ' THR . 61.1 t0 -149.81 -108.0 0.07 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.736 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.51 HG23 ' OD1' ' A' ' 279' ' ' ASP . 64.4 p -108.4 20.08 19.04 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -52.44 -39.3 52.3 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 119.645 -1.264 . . . . 0.0 111.975 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.574 ' HB3' ' HA ' ' A' ' 276' ' ' LEU . 13.1 tm0? -64.98 -32.83 74.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.039 0.447 . . . . 0.0 111.424 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 48.0 p -57.2 -10.08 1.14 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.777 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -50.4 -36.95 35.16 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 121.406 -0.118 . . . . 0.0 110.908 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 151.57 26.72 0.05 OUTLIER Glycine 0 CA--C 1.524 0.601 0 C-N-CA 119.423 -1.37 . . . . 0.0 115.567 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.571 ' HA ' ' HA2' ' A' ' 248' ' ' GLY . 13.4 p90 -138.78 157.01 46.87 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.722 1.261 . . . . 0.0 111.184 178.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.742 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -148.26 166.02 29.02 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.777 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -113.52 130.03 56.43 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.629 ' HB ' HG12 ' A' ' 245' ' ' ILE . 40.8 t -125.57 133.34 69.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.849 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 52.2 m -114.79 135.38 54.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.546 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 24.5 m-85 -120.02 139.34 52.65 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.522 ' CA ' HG12 ' A' ' 270' ' ' ILE . 53.0 t0 -58.82 -36.93 75.31 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.763 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 99.8 p -123.12 147.73 46.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.406 0.622 . . . . 0.0 111.715 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.43 -30.55 70.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.439 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -55.56 -40.36 71.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.332 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.648 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -65.18 -37.58 87.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.792 0.329 . . . . 0.0 110.413 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.815 HG13 HG22 ' A' ' 245' ' ' ILE . 69.4 t -62.08 -49.07 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 CA-C-O 121.179 0.514 . . . . 0.0 109.738 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -66.68 -35.5 80.29 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.874 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.584 ' HD3' ' HB2' ' A' ' 266' ' ' TRP . 62.3 ttt-85 -56.19 -45.77 79.68 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.083 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.855 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 2.1 p -71.84 -35.35 54.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.964 0.411 . . . . 0.0 111.214 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 74.0 m -59.07 -40.74 86.12 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.701 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -57.57 -34.66 69.44 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.312 0.577 . . . . 0.0 109.843 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 305' ' ' PHE . 81.6 m-20 -83.85 4.77 27.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.686 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.706 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 30.7 tptt 44.04 -82.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.323 0.249 . . . . 0.0 110.575 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.719 ' HB3' ' HB3' ' A' ' 312' ' ' LYS . 3.1 m-30 -105.31 135.92 45.8 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.12 0.486 . . . . 0.0 110.269 178.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.694 ' CD1' HG23 ' A' ' 300' ' ' VAL . 0.9 OUTLIER -115.01 134.92 56.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.661 178.653 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -69.36 130.36 42.35 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.807 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.573 ' HE2' HG23 ' A' ' 254' ' ' VAL . 17.7 t80 -150.25 -72.56 0.17 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.89 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.46 ' HE3' ' CE2' ' A' ' 308' ' ' PHE . 4.0 mmpt? -91.96 -176.53 4.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.261 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -50.14 -30.57 11.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.911 0.386 . . . . 0.0 110.384 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -117.56 152.74 34.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.903 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.719 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 62.6 mttp -62.18 148.77 43.52 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.115 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.639 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 28.4 pt -107.81 138.63 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 314' ' ' GLU . . . . . 0.603 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 81.9 mt-10 -104.55 132.89 50.28 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 1.059 HG21 HD12 ' A' ' 245' ' ' ILE . 82.6 mt -119.31 128.55 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 121.394 0.616 . . . . 0.0 111.744 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -131.25 146.07 52.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.838 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -49.79 145.46 5.31 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.234 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.45 142.5 43.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.138 0.494 . . . . 0.0 111.463 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.477 179.806 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.676 ' SG ' HG21 ' A' ' 213' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 121.115 0.483 . . . . 0.0 110.039 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.792 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 6.7 tptm -117.92 135.65 53.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.639 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.925 ' SD ' HG13 ' A' ' 213' ' ' VAL . 89.0 mmm -117.72 145.19 44.62 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.628 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 3.3 t80 -110.43 130.79 55.48 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.477 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.785 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 19.9 mm -116.87 127.68 74.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.578 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.48 ' O ' ' HB ' ' A' ' 228' ' ' ILE . . . -128.81 161.52 22.42 Favored Glycine 0 CA--C 1.505 -0.562 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.518 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.418 ' C ' HG22 ' A' ' 228' ' ' ILE . . . 77.59 27.69 58.7 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.96 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.969 HD23 HG21 ' A' ' 228' ' ' ILE . 72.9 mt -86.45 140.44 29.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.636 0.255 . . . . 0.0 111.176 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -63.63 135.42 56.75 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.541 ' CE2' ' HD2' ' A' ' 198' ' ' ARG . 4.1 m-90 -53.6 143.21 20.61 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.176 -0.609 . . . . 0.0 109.906 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 168' ' ' TRP . 53.7 t0 74.21 36.53 0.66 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.742 -177.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.596 HG21 HD13 ' A' ' 166' ' ' LEU . 90.0 m -59.98 -34.67 73.62 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.17 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.508 ' C ' HD12 ' A' ' 190' ' ' ILE . 0.0 OUTLIER 59.66 127.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -178.519 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.765 ' N ' HD12 ' A' ' 190' ' ' ILE . 55.1 mp0 -58.15 -31.62 67.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.361 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.598 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.9 m-20 -55.46 -41.22 72.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.761 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 170' ' ' THR . 9.8 m120 -64.83 -37.63 88.26 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.871 HD22 HD21 ' A' ' 205' ' ' LEU . 4.8 mt -60.51 -45.41 93.91 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.598 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -67.68 -34.84 77.71 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.363 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.29 -37.96 89.28 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.028 0.442 . . . . 0.0 109.851 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.43 ' OH ' ' HB3' ' A' ' 221' ' ' HIS . 67.3 t80 -80.58 -61.47 1.96 Allowed 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.437 0.637 . . . . 0.0 110.936 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.604 ' CE2' HD23 ' A' ' 175' ' ' LEU . 72.2 m-85 -66.04 -25.68 67.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.776 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.25 -26.11 12.82 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.241 -0.98 . . . . 0.0 110.738 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.524 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 0.1 OUTLIER -54.29 -46.05 72.67 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.511 0.724 . . . . 0.0 111.02 179.007 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -70.31 -35.33 73.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.701 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 171.36 -169.89 42.86 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.19 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 48.1 m -84.0 138.48 33.08 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 206' ' ' SER . 7.1 p -102.34 124.37 56.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.793 HG23 ' N ' ' A' ' 208' ' ' GLU . 69.4 p -69.63 -40.6 76.46 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.792 0.33 . . . . 0.0 111.136 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.501 ' OD1' ' O ' ' A' ' 186' ' ' THR . 86.3 m-20 -149.11 161.99 40.87 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.342 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' A' ' 175' ' ' LEU . 0.0 OUTLIER -138.4 144.23 40.13 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.207 -178.757 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 11.2 tptt -140.5 121.57 14.69 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 178.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.765 HD12 ' N ' ' A' ' 172' ' ' GLU . 11.4 mt -124.56 130.82 73.39 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.796 176.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.619 ' HB2' ' HB2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -86.2 109.12 18.69 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.228 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -121.4 148.11 44.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.733 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 198' ' ' ARG . 10.7 t0 -123.76 77.46 56.83 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -56.73 -23.25 48.71 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.678 2.252 . . . . 0.0 112.758 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.66 -74.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.53 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.1 p -69.75 -26.05 64.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.03 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.87 -2.97 67.04 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.389 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.541 ' HD2' ' CE2' ' A' ' 168' ' ' TRP . 9.8 tpp85 -129.41 137.0 50.66 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.73 -167.22 1.94 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.391 0.615 . . . . 0.0 112.48 -178.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.947 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 66.8 mmt-85 -53.52 -38.49 63.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.474 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 166' ' ' LEU . . . 81.2 18.05 70.28 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.955 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.947 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 32.2 p90 -139.52 159.81 41.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.669 0.271 . . . . 0.0 110.534 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.571 ' HA2' ' HE2' ' A' ' 191' ' ' MET . . . -142.51 160.07 27.28 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.948 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.628 ' CE2' ' CD1' ' A' ' 162' ' ' PHE . 97.5 m-85 -108.37 129.05 55.26 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.871 HD21 HD22 ' A' ' 175' ' ' LEU . 65.7 mt -108.31 142.05 39.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.939 0.399 . . . . 0.0 111.969 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.7 ' O ' HG23 ' A' ' 185' ' ' VAL . 33.8 t -125.01 128.2 48.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.314 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -117.02 138.93 51.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.95 0.405 . . . . 0.0 111.975 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.793 ' N ' HG23 ' A' ' 186' ' ' THR . 84.4 tt0 -62.81 -34.52 77.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.727 178.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.92 117.48 53.72 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.509 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.04 -21.13 33.14 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.639 2.226 . . . . 0.0 113.296 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.7 m -57.31 -39.02 74.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.617 0.246 . . . . 0.0 111.553 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.931 ' O ' HG23 ' A' ' 216' ' ' VAL . 21.2 m -60.82 -37.53 82.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.818 0.342 . . . . 0.0 110.696 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.925 HG13 ' SD ' ' A' ' 161' ' ' MET . 62.0 t -61.51 -43.81 97.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.376 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -61.47 -41.43 97.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.931 0.396 . . . . 0.0 111.045 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.462 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 21.7 pt-20 -76.76 -29.44 56.11 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 212' ' ' SER . 79.5 t -61.85 -43.89 98.03 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-O 121.027 0.442 . . . . 0.0 110.639 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 50.1 t -71.87 -45.53 64.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -60.15 -38.76 84.12 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.475 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 35.5 m -81.72 144.28 31.24 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -80.21 138.67 36.88 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.836 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 41.0 m-70 -122.34 132.16 54.25 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -176.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.86 HD12 HG12 ' A' ' 227' ' ' VAL . 29.1 mm -122.24 110.56 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.492 HD23 ' CG ' ' A' ' 224' ' ' ASP . 7.7 tt -122.4 126.72 48.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.926 0.393 . . . . 0.0 111.061 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.492 ' CG ' HD23 ' A' ' 223' ' ' LEU . 84.9 m-20 55.4 41.81 30.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.226 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 74.32 14.03 81.06 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.707 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -125.73 152.63 45.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.981 0.39 . . . . 0.0 111.721 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.86 HG12 HD12 ' A' ' 222' ' ' ILE . 27.5 m -99.89 130.64 48.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.312 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.969 HG21 HD23 ' A' ' 166' ' ' LEU . 33.6 pt -126.04 158.44 35.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.396 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.57 80.48 71.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.159 0.504 . . . . 0.0 110.786 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.558 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 61.8 Cg_exo -56.66 127.97 28.1 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 123.07 2.513 . . . . 0.0 112.096 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 8.8 mtmm -133.13 156.06 48.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.008 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -60.14 137.18 58.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.769 0.318 . . . . 0.0 110.98 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.792 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -64.34 144.52 57.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.269 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.483 HG22 ' HD2' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -122.41 137.03 27.1 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.645 179.304 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.5 ' HD2' ' OE1' ' A' ' 238' ' ' GLU . 34.8 Cg_exo -56.26 145.05 79.43 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 121.923 1.749 . . . . 0.0 110.727 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.411 ' C ' ' HD3' ' A' ' 236' ' ' ARG . 4.2 tmt_? -55.38 -40.97 71.99 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.931 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -61.72 -41.76 98.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.436 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.5 ' OE1' ' HD2' ' A' ' 235' ' ' PRO . 94.4 mt-10 -66.14 -35.25 79.99 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.906 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -59.98 -37.0 78.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.07 0.462 . . . . 0.0 110.259 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -59.79 -38.17 81.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.975 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -58.66 -37.98 77.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.193 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 19.2 p -84.8 161.98 19.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.114 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.04 161.74 24.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.809 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.482 ' HD2' ' CE2' ' A' ' 288' ' ' PHE . 7.6 ttpm? -138.7 131.99 30.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.812 0.306 . . . . 0.0 111.182 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.675 ' CG2' HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -120.9 162.52 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 121.409 0.623 . . . . 0.0 112.23 -178.753 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.522 ' HB3' ' O ' ' A' ' 316' ' ' LYS . 85.1 t80 -104.19 138.22 40.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.746 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.704 HG23 HG12 ' A' ' 315' ' ' ILE . 9.2 p -131.99 147.61 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.546 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -125.99 165.18 19.28 Favored Glycine 0 C--O 1.226 -0.389 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 178.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 85.59 14.66 67.56 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.586 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.666 ' CG2' HG11 ' A' ' 254' ' ' VAL . 35.8 mm -54.95 -45.7 76.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 1.015 ' O ' HG12 ' A' ' 254' ' ' VAL . . . 59.44 129.77 0.01 OUTLIER Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.961 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.93 -27.11 52.23 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.326 2.017 . . . . 0.0 113.137 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -59.25 -33.97 71.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.919 0.39 . . . . 0.0 111.427 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 1.015 HG12 ' O ' ' A' ' 251' ' ' GLY . 7.1 p -50.5 -39.55 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.443 ' N ' HG13 ' A' ' 254' ' ' VAL . 7.7 tpt180 68.11 126.65 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.445 ' HB3' ' HG ' ' A' ' 274' ' ' LEU . 8.9 Cg_endo -51.08 -26.62 19.56 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 121.904 1.736 . . . . 0.0 112.827 -177.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -62.01 -45.5 93.34 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 78.2 mm-40 -66.38 -38.41 87.48 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.701 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 40.6 t80 -60.88 -45.56 94.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.166 -178.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.49 -43.4 97.37 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.594 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -78.12 -28.52 48.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.013 0.435 . . . . 0.0 111.012 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.599 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 4.3 t80 -59.12 -58.61 7.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.918 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.702 ' CG ' HG21 ' A' ' 289' ' ' VAL . 5.8 m-85 -63.51 -23.63 67.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.218 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.685 ' N ' HD11 ' A' ' 269' ' ' ILE . 23.1 t -55.13 -29.82 58.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.842 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -52.35 -35.47 51.17 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.361 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.68 ' CZ2' ' CD2' ' A' ' 263' ' ' PHE . 9.0 p90 -116.13 41.72 2.53 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.215 0.531 . . . . 0.0 111.526 179.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.509 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 159.39 157.12 8.38 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.81 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 4.5 t -73.45 -25.19 60.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.339 . . . . 0.0 111.011 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.685 HD11 ' N ' ' A' ' 264' ' ' SER . 75.1 mt 58.11 124.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.768 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.562 HD11 ' HB2' ' A' ' 292' ' ' ASP . 25.3 mm -93.2 -74.45 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.14 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -92.09 -72.54 0.59 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.793 0.33 . . . . 0.0 111.738 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 289' ' ' VAL . . . 46.56 101.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.353 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 273' ' ' GLN . . . . . 0.509 ' HG3' ' HG2' ' A' ' 275' ' ' MET . 14.1 pt20 -143.17 158.22 43.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.115 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.607 ' HB3' ' CD ' ' A' ' 282' ' ' GLN . 42.6 mt -63.78 -33.98 76.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.181 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.698 ' O ' ' HB3' ' A' ' 282' ' ' GLN . 8.0 mtm 68.11 71.13 0.32 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.634 0.254 . . . . 0.0 110.96 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.542 HD23 ' HG2' ' A' ' 282' ' ' GLN . 9.7 mt -76.4 126.64 31.36 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.129 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -58.93 -38.17 78.37 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.888 0.852 . . . . 0.0 108.726 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -157.34 -101.05 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 113.993 -1.458 . . . . 0.0 108.026 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.782 ' O ' HG23 ' A' ' 280' ' ' THR . 89.5 m-20 -62.77 -39.08 93.06 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.574 178.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.5 OUTLIER 170.77 50.07 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.005 -179.729 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -56.16 -38.38 76.79 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.092 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.698 ' HB3' ' O ' ' A' ' 275' ' ' MET . 0.0 OUTLIER -61.81 -30.07 70.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.197 0.522 . . . . 0.0 111.632 179.697 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 52.2 p -54.55 -14.18 1.21 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.626 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -51.33 -36.64 43.7 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 121.332 -0.147 . . . . 0.0 110.775 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 157.37 23.75 0.03 OUTLIER Glycine 0 CA--C 1.526 0.721 0 C-N-CA 119.596 -1.288 . . . . 0.0 115.379 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.492 ' O ' ' NE2' ' A' ' 282' ' ' GLN . 2.0 p90 -138.43 163.17 32.59 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.672 1.236 . . . . 0.0 111.073 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.691 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -142.17 159.83 27.11 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.525 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.496 ' CD2' ' SD ' ' A' ' 275' ' ' MET . 0.1 OUTLIER -122.41 124.17 43.02 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.702 HG21 ' CG ' ' A' ' 263' ' ' PHE . 52.4 t -125.89 136.19 61.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.083 0.468 . . . . 0.0 111.501 178.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 55.7 m -116.44 136.24 53.16 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.509 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 42.8 m-85 -114.1 136.92 52.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.355 0.598 . . . . 0.0 112.398 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.562 ' HB2' HD11 ' A' ' 270' ' ' ILE . 51.7 t0 -57.09 -36.11 70.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.638 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 50.4 m -121.97 145.2 48.35 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.337 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.912 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -65.77 -28.99 69.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.531 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -54.68 -35.62 63.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.872 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.45 -39.26 83.03 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.912 HG12 ' O ' ' A' ' 294' ' ' ALA . 7.3 p -60.0 -37.51 72.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.974 0.416 . . . . 0.0 111.331 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -61.98 -39.31 91.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.846 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -61.08 -43.83 98.29 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.649 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 0.9 OUTLIER -69.38 -34.1 60.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.32 -179.322 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 89.5 m -57.77 -45.28 86.18 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.062 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -62.23 -39.72 93.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.213 0.53 . . . . 0.0 109.883 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.6 m-20 -62.38 -33.64 75.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.123 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.638 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 22.6 tptm 68.47 -69.06 0.16 Allowed 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -177.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.638 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.4 m-30 -116.28 151.11 36.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.121 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.625 HD11 HG23 ' A' ' 300' ' ' VAL . 8.4 mm -116.53 136.35 53.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.502 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -79.93 65.12 4.98 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.599 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 3.9 t80 -65.86 -63.44 1.09 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.461 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 5.5 mmpt? -105.91 38.79 1.92 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.376 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 61.47 34.24 18.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -175.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -151.01 163.96 37.52 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 113.167 -1.833 . . . . 0.0 107.351 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 68.5 mttt -97.15 136.26 37.92 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.514 0.673 . . . . 0.0 112.711 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 305' ' ' PHE . 36.3 pt -117.62 150.95 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 314' ' ' GLU . . . . . 0.535 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 87.7 mt-10 -106.06 133.35 50.91 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.86 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 0.704 HG12 HG23 ' A' ' 247' ' ' VAL . 74.3 mt -122.59 129.32 75.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.227 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.522 ' O ' ' HB3' ' A' ' 246' ' ' PHE . 8.8 tptt -133.94 141.22 47.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.717 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -53.69 150.56 7.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.669 0.271 . . . . 0.0 110.332 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -49.69 142.86 7.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.948 0.404 . . . . 0.0 111.232 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.718 -179.06 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 43.5 t . . . . . 0 CA--C 1.529 0.144 0 CA-C-O 120.755 0.312 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -138.94 137.41 36.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.099 0.475 . . . . 0.0 111.198 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.827 ' SD ' HG13 ' A' ' 213' ' ' VAL . 94.6 mmm -113.56 148.07 36.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.26 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.583 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 2.9 t80 -104.06 127.79 51.64 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 203' ' ' GLY . 20.3 mm -116.71 129.1 73.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.734 0.302 . . . . 0.0 111.364 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -133.33 163.27 24.36 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 178.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.84 36.63 52.37 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.981 -1.104 . . . . 0.0 112.024 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 64.3 mt -59.36 -26.73 65.33 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 52.2 t30 69.67 40.38 1.38 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -177.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 15.4 m0 30.9 38.5 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 114.636 -1.166 . . . . 0.0 112.76 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -164.34 13.56 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.789 HG22 ' HB2' ' A' ' 175' ' ' LEU . 63.1 m -60.74 -38.17 84.24 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.569 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.1 OUTLIER 51.92 135.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.178 0.514 . . . . 0.0 111.591 -179.432 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.574 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 97.8 mt-10 -61.15 -33.77 73.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.028 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.43 ' O ' ' HG3' ' A' ' 177' ' ' GLU . 91.5 m-20 -59.37 -44.49 92.71 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.629 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 170' ' ' THR . 81.9 m-20 -77.16 -42.23 38.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.376 0.608 . . . . 0.0 110.735 178.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.789 ' HB2' HG22 ' A' ' 170' ' ' THR . 41.1 tp -66.63 -48.75 68.46 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.419 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.505 ' HG3' HG11 ' A' ' 185' ' ' VAL . 68.0 ttp85 -63.13 -44.42 95.63 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.806 0.336 . . . . 0.0 111.015 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 173' ' ' ASP . 98.3 mt-10 -67.03 -37.29 83.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.476 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.663 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 69.5 t80 -61.16 -48.21 82.64 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.1 0.476 . . . . 0.0 110.864 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -82.76 -12.06 57.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.885 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.17 -29.85 53.33 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 177.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.499 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 0.3 OUTLIER -56.48 -45.27 81.01 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.307 -0.947 . . . . 0.0 110.764 178.761 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -70.64 -33.66 71.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.331 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -173.38 -179.7 44.22 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.26 -0.971 . . . . 0.0 113.166 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 46.6 m -63.07 -31.09 72.15 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.833 HG23 ' CE1' ' A' ' 207' ' ' PHE . 1.2 t 63.95 85.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -177.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -59.22 -50.98 71.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.019 -178.005 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 206' ' ' SER . 60.7 t0 -147.49 105.87 3.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.171 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.99 ' O ' HD13 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -97.93 144.44 27.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.903 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.869 ' N ' HD22 ' A' ' 188' ' ' LEU . 30.7 tptt -127.26 128.68 46.41 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.627 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.574 ' HB ' ' HG2' ' A' ' 172' ' ' GLU . 1.5 tt -117.82 -10.35 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.845 -0.162 . . . . 0.0 111.428 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.84 ' HE3' ' O ' ' A' ' 202' ' ' PHE . 17.0 mtm 51.44 150.18 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.987 0.422 . . . . 0.0 111.543 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.4 ' HG3' ' HD3' ' A' ' 194' ' ' PRO . 7.5 ptmt -134.5 163.66 29.21 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.095 0.474 . . . . 0.0 112.223 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.642 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 1.3 t70 -124.23 76.55 60.64 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.619 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.4 ' HD3' ' HG3' ' A' ' 192' ' ' LYS . 38.8 Cg_exo -58.03 -25.46 70.66 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.711 2.274 . . . . 0.0 112.98 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -68.94 -66.66 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.32 . . . . 0.0 111.588 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.0 p -71.98 -20.31 61.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.772 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 88.07 12.88 65.1 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.369 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.642 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 55.5 mtt180 -118.47 167.75 11.3 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 121.094 0.473 . . . . 0.0 112.253 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.9 t -69.71 152.19 44.95 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.254 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.897 ' HG3' ' CE1' ' A' ' 202' ' ' PHE . 15.2 tpt180 -52.68 -32.02 40.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.977 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.406 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 98.1 -4.11 60.57 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.485 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.897 ' CE1' ' HG3' ' A' ' 200' ' ' ARG . 12.1 p90 -151.41 159.45 44.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.721 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -152.71 150.43 22.22 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.274 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.666 ' HA ' ' O ' ' A' ' 161' ' ' MET . 94.8 m-85 -106.78 125.63 51.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.081 0.44 . . . . 0.0 109.82 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 161' ' ' MET . 46.6 mt -103.1 138.92 39.3 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.911 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 23.2 t -123.17 132.77 54.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.119 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.833 ' CE1' HG23 ' A' ' 185' ' ' VAL . 96.9 m-85 -117.89 140.55 49.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 111.695 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.424 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.2 tt0 -60.66 -34.12 73.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.198 0.523 . . . . 0.0 109.673 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.2 115.17 50.36 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.609 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.62 -21.76 32.81 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.665 2.244 . . . . 0.0 113.22 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.5 m -56.86 -35.7 69.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.726 0.298 . . . . 0.0 111.307 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.923 ' O ' HG23 ' A' ' 216' ' ' VAL . 32.3 m -58.49 -36.96 74.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.851 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.827 HG13 ' SD ' ' A' ' 161' ' ' MET . 63.0 t -60.83 -42.02 90.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.179 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.423 ' O ' HG12 ' A' ' 217' ' ' VAL . 94.6 m-20 -59.29 -40.64 86.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.877 0.37 . . . . 0.0 111.177 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.401 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 12.9 pt-20 -80.81 -27.38 36.59 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 212' ' ' SER . 53.1 t -62.07 -45.77 97.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 CA-C-O 120.773 0.32 . . . . 0.0 111.693 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 214' ' ' ASP . 8.3 p -60.01 -36.55 68.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -60.96 -35.87 77.89 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.753 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 29.6 m -80.66 143.27 33.19 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 93.1 mt-30 -65.97 -36.83 84.37 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.863 ' HB3' HD11 ' A' ' 228' ' ' ILE . 82.4 m-70 78.4 44.33 0.07 Allowed 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 75.4 mt -75.38 82.2 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.2 tt -82.52 -75.47 0.31 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -176.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 49.2 p30 -94.67 13.22 25.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.582 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 95.17 7.4 59.56 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.052 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.12 137.0 52.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.6 p -69.73 126.17 29.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.277 0.56 . . . . 0.0 111.773 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.863 HD11 ' HB3' ' A' ' 221' ' ' HIS . 34.5 pt -124.84 157.52 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.329 178.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.8 77.21 76.6 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.202 0.525 . . . . 0.0 112.4 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.637 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 35.0 Cg_exo -63.55 84.98 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 123.087 2.524 . . . . 0.0 111.653 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -100.73 157.13 16.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.825 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.507 ' HD3' HG11 ' A' ' 213' ' ' VAL . 37.7 tpt85 -60.27 137.04 58.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.935 0.397 . . . . 0.0 111.574 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -59.91 145.79 44.58 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.06 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 9.7 mt -109.51 124.36 34.05 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.282 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.69 143.44 57.87 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 121.802 1.668 . . . . 0.0 110.753 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 32.5 mmm180 -57.53 -39.27 76.2 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.695 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 55.2 p30 -63.88 -41.69 97.67 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.978 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.613 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 97.5 mt-10 -73.43 -37.92 65.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.558 0.694 . . . . 0.0 109.703 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -60.41 -39.98 89.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.314 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -59.52 -40.24 86.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.211 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -61.13 -35.05 76.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.148 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 292' ' ' ASP . 16.3 p -82.87 161.39 21.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.392 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -149.03 173.02 29.05 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.193 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.56 ' O ' ' HB2' ' A' ' 318' ' ' ALA . 6.9 tptm -135.01 131.7 37.41 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.728 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -121.48 162.24 20.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.348 0.594 . . . . 0.0 111.011 179.486 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -104.6 136.56 43.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.35 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.75 HG11 ' CE1' ' A' ' 259' ' ' PHE . 14.7 p -131.49 147.87 32.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.422 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -129.11 166.59 21.46 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.404 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 84.2 22.79 53.8 Favored Glycine 0 C--N 1.328 0.107 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.476 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.534 HG23 HG21 ' A' ' 254' ' ' VAL . 43.0 mm -54.97 -48.99 74.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.725 ' O ' HG22 ' A' ' 254' ' ' VAL . . . 57.88 129.64 0.01 OUTLIER Glycine 0 CA--C 1.525 0.679 0 C-N-CA 119.807 -1.187 . . . . 0.0 111.436 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' PRO . . . . . 0.5 ' HD3' ' HG3' ' A' ' 284' ' ' ARG . 52.0 Cg_exo -54.04 -24.92 34.49 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.165 1.91 . . . . 0.0 112.907 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -57.84 -36.49 72.37 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 251' ' ' GLY . 16.2 m -65.98 -36.76 78.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 62.35 153.32 0.11 Allowed Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -56.54 -31.12 85.39 Favored 'Trans proline' 0 CA--C 1.527 0.154 0 C-N-CA 122.39 2.06 . . . . 0.0 113.478 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -64.12 -49.0 73.9 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.562 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 97.8 mt-10 -66.22 -35.57 80.78 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.938 0.399 . . . . 0.0 112.029 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.75 ' CE1' HG11 ' A' ' 247' ' ' VAL . 35.5 t80 -59.62 -45.34 92.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.471 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.4 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.5 tt0 -64.73 -40.58 95.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.455 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 258' ' ' GLU . 20.5 pt-20 -75.79 -33.5 60.16 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.7 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.714 ' CE2' HD11 ' A' ' 313' ' ' ILE . 83.8 t80 -58.9 -56.78 17.84 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.652 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 18.6 m-85 -65.83 -24.61 66.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.326 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.713 ' N ' HD11 ' A' ' 269' ' ' ILE . 24.9 t -56.21 -31.14 63.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.55 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -53.99 -36.15 62.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.526 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.708 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 6.9 p90 -119.18 50.58 1.21 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.49 0.662 . . . . 0.0 111.213 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.566 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 148.86 145.85 4.21 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.634 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.444 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 41.1 m -59.74 -38.1 80.77 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.713 HD11 ' N ' ' A' ' 264' ' ' SER . 76.9 mt 70.72 84.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.533 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.619 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 66.5 mt -59.69 -38.72 77.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.836 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -131.99 -84.89 0.49 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 289' ' ' VAL . . . 61.68 113.08 0.02 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.705 0.288 . . . . 0.0 110.867 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -139.29 155.23 47.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.362 0.601 . . . . 0.0 112.07 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.557 HD21 ' CB ' ' A' ' 283' ' ' SER . 35.5 tp -65.05 -35.19 80.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.251 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.549 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 95.7 mmm 76.66 12.81 2.41 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.577 ' O ' HD23 ' A' ' 276' ' ' LEU . 0.9 OUTLIER -56.64 119.09 5.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.215 0.531 . . . . 0.0 111.334 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 279' ' ' ASP . 58.3 t0 -88.79 119.0 28.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.852 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 62.9 -75.31 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.273 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.428 ' OD1' HG23 ' A' ' 280' ' ' THR . 51.6 t0 -142.53 98.75 3.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.781 0.324 . . . . 0.0 111.648 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.428 HG23 ' OD1' ' A' ' 279' ' ' ASP . 2.8 p 44.62 50.54 8.38 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -84.48 -74.7 1.23 Allowed Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.028 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 286' ' ' PHE . 92.4 mm-40 -60.94 -32.02 71.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.243 0.544 . . . . 0.0 109.814 179.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.559 ' O ' ' HB3' ' A' ' 284' ' ' ARG . 54.1 p -63.17 168.27 4.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.45 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.559 ' HB3' ' O ' ' A' ' 283' ' ' SER . 39.1 ttt85 81.03 -41.39 0.16 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.826 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -94.94 -52.16 1.82 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.225 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 29.0 p90 -143.45 167.7 21.57 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.193 0.521 . . . . 0.0 112.209 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.744 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -137.13 158.39 24.28 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.141 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.516 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.7 OUTLIER -115.34 127.44 55.42 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.734 -0.274 . . . . 0.0 111.207 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.728 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 21.8 t -124.2 136.38 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.799 0.333 . . . . 0.0 111.69 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 33.6 m -115.68 136.22 53.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.659 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.566 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 31.5 m-85 -118.33 139.21 51.69 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.619 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 55.8 p30 -62.56 -32.22 73.15 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.663 179.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 293' ' ' SER . . . . . 0.573 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 99.0 p -122.23 145.81 47.86 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.27 0.557 . . . . 0.0 111.556 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.98 -33.63 75.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.169 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -57.31 -37.39 72.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.361 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.59 82.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.914 0.387 . . . . 0.0 110.915 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.511 ' O ' HG12 ' A' ' 300' ' ' VAL . 83.3 t -62.23 -42.42 95.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.981 0.42 . . . . 0.0 110.96 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -60.94 -36.62 79.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.356 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -56.98 -43.31 81.56 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.708 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 1.3 p -69.15 -34.55 63.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.656 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 80.8 m -58.01 -45.92 86.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.473 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -62.68 -39.54 94.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.252 0.549 . . . . 0.0 110.258 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -63.36 -31.99 73.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.955 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.686 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 38.4 tptt 67.81 -75.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.686 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.9 m-30 -111.16 135.57 51.49 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.702 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.683 HD11 HG23 ' A' ' 300' ' ' VAL . 1.0 OUTLIER -118.55 137.41 52.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.192 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -79.08 112.64 16.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.965 0.412 . . . . 0.0 110.287 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.583 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 1.3 t80 -91.99 -89.22 0.19 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.809 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.503 ' HD3' ' CE1' ' A' ' 308' ' ' PHE . 0.0 OUTLIER -92.41 -74.86 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.939 0.399 . . . . 0.0 110.981 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -131.78 -15.79 3.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.259 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -122.02 157.36 31.53 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.518 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 312' ' ' LYS . 11.9 mptt -79.04 143.34 35.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.935 0.398 . . . . 0.0 111.093 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.714 HD11 ' CE2' ' A' ' 262' ' ' PHE . 29.9 pt -115.3 147.81 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 314' ' ' GLU . . . . . 0.561 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 84.1 mt-10 -104.78 133.3 49.83 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.651 -0.42 . . . . 0.0 109.982 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 0.69 HG12 HG23 ' A' ' 247' ' ' VAL . 73.5 mt -122.55 127.95 75.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.069 0.461 . . . . 0.0 111.253 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -126.01 155.05 42.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.725 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 70.0 ttp85 -58.87 146.12 38.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.718 0.294 . . . . 0.0 110.378 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 244' ' ' LYS . . . -55.71 145.26 24.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.076 0.465 . . . . 0.0 111.442 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.549 -179.928 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 45.8 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.959 0.409 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.764 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 62.9 tttt -129.66 141.36 50.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.574 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.853 ' SD ' HG13 ' A' ' 213' ' ' VAL . 95.1 mmm -118.08 146.38 44.15 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.536 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 6.7 t80 -106.09 127.55 53.26 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.939 HG23 HD12 ' A' ' 228' ' ' ILE . 11.1 mm -115.37 117.45 55.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.249 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 202' ' ' PHE . . . -91.54 178.86 41.53 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.813 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.887 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 26.69 80.11 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 114.387 0.515 . . . . 0.0 114.387 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.449 ' O ' ' HB ' ' A' ' 170' ' ' THR . 58.8 mt -85.76 2.13 46.81 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.881 ' O ' ' N ' ' A' ' 169' ' ' ASP . 41.7 t-20 61.04 41.39 13.96 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 16.9 m0 34.49 -55.97 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.053 0.941 . . . . 0.0 113.522 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.881 ' N ' ' O ' ' A' ' 167' ' ' ASN . 93.1 m-20 -53.21 -34.84 58.74 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 166' ' ' LEU . 55.8 m -62.95 139.43 58.75 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.189 0.518 . . . . 0.0 111.206 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 10.5 p -116.12 167.43 11.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.324 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.84 ' N ' HD12 ' A' ' 190' ' ' ILE . 21.2 pt-20 -59.85 -27.08 66.35 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 89.6 m-20 -62.07 -43.01 99.76 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.044 0.449 . . . . 0.0 110.3 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -67.05 -36.66 82.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.766 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.527 HD23 ' CE2' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -53.63 -49.82 67.04 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -179.025 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 180' ' ' GLY . 0.0 OUTLIER -65.29 -33.45 76.01 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.623 178.881 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -62.02 -41.36 97.99 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.255 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.444 ' OH ' ' HB3' ' A' ' 221' ' ' HIS . 64.0 t80 -75.74 -60.0 2.51 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.628 0.727 . . . . 0.0 111.003 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.527 ' CE2' HD23 ' A' ' 175' ' ' LEU . 80.8 m-85 -69.0 -21.1 64.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.652 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.95 -25.53 16.82 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.687 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.821 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -55.7 -40.72 72.78 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.0 0.428 . . . . 0.0 110.795 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.821 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 64.6 m-85 -69.96 -32.49 70.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.43 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 167.08 -133.11 2.8 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.831 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.4 m -119.93 139.06 53.02 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.77 HG21 ' HB3' ' A' ' 188' ' ' LEU . 0.8 OUTLIER -91.22 117.63 34.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.2 t -66.7 -43.77 83.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.138 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -156.28 98.34 1.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.77 ' HB3' HG21 ' A' ' 185' ' ' VAL . 0.0 OUTLIER -94.34 142.1 27.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.499 178.587 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.627 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 49.1 tptt -130.92 128.0 39.62 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.84 HD12 ' N ' ' A' ' 172' ' ' GLU . 1.4 mt -122.54 129.53 75.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.623 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.52 ' HE1' ' HA2' ' A' ' 203' ' ' GLY . 2.6 mpp? -92.6 135.08 34.39 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.404 ' HG3' ' HD3' ' A' ' 194' ' ' PRO . 26.2 pttm -131.91 168.67 17.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.163 0.506 . . . . 0.0 112.168 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 0.6 OUTLIER -125.43 85.24 58.84 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.742 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.404 ' HD3' ' HG3' ' A' ' 192' ' ' LYS . 11.9 Cg_endo -55.77 -24.57 47.28 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.305 2.003 . . . . 0.0 112.313 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -73.37 -70.66 0.35 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.372 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 55.0 p -71.49 -21.08 61.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.019 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 84.18 19.57 60.58 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.376 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.558 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 79.7 mtt180 -120.43 163.59 17.67 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.6 m -111.95 154.5 25.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.104 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.713 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 14.3 mmp_? -51.35 -29.43 15.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.476 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 98.08 -1.84 59.47 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.706 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.713 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 36.4 p90 -140.86 158.64 43.66 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.326 -0.437 . . . . 0.0 110.448 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.52 ' HA2' ' HE1' ' A' ' 191' ' ' MET . . . -142.92 161.99 27.49 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.627 ' HB2' ' HB3' ' A' ' 189' ' ' LYS . 94.8 m-85 -104.68 122.16 45.08 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.706 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 63.1 tp -109.75 126.34 53.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.813 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.594 ' O ' HG23 ' A' ' 185' ' ' VAL . 29.4 t -118.31 139.05 51.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.973 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.711 ' CE2' HG21 ' A' ' 216' ' ' VAL . 82.1 m-85 -119.4 146.51 45.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.95 0.405 . . . . 0.0 111.497 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.55 -36.12 82.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.616 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -111.07 121.81 39.62 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.363 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -56.33 -27.17 65.85 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.491 2.127 . . . . 0.0 112.923 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.0 t -58.35 -36.34 73.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.768 0.318 . . . . 0.0 110.713 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.87 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.8 m -58.83 -35.21 72.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.28 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.853 HG13 ' SD ' ' A' ' 161' ' ' MET . 82.3 t -61.47 -40.89 87.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.887 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -58.21 -43.57 87.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.783 0.325 . . . . 0.0 110.769 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.27 -34.83 75.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.132 0.492 . . . . 0.0 111.197 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.9 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 79.9 t -60.85 -43.02 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.785 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.713 HG21 ' NH2' ' A' ' 232' ' ' ARG . 25.1 m -86.52 -31.84 6.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -59.64 -35.26 74.06 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.472 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 74.4 m -100.59 147.01 26.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -78.96 139.24 38.28 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.9 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 44.0 m-70 -120.63 129.26 53.64 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -176.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 68.6 mt -122.44 115.4 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.1 tt -117.94 127.25 53.66 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.758 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 58.9 t0 52.87 36.34 21.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.959 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.06 13.86 82.9 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.731 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -126.48 156.39 40.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.994 0.397 . . . . 0.0 111.626 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.599 HG12 ' OD2' ' A' ' 229' ' ' ASP . 44.0 t -99.94 129.61 50.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.801 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.939 HD12 HG23 ' A' ' 163' ' ' ILE . 29.0 pt -109.3 -30.95 2.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.599 ' OD2' HG12 ' A' ' 227' ' ' VAL . 9.9 m-20 48.09 76.66 0.53 Allowed Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 121.246 0.546 . . . . 0.0 110.855 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.487 ' HD3' HG13 ' A' ' 228' ' ' ILE . 34.9 Cg_exo -59.8 135.58 64.58 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 123.234 2.622 . . . . 0.0 112.117 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 162' ' ' PHE . 5.5 ttpt -136.73 142.08 43.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.184 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.713 ' NH2' HG21 ' A' ' 217' ' ' VAL . 6.1 mpt_? -51.78 142.02 15.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.974 0.416 . . . . 0.0 111.355 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.764 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -68.96 143.13 54.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.21 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.553 HD12 ' HG2' ' A' ' 239' ' ' GLN . 0.1 OUTLIER -119.17 128.33 26.0 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.668 179.233 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.9 149.79 25.11 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.061 1.841 . . . . 0.0 110.858 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -53.25 -41.96 65.99 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.772 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -63.2 -40.79 98.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.971 0.415 . . . . 0.0 110.459 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -66.05 -36.94 84.58 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.649 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.553 ' HG2' HD12 ' A' ' 234' ' ' ILE . 95.2 mt-30 -60.47 -37.95 82.64 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.861 0.362 . . . . 0.0 110.568 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -60.23 -40.05 88.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.975 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -60.57 -35.12 75.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.289 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.425 HG22 HD11 ' A' ' 270' ' ' ILE . 18.3 p -83.22 162.44 21.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.521 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -155.98 108.02 0.35 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.21 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.614 ' O ' ' HB2' ' A' ' 318' ' ' ALA . 7.3 ttpm? -81.34 136.18 35.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.656 0.265 . . . . 0.0 110.935 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.67 HD13 ' O ' ' A' ' 245' ' ' ILE . 0.0 OUTLIER -119.39 162.87 17.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.498 0.666 . . . . 0.0 111.832 -179.139 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -101.72 137.07 40.52 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.066 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.854 HG11 ' CE1' ' A' ' 259' ' ' PHE . 11.7 p -131.11 145.45 35.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.934 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.648 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -130.5 164.67 22.93 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 98.1 -1.61 59.33 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.129 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.94 HD11 ' HA3' ' A' ' 287' ' ' GLY . 41.1 pt -116.62 139.49 43.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 117.192 0.496 . . . . 0.0 110.636 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.433 ' N ' HG11 ' A' ' 254' ' ' VAL . . . 177.77 -103.05 0.17 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 119.599 -1.286 . . . . 0.0 114.495 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -53.15 -25.99 31.58 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.822 2.348 . . . . 0.0 113.173 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -131.99 95.02 3.59 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.523 ' O ' ' HB2' ' A' ' 258' ' ' GLU . 0.5 OUTLIER -178.19 -46.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.152 -179.276 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 28.1 mmt180 68.37 128.02 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -177.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.38 -29.03 37.44 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.012 1.808 . . . . 0.0 112.809 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -61.72 -43.3 99.13 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.574 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 97.0 mt-10 -67.74 -35.52 78.88 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 111.368 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.893 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 19.2 t80 -59.15 -49.09 79.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.459 -178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.74 -37.7 88.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -63.71 -40.1 95.94 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.828 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.829 ' CE2' HD11 ' A' ' 313' ' ' ILE . 84.0 t80 -65.41 -55.12 19.82 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.74 ' CG ' HG21 ' A' ' 289' ' ' VAL . 9.3 m-85 -65.19 -27.24 68.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.791 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.702 ' N ' HD11 ' A' ' 269' ' ' ILE . 33.4 t -54.48 -26.97 34.46 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -50.17 -38.12 38.11 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.794 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.722 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 24.3 p90 -127.42 54.24 1.68 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.267 0.556 . . . . 0.0 111.18 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.485 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 151.48 153.28 6.14 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.432 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.402 ' HG1' ' CG ' ' A' ' 292' ' ' ASP . 32.8 p -71.43 -23.0 61.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.899 0.38 . . . . 0.0 111.14 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.702 HD11 ' N ' ' A' ' 264' ' ' SER . 77.8 mt 55.53 99.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.589 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.632 HD11 ' HA ' ' A' ' 292' ' ' ASP . 73.4 mt -58.47 -40.84 79.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.174 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -174.92 106.06 0.1 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.516 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.622 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -100.7 135.59 41.9 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.469 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -146.01 161.99 38.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.325 0.583 . . . . 0.0 112.546 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.614 ' O ' ' HB2' ' A' ' 275' ' ' MET . 56.7 mt -88.71 3.67 50.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.694 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.614 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 90.4 mtp 81.65 -49.53 0.24 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.584 0.354 . . . . 0.0 111.767 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.633 ' N ' HD22 ' A' ' 276' ' ' LEU . 1.8 mm? 47.2 56.94 6.24 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -77.65 114.48 16.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.083 0.468 . . . . 0.0 110.276 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.633 ' O ' HG22 ' A' ' 280' ' ' THR . 80.4 tttt 44.34 25.97 0.15 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.836 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 53.19 44.82 29.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.372 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.633 HG22 ' O ' ' A' ' 278' ' ' LYS . 1.7 t -171.53 -37.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.908 0.385 . . . . 0.0 111.294 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -54.42 -27.99 42.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.948 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.624 ' NE2' HD13 ' A' ' 276' ' ' LEU . 4.8 pp0? -137.07 162.79 32.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.601 0.239 . . . . 0.0 111.583 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.579 ' CB ' ' O ' ' A' ' 282' ' ' GLN . 83.2 p 121.91 -8.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 O-C-N 124.226 0.954 . . . . 0.0 110.385 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 67.6 mtt85 -57.36 -33.62 67.97 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.617 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 250' ' ' ILE . . . 158.28 35.38 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.618 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.412 ' HA ' ' HA2' ' A' ' 248' ' ' GLY . 7.5 p90 -144.36 165.18 28.65 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.524 0.662 . . . . 0.0 110.997 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.94 ' HA3' HD11 ' A' ' 250' ' ' ILE . . . -145.98 166.18 27.99 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.069 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.45 ' CE2' ' CE ' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -120.43 122.11 40.0 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 122.892 -0.181 . . . . 0.0 111.27 179.576 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.893 HG23 ' CZ ' ' A' ' 259' ' ' PHE . 57.6 t -123.84 137.67 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.049 0.452 . . . . 0.0 111.58 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 48.7 m -115.38 135.98 53.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.638 178.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.485 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 41.1 m-85 -114.95 136.94 52.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.15 0.5 . . . . 0.0 112.007 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.632 ' HA ' HD11 ' A' ' 270' ' ' ILE . 31.9 p-10 -62.38 -33.25 74.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.19 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 293' ' ' SER . . . . . 0.427 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 28.6 t -123.15 140.06 53.41 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.636 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.33 -30.96 72.0 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.067 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.4 -38.18 68.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.211 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.473 ' O ' ' HD1' ' A' ' 266' ' ' TRP . . . -62.19 -37.04 83.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.907 0.384 . . . . 0.0 110.478 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.545 ' O ' HG12 ' A' ' 300' ' ' VAL . 81.3 t -61.89 -42.24 93.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.201 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.99 -36.7 77.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.147 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -57.25 -43.9 83.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.911 0.386 . . . . 0.0 112.027 -178.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.741 HG23 HD11 ' A' ' 306' ' ' ILE . 1.0 OUTLIER -69.86 -33.6 56.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.632 -179.141 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 76.8 m -57.44 -45.37 84.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.416 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -61.94 -41.42 97.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.25 0.547 . . . . 0.0 110.55 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -62.8 -32.5 73.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.433 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.682 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 10.6 tptm 67.94 -75.96 0.06 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -177.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.682 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.3 m-30 -110.52 136.1 50.16 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.741 HD11 HG23 ' A' ' 300' ' ' VAL . 1.1 mt -117.05 136.95 52.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.506 ' O ' ' OD1' ' A' ' 307' ' ' ASP . 52.4 p30 -72.83 96.94 2.15 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.146 0.498 . . . . 0.0 111.705 -178.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.656 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 6.2 t80 -102.27 -75.16 0.61 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.345 0.593 . . . . 0.0 110.375 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.456 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 10.2 mmpt? -95.14 -167.9 1.71 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.152 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -52.04 -27.72 14.71 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.836 0.35 . . . . 0.0 110.753 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 311' ' ' ARG . 60.9 mtt180 -116.67 160.48 20.67 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.414 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 71.4 mttt -71.85 147.82 46.77 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.53 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.829 HD11 ' CE2' ' A' ' 262' ' ' PHE . 28.6 pt -115.37 144.47 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 314' ' ' GLU . . . . . 0.596 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 83.4 mt-10 -104.29 134.52 47.38 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.059 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 0.802 HG12 HG23 ' A' ' 247' ' ' VAL . 73.5 mt -122.35 126.25 73.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.072 0.463 . . . . 0.0 111.466 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -129.96 155.42 46.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.776 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -55.46 148.42 15.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.794 0.33 . . . . 0.0 110.494 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 244' ' ' LYS . . . -56.03 145.85 24.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.995 0.426 . . . . 0.0 111.409 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.952 -179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 10.5 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.912 0.387 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 82.7 tttt -62.03 139.91 58.4 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.457 0.646 . . . . 0.0 111.74 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.818 ' SD ' HG13 ' A' ' 213' ' ' VAL . 92.7 mmm -121.08 149.13 43.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.617 -179.045 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.596 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 8.4 t80 -105.92 129.42 54.07 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.713 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.775 ' CG2' HD21 ' A' ' 166' ' ' LEU . 14.9 mm -114.76 127.51 72.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.835 -178.719 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 228' ' ' ILE . . . -130.09 162.25 23.07 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.908 179.216 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.473 ' C ' HG22 ' A' ' 228' ' ' ILE . . . 75.6 27.39 63.29 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 119.861 -1.161 . . . . 0.0 111.691 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.938 HD23 HG21 ' A' ' 228' ' ' ILE . 84.6 mt -85.1 140.32 31.06 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 120.802 0.335 . . . . 0.0 111.414 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.484 ' N ' ' HG1' ' A' ' 170' ' ' THR . 0.1 OUTLIER -63.07 136.75 57.98 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.423 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.449 ' CD2' ' HD2' ' A' ' 198' ' ' ARG . 3.9 m0 -51.9 -28.23 15.58 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.811 0.339 . . . . 0.0 110.882 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -92.4 9.04 35.89 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.564 178.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.585 ' O ' ' HB2' ' A' ' 174' ' ' ASN . 89.6 m -56.24 -37.2 69.41 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.475 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.566 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.7 OUTLIER 53.64 145.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.247 0.546 . . . . 0.0 110.794 -178.38 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.605 ' N ' HD12 ' A' ' 190' ' ' ILE . 97.3 mt-10 -61.45 -33.15 73.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.766 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.577 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 92.6 m-20 -57.38 -41.26 79.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.872 -178.713 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.585 ' HB2' ' O ' ' A' ' 170' ' ' THR . 10.2 m120 -64.49 -35.71 81.83 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.768 HD12 HD11 ' A' ' 190' ' ' ILE . 2.4 mt -54.02 -51.15 64.9 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.117 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.577 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -63.58 -36.76 84.85 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.935 179.605 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -66.4 -44.8 82.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.085 0.469 . . . . 0.0 110.34 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.605 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 62.4 t80 -66.33 -47.32 73.88 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.922 179.207 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.513 ' CE2' HD23 ' A' ' 175' ' ' LEU . 86.4 m-85 -91.39 -1.77 57.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.108 -178.78 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -61.89 -28.86 70.94 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.486 179.012 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.442 ' CD ' ' H ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -58.19 -37.41 74.71 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.715 0.769 . . . . 0.0 110.797 -178.722 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -66.72 -30.69 70.98 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.062 -178.163 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 163.97 -126.64 1.55 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.195 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 57.3 m -119.23 141.46 48.89 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.53 HG21 ' CD2' ' A' ' 188' ' ' LEU . 13.8 p -106.69 128.73 61.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.586 -0.445 . . . . 0.0 109.972 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.411 HG23 ' CB ' ' A' ' 206' ' ' SER . 1.2 t -84.49 -43.49 14.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.535 -178.516 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -138.68 136.18 35.58 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -178.847 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.722 HD11 ' CB ' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -116.07 128.76 55.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.091 179.008 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 8.9 tptt -140.29 113.69 8.56 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.768 HD11 HD12 ' A' ' 175' ' ' LEU . 79.4 mt -126.77 126.62 68.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 174.685 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.686 ' HB2' ' HB2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -81.31 77.25 8.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.235 0.541 . . . . 0.0 110.644 -178.587 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -73.06 141.66 47.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.258 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 10.2 m-20 -92.36 100.55 3.82 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 193' ' ' ASP . 27.9 Cg_endo -62.06 -27.07 78.84 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.523 2.149 . . . . 0.0 112.796 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -75.34 -76.3 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.707 -179.484 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 57.9 p -69.99 -22.5 63.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 80.54 24.62 58.37 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.234 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.501 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 16.4 tpp85 -113.07 129.73 56.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.971 0.415 . . . . 0.0 111.395 -179.552 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.404 ' HB2' ' HA ' ' A' ' 168' ' ' TRP . 49.8 m -66.48 151.35 47.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.097 0.475 . . . . 0.0 111.288 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.8 ' HG3' ' CE1' ' A' ' 202' ' ' PHE . 17.3 tpt85 -59.55 -29.34 67.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.48 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 102.35 -9.75 56.14 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.722 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.8 ' CE1' ' HG3' ' A' ' 200' ' ' ARG . 21.0 p90 -144.24 155.3 43.81 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.448 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -144.79 164.13 27.86 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.828 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.596 ' CE2' ' CD1' ' A' ' 162' ' ' PHE . 96.5 m-85 -105.17 123.49 47.92 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.058 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.69 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 58.2 tp -108.02 125.52 51.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.442 -178.124 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.417 ' O ' HG23 ' A' ' 185' ' ' VAL . 27.3 t -118.29 134.51 54.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.671 0.272 . . . . 0.0 110.983 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.69 ' CZ ' HD21 ' A' ' 205' ' ' LEU . 88.5 m-85 -115.42 138.67 50.76 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 120.963 0.411 . . . . 0.0 112.012 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -62.04 -35.03 77.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.842 178.385 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.84 117.51 53.76 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.631 179.515 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -56.79 -22.88 47.22 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.512 2.142 . . . . 0.0 112.875 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.3 t -57.37 -36.74 71.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.407 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.931 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.0 m -58.88 -35.64 73.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.809 0.337 . . . . 0.0 110.733 179.634 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.818 HG13 ' SD ' ' A' ' 161' ' ' MET . 87.1 t -61.47 -42.33 93.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -59.57 -42.2 91.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.33 . . . . 0.0 111.003 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.464 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 15.2 pt-20 -74.58 -29.26 61.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.669 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 212' ' ' SER . 75.3 t -61.97 -42.95 96.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.129 0.49 . . . . 0.0 110.346 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.77 -40.31 88.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -58.61 -38.7 78.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.679 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 39.5 m -82.39 140.2 33.61 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.071 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 60.7 tp60 -66.23 -40.01 89.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.539 178.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.814 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 85.9 m-70 82.34 97.68 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 178.134 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 72.1 mt -115.34 109.54 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 176.232 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.411 HD12 ' CG ' ' A' ' 178' ' ' TYR . 6.9 tt -116.54 128.05 55.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.935 0.397 . . . . 0.0 111.593 -178.27 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 22.4 t70 49.02 38.41 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.405 179.133 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 83.46 7.44 86.37 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.526 178.752 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.456 ' HD3' ' HE2' ' A' ' 278' ' ' LYS . 35.4 mmtp -120.49 152.09 38.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.778 0.323 . . . . 0.0 111.398 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 41.3 t -104.93 132.8 50.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.489 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.938 HG21 HD23 ' A' ' 166' ' ' LEU . 38.8 pt -123.73 159.72 28.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.193 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -125.19 77.85 67.35 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.307 0.575 . . . . 0.0 111.081 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.59 ' HD2' ' CD2' ' A' ' 221' ' ' HIS . 50.5 Cg_exo -59.1 123.86 14.38 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.4 2.733 . . . . 0.0 111.735 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.42 ' NZ ' ' OD2' ' A' ' 271' ' ' ASP . 9.1 mtmm -134.05 153.44 51.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.793 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -56.26 138.06 51.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.042 0.449 . . . . 0.0 111.77 -179.438 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -64.03 145.13 56.43 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.591 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 2.5 mt -114.21 135.76 22.19 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.589 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.45 ' HG2' ' HB3' ' A' ' 238' ' ' GLU . 10.8 Cg_endo -55.6 139.2 82.59 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.814 1.676 . . . . 0.0 111.099 179.247 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -57.0 -41.33 78.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.67 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -61.09 -45.62 93.99 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.494 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.45 ' HB3' ' HG2' ' A' ' 235' ' ' PRO . 84.2 tt0 -70.2 -38.51 75.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.673 0.749 . . . . 0.0 109.569 178.093 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -59.53 -39.83 85.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.289 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.19 -40.88 91.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.35 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.426 ' HE3' ' HA ' ' A' ' 238' ' ' GLU . 10.5 mtmp? -61.98 -35.39 78.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.684 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.656 HG21 ' CD1' ' A' ' 270' ' ' ILE . 18.2 p -84.18 162.51 20.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.221 0.534 . . . . 0.0 111.826 -178.799 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -165.34 172.85 41.03 Favored Glycine 0 C--O 1.226 -0.383 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.448 179.228 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.554 ' HE2' ' CE2' ' A' ' 288' ' ' PHE . 14.0 pttm -135.99 151.36 49.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.384 0.592 . . . . 0.0 111.603 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.615 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -118.82 165.58 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 121.457 0.646 . . . . 0.0 111.916 -178.395 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.422 ' CE1' ' CD2' ' A' ' 286' ' ' PHE . 82.5 t80 -99.93 133.74 43.86 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.407 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.819 HG11 ' CE1' ' A' ' 259' ' ' PHE . 13.1 p -131.16 143.57 40.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.758 179.305 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 313' ' ' ILE . . . -126.85 169.43 18.78 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.288 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.22 15.84 56.69 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.161 -1.018 . . . . 0.0 112.456 -179.32 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.499 ' CG2' HG21 ' A' ' 254' ' ' VAL . 65.3 mt -110.78 131.15 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 120.961 0.41 . . . . 0.0 110.971 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.88 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -174.04 -101.73 0.15 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.324 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.79 139.34 56.99 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.273 1.982 . . . . 0.0 113.01 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 55.15 45.45 25.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 178.31 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 251' ' ' GLY . 15.4 m -125.39 -48.52 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.232 178.455 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.565 ' HB3' ' OE1' ' A' ' 258' ' ' GLU . 2.4 tpp85 57.09 136.51 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.214 0 CA-C-O 120.833 0.349 . . . . 0.0 110.17 -179.365 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.14 -26.91 53.21 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.518 2.146 . . . . 0.0 113.466 -178.612 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -59.8 -48.01 83.41 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.698 -179.318 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.565 ' OE1' ' HB3' ' A' ' 255' ' ' ARG . 58.8 mp0 -67.97 -35.56 78.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.029 0.442 . . . . 0.0 111.246 179.119 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.819 ' CE1' HG11 ' A' ' 247' ' ' VAL . 29.8 t80 -60.67 -45.31 94.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.914 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.444 ' HG2' ' HB3' ' A' ' 272' ' ' ALA . 97.1 mt-10 -65.59 -39.41 91.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.154 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.529 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.1 pt-20 -75.75 -30.51 59.21 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.742 0.306 . . . . 0.0 110.773 179.495 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.945 ' CE2' HD11 ' A' ' 313' ' ' ILE . 79.0 t80 -58.18 -57.48 12.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.136 0.493 . . . . 0.0 111.924 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.726 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 30.9 m-85 -68.28 -21.66 64.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.611 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.719 ' N ' HD11 ' A' ' 269' ' ' ILE . 34.0 t -55.35 -25.27 34.02 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.043 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -47.82 -38.6 16.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.705 178.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.726 ' CZ2' ' CD2' ' A' ' 263' ' ' PHE . 24.3 p90 -132.15 55.79 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.237 0.541 . . . . 0.0 111.444 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.458 ' HA3' ' CD1' ' A' ' 291' ' ' TYR . . . 151.59 145.29 4.1 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.652 179.308 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.414 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 52.8 m -58.68 -36.38 74.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.847 0.356 . . . . 0.0 111.133 179.816 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.719 HD11 ' N ' ' A' ' 264' ' ' SER . 73.8 mt 67.74 86.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.177 -178.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.656 ' CD1' HG21 ' A' ' 242' ' ' THR . 78.9 mt -55.98 -44.6 78.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.798 179.377 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.42 ' OD2' ' NZ ' ' A' ' 231' ' ' LYS . 59.5 t0 -166.89 105.02 0.58 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.703 0.287 . . . . 0.0 111.667 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.612 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -100.19 136.84 39.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.701 179.242 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -139.46 145.45 38.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.114 0.483 . . . . 0.0 111.9 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.533 ' O ' ' HB2' ' A' ' 275' ' ' MET . 23.3 tp -67.39 -38.07 84.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.351 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.567 ' O ' HD23 ' A' ' 276' ' ' LEU . 92.5 mmm 101.87 115.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.937 0.895 . . . . 0.0 109.52 -178.69 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.567 HD23 ' O ' ' A' ' 275' ' ' MET . 29.7 mt -123.39 140.8 52.64 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.204 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.569 ' HB3' ' HA3' ' A' ' 281' ' ' GLY . 59.4 t0 -157.66 93.72 1.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.053 177.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.456 ' HE2' ' HD3' ' A' ' 226' ' ' LYS . 11.2 mmtt 69.41 48.13 0.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.205 0.526 . . . . 0.0 110.189 -177.865 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 60.0 t0 67.14 -70.68 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.719 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 59.5 p -69.32 -14.13 62.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.436 -179.743 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 281' ' ' GLY . . . . . 0.569 ' HA3' ' HB3' ' A' ' 277' ' ' ASP . . . -55.12 126.48 38.91 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.866 -178.767 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.436 ' HB2' ' CB ' ' A' ' 275' ' ' MET . 58.2 mm-40 41.25 36.79 0.52 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.996 -0.602 . . . . 0.0 110.87 178.641 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 90.8 p -126.57 157.88 37.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.859 -179.441 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.466 ' HA ' ' HA2' ' A' ' 251' ' ' GLY . 72.0 ttt180 58.16 39.78 25.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.118 0.485 . . . . 0.0 109.808 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -160.46 -68.83 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.945 -179.531 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.485 ' HB2' ' O ' ' A' ' 247' ' ' VAL . 29.7 p90 -136.82 166.85 22.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.967 0.413 . . . . 0.0 111.462 -178.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.756 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -135.27 158.15 23.48 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.883 179.012 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.554 ' CE2' ' HE2' ' A' ' 244' ' ' LYS . 0.2 OUTLIER -115.13 127.95 55.89 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 122.254 0.222 . . . . 0.0 110.624 179.419 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.624 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 48.2 t -121.21 135.18 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.689 178.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 48.8 m -111.38 136.36 50.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.537 178.848 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.649 ' OH ' ' HB3' ' A' ' 263' ' ' PHE . 39.2 m-85 -116.08 138.69 51.02 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.371 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.601 ' O ' HG22 ' A' ' 242' ' ' THR . 21.7 t70 -57.82 -34.04 69.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.56 178.091 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 28.9 t -119.06 137.41 53.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.351 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.83 -29.76 70.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.1 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -56.05 -37.05 68.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.419 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.655 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -60.2 -35.84 76.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.908 0.385 . . . . 0.0 110.811 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.559 HG13 HG22 ' A' ' 245' ' ' ILE . 71.2 t -60.57 -44.3 96.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.988 0.423 . . . . 0.0 110.658 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -63.43 -37.23 86.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.071 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -58.16 -42.74 86.62 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.84 HG23 HD11 ' A' ' 306' ' ' ILE . 1.2 p -68.99 -33.7 60.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.797 0.332 . . . . 0.0 111.603 -179.405 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 72.6 m -55.2 -42.24 73.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.106 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -61.83 -37.35 84.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.085 0.469 . . . . 0.0 110.529 179.399 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.55 ' OD1' ' C ' ' A' ' 305' ' ' PHE . 0.0 OUTLIER -62.96 -35.99 81.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.654 -179.795 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.696 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 45.1 tptt 70.69 -71.86 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.457 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.696 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 32.7 m-85 -119.89 130.08 54.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.733 178.856 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.84 HD11 HG23 ' A' ' 300' ' ' VAL . 39.8 mt -113.11 136.42 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.765 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -78.04 95.22 4.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.0 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.708 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 4.9 t80 -87.36 -85.43 0.17 Allowed 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.991 179.451 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.561 ' HG3' HG12 ' A' ' 254' ' ' VAL . 12.1 mmmt -94.91 4.5 53.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.56 ' HB2' ' O ' ' A' ' 309' ' ' LYS . 83.5 m-20 107.68 -31.34 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.04 0.936 . . . . 0.0 110.499 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' A' ' 312' ' ' LYS . 28.9 tpt180 -57.43 -35.46 70.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.945 179.337 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.579 ' HG3' ' HB3' ' A' ' 305' ' ' PHE . 16.4 tptt 96.12 71.6 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.537 -179.349 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.945 HD11 ' CE2' ' A' ' 262' ' ' PHE . 29.9 pt -57.2 98.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.624 0.726 . . . . 0.0 110.173 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 314' ' ' GLU . . . . . 0.678 ' HG2' ' CE2' ' A' ' 305' ' ' PHE . 77.0 mt-10 -61.85 138.04 58.31 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 0.651 HG12 HG23 ' A' ' 247' ' ' VAL . 72.3 mt -121.93 128.54 75.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.922 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 19.4 mtpt -131.61 150.98 51.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.7 178.745 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -58.13 144.77 39.2 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.467 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 244' ' ' LYS . . . -65.06 143.63 57.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.972 0.415 . . . . 0.0 111.244 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 319' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 318' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.285 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 26.3 m . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.539 0.209 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 38.6 ttpt -74.36 139.25 43.97 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.168 0.509 . . . . 0.0 111.58 -179.452 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.734 ' SD ' HG13 ' A' ' 213' ' ' VAL . 87.3 mmm -112.52 149.32 32.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.504 -179.304 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 230' ' ' PRO . 4.6 t80 -103.08 129.19 49.83 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.474 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.751 HG21 HD21 ' A' ' 175' ' ' LEU . 17.8 mm -116.8 125.91 73.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.943 -179.517 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.533 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -120.91 155.97 16.18 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 178.404 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.57 41.53 35.6 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 119.971 -1.109 . . . . 0.0 111.8 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.727 HD22 HD11 ' A' ' 175' ' ' LEU . 75.0 mt -58.81 -28.18 65.76 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.639 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.774 ' O ' ' N ' ' A' ' 169' ' ' ASP . 52.5 t30 71.98 45.41 0.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -177.596 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.424 ' CZ3' ' NH2' ' A' ' 198' ' ' ARG . 10.9 m0 23.36 -62.62 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.534 1.134 . . . . 0.0 113.911 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.774 ' N ' ' O ' ' A' ' 167' ' ' ASN . 92.3 m-20 -53.91 -33.82 57.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.142 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.461 ' C ' HG23 ' A' ' 171' ' ' THR . 87.9 m -52.92 -39.31 62.69 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.593 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.626 ' C ' HD12 ' A' ' 190' ' ' ILE . 0.1 OUTLIER 55.44 166.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.073 0.464 . . . . 0.0 109.822 -177.846 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.884 ' N ' HD12 ' A' ' 190' ' ' ILE . 21.0 pt-20 -67.76 -23.0 65.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.399 -179.42 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.616 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.8 m-20 -58.68 -44.29 90.17 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.459 -178.932 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.433 ' HB2' ' CG2' ' A' ' 170' ' ' THR . 83.9 m-20 -68.11 -35.33 77.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.677 0.275 . . . . 0.0 111.542 179.27 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.898 HD12 HD11 ' A' ' 190' ' ' ILE . 1.5 mt -55.91 -44.8 78.63 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.19 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.616 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -64.37 -38.77 92.2 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.978 179.312 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.435 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 75.6 mm-40 -69.41 -42.49 75.01 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.536 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 53.8 t80 -64.96 -47.59 77.06 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.421 0.629 . . . . 0.0 111.565 179.471 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.496 ' CE2' HD23 ' A' ' 175' ' ' LEU . 82.4 m-85 -92.42 -1.04 57.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.224 -178.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -58.45 -31.16 66.08 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.205 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -41.18 90.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.543 0.687 . . . . 0.0 110.576 -179.322 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -68.34 -33.89 75.1 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.209 -178.301 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.44 -174.62 44.85 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.862 -179.827 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 54.5 m -63.48 -28.29 69.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.777 0.322 . . . . 0.0 111.319 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.766 HG22 HD11 ' A' ' 205' ' ' LEU . 1.2 t 64.86 82.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -176.697 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.615 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 3.1 m -56.72 -42.87 79.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.414 -176.473 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -148.34 144.62 27.67 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.946 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.417 ' HA ' HD13 ' A' ' 188' ' ' LEU . 0.2 OUTLIER -115.4 134.7 54.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.571 178.577 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.561 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 11.1 tptt -141.39 67.13 1.35 Allowed 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.898 HD11 HD12 ' A' ' 175' ' ' LEU . 3.3 mt -66.43 -9.93 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 121.104 0.478 . . . . 0.0 110.377 177.359 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.618 ' HE2' ' HA2' ' A' ' 203' ' ' GLY . 1.8 mpp? 74.53 -56.62 0.63 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.588 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 199' ' ' SER . 8.0 mtmp? 56.43 152.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.077 0.465 . . . . 0.0 111.597 179.392 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.682 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 0.7 OUTLIER -126.08 78.58 70.35 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.519 -179.762 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -56.51 -25.41 58.26 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 121.988 1.792 . . . . 0.0 111.706 179.442 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.77 -67.16 0.66 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.66 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.5 p -67.25 -26.83 66.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.507 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 93.14 0.77 67.66 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.818 -0.706 . . . . 0.0 113.151 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.682 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 1.5 tpt180 -127.41 125.94 41.53 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 117.162 0.481 . . . . 0.0 110.743 179.708 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 192' ' ' LYS . 42.8 m -58.11 155.46 11.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.161 0.505 . . . . 0.0 111.59 -179.404 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.553 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 40.3 mmt180 -55.68 -30.46 61.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.666 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.405 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 97.82 0.16 59.06 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.853 -178.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.692 ' C ' HD11 ' A' ' 166' ' ' LEU . 28.2 p90 -148.36 159.18 44.27 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.618 ' HA2' ' HE2' ' A' ' 191' ' ' MET . . . -147.04 163.75 28.63 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.09 -1.052 . . . . 0.0 111.548 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.561 ' HB2' ' HB3' ' A' ' 189' ' ' LYS . 99.0 m-85 -104.63 122.16 45.06 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.855 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.766 HD11 HG22 ' A' ' 185' ' ' VAL . 53.5 tp -102.77 127.1 50.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.209 -177.925 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 186' ' ' THR . 51.8 m -119.7 139.88 51.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.453 -179.573 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.659 ' CZ ' HD21 ' A' ' 205' ' ' LEU . 94.9 m-85 -122.6 139.68 53.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.578 178.455 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.615 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.5 tt0 -59.98 -33.83 72.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.924 0.392 . . . . 0.0 110.114 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 13.3 mtmm -114.51 122.91 33.19 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.008 179.383 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -56.78 -20.44 35.44 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.744 2.296 . . . . 0.0 113.023 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.9 m -56.48 -36.93 69.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.694 0.283 . . . . 0.0 111.306 -179.269 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.936 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.4 m -59.18 -35.87 74.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.798 0.333 . . . . 0.0 110.764 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.734 HG13 ' SD ' ' A' ' 161' ' ' MET . 83.2 t -61.56 -42.5 94.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.069 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.48 ' O ' HG22 ' A' ' 217' ' ' VAL . 55.4 t0 -59.58 -42.4 92.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.744 0.306 . . . . 0.0 111.091 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.453 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 14.8 pt-20 -74.38 -29.41 61.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.596 179.454 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 212' ' ' SER . 64.6 t -59.77 -42.37 88.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.064 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 214' ' ' ASP . 24.2 m -72.5 -26.95 24.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.495 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -58.63 -31.69 68.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.458 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.615 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 68.7 m -108.42 140.01 42.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.893 0.378 . . . . 0.0 111.605 -179.129 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 63.4 tt0 -65.53 -40.74 93.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.64 179.079 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.729 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 71.7 m-70 84.47 110.74 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 178.352 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 1.031 HD12 HG12 ' A' ' 227' ' ' VAL . 20.3 mm -116.66 114.05 44.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 175.788 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.429 HD12 ' CG ' ' A' ' 178' ' ' TYR . 5.8 tt -122.58 122.3 38.54 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.469 -178.092 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 51.5 42.39 29.36 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 178.781 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.07 8.26 87.95 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.562 -0.827 . . . . 0.0 113.443 178.722 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.416 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 35.5 mmtp -121.5 155.37 35.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.753 0.311 . . . . 0.0 111.008 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 1.031 HG12 HD12 ' A' ' 222' ' ' ILE . 32.8 m -110.5 134.94 51.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.04 0.447 . . . . 0.0 110.349 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 164' ' ' GLY . 36.5 pt -124.32 158.63 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.866 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -126.74 79.2 72.28 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 121.16 0.505 . . . . 0.0 111.175 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 162' ' ' PHE . 51.1 Cg_exo -58.98 120.87 9.01 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.739 2.293 . . . . 0.0 110.669 179.232 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -134.1 146.97 50.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.686 0.279 . . . . 0.0 111.712 -179.065 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.535 ' N ' ' HD2' ' A' ' 232' ' ' ARG . 0.0 OUTLIER -49.4 134.91 18.38 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.986 0.422 . . . . 0.0 110.989 -179.557 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -65.45 145.66 55.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.915 -179.616 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 1.2 mt -118.13 137.55 24.65 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.167 179.223 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.447 ' HG2' ' HB2' ' A' ' 238' ' ' GLU . 9.5 Cg_endo -54.28 141.03 72.11 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 121.8 1.666 . . . . 0.0 110.97 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -55.76 -41.76 74.45 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -178.589 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -60.83 -41.79 96.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.782 0.325 . . . . 0.0 111.047 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.462 ' O ' HG23 ' A' ' 242' ' ' THR . 84.5 tt0 -64.75 -36.59 84.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.601 179.394 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -60.0 -38.83 83.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.704 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -61.12 -39.42 89.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.207 0.527 . . . . 0.0 110.394 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -60.97 -31.4 70.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.347 179.581 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.541 HG22 ' CD1' ' A' ' 270' ' ' ILE . 10.4 p -75.31 161.44 29.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.911 -178.136 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.69 112.72 0.85 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.086 179.53 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.61 ' HE3' ' CD2' ' A' ' 288' ' ' PHE . 5.3 tptp -85.8 129.2 34.89 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -179.629 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.689 HG21 HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -120.84 160.71 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.474 0.654 . . . . 0.0 111.865 -179.55 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.49 ' HB2' ' HA ' ' A' ' 318' ' ' ALA . 76.2 t80 -104.31 137.45 42.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.951 179.416 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.758 HG23 HG12 ' A' ' 315' ' ' ILE . 7.2 p -128.68 147.17 33.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.644 -179.773 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.673 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -128.7 166.96 21.01 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.026 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 81.02 42.19 9.76 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.804 -179.777 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.566 ' CG2' HG11 ' A' ' 254' ' ' VAL . 27.3 mm -55.65 -36.29 41.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.849 0.357 . . . . 0.0 111.295 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 60.79 169.02 0.5 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.868 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.26 144.66 81.59 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.032 2.488 . . . . 0.0 113.674 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 55.11 42.47 30.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.936 178.245 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.623 HG23 ' HE2' ' A' ' 308' ' ' PHE . 12.5 p -63.72 -38.3 81.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.996 178.612 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.615 ' O ' ' O ' ' A' ' 254' ' ' VAL . 4.5 mpt_? 50.31 126.29 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.43 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.48 -28.28 44.13 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.077 1.852 . . . . 0.0 112.668 -178.831 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -61.17 -47.79 84.55 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.614 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.527 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 53.0 mp0 -69.44 -39.62 77.69 Favored 'General case' 0 C--O 1.224 -0.261 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.693 ' CE1' HG11 ' A' ' 247' ' ' VAL . 27.4 t80 -61.37 -47.25 86.68 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.21 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.531 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.5 tt0 -65.58 -43.11 90.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.736 0.303 . . . . 0.0 111.295 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.527 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.8 pt-20 -76.47 -28.86 56.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.129 0.49 . . . . 0.0 110.877 179.444 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.662 ' CZ ' ' HB2' ' A' ' 308' ' ' PHE . 11.6 t80 -61.93 -56.48 18.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.13 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.763 ' CG ' HG21 ' A' ' 289' ' ' VAL . 5.2 m-85 -67.67 -27.56 66.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.069 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.745 ' N ' HD11 ' A' ' 269' ' ' ILE . 80.1 p -56.44 -23.97 42.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.736 0.303 . . . . 0.0 111.113 -178.667 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -56.68 -35.94 69.01 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.275 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.677 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 19.4 p90 -111.66 48.99 0.92 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -179.648 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 133.43 150.39 6.31 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.184 178.463 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.4 m -70.3 131.68 44.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.782 HG23 ' O ' ' A' ' 290' ' ' THR . 74.5 mt -102.9 118.65 50.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.84 -178.73 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.683 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 72.7 mt -69.51 -39.4 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 120.289 -0.565 . . . . 0.0 112.236 179.359 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -136.38 -87.44 0.32 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.761 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.725 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . 65.14 110.42 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.709 0.29 . . . . 0.0 110.886 -178.659 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 273' ' ' GLN . . . . . 0.419 ' O ' ' NE2' ' A' ' 282' ' ' GLN . 21.6 pt20 -141.23 158.67 43.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.253 0.549 . . . . 0.0 111.853 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 1.038 HD23 HD11 ' A' ' 276' ' ' LEU . 28.6 tp -66.1 -26.86 67.66 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.09 -179.608 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.66 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 66.8 mmm 82.51 -80.91 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.457 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 1.038 HD11 HD23 ' A' ' 274' ' ' LEU . 5.2 mp 55.53 72.25 0.5 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.16 -178.579 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.483 ' HB3' ' HA3' ' A' ' 281' ' ' GLY . 60.2 t0 -79.91 113.56 18.16 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.001 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 18.6 mttt 69.76 -59.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.358 -178.496 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.728 ' OD1' HG23 ' A' ' 280' ' ' THR . 53.7 p30 -178.1 -31.12 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 179.133 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.728 HG23 ' OD1' ' A' ' 279' ' ' ASP . 68.2 p -109.46 10.89 25.22 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.493 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 281' ' ' GLY . . . . . 0.483 ' HA3' ' HB3' ' A' ' 277' ' ' ASP . . . -91.37 99.07 2.52 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.209 -0.995 . . . . 0.0 113.149 -179.525 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.693 ' HB2' ' CZ ' ' A' ' 286' ' ' PHE . 38.2 tt0 75.38 -8.1 1.65 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.89 0.476 . . . . 0.0 112.18 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 21.9 m -57.77 -38.46 75.46 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -137.79 142.59 40.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.31 178.654 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.05 -46.46 1.71 Allowed Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.484 -0.865 . . . . 0.0 114.399 178.591 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.693 ' CZ ' ' HB2' ' A' ' 282' ' ' GLN . 23.7 p90 -140.24 168.38 19.93 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.224 1.012 . . . . 0.0 113.076 -179.162 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.506 ' C ' HG12 ' A' ' 247' ' ' VAL . . . -138.03 174.35 21.95 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.173 179.164 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.61 ' CD2' ' HE3' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -137.17 123.33 20.44 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.294 0.547 . . . . 0.0 111.44 -179.948 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.763 HG21 ' CG ' ' A' ' 263' ' ' PHE . 56.8 t -126.44 137.6 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.008 0.432 . . . . 0.0 111.815 178.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.782 ' O ' HG23 ' A' ' 269' ' ' ILE . 32.6 m -110.73 136.45 49.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.7 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.436 ' OH ' ' O ' ' A' ' 263' ' ' PHE . 31.0 m-85 -117.96 136.1 53.72 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.683 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 55.7 t0 -59.05 -36.18 74.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.254 178.6 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 49.9 m -121.53 143.88 49.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.471 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.92 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -66.57 -28.72 68.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.389 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -56.01 -36.59 68.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.824 -179.126 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.71 91.46 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.292 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.92 HG12 ' O ' ' A' ' 294' ' ' ALA . 6.2 p -59.62 -36.96 68.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.219 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -62.18 -38.41 88.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.346 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -59.87 -43.41 94.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.894 -178.698 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.833 HG23 HD11 ' A' ' 306' ' ' ILE . 0.8 OUTLIER -69.4 -34.84 64.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.375 -179.334 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 80.2 m -59.33 -46.6 88.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.155 -179.569 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -62.49 -38.83 91.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.199 0.523 . . . . 0.0 109.965 179.252 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 305' ' ' PHE . 88.5 m-20 -61.55 -32.36 72.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.257 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.645 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 18.8 tptm 69.24 -69.55 0.16 Allowed 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.562 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.645 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.7 m-30 -113.95 143.0 45.43 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.758 178.063 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.833 HD11 HG23 ' A' ' 300' ' ' VAL . 6.9 mm -111.94 136.35 48.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -72.41 83.69 1.08 Allowed 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.198 -179.305 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.662 ' HB2' ' CZ ' ' A' ' 262' ' ' PHE . 4.9 t80 -105.9 142.84 34.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.556 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.533 ' HG2' ' CD2' ' A' ' 308' ' ' PHE . 18.8 mmmt 46.34 -135.89 0.79 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.116 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -96.74 9.77 40.74 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -178.711 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -151.05 165.82 32.63 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.325 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.479 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 53.0 mttt -78.86 143.46 35.94 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.76 179.159 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.673 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 33.7 pt -121.1 153.76 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.088 179.185 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 314' ' ' GLU . . . . . 0.604 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 84.0 mt-10 -110.16 134.98 51.65 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.414 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 0.758 HG12 HG23 ' A' ' 247' ' ' VAL . 76.7 mt -122.28 128.61 75.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.268 0.556 . . . . 0.0 112.17 -179.287 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -128.4 156.66 42.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.113 179.703 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -54.68 146.97 15.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.64 0.257 . . . . 0.0 110.363 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.49 ' HA ' ' HB2' ' A' ' 246' ' ' PHE . . . -54.26 -98.28 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.042 -179.273 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 319' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 318' ' ' ALA . 56.3 mm-40 . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.416 0.151 . . . . 0.0 111.351 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.531 ' HA ' HG21 ' A' ' 213' ' ' VAL . 8.2 m . . . . . 0 CA--C 1.529 0.173 0 CA-C-O 120.806 0.336 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 74.2 tttt -56.74 139.69 49.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.179 0.514 . . . . 0.0 111.896 -178.607 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.758 ' SD ' HG13 ' A' ' 213' ' ' VAL . 94.7 mmm -121.94 150.46 41.98 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.896 -178.925 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.711 ' CE1' ' CZ ' ' A' ' 204' ' ' PHE . 1.5 t80 -108.42 129.64 55.25 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.262 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.604 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 24.4 mm -116.83 131.04 70.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.253 -179.221 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 228' ' ' ILE . . . -130.17 166.2 22.25 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 178.774 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.78 32.54 59.02 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.937 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.709 HD22 HG21 ' A' ' 170' ' ' THR . 65.2 mt -59.57 -23.43 62.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -179.234 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 169' ' ' ASP . 33.3 t-20 70.3 37.29 1.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -177.549 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.542 ' CZ2' ' HD2' ' A' ' 198' ' ' ARG . 18.6 m0 37.12 17.95 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.28 -1.327 . . . . 0.0 113.829 179.453 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 167' ' ' ASN . 93.3 m-20 -139.28 10.04 2.52 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.779 ' CG2' HD13 ' A' ' 223' ' ' LEU . 95.1 m -57.24 -38.52 73.94 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.465 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.552 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.2 OUTLIER 54.78 142.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.108 0.48 . . . . 0.0 110.459 -178.344 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.6 ' CA ' HD12 ' A' ' 190' ' ' ILE . 97.2 mt-10 -61.63 -34.96 76.58 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.704 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.597 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 60.1 t0 -57.28 -42.45 81.7 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.601 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 170' ' ' THR . 10.9 m120 -64.13 -37.8 88.76 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.022 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.956 HD22 HD21 ' A' ' 205' ' ' LEU . 11.0 mt -56.76 -50.5 72.09 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.229 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.597 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -67.46 -34.71 77.74 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.429 179.506 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -59.44 -38.91 81.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.395 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.622 ' CE2' ' CE2' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -94.69 -55.71 3.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.676 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.686 ' CE2' HD23 ' A' ' 175' ' ' LEU . 72.0 m-85 -60.62 -29.55 69.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.28 179.145 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.63 -24.13 23.62 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.904 179.073 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.804 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -55.71 -38.75 70.14 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.896 0.379 . . . . 0.0 111.483 -179.632 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.804 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 59.2 m-85 -68.1 -30.78 70.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.516 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 166.9 -129.33 1.9 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.092 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 59.7 m -117.4 141.78 47.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.227 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 206' ' ' SER . 10.5 p -104.41 125.44 59.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.736 HG23 ' N ' ' A' ' 208' ' ' GLU . 43.4 p -70.75 -35.48 72.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.605 -178.722 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -154.14 149.75 27.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.338 0.59 . . . . 0.0 112.253 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.503 HD22 HG21 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -118.63 130.14 55.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.476 179.689 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.549 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 35.5 tptt -128.57 118.87 23.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.211 0.529 . . . . 0.0 111.341 179.391 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.6 HD12 ' CA ' ' A' ' 172' ' ' GLU . 0.3 OUTLIER -124.44 138.48 53.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.696 177.676 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.718 ' HB2' ' HB3' ' A' ' 200' ' ' ARG . 15.1 mmt -86.29 135.08 33.68 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.901 -179.213 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -139.25 134.67 32.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.052 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 0.8 OUTLIER -123.31 78.02 53.29 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.676 -179.939 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.63 -27.9 72.32 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.252 1.968 . . . . 0.0 112.117 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -71.82 -63.01 1.22 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.083 0.468 . . . . 0.0 111.036 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 55.2 p -72.88 -18.83 61.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.512 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 79.6 28.9 50.45 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.36 -179.776 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.542 ' HD2' ' CZ2' ' A' ' 168' ' ' TRP . 7.8 ttp180 -124.91 141.81 51.88 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 121.048 0.452 . . . . 0.0 111.854 -179.399 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 191' ' ' MET . 22.6 p -84.73 8.23 17.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.649 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.813 ' HG3' ' CE1' ' A' ' 202' ' ' PHE . 11.4 tpt180 76.48 -42.64 0.44 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.065 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.548 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 96.37 4.73 59.48 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.851 -0.69 . . . . 0.0 114.219 178.311 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.813 ' CE1' ' HG3' ' A' ' 200' ' ' ARG . 36.6 p90 -149.54 159.13 44.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.257 0.551 . . . . 0.0 112.106 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -151.66 170.88 31.16 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.418 179.577 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.711 ' CZ ' ' CE1' ' A' ' 162' ' ' PHE . 78.9 m-85 -114.98 134.94 54.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.025 0.441 . . . . 0.0 112.058 -179.558 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.956 HD21 HD22 ' A' ' 175' ' ' LEU . 59.5 mt -107.73 139.65 41.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.349 179.112 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.625 ' O ' HG23 ' A' ' 185' ' ' VAL . 20.1 t -123.24 126.97 47.93 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.928 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.712 ' CE2' HG21 ' A' ' 216' ' ' VAL . 84.4 m-85 -114.64 135.18 54.43 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.736 ' N ' HG23 ' A' ' 186' ' ' THR . 84.5 tt0 -63.35 -35.56 80.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.153 178.583 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.69 117.39 54.26 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.879 179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.78 -28.09 74.65 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.58 2.187 . . . . 0.0 113.041 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 20.4 m -59.02 -39.65 82.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.796 0.331 . . . . 0.0 110.724 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.855 ' O ' HG23 ' A' ' 216' ' ' VAL . 23.8 m -61.42 -35.58 77.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.222 0.534 . . . . 0.0 110.095 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.758 HG13 ' SD ' ' A' ' 161' ' ' MET . 96.7 t -62.19 -41.74 92.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.392 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 218' ' ' LYS . 92.4 m-20 -58.62 -43.61 89.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.305 -179.345 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -70.02 -34.35 73.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.855 0.36 . . . . 0.0 111.708 178.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 212' ' ' SER . 87.0 t -60.35 -44.36 95.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.18 -178.766 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.611 HG11 ' NE ' ' A' ' 232' ' ' ARG . 10.4 p -80.75 -44.84 21.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.464 ' N ' HG13 ' A' ' 217' ' ' VAL . 15.0 mtpt -59.21 -34.19 71.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.713 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 27.5 m -96.46 143.65 27.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.135 0.493 . . . . 0.0 111.745 -178.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -93.3 125.28 37.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.902 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.603 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 0.0 OUTLIER -131.79 152.34 51.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.201 -179.028 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.581 HG22 ' H ' ' A' ' 225' ' ' GLY . 70.7 mt -121.91 128.41 75.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.871 179.393 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.779 HD13 ' CG2' ' A' ' 170' ' ' THR . 4.7 mt -88.1 -72.78 0.51 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -93.07 14.15 18.7 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.143 -178.786 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.581 ' H ' HG22 ' A' ' 222' ' ' ILE . . . 100.19 -0.32 56.0 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.987 -178.696 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -112.22 132.58 54.84 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 227' ' ' VAL . 34.3 m -59.01 120.05 4.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.498 -179.325 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.745 HG13 ' HD3' ' A' ' 230' ' ' PRO . 31.1 pt -97.47 -33.0 4.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.298 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 47.57 73.72 0.94 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.079 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.745 ' HD3' HG13 ' A' ' 228' ' ' ILE . 31.0 Cg_endo -60.54 135.01 58.07 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.736 2.291 . . . . 0.0 112.143 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -128.53 151.99 48.81 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.547 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.611 ' NE ' HG11 ' A' ' 217' ' ' VAL . 1.9 mpt_? -59.47 143.45 49.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.206 0.527 . . . . 0.0 112.233 -178.621 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -74.95 150.14 39.16 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.613 179.611 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 234' ' ' ILE . . . . . 0.885 HD12 ' HG2' ' A' ' 239' ' ' GLN . 0.1 OUTLIER -124.89 133.49 24.84 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.287 178.873 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.559 ' HD2' ' OE1' ' A' ' 238' ' ' GLU . 44.0 Cg_exo -54.96 145.64 61.81 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 121.775 1.65 . . . . 0.0 110.092 178.321 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 48.7 tpt85 -54.55 -40.53 68.79 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.565 -178.364 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.599 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 53.4 p30 -65.24 -37.31 86.84 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.371 179.414 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.599 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 93.1 mt-10 -68.29 -34.85 76.92 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.008 179.393 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.885 ' HG2' HD12 ' A' ' 234' ' ' ILE . 97.4 mt-30 -58.89 -38.62 79.28 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.045 0.45 . . . . 0.0 109.901 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -61.51 -39.08 89.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.048 178.594 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -60.05 -34.76 73.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.393 179.529 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.757 HG21 HD11 ' A' ' 270' ' ' ILE . 12.1 p -105.38 162.96 12.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.407 -178.607 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.22 168.62 25.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.519 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 289' ' ' VAL . 7.2 ttpm? -134.31 139.6 45.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.431 0.158 . . . . 0.0 110.678 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.823 HD12 HG11 ' A' ' 300' ' ' VAL . 0.1 OUTLIER -118.71 157.53 20.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 121.13 0.491 . . . . 0.0 111.465 -179.361 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -102.8 128.37 49.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.645 178.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.835 HG11 HD12 ' A' ' 313' ' ' ILE . 41.5 t -124.55 131.27 72.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.885 0.374 . . . . 0.0 111.44 179.303 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.655 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -105.45 174.19 20.94 Favored Glycine 0 C--O 1.225 -0.411 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.907 179.219 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 285' ' ' GLY . . . 82.86 16.22 70.79 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.933 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.574 ' CD1' ' CE1' ' A' ' 259' ' ' PHE . 64.0 mt -116.13 132.66 65.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.94 0.4 . . . . 0.0 111.519 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.695 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -168.02 -116.3 0.36 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.666 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.89 143.53 99.58 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.616 2.211 . . . . 0.0 113.389 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 55.34 41.81 30.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.953 178.765 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.738 HG12 ' HG2' ' A' ' 309' ' ' LYS . 16.6 m -118.8 -1.84 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.369 178.099 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.597 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.2 OUTLIER 37.61 111.91 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.431 0 O-C-N 123.365 0.415 . . . . 0.0 111.804 -179.851 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.19 -39.72 51.82 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.542 1.495 . . . . 0.0 111.492 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -62.6 -40.99 98.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.014 0.435 . . . . 0.0 109.959 178.23 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.511 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 85.0 tt0 -65.11 -37.47 87.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.822 179.502 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.574 ' CE1' ' CD1' ' A' ' 250' ' ' ILE . 35.1 t80 -60.51 -45.46 93.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.643 179.076 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.543 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.4 tt0 -64.1 -42.01 97.08 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.511 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.3 pt-20 -74.73 -30.23 61.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.015 0.436 . . . . 0.0 110.362 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.57 ' CE1' ' HD1' ' A' ' 308' ' ' PHE . 88.1 t80 -58.78 -46.56 87.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.885 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.757 ' HZ ' HG11 ' A' ' 247' ' ' VAL . 34.8 m-85 -88.09 -7.12 57.44 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.745 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.499 ' N ' HD11 ' A' ' 269' ' ' ILE . 81.6 p -62.6 -26.28 68.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.039 0.447 . . . . 0.0 111.107 -179.668 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -57.16 -38.41 73.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.911 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.641 ' HH2' HG21 ' A' ' 306' ' ' ILE . 11.6 m-90 -59.26 -38.35 79.89 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.342 0.591 . . . . 0.0 111.199 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 264' ' ' SER . . . 174.83 -159.77 28.51 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.069 -178.757 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 51.3 m -79.57 130.73 35.65 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.143 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.829 HG23 ' O ' ' A' ' 290' ' ' THR . 72.2 mt -106.59 118.32 54.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.757 HD11 HG21 ' A' ' 242' ' ' THR . 69.5 mt -61.17 -52.46 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 120.089 -0.645 . . . . 0.0 112.288 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 270' ' ' ILE . 72.9 m-20 -162.97 68.9 0.22 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.668 ' HB2' HG21 ' A' ' 269' ' ' ILE . . . -73.87 135.71 43.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.387 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -139.63 149.43 43.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.451 0.643 . . . . 0.0 111.969 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.569 ' O ' ' HB2' ' A' ' 275' ' ' MET . 22.6 tp -65.14 -37.91 88.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.855 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.731 ' C ' HD12 ' A' ' 276' ' ' LEU . 93.6 mmm 84.62 148.59 0.07 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.14 0.576 . . . . 0.0 109.899 -178.293 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.731 HD12 ' C ' ' A' ' 275' ' ' MET . 5.5 mp -158.57 133.34 8.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.632 0.253 . . . . 0.0 110.734 179.453 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -74.82 -134.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.129 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.41 ' O ' ' OD1' ' A' ' 279' ' ' ASP . 86.4 mttt -58.78 -37.14 75.65 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.764 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.499 ' O ' HD23 ' A' ' 276' ' ' LEU . 95.9 m-20 -140.34 -85.07 0.22 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.762 179.125 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 57.8 p -116.04 24.31 11.54 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.711 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -51.88 -41.92 52.55 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.805 -179.08 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.702 ' HG3' ' HB2' ' A' ' 275' ' ' MET . 6.9 tm0? -64.52 -34.74 78.94 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.972 0.415 . . . . 0.0 111.493 178.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 39.4 t -49.59 -15.14 0.14 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.244 -177.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -51.18 -36.87 43.36 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.098 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 249' ' ' GLY . . . 154.2 31.09 0.03 OUTLIER Glycine 0 CA--C 1.528 0.888 0 C-N-CA 118.828 -1.653 . . . . 0.0 116.636 178.419 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.586 ' O ' ' NE2' ' A' ' 282' ' ' GLN . 12.7 p90 -143.89 160.6 40.51 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.51 1.655 . . . . 0.0 111.962 178.322 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -147.2 163.34 28.68 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.952 179.286 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.442 ' CE2' ' HE3' ' A' ' 244' ' ' LYS . 1.4 m-30 -113.68 128.07 56.28 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.485 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 39.8 t -121.52 132.67 70.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.527 0.203 . . . . 0.0 110.462 177.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.829 ' O ' HG23 ' A' ' 269' ' ' ILE . 49.7 m -120.26 136.51 54.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.642 0.258 . . . . 0.0 110.42 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.555 ' CE1' HG12 ' A' ' 269' ' ' ILE . 45.7 m-85 -119.23 134.98 54.91 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.671 ' HA ' HD11 ' A' ' 270' ' ' ILE . 55.0 t0 -60.52 -34.84 74.68 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.649 178.07 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 23.3 t -117.32 140.79 49.12 Favored 'General case' 0 N--CA 1.46 0.047 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.066 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.53 -28.36 69.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.873 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 296' ' ' ALA . 53.8 p30 -59.26 -35.87 74.49 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.53 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.575 ' N ' ' OD1' ' A' ' 295' ' ' ASP . . . -64.29 -33.83 76.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.979 0.419 . . . . 0.0 110.335 179.215 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.691 HG13 ' CG2' ' A' ' 245' ' ' ILE . 72.2 t -62.55 -43.44 98.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.196 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -61.35 -42.58 98.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.751 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -64.49 -42.81 95.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.151 0.501 . . . . 0.0 112.116 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.987 HG22 HD13 ' A' ' 315' ' ' ILE . 1.4 p -66.59 -36.23 76.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.618 -178.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 75.1 m -71.3 -42.41 68.69 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -57.76 -39.46 77.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.811 0.339 . . . . 0.0 111.697 -178.873 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.48 ' HB2' HD11 ' A' ' 306' ' ' ILE . 89.1 m-20 -57.84 -30.85 66.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.557 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.695 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 7.4 tptt 70.13 -71.8 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.55 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.695 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.8 m-30 -111.68 138.16 48.61 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.042 0.448 . . . . 0.0 110.949 178.883 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.641 HG21 ' HH2' ' A' ' 266' ' ' TRP . 21.9 mm -117.97 137.33 52.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.522 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -75.51 86.35 2.62 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.996 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.57 ' HD1' ' CE1' ' A' ' 262' ' ' PHE . 5.1 t80 -110.24 129.04 55.8 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.44 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.738 ' HG2' HG12 ' A' ' 254' ' ' VAL . 0.0 OUTLIER 59.01 40.33 22.39 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.751 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 53.98 37.5 26.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.514 0.673 . . . . 0.0 109.274 -178.014 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -148.59 162.51 39.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.93 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.65 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 30.6 mttt -93.89 133.69 37.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.232 0.539 . . . . 0.0 111.509 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.835 HD12 HG11 ' A' ' 247' ' ' VAL . 32.2 pt -118.06 144.17 26.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.196 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 314' ' ' GLU . . . . . 0.514 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 89.1 mt-10 -101.55 142.13 33.38 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.731 -178.919 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 0.987 HD13 HG22 ' A' ' 300' ' ' VAL . 69.6 mt -118.71 126.51 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 121.095 0.474 . . . . 0.0 111.496 -179.514 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -137.64 137.4 38.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.846 179.34 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -48.66 144.67 4.17 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.566 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 244' ' ' LYS . . . -55.92 143.81 30.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.008 0.432 . . . . 0.0 111.259 -179.083 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.245 -179.824 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.8 p . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.918 0.389 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.545 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 5.3 tptm -67.55 138.49 56.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.031 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.688 ' O ' ' HA ' ' A' ' 204' ' ' PHE . 90.0 mtp -129.46 160.0 34.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.077 0.465 . . . . 0.0 111.906 -179.659 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.564 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 1.6 t80 -107.63 129.54 54.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.771 178.983 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.503 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 20.4 mm -118.49 130.62 73.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 121.263 -0.175 . . . . 0.0 111.205 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.525 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -128.53 158.37 21.71 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.726 178.889 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.23 36.61 34.4 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.586 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 68.3 mt -59.79 -26.03 65.4 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.446 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 169' ' ' ASP . 54.3 t30 74.11 39.88 0.48 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.93 0.395 . . . . 0.0 110.207 -178.188 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.434 ' CE2' ' HD2' ' A' ' 198' ' ' ARG . 9.6 m0 30.65 30.06 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.638 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 167' ' ' ASN . 89.6 m-20 -130.97 5.8 4.57 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 172' ' ' GLU . 23.6 m -82.73 133.76 35.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 110.348 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 172' ' ' GLU . 5.3 p -109.49 14.69 23.43 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.104 -179.409 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.71 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 95.5 mt-10 77.67 -30.28 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -177.619 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.709 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 90.1 m-20 -62.92 -41.0 99.31 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 121.114 0.483 . . . . 0.0 111.486 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.519 ' HB3' HD21 ' A' ' 223' ' ' LEU . 85.1 m-20 -61.53 -38.0 85.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.685 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.745 HD22 HD21 ' A' ' 205' ' ' LEU . 18.9 mt -62.81 -41.93 99.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -178.247 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.709 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -68.83 -42.73 76.77 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.752 179.955 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.518 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 84.2 tt0 -72.64 -44.38 61.97 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.031 0.443 . . . . 0.0 110.811 179.014 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.606 ' OH ' ' CB ' ' A' ' 221' ' ' HIS . 43.1 t80 -62.62 -44.39 96.41 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.575 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.616 ' CE2' HD23 ' A' ' 175' ' ' LEU . 95.3 m-85 -97.8 -0.27 45.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.061 -178.531 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -59.32 -29.75 66.61 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.822 178.483 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.575 ' H ' ' CD ' ' A' ' 181' ' ' LYS . 0.5 OUTLIER -57.34 -42.29 81.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 122.093 0.949 . . . . 0.0 110.356 -179.897 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -69.65 -34.1 73.53 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.702 -1.59 . . . . 0.0 112.492 -177.679 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -175.39 -173.43 41.14 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 119.46 -1.353 . . . . 0.0 114.187 -179.742 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.545 ' O ' HG12 ' A' ' 185' ' ' VAL . 51.7 m -61.74 -26.53 68.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.533 -0.833 . . . . 0.0 112.05 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 184' ' ' THR . 8.0 p 51.31 73.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.831 0.824 . . . . 0.0 109.427 -177.292 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.4 t -54.23 -46.36 72.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.62 -1.173 . . . . 0.0 113.275 -177.584 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -137.45 157.33 46.8 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.587 0.708 . . . . 0.0 112.849 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.718 HD11 ' HB2' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -127.32 130.87 50.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.429 179.599 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 20.0 tptt -134.26 120.58 20.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 179.676 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.71 ' HB ' ' HG2' ' A' ' 172' ' ' GLU . 1.0 OUTLIER -127.88 134.61 64.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.139 176.868 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.591 ' N ' ' SD ' ' A' ' 191' ' ' MET . 0.0 OUTLIER -92.8 135.95 33.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.456 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -127.93 150.94 49.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.608 -178.817 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.631 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 17.8 m-20 -119.76 78.11 22.2 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.665 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.94 -26.41 74.47 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.11 1.874 . . . . 0.0 111.701 179.176 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.29 -66.55 0.71 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.444 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.8 p -67.58 -27.51 66.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.125 179.66 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 90.6 6.14 68.29 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.411 179.354 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.631 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 6.2 ttp85 -128.82 129.48 45.68 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 117.519 0.66 . . . . 0.0 111.816 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.5 t -66.37 155.46 37.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.807 -179.669 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.685 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 1.1 mpt_? -53.95 -34.03 58.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.131 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.489 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 93.82 1.85 65.29 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.842 -179.103 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.685 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 33.6 p90 -139.54 156.6 46.8 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.953 0.406 . . . . 0.0 110.919 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.521 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -144.31 158.92 27.63 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.819 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.688 ' HA ' ' O ' ' A' ' 161' ' ' MET . 90.5 m-85 -108.7 130.0 55.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 117.082 0.441 . . . . 0.0 110.463 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.745 HD21 HD22 ' A' ' 175' ' ' LEU . 64.2 mt -106.68 138.06 43.55 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.861 0.362 . . . . 0.0 111.943 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 49.0 m -121.29 136.2 55.0 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.717 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -123.36 145.29 48.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.748 0.309 . . . . 0.0 111.108 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.45 -34.36 76.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.952 178.782 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.7 115.34 51.39 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.336 179.161 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.37 -24.34 51.43 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.643 2.228 . . . . 0.0 113.61 -179.111 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 85.4 p -60.82 -31.42 70.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.586 0.232 . . . . 0.0 111.444 -179.405 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.862 ' O ' HG23 ' A' ' 216' ' ' VAL . 19.5 m -59.68 -36.11 75.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.912 0.387 . . . . 0.0 110.771 179.528 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.529 HG13 ' SD ' ' A' ' 161' ' ' MET . 85.8 t -62.13 -41.95 93.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.435 -179.558 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -59.26 -41.38 88.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.66 -179.698 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.403 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 16.3 pt-20 -76.79 -34.55 57.97 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 212' ' ' SER . 76.4 t -62.23 -46.31 96.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.25 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 230' ' ' PRO . 13.3 p -68.24 -45.53 82.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.022 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.489 ' N ' HG13 ' A' ' 217' ' ' VAL . 27.0 mttp -61.31 -36.19 79.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.026 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.405 ' O ' ' O ' ' A' ' 220' ' ' GLN . 47.9 m -59.11 -38.78 80.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.783 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.405 ' O ' ' O ' ' A' ' 219' ' ' THR . 63.9 tt0 60.67 107.26 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -177.442 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.614 ' O ' HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -136.92 167.63 21.12 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -176.568 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.755 HG23 ' O ' ' A' ' 226' ' ' LYS . 3.0 mt -125.58 118.8 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.321 176.832 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.606 HD23 ' OD1' ' A' ' 224' ' ' ASP . 8.4 tt -91.16 -54.27 4.01 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -177.468 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.606 ' OD1' HD23 ' A' ' 223' ' ' LEU . 97.4 m-20 -101.14 16.13 26.44 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.056 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.419 ' H ' HG22 ' A' ' 222' ' ' ILE . . . 98.92 -1.86 58.06 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.568 -178.702 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.755 ' O ' HG23 ' A' ' 222' ' ' ILE . 32.8 mmtp -110.76 139.23 46.24 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.105 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.701 HG21 ' O ' ' A' ' 276' ' ' LEU . 16.1 m -64.29 123.99 18.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.903 -179.457 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 221' ' ' HIS . 34.0 pt -120.78 151.21 23.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.624 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -128.54 80.4 72.57 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 121.073 0.463 . . . . 0.0 111.502 -179.356 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.676 ' O ' HG23 ' A' ' 217' ' ' VAL . 72.4 Cg_exo -53.01 126.31 21.07 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.43 2.087 . . . . 0.0 110.583 179.208 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.479 ' HZ3' ' HB2' ' A' ' 231' ' ' LYS . 1.2 ttmm -131.9 149.52 52.42 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.725 -178.487 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 14.1 ttp-105 -64.27 133.64 53.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.281 179.24 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.545 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -56.86 145.18 30.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.85 0.357 . . . . 0.0 111.033 -179.413 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 5.1 mt -108.67 125.08 32.56 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.487 -179.412 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.54 152.16 12.85 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.077 1.851 . . . . 0.0 110.503 178.88 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.47 ' HD3' ' OE1' ' A' ' 239' ' ' GLN . 31.2 mmt180 -55.89 -40.26 72.74 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.148 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -63.8 -46.35 85.58 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.17 179.12 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.29 -35.2 73.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.301 0.572 . . . . 0.0 109.923 178.172 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.47 ' OE1' ' HD3' ' A' ' 236' ' ' ARG . 61.1 tt0 -58.25 -42.27 86.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.183 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -63.08 -40.31 97.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.327 0.584 . . . . 0.0 110.011 178.314 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 242' ' ' THR . 24.2 mttp -62.63 -34.05 76.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.384 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 291' ' ' TYR . 68.2 p -29.08 -81.26 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -178.179 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 76.71 46.28 11.59 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.96 179.204 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 7.9 ttpm? -59.73 136.21 57.92 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.675 ' CG2' HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -123.31 161.2 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.771 0.796 . . . . 0.0 112.919 -179.307 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 315' ' ' ILE . 91.8 t80 -99.2 135.92 39.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.866 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.671 HG12 ' O ' ' A' ' 287' ' ' GLY . 9.6 p -129.92 144.03 39.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.238 0.542 . . . . 0.0 111.601 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.634 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.75 171.55 18.42 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.87 16.93 58.91 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.045 -1.074 . . . . 0.0 111.994 -179.111 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.739 HG22 HG21 ' A' ' 254' ' ' VAL . 68.7 mt -110.52 129.33 65.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.961 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -169.75 -99.08 0.12 Allowed Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.135 -179.592 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 252' ' ' PRO . . . . . 0.542 ' O ' HG13 ' A' ' 254' ' ' VAL . 32.1 Cg_exo -60.02 136.37 68.96 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.399 2.066 . . . . 0.0 113.255 -179.238 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 51.72 43.01 30.25 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.245 178.599 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.961 HG22 ' O ' ' A' ' 251' ' ' GLY . 14.8 m -127.0 45.4 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 254' ' ' VAL . 0.1 OUTLIER -40.77 151.67 0.26 Allowed Pre-proline 0 N--CA 1.462 0.155 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.859 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.415 ' N ' HD11 ' A' ' 274' ' ' LEU . 11.1 Cg_endo -55.28 -28.02 60.21 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 121.982 1.788 . . . . 0.0 112.381 -178.308 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -61.44 -44.62 96.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.293 179.492 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.506 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 55.6 mp0 -67.43 -38.7 84.95 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.902 0.382 . . . . 0.0 111.716 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.737 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 31.6 t80 -64.72 -47.52 77.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.534 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.46 -41.55 98.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.832 0.348 . . . . 0.0 110.626 179.589 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.5 pt-20 -75.39 -28.84 59.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.424 178.998 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.598 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 3.7 t80 -62.57 -56.87 13.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.607 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.694 ' C ' HD11 ' A' ' 269' ' ' ILE . 7.0 m-85 -65.89 -21.42 66.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.064 -179.384 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.701 ' N ' HD11 ' A' ' 269' ' ' ILE . 67.5 p -57.87 -20.12 34.28 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.742 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -47.67 -38.43 14.94 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.059 178.901 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.731 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 23.5 p90 -131.17 44.0 3.01 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 264' ' ' SER . . . 161.47 150.03 5.8 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.164 179.137 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.417 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 55.7 m -59.98 -34.83 73.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.876 0.369 . . . . 0.0 111.005 179.443 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.701 HD11 ' N ' ' A' ' 264' ' ' SER . 79.0 mt 68.44 112.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.075 -178.804 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.606 HG22 ' HB ' ' A' ' 290' ' ' THR . 14.7 tt -61.04 -29.43 45.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.916 0.388 . . . . 0.0 110.359 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 272' ' ' ALA . 55.8 t0 -176.9 -48.53 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.533 179.433 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.849 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . 52.13 122.11 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.879 0.371 . . . . 0.0 111.755 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -141.34 155.19 45.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.394 0.616 . . . . 0.0 112.43 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.761 ' HB2' HD11 ' A' ' 276' ' ' LEU . 64.0 mt -66.41 -31.79 72.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.212 178.703 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.569 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 94.2 mmm 102.1 -80.8 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.643 0.777 . . . . 0.0 110.397 -178.916 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.761 HD11 ' HB2' ' A' ' 274' ' ' LEU . 0.1 OUTLIER 38.57 64.74 0.71 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.345 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.628 ' O ' HG22 ' A' ' 227' ' ' VAL . 57.1 t0 -56.57 -39.81 74.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.943 0.402 . . . . 0.0 110.747 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.617 ' O ' HG22 ' A' ' 280' ' ' THR . 17.2 mtpt -95.07 9.56 39.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.39 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.2 t70 60.56 42.25 14.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.143 0.497 . . . . 0.0 110.386 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 278' ' ' LYS . 0.0 OUTLIER -171.26 -67.26 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.346 179.834 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 281' ' ' GLY . . . . . 0.523 ' H ' HG23 ' A' ' 280' ' ' THR . . . -83.19 175.56 52.8 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.467 179.201 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 64.05 45.06 4.31 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.013 0.435 . . . . 0.0 110.88 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.521 ' OG ' HD23 ' A' ' 276' ' ' LEU . 10.3 p -167.98 -40.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.033 179.79 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.443 ' O ' ' HA3' ' A' ' 251' ' ' GLY . 41.2 ttm180 -55.2 -31.34 61.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.933 179.299 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -105.77 -39.18 2.23 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.746 -0.74 . . . . 0.0 114.571 -178.305 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -136.6 167.24 21.77 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.001 0.9 . . . . 0.0 112.828 -178.17 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.671 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -132.44 159.14 23.29 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.187 178.685 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.425 ' HB2' ' HG2' ' A' ' 275' ' ' MET . 0.1 OUTLIER -119.21 124.6 47.16 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 122.734 -0.274 . . . . 0.0 111.612 -179.502 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.849 HG13 ' HB2' ' A' ' 272' ' ' ALA . 57.4 t -128.98 135.72 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 178.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.606 ' HB ' HG22 ' A' ' 270' ' ' ILE . 26.5 m -122.4 139.9 53.31 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.358 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.615 ' O ' ' HA ' ' A' ' 242' ' ' THR . 74.5 m-85 -113.35 137.32 51.69 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.882 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 293' ' ' SER . 54.1 p30 -63.35 -30.14 71.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.295 178.55 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 293' ' ' SER . . . . . 0.537 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 99.1 p -115.55 144.1 44.37 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.272 0.558 . . . . 0.0 111.362 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.942 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -69.03 -33.32 73.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.348 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -57.04 -36.9 71.03 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.677 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.79 -39.09 87.59 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.942 HG12 ' O ' ' A' ' 294' ' ' ALA . 8.7 p -59.68 -37.83 72.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.437 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -62.79 -39.03 92.97 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -179.142 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -60.56 -43.29 97.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.666 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.902 HG23 HD11 ' A' ' 306' ' ' ILE . 0.9 OUTLIER -67.71 -34.18 66.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.671 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 77.4 m -57.82 -45.88 85.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.497 -179.166 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -61.59 -40.47 94.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.205 0.526 . . . . 0.0 110.704 179.68 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -60.52 -33.25 72.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.18 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.669 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 47.8 tptt 68.52 -73.21 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -177.744 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.669 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.6 m-30 -114.42 144.25 43.62 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.276 178.43 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.902 HD11 HG23 ' A' ' 300' ' ' VAL . 24.4 mt -118.89 133.4 65.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.639 178.204 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -76.84 75.69 3.46 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.883 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.598 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 5.2 t80 -72.8 -52.03 16.61 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.553 0.692 . . . . 0.0 110.927 -179.196 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.466 ' HD3' ' CE1' ' A' ' 308' ' ' PHE . 23.6 mmmt -128.39 -151.78 0.49 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.191 -179.147 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -58.08 -26.48 62.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.386 179.198 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -121.29 159.69 25.48 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.109 0.481 . . . . 0.0 112.237 -178.149 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.528 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 49.2 mttt -75.78 149.04 38.03 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.167 179.508 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.634 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 36.8 pt -117.84 149.52 20.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.311 178.466 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 314' ' ' GLU . . . . . 0.587 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 83.0 mt-10 -110.79 132.13 54.46 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.584 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 0.573 HG12 HG23 ' A' ' 247' ' ' VAL . 79.7 mt -121.05 126.9 75.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.14 0.495 . . . . 0.0 111.685 -179.487 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -126.09 150.31 48.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.133 179.666 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.572 ' HA ' HG22 ' A' ' 245' ' ' ILE . 95.1 mtm-85 -55.83 144.13 28.87 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.264 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 244' ' ' LYS . . . -61.66 142.66 57.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.983 0.42 . . . . 0.0 111.34 -179.337 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.128 179.551 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.087 0.47 . . . . 0.0 109.949 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.477 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 74.9 tttt -127.01 139.1 53.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.851 -179.505 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.826 ' SD ' HG13 ' A' ' 213' ' ' VAL . 93.2 mmm -116.29 147.56 41.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.42 -178.609 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.574 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 2.9 t80 -104.74 130.22 52.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.446 -0.797 . . . . 0.0 108.912 178.314 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.496 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 21.8 mm -117.42 130.84 71.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.312 -179.217 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.574 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -128.5 162.81 22.12 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 178.677 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.46 36.43 34.05 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.14 -1.029 . . . . 0.0 111.992 -179.717 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.483 HD22 HG21 ' A' ' 170' ' ' THR . 50.7 mt -60.68 -26.12 66.86 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -178.774 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.461 ' HB2' ' HG3' ' A' ' 226' ' ' LYS . 42.0 t30 71.38 40.76 0.81 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -176.902 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 8.2 m0 31.4 41.76 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.948 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -174.84 21.89 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 179.372 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.522 ' O ' ' O ' ' A' ' 171' ' ' THR . 98.1 m -61.62 -38.19 86.72 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.524 ' C ' HD12 ' A' ' 190' ' ' ILE . 0.0 OUTLIER 57.82 130.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -177.657 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.944 ' N ' HD12 ' A' ' 190' ' ' ILE . 21.6 pt-20 -58.77 -29.49 66.82 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -178.29 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.533 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.1 m-20 -60.06 -40.67 90.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.71 0.29 . . . . 0.0 111.582 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 170' ' ' THR . 9.5 m120 -64.91 -37.17 86.75 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -179.138 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.687 HD23 ' CE2' ' A' ' 179' ' ' PHE . 7.2 mt -55.8 -47.78 76.53 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.815 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.533 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -65.1 -33.03 75.06 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.068 179.269 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -62.23 -39.02 91.41 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.672 -179.189 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.827 ' CD2' HD12 ' A' ' 223' ' ' LEU . 0.0 OUTLIER -94.59 -45.91 7.18 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-O 120.723 0.297 . . . . 0.0 110.755 179.614 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.687 ' CE2' HD23 ' A' ' 175' ' ' LEU . 75.0 m-85 -72.93 -13.96 61.36 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 179.074 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.69 -26.45 24.79 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.27 -0.49 . . . . 0.0 113.564 -179.297 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.752 ' HD3' ' H ' ' A' ' 181' ' ' LYS . 0.5 OUTLIER -56.47 -41.95 77.39 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.909 0.861 . . . . 0.0 110.796 -179.719 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.762 ' OH ' HG21 ' A' ' 219' ' ' THR . 66.6 m-85 -69.72 -35.15 74.78 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.054 -1.43 . . . . 0.0 112.927 -177.345 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 174.93 -175.08 47.02 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.352 -1.404 . . . . 0.0 114.171 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.556 ' O ' HG12 ' A' ' 185' ' ' VAL . 54.1 m -63.11 -25.11 68.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.573 -0.814 . . . . 0.0 111.659 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.593 HG21 HD23 ' A' ' 188' ' ' LEU . 7.9 p 52.75 79.66 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 CA-C-O 121.962 0.887 . . . . 0.0 109.091 -177.006 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -47.19 -50.95 19.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.664 -177.175 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 206' ' ' SER . 22.9 t70 -146.02 124.52 12.42 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.504 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.593 HD23 HG21 ' A' ' 185' ' ' VAL . 0.0 OUTLIER -108.97 153.87 22.97 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.708 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.605 ' HG3' ' SD ' ' A' ' 191' ' ' MET . 11.8 tptt -138.07 125.24 21.57 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -177.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 190' ' ' ILE . . . . . 0.944 HD12 ' N ' ' A' ' 172' ' ' GLU . 5.6 mt -123.67 126.55 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.564 175.58 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 191' ' ' MET . . . . . 0.605 ' SD ' ' HG3' ' A' ' 189' ' ' LYS . 2.6 mpp? -94.6 57.98 2.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.295 -179.489 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.401 ' HA ' ' OG ' ' A' ' 199' ' ' SER . 34.2 tttm -63.9 149.49 47.02 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.81 -179.033 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.526 ' HB3' ' O ' ' A' ' 198' ' ' ARG . 2.1 t0 -120.4 75.85 24.88 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.594 -179.48 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.14 -23.88 75.09 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.59 2.193 . . . . 0.0 112.767 179.608 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -68.28 -73.85 0.14 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.883 -179.041 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.7 p -68.05 -25.54 65.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.704 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 93.95 -0.23 66.76 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.591 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.526 ' O ' ' HB3' ' A' ' 193' ' ' ASP . 0.8 OUTLIER -127.29 131.9 50.42 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.71 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.442 ' OG ' ' NH1' ' A' ' 200' ' ' ARG . 13.3 t -110.5 155.37 22.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.552 0.692 . . . . 0.0 112.799 -178.009 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.651 ' NH2' HG23 ' A' ' 190' ' ' ILE . 0.5 OUTLIER -45.01 -32.21 1.58 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.731 -179.801 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.486 ' H ' ' HD3' ' A' ' 200' ' ' ARG . . . 90.11 22.17 36.33 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.59 -0.814 . . . . 0.0 114.849 178.607 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.61 ' CE2' ' HB2' ' A' ' 200' ' ' ARG . 41.5 p90 -150.83 152.66 34.06 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 117.503 0.652 . . . . 0.0 111.008 178.773 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -138.54 161.69 25.75 Favored Glycine 0 C--O 1.228 -0.265 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.355 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.575 ' HB2' ' HB3' ' A' ' 189' ' ' LYS . 85.3 m-85 -110.73 126.0 54.1 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.9 -179.836 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.609 HD21 HD22 ' A' ' 175' ' ' LEU . 53.9 mt -107.73 142.01 38.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.687 0.28 . . . . 0.0 110.8 179.811 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 187' ' ' ASP . 26.3 t -124.65 130.12 51.82 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.614 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.831 ' CE2' HG21 ' A' ' 216' ' ' VAL . 97.6 m-85 -114.76 135.75 53.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.94 0.4 . . . . 0.0 111.31 179.603 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.43 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.4 tt0 -60.23 -34.23 73.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.473 179.204 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.62 116.96 56.79 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.823 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.85 -29.5 81.7 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.515 2.143 . . . . 0.0 113.189 -179.372 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.7 m -59.15 -37.91 78.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.786 0.327 . . . . 0.0 110.853 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.821 ' O ' HG23 ' A' ' 216' ' ' VAL . 23.3 m -59.83 -34.42 73.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.194 0.521 . . . . 0.0 110.31 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.826 HG13 ' SD ' ' A' ' 161' ' ' MET . 78.1 t -60.38 -41.24 86.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.094 -179.658 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -57.82 -43.95 86.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.026 0.441 . . . . 0.0 110.754 -179.754 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.7 -33.36 72.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.044 178.674 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.831 HG21 ' CE2' ' A' ' 207' ' ' PHE . 96.8 t -60.39 -43.07 93.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.589 -178.512 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 230' ' ' PRO . 9.0 p -84.23 -49.5 16.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.121 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 218' ' ' LYS . . . . . 0.514 ' N ' HG13 ' A' ' 217' ' ' VAL . 81.4 tttt -59.93 -39.68 86.3 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.424 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.762 HG21 ' OH ' ' A' ' 182' ' ' TYR . 70.5 m -59.19 -38.89 80.94 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.329 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.408 ' O ' ' O ' ' A' ' 219' ' ' THR . 63.1 tt0 62.1 114.67 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.03 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.686 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 0.0 OUTLIER -134.2 169.03 17.79 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -176.707 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.887 ' CD1' HG13 ' A' ' 227' ' ' VAL . 16.1 mm -117.62 128.39 74.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.839 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.827 HD12 ' CD2' ' A' ' 178' ' ' TYR . 8.5 tt -117.3 126.0 52.0 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.708 179.366 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.414 ' CG ' HD23 ' A' ' 223' ' ' LEU . 86.9 m-20 53.53 41.89 32.02 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 178.366 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 90.35 -23.88 19.5 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.412 -0.899 . . . . 0.0 114.337 177.444 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.605 ' O ' HG23 ' A' ' 222' ' ' ILE . 34.7 mmtp -95.66 151.21 19.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.202 0.501 . . . . 0.0 111.405 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.887 HG13 ' CD1' ' A' ' 222' ' ' ILE . 26.3 t -92.28 128.76 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.769 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 164' ' ' GLY . 28.3 pt -125.67 154.98 34.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.253 -179.341 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.58 78.21 75.86 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.121 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 230' ' ' PRO . . . . . 0.646 ' O ' HG23 ' A' ' 217' ' ' VAL . 9.4 Cg_endo -52.28 131.59 40.51 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.636 2.224 . . . . 0.0 111.775 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 162' ' ' PHE . 5.4 ttpm? -136.21 139.73 43.01 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.731 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.446 ' HG3' ' CG1' ' A' ' 213' ' ' VAL . 0.9 OUTLIER -50.82 141.98 12.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.088 0.471 . . . . 0.0 111.743 -179.494 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 233' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -62.45 144.44 55.92 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.391 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -107.68 135.81 19.73 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 121.353 -0.139 . . . . 0.0 110.902 179.761 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.91 139.95 85.03 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 121.789 1.659 . . . . 0.0 110.623 178.693 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -58.52 -37.55 75.86 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.758 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -60.18 -48.29 82.36 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.711 -179.856 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -73.04 -41.33 64.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.567 0.699 . . . . 0.0 110.168 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.518 ' O ' HG23 ' A' ' 242' ' ' THR . 61.1 tt0 -60.36 -37.06 79.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.505 -179.479 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -56.25 -37.42 69.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.613 -179.368 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 242' ' ' THR . 39.8 mttm -82.62 -74.09 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.468 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 239' ' ' GLN . 33.5 p 38.62 -168.01 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.087 0.47 . . . . 0.0 112.215 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -168.08 49.75 0.23 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.353 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 15.3 tttp -72.82 128.72 36.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.76 0.314 . . . . 0.0 110.532 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.716 ' CG2' HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -125.02 162.94 26.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -179.409 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.421 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 87.4 t80 -101.45 134.15 44.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.647 -1.161 . . . . 0.0 111.181 179.566 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.754 HG11 ' CE1' ' A' ' 259' ' ' PHE . 14.0 p -127.79 136.38 60.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.687 179.006 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -125.04 4.66 8.38 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.747 -178.702 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.624 ' O ' HG22 ' A' ' 313' ' ' ILE . . . -88.14 9.16 76.0 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.744 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.996 HD11 ' HA3' ' A' ' 287' ' ' GLY . 31.9 pt -120.61 154.75 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 121.004 0.43 . . . . 0.0 111.521 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.816 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -167.51 -142.58 3.5 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.839 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.07 -19.71 34.25 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.55 2.167 . . . . 0.0 112.449 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -82.9 3.18 30.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.81 -179.431 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.816 HG22 ' O ' ' A' ' 251' ' ' GLY . 19.1 m -126.77 157.04 38.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.718 0.294 . . . . 0.0 110.792 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.4 ' HD2' ' HD2' ' A' ' 256' ' ' PRO . 17.0 mmt85 -111.65 154.94 43.75 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.102 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.4 ' HD2' ' HD2' ' A' ' 255' ' ' ARG . 13.8 Cg_endo -57.49 -43.01 55.23 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 121.793 1.662 . . . . 0.0 111.797 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 257' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 261' ' ' GLU . 35.3 mttp -63.14 -43.14 99.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.129 179.349 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 261' ' ' GLU . 76.3 mm-40 -66.53 -36.87 83.75 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.576 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.754 ' CE1' HG11 ' A' ' 247' ' ' VAL . 25.2 t80 -63.67 -52.37 61.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.21 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -64.11 -37.25 86.76 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.315 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 258' ' ' GLU . 72.7 tt0 -61.88 -38.03 86.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.876 -1.511 . . . . 0.0 111.968 178.213 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.779 ' CE2' HD11 ' A' ' 313' ' ' ILE . 71.6 t80 -69.61 -56.52 7.06 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -179.445 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.704 ' C ' HD11 ' A' ' 269' ' ' ILE . 18.9 m-85 -65.2 -24.08 67.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.932 -179.377 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.711 ' N ' HD11 ' A' ' 269' ' ' ILE . 86.1 p -59.48 -25.91 64.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.376 -179.312 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -57.54 -36.89 72.22 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.296 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 266' ' ' TRP . . . . . 0.75 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 11.9 p90 -115.18 39.81 2.82 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.113 0.482 . . . . 0.0 111.765 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.508 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 157.51 146.74 4.58 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.709 178.915 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.434 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 59.8 m -58.94 -37.49 76.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.754 0.311 . . . . 0.0 111.27 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.711 HD11 ' N ' ' A' ' 264' ' ' SER . 73.9 mt 69.3 90.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.099 -179.202 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.63 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 75.0 mt -54.97 -44.76 75.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.932 179.009 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 271' ' ' ASP . . . . . 0.467 ' O ' ' HB ' ' A' ' 290' ' ' THR . 54.0 t0 -156.49 146.76 21.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.824 179.079 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.402 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -154.69 141.37 18.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.348 178.879 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -146.61 155.83 42.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.505 0.669 . . . . 0.0 112.378 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 274' ' ' LEU . . . . . 0.631 HD23 HD22 ' A' ' 276' ' ' LEU . 27.0 tp -64.44 -33.9 76.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.426 179.382 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 275' ' ' MET . . . . . 0.585 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 72.9 mmm 69.48 80.74 0.18 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 -178.478 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.631 HD22 HD23 ' A' ' 274' ' ' LEU . 0.2 OUTLIER -119.38 126.67 51.94 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.34 179.578 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.459 ' HB2' ' HG2' ' A' ' 282' ' ' GLN . 60.0 t0 -86.63 118.71 26.22 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.128 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 278' ' ' LYS . . . . . 0.458 ' CE ' ' HE2' ' A' ' 226' ' ' LYS . 26.9 mmtp 59.22 -150.23 0.44 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.602 -0.439 . . . . 0.0 109.911 -178.358 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.2 -38.73 68.75 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.222 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 280' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 280' ' ' THR . 14.4 t -168.42 114.37 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.906 0.384 . . . . 0.0 111.448 179.282 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 281' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 277' ' ' ASP . . . -145.4 -90.91 0.11 Allowed Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.207 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.585 ' HB2' ' O ' ' A' ' 275' ' ' MET . 29.6 mm100 -56.39 -31.26 63.69 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.934 0.494 . . . . 0.0 111.946 -179.084 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.476 ' HB2' ' CD2' ' A' ' 274' ' ' LEU . 91.8 p -72.76 -4.71 33.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.562 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -51.9 -34.64 42.25 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 250' ' ' ILE . . . -156.22 9.51 0.29 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 119.318 -1.42 . . . . 0.0 115.398 -179.094 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 16.4 p90 -145.87 164.65 31.28 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.976 1.388 . . . . 0.0 112.084 179.12 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.996 ' HA3' HD11 ' A' ' 250' ' ' ILE . . . -140.1 164.68 26.13 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.254 179.126 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.496 ' HB2' ' HG2' ' A' ' 275' ' ' MET . 0.2 OUTLIER -119.4 128.54 54.14 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.367 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.672 HG23 ' CZ ' ' A' ' 259' ' ' PHE . 44.1 t -128.31 138.27 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.813 0.34 . . . . 0.0 111.524 178.289 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 36.2 m -117.34 136.41 53.15 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 291' ' ' TYR . . . . . 0.508 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 39.7 m-85 -115.31 136.01 53.55 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.416 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.63 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 55.3 p30 -64.79 -32.93 74.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.724 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 293' ' ' SER . . . . . 0.57 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 51.0 m -121.98 144.42 48.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.312 0.577 . . . . 0.0 112.237 -178.779 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.989 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -66.23 -32.06 73.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.075 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -56.61 -38.19 71.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.098 -179.717 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -64.42 -41.59 96.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.767 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.989 HG12 ' O ' ' A' ' 294' ' ' ALA . 9.7 p -59.83 -37.05 69.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.014 0.435 . . . . 0.0 111.479 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -61.75 -37.26 83.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.717 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -58.88 -44.13 91.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.165 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.75 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 0.7 OUTLIER -73.41 -35.87 47.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.927 0.394 . . . . 0.0 111.274 -179.642 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 79.3 m -58.53 -46.14 87.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.032 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -63.6 -40.62 97.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.225 0.536 . . . . 0.0 110.192 179.198 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.416 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.4 m-20 -64.3 -35.6 81.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.865 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.675 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 35.5 tptt 67.76 -67.37 0.19 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.168 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.675 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 17.5 m-85 -113.98 131.84 56.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.929 179.148 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 306' ' ' ILE . . . . . 0.667 HD11 HG23 ' A' ' 300' ' ' VAL . 1.3 mt -122.18 138.69 51.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.127 178.822 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.494 ' OD1' ' CD ' ' A' ' 312' ' ' LYS . 94.0 m-20 -73.89 119.21 17.79 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.422 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.728 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 9.4 t80 -119.75 -76.07 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.417 0.627 . . . . 0.0 109.948 178.558 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.522 ' CG ' HG12 ' A' ' 254' ' ' VAL . 6.4 mmpt? -97.72 -163.39 1.04 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.513 178.996 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -52.93 -31.31 39.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.785 0.326 . . . . 0.0 110.742 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -112.15 153.62 26.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.106 0.479 . . . . 0.0 111.351 -179.369 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.598 ' CG ' ' HB3' ' A' ' 305' ' ' PHE . 19.7 tptt -70.77 143.96 51.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.541 -179.091 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.779 HD11 ' CE2' ' A' ' 262' ' ' PHE . 26.4 pt -111.31 141.38 26.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.799 179.218 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -101.48 131.69 47.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.716 179.748 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 315' ' ' ILE . . . . . 0.624 HD13 ' CE2' ' A' ' 263' ' ' PHE . 72.2 mt -119.92 129.57 75.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.156 0.503 . . . . 0.0 111.421 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 30.5 tttp -131.6 141.49 49.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.162 -179.753 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.458 ' HA ' HG22 ' A' ' 245' ' ' ILE . 34.9 ttp180 -54.55 137.75 42.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 0.0 110.581 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.72 140.73 56.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.332 -179.269 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.191 179.089 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.422 ' HG3' ' H ' ' A' ' 158' ' ' SER . 52.3 pttt . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.313 0.102 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.69 -34.3 74.14 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.6 0.238 . . . . 0.0 111.57 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.422 ' H ' ' HG3' ' A' ' 156' ' ' LYS . 22.4 m -57.98 -35.53 71.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 110.937 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 44.0 m -89.24 4.68 47.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.168 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -72.43 138.44 47.12 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 121.573 0.701 . . . . 0.0 112.215 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.832 ' SD ' HG13 ' A' ' 213' ' ' VAL . 82.1 mmm -116.08 150.63 37.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.653 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.601 ' CE2' ' N9 ' ' B' ' 6' ' ' ' A' . 4.8 t80 -103.57 128.57 50.8 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.61 ' CG2' HD21 ' A' ' 166' ' ' LEU . 16.2 mm -115.26 127.72 72.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.702 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -132.31 163.63 23.96 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.511 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.43 29.78 59.44 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.352 -0.927 . . . . 0.0 112.269 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.946 HD23 HG21 ' A' ' 228' ' ' ILE . 76.4 mt -86.84 140.63 29.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.744 0.307 . . . . 0.0 111.164 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.51 ' HB2' ' HG3' ' A' ' 226' ' ' LYS . 22.2 t30 -66.13 133.68 51.21 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.612 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 4.1 m-90 -52.09 -38.47 57.39 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.99 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.432 ' HB3' HD22 ' A' ' 167' ' ' ASN . 48.2 t0 -62.97 -26.85 69.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.5 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 51.5 m -54.07 139.86 33.59 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.542 0.687 . . . . 0.0 111.383 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 28.5 m -119.39 151.5 38.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.7 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.791 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 98.5 mt-10 -55.33 -36.3 66.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.854 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -58.3 -43.81 88.26 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 120.602 -0.439 . . . . 0.0 109.861 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -65.45 -37.3 86.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.622 HD13 HD12 ' A' ' 188' ' ' LEU . 1.0 OUTLIER -55.43 -62.37 1.72 Allowed 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.332 178.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.481 ' O ' ' N ' ' A' ' 180' ' ' GLY . 67.2 ttp85 -57.19 -41.04 78.58 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.912 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.08 -40.23 94.35 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.742 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.551 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 62.7 t80 -61.98 -48.07 81.99 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.637 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.566 ' CD2' HD23 ' A' ' 175' ' ' LEU . 88.8 m-85 -87.93 0.0 56.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.395 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -61.2 -28.84 69.79 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.595 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.443 ' CD ' ' H ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -58.64 -38.67 78.58 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.803 0.811 . . . . 0.0 110.04 -179.049 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -67.63 -30.03 69.49 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.62 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 159.46 -132.83 3.13 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.238 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 52.8 m -119.92 139.62 52.15 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.914 HG12 ' CE1' ' A' ' 207' ' ' PHE . 3.4 m -100.81 122.8 53.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.489 -0.485 . . . . 0.0 110.502 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.3 t -73.22 -46.92 47.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.288 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -145.73 121.7 10.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.016 0.436 . . . . 0.0 111.455 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -118.6 139.69 51.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.572 179.462 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.588 ' O ' ' CA ' ' A' ' 203' ' ' GLY . 8.7 tptt -133.01 83.38 2.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.841 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.791 ' HB ' ' HG2' ' A' ' 172' ' ' GLU . 12.0 tt -60.45 -22.64 26.02 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-O 121.146 0.498 . . . . 0.0 109.77 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.635 ' HE1' ' HA2' ' A' ' 203' ' ' GLY . 0.0 OUTLIER 73.13 55.38 0.12 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.486 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.63 152.07 46.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.467 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 1.5 t0 -124.16 75.85 59.77 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.23 -25.43 80.06 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.462 2.108 . . . . 0.0 112.308 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.74 -66.52 0.6 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.806 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 70.9 p -68.65 -24.83 64.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.195 0.521 . . . . 0.0 110.281 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.59 -3.35 68.27 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.431 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.484 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 6.3 ttp180 -130.35 124.37 32.1 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.971 0.415 . . . . 0.0 111.268 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.1 m -64.41 156.14 30.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.779 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.667 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 5.4 mpt_? -57.07 -33.91 67.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.083 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.604 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 93.17 3.37 65.42 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.668 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.667 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 40.4 p90 -144.62 154.8 43.19 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.635 ' HA2' ' HE1' ' A' ' 191' ' ' MET . . . -151.18 169.11 30.84 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 119.373 -1.394 . . . . 0.0 113.273 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.85 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 98.0 m-85 -106.54 120.47 42.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.188 0.518 . . . . 0.0 109.674 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.618 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 55.3 tp -108.39 125.56 51.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.955 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 50.2 m -118.55 143.56 46.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.312 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.914 ' CE1' HG12 ' A' ' 185' ' ' VAL . 74.3 m-85 -120.81 144.33 48.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.394 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.18 -34.8 77.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.943 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -110.87 119.51 45.89 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.787 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -56.55 -22.05 41.29 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.673 2.249 . . . . 0.0 113.139 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.7 m -57.14 -37.35 71.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.577 0.227 . . . . 0.0 111.558 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.939 ' O ' HG23 ' A' ' 216' ' ' VAL . 21.6 m -59.33 -35.81 74.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.816 0.341 . . . . 0.0 110.745 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.832 HG13 ' SD ' ' A' ' 161' ' ' MET . 78.1 t -61.16 -42.3 92.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.243 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.406 ' O ' HG22 ' A' ' 217' ' ' VAL . 54.0 t0 -59.22 -41.92 89.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.869 0.366 . . . . 0.0 111.179 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.42 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 15.3 pt-20 -76.34 -29.17 57.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.82 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.939 HG23 ' O ' ' A' ' 212' ' ' SER . 77.1 t -60.05 -41.54 86.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.441 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 214' ' ' ASP . 21.9 m -72.17 -30.02 34.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -59.12 -37.67 77.75 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.704 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 43.4 m -91.86 142.27 27.75 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 63.7 tt0 -66.19 -41.68 89.9 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.666 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.798 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 79.3 m-70 81.65 111.2 0.07 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.482 HD13 ' O ' ' A' ' 221' ' ' HIS . 20.5 mm -119.24 113.38 41.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.8 tt -120.67 124.63 45.67 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.937 0.399 . . . . 0.0 111.736 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 52.67 43.0 31.77 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.47 8.35 87.63 Favored Glycine 0 CA--C 1.516 0.141 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.345 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.51 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 2.4 mmmm -120.11 164.61 15.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.68 0.276 . . . . 0.0 110.532 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.9 p -117.52 135.99 56.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.087 0.47 . . . . 0.0 110.263 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.946 HG21 HD23 ' A' ' 166' ' ' LEU . 37.4 pt -126.96 160.47 35.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.61 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -127.83 79.22 74.01 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.158 0.504 . . . . 0.0 110.744 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.559 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 52.3 Cg_exo -58.78 124.06 14.91 Favored 'Trans proline' 0 CA--C 1.528 0.185 0 C-N-CA 122.934 2.423 . . . . 0.0 111.454 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 8.9 mtmm -133.58 157.18 46.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.915 0.388 . . . . 0.0 111.454 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 35.6 tpt85 -57.6 136.06 56.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.407 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.29 144.44 56.95 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.947 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.519 ' CD1' ' C6 ' ' B' ' 6' ' ' ' A' . 11.5 mt -111.06 125.25 31.0 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.67 143.44 46.69 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 121.82 1.68 . . . . 0.0 110.707 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.429 ' NH1' HE22 ' A' ' 239' ' ' GLN . 16.8 mmm180 -57.62 -39.86 77.86 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -62.27 -46.19 89.91 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.295 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.456 ' O ' HG23 ' A' ' 242' ' ' THR . 84.4 tt0 -69.78 -38.16 76.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.578 0.704 . . . . 0.0 109.762 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.429 HE22 ' NH1' ' A' ' 236' ' ' ARG . 19.7 tt0 -59.27 -40.96 87.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.027 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -61.61 -40.53 95.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.896 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -61.21 -34.59 75.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.46 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.729 HG22 ' HA ' ' A' ' 292' ' ' ASP . 19.1 p -80.71 161.93 24.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.535 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -147.46 175.77 26.64 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.178 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.517 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 49.1 tptt -131.08 129.94 42.56 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.648 HD13 ' O ' ' A' ' 245' ' ' ILE . 0.0 OUTLIER -119.74 161.12 19.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.377 0.608 . . . . 0.0 111.116 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.524 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 86.6 t80 -103.96 135.99 44.45 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.451 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 287' ' ' GLY . 7.5 p -129.48 144.55 37.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.563 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.65 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -129.8 176.87 18.45 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.82 32.73 26.13 Favored Glycine 0 C--N 1.32 -0.333 0 C-N-CA 119.895 -1.145 . . . . 0.0 112.211 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 1.023 HG23 HG21 ' A' ' 254' ' ' VAL . 69.3 mt -107.86 130.89 59.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -143.0 -163.12 9.6 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.438 -0.886 . . . . 0.0 113.39 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -52.32 147.69 27.88 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.934 2.423 . . . . 0.0 112.463 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 50.1 t0 74.16 -3.7 2.47 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.672 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 1.023 HG21 HG23 ' A' ' 250' ' ' ILE . 11.3 p -60.93 -38.58 79.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.1 OUTLIER 54.56 115.25 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.403 -179.452 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.21 -34.42 69.27 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 121.664 1.576 . . . . 0.0 111.998 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -61.75 -43.31 99.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.682 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.519 ' HB3' ' O ' ' A' ' 254' ' ' VAL . 84.3 tt0 -65.86 -35.66 81.28 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.281 0.563 . . . . 0.0 110.548 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.63 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 13.9 t80 -58.65 -45.16 89.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.594 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.414 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.4 tt0 -65.38 -41.96 93.17 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.3 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 258' ' ' GLU . 20.3 pt-20 -73.65 -30.8 63.14 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.01 0.433 . . . . 0.0 110.506 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.511 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 8.5 t80 -61.16 -53.23 59.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.224 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.688 ' CD2' HG21 ' A' ' 289' ' ' VAL . 4.3 m-85 -70.0 -23.5 63.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.888 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.637 ' N ' HD11 ' A' ' 269' ' ' ILE . 70.8 p -58.41 -25.61 62.34 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.734 0.302 . . . . 0.0 111.541 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -55.38 -34.51 64.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.242 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.687 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 11.2 p90 -117.05 45.12 1.94 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.259 0.552 . . . . 0.0 111.434 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.504 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 152.44 147.69 4.66 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.745 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 49.8 m -59.41 -37.99 79.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 111.348 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.68 HD11 ' C ' ' A' ' 263' ' ' PHE . 70.4 mt 67.55 86.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.873 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 292' ' ' ASP . 34.0 mm -58.56 -38.94 73.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.9 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -155.98 150.34 25.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.095 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -153.2 132.38 12.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.087 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -149.93 163.04 39.13 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 275' ' ' MET . 1.6 mm? -95.83 7.77 45.4 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.643 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.887 ' O ' HD12 ' A' ' 276' ' ' LEU . 86.0 mtp 71.02 -80.28 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.14 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.887 HD12 ' O ' ' A' ' 275' ' ' MET . 0.1 OUTLIER 37.95 49.42 1.17 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 178.694 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.464 ' HB2' ' OP1' ' B' ' 4' ' ' ' A' . 22.0 t70 -57.28 -45.04 84.47 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.386 -0.525 . . . . 0.0 110.661 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.512 ' O ' HG23 ' A' ' 280' ' ' THR . 61.4 mttp -108.02 3.42 24.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.09 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.484 ' OD1' ' HB2' ' A' ' 276' ' ' LEU . 83.3 m-20 51.28 38.13 20.57 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 278' ' ' LYS . 63.6 p -111.17 0.18 16.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.924 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.62 -30.73 0.26 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 119.409 -1.377 . . . . 0.0 114.334 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.528 ' HB2' ' HA ' ' A' ' 276' ' ' LEU . 94.9 mt-30 -57.46 -31.15 65.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.33 0.565 . . . . 0.0 110.641 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.714 ' CB ' HD23 ' A' ' 276' ' ' LEU . 95.4 p -59.32 -26.0 64.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.393 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -127.3 154.87 44.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.315 0.578 . . . . 0.0 111.389 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.52 -50.49 0.98 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.727 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.52 ' C ' HD12 ' A' ' 250' ' ' ILE . 22.4 p90 -145.16 165.07 29.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.862 0.331 . . . . 0.0 110.748 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.682 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -137.24 163.68 25.36 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.421 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.517 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -122.4 124.96 44.85 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.278 0.231 . . . . 0.0 110.8 179.489 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.688 HG21 ' CD2' ' A' ' 263' ' ' PHE . 43.4 t -127.12 139.9 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.009 0.433 . . . . 0.0 112.032 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.422 ' OG1' ' CD ' ' A' ' 244' ' ' LYS . 34.8 m -114.69 137.87 51.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.858 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.504 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 37.8 m-85 -117.43 140.11 50.02 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.729 ' HA ' HG22 ' A' ' 242' ' ' THR . 29.2 p-10 -61.53 -33.79 74.43 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.236 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.424 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 31.1 t -124.16 139.06 54.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.423 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.82 -31.73 73.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.61 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -56.12 -37.24 69.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.97 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -60.92 -36.65 79.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.957 0.408 . . . . 0.0 110.352 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 300' ' ' VAL . 82.0 t -61.1 -40.87 87.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.143 0.497 . . . . 0.0 110.194 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -59.47 -36.61 76.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.407 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -56.84 -42.91 80.5 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.085 0.469 . . . . 0.0 111.046 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.809 HG23 HD11 ' A' ' 306' ' ' ILE . 0.3 OUTLIER -75.71 -30.22 21.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.667 179.586 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 80.9 m -56.43 -45.87 80.55 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -64.15 -34.31 77.76 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -100.54 70.58 1.47 Allowed 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.204 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.609 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 7.6 tptt -53.81 -43.74 69.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.239 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.609 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.9 m-85 -113.55 126.0 54.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.302 0.572 . . . . 0.0 110.899 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.809 HD11 HG23 ' A' ' 300' ' ' VAL . 25.8 mt -117.68 139.17 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.192 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -79.54 102.39 8.81 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.595 ' HE2' HG23 ' A' ' 254' ' ' VAL . 5.7 t80 -107.4 -72.57 0.72 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.385 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.528 ' HD3' ' CE2' ' A' ' 308' ' ' PHE . 3.7 mmmt -100.15 26.28 6.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.346 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 63.03 41.56 8.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.697 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 312' ' ' LYS . 94.6 mtt180 -150.78 7.86 0.56 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.151 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 311' ' ' ARG . 24.0 mmtm 56.71 138.53 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.537 0.684 . . . . 0.0 112.129 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.65 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 36.3 pt -120.81 148.01 24.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.221 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' GLU . . . . . 0.408 ' CG ' ' HE3' ' A' ' 304' ' ' LYS . 84.9 tt0 -104.32 127.35 51.96 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 0.608 HG12 HG23 ' A' ' 247' ' ' VAL . 86.8 mt -118.19 130.86 72.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.324 0.583 . . . . 0.0 112.074 -178.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -132.51 142.84 49.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.526 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 69.3 mtt85 -53.11 149.13 7.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.641 0.258 . . . . 0.0 110.378 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 244' ' ' LYS . . . -54.27 141.88 28.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.91 0.386 . . . . 0.0 111.116 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -137.17 160.29 66.43 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.313 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.45 146.58 94.58 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.711 2.274 . . . . 0.0 112.124 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.0 -34.97 70.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.789 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.396 -179.943 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.433 ' O2 ' " O4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.429 -0.67 0 C3'-C2'-O2' 111.205 -0.722 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.524 ' C5 ' ' CE1' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.945 0 C3'-C2'-O2' 111.423 -0.647 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.535 ' O2 ' ' P ' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -1.022 0 C3'-C2'-C1' 100.76 -0.823 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.612 ' C2 ' ' CZ3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.426 -0.848 0 C4'-C3'-C2' 103.749 1.049 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.867 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.75 0 C4'-C3'-C2' 103.66 0.96 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.867 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.976 0 C3'-C2'-O2' 111.004 -0.792 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.85 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.955 0 C3'-C2'-O2' 111.289 -0.693 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.937 0 C3'-C2'-O2' 111.251 -0.706 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.2 tptt . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.776 0.322 . . . . 0.0 111.324 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -111.97 154.13 25.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.27 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 93.7 p -62.3 -23.61 66.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.087 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 37.4 m -50.33 -24.29 2.88 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.502 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -56.15 141.25 41.41 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.288 0.566 . . . . 0.0 111.621 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.671 ' CG ' HG23 ' A' ' 213' ' ' VAL . 93.8 mtp -115.83 156.04 26.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.435 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.621 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 3.5 t80 -105.16 129.57 53.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.894 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.638 HG23 HD12 ' A' ' 228' ' ' ILE . 16.0 mm -116.98 131.37 69.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.478 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.679 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -134.48 164.08 24.62 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.411 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.2 25.32 66.51 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.368 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.981 HD23 HG21 ' A' ' 228' ' ' ILE . 75.6 mt -86.88 143.05 27.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.734 0.302 . . . . 0.0 110.949 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.4 ' OD1' ' N6 ' ' B' ' 4' ' ' ' A' . 39.8 t-20 -61.12 133.23 55.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.581 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 4.8 m0 -52.32 -28.18 18.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.703 0.287 . . . . 0.0 111.013 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 50.2 p30 -83.81 8.5 14.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.16 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 88.8 m -70.77 140.23 51.24 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.351 0.596 . . . . 0.0 110.164 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 173' ' ' ASP . 27.9 m -114.97 144.38 43.68 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.566 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.948 ' HB3' HD21 ' A' ' 188' ' ' LEU . 98.3 mt-10 -55.73 -35.42 66.13 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.865 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.795 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 92.1 m-20 -57.1 -40.46 77.05 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -65.15 -38.69 91.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.11 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.722 HD22 HD21 ' A' ' 205' ' ' LEU . 3.6 mt -63.22 -48.32 78.76 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.795 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -71.63 -34.11 69.52 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.033 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -62.08 -38.57 89.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.536 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 63.8 t80 -80.25 -61.86 1.85 Allowed 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.942 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.575 ' CE2' HD23 ' A' ' 175' ' ' LEU . 72.6 m-85 -66.62 -21.47 66.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.314 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -50.56 -27.97 13.85 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.512 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 1.7 tmtt? -55.15 -43.14 73.92 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.864 -0.668 . . . . 0.0 110.062 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.467 ' CG ' HG22 ' A' ' 216' ' ' VAL . 46.0 m-85 -71.08 -33.94 70.69 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.454 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.419 ' O ' ' HA2' ' A' ' 180' ' ' GLY . . . -177.38 179.99 47.89 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.334 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 54.1 m -62.89 -33.85 76.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.805 0.336 . . . . 0.0 111.68 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.818 HG23 ' CE1' ' A' ' 207' ' ' PHE . 0.5 OUTLIER 64.99 102.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 121.205 0.526 . . . . 0.0 109.654 -178.184 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.75 HG23 ' N ' ' A' ' 208' ' ' GLU . 43.9 p -67.29 -37.68 83.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.965 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 206' ' ' SER . 20.1 t70 -160.81 160.77 31.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.948 HD21 ' HB3' ' A' ' 172' ' ' GLU . 0.1 OUTLIER -158.43 144.13 16.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.055 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.518 ' CG ' ' HB2' ' A' ' 204' ' ' PHE . 0.0 OUTLIER -131.71 113.56 13.7 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.724 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.696 ' HB ' ' HG2' ' A' ' 172' ' ' GLU . 2.0 tt -93.05 11.1 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.542 ' CG ' " H1'" ' B' ' 7' ' ' ' U' . 0.0 OUTLIER 67.21 -71.09 0.1 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.763 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.724 ' HA ' ' HA ' ' A' ' 199' ' ' SER . 20.0 ttmm 59.81 133.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.095 0.474 . . . . 0.0 111.261 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 88.2 m-20 -120.73 87.78 42.74 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.893 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.59 -24.71 37.83 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.342 2.028 . . . . 0.0 112.306 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -75.46 -75.63 0.17 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.402 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 62.8 p -70.36 -24.43 62.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.051 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 91.26 9.8 63.0 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.992 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 17.9 ttp85 -96.15 133.01 40.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.213 0.53 . . . . 0.0 111.827 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.724 ' HA ' ' HA ' ' A' ' 192' ' ' LYS . 75.4 m -85.83 10.22 14.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.132 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.515 ' HG3' ' CB ' ' A' ' 191' ' ' MET . 40.2 mmt180 74.94 -41.88 0.48 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.586 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 92.95 6.01 63.77 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.331 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.613 ' HB2' ' O ' ' A' ' 163' ' ' ILE . 33.9 p90 -147.37 155.48 42.01 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.441 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -154.92 166.65 32.53 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.148 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.656 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 91.1 m-85 -109.92 128.39 55.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.655 0.264 . . . . 0.0 110.416 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.722 HD21 HD22 ' A' ' 175' ' ' LEU . 63.3 mt -104.99 140.5 38.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.837 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 33.1 t -123.21 130.69 53.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.347 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.818 ' CE1' HG23 ' A' ' 185' ' ' VAL . 94.7 m-85 -117.25 138.33 51.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.001 0.429 . . . . 0.0 111.538 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.75 ' N ' HG23 ' A' ' 186' ' ' THR . 84.4 tt0 -61.48 -34.62 75.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.095 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -113.36 120.49 39.8 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.955 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.755 ' O ' HG12 ' A' ' 213' ' ' VAL . 49.6 Cg_exo -56.17 -22.29 39.46 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.537 2.158 . . . . 0.0 112.989 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.6 m -56.61 -37.91 71.33 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.688 0.28 . . . . 0.0 111.291 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.867 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.4 m -59.68 -35.69 74.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 0.0 110.284 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 210' ' ' PRO . 0.4 OUTLIER -59.48 -40.51 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.721 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -62.57 -41.88 99.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.432 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.401 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 10.1 pt-20 -77.68 -34.08 53.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.997 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 212' ' ' SER . 84.0 t -62.62 -47.09 94.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 CA-C-O 121.104 0.478 . . . . 0.0 110.522 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.22 -34.09 67.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -57.99 -37.43 74.23 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.685 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 38.5 m -96.0 141.73 29.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.724 0.297 . . . . 0.0 111.619 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 228' ' ' ILE . 63.6 tt0 -67.05 -41.53 86.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.765 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 47.0 m-70 77.61 122.3 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.996 HD12 HG12 ' A' ' 227' ' ' VAL . 21.0 mm -116.38 110.65 32.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 175.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.494 HD23 ' CG ' ' A' ' 224' ' ' ASP . 7.1 tt -121.77 125.91 47.64 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.228 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.494 ' CG ' HD23 ' A' ' 223' ' ' LEU . 86.7 m-20 53.92 41.56 32.0 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 76.5 12.86 83.98 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.551 -0.833 . . . . 0.0 114.162 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -126.13 156.48 40.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.482 0.641 . . . . 0.0 111.764 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.996 HG12 HD12 ' A' ' 222' ' ' ILE . 33.7 m -107.82 136.52 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.298 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.981 HG21 HD23 ' A' ' 166' ' ' LEU . 34.3 pt -126.78 162.76 30.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.012 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -129.02 79.18 75.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.046 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.732 ' HG3' ' CD2' ' A' ' 221' ' ' HIS . 9.6 Cg_endo -54.21 133.48 55.85 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.417 2.078 . . . . 0.0 111.681 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.623 ' HE2' ' H62' ' B' ' 6' ' ' ' A' . 4.3 ttpm? -137.65 147.78 45.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.619 0.247 . . . . 0.0 110.774 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -56.28 137.53 52.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 111.391 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.75 148.87 51.35 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.114 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.55 HG13 ' N6 ' ' B' ' 6' ' ' ' A' . 5.6 mt -114.27 142.84 28.68 Favored Pre-proline 0 N--CA 1.464 0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.581 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.465 ' HD2' HG22 ' A' ' 234' ' ' ILE . 37.3 Cg_exo -56.94 138.88 88.0 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 121.763 1.642 . . . . 0.0 110.732 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -60.06 -40.4 89.32 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.608 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 56.7 p30 -64.67 -40.8 96.06 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.573 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.608 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 97.3 mt-10 -71.47 -35.93 71.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.579 0.704 . . . . 0.0 109.363 177.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -58.42 -42.01 86.3 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.752 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -63.53 -40.09 96.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.057 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -60.06 -36.45 77.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.708 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.722 HG21 ' CD1' ' A' ' 270' ' ' ILE . 17.2 p -78.84 160.63 27.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.532 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -142.11 169.26 25.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.424 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 7.9 ttpm? -134.79 136.07 42.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.54 0.21 . . . . 0.0 110.839 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.835 HD12 HG21 ' A' ' 315' ' ' ILE . 9.6 pt -120.29 156.6 23.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.127 0.489 . . . . 0.0 111.53 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 315' ' ' ILE . 78.9 t80 -94.41 131.44 40.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.15 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.851 HG21 ' CZ ' ' A' ' 263' ' ' PHE . 25.1 t -124.47 135.9 62.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.396 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.558 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -132.57 178.32 18.16 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.71 26.35 46.44 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.037 -1.078 . . . . 0.0 112.268 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.65 HD11 ' C ' ' A' ' 286' ' ' PHE . 32.0 pt -118.44 154.79 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 121.04 0.448 . . . . 0.0 111.339 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.763 ' O ' HG12 ' A' ' 254' ' ' VAL . . . -127.43 176.01 18.02 Favored Glycine 0 C--O 1.226 -0.344 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.972 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' PRO . . . . . 0.419 ' HD3' ' HG3' ' A' ' 284' ' ' ARG . 54.1 Cg_exo -51.69 -28.61 30.3 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 121.92 1.746 . . . . 0.0 111.304 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -61.32 -30.53 70.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.177 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.763 HG12 ' O ' ' A' ' 251' ' ' GLY . 7.8 p -47.54 -38.59 6.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.819 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.0 OUTLIER 56.34 125.68 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.281 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.47 -35.8 86.28 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 121.787 1.658 . . . . 0.0 112.656 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -63.56 -47.76 80.21 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 85.0 tt0 -68.07 -37.05 80.83 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.126 0.488 . . . . 0.0 111.15 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.504 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 27.4 t80 -58.88 -45.68 89.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.061 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.426 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.4 tt0 -66.84 -40.98 88.11 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.944 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' A' ' 258' ' ' GLU . 19.5 pt-20 -70.26 -34.09 72.39 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.882 0.372 . . . . 0.0 110.491 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.603 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 83.7 t80 -60.4 -54.33 46.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.454 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.851 ' CZ ' HG21 ' A' ' 247' ' ' VAL . 26.9 m-85 -69.22 -28.39 66.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.67 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.651 ' N ' HD11 ' A' ' 269' ' ' ILE . 22.7 t -57.05 -29.67 63.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.455 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 262' ' ' PHE . 7.1 pt20 -53.26 -36.09 60.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.822 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.814 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 12.5 p90 -115.19 40.99 2.53 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.915 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 170.91 -179.01 43.08 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.465 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.518 HG23 ' HB3' ' A' ' 292' ' ' ASP . 0.0 OUTLIER -104.81 0.75 28.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.77 0.319 . . . . 0.0 110.345 179.045 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.651 HD11 ' N ' ' A' ' 264' ' ' SER . 75.5 mt 28.91 97.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.722 ' CD1' HG21 ' A' ' 242' ' ' THR . 72.5 mt -60.44 -45.47 96.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.581 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -164.83 94.02 0.66 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -99.09 136.4 39.1 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -142.16 154.52 44.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.624 0.726 . . . . 0.0 112.745 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.794 HD21 ' O ' ' A' ' 283' ' ' SER . 35.7 tp -64.68 -37.38 87.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.648 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.611 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 95.8 mmm 93.32 114.75 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.518 -178.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.415 HD22 ' OG ' ' A' ' 283' ' ' SER . 28.5 mt -111.15 141.9 44.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.421 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.681 ' HB3' ' HA3' ' A' ' 281' ' ' GLY . 59.8 t0 -144.52 88.01 1.9 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.156 0.503 . . . . 0.0 110.405 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.704 ' O ' HG22 ' A' ' 280' ' ' THR . 3.5 mtmp? 64.6 37.13 8.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.568 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.461 ' O ' ' HB ' ' A' ' 280' ' ' THR . 86.0 m-20 51.84 44.23 29.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.961 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.704 HG22 ' O ' ' A' ' 278' ' ' LYS . 1.6 t 169.66 46.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.911 0.386 . . . . 0.0 110.729 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLY . . . . . 0.681 ' HA3' ' HB3' ' A' ' 277' ' ' ASP . . . -136.43 -111.82 1.13 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.313 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.51 ' OE1' ' HB3' ' A' ' 275' ' ' MET . 91.9 mt-30 -56.9 -24.99 56.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.027 -0.587 . . . . 0.0 111.101 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.794 ' O ' HD21 ' A' ' 274' ' ' LEU . 16.8 m -49.52 -31.9 11.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.086 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.419 ' HG3' ' HD3' ' A' ' 252' ' ' PRO . 70.7 ttp85 -116.36 136.98 52.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.161 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.16 -57.03 0.44 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.799 -0.715 . . . . 0.0 114.071 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.65 ' C ' HD11 ' A' ' 250' ' ' ILE . 35.1 p90 -141.62 167.98 20.86 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.555 0.677 . . . . 0.0 112.02 -178.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.448 ' N ' HD11 ' A' ' 250' ' ' ILE . . . -134.45 156.02 22.21 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.238 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.515 ' HB2' ' HG2' ' A' ' 275' ' ' MET . 0.1 OUTLIER -111.97 129.85 56.05 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.709 0.29 . . . . 0.0 111.722 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.54 HG21 ' CG ' ' A' ' 263' ' ' PHE . 38.4 t -122.39 135.04 63.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 111.496 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 52.0 m -118.48 135.64 54.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.444 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 38.7 m-85 -116.87 134.99 54.08 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.633 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 54.4 t0 -59.43 -36.08 75.22 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.5 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 50.5 m -120.77 143.92 48.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.266 0.555 . . . . 0.0 111.436 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.63 -30.61 71.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.158 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -56.47 -38.9 72.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.278 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.8 88.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.074 0.464 . . . . 0.0 110.299 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.702 HG13 HG21 ' A' ' 245' ' ' ILE . 71.6 t -62.2 -42.99 97.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.707 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -60.57 -37.72 82.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.125 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -58.59 -43.81 89.62 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.814 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 0.4 OUTLIER -74.34 -34.38 36.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.953 0.406 . . . . 0.0 111.045 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 97.8 m -58.24 -44.69 88.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.193 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -62.22 -40.12 95.08 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.312 0.577 . . . . 0.0 109.91 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -63.81 -32.67 74.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.369 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.707 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 22.5 tptm 67.47 -74.89 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.629 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.707 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.5 m-30 -109.06 131.85 54.67 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.127 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.66 HD11 HG23 ' A' ' 300' ' ' VAL . 1.7 mt -121.07 138.08 52.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.48 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.414 ' OD1' ' CE ' ' A' ' 312' ' ' LYS . 86.9 m-20 -67.55 138.46 56.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.603 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 2.2 t80 -140.62 -107.98 0.15 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.209 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 310' ' ' ASP . 2.6 mmpt? -58.92 -38.54 79.18 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.834 0.35 . . . . 0.0 111.862 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 309' ' ' LYS . 58.3 t0 176.7 -29.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.227 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 88.2 mmt-85 -113.66 160.32 18.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.607 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 37.0 mmtm -66.65 140.67 57.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.092 0.472 . . . . 0.0 111.567 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.558 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 34.5 pt -110.45 133.75 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' GLU . . . . . 0.548 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 84.2 mt-10 -96.04 131.49 42.38 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.798 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 0.835 HG21 HD12 ' A' ' 245' ' ' ILE . 68.6 mt -120.3 123.92 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.068 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -130.41 154.81 47.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.983 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -56.12 151.53 12.11 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -48.29 142.98 5.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.975 0.417 . . . . 0.0 110.866 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -124.31 168.38 13.11 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.731 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.68 152.01 29.54 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.792 2.328 . . . . 0.0 111.801 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -55.86 -34.99 65.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.877 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 84.1 t60 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.293 -0.86 . . . . 0.0 110.868 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.706 0 C3'-C2'-O2' 111.206 -0.722 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.514 ' C6 ' ' CG ' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.918 0 C3'-C2'-O2' 111.286 -0.695 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.538 " H2'" ' OP2' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.951 0 C3'-C2'-O2' 111.402 -0.655 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.586 " O2'" ' HA3' ' A' ' 201' ' ' GLY . . . . . . . . 0 O5'--C5' 1.425 -0.944 0 C4'-C3'-C2' 103.861 1.161 . 0.01 2u . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.679 ' C6 ' ' HA3' ' A' ' 164' ' ' GLY . . . . . . . . 0 O5'--C5' 1.424 -0.992 0 C4'-C3'-C2' 103.658 0.958 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.626 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.892 0 C3'-C2'-O2' 111.186 -0.729 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.656 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.939 0 C4'-C3'-C2' 103.686 0.986 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.893 0 C3'-C2'-O2' 111.249 -0.707 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.6 pttp . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.642 0.258 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -58.62 -37.11 75.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.018 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 69.3 m -150.5 8.61 0.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.917 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.3 m -60.59 -26.36 66.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.835 0.35 . . . . 0.0 110.844 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.511 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 6.3 tptt -56.85 136.37 55.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.47 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.68 ' SD ' HG13 ' A' ' 213' ' ' VAL . 90.3 mtp -125.74 155.88 40.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.303 0.573 . . . . 0.0 112.016 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.596 ' CD2' ' C5 ' ' B' ' 6' ' ' ' A' . 3.1 t80 -105.22 130.88 53.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.376 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.828 HG23 HD12 ' A' ' 228' ' ' ILE . 22.4 mm -117.4 128.89 74.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.556 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.525 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -122.43 157.15 17.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.968 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.565 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 74.68 54.52 5.91 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.218 -0.992 . . . . 0.0 112.27 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.532 HD11 ' N ' ' A' ' 203' ' ' GLY . 69.4 mt -83.55 3.47 32.34 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.659 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 36.9 t30 58.27 39.95 25.12 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.842 -0.536 . . . . 0.0 110.109 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.57 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 8.8 m0 33.32 35.05 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.075 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -175.72 22.48 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.504 ' OG1' ' O ' ' A' ' 166' ' ' LEU . 95.1 m -59.84 -34.65 73.38 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 122.137 -0.352 . . . . 0.0 111.795 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.0 OUTLIER 62.33 131.23 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -178.196 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.63 ' N ' HD12 ' A' ' 190' ' ' ILE . 96.5 mt-10 -59.02 -34.95 72.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.633 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.638 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.9 m-20 -57.04 -40.77 77.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.886 0.374 . . . . 0.0 111.386 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 170' ' ' THR . 9.7 m120 -63.12 -36.19 82.77 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.742 ' CB ' HD11 ' A' ' 188' ' ' LEU . 6.3 mt -59.93 -42.25 93.57 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.638 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -65.29 -38.82 91.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.016 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.447 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 75.8 mm-40 -70.82 -44.11 67.21 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.043 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.556 ' O ' ' HD3' ' A' ' 181' ' ' LYS . 58.4 t80 -65.28 -44.56 87.59 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.223 0.535 . . . . 0.0 111.435 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.609 ' CE2' HD23 ' A' ' 175' ' ' LEU . 88.5 m-85 -94.86 -1.82 51.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.206 -0.907 . . . . 0.0 112.452 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -61.54 -26.97 67.25 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.312 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.621 ' H ' ' CD ' ' A' ' 181' ' ' LYS . 0.8 OUTLIER -56.11 -39.76 72.69 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.032 0.92 . . . . 0.0 111.002 -179.259 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -67.51 -27.86 67.34 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.711 -1.586 . . . . 0.0 112.012 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 159.64 -123.15 1.2 Allowed Glycine 0 CA--C 1.507 -0.432 0 C-N-CA 120.678 -0.773 . . . . 0.0 111.674 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.492 ' O ' ' HD1' ' A' ' 207' ' ' PHE . 28.3 p -119.88 160.0 23.55 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 206' ' ' SER . 8.1 p -122.67 130.25 74.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.332 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.769 HG23 ' N ' ' A' ' 208' ' ' GLU . 50.9 p -77.12 -38.86 51.22 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -155.29 150.98 27.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.472 0.653 . . . . 0.0 112.564 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.742 HD11 ' CB ' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -122.06 130.88 53.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.454 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 9.5 tptp -136.41 120.54 17.77 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.63 HD12 ' N ' ' A' ' 172' ' ' GLU . 6.4 mt -130.28 130.63 65.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.771 176.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.541 ' SD ' ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -90.38 122.26 33.09 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.53 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.56 ' HG3' HG22 ' A' ' 190' ' ' ILE . 58.9 mttm -126.76 156.46 41.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.752 0.31 . . . . 0.0 111.496 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.649 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 7.7 t70 -122.19 80.24 44.12 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.378 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.41 -25.88 50.53 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.429 2.086 . . . . 0.0 112.57 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -72.19 -67.44 0.54 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.916 0.389 . . . . 0.0 111.235 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 61.4 p -71.63 -22.12 61.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.629 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 84.21 18.2 63.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.378 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.649 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 2.1 ttt-85 -122.98 144.24 49.38 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 120.92 0.39 . . . . 0.0 111.273 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.435 ' OG ' ' HA ' ' A' ' 168' ' ' TRP . 90.1 p -110.38 157.61 19.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.979 0.419 . . . . 0.0 111.039 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.557 ' N ' ' HD2' ' A' ' 200' ' ' ARG . 1.5 mpt_? -53.53 -32.43 50.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.502 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.435 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 94.42 -0.09 65.51 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.352 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.554 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 23.9 p90 -139.15 154.86 48.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.222 0.534 . . . . 0.0 110.873 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.532 ' N ' HD11 ' A' ' 166' ' ' LEU . . . -140.42 162.2 26.52 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.23 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.701 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 95.6 m-85 -106.21 127.46 53.24 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.979 0.418 . . . . 0.0 109.982 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.664 HD23 ' N ' ' A' ' 206' ' ' SER . 2.0 tt -107.23 128.03 54.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.807 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.664 ' N ' HD23 ' A' ' 205' ' ' LEU . 11.9 t -117.0 132.45 56.7 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.494 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 205' ' ' LEU . 72.5 m-85 -117.5 141.55 48.22 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.769 ' N ' HG23 ' A' ' 186' ' ' THR . 47.0 tp10 -63.07 -36.08 82.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.6 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.24 116.57 51.0 Favored Pre-proline 0 CA--C 1.529 0.141 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.624 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.97 -26.02 65.86 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.346 2.031 . . . . 0.0 112.584 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 21.4 m -57.98 -37.28 73.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.26 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.915 ' O ' HG23 ' A' ' 216' ' ' VAL . 23.5 m -59.08 -35.61 73.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.942 0.401 . . . . 0.0 110.399 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.68 HG13 ' SD ' ' A' ' 161' ' ' MET . 86.0 t -61.68 -42.32 93.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.022 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -59.6 -41.63 90.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.131 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.43 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 18.7 pt-20 -75.1 -31.49 61.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.818 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 212' ' ' SER . 77.7 t -60.99 -44.69 98.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.278 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 230' ' ' PRO . 21.1 m -76.23 -29.24 19.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.028 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -58.31 -33.04 69.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.667 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 88.5 m -111.53 145.49 38.99 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -76.87 145.12 38.53 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.776 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 63.7 m-70 -120.57 134.05 55.32 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -176.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.61 HD13 HG23 ' A' ' 227' ' ' VAL . 28.3 mm -119.61 113.64 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.1 tt -121.66 126.77 49.8 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.74 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 56.4 t0 52.75 37.38 23.62 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 93.47 -24.67 24.49 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.839 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.523 ' HZ2' ' N6 ' ' B' ' 4' ' ' ' A' . 30.9 mmtp -97.58 170.96 8.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.841 0.353 . . . . 0.0 111.324 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.61 HG23 HD13 ' A' ' 222' ' ' ILE . 11.7 p -120.89 139.97 46.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.927 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.828 HD12 HG23 ' A' ' 163' ' ' ILE . 36.0 pt -123.64 159.86 27.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.097 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -125.25 81.39 63.64 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.172 0.51 . . . . 0.0 110.834 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.724 ' O ' HG12 ' A' ' 217' ' ' VAL . 51.0 Cg_exo -57.83 129.05 31.47 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.966 2.444 . . . . 0.0 111.551 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.618 ' HE2' ' H62' ' B' ' 6' ' ' ' A' . 3.3 ttpm? -140.74 155.94 46.32 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.571 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.595 ' CD ' HG11 ' A' ' 213' ' ' VAL . 52.5 mmm-85 -56.08 140.11 44.85 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.515 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.35 147.43 52.58 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.886 0.374 . . . . 0.0 111.506 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.606 HD12 ' C6 ' ' B' ' 6' ' ' ' A' . 35.7 mt -118.48 125.73 27.64 Favored Pre-proline 0 C--N 1.333 -0.132 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.155 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.451 ' HG2' ' CB ' ' A' ' 238' ' ' GLU . 9.8 Cg_endo -54.3 146.13 52.16 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 121.461 1.44 . . . . 0.0 110.072 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -55.98 -40.25 73.01 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.48 -44.13 95.27 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.897 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.451 ' CB ' ' HG2' ' A' ' 235' ' ' PRO . 84.3 tt0 -67.43 -38.14 84.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.038 0.447 . . . . 0.0 110.645 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.416 ' O ' HG23 ' A' ' 242' ' ' THR . 59.8 tp60 -58.95 -40.71 85.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.998 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -60.38 -40.38 90.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.082 0.468 . . . . 0.0 110.661 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -61.52 -36.58 80.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.267 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 291' ' ' TYR . 69.5 p -31.31 -75.57 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 80.61 47.77 6.6 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.918 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 16.8 tttp -58.77 138.54 57.09 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 122.449 0.299 . . . . 0.0 110.785 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.474 HG21 HG13 ' A' ' 297' ' ' VAL . 0.2 OUTLIER -121.41 161.52 21.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.527 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 75.2 t80 -96.03 131.24 42.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.82 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.848 HG21 ' CE2' ' A' ' 263' ' ' PHE . 59.9 t -124.02 139.97 48.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.494 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.66 -174.32 13.79 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.456 ' O ' ' CG2' ' A' ' 313' ' ' ILE . . . 79.98 57.14 3.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 119.765 -1.207 . . . . 0.0 112.882 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.578 ' CG2' HG21 ' A' ' 254' ' ' VAL . 31.6 mm -104.41 129.41 56.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.919 ' O ' HG13 ' A' ' 254' ' ' VAL . . . -107.81 169.25 14.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.004 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.39 141.54 89.35 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.454 2.103 . . . . 0.0 112.622 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 55.76 42.45 29.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.254 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.919 HG13 ' O ' ' A' ' 251' ' ' GLY . 2.5 m -73.15 -35.79 48.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.675 0.274 . . . . 0.0 110.916 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.21 124.29 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.09 -28.68 51.94 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 121.867 1.711 . . . . 0.0 111.9 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -60.75 -42.94 98.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.015 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 96.7 mt-10 -66.21 -39.4 89.58 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.925 0.393 . . . . 0.0 111.128 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.699 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 37.1 t80 -64.9 -46.75 80.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.385 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.528 ' O ' HD12 ' A' ' 269' ' ' ILE . 96.8 mt-10 -64.47 -40.58 95.97 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.717 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 21.1 pt-20 -76.3 -29.71 57.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 110.391 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.722 ' HE2' HD11 ' A' ' 313' ' ' ILE . 18.3 t80 -61.53 -57.2 13.08 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.944 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.903 ' CB ' HD11 ' A' ' 269' ' ' ILE . 7.4 m-85 -67.41 -27.22 66.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.106 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 267' ' ' GLY . 34.8 m -54.53 -27.24 36.89 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -46.77 -38.21 9.74 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.348 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.72 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 19.9 p90 -126.66 42.66 3.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.09 0.471 . . . . 0.0 111.269 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 264' ' ' SER . . . 162.71 154.17 7.49 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.756 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.407 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 50.9 m -61.27 -35.6 77.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.888 0.375 . . . . 0.0 111.593 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.903 HD11 ' CB ' ' A' ' 263' ' ' PHE . 2.5 mt 69.39 80.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.633 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.618 HD11 ' HB3' ' A' ' 292' ' ' ASP . 34.4 mm -59.85 -41.75 86.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.51 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -157.86 86.48 0.91 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.559 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -105.23 130.59 53.34 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -147.39 155.82 42.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.334 0.588 . . . . 0.0 112.506 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.726 HD21 ' O ' ' A' ' 283' ' ' SER . 34.5 tp -65.08 -36.98 86.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.825 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.69 ' O ' HD23 ' A' ' 276' ' ' LEU . 95.7 mmm 81.24 119.92 0.05 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.329 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.728 HD22 ' HB2' ' A' ' 283' ' ' SER . 25.4 mt -127.03 129.03 47.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.598 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -62.24 -39.57 93.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.616 0.722 . . . . 0.0 109.599 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -161.77 -46.94 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.907 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.465 ' O ' HD13 ' A' ' 276' ' ' LEU . 91.9 m-20 -131.19 -79.93 0.53 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.653 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.435 ' HA ' ' HB2' ' A' ' 283' ' ' SER . 68.7 p -116.3 13.36 15.57 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.891 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -49.87 -81.54 0.05 OUTLIER Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.419 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.689 ' OE1' H5'' ' B' ' 2' ' ' ' A' . 68.8 mm-40 -83.97 6.38 22.12 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 122.781 0.433 . . . . 0.0 110.791 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.728 ' HB2' HD22 ' A' ' 276' ' ' LEU . 22.8 t -56.95 -31.57 65.13 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.233 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 20.9 ptp180 -130.27 158.17 40.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.399 0.618 . . . . 0.0 111.902 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.68 -34.79 5.39 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.048 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 18.1 p90 -155.27 164.28 39.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 117.286 0.543 . . . . 0.0 111.768 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -135.13 150.92 20.32 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.121 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.511 ' HB2' ' HG2' ' A' ' 275' ' ' MET . 0.1 OUTLIER -112.26 125.61 54.35 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.859 -0.201 . . . . 0.0 111.483 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.699 HG23 ' CZ ' ' A' ' 259' ' ' PHE . 60.5 t -130.22 137.43 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 27.8 m -119.32 137.54 53.64 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.578 ' O ' ' HA ' ' A' ' 242' ' ' THR . 43.7 m-85 -114.44 142.25 46.61 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.618 ' HB3' HD11 ' A' ' 270' ' ' ILE . 27.7 p-10 -62.63 -33.9 75.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.03 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.421 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 50.9 m -123.46 144.49 49.49 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.308 0.575 . . . . 0.0 111.719 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.4 -28.86 68.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.209 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 296' ' ' ALA . 52.4 p30 -60.27 -33.3 72.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.661 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.566 ' N ' ' OD1' ' A' ' 295' ' ' ASP . . . -61.33 -36.85 81.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.083 0.468 . . . . 0.0 110.368 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 300' ' ' VAL . 83.2 t -62.06 -42.51 95.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.089 0.471 . . . . 0.0 110.442 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -61.43 -38.09 85.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.624 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -59.39 -43.77 92.88 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.942 0.401 . . . . 0.0 111.73 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.995 HG23 HD11 ' A' ' 306' ' ' ILE . 0.7 OUTLIER -72.16 -34.91 51.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.368 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 85.5 m -59.07 -45.65 90.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.164 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -62.63 -39.17 92.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.253 0.549 . . . . 0.0 110.089 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -62.53 -32.9 73.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.744 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.655 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 7.1 tptt 69.2 -72.76 0.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.67 ' HB3' ' HB3' ' A' ' 312' ' ' LYS . 3.8 m-30 -114.76 142.62 46.28 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.576 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.995 HD11 HG23 ' A' ' 300' ' ' VAL . 6.8 mt -120.11 133.73 65.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -75.37 80.65 2.44 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.183 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.608 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 11.7 t80 -76.9 -57.68 3.71 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.775 0.798 . . . . 0.0 109.869 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.459 ' HE3' ' CE2' ' A' ' 308' ' ' PHE . 9.3 mmpt? -109.87 -165.04 0.97 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.453 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -55.2 -23.45 22.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.758 0.313 . . . . 0.0 110.478 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -118.59 159.68 23.15 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.014 0.435 . . . . 0.0 111.558 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.67 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 78.5 mttt -76.58 147.96 37.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.818 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.722 HD11 ' HE2' ' A' ' 262' ' ' PHE . 23.4 pt -118.16 151.4 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' GLU . . . . . 0.604 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 81.9 mt-10 -106.6 135.72 47.63 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.259 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 0.79 HG23 HG22 ' A' ' 247' ' ' VAL . 72.1 mt -120.51 126.91 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 120.927 0.394 . . . . 0.0 110.977 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm -128.43 154.54 45.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.147 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 40.9 ptt85 -55.47 147.91 16.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.352 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.97 139.57 58.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.143 0.497 . . . . 0.0 111.407 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -129.93 77.93 75.83 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.173 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.15 132.9 52.82 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.038 1.825 . . . . 0.0 111.959 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -61.13 -34.69 75.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.82 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.05 179.879 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.672 0 C1'-C2'-O2' 108.51 -0.697 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.689 H5'' ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.934 0 C3'-C2'-O2' 111.521 -0.613 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.427 " H2'" ' OP2' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.003 0 C3'-C2'-O2' 111.219 -0.718 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.659 ' N7 ' ' HA ' ' A' ' 167' ' ' ASN . . . . . . . . 0 O5'--C5' 1.425 -0.94 0 C4'-C3'-C2' 103.742 1.042 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.658 H5'' " H3'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.79 0 C5'-C4'-O4' 107.806 -0.996 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.618 ' H62' ' HE2' ' A' ' 231' ' ' LYS . . . . . . . . 0 O5'--C5' 1.425 -0.94 0 C1'-C2'-O2' 108.54 -0.687 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.701 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.968 0 C3'-C2'-O2' 111.182 -0.73 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -1.003 0 C3'-C2'-O2' 111.281 -0.696 . 0.0 OUTLIER '7D dist 2u wannabe' 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.553 ' HG3' ' H ' ' A' ' 158' ' ' SER . 15.0 pttm . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.407 0.146 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -60.68 -34.13 73.88 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.847 0.356 . . . . 0.0 111.516 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.553 ' H ' ' HG3' ' A' ' 156' ' ' LYS . 86.2 p -62.28 -24.23 67.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.36 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.606 ' SG ' HG21 ' A' ' 213' ' ' VAL . 0.2 OUTLIER 62.76 59.6 1.4 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.274 0.559 . . . . 0.0 110.173 -179.339 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 68.1 tttt -69.58 140.3 53.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.506 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.827 ' SD ' HG13 ' A' ' 213' ' ' VAL . 86.4 mmm -115.03 147.95 39.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.78 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.635 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 5.6 t80 -108.71 130.97 55.36 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.614 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 16.6 mm -111.65 127.82 68.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.687 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -133.85 165.34 24.28 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.795 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.453 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 75.74 28.68 60.62 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.254 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.964 HD23 HG21 ' A' ' 228' ' ' ILE . 66.1 mt -86.99 139.62 30.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.883 0.373 . . . . 0.0 110.744 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.546 ' O ' ' N ' ' A' ' 169' ' ' ASP . 30.3 t30 -65.48 136.39 56.38 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.635 ' HD1' ' HG ' ' A' ' 199' ' ' SER . 6.2 m0 -60.27 75.95 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 167' ' ' ASN . 58.4 t0 178.28 -22.31 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.656 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 88.8 m -65.07 138.53 58.38 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.182 0.515 . . . . 0.0 111.038 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.505 ' C ' HD12 ' A' ' 190' ' ' ILE . 7.4 p -115.96 166.37 12.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.923 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.7 ' N ' HD12 ' A' ' 190' ' ' ILE . 53.1 mp0 -58.34 -28.91 65.52 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.813 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.1 m-20 -58.07 -43.46 86.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.846 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -65.99 -38.41 88.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.607 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.668 HD12 HD11 ' A' ' 190' ' ' ILE . 4.7 mt -61.65 -42.71 99.27 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.813 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -66.04 -38.22 87.82 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.798 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.45 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 97.1 mt-10 -69.55 -43.43 72.96 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.124 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.485 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 56.2 t80 -67.22 -48.66 67.16 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.477 0.656 . . . . 0.0 111.603 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.663 ' CB ' HD11 ' A' ' 205' ' ' LEU . 94.9 m-85 -91.75 -1.59 57.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.128 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -57.95 -29.15 61.71 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.22 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.844 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -57.05 -40.49 76.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.19 -0.505 . . . . 0.0 110.841 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.844 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 78.1 m-85 -70.34 -34.97 73.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.122 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 178.74 -173.88 46.12 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 119.938 -1.125 . . . . 0.0 113.652 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.6 m -62.38 -30.69 71.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.13 -0.535 . . . . 0.0 111.178 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.638 ' CG1' ' O ' ' A' ' 185' ' ' VAL . 0.4 OUTLIER 67.47 89.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -177.399 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.461 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -56.13 -49.32 74.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.517 -177.073 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -142.45 137.68 30.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.28 0.562 . . . . 0.0 112.409 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.66 HD11 ' HB3' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -115.08 133.03 56.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.524 179.115 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 15.3 tptt -133.78 122.61 23.54 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.7 HD12 ' N ' ' A' ' 172' ' ' GLU . 4.7 mt -128.58 130.41 68.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.757 176.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.585 ' CE ' ' HA2' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -93.01 126.44 38.09 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.444 ' HG3' HG22 ' A' ' 190' ' ' ILE . 12.6 mtpt -126.08 152.85 45.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.972 0.415 . . . . 0.0 111.933 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.615 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 4.6 m-20 -122.72 68.87 33.62 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.885 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.9 -24.99 80.56 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.925 2.417 . . . . 0.0 113.098 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -60.98 -47.38 86.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.929 0.395 . . . . 0.0 111.265 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 55.2 p -96.83 -4.04 41.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.235 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 76.68 24.97 66.12 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.619 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.615 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 5.9 tpt180 -121.83 159.84 25.91 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.635 ' HG ' ' HD1' ' A' ' 168' ' ' TRP . 97.8 p -128.32 154.16 46.23 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.21 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.556 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 4.9 mpt_? -55.76 -35.63 66.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.362 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 166' ' ' LEU . . . 86.8 5.06 81.81 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.59 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.614 ' HB2' ' O ' ' A' ' 163' ' ' ILE . 39.6 p90 -144.93 157.31 44.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.864 0.364 . . . . 0.0 110.647 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.585 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -150.45 166.45 30.15 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.015 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.747 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 95.4 m-85 -105.92 127.19 52.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.16 0.505 . . . . 0.0 109.89 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.663 HD11 ' CB ' ' A' ' 179' ' ' PHE . 6.3 tt -108.45 130.45 55.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.942 -178.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.586 ' N ' HD23 ' A' ' 205' ' ' LEU . 54.9 m -120.84 140.3 51.95 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.724 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.648 ' CE2' HD22 ' A' ' 205' ' ' LEU . 84.9 m-85 -121.05 142.74 49.54 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.395 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.461 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.5 tt0 -63.36 -35.38 80.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.195 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.42 119.27 47.18 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.92 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -56.84 -28.21 75.83 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.609 2.206 . . . . 0.0 113.102 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.6 m -58.67 -35.42 72.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.383 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.407 ' OG ' ' CG ' ' A' ' 207' ' ' PHE . 87.2 p -61.13 -30.15 70.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.92 0.391 . . . . 0.0 110.725 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.827 HG13 ' SD ' ' A' ' 161' ' ' MET . 70.1 t -62.71 -39.2 83.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.167 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -56.38 -41.85 76.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.847 0.356 . . . . 0.0 111.238 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.42 ' HB2' ' HD2' ' A' ' 182' ' ' TYR . 97.1 mt-10 -67.36 -34.77 77.99 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.774 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 94.2 t -63.06 -45.3 99.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.073 0.463 . . . . 0.0 111.31 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 52.8 t -70.09 -43.42 79.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -59.39 -35.99 74.99 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.429 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 61.9 m -98.05 143.73 28.3 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -76.13 147.61 38.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.774 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 35.8 m-70 -126.31 132.38 51.65 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 226' ' ' LYS . 68.3 mt -122.2 115.24 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.505 HD23 ' CG ' ' A' ' 224' ' ' ASP . 7.3 tt -121.78 127.11 50.26 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.515 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.505 ' CG ' HD23 ' A' ' 223' ' ' LEU . 85.6 m-20 54.45 42.52 31.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.999 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 73.91 18.32 79.59 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.005 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 222' ' ' ILE . 0.5 OUTLIER -128.21 153.46 46.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.801 0.301 . . . . 0.0 110.893 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.13 130.34 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.983 0.42 . . . . 0.0 110.259 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.964 HG21 HD23 ' A' ' 166' ' ' LEU . 34.5 pt -127.19 159.54 37.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.796 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -128.27 79.73 73.52 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.217 0.532 . . . . 0.0 111.037 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.483 ' HB2' HG12 ' A' ' 216' ' ' VAL . 37.3 Cg_exo -60.36 126.97 21.44 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 123.176 2.584 . . . . 0.0 111.687 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 12.4 mtmm -132.7 156.55 46.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.846 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -58.92 136.46 57.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.935 0.398 . . . . 0.0 111.608 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -66.99 143.9 56.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.089 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.579 ' CG1' ' C6 ' ' B' ' 6' ' ' ' A' . 0.0 OUTLIER -114.76 124.57 30.26 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.803 179.195 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.418 ' HG2' ' CG ' ' A' ' 238' ' ' GLU . 10.4 Cg_endo -53.93 151.06 28.14 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 121.987 1.791 . . . . 0.0 110.643 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.457 ' NH2' H5'' ' B' ' 7' ' ' ' U' . 21.0 mmt180 -54.29 -37.21 64.51 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -60.25 -43.53 96.03 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.964 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.418 ' CG ' ' HG2' ' A' ' 235' ' ' PRO . 97.7 mt-10 -72.6 -38.66 67.77 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.313 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.457 ' NE2' ' O ' ' A' ' 234' ' ' ILE . 87.8 mt-30 -60.86 -39.38 88.95 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.844 0.354 . . . . 0.0 110.691 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -62.69 -40.35 96.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.171 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -60.19 -38.18 82.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.811 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 25.7 p -82.55 161.46 22.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.009 0.433 . . . . 0.0 111.55 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -154.02 114.79 0.64 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.961 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.459 ' NZ ' ' CE2' ' A' ' 288' ' ' PHE . 19.8 ttpp -85.77 134.33 33.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.645 0.259 . . . . 0.0 111.134 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.698 HG21 HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -118.42 163.24 15.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.479 0.657 . . . . 0.0 111.407 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.526 ' CG ' ' C6 ' ' B' ' 2' ' ' ' A' . 91.8 t80 -103.41 137.44 41.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.765 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.847 HG11 ' CE1' ' A' ' 259' ' ' PHE . 10.8 p -131.35 146.87 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.878 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.523 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -129.83 172.09 20.15 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 84.65 28.74 31.5 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.086 -1.054 . . . . 0.0 112.508 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.528 HG23 HG11 ' A' ' 254' ' ' VAL . 68.1 mt -110.52 133.0 57.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.819 0.342 . . . . 0.0 110.575 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.4 ' O ' ' HB ' ' A' ' 254' ' ' VAL . . . -123.03 172.2 15.88 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.392 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' PRO . . . . . 0.437 ' HG3' ' NE ' ' A' ' 284' ' ' ARG . 51.6 Cg_exo -53.78 -31.06 59.88 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.054 1.836 . . . . 0.0 111.667 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -60.15 -36.58 77.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.156 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.528 HG11 HG23 ' A' ' 250' ' ' ILE . 25.5 t -58.13 -45.1 88.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.486 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 254' ' ' VAL . 2.0 mmm180 60.97 141.84 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.28 -28.31 52.04 Favored 'Trans proline' 0 CA--C 1.528 0.189 0 C-N-CA 122.033 1.822 . . . . 0.0 112.919 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -61.69 -45.96 91.74 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 97.6 mt-10 -69.05 -38.39 79.09 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.171 0.51 . . . . 0.0 111.691 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.847 ' CE1' HG11 ' A' ' 247' ' ' VAL . 20.3 t80 -61.23 -47.19 87.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.805 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.439 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.4 tt0 -65.21 -41.84 94.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.601 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.8 pt-20 -75.05 -34.09 61.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.919 0.39 . . . . 0.0 111.211 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.671 ' HE2' HD11 ' A' ' 313' ' ' ILE . 16.4 t80 -62.2 -55.0 32.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.063 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.837 ' CD2' HG21 ' A' ' 289' ' ' VAL . 4.5 m-85 -67.92 -23.62 65.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.074 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.654 ' N ' HD11 ' A' ' 269' ' ' ILE . 23.2 t -55.91 -31.38 62.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.818 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -53.64 -35.79 61.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.644 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.647 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 11.3 p90 -115.89 48.69 1.19 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.363 0.601 . . . . 0.0 111.148 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.574 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 148.39 146.18 4.29 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.671 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.425 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 45.2 m -59.41 -37.47 78.1 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.654 HD11 ' N ' ' A' ' 264' ' ' SER . 74.2 mt 69.7 83.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.417 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.509 HD11 ' CG ' ' A' ' 292' ' ' ASP . 32.1 mm -57.25 -43.59 82.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.543 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -161.63 93.1 0.9 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.576 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -103.32 134.65 46.34 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -143.63 155.47 44.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.467 0.651 . . . . 0.0 112.331 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.747 HD21 ' O ' ' A' ' 283' ' ' SER . 32.7 tp -64.3 -38.41 90.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.364 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.588 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 93.6 mmm 95.0 115.48 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.466 0.706 . . . . 0.0 110.966 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 275' ' ' MET . 29.7 mt -120.42 116.68 25.94 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.931 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -64.05 -38.98 93.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.778 0.799 . . . . 0.0 109.179 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -150.39 -49.38 0.13 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.583 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 280' ' ' THR . 35.5 p-10 -150.38 -54.32 0.15 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.874 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.4 ' N ' ' OD1' ' A' ' 279' ' ' ASP . 64.4 p -126.49 14.17 7.63 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -56.74 -80.93 0.07 OUTLIER Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.64 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.989 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 78.4 mm-40 -83.38 3.21 32.75 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.562 0.345 . . . . 0.0 110.532 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.747 ' O ' HD21 ' A' ' 274' ' ' LEU . 86.4 p -61.35 -26.31 67.73 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.619 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.437 ' NE ' ' HG3' ' A' ' 252' ' ' PRO . 98.2 mtt180 -119.38 146.4 45.37 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.145 0.497 . . . . 0.0 111.85 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.95 -43.39 1.8 Allowed Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.505 -0.77 . . . . 0.0 114.327 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 23.2 p90 -149.29 165.13 32.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.914 0.857 . . . . 0.0 112.732 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.65 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -135.12 161.13 24.56 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.752 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.459 ' CE2' ' NZ ' ' A' ' 244' ' ' LYS . 0.2 OUTLIER -118.05 126.95 53.28 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.498 0.185 . . . . 0.0 111.498 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.837 HG21 ' CD2' ' A' ' 263' ' ' PHE . 60.1 t -124.87 136.02 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.017 0.436 . . . . 0.0 111.685 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 50.4 m -114.72 134.65 54.92 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.574 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 30.4 m-85 -114.74 137.01 52.44 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.509 ' CG ' HD11 ' A' ' 270' ' ' ILE . 52.5 t0 -56.73 -36.14 69.37 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.027 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 31.0 t -122.33 139.35 53.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.498 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.913 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -64.27 -30.05 71.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.985 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -54.96 -35.08 63.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.491 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -59.09 -38.37 79.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.616 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.913 HG12 ' O ' ' A' ' 294' ' ' ALA . 7.0 p -59.2 -37.66 69.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.824 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -62.37 -37.7 86.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.305 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -58.65 -43.23 89.73 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.636 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.974 HG23 HD11 ' A' ' 306' ' ' ILE . 0.9 OUTLIER -70.58 -35.52 61.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.696 -179.127 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 75.2 m -60.28 -44.04 95.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.86 0.362 . . . . 0.0 110.579 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.69 -33.93 74.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.189 0.518 . . . . 0.0 110.175 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.623 ' O ' ' N ' ' A' ' 305' ' ' PHE . 80.6 m-20 -85.66 5.36 32.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.943 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.694 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 13.4 tptt 37.62 -81.57 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.719 0.407 . . . . 0.0 111.03 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.694 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 2.7 m-30 -108.52 143.86 36.95 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.856 0.36 . . . . 0.0 110.23 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.974 HD11 HG23 ' A' ' 300' ' ' VAL . 25.3 mt -118.0 138.04 49.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.142 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.544 ' OD1' ' O ' ' A' ' 307' ' ' ASP . 51.0 p30 -75.34 114.36 13.78 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.017 0.437 . . . . 0.0 109.951 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.538 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 1.9 t80 -106.16 -109.37 0.29 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.457 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 1.5 mmpt? -59.38 -37.24 77.45 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.933 0.397 . . . . 0.0 111.896 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -179.6 -27.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.889 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 60.5 mtp85 -112.67 153.85 27.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.989 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.475 ' HG3' ' HB3' ' A' ' 305' ' ' PHE . 2.1 tptm -72.17 139.89 48.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.975 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.671 HD11 ' HE2' ' A' ' 262' ' ' PHE . 35.9 pt -115.46 152.09 17.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.884 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -100.71 132.17 46.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.017 0.437 . . . . 0.0 110.908 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 0.675 HG12 HG23 ' A' ' 247' ' ' VAL . 74.5 mt -120.35 128.45 75.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.819 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -132.85 147.18 52.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.916 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -50.97 149.65 3.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.712 0.291 . . . . 0.0 110.435 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 244' ' ' LYS . . . -55.36 141.6 35.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.07 0.462 . . . . 0.0 111.417 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -113.51 118.17 43.85 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.992 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.33 -20.98 34.54 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.272 1.981 . . . . 0.0 112.03 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.454 ' O ' ' CG ' ' A' ' 322' ' ' HIS . 17.9 mmm180 65.27 -71.0 0.08 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.0 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' HIS . . . . . 0.454 ' CG ' ' O ' ' A' ' 321' ' ' ARG . 2.3 m80 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.749 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.695 0 C3'-C2'-O2' 111.261 -0.703 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.989 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.953 0 C3'-C2'-O2' 111.371 -0.665 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.459 " H2'" ' OP2' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.944 0 C3'-C2'-O2' 111.24 -0.71 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.577 ' C2 ' ' CZ3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.425 -0.913 0 C4'-C3'-C2' 103.69 0.99 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.992 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.85 0 C4'-C3'-C2' 103.73 1.03 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.992 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.971 0 C3'-C2'-O2' 111.242 -0.71 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.747 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.423 -1.058 0 C3'-C2'-O2' 111.304 -0.688 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.959 0 C1'-C2'-O2' 108.535 -0.688 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 42.3 tttt . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.869 0.366 . . . . 0.0 111.336 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 60.8 mp0 -61.85 -33.29 73.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.017 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.3 m -119.83 146.96 45.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.003 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 20.0 p 178.55 -26.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.322 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -64.33 139.59 58.78 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.908 0.385 . . . . 0.0 110.682 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.662 ' O ' ' HA ' ' A' ' 204' ' ' PHE . 91.2 mtp -115.61 151.1 35.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.827 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.603 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 3.5 t80 -104.88 127.44 52.71 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.714 HG23 HD12 ' A' ' 228' ' ' ILE . 13.4 mt -121.68 127.12 75.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.797 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 202' ' ' PHE . . . -117.9 149.03 18.57 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.43 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.51 36.26 39.0 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.458 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.632 HD22 HD11 ' A' ' 175' ' ' LEU . 74.5 mt -59.1 -34.33 71.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.682 ' O ' ' N ' ' A' ' 169' ' ' ASP . 26.4 t30 101.8 37.34 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.638 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 9.3 m0 40.91 -68.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.382 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.682 ' N ' ' O ' ' A' ' 167' ' ' ASN . 92.5 m-20 -55.37 -30.0 59.52 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.629 ' O ' ' ND2' ' A' ' 174' ' ' ASN . 86.7 m -44.39 -36.03 2.66 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.581 ' C ' HD12 ' A' ' 190' ' ' ILE . 0.0 OUTLIER 54.88 165.06 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.726 -0.609 . . . . 0.0 110.969 -179.154 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.732 ' N ' HD12 ' A' ' 190' ' ' ILE . 53.7 mp0 -63.49 -35.79 81.62 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 174' ' ' ASN . 54.4 p30 -61.68 -39.2 90.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.629 ' ND2' ' O ' ' A' ' 170' ' ' THR . 63.9 m-80 -64.7 -37.6 88.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.632 HD11 HD22 ' A' ' 166' ' ' LEU . 3.6 mm? -62.85 -39.9 95.81 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 120.919 0.39 . . . . 0.0 111.192 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 180' ' ' GLY . 69.9 ttp85 -56.53 -41.89 77.54 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.08 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -68.28 -43.6 77.38 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.346 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.455 ' O ' ' HD3' ' A' ' 181' ' ' LYS . 61.4 t80 -65.14 -46.38 81.18 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.87 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.627 ' CB ' HD11 ' A' ' 205' ' ' LEU . 78.3 m-85 -91.64 -3.66 56.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.072 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -60.42 -31.15 73.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.294 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.455 ' HD3' ' O ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -57.69 -41.15 81.05 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.512 0.673 . . . . 0.0 110.841 -179.136 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -67.08 -33.44 75.5 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.14 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.64 -177.2 47.11 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.91 -1.138 . . . . 0.0 113.354 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 44.2 m -61.6 -31.56 71.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.289 -0.456 . . . . 0.0 110.72 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.852 HG23 ' CE1' ' A' ' 207' ' ' PHE . 0.9 OUTLIER 65.19 95.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -178.031 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.469 ' O ' ' OD1' ' A' ' 187' ' ' ASP . 2.3 t -63.55 -45.57 89.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.084 -178.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 186' ' ' THR . 91.5 m-20 -141.65 153.86 44.99 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.475 HD23 HG11 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -129.55 129.77 44.89 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.312 178.632 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 19.4 tptt -136.48 116.73 13.54 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.732 HD12 ' N ' ' A' ' 172' ' ' GLU . 86.0 mt -127.64 131.0 70.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.728 174.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.503 ' SD ' ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -78.23 99.07 6.11 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.76 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 41.8 pttt -89.36 153.02 21.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.048 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 1.3 m-20 -124.72 78.77 63.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.251 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.77 -24.69 64.96 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.41 2.073 . . . . 0.0 112.132 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.01 -74.65 0.18 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.456 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.1 p -68.2 -27.72 66.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.578 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.38 7.88 64.84 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.696 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 0.8 OUTLIER -122.87 121.48 36.32 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 117.651 0.725 . . . . 0.0 111.313 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 56.6 m -75.64 161.06 29.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.684 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.552 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -55.45 -33.46 63.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.858 178.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.551 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 96.3 -5.24 65.21 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.014 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.571 ' CD2' " H4'" ' B' ' 5' ' ' ' U' . 35.5 p90 -134.2 154.34 51.3 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.462 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -146.38 167.71 27.95 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.12 -1.038 . . . . 0.0 112.412 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.719 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 89.1 m-85 -108.59 125.83 52.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.677 HD21 HG22 ' A' ' 185' ' ' VAL . 7.4 tt -109.13 131.84 54.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.161 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.509 ' N ' HD23 ' A' ' 205' ' ' LEU . 22.8 t -120.71 135.86 55.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.9 0.381 . . . . 0.0 111.8 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.852 ' CE1' HG23 ' A' ' 185' ' ' VAL . 87.2 m-85 -116.69 143.65 45.39 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.681 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -60.94 -34.57 74.92 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -114.23 115.73 44.91 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.211 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.74 -23.56 41.96 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.547 2.165 . . . . 0.0 113.171 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.566 ' O ' ' OE1' ' A' ' 215' ' ' GLU . 23.3 t -57.79 -38.15 74.97 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.498 ' HA ' ' OE1' ' A' ' 215' ' ' GLU . 24.0 m -56.97 -34.37 68.01 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.911 0.386 . . . . 0.0 110.314 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.724 HG11 ' CD ' ' A' ' 232' ' ' ARG . 85.0 t -60.35 -39.26 80.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.312 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 218' ' ' LYS . 92.9 m-20 -57.37 -41.2 79.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.403 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.566 ' OE1' ' O ' ' A' ' 211' ' ' SER . 47.6 mp0 -65.44 -35.74 81.82 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.076 0.465 . . . . 0.0 111.788 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.753 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 85.5 t -59.96 -44.01 93.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.964 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 214' ' ' ASP . 22.3 m -73.24 -35.51 47.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 214' ' ' ASP . 56.0 mtmt -60.09 -30.31 69.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 79.3 m -110.98 144.76 39.57 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -78.8 145.02 34.55 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.753 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 44.2 m-70 -120.96 129.51 53.46 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.469 HG12 HG22 ' A' ' 227' ' ' VAL . 68.3 mt -121.98 113.25 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 176.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.55 ' CD1' HD13 ' A' ' 175' ' ' LEU . 6.0 tt -122.23 124.06 42.93 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.163 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 53.29 42.48 32.08 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.85 9.2 87.01 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.719 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.523 ' NZ ' ' C6 ' ' B' ' 4' ' ' ' A' . 34.3 mmtp -123.66 150.41 44.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.897 0.379 . . . . 0.0 111.32 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.469 HG22 HG12 ' A' ' 222' ' ' ILE . 40.0 t -106.24 132.83 52.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.377 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.714 HD12 HG23 ' A' ' 163' ' ' ILE . 34.7 pt -123.82 159.13 29.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.517 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.74 82.05 64.49 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.425 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.599 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 73.4 Cg_exo -55.23 130.82 42.71 Favored 'Trans proline' 0 CA--C 1.528 0.195 0 C-N-CA 122.998 2.465 . . . . 0.0 112.189 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.54 ' CE ' ' H62' ' B' ' 6' ' ' ' A' . 9.5 ttpt -139.75 144.16 37.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.579 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.724 ' CD ' HG11 ' A' ' 213' ' ' VAL . 56.1 mmm-85 -52.58 142.71 17.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.015 0.436 . . . . 0.0 111.051 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.03 143.62 52.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.654 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.633 HG22 ' HB2' ' A' ' 238' ' ' GLU . 0.3 OUTLIER -115.44 123.31 31.67 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.536 179.117 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.47 ' HD2' ' OE1' ' A' ' 238' ' ' GLU . 78.2 Cg_exo -50.36 148.7 14.08 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 121.908 1.738 . . . . 0.0 110.996 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -53.7 -39.89 65.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.592 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 54.5 p30 -64.42 -37.57 87.99 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.914 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.633 ' HB2' HG22 ' A' ' 234' ' ' ILE . 94.9 mt-10 -68.23 -36.38 79.39 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.264 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -60.01 -37.29 79.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.911 0.386 . . . . 0.0 110.342 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -60.4 -39.43 87.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.631 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -60.5 -36.21 77.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.117 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 20.6 p -89.09 162.92 15.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.445 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.27 167.3 24.75 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.907 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.558 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 6.6 tptm -133.69 133.31 41.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.796 0.298 . . . . 0.0 110.591 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.634 HD12 HG21 ' A' ' 315' ' ' ILE . 5.7 pt -123.87 157.15 30.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.345 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.523 ' CZ ' ' N7 ' ' B' ' 2' ' ' ' A' . 88.9 t80 -97.27 131.0 44.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.926 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.821 HG21 ' CZ ' ' A' ' 263' ' ' PHE . 26.7 t -123.58 137.37 57.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.883 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.494 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -127.22 173.95 18.42 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.278 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 81.35 34.75 25.17 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.062 -1.066 . . . . 0.0 111.628 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.833 HG22 HG21 ' A' ' 254' ' ' VAL . 64.2 mt -110.52 130.82 63.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.698 0.285 . . . . 0.0 110.65 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.872 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -165.12 -107.54 0.2 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.184 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' PRO . . . . . 0.472 ' O ' HG13 ' A' ' 254' ' ' VAL . 25.1 Cg_endo -62.2 137.7 67.72 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.522 2.148 . . . . 0.0 113.465 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 52.03 42.85 30.66 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.266 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 251' ' ' GLY . 18.8 m -121.68 27.17 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.439 ' HB2' ' OE1' ' A' ' 258' ' ' GLU . 3.2 mmt180 -41.62 155.91 0.22 Allowed Pre-proline 0 N--CA 1.462 0.163 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -50.93 -28.01 22.63 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.011 1.808 . . . . 0.0 112.177 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -61.81 -47.15 86.41 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.004 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.475 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 54.8 mp0 -69.76 -40.17 76.26 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.85 0.357 . . . . 0.0 111.431 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.511 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 48.8 t80 -65.05 -46.69 80.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.117 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.33 -40.87 96.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.965 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.8 pt-20 -74.55 -32.6 62.49 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.974 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.735 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 78.3 t80 -59.93 -58.41 8.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.225 0.536 . . . . 0.0 111.713 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.821 ' CZ ' HG21 ' A' ' 247' ' ' VAL . 33.0 m-85 -66.78 -24.62 66.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.828 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.711 ' N ' HD11 ' A' ' 269' ' ' ILE . 34.6 t -55.7 -24.21 33.23 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -47.01 -38.76 11.34 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.063 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.797 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 23.0 p90 -132.34 53.6 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.086 0.47 . . . . 0.0 111.574 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.526 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 153.34 148.89 5.02 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.937 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.44 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 56.7 m -59.88 -37.09 78.35 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.711 HD11 ' N ' ' A' ' 264' ' ' SER . 72.1 mt 69.74 78.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.223 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 292' ' ' ASP . 33.6 mm -59.0 -44.51 91.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.961 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 270' ' ' ILE . 75.8 m-20 -153.51 86.99 1.22 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.58 ' HB2' HG23 ' A' ' 269' ' ' ILE . . . -103.27 135.99 43.88 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -141.66 151.1 42.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.498 0.665 . . . . 0.0 112.125 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.575 ' CD2' ' HB2' ' A' ' 283' ' ' SER . 37.1 tp -67.14 -34.89 78.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.625 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.613 ' HE2' ' HB2' ' A' ' 288' ' ' PHE . 2.9 ttm 86.46 145.8 0.06 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.008 0.523 . . . . 0.0 110.624 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.581 ' CB ' ' HA ' ' A' ' 280' ' ' THR . 0.5 OUTLIER 174.41 87.18 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 120.641 0.258 . . . . 0.0 111.048 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.01 -42.16 89.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.868 0.366 . . . . 0.0 110.656 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.446 ' O ' ' OD1' ' A' ' 279' ' ' ASP . 50.5 mttt -139.51 133.88 31.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.666 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.474 ' C ' HG23 ' A' ' 280' ' ' THR . 44.1 p30 30.12 44.51 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.581 ' HA ' ' CB ' ' A' ' 276' ' ' LEU . 1.3 p 70.23 29.52 3.66 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 278' ' ' LYS . . . -66.29 -58.72 8.25 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.246 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.911 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 97.4 mm-40 -64.04 -29.85 70.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.834 0.35 . . . . 0.0 111.353 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.575 ' HB2' ' CD2' ' A' ' 274' ' ' LEU . 87.0 p -56.55 -27.82 58.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.712 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -87.3 126.9 35.13 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.02 0.438 . . . . 0.0 111.537 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.14 -37.1 3.52 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 114.989 0.755 . . . . 0.0 114.989 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.545 ' CE2' ' CE ' ' A' ' 275' ' ' MET . 12.3 p90 -147.23 162.6 38.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.415 1.107 . . . . 0.0 112.733 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.704 ' N ' HD12 ' A' ' 250' ' ' ILE . . . -143.25 163.91 27.36 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 121.102 -0.57 . . . . 0.0 113.264 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.613 ' HB2' ' HE2' ' A' ' 275' ' ' MET . 0.3 OUTLIER -113.5 132.38 55.7 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.511 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 42.6 t -123.74 136.09 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 35.8 m -118.39 136.99 53.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.509 178.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.526 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 30.7 m-85 -120.65 140.56 51.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.514 ' HB2' HD11 ' A' ' 270' ' ' ILE . 51.3 t0 -57.88 -36.28 72.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.307 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 93.7 p -125.86 149.19 48.86 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.331 0.586 . . . . 0.0 111.784 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.96 -29.68 69.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.18 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -56.16 -38.23 70.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.333 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.498 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -61.38 -37.51 83.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.055 0.455 . . . . 0.0 110.468 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.556 HG13 ' CG2' ' A' ' 245' ' ' ILE . 77.1 t -61.91 -44.62 99.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.713 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -61.82 -37.6 85.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.346 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -58.42 -43.4 88.66 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.917 HG23 HD11 ' A' ' 306' ' ' ILE . 0.5 OUTLIER -73.18 -32.04 36.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.915 0.388 . . . . 0.0 111.152 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 91.6 m -54.97 -44.55 74.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.046 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -62.76 -40.07 96.12 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.003 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.44 ' O ' ' N ' ' A' ' 305' ' ' PHE . 86.1 m-20 -63.98 -36.22 83.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.518 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.681 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 19.1 tptm 66.57 -67.84 0.15 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.792 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.681 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 20.9 m-85 -115.87 136.24 53.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.235 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.917 HD11 HG23 ' A' ' 300' ' ' VAL . 30.0 mt -121.55 137.97 53.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.965 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 307' ' ' ASP . 52.6 p30 -78.99 85.46 4.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.977 0.417 . . . . 0.0 111.199 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.735 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 4.1 t80 -79.36 -71.78 0.43 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.5 ' HE3' ' CE1' ' A' ' 308' ' ' PHE . 8.1 mmpt? -104.56 -145.56 0.38 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.151 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.493 ' OD1' ' HG3' ' A' ' 311' ' ' ARG . 54.5 p30 -81.59 2.48 29.07 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.13 0.49 . . . . 0.0 109.952 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.493 ' HG3' ' OD1' ' A' ' 310' ' ' ASP . 94.0 mtt-85 -126.24 149.16 49.27 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.588 ' HG2' ' HB3' ' A' ' 305' ' ' PHE . 11.3 tttp -80.02 137.2 36.76 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.654 HD11 ' CE2' ' A' ' 262' ' ' PHE . 21.7 pt -105.01 135.85 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.82 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' GLU . . . . . 0.417 ' HB2' ' CE2' ' A' ' 305' ' ' PHE . 84.6 tt0 -102.15 130.31 48.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.812 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 0.638 HD13 ' CE2' ' A' ' 263' ' ' PHE . 67.5 mt -119.34 128.54 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-O 121.024 0.44 . . . . 0.0 111.125 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -130.91 144.19 51.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.253 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -51.85 138.05 24.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.93 0.395 . . . . 0.0 110.424 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 244' ' ' LYS . . . -64.68 145.27 56.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.004 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' GLU . . . . . 0.444 ' HG3' ' HD2' ' A' ' 320' ' ' PRO . 58.2 tt0 -114.62 146.44 35.98 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.614 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.444 ' HD2' ' HG3' ' A' ' 319' ' ' GLU . 46.5 Cg_exo -56.47 134.18 62.71 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 121.957 1.772 . . . . 0.0 111.981 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -58.34 -37.91 76.1 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.966 0.412 . . . . 0.0 110.965 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.899 -179.898 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.671 0 C3'-C2'-O2' 111.256 -0.705 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.911 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.424 -1.001 0 C1'-C2'-O2' 108.599 -0.667 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.424 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -1.015 0 C4'-C3'-C2' 103.756 1.056 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.638 ' C2 ' ' CZ3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.425 -0.929 0 C4'-C3'-C2' 103.993 1.293 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.784 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.826 0 C5'-C4'-O4' 107.973 -0.877 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.784 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.927 0 C3'-C2'-C1' 100.832 -0.742 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.719 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.914 0 C3'-C2'-C1' 100.861 -0.71 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . 0.495 ' N3 ' " H2'" ' B' ' 8' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.944 0 C3'-C2'-O2' 111.221 -0.717 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.9 pttp . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.9 0.381 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.87 145.37 35.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.691 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.5 m -116.17 146.06 42.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.087 0.47 . . . . 0.0 111.038 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 20.5 m -90.01 8.9 30.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.544 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.483 ' HE3' ' HB1' ' A' ' 233' ' ' ALA . 36.6 ttpt -64.45 137.46 57.89 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.428 0.632 . . . . 0.0 111.458 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.825 ' SD ' HG13 ' A' ' 213' ' ' VAL . 85.2 mmm -117.2 151.79 36.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.215 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.581 ' CE2' ' N9 ' ' B' ' 6' ' ' ' A' . 5.9 t80 -106.13 129.31 54.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.678 ' CG2' HD21 ' A' ' 166' ' ' LEU . 12.9 mm -116.45 127.61 74.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.73 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -130.45 163.97 23.05 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.492 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 73.88 28.58 64.55 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.809 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.678 HD21 ' CG2' ' A' ' 163' ' ' ILE . 74.3 mt -86.7 142.15 28.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.782 0.325 . . . . 0.0 111.604 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -64.65 135.42 55.91 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.581 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 4.7 m0 -52.06 -31.52 30.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.688 0.28 . . . . 0.0 111.003 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -91.17 5.41 49.17 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.614 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.52 ' O ' ' O ' ' A' ' 171' ' ' THR . 86.1 m -58.04 -40.43 80.88 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.558 ' C ' HD12 ' A' ' 190' ' ' ILE . 0.1 OUTLIER 53.16 157.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.189 0.519 . . . . 0.0 110.1 -177.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.54 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 97.4 mt-10 -62.41 -26.78 68.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.704 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.685 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 93.0 m-20 -53.53 -42.85 67.87 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.464 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -68.09 -38.0 81.85 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.526 HD23 ' CE2' ' A' ' 179' ' ' PHE . 5.1 mt -59.69 -47.6 85.0 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.685 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -68.02 -37.2 81.11 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.194 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.417 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 48.5 tp10 -67.76 -45.51 74.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.866 0.365 . . . . 0.0 110.421 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.607 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 72.2 t80 -67.17 -48.28 68.44 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.767 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.535 ' CB ' HD11 ' A' ' 205' ' ' LEU . 81.3 m-85 -88.73 -4.52 58.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.185 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -58.67 -32.02 68.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.199 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -41.5 89.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.707 0.765 . . . . 0.0 109.988 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -68.55 -34.24 75.5 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.89 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -179.12 -176.84 47.21 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.247 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.521 ' O ' HG22 ' A' ' 185' ' ' VAL . 49.0 m -63.3 -30.09 71.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.518 -0.341 . . . . 0.0 111.559 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.652 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 0.6 OUTLIER 64.85 83.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 122.355 1.074 . . . . 0.0 108.478 -177.309 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.476 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -53.13 -47.74 68.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.723 -177.097 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 186' ' ' THR . 92.2 m-20 -138.95 156.08 47.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.213 0.53 . . . . 0.0 112.391 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -132.77 136.78 46.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.876 179.252 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.587 ' O ' ' HA2' ' A' ' 203' ' ' GLY . 7.8 tptt -142.79 66.05 1.33 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.584 0.231 . . . . 0.0 111.415 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.561 ' HA ' ' HA3' ' A' ' 203' ' ' GLY . 8.7 tt -61.82 -19.16 20.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.59 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.67 ' CE ' ' HA2' ' A' ' 203' ' ' GLY . 10.8 mtm 64.07 131.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.741 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.55 ' HG3' ' HD3' ' A' ' 194' ' ' PRO . 6.2 pttt -132.2 156.49 46.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.958 0.408 . . . . 0.0 111.805 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 10.7 t0 -125.65 74.63 69.94 Favored Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.901 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.55 ' HD3' ' HG3' ' A' ' 192' ' ' LYS . 19.9 Cg_endo -59.98 -27.67 85.43 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.616 2.211 . . . . 0.0 112.788 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -66.81 -59.12 3.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.952 0.406 . . . . 0.0 111.366 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 65.8 p -74.27 -18.43 60.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.417 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 89.7 9.19 66.66 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.134 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 25.1 mmt85 -120.95 -179.22 3.95 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.294 0.569 . . . . 0.0 111.859 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.482 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 51.0 m -119.93 152.64 37.11 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.969 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.472 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 5.9 mpt_? -51.35 -34.87 35.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.833 0.349 . . . . 0.0 110.745 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.746 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 87.81 2.57 81.32 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.419 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.651 ' O ' ' HE3' ' A' ' 191' ' ' MET . 14.8 p90 -139.37 153.74 47.71 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.67 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -145.06 155.97 26.72 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.062 -1.066 . . . . 0.0 112.413 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.691 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 97.4 m-85 -102.88 123.37 46.4 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.691 HD23 ' N ' ' A' ' 206' ' ' SER . 1.6 tt -106.37 127.81 53.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.168 -177.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.691 ' N ' HD23 ' A' ' 205' ' ' LEU . 34.5 t -115.8 133.62 55.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.765 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.606 ' CE2' HD22 ' A' ' 205' ' ' LEU . 95.7 m-85 -116.18 136.4 53.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.408 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.476 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.5 tt0 -61.54 -33.76 74.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.136 0.493 . . . . 0.0 109.75 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -110.09 120.4 44.63 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.802 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.91 -23.06 49.17 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.522 2.148 . . . . 0.0 113.073 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.1 m -57.12 -36.76 71.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.543 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.915 ' O ' HG23 ' A' ' 216' ' ' VAL . 23.0 m -58.85 -36.45 74.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.698 0.285 . . . . 0.0 110.938 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.825 HG13 ' SD ' ' A' ' 161' ' ' MET . 73.4 t -62.12 -42.88 96.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.231 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -60.11 -41.76 93.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.314 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.465 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 19.3 pt-20 -73.94 -28.51 61.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.903 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 212' ' ' SER . 70.3 t -59.89 -42.7 90.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.638 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.2 m -73.87 -27.38 22.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -58.54 -31.38 67.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.74 0.305 . . . . 0.0 111.488 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.59 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 67.3 m -108.29 142.41 38.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.818 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.409 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 14.1 pt20 -68.51 -40.71 80.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.463 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.712 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 61.0 m-70 81.97 118.52 0.05 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 72.8 mt -114.26 106.47 20.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.497 HD21 HG23 ' A' ' 170' ' ' THR . 6.9 tt -122.62 121.39 36.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.82 0.343 . . . . 0.0 110.781 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 50.14 40.31 21.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.53 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.79 11.21 84.88 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.503 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 31.6 mmtm -113.4 139.48 48.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 117.233 0.517 . . . . 0.0 111.595 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.81 ' O ' ' O ' ' A' ' 228' ' ' ILE . 17.2 m -73.61 -30.45 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.999 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.81 ' O ' ' O ' ' A' ' 227' ' ' VAL . 17.0 pt 34.42 136.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -123.7 80.87 55.22 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.171 0.51 . . . . 0.0 111.258 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.471 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 46.9 Cg_exo -59.13 126.15 20.16 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.151 2.567 . . . . 0.0 112.202 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt -134.25 153.67 51.72 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.432 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -56.06 145.29 26.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.995 0.426 . . . . 0.0 111.767 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.483 ' HB1' ' HE3' ' A' ' 160' ' ' LYS . . . -64.85 146.76 54.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.054 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 1.023 HG22 ' C2 ' ' B' ' 6' ' ' ' A' . 3.2 tt -108.25 137.14 19.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.318 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.452 ' HG2' ' HG3' ' A' ' 238' ' ' GLU . 13.0 Cg_endo -55.93 143.19 83.16 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.826 1.684 . . . . 0.0 110.709 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -54.53 -36.61 64.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.739 0.304 . . . . 0.0 111.25 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.31 -41.49 84.61 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 242' ' ' THR . 97.4 mt-10 -68.14 -35.88 78.8 Favored 'General case' 0 C--O 1.23 0.07 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.484 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -60.82 -36.76 79.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.045 0.45 . . . . 0.0 111.039 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -58.66 -38.86 79.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.533 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 242' ' ' THR . 75.2 mmtt -87.47 -76.9 0.36 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 238' ' ' GLU . 76.9 p 34.66 -165.68 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -162.97 55.62 0.29 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.728 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.532 ' CE ' ' CD2' ' A' ' 288' ' ' PHE . 7.9 tptt -73.7 121.17 20.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.692 0.282 . . . . 0.0 110.399 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.7 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -130.01 164.58 32.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.176 0.512 . . . . 0.0 110.848 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -104.91 136.57 44.16 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.316 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.85 HG11 ' CE1' ' A' ' 259' ' ' PHE . 15.0 p -130.7 144.83 36.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.719 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.643 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -130.37 170.14 21.02 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.93 21.52 35.89 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 119.889 -1.148 . . . . 0.0 112.377 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 287' ' ' GLY . 67.0 mt -106.52 128.9 60.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.874 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -166.09 -115.28 0.32 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.329 -0.938 . . . . 0.0 113.272 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.43 138.63 86.86 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.334 2.023 . . . . 0.0 113.506 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 54.02 44.45 29.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.34 -0.845 . . . . 0.0 113.215 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.874 HG22 ' O ' ' A' ' 251' ' ' GLY . 8.8 m -109.49 -54.23 5.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.443 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.477 ' N ' HG23 ' A' ' 254' ' ' VAL . 13.2 mmt180 60.85 135.98 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -54.82 -31.9 74.61 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.192 1.928 . . . . 0.0 113.418 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -60.12 -45.08 94.22 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.792 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.682 ' HA ' ' HB3' ' A' ' 261' ' ' GLU . 58.6 mp0 -68.52 -33.69 74.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.828 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.85 ' CE1' HG11 ' A' ' 247' ' ' VAL . 13.2 t80 -61.93 -52.73 62.85 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.897 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.664 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.3 tt0 -63.77 -37.14 86.24 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.682 ' HB3' ' HA ' ' A' ' 258' ' ' GLU . 81.7 tt0 -61.41 -37.74 84.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 113.824 -1.534 . . . . 0.0 111.717 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.882 ' CE2' HD11 ' A' ' 313' ' ' ILE . 84.3 t80 -68.93 -54.72 13.9 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.782 ' CB ' HD11 ' A' ' 269' ' ' ILE . 7.3 m-85 -66.04 -25.22 66.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.208 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 86.5 p -56.32 -23.06 34.59 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -52.29 -39.68 60.82 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.298 -1.319 . . . . 0.0 113.072 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.665 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 43.9 p90 -120.87 58.33 0.95 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.543 0.687 . . . . 0.0 112.268 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.422 ' HA3' ' HB1' ' A' ' 296' ' ' ALA . . . 122.32 153.9 8.98 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.012 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.7 m -72.49 132.18 43.51 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.782 HD11 ' CB ' ' A' ' 263' ' ' PHE . 74.9 mt -93.98 126.14 46.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.711 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.772 HG22 ' HB ' ' A' ' 290' ' ' THR . 10.5 tt -65.55 -36.25 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.281 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 270' ' ' ILE . 51.2 p30 171.79 73.71 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.894 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.573 ' HB2' HG21 ' A' ' 269' ' ' ILE . . . -67.76 142.53 56.21 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.408 0.147 . . . . 0.0 111.01 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -144.03 152.16 40.64 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.84 HD23 ' HG ' ' A' ' 276' ' ' LEU . 22.3 tp -65.89 -35.87 81.85 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.087 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.582 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 93.1 mmm 99.5 -13.66 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.925 0.89 . . . . 0.0 112.574 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.84 ' HG ' HD23 ' A' ' 274' ' ' LEU . 0.0 OUTLIER -64.59 50.44 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.489 ' O ' HG22 ' A' ' 227' ' ' VAL . 21.8 t70 -59.0 -40.51 85.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.075 0.464 . . . . 0.0 110.592 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 279' ' ' ASP . 37.1 mtpt -59.79 -26.92 66.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.326 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 278' ' ' LYS . 54.3 t0 80.44 38.62 0.09 Allowed 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.096 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 281' ' ' GLY . 0.1 OUTLIER -166.62 -61.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.061 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 281' ' ' GLY . . . . . 0.557 ' H ' HG23 ' A' ' 280' ' ' THR . . . -82.49 164.28 43.39 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.396 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.405 ' OE1' ' HB3' ' A' ' 275' ' ' MET . 48.3 mt-30 59.36 41.65 19.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.883 0.373 . . . . 0.0 110.12 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.492 ' HA ' HD21 ' A' ' 274' ' ' LEU . 29.8 t -127.45 142.14 51.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.896 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.477 ' CA ' ' HA2' ' A' ' 251' ' ' GLY . 60.6 mtm180 45.85 25.49 0.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.671 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -119.53 -62.85 0.27 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.039 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.473 ' CZ ' " C4'" ' B' ' 2' ' ' ' A' . 41.6 p90 -139.23 164.9 28.6 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.805 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -130.39 156.54 21.63 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 119.927 -1.13 . . . . 0.0 113.625 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.532 ' CD2' ' CE ' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -119.3 123.08 43.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.729 -0.236 . . . . 0.0 110.465 179.364 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.815 HG23 ' CZ ' ' A' ' 259' ' ' PHE . 57.4 t -123.91 137.37 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.195 0.521 . . . . 0.0 112.105 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.772 ' HB ' HG22 ' A' ' 270' ' ' ILE . 20.8 m -120.41 138.33 53.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.407 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -114.91 138.96 50.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.145 0.498 . . . . 0.0 111.776 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 293' ' ' SER . 53.0 p30 -62.42 -30.47 71.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.928 178.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.55 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 51.0 m -119.76 142.65 48.36 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 121.18 0.514 . . . . 0.0 111.3 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.6 -31.83 72.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.72 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.48 -37.12 69.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.618 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.434 ' O ' ' HD1' ' A' ' 266' ' ' TRP . . . -61.15 -38.01 84.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.416 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 79.9 t -60.99 -40.01 84.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.933 0.397 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -58.08 -36.89 73.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.937 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -56.78 -43.75 81.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.987 0.422 . . . . 0.0 111.704 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.817 HG23 HD11 ' A' ' 306' ' ' ILE . 0.3 OUTLIER -76.1 -30.07 20.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.815 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 84.9 m -55.91 -45.29 78.72 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.77 -34.76 79.1 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.08 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -102.15 79.89 1.92 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.602 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.633 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 11.9 tptt -55.74 -44.59 77.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.048 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.633 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 8.5 m-85 -117.06 126.73 53.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.514 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.817 HD11 HG23 ' A' ' 300' ' ' VAL . 2.4 mt -121.37 139.38 48.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.228 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -78.76 113.32 16.74 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.376 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.601 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 7.0 t80 -112.3 -77.28 0.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.928 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.412 ' HG3' HG12 ' A' ' 254' ' ' VAL . 6.4 mmpt? -97.41 -167.29 1.51 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.967 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -51.84 -29.78 20.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.839 0.352 . . . . 0.0 110.486 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -105.42 144.59 31.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.05 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.578 ' HE2' ' HB3' ' A' ' 305' ' ' PHE . 10.3 tptt -70.74 142.04 51.45 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.882 HD11 ' CE2' ' A' ' 262' ' ' PHE . 28.8 pt -109.64 141.2 25.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.034 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' GLU . . . . . 0.506 ' HG3' ' CE1' ' A' ' 305' ' ' PHE . 85.6 tt0 -101.59 131.82 47.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.813 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 0.781 HG12 HG23 ' A' ' 247' ' ' VAL . 71.3 mt -119.91 128.29 75.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.108 0.48 . . . . 0.0 111.766 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.415 ' HE3' ' OE2' ' A' ' 314' ' ' GLU . 38.1 mttp -127.89 156.06 43.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.83 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -60.46 148.46 37.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -53.95 137.46 39.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.19 0.519 . . . . 0.0 111.611 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -133.27 81.06 56.99 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.649 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.25 137.65 71.22 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.187 1.925 . . . . 0.0 112.002 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -59.66 -35.42 74.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.106 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 79.5 m80 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.928 -179.893 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.722 0 C3'-C2'-O2' 111.244 -0.709 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.473 " C4'" ' CZ ' ' A' ' 286' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.972 0 C3'-C2'-O2' 111.208 -0.721 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.567 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.964 0 C3'-C2'-C1' 100.855 -0.716 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.746 " O2'" ' HA3' ' A' ' 201' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.853 0 C4'-C3'-C2' 103.957 1.257 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.902 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.818 0 C4'-C3'-C2' 103.573 0.873 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 1.023 ' C2 ' HG22 ' A' ' 234' ' ' ILE . . . . . . . . 0 O5'--C5' 1.426 -0.893 0 C4'-C3'-C2' 103.547 0.847 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.691 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.423 -1.068 0 C3'-C2'-O2' 111.416 -0.65 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . 0.753 ' N3 ' " H2'" ' B' ' 8' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.423 -1.032 0 O4'-C1'-C2' 107.485 0.775 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 27.7 tptp . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.655 0.264 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 158' ' ' SER . 84.5 tt0 -104.26 136.33 44.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.975 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 157' ' ' GLU . 2.2 m 48.91 174.15 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.616 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.96 77.83 1.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.694 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.47 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 79.4 tttt -87.69 134.62 33.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.88 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.415 ' N ' ' O ' ' A' ' 205' ' ' LEU . 5.0 tpp -120.39 147.37 45.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.648 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.626 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 5.0 t80 -100.19 129.35 46.2 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.807 HG23 HD12 ' A' ' 228' ' ' ILE . 21.8 mm -116.79 128.37 74.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.792 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.673 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -130.67 165.93 22.65 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.198 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.9 27.75 62.01 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.571 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.964 HD23 HG21 ' A' ' 228' ' ' ILE . 80.9 mt -87.41 144.28 26.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.737 0.303 . . . . 0.0 111.714 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.46 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 9.4 t30 -66.92 133.77 50.68 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.587 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 5.0 m-90 -50.23 -34.77 24.1 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.298 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -63.73 -20.63 65.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.5 m -50.83 139.24 17.28 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.786 0.803 . . . . 0.0 111.89 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.515 ' C ' HD12 ' A' ' 190' ' ' ILE . 32.6 m -120.51 148.38 43.91 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.778 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.887 ' N ' HD12 ' A' ' 190' ' ' ILE . 96.2 mt-10 -56.63 -34.84 67.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.606 0.241 . . . . 0.0 110.544 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.632 ' OD1' ' N ' ' A' ' 174' ' ' ASN . 54.9 p30 -61.46 -38.04 85.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.576 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.632 ' N ' ' OD1' ' A' ' 173' ' ' ASP . 84.0 m-20 -65.56 -36.13 82.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.159 0.504 . . . . 0.0 110.526 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.543 HD12 HD11 ' A' ' 190' ' ' ILE . 0.4 OUTLIER -53.42 -48.6 68.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.273 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.544 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -64.18 -37.0 85.88 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.107 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.425 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 84.4 tt0 -65.92 -44.13 86.05 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.722 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.48 ' OH ' ' HB3' ' A' ' 221' ' ' HIS . 73.2 t80 -64.88 -46.59 81.14 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.144 0.497 . . . . 0.0 111.429 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.485 ' HE1' HG13 ' A' ' 216' ' ' VAL . 91.5 m-85 -91.18 1.67 56.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.255 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -60.73 -28.69 68.52 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.381 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.465 ' CD ' ' H ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -58.98 -38.05 78.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.705 0.764 . . . . 0.0 110.445 -179.01 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.418 ' CE2' ' HA ' ' A' ' 216' ' ' VAL . 47.9 m-85 -67.31 -29.62 69.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.526 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 153.76 -124.31 1.55 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.892 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 56.8 m -117.16 139.01 51.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.95 HG12 ' CE1' ' A' ' 207' ' ' PHE . 4.8 m -109.56 126.2 66.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.685 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.81 HG23 ' N ' ' A' ' 208' ' ' GLU . 43.9 p -75.1 -31.89 61.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.58 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.851 ' C ' HD13 ' A' ' 188' ' ' LEU . 51.5 t0 -150.6 150.01 30.63 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.851 HD13 ' C ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -141.49 81.45 1.78 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.013 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.576 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 8.4 tptp -79.41 119.43 22.43 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.887 HD12 ' N ' ' A' ' 172' ' ' GLU . 74.0 mt -127.26 112.42 28.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 174.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.634 ' HB2' ' HD3' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -61.37 -34.43 75.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.2 -177.245 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.47 ' O ' ' O ' ' A' ' 191' ' ' MET . 52.2 tttm 49.6 162.79 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.455 ' N ' ' HG2' ' A' ' 192' ' ' LYS . 5.2 t70 -112.18 100.27 48.85 Favored Pre-proline 0 N--CA 1.463 0.206 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.347 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.8 -29.15 85.0 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.325 2.016 . . . . 0.0 113.165 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -78.96 -88.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.6 p -70.79 -27.11 63.66 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 193' ' ' ASP . . . 97.66 -8.28 63.78 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.204 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 199' ' ' SER . 33.3 mtm-85 -124.65 133.38 53.25 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.242 0.544 . . . . 0.0 111.849 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.575 ' O ' ' HB3' ' A' ' 200' ' ' ARG . 36.2 t 162.22 -177.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.071 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.833 ' HG2' ' H ' ' A' ' 202' ' ' PHE . 58.2 ttp85 68.52 -95.42 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.24 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.545 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 85.11 9.53 80.06 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.386 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.833 ' H ' ' HG2' ' A' ' 200' ' ' ARG . 34.5 p90 -146.14 153.53 40.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -148.65 166.59 29.22 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 119.858 -1.163 . . . . 0.0 112.209 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.802 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 89.9 m-85 -108.75 122.53 47.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.016 0.436 . . . . 0.0 110.023 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.948 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 0.7 OUTLIER -114.75 129.55 56.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.493 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.792 ' N ' HD12 ' A' ' 205' ' ' LEU . 58.5 m -115.18 143.08 45.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.251 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.95 ' CE1' HG12 ' A' ' 185' ' ' VAL . 92.5 m-85 -117.74 138.09 52.26 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.81 ' N ' HG23 ' A' ' 186' ' ' THR . 84.5 tt0 -63.68 -35.59 81.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.892 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.17 116.34 56.93 Favored Pre-proline 0 C--N 1.333 -0.123 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.388 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.914 ' O ' HG12 ' A' ' 213' ' ' VAL . 46.4 Cg_exo -56.13 -25.01 52.71 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.241 1.96 . . . . 0.0 112.829 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.7 m -58.84 -36.25 74.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.65 0.262 . . . . 0.0 111.47 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.758 ' O ' HG23 ' A' ' 216' ' ' VAL . 89.7 p -62.53 -32.7 73.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.453 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.914 HG12 ' O ' ' A' ' 210' ' ' PRO . 3.0 p -62.66 -37.2 78.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.892 0.377 . . . . 0.0 110.754 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 218' ' ' LYS . 54.9 t0 -61.99 -42.98 99.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.589 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 212' ' ' SER . 4.5 pt-20 -74.06 -32.34 63.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.904 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.826 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 92.7 t -63.61 -44.63 98.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.073 0.463 . . . . 0.0 110.894 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 213' ' ' VAL . 59.1 t -68.02 -46.14 82.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 214' ' ' ASP . 47.0 mmtm -61.11 -34.51 75.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.403 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 49.2 m -88.37 144.03 26.65 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -79.74 141.41 36.37 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.826 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 55.2 m-70 -121.15 130.77 53.88 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -176.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.565 HG12 HG22 ' A' ' 227' ' ' VAL . 69.0 mt -123.63 112.31 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.264 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.559 HD23 ' CG ' ' A' ' 224' ' ' ASP . 6.7 tt -119.12 127.23 53.17 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.139 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.559 ' CG ' HD23 ' A' ' 223' ' ' LEU . 86.0 m-20 55.05 42.46 30.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.314 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 77.62 10.95 85.91 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.56 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 222' ' ' ILE . 6.3 mptt -126.67 153.76 44.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.976 0.388 . . . . 0.0 110.753 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.565 HG22 HG12 ' A' ' 222' ' ' ILE . 43.4 t -102.25 132.8 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.917 0.389 . . . . 0.0 110.859 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.964 HG21 HD23 ' A' ' 166' ' ' LEU . 30.8 pt -125.27 159.62 32.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.377 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -126.86 82.86 66.89 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 121.13 0.49 . . . . 0.0 110.981 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.537 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 56.0 Cg_exo -56.73 128.57 30.55 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.195 2.597 . . . . 0.0 112.15 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.682 ' HE3' ' O4 ' ' B' ' 5' ' ' ' U' . 10.2 mtmp? -133.98 157.26 46.51 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.665 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 40.1 tpt85 -58.74 135.08 57.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.987 0.423 . . . . 0.0 111.165 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -65.81 145.85 55.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.088 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.795 HG22 ' HB2' ' A' ' 238' ' ' GLU . 6.1 mt -117.96 120.46 32.57 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.561 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.545 ' HB2' ' OE1' ' A' ' 238' ' ' GLU . 34.5 Cg_exo -53.89 152.69 22.38 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 121.548 1.499 . . . . 0.0 110.634 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 52.3 mmm-85 -54.23 -35.63 62.65 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.32 -40.74 82.86 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.795 ' HB2' HG22 ' A' ' 234' ' ' ILE . 55.3 mp0 -65.85 -35.82 81.73 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.587 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -59.35 -39.81 84.38 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.598 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -64.14 -45.19 89.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.053 0.454 . . . . 0.0 110.185 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -65.09 -40.08 94.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.649 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.742 HG23 ' O ' ' A' ' 238' ' ' GLU . 24.8 p -83.69 161.42 21.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.129 -178.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.53 166.27 25.88 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.34 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.496 ' HE3' ' CE2' ' A' ' 288' ' ' PHE . 4.6 ttpt -137.45 135.61 37.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.075 0.437 . . . . 0.0 111.233 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.956 HD12 ' CG2' ' A' ' 315' ' ' ILE . 7.4 pt -120.05 159.83 20.98 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 121.176 0.512 . . . . 0.0 110.933 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.55 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 90.0 t80 -99.52 129.62 45.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.675 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.458 HG22 HD12 ' A' ' 315' ' ' ILE . 44.0 t -119.83 137.32 54.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.349 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.05 167.72 18.38 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.564 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 94.48 8.58 59.64 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.197 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.965 HG22 HG21 ' A' ' 254' ' ' VAL . 27.8 mm -56.8 -39.89 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 120.762 0.315 . . . . 0.0 110.581 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 250' ' ' ILE . . . 27.56 -145.36 0.01 OUTLIER Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.677 -0.692 . . . . 0.0 114.419 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.9 169.25 11.89 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.338 2.692 . . . . 0.0 113.533 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 60.46 43.47 13.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.313 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.965 HG21 HG22 ' A' ' 250' ' ' ILE . 26.8 m -133.8 156.88 41.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.924 0.392 . . . . 0.0 110.991 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.92 155.12 74.84 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.778 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -57.01 -40.3 85.01 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 121.532 1.488 . . . . 0.0 110.851 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.52 -42.62 98.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.773 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 262' ' ' PHE . 74.6 mm-40 -65.43 -41.34 93.64 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.491 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.478 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 43.1 t80 -66.91 -48.96 67.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.722 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -64.65 -40.89 96.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.774 0.321 . . . . 0.0 111.058 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.1 pt-20 -74.69 -30.72 61.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.892 0.377 . . . . 0.0 110.548 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.669 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 91.4 t80 -57.38 -44.65 84.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.172 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.659 ' HZ ' HD12 ' A' ' 313' ' ' ILE . 86.7 m-85 -92.7 -2.22 56.22 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 267' ' ' GLY . 47.2 t -60.09 -30.16 69.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -56.36 -39.8 73.46 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.44 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.699 ' HH2' HG21 ' A' ' 306' ' ' ILE . 17.3 m-90 -60.42 -39.23 86.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.085 0.469 . . . . 0.0 110.811 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 264' ' ' SER . . . -173.71 -172.55 39.18 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.663 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 90.7 m -58.34 -37.18 74.64 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.625 HD11 ' C ' ' A' ' 263' ' ' PHE . 49.2 mt 61.7 86.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.65 HD11 ' HB3' ' A' ' 292' ' ' ASP . 31.4 mm -55.09 -44.5 74.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -159.66 92.48 1.04 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -104.86 133.98 48.75 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -144.68 154.94 43.3 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.812 ' CD1' HG21 ' A' ' 250' ' ' ILE . 31.8 tp -66.19 -37.83 86.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.23 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.625 ' O ' HD23 ' A' ' 276' ' ' LEU . 93.2 mmm 84.21 138.08 0.06 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.199 -178.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 275' ' ' MET . 0.2 OUTLIER 173.59 89.78 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.841 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 278' ' ' LYS . 55.4 p30 -64.16 -39.86 94.92 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.688 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.615 ' N ' ' OD1' ' A' ' 277' ' ' ASP . 60.1 mttm -101.11 7.98 43.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.978 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.461 ' HA ' ' CD1' ' A' ' 276' ' ' LEU . 51.2 t0 78.94 -13.69 0.94 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.857 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 46.4 p -139.43 12.13 2.55 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -94.58 -74.63 1.25 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.761 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.983 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 80.1 mm-40 -60.1 -32.47 71.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.049 0.452 . . . . 0.0 111.232 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.697 ' OG ' HD21 ' A' ' 274' ' ' LEU . 33.1 t -61.66 -4.7 1.52 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.911 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -49.94 -38.2 35.4 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 178.91 19.17 0.03 OUTLIER Glycine 0 CA--C 1.524 0.604 0 C-N-CA 118.717 -1.706 . . . . 0.0 115.847 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.444 ' CZ ' " C4'" ' B' ' 2' ' ' ' A' . 24.9 p90 -137.93 160.53 39.07 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.755 1.278 . . . . 0.0 111.022 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -139.36 157.27 24.97 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.319 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.496 ' CE2' ' HE3' ' A' ' 244' ' ' LYS . 0.6 OUTLIER -111.13 129.18 56.01 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.582 0.353 . . . . 0.0 110.919 179.574 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.492 ' O ' ' HG3' ' A' ' 244' ' ' LYS . 42.3 t -122.76 133.14 69.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.712 0.292 . . . . 0.0 111.16 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 52.5 m -119.61 138.02 53.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.379 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.515 ' CE1' HG12 ' A' ' 269' ' ' ILE . 47.8 m-85 -120.45 143.42 48.5 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.65 ' HB3' HD11 ' A' ' 270' ' ' ILE . 52.9 p30 -63.56 -32.65 74.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.499 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.611 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 98.2 p -127.06 149.34 49.96 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 121.26 0.552 . . . . 0.0 111.806 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -68.35 -32.76 73.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.092 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -56.25 -39.6 72.83 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.658 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -63.88 -34.72 78.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.173 0.511 . . . . 0.0 110.591 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.753 HG13 ' CG2' ' A' ' 245' ' ' ILE . 78.1 t -63.14 -42.1 95.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.664 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -60.55 -42.01 95.72 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -64.33 -45.86 86.01 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.85 HG22 HG13 ' A' ' 315' ' ' ILE . 7.5 p -70.62 -40.65 77.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 95.1 m -67.69 -40.11 84.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.737 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -56.85 -39.91 75.15 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.872 0.368 . . . . 0.0 111.022 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.777 ' HB3' HD11 ' A' ' 306' ' ' ILE . 0.3 OUTLIER -60.2 -33.34 72.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.736 179.308 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.681 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 6.7 tptm 75.24 -62.56 0.44 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.336 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.681 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 24.4 m-85 -116.07 132.78 56.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.236 0.541 . . . . 0.0 111.994 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.777 HD11 ' HB3' ' A' ' 303' ' ' ASN . 20.7 mm -121.22 140.85 44.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.002 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -78.82 130.0 35.22 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.669 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 1.8 t80 -118.23 -127.06 0.28 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.451 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.5 ' HD3' ' CE1' ' A' ' 308' ' ' PHE . 0.0 OUTLIER -60.21 -36.05 76.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.194 0.521 . . . . 0.0 110.563 -179.091 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -177.43 -35.78 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.218 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -86.59 144.93 26.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.423 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.53 ' HE3' ' HB3' ' A' ' 305' ' ' PHE . 3.0 tptt -74.26 136.6 42.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 306' ' ' ILE . 30.8 pt -112.56 143.57 22.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.298 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -102.41 138.63 39.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 0.956 ' CG2' HD12 ' A' ' 245' ' ' ILE . 15.2 mm -112.37 127.14 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -136.53 137.02 39.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.479 0.181 . . . . 0.0 110.988 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -55.51 146.82 19.21 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 244' ' ' LYS . . . -51.37 135.49 26.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.284 0.564 . . . . 0.0 111.245 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -132.37 84.62 51.21 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.431 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.51 137.69 32.24 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 121.762 1.641 . . . . 0.0 111.696 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -58.01 -34.93 70.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.302 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 83.7 t60 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.843 -179.815 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.46 " O2'" ' N7 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.728 0 C3'-C2'-O2' 111.181 -0.731 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.983 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.952 0 C1'-C2'-O2' 108.571 -0.676 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.527 " H4'" ' HG3' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.424 -1.024 0 C3'-C2'-O2' 111.163 -0.737 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.587 ' C5 ' ' CE3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.425 -0.921 0 C4'-C3'-C2' 103.906 1.206 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.774 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.819 0 C4'-C3'-C2' 103.621 0.921 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.774 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.0 0 C4'-C3'-C2' 103.463 0.763 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.802 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.897 0 C3'-C2'-C1' 100.796 -0.782 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.937 0 O4'-C1'-C2' 107.431 0.736 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.835 0.35 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.32 -33.15 69.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.077 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.5 p -67.94 160.5 28.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.99 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.58 97.2 4.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.42 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.64 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 75.6 tttt -100.08 141.59 32.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.205 0.526 . . . . 0.0 111.829 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.506 ' N ' ' O ' ' A' ' 205' ' ' LEU . 82.4 mmm -124.02 145.86 48.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.649 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.65 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 3.6 t80 -105.5 127.52 53.06 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.672 HG22 HD21 ' A' ' 166' ' ' LEU . 18.2 mt -122.28 130.11 74.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.445 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.442 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -128.73 163.98 22.0 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.747 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.524 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 72.51 47.31 28.42 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 119.829 -1.177 . . . . 0.0 111.481 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.76 HD12 HH21 ' A' ' 200' ' ' ARG . 45.2 mt -83.63 9.67 11.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.52 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 49.4 t30 62.81 43.61 6.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.023 0.44 . . . . 0.0 110.195 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.537 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 6.0 m0 39.15 39.45 0.41 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.267 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 171' ' ' THR . 59.8 t0 -162.44 -111.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.263 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.779 HG22 ' HB2' ' A' ' 175' ' ' LEU . 77.0 m 63.26 -40.97 0.2 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.617 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.5 OUTLIER 47.74 155.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.553 0.692 . . . . 0.0 111.374 -179.296 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.528 ' N ' HD12 ' A' ' 190' ' ' ILE . 96.3 mt-10 -62.5 -31.98 72.83 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.659 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -64.0 -61.53 2.22 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.563 ' HB2' ' O ' ' A' ' 170' ' ' THR . 85.9 m-20 -62.57 -37.19 85.23 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.226 0.536 . . . . 0.0 110.016 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.779 ' HB2' HG22 ' A' ' 170' ' ' THR . 52.3 tp -61.86 -42.97 99.69 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.359 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 -61.65 -42.52 99.02 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.169 0.509 . . . . 0.0 110.173 177.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -66.82 -40.31 88.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.224 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.496 ' OH ' ' HB3' ' A' ' 221' ' ' HIS . 50.6 t80 -59.91 -45.26 93.12 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.163 0.506 . . . . 0.0 110.898 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.406 ' HB3' HD21 ' A' ' 205' ' ' LEU . 97.5 m-85 -95.46 -0.99 51.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.072 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.27 -30.85 64.98 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.008 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.426 ' HD3' ' O ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -58.34 -41.78 85.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.534 0.683 . . . . 0.0 110.644 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -67.39 -35.35 79.13 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.613 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -179.42 -177.19 47.61 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 119.719 -1.229 . . . . 0.0 113.483 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.52 ' C ' HG13 ' A' ' 185' ' ' VAL . 46.7 m -63.11 -30.69 71.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.029 -0.586 . . . . 0.0 110.995 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.619 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 0.6 OUTLIER 64.38 91.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.857 0.837 . . . . 0.0 108.954 -177.797 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.7 t -58.49 -44.48 89.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.581 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 206' ' ' SER . 89.0 m-20 -135.59 149.31 49.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.49 0.662 . . . . 0.0 112.687 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.522 ' CD1' HD23 ' A' ' 175' ' ' LEU . 0.2 OUTLIER -126.83 127.62 45.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.099 179.144 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.539 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 13.0 tptt -135.95 120.78 18.55 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.528 HD12 ' N ' ' A' ' 172' ' ' GLU . 0.8 OUTLIER -130.35 132.0 65.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.83 176.671 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.695 ' HB2' ' HD2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -99.23 156.49 16.95 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.432 -179.156 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.492 ' HG3' ' HD3' ' A' ' 194' ' ' PRO . 13.4 pttt -132.23 161.93 32.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.641 0.258 . . . . 0.0 110.881 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 1.0 OUTLIER -125.49 75.65 69.36 Favored Pre-proline 0 C--O 1.232 0.144 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.189 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.492 ' HD3' ' HG3' ' A' ' 192' ' ' LYS . 26.8 Cg_exo -61.77 -25.46 78.63 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.504 2.136 . . . . 0.0 112.019 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.45 -71.16 0.36 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.882 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 58.5 p -66.9 -28.71 68.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.072 0.463 . . . . 0.0 110.458 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 89.53 6.8 70.08 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.209 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 3.3 tpt180 -123.6 124.08 42.01 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.291 0.546 . . . . 0.0 110.632 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.472 ' HB3' ' NH1' ' A' ' 200' ' ' ARG . 54.8 m -62.31 147.9 46.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.164 0.507 . . . . 0.0 112.047 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.76 HH21 HD12 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -60.62 -35.59 76.54 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.849 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 91.89 7.59 64.26 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 114.973 0.749 . . . . 0.0 114.973 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.622 ' H ' ' HG2' ' A' ' 200' ' ' ARG . 36.6 p90 -141.12 153.91 45.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.23 0.538 . . . . 0.0 111.371 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.515 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -142.51 161.61 27.35 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.606 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.795 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 97.7 m-85 -105.75 124.56 49.77 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.626 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 44.2 tp -111.01 127.37 55.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.321 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' A' ' 187' ' ' ASP . 49.9 m -117.81 142.05 47.73 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.786 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.626 ' CZ ' HD21 ' A' ' 205' ' ' LEU . 93.5 m-85 -120.73 146.16 46.76 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.063 0.458 . . . . 0.0 111.707 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.72 -34.95 79.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.752 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 0.6 OUTLIER -118.54 135.91 23.85 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.934 -179.308 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.998 ' O ' HG12 ' A' ' 213' ' ' VAL . 39.6 Cg_exo -60.53 -26.36 82.66 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.846 2.364 . . . . 0.0 113.286 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 31.4 m -58.08 -38.45 76.4 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.188 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.63 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.9 m -61.41 -37.88 85.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.809 0.338 . . . . 0.0 111.069 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.998 HG12 ' O ' ' A' ' 210' ' ' PRO . 3.0 p -61.43 -35.87 69.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.466 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.431 ' O ' ' HG3' ' A' ' 218' ' ' LYS . 92.6 m-20 -60.79 -43.54 97.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.793 0.33 . . . . 0.0 111.375 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.29 -34.64 77.82 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.788 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 98.4 t -60.58 -43.47 94.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 230' ' ' PRO . 20.9 m -83.51 -37.8 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 214' ' ' ASP . 25.7 mttm -60.51 -32.77 71.77 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.405 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 48.3 m -99.49 144.91 28.04 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -76.84 145.41 38.4 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.788 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 74.2 m-70 -121.87 128.15 51.29 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -176.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 70.9 mt -128.41 89.07 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.436 ' CD1' HG23 ' A' ' 170' ' ' THR . 6.8 tt -67.36 -38.68 85.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -163.8 50.32 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.005 0.431 . . . . 0.0 111.353 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 91.28 2.44 70.82 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.661 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.611 ' HZ2' ' N6 ' ' B' ' 4' ' ' ' A' . 10.7 mmtp -116.58 152.25 34.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 41.6 t -105.12 131.62 53.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.132 0.491 . . . . 0.0 110.932 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.587 HD12 HG23 ' A' ' 163' ' ' ILE . 36.8 pt -123.66 159.82 28.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.113 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -126.93 79.82 72.12 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-O 121.127 0.489 . . . . 0.0 111.125 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.613 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 52.0 Cg_exo -57.93 124.02 15.02 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.649 2.233 . . . . 0.0 111.107 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.546 ' HE2' ' H62' ' B' ' 6' ' ' ' A' . 4.0 ttpm? -134.88 149.08 50.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.639 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -52.5 141.16 20.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.9 0.381 . . . . 0.0 110.769 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.64 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -64.98 148.52 51.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.982 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.651 HD12 ' C6 ' ' B' ' 6' ' ' ' A' . 65.3 mt -109.64 128.58 25.15 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.407 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.89 141.0 57.13 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 121.623 1.548 . . . . 0.0 110.802 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 57.4 mmm-85 -57.37 -39.66 76.51 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.382 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.07 -43.19 99.28 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.018 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.481 ' O ' HG23 ' A' ' 242' ' ' THR . 97.0 mt-10 -68.72 -37.25 79.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.088 0.471 . . . . 0.0 110.552 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -60.1 -40.69 90.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.92 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -60.59 -39.8 89.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.811 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -60.78 -32.7 72.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.411 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.791 HG22 HD12 ' A' ' 270' ' ' ILE . 11.3 p -77.91 161.98 27.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.129 0.49 . . . . 0.0 111.818 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -146.55 115.25 0.78 Allowed Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.86 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.472 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 46.3 tptt -82.44 130.61 35.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.519 0.2 . . . . 0.0 110.918 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.684 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -120.97 159.79 22.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.249 0.547 . . . . 0.0 110.758 179.199 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.55 ' CG ' ' C6 ' ' B' ' 2' ' ' ' A' . 91.9 t80 -103.26 137.52 41.28 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.061 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.837 HG23 HG12 ' A' ' 315' ' ' ILE . 7.2 p -130.46 143.98 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.818 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.626 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -131.92 165.47 23.44 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 94.43 13.42 53.97 Favored Glycine 0 C--N 1.321 -0.264 0 C-N-CA 119.952 -1.118 . . . . 0.0 112.333 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.833 HD11 ' CA ' ' A' ' 287' ' ' GLY . 36.4 pt -117.9 155.69 19.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.771 0.32 . . . . 0.0 110.93 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.666 ' H ' HG12 ' A' ' 254' ' ' VAL . . . 178.2 -134.69 2.46 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.292 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.67 -28.03 63.91 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.973 1.782 . . . . 0.0 111.179 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.03 -31.99 70.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.374 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.772 HG11 ' HB ' ' A' ' 250' ' ' ILE . 7.9 p -122.55 143.23 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.668 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.8 mmm-85 -102.39 163.12 18.29 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.08 -40.39 81.74 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 121.483 1.455 . . . . 0.0 112.003 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -64.37 -46.32 83.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.847 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.432 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 84.1 tt0 -65.59 -39.79 91.97 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-O 120.913 0.387 . . . . 0.0 111.881 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.643 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 26.3 t80 -61.66 -45.91 92.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.011 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -64.53 -42.17 95.91 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.478 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.432 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.7 pt-20 -74.1 -30.78 62.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.187 0.518 . . . . 0.0 110.432 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.709 ' CZ ' HG21 ' A' ' 306' ' ' ILE . 5.7 t80 -60.45 -56.53 20.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.817 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.679 ' C ' HD11 ' A' ' 269' ' ' ILE . 4.6 m-85 -64.64 -23.46 67.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.041 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.686 ' N ' HD11 ' A' ' 269' ' ' ILE . 22.7 t -55.12 -30.55 59.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.941 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -52.72 -35.33 55.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.096 -0.242 . . . . 0.0 111.398 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.665 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 7.4 p90 -117.55 45.27 1.96 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 121.16 0.505 . . . . 0.0 111.593 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.516 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 152.48 146.79 4.43 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.857 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.406 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 46.2 m -59.32 -38.21 79.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.769 0.319 . . . . 0.0 111.358 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.686 HD11 ' N ' ' A' ' 264' ' ' SER . 75.3 mt 68.0 82.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.487 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.791 HD12 HG22 ' A' ' 242' ' ' THR . 71.2 mt -58.35 -40.52 78.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.4 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 290' ' ' THR . 58.0 t0 -149.83 142.48 24.54 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.992 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.44 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -158.08 136.97 11.4 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.623 0.249 . . . . 0.0 111.046 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' GLN . . . . . 0.402 ' HG3' ' SD ' ' A' ' 275' ' ' MET . 9.2 pt20 -148.69 154.04 39.09 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.143 0.497 . . . . 0.0 112.018 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.569 ' O ' ' HB2' ' A' ' 275' ' ' MET . 31.9 tp -66.02 -37.01 84.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.859 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.569 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 92.2 mmm 86.95 126.55 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.471 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.51 ' HB3' ' OG ' ' A' ' 283' ' ' SER . 0.0 OUTLIER -154.66 138.68 16.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 111.134 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -81.7 -132.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -56.6 -35.01 67.76 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 122.115 -0.366 . . . . 0.0 110.547 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 276' ' ' LEU . 93.2 m-20 -135.58 -101.46 0.22 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.583 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 63.7 p -111.04 16.78 20.97 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -42.09 -79.85 0.05 OUTLIER Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.564 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.491 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 90.3 mm-40 -59.29 -33.16 70.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.082 0.468 . . . . 0.0 110.011 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.623 ' O ' ' HG2' ' A' ' 284' ' ' ARG . 58.8 m -64.56 171.84 3.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.529 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 283' ' ' SER . 42.2 ptt85 49.55 46.68 23.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.305 0.574 . . . . 0.0 110.398 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -167.87 -67.78 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.455 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.526 ' CD2' ' HE1' ' A' ' 246' ' ' PHE . 35.7 p90 -139.29 167.0 23.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.731 0.301 . . . . 0.0 111.212 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.833 ' CA ' HD11 ' A' ' 250' ' ' ILE . . . -133.88 164.29 24.43 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.702 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.472 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.2 OUTLIER -118.5 126.8 52.79 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.442 -0.379 . . . . 0.0 110.822 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.684 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 46.6 t -127.53 139.7 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.443 ' OG1' ' CD ' ' A' ' 244' ' ' LYS . 32.5 m -116.66 137.69 52.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.408 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.516 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 40.2 m-85 -117.95 140.49 49.66 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 293' ' ' SER . 54.0 p30 -62.1 -32.14 72.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.285 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.591 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 29.7 t -124.46 139.43 53.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.209 0.528 . . . . 0.0 111.508 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.81 -30.93 71.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.177 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -56.48 -37.66 70.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.202 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -61.31 -36.86 81.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 0.0 110.736 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.576 ' O ' HG12 ' A' ' 300' ' ' VAL . 95.0 t -61.17 -43.11 95.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.029 0.442 . . . . 0.0 110.501 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -61.77 -36.5 81.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.719 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -57.18 -42.8 81.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.826 0.346 . . . . 0.0 111.917 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.665 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 1.2 p -68.94 -33.53 59.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.397 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 76.3 m -57.49 -44.28 84.79 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.998 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.77 -38.82 89.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.232 0.539 . . . . 0.0 109.93 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.6 m-20 -61.12 -33.38 73.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.999 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.628 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 52.4 tptt 67.4 -70.4 0.12 Allowed 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -177.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.628 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.0 m-30 -115.56 148.46 39.54 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.755 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.709 HG21 ' CZ ' ' A' ' 262' ' ' PHE . 5.7 mm -115.18 137.56 48.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -78.19 46.36 0.6 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.03 0.443 . . . . 0.0 110.36 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.546 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 7.3 t80 -56.95 -65.48 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.402 ' HE2' ' C ' ' A' ' 308' ' ' PHE . 4.4 mmpt? -101.28 20.92 14.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.506 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 58.99 35.77 24.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.527 0.68 . . . . 0.0 109.293 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -139.07 0.95 1.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.614 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.441 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 98.4 mttt 64.78 123.25 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.242 0.544 . . . . 0.0 112.004 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.626 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 34.4 pt -116.46 146.46 20.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.281 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -100.71 130.78 46.79 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.785 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 0.837 HG12 HG23 ' A' ' 247' ' ' VAL . 72.3 mt -121.26 131.4 73.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.594 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 246' ' ' PHE . 8.0 tptp -131.71 144.61 51.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.643 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -57.71 144.52 37.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.936 0.398 . . . . 0.0 110.805 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.08 147.17 40.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.375 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -110.09 151.15 42.33 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.055 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.566 ' O ' ' CB ' ' A' ' 321' ' ' ARG . 20.4 Cg_endo -60.27 -24.17 76.49 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.7 2.266 . . . . 0.0 112.402 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.566 ' CB ' ' O ' ' A' ' 320' ' ' PRO . 52.5 mmm-85 111.55 125.5 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.931 0.892 . . . . 0.0 110.514 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.904 -179.845 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.43 -0.644 0 C3'-C2'-O2' 111.241 -0.71 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.55 ' C6 ' ' CG ' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.935 0 C3'-C2'-O2' 111.306 -0.688 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.503 " C3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -1.018 0 C1'-C2'-O2' 108.61 -0.663 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.611 ' N6 ' ' HZ2' ' A' ' 226' ' ' LYS . . . . . . . . 0 O5'--C5' 1.425 -0.948 0 C4'-C3'-C2' 103.906 1.206 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.988 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.89 0 C5'-C4'-O4' 108.032 -0.835 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.988 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.972 0 C3'-C2'-O2' 111.304 -0.688 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.795 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.423 -1.037 0 C3'-C2'-O2' 111.213 -0.72 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.979 0 C3'-C2'-O2' 111.16 -0.738 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.435 ' HG2' ' HG2' ' A' ' 157' ' ' GLU . 70.5 tttt . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.632 0.253 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.435 ' HG2' ' HG2' ' A' ' 156' ' ' LYS . 75.3 mm-40 60.24 -79.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.238 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 156' ' ' LYS . 10.1 t 53.74 18.51 1.55 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.574 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 14.0 m -59.45 -27.73 66.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.79 0.329 . . . . 0.0 111.029 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -56.72 143.79 35.16 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.236 0.541 . . . . 0.0 111.452 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.823 ' SD ' HG13 ' A' ' 213' ' ' VAL . 84.0 mmm -116.21 149.64 38.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.792 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.762 ' HB3' ' HG2' ' A' ' 231' ' ' LYS . 4.2 t80 -104.1 128.87 51.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.543 HG22 HD21 ' A' ' 166' ' ' LEU . 15.9 mm -113.88 127.09 71.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.674 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -131.95 166.8 23.04 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.537 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.459 ' C ' HG22 ' A' ' 228' ' ' ILE . . . 76.89 33.54 45.79 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.353 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.614 ' O ' ' C8 ' ' B' ' 4' ' ' ' A' . 61.4 mt -80.74 146.55 30.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 169' ' ' ASP . 43.8 t30 -79.85 59.48 3.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.712 0.291 . . . . 0.0 111.421 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.538 ' CG ' ' C8 ' ' B' ' 4' ' ' ' A' . 12.2 m0 28.92 37.83 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.502 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 167' ' ' ASN . 54.8 t0 -163.14 20.08 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.799 HG22 HD11 ' A' ' 190' ' ' ILE . 59.9 m -76.26 136.55 39.66 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.861 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 173' ' ' ASP . 30.8 m -114.46 144.47 43.28 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.23 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.553 ' N ' HD12 ' A' ' 190' ' ' ILE . 54.5 mp0 -56.43 -36.55 69.11 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.404 -0.519 . . . . 0.0 109.878 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.408 ' H ' HG22 ' A' ' 171' ' ' THR . 89.4 m-20 -65.65 -48.62 71.52 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.795 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -66.37 -41.7 89.06 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.584 0.706 . . . . 0.0 109.976 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.744 HD23 ' CD1' ' A' ' 188' ' ' LEU . 63.9 tp -64.19 -41.62 97.01 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.173 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -62.87 -45.23 93.51 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.267 0.556 . . . . 0.0 110.167 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -66.85 -38.13 85.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.871 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.566 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 52.4 t80 -57.9 -46.05 85.52 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.223 0.535 . . . . 0.0 110.87 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.462 ' CD2' ' HD1' ' A' ' 178' ' ' TYR . 96.1 m-85 -93.66 1.26 56.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.647 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -59.28 -28.43 64.38 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.23 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.443 ' CD ' ' H ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -58.51 -39.14 79.24 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.759 0.79 . . . . 0.0 110.503 -179.11 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -67.53 -31.81 72.16 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.045 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 161.72 -133.27 3.09 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.283 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.0 m -119.28 140.16 50.74 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.955 HG21 HD23 ' A' ' 188' ' ' LEU . 2.8 m -102.36 126.68 56.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.405 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.749 HG23 ' N ' ' A' ' 208' ' ' GLU . 51.8 p -69.92 -37.91 76.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.291 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 186' ' ' THR . 90.9 m-20 -143.74 155.68 44.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.195 0.521 . . . . 0.0 112.029 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.955 HD23 HG21 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -133.79 126.41 30.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.567 179.335 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 15.2 tptt -134.6 119.67 18.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.345 0.593 . . . . 0.0 112.225 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.799 HD11 HG22 ' A' ' 170' ' ' THR . 0.8 OUTLIER -125.49 129.61 72.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.022 176.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.667 ' CE ' ' HA2' ' A' ' 203' ' ' GLY . 3.1 mtm -96.23 134.56 39.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.191 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -128.48 155.56 44.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.852 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.524 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 6.0 m-20 -123.21 73.15 48.35 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.509 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.72 -28.75 88.05 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.718 2.279 . . . . 0.0 113.131 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -64.86 -57.86 7.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 0.0 110.95 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 55.9 p -78.74 -15.02 58.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.224 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 80.16 24.28 59.72 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.573 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 1.9 tpt180 -124.22 175.61 6.93 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 120.687 0.279 . . . . 0.0 110.509 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.423 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 32.6 t -126.4 147.4 49.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.626 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 36.6 mmt180 -54.48 -35.07 62.69 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.23 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.609 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 90.2 3.34 72.83 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.532 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.626 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 26.3 p90 -139.8 157.5 45.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.777 0.323 . . . . 0.0 110.653 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.667 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -147.0 160.07 28.17 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.935 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.811 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 98.1 m-85 -105.6 124.27 49.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.361 0.6 . . . . 0.0 109.971 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.663 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 60.2 tp -111.51 125.73 54.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.367 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 23.9 t -118.86 136.91 53.78 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.684 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.893 ' CE1' HG12 ' A' ' 185' ' ' VAL . 68.3 m-85 -119.84 143.8 47.7 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.668 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.749 ' N ' HG23 ' A' ' 186' ' ' THR . 84.5 tt0 -63.95 -34.85 78.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.941 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.81 115.54 55.25 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.764 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.25 -21.1 34.56 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.591 2.194 . . . . 0.0 112.87 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.9 m -56.73 -36.3 69.56 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.946 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.4 m -58.39 -35.1 71.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.935 0.398 . . . . 0.0 110.296 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.823 HG13 ' SD ' ' A' ' 161' ' ' MET . 75.1 t -60.39 -42.28 90.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.95 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.41 ' O ' HG22 ' A' ' 217' ' ' VAL . 22.0 t70 -58.98 -41.98 88.86 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.899 0.381 . . . . 0.0 110.837 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.415 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 20.3 pt-20 -76.89 -30.62 56.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.752 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.946 HG23 ' O ' ' A' ' 212' ' ' SER . 77.6 t -60.22 -41.32 86.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.418 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 214' ' ' ASP . 21.0 m -71.53 -31.99 44.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -59.93 -38.8 83.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.723 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 35.0 m -85.13 143.16 29.0 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 63.3 tt0 -66.0 -40.96 91.6 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.935 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.86 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 85.2 m-70 78.84 97.81 0.06 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 72.2 mt -117.07 107.66 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.443 ' HG ' ' CD2' ' A' ' 178' ' ' TYR . 3.6 tt -97.66 -74.13 0.59 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.401 ' OD1' HD23 ' A' ' 223' ' ' LEU . 92.6 m-20 -90.78 14.86 12.4 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 101.99 -6.78 54.38 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.226 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.406 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -99.69 -172.59 2.27 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.632 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 15.0 p -120.03 135.91 58.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.241 0.543 . . . . 0.0 111.159 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.493 HD11 ' HB3' ' A' ' 221' ' ' HIS . 36.0 pt -124.98 156.66 33.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.199 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.468 ' O ' ' O4 ' ' B' ' 5' ' ' ' U' . 25.9 t0 -127.84 78.51 75.0 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.207 0.527 . . . . 0.0 111.289 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.581 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 74.4 Cg_exo -55.39 131.21 44.89 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.844 2.363 . . . . 0.0 111.299 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.762 ' HG2' ' HB3' ' A' ' 162' ' ' PHE . 0.5 OUTLIER -136.78 170.3 16.31 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -70.82 140.09 51.11 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.125 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.58 143.8 56.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.763 0.316 . . . . 0.0 111.184 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.52 HD12 ' C6 ' ' B' ' 6' ' ' ' A' . 28.6 mt -111.44 121.91 38.94 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.015 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.51 144.14 52.76 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.836 1.691 . . . . 0.0 110.986 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -56.81 -39.11 73.56 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.486 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -61.3 -46.53 89.91 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.115 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 242' ' ' THR . 84.6 tt0 -68.85 -37.22 78.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.358 0.599 . . . . 0.0 109.737 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -58.5 -43.46 89.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.742 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -65.14 -40.26 94.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.408 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -60.11 -37.77 81.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.218 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 238' ' ' GLU . 19.9 p -81.39 161.71 23.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.167 0.508 . . . . 0.0 111.987 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.56 163.72 25.18 Favored Glycine 0 C--N 1.332 0.338 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.424 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.651 ' C ' ' HB2' ' A' ' 318' ' ' ALA . 11.8 tttm -138.07 137.76 38.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.141 0.471 . . . . 0.0 110.719 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.701 HD13 ' O ' ' A' ' 245' ' ' ILE . 0.0 OUTLIER -123.06 164.21 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.688 0.756 . . . . 0.0 112.538 -179.245 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.559 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 86.0 t80 -105.1 138.62 41.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.565 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.638 HG12 ' O ' ' A' ' 287' ' ' GLY . 7.4 p -127.45 133.75 67.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -105.48 -4.04 40.51 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.586 -0.816 . . . . 0.0 114.178 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 313' ' ' ILE . . . -115.82 115.72 3.46 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.72 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.606 ' O ' HG21 ' A' ' 254' ' ' VAL . 24.5 mm -94.22 -78.42 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.475 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 119.21 162.29 11.96 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.075 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.69 128.25 22.85 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.143 1.896 . . . . 0.0 112.719 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 51.47 42.18 29.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.65 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.722 ' O ' ' HB3' ' A' ' 258' ' ' GLU . 6.4 t -63.91 -44.26 97.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.404 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.4 OUTLIER 61.51 134.86 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.43 -31.01 66.46 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 121.946 1.764 . . . . 0.0 112.706 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -63.99 -48.63 75.63 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.722 ' HB3' ' O ' ' A' ' 254' ' ' VAL . 42.8 tp10 -64.6 -38.15 90.0 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.044 0.45 . . . . 0.0 111.054 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.616 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 44.8 t80 -59.49 -44.19 93.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.165 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.464 ' O ' HD12 ' A' ' 269' ' ' ILE . 97.2 mt-10 -65.34 -40.58 93.84 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.557 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 264' ' ' SER . 20.6 pt-20 -77.72 -30.63 51.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.21 0.529 . . . . 0.0 110.466 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.711 ' CZ ' HG21 ' A' ' 306' ' ' ILE . 5.5 t80 -61.9 -54.87 35.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.436 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.85 ' CD2' HG21 ' A' ' 289' ' ' VAL . 4.3 m-85 -65.17 -23.82 67.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.553 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.704 ' N ' HD11 ' A' ' 269' ' ' ILE . 23.5 t -54.82 -25.47 28.66 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -46.45 -37.34 7.62 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.41 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.713 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 23.2 p90 -129.83 54.45 1.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.052 0.453 . . . . 0.0 111.472 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 264' ' ' SER . . . 149.11 146.52 4.34 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.803 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.449 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 53.1 m -59.26 -37.51 77.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.758 0.313 . . . . 0.0 111.354 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.704 HD11 ' N ' ' A' ' 264' ' ' SER . 74.8 mt 71.55 85.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.848 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.594 HD11 ' HB3' ' A' ' 292' ' ' ASP . 34.8 mm -59.36 -35.51 58.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.198 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.58 ' O ' ' HB3' ' A' ' 272' ' ' ALA . 61.6 t0 -137.97 -104.76 0.18 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.079 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.608 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . 80.36 113.93 0.06 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.934 0.397 . . . . 0.0 112.016 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -141.99 155.83 45.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.317 0.579 . . . . 0.0 111.382 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.541 ' O ' ' HB2' ' A' ' 275' ' ' MET . 22.9 tp -63.63 -36.49 83.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.421 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.569 ' HG2' ' HB2' ' A' ' 288' ' ' PHE . 95.8 mmm 76.96 123.37 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.674 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.504 ' HG ' ' HB3' ' A' ' 283' ' ' SER . 5.1 mp -128.35 125.81 39.45 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.497 ' H ' ' H ' ' A' ' 282' ' ' GLN . 55.9 t0 -62.67 -40.75 98.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.594 0.712 . . . . 0.0 109.697 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -162.12 -73.7 0.05 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.781 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.408 ' O ' HD23 ' A' ' 276' ' ' LEU . 60.8 t0 -94.56 -75.75 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.484 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 73.3 p -129.33 13.57 6.08 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.357 -0.383 . . . . 0.0 112.015 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -44.99 -91.01 0.01 OUTLIER Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.037 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.497 ' H ' ' H ' ' A' ' 277' ' ' ASP . 98.7 mt-30 -60.26 -25.65 65.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.167 -0.517 . . . . 0.0 111.599 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.51 ' O ' HD21 ' A' ' 274' ' ' LEU . 63.5 p -51.89 -27.32 12.42 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.73 0.3 . . . . 0.0 110.938 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -122.5 139.07 54.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.911 0.386 . . . . 0.0 110.557 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.63 -53.52 0.58 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.25 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.571 ' C ' HD11 ' A' ' 250' ' ' ILE . 33.3 p90 -142.56 166.27 25.13 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 117.425 0.612 . . . . 0.0 111.708 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.638 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -134.42 157.36 22.89 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.259 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.569 ' HB2' ' HG2' ' A' ' 275' ' ' MET . 0.2 OUTLIER -118.16 125.24 49.82 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.868 -0.195 . . . . 0.0 111.171 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.85 HG21 ' CD2' ' A' ' 263' ' ' PHE . 53.3 t -128.4 137.57 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.036 0.445 . . . . 0.0 112.151 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 54.8 m -117.02 136.69 52.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.311 178.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.47 ' CD1' ' HA3' ' A' ' 267' ' ' GLY . 47.5 m-85 -118.03 142.6 47.21 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 293' ' ' SER . 54.7 p30 -62.13 -31.58 72.07 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.108 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.613 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 27.6 t -124.67 139.54 53.77 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.161 0.505 . . . . 0.0 111.963 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.91 -31.58 72.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.946 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -55.46 -36.54 66.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.966 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -60.64 -34.86 74.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.649 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.589 ' O ' HG12 ' A' ' 300' ' ' VAL . 84.6 t -59.55 -43.73 91.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.148 0.499 . . . . 0.0 110.309 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -62.43 -36.36 82.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.693 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 89.7 mtt-85 -57.12 -43.91 82.8 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.002 0.429 . . . . 0.0 111.976 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.713 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 1.3 p -68.77 -32.28 54.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.356 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 76.2 m -57.13 -43.74 82.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.207 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -60.45 -41.27 93.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.218 0.532 . . . . 0.0 110.186 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.416 ' O ' ' N ' ' A' ' 305' ' ' PHE . 88.3 m-20 -61.81 -33.53 74.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.399 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.639 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 7.9 tptm 67.05 -73.5 0.08 Allowed 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -178.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.639 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.5 m-30 -115.82 147.63 40.79 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.43 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.711 HG21 ' CZ ' ' A' ' 262' ' ' PHE . 37.6 mt -119.92 129.51 75.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -59.48 -35.43 74.1 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.438 0.637 . . . . 0.0 111.005 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.529 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 1.3 t80 49.88 -124.86 2.11 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.299 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.526 ' HE3' ' CE1' ' A' ' 308' ' ' PHE . 2.0 mmpt? -59.57 -37.51 78.67 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.931 0.396 . . . . 0.0 110.997 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 309' ' ' LYS . 23.3 t70 170.35 -0.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.26 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -122.12 152.39 39.94 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.785 0.326 . . . . 0.0 110.2 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 79.7 mttt -77.78 129.38 35.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.078 0.466 . . . . 0.0 111.222 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 305' ' ' PHE . 26.8 pt -115.3 143.33 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.375 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' GLU . . . . . 0.571 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 85.6 mt-10 -100.91 133.25 45.67 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.471 -0.492 . . . . 0.0 109.897 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 0.631 HG12 HG23 ' A' ' 247' ' ' VAL . 82.4 mt -122.21 126.07 73.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.144 0.497 . . . . 0.0 111.898 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 322' ' ' HIS . 52.1 mttp -133.05 -170.45 2.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.456 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.545 ' O ' ' HB3' ' A' ' 246' ' ' PHE . 74.7 mtp180 -57.34 146.8 27.74 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.728 0.299 . . . . 0.0 110.623 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.876 ' O ' ' H2 ' ' B' ' 2' ' ' ' A' . . . -60.86 -23.16 64.93 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' GLU . . . . . 0.491 ' CB ' ' CD ' ' A' ' 320' ' ' PRO . 24.6 tt0 -111.61 -72.99 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.511 ' HG2' ' HB2' ' A' ' 317' ' ' ARG . 9.9 Cg_endo -54.16 138.15 71.19 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 121.769 1.646 . . . . 0.0 112.377 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.491 ' HA ' ' N6 ' ' B' ' 2' ' ' ' A' . 27.0 mmt85 -59.44 -35.27 73.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.121 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' HIS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 316' ' ' LYS . 77.5 m80 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.18 -0.914 . . . . 0.0 111.078 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.43 -0.635 0 C3'-C2'-O2' 111.258 -0.704 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.876 ' H2 ' ' O ' ' A' ' 318' ' ' ALA . . . . . . . . 0 O5'--C5' 1.425 -0.949 0 C1'-C2'-O2' 108.747 -0.618 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.641 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -1.009 0 C3'-C2'-O2' 111.305 -0.688 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.641 " H4'" " H3'" ' B' ' 3' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.897 0 C4'-C3'-C2' 103.887 1.187 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.674 ' C6 ' ' HA3' ' A' ' 164' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.843 0 C5'-C4'-O4' 108.171 -0.735 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.616 ' N9 ' ' CE2' ' A' ' 162' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.926 0 C4'-C3'-C2' 103.389 0.689 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.811 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.972 0 C4'-C3'-C2' 103.541 0.841 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . 0.661 ' N3 ' " H2'" ' B' ' 8' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.896 0 C3'-C2'-O2' 111.175 -0.733 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 79.5 tttt . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.864 0.364 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.72 -33.5 68.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.008 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.4 m -57.47 -34.85 69.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.127 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.6 p -55.0 -21.73 12.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.273 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.57 ' HE2' ' HB3' ' A' ' 204' ' ' PHE . 15.4 tptm -56.27 140.06 46.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.453 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.797 ' SD ' HG13 ' A' ' 213' ' ' VAL . 86.1 mmm -118.15 150.0 40.11 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.075 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.613 ' CE2' ' N9 ' ' B' ' 6' ' ' ' A' . 4.3 t80 -106.79 130.17 54.54 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.683 ' CG2' HD21 ' A' ' 166' ' ' LEU . 17.2 mm -115.41 121.81 67.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.024 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.685 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -126.44 164.8 19.89 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.441 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.725 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 74.79 27.13 65.5 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.547 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.683 HD21 ' CG2' ' A' ' 163' ' ' ILE . 71.0 mt -87.63 142.21 28.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.901 0.381 . . . . 0.0 111.349 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.402 ' OD1' ' N6 ' ' B' ' 4' ' ' ' A' . 9.5 t30 -67.23 134.16 51.12 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.569 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 4.7 m-90 -52.15 -36.77 52.4 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.999 -0.281 . . . . 0.0 111.404 -178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -60.23 -31.47 70.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.689 0.281 . . . . 0.0 111.359 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.466 HG23 ' HB3' ' A' ' 174' ' ' ASN . 79.6 m -58.3 140.18 53.82 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.335 0.588 . . . . 0.0 111.971 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.42 ' C ' HD12 ' A' ' 190' ' ' ILE . 1.5 p -118.36 167.76 11.26 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.495 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.822 ' N ' HD12 ' A' ' 190' ' ' ILE . 96.1 mt-10 -58.91 -33.26 70.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -60.43 -41.23 93.57 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.466 ' HB3' HG23 ' A' ' 170' ' ' THR . 0.4 OUTLIER -61.63 -41.71 97.87 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.538 178.525 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.717 HD12 HD11 ' A' ' 190' ' ' ILE . 3.9 mt -65.56 -42.94 91.25 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.703 178.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.938 ' HG3' HG11 ' A' ' 185' ' ' VAL . 70.7 ttp85 -60.9 -44.51 97.03 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.735 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -67.86 -39.16 83.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.573 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 67.0 t80 -70.89 -62.1 1.52 Allowed 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.308 0.575 . . . . 0.0 111.41 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.538 ' CE2' HD23 ' A' ' 175' ' ' LEU . 67.4 m-85 -70.52 -24.21 62.78 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.516 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 183' ' ' GLY . . . -51.29 -27.03 14.89 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.672 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.5 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -56.2 -43.96 79.02 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.405 0.682 . . . . 0.0 110.99 178.866 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -71.51 -34.4 70.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.727 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 180' ' ' GLY . . . -164.62 -173.8 33.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.147 -1.025 . . . . 0.0 113.258 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.956 ' O ' HG12 ' A' ' 185' ' ' VAL . 51.0 m -59.22 -35.05 72.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.425 0.155 . . . . 0.0 110.782 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.956 HG12 ' O ' ' A' ' 184' ' ' THR . 1.0 OUTLIER 78.67 69.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 CA-C-O 122.631 1.205 . . . . 0.0 108.749 -178.231 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.67 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 5.7 m -52.34 -42.55 63.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.08 -1.418 . . . . 0.0 112.801 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.418 ' HB3' ' HB3' ' A' ' 206' ' ' SER . 54.5 t0 -148.35 141.49 25.0 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.71 HD11 ' HB3' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -121.22 131.21 54.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.562 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 8.5 tptp -136.23 121.05 18.57 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.822 HD12 ' N ' ' A' ' 172' ' ' GLU . 4.3 mt -127.05 132.45 69.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.663 176.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.574 ' HB2' ' CG ' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -92.15 125.11 36.7 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.969 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 199' ' ' SER . 4.1 mtmp? -126.7 155.04 43.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.895 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 9.1 t70 -97.22 108.8 46.48 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.693 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.69 -26.18 81.35 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.549 2.166 . . . . 0.0 112.958 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.412 ' HB3' ' OD1' ' A' ' 193' ' ' ASP . . . -74.68 -86.64 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 51.8 p -71.66 -21.52 61.8 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 193' ' ' ASP . . . 93.12 4.88 64.37 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.119 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.479 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 11.0 tpt180 -74.93 143.05 43.9 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.481 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 23.6 t -103.32 148.77 25.45 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.746 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.645 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 15.0 mmm180 -53.18 -30.6 38.26 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.761 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 95.93 -0.87 62.82 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.86 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.686 ' CD1' " H4'" ' B' ' 5' ' ' ' U' . 25.4 p90 -136.62 156.4 48.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.875 0.369 . . . . 0.0 110.299 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.563 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -142.87 162.5 27.44 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.982 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.742 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 97.8 m-85 -105.06 125.3 50.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.363 0.602 . . . . 0.0 109.521 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.658 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 46.8 tp -106.7 130.3 54.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.041 -177.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' A' ' 187' ' ' ASP . 28.0 t -124.3 135.13 53.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.883 0.373 . . . . 0.0 111.979 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.658 ' CZ ' HD21 ' A' ' 205' ' ' LEU . 95.4 m-85 -119.48 140.05 51.09 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.782 178.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.67 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.3 tt0 -60.58 -34.47 74.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.026 0.441 . . . . 0.0 110.087 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.5 119.48 49.3 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.499 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.59 -20.55 27.66 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.516 2.144 . . . . 0.0 112.801 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 85.1 p -59.97 -31.07 69.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.667 0.27 . . . . 0.0 111.234 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.932 ' O ' HG23 ' A' ' 216' ' ' VAL . 23.0 m -59.44 -36.06 75.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.603 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.797 HG13 ' SD ' ' A' ' 161' ' ' MET . 70.5 t -61.61 -43.52 97.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.305 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -59.81 -42.03 92.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.01 0.433 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.02 -31.9 61.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.77 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 212' ' ' SER . 66.0 t -60.76 -42.27 91.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 120.662 0.267 . . . . 0.0 110.983 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 24.3 m -73.15 -27.55 24.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -58.72 -35.5 72.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.659 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.694 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 57.4 m -100.13 141.52 32.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.852 0.358 . . . . 0.0 111.863 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 59.7 tp60 -66.09 -40.64 90.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.737 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.79 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 64.8 m-70 79.31 116.49 0.06 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 24.6 mm -116.4 107.4 22.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.2 tt -121.32 122.96 41.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.789 0.328 . . . . 0.0 110.177 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 51.73 40.17 26.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.148 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 73.64 20.32 79.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.342 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -115.21 136.23 53.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.329 0.565 . . . . 0.0 111.506 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.756 ' O ' ' O ' ' A' ' 228' ' ' ILE . 9.5 p -62.04 -35.89 71.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.096 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.756 ' O ' ' O ' ' A' ' 227' ' ' VAL . 9.0 pt 30.9 128.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.513 0.725 . . . . 0.0 112.68 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -123.29 84.56 51.94 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 121.056 0.455 . . . . 0.0 111.315 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.498 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 50.7 Cg_exo -56.05 135.34 69.31 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.912 2.408 . . . . 0.0 111.986 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.403 ' HZ3' ' H3 ' ' B' ' 5' ' ' ' U' . 9.3 ttpt -136.88 157.3 47.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.909 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -55.93 133.45 51.53 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.747 0.308 . . . . 0.0 110.852 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 160' ' ' LYS . . . -72.91 148.05 44.71 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.514 ' CD1' ' C6 ' ' B' ' 6' ' ' ' A' . 0.7 OUTLIER -122.13 125.58 26.56 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.674 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.444 ' HG2' ' CG ' ' A' ' 238' ' ' GLU . 9.4 Cg_endo -51.84 145.62 31.2 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 121.791 1.66 . . . . 0.0 111.14 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 236' ' ' ARG . 6.2 tmm_? -54.66 -39.25 67.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.78 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 55.3 p30 -61.42 -38.51 87.39 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.702 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.586 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 97.9 mt-10 -68.17 -34.13 75.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.995 0.426 . . . . 0.0 110.381 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -59.61 -38.28 80.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.281 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.93 -40.47 93.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.627 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -61.69 -34.94 76.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.162 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 22.4 p -83.41 162.23 21.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.572 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -146.47 112.71 0.63 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.847 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 17.5 ttpp -88.72 134.27 33.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.893 0.378 . . . . 0.0 111.194 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.686 HG21 HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -117.46 164.02 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.537 0.684 . . . . 0.0 111.43 -179.247 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.581 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 93.5 t80 -101.85 136.34 41.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.518 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.821 HG11 ' CE1' ' A' ' 259' ' ' PHE . 12.5 p -131.57 146.37 33.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.314 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.646 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -131.66 169.43 21.94 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 89.92 17.82 52.77 Favored Glycine 0 N--CA 1.454 -0.147 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.727 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.91 HG23 HG21 ' A' ' 254' ' ' VAL . 23.3 mm -54.96 -43.84 70.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.841 0.353 . . . . 0.0 110.792 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 50.51 174.12 0.01 OUTLIER Glycine 0 CA--C 1.521 0.451 0 CA-C-N 116.074 -0.512 . . . . 0.0 114.086 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.09 154.68 65.83 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.62 2.88 . . . . 0.0 113.616 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 57.62 41.67 25.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.919 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.91 HG21 HG23 ' A' ' 250' ' ' ILE . 2.4 p -85.79 -40.69 14.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.542 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.6 OUTLIER 60.05 118.97 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.595 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.92 -33.78 63.48 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 121.743 1.629 . . . . 0.0 112.426 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -61.51 -41.74 97.77 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.998 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.656 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 98.3 mt-10 -66.16 -36.15 82.36 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.627 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.821 ' CE1' HG11 ' A' ' 247' ' ' VAL . 16.5 t80 -63.86 -50.11 70.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.782 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.725 ' HG2' ' HB3' ' A' ' 272' ' ' ALA . 97.2 mt-10 -64.67 -37.03 86.18 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.605 ' HB3' ' HA ' ' A' ' 258' ' ' GLU . 78.5 tt0 -63.03 -37.9 89.04 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.646 -1.616 . . . . 0.0 111.883 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.815 ' CE2' HD11 ' A' ' 313' ' ' ILE . 86.4 t80 -67.78 -55.08 14.41 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.683 ' CE2' HD11 ' A' ' 245' ' ' ILE . 10.0 m-85 -66.45 -25.29 66.66 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.727 ' N ' HD11 ' A' ' 269' ' ' ILE . 35.1 t -55.29 -31.31 61.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.689 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -56.15 -36.48 68.33 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.291 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.664 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 9.0 p90 -117.57 51.79 1.02 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.44 0.638 . . . . 0.0 111.16 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.512 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 148.3 148.03 4.66 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.508 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.444 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 11.8 t -64.06 -35.8 81.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 110.928 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.727 HD11 ' N ' ' A' ' 264' ' ' SER . 79.3 mt 71.66 83.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.223 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.507 HG12 ' CA ' ' A' ' 292' ' ' ASP . 36.0 mm -58.98 -38.58 74.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.984 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -149.46 150.91 33.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.185 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.725 ' HB3' ' HG2' ' A' ' 260' ' ' GLU . . . -170.59 122.31 0.62 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.577 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -142.85 152.3 42.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.22 0.533 . . . . 0.0 111.861 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.81 HD11 HG21 ' A' ' 250' ' ' ILE . 29.2 tp -64.23 -37.82 88.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.901 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.524 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 91.8 mmm 101.59 102.87 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.441 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.412 ' CD2' ' HB3' ' A' ' 283' ' ' SER . 23.9 mt -108.05 139.02 43.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.521 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.605 ' HB3' ' HA3' ' A' ' 281' ' ' GLY . 59.9 t0 -145.39 93.31 2.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.092 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.855 ' O ' HG22 ' A' ' 280' ' ' THR . 40.8 mtpt 65.38 39.18 5.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.873 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.468 ' O ' ' HB ' ' A' ' 280' ' ' THR . 57.4 t0 46.31 41.75 9.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.782 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.855 HG22 ' O ' ' A' ' 278' ' ' LYS . 2.0 t 171.2 50.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.911 0.386 . . . . 0.0 110.709 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' GLY . . . . . 0.605 ' HA3' ' HB3' ' A' ' 277' ' ' ASP . . . -131.49 -112.11 1.42 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.448 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 1.023 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 78.8 mm-40 -57.9 -28.36 64.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.415 -0.392 . . . . 0.0 110.431 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.412 ' HB3' ' CD2' ' A' ' 276' ' ' LEU . 86.3 p -57.69 -22.64 47.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.215 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -52.73 -36.63 57.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.92 0.39 . . . . 0.0 110.749 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 286' ' ' PHE . . . -166.61 -176.62 37.86 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.091 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.558 ' O ' ' O ' ' A' ' 285' ' ' GLY . 3.1 p90 48.54 155.13 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.175 0.512 . . . . 0.0 112.075 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.69 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -139.25 164.41 25.9 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.153 -1.022 . . . . 0.0 113.783 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.452 ' CE2' ' NZ ' ' A' ' 244' ' ' LYS . 0.4 OUTLIER -119.73 125.6 49.04 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.669 0.388 . . . . 0.0 110.949 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.684 HG23 ' CZ ' ' A' ' 259' ' ' PHE . 48.9 t -127.45 137.07 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.003 0.43 . . . . 0.0 111.748 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 44.4 m -113.55 135.8 53.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.605 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.584 ' OH ' ' HB3' ' A' ' 263' ' ' PHE . 34.5 m-85 -117.15 137.21 52.47 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.507 ' CA ' HG12 ' A' ' 270' ' ' ILE . 50.5 t0 -58.84 -35.65 73.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.558 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 30.5 t -119.99 140.18 51.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.28 0.562 . . . . 0.0 111.887 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.962 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -63.66 -30.64 71.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.526 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -55.74 -35.12 65.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.029 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.26 90.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.539 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.962 HG12 ' O ' ' A' ' 294' ' ' ALA . 9.5 p -61.16 -37.14 76.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.001 0.429 . . . . 0.0 110.735 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.94 -38.18 90.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.527 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -59.16 -43.37 92.08 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.906 0.384 . . . . 0.0 111.943 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.752 HG23 HD11 ' A' ' 306' ' ' ILE . 0.9 OUTLIER -72.58 -36.68 54.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.638 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 74.5 m -59.23 -42.93 92.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.833 0.349 . . . . 0.0 110.447 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -61.78 -34.17 75.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.215 0.531 . . . . 0.0 110.013 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.65 ' O ' ' N ' ' A' ' 305' ' ' PHE . 80.6 m-20 -87.04 4.9 40.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.213 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.656 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 19.9 tptm 41.85 -80.85 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.605 0.24 . . . . 0.0 110.4 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.656 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 2.2 m-30 -107.58 141.26 39.33 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.752 HD11 HG23 ' A' ' 300' ' ' VAL . 1.0 OUTLIER -116.58 134.47 59.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.538 ' O ' ' HE1' ' A' ' 262' ' ' PHE . 89.0 m-20 -70.67 124.59 24.63 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.556 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 2.0 t80 -112.0 -109.89 0.35 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.501 ' HE2' ' OE1' ' A' ' 258' ' ' GLU . 1.2 mmmp? -60.15 -37.42 80.07 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.743 0.306 . . . . 0.0 111.386 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.406 ' CG ' ' O ' ' A' ' 309' ' ' LYS . 32.5 m-20 -177.96 -27.39 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.219 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -113.13 160.81 17.82 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.951 0.405 . . . . 0.0 110.841 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 43.9 mttt -71.67 143.63 49.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.351 0.596 . . . . 0.0 112.114 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.815 HD11 ' CE2' ' A' ' 262' ' ' PHE . 31.6 pt -118.93 147.87 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' GLU . . . . . 0.532 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 87.4 mt-10 -101.05 129.73 46.95 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.515 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 0.763 HG12 HG23 ' A' ' 247' ' ' VAL . 74.7 mt -123.31 127.61 74.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.207 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.486 ' HG2' ' HD2' ' A' ' 246' ' ' PHE . 3.4 ptpt -135.2 163.62 29.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.601 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 45.8 ptt85 -59.03 148.84 29.37 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.45 133.19 55.56 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.79 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -137.62 82.93 26.17 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.964 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.43 129.15 32.3 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 121.571 1.514 . . . . 0.0 111.474 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.412 ' HG3' " O2'" ' B' ' 2' ' ' ' A' . 25.6 mmt85 -60.88 -34.9 75.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.209 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.873 -179.891 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.449 ' N3 ' ' HA3' ' A' ' 248' ' ' GLY . . . . . . . . 0 O5'--C5' 1.428 -0.726 0 C3'-C2'-O2' 111.357 -0.67 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 1.023 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.951 0 C3'-C2'-O2' 111.199 -0.724 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.543 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.956 0 C3'-C2'-C1' 100.735 -0.85 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.761 " O2'" ' HA3' ' A' ' 201' ' ' GLY . . . . . . . . 0 O5'--C5' 1.425 -0.96 0 C4'-C3'-C2' 104.091 1.391 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.928 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.796 0 C4'-C3'-C2' 103.742 1.042 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.928 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.038 0 C3'-C2'-O2' 111.239 -0.711 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.742 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -1.011 0 C1'-C2'-O2' 108.514 -0.695 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . 0.439 ' N3 ' " C2'" ' B' ' 8' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -1.016 0 C3'-C2'-O2' 111.272 -0.699 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 60.7 mttp . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.831 0.348 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -58.02 142.97 44.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.882 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.1 m -120.86 147.72 45.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.125 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.718 ' HA ' HG21 ' A' ' 213' ' ' VAL . 7.8 p -83.99 6.28 22.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.385 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.586 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 5.3 tptm -69.56 131.6 44.94 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.825 ' SD ' HG13 ' A' ' 213' ' ' VAL . 93.3 mmm -120.67 143.57 48.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.877 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.607 ' CD2' ' C4 ' ' B' ' 6' ' ' ' A' . 2.7 t80 -108.29 125.74 52.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.921 ' HB ' HD21 ' A' ' 166' ' ' LEU . 0.3 OUTLIER -120.88 127.86 75.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.615 -179.446 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.597 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -121.49 153.34 16.7 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.318 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.464 ' C ' HG22 ' A' ' 228' ' ' ILE . . . 73.44 29.08 64.49 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.151 -1.023 . . . . 0.0 110.994 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.921 HD21 ' HB ' ' A' ' 163' ' ' ILE . 69.1 mt -59.06 -33.3 70.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.728 ' O ' ' N ' ' A' ' 169' ' ' ASP . 21.1 t30 107.63 37.19 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.977 0.511 . . . . 0.0 110.669 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.612 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 5.1 m0 45.99 -59.7 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.728 ' N ' ' O ' ' A' ' 167' ' ' ASN . 89.4 m-20 -83.4 19.73 1.48 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.627 ' OG1' ' HB3' ' A' ' 166' ' ' LEU . 57.6 m -51.88 -36.08 47.35 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.502 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.0 OUTLIER 58.26 139.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.157 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.661 ' O ' ' HD3' ' A' ' 176' ' ' ARG . 58.1 mp0 -60.39 -36.25 77.65 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -58.8 -40.9 85.42 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.596 ' HB2' ' O ' ' A' ' 170' ' ' THR . 9.4 m120 -61.69 -36.63 81.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.695 HD23 ' CE2' ' A' ' 179' ' ' PHE . 7.0 mt -55.74 -51.31 67.79 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.661 ' HD3' ' O ' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -67.93 -30.36 69.66 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.298 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -58.42 -39.35 79.52 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.37 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.64 ' OH ' ' CG ' ' A' ' 221' ' ' HIS . 0.0 OUTLIER -96.04 -55.52 2.95 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.25 179.199 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.695 ' CE2' HD23 ' A' ' 175' ' ' LEU . 72.5 m-85 -60.14 -27.15 66.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.397 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.42 -23.58 9.35 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.199 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.827 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -54.05 -40.46 67.13 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.992 0.425 . . . . 0.0 110.714 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.827 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 53.8 m-85 -69.85 -32.21 70.48 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.275 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 164.81 -130.19 2.13 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.262 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 49.1 m -120.96 140.28 52.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.659 HG21 HD23 ' A' ' 188' ' ' LEU . 0.2 OUTLIER -92.88 120.65 42.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.257 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.5 t -71.61 -45.53 61.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.348 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -149.9 109.51 4.02 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.659 HD23 HG21 ' A' ' 185' ' ' VAL . 0.1 OUTLIER -102.65 150.16 23.71 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.341 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 204' ' ' PHE . 18.9 tptt -133.69 124.53 26.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.94 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.582 HD12 ' CA ' ' A' ' 172' ' ' GLU . 1.0 OUTLIER -123.0 134.31 66.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.582 ' HB2' ' HB2' ' A' ' 200' ' ' ARG . 10.0 mmt -86.93 135.16 33.4 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -131.79 138.75 48.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.736 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 7.4 t0 -121.72 75.7 36.56 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.594 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -60.47 -25.81 81.38 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.521 2.147 . . . . 0.0 111.998 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -71.83 -67.9 0.5 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.255 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 49.2 p -68.95 -26.98 65.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.112 0.482 . . . . 0.0 110.079 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.93 4.09 67.48 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.585 -0.734 . . . . 0.0 113.09 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.465 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 6.0 tpt180 -127.13 121.85 32.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.239 0.52 . . . . 0.0 110.329 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.574 ' HG ' ' HD1' ' A' ' 168' ' ' TRP . 66.5 p -71.91 160.56 32.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.919 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.585 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 23.9 mmm180 -58.3 -34.34 70.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.861 0.362 . . . . 0.0 110.093 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.484 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 94.39 -0.98 66.33 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.526 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.617 ' CD2' " H4'" ' B' ' 5' ' ' ' U' . 38.7 p90 -137.96 159.04 43.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.934 0.397 . . . . 0.0 110.426 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 189' ' ' LYS . . . -153.21 171.33 32.16 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.028 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.749 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 73.0 m-85 -110.2 125.3 52.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.833 0.349 . . . . 0.0 110.756 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.771 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 23.5 tp -110.1 132.18 54.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.427 ' O ' HG23 ' A' ' 185' ' ' VAL . 45.7 m -121.48 145.69 47.68 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.182 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 1.007 ' CE2' HG21 ' A' ' 216' ' ' VAL . 96.9 m-85 -121.4 147.59 45.52 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.862 0.363 . . . . 0.0 111.826 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.44 -35.7 80.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.328 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.45 119.19 53.63 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.603 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.15 -29.73 76.36 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.32 2.013 . . . . 0.0 112.636 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.3 t -59.54 -37.46 78.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 0.0 110.858 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.844 ' O ' HG23 ' A' ' 216' ' ' VAL . 24.0 m -59.25 -34.87 72.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.047 0.451 . . . . 0.0 110.5 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.825 HG13 ' SD ' ' A' ' 161' ' ' MET . 70.8 t -61.1 -42.74 94.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.211 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -59.55 -43.4 93.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.921 0.391 . . . . 0.0 111.046 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.429 ' HB3' ' CE2' ' A' ' 182' ' ' TYR . 98.4 mt-10 -69.38 -35.38 75.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.368 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 1.007 HG21 ' CE2' ' A' ' 207' ' ' PHE . 99.0 t -60.91 -46.42 96.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.899 0.38 . . . . 0.0 110.829 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 230' ' ' PRO . 14.8 p -75.44 -40.01 41.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -59.11 -36.96 76.08 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 29.9 m -96.37 144.61 26.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.156 0.503 . . . . 0.0 112.077 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -92.09 125.24 36.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.851 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.64 ' CG ' ' OH ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -130.58 155.89 45.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.177 0.513 . . . . 0.0 111.39 -178.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 226' ' ' LYS . 73.5 mt -122.12 125.76 73.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.297 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.648 HD12 HD13 ' A' ' 228' ' ' ILE . 3.8 mt -103.26 125.36 49.88 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.927 0.394 . . . . 0.0 111.607 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 52.58 41.16 31.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.29 2.18 87.06 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.897 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.763 ' O ' HG23 ' A' ' 222' ' ' ILE . 21.8 mmtt -107.18 137.96 44.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.3 0.55 . . . . 0.0 111.131 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 227' ' ' VAL . 10.1 p -80.49 125.08 39.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.138 0.494 . . . . 0.0 111.094 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.807 HD12 ' CG2' ' A' ' 163' ' ' ILE . 34.4 pt -126.38 156.34 36.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.95 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -131.05 83.38 60.91 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.384 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.726 ' O ' HG23 ' A' ' 217' ' ' VAL . 72.8 Cg_exo -52.76 130.73 38.53 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.606 2.204 . . . . 0.0 112.061 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.533 ' CE ' ' H62' ' B' ' 6' ' ' ' A' . 6.3 ttpt -136.72 144.29 43.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.0 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.431 ' HD2' ' N ' ' A' ' 233' ' ' ALA . 3.8 tmm_? -54.61 140.53 34.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.993 0.425 . . . . 0.0 111.188 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -59.74 149.17 31.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.184 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.991 HG22 ' C2 ' ' B' ' 6' ' ' ' A' . 3.5 tt -112.62 134.98 21.53 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.019 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.425 ' HG2' ' HB2' ' A' ' 238' ' ' GLU . 18.1 Cg_endo -59.14 144.27 99.45 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.587 1.525 . . . . 0.0 109.547 177.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.3 mmt180 -55.84 -36.57 67.66 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.745 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -60.97 -43.03 99.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.388 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.425 ' HB2' ' HG2' ' A' ' 235' ' ' PRO . 85.0 tt0 -68.43 -37.52 80.36 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.115 0.483 . . . . 0.0 110.719 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.466 ' OE1' HG21 ' A' ' 234' ' ' ILE . 57.7 tp60 -59.11 -43.58 91.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.908 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -65.46 -39.1 91.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.718 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -59.49 -39.24 83.11 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 21.1 p -90.64 161.23 15.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.178 0.513 . . . . 0.0 112.005 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.36 166.56 25.76 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.626 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.535 ' HG3' ' O ' ' A' ' 289' ' ' VAL . 39.7 ttpt -136.85 132.31 34.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.864 0.332 . . . . 0.0 111.338 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.674 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -115.74 163.76 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-O 121.282 0.563 . . . . 0.0 111.028 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.555 ' CD1' ' C5 ' ' B' ' 2' ' ' ' A' . 89.0 t80 -100.23 137.38 38.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.67 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.683 HG12 ' O ' ' A' ' 287' ' ' GLY . 7.9 p -129.78 145.39 35.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.963 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.594 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.07 166.85 18.66 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.49 15.7 56.5 Favored Glycine 0 N--CA 1.454 -0.131 0 C-N-CA 120.015 -1.088 . . . . 0.0 112.533 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.839 HG23 HG21 ' A' ' 254' ' ' VAL . 69.8 mt -110.66 131.99 60.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.516 0.198 . . . . 0.0 110.595 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.685 ' O ' HG12 ' A' ' 254' ' ' VAL . . . -167.98 -116.29 0.36 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.239 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.82 142.13 98.63 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.623 2.216 . . . . 0.0 113.294 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 54.98 43.58 29.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.351 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.839 HG21 HG23 ' A' ' 250' ' ' ILE . 7.1 p -108.31 -50.87 7.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.239 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.525 ' N ' HG13 ' A' ' 254' ' ' VAL . 7.7 mpt_? 59.07 132.01 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.224 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.5 -27.97 52.49 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.154 1.903 . . . . 0.0 112.911 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -60.72 -48.09 83.37 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.584 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 261' ' ' GLU . 61.0 mp0 -69.3 -36.98 77.58 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.669 ' CE1' HG11 ' A' ' 247' ' ' VAL . 18.6 t80 -61.8 -49.52 75.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.649 0.262 . . . . 0.0 110.679 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.826 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.4 tt0 -64.15 -37.73 88.5 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 258' ' ' GLU . 43.0 tp10 -62.62 -39.28 93.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.669 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.846 ' CE2' HD11 ' A' ' 313' ' ' ILE . 89.8 t80 -64.87 -58.52 5.95 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 1.022 ' HB2' HD11 ' A' ' 269' ' ' ILE . 33.4 m-85 -69.7 -23.24 63.4 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 260' ' ' GLU . 30.4 t -56.57 -32.33 65.1 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -54.71 -34.23 62.1 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.8 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 8.5 p90 -119.86 56.53 0.95 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.255 0.55 . . . . 0.0 112.073 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.585 ' HA3' ' CD1' ' A' ' 291' ' ' TYR . . . 160.65 -31.74 0.37 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.786 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.574 HG22 ' O ' ' A' ' 267' ' ' GLY . 0.5 OUTLIER 85.34 2.82 0.65 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.777 0.431 . . . . 0.0 111.544 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 1.022 HD11 ' HB2' ' A' ' 263' ' ' PHE . 76.4 mt 30.13 108.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.747 HD11 ' HB3' ' A' ' 292' ' ' ASP . 32.0 mm -68.49 -36.01 72.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.486 175.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -137.45 -88.42 0.27 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.636 ' HB3' HG21 ' A' ' 269' ' ' ILE . . . 61.17 123.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.948 0.404 . . . . 0.0 111.548 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -141.37 154.92 45.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.031 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.623 ' O ' ' HB2' ' A' ' 275' ' ' MET . 20.0 tp -62.74 -37.58 87.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.259 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.775 ' HB2' ' HB3' ' A' ' 282' ' ' GLN . 93.8 mmm 93.83 176.71 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.848 0.717 . . . . 0.0 109.857 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.744 HD22 ' O ' ' A' ' 275' ' ' MET . 0.0 OUTLIER -179.43 78.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.621 0.248 . . . . 0.0 111.053 -179.816 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -84.37 109.66 18.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.935 0.398 . . . . 0.0 110.241 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.669 ' O ' HG22 ' A' ' 280' ' ' THR . 59.6 mttp 57.12 35.43 26.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.685 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.425 ' O ' ' HB ' ' A' ' 280' ' ' THR . 85.6 m-20 53.82 44.26 29.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.74 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.669 HG22 ' O ' ' A' ' 278' ' ' LYS . 1.7 t 174.98 35.16 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.726 0.298 . . . . 0.0 111.585 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -99.46 -73.33 1.07 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.696 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.775 ' HB3' ' HB2' ' A' ' 275' ' ' MET . 5.0 pp0? -59.69 -30.96 69.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.43 ' N ' ' CD ' ' A' ' 282' ' ' GLN . 85.0 p -56.85 -22.96 40.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.555 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -56.52 -33.34 65.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.249 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 250' ' ' ILE . . . 144.98 28.08 0.1 OUTLIER Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.116 -1.04 . . . . 0.0 114.733 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.537 ' CE1' ' HA ' ' A' ' 282' ' ' GLN . 17.6 p90 -141.82 165.75 26.61 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.416 1.108 . . . . 0.0 112.19 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.683 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -143.98 165.65 27.27 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.774 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.431 ' HE2' ' HZ2' ' A' ' 244' ' ' LYS . 0.4 OUTLIER -116.48 127.11 54.27 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.221 0.208 . . . . 0.0 111.252 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.674 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 21.5 t -122.32 135.68 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.88 0.371 . . . . 0.0 111.924 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 52.6 m -113.84 136.02 53.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.402 178.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.585 ' CD1' ' HA3' ' A' ' 267' ' ' GLY . 31.3 m-85 -120.1 143.15 48.31 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.747 ' HB3' HD11 ' A' ' 270' ' ' ILE . 52.9 p30 -62.34 -33.97 75.74 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.329 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.65 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 50.8 m -127.04 145.18 50.81 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.147 0.499 . . . . 0.0 111.746 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.05 -30.69 71.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.933 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -56.61 -37.04 70.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.421 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.67 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -60.44 -35.46 75.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.384 . . . . 0.0 110.803 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.571 HG22 ' CG2' ' A' ' 245' ' ' ILE . 96.7 t -61.36 -44.05 97.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.155 0.502 . . . . 0.0 110.527 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.75 -36.8 84.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.129 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -57.55 -43.51 84.51 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.8 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 0.7 OUTLIER -72.2 -32.25 42.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.919 0.39 . . . . 0.0 110.973 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 81.6 m -56.29 -44.74 80.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.269 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -62.42 -40.2 95.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.271 0.558 . . . . 0.0 110.054 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -63.4 -34.47 77.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.419 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.675 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 15.9 tptm 66.11 -72.7 0.08 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.803 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.675 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 16.3 m-85 -111.17 127.79 55.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.334 0.588 . . . . 0.0 111.682 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.72 HD11 HG23 ' A' ' 300' ' ' VAL . 1.4 mt -118.22 138.99 47.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.584 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.425 ' OD1' ' CE ' ' A' ' 312' ' ' LYS . 73.4 m-20 -76.47 110.98 11.46 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.323 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.658 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 6.0 t80 -108.11 -70.16 0.82 Allowed 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.601 0.715 . . . . 0.0 110.063 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.474 ' HD3' ' CE2' ' A' ' 308' ' ' PHE . 0.0 OUTLIER -106.91 -158.5 0.66 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.169 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -54.88 -32.88 61.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.818 0.342 . . . . 0.0 110.789 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -113.85 153.16 29.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.012 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.425 ' CE ' ' OD1' ' A' ' 307' ' ' ASP . 18.8 mmtp -67.18 152.46 45.71 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.043 0.449 . . . . 0.0 111.008 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.846 HD11 ' CE2' ' A' ' 262' ' ' PHE . 27.7 pt -114.1 132.22 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -95.2 131.45 41.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 0.638 HD13 ' CE2' ' A' ' 263' ' ' PHE . 74.4 mt -118.76 125.26 74.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.429 0.633 . . . . 0.0 112.488 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -132.8 155.65 48.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.908 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -55.3 144.96 23.18 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.574 ' O ' ' CB ' ' A' ' 319' ' ' GLU . . . -94.67 131.62 40.27 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 319' ' ' GLU . . . . . 0.603 ' HB3' ' HD3' ' A' ' 320' ' ' PRO . 4.4 tm-20 106.74 -53.9 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.39 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.984 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.603 ' HD3' ' HB3' ' A' ' 319' ' ' GLU . 32.5 Cg_exo -57.24 -27.44 74.95 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 121.688 1.592 . . . . 0.0 111.71 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.57 45.03 27.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.698 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 40.6 m80 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.779 179.489 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.717 0 C3'-C2'-O2' 111.215 -0.719 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.555 ' C5 ' ' CD1' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.939 0 C3'-C2'-O2' 111.362 -0.668 . 0.077 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.571 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.997 0 C3'-C2'-O2' 111.34 -0.676 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.612 ' C2 ' ' CZ3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.423 -1.042 0 C3'-C2'-O2' 110.793 -0.864 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.961 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.843 0 C4'-C3'-C2' 103.672 0.972 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.991 ' C2 ' HG22 ' A' ' 234' ' ' ILE . . . . . . . . 0 O5'--C5' 1.425 -0.917 0 C4'-C3'-C2' 103.579 0.879 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.749 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.931 0 C3'-C2'-O2' 111.312 -0.685 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.894 0 C3'-C2'-O2' 111.24 -0.71 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.695 0.284 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 60.5 mp0 -61.91 -34.04 75.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.214 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.4 p -127.65 154.11 45.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.09 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.2 p 166.64 43.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.683 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.433 ' HG2' ' CB ' ' A' ' 233' ' ' ALA . 74.5 tttt -129.99 142.13 50.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.062 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.586 ' HE2' HG11 ' A' ' 216' ' ' VAL . 87.4 mmm -118.84 148.69 42.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.451 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.594 ' CE2' ' N9 ' ' B' ' 6' ' ' ' A' . 4.2 t80 -107.03 129.05 54.86 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.958 HG23 HD12 ' A' ' 228' ' ' ILE . 7.7 mm -116.64 125.05 73.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.783 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 228' ' ' ILE . . . -125.63 158.79 20.04 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 178.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.43 33.37 53.11 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.194 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 83.0 mt -59.38 -18.63 40.42 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.785 ' O ' ' N ' ' A' ' 169' ' ' ASP . 58.2 t30 73.5 41.97 0.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -177.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.611 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 9.5 m0 41.32 -55.65 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.858 -1.064 . . . . 0.0 113.823 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.785 ' N ' ' O ' ' A' ' 167' ' ' ASN . 52.9 p30 -58.02 -31.2 66.74 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.521 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 86.2 m -65.56 138.11 57.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.248 0.547 . . . . 0.0 111.293 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.445 ' C ' HD12 ' A' ' 190' ' ' ILE . 9.3 p -117.64 166.93 11.82 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.345 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.928 ' N ' HD12 ' A' ' 190' ' ' ILE . 20.8 pt-20 -60.73 -25.78 66.69 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.676 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 90.6 m-20 -61.37 -43.69 98.44 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.133 0.492 . . . . 0.0 110.095 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -67.36 -37.65 83.53 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.861 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.581 HD23 ' CE2' ' A' ' 179' ' ' PHE . 3.3 mt -58.43 -43.73 88.86 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.676 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -67.02 -36.72 82.75 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.295 179.202 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.433 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 48.6 tp10 -64.56 -40.91 96.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.065 0.46 . . . . 0.0 110.411 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 59.4 t80 -74.93 -61.68 1.8 Allowed 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.604 0.716 . . . . 0.0 111.111 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.88 ' HZ ' HD11 ' A' ' 228' ' ' ILE . 80.1 m-85 -70.68 -15.7 62.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.514 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.71 -27.76 20.67 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.243 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.828 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -57.5 -41.93 81.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.107 0.479 . . . . 0.0 110.431 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.828 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 68.6 m-85 -70.39 -35.56 73.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.841 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -177.09 -176.65 45.39 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.464 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.521 ' C ' HG13 ' A' ' 185' ' ' VAL . 44.2 m -64.53 -30.75 71.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.123 -0.538 . . . . 0.0 111.476 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.631 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 0.6 OUTLIER 65.54 90.14 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 121.854 0.835 . . . . 0.0 108.91 -177.526 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.0 t -59.23 -44.02 92.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.915 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -139.72 136.26 34.01 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.464 HD23 ' CG2' ' A' ' 185' ' ' VAL . 0.3 OUTLIER -117.58 133.04 56.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.316 178.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.567 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 9.1 tptp -134.01 120.95 20.91 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.928 HD12 ' N ' ' A' ' 172' ' ' GLU . 0.4 OUTLIER -128.24 134.08 65.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.361 176.662 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.543 ' CE ' ' HA2' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -90.47 140.03 30.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.746 -179.078 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -133.31 168.48 18.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.919 0.39 . . . . 0.0 111.377 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 7.4 m-20 -117.7 93.92 44.77 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.383 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.53 -24.64 29.46 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.335 2.024 . . . . 0.0 112.693 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -75.55 -83.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.673 0.273 . . . . 0.0 111.449 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 63.2 p -71.77 -24.13 61.7 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.443 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 92.47 7.15 63.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.772 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 4.2 tpt180 -82.22 154.25 25.52 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.946 0.403 . . . . 0.0 110.781 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 28.3 t -105.69 146.84 29.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.718 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.648 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 34.2 mmt180 -54.33 -30.89 52.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.894 0.378 . . . . 0.0 110.296 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.577 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 97.25 -2.02 60.96 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.237 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.648 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 39.7 p90 -139.4 155.57 47.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.058 0.456 . . . . 0.0 110.387 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.543 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -148.31 169.28 28.97 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.664 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.785 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 95.9 m-85 -107.84 125.76 51.83 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.083 0.468 . . . . 0.0 109.945 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.627 HD22 ' CE2' ' A' ' 207' ' ' PHE . 6.0 tt -108.42 128.56 54.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.577 -178.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.547 ' N ' HD23 ' A' ' 205' ' ' LEU . 49.9 m -120.34 142.53 49.05 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.331 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.649 ' CE2' HG21 ' A' ' 216' ' ' VAL . 84.8 m-85 -119.14 141.21 49.02 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.712 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.06 -35.51 80.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.166 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -108.17 117.37 55.04 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.756 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.885 ' O ' HG12 ' A' ' 213' ' ' VAL . 45.5 Cg_exo -56.74 -26.38 65.6 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.563 2.175 . . . . 0.0 113.276 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 85.7 p -61.78 -32.35 72.61 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.325 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.62 ' O ' HG23 ' A' ' 216' ' ' VAL . 24.7 m -60.31 -35.5 75.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.809 0.338 . . . . 0.0 110.706 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.885 HG12 ' O ' ' A' ' 210' ' ' PRO . 2.6 p -58.85 -35.34 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.981 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.454 ' O ' HG22 ' A' ' 217' ' ' VAL . 20.4 t70 -59.06 -44.63 91.86 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.008 0.432 . . . . 0.0 110.73 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -68.25 -33.07 73.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.58 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.945 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 99.0 t -58.97 -40.68 81.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.261 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 214' ' ' ASP . 24.2 m -77.73 -29.85 16.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.16 -0.616 . . . . 0.0 112.062 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -60.15 -38.78 84.17 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.779 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 60.4 m -91.48 146.59 23.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.761 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.498 ' HG2' HG21 ' A' ' 227' ' ' VAL . 63.4 tt0 -67.13 -42.0 85.19 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.529 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.945 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 57.8 m-70 74.95 96.04 0.07 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 72.3 mt -113.53 115.81 50.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.492 HD23 ' CG ' ' A' ' 224' ' ' ASP . 6.6 tt -123.77 126.07 45.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.008 0.433 . . . . 0.0 111.148 -178.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.492 ' CG ' HD23 ' A' ' 223' ' ' LEU . 86.6 m-20 54.63 42.45 31.25 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 91.0 -30.95 5.88 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.612 -0.804 . . . . 0.0 114.33 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -103.13 155.82 18.14 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 221' ' ' HIS . 11.9 p -102.81 124.48 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.958 HD12 HG23 ' A' ' 163' ' ' ILE . 17.8 pt -84.94 -26.9 6.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -177.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 23.7 t70 52.37 70.58 1.81 Allowed Pre-proline 0 C--N 1.318 -0.802 0 CA-C-O 121.532 0.682 . . . . 0.0 110.802 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.677 ' HD2' ' CD2' ' A' ' 221' ' ' HIS . 43.6 Cg_exo -58.83 136.39 73.32 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.942 3.095 . . . . 0.0 112.122 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.406 ' N ' ' HE3' ' A' ' 161' ' ' MET . 14.1 ttpt -138.35 150.11 46.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.351 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -48.35 147.17 2.45 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 110.789 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.433 ' CB ' ' HG2' ' A' ' 160' ' ' LYS . . . -98.0 145.0 26.94 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.209 0.528 . . . . 0.0 112.199 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.853 HD11 ' OD2' ' A' ' 271' ' ' ASP . 0.7 OUTLIER -110.9 126.22 29.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.13 179.3 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.561 ' HB2' ' OE1' ' A' ' 238' ' ' GLU . 36.8 Cg_exo -54.49 152.54 26.29 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.492 1.462 . . . . 0.0 110.549 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -52.32 -37.83 56.96 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -57.88 -43.57 86.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.886 ' O ' HG23 ' A' ' 242' ' ' THR . 58.9 mp0 -67.9 -36.99 81.17 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.705 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -59.98 -38.15 81.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.988 0.423 . . . . 0.0 110.732 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -61.2 -37.21 82.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.543 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -88.44 4.26 47.07 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.886 HG23 ' O ' ' A' ' 238' ' ' GLU . 16.7 p -121.33 160.86 23.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.052 0.453 . . . . 0.0 112.021 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.27 167.52 25.18 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.606 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.575 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 78.2 tttt -136.57 137.21 39.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.209 0.505 . . . . 0.0 110.905 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.62 HD12 ' CG2' ' A' ' 315' ' ' ILE . 7.1 pt -120.31 157.54 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.39 0.614 . . . . 0.0 112.126 -178.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.521 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 81.0 t80 -94.78 130.34 41.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.96 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.981 HG21 ' CZ ' ' A' ' 263' ' ' PHE . 57.2 t -124.6 133.17 70.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.643 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.701 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -119.98 166.96 13.51 Favored Glycine 0 C--O 1.225 -0.445 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.746 ' O ' HG22 ' A' ' 313' ' ' ILE . . . 94.54 13.36 53.98 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.132 -1.033 . . . . 0.0 112.103 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.556 HG23 HG11 ' A' ' 254' ' ' VAL . 67.4 mt -108.84 130.61 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 120.812 0.339 . . . . 0.0 110.491 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.827 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -165.27 -119.11 0.46 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.544 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.38 144.08 96.77 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 122.313 2.009 . . . . 0.0 113.137 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 57.34 45.68 19.67 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.827 HG22 ' O ' ' A' ' 251' ' ' GLY . 16.1 m -118.33 -50.89 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.388 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.521 ' N ' HG23 ' A' ' 254' ' ' VAL . 9.8 mmt180 62.83 130.25 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.195 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.68 -28.62 47.6 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 121.98 1.787 . . . . 0.0 112.194 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 12.7 tptp -60.6 -44.14 96.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.142 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.578 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 79.3 mm-40 -66.91 -39.77 87.48 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.84 0.352 . . . . 0.0 111.085 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.599 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 30.5 t80 -63.25 -48.01 80.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.537 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.427 ' O ' ' CD1' ' A' ' 269' ' ' ILE . 84.3 tt0 -64.46 -42.74 95.76 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.36 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.406 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.9 pt-20 -76.7 -28.85 56.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.83 0.348 . . . . 0.0 110.81 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.874 ' CE2' HD11 ' A' ' 313' ' ' ILE . 12.8 t80 -60.66 -55.59 31.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.169 0.509 . . . . 0.0 111.39 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.981 ' CZ ' HG21 ' A' ' 247' ' ' VAL . 10.4 m-85 -69.64 -22.45 63.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.994 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.707 ' N ' HD11 ' A' ' 269' ' ' ILE . 27.8 t -57.22 -30.94 65.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.892 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -54.04 -36.11 62.71 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.754 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 7.3 p90 -117.76 41.36 2.88 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.763 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.496 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 159.92 147.93 5.07 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.985 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.423 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 52.5 m -59.52 -36.85 76.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 0.0 111.285 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.707 HD11 ' N ' ' A' ' 264' ' ' SER . 69.8 mt 68.81 78.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.395 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.545 ' O ' ' OD1' ' A' ' 271' ' ' ASP . 32.1 mm -58.91 -45.59 91.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.449 -0.5 . . . . 0.0 112.094 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.853 ' OD2' HD11 ' A' ' 234' ' ' ILE . 83.4 m-20 -151.26 90.7 1.61 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.583 ' HB2' HG23 ' A' ' 269' ' ' ILE . . . -106.03 132.62 51.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.528 0.204 . . . . 0.0 110.506 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -145.61 151.61 38.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.285 0.564 . . . . 0.0 111.885 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.59 ' O ' ' HB2' ' A' ' 275' ' ' MET . 26.3 tp -66.05 -36.57 83.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.713 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.59 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 96.0 mmm 84.13 114.28 0.05 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.513 -178.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 276' ' ' LEU . 5.1 mp -122.39 138.58 54.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.744 0.306 . . . . 0.0 111.418 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.469 ' HB2' ' HA3' ' A' ' 281' ' ' GLY . 85.0 m-20 -129.4 100.39 5.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.084 0.469 . . . . 0.0 110.679 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.738 ' O ' HG22 ' A' ' 280' ' ' THR . 94.3 mttt 63.48 35.99 11.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.17 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.429 ' O ' ' HB ' ' A' ' 280' ' ' THR . 85.8 m-20 51.45 43.82 29.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.75 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 278' ' ' LYS . 0.9 OUTLIER 169.86 47.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.041 0.448 . . . . 0.0 110.753 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 281' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' A' ' 277' ' ' ASP . . . -139.53 -105.38 0.64 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.135 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.448 ' OE1' ' HB3' ' A' ' 275' ' ' MET . 96.5 mt-30 -56.85 -27.04 59.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.209 -0.496 . . . . 0.0 111.525 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.561 ' O ' HD21 ' A' ' 274' ' ' LEU . 83.3 p -53.18 -24.63 11.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.95 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -118.58 136.89 53.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.652 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 105.96 -57.95 0.46 Allowed Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.573 -0.823 . . . . 0.0 114.242 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.461 ' CZ ' " O4'" ' B' ' 2' ' ' ' A' . 32.5 p90 -140.72 166.77 23.84 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.757 0.779 . . . . 0.0 112.652 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -135.93 154.83 22.04 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.461 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.575 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -110.22 129.89 55.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.747 0.308 . . . . 0.0 111.711 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.67 HG21 ' CD2' ' A' ' 263' ' ' PHE . 55.1 t -124.48 134.84 65.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.978 0.418 . . . . 0.0 111.901 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 63.0 m -115.48 135.75 53.79 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.496 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 38.9 m-85 -117.04 139.51 50.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.511 ' CA ' HG12 ' A' ' 270' ' ' ILE . 51.1 t0 -58.22 -36.53 73.28 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.421 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 49.1 m -123.66 144.2 49.78 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.318 0.58 . . . . 0.0 112.053 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.92 -30.61 71.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.693 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -56.26 -37.53 69.91 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.005 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -61.21 -36.65 80.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.011 0.434 . . . . 0.0 110.403 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.583 HG13 HG21 ' A' ' 245' ' ' ILE . 75.1 t -61.74 -42.82 95.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.234 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -61.5 -37.68 84.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.53 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -59.06 -44.09 91.8 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.965 HG23 HD11 ' A' ' 306' ' ' ILE . 0.8 OUTLIER -71.9 -33.04 46.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.175 -179.654 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 89.0 m -57.88 -45.6 86.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.142 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -61.09 -41.46 96.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.254 0.549 . . . . 0.0 110.018 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -61.91 -33.05 73.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.211 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.648 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 31.8 tptt 68.16 -74.21 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -178.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.648 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.0 m-30 -113.31 141.55 46.88 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.424 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.965 HD11 HG23 ' A' ' 300' ' ' VAL . 34.6 mt -116.98 136.65 53.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -75.09 79.82 2.25 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.367 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.531 ' CD2' HD13 ' A' ' 313' ' ' ILE . 9.1 t80 -83.17 -105.7 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.978 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 310' ' ' ASP . 4.2 mmpt? -60.71 -34.96 75.17 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 309' ' ' LYS . 52.2 p30 137.78 0.17 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.997 0.919 . . . . 0.0 111.142 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 312' ' ' LYS . 73.3 mtt85 -98.18 4.44 48.96 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.451 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 95.1 mttt 65.04 54.07 1.29 Allowed 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.109 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.874 HD11 ' CE2' ' A' ' 262' ' ' PHE . 20.3 pt -50.14 99.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.777 0.799 . . . . 0.0 110.784 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 314' ' ' GLU . . . . . 0.567 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 92.4 mt-10 -60.91 139.53 57.97 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.19 -178.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 0.772 HG23 HG22 ' A' ' 247' ' ' VAL . 63.2 mt -121.65 128.14 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.009 0.433 . . . . 0.0 111.065 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -133.85 142.78 47.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.112 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 21.7 ttp-105 -50.8 146.74 5.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.699 0.285 . . . . 0.0 110.624 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.23 143.51 27.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.402 . . . . 0.0 111.131 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -99.43 123.88 46.66 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.358 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -55.77 -21.35 32.15 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.54 2.16 . . . . 0.0 112.129 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.478 ' NH1' ' C4 ' ' B' ' 3' ' ' ' U' . 0.0 OUTLIER 76.92 0.72 3.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.092 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 68.6 m80 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.767 179.744 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.735 0 C3'-C2'-O2' 111.235 -0.712 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.521 ' C5 ' ' CE1' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.957 0 C3'-C2'-O2' 111.273 -0.699 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.478 ' C4 ' ' NH1' ' A' ' 321' ' ' ARG . . . . . . . . 0 O5'--C5' 1.423 -1.052 0 C3'-C2'-O2' 111.488 -0.625 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.713 ' N7 ' ' HA ' ' A' ' 167' ' ' ASN . . . . . . . . 0 O5'--C5' 1.426 -0.905 0 C4'-C3'-C2' 103.706 1.006 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.589 " H4'" ' CD1' ' A' ' 202' ' ' PHE . . . . . . . . 0 O5'--C5' 1.428 -0.756 0 C4'-C3'-C2' 103.67 0.97 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.594 ' N9 ' ' CE2' ' A' ' 162' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -1.008 0 C4'-C3'-C2' 103.567 0.867 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.785 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -1.027 0 C3'-C2'-O2' 111.128 -0.749 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . 0.498 H5'' " O2'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.96 0 C3'-C2'-O2' 111.143 -0.744 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 26.1 pttm . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.65 0.262 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -108.97 148.59 30.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.776 0.322 . . . . 0.0 110.909 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 86.5 p -62.71 -29.1 70.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.26 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.5 p 34.69 35.01 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.881 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.484 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 21.8 tttt -96.2 137.5 35.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.499 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.64 ' HE2' ' HB ' ' A' ' 216' ' ' VAL . 8.5 tpp -114.36 145.4 41.87 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.637 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 6.8 t80 -102.85 131.85 49.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.925 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.112 HG22 HD11 ' A' ' 166' ' ' LEU . 17.5 mm -116.63 132.37 66.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.354 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.604 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -123.59 156.64 17.9 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.294 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.405 ' HA2' " H5'" ' B' ' 4' ' ' ' A' . . . 76.31 34.95 44.2 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.407 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 1.112 HD11 HG22 ' A' ' 163' ' ' ILE . 4.4 mp -92.62 141.75 28.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.638 0.256 . . . . 0.0 110.732 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.56 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 0.6 OUTLIER -60.16 135.44 57.72 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.198 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.626 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 4.3 m0 -53.91 -33.66 57.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.794 0.331 . . . . 0.0 110.754 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -93.22 9.72 34.91 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.422 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' THR . . . . . 1.131 HG21 HD21 ' A' ' 223' ' ' LEU . 98.5 m -56.98 -40.54 76.72 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.49 HG23 ' C ' ' A' ' 170' ' ' THR . 0.1 OUTLIER 54.32 162.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -177.322 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.532 ' O ' ' HD3' ' A' ' 176' ' ' ARG . 57.2 mp0 -62.73 -28.56 70.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.113 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.575 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 92.6 m-20 -55.47 -43.44 75.53 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -67.46 -36.95 82.17 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 1.009 HD22 HD21 ' A' ' 205' ' ' LEU . 6.1 mt -56.38 -48.39 76.97 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.575 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -68.42 -30.36 69.24 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.333 179.15 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -56.89 -39.4 74.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.577 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.792 ' HD2' HD12 ' A' ' 223' ' ' LEU . 0.0 OUTLIER -96.37 -59.47 1.82 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.967 0.413 . . . . 0.0 110.092 178.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.635 ' CE2' HD23 ' A' ' 175' ' ' LEU . 70.9 m-85 -59.87 -31.95 70.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.544 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.13 -25.37 7.75 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.11 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.825 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -56.41 -41.19 75.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.775 0.321 . . . . 0.0 111.487 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.825 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 69.8 m-85 -70.56 -35.74 73.25 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -174.66 -177.54 43.87 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.475 -1.345 . . . . 0.0 114.195 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 61.1 m -62.73 -34.38 77.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.699 -0.75 . . . . 0.0 111.867 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.848 HG23 ' CE1' ' A' ' 207' ' ' PHE . 0.5 OUTLIER 67.15 106.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.645 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.76 HG23 ' N ' ' A' ' 208' ' ' GLU . 43.3 p -64.78 -36.79 85.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.983 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -154.01 150.65 28.49 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.473 HD23 HG11 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -118.47 133.66 55.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.348 179.188 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 10.5 tptt -133.48 119.09 19.13 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 172' ' ' GLU . 0.8 OUTLIER -128.58 137.66 56.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.034 177.506 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.566 ' HB2' ' HB2' ' A' ' 200' ' ' ARG . 0.3 OUTLIER -96.19 127.53 42.28 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.857 -179.525 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -131.95 155.52 47.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.983 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.601 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 15.2 t0 -120.55 80.82 31.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.442 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.09 -24.85 42.49 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.52 2.147 . . . . 0.0 112.642 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.79 -70.52 0.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.867 0.365 . . . . 0.0 111.111 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 49.4 p -73.08 -20.56 60.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.812 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 84.87 19.72 59.06 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.53 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.601 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 8.3 tpt180 -115.6 151.92 34.05 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 120.756 0.312 . . . . 0.0 110.466 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.546 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 49.1 m -117.34 153.4 33.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.904 0.383 . . . . 0.0 110.809 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.653 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 30.5 mmt180 -54.34 -34.5 61.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 110.961 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.522 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 90.71 5.61 68.59 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.231 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.962 ' HA ' HD13 ' A' ' 166' ' ' LEU . 22.5 p90 -140.36 158.92 43.29 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.881 0.372 . . . . 0.0 110.641 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.456 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -143.02 162.9 27.47 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.402 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.637 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 95.8 m-85 -109.68 129.59 55.59 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.867 0.365 . . . . 0.0 110.199 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 1.009 HD21 HD22 ' A' ' 175' ' ' LEU . 61.1 mt -104.54 141.21 36.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.778 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 186' ' ' THR . 18.0 t -127.94 128.37 44.98 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.848 ' CE1' HG23 ' A' ' 185' ' ' VAL . 98.1 m-85 -120.41 143.08 48.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.14 0.495 . . . . 0.0 112.073 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.76 ' N ' HG23 ' A' ' 186' ' ' THR . 47.3 tp10 -62.14 -34.37 76.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.063 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -110.83 116.23 52.29 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.4 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.7 -30.59 76.31 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.454 2.103 . . . . 0.0 113.064 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.418 ' O ' ' OD1' ' A' ' 214' ' ' ASP . 25.6 m -59.39 -35.51 74.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.626 0.25 . . . . 0.0 110.926 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.821 ' O ' HG23 ' A' ' 216' ' ' VAL . 24.8 m -57.01 -34.61 68.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.131 0.491 . . . . 0.0 109.898 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.51 HG11 ' CD ' ' A' ' 232' ' ' ARG . 83.5 t -63.49 -38.4 82.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.678 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.695 ' OD1' ' N ' ' A' ' 215' ' ' GLU . 36.4 p30 -60.35 -39.4 87.0 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.746 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.695 ' N ' ' OD1' ' A' ' 214' ' ' ASP . 97.8 mt-10 -70.95 -35.52 72.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.527 0.68 . . . . 0.0 110.714 177.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 212' ' ' SER . 93.9 t -60.44 -36.88 72.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.528 -178.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 230' ' ' PRO . 6.5 p -87.21 -54.22 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.493 ' N ' HG13 ' A' ' 217' ' ' VAL . 26.2 mttt -60.44 -36.74 78.93 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.424 ' HB ' ' CE1' ' A' ' 221' ' ' HIS . 62.0 m -58.26 -37.75 75.58 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 63.86 110.56 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -177.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.723 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 0.0 OUTLIER -137.98 175.13 9.86 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -176.037 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.861 HG23 ' O ' ' A' ' 226' ' ' LYS . 17.8 mm -115.36 120.25 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.75 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 1.131 HD21 HG21 ' A' ' 170' ' ' THR . 18.8 tp -69.64 -43.81 71.89 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.644 -0.423 . . . . 0.0 112.017 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -177.36 69.68 0.02 OUTLIER 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.741 0.305 . . . . 0.0 111.774 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 95.21 -8.09 69.54 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.467 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.861 ' O ' HG23 ' A' ' 222' ' ' ILE . 76.2 mttt -124.08 157.76 33.81 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 117.036 0.418 . . . . 0.0 111.584 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.91 HG21 ' OD2' ' A' ' 279' ' ' ASP . 44.3 t -93.88 126.95 46.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.165 0.507 . . . . 0.0 110.26 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.63 HD13 ' HB2' ' A' ' 223' ' ' LEU . 31.6 pt -126.87 155.98 37.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.048 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 8.7 p30 -132.15 81.57 61.15 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 121.191 0.519 . . . . 0.0 110.421 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.771 ' O ' HG23 ' A' ' 217' ' ' VAL . 92.8 Cg_exo -47.51 127.02 13.05 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.72 2.28 . . . . 0.0 111.345 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.454 ' HE2' ' H62' ' B' ' 6' ' ' ' A' . 5.6 ttpt -132.45 144.96 50.83 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.684 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.51 ' CD ' HG11 ' A' ' 213' ' ' VAL . 57.3 mmm-85 -50.06 143.1 8.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.202 0.525 . . . . 0.0 111.269 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -68.62 150.08 48.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.787 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.57 HD12 ' C6 ' ' B' ' 6' ' ' ' A' . 34.4 mt -117.44 140.4 27.32 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.935 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.475 ' HD2' ' OE1' ' A' ' 238' ' ' GLU . 45.0 Cg_exo -55.26 139.84 81.27 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 121.758 1.639 . . . . 0.0 111.229 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.449 ' O ' ' HD3' ' A' ' 236' ' ' ARG . 3.2 tmt_? -56.83 -41.12 77.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.728 0.299 . . . . 0.0 111.123 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -60.01 -39.35 85.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.368 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.503 ' O ' HG23 ' A' ' 242' ' ' THR . 94.8 mt-10 -63.66 -32.62 74.16 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.701 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.501 ' OE1' " H2'" ' B' ' 6' ' ' ' A' . 98.9 mm-40 -58.24 -38.52 77.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.998 0.428 . . . . 0.0 110.213 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -61.06 -42.33 98.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.223 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -63.15 -36.0 82.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.461 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 238' ' ' GLU . 21.0 p -83.26 161.44 21.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.155 0.502 . . . . 0.0 111.897 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.94 169.99 25.07 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.609 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.539 ' CE ' ' CD2' ' A' ' 288' ' ' PHE . 46.9 tptt -134.71 130.36 36.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.861 0.331 . . . . 0.0 110.706 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.656 HD12 HG21 ' A' ' 315' ' ' ILE . 5.5 pt -123.5 154.84 29.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 121.11 0.481 . . . . 0.0 110.65 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.556 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 92.9 t80 -97.28 133.37 42.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.651 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.752 HG21 ' CZ ' ' A' ' 263' ' ' PHE . 21.4 t -121.42 139.36 48.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.032 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.595 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -129.02 171.93 19.77 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.18 36.9 16.56 Favored Glycine 0 C--N 1.323 -0.181 0 C-N-CA 120.071 -1.061 . . . . 0.0 111.901 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.866 HG22 HG21 ' A' ' 254' ' ' VAL . 69.8 mt -111.66 132.32 60.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.598 0.237 . . . . 0.0 110.81 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.862 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -158.16 -119.59 0.57 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.246 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.63 140.58 95.45 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.38 2.053 . . . . 0.0 113.482 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 54.15 44.06 29.74 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.402 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.866 HG21 HG22 ' A' ' 250' ' ' ILE . 22.4 m -121.04 27.77 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.529 ' HG3' ' HD2' ' A' ' 256' ' ' PRO . 0.2 OUTLIER -39.96 155.12 0.18 Allowed Pre-proline 0 N--CA 1.465 0.304 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.529 ' HD2' ' HG3' ' A' ' 255' ' ' ARG . 7.5 Cg_endo -50.19 -29.47 22.77 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.051 1.834 . . . . 0.0 112.128 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -62.05 -45.72 92.31 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.036 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -68.29 -42.11 79.97 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.101 0.477 . . . . 0.0 111.066 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.468 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 35.3 t80 -66.13 -47.2 74.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.294 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.733 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.4 tt0 -64.9 -41.37 95.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.333 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -75.01 -31.98 61.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.613 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.685 ' CE2' HD11 ' A' ' 313' ' ' ILE . 83.4 t80 -59.51 -55.61 32.42 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.818 ' CB ' HD11 ' A' ' 269' ' ' ILE . 25.3 m-85 -66.85 -30.65 70.88 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.537 ' HA ' HG13 ' A' ' 269' ' ' ILE . 16.5 m -56.01 -27.43 52.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.758 0.313 . . . . 0.0 111.194 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -51.89 -38.04 54.66 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.745 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 19.9 p90 -110.84 48.08 0.94 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.586 0.708 . . . . 0.0 111.954 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 133.28 149.08 6.04 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.313 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 53.4 m -69.76 131.85 45.18 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.818 HD11 ' CB ' ' A' ' 263' ' ' PHE . 49.6 mt -94.44 135.92 27.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.005 0.431 . . . . 0.0 111.395 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' A' ' 292' ' ' ASP . 27.3 mm -92.38 -75.09 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.49 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 272' ' ' ALA . 90.4 m-20 -93.0 -75.51 0.49 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.489 ' HB3' HG21 ' A' ' 269' ' ' ILE . . . 42.79 108.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -140.64 157.73 45.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.222 0.534 . . . . 0.0 111.68 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.573 ' O ' ' HB2' ' A' ' 275' ' ' MET . 25.9 tp -62.17 -37.39 85.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.537 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.709 ' O ' HD23 ' A' ' 276' ' ' LEU . 84.9 mtp 86.27 128.26 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.95 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 275' ' ' MET . 31.9 mt -130.14 120.9 25.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.853 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.444 ' O ' ' HG3' ' A' ' 278' ' ' LYS . 55.1 t0 -61.0 -41.75 97.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.213 0.53 . . . . 0.0 110.192 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.542 ' O ' HG22 ' A' ' 280' ' ' THR . 98.8 mttt -165.28 59.09 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.975 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.91 ' OD2' HG21 ' A' ' 227' ' ' VAL . 83.7 m-20 58.17 44.62 18.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.739 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 278' ' ' LYS . 1.5 t -178.66 -34.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.401 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 276' ' ' LEU . . . -83.39 178.48 52.71 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.436 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.491 ' NE2' " O3'" ' B' ' 2' ' ' ' A' . 98.1 mt-30 42.9 21.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.483 ' O ' HD21 ' A' ' 274' ' ' LEU . 94.0 p -80.54 -30.82 37.1 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -134.36 154.04 51.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.362 0.601 . . . . 0.0 112.463 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.13 -40.94 2.27 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.041 -0.981 . . . . 0.0 114.422 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.664 ' C ' HD12 ' A' ' 250' ' ' ILE . 12.4 p90 -149.0 165.55 31.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.792 0.796 . . . . 0.0 111.556 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.788 ' N ' HD12 ' A' ' 250' ' ' ILE . . . -138.99 153.79 22.94 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.975 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.539 ' CD2' ' CE ' ' A' ' 244' ' ' LYS . 0.3 OUTLIER -109.59 127.38 54.47 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.594 0.358 . . . . 0.0 110.364 179.255 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.556 HG21 ' CG ' ' A' ' 263' ' ' PHE . 38.5 t -125.32 135.45 63.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.453 ' OG1' ' CD ' ' A' ' 244' ' ' LYS . 47.5 m -120.27 136.52 54.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.313 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.407 ' OH ' ' O ' ' A' ' 263' ' ' PHE . 40.5 m-85 -116.21 138.4 51.32 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.617 ' HB2' HD11 ' A' ' 270' ' ' ILE . 51.4 t0 -57.3 -36.35 70.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.507 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 50.6 m -122.37 145.04 48.64 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.247 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.83 -27.84 68.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.649 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -55.56 -38.42 69.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.626 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.44 -37.38 85.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.977 0.417 . . . . 0.0 110.901 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.566 HG13 ' CG2' ' A' ' 245' ' ' ILE . 73.1 t -62.71 -43.66 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.258 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -61.58 -38.66 88.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.29 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -59.51 -43.32 93.41 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.895 HG23 HD11 ' A' ' 306' ' ' ILE . 1.2 p -70.92 -33.04 50.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.466 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 81.6 m -57.5 -45.63 84.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.278 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -61.76 -42.2 98.68 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.207 0.527 . . . . 0.0 110.364 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.9 m-20 -63.04 -35.25 79.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.607 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.677 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 16.2 tptm 67.58 -67.79 0.17 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.677 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 16.1 m-85 -114.97 133.35 56.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.166 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.895 HD11 HG23 ' A' ' 300' ' ' VAL . 14.8 mt -121.45 140.17 46.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.92 178.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.54 ' OD1' ' O ' ' A' ' 307' ' ' ASP . 50.7 p30 -77.1 110.21 11.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.224 0.535 . . . . 0.0 110.884 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.637 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 7.9 t80 -110.21 -79.65 0.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.543 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.463 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 6.7 mmpt? -97.89 -162.4 0.95 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.505 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -52.76 -28.97 24.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.759 0.314 . . . . 0.0 110.456 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -109.99 152.66 25.61 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.534 ' HG2' ' HB3' ' A' ' 305' ' ' PHE . 14.2 tttp -75.29 139.99 42.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.527 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.685 HD11 ' CE2' ' A' ' 262' ' ' PHE . 27.4 pt -105.49 136.63 38.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.236 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' GLU . . . . . 0.434 ' HB2' ' CE2' ' A' ' 305' ' ' PHE . 84.5 tt0 -101.25 131.32 47.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.651 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 0.683 HD13 ' CE2' ' A' ' 263' ' ' PHE . 66.0 mt -119.48 127.51 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-O 121.052 0.454 . . . . 0.0 111.2 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -131.34 144.7 51.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.482 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -49.62 146.19 4.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.017 0.437 . . . . 0.0 111.065 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.32 147.36 36.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.632 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' GLU . . . . . 0.401 ' HG2' ' HD2' ' A' ' 320' ' ' PRO . 0.3 OUTLIER -115.01 152.68 46.81 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.938 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.401 ' HD2' ' HG2' ' A' ' 319' ' ' GLU . 31.3 Cg_exo -59.29 -26.19 80.97 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.512 2.141 . . . . 0.0 112.341 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 32.9 mmm180 35.23 53.22 0.71 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.857 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.962 179.941 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.724 0 C3'-C2'-O2' 111.318 -0.684 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.556 ' C5 ' ' CE1' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.974 0 C3'-C2'-O2' 111.454 -0.637 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.593 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.968 0 C3'-C2'-O2' 111.333 -0.678 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.626 ' C2 ' ' CZ3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.425 -0.94 0 C4'-C3'-C2' 103.876 1.176 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.897 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.788 0 C4'-C3'-C2' 103.709 1.009 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.897 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.895 0 C3'-C2'-O2' 111.265 -0.702 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.63 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.912 0 O4'-C1'-N19 109.482 1.282 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . 0.571 ' P ' " O2'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.427 -0.788 0 O4'-C1'-C2' 107.474 0.767 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 52.6 tttp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.864 0.364 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 57.09 22.09 7.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.166 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.6 m -120.14 147.58 44.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.698 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.4 m 47.62 25.3 0.64 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.23 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 205' ' ' LEU . 37.6 ttpt -89.49 136.59 32.94 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.099 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.805 ' SD ' HG13 ' A' ' 213' ' ' VAL . 29.0 mtm -124.86 164.14 20.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.147 0.499 . . . . 0.0 111.239 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.602 ' CD2' ' C4 ' ' B' ' 6' ' ' ' A' . 1.8 t80 -98.49 130.01 45.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.302 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.805 HG23 HD12 ' A' ' 228' ' ' ILE . 47.0 mt -119.28 127.73 75.84 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.67 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.705 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.645 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -127.27 165.63 20.35 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.73 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.13 34.71 40.66 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.962 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.556 HD22 HG21 ' A' ' 170' ' ' THR . 73.9 mt -59.25 -22.89 61.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.542 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 51.8 t30 75.59 39.61 0.33 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.198 0.523 . . . . 0.0 109.751 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.559 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 20.4 m0 33.53 35.22 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.143 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -153.94 8.2 0.35 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.556 HG21 HD22 ' A' ' 166' ' ' LEU . 55.4 m -78.71 137.16 37.65 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.372 0.606 . . . . 0.0 110.392 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.52 HG23 ' HZ1' ' A' ' 192' ' ' LYS . 30.5 m -116.42 145.02 43.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.825 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.554 ' N ' HD12 ' A' ' 190' ' ' ILE . 55.4 mp0 -55.66 -36.46 67.1 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.146 -0.621 . . . . 0.0 109.646 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.541 ' O ' ' HG2' ' A' ' 176' ' ' ARG . 89.6 m-20 -65.43 -48.29 73.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.973 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -67.25 -40.8 86.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.609 0.718 . . . . 0.0 110.158 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.835 HD22 HD11 ' A' ' 190' ' ' ILE . 65.8 tp -64.68 -41.42 96.06 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.107 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.541 ' HG2' ' O ' ' A' ' 173' ' ' ASP . 41.2 ptt85 -69.66 -40.03 76.68 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.395 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 173' ' ' ASP . 75.4 mm-40 -65.12 -37.86 88.8 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.037 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.439 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 65.2 t80 -61.72 -54.53 41.33 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.416 0.627 . . . . 0.0 110.135 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.607 ' HZ ' HD11 ' A' ' 228' ' ' ILE . 86.6 m-85 -73.58 -21.83 60.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.703 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.41 -26.54 22.86 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.222 -0.99 . . . . 0.0 110.847 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.507 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -54.91 -41.49 71.03 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 123.752 0.821 . . . . 0.0 111.072 179.211 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -69.02 -32.59 72.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.099 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 174.94 -125.34 1.08 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.306 -0.95 . . . . 0.0 112.702 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 57.1 m -117.44 143.33 46.13 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.903 HG21 ' CD2' ' A' ' 188' ' ' LEU . 15.0 p -109.8 135.07 49.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.715 0.293 . . . . 0.0 110.238 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.452 HG23 ' CB ' ' A' ' 206' ' ' SER . 0.5 OUTLIER -95.79 -47.58 6.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.928 -179.18 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.418 ' HB3' ' HB3' ' A' ' 206' ' ' SER . 59.6 t0 -136.6 132.19 34.76 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.281 0.562 . . . . 0.0 112.488 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.903 ' CD2' HG21 ' A' ' 185' ' ' VAL . 0.3 OUTLIER -116.22 129.72 56.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.58 179.278 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 11.7 tptt -137.03 116.07 12.41 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.835 HD11 HD22 ' A' ' 175' ' ' LEU . 55.1 mt -126.74 126.26 68.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.989 176.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.547 ' SD ' ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -86.03 114.95 23.31 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.52 ' HZ1' HG23 ' A' ' 171' ' ' THR . 69.5 mttt -117.84 153.35 33.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.856 0.36 . . . . 0.0 111.458 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.591 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 3.1 t0 -124.79 74.11 64.19 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.31 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.77 -28.7 83.17 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.54 2.16 . . . . 0.0 112.905 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -66.74 -58.72 4.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.057 0.456 . . . . 0.0 111.108 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.2 p -75.16 -18.6 60.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.341 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 86.29 12.17 70.87 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.802 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.591 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 88.7 mtt-85 -122.32 177.16 5.5 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-O 120.87 0.367 . . . . 0.0 111.974 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 86.0 p -139.7 160.85 38.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.37 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.546 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 39.5 mmt180 -55.47 -31.96 62.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.989 0.423 . . . . 0.0 110.081 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.474 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 92.87 6.57 63.46 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.378 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.547 ' CE1' ' SD ' ' A' ' 191' ' ' MET . 26.2 p90 -146.56 154.33 41.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.153 0.501 . . . . 0.0 111.102 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.535 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -142.88 159.2 27.34 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.88 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.744 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 90.5 m-85 -106.83 123.66 48.48 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.629 HD22 ' CE2' ' A' ' 207' ' ' PHE . 7.3 tt -115.07 131.48 56.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.394 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.498 ' N ' HD23 ' A' ' 205' ' ' LEU . 38.8 t -116.31 135.67 53.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.015 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.629 ' CE2' HD22 ' A' ' 205' ' ' LEU . 75.5 m-85 -111.92 135.49 52.48 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.29 -35.33 78.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.464 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -109.77 115.16 55.86 Favored Pre-proline 0 C--O 1.231 0.119 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.695 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -56.2 -23.08 43.33 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.519 2.146 . . . . 0.0 112.862 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.1 t -57.66 -38.32 74.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.78 0.324 . . . . 0.0 111.113 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.94 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.9 m -59.64 -36.56 76.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.595 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.805 HG13 ' SD ' ' A' ' 161' ' ' MET . 83.0 t -60.48 -42.75 92.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.921 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.407 ' O ' HG12 ' A' ' 217' ' ' VAL . 55.5 t0 -59.49 -41.45 89.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.88 0.371 . . . . 0.0 110.805 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.449 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 17.4 pt-20 -78.34 -36.41 46.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.726 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.94 HG23 ' O ' ' A' ' 212' ' ' SER . 93.8 t -63.5 -46.31 95.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 CA-C-O 120.924 0.393 . . . . 0.0 110.422 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 214' ' ' ASP . 8.0 p -62.01 -36.62 75.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -59.97 -38.7 83.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.706 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 31.4 m -87.66 142.39 27.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.918 0.389 . . . . 0.0 111.847 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 228' ' ' ILE . 60.1 tp60 -66.23 -40.89 90.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.455 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.845 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 58.2 m-70 74.55 105.73 0.07 Allowed 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.615 HG12 HG12 ' A' ' 227' ' ' VAL . 75.3 mt -112.28 108.02 24.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.5 tt -117.0 125.99 52.21 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.948 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 55.76 41.19 30.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.03 8.29 87.41 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.95 -0.643 . . . . 0.0 114.643 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.474 ' HG3' ' CB ' ' A' ' 167' ' ' ASN . 42.2 mmtm -127.2 153.76 45.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.55 0.675 . . . . 0.0 111.961 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.615 HG12 HG12 ' A' ' 222' ' ' ILE . 34.2 m -100.06 136.93 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.64 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.805 HD12 HG23 ' A' ' 163' ' ' ILE . 31.1 pt -123.75 161.85 25.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.083 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -124.95 80.3 63.79 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.119 0.485 . . . . 0.0 111.756 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.653 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 31.3 Cg_exo -63.92 76.31 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.399 2.733 . . . . 0.0 112.043 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 161' ' ' MET . 9.9 mtmt -95.5 159.42 15.01 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.117 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.458 ' HA ' ' HG2' ' A' ' 161' ' ' MET . 16.5 tpt180 -57.41 136.91 56.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.068 0.461 . . . . 0.0 111.578 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.31 145.71 55.0 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.49 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.542 HD12 ' C5 ' ' B' ' 6' ' ' ' A' . 13.9 mt -110.31 120.47 44.15 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.946 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.402 ' HG2' ' CG ' ' A' ' 238' ' ' GLU . 11.3 Cg_endo -54.97 147.76 50.78 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.04 1.827 . . . . 0.0 111.309 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.403 ' NH2' " H5'" ' B' ' 7' ' ' ' U' . 25.2 mmt180 -55.86 -36.71 67.88 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -57.68 -43.19 84.89 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.003 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.684 ' O ' HG23 ' A' ' 242' ' ' THR . 97.6 mt-10 -71.92 -39.66 69.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.084 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -61.18 -36.94 81.22 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.472 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -59.68 -37.31 78.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.999 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -86.41 -0.48 56.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 238' ' ' GLU . 27.3 p -87.85 162.54 16.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.081 0.467 . . . . 0.0 111.689 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -158.33 91.83 0.12 Allowed Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.767 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.584 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 77.5 tttt -79.2 132.42 36.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.764 0.316 . . . . 0.0 110.644 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.68 HD13 ' O ' ' A' ' 245' ' ' ILE . 0.0 OUTLIER -117.45 162.62 15.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.735 0.779 . . . . 0.0 112.254 -178.368 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.427 ' CG ' ' C6 ' ' B' ' 2' ' ' ' A' . 81.9 t80 -103.0 133.97 47.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.817 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.652 ' O ' ' HB2' ' A' ' 286' ' ' PHE . 8.2 p -128.15 135.05 63.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.351 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -123.96 12.03 8.2 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.349 -0.929 . . . . 0.0 113.694 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 313' ' ' ILE . . . -97.78 15.76 61.35 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.725 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.988 HD11 ' HA3' ' A' ' 287' ' ' GLY . 31.7 pt -120.9 155.56 24.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.489 0.662 . . . . 0.0 112.597 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.996 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -137.73 177.17 20.14 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.086 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.15 -26.96 44.39 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 121.981 1.787 . . . . 0.0 111.702 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.13 -35.1 72.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.592 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.996 HG22 ' O ' ' A' ' 251' ' ' GLY . 20.5 m -65.85 -28.1 43.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.74 127.35 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.07 -32.38 79.18 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.213 1.942 . . . . 0.0 113.126 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -61.15 -47.16 87.51 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.239 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 84.1 tt0 -66.67 -36.35 82.31 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.241 0.543 . . . . 0.0 110.944 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.72 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 31.3 t80 -59.5 -45.06 92.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.449 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.7 -40.32 92.16 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.321 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 258' ' ' GLU . 20.8 pt-20 -76.33 -30.64 57.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.08 0.467 . . . . 0.0 110.604 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.576 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 11.6 t80 -63.94 -55.56 21.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.057 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.832 ' CD2' HG21 ' A' ' 289' ' ' VAL . 4.2 m-85 -66.72 -24.66 66.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.547 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.634 ' N ' HD11 ' A' ' 269' ' ' ILE . 71.2 p -60.08 -24.78 64.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.537 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -54.89 -35.76 64.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.467 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.667 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 13.0 p90 -114.39 35.43 4.21 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.073 0.463 . . . . 0.0 111.604 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 264' ' ' SER . . . 164.31 149.03 5.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.641 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 44.5 m -59.91 -36.07 76.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.944 0.402 . . . . 0.0 110.92 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.651 HD11 ' C ' ' A' ' 263' ' ' PHE . 66.0 mt 64.82 90.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.161 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.611 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 80.5 mt -56.65 -42.47 76.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.201 178.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.451 ' OD2' ' CE ' ' A' ' 231' ' ' LYS . 61.9 t0 -168.69 100.88 0.4 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.745 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -98.73 136.72 38.37 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -143.02 155.43 44.64 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 1.073 HD23 HD11 ' A' ' 276' ' ' LEU . 30.6 tp -65.94 -35.45 80.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.176 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.657 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 86.7 mmm 105.58 -79.41 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.168 0.987 . . . . 0.0 112.234 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 1.073 HD11 HD23 ' A' ' 274' ' ' LEU . 6.5 mp 59.14 65.92 1.12 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.461 0.172 . . . . 0.0 111.017 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.424 ' HA ' ' OP2' ' B' ' 4' ' ' ' A' . 22.0 t70 -57.71 -41.31 81.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.383 0.611 . . . . 0.0 109.598 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' A' ' 280' ' ' THR . 55.8 mttp -142.0 114.87 8.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.966 177.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.68 ' O ' HD23 ' A' ' 276' ' ' LEU . 87.8 m-20 60.59 -65.44 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.034 -179.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 278' ' ' LYS . 0.3 OUTLIER 170.94 18.7 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -58.07 -38.58 89.94 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.691 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.918 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 96.1 mm-40 -60.96 -36.37 79.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.259 0.552 . . . . 0.0 110.349 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.819 ' OG ' HD21 ' A' ' 274' ' ' LEU . 36.8 t -60.58 -23.77 64.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.54 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -48.05 -33.4 7.99 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -144.6 -18.52 0.19 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 119.083 -1.532 . . . . 0.0 115.755 -178.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.652 ' HB2' ' O ' ' A' ' 247' ' ' VAL . 26.3 p90 -136.61 165.17 26.51 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.132 1.466 . . . . 0.0 113.269 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.988 ' HA3' HD11 ' A' ' 250' ' ' ILE . . . -141.62 163.57 26.84 Favored Glycine 0 CA--C 1.52 0.393 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.516 178.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.584 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -116.89 130.22 56.57 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.446 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.832 HG21 ' CD2' ' A' ' 263' ' ' PHE . 61.2 t -125.94 136.19 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.351 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 53.0 m -114.02 135.92 53.48 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.472 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 49.3 m-85 -115.76 136.35 53.14 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.611 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 21.8 t70 -59.18 -34.82 72.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.535 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 51.0 m -119.69 143.22 47.86 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.375 0.607 . . . . 0.0 111.763 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.55 -31.2 71.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.161 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 296' ' ' ALA . 53.5 p30 -60.8 -33.69 73.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.46 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.574 ' N ' ' OD1' ' A' ' 295' ' ' ASP . . . -62.16 -37.94 87.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.919 0.39 . . . . 0.0 110.65 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.593 ' O ' HG12 ' A' ' 300' ' ' VAL . 75.2 t -61.48 -42.07 92.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.031 0.443 . . . . 0.0 110.61 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -59.52 -37.17 77.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.592 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -58.35 -43.63 88.42 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.053 0.454 . . . . 0.0 111.821 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 1.008 HG23 HD11 ' A' ' 306' ' ' ILE . 1.0 OUTLIER -70.2 -34.4 58.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.456 -179.35 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 79.7 m -59.64 -47.24 86.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.333 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.19 -39.29 94.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.187 0.517 . . . . 0.0 110.419 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.1 m-20 -62.12 -34.75 76.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.772 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.675 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 23.2 tptm 65.39 -73.95 0.06 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.675 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 5.1 m-30 -108.87 134.51 51.45 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.888 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 1.008 HD11 HG23 ' A' ' 300' ' ' VAL . 14.9 mt -116.52 137.84 49.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.073 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.421 ' OD1' ' CE ' ' A' ' 312' ' ' LYS . 73.0 m-20 -75.99 87.53 2.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.68 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 7.8 t80 -97.76 -71.76 0.67 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.385 0.612 . . . . 0.0 110.655 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.629 ' HD2' HG12 ' A' ' 254' ' ' VAL . 4.6 mmpt? -96.69 -164.24 1.13 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.344 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.431 ' OD1' ' HG2' ' A' ' 311' ' ' ARG . 55.8 p30 -59.21 -21.8 60.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.702 0.287 . . . . 0.0 110.792 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.431 ' HG2' ' OD1' ' A' ' 310' ' ' ASP . 24.9 mmm180 -120.67 157.62 29.2 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.615 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.599 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 24.8 mmtm -72.5 154.02 41.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.634 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 249' ' ' GLY . 35.3 pt -117.46 148.86 19.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.118 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -106.48 130.17 54.32 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 0.628 HG12 HG23 ' A' ' 247' ' ' VAL . 81.7 mt -120.94 129.64 75.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.169 0.509 . . . . 0.0 112.231 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -128.99 153.24 47.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.545 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -63.54 144.43 57.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.73 0.3 . . . . 0.0 110.718 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.53 144.68 46.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.629 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -122.73 159.65 52.38 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.811 0.339 . . . . 0.0 111.501 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.76 -23.01 64.51 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.842 2.362 . . . . 0.0 112.68 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 41.05 97.26 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.969 0.414 . . . . 0.0 111.74 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 84.5 t60 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.034 179.875 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.43 -0.643 0 C3'-C2'-O2' 111.273 -0.699 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.918 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.921 0 C3'-C2'-O2' 111.307 -0.687 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.515 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.423 -1.084 0 C3'-C2'-O2' 111.3 -0.69 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.563 " H3'" " C5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.895 0 C4'-C3'-C2' 103.903 1.203 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.563 " C5'" " H3'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.782 0 C3'-C2'-O2' 110.927 -0.818 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.602 ' C4 ' ' CD2' ' A' ' 162' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.925 0 C3'-C2'-C1' 100.899 -0.668 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.744 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.984 0 C4'-C3'-C2' 103.614 0.914 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . 0.714 ' N3 ' " H2'" ' B' ' 8' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.998 0 C3'-C2'-O2' 111.203 -0.723 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.762 0.315 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -61.69 -32.35 72.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.792 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.9 m -57.38 -33.65 68.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.971 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.7 m -56.26 -33.49 65.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.721 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.447 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 80.9 tttt -64.46 138.74 58.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.423 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.542 ' CE ' HG11 ' A' ' 216' ' ' VAL . 89.8 mtp -127.27 157.87 38.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.283 0.563 . . . . 0.0 111.909 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.568 ' CE2' ' N9 ' ' B' ' 6' ' ' ' A' . 1.3 t80 -103.29 129.94 50.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.882 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 21.8 mm -114.07 129.34 70.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.357 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.544 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -128.58 163.09 22.14 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.821 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.527 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 76.4 38.37 33.62 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.888 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 75.7 mt -59.52 -25.45 64.5 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.596 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 38.7 t-20 72.52 41.02 0.6 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.973 0.416 . . . . 0.0 110.278 -178.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.58 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 23.5 m0 29.84 38.37 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.33 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 167' ' ' ASN . 58.4 t0 -156.54 28.43 0.33 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.798 0.332 . . . . 0.0 111.462 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.513 HG22 ' CD2' ' A' ' 175' ' ' LEU . 61.0 m -121.44 141.64 50.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 111.002 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.57 ' C ' HD12 ' A' ' 190' ' ' ILE . 15.8 p -117.35 163.09 16.87 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.635 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.779 ' N ' HD12 ' A' ' 190' ' ' ILE . 96.1 mt-10 -57.82 -33.24 68.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.515 ' O ' ' HG2' ' A' ' 176' ' ' ARG . 21.8 t70 -64.02 -41.34 97.47 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.974 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -63.54 -38.79 92.49 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.6 HD12 ' HE2' ' A' ' 179' ' ' PHE . 3.7 mm? -61.41 -40.32 93.96 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 173' ' ' ASP . 0.1 OUTLIER -61.77 -37.38 84.09 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.683 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.47 -37.39 87.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.022 0.439 . . . . 0.0 110.073 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.606 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 64.0 t80 -78.86 -64.72 1.12 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.44 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.6 ' HE2' HD12 ' A' ' 175' ' ' LEU . 78.0 m-85 -68.06 -20.76 64.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.385 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -50.79 -29.04 18.21 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.615 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.837 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -58.86 -41.23 86.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.2 0.524 . . . . 0.0 110.298 179.239 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.837 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 71.3 m-85 -71.04 -33.95 70.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.882 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -172.19 -172.91 38.49 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.881 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 33.9 p -72.72 -11.81 60.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.77 0.319 . . . . 0.0 110.875 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 185' ' ' VAL . 1.1 t 52.2 87.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -177.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 3.3 m -56.69 -43.47 80.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.696 -176.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -150.3 140.93 22.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.244 0.545 . . . . 0.0 112.311 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.554 HD23 ' CG1' ' A' ' 185' ' ' VAL . 0.2 OUTLIER -116.31 134.4 54.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.055 179.001 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 0.3 OUTLIER -131.81 123.6 27.92 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.382 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.779 HD12 ' N ' ' A' ' 172' ' ' GLU . 2.4 mt -125.07 128.09 72.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.396 176.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.832 ' HG2' " H1'" ' B' ' 7' ' ' ' U' . 3.1 mpp? -103.77 141.98 35.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.966 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 199' ' ' SER . 1.8 pttt -131.36 177.04 7.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.047 0.451 . . . . 0.0 111.56 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 74.3 m-20 -119.27 83.08 24.5 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.751 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.6 -26.3 54.44 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.269 1.979 . . . . 0.0 112.096 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.42 -67.4 0.63 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.295 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 56.1 p -70.71 -22.41 62.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.543 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 83.61 21.34 58.24 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.024 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.596 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 16.8 tpp85 -125.43 136.61 53.58 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 121.168 0.509 . . . . 0.0 111.934 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 192' ' ' LYS . 46.8 m -63.38 151.71 40.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.72 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.564 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 26.2 mmm180 -58.38 -32.2 68.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.943 0.401 . . . . 0.0 110.628 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.619 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 95.24 0.17 63.48 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.772 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 36.5 p90 -144.13 159.7 42.18 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.988 0.423 . . . . 0.0 111.067 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.461 ' HA2' ' HE1' ' A' ' 191' ' ' MET . . . -148.1 169.25 28.83 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.556 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.74 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 96.3 m-85 -110.07 129.19 55.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.092 0.472 . . . . 0.0 110.359 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.803 HD23 ' N ' ' A' ' 206' ' ' SER . 3.6 tt -108.78 132.7 53.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.404 -177.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.803 ' N ' HD23 ' A' ' 205' ' ' LEU . 33.1 t -122.22 131.61 54.02 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.305 178.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 205' ' ' LEU . 88.4 m-85 -118.23 136.92 53.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.057 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.589 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.4 tt0 -61.66 -35.14 77.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.053 0.454 . . . . 0.0 110.304 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -109.6 119.21 48.58 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.733 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.64 -26.6 73.36 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.413 2.075 . . . . 0.0 112.839 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.0 m -58.02 -36.44 72.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.567 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.447 ' O ' HG23 ' A' ' 216' ' ' VAL . 23.5 m -58.16 -34.07 69.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.964 0.411 . . . . 0.0 110.593 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.538 HG13 ' SD ' ' A' ' 161' ' ' MET . 78.0 t -61.0 -39.51 82.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.279 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.457 ' O ' HG22 ' A' ' 217' ' ' VAL . 21.6 t70 -56.0 -42.39 76.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.743 0.306 . . . . 0.0 111.178 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 182' ' ' TYR . 96.4 mt-10 -66.9 -33.61 75.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.071 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.775 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 92.7 t -59.13 -42.85 87.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.734 -178.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 214' ' ' ASP . 20.3 m -72.79 -32.52 40.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.31 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 214' ' ' ASP . 45.0 mmtt -60.57 -34.24 73.87 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.616 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 52.7 m -99.05 138.78 35.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.836 0.35 . . . . 0.0 111.534 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 57.8 tp60 -65.91 -41.64 91.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.078 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.775 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 64.2 m-70 83.04 115.0 0.06 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 178.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.901 HD12 HG12 ' A' ' 227' ' ' VAL . 21.5 mm -117.66 109.35 27.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 175.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.5 tt -122.39 130.48 53.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.061 0.458 . . . . 0.0 111.63 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 57.8 t0 52.84 33.61 14.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.682 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 83.14 5.68 88.84 Favored Glycine 0 CA--C 1.517 0.163 0 C-N-CA 120.588 -0.815 . . . . 0.0 114.665 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.437 ' NZ ' ' C6 ' ' B' ' 4' ' ' ' A' . 36.8 ttmt -133.32 131.96 40.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.816 0.808 . . . . 0.0 111.612 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.901 HG12 HD12 ' A' ' 222' ' ' ILE . 19.6 m -67.83 136.03 27.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.574 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 165' ' ' GLY . 35.6 pt -122.59 157.95 27.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.223 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.577 ' O ' ' O4 ' ' B' ' 5' ' ' ' U' . 1.1 m-20 -127.76 80.06 72.6 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.008 0.432 . . . . 0.0 111.92 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.539 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 47.7 Cg_exo -59.56 136.84 73.87 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 123.188 2.592 . . . . 0.0 111.542 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.65 ' HE2' ' H62' ' B' ' 6' ' ' ' A' . 7.2 ttpm? -138.46 154.54 48.85 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.715 -0.221 . . . . 0.0 110.721 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -57.57 136.97 56.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 0.0 111.319 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -72.36 146.47 47.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.605 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.771 HD12 ' HG2' ' A' ' 239' ' ' GLN . 1.2 pt -134.04 108.48 11.59 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.783 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 234' ' ' ILE . 1.6 Cg_endo -46.87 154.78 0.98 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.105 1.87 . . . . 0.0 110.884 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -51.47 -40.93 60.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.601 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 54.6 p30 -64.68 -38.74 92.01 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.215 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.601 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 96.8 mt-10 -70.48 -35.04 73.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.612 0.244 . . . . 0.0 111.181 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.771 ' HG2' HD12 ' A' ' 234' ' ' ILE . 84.2 mt-30 -59.21 -39.59 83.16 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.021 0.439 . . . . 0.0 110.0 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -62.71 -42.75 99.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.369 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -64.12 -39.65 94.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.542 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 238' ' ' GLU . 53.1 p -68.48 -38.22 80.82 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.879 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 61.54 142.41 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.016 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.543 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 6.8 tptm -131.66 131.04 42.84 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.952 HD12 HG21 ' A' ' 315' ' ' ILE . 8.4 pt -120.23 154.32 23.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.482 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.551 ' CZ ' ' N7 ' ' B' ' 2' ' ' ' A' . 88.3 t80 -100.91 132.24 46.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.838 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.826 HG21 ' CZ ' ' A' ' 263' ' ' PHE . 20.6 t -120.4 128.46 76.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.028 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -121.65 -7.34 8.16 Favored Glycine 0 C--N 1.329 0.163 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.441 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.544 ' O ' HG22 ' A' ' 313' ' ' ILE . . . -81.25 9.56 53.66 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.17 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.743 HD11 ' HA3' ' A' ' 287' ' ' GLY . 41.3 pt -111.7 133.68 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 116.968 0.384 . . . . 0.0 111.229 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 159.18 -49.43 0.4 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.693 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.96 -33.57 89.54 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.446 2.097 . . . . 0.0 112.72 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -162.68 64.03 0.2 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.077 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.526 HG21 ' HB ' ' A' ' 250' ' ' ILE . 27.6 m -131.36 156.22 42.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.529 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.68 156.43 79.51 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.449 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.57 -40.14 86.52 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 121.521 1.481 . . . . 0.0 111.562 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.24 -42.99 99.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.289 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' A' ' 262' ' ' PHE . 97.7 mt-10 -68.04 -41.07 82.62 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.95 0.405 . . . . 0.0 111.276 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.675 ' CE1' HD13 ' A' ' 250' ' ' ILE . 82.8 t80 -65.13 -47.84 75.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.12 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 264' ' ' SER . 84.4 tt0 -64.17 -42.03 96.89 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.094 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -76.39 -30.71 57.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.022 0.439 . . . . 0.0 111.085 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.694 ' CZ ' HG21 ' A' ' 306' ' ' ILE . 5.5 t80 -61.83 -64.82 0.81 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.019 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.995 ' CB ' HD11 ' A' ' 269' ' ' ILE . 32.8 m-85 -62.64 -27.51 69.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.064 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.455 ' OG ' ' HA ' ' A' ' 268' ' ' THR . 33.3 t -56.38 -28.53 59.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.087 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -53.13 -34.7 57.92 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.803 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 14.4 p90 -116.71 54.5 0.85 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.907 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.519 ' O ' HG22 ' A' ' 268' ' ' THR . . . 153.06 -12.77 0.61 Allowed Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.775 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.567 ' O ' ' O ' ' A' ' 269' ' ' ILE . 0.5 OUTLIER 66.95 -1.84 1.29 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.995 HD11 ' CB ' ' A' ' 263' ' ' PHE . 77.4 mt 33.54 115.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.622 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 75.7 mt -60.4 -42.06 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.06 176.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -166.16 97.47 0.61 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.927 ' HB2' HG21 ' A' ' 269' ' ' ILE . . . -104.82 142.72 34.22 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -140.07 150.59 44.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.444 0.64 . . . . 0.0 112.141 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.576 ' O ' ' HB2' ' A' ' 275' ' ' MET . 43.5 tp -66.49 -37.54 85.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.713 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.576 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 91.9 mmm 90.73 111.16 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.424 0.69 . . . . 0.0 111.147 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 276' ' ' LEU . 6.2 mp -118.46 124.11 46.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.704 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -62.41 -39.06 92.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.87 0.843 . . . . 0.0 109.045 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -161.09 -106.97 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.083 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -62.34 -37.2 84.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.014 0.435 . . . . 0.0 110.054 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 1.2 t 171.66 68.82 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.75 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -93.19 -75.35 1.3 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.094 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.785 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 96.0 mm-40 -57.54 -30.7 65.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.171 0.51 . . . . 0.0 110.034 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.485 ' HB2' ' CD2' ' A' ' 274' ' ' LEU . 76.5 p -64.18 163.2 13.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.465 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.425 ' O ' ' HG2' ' A' ' 284' ' ' ARG . 59.4 ttp180 69.69 6.26 5.63 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.252 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -130.92 -48.02 0.12 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.65 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 40.6 p90 -148.67 166.77 27.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.542 0.211 . . . . 0.0 111.029 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.743 ' HA3' HD11 ' A' ' 250' ' ' ILE . . . -136.72 157.06 23.5 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.263 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.543 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.9 OUTLIER -109.75 129.84 55.58 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.748 0.419 . . . . 0.0 110.552 179.47 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.508 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 48.5 t -126.16 134.22 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.801 ' O ' HG23 ' A' ' 269' ' ' ILE . 30.5 m -123.01 139.44 54.08 Favored 'General case' 0 C--O 1.23 0.063 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 242' ' ' THR . 51.0 m-85 -117.5 140.32 49.77 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.622 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 21.4 t70 -56.34 -34.86 67.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.599 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 51.1 m -119.86 142.74 48.39 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.948 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.47 -32.05 73.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.045 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -56.21 -36.5 68.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.467 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -60.06 -37.07 78.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.408 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.692 HG13 ' CG2' ' A' ' 245' ' ' ILE . 71.4 t -61.79 -44.13 98.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.037 0.446 . . . . 0.0 110.405 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -63.2 -37.48 87.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.1 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -58.38 -43.14 88.37 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.803 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 0.4 OUTLIER -73.45 -32.82 38.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.923 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 83.9 m -57.21 -44.39 83.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -60.43 -40.26 90.42 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.329 0.585 . . . . 0.0 109.812 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 305' ' ' PHE . 88.0 m-20 -60.41 -32.48 71.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.407 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.635 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 22.0 tptt 69.88 -68.2 0.21 Allowed 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.635 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.0 m-30 -115.5 149.72 37.66 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.445 178.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.694 HG21 ' CZ ' ' A' ' 262' ' ' PHE . 23.7 mm -117.23 140.18 41.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.742 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -80.28 39.74 0.46 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.961 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.62 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 6.2 t80 -48.24 -68.4 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.478 ' HD3' ' CZ ' ' A' ' 308' ' ' PHE . 16.9 mmmt -105.6 19.41 20.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.811 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 53.6 t0 69.25 9.69 7.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.732 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -109.88 2.02 19.57 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.037 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.423 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 22.6 mttm 62.2 121.55 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.017 0.437 . . . . 0.0 111.714 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 249' ' ' GLY . 31.6 pt -116.28 147.09 19.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.444 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' GLU . . . . . 0.564 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 84.7 mt-10 -103.93 132.19 50.43 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.847 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 0.952 HG21 HD12 ' A' ' 245' ' ' ILE . 63.2 mt -120.35 127.98 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.589 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -126.7 148.39 49.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.716 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -55.53 148.3 15.96 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.03 140.92 36.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.139 0.495 . . . . 0.0 111.394 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -117.39 111.03 40.3 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.63 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -49.99 102.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.906 1.737 . . . . 0.0 111.885 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -57.97 -38.1 75.42 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.15 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 85.1 t60 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.873 -179.759 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.676 0 C3'-C2'-O2' 111.178 -0.732 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.785 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.967 0 O4'-C1'-C2' 107.474 0.767 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.786 ' O2 ' " H3'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.023 0 C3'-C2'-O2' 111.36 -0.669 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.619 " O2'" ' HA3' ' A' ' 201' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.882 0 C4'-C3'-C2' 104.05 1.35 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.797 " O2'" ' P ' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.883 0 C3'-C2'-C1' 100.321 -1.31 OUTLIER-EPSILON 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.797 ' P ' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.957 0 C4'-C3'-C2' 103.464 0.764 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.832 " H1'" ' HG2' ' A' ' 191' ' ' MET . . . . . . . . 0 O5'--C5' 1.425 -0.92 0 C1'-C2'-O2' 108.509 -0.697 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . 0.481 ' N7 ' " H2'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.983 0 C3'-C2'-O2' 111.219 -0.718 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 65.2 mttp . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.636 0.255 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.603 ' HG3' ' H ' ' A' ' 159' ' ' CYS . 43.7 tp10 -101.55 138.54 38.41 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.786 0.327 . . . . 0.0 110.543 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 53.7 p -80.31 -2.52 45.64 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.198 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.603 ' H ' ' HG3' ' A' ' 157' ' ' GLU . 4.0 m -85.07 13.45 6.14 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.667 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 8.5 tptm -63.25 134.07 55.27 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.76 0.314 . . . . 0.0 110.342 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.785 ' SD ' HG13 ' A' ' 213' ' ' VAL . 89.8 mmm -123.4 147.28 47.26 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.62 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 3.4 t80 -109.56 126.05 53.17 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.823 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 3.7 mt -121.96 130.16 74.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.112 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.509 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -125.05 156.04 18.84 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.038 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.85 33.34 57.81 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.707 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.607 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 69.7 mt -58.68 -32.45 69.14 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.645 ' O ' ' N ' ' A' ' 169' ' ' ASP . 45.4 t30 110.49 31.22 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.283 0.633 . . . . 0.0 110.99 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.571 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 6.5 m0 53.04 -49.25 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.645 ' N ' ' O ' ' A' ' 167' ' ' ASN . 50.3 p30 -82.27 9.27 9.16 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 166' ' ' LEU . 85.7 m -68.99 137.81 54.02 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.203 0.525 . . . . 0.0 109.975 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 30.6 m -112.14 148.33 34.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.387 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.662 ' N ' HD12 ' A' ' 190' ' ' ILE . 55.6 mp0 -54.56 -37.51 65.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.555 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 89.5 m-20 -63.2 -40.12 96.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.946 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -61.6 -36.69 81.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.302 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.673 HD23 ' CE2' ' A' ' 179' ' ' PHE . 5.8 mt -55.34 -49.38 72.37 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.555 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -67.05 -31.94 72.8 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.482 179.073 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.43 -39.0 78.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.695 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.636 ' CE2' ' CE2' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -94.08 -55.62 3.14 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.113 179.288 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.823 ' CZ ' HD13 ' A' ' 163' ' ' ILE . 64.0 m-85 -60.72 -28.95 69.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.874 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.93 -23.28 10.86 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.169 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.82 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -54.52 -40.52 68.69 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.882 0.373 . . . . 0.0 111.14 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.82 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 55.5 m-85 -69.32 -31.67 70.29 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.243 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 166.97 -134.41 3.26 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.871 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 57.7 m -117.64 136.89 53.01 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.887 HG23 ' CE1' ' A' ' 207' ' ' PHE . 0.9 OUTLIER -95.0 127.79 46.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.613 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.746 HG23 ' N ' ' A' ' 208' ' ' GLU . 54.0 p -70.18 -35.94 74.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.397 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -148.86 145.24 27.39 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.879 HD22 HG11 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -116.45 129.06 56.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.749 178.915 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.565 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 7.3 tppt? -138.59 111.36 7.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 172' ' ' GLU . 82.3 mt -125.68 123.13 63.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 174.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.588 ' O ' ' O ' ' A' ' 192' ' ' LYS . 0.0 OUTLIER -59.9 -37.61 79.93 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.084 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.588 ' O ' ' O ' ' A' ' 191' ' ' MET . 26.7 tttt 49.18 149.68 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.268 0.556 . . . . 0.0 112.008 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 9.9 t0 -128.3 78.48 75.52 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.366 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.74 -24.17 61.96 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.408 2.072 . . . . 0.0 112.011 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -73.82 -72.0 0.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.572 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 48.4 p -69.03 -26.21 64.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.624 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.66 7.01 65.22 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.707 -0.759 . . . . 0.0 113.241 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 20.9 tpp180 -124.38 125.78 44.87 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-N 117.267 0.534 . . . . 0.0 111.181 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.1 t -70.27 156.99 38.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.63 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.663 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 83.8 mmt-85 -55.55 -31.75 62.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.705 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.442 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 95.78 0.49 62.28 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.675 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.663 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 42.6 p90 -142.47 154.41 44.51 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.418 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -150.45 170.66 30.36 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.666 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.848 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 89.5 m-85 -107.91 125.55 51.62 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.109 0.481 . . . . 0.0 109.963 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.669 HD11 HG21 ' A' ' 185' ' ' VAL . 16.8 tp -112.61 131.19 55.74 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.197 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.577 ' O ' HG22 ' A' ' 185' ' ' VAL . 49.1 m -120.1 140.39 51.12 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.723 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.887 ' CE1' HG23 ' A' ' 185' ' ' VAL . 78.4 m-85 -121.65 141.88 50.69 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.567 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.746 ' N ' HG23 ' A' ' 186' ' ' THR . 84.5 tt0 -64.45 -34.75 78.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.245 178.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -110.76 115.58 53.27 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.926 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.406 ' O ' ' HB ' ' A' ' 213' ' ' VAL . 52.5 Cg_exo -56.25 -25.78 57.83 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.582 2.188 . . . . 0.0 113.033 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.2 m -58.06 -37.42 74.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.0 110.555 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.887 ' O ' HG23 ' A' ' 216' ' ' VAL . 25.0 m -59.97 -34.76 73.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.244 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.785 HG13 ' SD ' ' A' ' 161' ' ' MET . 71.2 t -60.39 -41.0 85.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.214 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -57.4 -44.86 84.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.051 0.453 . . . . 0.0 110.487 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.58 -33.77 73.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.384 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 212' ' ' SER . 74.9 t -59.65 -40.59 82.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.692 -178.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 230' ' ' PRO . 21.3 m -88.87 -38.68 11.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -178.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -60.14 -34.73 73.95 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.495 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 32.2 m -93.37 146.28 23.86 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -79.76 140.76 36.8 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.855 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 41.8 m-70 -125.85 139.41 53.51 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -176.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.593 HG22 ' H ' ' A' ' 225' ' ' GLY . 67.7 mt -125.52 114.61 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.347 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.434 ' HG ' ' CD2' ' A' ' 178' ' ' TYR . 1.0 OUTLIER -82.22 -50.83 8.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.04 0.448 . . . . 0.0 111.99 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -142.86 43.68 1.58 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.788 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.593 ' H ' HG22 ' A' ' 222' ' ' ILE . . . 96.17 -0.65 62.22 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.978 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.436 ' CG ' ' OD1' ' A' ' 167' ' ' ASN . 12.2 mmmm -99.36 169.49 9.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.663 0.268 . . . . 0.0 110.352 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 14.6 p -118.33 132.91 66.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.948 0.404 . . . . 0.0 110.125 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.642 HD12 ' CG2' ' A' ' 163' ' ' ILE . 35.9 pt -129.41 161.13 39.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.949 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -129.63 81.01 70.64 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.0 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.746 ' O ' HG12 ' A' ' 217' ' ' VAL . 78.1 Cg_exo -54.97 129.48 35.56 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.958 2.438 . . . . 0.0 112.782 -178.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.409 ' HE2' ' O4 ' ' B' ' 5' ' ' ' U' . 9.8 mtmm -132.86 154.58 50.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.423 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.604 ' HD3' ' N ' ' A' ' 233' ' ' ALA . 1.5 tmt_? -63.5 135.08 56.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.902 0.382 . . . . 0.0 110.759 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.667 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -63.91 145.77 55.24 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.286 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.505 ' CD1' ' C6 ' ' B' ' 6' ' ' ' A' . 0.8 OUTLIER -109.92 130.67 22.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.479 179.498 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.43 ' HG2' ' HB2' ' A' ' 238' ' ' GLU . 9.6 Cg_endo -53.45 138.84 65.87 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 121.772 1.648 . . . . 0.0 110.85 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -56.56 -40.39 75.08 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.16 -45.6 92.53 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.496 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.43 ' HB2' ' HG2' ' A' ' 235' ' ' PRO . 97.1 mt-10 -71.61 -37.32 70.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.599 0.714 . . . . 0.0 109.842 178.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.438 ' NE2' " O2'" ' B' ' 6' ' ' ' A' . 45.3 tt0 -59.5 -39.48 83.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.979 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -59.51 -39.28 83.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.037 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -60.35 -35.3 75.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.54 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.528 HG21 ' CD1' ' A' ' 270' ' ' ILE . 19.3 p -84.08 162.21 20.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.991 0.424 . . . . 0.0 111.65 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -154.27 118.54 0.87 Allowed Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.13 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 18.2 ttpp -88.49 135.93 33.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.732 0.301 . . . . 0.0 111.127 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.73 HG21 HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -119.51 164.6 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.358 0.599 . . . . 0.0 111.781 -179.012 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.54 ' CZ ' ' N7 ' ' B' ' 2' ' ' ' A' . 88.2 t80 -101.27 136.98 40.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.156 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.853 HG23 HG12 ' A' ' 315' ' ' ILE . 9.2 p -129.72 145.13 36.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.107 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.56 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -131.84 165.36 23.44 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 97.31 -2.69 61.25 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.986 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.79 HD11 ' HA3' ' A' ' 287' ' ' GLY . 43.7 pt -117.64 137.92 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-O 121.172 0.511 . . . . 0.0 111.604 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.868 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -174.18 -89.26 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.488 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.66 132.57 43.58 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.455 2.103 . . . . 0.0 112.984 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 51.17 40.17 25.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.818 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 251' ' ' GLY . 29.8 m -105.84 -35.49 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.049 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 254' ' ' VAL . 13.4 mmm180 57.39 132.63 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.76 -30.22 66.09 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.892 1.728 . . . . 0.0 112.35 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 39.0 tttm -61.28 -44.14 97.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.604 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.681 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 98.0 mt-10 -67.0 -39.87 87.22 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.164 0.506 . . . . 0.0 110.599 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.78 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 15.7 t80 -62.55 -45.49 92.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.029 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 257' ' ' LYS . 20.3 pt-20 -69.23 -41.16 77.39 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.795 0.331 . . . . 0.0 111.021 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.412 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.7 pt-20 -74.26 -29.76 61.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.288 0.566 . . . . 0.0 110.157 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.571 ' CZ ' HD11 ' A' ' 313' ' ' ILE . 5.8 t80 -60.94 -57.28 13.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.884 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.701 ' CD2' HG21 ' A' ' 289' ' ' VAL . 3.7 m-85 -65.18 -23.44 67.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.355 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.653 ' N ' HD11 ' A' ' 269' ' ' ILE . 27.2 t -53.97 -30.14 45.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.616 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -53.39 -34.75 58.92 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.105 -0.238 . . . . 0.0 111.116 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.757 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 7.4 p90 -119.0 46.02 1.96 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.21 0.529 . . . . 0.0 111.74 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.486 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 156.31 152.92 6.41 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.916 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 43.0 p -70.28 -25.53 63.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.041 0.448 . . . . 0.0 110.748 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.653 HD11 ' N ' ' A' ' 264' ' ' SER . 76.9 mt 54.55 96.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.111 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.576 HG13 ' CA ' ' A' ' 292' ' ' ASP . 79.3 mt -59.18 -40.61 81.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.207 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 50.3 p30 -169.77 156.55 6.42 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.496 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -155.07 145.32 21.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.866 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -145.45 150.71 36.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.11 0.481 . . . . 0.0 111.852 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.59 ' O ' ' HB2' ' A' ' 275' ' ' MET . 24.7 tp -66.17 -39.75 89.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.229 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.922 ' O ' HD12 ' A' ' 276' ' ' LEU . 94.8 mmm 98.2 151.85 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.495 0.718 . . . . 0.0 109.659 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.922 HD12 ' O ' ' A' ' 275' ' ' MET . 0.3 OUTLIER -162.04 84.44 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.562 0.22 . . . . 0.0 111.427 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -85.89 110.84 19.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.912 0.386 . . . . 0.0 110.621 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.635 ' O ' HG22 ' A' ' 280' ' ' THR . 40.8 mttm 55.95 30.69 16.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.91 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 51.51 43.95 29.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.135 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.635 HG22 ' O ' ' A' ' 278' ' ' LYS . 1.6 t -165.83 -41.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.717 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -55.0 -37.49 62.9 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.475 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.571 ' HG2' ' HB2' ' A' ' 275' ' ' MET . 3.4 tp-100 -109.41 132.51 54.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.747 0.308 . . . . 0.0 111.494 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 282' ' ' GLN . 27.5 p 148.89 -18.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.059 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 51.1 ttt85 -56.46 -37.97 71.03 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.226 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 250' ' ' ILE . . . 144.59 43.08 0.05 OUTLIER Glycine 0 CA--C 1.522 0.503 0 C-N-CA 119.984 -1.103 . . . . 0.0 114.147 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.521 ' CE1' " H4'" ' B' ' 2' ' ' ' A' . 15.5 p90 -140.28 167.47 22.06 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 117.483 0.641 . . . . 0.0 110.409 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.79 ' HA3' HD11 ' A' ' 250' ' ' ILE . . . -147.51 169.28 28.43 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.579 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.445 ' CE2' ' NZ ' ' A' ' 244' ' ' LYS . 0.3 OUTLIER -122.42 124.16 42.99 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 122.346 0.258 . . . . 0.0 111.053 179.429 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.78 HG23 ' CZ ' ' A' ' 259' ' ' PHE . 61.2 t -127.67 138.07 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.033 0.445 . . . . 0.0 112.142 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 44.4 m -116.04 137.09 52.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.241 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.486 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 41.7 m-85 -115.1 135.19 54.47 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.576 ' CA ' HG13 ' A' ' 270' ' ' ILE . 55.1 t0 -59.01 -35.37 73.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.652 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 30.5 t -118.35 139.31 51.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.207 0.527 . . . . 0.0 111.61 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.914 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -64.08 -31.89 73.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.02 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -57.06 -35.61 69.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.299 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.2 -37.33 77.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.705 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.914 HG12 ' O ' ' A' ' 294' ' ' ALA . 6.2 p -58.73 -38.21 70.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.005 0.431 . . . . 0.0 110.662 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -63.3 -37.43 87.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.181 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 302' ' ' GLN . 92.8 mtt-85 -58.23 -41.13 83.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.893 -178.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.757 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 2.3 p -65.12 -33.68 65.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.066 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 74.5 m -56.92 -39.75 75.06 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' GLN . . . . . 0.409 ' HB3' ' O ' ' A' ' 299' ' ' ARG . 50.6 tp60 -62.77 -35.5 80.03 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.924 177.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.756 ' ND2' HD12 ' A' ' 306' ' ' ILE . 22.9 p30 -101.2 42.76 1.1 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.008 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.638 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 18.7 tptm -16.08 -65.07 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.915 0.388 . . . . 0.0 110.432 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.638 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.1 m-30 -110.22 142.36 41.89 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.756 HD12 ' ND2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -117.01 130.23 72.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.732 179.681 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -73.18 71.55 1.18 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.535 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 2.9 t80 -62.47 -105.6 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.344 -177.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.46 ' HD2' ' CE1' ' A' ' 308' ' ' PHE . 12.6 mmmm -61.83 -37.17 83.46 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.054 0.454 . . . . 0.0 111.316 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 309' ' ' LYS . 60.3 t0 175.8 -25.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.791 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -111.8 159.43 18.31 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.199 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.628 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 42.4 mttp -72.99 140.48 47.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.333 0.587 . . . . 0.0 111.905 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 305' ' ' PHE . 36.3 pt -119.0 152.79 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.615 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -107.54 131.48 54.29 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.617 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 0.853 HG12 HG23 ' A' ' 247' ' ' VAL . 74.1 mt -119.85 129.71 75.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.38 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 22.9 tttm -133.08 144.37 49.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.5 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -54.1 144.99 18.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.721 0.296 . . . . 0.0 110.314 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.67 140.14 55.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 111.073 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -87.46 143.3 33.94 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.932 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.64 -19.86 47.57 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.472 2.114 . . . . 0.0 111.763 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.506 ' HD3' ' C5 ' ' B' ' 3' ' ' ' U' . 1.9 ttt-85 41.63 92.98 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.687 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 54.5 p-80 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.909 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.754 0 C3'-C2'-O2' 111.243 -0.709 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.54 ' N7 ' ' CZ ' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.989 0 C3'-C2'-O2' 111.382 -0.661 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.559 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.423 -1.036 0 C3'-C2'-O2' 111.227 -0.715 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.584 " H3'" " C5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.909 0 C4'-C3'-C2' 103.782 1.082 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.902 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.857 0 C3'-C2'-O2' 110.962 -0.806 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.902 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.005 0 C3'-C2'-O2' 111.122 -0.751 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.848 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.987 0 C4'-C3'-C2' 103.694 0.994 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . 0.622 ' N3 ' " H2'" ' B' ' 8' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.954 0 C3'-C2'-O2' 111.257 -0.704 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 97.0 mttt . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.822 0.344 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 60.1 mp0 -61.48 -33.87 74.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.575 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.7 p 28.89 94.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.651 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 51.7 t -124.85 92.63 3.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.214 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.864 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 6.5 tptt -135.07 142.73 46.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.584 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.794 ' SD ' HG13 ' A' ' 213' ' ' VAL . 87.0 mmm -122.21 147.01 46.72 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.619 ' CE2' ' N9 ' ' B' ' 6' ' ' ' A' . 1.6 t80 -108.81 125.6 52.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.036 177.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 202' ' ' PHE . 20.9 mm -118.04 129.71 74.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.613 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -127.06 162.73 21.12 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.007 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.67 36.12 38.58 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.745 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.543 HD22 HG21 ' A' ' 170' ' ' THR . 70.7 mt -59.61 -24.55 63.91 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.563 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 42.2 t-20 72.48 43.78 0.45 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.136 0.494 . . . . 0.0 110.505 -178.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.572 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 21.1 m0 31.39 39.38 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.429 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -160.54 46.57 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.353 . . . . 0.0 111.304 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.543 HG21 HD22 ' A' ' 166' ' ' LEU . 90.4 m -123.96 139.92 53.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.019 0.438 . . . . 0.0 110.899 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 33.5 p -119.93 160.07 23.44 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.393 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.535 ' N ' HD12 ' A' ' 190' ' ' ILE . 55.8 mp0 -61.98 -30.54 71.0 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.844 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 88.8 m-20 -61.03 -42.89 99.33 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.907 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -65.93 -38.54 88.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.121 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.979 HD22 HD21 ' A' ' 205' ' ' LEU . 10.6 mt -61.87 -42.47 99.09 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.844 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -65.78 -38.82 90.06 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.893 179.329 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.45 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 84.5 tt0 -70.89 -45.01 65.09 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.134 0.492 . . . . 0.0 110.457 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.984 ' OH ' ' HB2' ' A' ' 221' ' ' HIS . 19.0 t80 -63.17 -45.14 93.2 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.28 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.606 ' CE2' HD23 ' A' ' 175' ' ' LEU . 96.0 m-85 -98.04 2.02 48.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.34 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -58.51 -28.1 61.89 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.358 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.566 ' H ' ' CD ' ' A' ' 181' ' ' LYS . 0.6 OUTLIER -56.72 -42.73 79.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.959 0.885 . . . . 0.0 110.328 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -70.99 -35.19 72.0 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 113.781 -1.554 . . . . 0.0 112.75 -177.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 177.55 -174.37 46.87 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 119.679 -1.248 . . . . 0.0 113.741 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.8 m -63.82 -28.55 69.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.042 -0.579 . . . . 0.0 111.241 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.642 ' CG1' ' O ' ' A' ' 185' ' ' VAL . 0.4 OUTLIER 64.3 87.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -176.775 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -54.77 -46.15 74.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.033 -176.661 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 186' ' ' THR . 90.8 m-20 -139.25 152.36 47.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.226 0.536 . . . . 0.0 112.012 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.701 HD11 ' CB ' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -125.55 129.08 49.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.505 179.452 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.491 ' HE2' ' C2 ' ' B' ' 7' ' ' ' U' . 22.8 tptt -132.33 119.26 20.5 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.488 0.661 . . . . 0.0 112.643 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.535 HD12 ' N ' ' A' ' 172' ' ' GLU . 1.9 mt -128.83 131.95 67.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.662 177.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.622 ' SD ' ' CE2' ' A' ' 202' ' ' PHE . 0.8 OUTLIER -88.77 127.32 35.6 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -133.24 162.74 30.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.979 0.418 . . . . 0.0 111.593 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.578 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 32.3 m-20 -124.81 84.37 58.33 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.348 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.34 -25.42 39.06 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.241 1.961 . . . . 0.0 112.362 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.88 -71.29 0.36 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.9 0.381 . . . . 0.0 111.313 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.4 p -71.8 -21.56 61.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.178 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 80.36 26.76 54.02 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.32 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.578 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 15.8 ttp180 -119.78 149.95 41.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.26 0.552 . . . . 0.0 112.372 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.8 t -108.71 148.41 30.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.593 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.626 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 59.8 mmt-85 -53.35 -29.92 36.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.758 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.59 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 97.56 2.16 58.81 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.137 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.626 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 25.6 p90 -142.96 155.35 44.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.937 0.398 . . . . 0.0 110.819 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.507 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -142.94 161.73 27.52 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.768 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.672 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 89.7 m-85 -111.65 130.55 55.73 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.827 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.979 HD21 HD22 ' A' ' 175' ' ' LEU . 44.8 mt -109.35 141.67 41.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.974 0.416 . . . . 0.0 111.667 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 33.1 t -127.15 131.15 50.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.346 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.583 ' CE1' HG23 ' A' ' 185' ' ' VAL . 99.1 m-85 -119.15 140.58 49.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.814 0.34 . . . . 0.0 111.562 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.501 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.3 tt0 -60.87 -34.63 74.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.089 0.471 . . . . 0.0 110.089 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.1 114.08 51.44 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.395 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.74 -26.83 58.58 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.389 2.059 . . . . 0.0 113.005 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.2 m -58.61 -36.17 73.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.775 0.321 . . . . 0.0 111.153 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.422 ' O ' HG23 ' A' ' 216' ' ' VAL . 21.9 m -58.63 -35.04 71.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.049 0.452 . . . . 0.0 110.66 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.794 HG13 ' SD ' ' A' ' 161' ' ' MET . 54.6 t -60.94 -38.67 79.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.784 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -54.2 -42.82 70.16 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.347 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -69.69 -34.34 73.8 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.71 HG12 ' HB2' ' A' ' 230' ' ' PRO . 98.3 t -60.64 -44.77 97.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.967 0.413 . . . . 0.0 111.346 -178.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.597 HG22 ' HE1' ' A' ' 161' ' ' MET . 41.9 t -76.77 -51.68 18.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 7.8 tptm -61.17 -40.5 94.14 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 220' ' ' GLN . 88.7 m -59.0 -38.27 78.81 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 219' ' ' THR . 63.7 tt0 60.69 111.7 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -177.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.984 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -139.92 167.12 22.84 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -176.839 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.814 HG23 ' C ' ' A' ' 226' ' ' LYS . 3.6 mp -118.0 126.05 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.207 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.757 HD12 ' CG ' ' A' ' 178' ' ' TYR . 7.5 tt -119.0 132.21 56.05 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.157 0.503 . . . . 0.0 111.744 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.516 ' HB2' HD23 ' A' ' 223' ' ' LEU . 19.5 t70 63.81 28.82 14.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.093 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 94.11 -14.3 65.58 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.542 -0.837 . . . . 0.0 115.037 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.814 ' C ' HG23 ' A' ' 222' ' ' ILE . 66.6 mttt -113.49 137.54 51.41 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 117.953 0.877 . . . . 0.0 112.338 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.809 HG12 HG12 ' A' ' 222' ' ' ILE . 33.7 m -64.77 128.27 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.282 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.613 HG22 ' O ' ' A' ' 164' ' ' GLY . 37.6 pt -124.28 155.1 31.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.045 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.1 76.69 78.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.295 0.569 . . . . 0.0 110.619 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.71 ' HB2' HG12 ' A' ' 216' ' ' VAL . 80.2 Cg_exo -53.0 128.67 29.86 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.12 2.547 . . . . 0.0 111.537 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -139.03 148.3 43.22 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.317 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.692 ' HE ' HG11 ' A' ' 213' ' ' VAL . 15.2 mmt85 -48.97 138.76 11.14 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.12 0.485 . . . . 0.0 111.523 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.864 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -75.72 146.07 40.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.98 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.515 ' CG1' ' C6 ' ' B' ' 6' ' ' ' A' . 0.0 OUTLIER -112.84 129.1 24.8 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.417 179.286 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.04 149.15 21.8 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 121.915 1.744 . . . . 0.0 110.911 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 52.6 mmm-85 -54.62 -40.44 68.93 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.671 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -64.57 -40.32 95.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.596 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -65.51 -36.39 83.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.6 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -60.14 -37.59 80.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.991 0.424 . . . . 0.0 110.521 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -60.07 -38.62 83.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.129 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -59.68 -35.58 74.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.665 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.454 HG22 ' HA ' ' A' ' 292' ' ' ASP . 20.7 p -87.13 161.86 17.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.005 0.431 . . . . 0.0 111.666 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -142.87 113.91 0.82 Allowed Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.722 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 33.0 ttpt -85.33 140.75 30.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.96 0.409 . . . . 0.0 111.599 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 1.059 HD12 HG21 ' A' ' 315' ' ' ILE . 10.1 pt -118.36 160.52 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.488 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.544 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 84.6 t80 -99.63 132.46 44.96 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 287' ' ' GLY . 14.0 p -128.55 145.34 35.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.639 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.41 166.11 19.32 Favored Glycine 0 C--O 1.226 -0.378 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.92 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 78.41 30.81 48.33 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.262 -0.971 . . . . 0.0 111.799 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.698 HD11 HG13 ' A' ' 247' ' ' VAL . 34.7 mm -55.27 -46.61 78.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 81.47 126.41 0.81 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.024 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -56.49 -29.56 78.71 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.604 2.202 . . . . 0.0 113.332 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -91.64 10.66 27.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.391 . . . . 0.0 111.388 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.67 ' HB ' ' O ' ' A' ' 250' ' ' ILE . 13.0 p -56.24 -40.9 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.524 ' N ' HG13 ' A' ' 254' ' ' VAL . 11.2 tpp85 63.59 116.08 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -176.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -50.29 -30.4 26.23 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 121.994 1.796 . . . . 0.0 112.561 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -60.51 -42.13 95.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.315 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 77.5 mm-40 -68.24 -39.66 82.21 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.049 0.452 . . . . 0.0 111.556 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.561 ' CZ ' HG22 ' A' ' 289' ' ' VAL . 40.6 t80 -62.63 -47.01 85.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.782 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.19 -42.43 93.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.694 0.283 . . . . 0.0 111.556 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -78.18 -31.16 49.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.806 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.506 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 15.1 t80 -60.66 -57.1 14.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.153 0.501 . . . . 0.0 111.698 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.708 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 16.9 m-85 -66.38 -23.8 66.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.715 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.703 ' N ' HD11 ' A' ' 269' ' ' ILE . 25.2 t -56.64 -30.51 63.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.527 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -53.55 -36.62 62.04 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.855 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 9.2 p90 -116.82 42.76 2.41 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.119 0.485 . . . . 0.0 111.51 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.546 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 156.97 148.42 5.09 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.824 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.437 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 50.1 m -59.85 -36.92 77.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.729 0.3 . . . . 0.0 111.72 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.703 HD11 ' N ' ' A' ' 264' ' ' SER . 69.9 mt 69.86 77.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.394 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.522 HG12 ' CA ' ' A' ' 292' ' ' ASP . 35.4 mm -59.84 -40.97 84.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.806 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -154.28 86.71 1.16 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.586 ' HB2' HG23 ' A' ' 269' ' ' ILE . . . -101.85 131.26 48.29 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -143.66 152.57 41.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.504 0.668 . . . . 0.0 112.712 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 1.023 HD23 HD11 ' A' ' 276' ' ' LEU . 21.1 tp -68.43 -31.57 70.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.783 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.718 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 10.3 mmm 92.86 -86.61 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.001 0.92 . . . . 0.0 112.721 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 1.023 HD11 HD23 ' A' ' 274' ' ' LEU . 5.9 mp 62.27 145.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.227 0.537 . . . . 0.0 111.268 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.432 ' HA ' ' OP1' ' B' ' 4' ' ' ' A' . 51.6 p30 -113.08 -132.24 0.33 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.388 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -55.99 -32.45 63.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.51 ' OD1' HG23 ' A' ' 280' ' ' THR . 61.1 t0 -149.81 -108.0 0.07 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.736 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.51 HG23 ' OD1' ' A' ' 279' ' ' ASP . 64.4 p -108.4 20.08 19.04 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -52.44 -39.3 52.3 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 119.645 -1.264 . . . . 0.0 111.975 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.574 ' HB3' ' HA ' ' A' ' 276' ' ' LEU . 13.1 tm0? -64.98 -32.83 74.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.039 0.447 . . . . 0.0 111.424 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 48.0 p -57.2 -10.08 1.14 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.777 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -50.4 -36.95 35.16 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 121.406 -0.118 . . . . 0.0 110.908 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 151.57 26.72 0.05 OUTLIER Glycine 0 CA--C 1.524 0.601 0 C-N-CA 119.423 -1.37 . . . . 0.0 115.567 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.571 ' HA ' ' HA2' ' A' ' 248' ' ' GLY . 13.4 p90 -138.78 157.01 46.87 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.722 1.261 . . . . 0.0 111.184 178.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.742 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -148.26 166.02 29.02 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.777 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -113.52 130.03 56.43 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.629 ' HB ' HG12 ' A' ' 245' ' ' ILE . 40.8 t -125.57 133.34 69.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.849 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 52.2 m -114.79 135.38 54.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.546 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 24.5 m-85 -120.02 139.34 52.65 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.522 ' CA ' HG12 ' A' ' 270' ' ' ILE . 53.0 t0 -58.82 -36.93 75.31 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.763 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 99.8 p -123.12 147.73 46.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.406 0.622 . . . . 0.0 111.715 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.43 -30.55 70.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.439 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -55.56 -40.36 71.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.332 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.648 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -65.18 -37.58 87.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.792 0.329 . . . . 0.0 110.413 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.815 HG13 HG22 ' A' ' 245' ' ' ILE . 69.4 t -62.08 -49.07 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 CA-C-O 121.179 0.514 . . . . 0.0 109.738 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -66.68 -35.5 80.29 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.874 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.584 ' HD3' ' HB2' ' A' ' 266' ' ' TRP . 62.3 ttt-85 -56.19 -45.77 79.68 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.083 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.855 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 2.1 p -71.84 -35.35 54.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.964 0.411 . . . . 0.0 111.214 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 74.0 m -59.07 -40.74 86.12 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.701 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -57.57 -34.66 69.44 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.312 0.577 . . . . 0.0 109.843 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 305' ' ' PHE . 81.6 m-20 -83.85 4.77 27.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.686 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.706 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 30.7 tptt 44.04 -82.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.323 0.249 . . . . 0.0 110.575 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.719 ' HB3' ' HB3' ' A' ' 312' ' ' LYS . 3.1 m-30 -105.31 135.92 45.8 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.12 0.486 . . . . 0.0 110.269 178.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.694 ' CD1' HG23 ' A' ' 300' ' ' VAL . 0.9 OUTLIER -115.01 134.92 56.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.661 178.653 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -69.36 130.36 42.35 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.807 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.573 ' HE2' HG23 ' A' ' 254' ' ' VAL . 17.7 t80 -150.25 -72.56 0.17 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.89 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.46 ' HE3' ' CE2' ' A' ' 308' ' ' PHE . 4.0 mmpt? -91.96 -176.53 4.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.261 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -50.14 -30.57 11.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.911 0.386 . . . . 0.0 110.384 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -117.56 152.74 34.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.903 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.719 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 62.6 mttp -62.18 148.77 43.52 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.115 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.639 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 28.4 pt -107.81 138.63 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 314' ' ' GLU . . . . . 0.603 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 81.9 mt-10 -104.55 132.89 50.28 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 1.059 HG21 HD12 ' A' ' 245' ' ' ILE . 82.6 mt -119.31 128.55 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 121.394 0.616 . . . . 0.0 111.744 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -131.25 146.07 52.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.838 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -49.79 145.46 5.31 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.234 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.45 142.5 43.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.138 0.494 . . . . 0.0 111.463 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -126.83 82.18 67.99 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.477 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.416 ' HA ' ' O4 ' ' B' ' 3' ' ' ' U' . 77.8 Cg_exo -50.57 143.27 28.69 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.231 1.954 . . . . 0.0 111.969 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.434 ' NH2' H5'' ' B' ' 3' ' ' ' U' . 20.5 mmt85 -56.74 -34.98 68.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.824 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.839 179.974 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.739 0 C3'-C2'-O2' 111.167 -0.736 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.544 ' C5 ' ' CE1' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.962 0 C1'-C2'-O2' 108.463 -0.712 . 0.51 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.496 " C3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.998 0 C4'-C3'-C2' 103.614 0.914 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.59 " O2'" ' HA3' ' A' ' 201' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.883 0 C4'-C3'-C2' 103.923 1.223 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.56 " H1'" ' CE2' ' A' ' 162' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.89 0 O4'-C1'-N19 109.123 0.923 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.63 ' N1 ' ' HA ' ' A' ' 233' ' ' ALA . . . . . . . . 0 O5'--C5' 1.423 -1.067 0 C3'-C2'-O2' 111.311 -0.686 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.672 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -1.03 0 C3'-C2'-O2' 111.226 -0.715 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.96 0 C3'-C2'-O2' 111.236 -0.712 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 48.3 tttp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.766 0.317 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 158' ' ' SER . 75.8 mm-40 -111.12 154.6 24.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 157' ' ' GLU . 3.9 m 90.39 93.47 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.003 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.676 ' SG ' HG21 ' A' ' 213' ' ' VAL . 0.0 OUTLIER -135.74 109.01 7.78 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.115 0.483 . . . . 0.0 110.039 179.16 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.792 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 6.7 tptm -117.92 135.65 53.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.639 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.925 ' SD ' HG13 ' A' ' 213' ' ' VAL . 89.0 mmm -117.72 145.19 44.62 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.628 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 3.3 t80 -110.43 130.79 55.48 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.477 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.785 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 19.9 mm -116.87 127.68 74.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.578 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.678 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -128.81 161.52 22.42 Favored Glycine 0 CA--C 1.505 -0.562 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.518 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.45 ' HA2' " C5'" ' B' ' 4' ' ' ' A' . . . 77.59 27.69 58.7 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.96 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.969 HD23 HG21 ' A' ' 228' ' ' ILE . 72.9 mt -86.45 140.44 29.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.636 0.255 . . . . 0.0 111.176 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.486 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 18.2 t30 -63.63 135.42 56.75 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.576 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 4.1 m-90 -53.6 143.21 20.61 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.176 -0.609 . . . . 0.0 109.906 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 168' ' ' TRP . 53.7 t0 74.21 36.53 0.66 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.742 -177.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.596 HG21 HD13 ' A' ' 166' ' ' LEU . 90.0 m -59.98 -34.67 73.62 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.17 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.508 ' C ' HD12 ' A' ' 190' ' ' ILE . 0.0 OUTLIER 59.66 127.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -178.519 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.765 ' N ' HD12 ' A' ' 190' ' ' ILE . 55.1 mp0 -58.15 -31.62 67.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.361 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.598 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.9 m-20 -55.46 -41.22 72.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.761 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 170' ' ' THR . 9.8 m120 -64.83 -37.63 88.26 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.871 HD22 HD21 ' A' ' 205' ' ' LEU . 4.8 mt -60.51 -45.41 93.91 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.598 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -67.68 -34.84 77.71 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.363 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.29 -37.96 89.28 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.028 0.442 . . . . 0.0 109.851 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.43 ' OH ' ' HB3' ' A' ' 221' ' ' HIS . 67.3 t80 -80.58 -61.47 1.96 Allowed 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.437 0.637 . . . . 0.0 110.936 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.604 ' CE2' HD23 ' A' ' 175' ' ' LEU . 72.2 m-85 -66.04 -25.68 67.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.776 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.25 -26.11 12.82 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.241 -0.98 . . . . 0.0 110.738 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.524 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 0.1 OUTLIER -54.29 -46.05 72.67 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.511 0.724 . . . . 0.0 111.02 179.007 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -70.31 -35.33 73.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.701 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 171.36 -169.89 42.86 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.19 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 48.1 m -84.0 138.48 33.08 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 206' ' ' SER . 7.1 p -102.34 124.37 56.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.793 HG23 ' N ' ' A' ' 208' ' ' GLU . 69.4 p -69.63 -40.6 76.46 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.792 0.33 . . . . 0.0 111.136 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.501 ' OD1' ' O ' ' A' ' 186' ' ' THR . 86.3 m-20 -149.11 161.99 40.87 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.342 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' A' ' 175' ' ' LEU . 0.0 OUTLIER -138.4 144.23 40.13 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.207 -178.757 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 11.2 tptt -140.5 121.57 14.69 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 178.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.765 HD12 ' N ' ' A' ' 172' ' ' GLU . 11.4 mt -124.56 130.82 73.39 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.796 176.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.619 ' HB2' ' HB2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -86.2 109.12 18.69 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.228 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -121.4 148.11 44.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.733 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 198' ' ' ARG . 10.7 t0 -123.76 77.46 56.83 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -56.73 -23.25 48.71 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.678 2.252 . . . . 0.0 112.758 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.66 -74.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.53 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.1 p -69.75 -26.05 64.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.03 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.87 -2.97 67.04 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.389 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.541 ' HD2' ' CE2' ' A' ' 168' ' ' TRP . 9.8 tpp85 -129.41 137.0 50.66 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.73 -167.22 1.94 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.391 0.615 . . . . 0.0 112.48 -178.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.947 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 66.8 mmt-85 -53.52 -38.49 63.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.474 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.474 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 81.2 18.05 70.28 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.955 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.947 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 32.2 p90 -139.52 159.81 41.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.669 0.271 . . . . 0.0 110.534 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.571 ' HA2' ' HE2' ' A' ' 191' ' ' MET . . . -142.51 160.07 27.28 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.948 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.69 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 97.5 m-85 -108.37 129.05 55.26 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.871 HD21 HD22 ' A' ' 175' ' ' LEU . 65.7 mt -108.31 142.05 39.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.939 0.399 . . . . 0.0 111.969 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.7 ' O ' HG23 ' A' ' 185' ' ' VAL . 33.8 t -125.01 128.2 48.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.314 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -117.02 138.93 51.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.95 0.405 . . . . 0.0 111.975 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.793 ' N ' HG23 ' A' ' 186' ' ' THR . 84.4 tt0 -62.81 -34.52 77.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.727 178.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.92 117.48 53.72 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.509 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.04 -21.13 33.14 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.639 2.226 . . . . 0.0 113.296 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.7 m -57.31 -39.02 74.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.617 0.246 . . . . 0.0 111.553 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.931 ' O ' HG23 ' A' ' 216' ' ' VAL . 21.2 m -60.82 -37.53 82.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.818 0.342 . . . . 0.0 110.696 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.925 HG13 ' SD ' ' A' ' 161' ' ' MET . 62.0 t -61.51 -43.81 97.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.376 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -61.47 -41.43 97.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.931 0.396 . . . . 0.0 111.045 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.462 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 21.7 pt-20 -76.76 -29.44 56.11 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 212' ' ' SER . 79.5 t -61.85 -43.89 98.03 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-O 121.027 0.442 . . . . 0.0 110.639 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 50.1 t -71.87 -45.53 64.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -60.15 -38.76 84.12 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.475 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 35.5 m -81.72 144.28 31.24 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -80.21 138.67 36.88 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.836 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 41.0 m-70 -122.34 132.16 54.25 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -176.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.86 HD12 HG12 ' A' ' 227' ' ' VAL . 29.1 mm -122.24 110.56 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.492 HD23 ' CG ' ' A' ' 224' ' ' ASP . 7.7 tt -122.4 126.72 48.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.926 0.393 . . . . 0.0 111.061 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.492 ' CG ' HD23 ' A' ' 223' ' ' LEU . 84.9 m-20 55.4 41.81 30.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.226 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 74.32 14.03 81.06 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.707 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.444 ' NZ ' ' N6 ' ' B' ' 4' ' ' ' A' . 35.8 mmtp -125.73 152.63 45.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.981 0.39 . . . . 0.0 111.721 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.86 HG12 HD12 ' A' ' 222' ' ' ILE . 27.5 m -99.89 130.64 48.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.312 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.969 HG21 HD23 ' A' ' 166' ' ' LEU . 33.6 pt -126.04 158.44 35.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.396 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.57 80.48 71.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.159 0.504 . . . . 0.0 110.786 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.558 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 61.8 Cg_exo -56.66 127.97 28.1 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 123.07 2.513 . . . . 0.0 112.096 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.4 ' HE2' ' O4 ' ' B' ' 5' ' ' ' U' . 8.8 mtmm -133.13 156.06 48.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.008 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -60.14 137.18 58.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.769 0.318 . . . . 0.0 110.98 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.792 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -64.34 144.52 57.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.269 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.619 HD11 ' N6 ' ' B' ' 6' ' ' ' A' . 0.1 OUTLIER -122.41 137.03 27.1 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.645 179.304 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.5 ' HD2' ' OE1' ' A' ' 238' ' ' GLU . 34.8 Cg_exo -56.26 145.05 79.43 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 121.923 1.749 . . . . 0.0 110.727 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.411 ' C ' ' HD3' ' A' ' 236' ' ' ARG . 4.2 tmt_? -55.38 -40.97 71.99 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.931 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -61.72 -41.76 98.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.436 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.5 ' OE1' ' HD2' ' A' ' 235' ' ' PRO . 94.4 mt-10 -66.14 -35.25 79.99 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.906 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -59.98 -37.0 78.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.07 0.462 . . . . 0.0 110.259 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -59.79 -38.17 81.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.975 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -58.66 -37.98 77.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.193 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 19.2 p -84.8 161.98 19.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.114 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.04 161.74 24.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.809 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.482 ' HD2' ' CE2' ' A' ' 288' ' ' PHE . 7.6 ttpm? -138.7 131.99 30.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.812 0.306 . . . . 0.0 111.182 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.675 ' CG2' HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -120.9 162.52 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 121.409 0.623 . . . . 0.0 112.23 -178.753 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.539 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 85.1 t80 -104.19 138.22 40.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.746 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.704 HG23 HG12 ' A' ' 315' ' ' ILE . 9.2 p -131.99 147.61 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.546 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -125.99 165.18 19.28 Favored Glycine 0 C--O 1.226 -0.389 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 178.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 85.59 14.66 67.56 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.586 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.666 ' CG2' HG11 ' A' ' 254' ' ' VAL . 35.8 mm -54.95 -45.7 76.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 1.015 ' O ' HG12 ' A' ' 254' ' ' VAL . . . 59.44 129.77 0.01 OUTLIER Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.961 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.93 -27.11 52.23 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.326 2.017 . . . . 0.0 113.137 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -59.25 -33.97 71.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.919 0.39 . . . . 0.0 111.427 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 1.015 HG12 ' O ' ' A' ' 251' ' ' GLY . 7.1 p -50.5 -39.55 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.443 ' N ' HG13 ' A' ' 254' ' ' VAL . 7.7 tpt180 68.11 126.65 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.445 ' HB3' ' HG ' ' A' ' 274' ' ' LEU . 8.9 Cg_endo -51.08 -26.62 19.56 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 121.904 1.736 . . . . 0.0 112.827 -177.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -62.01 -45.5 93.34 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 78.2 mm-40 -66.38 -38.41 87.48 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.701 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 40.6 t80 -60.88 -45.56 94.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.166 -178.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.49 -43.4 97.37 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.594 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -78.12 -28.52 48.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.013 0.435 . . . . 0.0 111.012 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.599 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 4.3 t80 -59.12 -58.61 7.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.918 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.702 ' CG ' HG21 ' A' ' 289' ' ' VAL . 5.8 m-85 -63.51 -23.63 67.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.218 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.685 ' N ' HD11 ' A' ' 269' ' ' ILE . 23.1 t -55.13 -29.82 58.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.842 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -52.35 -35.47 51.17 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.361 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.68 ' CZ2' ' CD2' ' A' ' 263' ' ' PHE . 9.0 p90 -116.13 41.72 2.53 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.215 0.531 . . . . 0.0 111.526 179.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.509 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 159.39 157.12 8.38 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.81 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 4.5 t -73.45 -25.19 60.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.339 . . . . 0.0 111.011 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.685 HD11 ' N ' ' A' ' 264' ' ' SER . 75.1 mt 58.11 124.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.768 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.562 HD11 ' HB2' ' A' ' 292' ' ' ASP . 25.3 mm -93.2 -74.45 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.14 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -92.09 -72.54 0.59 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.793 0.33 . . . . 0.0 111.738 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 289' ' ' VAL . . . 46.56 101.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.353 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' GLN . . . . . 0.509 ' HG3' ' HG2' ' A' ' 275' ' ' MET . 14.1 pt20 -143.17 158.22 43.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.115 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.607 ' HB3' ' CD ' ' A' ' 282' ' ' GLN . 42.6 mt -63.78 -33.98 76.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.181 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.698 ' O ' ' HB3' ' A' ' 282' ' ' GLN . 8.0 mtm 68.11 71.13 0.32 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.634 0.254 . . . . 0.0 110.96 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.542 HD23 ' HG2' ' A' ' 282' ' ' GLN . 9.7 mt -76.4 126.64 31.36 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.129 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -58.93 -38.17 78.37 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.888 0.852 . . . . 0.0 108.726 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -157.34 -101.05 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 113.993 -1.458 . . . . 0.0 108.026 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.782 ' O ' HG23 ' A' ' 280' ' ' THR . 89.5 m-20 -62.77 -39.08 93.06 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.574 178.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.5 OUTLIER 170.77 50.07 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.005 -179.729 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -56.16 -38.38 76.79 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.092 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.698 ' HB3' ' O ' ' A' ' 275' ' ' MET . 0.0 OUTLIER -61.81 -30.07 70.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.197 0.522 . . . . 0.0 111.632 179.697 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 52.2 p -54.55 -14.18 1.21 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.626 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -51.33 -36.64 43.7 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 121.332 -0.147 . . . . 0.0 110.775 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 157.37 23.75 0.03 OUTLIER Glycine 0 CA--C 1.526 0.721 0 C-N-CA 119.596 -1.288 . . . . 0.0 115.379 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.517 ' CE1' " H4'" ' B' ' 2' ' ' ' A' . 2.0 p90 -138.43 163.17 32.59 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.672 1.236 . . . . 0.0 111.073 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.691 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -142.17 159.83 27.11 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.525 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.496 ' CD2' ' SD ' ' A' ' 275' ' ' MET . 0.1 OUTLIER -122.41 124.17 43.02 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.702 HG21 ' CG ' ' A' ' 263' ' ' PHE . 52.4 t -125.89 136.19 61.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.083 0.468 . . . . 0.0 111.501 178.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 55.7 m -116.44 136.24 53.16 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.509 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 42.8 m-85 -114.1 136.92 52.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.355 0.598 . . . . 0.0 112.398 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.562 ' HB2' HD11 ' A' ' 270' ' ' ILE . 51.7 t0 -57.09 -36.11 70.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.638 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 50.4 m -121.97 145.2 48.35 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.337 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.912 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -65.77 -28.99 69.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.531 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -54.68 -35.62 63.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.872 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.45 -39.26 83.03 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.912 HG12 ' O ' ' A' ' 294' ' ' ALA . 7.3 p -60.0 -37.51 72.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.974 0.416 . . . . 0.0 111.331 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -61.98 -39.31 91.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.846 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -61.08 -43.83 98.29 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.649 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 0.9 OUTLIER -69.38 -34.1 60.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.32 -179.322 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 89.5 m -57.77 -45.28 86.18 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.062 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -62.23 -39.72 93.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.213 0.53 . . . . 0.0 109.883 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.6 m-20 -62.38 -33.64 75.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.123 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.638 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 22.6 tptm 68.47 -69.06 0.16 Allowed 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -177.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.638 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.4 m-30 -116.28 151.11 36.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.121 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.625 HD11 HG23 ' A' ' 300' ' ' VAL . 8.4 mm -116.53 136.35 53.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.502 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -79.93 65.12 4.98 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.599 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 3.9 t80 -65.86 -63.44 1.09 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.461 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 5.5 mmpt? -105.91 38.79 1.92 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.376 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 61.47 34.24 18.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -175.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -151.01 163.96 37.52 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 113.167 -1.833 . . . . 0.0 107.351 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 68.5 mttt -97.15 136.26 37.92 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.514 0.673 . . . . 0.0 112.711 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 305' ' ' PHE . 36.3 pt -117.62 150.95 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 314' ' ' GLU . . . . . 0.535 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 87.7 mt-10 -106.06 133.35 50.91 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.86 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 0.704 HG12 HG23 ' A' ' 247' ' ' VAL . 74.3 mt -122.59 129.32 75.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.227 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.522 ' O ' ' HB3' ' A' ' 246' ' ' PHE . 8.8 tptt -133.94 141.22 47.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.717 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -53.69 150.56 7.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.669 0.271 . . . . 0.0 110.332 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -49.69 142.86 7.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.948 0.404 . . . . 0.0 111.232 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -96.61 149.82 36.26 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.718 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 321' ' ' ARG . 36.7 Cg_exo -59.66 -18.77 49.69 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.952 2.435 . . . . 0.0 112.439 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 320' ' ' PRO . 51.0 mmm-85 70.27 -61.03 0.47 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.964 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.884 179.857 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.758 0 C3'-C2'-O2' 111.285 -0.695 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.539 ' C5 ' ' CE1' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.869 0 C3'-C2'-O2' 111.231 -0.714 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.585 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.423 -1.047 0 C1'-C2'-O2' 108.294 -0.769 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.585 " H4'" " H3'" ' B' ' 3' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.9 0 C4'-C3'-C2' 103.861 1.161 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.954 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.791 0 C4'-C3'-C2' 103.758 1.058 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.954 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.999 0 C3'-C2'-O2' 111.247 -0.708 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.69 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.996 0 C1'-C2'-O2' 108.524 -0.692 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . 0.513 ' P ' " O2'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.01 0 C3'-C2'-O2' 111.308 -0.687 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.928 0.394 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -62.05 -31.27 71.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.058 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 86.6 p -60.13 -26.49 66.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.39 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 43.5 t -133.66 95.76 3.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.755 0.312 . . . . 0.0 111.246 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -138.94 137.41 36.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.099 0.475 . . . . 0.0 111.198 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.827 ' SD ' HG13 ' A' ' 213' ' ' VAL . 94.6 mmm -113.56 148.07 36.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.26 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.626 ' CE2' ' N9 ' ' B' ' 6' ' ' ' A' . 2.9 t80 -104.06 127.79 51.64 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 203' ' ' GLY . 20.3 mm -116.71 129.1 73.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.734 0.302 . . . . 0.0 111.364 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.561 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -133.33 163.27 24.36 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 178.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.84 36.63 52.37 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.981 -1.104 . . . . 0.0 112.024 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 64.3 mt -59.36 -26.73 65.33 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.66 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 52.2 t30 69.67 40.38 1.38 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -177.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.63 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 15.4 m0 30.9 38.5 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 114.636 -1.166 . . . . 0.0 112.76 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -164.34 13.56 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.789 HG22 ' HB2' ' A' ' 175' ' ' LEU . 63.1 m -60.74 -38.17 84.24 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.569 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.1 OUTLIER 51.92 135.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.178 0.514 . . . . 0.0 111.591 -179.432 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.574 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 97.8 mt-10 -61.15 -33.77 73.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.028 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.43 ' O ' ' HG3' ' A' ' 177' ' ' GLU . 91.5 m-20 -59.37 -44.49 92.71 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.629 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 170' ' ' THR . 81.9 m-20 -77.16 -42.23 38.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.376 0.608 . . . . 0.0 110.735 178.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.789 ' HB2' HG22 ' A' ' 170' ' ' THR . 41.1 tp -66.63 -48.75 68.46 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.419 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.505 ' HG3' HG11 ' A' ' 185' ' ' VAL . 68.0 ttp85 -63.13 -44.42 95.63 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.806 0.336 . . . . 0.0 111.015 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 173' ' ' ASP . 98.3 mt-10 -67.03 -37.29 83.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.476 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.663 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 69.5 t80 -61.16 -48.21 82.64 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.1 0.476 . . . . 0.0 110.864 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -82.76 -12.06 57.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.885 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.17 -29.85 53.33 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 177.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.499 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 0.3 OUTLIER -56.48 -45.27 81.01 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.307 -0.947 . . . . 0.0 110.764 178.761 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -70.64 -33.66 71.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.331 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -173.38 -179.7 44.22 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.26 -0.971 . . . . 0.0 113.166 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 46.6 m -63.07 -31.09 72.15 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.833 HG23 ' CE1' ' A' ' 207' ' ' PHE . 1.2 t 63.95 85.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -177.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -59.22 -50.98 71.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.019 -178.005 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 206' ' ' SER . 60.7 t0 -147.49 105.87 3.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.171 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.99 HD13 ' O ' ' A' ' 188' ' ' LEU . 0.0 OUTLIER -97.93 144.44 27.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.903 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.869 ' N ' HD22 ' A' ' 188' ' ' LEU . 30.7 tptt -127.26 128.68 46.41 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.627 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.574 ' HB ' ' HG2' ' A' ' 172' ' ' GLU . 1.5 tt -117.82 -10.35 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.845 -0.162 . . . . 0.0 111.428 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.84 ' HE3' ' O ' ' A' ' 202' ' ' PHE . 17.0 mtm 51.44 150.18 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.987 0.422 . . . . 0.0 111.543 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.4 ' HG3' ' HD3' ' A' ' 194' ' ' PRO . 7.5 ptmt -134.5 163.66 29.21 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.095 0.474 . . . . 0.0 112.223 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.642 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 1.3 t70 -124.23 76.55 60.64 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.619 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.4 ' HD3' ' HG3' ' A' ' 192' ' ' LYS . 38.8 Cg_exo -58.03 -25.46 70.66 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.711 2.274 . . . . 0.0 112.98 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -68.94 -66.66 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.32 . . . . 0.0 111.588 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.0 p -71.98 -20.31 61.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.772 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 88.07 12.88 65.1 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.369 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.642 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 55.5 mtt180 -118.47 167.75 11.3 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 121.094 0.473 . . . . 0.0 112.253 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.9 t -69.71 152.19 44.95 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.254 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.897 ' HG3' ' CE1' ' A' ' 202' ' ' PHE . 15.2 tpt180 -52.68 -32.02 40.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.977 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.481 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 98.1 -4.11 60.57 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.485 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.897 ' CE1' ' HG3' ' A' ' 200' ' ' ARG . 12.1 p90 -151.41 159.45 44.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.721 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -152.71 150.43 22.22 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.274 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.717 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 94.8 m-85 -106.78 125.63 51.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.081 0.44 . . . . 0.0 109.82 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 161' ' ' MET . 46.6 mt -103.1 138.92 39.3 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.911 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 23.2 t -123.17 132.77 54.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.119 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.833 ' CE1' HG23 ' A' ' 185' ' ' VAL . 96.9 m-85 -117.89 140.55 49.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 111.695 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.424 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.2 tt0 -60.66 -34.12 73.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.198 0.523 . . . . 0.0 109.673 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.2 115.17 50.36 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.609 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.62 -21.76 32.81 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.665 2.244 . . . . 0.0 113.22 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.5 m -56.86 -35.7 69.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.726 0.298 . . . . 0.0 111.307 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.923 ' O ' HG23 ' A' ' 216' ' ' VAL . 32.3 m -58.49 -36.96 74.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.851 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.827 HG13 ' SD ' ' A' ' 161' ' ' MET . 63.0 t -60.83 -42.02 90.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.179 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.423 ' O ' HG12 ' A' ' 217' ' ' VAL . 94.6 m-20 -59.29 -40.64 86.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.877 0.37 . . . . 0.0 111.177 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.401 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 12.9 pt-20 -80.81 -27.38 36.59 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 212' ' ' SER . 53.1 t -62.07 -45.77 97.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 CA-C-O 120.773 0.32 . . . . 0.0 111.693 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 214' ' ' ASP . 8.3 p -60.01 -36.55 68.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -60.96 -35.87 77.89 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.753 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 29.6 m -80.66 143.27 33.19 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 93.1 mt-30 -65.97 -36.83 84.37 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.863 ' HB3' HD11 ' A' ' 228' ' ' ILE . 82.4 m-70 78.4 44.33 0.07 Allowed 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 75.4 mt -75.38 82.2 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.2 tt -82.52 -75.47 0.31 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -176.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 49.2 p30 -94.67 13.22 25.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.582 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 95.17 7.4 59.56 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.052 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.12 137.0 52.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.6 p -69.73 126.17 29.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.277 0.56 . . . . 0.0 111.773 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.863 HD11 ' HB3' ' A' ' 221' ' ' HIS . 34.5 pt -124.84 157.52 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.329 178.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.446 ' O ' ' O4 ' ' B' ' 5' ' ' ' U' . 0.3 OUTLIER -127.8 77.21 76.6 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.202 0.525 . . . . 0.0 112.4 -179.096 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.637 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 35.0 Cg_exo -63.55 84.98 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 123.087 2.524 . . . . 0.0 111.653 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -100.73 157.13 16.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.825 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.507 ' HD3' HG11 ' A' ' 213' ' ' VAL . 37.7 tpt85 -60.27 137.04 58.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.935 0.397 . . . . 0.0 111.574 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.521 ' HA ' ' N1 ' ' B' ' 6' ' ' ' A' . . . -59.91 145.79 44.58 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.06 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.555 HG13 ' N6 ' ' B' ' 6' ' ' ' A' . 9.7 mt -109.51 124.36 34.05 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.282 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.69 143.44 57.87 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 121.802 1.668 . . . . 0.0 110.753 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 32.5 mmm180 -57.53 -39.27 76.2 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.695 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 55.2 p30 -63.88 -41.69 97.67 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.978 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.613 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 97.5 mt-10 -73.43 -37.92 65.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.558 0.694 . . . . 0.0 109.703 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.563 ' NE2' " O2'" ' B' ' 6' ' ' ' A' . 61.1 tt0 -60.41 -39.98 89.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.314 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -59.52 -40.24 86.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.211 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -61.13 -35.05 76.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.148 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 292' ' ' ASP . 16.3 p -82.87 161.39 21.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.392 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -149.03 173.02 29.05 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.193 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.56 ' O ' ' HB2' ' A' ' 318' ' ' ALA . 6.9 tptm -135.01 131.7 37.41 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.728 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -121.48 162.24 20.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.348 0.594 . . . . 0.0 111.011 179.486 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -104.6 136.56 43.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.35 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.75 HG11 ' CE1' ' A' ' 259' ' ' PHE . 14.7 p -131.49 147.87 32.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.422 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -129.11 166.59 21.46 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.404 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 84.2 22.79 53.8 Favored Glycine 0 C--N 1.328 0.107 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.476 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.534 HG23 HG21 ' A' ' 254' ' ' VAL . 43.0 mm -54.97 -48.99 74.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.725 ' O ' HG22 ' A' ' 254' ' ' VAL . . . 57.88 129.64 0.01 OUTLIER Glycine 0 CA--C 1.525 0.679 0 C-N-CA 119.807 -1.187 . . . . 0.0 111.436 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' PRO . . . . . 0.5 ' HD3' ' HG3' ' A' ' 284' ' ' ARG . 52.0 Cg_exo -54.04 -24.92 34.49 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.165 1.91 . . . . 0.0 112.907 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -57.84 -36.49 72.37 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 251' ' ' GLY . 16.2 m -65.98 -36.76 78.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 62.35 153.32 0.11 Allowed Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -56.54 -31.12 85.39 Favored 'Trans proline' 0 CA--C 1.527 0.154 0 C-N-CA 122.39 2.06 . . . . 0.0 113.478 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -64.12 -49.0 73.9 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.562 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 97.8 mt-10 -66.22 -35.57 80.78 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.938 0.399 . . . . 0.0 112.029 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.75 ' CE1' HG11 ' A' ' 247' ' ' VAL . 35.5 t80 -59.62 -45.34 92.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.471 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.4 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.5 tt0 -64.73 -40.58 95.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.455 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 258' ' ' GLU . 20.5 pt-20 -75.79 -33.5 60.16 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.7 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.714 ' CE2' HD11 ' A' ' 313' ' ' ILE . 83.8 t80 -58.9 -56.78 17.84 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.652 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 18.6 m-85 -65.83 -24.61 66.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.326 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.713 ' N ' HD11 ' A' ' 269' ' ' ILE . 24.9 t -56.21 -31.14 63.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.55 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -53.99 -36.15 62.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.526 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.708 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 6.9 p90 -119.18 50.58 1.21 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.49 0.662 . . . . 0.0 111.213 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.566 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 148.86 145.85 4.21 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.634 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.444 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 41.1 m -59.74 -38.1 80.77 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.713 HD11 ' N ' ' A' ' 264' ' ' SER . 76.9 mt 70.72 84.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.533 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.619 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 66.5 mt -59.69 -38.72 77.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.836 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -131.99 -84.89 0.49 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 289' ' ' VAL . . . 61.68 113.08 0.02 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.705 0.288 . . . . 0.0 110.867 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -139.29 155.23 47.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.362 0.601 . . . . 0.0 112.07 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.557 HD21 ' CB ' ' A' ' 283' ' ' SER . 35.5 tp -65.05 -35.19 80.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.251 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.549 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 95.7 mmm 76.66 12.81 2.41 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.577 ' O ' HD23 ' A' ' 276' ' ' LEU . 0.9 OUTLIER -56.64 119.09 5.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.215 0.531 . . . . 0.0 111.334 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 279' ' ' ASP . 58.3 t0 -88.79 119.0 28.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.852 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 62.9 -75.31 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.273 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.428 ' OD1' HG23 ' A' ' 280' ' ' THR . 51.6 t0 -142.53 98.75 3.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.781 0.324 . . . . 0.0 111.648 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.428 HG23 ' OD1' ' A' ' 279' ' ' ASP . 2.8 p 44.62 50.54 8.38 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -84.48 -74.7 1.23 Allowed Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.028 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.94 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 92.4 mm-40 -60.94 -32.02 71.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.243 0.544 . . . . 0.0 109.814 179.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.559 ' O ' ' HB3' ' A' ' 284' ' ' ARG . 54.1 p -63.17 168.27 4.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.45 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.559 ' HB3' ' O ' ' A' ' 283' ' ' SER . 39.1 ttt85 81.03 -41.39 0.16 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.826 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -94.94 -52.16 1.82 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.225 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.513 ' CZ ' " O4'" ' B' ' 2' ' ' ' A' . 29.0 p90 -143.45 167.7 21.57 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.193 0.521 . . . . 0.0 112.209 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.744 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -137.13 158.39 24.28 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.141 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.516 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.7 OUTLIER -115.34 127.44 55.42 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.734 -0.274 . . . . 0.0 111.207 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.728 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 21.8 t -124.2 136.38 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.799 0.333 . . . . 0.0 111.69 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 33.6 m -115.68 136.22 53.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.659 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.566 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 31.5 m-85 -118.33 139.21 51.69 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.619 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 55.8 p30 -62.56 -32.22 73.15 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.663 179.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.573 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 99.0 p -122.23 145.81 47.86 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.27 0.557 . . . . 0.0 111.556 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.98 -33.63 75.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.169 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -57.31 -37.39 72.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.361 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.59 82.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.914 0.387 . . . . 0.0 110.915 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.511 ' O ' HG12 ' A' ' 300' ' ' VAL . 83.3 t -62.23 -42.42 95.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.981 0.42 . . . . 0.0 110.96 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -60.94 -36.62 79.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.356 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -56.98 -43.31 81.56 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.708 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 1.3 p -69.15 -34.55 63.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.656 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 80.8 m -58.01 -45.92 86.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.473 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -62.68 -39.54 94.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.252 0.549 . . . . 0.0 110.258 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -63.36 -31.99 73.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.955 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.686 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 38.4 tptt 67.81 -75.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.686 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.9 m-30 -111.16 135.57 51.49 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.702 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.683 HD11 HG23 ' A' ' 300' ' ' VAL . 1.0 OUTLIER -118.55 137.41 52.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.192 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -79.08 112.64 16.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.965 0.412 . . . . 0.0 110.287 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.583 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 1.3 t80 -91.99 -89.22 0.19 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.809 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.503 ' HD3' ' CE1' ' A' ' 308' ' ' PHE . 0.0 OUTLIER -92.41 -74.86 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.939 0.399 . . . . 0.0 110.981 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -131.78 -15.79 3.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.259 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -122.02 157.36 31.53 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.518 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 312' ' ' LYS . 11.9 mptt -79.04 143.34 35.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.935 0.398 . . . . 0.0 111.093 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.714 HD11 ' CE2' ' A' ' 262' ' ' PHE . 29.9 pt -115.3 147.81 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 314' ' ' GLU . . . . . 0.561 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 84.1 mt-10 -104.78 133.3 49.83 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.651 -0.42 . . . . 0.0 109.982 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 0.69 HG12 HG23 ' A' ' 247' ' ' VAL . 73.5 mt -122.55 127.95 75.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.069 0.461 . . . . 0.0 111.253 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -126.01 155.05 42.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.725 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 70.0 ttp85 -58.87 146.12 38.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.718 0.294 . . . . 0.0 110.378 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 244' ' ' LYS . . . -55.71 145.26 24.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.076 0.465 . . . . 0.0 111.442 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -124.24 86.19 54.67 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.549 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.447 ' HA ' ' O4 ' ' B' ' 3' ' ' ' U' . 72.8 Cg_exo -49.37 142.02 23.52 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.353 2.035 . . . . 0.0 112.261 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -57.86 -35.29 70.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.19 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 77.6 m80 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.842 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.698 0 C3'-C2'-O2' 111.247 -0.708 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.94 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.946 0 C3'-C2'-O2' 111.284 -0.695 . 0.211 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.465 " H2'" ' OP2' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.027 0 C3'-C2'-O2' 111.254 -0.705 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.66 ' N7 ' ' HA ' ' A' ' 167' ' ' ASN . . . . . . . . 0 O5'--C5' 1.425 -0.927 0 C4'-C3'-C2' 103.786 1.086 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.561 ' C6 ' ' HA3' ' A' ' 164' ' ' GLY . . . . . . . . 0 O5'--C5' 1.425 -0.932 0 N19-C1'-C2' 114.789 0.868 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.626 ' N9 ' ' CE2' ' A' ' 162' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.968 0 C4'-C3'-C2' 103.737 1.037 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.717 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.954 0 C4'-C3'-C2' 103.421 0.721 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . 0.457 ' P ' " O2'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.922 0 C3'-C2'-O2' 111.326 -0.681 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.7 tttt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.794 0.33 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -103.46 138.89 39.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.652 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.9 p -127.75 154.62 45.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.945 0.403 . . . . 0.0 111.222 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 45.8 t -175.12 61.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.457 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.764 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 62.9 tttt -129.66 141.36 50.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.574 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.853 ' SD ' HG13 ' A' ' 213' ' ' VAL . 95.1 mmm -118.08 146.38 44.15 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.635 ' CE2' ' C8 ' ' B' ' 6' ' ' ' A' . 6.7 t80 -106.09 127.55 53.26 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.939 HG23 HD12 ' A' ' 228' ' ' ILE . 11.1 mm -115.37 117.45 55.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.249 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 202' ' ' PHE . . . -91.54 178.86 41.53 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.813 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.887 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 26.69 80.11 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 114.387 0.515 . . . . 0.0 114.387 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.449 ' O ' ' HB ' ' A' ' 170' ' ' THR . 58.8 mt -85.76 2.13 46.81 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.881 ' O ' ' N ' ' A' ' 169' ' ' ASP . 41.7 t-20 61.04 41.39 13.96 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.573 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 16.9 m0 34.49 -55.97 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.053 0.941 . . . . 0.0 113.522 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.881 ' N ' ' O ' ' A' ' 167' ' ' ASN . 93.1 m-20 -53.21 -34.84 58.74 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 166' ' ' LEU . 55.8 m -62.95 139.43 58.75 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.189 0.518 . . . . 0.0 111.206 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 10.5 p -116.12 167.43 11.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.324 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.84 ' N ' HD12 ' A' ' 190' ' ' ILE . 21.2 pt-20 -59.85 -27.08 66.35 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 89.6 m-20 -62.07 -43.01 99.76 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.044 0.449 . . . . 0.0 110.3 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -67.05 -36.66 82.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.766 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.527 HD23 ' CE2' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -53.63 -49.82 67.04 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -179.025 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 180' ' ' GLY . 0.0 OUTLIER -65.29 -33.45 76.01 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.623 178.881 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -62.02 -41.36 97.99 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.255 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.444 ' OH ' ' HB3' ' A' ' 221' ' ' HIS . 64.0 t80 -75.74 -60.0 2.51 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.628 0.727 . . . . 0.0 111.003 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.527 ' CE2' HD23 ' A' ' 175' ' ' LEU . 80.8 m-85 -69.0 -21.1 64.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.652 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.95 -25.53 16.82 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.687 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.821 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -55.7 -40.72 72.78 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.0 0.428 . . . . 0.0 110.795 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.821 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 64.6 m-85 -69.96 -32.49 70.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.43 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 167.08 -133.11 2.8 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.831 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.4 m -119.93 139.06 53.02 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.77 HG21 ' HB3' ' A' ' 188' ' ' LEU . 0.8 OUTLIER -91.22 117.63 34.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.2 t -66.7 -43.77 83.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.138 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -156.28 98.34 1.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.77 ' HB3' HG21 ' A' ' 185' ' ' VAL . 0.0 OUTLIER -94.34 142.1 27.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.499 178.587 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.627 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 49.1 tptt -130.92 128.0 39.62 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.84 HD12 ' N ' ' A' ' 172' ' ' GLU . 1.4 mt -122.54 129.53 75.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.623 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.58 ' HG2' " H1'" ' B' ' 7' ' ' ' U' . 2.6 mpp? -92.6 135.08 34.39 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.404 ' HG3' ' HD3' ' A' ' 194' ' ' PRO . 26.2 pttm -131.91 168.67 17.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.163 0.506 . . . . 0.0 112.168 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 0.6 OUTLIER -125.43 85.24 58.84 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.742 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.404 ' HD3' ' HG3' ' A' ' 192' ' ' LYS . 11.9 Cg_endo -55.77 -24.57 47.28 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.305 2.003 . . . . 0.0 112.313 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -73.37 -70.66 0.35 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.372 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 55.0 p -71.49 -21.08 61.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.019 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 84.18 19.57 60.58 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.376 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.558 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 79.7 mtt180 -120.43 163.59 17.67 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.6 m -111.95 154.5 25.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.104 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.713 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 14.3 mmp_? -51.35 -29.43 15.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.476 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.537 ' HA3' " C2'" ' B' ' 4' ' ' ' A' . . . 98.08 -1.84 59.47 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.706 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.713 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 36.4 p90 -140.86 158.64 43.66 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.326 -0.437 . . . . 0.0 110.448 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.52 ' HA2' ' HE1' ' A' ' 191' ' ' MET . . . -142.92 161.99 27.49 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.674 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 94.8 m-85 -104.68 122.16 45.08 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.706 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 63.1 tp -109.75 126.34 53.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.813 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.594 ' O ' HG23 ' A' ' 185' ' ' VAL . 29.4 t -118.31 139.05 51.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.973 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.711 ' CE2' HG21 ' A' ' 216' ' ' VAL . 82.1 m-85 -119.4 146.51 45.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.95 0.405 . . . . 0.0 111.497 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.55 -36.12 82.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.616 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -111.07 121.81 39.62 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.363 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -56.33 -27.17 65.85 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.491 2.127 . . . . 0.0 112.923 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.0 t -58.35 -36.34 73.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.768 0.318 . . . . 0.0 110.713 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.87 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.8 m -58.83 -35.21 72.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.28 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.853 HG13 ' SD ' ' A' ' 161' ' ' MET . 82.3 t -61.47 -40.89 87.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.887 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -58.21 -43.57 87.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.783 0.325 . . . . 0.0 110.769 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.27 -34.83 75.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.132 0.492 . . . . 0.0 111.197 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.9 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 79.9 t -60.85 -43.02 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.785 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.713 HG21 ' NH2' ' A' ' 232' ' ' ARG . 25.1 m -86.52 -31.84 6.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -59.64 -35.26 74.06 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.472 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 74.4 m -100.59 147.01 26.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -78.96 139.24 38.28 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.9 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 44.0 m-70 -120.63 129.26 53.64 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -176.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 68.6 mt -122.44 115.4 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.1 tt -117.94 127.25 53.66 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.758 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 58.9 t0 52.87 36.34 21.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.959 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.06 13.86 82.9 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.731 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -126.48 156.39 40.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.994 0.397 . . . . 0.0 111.626 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.599 HG12 ' OD2' ' A' ' 229' ' ' ASP . 44.0 t -99.94 129.61 50.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.801 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.939 HD12 HG23 ' A' ' 163' ' ' ILE . 29.0 pt -109.3 -30.95 2.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.599 ' OD2' HG12 ' A' ' 227' ' ' VAL . 9.9 m-20 48.09 76.66 0.53 Allowed Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 121.246 0.546 . . . . 0.0 110.855 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.487 ' HD3' HG13 ' A' ' 228' ' ' ILE . 34.9 Cg_exo -59.8 135.58 64.58 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 123.234 2.622 . . . . 0.0 112.117 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.591 ' HE2' ' H62' ' B' ' 6' ' ' ' A' . 5.5 ttpt -136.73 142.08 43.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.184 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.713 ' NH2' HG21 ' A' ' 217' ' ' VAL . 6.1 mpt_? -51.78 142.02 15.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.974 0.416 . . . . 0.0 111.355 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.764 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -68.96 143.13 54.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.21 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.553 HD12 ' HG2' ' A' ' 239' ' ' GLN . 0.1 OUTLIER -119.17 128.33 26.0 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.668 179.233 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.9 149.79 25.11 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.061 1.841 . . . . 0.0 110.858 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -53.25 -41.96 65.99 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.772 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -63.2 -40.79 98.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.971 0.415 . . . . 0.0 110.459 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -66.05 -36.94 84.58 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.649 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.553 ' HG2' HD12 ' A' ' 234' ' ' ILE . 25.4 mt-30 -60.47 -37.95 82.64 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.861 0.362 . . . . 0.0 110.568 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -60.23 -40.05 88.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.975 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -60.57 -35.12 75.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.289 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.425 HG22 HD11 ' A' ' 270' ' ' ILE . 18.3 p -83.22 162.44 21.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.521 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -155.98 108.02 0.35 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.21 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.614 ' O ' ' HB2' ' A' ' 318' ' ' ALA . 7.3 ttpm? -81.34 136.18 35.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.656 0.265 . . . . 0.0 110.935 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.67 HD13 ' O ' ' A' ' 245' ' ' ILE . 0.0 OUTLIER -119.39 162.87 17.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.498 0.666 . . . . 0.0 111.832 -179.139 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.515 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 91.2 t80 -101.72 137.07 40.52 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.066 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.854 HG11 ' CE1' ' A' ' 259' ' ' PHE . 11.7 p -131.11 145.45 35.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.934 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.648 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -130.5 164.67 22.93 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 98.1 -1.61 59.33 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.129 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.94 HD11 ' HA3' ' A' ' 287' ' ' GLY . 41.1 pt -116.62 139.49 43.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 117.192 0.496 . . . . 0.0 110.636 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.433 ' N ' HG11 ' A' ' 254' ' ' VAL . . . 177.77 -103.05 0.17 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 119.599 -1.286 . . . . 0.0 114.495 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -53.15 -25.99 31.58 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.822 2.348 . . . . 0.0 113.173 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -131.99 95.02 3.59 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.523 ' O ' ' HB2' ' A' ' 258' ' ' GLU . 0.5 OUTLIER -178.19 -46.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.152 -179.276 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 28.1 mmt180 68.37 128.02 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -177.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.38 -29.03 37.44 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.012 1.808 . . . . 0.0 112.809 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -61.72 -43.3 99.13 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.574 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 97.0 mt-10 -67.74 -35.52 78.88 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 111.368 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.893 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 19.2 t80 -59.15 -49.09 79.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.459 -178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.74 -37.7 88.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -63.71 -40.1 95.94 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.828 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.829 ' CE2' HD11 ' A' ' 313' ' ' ILE . 84.0 t80 -65.41 -55.12 19.82 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.74 ' CG ' HG21 ' A' ' 289' ' ' VAL . 9.3 m-85 -65.19 -27.24 68.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.791 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.702 ' N ' HD11 ' A' ' 269' ' ' ILE . 33.4 t -54.48 -26.97 34.46 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -50.17 -38.12 38.11 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.794 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.722 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 24.3 p90 -127.42 54.24 1.68 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.267 0.556 . . . . 0.0 111.18 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.485 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 151.48 153.28 6.14 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.432 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.402 ' HG1' ' CG ' ' A' ' 292' ' ' ASP . 32.8 p -71.43 -23.0 61.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.899 0.38 . . . . 0.0 111.14 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.702 HD11 ' N ' ' A' ' 264' ' ' SER . 77.8 mt 55.53 99.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.589 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.632 HD11 ' HA ' ' A' ' 292' ' ' ASP . 73.4 mt -58.47 -40.84 79.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.174 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -174.92 106.06 0.1 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.516 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.622 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -100.7 135.59 41.9 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.469 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -146.01 161.99 38.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.325 0.583 . . . . 0.0 112.546 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.614 ' O ' ' HB2' ' A' ' 275' ' ' MET . 56.7 mt -88.71 3.67 50.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.694 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.614 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 90.4 mtp 81.65 -49.53 0.24 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.584 0.354 . . . . 0.0 111.767 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.633 HD22 ' N ' ' A' ' 276' ' ' LEU . 1.8 mm? 47.2 56.94 6.24 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.403 ' OD2' ' HE2' ' A' ' 275' ' ' MET . 88.6 m-20 -77.65 114.48 16.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.083 0.468 . . . . 0.0 110.276 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.633 ' O ' HG22 ' A' ' 280' ' ' THR . 80.4 tttt 44.34 25.97 0.15 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.836 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 53.19 44.82 29.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.372 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.633 HG22 ' O ' ' A' ' 278' ' ' LYS . 1.7 t -171.53 -37.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.908 0.385 . . . . 0.0 111.294 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -54.42 -27.99 42.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.948 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.624 ' NE2' HD13 ' A' ' 276' ' ' LEU . 4.8 pp0? -137.07 162.79 32.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.601 0.239 . . . . 0.0 111.583 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.579 ' CB ' ' O ' ' A' ' 282' ' ' GLN . 83.2 p 121.91 -8.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 O-C-N 124.226 0.954 . . . . 0.0 110.385 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 67.6 mtt85 -57.36 -33.62 67.97 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.617 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 250' ' ' ILE . . . 158.28 35.38 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.618 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.465 ' CE1' " H5'" ' B' ' 2' ' ' ' A' . 7.5 p90 -144.36 165.18 28.65 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.524 0.662 . . . . 0.0 110.997 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.94 ' HA3' HD11 ' A' ' 250' ' ' ILE . . . -145.98 166.18 27.99 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.069 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.45 ' CE2' ' CE ' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -120.43 122.11 40.0 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 122.892 -0.181 . . . . 0.0 111.27 179.576 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.893 HG23 ' CZ ' ' A' ' 259' ' ' PHE . 57.6 t -123.84 137.67 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.049 0.452 . . . . 0.0 111.58 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 48.7 m -115.38 135.98 53.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.638 178.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.485 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 41.1 m-85 -114.95 136.94 52.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.15 0.5 . . . . 0.0 112.007 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.632 ' HA ' HD11 ' A' ' 270' ' ' ILE . 31.9 p-10 -62.38 -33.25 74.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.19 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.427 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 28.6 t -123.15 140.06 53.41 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.636 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.33 -30.96 72.0 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.067 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.4 -38.18 68.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.211 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.473 ' O ' ' HD1' ' A' ' 266' ' ' TRP . . . -62.19 -37.04 83.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.907 0.384 . . . . 0.0 110.478 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.545 ' O ' HG12 ' A' ' 300' ' ' VAL . 81.3 t -61.89 -42.24 93.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.201 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.99 -36.7 77.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.147 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -57.25 -43.9 83.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.911 0.386 . . . . 0.0 112.027 -178.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.741 HG23 HD11 ' A' ' 306' ' ' ILE . 1.0 OUTLIER -69.86 -33.6 56.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.632 -179.141 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 76.8 m -57.44 -45.37 84.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.416 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -61.94 -41.42 97.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.25 0.547 . . . . 0.0 110.55 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -62.8 -32.5 73.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.433 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.682 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 10.6 tptm 67.94 -75.96 0.06 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -177.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.682 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.3 m-30 -110.52 136.1 50.16 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.741 HD11 HG23 ' A' ' 300' ' ' VAL . 1.1 mt -117.05 136.95 52.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.506 ' OD1' ' O ' ' A' ' 307' ' ' ASP . 52.4 p30 -72.83 96.94 2.15 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.146 0.498 . . . . 0.0 111.705 -178.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.656 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 6.2 t80 -102.27 -75.16 0.61 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.345 0.593 . . . . 0.0 110.375 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.456 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 10.2 mmpt? -95.14 -167.9 1.71 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.152 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -52.04 -27.72 14.71 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.836 0.35 . . . . 0.0 110.753 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 311' ' ' ARG . 60.9 mtt180 -116.67 160.48 20.67 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.414 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 71.4 mttt -71.85 147.82 46.77 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.53 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.829 HD11 ' CE2' ' A' ' 262' ' ' PHE . 28.6 pt -115.37 144.47 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 314' ' ' GLU . . . . . 0.596 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 83.4 mt-10 -104.29 134.52 47.38 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.059 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 0.802 HG12 HG23 ' A' ' 247' ' ' VAL . 73.5 mt -122.35 126.25 73.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.072 0.463 . . . . 0.0 111.466 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -129.96 155.42 46.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.776 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -55.46 148.42 15.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.794 0.33 . . . . 0.0 110.494 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 244' ' ' LYS . . . -56.03 145.85 24.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.995 0.426 . . . . 0.0 111.409 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.1 101.49 53.91 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.952 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.53 ' O ' ' HB2' ' A' ' 321' ' ' ARG . 53.0 Cg_exo -54.96 -20.26 22.44 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.517 2.145 . . . . 0.0 112.354 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.53 ' HB2' ' O ' ' A' ' 320' ' ' PRO . 50.2 mmm-85 93.44 -0.0 0.09 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.282 0.633 . . . . 0.0 111.169 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.107 179.753 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.657 0 C3'-C2'-O2' 111.256 -0.705 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.515 ' C5 ' ' CE1' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.98 0 C3'-C2'-O2' 111.313 -0.685 . 0.01 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.695 " O2'" " H3'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.01 0 C3'-C2'-O2' 111.292 -0.692 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.573 ' C2 ' ' CZ3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.424 -0.984 0 O4'-C1'-C2' 107.773 0.981 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.695 " H3'" " O2'" ' B' ' 3' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.427 -0.832 0 C5'-C4'-O4' 107.741 -1.042 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.649 ' OP2' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.861 0 C3'-C2'-O2' 111.297 -0.691 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.674 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -1.026 0 C4'-C3'-C2' 103.444 0.744 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . 0.714 ' N3 ' " H2'" ' B' ' 8' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -1.017 0 C3'-C2'-O2' 111.204 -0.723 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 52.2 tttp . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.722 0.296 . . . . 0.0 111.392 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -59.47 -33.62 71.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.321 -179.723 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.5 m -56.89 -36.06 69.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.94 0.4 . . . . 0.0 110.785 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 10.5 m -60.1 -29.42 68.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.421 179.292 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 82.7 tttt -62.03 139.91 58.4 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.457 0.646 . . . . 0.0 111.74 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.818 ' SD ' HG13 ' A' ' 213' ' ' VAL . 92.7 mmm -121.08 149.13 43.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.617 -179.045 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.596 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 8.4 t80 -105.92 129.42 54.07 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.775 ' CG2' HD21 ' A' ' 166' ' ' LEU . 14.9 mm -114.76 127.51 72.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.835 -178.719 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.743 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -130.09 162.25 23.07 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.908 179.216 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.538 ' HA2' " H5'" ' B' ' 4' ' ' ' A' . . . 75.6 27.39 63.29 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 119.861 -1.161 . . . . 0.0 111.691 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.938 HD23 HG21 ' A' ' 228' ' ' ILE . 84.6 mt -85.1 140.32 31.06 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 120.802 0.335 . . . . 0.0 111.414 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.484 ' N ' ' HG1' ' A' ' 170' ' ' THR . 2.1 t-20 -63.07 136.75 57.98 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.423 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.61 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 3.9 m0 -51.9 -28.23 15.58 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.811 0.339 . . . . 0.0 110.882 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -92.4 9.04 35.89 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.564 178.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.585 ' O ' ' HB2' ' A' ' 174' ' ' ASN . 89.6 m -56.24 -37.2 69.41 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.475 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.566 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.7 OUTLIER 53.64 145.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.247 0.546 . . . . 0.0 110.794 -178.38 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.605 ' N ' HD12 ' A' ' 190' ' ' ILE . 97.3 mt-10 -61.45 -33.15 73.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.766 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.577 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 92.6 m-20 -57.38 -41.26 79.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.872 -178.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.585 ' HB2' ' O ' ' A' ' 170' ' ' THR . 10.2 m120 -64.49 -35.71 81.83 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.768 HD12 HD11 ' A' ' 190' ' ' ILE . 2.4 mt -54.02 -51.15 64.9 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.117 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.577 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -63.58 -36.76 84.85 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.935 179.605 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -66.4 -44.8 82.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.085 0.469 . . . . 0.0 110.34 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.605 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 62.4 t80 -66.33 -47.32 73.88 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.922 179.207 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.513 ' CE2' HD23 ' A' ' 175' ' ' LEU . 86.4 m-85 -91.39 -1.77 57.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.108 -178.78 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -61.89 -28.86 70.94 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.486 179.012 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.442 ' CD ' ' H ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -58.19 -37.41 74.71 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.715 0.769 . . . . 0.0 110.797 -178.722 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -66.72 -30.69 70.98 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.062 -178.163 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 163.97 -126.64 1.55 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.195 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 57.3 m -119.23 141.46 48.89 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.53 HG21 ' CD2' ' A' ' 188' ' ' LEU . 13.8 p -106.69 128.73 61.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.586 -0.445 . . . . 0.0 109.972 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.411 HG23 ' CB ' ' A' ' 206' ' ' SER . 1.2 t -84.49 -43.49 14.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.535 -178.516 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -138.68 136.18 35.58 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -178.847 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.722 HD11 ' CB ' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -116.07 128.76 55.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.091 179.008 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 8.9 tptt -140.29 113.69 8.56 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.768 HD11 HD12 ' A' ' 175' ' ' LEU . 79.4 mt -126.77 126.62 68.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 174.685 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.686 ' HB2' ' HB2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -81.31 77.25 8.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.235 0.541 . . . . 0.0 110.644 -178.587 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -73.06 141.66 47.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.258 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 10.2 m-20 -92.36 100.55 3.82 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 193' ' ' ASP . 27.9 Cg_endo -62.06 -27.07 78.84 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.523 2.149 . . . . 0.0 112.796 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -75.34 -76.3 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.707 -179.484 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 57.9 p -69.99 -22.5 63.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 80.54 24.62 58.37 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.234 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.501 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 16.4 tpp85 -113.07 129.73 56.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.971 0.415 . . . . 0.0 111.395 -179.552 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.404 ' HB2' ' HA ' ' A' ' 168' ' ' TRP . 49.8 m -66.48 151.35 47.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.097 0.475 . . . . 0.0 111.288 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.8 ' HG3' ' CE1' ' A' ' 202' ' ' PHE . 17.3 tpt85 -59.55 -29.34 67.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.48 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.673 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 102.35 -9.75 56.14 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.722 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.8 ' CE1' ' HG3' ' A' ' 200' ' ' ARG . 21.0 p90 -144.24 155.3 43.81 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.448 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -144.79 164.13 27.86 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.828 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.74 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 96.5 m-85 -105.17 123.49 47.92 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.058 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.69 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 58.2 tp -108.02 125.52 51.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.442 -178.124 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.417 ' O ' HG23 ' A' ' 185' ' ' VAL . 27.3 t -118.29 134.51 54.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.671 0.272 . . . . 0.0 110.983 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.69 ' CZ ' HD21 ' A' ' 205' ' ' LEU . 88.5 m-85 -115.42 138.67 50.76 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 120.963 0.411 . . . . 0.0 112.012 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -62.04 -35.03 77.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.842 178.385 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.84 117.51 53.76 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.631 179.515 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -56.79 -22.88 47.22 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.512 2.142 . . . . 0.0 112.875 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.3 t -57.37 -36.74 71.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.407 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.931 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.0 m -58.88 -35.64 73.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.809 0.337 . . . . 0.0 110.733 179.634 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.818 HG13 ' SD ' ' A' ' 161' ' ' MET . 87.1 t -61.47 -42.33 93.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -59.57 -42.2 91.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.33 . . . . 0.0 111.003 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.464 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 15.2 pt-20 -74.58 -29.26 61.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.669 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 212' ' ' SER . 75.3 t -61.97 -42.95 96.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.129 0.49 . . . . 0.0 110.346 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.77 -40.31 88.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -58.61 -38.7 78.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.679 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 39.5 m -82.39 140.2 33.61 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.071 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 60.7 tp60 -66.23 -40.01 89.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.539 178.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.814 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 85.9 m-70 82.34 97.68 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 178.134 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 72.1 mt -115.34 109.54 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 176.232 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.411 HD12 ' CG ' ' A' ' 178' ' ' TYR . 6.9 tt -116.54 128.05 55.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.935 0.397 . . . . 0.0 111.593 -178.27 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 22.4 t70 49.02 38.41 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.405 179.133 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 83.46 7.44 86.37 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.526 178.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.456 ' HD3' ' HE2' ' A' ' 278' ' ' LYS . 35.4 mmtp -120.49 152.09 38.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.778 0.323 . . . . 0.0 111.398 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 41.3 t -104.93 132.8 50.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.489 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.938 HG21 HD23 ' A' ' 166' ' ' LEU . 38.8 pt -123.73 159.72 28.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.193 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -125.19 77.85 67.35 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.307 0.575 . . . . 0.0 111.081 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.59 ' HD2' ' CD2' ' A' ' 221' ' ' HIS . 50.5 Cg_exo -59.1 123.86 14.38 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.4 2.733 . . . . 0.0 111.735 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.42 ' NZ ' ' OD2' ' A' ' 271' ' ' ASP . 9.1 mtmm -134.05 153.44 51.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.793 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -56.26 138.06 51.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.042 0.449 . . . . 0.0 111.77 -179.438 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -64.03 145.13 56.43 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.591 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.506 ' CD1' ' C6 ' ' B' ' 6' ' ' ' A' . 2.5 mt -114.21 135.76 22.19 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.589 179.279 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.45 ' HG2' ' HB3' ' A' ' 238' ' ' GLU . 10.8 Cg_endo -55.6 139.2 82.59 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.814 1.676 . . . . 0.0 111.099 179.247 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -57.0 -41.33 78.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -61.09 -45.62 93.99 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.494 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.45 ' HB3' ' HG2' ' A' ' 235' ' ' PRO . 84.2 tt0 -70.2 -38.51 75.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.673 0.749 . . . . 0.0 109.569 178.093 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.437 ' NE2' " O2'" ' B' ' 6' ' ' ' A' . 45.2 tt0 -59.53 -39.83 85.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.289 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.19 -40.88 91.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.35 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.426 ' HE3' ' HA ' ' A' ' 238' ' ' GLU . 10.5 mtmp? -61.98 -35.39 78.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.684 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.656 HG21 ' CD1' ' A' ' 270' ' ' ILE . 18.2 p -84.18 162.51 20.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.221 0.534 . . . . 0.0 111.826 -178.799 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -165.34 172.85 41.03 Favored Glycine 0 C--O 1.226 -0.383 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.448 179.228 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.554 ' HE2' ' CE2' ' A' ' 288' ' ' PHE . 14.0 pttm -135.99 151.36 49.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.384 0.592 . . . . 0.0 111.603 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.615 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -118.82 165.58 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 121.457 0.646 . . . . 0.0 111.916 -178.395 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.462 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 82.5 t80 -99.93 133.74 43.86 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.407 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.819 HG11 ' CE1' ' A' ' 259' ' ' PHE . 13.1 p -131.16 143.57 40.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.758 179.305 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 313' ' ' ILE . . . -126.85 169.43 18.78 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.288 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.22 15.84 56.69 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.161 -1.018 . . . . 0.0 112.456 -179.32 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.499 ' CG2' HG21 ' A' ' 254' ' ' VAL . 65.3 mt -110.78 131.15 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 120.961 0.41 . . . . 0.0 110.971 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.88 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -174.04 -101.73 0.15 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.324 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.79 139.34 56.99 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.273 1.982 . . . . 0.0 113.01 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 55.15 45.45 25.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 178.31 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 251' ' ' GLY . 15.4 m -125.39 -48.52 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.232 178.455 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.565 ' HB3' ' OE1' ' A' ' 258' ' ' GLU . 2.4 tpp85 57.09 136.51 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.214 0 CA-C-O 120.833 0.349 . . . . 0.0 110.17 -179.365 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.14 -26.91 53.21 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.518 2.146 . . . . 0.0 113.466 -178.612 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -59.8 -48.01 83.41 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.698 -179.318 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.565 ' OE1' ' HB3' ' A' ' 255' ' ' ARG . 58.8 mp0 -67.97 -35.56 78.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.029 0.442 . . . . 0.0 111.246 179.119 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.819 ' CE1' HG11 ' A' ' 247' ' ' VAL . 29.8 t80 -60.67 -45.31 94.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.914 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.444 ' HG2' ' HB3' ' A' ' 272' ' ' ALA . 97.1 mt-10 -65.59 -39.41 91.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.154 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.529 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.1 pt-20 -75.75 -30.51 59.21 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.742 0.306 . . . . 0.0 110.773 179.495 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.945 ' CE2' HD11 ' A' ' 313' ' ' ILE . 79.0 t80 -58.18 -57.48 12.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.136 0.493 . . . . 0.0 111.924 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.726 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 30.9 m-85 -68.28 -21.66 64.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.611 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.719 ' N ' HD11 ' A' ' 269' ' ' ILE . 34.0 t -55.35 -25.27 34.02 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.043 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -47.82 -38.6 16.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.705 178.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.726 ' CZ2' ' CD2' ' A' ' 263' ' ' PHE . 24.3 p90 -132.15 55.79 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.237 0.541 . . . . 0.0 111.444 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.458 ' HA3' ' CD1' ' A' ' 291' ' ' TYR . . . 151.59 145.29 4.1 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.652 179.308 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.414 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 52.8 m -58.68 -36.38 74.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.847 0.356 . . . . 0.0 111.133 179.816 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.719 HD11 ' N ' ' A' ' 264' ' ' SER . 73.8 mt 67.74 86.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.177 -178.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.656 ' CD1' HG21 ' A' ' 242' ' ' THR . 78.9 mt -55.98 -44.6 78.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.798 179.377 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.42 ' OD2' ' NZ ' ' A' ' 231' ' ' LYS . 59.5 t0 -166.89 105.02 0.58 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.703 0.287 . . . . 0.0 111.667 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.612 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -100.19 136.84 39.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.701 179.242 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -139.46 145.45 38.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.114 0.483 . . . . 0.0 111.9 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.533 ' O ' ' HB2' ' A' ' 275' ' ' MET . 23.3 tp -67.39 -38.07 84.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.351 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.567 ' O ' HD23 ' A' ' 276' ' ' LEU . 92.5 mmm 101.87 115.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.937 0.895 . . . . 0.0 109.52 -178.69 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.567 HD23 ' O ' ' A' ' 275' ' ' MET . 29.7 mt -123.39 140.8 52.64 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.204 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.569 ' HB3' ' HA3' ' A' ' 281' ' ' GLY . 59.4 t0 -157.66 93.72 1.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.053 177.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.456 ' HE2' ' HD3' ' A' ' 226' ' ' LYS . 11.2 mmtt 69.41 48.13 0.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.205 0.526 . . . . 0.0 110.189 -177.865 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 60.0 t0 67.14 -70.68 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.719 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 59.5 p -69.32 -14.13 62.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.436 -179.743 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 281' ' ' GLY . . . . . 0.569 ' HA3' ' HB3' ' A' ' 277' ' ' ASP . . . -55.12 126.48 38.91 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.866 -178.767 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.971 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 58.2 mm-40 41.25 36.79 0.52 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.996 -0.602 . . . . 0.0 110.87 178.641 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 90.8 p -126.57 157.88 37.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.859 -179.441 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.466 ' HA ' ' HA2' ' A' ' 251' ' ' GLY . 72.0 ttt180 58.16 39.78 25.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.118 0.485 . . . . 0.0 109.808 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -160.46 -68.83 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.945 -179.531 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.517 ' CE1' " C4'" ' B' ' 2' ' ' ' A' . 29.7 p90 -136.82 166.85 22.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.967 0.413 . . . . 0.0 111.462 -178.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.756 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -135.27 158.15 23.48 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.883 179.012 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.554 ' CE2' ' HE2' ' A' ' 244' ' ' LYS . 0.2 OUTLIER -115.13 127.95 55.89 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 122.254 0.222 . . . . 0.0 110.624 179.419 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.624 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 48.2 t -121.21 135.18 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.689 178.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 48.8 m -111.38 136.36 50.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.537 178.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.649 ' OH ' ' HB3' ' A' ' 263' ' ' PHE . 39.2 m-85 -116.08 138.69 51.02 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.371 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.601 ' O ' HG22 ' A' ' 242' ' ' THR . 21.7 t70 -57.82 -34.04 69.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.56 178.091 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 28.9 t -119.06 137.41 53.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.351 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.83 -29.76 70.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.1 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -56.05 -37.05 68.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.419 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.655 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -60.2 -35.84 76.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.908 0.385 . . . . 0.0 110.811 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.559 HG13 HG22 ' A' ' 245' ' ' ILE . 71.2 t -60.57 -44.3 96.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.988 0.423 . . . . 0.0 110.658 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -63.43 -37.23 86.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.071 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -58.16 -42.74 86.62 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.84 HG23 HD11 ' A' ' 306' ' ' ILE . 1.2 p -68.99 -33.7 60.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.797 0.332 . . . . 0.0 111.603 -179.405 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 72.6 m -55.2 -42.24 73.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.106 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -61.83 -37.35 84.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.085 0.469 . . . . 0.0 110.529 179.399 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.55 ' OD1' ' C ' ' A' ' 305' ' ' PHE . 0.0 OUTLIER -62.96 -35.99 81.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.654 -179.795 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.696 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 45.1 tptt 70.69 -71.86 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.457 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.696 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 32.7 m-85 -119.89 130.08 54.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.733 178.856 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.84 HD11 HG23 ' A' ' 300' ' ' VAL . 39.8 mt -113.11 136.42 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.765 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -78.04 95.22 4.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.0 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.708 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 4.9 t80 -87.36 -85.43 0.17 Allowed 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.991 179.451 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.561 ' HG3' HG12 ' A' ' 254' ' ' VAL . 12.1 mmmt -94.91 4.5 53.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.56 ' HB2' ' O ' ' A' ' 309' ' ' LYS . 83.5 m-20 107.68 -31.34 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.04 0.936 . . . . 0.0 110.499 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' A' ' 312' ' ' LYS . 28.9 tpt180 -57.43 -35.46 70.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.945 179.337 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.579 ' HG3' ' HB3' ' A' ' 305' ' ' PHE . 16.4 tptt 96.12 71.6 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.537 -179.349 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.945 HD11 ' CE2' ' A' ' 262' ' ' PHE . 29.9 pt -57.2 98.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.624 0.726 . . . . 0.0 110.173 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 314' ' ' GLU . . . . . 0.678 ' HG2' ' CE2' ' A' ' 305' ' ' PHE . 77.0 mt-10 -61.85 138.04 58.31 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 0.651 HG12 HG23 ' A' ' 247' ' ' VAL . 72.3 mt -121.93 128.54 75.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 19.4 mtpt -131.61 150.98 51.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.7 178.745 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -58.13 144.77 39.2 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.467 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 244' ' ' LYS . . . -65.06 143.63 57.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.972 0.415 . . . . 0.0 111.244 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 319' ' ' GLU . . . . . 0.43 ' O ' ' C2 ' ' B' ' 2' ' ' ' A' . 0.9 OUTLIER 177.52 137.32 0.22 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.285 -179.85 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -55.98 126.75 23.43 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 121.541 1.494 . . . . 0.0 111.026 179.519 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.428 ' CB ' " O2'" ' B' ' 2' ' ' ' A' . 38.1 tpt85 -58.84 -37.82 77.32 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 120.931 0.396 . . . . 0.0 111.103 -179.387 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 77.1 m80 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.938 -179.861 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.692 0 C3'-C2'-O2' 111.214 -0.719 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.971 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.942 0 C3'-C2'-O2' 110.883 -0.834 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.55 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.423 -1.068 0 C3'-C2'-O2' 111.349 -0.673 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.673 " O2'" ' HA3' ' A' ' 201' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.888 0 C4'-C3'-C2' 104.034 1.334 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.743 ' C6 ' ' HA3' ' A' ' 164' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.783 0 O4'-C1'-N19 109.166 0.966 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.602 " O5'" " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.001 0 C4'-C3'-C2' 103.646 0.946 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.74 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.963 0 C3'-C2'-O2' 111.101 -0.758 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . 0.412 ' OP1' ' NH2' ' A' ' 200' ' ' ARG . . . . . . . . 0 O5'--C5' 1.425 -0.968 0 C3'-C2'-O2' 111.242 -0.71 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.864 0.364 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 60.4 mp0 -61.84 -34.22 75.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.0 t -126.09 142.27 51.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.103 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 26.3 m -86.64 0.35 54.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.041 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 38.6 ttpt -74.36 139.25 43.97 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.168 0.509 . . . . 0.0 111.58 -179.452 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.734 ' SD ' HG13 ' A' ' 213' ' ' VAL . 87.3 mmm -112.52 149.32 32.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.504 -179.304 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.58 ' CE2' ' N9 ' ' B' ' 6' ' ' ' A' . 4.6 t80 -103.08 129.19 49.83 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.474 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.751 HG21 HD21 ' A' ' 175' ' ' LEU . 17.8 mm -116.8 125.91 73.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.943 -179.517 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.574 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -120.91 155.97 16.18 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 178.404 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.57 41.53 35.6 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 119.971 -1.109 . . . . 0.0 111.8 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.727 HD22 HD11 ' A' ' 175' ' ' LEU . 75.0 mt -58.81 -28.18 65.76 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.639 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.774 ' O ' ' N ' ' A' ' 169' ' ' ASP . 52.5 t30 71.98 45.41 0.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -177.596 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.655 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 10.9 m0 23.36 -62.62 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.534 1.134 . . . . 0.0 113.911 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.774 ' N ' ' O ' ' A' ' 167' ' ' ASN . 92.3 m-20 -53.91 -33.82 57.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.142 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.461 ' C ' HG23 ' A' ' 171' ' ' THR . 87.9 m -52.92 -39.31 62.69 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.593 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.626 ' C ' HD12 ' A' ' 190' ' ' ILE . 0.1 OUTLIER 55.44 166.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.073 0.464 . . . . 0.0 109.822 -177.846 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.884 ' N ' HD12 ' A' ' 190' ' ' ILE . 21.0 pt-20 -67.76 -23.0 65.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.399 -179.42 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.616 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.8 m-20 -58.68 -44.29 90.17 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.459 -178.932 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.433 ' HB2' ' CG2' ' A' ' 170' ' ' THR . 83.9 m-20 -68.11 -35.33 77.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.677 0.275 . . . . 0.0 111.542 179.27 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.898 HD12 HD11 ' A' ' 190' ' ' ILE . 1.5 mt -55.91 -44.8 78.63 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.19 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.616 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -64.37 -38.77 92.2 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.978 179.312 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.435 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 75.6 mm-40 -69.41 -42.49 75.01 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.536 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 53.8 t80 -64.96 -47.59 77.06 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.421 0.629 . . . . 0.0 111.565 179.471 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.496 ' CE2' HD23 ' A' ' 175' ' ' LEU . 82.4 m-85 -92.42 -1.04 57.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.224 -178.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -58.45 -31.16 66.08 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.205 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -41.18 90.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.543 0.687 . . . . 0.0 110.576 -179.322 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -68.34 -33.89 75.1 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.209 -178.301 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.44 -174.62 44.85 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.862 -179.827 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 54.5 m -63.48 -28.29 69.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.777 0.322 . . . . 0.0 111.319 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.766 HG22 HD11 ' A' ' 205' ' ' LEU . 1.2 t 64.86 82.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -176.697 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.615 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 3.1 m -56.72 -42.87 79.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.414 -176.473 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -148.34 144.62 27.67 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.417 ' HA ' HD13 ' A' ' 188' ' ' LEU . 0.2 OUTLIER -115.4 134.7 54.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.571 178.577 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.561 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 11.1 tptt -141.39 67.13 1.35 Allowed 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.898 HD11 HD12 ' A' ' 175' ' ' LEU . 3.3 mt -66.43 -9.93 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 121.104 0.478 . . . . 0.0 110.377 177.359 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.618 ' HE2' ' HA2' ' A' ' 203' ' ' GLY . 1.8 mpp? 74.53 -56.62 0.63 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.588 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 199' ' ' SER . 8.0 mtmp? 56.43 152.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.077 0.465 . . . . 0.0 111.597 179.392 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.682 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 0.7 OUTLIER -126.08 78.58 70.35 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.519 -179.762 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -56.51 -25.41 58.26 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 121.988 1.792 . . . . 0.0 111.706 179.442 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.77 -67.16 0.66 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.66 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.5 p -67.25 -26.83 66.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.507 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 93.14 0.77 67.66 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.818 -0.706 . . . . 0.0 113.151 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.682 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 1.5 tpt180 -127.41 125.94 41.53 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 117.162 0.481 . . . . 0.0 110.743 179.708 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 192' ' ' LYS . 42.8 m -58.11 155.46 11.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.161 0.505 . . . . 0.0 111.59 -179.404 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.553 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 40.3 mmt180 -55.68 -30.46 61.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.666 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.671 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 97.82 0.16 59.06 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.853 -178.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.692 ' C ' HD11 ' A' ' 166' ' ' LEU . 28.2 p90 -148.36 159.18 44.27 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.618 ' HA2' ' HE2' ' A' ' 191' ' ' MET . . . -147.04 163.75 28.63 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.09 -1.052 . . . . 0.0 111.548 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.742 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 99.0 m-85 -104.63 122.16 45.06 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.855 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.766 HD11 HG22 ' A' ' 185' ' ' VAL . 53.5 tp -102.77 127.1 50.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.209 -177.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 186' ' ' THR . 51.8 m -119.7 139.88 51.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.453 -179.573 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.659 ' CZ ' HD21 ' A' ' 205' ' ' LEU . 94.9 m-85 -122.6 139.68 53.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.578 178.455 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.615 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.5 tt0 -59.98 -33.83 72.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.924 0.392 . . . . 0.0 110.114 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 13.3 mtmm -114.51 122.91 33.19 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.008 179.383 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -56.78 -20.44 35.44 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.744 2.296 . . . . 0.0 113.023 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.9 m -56.48 -36.93 69.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.694 0.283 . . . . 0.0 111.306 -179.269 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.936 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.4 m -59.18 -35.87 74.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.798 0.333 . . . . 0.0 110.764 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.734 HG13 ' SD ' ' A' ' 161' ' ' MET . 83.2 t -61.56 -42.5 94.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.069 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.48 ' O ' HG22 ' A' ' 217' ' ' VAL . 55.4 t0 -59.58 -42.4 92.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.744 0.306 . . . . 0.0 111.091 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.453 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 14.8 pt-20 -74.38 -29.41 61.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.596 179.454 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 212' ' ' SER . 64.6 t -59.77 -42.37 88.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.064 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 214' ' ' ASP . 24.2 m -72.5 -26.95 24.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.495 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -58.63 -31.69 68.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.458 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.615 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 68.7 m -108.42 140.01 42.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.893 0.378 . . . . 0.0 111.605 -179.129 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 63.4 tt0 -65.53 -40.74 93.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.64 179.079 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.729 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 71.7 m-70 84.47 110.74 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 178.352 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 1.031 HD12 HG12 ' A' ' 227' ' ' VAL . 20.3 mm -116.66 114.05 44.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 175.788 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.429 HD12 ' CG ' ' A' ' 178' ' ' TYR . 5.8 tt -122.58 122.3 38.54 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.469 -178.092 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 51.5 42.39 29.36 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 178.781 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.07 8.26 87.95 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.562 -0.827 . . . . 0.0 113.443 178.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.416 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 35.5 mmtp -121.5 155.37 35.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.753 0.311 . . . . 0.0 111.008 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 1.031 HG12 HD12 ' A' ' 222' ' ' ILE . 32.8 m -110.5 134.94 51.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.04 0.447 . . . . 0.0 110.349 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 164' ' ' GLY . 36.5 pt -124.32 158.63 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.866 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -126.74 79.2 72.28 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 121.16 0.505 . . . . 0.0 111.175 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 162' ' ' PHE . 51.1 Cg_exo -58.98 120.87 9.01 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.739 2.293 . . . . 0.0 110.669 179.232 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.537 ' HD3' ' O4 ' ' B' ' 5' ' ' ' U' . 28.7 mtpt -134.1 146.97 50.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.686 0.279 . . . . 0.0 111.712 -179.065 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.535 ' N ' ' HD2' ' A' ' 232' ' ' ARG . 0.0 OUTLIER -49.4 134.91 18.38 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.986 0.422 . . . . 0.0 110.989 -179.557 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.447 ' HA ' ' N1 ' ' B' ' 6' ' ' ' A' . . . -65.45 145.66 55.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.915 -179.616 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.501 HD11 ' N6 ' ' B' ' 6' ' ' ' A' . 1.2 mt -118.13 137.55 24.65 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.167 179.223 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.447 ' HG2' ' HB2' ' A' ' 238' ' ' GLU . 9.5 Cg_endo -54.28 141.03 72.11 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 121.8 1.666 . . . . 0.0 110.97 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -55.76 -41.76 74.45 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -178.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -60.83 -41.79 96.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.782 0.325 . . . . 0.0 111.047 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.462 ' O ' HG23 ' A' ' 242' ' ' THR . 84.5 tt0 -64.75 -36.59 84.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.601 179.394 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.408 ' NE2' ' N3 ' ' B' ' 6' ' ' ' A' . 94.8 mt-30 -60.0 -38.83 83.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.704 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -61.12 -39.42 89.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.207 0.527 . . . . 0.0 110.394 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -60.97 -31.4 70.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.347 179.581 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.541 HG22 ' CD1' ' A' ' 270' ' ' ILE . 10.4 p -75.31 161.44 29.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.911 -178.136 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.69 112.72 0.85 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.086 179.53 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.61 ' HE3' ' CD2' ' A' ' 288' ' ' PHE . 5.3 tptp -85.8 129.2 34.89 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -179.629 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.689 HG21 HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -120.84 160.71 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.474 0.654 . . . . 0.0 111.865 -179.55 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.491 ' CE1' ' C4 ' ' B' ' 2' ' ' ' A' . 76.2 t80 -104.31 137.45 42.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.951 179.416 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.758 HG23 HG12 ' A' ' 315' ' ' ILE . 7.2 p -128.68 147.17 33.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.644 -179.773 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.673 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -128.7 166.96 21.01 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.026 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 81.02 42.19 9.76 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.804 -179.777 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.566 ' CG2' HG11 ' A' ' 254' ' ' VAL . 27.3 mm -55.65 -36.29 41.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.849 0.357 . . . . 0.0 111.295 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 60.79 169.02 0.5 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.868 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.26 144.66 81.59 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.032 2.488 . . . . 0.0 113.674 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 55.11 42.47 30.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.936 178.245 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.623 HG23 ' HE2' ' A' ' 308' ' ' PHE . 12.5 p -63.72 -38.3 81.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.996 178.612 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.615 ' O ' ' O ' ' A' ' 254' ' ' VAL . 4.5 mpt_? 50.31 126.29 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.43 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.48 -28.28 44.13 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.077 1.852 . . . . 0.0 112.668 -178.831 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -61.17 -47.79 84.55 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.614 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.527 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 53.0 mp0 -69.44 -39.62 77.69 Favored 'General case' 0 C--O 1.224 -0.261 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.693 ' CE1' HG11 ' A' ' 247' ' ' VAL . 27.4 t80 -61.37 -47.25 86.68 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.21 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.531 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.5 tt0 -65.58 -43.11 90.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.736 0.303 . . . . 0.0 111.295 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.527 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.8 pt-20 -76.47 -28.86 56.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.129 0.49 . . . . 0.0 110.877 179.444 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.662 ' CZ ' ' HB2' ' A' ' 308' ' ' PHE . 11.6 t80 -61.93 -56.48 18.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.13 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.763 ' CG ' HG21 ' A' ' 289' ' ' VAL . 5.2 m-85 -67.67 -27.56 66.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.069 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.745 ' N ' HD11 ' A' ' 269' ' ' ILE . 80.1 p -56.44 -23.97 42.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.736 0.303 . . . . 0.0 111.113 -178.667 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -56.68 -35.94 69.01 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.275 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.677 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 19.4 p90 -111.66 48.99 0.92 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -179.648 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 133.43 150.39 6.31 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.184 178.463 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.4 m -70.3 131.68 44.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.782 HG23 ' O ' ' A' ' 290' ' ' THR . 74.5 mt -102.9 118.65 50.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.84 -178.73 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.683 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 72.7 mt -69.51 -39.4 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 120.289 -0.565 . . . . 0.0 112.236 179.359 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -136.38 -87.44 0.32 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.725 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . 65.14 110.42 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.709 0.29 . . . . 0.0 110.886 -178.659 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 273' ' ' GLN . . . . . 0.419 ' O ' ' NE2' ' A' ' 282' ' ' GLN . 21.6 pt20 -141.23 158.67 43.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.253 0.549 . . . . 0.0 111.853 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 1.038 HD23 HD11 ' A' ' 276' ' ' LEU . 28.6 tp -66.1 -26.86 67.66 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.09 -179.608 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.818 ' HE1' " O3'" ' B' ' 3' ' ' ' U' . 66.8 mmm 82.51 -80.91 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.457 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 1.038 HD11 HD23 ' A' ' 274' ' ' LEU . 5.2 mp 55.53 72.25 0.5 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.16 -178.579 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.483 ' HB3' ' HA3' ' A' ' 281' ' ' GLY . 60.2 t0 -79.91 113.56 18.16 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.001 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 18.6 mttt 69.76 -59.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.358 -178.496 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.728 ' OD1' HG23 ' A' ' 280' ' ' THR . 53.7 p30 -178.1 -31.12 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 179.133 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.728 HG23 ' OD1' ' A' ' 279' ' ' ASP . 68.2 p -109.46 10.89 25.22 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.493 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 281' ' ' GLY . . . . . 0.483 ' HA3' ' HB3' ' A' ' 277' ' ' ASP . . . -91.37 99.07 2.52 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.209 -0.995 . . . . 0.0 113.149 -179.525 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.693 ' HB2' ' CZ ' ' A' ' 286' ' ' PHE . 38.2 tt0 75.38 -8.1 1.65 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.89 0.476 . . . . 0.0 112.18 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 21.9 m -57.77 -38.46 75.46 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -137.79 142.59 40.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.31 178.654 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.05 -46.46 1.71 Allowed Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.484 -0.865 . . . . 0.0 114.399 178.591 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.693 ' CZ ' ' HB2' ' A' ' 282' ' ' GLN . 23.7 p90 -140.24 168.38 19.93 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.224 1.012 . . . . 0.0 113.076 -179.162 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.506 ' C ' HG12 ' A' ' 247' ' ' VAL . . . -138.03 174.35 21.95 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.173 179.164 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.61 ' CD2' ' HE3' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -137.17 123.33 20.44 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.294 0.547 . . . . 0.0 111.44 -179.948 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.763 HG21 ' CG ' ' A' ' 263' ' ' PHE . 56.8 t -126.44 137.6 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.008 0.432 . . . . 0.0 111.815 178.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.782 ' O ' HG23 ' A' ' 269' ' ' ILE . 32.6 m -110.73 136.45 49.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.7 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.436 ' OH ' ' O ' ' A' ' 263' ' ' PHE . 31.0 m-85 -117.96 136.1 53.72 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.683 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 55.7 t0 -59.05 -36.18 74.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.254 178.6 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 49.9 m -121.53 143.88 49.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.471 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.92 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -66.57 -28.72 68.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.389 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -56.01 -36.59 68.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.824 -179.126 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.71 91.46 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.292 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.92 HG12 ' O ' ' A' ' 294' ' ' ALA . 6.2 p -59.62 -36.96 68.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.219 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -62.18 -38.41 88.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.346 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -59.87 -43.41 94.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.894 -178.698 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.833 HG23 HD11 ' A' ' 306' ' ' ILE . 0.8 OUTLIER -69.4 -34.84 64.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.375 -179.334 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 80.2 m -59.33 -46.6 88.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.155 -179.569 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -62.49 -38.83 91.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.199 0.523 . . . . 0.0 109.965 179.252 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 305' ' ' PHE . 88.5 m-20 -61.55 -32.36 72.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.257 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.645 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 18.8 tptm 69.24 -69.55 0.16 Allowed 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.562 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.645 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.7 m-30 -113.95 143.0 45.43 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.758 178.063 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.833 HD11 HG23 ' A' ' 300' ' ' VAL . 6.9 mm -111.94 136.35 48.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -72.41 83.69 1.08 Allowed 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.198 -179.305 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.662 ' HB2' ' CZ ' ' A' ' 262' ' ' PHE . 4.9 t80 -105.9 142.84 34.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.556 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.533 ' HG2' ' CD2' ' A' ' 308' ' ' PHE . 18.8 mmmt 46.34 -135.89 0.79 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.116 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -96.74 9.77 40.74 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -178.711 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -151.05 165.82 32.63 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.325 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.479 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 53.0 mttt -78.86 143.46 35.94 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.76 179.159 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.673 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 33.7 pt -121.1 153.76 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.088 179.185 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 314' ' ' GLU . . . . . 0.604 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 84.0 mt-10 -110.16 134.98 51.65 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.414 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 0.758 HG12 HG23 ' A' ' 247' ' ' VAL . 76.7 mt -122.28 128.61 75.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.268 0.556 . . . . 0.0 112.17 -179.287 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -128.4 156.66 42.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.113 179.703 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -54.68 146.97 15.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.64 0.257 . . . . 0.0 110.363 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.57 ' O ' ' N1 ' ' B' ' 2' ' ' ' A' . . . -54.26 -98.28 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.042 -179.273 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 319' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 318' ' ' ALA . 56.3 mm-40 69.38 102.4 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.416 0.151 . . . . 0.0 111.351 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 319' ' ' GLU . 18.7 Cg_endo -58.97 143.66 99.6 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.232 1.954 . . . . 0.0 111.842 179.481 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -58.08 -34.88 70.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.052 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 77.4 m80 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.916 179.973 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.697 0 C3'-C2'-O2' 111.206 -0.722 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.57 ' N1 ' ' O ' ' A' ' 318' ' ' ALA . . . . . . . . 0 O5'--C5' 1.425 -0.939 0 C1'-C2'-O2' 108.559 -0.68 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.818 " O3'" ' HE1' ' A' ' 275' ' ' MET . . . . . . . . 0 O5'--C5' 1.423 -1.043 0 C1'-C2'-O2' 108.379 -0.74 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.685 ' N7 ' ' HA ' ' A' ' 167' ' ' ASN . . . . . . . . 0 O5'--C5' 1.426 -0.875 0 C4'-C3'-C2' 103.801 1.101 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.702 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.729 0 C5'-C4'-O4' 107.771 -1.021 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.702 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.916 0 C3'-C2'-O2' 111.08 -0.766 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.742 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.89 0 C4'-C3'-C2' 103.543 0.843 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . 0.774 " H3'" ' N3 ' ' B' ' 8' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.997 0 O4'-C1'-C2' 107.384 0.703 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.4 tttt . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.89 0.376 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.447 ' OE2' ' HG2' ' A' ' 232' ' ' ARG . 47.9 tp10 -105.81 145.29 31.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.906 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.2 m -116.71 144.69 44.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.109 0.481 . . . . 0.0 111.292 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.531 ' HA ' HG21 ' A' ' 213' ' ' VAL . 8.2 m -65.29 -29.75 70.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.56 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 74.2 tttt -56.74 139.69 49.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.179 0.514 . . . . 0.0 111.896 -178.607 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.758 ' SD ' HG13 ' A' ' 213' ' ' VAL . 94.7 mmm -121.94 150.46 41.98 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.896 -178.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.711 ' CE1' ' CZ ' ' A' ' 204' ' ' PHE . 1.5 t80 -108.42 129.64 55.25 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.262 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.604 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 24.4 mm -116.83 131.04 70.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.253 -179.221 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 228' ' ' ILE . . . -130.17 166.2 22.25 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 178.774 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.78 32.54 59.02 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.937 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.709 HD22 HG21 ' A' ' 170' ' ' THR . 65.2 mt -59.57 -23.43 62.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -179.234 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.587 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 33.3 t-20 70.3 37.29 1.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -177.549 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.625 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 18.6 m0 37.12 17.95 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.28 -1.327 . . . . 0.0 113.829 179.453 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 167' ' ' ASN . 93.3 m-20 -139.28 10.04 2.52 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.779 ' CG2' HD13 ' A' ' 223' ' ' LEU . 95.1 m -57.24 -38.52 73.94 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.465 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.552 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.2 OUTLIER 54.78 142.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.108 0.48 . . . . 0.0 110.459 -178.344 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.6 ' CA ' HD12 ' A' ' 190' ' ' ILE . 97.2 mt-10 -61.63 -34.96 76.58 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.704 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.597 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 60.1 t0 -57.28 -42.45 81.7 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.601 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 170' ' ' THR . 10.9 m120 -64.13 -37.8 88.76 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.022 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.956 HD22 HD21 ' A' ' 205' ' ' LEU . 11.0 mt -56.76 -50.5 72.09 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.229 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.597 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -67.46 -34.71 77.74 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.429 179.506 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -59.44 -38.91 81.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.395 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.622 ' CE2' ' CE2' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -94.69 -55.71 3.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.676 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.686 ' CE2' HD23 ' A' ' 175' ' ' LEU . 72.0 m-85 -60.62 -29.55 69.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.28 179.145 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.63 -24.13 23.62 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.904 179.073 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.804 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -55.71 -38.75 70.14 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.896 0.379 . . . . 0.0 111.483 -179.632 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.804 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 59.2 m-85 -68.1 -30.78 70.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.516 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 166.9 -129.33 1.9 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.092 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 59.7 m -117.4 141.78 47.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.227 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 206' ' ' SER . 10.5 p -104.41 125.44 59.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.736 HG23 ' N ' ' A' ' 208' ' ' GLU . 43.4 p -70.75 -35.48 72.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.605 -178.722 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -154.14 149.75 27.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.338 0.59 . . . . 0.0 112.253 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.503 HD22 HG21 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -118.63 130.14 55.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.476 179.689 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.549 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 35.5 tptt -128.57 118.87 23.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.211 0.529 . . . . 0.0 111.341 179.391 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.6 HD12 ' CA ' ' A' ' 172' ' ' GLU . 0.3 OUTLIER -124.44 138.48 53.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.696 177.676 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.718 ' HB2' ' HB3' ' A' ' 200' ' ' ARG . 15.1 mmt -86.29 135.08 33.68 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.901 -179.213 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -139.25 134.67 32.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.052 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 0.8 OUTLIER -123.31 78.02 53.29 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.676 -179.939 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.63 -27.9 72.32 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.252 1.968 . . . . 0.0 112.117 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -71.82 -63.01 1.22 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.083 0.468 . . . . 0.0 111.036 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 55.2 p -72.88 -18.83 61.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.512 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 79.6 28.9 50.45 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.36 -179.776 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.542 ' HD2' ' CZ2' ' A' ' 168' ' ' TRP . 7.8 ttp180 -124.91 141.81 51.88 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 121.048 0.452 . . . . 0.0 111.854 -179.399 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 191' ' ' MET . 22.6 p -84.73 8.23 17.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.649 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.813 ' HG3' ' CE1' ' A' ' 202' ' ' PHE . 11.4 tpt180 76.48 -42.64 0.44 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.065 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.548 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 96.37 4.73 59.48 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.851 -0.69 . . . . 0.0 114.219 178.311 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.813 ' CE1' ' HG3' ' A' ' 200' ' ' ARG . 36.6 p90 -149.54 159.13 44.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.257 0.551 . . . . 0.0 112.106 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -151.66 170.88 31.16 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.418 179.577 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.745 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 78.9 m-85 -114.98 134.94 54.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.025 0.441 . . . . 0.0 112.058 -179.558 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.956 HD21 HD22 ' A' ' 175' ' ' LEU . 59.5 mt -107.73 139.65 41.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.349 179.112 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.625 ' O ' HG23 ' A' ' 185' ' ' VAL . 20.1 t -123.24 126.97 47.93 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.928 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.712 ' CE2' HG21 ' A' ' 216' ' ' VAL . 84.4 m-85 -114.64 135.18 54.43 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.736 ' N ' HG23 ' A' ' 186' ' ' THR . 84.5 tt0 -63.35 -35.56 80.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.153 178.583 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.69 117.39 54.26 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.879 179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.78 -28.09 74.65 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.58 2.187 . . . . 0.0 113.041 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 20.4 m -59.02 -39.65 82.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.796 0.331 . . . . 0.0 110.724 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.855 ' O ' HG23 ' A' ' 216' ' ' VAL . 23.8 m -61.42 -35.58 77.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.222 0.534 . . . . 0.0 110.095 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.758 HG13 ' SD ' ' A' ' 161' ' ' MET . 96.7 t -62.19 -41.74 92.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.392 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 218' ' ' LYS . 92.4 m-20 -58.62 -43.61 89.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.305 -179.345 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -70.02 -34.35 73.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.855 0.36 . . . . 0.0 111.708 178.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 212' ' ' SER . 87.0 t -60.35 -44.36 95.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.18 -178.766 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.611 HG11 ' NE ' ' A' ' 232' ' ' ARG . 10.4 p -80.75 -44.84 21.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.464 ' N ' HG13 ' A' ' 217' ' ' VAL . 15.0 mtpt -59.21 -34.19 71.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.713 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 27.5 m -96.46 143.65 27.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.135 0.493 . . . . 0.0 111.745 -178.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -93.3 125.28 37.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.902 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.603 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 0.0 OUTLIER -131.79 152.34 51.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.201 -179.028 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.581 HG22 ' H ' ' A' ' 225' ' ' GLY . 70.7 mt -121.91 128.41 75.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.871 179.393 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.779 HD13 ' CG2' ' A' ' 170' ' ' THR . 4.7 mt -88.1 -72.78 0.51 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -93.07 14.15 18.7 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.143 -178.786 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.581 ' H ' HG22 ' A' ' 222' ' ' ILE . . . 100.19 -0.32 56.0 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.987 -178.696 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -112.22 132.58 54.84 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 227' ' ' VAL . 34.3 m -59.01 120.05 4.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.498 -179.325 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.745 HG13 ' HD3' ' A' ' 230' ' ' PRO . 31.1 pt -97.47 -33.0 4.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.298 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 47.57 73.72 0.94 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.079 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.745 ' HD3' HG13 ' A' ' 228' ' ' ILE . 31.0 Cg_endo -60.54 135.01 58.07 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.736 2.291 . . . . 0.0 112.143 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.425 ' HE2' ' O4 ' ' B' ' 5' ' ' ' U' . 16.3 mtmm -128.53 151.99 48.81 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.547 179.047 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.611 ' NE ' HG11 ' A' ' 217' ' ' VAL . 1.9 mpt_? -59.47 143.45 49.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.206 0.527 . . . . 0.0 112.233 -178.621 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -74.95 150.14 39.16 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.613 179.611 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.885 HD12 ' HG2' ' A' ' 239' ' ' GLN . 0.1 OUTLIER -124.89 133.49 24.84 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.287 178.873 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.559 ' HD2' ' OE1' ' A' ' 238' ' ' GLU . 44.0 Cg_exo -54.96 145.64 61.81 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 121.775 1.65 . . . . 0.0 110.092 178.321 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 48.7 tpt85 -54.55 -40.53 68.79 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.565 -178.364 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.599 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 53.4 p30 -65.24 -37.31 86.84 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.371 179.414 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.599 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 93.1 mt-10 -68.29 -34.85 76.92 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.008 179.393 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.885 ' HG2' HD12 ' A' ' 234' ' ' ILE . 97.4 mt-30 -58.89 -38.62 79.28 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.045 0.45 . . . . 0.0 109.901 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -61.51 -39.08 89.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.048 178.594 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -60.05 -34.76 73.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.393 179.529 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.757 HG21 HD11 ' A' ' 270' ' ' ILE . 12.1 p -105.38 162.96 12.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.407 -178.607 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.22 168.62 25.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.519 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 289' ' ' VAL . 7.2 ttpm? -134.31 139.6 45.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.431 0.158 . . . . 0.0 110.678 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.823 HD12 HG11 ' A' ' 300' ' ' VAL . 0.1 OUTLIER -118.71 157.53 20.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 121.13 0.491 . . . . 0.0 111.465 -179.361 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.555 ' CE1' ' C4 ' ' B' ' 2' ' ' ' A' . 88.1 t80 -102.8 128.37 49.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.645 178.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.835 HG11 HD12 ' A' ' 313' ' ' ILE . 41.5 t -124.55 131.27 72.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.885 0.374 . . . . 0.0 111.44 179.303 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.655 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -105.45 174.19 20.94 Favored Glycine 0 C--O 1.225 -0.411 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.907 179.219 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 285' ' ' GLY . . . 82.86 16.22 70.79 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.933 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.574 ' CD1' ' CE1' ' A' ' 259' ' ' PHE . 64.0 mt -116.13 132.66 65.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.94 0.4 . . . . 0.0 111.519 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.695 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -168.02 -116.3 0.36 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.666 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.89 143.53 99.58 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.616 2.211 . . . . 0.0 113.389 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 55.34 41.81 30.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.953 178.765 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.738 HG12 ' HG2' ' A' ' 309' ' ' LYS . 16.6 m -118.8 -1.84 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.369 178.099 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.597 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.2 OUTLIER 37.61 111.91 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.431 0 O-C-N 123.365 0.415 . . . . 0.0 111.804 -179.851 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.19 -39.72 51.82 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.542 1.495 . . . . 0.0 111.492 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -62.6 -40.99 98.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.014 0.435 . . . . 0.0 109.959 178.23 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.511 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 85.0 tt0 -65.11 -37.47 87.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.822 179.502 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.574 ' CE1' ' CD1' ' A' ' 250' ' ' ILE . 35.1 t80 -60.51 -45.46 93.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.643 179.076 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.543 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.4 tt0 -64.1 -42.01 97.08 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.511 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.3 pt-20 -74.73 -30.23 61.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.015 0.436 . . . . 0.0 110.362 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.57 ' CE1' ' HD1' ' A' ' 308' ' ' PHE . 88.1 t80 -58.78 -46.56 87.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.885 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.757 ' HZ ' HG11 ' A' ' 247' ' ' VAL . 34.8 m-85 -88.09 -7.12 57.44 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.745 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.499 ' N ' HD11 ' A' ' 269' ' ' ILE . 81.6 p -62.6 -26.28 68.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.039 0.447 . . . . 0.0 111.107 -179.668 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -57.16 -38.41 73.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.911 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.641 ' HH2' HG21 ' A' ' 306' ' ' ILE . 11.6 m-90 -59.26 -38.35 79.89 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.342 0.591 . . . . 0.0 111.199 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 264' ' ' SER . . . 174.83 -159.77 28.51 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.069 -178.757 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 51.3 m -79.57 130.73 35.65 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.143 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.829 HG23 ' O ' ' A' ' 290' ' ' THR . 72.2 mt -106.59 118.32 54.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.757 HD11 HG21 ' A' ' 242' ' ' THR . 69.5 mt -61.17 -52.46 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 120.089 -0.645 . . . . 0.0 112.288 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 270' ' ' ILE . 72.9 m-20 -162.97 68.9 0.22 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.668 ' HB2' HG21 ' A' ' 269' ' ' ILE . . . -73.87 135.71 43.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.387 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -139.63 149.43 43.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.451 0.643 . . . . 0.0 111.969 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.569 ' O ' ' HB2' ' A' ' 275' ' ' MET . 22.6 tp -65.14 -37.91 88.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.855 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.731 ' C ' HD12 ' A' ' 276' ' ' LEU . 93.6 mmm 84.62 148.59 0.07 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.14 0.576 . . . . 0.0 109.899 -178.293 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.731 HD12 ' C ' ' A' ' 275' ' ' MET . 5.5 mp -158.57 133.34 8.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.632 0.253 . . . . 0.0 110.734 179.453 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -74.82 -134.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.129 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.41 ' O ' ' OD1' ' A' ' 279' ' ' ASP . 86.4 mttt -58.78 -37.14 75.65 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.764 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.499 ' O ' HD23 ' A' ' 276' ' ' LEU . 95.9 m-20 -140.34 -85.07 0.22 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.762 179.125 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 57.8 p -116.04 24.31 11.54 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.711 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -51.88 -41.92 52.55 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.805 -179.08 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.702 ' HG3' ' HB2' ' A' ' 275' ' ' MET . 6.9 tm0? -64.52 -34.74 78.94 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.972 0.415 . . . . 0.0 111.493 178.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 39.4 t -49.59 -15.14 0.14 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.244 -177.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.409 ' NH2' ' OP1' ' B' ' 2' ' ' ' A' . 59.2 ttp180 -51.18 -36.87 43.36 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.098 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 249' ' ' GLY . . . 154.2 31.09 0.03 OUTLIER Glycine 0 CA--C 1.528 0.888 0 C-N-CA 118.828 -1.653 . . . . 0.0 116.636 178.419 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.586 ' O ' ' NE2' ' A' ' 282' ' ' GLN . 12.7 p90 -143.89 160.6 40.51 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.51 1.655 . . . . 0.0 111.962 178.322 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -147.2 163.34 28.68 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.952 179.286 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.442 ' CE2' ' HE3' ' A' ' 244' ' ' LYS . 1.4 m-30 -113.68 128.07 56.28 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.485 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 39.8 t -121.52 132.67 70.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.527 0.203 . . . . 0.0 110.462 177.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.829 ' O ' HG23 ' A' ' 269' ' ' ILE . 49.7 m -120.26 136.51 54.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.642 0.258 . . . . 0.0 110.42 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.555 ' CE1' HG12 ' A' ' 269' ' ' ILE . 45.7 m-85 -119.23 134.98 54.91 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.671 ' HA ' HD11 ' A' ' 270' ' ' ILE . 55.0 t0 -60.52 -34.84 74.68 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.649 178.07 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 23.3 t -117.32 140.79 49.12 Favored 'General case' 0 N--CA 1.46 0.047 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.066 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.53 -28.36 69.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.873 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 296' ' ' ALA . 53.8 p30 -59.26 -35.87 74.49 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.53 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.575 ' N ' ' OD1' ' A' ' 295' ' ' ASP . . . -64.29 -33.83 76.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.979 0.419 . . . . 0.0 110.335 179.215 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.691 HG13 ' CG2' ' A' ' 245' ' ' ILE . 72.2 t -62.55 -43.44 98.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.196 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -61.35 -42.58 98.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.751 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -64.49 -42.81 95.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.151 0.501 . . . . 0.0 112.116 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.987 HG22 HD13 ' A' ' 315' ' ' ILE . 1.4 p -66.59 -36.23 76.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.618 -178.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 75.1 m -71.3 -42.41 68.69 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -57.76 -39.46 77.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.811 0.339 . . . . 0.0 111.697 -178.873 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.48 ' HB2' HD11 ' A' ' 306' ' ' ILE . 89.1 m-20 -57.84 -30.85 66.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.557 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.695 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 7.4 tptt 70.13 -71.8 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.55 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.695 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.8 m-30 -111.68 138.16 48.61 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.042 0.448 . . . . 0.0 110.949 178.883 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.641 HG21 ' HH2' ' A' ' 266' ' ' TRP . 21.9 mm -117.97 137.33 52.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.522 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -75.51 86.35 2.62 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.996 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.57 ' HD1' ' CE1' ' A' ' 262' ' ' PHE . 5.1 t80 -110.24 129.04 55.8 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.44 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.738 ' HG2' HG12 ' A' ' 254' ' ' VAL . 0.0 OUTLIER 59.01 40.33 22.39 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.751 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 53.98 37.5 26.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.514 0.673 . . . . 0.0 109.274 -178.014 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -148.59 162.51 39.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.93 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.65 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 30.6 mttt -93.89 133.69 37.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.232 0.539 . . . . 0.0 111.509 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.835 HD12 HG11 ' A' ' 247' ' ' VAL . 32.2 pt -118.06 144.17 26.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.196 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 314' ' ' GLU . . . . . 0.514 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 89.1 mt-10 -101.55 142.13 33.38 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.731 -178.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 0.987 HD13 HG22 ' A' ' 300' ' ' VAL . 69.6 mt -118.71 126.51 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 121.095 0.474 . . . . 0.0 111.496 -179.514 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -137.64 137.4 38.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.846 179.34 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -48.66 144.67 4.17 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.566 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 244' ' ' LYS . . . -55.92 143.81 30.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.008 0.432 . . . . 0.0 111.259 -179.083 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 319' ' ' GLU . . . . . 0.429 ' HG3' ' CD ' ' A' ' 320' ' ' PRO . 1.9 tt0 -123.65 143.69 42.45 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.245 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.429 ' CD ' ' HG3' ' A' ' 319' ' ' GLU . 13.7 Cg_endo -56.53 139.61 87.9 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.119 1.879 . . . . 0.0 111.59 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 46.5 tpt85 -57.01 -37.63 71.96 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.881 0.372 . . . . 0.0 110.998 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 83.7 t60 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.864 179.913 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.455 " O3'" ' H8 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.728 0 C3'-C2'-O2' 111.246 -0.708 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.555 ' C4 ' ' CE1' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.917 0 C3'-C2'-O2' 111.195 -0.726 . 0.0 OUTLIER '7D dist 0b' 0.0 . . . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.532 ' H6 ' " O2'" ' B' ' 2' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.99 0 C1'-C2'-O2' 108.453 -0.716 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.625 ' C5 ' ' CE3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.426 -0.861 0 C4'-C3'-C2' 103.792 1.092 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.806 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.787 0 C4'-C3'-C2' 103.709 1.009 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.806 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.031 0 C4'-C3'-C2' 103.637 0.937 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.745 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.421 -1.16 0 C5'-C4'-O4' 107.003 -1.569 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.97 0 C3'-C2'-O2' 111.284 -0.695 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 88.3 mttt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.9 0.381 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 61.31 19.23 9.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.258 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 24.0 m -57.97 -36.02 71.99 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.831 0.348 . . . . 0.0 110.883 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.8 p -60.78 -30.84 70.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.714 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.545 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 5.3 tptm -67.55 138.49 56.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.031 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.688 ' O ' ' HA ' ' A' ' 204' ' ' PHE . 90.0 mtp -129.46 160.0 34.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.077 0.465 . . . . 0.0 111.906 -179.659 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.564 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 1.6 t80 -107.63 129.54 54.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.771 178.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.503 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 20.4 mm -118.49 130.62 73.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 121.263 -0.175 . . . . 0.0 111.205 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.525 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -128.53 158.37 21.71 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.726 178.889 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.23 36.61 34.4 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.586 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 68.3 mt -59.79 -26.03 65.4 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.446 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.738 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 54.3 t30 74.11 39.88 0.48 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.93 0.395 . . . . 0.0 110.207 -178.188 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.648 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 9.6 m0 30.65 30.06 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.638 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 167' ' ' ASN . 89.6 m-20 -130.97 5.8 4.57 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 172' ' ' GLU . 23.6 m -82.73 133.76 35.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 110.348 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 172' ' ' GLU . 5.3 p -109.49 14.69 23.43 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.104 -179.409 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.71 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 95.5 mt-10 77.67 -30.28 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -177.619 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.709 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 90.1 m-20 -62.92 -41.0 99.31 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 121.114 0.483 . . . . 0.0 111.486 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.519 ' HB3' HD21 ' A' ' 223' ' ' LEU . 85.1 m-20 -61.53 -38.0 85.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.685 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.745 HD22 HD21 ' A' ' 205' ' ' LEU . 18.9 mt -62.81 -41.93 99.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -178.247 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.709 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -68.83 -42.73 76.77 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.752 179.955 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.518 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 84.2 tt0 -72.64 -44.38 61.97 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.031 0.443 . . . . 0.0 110.811 179.014 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.606 ' OH ' ' CB ' ' A' ' 221' ' ' HIS . 43.1 t80 -62.62 -44.39 96.41 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.575 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.616 ' CE2' HD23 ' A' ' 175' ' ' LEU . 95.3 m-85 -97.8 -0.27 45.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.061 -178.531 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -59.32 -29.75 66.61 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.822 178.483 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.575 ' H ' ' CD ' ' A' ' 181' ' ' LYS . 0.5 OUTLIER -57.34 -42.29 81.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 122.093 0.949 . . . . 0.0 110.356 -179.897 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -69.65 -34.1 73.53 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.702 -1.59 . . . . 0.0 112.492 -177.679 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -175.39 -173.43 41.14 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 119.46 -1.353 . . . . 0.0 114.187 -179.742 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.545 ' O ' HG12 ' A' ' 185' ' ' VAL . 51.7 m -61.74 -26.53 68.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.533 -0.833 . . . . 0.0 112.05 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 184' ' ' THR . 8.0 p 51.31 73.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.831 0.824 . . . . 0.0 109.427 -177.292 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.4 t -54.23 -46.36 72.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.62 -1.173 . . . . 0.0 113.275 -177.584 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -137.45 157.33 46.8 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.587 0.708 . . . . 0.0 112.849 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.718 HD11 ' HB2' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -127.32 130.87 50.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.429 179.599 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 20.0 tptt -134.26 120.58 20.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 179.676 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.71 ' HB ' ' HG2' ' A' ' 172' ' ' GLU . 1.0 OUTLIER -127.88 134.61 64.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.139 176.868 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.591 ' N ' ' SD ' ' A' ' 191' ' ' MET . 0.0 OUTLIER -92.8 135.95 33.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.456 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -127.93 150.94 49.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.608 -178.817 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.631 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 17.8 m-20 -119.76 78.11 22.2 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.665 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.94 -26.41 74.47 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.11 1.874 . . . . 0.0 111.701 179.176 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.29 -66.55 0.71 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.444 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.8 p -67.58 -27.51 66.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.125 179.66 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 90.6 6.14 68.29 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.411 179.354 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.631 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 6.2 ttp85 -128.82 129.48 45.68 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 117.519 0.66 . . . . 0.0 111.816 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.5 t -66.37 155.46 37.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.807 -179.669 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.685 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 1.1 mpt_? -53.95 -34.03 58.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.131 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.489 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 93.82 1.85 65.29 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.842 -179.103 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.685 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 33.6 p90 -139.54 156.6 46.8 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.953 0.406 . . . . 0.0 110.919 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.521 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -144.31 158.92 27.63 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.819 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.688 ' HA ' ' O ' ' A' ' 161' ' ' MET . 90.5 m-85 -108.7 130.0 55.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 117.082 0.441 . . . . 0.0 110.463 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.745 HD21 HD22 ' A' ' 175' ' ' LEU . 64.2 mt -106.68 138.06 43.55 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.861 0.362 . . . . 0.0 111.943 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 49.0 m -121.29 136.2 55.0 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.717 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -123.36 145.29 48.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.748 0.309 . . . . 0.0 111.108 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.45 -34.36 76.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.952 178.782 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.7 115.34 51.39 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.336 179.161 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.37 -24.34 51.43 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.643 2.228 . . . . 0.0 113.61 -179.111 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 85.4 p -60.82 -31.42 70.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.586 0.232 . . . . 0.0 111.444 -179.405 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.862 ' O ' HG23 ' A' ' 216' ' ' VAL . 19.5 m -59.68 -36.11 75.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.912 0.387 . . . . 0.0 110.771 179.528 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.529 HG13 ' SD ' ' A' ' 161' ' ' MET . 85.8 t -62.13 -41.95 93.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.435 -179.558 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -59.26 -41.38 88.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.66 -179.698 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.403 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 16.3 pt-20 -76.79 -34.55 57.97 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 212' ' ' SER . 76.4 t -62.23 -46.31 96.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.25 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 230' ' ' PRO . 13.3 p -68.24 -45.53 82.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.022 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.489 ' N ' HG13 ' A' ' 217' ' ' VAL . 27.0 mttp -61.31 -36.19 79.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.026 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.405 ' O ' ' O ' ' A' ' 220' ' ' GLN . 47.9 m -59.11 -38.78 80.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.783 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.405 ' O ' ' O ' ' A' ' 219' ' ' THR . 63.9 tt0 60.67 107.26 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -177.442 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.614 ' O ' HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -136.92 167.63 21.12 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -176.568 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.755 HG23 ' O ' ' A' ' 226' ' ' LYS . 3.0 mt -125.58 118.8 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.321 176.832 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.606 HD23 ' OD1' ' A' ' 224' ' ' ASP . 8.4 tt -91.16 -54.27 4.01 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -177.468 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.606 ' OD1' HD23 ' A' ' 223' ' ' LEU . 97.4 m-20 -101.14 16.13 26.44 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.056 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.419 ' H ' HG22 ' A' ' 222' ' ' ILE . . . 98.92 -1.86 58.06 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.568 -178.702 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.755 ' O ' HG23 ' A' ' 222' ' ' ILE . 32.8 mmtp -110.76 139.23 46.24 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.105 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.701 HG21 ' O ' ' A' ' 276' ' ' LEU . 16.1 m -64.29 123.99 18.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.903 -179.457 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 221' ' ' HIS . 34.0 pt -120.78 151.21 23.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.624 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -128.54 80.4 72.57 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 121.073 0.463 . . . . 0.0 111.502 -179.356 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.676 ' O ' HG23 ' A' ' 217' ' ' VAL . 72.4 Cg_exo -53.01 126.31 21.07 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.43 2.087 . . . . 0.0 110.583 179.208 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.551 ' HD2' ' H62' ' B' ' 6' ' ' ' A' . 1.2 ttmm -131.9 149.52 52.42 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.725 -178.487 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 14.1 ttp-105 -64.27 133.64 53.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.281 179.24 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.545 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -56.86 145.18 30.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.85 0.357 . . . . 0.0 111.033 -179.413 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.522 HD12 ' C5 ' ' B' ' 6' ' ' ' A' . 5.1 mt -108.67 125.08 32.56 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.487 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.54 152.16 12.85 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.077 1.851 . . . . 0.0 110.503 178.88 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.47 ' HD3' ' OE1' ' A' ' 239' ' ' GLN . 31.2 mmt180 -55.89 -40.26 72.74 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.148 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -63.8 -46.35 85.58 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.17 179.12 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.29 -35.2 73.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.301 0.572 . . . . 0.0 109.923 178.172 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.47 ' OE1' ' HD3' ' A' ' 236' ' ' ARG . 61.1 tt0 -58.25 -42.27 86.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.183 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -63.08 -40.31 97.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.327 0.584 . . . . 0.0 110.011 178.314 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 242' ' ' THR . 24.2 mttp -62.63 -34.05 76.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.384 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 291' ' ' TYR . 68.2 p -29.08 -81.26 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -178.179 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 76.71 46.28 11.59 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.96 179.204 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 7.9 ttpm? -59.73 136.21 57.92 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.675 ' CG2' HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -123.31 161.2 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.771 0.796 . . . . 0.0 112.919 -179.307 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.505 ' CD1' ' C5 ' ' B' ' 2' ' ' ' A' . 91.8 t80 -99.2 135.92 39.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.866 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.671 HG12 ' O ' ' A' ' 287' ' ' GLY . 9.6 p -129.92 144.03 39.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.238 0.542 . . . . 0.0 111.601 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.634 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.75 171.55 18.42 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.87 16.93 58.91 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.045 -1.074 . . . . 0.0 111.994 -179.111 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.739 HG22 HG21 ' A' ' 254' ' ' VAL . 68.7 mt -110.52 129.33 65.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.961 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -169.75 -99.08 0.12 Allowed Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.135 -179.592 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 252' ' ' PRO . . . . . 0.542 ' O ' HG13 ' A' ' 254' ' ' VAL . 32.1 Cg_exo -60.02 136.37 68.96 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.399 2.066 . . . . 0.0 113.255 -179.238 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 51.72 43.01 30.25 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.245 178.599 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.961 HG22 ' O ' ' A' ' 251' ' ' GLY . 14.8 m -127.0 45.4 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 254' ' ' VAL . 0.1 OUTLIER -40.77 151.67 0.26 Allowed Pre-proline 0 N--CA 1.462 0.155 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.859 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.415 ' N ' HD11 ' A' ' 274' ' ' LEU . 11.1 Cg_endo -55.28 -28.02 60.21 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 121.982 1.788 . . . . 0.0 112.381 -178.308 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -61.44 -44.62 96.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.293 179.492 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.506 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 55.6 mp0 -67.43 -38.7 84.95 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.902 0.382 . . . . 0.0 111.716 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.737 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 31.6 t80 -64.72 -47.52 77.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.534 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.46 -41.55 98.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.832 0.348 . . . . 0.0 110.626 179.589 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.5 pt-20 -75.39 -28.84 59.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.424 178.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.598 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 3.7 t80 -62.57 -56.87 13.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.607 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.694 ' C ' HD11 ' A' ' 269' ' ' ILE . 7.0 m-85 -65.89 -21.42 66.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.064 -179.384 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.701 ' N ' HD11 ' A' ' 269' ' ' ILE . 67.5 p -57.87 -20.12 34.28 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.742 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -47.67 -38.43 14.94 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.059 178.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.731 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 23.5 p90 -131.17 44.0 3.01 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 264' ' ' SER . . . 161.47 150.03 5.8 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.164 179.137 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.417 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 55.7 m -59.98 -34.83 73.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.876 0.369 . . . . 0.0 111.005 179.443 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.701 HD11 ' N ' ' A' ' 264' ' ' SER . 79.0 mt 68.44 112.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.075 -178.804 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.606 HG22 ' HB ' ' A' ' 290' ' ' THR . 14.7 tt -61.04 -29.43 45.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.916 0.388 . . . . 0.0 110.359 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 272' ' ' ALA . 55.8 t0 -176.9 -48.53 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.533 179.433 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.849 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . 52.13 122.11 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.879 0.371 . . . . 0.0 111.755 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -141.34 155.19 45.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.394 0.616 . . . . 0.0 112.43 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.761 ' HB2' HD11 ' A' ' 276' ' ' LEU . 64.0 mt -66.41 -31.79 72.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.212 178.703 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.569 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 94.2 mmm 102.1 -80.8 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.643 0.777 . . . . 0.0 110.397 -178.916 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.761 HD11 ' HB2' ' A' ' 274' ' ' LEU . 0.1 OUTLIER 38.57 64.74 0.71 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.345 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.628 ' O ' HG22 ' A' ' 227' ' ' VAL . 57.1 t0 -56.57 -39.81 74.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.943 0.402 . . . . 0.0 110.747 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.617 ' O ' HG22 ' A' ' 280' ' ' THR . 17.2 mtpt -95.07 9.56 39.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.39 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.2 t70 60.56 42.25 14.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.143 0.497 . . . . 0.0 110.386 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 278' ' ' LYS . 0.0 OUTLIER -171.26 -67.26 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.346 179.834 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 281' ' ' GLY . . . . . 0.523 ' H ' HG23 ' A' ' 280' ' ' THR . . . -83.19 175.56 52.8 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.467 179.201 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.897 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 94.0 mm-40 64.05 45.06 4.31 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.013 0.435 . . . . 0.0 110.88 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.521 ' OG ' HD23 ' A' ' 276' ' ' LEU . 10.3 p -167.98 -40.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.033 179.79 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.443 ' O ' ' HA3' ' A' ' 251' ' ' GLY . 41.2 ttm180 -55.2 -31.34 61.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.933 179.299 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -105.77 -39.18 2.23 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.746 -0.74 . . . . 0.0 114.571 -178.305 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.491 ' CE1' " C4'" ' B' ' 2' ' ' ' A' . 27.3 p90 -136.6 167.24 21.77 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.001 0.9 . . . . 0.0 112.828 -178.17 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.671 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -132.44 159.14 23.29 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.187 178.685 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.425 ' HB2' ' HG2' ' A' ' 275' ' ' MET . 0.1 OUTLIER -119.21 124.6 47.16 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 122.734 -0.274 . . . . 0.0 111.612 -179.502 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.849 HG13 ' HB2' ' A' ' 272' ' ' ALA . 57.4 t -128.98 135.72 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 178.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.606 ' HB ' HG22 ' A' ' 270' ' ' ILE . 26.5 m -122.4 139.9 53.31 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.358 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.615 ' O ' ' HA ' ' A' ' 242' ' ' THR . 74.5 m-85 -113.35 137.32 51.69 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.882 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 293' ' ' SER . 54.1 p30 -63.35 -30.14 71.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.295 178.55 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.537 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 99.1 p -115.55 144.1 44.37 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.272 0.558 . . . . 0.0 111.362 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.942 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -69.03 -33.32 73.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.348 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -57.04 -36.9 71.03 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.677 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.79 -39.09 87.59 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.942 HG12 ' O ' ' A' ' 294' ' ' ALA . 8.7 p -59.68 -37.83 72.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.437 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -62.79 -39.03 92.97 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -179.142 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -60.56 -43.29 97.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.666 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.902 HG23 HD11 ' A' ' 306' ' ' ILE . 0.9 OUTLIER -67.71 -34.18 66.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.671 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 77.4 m -57.82 -45.88 85.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.497 -179.166 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -61.59 -40.47 94.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.205 0.526 . . . . 0.0 110.704 179.68 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -60.52 -33.25 72.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.18 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.669 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 47.8 tptt 68.52 -73.21 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -177.744 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.669 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.6 m-30 -114.42 144.25 43.62 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.276 178.43 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.902 HD11 HG23 ' A' ' 300' ' ' VAL . 24.4 mt -118.89 133.4 65.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.639 178.204 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -76.84 75.69 3.46 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.598 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 5.2 t80 -72.8 -52.03 16.61 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.553 0.692 . . . . 0.0 110.927 -179.196 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.466 ' HD3' ' CE1' ' A' ' 308' ' ' PHE . 23.6 mmmt -128.39 -151.78 0.49 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.191 -179.147 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -58.08 -26.48 62.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.386 179.198 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -121.29 159.69 25.48 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.109 0.481 . . . . 0.0 112.237 -178.149 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.528 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 49.2 mttt -75.78 149.04 38.03 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.167 179.508 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.634 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 36.8 pt -117.84 149.52 20.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.311 178.466 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 314' ' ' GLU . . . . . 0.587 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 83.0 mt-10 -110.79 132.13 54.46 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.584 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 0.573 HG12 HG23 ' A' ' 247' ' ' VAL . 79.7 mt -121.05 126.9 75.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.14 0.495 . . . . 0.0 111.685 -179.487 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -126.09 150.31 48.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.133 179.666 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.572 ' HA ' HG22 ' A' ' 245' ' ' ILE . 95.1 mtm-85 -55.83 144.13 28.87 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.264 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 244' ' ' LYS . . . -61.66 142.66 57.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.983 0.42 . . . . 0.0 111.34 -179.337 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -109.62 136.94 20.25 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.128 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.38 130.98 42.99 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 121.823 1.682 . . . . 0.0 111.438 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 44.6 tpt85 -58.52 -37.72 76.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 84.0 t60 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.925 -179.96 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.756 0 C3'-C2'-O2' 111.229 -0.714 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.897 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.947 0 C3'-C2'-O2' 111.331 -0.679 . 0.18 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.606 ' O2 ' " H3'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.983 0 C1'-C2'-O2' 108.572 -0.676 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.738 ' N7 ' ' HA ' ' A' ' 167' ' ' ASN . . . . . . . . 0 O5'--C5' 1.427 -0.829 0 C4'-C3'-C2' 103.998 1.298 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.758 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.429 -0.662 0 O4'-C1'-N19 109.036 0.836 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.758 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.939 0 C4'-C3'-O3' 113.176 0.991 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.634 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.985 0 C4'-C3'-C2' 103.461 0.761 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . 0.406 ' OP2' ' HG3' ' A' ' 200' ' ' ARG . . . . . . . . 0 O5'--C5' 1.425 -0.95 0 C3'-C2'-O2' 111.262 -0.703 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.991 0.424 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -61.6 -32.34 72.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.791 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.1 t -116.2 145.22 43.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.956 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.67 91.27 3.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.949 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.477 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 74.9 tttt -127.01 139.1 53.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.851 -179.505 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.826 ' SD ' HG13 ' A' ' 213' ' ' VAL . 93.2 mmm -116.29 147.56 41.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.42 -178.609 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.682 ' CE2' ' C8 ' ' B' ' 6' ' ' ' A' . 2.9 t80 -104.74 130.22 52.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.446 -0.797 . . . . 0.0 108.912 178.314 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.496 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 21.8 mm -117.42 130.84 71.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.312 -179.217 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.574 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -128.5 162.81 22.12 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 178.677 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.412 ' HA2' H5'' ' B' ' 4' ' ' ' A' . . . 77.46 36.43 34.05 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.14 -1.029 . . . . 0.0 111.992 -179.717 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.483 HD22 HG21 ' A' ' 170' ' ' THR . 50.7 mt -60.68 -26.12 66.86 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -178.774 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.75 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 42.0 t30 71.38 40.76 0.81 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -176.902 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.603 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 8.2 m0 31.4 41.76 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.948 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -174.84 21.89 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 179.372 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.522 ' O ' ' O ' ' A' ' 171' ' ' THR . 98.1 m -61.62 -38.19 86.72 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.524 ' C ' HD12 ' A' ' 190' ' ' ILE . 0.0 OUTLIER 57.82 130.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -177.657 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.944 ' N ' HD12 ' A' ' 190' ' ' ILE . 21.6 pt-20 -58.77 -29.49 66.82 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -178.29 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.533 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.1 m-20 -60.06 -40.67 90.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.71 0.29 . . . . 0.0 111.582 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 170' ' ' THR . 9.5 m120 -64.91 -37.17 86.75 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -179.138 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.687 HD23 ' CE2' ' A' ' 179' ' ' PHE . 7.2 mt -55.8 -47.78 76.53 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.815 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.533 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -65.1 -33.03 75.06 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.068 179.269 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -62.23 -39.02 91.41 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.672 -179.189 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.827 ' CD2' HD12 ' A' ' 223' ' ' LEU . 0.0 OUTLIER -94.59 -45.91 7.18 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-O 120.723 0.297 . . . . 0.0 110.755 179.614 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.687 ' CE2' HD23 ' A' ' 175' ' ' LEU . 75.0 m-85 -72.93 -13.96 61.36 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 179.074 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.69 -26.45 24.79 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.27 -0.49 . . . . 0.0 113.564 -179.297 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.752 ' HD3' ' H ' ' A' ' 181' ' ' LYS . 0.5 OUTLIER -56.47 -41.95 77.39 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.909 0.861 . . . . 0.0 110.796 -179.719 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.762 ' OH ' HG21 ' A' ' 219' ' ' THR . 66.6 m-85 -69.72 -35.15 74.78 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.054 -1.43 . . . . 0.0 112.927 -177.345 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 174.93 -175.08 47.02 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.352 -1.404 . . . . 0.0 114.171 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.556 ' O ' HG12 ' A' ' 185' ' ' VAL . 54.1 m -63.11 -25.11 68.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.573 -0.814 . . . . 0.0 111.659 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.593 HG21 HD23 ' A' ' 188' ' ' LEU . 7.9 p 52.75 79.66 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 CA-C-O 121.962 0.887 . . . . 0.0 109.091 -177.006 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -47.19 -50.95 19.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.664 -177.175 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 206' ' ' SER . 22.9 t70 -146.02 124.52 12.42 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.504 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.593 HD23 HG21 ' A' ' 185' ' ' VAL . 0.0 OUTLIER -108.97 153.87 22.97 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.708 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.605 ' HG3' ' SD ' ' A' ' 191' ' ' MET . 11.8 tptt -138.07 125.24 21.57 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -177.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 190' ' ' ILE . . . . . 0.944 HD12 ' N ' ' A' ' 172' ' ' GLU . 5.6 mt -123.67 126.55 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.564 175.58 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 191' ' ' MET . . . . . 0.605 ' SD ' ' HG3' ' A' ' 189' ' ' LYS . 2.6 mpp? -94.6 57.98 2.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.295 -179.489 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.401 ' HA ' ' OG ' ' A' ' 199' ' ' SER . 34.2 tttm -63.9 149.49 47.02 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.81 -179.033 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.526 ' HB3' ' O ' ' A' ' 198' ' ' ARG . 2.1 t0 -120.4 75.85 24.88 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.594 -179.48 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.14 -23.88 75.09 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.59 2.193 . . . . 0.0 112.767 179.608 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -68.28 -73.85 0.14 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.883 -179.041 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.7 p -68.05 -25.54 65.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.704 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 93.95 -0.23 66.76 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.591 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.526 ' O ' ' HB3' ' A' ' 193' ' ' ASP . 0.8 OUTLIER -127.29 131.9 50.42 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.71 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.442 ' OG ' ' NH1' ' A' ' 200' ' ' ARG . 13.3 t -110.5 155.37 22.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.552 0.692 . . . . 0.0 112.799 -178.009 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.651 ' NH2' HG23 ' A' ' 190' ' ' ILE . 0.5 OUTLIER -45.01 -32.21 1.58 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.731 -179.801 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.628 ' HA3' " H2'" ' B' ' 4' ' ' ' A' . . . 90.11 22.17 36.33 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.59 -0.814 . . . . 0.0 114.849 178.607 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.61 ' CE2' ' HB2' ' A' ' 200' ' ' ARG . 41.5 p90 -150.83 152.66 34.06 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 117.503 0.652 . . . . 0.0 111.008 178.773 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -138.54 161.69 25.75 Favored Glycine 0 C--O 1.228 -0.265 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.355 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.713 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 85.3 m-85 -110.73 126.0 54.1 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.9 -179.836 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.609 HD21 HD22 ' A' ' 175' ' ' LEU . 53.9 mt -107.73 142.01 38.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.687 0.28 . . . . 0.0 110.8 179.811 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 187' ' ' ASP . 26.3 t -124.65 130.12 51.82 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.614 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.831 ' CE2' HG21 ' A' ' 216' ' ' VAL . 97.6 m-85 -114.76 135.75 53.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.94 0.4 . . . . 0.0 111.31 179.603 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.43 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.4 tt0 -60.23 -34.23 73.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.473 179.204 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.62 116.96 56.79 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.823 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.85 -29.5 81.7 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.515 2.143 . . . . 0.0 113.189 -179.372 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.7 m -59.15 -37.91 78.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.786 0.327 . . . . 0.0 110.853 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.821 ' O ' HG23 ' A' ' 216' ' ' VAL . 23.3 m -59.83 -34.42 73.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.194 0.521 . . . . 0.0 110.31 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.826 HG13 ' SD ' ' A' ' 161' ' ' MET . 78.1 t -60.38 -41.24 86.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.094 -179.658 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -57.82 -43.95 86.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.026 0.441 . . . . 0.0 110.754 -179.754 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.7 -33.36 72.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.044 178.674 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.831 HG21 ' CE2' ' A' ' 207' ' ' PHE . 96.8 t -60.39 -43.07 93.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.589 -178.512 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 230' ' ' PRO . 9.0 p -84.23 -49.5 16.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.121 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.514 ' N ' HG13 ' A' ' 217' ' ' VAL . 81.4 tttt -59.93 -39.68 86.3 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.424 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.762 HG21 ' OH ' ' A' ' 182' ' ' TYR . 70.5 m -59.19 -38.89 80.94 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.329 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.408 ' O ' ' O ' ' A' ' 219' ' ' THR . 63.1 tt0 62.1 114.67 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.03 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.686 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 0.0 OUTLIER -134.2 169.03 17.79 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -176.707 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.887 ' CD1' HG13 ' A' ' 227' ' ' VAL . 16.1 mm -117.62 128.39 74.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.839 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.827 HD12 ' CD2' ' A' ' 178' ' ' TYR . 8.5 tt -117.3 126.0 52.0 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.708 179.366 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.414 ' CG ' HD23 ' A' ' 223' ' ' LEU . 86.9 m-20 53.53 41.89 32.02 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 178.366 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 90.35 -23.88 19.5 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.412 -0.899 . . . . 0.0 114.337 177.444 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.605 ' O ' HG23 ' A' ' 222' ' ' ILE . 34.7 mmtp -95.66 151.21 19.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.202 0.501 . . . . 0.0 111.405 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.887 HG13 ' CD1' ' A' ' 222' ' ' ILE . 26.3 t -92.28 128.76 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.769 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 164' ' ' GLY . 28.3 pt -125.67 154.98 34.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.253 -179.341 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.58 78.21 75.86 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.121 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 230' ' ' PRO . . . . . 0.646 ' O ' HG23 ' A' ' 217' ' ' VAL . 9.4 Cg_endo -52.28 131.59 40.51 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.636 2.224 . . . . 0.0 111.775 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 162' ' ' PHE . 5.4 ttpm? -136.21 139.73 43.01 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.731 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.446 ' HG3' ' CG1' ' A' ' 213' ' ' VAL . 0.9 OUTLIER -50.82 141.98 12.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.088 0.471 . . . . 0.0 111.743 -179.494 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.531 ' HA ' ' N1 ' ' B' ' 6' ' ' ' A' . . . -62.45 144.44 55.92 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.391 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.581 HG13 ' N6 ' ' B' ' 6' ' ' ' A' . 0.4 OUTLIER -107.68 135.81 19.73 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 121.353 -0.139 . . . . 0.0 110.902 179.761 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.91 139.95 85.03 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 121.789 1.659 . . . . 0.0 110.623 178.693 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -58.52 -37.55 75.86 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.758 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -60.18 -48.29 82.36 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.711 -179.856 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -73.04 -41.33 64.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.567 0.699 . . . . 0.0 110.168 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.518 ' O ' HG23 ' A' ' 242' ' ' THR . 7.8 tt0 -60.36 -37.06 79.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.505 -179.479 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -56.25 -37.42 69.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.613 -179.368 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 242' ' ' THR . 39.8 mttm -82.62 -74.09 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.468 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 239' ' ' GLN . 33.5 p 38.62 -168.01 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.087 0.47 . . . . 0.0 112.215 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -168.08 49.75 0.23 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.353 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 15.3 tttp -72.82 128.72 36.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.76 0.314 . . . . 0.0 110.532 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.716 ' CG2' HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -125.02 162.94 26.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -179.409 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.421 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 87.4 t80 -101.45 134.15 44.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.647 -1.161 . . . . 0.0 111.181 179.566 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.754 HG11 ' CE1' ' A' ' 259' ' ' PHE . 14.0 p -127.79 136.38 60.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.687 179.006 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -125.04 4.66 8.38 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.747 -178.702 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.624 ' O ' HG22 ' A' ' 313' ' ' ILE . . . -88.14 9.16 76.0 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.744 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.996 HD11 ' HA3' ' A' ' 287' ' ' GLY . 31.9 pt -120.61 154.75 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 121.004 0.43 . . . . 0.0 111.521 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.816 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -167.51 -142.58 3.5 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.839 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.07 -19.71 34.25 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.55 2.167 . . . . 0.0 112.449 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -82.9 3.18 30.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.81 -179.431 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.816 HG22 ' O ' ' A' ' 251' ' ' GLY . 19.1 m -126.77 157.04 38.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.718 0.294 . . . . 0.0 110.792 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.4 ' HD2' ' HD2' ' A' ' 256' ' ' PRO . 17.0 mmt85 -111.65 154.94 43.75 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.102 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.4 ' HD2' ' HD2' ' A' ' 255' ' ' ARG . 13.8 Cg_endo -57.49 -43.01 55.23 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 121.793 1.662 . . . . 0.0 111.797 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 261' ' ' GLU . 35.3 mttp -63.14 -43.14 99.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.129 179.349 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 261' ' ' GLU . 76.3 mm-40 -66.53 -36.87 83.75 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.576 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.754 ' CE1' HG11 ' A' ' 247' ' ' VAL . 25.2 t80 -63.67 -52.37 61.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.21 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -64.11 -37.25 86.76 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.315 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 258' ' ' GLU . 72.7 tt0 -61.88 -38.03 86.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.876 -1.511 . . . . 0.0 111.968 178.213 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.779 ' CE2' HD11 ' A' ' 313' ' ' ILE . 71.6 t80 -69.61 -56.52 7.06 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -179.445 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.704 ' C ' HD11 ' A' ' 269' ' ' ILE . 18.9 m-85 -65.2 -24.08 67.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.932 -179.377 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.711 ' N ' HD11 ' A' ' 269' ' ' ILE . 86.1 p -59.48 -25.91 64.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.376 -179.312 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -57.54 -36.89 72.22 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.296 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 266' ' ' TRP . . . . . 0.75 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 11.9 p90 -115.18 39.81 2.82 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.113 0.482 . . . . 0.0 111.765 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.508 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 157.51 146.74 4.58 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.709 178.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.434 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 59.8 m -58.94 -37.49 76.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.754 0.311 . . . . 0.0 111.27 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.711 HD11 ' N ' ' A' ' 264' ' ' SER . 73.9 mt 69.3 90.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.099 -179.202 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.63 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 75.0 mt -54.97 -44.76 75.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.932 179.009 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 271' ' ' ASP . . . . . 0.467 ' O ' ' HB ' ' A' ' 290' ' ' THR . 54.0 t0 -156.49 146.76 21.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.824 179.079 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.402 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -154.69 141.37 18.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.348 178.879 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -146.61 155.83 42.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.505 0.669 . . . . 0.0 112.378 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 274' ' ' LEU . . . . . 0.631 HD23 HD22 ' A' ' 276' ' ' LEU . 27.0 tp -64.44 -33.9 76.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.426 179.382 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 275' ' ' MET . . . . . 0.585 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 72.9 mmm 69.48 80.74 0.18 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 -178.478 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.631 HD22 HD23 ' A' ' 274' ' ' LEU . 0.2 OUTLIER -119.38 126.67 51.94 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.34 179.578 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.459 ' HB2' ' HG2' ' A' ' 282' ' ' GLN . 60.0 t0 -86.63 118.71 26.22 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.128 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 278' ' ' LYS . . . . . 0.458 ' CE ' ' HE2' ' A' ' 226' ' ' LYS . 26.9 mmtp 59.22 -150.23 0.44 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.602 -0.439 . . . . 0.0 109.911 -178.358 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.2 -38.73 68.75 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.222 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 280' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 280' ' ' THR . 14.4 t -168.42 114.37 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.906 0.384 . . . . 0.0 111.448 179.282 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 281' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 277' ' ' ASP . . . -145.4 -90.91 0.11 Allowed Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.207 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.948 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 97.3 mm-40 -56.39 -31.26 63.69 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.934 0.494 . . . . 0.0 111.946 -179.084 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.476 ' HB2' ' CD2' ' A' ' 274' ' ' LEU . 91.8 p -72.76 -4.71 33.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.562 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -51.9 -34.64 42.25 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 250' ' ' ILE . . . -156.22 9.51 0.29 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 119.318 -1.42 . . . . 0.0 115.398 -179.094 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 16.4 p90 -145.87 164.65 31.28 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.976 1.388 . . . . 0.0 112.084 179.12 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.996 ' HA3' HD11 ' A' ' 250' ' ' ILE . . . -140.1 164.68 26.13 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.254 179.126 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.496 ' HB2' ' HG2' ' A' ' 275' ' ' MET . 0.2 OUTLIER -119.4 128.54 54.14 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.367 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.672 HG23 ' CZ ' ' A' ' 259' ' ' PHE . 44.1 t -128.31 138.27 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.813 0.34 . . . . 0.0 111.524 178.289 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 36.2 m -117.34 136.41 53.15 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.508 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 39.7 m-85 -115.31 136.01 53.55 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.416 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.63 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 55.3 p30 -64.79 -32.93 74.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.724 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.57 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 51.0 m -121.98 144.42 48.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.312 0.577 . . . . 0.0 112.237 -178.779 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.989 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -66.23 -32.06 73.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.075 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -56.61 -38.19 71.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.098 -179.717 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -64.42 -41.59 96.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.767 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.989 HG12 ' O ' ' A' ' 294' ' ' ALA . 9.7 p -59.83 -37.05 69.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.014 0.435 . . . . 0.0 111.479 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -61.75 -37.26 83.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.717 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -58.88 -44.13 91.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.165 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.75 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 0.7 OUTLIER -73.41 -35.87 47.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.927 0.394 . . . . 0.0 111.274 -179.642 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 79.3 m -58.53 -46.14 87.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.032 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -63.6 -40.62 97.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.225 0.536 . . . . 0.0 110.192 179.198 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.416 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.4 m-20 -64.3 -35.6 81.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.865 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.675 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 35.5 tptt 67.76 -67.37 0.19 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.168 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.675 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 17.5 m-85 -113.98 131.84 56.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.929 179.148 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 306' ' ' ILE . . . . . 0.667 HD11 HG23 ' A' ' 300' ' ' VAL . 1.3 mt -122.18 138.69 51.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.127 178.822 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.494 ' OD1' ' CD ' ' A' ' 312' ' ' LYS . 94.0 m-20 -73.89 119.21 17.79 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.422 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.728 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 9.4 t80 -119.75 -76.07 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.417 0.627 . . . . 0.0 109.948 178.558 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.522 ' CG ' HG12 ' A' ' 254' ' ' VAL . 6.4 mmpt? -97.72 -163.39 1.04 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.513 178.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -52.93 -31.31 39.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.785 0.326 . . . . 0.0 110.742 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -112.15 153.62 26.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.106 0.479 . . . . 0.0 111.351 -179.369 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.598 ' CG ' ' HB3' ' A' ' 305' ' ' PHE . 19.7 tptt -70.77 143.96 51.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.541 -179.091 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.779 HD11 ' CE2' ' A' ' 262' ' ' PHE . 26.4 pt -111.31 141.38 26.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.799 179.218 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -101.48 131.69 47.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.716 179.748 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 315' ' ' ILE . . . . . 0.624 HD13 ' CE2' ' A' ' 263' ' ' PHE . 72.2 mt -119.92 129.57 75.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.156 0.503 . . . . 0.0 111.421 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 30.5 tttp -131.6 141.49 49.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.162 -179.753 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.458 ' HA ' HG22 ' A' ' 245' ' ' ILE . 34.9 ttp180 -54.55 137.75 42.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 0.0 110.581 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.72 140.73 56.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.332 -179.269 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -75.42 152.5 85.66 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.191 179.089 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.7 -23.83 42.94 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.25 1.967 . . . . 0.0 111.712 179.685 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.485 ' HG3' ' O4 ' ' B' ' 3' ' ' ' U' . 31.6 mmm180 38.09 40.58 0.32 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.482 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.895 -179.683 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.725 0 C3'-C2'-O2' 111.32 -0.683 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.948 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.424 -1.008 0 C3'-C2'-O2' 111.274 -0.698 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.521 ' O2 ' " H3'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.028 0 C3'-C2'-O2' 111.117 -0.753 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.753 " H3'" H5'' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.998 0 O4'-C1'-C2' 107.771 0.979 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.753 H5'' " H3'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.731 0 C4'-C3'-C2' 103.548 0.848 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.682 ' C8 ' ' CE2' ' A' ' 162' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.961 0 C4'-C3'-C2' 103.574 0.874 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.713 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -1.0 0 C3'-C2'-O2' 111.341 -0.675 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.984 0 C3'-C2'-O2' 111.26 -0.703 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 44.0 m . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.543 0.211 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -72.43 138.44 47.12 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 121.573 0.701 . . . . 0.0 112.215 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.832 ' SD ' HG13 ' A' ' 213' ' ' VAL . 82.1 mmm -116.08 150.63 37.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.653 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.541 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 4.8 t80 -103.57 128.57 50.8 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.61 ' CG2' HD21 ' A' ' 166' ' ' LEU . 16.2 mm -115.26 127.72 72.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -132.31 163.63 23.96 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.511 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.43 29.78 59.44 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.352 -0.927 . . . . 0.0 112.269 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.946 HD23 HG21 ' A' ' 228' ' ' ILE . 76.4 mt -86.84 140.63 29.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.744 0.307 . . . . 0.0 111.164 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.51 ' HB2' ' HG3' ' A' ' 226' ' ' LYS . 22.2 t30 -66.13 133.68 51.21 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 -52.09 -38.47 57.39 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.99 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.432 ' HB3' HD22 ' A' ' 167' ' ' ASN . 48.2 t0 -62.97 -26.85 69.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.5 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 51.5 m -54.07 139.86 33.59 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.542 0.687 . . . . 0.0 111.383 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 28.5 m -119.39 151.5 38.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.7 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.791 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 98.5 mt-10 -55.33 -36.3 66.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.854 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -58.3 -43.81 88.26 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 120.602 -0.439 . . . . 0.0 109.861 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -65.45 -37.3 86.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.622 HD13 HD12 ' A' ' 188' ' ' LEU . 1.0 OUTLIER -55.43 -62.37 1.72 Allowed 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.332 178.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.481 ' O ' ' N ' ' A' ' 180' ' ' GLY . 67.2 ttp85 -57.19 -41.04 78.58 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.912 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.08 -40.23 94.35 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.742 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.551 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 62.7 t80 -61.98 -48.07 81.99 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.637 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.566 ' CD2' HD23 ' A' ' 175' ' ' LEU . 88.8 m-85 -87.93 0.0 56.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.395 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -61.2 -28.84 69.79 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.595 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.443 ' CD ' ' H ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -58.64 -38.67 78.58 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.803 0.811 . . . . 0.0 110.04 -179.049 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -67.63 -30.03 69.49 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.62 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 159.46 -132.83 3.13 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.238 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 52.8 m -119.92 139.62 52.15 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.914 HG12 ' CE1' ' A' ' 207' ' ' PHE . 3.4 m -100.81 122.8 53.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.489 -0.485 . . . . 0.0 110.502 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.3 t -73.22 -46.92 47.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.288 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -145.73 121.7 10.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.016 0.436 . . . . 0.0 111.455 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -118.6 139.69 51.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.572 179.462 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.588 ' O ' ' CA ' ' A' ' 203' ' ' GLY . 8.7 tptt -133.01 83.38 2.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.841 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.791 ' HB ' ' HG2' ' A' ' 172' ' ' GLU . 12.0 tt -60.45 -22.64 26.02 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-O 121.146 0.498 . . . . 0.0 109.77 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.635 ' HE1' ' HA2' ' A' ' 203' ' ' GLY . 0.0 OUTLIER 73.13 55.38 0.12 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.486 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.63 152.07 46.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.467 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 1.5 t0 -124.16 75.85 59.77 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.23 -25.43 80.06 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.462 2.108 . . . . 0.0 112.308 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.74 -66.52 0.6 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.806 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 70.9 p -68.65 -24.83 64.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.195 0.521 . . . . 0.0 110.281 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.59 -3.35 68.27 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.431 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.484 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 6.3 ttp180 -130.35 124.37 32.1 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.971 0.415 . . . . 0.0 111.268 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.1 m -64.41 156.14 30.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.779 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.667 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 5.4 mpt_? -57.07 -33.91 67.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.083 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 93.17 3.37 65.42 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.668 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.667 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 40.4 p90 -144.62 154.8 43.19 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.635 ' HA2' ' HE1' ' A' ' 191' ' ' MET . . . -151.18 169.11 30.84 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 119.373 -1.394 . . . . 0.0 113.273 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.541 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 98.0 m-85 -106.54 120.47 42.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.188 0.518 . . . . 0.0 109.674 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.618 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 55.3 tp -108.39 125.56 51.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.955 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 50.2 m -118.55 143.56 46.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.312 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.914 ' CE1' HG12 ' A' ' 185' ' ' VAL . 74.3 m-85 -120.81 144.33 48.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.394 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.18 -34.8 77.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.943 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -110.87 119.51 45.89 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.787 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -56.55 -22.05 41.29 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.673 2.249 . . . . 0.0 113.139 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.7 m -57.14 -37.35 71.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.577 0.227 . . . . 0.0 111.558 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.939 ' O ' HG23 ' A' ' 216' ' ' VAL . 21.6 m -59.33 -35.81 74.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.816 0.341 . . . . 0.0 110.745 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.832 HG13 ' SD ' ' A' ' 161' ' ' MET . 78.1 t -61.16 -42.3 92.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.243 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.406 ' O ' HG22 ' A' ' 217' ' ' VAL . 54.0 t0 -59.22 -41.92 89.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.869 0.366 . . . . 0.0 111.179 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.42 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 15.3 pt-20 -76.34 -29.17 57.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.82 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.939 HG23 ' O ' ' A' ' 212' ' ' SER . 77.1 t -60.05 -41.54 86.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.441 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 214' ' ' ASP . 21.9 m -72.17 -30.02 34.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -59.12 -37.67 77.75 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.704 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 43.4 m -91.86 142.27 27.75 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 63.7 tt0 -66.19 -41.68 89.9 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.666 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.798 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 79.3 m-70 81.65 111.2 0.07 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.482 HD13 ' O ' ' A' ' 221' ' ' HIS . 20.5 mm -119.24 113.38 41.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.8 tt -120.67 124.63 45.67 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.937 0.399 . . . . 0.0 111.736 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 52.67 43.0 31.77 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.47 8.35 87.63 Favored Glycine 0 CA--C 1.516 0.141 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.345 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.51 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 2.4 mmmm -120.11 164.61 15.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.68 0.276 . . . . 0.0 110.532 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.9 p -117.52 135.99 56.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.087 0.47 . . . . 0.0 110.263 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.946 HG21 HD23 ' A' ' 166' ' ' LEU . 37.4 pt -126.96 160.47 35.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.61 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -127.83 79.22 74.01 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.158 0.504 . . . . 0.0 110.744 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.559 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 52.3 Cg_exo -58.78 124.06 14.91 Favored 'Trans proline' 0 CA--C 1.528 0.185 0 C-N-CA 122.934 2.423 . . . . 0.0 111.454 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 8.9 mtmm -133.58 157.18 46.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.915 0.388 . . . . 0.0 111.454 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 35.6 tpt85 -57.6 136.06 56.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.407 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.29 144.44 56.95 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.947 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 11.5 mt -111.06 125.25 31.0 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.67 143.44 46.69 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 121.82 1.68 . . . . 0.0 110.707 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -57.62 -39.86 77.86 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -62.27 -46.19 89.91 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.295 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.456 ' O ' HG23 ' A' ' 242' ' ' THR . 84.4 tt0 -69.78 -38.16 76.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.578 0.704 . . . . 0.0 109.762 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -59.27 -40.96 87.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.027 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -61.61 -40.53 95.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.896 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -61.21 -34.59 75.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.46 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.729 HG22 ' HA ' ' A' ' 292' ' ' ASP . 19.1 p -80.71 161.93 24.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.535 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -147.46 175.77 26.64 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.178 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.517 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 49.1 tptt -131.08 129.94 42.56 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.648 HD13 ' O ' ' A' ' 245' ' ' ILE . 0.0 OUTLIER -119.74 161.12 19.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.377 0.608 . . . . 0.0 111.116 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.408 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 86.6 t80 -103.96 135.99 44.45 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.451 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 287' ' ' GLY . 7.5 p -129.48 144.55 37.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.563 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.65 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -129.8 176.87 18.45 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.82 32.73 26.13 Favored Glycine 0 C--N 1.32 -0.333 0 C-N-CA 119.895 -1.145 . . . . 0.0 112.211 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 1.023 HG23 HG21 ' A' ' 254' ' ' VAL . 69.3 mt -107.86 130.89 59.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -143.0 -163.12 9.6 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.438 -0.886 . . . . 0.0 113.39 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -52.32 147.69 27.88 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.934 2.423 . . . . 0.0 112.463 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 50.1 t0 74.16 -3.7 2.47 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.672 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 1.023 HG21 HG23 ' A' ' 250' ' ' ILE . 11.3 p -60.93 -38.58 79.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.1 OUTLIER 54.56 115.25 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.403 -179.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.21 -34.42 69.27 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 121.664 1.576 . . . . 0.0 111.998 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -61.75 -43.31 99.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.682 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.519 ' HB3' ' O ' ' A' ' 254' ' ' VAL . 84.3 tt0 -65.86 -35.66 81.28 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.281 0.563 . . . . 0.0 110.548 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.63 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 13.9 t80 -58.65 -45.16 89.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.594 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.414 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.4 tt0 -65.38 -41.96 93.17 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.3 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 258' ' ' GLU . 20.3 pt-20 -73.65 -30.8 63.14 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.01 0.433 . . . . 0.0 110.506 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.511 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 8.5 t80 -61.16 -53.23 59.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.224 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.688 ' CD2' HG21 ' A' ' 289' ' ' VAL . 4.3 m-85 -70.0 -23.5 63.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.888 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.637 ' N ' HD11 ' A' ' 269' ' ' ILE . 70.8 p -58.41 -25.61 62.34 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.734 0.302 . . . . 0.0 111.541 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -55.38 -34.51 64.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.242 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.687 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 11.2 p90 -117.05 45.12 1.94 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.259 0.552 . . . . 0.0 111.434 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.504 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 152.44 147.69 4.66 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.745 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 49.8 m -59.41 -37.99 79.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 111.348 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.68 HD11 ' C ' ' A' ' 263' ' ' PHE . 70.4 mt 67.55 86.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.873 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 292' ' ' ASP . 34.0 mm -58.56 -38.94 73.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.9 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -155.98 150.34 25.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.095 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -153.2 132.38 12.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.087 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -149.93 163.04 39.13 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 275' ' ' MET . 1.6 mm? -95.83 7.77 45.4 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.643 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.887 ' O ' HD12 ' A' ' 276' ' ' LEU . 86.0 mtp 71.02 -80.28 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.14 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.887 HD12 ' O ' ' A' ' 275' ' ' MET . 0.1 OUTLIER 37.95 49.42 1.17 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 178.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.28 -45.04 84.47 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.386 -0.525 . . . . 0.0 110.661 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.512 ' O ' HG23 ' A' ' 280' ' ' THR . 61.4 mttp -108.02 3.42 24.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.09 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.484 ' OD1' ' HB2' ' A' ' 276' ' ' LEU . 83.3 m-20 51.28 38.13 20.57 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 278' ' ' LYS . 63.6 p -111.17 0.18 16.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.924 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.62 -30.73 0.26 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 119.409 -1.377 . . . . 0.0 114.334 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.528 ' HB2' ' HA ' ' A' ' 276' ' ' LEU . 94.9 mt-30 -57.46 -31.15 65.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.33 0.565 . . . . 0.0 110.641 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.714 ' CB ' HD23 ' A' ' 276' ' ' LEU . 95.4 p -59.32 -26.0 64.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.393 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -127.3 154.87 44.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.315 0.578 . . . . 0.0 111.389 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.52 -50.49 0.98 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.727 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.52 ' C ' HD12 ' A' ' 250' ' ' ILE . 22.4 p90 -145.16 165.07 29.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.862 0.331 . . . . 0.0 110.748 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.682 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -137.24 163.68 25.36 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.421 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.517 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -122.4 124.96 44.85 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.278 0.231 . . . . 0.0 110.8 179.489 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.688 HG21 ' CD2' ' A' ' 263' ' ' PHE . 43.4 t -127.12 139.9 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.009 0.433 . . . . 0.0 112.032 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.422 ' OG1' ' CD ' ' A' ' 244' ' ' LYS . 34.8 m -114.69 137.87 51.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.858 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.504 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 37.8 m-85 -117.43 140.11 50.02 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.729 ' HA ' HG22 ' A' ' 242' ' ' THR . 29.2 p-10 -61.53 -33.79 74.43 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.236 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . 0.424 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 31.1 t -124.16 139.06 54.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.423 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.82 -31.73 73.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.61 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -56.12 -37.24 69.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.97 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -60.92 -36.65 79.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.957 0.408 . . . . 0.0 110.352 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 300' ' ' VAL . 82.0 t -61.1 -40.87 87.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.143 0.497 . . . . 0.0 110.194 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -59.47 -36.61 76.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.407 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -56.84 -42.91 80.5 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.085 0.469 . . . . 0.0 111.046 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.809 HG23 HD11 ' A' ' 306' ' ' ILE . 0.3 OUTLIER -75.71 -30.22 21.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.667 179.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 80.9 m -56.43 -45.87 80.55 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -64.15 -34.31 77.76 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -100.54 70.58 1.47 Allowed 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.204 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.609 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 7.6 tptt -53.81 -43.74 69.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.239 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.609 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.9 m-85 -113.55 126.0 54.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.302 0.572 . . . . 0.0 110.899 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.809 HD11 HG23 ' A' ' 300' ' ' VAL . 25.8 mt -117.68 139.17 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.192 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -79.54 102.39 8.81 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.595 ' HE2' HG23 ' A' ' 254' ' ' VAL . 5.7 t80 -107.4 -72.57 0.72 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.385 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.528 ' HD3' ' CE2' ' A' ' 308' ' ' PHE . 3.7 mmmt -100.15 26.28 6.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.346 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 63.03 41.56 8.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.697 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 312' ' ' LYS . 94.6 mtt180 -150.78 7.86 0.56 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.151 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 311' ' ' ARG . 24.0 mmtm 56.71 138.53 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.537 0.684 . . . . 0.0 112.129 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.65 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 36.3 pt -120.81 148.01 24.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.221 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . 0.408 ' CG ' ' HE3' ' A' ' 304' ' ' LYS . 84.9 tt0 -104.32 127.35 51.96 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 0.608 HG12 HG23 ' A' ' 247' ' ' VAL . 86.8 mt -118.19 130.86 72.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.324 0.583 . . . . 0.0 112.074 -178.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -132.51 142.84 49.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.526 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 69.3 mtt85 -53.11 149.13 7.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.641 0.258 . . . . 0.0 110.378 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 244' ' ' LYS . . . -54.27 141.88 28.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.91 0.386 . . . . 0.0 111.116 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.313 -179.488 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 37.4 m . . . . . 0 CA--C 1.531 0.25 0 CA-C-O 120.625 0.25 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -56.15 141.25 41.41 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.288 0.566 . . . . 0.0 111.621 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.671 ' CG ' HG23 ' A' ' 213' ' ' VAL . 93.8 mtp -115.83 156.04 26.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.435 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.621 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 3.5 t80 -105.16 129.57 53.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.894 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.638 HG23 HD12 ' A' ' 228' ' ' ILE . 16.0 mm -116.98 131.37 69.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.478 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -134.48 164.08 24.62 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.411 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.2 25.32 66.51 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.368 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.981 HD23 HG21 ' A' ' 228' ' ' ILE . 75.6 mt -86.88 143.05 27.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.734 0.302 . . . . 0.0 110.949 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -61.12 133.23 55.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -52.32 -28.18 18.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.703 0.287 . . . . 0.0 111.013 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 50.2 p30 -83.81 8.5 14.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.16 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 88.8 m -70.77 140.23 51.24 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.351 0.596 . . . . 0.0 110.164 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 173' ' ' ASP . 27.9 m -114.97 144.38 43.68 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.566 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.948 ' HB3' HD21 ' A' ' 188' ' ' LEU . 98.3 mt-10 -55.73 -35.42 66.13 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.865 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.795 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 92.1 m-20 -57.1 -40.46 77.05 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -65.15 -38.69 91.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.11 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.722 HD22 HD21 ' A' ' 205' ' ' LEU . 3.6 mt -63.22 -48.32 78.76 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.795 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -71.63 -34.11 69.52 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.033 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -62.08 -38.57 89.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.536 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 63.8 t80 -80.25 -61.86 1.85 Allowed 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.942 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.575 ' CE2' HD23 ' A' ' 175' ' ' LEU . 72.6 m-85 -66.62 -21.47 66.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.314 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -50.56 -27.97 13.85 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.512 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 1.7 tmtt? -55.15 -43.14 73.92 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.864 -0.668 . . . . 0.0 110.062 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.467 ' CG ' HG22 ' A' ' 216' ' ' VAL . 46.0 m-85 -71.08 -33.94 70.69 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.454 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.419 ' O ' ' HA2' ' A' ' 180' ' ' GLY . . . -177.38 179.99 47.89 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.334 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 54.1 m -62.89 -33.85 76.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.805 0.336 . . . . 0.0 111.68 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.818 HG23 ' CE1' ' A' ' 207' ' ' PHE . 0.5 OUTLIER 64.99 102.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 121.205 0.526 . . . . 0.0 109.654 -178.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.75 HG23 ' N ' ' A' ' 208' ' ' GLU . 43.9 p -67.29 -37.68 83.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.965 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 206' ' ' SER . 20.1 t70 -160.81 160.77 31.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.948 HD21 ' HB3' ' A' ' 172' ' ' GLU . 0.1 OUTLIER -158.43 144.13 16.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.055 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.518 ' CG ' ' HB2' ' A' ' 204' ' ' PHE . 0.0 OUTLIER -131.71 113.56 13.7 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.696 ' HB ' ' HG2' ' A' ' 172' ' ' GLU . 2.0 tt -93.05 11.1 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.515 ' CB ' ' HG3' ' A' ' 200' ' ' ARG . 0.0 OUTLIER 67.21 -71.09 0.1 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.763 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.724 ' HA ' ' HA ' ' A' ' 199' ' ' SER . 20.0 ttmm 59.81 133.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.095 0.474 . . . . 0.0 111.261 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 88.2 m-20 -120.73 87.78 42.74 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.893 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.59 -24.71 37.83 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.342 2.028 . . . . 0.0 112.306 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -75.46 -75.63 0.17 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.402 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 62.8 p -70.36 -24.43 62.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.051 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 91.26 9.8 63.0 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.992 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 17.9 ttp85 -96.15 133.01 40.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.213 0.53 . . . . 0.0 111.827 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.724 ' HA ' ' HA ' ' A' ' 192' ' ' LYS . 75.4 m -85.83 10.22 14.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.132 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.515 ' HG3' ' CB ' ' A' ' 191' ' ' MET . 40.2 mmt180 74.94 -41.88 0.48 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 166' ' ' LEU . . . 92.95 6.01 63.77 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.331 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.613 ' HB2' ' O ' ' A' ' 163' ' ' ILE . 33.9 p90 -147.37 155.48 42.01 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.441 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -154.92 166.65 32.53 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.148 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.621 ' CE2' ' CD1' ' A' ' 162' ' ' PHE . 91.1 m-85 -109.92 128.39 55.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.655 0.264 . . . . 0.0 110.416 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.722 HD21 HD22 ' A' ' 175' ' ' LEU . 63.3 mt -104.99 140.5 38.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.837 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 33.1 t -123.21 130.69 53.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.347 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.818 ' CE1' HG23 ' A' ' 185' ' ' VAL . 94.7 m-85 -117.25 138.33 51.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.001 0.429 . . . . 0.0 111.538 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.75 ' N ' HG23 ' A' ' 186' ' ' THR . 84.4 tt0 -61.48 -34.62 75.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.095 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -113.36 120.49 39.8 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.955 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 0.755 ' O ' HG12 ' A' ' 213' ' ' VAL . 49.6 Cg_exo -56.17 -22.29 39.46 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.537 2.158 . . . . 0.0 112.989 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.6 m -56.61 -37.91 71.33 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.688 0.28 . . . . 0.0 111.291 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.867 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.4 m -59.68 -35.69 74.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 0.0 110.284 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 210' ' ' PRO . 0.4 OUTLIER -59.48 -40.51 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.721 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -62.57 -41.88 99.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.432 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.401 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 10.1 pt-20 -77.68 -34.08 53.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.997 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 212' ' ' SER . 84.0 t -62.62 -47.09 94.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 CA-C-O 121.104 0.478 . . . . 0.0 110.522 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.22 -34.09 67.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -57.99 -37.43 74.23 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.685 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 38.5 m -96.0 141.73 29.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.724 0.297 . . . . 0.0 111.619 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 228' ' ' ILE . 63.6 tt0 -67.05 -41.53 86.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.765 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 47.0 m-70 77.61 122.3 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.996 HD12 HG12 ' A' ' 227' ' ' VAL . 21.0 mm -116.38 110.65 32.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 175.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.494 HD23 ' CG ' ' A' ' 224' ' ' ASP . 7.1 tt -121.77 125.91 47.64 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.228 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.494 ' CG ' HD23 ' A' ' 223' ' ' LEU . 86.7 m-20 53.92 41.56 32.0 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 76.5 12.86 83.98 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.551 -0.833 . . . . 0.0 114.162 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -126.13 156.48 40.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.482 0.641 . . . . 0.0 111.764 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.996 HG12 HD12 ' A' ' 222' ' ' ILE . 33.7 m -107.82 136.52 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.298 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.981 HG21 HD23 ' A' ' 166' ' ' LEU . 34.3 pt -126.78 162.76 30.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.012 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -129.02 79.18 75.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.046 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.732 ' HG3' ' CD2' ' A' ' 221' ' ' HIS . 9.6 Cg_endo -54.21 133.48 55.85 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.417 2.078 . . . . 0.0 111.681 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -137.65 147.78 45.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.619 0.247 . . . . 0.0 110.774 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -56.28 137.53 52.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 111.391 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.75 148.87 51.35 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.114 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.465 HG22 ' HD2' ' A' ' 235' ' ' PRO . 5.6 mt -114.27 142.84 28.68 Favored Pre-proline 0 N--CA 1.464 0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.581 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.465 ' HD2' HG22 ' A' ' 234' ' ' ILE . 37.3 Cg_exo -56.94 138.88 88.0 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 121.763 1.642 . . . . 0.0 110.732 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -60.06 -40.4 89.32 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.608 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 56.7 p30 -64.67 -40.8 96.06 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.573 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.608 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 97.3 mt-10 -71.47 -35.93 71.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.579 0.704 . . . . 0.0 109.363 177.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -58.42 -42.01 86.3 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.752 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -63.53 -40.09 96.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.057 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -60.06 -36.45 77.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.708 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.722 HG21 ' CD1' ' A' ' 270' ' ' ILE . 17.2 p -78.84 160.63 27.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.532 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -142.11 169.26 25.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.424 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 7.9 ttpm? -134.79 136.07 42.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.54 0.21 . . . . 0.0 110.839 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.835 HD12 HG21 ' A' ' 315' ' ' ILE . 9.6 pt -120.29 156.6 23.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.127 0.489 . . . . 0.0 111.53 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 315' ' ' ILE . 78.9 t80 -94.41 131.44 40.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.15 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.851 HG21 ' CZ ' ' A' ' 263' ' ' PHE . 25.1 t -124.47 135.9 62.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.396 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.558 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -132.57 178.32 18.16 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.71 26.35 46.44 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.037 -1.078 . . . . 0.0 112.268 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.65 HD11 ' C ' ' A' ' 286' ' ' PHE . 32.0 pt -118.44 154.79 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 121.04 0.448 . . . . 0.0 111.339 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.763 ' O ' HG12 ' A' ' 254' ' ' VAL . . . -127.43 176.01 18.02 Favored Glycine 0 C--O 1.226 -0.344 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.972 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . 0.419 ' HD3' ' HG3' ' A' ' 284' ' ' ARG . 54.1 Cg_exo -51.69 -28.61 30.3 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 121.92 1.746 . . . . 0.0 111.304 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -61.32 -30.53 70.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.177 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.763 HG12 ' O ' ' A' ' 251' ' ' GLY . 7.8 p -47.54 -38.59 6.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.819 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.0 OUTLIER 56.34 125.68 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.281 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.47 -35.8 86.28 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 121.787 1.658 . . . . 0.0 112.656 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -63.56 -47.76 80.21 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 85.0 tt0 -68.07 -37.05 80.83 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.126 0.488 . . . . 0.0 111.15 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.504 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 27.4 t80 -58.88 -45.68 89.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.061 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.426 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.4 tt0 -66.84 -40.98 88.11 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.944 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' A' ' 258' ' ' GLU . 19.5 pt-20 -70.26 -34.09 72.39 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.882 0.372 . . . . 0.0 110.491 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.603 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 83.7 t80 -60.4 -54.33 46.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.454 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.851 ' CZ ' HG21 ' A' ' 247' ' ' VAL . 26.9 m-85 -69.22 -28.39 66.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.67 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.651 ' N ' HD11 ' A' ' 269' ' ' ILE . 22.7 t -57.05 -29.67 63.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.455 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 262' ' ' PHE . 19.9 pt20 -53.26 -36.09 60.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.822 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.814 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 12.5 p90 -115.19 40.99 2.53 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.915 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 170.91 -179.01 43.08 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.465 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.518 HG23 ' HB3' ' A' ' 292' ' ' ASP . 0.0 OUTLIER -104.81 0.75 28.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.77 0.319 . . . . 0.0 110.345 179.045 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.651 HD11 ' N ' ' A' ' 264' ' ' SER . 75.5 mt 28.91 97.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.722 ' CD1' HG21 ' A' ' 242' ' ' THR . 72.5 mt -60.44 -45.47 96.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.581 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -164.83 94.02 0.66 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -99.09 136.4 39.1 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -142.16 154.52 44.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.624 0.726 . . . . 0.0 112.745 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.794 HD21 ' O ' ' A' ' 283' ' ' SER . 35.7 tp -64.68 -37.38 87.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.648 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.611 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 95.8 mmm 93.32 114.75 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.518 -178.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.415 HD22 ' OG ' ' A' ' 283' ' ' SER . 28.5 mt -111.15 141.9 44.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.421 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.681 ' HB3' ' HA3' ' A' ' 281' ' ' GLY . 59.8 t0 -144.52 88.01 1.9 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.156 0.503 . . . . 0.0 110.405 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.704 ' O ' HG22 ' A' ' 280' ' ' THR . 3.5 mtmp? 64.6 37.13 8.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.568 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.461 ' O ' ' HB ' ' A' ' 280' ' ' THR . 86.0 m-20 51.84 44.23 29.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.961 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.704 HG22 ' O ' ' A' ' 278' ' ' LYS . 1.6 t 169.66 46.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.911 0.386 . . . . 0.0 110.729 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . 0.681 ' HA3' ' HB3' ' A' ' 277' ' ' ASP . . . -136.43 -111.82 1.13 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.313 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.51 ' OE1' ' HB3' ' A' ' 275' ' ' MET . 91.9 mt-30 -56.9 -24.99 56.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.027 -0.587 . . . . 0.0 111.101 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.794 ' O ' HD21 ' A' ' 274' ' ' LEU . 16.8 m -49.52 -31.9 11.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.086 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.419 ' HG3' ' HD3' ' A' ' 252' ' ' PRO . 70.7 ttp85 -116.36 136.98 52.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.161 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.16 -57.03 0.44 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.799 -0.715 . . . . 0.0 114.071 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.65 ' C ' HD11 ' A' ' 250' ' ' ILE . 35.1 p90 -141.62 167.98 20.86 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.555 0.677 . . . . 0.0 112.02 -178.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.448 ' N ' HD11 ' A' ' 250' ' ' ILE . . . -134.45 156.02 22.21 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.238 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.515 ' HB2' ' HG2' ' A' ' 275' ' ' MET . 0.1 OUTLIER -111.97 129.85 56.05 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.709 0.29 . . . . 0.0 111.722 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.54 HG21 ' CG ' ' A' ' 263' ' ' PHE . 38.4 t -122.39 135.04 63.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 111.496 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 52.0 m -118.48 135.64 54.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.444 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 38.7 m-85 -116.87 134.99 54.08 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.633 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 54.4 t0 -59.43 -36.08 75.22 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.5 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 50.5 m -120.77 143.92 48.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.266 0.555 . . . . 0.0 111.436 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.63 -30.61 71.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.158 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -56.47 -38.9 72.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.278 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.8 88.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.074 0.464 . . . . 0.0 110.299 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.702 HG13 HG21 ' A' ' 245' ' ' ILE . 71.6 t -62.2 -42.99 97.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.707 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -60.57 -37.72 82.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.125 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -58.59 -43.81 89.62 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.814 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 0.4 OUTLIER -74.34 -34.38 36.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.953 0.406 . . . . 0.0 111.045 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 97.8 m -58.24 -44.69 88.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.193 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -62.22 -40.12 95.08 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.312 0.577 . . . . 0.0 109.91 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -63.81 -32.67 74.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.369 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.707 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 22.5 tptm 67.47 -74.89 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.629 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.707 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.5 m-30 -109.06 131.85 54.67 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.127 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.66 HD11 HG23 ' A' ' 300' ' ' VAL . 1.7 mt -121.07 138.08 52.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.48 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.414 ' OD1' ' CE ' ' A' ' 312' ' ' LYS . 86.9 m-20 -67.55 138.46 56.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.603 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 2.2 t80 -140.62 -107.98 0.15 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.209 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 310' ' ' ASP . 2.6 mmpt? -58.92 -38.54 79.18 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.834 0.35 . . . . 0.0 111.862 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 309' ' ' LYS . 58.3 t0 176.7 -29.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.227 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 88.2 mmt-85 -113.66 160.32 18.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.607 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 37.0 mmtm -66.65 140.67 57.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.092 0.472 . . . . 0.0 111.567 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.558 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 34.5 pt -110.45 133.75 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . 0.548 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 84.2 mt-10 -96.04 131.49 42.38 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.798 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 0.835 HG21 HD12 ' A' ' 245' ' ' ILE . 68.6 mt -120.3 123.92 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.068 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -130.41 154.81 47.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.983 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -56.12 151.53 12.11 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -48.29 142.98 5.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.975 0.417 . . . . 0.0 110.866 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.731 -178.601 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.3 m . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.835 0.35 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.511 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 6.3 tptt -56.85 136.37 55.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.47 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.68 ' SD ' HG13 ' A' ' 213' ' ' VAL . 90.3 mtp -125.74 155.88 40.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.303 0.573 . . . . 0.0 112.016 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.549 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 3.1 t80 -105.22 130.88 53.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.376 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.828 HG23 HD12 ' A' ' 228' ' ' ILE . 22.4 mm -117.4 128.89 74.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.556 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.525 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -122.43 157.15 17.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.968 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.565 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 74.68 54.52 5.91 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.218 -0.992 . . . . 0.0 112.27 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.532 HD11 ' N ' ' A' ' 203' ' ' GLY . 69.4 mt -83.55 3.47 32.34 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.514 ' HB2' ' HG3' ' A' ' 226' ' ' LYS . 36.9 t30 58.27 39.95 25.12 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.842 -0.536 . . . . 0.0 110.109 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.435 ' HA ' ' OG ' ' A' ' 199' ' ' SER . 8.8 m0 33.32 35.05 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.075 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -175.72 22.48 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.504 ' OG1' ' O ' ' A' ' 166' ' ' LEU . 95.1 m -59.84 -34.65 73.38 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 122.137 -0.352 . . . . 0.0 111.795 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.0 OUTLIER 62.33 131.23 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -178.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.63 ' N ' HD12 ' A' ' 190' ' ' ILE . 96.5 mt-10 -59.02 -34.95 72.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.633 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.638 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.9 m-20 -57.04 -40.77 77.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.886 0.374 . . . . 0.0 111.386 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 170' ' ' THR . 85.9 m-20 -63.12 -36.19 82.77 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.742 ' CB ' HD11 ' A' ' 188' ' ' LEU . 6.3 mt -59.93 -42.25 93.57 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.638 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -65.29 -38.82 91.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.016 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.447 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 75.8 mm-40 -70.82 -44.11 67.21 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.043 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.556 ' O ' ' HD3' ' A' ' 181' ' ' LYS . 58.4 t80 -65.28 -44.56 87.59 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.223 0.535 . . . . 0.0 111.435 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.609 ' CE2' HD23 ' A' ' 175' ' ' LEU . 88.5 m-85 -94.86 -1.82 51.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.206 -0.907 . . . . 0.0 112.452 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -61.54 -26.97 67.25 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.312 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.621 ' H ' ' CD ' ' A' ' 181' ' ' LYS . 0.8 OUTLIER -56.11 -39.76 72.69 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.032 0.92 . . . . 0.0 111.002 -179.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -67.51 -27.86 67.34 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.711 -1.586 . . . . 0.0 112.012 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 159.64 -123.15 1.2 Allowed Glycine 0 CA--C 1.507 -0.432 0 C-N-CA 120.678 -0.773 . . . . 0.0 111.674 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.492 ' O ' ' HD1' ' A' ' 207' ' ' PHE . 28.3 p -119.88 160.0 23.55 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 206' ' ' SER . 8.1 p -122.67 130.25 74.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.332 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.769 HG23 ' N ' ' A' ' 208' ' ' GLU . 50.9 p -77.12 -38.86 51.22 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -155.29 150.98 27.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.472 0.653 . . . . 0.0 112.564 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.742 HD11 ' CB ' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -122.06 130.88 53.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.454 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 9.5 tptp -136.41 120.54 17.77 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.63 HD12 ' N ' ' A' ' 172' ' ' GLU . 6.4 mt -130.28 130.63 65.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.771 176.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.541 ' SD ' ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -90.38 122.26 33.09 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.53 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.56 ' HG3' HG22 ' A' ' 190' ' ' ILE . 58.9 mttm -126.76 156.46 41.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.752 0.31 . . . . 0.0 111.496 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.649 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 7.7 t70 -122.19 80.24 44.12 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.378 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.41 -25.88 50.53 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.429 2.086 . . . . 0.0 112.57 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -72.19 -67.44 0.54 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.916 0.389 . . . . 0.0 111.235 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 61.4 p -71.63 -22.12 61.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.629 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 84.21 18.2 63.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.378 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.649 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 2.1 ttt-85 -122.98 144.24 49.38 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 120.92 0.39 . . . . 0.0 111.273 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.435 ' OG ' ' HA ' ' A' ' 168' ' ' TRP . 90.1 p -110.38 157.61 19.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.979 0.419 . . . . 0.0 111.039 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.557 ' HD2' ' N ' ' A' ' 200' ' ' ARG . 1.5 mpt_? -53.53 -32.43 50.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.502 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.435 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 94.42 -0.09 65.51 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.352 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.554 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 23.9 p90 -139.15 154.86 48.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.222 0.534 . . . . 0.0 110.873 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.532 ' N ' HD11 ' A' ' 166' ' ' LEU . . . -140.42 162.2 26.52 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.23 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.549 ' CE2' ' CD1' ' A' ' 162' ' ' PHE . 95.6 m-85 -106.21 127.46 53.24 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.979 0.418 . . . . 0.0 109.982 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.664 HD23 ' N ' ' A' ' 206' ' ' SER . 2.0 tt -107.23 128.03 54.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.807 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.664 ' N ' HD23 ' A' ' 205' ' ' LEU . 11.9 t -117.0 132.45 56.7 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.494 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 205' ' ' LEU . 72.5 m-85 -117.5 141.55 48.22 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.769 ' N ' HG23 ' A' ' 186' ' ' THR . 47.0 tp10 -63.07 -36.08 82.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.6 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.24 116.57 51.0 Favored Pre-proline 0 CA--C 1.529 0.141 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.624 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.97 -26.02 65.86 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.346 2.031 . . . . 0.0 112.584 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 21.4 m -57.98 -37.28 73.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.26 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.915 ' O ' HG23 ' A' ' 216' ' ' VAL . 23.5 m -59.08 -35.61 73.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.942 0.401 . . . . 0.0 110.399 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.68 HG13 ' SD ' ' A' ' 161' ' ' MET . 86.0 t -61.68 -42.32 93.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.022 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -59.6 -41.63 90.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.131 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.43 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 18.7 pt-20 -75.1 -31.49 61.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.818 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 212' ' ' SER . 77.7 t -60.99 -44.69 98.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.278 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 230' ' ' PRO . 21.1 m -76.23 -29.24 19.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.028 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -58.31 -33.04 69.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.667 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 88.5 m -111.53 145.49 38.99 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -76.87 145.12 38.53 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.776 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 63.7 m-70 -120.57 134.05 55.32 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -176.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.61 HD13 HG23 ' A' ' 227' ' ' VAL . 28.3 mm -119.61 113.64 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.1 tt -121.66 126.77 49.8 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.74 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 56.4 t0 52.75 37.38 23.62 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 93.47 -24.67 24.49 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.839 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.514 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 30.9 mmtp -97.58 170.96 8.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.841 0.353 . . . . 0.0 111.324 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.61 HG23 HD13 ' A' ' 222' ' ' ILE . 11.7 p -120.89 139.97 46.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.927 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.828 HD12 HG23 ' A' ' 163' ' ' ILE . 36.0 pt -123.64 159.86 27.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.097 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -125.25 81.39 63.64 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.172 0.51 . . . . 0.0 110.834 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.724 ' O ' HG12 ' A' ' 217' ' ' VAL . 51.0 Cg_exo -57.83 129.05 31.47 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.966 2.444 . . . . 0.0 111.551 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -140.74 155.94 46.32 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.571 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.595 ' CD ' HG11 ' A' ' 213' ' ' VAL . 52.5 mmm-85 -56.08 140.11 44.85 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.515 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.35 147.43 52.58 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.886 0.374 . . . . 0.0 111.506 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 35.7 mt -118.48 125.73 27.64 Favored Pre-proline 0 C--N 1.333 -0.132 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.155 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.451 ' HG2' ' CB ' ' A' ' 238' ' ' GLU . 9.8 Cg_endo -54.3 146.13 52.16 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 121.461 1.44 . . . . 0.0 110.072 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -55.98 -40.25 73.01 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.48 -44.13 95.27 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.897 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.451 ' CB ' ' HG2' ' A' ' 235' ' ' PRO . 84.3 tt0 -67.43 -38.14 84.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.038 0.447 . . . . 0.0 110.645 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.416 ' O ' HG23 ' A' ' 242' ' ' THR . 59.8 tp60 -58.95 -40.71 85.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.998 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -60.38 -40.38 90.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.082 0.468 . . . . 0.0 110.661 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -61.52 -36.58 80.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.267 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 291' ' ' TYR . 69.5 p -31.31 -75.57 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 80.61 47.77 6.6 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.918 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 16.8 tttp -58.77 138.54 57.09 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 122.449 0.299 . . . . 0.0 110.785 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.474 HG21 HG13 ' A' ' 297' ' ' VAL . 0.2 OUTLIER -121.41 161.52 21.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -96.03 131.24 42.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.82 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.848 HG21 ' CE2' ' A' ' 263' ' ' PHE . 59.9 t -124.02 139.97 48.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.494 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.66 -174.32 13.79 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.456 ' O ' ' CG2' ' A' ' 313' ' ' ILE . . . 79.98 57.14 3.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 119.765 -1.207 . . . . 0.0 112.882 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.578 ' CG2' HG21 ' A' ' 254' ' ' VAL . 31.6 mm -104.41 129.41 56.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.919 ' O ' HG13 ' A' ' 254' ' ' VAL . . . -107.81 169.25 14.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.004 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.39 141.54 89.35 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.454 2.103 . . . . 0.0 112.622 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 55.76 42.45 29.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.254 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.919 HG13 ' O ' ' A' ' 251' ' ' GLY . 2.5 m -73.15 -35.79 48.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.675 0.274 . . . . 0.0 110.916 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.21 124.29 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.09 -28.68 51.94 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 121.867 1.711 . . . . 0.0 111.9 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -60.75 -42.94 98.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.015 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 96.7 mt-10 -66.21 -39.4 89.58 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.925 0.393 . . . . 0.0 111.128 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.699 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 37.1 t80 -64.9 -46.75 80.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.385 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.528 ' O ' HD12 ' A' ' 269' ' ' ILE . 96.8 mt-10 -64.47 -40.58 95.97 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.717 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 21.1 pt-20 -76.3 -29.71 57.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 110.391 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.722 ' HE2' HD11 ' A' ' 313' ' ' ILE . 18.3 t80 -61.53 -57.2 13.08 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.944 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.903 ' CB ' HD11 ' A' ' 269' ' ' ILE . 7.4 m-85 -67.41 -27.22 66.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.106 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 267' ' ' GLY . 34.8 m -54.53 -27.24 36.89 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -46.77 -38.21 9.74 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.348 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.72 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 19.9 p90 -126.66 42.66 3.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.09 0.471 . . . . 0.0 111.269 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 264' ' ' SER . . . 162.71 154.17 7.49 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.756 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.407 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 50.9 m -61.27 -35.6 77.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.888 0.375 . . . . 0.0 111.593 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.903 HD11 ' CB ' ' A' ' 263' ' ' PHE . 2.5 mt 69.39 80.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.633 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.618 HD11 ' HB3' ' A' ' 292' ' ' ASP . 34.4 mm -59.85 -41.75 86.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.51 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -157.86 86.48 0.91 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.559 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -105.23 130.59 53.34 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -147.39 155.82 42.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.334 0.588 . . . . 0.0 112.506 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.726 HD21 ' O ' ' A' ' 283' ' ' SER . 34.5 tp -65.08 -36.98 86.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.825 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.69 ' O ' HD23 ' A' ' 276' ' ' LEU . 95.7 mmm 81.24 119.92 0.05 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.329 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.728 HD22 ' HB2' ' A' ' 283' ' ' SER . 25.4 mt -127.03 129.03 47.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.598 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -62.24 -39.57 93.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.616 0.722 . . . . 0.0 109.599 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -161.77 -46.94 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.907 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.465 ' O ' HD13 ' A' ' 276' ' ' LEU . 91.9 m-20 -131.19 -79.93 0.53 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.653 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.435 ' HA ' ' HB2' ' A' ' 283' ' ' SER . 68.7 p -116.3 13.36 15.57 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.891 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -49.87 -81.54 0.05 OUTLIER Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.419 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 286' ' ' PHE . 68.8 mm-40 -83.97 6.38 22.12 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 122.781 0.433 . . . . 0.0 110.791 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.728 ' HB2' HD22 ' A' ' 276' ' ' LEU . 22.8 t -56.95 -31.57 65.13 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.233 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 20.9 ptp180 -130.27 158.17 40.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.399 0.618 . . . . 0.0 111.902 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.68 -34.79 5.39 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.048 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 18.1 p90 -155.27 164.28 39.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 117.286 0.543 . . . . 0.0 111.768 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -135.13 150.92 20.32 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.121 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.511 ' HB2' ' HG2' ' A' ' 275' ' ' MET . 0.1 OUTLIER -112.26 125.61 54.35 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.859 -0.201 . . . . 0.0 111.483 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.699 HG23 ' CZ ' ' A' ' 259' ' ' PHE . 60.5 t -130.22 137.43 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 27.8 m -119.32 137.54 53.64 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.578 ' O ' ' HA ' ' A' ' 242' ' ' THR . 43.7 m-85 -114.44 142.25 46.61 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.618 ' HB3' HD11 ' A' ' 270' ' ' ILE . 27.7 p-10 -62.63 -33.9 75.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.03 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . 0.421 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 50.9 m -123.46 144.49 49.49 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.308 0.575 . . . . 0.0 111.719 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.4 -28.86 68.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.209 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 296' ' ' ALA . 52.4 p30 -60.27 -33.3 72.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.661 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.566 ' N ' ' OD1' ' A' ' 295' ' ' ASP . . . -61.33 -36.85 81.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.083 0.468 . . . . 0.0 110.368 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 300' ' ' VAL . 83.2 t -62.06 -42.51 95.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.089 0.471 . . . . 0.0 110.442 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -61.43 -38.09 85.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.624 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -59.39 -43.77 92.88 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.942 0.401 . . . . 0.0 111.73 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.995 HG23 HD11 ' A' ' 306' ' ' ILE . 0.7 OUTLIER -72.16 -34.91 51.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.368 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 85.5 m -59.07 -45.65 90.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.164 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -62.63 -39.17 92.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.253 0.549 . . . . 0.0 110.089 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -62.53 -32.9 73.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.744 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.655 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 7.1 tptt 69.2 -72.76 0.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.67 ' HB3' ' HB3' ' A' ' 312' ' ' LYS . 3.8 m-30 -114.76 142.62 46.28 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.576 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.995 HD11 HG23 ' A' ' 300' ' ' VAL . 6.8 mt -120.11 133.73 65.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -75.37 80.65 2.44 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.183 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.608 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 11.7 t80 -76.9 -57.68 3.71 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.775 0.798 . . . . 0.0 109.869 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.459 ' HE3' ' CE2' ' A' ' 308' ' ' PHE . 9.3 mmpt? -109.87 -165.04 0.97 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.453 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -55.2 -23.45 22.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.758 0.313 . . . . 0.0 110.478 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -118.59 159.68 23.15 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.014 0.435 . . . . 0.0 111.558 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.67 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 78.5 mttt -76.58 147.96 37.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.818 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.722 HD11 ' HE2' ' A' ' 262' ' ' PHE . 23.4 pt -118.16 151.4 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . 0.604 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 81.9 mt-10 -106.6 135.72 47.63 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.259 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 0.79 HG23 HG22 ' A' ' 247' ' ' VAL . 72.1 mt -120.51 126.91 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 120.927 0.394 . . . . 0.0 110.977 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm -128.43 154.54 45.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.147 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 40.9 ptt85 -55.47 147.91 16.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.352 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.97 139.57 58.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.143 0.497 . . . . 0.0 111.407 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.173 179.575 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.606 ' SG ' HG21 ' A' ' 213' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 121.274 0.559 . . . . 0.0 110.173 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 68.1 tttt -69.58 140.3 53.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.506 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.827 ' SD ' HG13 ' A' ' 213' ' ' VAL . 86.4 mmm -115.03 147.95 39.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.78 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.635 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 5.6 t80 -108.71 130.97 55.36 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.614 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 16.6 mm -111.65 127.82 68.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 228' ' ' ILE . . . -133.85 165.34 24.28 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.795 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.453 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 75.74 28.68 60.62 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.254 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.964 HD23 HG21 ' A' ' 228' ' ' ILE . 66.1 mt -86.99 139.62 30.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.883 0.373 . . . . 0.0 110.744 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.546 ' O ' ' N ' ' A' ' 169' ' ' ASP . 30.3 t30 -65.48 136.39 56.38 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.635 ' HD1' ' HG ' ' A' ' 199' ' ' SER . 6.2 m0 -60.27 75.95 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 167' ' ' ASN . 58.4 t0 178.28 -22.31 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.656 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 88.8 m -65.07 138.53 58.38 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.182 0.515 . . . . 0.0 111.038 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.505 ' C ' HD12 ' A' ' 190' ' ' ILE . 7.4 p -115.96 166.37 12.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.923 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.7 ' N ' HD12 ' A' ' 190' ' ' ILE . 53.1 mp0 -58.34 -28.91 65.52 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.813 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.1 m-20 -58.07 -43.46 86.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.846 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -65.99 -38.41 88.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.607 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.668 HD12 HD11 ' A' ' 190' ' ' ILE . 4.7 mt -61.65 -42.71 99.27 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.813 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -66.04 -38.22 87.82 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.798 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.45 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 97.1 mt-10 -69.55 -43.43 72.96 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.124 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.485 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 56.2 t80 -67.22 -48.66 67.16 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.477 0.656 . . . . 0.0 111.603 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.663 ' CB ' HD11 ' A' ' 205' ' ' LEU . 94.9 m-85 -91.75 -1.59 57.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.128 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -57.95 -29.15 61.71 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.22 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.844 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -57.05 -40.49 76.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.19 -0.505 . . . . 0.0 110.841 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.844 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 78.1 m-85 -70.34 -34.97 73.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.122 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 178.74 -173.88 46.12 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 119.938 -1.125 . . . . 0.0 113.652 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.6 m -62.38 -30.69 71.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.13 -0.535 . . . . 0.0 111.178 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.638 ' CG1' ' O ' ' A' ' 185' ' ' VAL . 0.4 OUTLIER 67.47 89.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -177.399 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.461 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -56.13 -49.32 74.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.517 -177.073 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -142.45 137.68 30.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.28 0.562 . . . . 0.0 112.409 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.66 HD11 ' HB3' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -115.08 133.03 56.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.524 179.115 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 15.3 tptt -133.78 122.61 23.54 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.7 HD12 ' N ' ' A' ' 172' ' ' GLU . 4.7 mt -128.58 130.41 68.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.757 176.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.585 ' CE ' ' HA2' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -93.01 126.44 38.09 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.444 ' HG3' HG22 ' A' ' 190' ' ' ILE . 12.6 mtpt -126.08 152.85 45.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.972 0.415 . . . . 0.0 111.933 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.615 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 4.6 m-20 -122.72 68.87 33.62 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.885 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.9 -24.99 80.56 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.925 2.417 . . . . 0.0 113.098 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -60.98 -47.38 86.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.929 0.395 . . . . 0.0 111.265 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 55.2 p -96.83 -4.04 41.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.235 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 76.68 24.97 66.12 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.619 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.615 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 5.9 tpt180 -121.83 159.84 25.91 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.635 ' HG ' ' HD1' ' A' ' 168' ' ' TRP . 97.8 p -128.32 154.16 46.23 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.21 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.556 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 4.9 mpt_? -55.76 -35.63 66.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.362 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 166' ' ' LEU . . . 86.8 5.06 81.81 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.59 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.614 ' HB2' ' O ' ' A' ' 163' ' ' ILE . 39.6 p90 -144.93 157.31 44.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.864 0.364 . . . . 0.0 110.647 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.585 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -150.45 166.45 30.15 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.015 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 162' ' ' PHE . 95.4 m-85 -105.92 127.19 52.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.16 0.505 . . . . 0.0 109.89 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.663 HD11 ' CB ' ' A' ' 179' ' ' PHE . 6.3 tt -108.45 130.45 55.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.942 -178.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.586 ' N ' HD23 ' A' ' 205' ' ' LEU . 54.9 m -120.84 140.3 51.95 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.724 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.648 ' CE2' HD22 ' A' ' 205' ' ' LEU . 84.9 m-85 -121.05 142.74 49.54 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.395 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.461 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.5 tt0 -63.36 -35.38 80.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.195 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.42 119.27 47.18 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.92 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -56.84 -28.21 75.83 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.609 2.206 . . . . 0.0 113.102 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.6 m -58.67 -35.42 72.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.383 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.407 ' OG ' ' CG ' ' A' ' 207' ' ' PHE . 87.2 p -61.13 -30.15 70.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.92 0.391 . . . . 0.0 110.725 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.827 HG13 ' SD ' ' A' ' 161' ' ' MET . 70.1 t -62.71 -39.2 83.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.167 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -56.38 -41.85 76.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.847 0.356 . . . . 0.0 111.238 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.42 ' HB2' ' HD2' ' A' ' 182' ' ' TYR . 97.1 mt-10 -67.36 -34.77 77.99 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.774 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 94.2 t -63.06 -45.3 99.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.073 0.463 . . . . 0.0 111.31 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 52.8 t -70.09 -43.42 79.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -59.39 -35.99 74.99 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.429 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 61.9 m -98.05 143.73 28.3 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -76.13 147.61 38.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.774 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 35.8 m-70 -126.31 132.38 51.65 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 226' ' ' LYS . 68.3 mt -122.2 115.24 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.505 HD23 ' CG ' ' A' ' 224' ' ' ASP . 7.3 tt -121.78 127.11 50.26 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.515 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.505 ' CG ' HD23 ' A' ' 223' ' ' LEU . 85.6 m-20 54.45 42.52 31.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.999 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 73.91 18.32 79.59 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.005 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 222' ' ' ILE . 0.5 OUTLIER -128.21 153.46 46.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.801 0.301 . . . . 0.0 110.893 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.13 130.34 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.983 0.42 . . . . 0.0 110.259 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.964 HG21 HD23 ' A' ' 166' ' ' LEU . 34.5 pt -127.19 159.54 37.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.796 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -128.27 79.73 73.52 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.217 0.532 . . . . 0.0 111.037 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.483 ' HB2' HG12 ' A' ' 216' ' ' VAL . 37.3 Cg_exo -60.36 126.97 21.44 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 123.176 2.584 . . . . 0.0 111.687 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 12.4 mtmm -132.7 156.55 46.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.846 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -58.92 136.46 57.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.935 0.398 . . . . 0.0 111.608 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -66.99 143.9 56.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.089 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.76 124.57 30.26 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.803 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.418 ' HG2' ' CG ' ' A' ' 238' ' ' GLU . 10.4 Cg_endo -53.93 151.06 28.14 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 121.987 1.791 . . . . 0.0 110.643 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -54.29 -37.21 64.51 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -60.25 -43.53 96.03 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.964 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.418 ' CG ' ' HG2' ' A' ' 235' ' ' PRO . 97.7 mt-10 -72.6 -38.66 67.77 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.313 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -60.86 -39.38 88.95 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.844 0.354 . . . . 0.0 110.691 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -62.69 -40.35 96.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.171 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -60.19 -38.18 82.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.811 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 25.7 p -82.55 161.46 22.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.009 0.433 . . . . 0.0 111.55 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -154.02 114.79 0.64 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.961 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.459 ' NZ ' ' CE2' ' A' ' 288' ' ' PHE . 19.8 ttpp -85.77 134.33 33.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.645 0.259 . . . . 0.0 111.134 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.698 HG21 HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -118.42 163.24 15.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.479 0.657 . . . . 0.0 111.407 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.449 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 91.8 t80 -103.41 137.44 41.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.765 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.847 HG11 ' CE1' ' A' ' 259' ' ' PHE . 10.8 p -131.35 146.87 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.878 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.523 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -129.83 172.09 20.15 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 84.65 28.74 31.5 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.086 -1.054 . . . . 0.0 112.508 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.528 HG23 HG11 ' A' ' 254' ' ' VAL . 68.1 mt -110.52 133.0 57.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.819 0.342 . . . . 0.0 110.575 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.4 ' O ' ' HB ' ' A' ' 254' ' ' VAL . . . -123.03 172.2 15.88 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.392 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . 0.437 ' HG3' ' NE ' ' A' ' 284' ' ' ARG . 51.6 Cg_exo -53.78 -31.06 59.88 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.054 1.836 . . . . 0.0 111.667 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -60.15 -36.58 77.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.156 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.528 HG11 HG23 ' A' ' 250' ' ' ILE . 25.5 t -58.13 -45.1 88.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.486 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 254' ' ' VAL . 2.0 mmm180 60.97 141.84 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.28 -28.31 52.04 Favored 'Trans proline' 0 CA--C 1.528 0.189 0 C-N-CA 122.033 1.822 . . . . 0.0 112.919 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -61.69 -45.96 91.74 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 97.6 mt-10 -69.05 -38.39 79.09 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.171 0.51 . . . . 0.0 111.691 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.847 ' CE1' HG11 ' A' ' 247' ' ' VAL . 20.3 t80 -61.23 -47.19 87.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.805 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.439 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.4 tt0 -65.21 -41.84 94.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.601 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.8 pt-20 -75.05 -34.09 61.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.919 0.39 . . . . 0.0 111.211 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.671 ' HE2' HD11 ' A' ' 313' ' ' ILE . 16.4 t80 -62.2 -55.0 32.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.063 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.837 ' CD2' HG21 ' A' ' 289' ' ' VAL . 4.5 m-85 -67.92 -23.62 65.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.074 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.654 ' N ' HD11 ' A' ' 269' ' ' ILE . 23.2 t -55.91 -31.38 62.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.818 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -53.64 -35.79 61.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.644 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.647 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 11.3 p90 -115.89 48.69 1.19 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.363 0.601 . . . . 0.0 111.148 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.574 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 148.39 146.18 4.29 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.671 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.425 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 45.2 m -59.41 -37.47 78.1 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.654 HD11 ' N ' ' A' ' 264' ' ' SER . 74.2 mt 69.7 83.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.417 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.509 HD11 ' CG ' ' A' ' 292' ' ' ASP . 32.1 mm -57.25 -43.59 82.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.543 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -161.63 93.1 0.9 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.576 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -103.32 134.65 46.34 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -143.63 155.47 44.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.467 0.651 . . . . 0.0 112.331 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.747 HD21 ' O ' ' A' ' 283' ' ' SER . 32.7 tp -64.3 -38.41 90.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.364 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.588 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 93.6 mmm 95.0 115.48 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.466 0.706 . . . . 0.0 110.966 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 275' ' ' MET . 29.7 mt -120.42 116.68 25.94 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.931 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -64.05 -38.98 93.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.778 0.799 . . . . 0.0 109.179 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -150.39 -49.38 0.13 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.583 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 280' ' ' THR . 35.5 p-10 -150.38 -54.32 0.15 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.874 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.4 ' N ' ' OD1' ' A' ' 279' ' ' ASP . 64.4 p -126.49 14.17 7.63 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -56.74 -80.93 0.07 OUTLIER Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.64 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 286' ' ' PHE . 78.4 mm-40 -83.38 3.21 32.75 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.562 0.345 . . . . 0.0 110.532 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.747 ' O ' HD21 ' A' ' 274' ' ' LEU . 86.4 p -61.35 -26.31 67.73 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.619 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.437 ' NE ' ' HG3' ' A' ' 252' ' ' PRO . 98.2 mtt180 -119.38 146.4 45.37 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.145 0.497 . . . . 0.0 111.85 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.95 -43.39 1.8 Allowed Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.505 -0.77 . . . . 0.0 114.327 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 23.2 p90 -149.29 165.13 32.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.914 0.857 . . . . 0.0 112.732 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.65 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -135.12 161.13 24.56 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.752 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.459 ' CE2' ' NZ ' ' A' ' 244' ' ' LYS . 0.2 OUTLIER -118.05 126.95 53.28 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.498 0.185 . . . . 0.0 111.498 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.837 HG21 ' CD2' ' A' ' 263' ' ' PHE . 60.1 t -124.87 136.02 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.017 0.436 . . . . 0.0 111.685 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 50.4 m -114.72 134.65 54.92 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.574 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 30.4 m-85 -114.74 137.01 52.44 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.509 ' CG ' HD11 ' A' ' 270' ' ' ILE . 52.5 t0 -56.73 -36.14 69.37 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.027 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 31.0 t -122.33 139.35 53.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.498 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.913 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -64.27 -30.05 71.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.985 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -54.96 -35.08 63.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.491 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -59.09 -38.37 79.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.616 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.913 HG12 ' O ' ' A' ' 294' ' ' ALA . 7.0 p -59.2 -37.66 69.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.824 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -62.37 -37.7 86.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.305 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -58.65 -43.23 89.73 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.636 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.974 HG23 HD11 ' A' ' 306' ' ' ILE . 0.9 OUTLIER -70.58 -35.52 61.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.696 -179.127 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 75.2 m -60.28 -44.04 95.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.86 0.362 . . . . 0.0 110.579 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.69 -33.93 74.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.189 0.518 . . . . 0.0 110.175 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.623 ' O ' ' N ' ' A' ' 305' ' ' PHE . 80.6 m-20 -85.66 5.36 32.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.943 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.694 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 13.4 tptt 37.62 -81.57 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.719 0.407 . . . . 0.0 111.03 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.694 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 2.7 m-30 -108.52 143.86 36.95 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.856 0.36 . . . . 0.0 110.23 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.974 HD11 HG23 ' A' ' 300' ' ' VAL . 25.3 mt -118.0 138.04 49.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.142 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.544 ' O ' ' OD1' ' A' ' 307' ' ' ASP . 51.0 p30 -75.34 114.36 13.78 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.017 0.437 . . . . 0.0 109.951 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.538 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 1.9 t80 -106.16 -109.37 0.29 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.457 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 1.5 mmpt? -59.38 -37.24 77.45 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.933 0.397 . . . . 0.0 111.896 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -179.6 -27.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.889 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 60.5 mtp85 -112.67 153.85 27.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.989 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.475 ' HG3' ' HB3' ' A' ' 305' ' ' PHE . 2.1 tptm -72.17 139.89 48.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.975 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.671 HD11 ' HE2' ' A' ' 262' ' ' PHE . 35.9 pt -115.46 152.09 17.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.884 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -100.71 132.17 46.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.017 0.437 . . . . 0.0 110.908 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 0.675 HG12 HG23 ' A' ' 247' ' ' VAL . 74.5 mt -120.35 128.45 75.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.819 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -132.85 147.18 52.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.916 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -50.97 149.65 3.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.712 0.291 . . . . 0.0 110.435 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 244' ' ' LYS . . . -55.36 141.6 35.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.07 0.462 . . . . 0.0 111.417 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.992 -179.816 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 20.0 p . . . . . 0 CA--C 1.531 0.217 0 CA-C-O 120.489 0.185 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -64.33 139.59 58.78 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.908 0.385 . . . . 0.0 110.682 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.662 ' O ' ' HA ' ' A' ' 204' ' ' PHE . 91.2 mtp -115.61 151.1 35.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.827 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.603 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 3.5 t80 -104.88 127.44 52.71 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.714 HG23 HD12 ' A' ' 228' ' ' ILE . 13.4 mt -121.68 127.12 75.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.797 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 202' ' ' PHE . . . -117.9 149.03 18.57 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.43 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.51 36.26 39.0 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.458 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.632 HD22 HD11 ' A' ' 175' ' ' LEU . 74.5 mt -59.1 -34.33 71.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.682 ' O ' ' N ' ' A' ' 169' ' ' ASP . 26.4 t30 101.8 37.34 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.481 ' CZ3' ' NH2' ' A' ' 198' ' ' ARG . 9.3 m0 40.91 -68.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.382 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.682 ' N ' ' O ' ' A' ' 167' ' ' ASN . 92.5 m-20 -55.37 -30.0 59.52 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.629 ' O ' ' ND2' ' A' ' 174' ' ' ASN . 86.7 m -44.39 -36.03 2.66 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.581 ' C ' HD12 ' A' ' 190' ' ' ILE . 0.0 OUTLIER 54.88 165.06 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.726 -0.609 . . . . 0.0 110.969 -179.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.732 ' N ' HD12 ' A' ' 190' ' ' ILE . 53.7 mp0 -63.49 -35.79 81.62 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 174' ' ' ASN . 54.4 p30 -61.68 -39.2 90.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.629 ' ND2' ' O ' ' A' ' 170' ' ' THR . 63.9 m-80 -64.7 -37.6 88.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.632 HD11 HD22 ' A' ' 166' ' ' LEU . 3.6 mm? -62.85 -39.9 95.81 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 120.919 0.39 . . . . 0.0 111.192 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 180' ' ' GLY . 69.9 ttp85 -56.53 -41.89 77.54 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.08 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -68.28 -43.6 77.38 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.346 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.455 ' O ' ' HD3' ' A' ' 181' ' ' LYS . 61.4 t80 -65.14 -46.38 81.18 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.87 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.627 ' CB ' HD11 ' A' ' 205' ' ' LEU . 78.3 m-85 -91.64 -3.66 56.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.072 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -60.42 -31.15 73.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.294 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.455 ' HD3' ' O ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -57.69 -41.15 81.05 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.512 0.673 . . . . 0.0 110.841 -179.136 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -67.08 -33.44 75.5 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.14 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.64 -177.2 47.11 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.91 -1.138 . . . . 0.0 113.354 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 44.2 m -61.6 -31.56 71.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.289 -0.456 . . . . 0.0 110.72 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.852 HG23 ' CE1' ' A' ' 207' ' ' PHE . 0.9 OUTLIER 65.19 95.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -178.031 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.469 ' O ' ' OD1' ' A' ' 187' ' ' ASP . 2.3 t -63.55 -45.57 89.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.084 -178.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 186' ' ' THR . 91.5 m-20 -141.65 153.86 44.99 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.475 HD23 HG11 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -129.55 129.77 44.89 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.312 178.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 19.4 tptt -136.48 116.73 13.54 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.732 HD12 ' N ' ' A' ' 172' ' ' GLU . 86.0 mt -127.64 131.0 70.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.728 174.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.503 ' SD ' ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -78.23 99.07 6.11 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.76 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 41.8 pttt -89.36 153.02 21.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.048 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 1.3 m-20 -124.72 78.77 63.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.251 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.77 -24.69 64.96 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.41 2.073 . . . . 0.0 112.132 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.01 -74.65 0.18 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.456 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.1 p -68.2 -27.72 66.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.578 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.38 7.88 64.84 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.696 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 0.8 OUTLIER -122.87 121.48 36.32 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 117.651 0.725 . . . . 0.0 111.313 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 56.6 m -75.64 161.06 29.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.684 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.552 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -55.45 -33.46 63.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.858 178.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 96.3 -5.24 65.21 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.014 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 35.5 p90 -134.2 154.34 51.3 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.462 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -146.38 167.71 27.95 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.12 -1.038 . . . . 0.0 112.412 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.662 ' HA ' ' O ' ' A' ' 161' ' ' MET . 89.1 m-85 -108.59 125.83 52.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.677 HD21 HG22 ' A' ' 185' ' ' VAL . 7.4 tt -109.13 131.84 54.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.161 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.509 ' N ' HD23 ' A' ' 205' ' ' LEU . 22.8 t -120.71 135.86 55.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.9 0.381 . . . . 0.0 111.8 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.852 ' CE1' HG23 ' A' ' 185' ' ' VAL . 87.2 m-85 -116.69 143.65 45.39 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.681 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -60.94 -34.57 74.92 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -114.23 115.73 44.91 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.211 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.74 -23.56 41.96 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.547 2.165 . . . . 0.0 113.171 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.566 ' O ' ' OE1' ' A' ' 215' ' ' GLU . 23.3 t -57.79 -38.15 74.97 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.498 ' HA ' ' OE1' ' A' ' 215' ' ' GLU . 24.0 m -56.97 -34.37 68.01 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.911 0.386 . . . . 0.0 110.314 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.724 HG11 ' CD ' ' A' ' 232' ' ' ARG . 85.0 t -60.35 -39.26 80.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.312 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 218' ' ' LYS . 92.9 m-20 -57.37 -41.2 79.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.403 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.566 ' OE1' ' O ' ' A' ' 211' ' ' SER . 47.6 mp0 -65.44 -35.74 81.82 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.076 0.465 . . . . 0.0 111.788 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.753 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 85.5 t -59.96 -44.01 93.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.964 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 214' ' ' ASP . 22.3 m -73.24 -35.51 47.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 214' ' ' ASP . 56.0 mtmt -60.09 -30.31 69.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 79.3 m -110.98 144.76 39.57 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -78.8 145.02 34.55 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.753 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 44.2 m-70 -120.96 129.51 53.46 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.469 HG12 HG22 ' A' ' 227' ' ' VAL . 68.3 mt -121.98 113.25 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 176.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.55 ' CD1' HD13 ' A' ' 175' ' ' LEU . 6.0 tt -122.23 124.06 42.93 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.163 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 53.29 42.48 32.08 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.85 9.2 87.01 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.719 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -123.66 150.41 44.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.897 0.379 . . . . 0.0 111.32 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.469 HG22 HG12 ' A' ' 222' ' ' ILE . 40.0 t -106.24 132.83 52.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.377 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.714 HD12 HG23 ' A' ' 163' ' ' ILE . 34.7 pt -123.82 159.13 29.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.517 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.74 82.05 64.49 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.425 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.599 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 73.4 Cg_exo -55.23 130.82 42.71 Favored 'Trans proline' 0 CA--C 1.528 0.195 0 C-N-CA 122.998 2.465 . . . . 0.0 112.189 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt -139.75 144.16 37.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.579 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.724 ' CD ' HG11 ' A' ' 213' ' ' VAL . 56.1 mmm-85 -52.58 142.71 17.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.015 0.436 . . . . 0.0 111.051 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.03 143.62 52.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.654 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.633 HG22 ' HB2' ' A' ' 238' ' ' GLU . 0.3 OUTLIER -115.44 123.31 31.67 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.536 179.117 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.47 ' HD2' ' OE1' ' A' ' 238' ' ' GLU . 78.2 Cg_exo -50.36 148.7 14.08 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 121.908 1.738 . . . . 0.0 110.996 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -53.7 -39.89 65.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.592 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 54.5 p30 -64.42 -37.57 87.99 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.914 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.633 ' HB2' HG22 ' A' ' 234' ' ' ILE . 94.9 mt-10 -68.23 -36.38 79.39 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.264 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -60.01 -37.29 79.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.911 0.386 . . . . 0.0 110.342 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -60.4 -39.43 87.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.631 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -60.5 -36.21 77.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.117 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 20.6 p -89.09 162.92 15.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.445 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.27 167.3 24.75 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.907 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.558 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 6.6 tptm -133.69 133.31 41.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.796 0.298 . . . . 0.0 110.591 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.634 HD12 HG21 ' A' ' 315' ' ' ILE . 5.7 pt -123.87 157.15 30.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.345 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.435 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 88.9 t80 -97.27 131.0 44.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.926 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.821 HG21 ' CZ ' ' A' ' 263' ' ' PHE . 26.7 t -123.58 137.37 57.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.883 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.494 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -127.22 173.95 18.42 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.278 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 81.35 34.75 25.17 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.062 -1.066 . . . . 0.0 111.628 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.833 HG22 HG21 ' A' ' 254' ' ' VAL . 64.2 mt -110.52 130.82 63.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.698 0.285 . . . . 0.0 110.65 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.872 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -165.12 -107.54 0.2 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.184 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . 0.472 ' O ' HG13 ' A' ' 254' ' ' VAL . 25.1 Cg_endo -62.2 137.7 67.72 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.522 2.148 . . . . 0.0 113.465 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 52.03 42.85 30.66 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.266 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 251' ' ' GLY . 18.8 m -121.68 27.17 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.439 ' HB2' ' OE1' ' A' ' 258' ' ' GLU . 3.2 mmt180 -41.62 155.91 0.22 Allowed Pre-proline 0 N--CA 1.462 0.163 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -50.93 -28.01 22.63 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.011 1.808 . . . . 0.0 112.177 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -61.81 -47.15 86.41 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.004 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.475 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 54.8 mp0 -69.76 -40.17 76.26 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.85 0.357 . . . . 0.0 111.431 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.511 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 48.8 t80 -65.05 -46.69 80.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.117 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.33 -40.87 96.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.965 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.8 pt-20 -74.55 -32.6 62.49 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.974 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.735 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 78.3 t80 -59.93 -58.41 8.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.225 0.536 . . . . 0.0 111.713 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.821 ' CZ ' HG21 ' A' ' 247' ' ' VAL . 33.0 m-85 -66.78 -24.62 66.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.828 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.711 ' N ' HD11 ' A' ' 269' ' ' ILE . 34.6 t -55.7 -24.21 33.23 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -47.01 -38.76 11.34 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.063 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.797 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 23.0 p90 -132.34 53.6 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.086 0.47 . . . . 0.0 111.574 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.526 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 153.34 148.89 5.02 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.937 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.44 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 56.7 m -59.88 -37.09 78.35 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.711 HD11 ' N ' ' A' ' 264' ' ' SER . 72.1 mt 69.74 78.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.223 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 292' ' ' ASP . 33.6 mm -59.0 -44.51 91.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.961 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 270' ' ' ILE . 75.8 m-20 -153.51 86.99 1.22 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.58 ' HB2' HG23 ' A' ' 269' ' ' ILE . . . -103.27 135.99 43.88 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -141.66 151.1 42.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.498 0.665 . . . . 0.0 112.125 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.575 ' CD2' ' HB2' ' A' ' 283' ' ' SER . 37.1 tp -67.14 -34.89 78.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.625 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.613 ' HE2' ' HB2' ' A' ' 288' ' ' PHE . 2.9 ttm 86.46 145.8 0.06 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.008 0.523 . . . . 0.0 110.624 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.581 ' CB ' ' HA ' ' A' ' 280' ' ' THR . 0.5 OUTLIER 174.41 87.18 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 120.641 0.258 . . . . 0.0 111.048 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.01 -42.16 89.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.868 0.366 . . . . 0.0 110.656 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.446 ' O ' ' OD1' ' A' ' 279' ' ' ASP . 50.5 mttt -139.51 133.88 31.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.666 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.474 ' C ' HG23 ' A' ' 280' ' ' THR . 44.1 p30 30.12 44.51 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.581 ' HA ' ' CB ' ' A' ' 276' ' ' LEU . 1.3 p 70.23 29.52 3.66 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 278' ' ' LYS . . . -66.29 -58.72 8.25 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.246 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 286' ' ' PHE . 97.4 mm-40 -64.04 -29.85 70.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.834 0.35 . . . . 0.0 111.353 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.575 ' HB2' ' CD2' ' A' ' 274' ' ' LEU . 87.0 p -56.55 -27.82 58.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.712 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -87.3 126.9 35.13 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.02 0.438 . . . . 0.0 111.537 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.14 -37.1 3.52 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 114.989 0.755 . . . . 0.0 114.989 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.545 ' CE2' ' CE ' ' A' ' 275' ' ' MET . 12.3 p90 -147.23 162.6 38.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.415 1.107 . . . . 0.0 112.733 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.704 ' N ' HD12 ' A' ' 250' ' ' ILE . . . -143.25 163.91 27.36 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 121.102 -0.57 . . . . 0.0 113.264 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.613 ' HB2' ' HE2' ' A' ' 275' ' ' MET . 0.3 OUTLIER -113.5 132.38 55.7 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.511 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 42.6 t -123.74 136.09 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 35.8 m -118.39 136.99 53.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.509 178.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.526 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 30.7 m-85 -120.65 140.56 51.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.514 ' HB2' HD11 ' A' ' 270' ' ' ILE . 51.3 t0 -57.88 -36.28 72.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.307 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 93.7 p -125.86 149.19 48.86 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.331 0.586 . . . . 0.0 111.784 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.96 -29.68 69.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.18 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -56.16 -38.23 70.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.333 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.498 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -61.38 -37.51 83.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.055 0.455 . . . . 0.0 110.468 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.556 HG13 ' CG2' ' A' ' 245' ' ' ILE . 77.1 t -61.91 -44.62 99.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.713 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -61.82 -37.6 85.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.346 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -58.42 -43.4 88.66 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.917 HG23 HD11 ' A' ' 306' ' ' ILE . 0.5 OUTLIER -73.18 -32.04 36.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.915 0.388 . . . . 0.0 111.152 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 91.6 m -54.97 -44.55 74.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.046 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -62.76 -40.07 96.12 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.003 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.44 ' O ' ' N ' ' A' ' 305' ' ' PHE . 86.1 m-20 -63.98 -36.22 83.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.518 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.681 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 19.1 tptm 66.57 -67.84 0.15 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.792 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.681 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 20.9 m-85 -115.87 136.24 53.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.235 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.917 HD11 HG23 ' A' ' 300' ' ' VAL . 30.0 mt -121.55 137.97 53.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.965 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 307' ' ' ASP . 52.6 p30 -78.99 85.46 4.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.977 0.417 . . . . 0.0 111.199 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.735 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 4.1 t80 -79.36 -71.78 0.43 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.5 ' HE3' ' CE1' ' A' ' 308' ' ' PHE . 8.1 mmpt? -104.56 -145.56 0.38 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.151 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.493 ' OD1' ' HG3' ' A' ' 311' ' ' ARG . 54.5 p30 -81.59 2.48 29.07 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.13 0.49 . . . . 0.0 109.952 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.493 ' HG3' ' OD1' ' A' ' 310' ' ' ASP . 94.0 mtt-85 -126.24 149.16 49.27 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.588 ' HG2' ' HB3' ' A' ' 305' ' ' PHE . 11.3 tttp -80.02 137.2 36.76 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.654 HD11 ' CE2' ' A' ' 262' ' ' PHE . 21.7 pt -105.01 135.85 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.82 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . 0.417 ' HB2' ' CE2' ' A' ' 305' ' ' PHE . 84.6 tt0 -102.15 130.31 48.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.812 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 0.638 HD13 ' CE2' ' A' ' 263' ' ' PHE . 67.5 mt -119.34 128.54 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-O 121.024 0.44 . . . . 0.0 111.125 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -130.91 144.19 51.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.253 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -51.85 138.05 24.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.93 0.395 . . . . 0.0 110.424 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 244' ' ' LYS . . . -64.68 145.27 56.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.004 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.614 179.129 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 20.5 m . . . . . 0 CA--C 1.529 0.155 0 N-CA-C 111.544 0.201 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.483 ' HE3' ' HB1' ' A' ' 233' ' ' ALA . 36.6 ttpt -64.45 137.46 57.89 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.428 0.632 . . . . 0.0 111.458 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.825 ' SD ' HG13 ' A' ' 213' ' ' VAL . 85.2 mmm -117.2 151.79 36.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.215 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.569 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 5.9 t80 -106.13 129.31 54.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.678 ' CG2' HD21 ' A' ' 166' ' ' LEU . 12.9 mm -116.45 127.61 74.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -130.45 163.97 23.05 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.492 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 73.88 28.58 64.55 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.809 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.678 HD21 ' CG2' ' A' ' 163' ' ' ILE . 74.3 mt -86.7 142.15 28.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.782 0.325 . . . . 0.0 111.604 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -64.65 135.42 55.91 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.482 ' CD1' ' O ' ' A' ' 199' ' ' SER . 4.7 m0 -52.06 -31.52 30.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.688 0.28 . . . . 0.0 111.003 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -91.17 5.41 49.17 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.614 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.52 ' O ' ' O ' ' A' ' 171' ' ' THR . 86.1 m -58.04 -40.43 80.88 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.558 ' C ' HD12 ' A' ' 190' ' ' ILE . 0.1 OUTLIER 53.16 157.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.189 0.519 . . . . 0.0 110.1 -177.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.54 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 97.4 mt-10 -62.41 -26.78 68.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.704 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.685 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 93.0 m-20 -53.53 -42.85 67.87 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.464 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -68.09 -38.0 81.85 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.526 HD23 ' CE2' ' A' ' 179' ' ' PHE . 5.1 mt -59.69 -47.6 85.0 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.685 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -68.02 -37.2 81.11 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.194 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.417 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 48.5 tp10 -67.76 -45.51 74.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.866 0.365 . . . . 0.0 110.421 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.607 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 72.2 t80 -67.17 -48.28 68.44 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.767 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.535 ' CB ' HD11 ' A' ' 205' ' ' LEU . 81.3 m-85 -88.73 -4.52 58.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.185 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -58.67 -32.02 68.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.199 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -41.5 89.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.707 0.765 . . . . 0.0 109.988 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -68.55 -34.24 75.5 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.89 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -179.12 -176.84 47.21 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.247 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.521 ' O ' HG22 ' A' ' 185' ' ' VAL . 49.0 m -63.3 -30.09 71.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.518 -0.341 . . . . 0.0 111.559 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.652 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 0.6 OUTLIER 64.85 83.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 122.355 1.074 . . . . 0.0 108.478 -177.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.476 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -53.13 -47.74 68.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.723 -177.097 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 186' ' ' THR . 92.2 m-20 -138.95 156.08 47.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.213 0.53 . . . . 0.0 112.391 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -132.77 136.78 46.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.876 179.252 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.587 ' O ' ' HA2' ' A' ' 203' ' ' GLY . 7.8 tptt -142.79 66.05 1.33 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.584 0.231 . . . . 0.0 111.415 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.561 ' HA ' ' HA3' ' A' ' 203' ' ' GLY . 8.7 tt -61.82 -19.16 20.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.59 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.67 ' CE ' ' HA2' ' A' ' 203' ' ' GLY . 10.8 mtm 64.07 131.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.741 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.55 ' HG3' ' HD3' ' A' ' 194' ' ' PRO . 6.2 pttt -132.2 156.49 46.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.958 0.408 . . . . 0.0 111.805 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 10.7 t0 -125.65 74.63 69.94 Favored Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.901 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.55 ' HD3' ' HG3' ' A' ' 192' ' ' LYS . 19.9 Cg_endo -59.98 -27.67 85.43 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.616 2.211 . . . . 0.0 112.788 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -66.81 -59.12 3.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.952 0.406 . . . . 0.0 111.366 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 65.8 p -74.27 -18.43 60.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.417 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 89.7 9.19 66.66 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.134 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 25.1 mmt85 -120.95 -179.22 3.95 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.294 0.569 . . . . 0.0 111.859 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.482 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 51.0 m -119.93 152.64 37.11 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.969 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.472 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 5.9 mpt_? -51.35 -34.87 35.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.833 0.349 . . . . 0.0 110.745 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 87.81 2.57 81.32 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.419 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.651 ' O ' ' HE3' ' A' ' 191' ' ' MET . 14.8 p90 -139.37 153.74 47.71 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.67 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -145.06 155.97 26.72 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.062 -1.066 . . . . 0.0 112.413 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.569 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 97.4 m-85 -102.88 123.37 46.4 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.691 HD23 ' N ' ' A' ' 206' ' ' SER . 1.6 tt -106.37 127.81 53.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.168 -177.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.691 ' N ' HD23 ' A' ' 205' ' ' LEU . 34.5 t -115.8 133.62 55.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.765 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.606 ' CE2' HD22 ' A' ' 205' ' ' LEU . 95.7 m-85 -116.18 136.4 53.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.408 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.476 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.5 tt0 -61.54 -33.76 74.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.136 0.493 . . . . 0.0 109.75 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -110.09 120.4 44.63 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.802 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.91 -23.06 49.17 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.522 2.148 . . . . 0.0 113.073 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.1 m -57.12 -36.76 71.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.543 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.915 ' O ' HG23 ' A' ' 216' ' ' VAL . 23.0 m -58.85 -36.45 74.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.698 0.285 . . . . 0.0 110.938 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.825 HG13 ' SD ' ' A' ' 161' ' ' MET . 73.4 t -62.12 -42.88 96.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.231 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -60.11 -41.76 93.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.314 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.465 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 19.3 pt-20 -73.94 -28.51 61.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.903 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 212' ' ' SER . 70.3 t -59.89 -42.7 90.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.638 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.2 m -73.87 -27.38 22.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -58.54 -31.38 67.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.74 0.305 . . . . 0.0 111.488 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.59 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 67.3 m -108.29 142.41 38.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.818 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.409 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 14.1 pt20 -68.51 -40.71 80.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.463 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.712 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 61.0 m-70 81.97 118.52 0.05 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 72.8 mt -114.26 106.47 20.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.497 HD21 HG23 ' A' ' 170' ' ' THR . 6.9 tt -122.62 121.39 36.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.82 0.343 . . . . 0.0 110.781 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 50.14 40.31 21.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.53 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.79 11.21 84.88 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.503 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 31.6 mmtm -113.4 139.48 48.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 117.233 0.517 . . . . 0.0 111.595 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.81 ' O ' ' O ' ' A' ' 228' ' ' ILE . 17.2 m -73.61 -30.45 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.999 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.81 ' O ' ' O ' ' A' ' 227' ' ' VAL . 17.0 pt 34.42 136.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -123.7 80.87 55.22 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.171 0.51 . . . . 0.0 111.258 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.471 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 46.9 Cg_exo -59.13 126.15 20.16 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.151 2.567 . . . . 0.0 112.202 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt -134.25 153.67 51.72 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.432 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -56.06 145.29 26.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.995 0.426 . . . . 0.0 111.767 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.483 ' HB1' ' HE3' ' A' ' 160' ' ' LYS . . . -64.85 146.76 54.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.054 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.604 HD11 ' CB ' ' A' ' 238' ' ' GLU . 3.2 tt -108.25 137.14 19.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.318 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.452 ' HG2' ' HG3' ' A' ' 238' ' ' GLU . 13.0 Cg_endo -55.93 143.19 83.16 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.826 1.684 . . . . 0.0 110.709 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -54.53 -36.61 64.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.739 0.304 . . . . 0.0 111.25 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.31 -41.49 84.61 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 242' ' ' THR . 97.4 mt-10 -68.14 -35.88 78.8 Favored 'General case' 0 C--O 1.23 0.07 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.484 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -60.82 -36.76 79.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.045 0.45 . . . . 0.0 111.039 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -58.66 -38.86 79.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.533 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 242' ' ' THR . 75.2 mmtt -87.47 -76.9 0.36 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 238' ' ' GLU . 76.9 p 34.66 -165.68 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -162.97 55.62 0.29 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.728 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.532 ' CE ' ' CD2' ' A' ' 288' ' ' PHE . 7.9 tptt -73.7 121.17 20.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.692 0.282 . . . . 0.0 110.399 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.7 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -130.01 164.58 32.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.176 0.512 . . . . 0.0 110.848 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -104.91 136.57 44.16 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.316 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.85 HG11 ' CE1' ' A' ' 259' ' ' PHE . 15.0 p -130.7 144.83 36.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.719 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.643 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -130.37 170.14 21.02 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.93 21.52 35.89 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 119.889 -1.148 . . . . 0.0 112.377 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 287' ' ' GLY . 67.0 mt -106.52 128.9 60.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.874 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -166.09 -115.28 0.32 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.329 -0.938 . . . . 0.0 113.272 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.43 138.63 86.86 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.334 2.023 . . . . 0.0 113.506 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 54.02 44.45 29.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.34 -0.845 . . . . 0.0 113.215 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.874 HG22 ' O ' ' A' ' 251' ' ' GLY . 8.8 m -109.49 -54.23 5.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.443 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.477 ' N ' HG23 ' A' ' 254' ' ' VAL . 13.2 mmt180 60.85 135.98 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -54.82 -31.9 74.61 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.192 1.928 . . . . 0.0 113.418 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -60.12 -45.08 94.22 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.792 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.682 ' HA ' ' HB3' ' A' ' 261' ' ' GLU . 58.6 mp0 -68.52 -33.69 74.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.828 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.85 ' CE1' HG11 ' A' ' 247' ' ' VAL . 13.2 t80 -61.93 -52.73 62.85 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.897 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.664 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.3 tt0 -63.77 -37.14 86.24 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.682 ' HB3' ' HA ' ' A' ' 258' ' ' GLU . 81.7 tt0 -61.41 -37.74 84.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 113.824 -1.534 . . . . 0.0 111.717 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.882 ' CE2' HD11 ' A' ' 313' ' ' ILE . 84.3 t80 -68.93 -54.72 13.9 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.782 ' CB ' HD11 ' A' ' 269' ' ' ILE . 7.3 m-85 -66.04 -25.22 66.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.208 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 86.5 p -56.32 -23.06 34.59 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -52.29 -39.68 60.82 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.298 -1.319 . . . . 0.0 113.072 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.665 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 43.9 p90 -120.87 58.33 0.95 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.543 0.687 . . . . 0.0 112.268 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.422 ' HA3' ' HB1' ' A' ' 296' ' ' ALA . . . 122.32 153.9 8.98 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.012 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.7 m -72.49 132.18 43.51 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.782 HD11 ' CB ' ' A' ' 263' ' ' PHE . 74.9 mt -93.98 126.14 46.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.711 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.772 HG22 ' HB ' ' A' ' 290' ' ' THR . 10.5 tt -65.55 -36.25 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.281 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 270' ' ' ILE . 51.2 p30 171.79 73.71 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.894 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.573 ' HB2' HG21 ' A' ' 269' ' ' ILE . . . -67.76 142.53 56.21 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.408 0.147 . . . . 0.0 111.01 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -144.03 152.16 40.64 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.84 HD23 ' HG ' ' A' ' 276' ' ' LEU . 22.3 tp -65.89 -35.87 81.85 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.087 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.582 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 93.1 mmm 99.5 -13.66 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.925 0.89 . . . . 0.0 112.574 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.84 ' HG ' HD23 ' A' ' 274' ' ' LEU . 0.0 OUTLIER -64.59 50.44 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.489 ' O ' HG22 ' A' ' 227' ' ' VAL . 21.8 t70 -59.0 -40.51 85.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.075 0.464 . . . . 0.0 110.592 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 279' ' ' ASP . 37.1 mtpt -59.79 -26.92 66.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.326 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 278' ' ' LYS . 54.3 t0 80.44 38.62 0.09 Allowed 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.096 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 281' ' ' GLY . 0.1 OUTLIER -166.62 -61.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.061 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . 0.557 ' H ' HG23 ' A' ' 280' ' ' THR . . . -82.49 164.28 43.39 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.396 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.405 ' OE1' ' HB3' ' A' ' 275' ' ' MET . 48.3 mt-30 59.36 41.65 19.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.883 0.373 . . . . 0.0 110.12 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.492 ' HA ' HD21 ' A' ' 274' ' ' LEU . 29.8 t -127.45 142.14 51.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.896 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.477 ' CA ' ' HA2' ' A' ' 251' ' ' GLY . 60.6 mtm180 45.85 25.49 0.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.671 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -119.53 -62.85 0.27 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.039 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -139.23 164.9 28.6 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.805 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -130.39 156.54 21.63 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 119.927 -1.13 . . . . 0.0 113.625 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.532 ' CD2' ' CE ' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -119.3 123.08 43.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.729 -0.236 . . . . 0.0 110.465 179.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.815 HG23 ' CZ ' ' A' ' 259' ' ' PHE . 57.4 t -123.91 137.37 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.195 0.521 . . . . 0.0 112.105 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.772 ' HB ' HG22 ' A' ' 270' ' ' ILE . 20.8 m -120.41 138.33 53.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.407 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -114.91 138.96 50.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.145 0.498 . . . . 0.0 111.776 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 293' ' ' SER . 53.0 p30 -62.42 -30.47 71.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.928 178.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . 0.55 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 51.0 m -119.76 142.65 48.36 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 121.18 0.514 . . . . 0.0 111.3 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.6 -31.83 72.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.72 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.48 -37.12 69.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.618 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.434 ' O ' ' HD1' ' A' ' 266' ' ' TRP . . . -61.15 -38.01 84.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.416 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 79.9 t -60.99 -40.01 84.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.933 0.397 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -58.08 -36.89 73.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.937 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -56.78 -43.75 81.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.987 0.422 . . . . 0.0 111.704 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.817 HG23 HD11 ' A' ' 306' ' ' ILE . 0.3 OUTLIER -76.1 -30.07 20.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.815 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 84.9 m -55.91 -45.29 78.72 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.77 -34.76 79.1 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.08 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -102.15 79.89 1.92 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.602 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.633 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 11.9 tptt -55.74 -44.59 77.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.048 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.633 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 8.5 m-85 -117.06 126.73 53.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.514 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.817 HD11 HG23 ' A' ' 300' ' ' VAL . 2.4 mt -121.37 139.38 48.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.228 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -78.76 113.32 16.74 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.376 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.601 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 7.0 t80 -112.3 -77.28 0.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.928 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.412 ' HG3' HG12 ' A' ' 254' ' ' VAL . 6.4 mmpt? -97.41 -167.29 1.51 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.967 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -51.84 -29.78 20.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.839 0.352 . . . . 0.0 110.486 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -105.42 144.59 31.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.05 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.578 ' HE2' ' HB3' ' A' ' 305' ' ' PHE . 10.3 tptt -70.74 142.04 51.45 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.882 HD11 ' CE2' ' A' ' 262' ' ' PHE . 28.8 pt -109.64 141.2 25.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.034 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . 0.506 ' HG3' ' CE1' ' A' ' 305' ' ' PHE . 85.6 tt0 -101.59 131.82 47.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.813 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 0.781 HG12 HG23 ' A' ' 247' ' ' VAL . 71.3 mt -119.91 128.29 75.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.108 0.48 . . . . 0.0 111.766 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.415 ' HE3' ' OE2' ' A' ' 314' ' ' GLU . 38.1 mttp -127.89 156.06 43.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.83 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -60.46 148.46 37.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -53.95 137.46 39.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.19 0.519 . . . . 0.0 111.611 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.649 179.927 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.965 0.412 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.47 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 79.4 tttt -87.69 134.62 33.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.88 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.415 ' N ' ' O ' ' A' ' 205' ' ' LEU . 5.0 tpp -120.39 147.37 45.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.648 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.626 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 5.0 t80 -100.19 129.35 46.2 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.807 HG23 HD12 ' A' ' 228' ' ' ILE . 21.8 mm -116.79 128.37 74.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.792 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -130.67 165.93 22.65 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.198 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.9 27.75 62.01 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.571 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.964 HD23 HG21 ' A' ' 228' ' ' ILE . 80.9 mt -87.41 144.28 26.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.737 0.303 . . . . 0.0 111.714 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -66.92 133.77 50.68 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.545 ' HD1' ' O ' ' A' ' 199' ' ' SER . 5.0 m-90 -50.23 -34.77 24.1 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.298 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -63.73 -20.63 65.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.5 m -50.83 139.24 17.28 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.786 0.803 . . . . 0.0 111.89 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.515 ' C ' HD12 ' A' ' 190' ' ' ILE . 32.6 m -120.51 148.38 43.91 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.778 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.887 ' N ' HD12 ' A' ' 190' ' ' ILE . 96.2 mt-10 -56.63 -34.84 67.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.606 0.241 . . . . 0.0 110.544 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.632 ' OD1' ' N ' ' A' ' 174' ' ' ASN . 54.9 p30 -61.46 -38.04 85.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.576 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.632 ' N ' ' OD1' ' A' ' 173' ' ' ASP . 84.0 m-20 -65.56 -36.13 82.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.159 0.504 . . . . 0.0 110.526 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.543 HD12 HD11 ' A' ' 190' ' ' ILE . 0.4 OUTLIER -53.42 -48.6 68.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.273 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.544 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -64.18 -37.0 85.88 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.107 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.425 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 84.4 tt0 -65.92 -44.13 86.05 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.722 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.48 ' OH ' ' HB3' ' A' ' 221' ' ' HIS . 73.2 t80 -64.88 -46.59 81.14 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.144 0.497 . . . . 0.0 111.429 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.485 ' HE1' HG13 ' A' ' 216' ' ' VAL . 91.5 m-85 -91.18 1.67 56.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.255 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -60.73 -28.69 68.52 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.381 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.465 ' CD ' ' H ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -58.98 -38.05 78.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.705 0.764 . . . . 0.0 110.445 -179.01 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.418 ' CE2' ' HA ' ' A' ' 216' ' ' VAL . 47.9 m-85 -67.31 -29.62 69.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.526 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 153.76 -124.31 1.55 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.892 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 56.8 m -117.16 139.01 51.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.95 HG12 ' CE1' ' A' ' 207' ' ' PHE . 4.8 m -109.56 126.2 66.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.685 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.81 HG23 ' N ' ' A' ' 208' ' ' GLU . 43.9 p -75.1 -31.89 61.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.58 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.851 ' C ' HD13 ' A' ' 188' ' ' LEU . 51.5 t0 -150.6 150.01 30.63 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.851 HD13 ' C ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -141.49 81.45 1.78 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.013 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.576 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 8.4 tptp -79.41 119.43 22.43 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.887 HD12 ' N ' ' A' ' 172' ' ' GLU . 74.0 mt -127.26 112.42 28.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 174.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.634 ' HB2' ' HD3' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -61.37 -34.43 75.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.2 -177.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.47 ' O ' ' O ' ' A' ' 191' ' ' MET . 52.2 tttm 49.6 162.79 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.455 ' N ' ' HG2' ' A' ' 192' ' ' LYS . 5.2 t70 -112.18 100.27 48.85 Favored Pre-proline 0 N--CA 1.463 0.206 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.347 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.8 -29.15 85.0 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.325 2.016 . . . . 0.0 113.165 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -78.96 -88.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.6 p -70.79 -27.11 63.66 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 193' ' ' ASP . . . 97.66 -8.28 63.78 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.204 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 199' ' ' SER . 33.3 mtm-85 -124.65 133.38 53.25 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.242 0.544 . . . . 0.0 111.849 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.575 ' O ' ' HB3' ' A' ' 200' ' ' ARG . 36.2 t 162.22 -177.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.071 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.833 ' HG2' ' H ' ' A' ' 202' ' ' PHE . 58.2 ttp85 68.52 -95.42 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.24 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 85.11 9.53 80.06 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.386 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.833 ' H ' ' HG2' ' A' ' 200' ' ' ARG . 34.5 p90 -146.14 153.53 40.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -148.65 166.59 29.22 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 119.858 -1.163 . . . . 0.0 112.209 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.626 ' CE2' ' CD1' ' A' ' 162' ' ' PHE . 89.9 m-85 -108.75 122.53 47.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.016 0.436 . . . . 0.0 110.023 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.948 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 0.7 OUTLIER -114.75 129.55 56.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.493 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.792 ' N ' HD12 ' A' ' 205' ' ' LEU . 58.5 m -115.18 143.08 45.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.251 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.95 ' CE1' HG12 ' A' ' 185' ' ' VAL . 92.5 m-85 -117.74 138.09 52.26 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.81 ' N ' HG23 ' A' ' 186' ' ' THR . 84.5 tt0 -63.68 -35.59 81.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.892 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.17 116.34 56.93 Favored Pre-proline 0 C--N 1.333 -0.123 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.388 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 0.914 ' O ' HG12 ' A' ' 213' ' ' VAL . 46.4 Cg_exo -56.13 -25.01 52.71 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.241 1.96 . . . . 0.0 112.829 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.7 m -58.84 -36.25 74.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.65 0.262 . . . . 0.0 111.47 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.758 ' O ' HG23 ' A' ' 216' ' ' VAL . 89.7 p -62.53 -32.7 73.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.453 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.914 HG12 ' O ' ' A' ' 210' ' ' PRO . 3.0 p -62.66 -37.2 78.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.892 0.377 . . . . 0.0 110.754 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 218' ' ' LYS . 54.9 t0 -61.99 -42.98 99.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.589 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 212' ' ' SER . 4.5 pt-20 -74.06 -32.34 63.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.904 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.826 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 92.7 t -63.61 -44.63 98.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.073 0.463 . . . . 0.0 110.894 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 213' ' ' VAL . 59.1 t -68.02 -46.14 82.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 214' ' ' ASP . 47.0 mmtm -61.11 -34.51 75.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.403 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 49.2 m -88.37 144.03 26.65 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -79.74 141.41 36.37 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.826 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 55.2 m-70 -121.15 130.77 53.88 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -176.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.565 HG12 HG22 ' A' ' 227' ' ' VAL . 69.0 mt -123.63 112.31 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.264 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.559 HD23 ' CG ' ' A' ' 224' ' ' ASP . 6.7 tt -119.12 127.23 53.17 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.139 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.559 ' CG ' HD23 ' A' ' 223' ' ' LEU . 86.0 m-20 55.05 42.46 30.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.314 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 77.62 10.95 85.91 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.56 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 222' ' ' ILE . 6.3 mptt -126.67 153.76 44.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.976 0.388 . . . . 0.0 110.753 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.565 HG22 HG12 ' A' ' 222' ' ' ILE . 43.4 t -102.25 132.8 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.917 0.389 . . . . 0.0 110.859 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.964 HG21 HD23 ' A' ' 166' ' ' LEU . 30.8 pt -125.27 159.62 32.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.377 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -126.86 82.86 66.89 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 121.13 0.49 . . . . 0.0 110.981 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.537 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 56.0 Cg_exo -56.73 128.57 30.55 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.195 2.597 . . . . 0.0 112.15 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -133.98 157.26 46.51 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.665 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 40.1 tpt85 -58.74 135.08 57.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.987 0.423 . . . . 0.0 111.165 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -65.81 145.85 55.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.088 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.795 HG22 ' HB2' ' A' ' 238' ' ' GLU . 6.1 mt -117.96 120.46 32.57 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.561 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.545 ' HB2' ' OE1' ' A' ' 238' ' ' GLU . 34.5 Cg_exo -53.89 152.69 22.38 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 121.548 1.499 . . . . 0.0 110.634 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 52.3 mmm-85 -54.23 -35.63 62.65 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.32 -40.74 82.86 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.795 ' HB2' HG22 ' A' ' 234' ' ' ILE . 55.3 mp0 -65.85 -35.82 81.73 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.587 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -59.35 -39.81 84.38 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.598 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -64.14 -45.19 89.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.053 0.454 . . . . 0.0 110.185 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -65.09 -40.08 94.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.649 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.742 HG23 ' O ' ' A' ' 238' ' ' GLU . 24.8 p -83.69 161.42 21.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.129 -178.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.53 166.27 25.88 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.34 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.496 ' HE3' ' CE2' ' A' ' 288' ' ' PHE . 4.6 ttpt -137.45 135.61 37.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.075 0.437 . . . . 0.0 111.233 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.956 HD12 ' CG2' ' A' ' 315' ' ' ILE . 7.4 pt -120.05 159.83 20.98 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 121.176 0.512 . . . . 0.0 110.933 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -99.52 129.62 45.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.675 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.458 HG22 HD12 ' A' ' 315' ' ' ILE . 44.0 t -119.83 137.32 54.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.349 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.05 167.72 18.38 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.564 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 94.48 8.58 59.64 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.197 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.965 HG22 HG21 ' A' ' 254' ' ' VAL . 27.8 mm -56.8 -39.89 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 120.762 0.315 . . . . 0.0 110.581 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 250' ' ' ILE . . . 27.56 -145.36 0.01 OUTLIER Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.677 -0.692 . . . . 0.0 114.419 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.9 169.25 11.89 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.338 2.692 . . . . 0.0 113.533 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 60.46 43.47 13.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.313 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.965 HG21 HG22 ' A' ' 250' ' ' ILE . 26.8 m -133.8 156.88 41.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.924 0.392 . . . . 0.0 110.991 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.92 155.12 74.84 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.778 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -57.01 -40.3 85.01 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 121.532 1.488 . . . . 0.0 110.851 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.52 -42.62 98.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.773 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 262' ' ' PHE . 74.6 mm-40 -65.43 -41.34 93.64 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.491 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.478 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 43.1 t80 -66.91 -48.96 67.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.722 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -64.65 -40.89 96.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.774 0.321 . . . . 0.0 111.058 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.1 pt-20 -74.69 -30.72 61.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.892 0.377 . . . . 0.0 110.548 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.669 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 91.4 t80 -57.38 -44.65 84.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.172 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.659 ' HZ ' HD12 ' A' ' 313' ' ' ILE . 86.7 m-85 -92.7 -2.22 56.22 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 267' ' ' GLY . 47.2 t -60.09 -30.16 69.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -56.36 -39.8 73.46 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.44 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.699 ' HH2' HG21 ' A' ' 306' ' ' ILE . 17.3 m-90 -60.42 -39.23 86.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.085 0.469 . . . . 0.0 110.811 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 264' ' ' SER . . . -173.71 -172.55 39.18 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.663 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 90.7 m -58.34 -37.18 74.64 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.625 HD11 ' C ' ' A' ' 263' ' ' PHE . 49.2 mt 61.7 86.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.65 HD11 ' HB3' ' A' ' 292' ' ' ASP . 31.4 mm -55.09 -44.5 74.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -159.66 92.48 1.04 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -104.86 133.98 48.75 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -144.68 154.94 43.3 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.812 ' CD1' HG21 ' A' ' 250' ' ' ILE . 31.8 tp -66.19 -37.83 86.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.23 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.625 ' O ' HD23 ' A' ' 276' ' ' LEU . 93.2 mmm 84.21 138.08 0.06 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.199 -178.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 275' ' ' MET . 0.2 OUTLIER 173.59 89.78 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.841 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 278' ' ' LYS . 55.4 p30 -64.16 -39.86 94.92 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.688 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.615 ' N ' ' OD1' ' A' ' 277' ' ' ASP . 60.1 mttm -101.11 7.98 43.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.978 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.461 ' HA ' ' CD1' ' A' ' 276' ' ' LEU . 51.2 t0 78.94 -13.69 0.94 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.857 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 46.4 p -139.43 12.13 2.55 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -94.58 -74.63 1.25 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.761 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 286' ' ' PHE . 80.1 mm-40 -60.1 -32.47 71.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.049 0.452 . . . . 0.0 111.232 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.697 ' OG ' HD21 ' A' ' 274' ' ' LEU . 33.1 t -61.66 -4.7 1.52 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.911 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -49.94 -38.2 35.4 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 178.91 19.17 0.03 OUTLIER Glycine 0 CA--C 1.524 0.604 0 C-N-CA 118.717 -1.706 . . . . 0.0 115.847 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 24.9 p90 -137.93 160.53 39.07 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.755 1.278 . . . . 0.0 111.022 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -139.36 157.27 24.97 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.319 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.496 ' CE2' ' HE3' ' A' ' 244' ' ' LYS . 0.6 OUTLIER -111.13 129.18 56.01 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.582 0.353 . . . . 0.0 110.919 179.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.492 ' O ' ' HG3' ' A' ' 244' ' ' LYS . 42.3 t -122.76 133.14 69.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.712 0.292 . . . . 0.0 111.16 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 52.5 m -119.61 138.02 53.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.379 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.515 ' CE1' HG12 ' A' ' 269' ' ' ILE . 47.8 m-85 -120.45 143.42 48.5 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.65 ' HB3' HD11 ' A' ' 270' ' ' ILE . 52.9 p30 -63.56 -32.65 74.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.499 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . 0.611 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 98.2 p -127.06 149.34 49.96 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 121.26 0.552 . . . . 0.0 111.806 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -68.35 -32.76 73.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.092 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -56.25 -39.6 72.83 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.658 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -63.88 -34.72 78.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.173 0.511 . . . . 0.0 110.591 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.753 HG13 ' CG2' ' A' ' 245' ' ' ILE . 78.1 t -63.14 -42.1 95.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.664 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -60.55 -42.01 95.72 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -64.33 -45.86 86.01 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.85 HG22 HG13 ' A' ' 315' ' ' ILE . 7.5 p -70.62 -40.65 77.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 95.1 m -67.69 -40.11 84.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.737 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -56.85 -39.91 75.15 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.872 0.368 . . . . 0.0 111.022 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.777 ' HB3' HD11 ' A' ' 306' ' ' ILE . 44.5 t-20 -60.2 -33.34 72.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.736 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.681 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 6.7 tptm 75.24 -62.56 0.44 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.336 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.681 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 24.4 m-85 -116.07 132.78 56.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.236 0.541 . . . . 0.0 111.994 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.777 HD11 ' HB3' ' A' ' 303' ' ' ASN . 20.7 mm -121.22 140.85 44.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.002 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -78.82 130.0 35.22 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.669 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 1.8 t80 -118.23 -127.06 0.28 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.451 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.5 ' HD3' ' CE1' ' A' ' 308' ' ' PHE . 0.0 OUTLIER -60.21 -36.05 76.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.194 0.521 . . . . 0.0 110.563 -179.091 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -177.43 -35.78 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.218 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -86.59 144.93 26.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.423 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.53 ' HE3' ' HB3' ' A' ' 305' ' ' PHE . 3.0 tptt -74.26 136.6 42.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 306' ' ' ILE . 30.8 pt -112.56 143.57 22.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.298 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -102.41 138.63 39.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 0.956 ' CG2' HD12 ' A' ' 245' ' ' ILE . 15.2 mm -112.37 127.14 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -136.53 137.02 39.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.479 0.181 . . . . 0.0 110.988 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -55.51 146.82 19.21 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 244' ' ' LYS . . . -51.37 135.49 26.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.284 0.564 . . . . 0.0 111.245 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.431 -179.784 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.786 0.327 . . . . 0.0 110.42 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.64 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 75.6 tttt -100.08 141.59 32.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.205 0.526 . . . . 0.0 111.829 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.506 ' N ' ' O ' ' A' ' 205' ' ' LEU . 82.4 mmm -124.02 145.86 48.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.649 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.65 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 3.6 t80 -105.5 127.52 53.06 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.672 HG22 HD21 ' A' ' 166' ' ' LEU . 18.2 mt -122.28 130.11 74.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.445 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.408 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -128.73 163.98 22.0 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.747 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.524 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 72.51 47.31 28.42 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 119.829 -1.177 . . . . 0.0 111.481 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.76 HD12 HH21 ' A' ' 200' ' ' ARG . 45.2 mt -83.63 9.67 11.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.473 ' HB2' ' HG3' ' A' ' 226' ' ' LYS . 49.4 t30 62.81 43.61 6.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.023 0.44 . . . . 0.0 110.195 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 6.0 m0 39.15 39.45 0.41 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.267 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 171' ' ' THR . 59.8 t0 -162.44 -111.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.263 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.779 HG22 ' HB2' ' A' ' 175' ' ' LEU . 77.0 m 63.26 -40.97 0.2 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.617 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.5 OUTLIER 47.74 155.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.553 0.692 . . . . 0.0 111.374 -179.296 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.528 ' N ' HD12 ' A' ' 190' ' ' ILE . 96.3 mt-10 -62.5 -31.98 72.83 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.659 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -64.0 -61.53 2.22 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.563 ' HB2' ' O ' ' A' ' 170' ' ' THR . 85.9 m-20 -62.57 -37.19 85.23 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.226 0.536 . . . . 0.0 110.016 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.779 ' HB2' HG22 ' A' ' 170' ' ' THR . 52.3 tp -61.86 -42.97 99.69 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.359 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 -61.65 -42.52 99.02 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.169 0.509 . . . . 0.0 110.173 177.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -66.82 -40.31 88.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.224 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.496 ' OH ' ' HB3' ' A' ' 221' ' ' HIS . 50.6 t80 -59.91 -45.26 93.12 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.163 0.506 . . . . 0.0 110.898 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.406 ' HB3' HD21 ' A' ' 205' ' ' LEU . 97.5 m-85 -95.46 -0.99 51.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.072 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.27 -30.85 64.98 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.008 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.426 ' HD3' ' O ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -58.34 -41.78 85.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.534 0.683 . . . . 0.0 110.644 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -67.39 -35.35 79.13 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.613 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -179.42 -177.19 47.61 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 119.719 -1.229 . . . . 0.0 113.483 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.52 ' C ' HG13 ' A' ' 185' ' ' VAL . 46.7 m -63.11 -30.69 71.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.029 -0.586 . . . . 0.0 110.995 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.619 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 0.6 OUTLIER 64.38 91.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.857 0.837 . . . . 0.0 108.954 -177.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.7 t -58.49 -44.48 89.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.581 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 206' ' ' SER . 89.0 m-20 -135.59 149.31 49.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.49 0.662 . . . . 0.0 112.687 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.522 ' CD1' HD23 ' A' ' 175' ' ' LEU . 0.2 OUTLIER -126.83 127.62 45.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.099 179.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.539 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 13.0 tptt -135.95 120.78 18.55 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.528 HD12 ' N ' ' A' ' 172' ' ' GLU . 0.8 OUTLIER -130.35 132.0 65.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.83 176.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.695 ' HB2' ' HD2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -99.23 156.49 16.95 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.432 -179.156 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.492 ' HG3' ' HD3' ' A' ' 194' ' ' PRO . 13.4 pttt -132.23 161.93 32.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.641 0.258 . . . . 0.0 110.881 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 1.0 OUTLIER -125.49 75.65 69.36 Favored Pre-proline 0 C--O 1.232 0.144 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.189 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.492 ' HD3' ' HG3' ' A' ' 192' ' ' LYS . 26.8 Cg_exo -61.77 -25.46 78.63 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.504 2.136 . . . . 0.0 112.019 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.45 -71.16 0.36 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.882 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 58.5 p -66.9 -28.71 68.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.072 0.463 . . . . 0.0 110.458 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 89.53 6.8 70.08 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.209 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 3.3 tpt180 -123.6 124.08 42.01 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.291 0.546 . . . . 0.0 110.632 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.472 ' HB3' ' NH1' ' A' ' 200' ' ' ARG . 54.8 m -62.31 147.9 46.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.164 0.507 . . . . 0.0 112.047 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.76 HH21 HD12 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -60.62 -35.59 76.54 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.849 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 91.89 7.59 64.26 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 114.973 0.749 . . . . 0.0 114.973 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.622 ' H ' ' HG2' ' A' ' 200' ' ' ARG . 36.6 p90 -141.12 153.91 45.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.23 0.538 . . . . 0.0 111.371 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.515 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -142.51 161.61 27.35 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.606 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.65 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 97.7 m-85 -105.75 124.56 49.77 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.626 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 44.2 tp -111.01 127.37 55.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.321 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' A' ' 187' ' ' ASP . 49.9 m -117.81 142.05 47.73 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.786 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.626 ' CZ ' HD21 ' A' ' 205' ' ' LEU . 93.5 m-85 -120.73 146.16 46.76 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.063 0.458 . . . . 0.0 111.707 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.72 -34.95 79.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.752 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 0.6 OUTLIER -118.54 135.91 23.85 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.934 -179.308 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 0.998 ' O ' HG12 ' A' ' 213' ' ' VAL . 39.6 Cg_exo -60.53 -26.36 82.66 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.846 2.364 . . . . 0.0 113.286 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 31.4 m -58.08 -38.45 76.4 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.188 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.63 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.9 m -61.41 -37.88 85.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.809 0.338 . . . . 0.0 111.069 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.998 HG12 ' O ' ' A' ' 210' ' ' PRO . 3.0 p -61.43 -35.87 69.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.466 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.431 ' O ' ' HG3' ' A' ' 218' ' ' LYS . 92.6 m-20 -60.79 -43.54 97.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.793 0.33 . . . . 0.0 111.375 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.29 -34.64 77.82 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.788 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 98.4 t -60.58 -43.47 94.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 230' ' ' PRO . 20.9 m -83.51 -37.8 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 214' ' ' ASP . 25.7 mttm -60.51 -32.77 71.77 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.405 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 48.3 m -99.49 144.91 28.04 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -76.84 145.41 38.4 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.788 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 74.2 m-70 -121.87 128.15 51.29 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -176.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 70.9 mt -128.41 89.07 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.436 ' CD1' HG23 ' A' ' 170' ' ' THR . 6.8 tt -67.36 -38.68 85.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -163.8 50.32 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.005 0.431 . . . . 0.0 111.353 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 91.28 2.44 70.82 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.661 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.473 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 10.7 mmtp -116.58 152.25 34.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 41.6 t -105.12 131.62 53.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.132 0.491 . . . . 0.0 110.932 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.587 HD12 HG23 ' A' ' 163' ' ' ILE . 36.8 pt -123.66 159.82 28.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.113 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -126.93 79.82 72.12 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-O 121.127 0.489 . . . . 0.0 111.125 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.613 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 52.0 Cg_exo -57.93 124.02 15.02 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.649 2.233 . . . . 0.0 111.107 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.46 ' N ' ' HE3' ' A' ' 161' ' ' MET . 4.0 ttpm? -134.88 149.08 50.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.639 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -52.5 141.16 20.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.9 0.381 . . . . 0.0 110.769 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.64 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -64.98 148.52 51.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.982 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 65.3 mt -109.64 128.58 25.15 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.407 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.89 141.0 57.13 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 121.623 1.548 . . . . 0.0 110.802 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 57.4 mmm-85 -57.37 -39.66 76.51 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.382 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.07 -43.19 99.28 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.018 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.481 ' O ' HG23 ' A' ' 242' ' ' THR . 97.0 mt-10 -68.72 -37.25 79.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.088 0.471 . . . . 0.0 110.552 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -60.1 -40.69 90.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.92 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -60.59 -39.8 89.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.811 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -60.78 -32.7 72.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.411 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.791 HG22 HD12 ' A' ' 270' ' ' ILE . 11.3 p -77.91 161.98 27.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.129 0.49 . . . . 0.0 111.818 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -146.55 115.25 0.78 Allowed Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.86 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.472 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 46.3 tptt -82.44 130.61 35.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.519 0.2 . . . . 0.0 110.918 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.684 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -120.97 159.79 22.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.249 0.547 . . . . 0.0 110.758 179.199 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.526 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 91.9 t80 -103.26 137.52 41.28 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.061 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.837 HG23 HG12 ' A' ' 315' ' ' ILE . 7.2 p -130.46 143.98 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.818 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.626 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -131.92 165.47 23.44 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 94.43 13.42 53.97 Favored Glycine 0 C--N 1.321 -0.264 0 C-N-CA 119.952 -1.118 . . . . 0.0 112.333 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.833 HD11 ' CA ' ' A' ' 287' ' ' GLY . 36.4 pt -117.9 155.69 19.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.771 0.32 . . . . 0.0 110.93 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.666 ' H ' HG12 ' A' ' 254' ' ' VAL . . . 178.2 -134.69 2.46 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.292 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.67 -28.03 63.91 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.973 1.782 . . . . 0.0 111.179 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.03 -31.99 70.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.374 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.772 HG11 ' HB ' ' A' ' 250' ' ' ILE . 7.9 p -122.55 143.23 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.668 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.8 mmm-85 -102.39 163.12 18.29 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.08 -40.39 81.74 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 121.483 1.455 . . . . 0.0 112.003 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -64.37 -46.32 83.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.847 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.432 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 84.1 tt0 -65.59 -39.79 91.97 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-O 120.913 0.387 . . . . 0.0 111.881 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.643 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 26.3 t80 -61.66 -45.91 92.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.011 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -64.53 -42.17 95.91 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.478 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.432 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.7 pt-20 -74.1 -30.78 62.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.187 0.518 . . . . 0.0 110.432 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.709 ' CZ ' HG21 ' A' ' 306' ' ' ILE . 5.7 t80 -60.45 -56.53 20.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.817 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.679 ' C ' HD11 ' A' ' 269' ' ' ILE . 4.6 m-85 -64.64 -23.46 67.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.041 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.686 ' N ' HD11 ' A' ' 269' ' ' ILE . 22.7 t -55.12 -30.55 59.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.941 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -52.72 -35.33 55.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.096 -0.242 . . . . 0.0 111.398 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.665 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 7.4 p90 -117.55 45.27 1.96 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 121.16 0.505 . . . . 0.0 111.593 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.516 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 152.48 146.79 4.43 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.857 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.406 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 46.2 m -59.32 -38.21 79.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.769 0.319 . . . . 0.0 111.358 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.686 HD11 ' N ' ' A' ' 264' ' ' SER . 75.3 mt 68.0 82.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.487 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.791 HD12 HG22 ' A' ' 242' ' ' THR . 71.2 mt -58.35 -40.52 78.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.4 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 290' ' ' THR . 58.0 t0 -149.83 142.48 24.54 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.992 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.44 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -158.08 136.97 11.4 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.623 0.249 . . . . 0.0 111.046 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . 0.402 ' HG3' ' SD ' ' A' ' 275' ' ' MET . 21.7 pt20 -148.69 154.04 39.09 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.143 0.497 . . . . 0.0 112.018 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.569 ' O ' ' HB2' ' A' ' 275' ' ' MET . 31.9 tp -66.02 -37.01 84.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.859 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.569 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 92.2 mmm 86.95 126.55 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.471 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.51 ' HB3' ' OG ' ' A' ' 283' ' ' SER . 0.0 OUTLIER -154.66 138.68 16.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 111.134 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -81.7 -132.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -56.6 -35.01 67.76 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 122.115 -0.366 . . . . 0.0 110.547 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 276' ' ' LEU . 93.2 m-20 -135.58 -101.46 0.22 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.583 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 63.7 p -111.04 16.78 20.97 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -42.09 -79.85 0.05 OUTLIER Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.564 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.448 ' HB2' ' C ' ' A' ' 275' ' ' MET . 90.3 mm-40 -59.29 -33.16 70.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.082 0.468 . . . . 0.0 110.011 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.623 ' O ' ' HG2' ' A' ' 284' ' ' ARG . 58.8 m -64.56 171.84 3.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.529 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 283' ' ' SER . 42.2 ptt85 49.55 46.68 23.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.305 0.574 . . . . 0.0 110.398 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -167.87 -67.78 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.455 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.526 ' CD2' ' HE1' ' A' ' 246' ' ' PHE . 35.7 p90 -139.29 167.0 23.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.731 0.301 . . . . 0.0 111.212 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.833 ' CA ' HD11 ' A' ' 250' ' ' ILE . . . -133.88 164.29 24.43 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.702 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.472 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.2 OUTLIER -118.5 126.8 52.79 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.442 -0.379 . . . . 0.0 110.822 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.684 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 46.6 t -127.53 139.7 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.443 ' OG1' ' CD ' ' A' ' 244' ' ' LYS . 32.5 m -116.66 137.69 52.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.408 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.516 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 40.2 m-85 -117.95 140.49 49.66 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 293' ' ' SER . 54.0 p30 -62.1 -32.14 72.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.285 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . 0.591 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 29.7 t -124.46 139.43 53.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.209 0.528 . . . . 0.0 111.508 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.81 -30.93 71.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.177 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -56.48 -37.66 70.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.202 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -61.31 -36.86 81.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 0.0 110.736 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.576 ' O ' HG12 ' A' ' 300' ' ' VAL . 95.0 t -61.17 -43.11 95.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.029 0.442 . . . . 0.0 110.501 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -61.77 -36.5 81.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.719 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -57.18 -42.8 81.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.826 0.346 . . . . 0.0 111.917 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.665 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 1.2 p -68.94 -33.53 59.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.397 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 76.3 m -57.49 -44.28 84.79 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.998 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.77 -38.82 89.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.232 0.539 . . . . 0.0 109.93 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.6 m-20 -61.12 -33.38 73.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.999 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.628 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 52.4 tptt 67.4 -70.4 0.12 Allowed 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -177.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.628 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.0 m-30 -115.56 148.46 39.54 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.755 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.709 HG21 ' CZ ' ' A' ' 262' ' ' PHE . 5.7 mm -115.18 137.56 48.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -78.19 46.36 0.6 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.03 0.443 . . . . 0.0 110.36 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.546 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 7.3 t80 -56.95 -65.48 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.402 ' HE2' ' C ' ' A' ' 308' ' ' PHE . 4.4 mmpt? -101.28 20.92 14.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.506 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 58.99 35.77 24.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.527 0.68 . . . . 0.0 109.293 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -139.07 0.95 1.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.614 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.441 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 98.4 mttt 64.78 123.25 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.242 0.544 . . . . 0.0 112.004 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.626 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 34.4 pt -116.46 146.46 20.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.281 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -100.71 130.78 46.79 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.785 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 0.837 HG12 HG23 ' A' ' 247' ' ' VAL . 72.3 mt -121.26 131.4 73.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.594 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 246' ' ' PHE . 8.0 tptp -131.71 144.61 51.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.643 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -57.71 144.52 37.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.936 0.398 . . . . 0.0 110.805 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.08 147.17 40.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.375 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.055 -179.762 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 14.0 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.79 0.329 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -56.72 143.79 35.16 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.236 0.541 . . . . 0.0 111.452 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.823 ' SD ' HG13 ' A' ' 213' ' ' VAL . 84.0 mmm -116.21 149.64 38.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.792 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.762 ' HB3' ' HG2' ' A' ' 231' ' ' LYS . 4.2 t80 -104.1 128.87 51.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.543 HG22 HD21 ' A' ' 166' ' ' LEU . 15.9 mm -113.88 127.09 71.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.482 ' O ' ' HB ' ' A' ' 228' ' ' ILE . . . -131.95 166.8 23.04 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.537 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.459 ' C ' HG22 ' A' ' 228' ' ' ILE . . . 76.89 33.54 45.79 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.353 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.543 HD21 HG22 ' A' ' 163' ' ' ILE . 61.4 mt -80.74 146.55 30.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 169' ' ' ASP . 43.8 t30 -79.85 59.48 3.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.712 0.291 . . . . 0.0 111.421 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.423 ' CD1' ' O ' ' A' ' 199' ' ' SER . 12.2 m0 28.92 37.83 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.502 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 167' ' ' ASN . 54.8 t0 -163.14 20.08 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.799 HG22 HD11 ' A' ' 190' ' ' ILE . 59.9 m -76.26 136.55 39.66 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.861 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 173' ' ' ASP . 30.8 m -114.46 144.47 43.28 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.23 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.553 ' N ' HD12 ' A' ' 190' ' ' ILE . 54.5 mp0 -56.43 -36.55 69.11 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.404 -0.519 . . . . 0.0 109.878 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.408 ' H ' HG22 ' A' ' 171' ' ' THR . 89.4 m-20 -65.65 -48.62 71.52 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.795 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -66.37 -41.7 89.06 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.584 0.706 . . . . 0.0 109.976 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.744 HD23 ' CD1' ' A' ' 188' ' ' LEU . 63.9 tp -64.19 -41.62 97.01 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.173 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -62.87 -45.23 93.51 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.267 0.556 . . . . 0.0 110.167 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -66.85 -38.13 85.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.871 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.566 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 52.4 t80 -57.9 -46.05 85.52 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.223 0.535 . . . . 0.0 110.87 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.462 ' CD2' ' HD1' ' A' ' 178' ' ' TYR . 96.1 m-85 -93.66 1.26 56.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.647 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -59.28 -28.43 64.38 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.23 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.443 ' CD ' ' H ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -58.51 -39.14 79.24 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.759 0.79 . . . . 0.0 110.503 -179.11 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -67.53 -31.81 72.16 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.045 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 161.72 -133.27 3.09 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.283 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.0 m -119.28 140.16 50.74 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.955 HG21 HD23 ' A' ' 188' ' ' LEU . 2.8 m -102.36 126.68 56.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.405 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.749 HG23 ' N ' ' A' ' 208' ' ' GLU . 51.8 p -69.92 -37.91 76.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.291 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 186' ' ' THR . 90.9 m-20 -143.74 155.68 44.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.195 0.521 . . . . 0.0 112.029 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.955 HD23 HG21 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -133.79 126.41 30.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.567 179.335 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 15.2 tptt -134.6 119.67 18.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.345 0.593 . . . . 0.0 112.225 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.799 HD11 HG22 ' A' ' 170' ' ' THR . 0.8 OUTLIER -125.49 129.61 72.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.022 176.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.667 ' CE ' ' HA2' ' A' ' 203' ' ' GLY . 3.1 mtm -96.23 134.56 39.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.191 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -128.48 155.56 44.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.852 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.524 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 6.0 m-20 -123.21 73.15 48.35 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.509 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.72 -28.75 88.05 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.718 2.279 . . . . 0.0 113.131 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -64.86 -57.86 7.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 0.0 110.95 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 55.9 p -78.74 -15.02 58.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.224 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 80.16 24.28 59.72 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.573 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 1.9 tpt180 -124.22 175.61 6.93 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 120.687 0.279 . . . . 0.0 110.509 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.423 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 32.6 t -126.4 147.4 49.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.626 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 36.6 mmt180 -54.48 -35.07 62.69 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.23 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.401 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 90.2 3.34 72.83 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.532 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.626 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 26.3 p90 -139.8 157.5 45.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.777 0.323 . . . . 0.0 110.653 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.667 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -147.0 160.07 28.17 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.935 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.576 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 98.1 m-85 -105.6 124.27 49.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.361 0.6 . . . . 0.0 109.971 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.663 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 60.2 tp -111.51 125.73 54.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.367 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 23.9 t -118.86 136.91 53.78 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.684 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.893 ' CE1' HG12 ' A' ' 185' ' ' VAL . 68.3 m-85 -119.84 143.8 47.7 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.668 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.749 ' N ' HG23 ' A' ' 186' ' ' THR . 84.5 tt0 -63.95 -34.85 78.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.941 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.81 115.54 55.25 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.764 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.25 -21.1 34.56 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.591 2.194 . . . . 0.0 112.87 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.9 m -56.73 -36.3 69.56 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.946 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.4 m -58.39 -35.1 71.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.935 0.398 . . . . 0.0 110.296 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.823 HG13 ' SD ' ' A' ' 161' ' ' MET . 75.1 t -60.39 -42.28 90.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.95 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.41 ' O ' HG22 ' A' ' 217' ' ' VAL . 22.0 t70 -58.98 -41.98 88.86 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.899 0.381 . . . . 0.0 110.837 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.415 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 20.3 pt-20 -76.89 -30.62 56.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.752 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.946 HG23 ' O ' ' A' ' 212' ' ' SER . 77.6 t -60.22 -41.32 86.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.418 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 214' ' ' ASP . 21.0 m -71.53 -31.99 44.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -59.93 -38.8 83.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.723 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 35.0 m -85.13 143.16 29.0 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 63.3 tt0 -66.0 -40.96 91.6 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.935 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.86 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 85.2 m-70 78.84 97.81 0.06 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 72.2 mt -117.07 107.66 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.443 ' HG ' ' CD2' ' A' ' 178' ' ' TYR . 3.6 tt -97.66 -74.13 0.59 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.401 ' OD1' HD23 ' A' ' 223' ' ' LEU . 92.6 m-20 -90.78 14.86 12.4 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 101.99 -6.78 54.38 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.226 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.406 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -99.69 -172.59 2.27 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.632 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 15.0 p -120.03 135.91 58.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.241 0.543 . . . . 0.0 111.159 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.493 HD11 ' HB3' ' A' ' 221' ' ' HIS . 36.0 pt -124.98 156.66 33.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.199 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -127.84 78.51 75.0 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.207 0.527 . . . . 0.0 111.289 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.581 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 74.4 Cg_exo -55.39 131.21 44.89 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.844 2.363 . . . . 0.0 111.299 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.762 ' HG2' ' HB3' ' A' ' 162' ' ' PHE . 0.5 OUTLIER -136.78 170.3 16.31 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -70.82 140.09 51.11 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.125 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.58 143.8 56.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.763 0.316 . . . . 0.0 111.184 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 28.6 mt -111.44 121.91 38.94 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.015 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.51 144.14 52.76 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.836 1.691 . . . . 0.0 110.986 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -56.81 -39.11 73.56 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.486 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -61.3 -46.53 89.91 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.115 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 242' ' ' THR . 84.6 tt0 -68.85 -37.22 78.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.358 0.599 . . . . 0.0 109.737 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -58.5 -43.46 89.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.742 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -65.14 -40.26 94.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.408 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -60.11 -37.77 81.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.218 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 238' ' ' GLU . 19.9 p -81.39 161.71 23.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.167 0.508 . . . . 0.0 111.987 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.56 163.72 25.18 Favored Glycine 0 C--N 1.332 0.338 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.424 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.651 ' C ' ' HB2' ' A' ' 318' ' ' ALA . 11.8 tttm -138.07 137.76 38.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.141 0.471 . . . . 0.0 110.719 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.701 HD13 ' O ' ' A' ' 245' ' ' ILE . 0.0 OUTLIER -123.06 164.21 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.688 0.756 . . . . 0.0 112.538 -179.245 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.545 ' HB3' ' O ' ' A' ' 317' ' ' ARG . 86.0 t80 -105.1 138.62 41.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.565 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.638 HG12 ' O ' ' A' ' 287' ' ' GLY . 7.4 p -127.45 133.75 67.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -105.48 -4.04 40.51 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.586 -0.816 . . . . 0.0 114.178 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 313' ' ' ILE . . . -115.82 115.72 3.46 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.72 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.606 ' O ' HG21 ' A' ' 254' ' ' VAL . 24.5 mm -94.22 -78.42 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.475 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 119.21 162.29 11.96 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.075 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.69 128.25 22.85 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.143 1.896 . . . . 0.0 112.719 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 51.47 42.18 29.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.65 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.722 ' O ' ' HB3' ' A' ' 258' ' ' GLU . 6.4 t -63.91 -44.26 97.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.404 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.4 OUTLIER 61.51 134.86 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.43 -31.01 66.46 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 121.946 1.764 . . . . 0.0 112.706 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -63.99 -48.63 75.63 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.722 ' HB3' ' O ' ' A' ' 254' ' ' VAL . 42.8 tp10 -64.6 -38.15 90.0 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.044 0.45 . . . . 0.0 111.054 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.616 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 44.8 t80 -59.49 -44.19 93.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.165 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.464 ' O ' HD12 ' A' ' 269' ' ' ILE . 97.2 mt-10 -65.34 -40.58 93.84 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.557 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 264' ' ' SER . 20.6 pt-20 -77.72 -30.63 51.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.21 0.529 . . . . 0.0 110.466 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.711 ' CZ ' HG21 ' A' ' 306' ' ' ILE . 5.5 t80 -61.9 -54.87 35.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.436 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.85 ' CD2' HG21 ' A' ' 289' ' ' VAL . 4.3 m-85 -65.17 -23.82 67.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.553 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.704 ' N ' HD11 ' A' ' 269' ' ' ILE . 23.5 t -54.82 -25.47 28.66 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -46.45 -37.34 7.62 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.41 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.713 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 23.2 p90 -129.83 54.45 1.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.052 0.453 . . . . 0.0 111.472 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 264' ' ' SER . . . 149.11 146.52 4.34 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.803 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.449 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 53.1 m -59.26 -37.51 77.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.758 0.313 . . . . 0.0 111.354 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.704 HD11 ' N ' ' A' ' 264' ' ' SER . 74.8 mt 71.55 85.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.848 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.594 HD11 ' HB3' ' A' ' 292' ' ' ASP . 34.8 mm -59.36 -35.51 58.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.198 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.58 ' O ' ' HB3' ' A' ' 272' ' ' ALA . 61.6 t0 -137.97 -104.76 0.18 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.079 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.608 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . 80.36 113.93 0.06 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.934 0.397 . . . . 0.0 112.016 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -141.99 155.83 45.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.317 0.579 . . . . 0.0 111.382 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.541 ' O ' ' HB2' ' A' ' 275' ' ' MET . 22.9 tp -63.63 -36.49 83.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.421 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.569 ' HG2' ' HB2' ' A' ' 288' ' ' PHE . 95.8 mmm 76.96 123.37 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.674 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.504 ' HG ' ' HB3' ' A' ' 283' ' ' SER . 5.1 mp -128.35 125.81 39.45 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.497 ' H ' ' H ' ' A' ' 282' ' ' GLN . 55.9 t0 -62.67 -40.75 98.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.594 0.712 . . . . 0.0 109.697 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -162.12 -73.7 0.05 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.781 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.408 ' O ' HD23 ' A' ' 276' ' ' LEU . 60.8 t0 -94.56 -75.75 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.484 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 73.3 p -129.33 13.57 6.08 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.357 -0.383 . . . . 0.0 112.015 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -44.99 -91.01 0.01 OUTLIER Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.037 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.497 ' H ' ' H ' ' A' ' 277' ' ' ASP . 98.7 mt-30 -60.26 -25.65 65.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.167 -0.517 . . . . 0.0 111.599 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.51 ' O ' HD21 ' A' ' 274' ' ' LEU . 63.5 p -51.89 -27.32 12.42 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.73 0.3 . . . . 0.0 110.938 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -122.5 139.07 54.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.911 0.386 . . . . 0.0 110.557 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.63 -53.52 0.58 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.25 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.571 ' C ' HD11 ' A' ' 250' ' ' ILE . 33.3 p90 -142.56 166.27 25.13 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 117.425 0.612 . . . . 0.0 111.708 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.638 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -134.42 157.36 22.89 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.259 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.569 ' HB2' ' HG2' ' A' ' 275' ' ' MET . 0.2 OUTLIER -118.16 125.24 49.82 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.868 -0.195 . . . . 0.0 111.171 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.85 HG21 ' CD2' ' A' ' 263' ' ' PHE . 53.3 t -128.4 137.57 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.036 0.445 . . . . 0.0 112.151 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 54.8 m -117.02 136.69 52.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.311 178.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.47 ' CD1' ' HA3' ' A' ' 267' ' ' GLY . 47.5 m-85 -118.03 142.6 47.21 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 293' ' ' SER . 54.7 p30 -62.13 -31.58 72.07 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.108 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . 0.613 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 27.6 t -124.67 139.54 53.77 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.161 0.505 . . . . 0.0 111.963 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.91 -31.58 72.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.946 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -55.46 -36.54 66.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.966 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -60.64 -34.86 74.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.649 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.589 ' O ' HG12 ' A' ' 300' ' ' VAL . 84.6 t -59.55 -43.73 91.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.148 0.499 . . . . 0.0 110.309 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -62.43 -36.36 82.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.693 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 89.7 mtt-85 -57.12 -43.91 82.8 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.002 0.429 . . . . 0.0 111.976 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.713 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 1.3 p -68.77 -32.28 54.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.356 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 76.2 m -57.13 -43.74 82.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.207 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -60.45 -41.27 93.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.218 0.532 . . . . 0.0 110.186 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.416 ' O ' ' N ' ' A' ' 305' ' ' PHE . 88.3 m-20 -61.81 -33.53 74.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.399 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.639 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 7.9 tptm 67.05 -73.5 0.08 Allowed 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -178.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.639 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.5 m-30 -115.82 147.63 40.79 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.43 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.711 HG21 ' CZ ' ' A' ' 262' ' ' PHE . 37.6 mt -119.92 129.51 75.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -59.48 -35.43 74.1 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.438 0.637 . . . . 0.0 111.005 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.529 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 1.3 t80 49.88 -124.86 2.11 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.299 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.526 ' HE3' ' CE1' ' A' ' 308' ' ' PHE . 2.0 mmpt? -59.57 -37.51 78.67 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.931 0.396 . . . . 0.0 110.997 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 309' ' ' LYS . 23.3 t70 170.35 -0.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.26 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -122.12 152.39 39.94 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.785 0.326 . . . . 0.0 110.2 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 79.7 mttt -77.78 129.38 35.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.078 0.466 . . . . 0.0 111.222 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 305' ' ' PHE . 26.8 pt -115.3 143.33 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.375 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . 0.571 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 85.6 mt-10 -100.91 133.25 45.67 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.471 -0.492 . . . . 0.0 109.897 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 0.631 HG12 HG23 ' A' ' 247' ' ' VAL . 82.4 mt -122.21 126.07 73.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.144 0.497 . . . . 0.0 111.898 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -133.05 -170.45 2.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.456 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.545 ' O ' ' HB3' ' A' ' 246' ' ' PHE . 74.7 mtp180 -57.34 146.8 27.74 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.728 0.299 . . . . 0.0 110.623 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.651 ' HB2' ' C ' ' A' ' 244' ' ' LYS . . . -60.86 -23.16 64.93 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 . . . . . 0 C--N 1.327 -0.378 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.297 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 CA--C 1.529 0.148 0 CA-C-O 120.727 0.298 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.57 ' HE2' ' HB3' ' A' ' 204' ' ' PHE . 15.4 tptm -56.27 140.06 46.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.453 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.797 ' SD ' HG13 ' A' ' 213' ' ' VAL . 86.1 mmm -118.15 150.0 40.11 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.075 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.61 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 4.3 t80 -106.79 130.17 54.54 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.683 ' CG2' HD21 ' A' ' 166' ' ' LEU . 17.2 mm -115.41 121.81 67.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.024 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -126.44 164.8 19.89 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.441 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.725 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 74.79 27.13 65.5 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.547 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.683 HD21 ' CG2' ' A' ' 163' ' ' ILE . 71.0 mt -87.63 142.21 28.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.901 0.381 . . . . 0.0 111.349 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -67.23 134.16 51.12 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 199' ' ' SER . 4.7 m-90 -52.15 -36.77 52.4 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.999 -0.281 . . . . 0.0 111.404 -178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -60.23 -31.47 70.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.689 0.281 . . . . 0.0 111.359 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.466 HG23 ' HB3' ' A' ' 174' ' ' ASN . 79.6 m -58.3 140.18 53.82 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.335 0.588 . . . . 0.0 111.971 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.42 ' C ' HD12 ' A' ' 190' ' ' ILE . 1.5 p -118.36 167.76 11.26 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.495 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.822 ' N ' HD12 ' A' ' 190' ' ' ILE . 96.1 mt-10 -58.91 -33.26 70.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -60.43 -41.23 93.57 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.466 ' HB3' HG23 ' A' ' 170' ' ' THR . 47.8 t-20 -61.63 -41.71 97.87 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.538 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.717 HD12 HD11 ' A' ' 190' ' ' ILE . 3.9 mt -65.56 -42.94 91.25 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.703 178.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.938 ' HG3' HG11 ' A' ' 185' ' ' VAL . 70.7 ttp85 -60.9 -44.51 97.03 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.735 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -67.86 -39.16 83.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.573 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 67.0 t80 -70.89 -62.1 1.52 Allowed 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.308 0.575 . . . . 0.0 111.41 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.538 ' CE2' HD23 ' A' ' 175' ' ' LEU . 67.4 m-85 -70.52 -24.21 62.78 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.516 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 183' ' ' GLY . . . -51.29 -27.03 14.89 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.672 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.5 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -56.2 -43.96 79.02 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.405 0.682 . . . . 0.0 110.99 178.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -71.51 -34.4 70.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.727 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 180' ' ' GLY . . . -164.62 -173.8 33.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.147 -1.025 . . . . 0.0 113.258 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.956 ' O ' HG12 ' A' ' 185' ' ' VAL . 51.0 m -59.22 -35.05 72.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.425 0.155 . . . . 0.0 110.782 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.956 HG12 ' O ' ' A' ' 184' ' ' THR . 1.0 OUTLIER 78.67 69.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 CA-C-O 122.631 1.205 . . . . 0.0 108.749 -178.231 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.67 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 5.7 m -52.34 -42.55 63.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.08 -1.418 . . . . 0.0 112.801 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.418 ' HB3' ' HB3' ' A' ' 206' ' ' SER . 54.5 t0 -148.35 141.49 25.0 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.71 HD11 ' HB3' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -121.22 131.21 54.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.562 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 8.5 tptp -136.23 121.05 18.57 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.822 HD12 ' N ' ' A' ' 172' ' ' GLU . 4.3 mt -127.05 132.45 69.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.663 176.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.574 ' HB2' ' CG ' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -92.15 125.11 36.7 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.969 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 199' ' ' SER . 4.1 mtmp? -126.7 155.04 43.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.895 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 9.1 t70 -97.22 108.8 46.48 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.693 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.69 -26.18 81.35 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.549 2.166 . . . . 0.0 112.958 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.412 ' HB3' ' OD1' ' A' ' 193' ' ' ASP . . . -74.68 -86.64 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 51.8 p -71.66 -21.52 61.8 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 193' ' ' ASP . . . 93.12 4.88 64.37 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.119 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.479 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 11.0 tpt180 -74.93 143.05 43.9 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.481 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 23.6 t -103.32 148.77 25.45 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.746 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.645 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 15.0 mmm180 -53.18 -30.6 38.26 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 166' ' ' LEU . . . 95.93 -0.87 62.82 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.86 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.645 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 25.4 p90 -136.62 156.4 48.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.875 0.369 . . . . 0.0 110.299 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.563 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -142.87 162.5 27.44 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.982 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.61 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 97.8 m-85 -105.06 125.3 50.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.363 0.602 . . . . 0.0 109.521 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.658 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 46.8 tp -106.7 130.3 54.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.041 -177.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' A' ' 187' ' ' ASP . 28.0 t -124.3 135.13 53.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.883 0.373 . . . . 0.0 111.979 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.658 ' CZ ' HD21 ' A' ' 205' ' ' LEU . 95.4 m-85 -119.48 140.05 51.09 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.782 178.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.67 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.3 tt0 -60.58 -34.47 74.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.026 0.441 . . . . 0.0 110.087 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.5 119.48 49.3 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.499 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.59 -20.55 27.66 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.516 2.144 . . . . 0.0 112.801 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 85.1 p -59.97 -31.07 69.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.667 0.27 . . . . 0.0 111.234 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.932 ' O ' HG23 ' A' ' 216' ' ' VAL . 23.0 m -59.44 -36.06 75.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.603 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.797 HG13 ' SD ' ' A' ' 161' ' ' MET . 70.5 t -61.61 -43.52 97.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.305 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -59.81 -42.03 92.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.01 0.433 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.02 -31.9 61.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.77 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 212' ' ' SER . 66.0 t -60.76 -42.27 91.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 120.662 0.267 . . . . 0.0 110.983 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 24.3 m -73.15 -27.55 24.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -58.72 -35.5 72.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.659 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.694 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 57.4 m -100.13 141.52 32.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.852 0.358 . . . . 0.0 111.863 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 59.7 tp60 -66.09 -40.64 90.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.737 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.79 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 64.8 m-70 79.31 116.49 0.06 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 24.6 mm -116.4 107.4 22.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.2 tt -121.32 122.96 41.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.789 0.328 . . . . 0.0 110.177 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 51.73 40.17 26.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.148 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 73.64 20.32 79.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.342 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -115.21 136.23 53.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.329 0.565 . . . . 0.0 111.506 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.756 ' O ' ' O ' ' A' ' 228' ' ' ILE . 9.5 p -62.04 -35.89 71.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.096 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.756 ' O ' ' O ' ' A' ' 227' ' ' VAL . 9.0 pt 30.9 128.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.513 0.725 . . . . 0.0 112.68 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -123.29 84.56 51.94 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 121.056 0.455 . . . . 0.0 111.315 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.498 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 50.7 Cg_exo -56.05 135.34 69.31 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.912 2.408 . . . . 0.0 111.986 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -136.88 157.3 47.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.909 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -55.93 133.45 51.53 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.747 0.308 . . . . 0.0 110.852 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 160' ' ' LYS . . . -72.91 148.05 44.71 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -122.13 125.58 26.56 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.674 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.444 ' HG2' ' CG ' ' A' ' 238' ' ' GLU . 9.4 Cg_endo -51.84 145.62 31.2 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 121.791 1.66 . . . . 0.0 111.14 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 236' ' ' ARG . 6.2 tmm_? -54.66 -39.25 67.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.78 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 55.3 p30 -61.42 -38.51 87.39 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.702 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.586 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 97.9 mt-10 -68.17 -34.13 75.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.995 0.426 . . . . 0.0 110.381 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -59.61 -38.28 80.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.281 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.93 -40.47 93.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.627 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -61.69 -34.94 76.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.162 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 22.4 p -83.41 162.23 21.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.572 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -146.47 112.71 0.63 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.847 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 17.5 ttpp -88.72 134.27 33.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.893 0.378 . . . . 0.0 111.194 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.686 HG21 HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -117.46 164.02 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.537 0.684 . . . . 0.0 111.43 -179.247 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.486 ' HD2' ' HG2' ' A' ' 316' ' ' LYS . 93.5 t80 -101.85 136.34 41.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.518 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.821 HG11 ' CE1' ' A' ' 259' ' ' PHE . 12.5 p -131.57 146.37 33.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.314 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.646 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -131.66 169.43 21.94 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 89.92 17.82 52.77 Favored Glycine 0 N--CA 1.454 -0.147 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.727 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.91 HG23 HG21 ' A' ' 254' ' ' VAL . 23.3 mm -54.96 -43.84 70.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.841 0.353 . . . . 0.0 110.792 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 50.51 174.12 0.01 OUTLIER Glycine 0 CA--C 1.521 0.451 0 CA-C-N 116.074 -0.512 . . . . 0.0 114.086 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.09 154.68 65.83 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.62 2.88 . . . . 0.0 113.616 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 57.62 41.67 25.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.919 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.91 HG21 HG23 ' A' ' 250' ' ' ILE . 2.4 p -85.79 -40.69 14.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.542 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.6 OUTLIER 60.05 118.97 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.92 -33.78 63.48 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 121.743 1.629 . . . . 0.0 112.426 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -61.51 -41.74 97.77 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.998 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.656 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 98.3 mt-10 -66.16 -36.15 82.36 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.627 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.821 ' CE1' HG11 ' A' ' 247' ' ' VAL . 16.5 t80 -63.86 -50.11 70.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.782 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.725 ' HG2' ' HB3' ' A' ' 272' ' ' ALA . 97.2 mt-10 -64.67 -37.03 86.18 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.605 ' HB3' ' HA ' ' A' ' 258' ' ' GLU . 78.5 tt0 -63.03 -37.9 89.04 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.646 -1.616 . . . . 0.0 111.883 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.815 ' CE2' HD11 ' A' ' 313' ' ' ILE . 86.4 t80 -67.78 -55.08 14.41 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.683 ' CE2' HD11 ' A' ' 245' ' ' ILE . 10.0 m-85 -66.45 -25.29 66.66 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.727 ' N ' HD11 ' A' ' 269' ' ' ILE . 35.1 t -55.29 -31.31 61.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.689 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -56.15 -36.48 68.33 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.291 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.664 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 9.0 p90 -117.57 51.79 1.02 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.44 0.638 . . . . 0.0 111.16 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.512 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 148.3 148.03 4.66 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.508 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.444 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 11.8 t -64.06 -35.8 81.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 110.928 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.727 HD11 ' N ' ' A' ' 264' ' ' SER . 79.3 mt 71.66 83.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.223 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.507 HG12 ' CA ' ' A' ' 292' ' ' ASP . 36.0 mm -58.98 -38.58 74.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.984 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -149.46 150.91 33.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.185 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.725 ' HB3' ' HG2' ' A' ' 260' ' ' GLU . . . -170.59 122.31 0.62 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.577 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -142.85 152.3 42.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.22 0.533 . . . . 0.0 111.861 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.81 HD11 HG21 ' A' ' 250' ' ' ILE . 29.2 tp -64.23 -37.82 88.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.901 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.524 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 91.8 mmm 101.59 102.87 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.441 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.412 ' CD2' ' HB3' ' A' ' 283' ' ' SER . 23.9 mt -108.05 139.02 43.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.521 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.605 ' HB3' ' HA3' ' A' ' 281' ' ' GLY . 59.9 t0 -145.39 93.31 2.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.092 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.855 ' O ' HG22 ' A' ' 280' ' ' THR . 40.8 mtpt 65.38 39.18 5.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.873 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.468 ' O ' ' HB ' ' A' ' 280' ' ' THR . 57.4 t0 46.31 41.75 9.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.782 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.855 HG22 ' O ' ' A' ' 278' ' ' LYS . 2.0 t 171.2 50.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.911 0.386 . . . . 0.0 110.709 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . 0.605 ' HA3' ' HB3' ' A' ' 277' ' ' ASP . . . -131.49 -112.11 1.42 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.448 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 275' ' ' MET . 78.8 mm-40 -57.9 -28.36 64.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.415 -0.392 . . . . 0.0 110.431 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.412 ' HB3' ' CD2' ' A' ' 276' ' ' LEU . 86.3 p -57.69 -22.64 47.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.215 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -52.73 -36.63 57.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.92 0.39 . . . . 0.0 110.749 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 286' ' ' PHE . . . -166.61 -176.62 37.86 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.091 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.558 ' O ' ' O ' ' A' ' 285' ' ' GLY . 3.1 p90 48.54 155.13 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.175 0.512 . . . . 0.0 112.075 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.69 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -139.25 164.41 25.9 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.153 -1.022 . . . . 0.0 113.783 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.452 ' CE2' ' NZ ' ' A' ' 244' ' ' LYS . 0.4 OUTLIER -119.73 125.6 49.04 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.669 0.388 . . . . 0.0 110.949 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.684 HG23 ' CZ ' ' A' ' 259' ' ' PHE . 48.9 t -127.45 137.07 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.003 0.43 . . . . 0.0 111.748 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 44.4 m -113.55 135.8 53.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.605 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.584 ' OH ' ' HB3' ' A' ' 263' ' ' PHE . 34.5 m-85 -117.15 137.21 52.47 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.507 ' CA ' HG12 ' A' ' 270' ' ' ILE . 50.5 t0 -58.84 -35.65 73.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.558 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 30.5 t -119.99 140.18 51.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.28 0.562 . . . . 0.0 111.887 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.962 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -63.66 -30.64 71.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.526 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -55.74 -35.12 65.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.029 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.26 90.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.539 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.962 HG12 ' O ' ' A' ' 294' ' ' ALA . 9.5 p -61.16 -37.14 76.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.001 0.429 . . . . 0.0 110.735 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.94 -38.18 90.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.527 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -59.16 -43.37 92.08 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.906 0.384 . . . . 0.0 111.943 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.752 HG23 HD11 ' A' ' 306' ' ' ILE . 0.9 OUTLIER -72.58 -36.68 54.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.638 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 74.5 m -59.23 -42.93 92.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.833 0.349 . . . . 0.0 110.447 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -61.78 -34.17 75.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.215 0.531 . . . . 0.0 110.013 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.65 ' O ' ' N ' ' A' ' 305' ' ' PHE . 80.6 m-20 -87.04 4.9 40.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.213 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.656 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 19.9 tptm 41.85 -80.85 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.605 0.24 . . . . 0.0 110.4 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.656 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 2.2 m-30 -107.58 141.26 39.33 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.752 HD11 HG23 ' A' ' 300' ' ' VAL . 1.0 OUTLIER -116.58 134.47 59.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.538 ' O ' ' HE1' ' A' ' 262' ' ' PHE . 89.0 m-20 -70.67 124.59 24.63 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.556 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 2.0 t80 -112.0 -109.89 0.35 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.501 ' HE2' ' OE1' ' A' ' 258' ' ' GLU . 1.2 mmmp? -60.15 -37.42 80.07 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.743 0.306 . . . . 0.0 111.386 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.406 ' CG ' ' O ' ' A' ' 309' ' ' LYS . 32.5 m-20 -177.96 -27.39 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.219 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -113.13 160.81 17.82 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.951 0.405 . . . . 0.0 110.841 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 43.9 mttt -71.67 143.63 49.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.351 0.596 . . . . 0.0 112.114 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.815 HD11 ' CE2' ' A' ' 262' ' ' PHE . 31.6 pt -118.93 147.87 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . 0.532 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 87.4 mt-10 -101.05 129.73 46.95 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.515 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 0.763 HG12 HG23 ' A' ' 247' ' ' VAL . 74.7 mt -123.31 127.61 74.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.207 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.486 ' HG2' ' HD2' ' A' ' 246' ' ' PHE . 3.4 ptpt -135.2 163.62 29.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.601 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 45.8 ptt85 -59.03 148.84 29.37 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.45 133.19 55.56 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.79 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.964 -179.61 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.718 ' HA ' HG21 ' A' ' 213' ' ' VAL . 7.8 p . . . . . 0 CA--C 1.53 0.21 0 CA-C-O 120.512 0.196 . . . . 0.0 111.385 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.586 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 5.3 tptm -69.56 131.6 44.94 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.825 ' SD ' HG13 ' A' ' 213' ' ' VAL . 93.3 mmm -120.67 143.57 48.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.877 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.567 ' CE1' ' CZ ' ' A' ' 204' ' ' PHE . 2.7 t80 -108.29 125.74 52.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.921 ' HB ' HD21 ' A' ' 166' ' ' LEU . 0.3 OUTLIER -120.88 127.86 75.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.615 -179.446 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.597 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -121.49 153.34 16.7 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.318 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.464 ' C ' HG22 ' A' ' 228' ' ' ILE . . . 73.44 29.08 64.49 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.151 -1.023 . . . . 0.0 110.994 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.921 HD21 ' HB ' ' A' ' 163' ' ' ILE . 69.1 mt -59.06 -33.3 70.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.728 ' O ' ' N ' ' A' ' 169' ' ' ASP . 21.1 t30 107.63 37.19 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.977 0.511 . . . . 0.0 110.669 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.574 ' HD1' ' HG ' ' A' ' 199' ' ' SER . 5.1 m0 45.99 -59.7 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.728 ' N ' ' O ' ' A' ' 167' ' ' ASN . 89.4 m-20 -83.4 19.73 1.48 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.627 ' OG1' ' HB3' ' A' ' 166' ' ' LEU . 57.6 m -51.88 -36.08 47.35 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.502 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.0 OUTLIER 58.26 139.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.157 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.661 ' O ' ' HD3' ' A' ' 176' ' ' ARG . 58.1 mp0 -60.39 -36.25 77.65 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -58.8 -40.9 85.42 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.596 ' HB2' ' O ' ' A' ' 170' ' ' THR . 82.8 m-20 -61.69 -36.63 81.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.695 HD23 ' CE2' ' A' ' 179' ' ' PHE . 7.0 mt -55.74 -51.31 67.79 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.661 ' HD3' ' O ' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -67.93 -30.36 69.66 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.298 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -58.42 -39.35 79.52 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.37 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.64 ' OH ' ' CG ' ' A' ' 221' ' ' HIS . 0.0 OUTLIER -96.04 -55.52 2.95 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.25 179.199 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.695 ' CE2' HD23 ' A' ' 175' ' ' LEU . 72.5 m-85 -60.14 -27.15 66.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.397 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.42 -23.58 9.35 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.199 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.827 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -54.05 -40.46 67.13 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.992 0.425 . . . . 0.0 110.714 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.827 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 53.8 m-85 -69.85 -32.21 70.48 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.275 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 164.81 -130.19 2.13 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.262 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 49.1 m -120.96 140.28 52.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.659 HG21 HD23 ' A' ' 188' ' ' LEU . 0.2 OUTLIER -92.88 120.65 42.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.257 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.5 t -71.61 -45.53 61.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.348 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -149.9 109.51 4.02 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.659 HD23 HG21 ' A' ' 185' ' ' VAL . 0.1 OUTLIER -102.65 150.16 23.71 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.341 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 204' ' ' PHE . 18.9 tptt -133.69 124.53 26.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.94 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.582 HD12 ' CA ' ' A' ' 172' ' ' GLU . 1.0 OUTLIER -123.0 134.31 66.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.582 ' HB2' ' HB2' ' A' ' 200' ' ' ARG . 10.0 mmt -86.93 135.16 33.4 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -131.79 138.75 48.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.736 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 7.4 t0 -121.72 75.7 36.56 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.594 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -60.47 -25.81 81.38 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.521 2.147 . . . . 0.0 111.998 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -71.83 -67.9 0.5 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.255 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 49.2 p -68.95 -26.98 65.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.112 0.482 . . . . 0.0 110.079 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.93 4.09 67.48 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.585 -0.734 . . . . 0.0 113.09 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.465 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 6.0 tpt180 -127.13 121.85 32.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.239 0.52 . . . . 0.0 110.329 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.574 ' HG ' ' HD1' ' A' ' 168' ' ' TRP . 66.5 p -71.91 160.56 32.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.919 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.585 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 23.9 mmm180 -58.3 -34.34 70.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.861 0.362 . . . . 0.0 110.093 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 94.39 -0.98 66.33 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.526 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.585 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 38.7 p90 -137.96 159.04 43.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.934 0.397 . . . . 0.0 110.426 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 189' ' ' LYS . . . -153.21 171.33 32.16 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.028 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.636 ' HA ' ' O ' ' A' ' 161' ' ' MET . 73.0 m-85 -110.2 125.3 52.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.833 0.349 . . . . 0.0 110.756 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.771 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 23.5 tp -110.1 132.18 54.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.427 ' O ' HG23 ' A' ' 185' ' ' VAL . 45.7 m -121.48 145.69 47.68 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.182 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 1.007 ' CE2' HG21 ' A' ' 216' ' ' VAL . 96.9 m-85 -121.4 147.59 45.52 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.862 0.363 . . . . 0.0 111.826 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.44 -35.7 80.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.328 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.45 119.19 53.63 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.603 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.15 -29.73 76.36 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.32 2.013 . . . . 0.0 112.636 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.3 t -59.54 -37.46 78.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 0.0 110.858 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.844 ' O ' HG23 ' A' ' 216' ' ' VAL . 24.0 m -59.25 -34.87 72.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.047 0.451 . . . . 0.0 110.5 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.825 HG13 ' SD ' ' A' ' 161' ' ' MET . 70.8 t -61.1 -42.74 94.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.211 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -59.55 -43.4 93.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.921 0.391 . . . . 0.0 111.046 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.429 ' HB3' ' CE2' ' A' ' 182' ' ' TYR . 98.4 mt-10 -69.38 -35.38 75.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.368 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 1.007 HG21 ' CE2' ' A' ' 207' ' ' PHE . 99.0 t -60.91 -46.42 96.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.899 0.38 . . . . 0.0 110.829 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 230' ' ' PRO . 14.8 p -75.44 -40.01 41.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -59.11 -36.96 76.08 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 29.9 m -96.37 144.61 26.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.156 0.503 . . . . 0.0 112.077 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -92.09 125.24 36.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.851 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.64 ' CG ' ' OH ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -130.58 155.89 45.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.177 0.513 . . . . 0.0 111.39 -178.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 226' ' ' LYS . 73.5 mt -122.12 125.76 73.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.297 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.648 HD12 HD13 ' A' ' 228' ' ' ILE . 3.8 mt -103.26 125.36 49.88 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.927 0.394 . . . . 0.0 111.607 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 52.58 41.16 31.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.29 2.18 87.06 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.897 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.763 ' O ' HG23 ' A' ' 222' ' ' ILE . 21.8 mmtt -107.18 137.96 44.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.3 0.55 . . . . 0.0 111.131 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.414 HG13 ' O ' ' A' ' 227' ' ' VAL . 10.1 p -80.49 125.08 39.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.138 0.494 . . . . 0.0 111.094 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.807 HD12 ' CG2' ' A' ' 163' ' ' ILE . 34.4 pt -126.38 156.34 36.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.95 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -131.05 83.38 60.91 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.384 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.726 ' O ' HG23 ' A' ' 217' ' ' VAL . 72.8 Cg_exo -52.76 130.73 38.53 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.606 2.204 . . . . 0.0 112.061 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -136.72 144.29 43.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.0 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.431 ' HD2' ' N ' ' A' ' 233' ' ' ALA . 3.8 tmm_? -54.61 140.53 34.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.993 0.425 . . . . 0.0 111.188 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -59.74 149.17 31.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.184 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.466 HG21 ' OE1' ' A' ' 239' ' ' GLN . 3.5 tt -112.62 134.98 21.53 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.019 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.425 ' HG2' ' HB2' ' A' ' 238' ' ' GLU . 18.1 Cg_endo -59.14 144.27 99.45 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.587 1.525 . . . . 0.0 109.547 177.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.3 mmt180 -55.84 -36.57 67.66 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.745 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -60.97 -43.03 99.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.388 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.425 ' HB2' ' HG2' ' A' ' 235' ' ' PRO . 85.0 tt0 -68.43 -37.52 80.36 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.115 0.483 . . . . 0.0 110.719 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.466 ' OE1' HG21 ' A' ' 234' ' ' ILE . 57.7 tp60 -59.11 -43.58 91.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.908 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -65.46 -39.1 91.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.718 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -59.49 -39.24 83.11 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 21.1 p -90.64 161.23 15.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.178 0.513 . . . . 0.0 112.005 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.36 166.56 25.76 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.626 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.535 ' HG3' ' O ' ' A' ' 289' ' ' VAL . 39.7 ttpt -136.85 132.31 34.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.864 0.332 . . . . 0.0 111.338 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.674 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -115.74 163.76 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-O 121.282 0.563 . . . . 0.0 111.028 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.478 ' N ' ' HB2' ' A' ' 318' ' ' ALA . 89.0 t80 -100.23 137.38 38.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.67 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.683 HG12 ' O ' ' A' ' 287' ' ' GLY . 7.9 p -129.78 145.39 35.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.963 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.594 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.07 166.85 18.66 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.49 15.7 56.5 Favored Glycine 0 N--CA 1.454 -0.131 0 C-N-CA 120.015 -1.088 . . . . 0.0 112.533 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.839 HG23 HG21 ' A' ' 254' ' ' VAL . 69.8 mt -110.66 131.99 60.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.516 0.198 . . . . 0.0 110.595 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.685 ' O ' HG12 ' A' ' 254' ' ' VAL . . . -167.98 -116.29 0.36 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.239 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.82 142.13 98.63 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.623 2.216 . . . . 0.0 113.294 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 54.98 43.58 29.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.351 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.839 HG21 HG23 ' A' ' 250' ' ' ILE . 7.1 p -108.31 -50.87 7.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.239 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.525 ' N ' HG13 ' A' ' 254' ' ' VAL . 7.7 mpt_? 59.07 132.01 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.224 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.5 -27.97 52.49 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.154 1.903 . . . . 0.0 112.911 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -60.72 -48.09 83.37 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.584 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 261' ' ' GLU . 61.0 mp0 -69.3 -36.98 77.58 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.669 ' CE1' HG11 ' A' ' 247' ' ' VAL . 18.6 t80 -61.8 -49.52 75.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.649 0.262 . . . . 0.0 110.679 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.826 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.4 tt0 -64.15 -37.73 88.5 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 258' ' ' GLU . 43.0 tp10 -62.62 -39.28 93.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.669 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.846 ' CE2' HD11 ' A' ' 313' ' ' ILE . 89.8 t80 -64.87 -58.52 5.95 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 1.022 ' HB2' HD11 ' A' ' 269' ' ' ILE . 33.4 m-85 -69.7 -23.24 63.4 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 260' ' ' GLU . 30.4 t -56.57 -32.33 65.1 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -54.71 -34.23 62.1 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.8 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 8.5 p90 -119.86 56.53 0.95 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.255 0.55 . . . . 0.0 112.073 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.585 ' HA3' ' CD1' ' A' ' 291' ' ' TYR . . . 160.65 -31.74 0.37 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.786 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.574 HG22 ' O ' ' A' ' 267' ' ' GLY . 0.5 OUTLIER 85.34 2.82 0.65 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.777 0.431 . . . . 0.0 111.544 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 1.022 HD11 ' HB2' ' A' ' 263' ' ' PHE . 76.4 mt 30.13 108.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.747 HD11 ' HB3' ' A' ' 292' ' ' ASP . 32.0 mm -68.49 -36.01 72.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.486 175.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -137.45 -88.42 0.27 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.636 ' HB3' HG21 ' A' ' 269' ' ' ILE . . . 61.17 123.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.948 0.404 . . . . 0.0 111.548 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -141.37 154.92 45.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.031 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.623 ' O ' ' HB2' ' A' ' 275' ' ' MET . 20.0 tp -62.74 -37.58 87.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.259 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.775 ' HB2' ' HB3' ' A' ' 282' ' ' GLN . 93.8 mmm 93.83 176.71 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.848 0.717 . . . . 0.0 109.857 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.744 HD22 ' O ' ' A' ' 275' ' ' MET . 0.0 OUTLIER -179.43 78.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.621 0.248 . . . . 0.0 111.053 -179.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -84.37 109.66 18.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.935 0.398 . . . . 0.0 110.241 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.669 ' O ' HG22 ' A' ' 280' ' ' THR . 59.6 mttp 57.12 35.43 26.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.685 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.425 ' O ' ' HB ' ' A' ' 280' ' ' THR . 85.6 m-20 53.82 44.26 29.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.74 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.669 HG22 ' O ' ' A' ' 278' ' ' LYS . 1.7 t 174.98 35.16 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.726 0.298 . . . . 0.0 111.585 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -99.46 -73.33 1.07 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.696 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.775 ' HB3' ' HB2' ' A' ' 275' ' ' MET . 5.0 pp0? -59.69 -30.96 69.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.43 ' N ' ' CD ' ' A' ' 282' ' ' GLN . 85.0 p -56.85 -22.96 40.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.555 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -56.52 -33.34 65.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.249 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 250' ' ' ILE . . . 144.98 28.08 0.1 OUTLIER Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.116 -1.04 . . . . 0.0 114.733 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.537 ' CE1' ' HA ' ' A' ' 282' ' ' GLN . 17.6 p90 -141.82 165.75 26.61 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.416 1.108 . . . . 0.0 112.19 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.683 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -143.98 165.65 27.27 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.774 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.41 ' CE2' ' HE3' ' A' ' 244' ' ' LYS . 0.4 OUTLIER -116.48 127.11 54.27 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.221 0.208 . . . . 0.0 111.252 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.674 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 21.5 t -122.32 135.68 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.88 0.371 . . . . 0.0 111.924 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 52.6 m -113.84 136.02 53.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.402 178.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.585 ' CD1' ' HA3' ' A' ' 267' ' ' GLY . 31.3 m-85 -120.1 143.15 48.31 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.747 ' HB3' HD11 ' A' ' 270' ' ' ILE . 52.9 p30 -62.34 -33.97 75.74 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.329 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . 0.65 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 50.8 m -127.04 145.18 50.81 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.147 0.499 . . . . 0.0 111.746 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.05 -30.69 71.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.933 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -56.61 -37.04 70.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.421 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.67 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -60.44 -35.46 75.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.384 . . . . 0.0 110.803 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.571 HG22 ' CG2' ' A' ' 245' ' ' ILE . 96.7 t -61.36 -44.05 97.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.155 0.502 . . . . 0.0 110.527 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.75 -36.8 84.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.129 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -57.55 -43.51 84.51 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.8 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 0.7 OUTLIER -72.2 -32.25 42.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.919 0.39 . . . . 0.0 110.973 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 81.6 m -56.29 -44.74 80.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.269 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -62.42 -40.2 95.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.271 0.558 . . . . 0.0 110.054 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -63.4 -34.47 77.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.419 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.675 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 15.9 tptm 66.11 -72.7 0.08 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.803 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.675 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 16.3 m-85 -111.17 127.79 55.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.334 0.588 . . . . 0.0 111.682 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.72 HD11 HG23 ' A' ' 300' ' ' VAL . 1.4 mt -118.22 138.99 47.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.584 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.425 ' OD1' ' CE ' ' A' ' 312' ' ' LYS . 73.4 m-20 -76.47 110.98 11.46 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.323 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.658 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 6.0 t80 -108.11 -70.16 0.82 Allowed 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.601 0.715 . . . . 0.0 110.063 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.474 ' HD3' ' CE2' ' A' ' 308' ' ' PHE . 0.0 OUTLIER -106.91 -158.5 0.66 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.169 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -54.88 -32.88 61.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.818 0.342 . . . . 0.0 110.789 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -113.85 153.16 29.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.012 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.425 ' CE ' ' OD1' ' A' ' 307' ' ' ASP . 18.8 mmtp -67.18 152.46 45.71 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.043 0.449 . . . . 0.0 111.008 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.846 HD11 ' CE2' ' A' ' 262' ' ' PHE . 27.7 pt -114.1 132.22 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -95.2 131.45 41.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 0.638 HD13 ' CE2' ' A' ' 263' ' ' PHE . 74.4 mt -118.76 125.26 74.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.429 0.633 . . . . 0.0 112.488 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -132.8 155.65 48.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.908 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -55.3 144.96 23.18 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.574 ' O ' ' CB ' ' A' ' 319' ' ' GLU . . . -94.67 131.62 40.27 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . 0.574 ' CB ' ' O ' ' A' ' 318' ' ' ALA . 4.4 tm-20 . . . . . 0 N--CA 1.467 0.39 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.984 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.463 0.197 0 CA-C-O 120.813 0.34 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.433 ' HG2' ' CB ' ' A' ' 233' ' ' ALA . 74.5 tttt -129.99 142.13 50.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.062 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.586 ' HE2' HG11 ' A' ' 216' ' ' VAL . 87.4 mmm -118.84 148.69 42.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.451 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.576 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 4.2 t80 -107.03 129.05 54.86 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.958 HG23 HD12 ' A' ' 228' ' ' ILE . 7.7 mm -116.64 125.05 73.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.783 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 228' ' ' ILE . . . -125.63 158.79 20.04 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 178.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.43 33.37 53.11 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.194 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 83.0 mt -59.38 -18.63 40.42 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.785 ' O ' ' N ' ' A' ' 169' ' ' ASP . 58.2 t30 73.5 41.97 0.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -177.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 9.5 m0 41.32 -55.65 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.858 -1.064 . . . . 0.0 113.823 178.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.785 ' N ' ' O ' ' A' ' 167' ' ' ASN . 52.9 p30 -58.02 -31.2 66.74 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.521 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 86.2 m -65.56 138.11 57.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.248 0.547 . . . . 0.0 111.293 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.445 ' C ' HD12 ' A' ' 190' ' ' ILE . 9.3 p -117.64 166.93 11.82 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.345 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.928 ' N ' HD12 ' A' ' 190' ' ' ILE . 20.8 pt-20 -60.73 -25.78 66.69 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.676 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 90.6 m-20 -61.37 -43.69 98.44 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.133 0.492 . . . . 0.0 110.095 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -67.36 -37.65 83.53 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.861 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.581 HD23 ' CE2' ' A' ' 179' ' ' PHE . 3.3 mt -58.43 -43.73 88.86 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.676 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -67.02 -36.72 82.75 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.295 179.202 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.433 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 48.6 tp10 -64.56 -40.91 96.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.065 0.46 . . . . 0.0 110.411 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 59.4 t80 -74.93 -61.68 1.8 Allowed 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.604 0.716 . . . . 0.0 111.111 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.88 ' HZ ' HD11 ' A' ' 228' ' ' ILE . 80.1 m-85 -70.68 -15.7 62.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.514 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.71 -27.76 20.67 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.243 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.828 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -57.5 -41.93 81.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.107 0.479 . . . . 0.0 110.431 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.828 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 68.6 m-85 -70.39 -35.56 73.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.841 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -177.09 -176.65 45.39 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.464 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.521 ' C ' HG13 ' A' ' 185' ' ' VAL . 44.2 m -64.53 -30.75 71.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.123 -0.538 . . . . 0.0 111.476 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.631 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 0.6 OUTLIER 65.54 90.14 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 121.854 0.835 . . . . 0.0 108.91 -177.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.0 t -59.23 -44.02 92.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.915 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -139.72 136.26 34.01 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.464 HD23 ' CG2' ' A' ' 185' ' ' VAL . 0.3 OUTLIER -117.58 133.04 56.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.316 178.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.567 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 9.1 tptp -134.01 120.95 20.91 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.928 HD12 ' N ' ' A' ' 172' ' ' GLU . 0.4 OUTLIER -128.24 134.08 65.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.361 176.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.543 ' CE ' ' HA2' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -90.47 140.03 30.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.746 -179.078 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -133.31 168.48 18.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.919 0.39 . . . . 0.0 111.377 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 7.4 m-20 -117.7 93.92 44.77 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.383 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.53 -24.64 29.46 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.335 2.024 . . . . 0.0 112.693 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -75.55 -83.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.673 0.273 . . . . 0.0 111.449 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 63.2 p -71.77 -24.13 61.7 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.443 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 92.47 7.15 63.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.772 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 4.2 tpt180 -82.22 154.25 25.52 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.946 0.403 . . . . 0.0 110.781 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 28.3 t -105.69 146.84 29.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.718 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.648 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 34.2 mmt180 -54.33 -30.89 52.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.894 0.378 . . . . 0.0 110.296 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.418 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 97.25 -2.02 60.96 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.237 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.648 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 39.7 p90 -139.4 155.57 47.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.058 0.456 . . . . 0.0 110.387 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.543 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -148.31 169.28 28.97 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.664 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.576 ' CE2' ' CD1' ' A' ' 162' ' ' PHE . 95.9 m-85 -107.84 125.76 51.83 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.083 0.468 . . . . 0.0 109.945 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.627 HD22 ' CE2' ' A' ' 207' ' ' PHE . 6.0 tt -108.42 128.56 54.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.577 -178.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.547 ' N ' HD23 ' A' ' 205' ' ' LEU . 49.9 m -120.34 142.53 49.05 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.331 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.649 ' CE2' HG21 ' A' ' 216' ' ' VAL . 84.8 m-85 -119.14 141.21 49.02 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.712 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.06 -35.51 80.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.166 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -108.17 117.37 55.04 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.756 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 0.885 ' O ' HG12 ' A' ' 213' ' ' VAL . 45.5 Cg_exo -56.74 -26.38 65.6 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.563 2.175 . . . . 0.0 113.276 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 85.7 p -61.78 -32.35 72.61 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.325 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.62 ' O ' HG23 ' A' ' 216' ' ' VAL . 24.7 m -60.31 -35.5 75.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.809 0.338 . . . . 0.0 110.706 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.885 HG12 ' O ' ' A' ' 210' ' ' PRO . 2.6 p -58.85 -35.34 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.981 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.454 ' O ' HG22 ' A' ' 217' ' ' VAL . 20.4 t70 -59.06 -44.63 91.86 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.008 0.432 . . . . 0.0 110.73 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -68.25 -33.07 73.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.58 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.945 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 99.0 t -58.97 -40.68 81.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.261 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 214' ' ' ASP . 24.2 m -77.73 -29.85 16.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.16 -0.616 . . . . 0.0 112.062 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -60.15 -38.78 84.17 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.779 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 60.4 m -91.48 146.59 23.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.761 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.498 ' HG2' HG21 ' A' ' 227' ' ' VAL . 63.4 tt0 -67.13 -42.0 85.19 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.529 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.945 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 57.8 m-70 74.95 96.04 0.07 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 72.3 mt -113.53 115.81 50.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.492 HD23 ' CG ' ' A' ' 224' ' ' ASP . 6.6 tt -123.77 126.07 45.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.008 0.433 . . . . 0.0 111.148 -178.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.492 ' CG ' HD23 ' A' ' 223' ' ' LEU . 86.6 m-20 54.63 42.45 31.25 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 91.0 -30.95 5.88 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.612 -0.804 . . . . 0.0 114.33 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -103.13 155.82 18.14 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 221' ' ' HIS . 11.9 p -102.81 124.48 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.958 HD12 HG23 ' A' ' 163' ' ' ILE . 17.8 pt -84.94 -26.9 6.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -177.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 23.7 t70 52.37 70.58 1.81 Allowed Pre-proline 0 C--N 1.318 -0.802 0 CA-C-O 121.532 0.682 . . . . 0.0 110.802 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.677 ' HD2' ' CD2' ' A' ' 221' ' ' HIS . 43.6 Cg_exo -58.83 136.39 73.32 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.942 3.095 . . . . 0.0 112.122 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.406 ' N ' ' HE3' ' A' ' 161' ' ' MET . 14.1 ttpt -138.35 150.11 46.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.351 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -48.35 147.17 2.45 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 110.789 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.433 ' CB ' ' HG2' ' A' ' 160' ' ' LYS . . . -98.0 145.0 26.94 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.209 0.528 . . . . 0.0 112.199 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.853 HD11 ' OD2' ' A' ' 271' ' ' ASP . 0.7 OUTLIER -110.9 126.22 29.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.13 179.3 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.561 ' HB2' ' OE1' ' A' ' 238' ' ' GLU . 36.8 Cg_exo -54.49 152.54 26.29 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.492 1.462 . . . . 0.0 110.549 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -52.32 -37.83 56.96 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -57.88 -43.57 86.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.886 ' O ' HG23 ' A' ' 242' ' ' THR . 58.9 mp0 -67.9 -36.99 81.17 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.705 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -59.98 -38.15 81.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.988 0.423 . . . . 0.0 110.732 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -61.2 -37.21 82.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.543 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -88.44 4.26 47.07 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.886 HG23 ' O ' ' A' ' 238' ' ' GLU . 16.7 p -121.33 160.86 23.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.052 0.453 . . . . 0.0 112.021 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.27 167.52 25.18 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.606 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.575 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 78.2 tttt -136.57 137.21 39.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.209 0.505 . . . . 0.0 110.905 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.62 HD12 ' CG2' ' A' ' 315' ' ' ILE . 7.1 pt -120.31 157.54 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.39 0.614 . . . . 0.0 112.126 -178.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.422 ' CE1' ' CD2' ' A' ' 286' ' ' PHE . 81.0 t80 -94.78 130.34 41.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.96 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.981 HG21 ' CZ ' ' A' ' 263' ' ' PHE . 57.2 t -124.6 133.17 70.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.643 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.701 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -119.98 166.96 13.51 Favored Glycine 0 C--O 1.225 -0.445 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.746 ' O ' HG22 ' A' ' 313' ' ' ILE . . . 94.54 13.36 53.98 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.132 -1.033 . . . . 0.0 112.103 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.556 HG23 HG11 ' A' ' 254' ' ' VAL . 67.4 mt -108.84 130.61 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 120.812 0.339 . . . . 0.0 110.491 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.827 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -165.27 -119.11 0.46 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.544 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.38 144.08 96.77 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 122.313 2.009 . . . . 0.0 113.137 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 57.34 45.68 19.67 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.827 HG22 ' O ' ' A' ' 251' ' ' GLY . 16.1 m -118.33 -50.89 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.388 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.521 ' N ' HG23 ' A' ' 254' ' ' VAL . 9.8 mmt180 62.83 130.25 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.195 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.68 -28.62 47.6 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 121.98 1.787 . . . . 0.0 112.194 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 12.7 tptp -60.6 -44.14 96.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.142 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.578 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 79.3 mm-40 -66.91 -39.77 87.48 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.84 0.352 . . . . 0.0 111.085 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.599 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 30.5 t80 -63.25 -48.01 80.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.537 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.427 ' O ' ' CD1' ' A' ' 269' ' ' ILE . 84.3 tt0 -64.46 -42.74 95.76 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.36 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.406 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.9 pt-20 -76.7 -28.85 56.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.83 0.348 . . . . 0.0 110.81 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.874 ' CE2' HD11 ' A' ' 313' ' ' ILE . 12.8 t80 -60.66 -55.59 31.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.169 0.509 . . . . 0.0 111.39 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.981 ' CZ ' HG21 ' A' ' 247' ' ' VAL . 10.4 m-85 -69.64 -22.45 63.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.994 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.707 ' N ' HD11 ' A' ' 269' ' ' ILE . 27.8 t -57.22 -30.94 65.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.892 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -54.04 -36.11 62.71 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.754 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 7.3 p90 -117.76 41.36 2.88 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.763 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.496 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 159.92 147.93 5.07 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.985 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.423 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 52.5 m -59.52 -36.85 76.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 0.0 111.285 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.707 HD11 ' N ' ' A' ' 264' ' ' SER . 69.8 mt 68.81 78.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.395 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.545 ' O ' ' OD1' ' A' ' 271' ' ' ASP . 32.1 mm -58.91 -45.59 91.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.449 -0.5 . . . . 0.0 112.094 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.853 ' OD2' HD11 ' A' ' 234' ' ' ILE . 83.4 m-20 -151.26 90.7 1.61 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.583 ' HB2' HG23 ' A' ' 269' ' ' ILE . . . -106.03 132.62 51.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.528 0.204 . . . . 0.0 110.506 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -145.61 151.61 38.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.285 0.564 . . . . 0.0 111.885 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.59 ' O ' ' HB2' ' A' ' 275' ' ' MET . 26.3 tp -66.05 -36.57 83.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.713 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.59 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 96.0 mmm 84.13 114.28 0.05 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.513 -178.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.484 HD12 ' N ' ' A' ' 276' ' ' LEU . 5.1 mp -122.39 138.58 54.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.744 0.306 . . . . 0.0 111.418 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.469 ' HB2' ' HA3' ' A' ' 281' ' ' GLY . 85.0 m-20 -129.4 100.39 5.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.084 0.469 . . . . 0.0 110.679 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.738 ' O ' HG22 ' A' ' 280' ' ' THR . 94.3 mttt 63.48 35.99 11.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.17 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.429 ' O ' ' HB ' ' A' ' 280' ' ' THR . 85.8 m-20 51.45 43.82 29.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.75 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 278' ' ' LYS . 0.9 OUTLIER 169.86 47.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.041 0.448 . . . . 0.0 110.753 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' A' ' 277' ' ' ASP . . . -139.53 -105.38 0.64 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.135 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.448 ' OE1' ' HB3' ' A' ' 275' ' ' MET . 96.5 mt-30 -56.85 -27.04 59.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.209 -0.496 . . . . 0.0 111.525 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.561 ' O ' HD21 ' A' ' 274' ' ' LEU . 83.3 p -53.18 -24.63 11.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.95 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -118.58 136.89 53.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.652 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 105.96 -57.95 0.46 Allowed Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.573 -0.823 . . . . 0.0 114.242 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 247' ' ' VAL . 32.5 p90 -140.72 166.77 23.84 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.757 0.779 . . . . 0.0 112.652 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -135.93 154.83 22.04 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.461 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.575 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -110.22 129.89 55.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.747 0.308 . . . . 0.0 111.711 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.67 HG21 ' CD2' ' A' ' 263' ' ' PHE . 55.1 t -124.48 134.84 65.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.978 0.418 . . . . 0.0 111.901 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 63.0 m -115.48 135.75 53.79 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.496 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 38.9 m-85 -117.04 139.51 50.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.511 ' CA ' HG12 ' A' ' 270' ' ' ILE . 51.1 t0 -58.22 -36.53 73.28 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.421 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 49.1 m -123.66 144.2 49.78 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.318 0.58 . . . . 0.0 112.053 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.92 -30.61 71.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.693 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -56.26 -37.53 69.91 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.005 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -61.21 -36.65 80.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.011 0.434 . . . . 0.0 110.403 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.583 HG13 HG21 ' A' ' 245' ' ' ILE . 75.1 t -61.74 -42.82 95.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.234 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -61.5 -37.68 84.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.53 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -59.06 -44.09 91.8 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.965 HG23 HD11 ' A' ' 306' ' ' ILE . 0.8 OUTLIER -71.9 -33.04 46.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.175 -179.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 89.0 m -57.88 -45.6 86.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.142 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -61.09 -41.46 96.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.254 0.549 . . . . 0.0 110.018 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -61.91 -33.05 73.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.211 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.648 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 31.8 tptt 68.16 -74.21 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -178.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.648 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.0 m-30 -113.31 141.55 46.88 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.424 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.965 HD11 HG23 ' A' ' 300' ' ' VAL . 34.6 mt -116.98 136.65 53.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -75.09 79.82 2.25 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.367 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.531 ' CD2' HD13 ' A' ' 313' ' ' ILE . 9.1 t80 -83.17 -105.7 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.978 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 310' ' ' ASP . 4.2 mmpt? -60.71 -34.96 75.17 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 309' ' ' LYS . 52.2 p30 137.78 0.17 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.997 0.919 . . . . 0.0 111.142 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 312' ' ' LYS . 73.3 mtt85 -98.18 4.44 48.96 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.451 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 95.1 mttt 65.04 54.07 1.29 Allowed 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.109 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.874 HD11 ' CE2' ' A' ' 262' ' ' PHE . 20.3 pt -50.14 99.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.777 0.799 . . . . 0.0 110.784 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . 0.567 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 92.4 mt-10 -60.91 139.53 57.97 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.19 -178.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 0.772 HG23 HG22 ' A' ' 247' ' ' VAL . 63.2 mt -121.65 128.14 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.009 0.433 . . . . 0.0 111.065 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -133.85 142.78 47.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.112 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 21.7 ttp-105 -50.8 146.74 5.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.699 0.285 . . . . 0.0 110.624 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.23 143.51 27.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.402 . . . . 0.0 111.131 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.358 -179.394 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.469 0.478 0 CA-C-O 120.846 0.355 . . . . 0.0 111.881 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.484 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 21.8 tttt -96.2 137.5 35.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.499 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.64 ' HE2' ' HB ' ' A' ' 216' ' ' VAL . 8.5 tpp -114.36 145.4 41.87 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.637 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 6.8 t80 -102.85 131.85 49.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.925 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.112 HG22 HD11 ' A' ' 166' ' ' LEU . 17.5 mm -116.63 132.37 66.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.354 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.582 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -123.59 156.64 17.9 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.294 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.31 34.95 44.2 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.407 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 1.112 HD11 HG22 ' A' ' 163' ' ' ILE . 4.4 mp -92.62 141.75 28.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.638 0.256 . . . . 0.0 110.732 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.16 135.44 57.72 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.546 ' CD1' ' O ' ' A' ' 199' ' ' SER . 4.3 m0 -53.91 -33.66 57.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.794 0.331 . . . . 0.0 110.754 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -93.22 9.72 34.91 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.422 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 1.131 HG21 HD21 ' A' ' 223' ' ' LEU . 98.5 m -56.98 -40.54 76.72 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.49 HG23 ' C ' ' A' ' 170' ' ' THR . 0.1 OUTLIER 54.32 162.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -177.322 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.532 ' O ' ' HD3' ' A' ' 176' ' ' ARG . 57.2 mp0 -62.73 -28.56 70.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.113 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.575 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 92.6 m-20 -55.47 -43.44 75.53 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -67.46 -36.95 82.17 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 1.009 HD22 HD21 ' A' ' 205' ' ' LEU . 6.1 mt -56.38 -48.39 76.97 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.575 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -68.42 -30.36 69.24 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.333 179.15 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -56.89 -39.4 74.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.577 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.792 ' HD2' HD12 ' A' ' 223' ' ' LEU . 0.0 OUTLIER -96.37 -59.47 1.82 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.967 0.413 . . . . 0.0 110.092 178.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.635 ' CE2' HD23 ' A' ' 175' ' ' LEU . 70.9 m-85 -59.87 -31.95 70.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.544 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.13 -25.37 7.75 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.11 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.825 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -56.41 -41.19 75.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.775 0.321 . . . . 0.0 111.487 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.825 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 69.8 m-85 -70.56 -35.74 73.25 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -174.66 -177.54 43.87 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.475 -1.345 . . . . 0.0 114.195 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 61.1 m -62.73 -34.38 77.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.699 -0.75 . . . . 0.0 111.867 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.848 HG23 ' CE1' ' A' ' 207' ' ' PHE . 0.5 OUTLIER 67.15 106.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.76 HG23 ' N ' ' A' ' 208' ' ' GLU . 43.3 p -64.78 -36.79 85.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.983 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -154.01 150.65 28.49 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.473 HD23 HG11 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -118.47 133.66 55.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.348 179.188 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 10.5 tptt -133.48 119.09 19.13 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 172' ' ' GLU . 0.8 OUTLIER -128.58 137.66 56.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.034 177.506 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.566 ' HB2' ' HB2' ' A' ' 200' ' ' ARG . 0.3 OUTLIER -96.19 127.53 42.28 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.857 -179.525 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -131.95 155.52 47.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.983 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.601 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 15.2 t0 -120.55 80.82 31.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.442 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.09 -24.85 42.49 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.52 2.147 . . . . 0.0 112.642 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.79 -70.52 0.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.867 0.365 . . . . 0.0 111.111 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 49.4 p -73.08 -20.56 60.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.812 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 84.87 19.72 59.06 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.53 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.601 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 8.3 tpt180 -115.6 151.92 34.05 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 120.756 0.312 . . . . 0.0 110.466 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.546 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 49.1 m -117.34 153.4 33.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.904 0.383 . . . . 0.0 110.809 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.653 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 30.5 mmt180 -54.34 -34.5 61.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 110.961 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 166' ' ' LEU . . . 90.71 5.61 68.59 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.231 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.962 ' HA ' HD13 ' A' ' 166' ' ' LEU . 22.5 p90 -140.36 158.92 43.29 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.881 0.372 . . . . 0.0 110.641 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.456 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -143.02 162.9 27.47 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.402 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.637 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 95.8 m-85 -109.68 129.59 55.59 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.867 0.365 . . . . 0.0 110.199 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 1.009 HD21 HD22 ' A' ' 175' ' ' LEU . 61.1 mt -104.54 141.21 36.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.778 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 186' ' ' THR . 18.0 t -127.94 128.37 44.98 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.848 ' CE1' HG23 ' A' ' 185' ' ' VAL . 98.1 m-85 -120.41 143.08 48.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.14 0.495 . . . . 0.0 112.073 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.76 ' N ' HG23 ' A' ' 186' ' ' THR . 47.3 tp10 -62.14 -34.37 76.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.063 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -110.83 116.23 52.29 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.4 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.7 -30.59 76.31 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.454 2.103 . . . . 0.0 113.064 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.418 ' O ' ' OD1' ' A' ' 214' ' ' ASP . 25.6 m -59.39 -35.51 74.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.626 0.25 . . . . 0.0 110.926 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.821 ' O ' HG23 ' A' ' 216' ' ' VAL . 24.8 m -57.01 -34.61 68.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.131 0.491 . . . . 0.0 109.898 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.51 HG11 ' CD ' ' A' ' 232' ' ' ARG . 83.5 t -63.49 -38.4 82.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.678 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.695 ' OD1' ' N ' ' A' ' 215' ' ' GLU . 36.4 p30 -60.35 -39.4 87.0 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.746 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.695 ' N ' ' OD1' ' A' ' 214' ' ' ASP . 97.8 mt-10 -70.95 -35.52 72.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.527 0.68 . . . . 0.0 110.714 177.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 212' ' ' SER . 93.9 t -60.44 -36.88 72.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.528 -178.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 230' ' ' PRO . 6.5 p -87.21 -54.22 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.493 ' N ' HG13 ' A' ' 217' ' ' VAL . 26.2 mttt -60.44 -36.74 78.93 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.424 ' HB ' ' CE1' ' A' ' 221' ' ' HIS . 62.0 m -58.26 -37.75 75.58 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 63.86 110.56 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -177.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.723 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 0.0 OUTLIER -137.98 175.13 9.86 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -176.037 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.861 HG23 ' O ' ' A' ' 226' ' ' LYS . 17.8 mm -115.36 120.25 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.75 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 1.131 HD21 HG21 ' A' ' 170' ' ' THR . 18.8 tp -69.64 -43.81 71.89 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.644 -0.423 . . . . 0.0 112.017 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -177.36 69.68 0.02 OUTLIER 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.741 0.305 . . . . 0.0 111.774 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 95.21 -8.09 69.54 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.467 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.861 ' O ' HG23 ' A' ' 222' ' ' ILE . 76.2 mttt -124.08 157.76 33.81 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 117.036 0.418 . . . . 0.0 111.584 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.91 HG21 ' OD2' ' A' ' 279' ' ' ASP . 44.3 t -93.88 126.95 46.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.165 0.507 . . . . 0.0 110.26 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.63 HD13 ' HB2' ' A' ' 223' ' ' LEU . 31.6 pt -126.87 155.98 37.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.048 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 8.7 p30 -132.15 81.57 61.15 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 121.191 0.519 . . . . 0.0 110.421 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.771 ' O ' HG23 ' A' ' 217' ' ' VAL . 92.8 Cg_exo -47.51 127.02 13.05 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.72 2.28 . . . . 0.0 111.345 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -132.45 144.96 50.83 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.684 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.51 ' CD ' HG11 ' A' ' 213' ' ' VAL . 57.3 mmm-85 -50.06 143.1 8.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.202 0.525 . . . . 0.0 111.269 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -68.62 150.08 48.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.787 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.411 ' HB ' ' NE2' ' A' ' 239' ' ' GLN . 34.4 mt -117.44 140.4 27.32 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.935 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.475 ' HD2' ' OE1' ' A' ' 238' ' ' GLU . 45.0 Cg_exo -55.26 139.84 81.27 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 121.758 1.639 . . . . 0.0 111.229 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.449 ' O ' ' HD3' ' A' ' 236' ' ' ARG . 3.2 tmt_? -56.83 -41.12 77.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.728 0.299 . . . . 0.0 111.123 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -60.01 -39.35 85.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.368 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.503 ' O ' HG23 ' A' ' 242' ' ' THR . 94.8 mt-10 -63.66 -32.62 74.16 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.701 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.411 ' NE2' ' HB ' ' A' ' 234' ' ' ILE . 98.9 mm-40 -58.24 -38.52 77.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.998 0.428 . . . . 0.0 110.213 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -61.06 -42.33 98.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.223 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -63.15 -36.0 82.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.461 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 238' ' ' GLU . 21.0 p -83.26 161.44 21.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.155 0.502 . . . . 0.0 111.897 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.94 169.99 25.07 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.609 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.539 ' CE ' ' CD2' ' A' ' 288' ' ' PHE . 46.9 tptt -134.71 130.36 36.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.861 0.331 . . . . 0.0 110.706 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.656 HD12 HG21 ' A' ' 315' ' ' ILE . 5.5 pt -123.5 154.84 29.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 121.11 0.481 . . . . 0.0 110.65 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.431 ' CE1' ' CD2' ' A' ' 286' ' ' PHE . 92.9 t80 -97.28 133.37 42.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.651 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.752 HG21 ' CZ ' ' A' ' 263' ' ' PHE . 21.4 t -121.42 139.36 48.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.032 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.595 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -129.02 171.93 19.77 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.18 36.9 16.56 Favored Glycine 0 C--N 1.323 -0.181 0 C-N-CA 120.071 -1.061 . . . . 0.0 111.901 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.866 HG22 HG21 ' A' ' 254' ' ' VAL . 69.8 mt -111.66 132.32 60.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.598 0.237 . . . . 0.0 110.81 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.862 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -158.16 -119.59 0.57 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.246 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.63 140.58 95.45 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.38 2.053 . . . . 0.0 113.482 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 54.15 44.06 29.74 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.402 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.866 HG21 HG22 ' A' ' 250' ' ' ILE . 22.4 m -121.04 27.77 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.529 ' HG3' ' HD2' ' A' ' 256' ' ' PRO . 0.2 OUTLIER -39.96 155.12 0.18 Allowed Pre-proline 0 N--CA 1.465 0.304 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.529 ' HD2' ' HG3' ' A' ' 255' ' ' ARG . 7.5 Cg_endo -50.19 -29.47 22.77 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.051 1.834 . . . . 0.0 112.128 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -62.05 -45.72 92.31 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.036 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -68.29 -42.11 79.97 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.101 0.477 . . . . 0.0 111.066 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.468 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 35.3 t80 -66.13 -47.2 74.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.294 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.733 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.4 tt0 -64.9 -41.37 95.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.333 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -75.01 -31.98 61.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.613 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.685 ' CE2' HD11 ' A' ' 313' ' ' ILE . 83.4 t80 -59.51 -55.61 32.42 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.818 ' CB ' HD11 ' A' ' 269' ' ' ILE . 25.3 m-85 -66.85 -30.65 70.88 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.537 ' HA ' HG13 ' A' ' 269' ' ' ILE . 16.5 m -56.01 -27.43 52.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.758 0.313 . . . . 0.0 111.194 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -51.89 -38.04 54.66 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.745 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 19.9 p90 -110.84 48.08 0.94 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.586 0.708 . . . . 0.0 111.954 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 133.28 149.08 6.04 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.313 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 53.4 m -69.76 131.85 45.18 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.818 HD11 ' CB ' ' A' ' 263' ' ' PHE . 49.6 mt -94.44 135.92 27.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.005 0.431 . . . . 0.0 111.395 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' A' ' 292' ' ' ASP . 27.3 mm -92.38 -75.09 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.49 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 272' ' ' ALA . 90.4 m-20 -93.0 -75.51 0.49 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.489 ' HB3' HG21 ' A' ' 269' ' ' ILE . . . 42.79 108.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -140.64 157.73 45.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.222 0.534 . . . . 0.0 111.68 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.573 ' O ' ' HB2' ' A' ' 275' ' ' MET . 25.9 tp -62.17 -37.39 85.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.537 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.709 ' O ' HD23 ' A' ' 276' ' ' LEU . 84.9 mtp 86.27 128.26 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.95 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 275' ' ' MET . 31.9 mt -130.14 120.9 25.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.853 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.444 ' O ' ' HG3' ' A' ' 278' ' ' LYS . 55.1 t0 -61.0 -41.75 97.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.213 0.53 . . . . 0.0 110.192 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.542 ' O ' HG22 ' A' ' 280' ' ' THR . 98.8 mttt -165.28 59.09 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.975 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.91 ' OD2' HG21 ' A' ' 227' ' ' VAL . 83.7 m-20 58.17 44.62 18.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.739 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 278' ' ' LYS . 1.5 t -178.66 -34.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.401 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 276' ' ' LEU . . . -83.39 178.48 52.71 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.436 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.486 ' OE1' ' HB3' ' A' ' 275' ' ' MET . 98.1 mt-30 42.9 21.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.483 ' O ' HD21 ' A' ' 274' ' ' LEU . 94.0 p -80.54 -30.82 37.1 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -134.36 154.04 51.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.362 0.601 . . . . 0.0 112.463 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.13 -40.94 2.27 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.041 -0.981 . . . . 0.0 114.422 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.664 ' C ' HD12 ' A' ' 250' ' ' ILE . 12.4 p90 -149.0 165.55 31.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.792 0.796 . . . . 0.0 111.556 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.788 ' N ' HD12 ' A' ' 250' ' ' ILE . . . -138.99 153.79 22.94 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.975 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.539 ' CD2' ' CE ' ' A' ' 244' ' ' LYS . 0.3 OUTLIER -109.59 127.38 54.47 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.594 0.358 . . . . 0.0 110.364 179.255 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.556 HG21 ' CG ' ' A' ' 263' ' ' PHE . 38.5 t -125.32 135.45 63.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.453 ' OG1' ' CD ' ' A' ' 244' ' ' LYS . 47.5 m -120.27 136.52 54.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.313 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.407 ' OH ' ' O ' ' A' ' 263' ' ' PHE . 40.5 m-85 -116.21 138.4 51.32 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.617 ' HB2' HD11 ' A' ' 270' ' ' ILE . 51.4 t0 -57.3 -36.35 70.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.507 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 50.6 m -122.37 145.04 48.64 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.247 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.83 -27.84 68.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.649 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -55.56 -38.42 69.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.626 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.44 -37.38 85.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.977 0.417 . . . . 0.0 110.901 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.566 HG13 ' CG2' ' A' ' 245' ' ' ILE . 73.1 t -62.71 -43.66 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.258 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -61.58 -38.66 88.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.29 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -59.51 -43.32 93.41 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.895 HG23 HD11 ' A' ' 306' ' ' ILE . 1.2 p -70.92 -33.04 50.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.466 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 81.6 m -57.5 -45.63 84.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.278 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -61.76 -42.2 98.68 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.207 0.527 . . . . 0.0 110.364 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.9 m-20 -63.04 -35.25 79.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.607 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.677 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 16.2 tptm 67.58 -67.79 0.17 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.677 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 16.1 m-85 -114.97 133.35 56.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.166 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.895 HD11 HG23 ' A' ' 300' ' ' VAL . 14.8 mt -121.45 140.17 46.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.92 178.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.54 ' OD1' ' O ' ' A' ' 307' ' ' ASP . 50.7 p30 -77.1 110.21 11.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.224 0.535 . . . . 0.0 110.884 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.637 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 7.9 t80 -110.21 -79.65 0.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.543 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.463 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 6.7 mmpt? -97.89 -162.4 0.95 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.505 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -52.76 -28.97 24.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.759 0.314 . . . . 0.0 110.456 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -109.99 152.66 25.61 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.534 ' HG2' ' HB3' ' A' ' 305' ' ' PHE . 14.2 tttp -75.29 139.99 42.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.527 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.685 HD11 ' CE2' ' A' ' 262' ' ' PHE . 27.4 pt -105.49 136.63 38.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.236 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . 0.434 ' HB2' ' CE2' ' A' ' 305' ' ' PHE . 84.5 tt0 -101.25 131.32 47.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.651 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 0.683 HD13 ' CE2' ' A' ' 263' ' ' PHE . 66.0 mt -119.48 127.51 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-O 121.052 0.454 . . . . 0.0 111.2 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -131.34 144.7 51.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.482 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -49.62 146.19 4.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.017 0.437 . . . . 0.0 111.065 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.32 147.36 36.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.632 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.938 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.4 m . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 120.698 0.285 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 205' ' ' LEU . 37.6 ttpt -89.49 136.59 32.94 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.099 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.805 ' SD ' HG13 ' A' ' 213' ' ' VAL . 29.0 mtm -124.86 164.14 20.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.147 0.499 . . . . 0.0 111.239 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.578 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 1.8 t80 -98.49 130.01 45.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.302 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.805 HG23 HD12 ' A' ' 228' ' ' ILE . 47.0 mt -119.28 127.73 75.84 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.67 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.705 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.645 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -127.27 165.63 20.35 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.73 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.13 34.71 40.66 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.962 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.556 HD22 HG21 ' A' ' 170' ' ' THR . 73.9 mt -59.25 -22.89 61.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.474 ' CB ' ' HG3' ' A' ' 226' ' ' LYS . 51.8 t30 75.59 39.61 0.33 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.198 0.523 . . . . 0.0 109.751 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 20.4 m0 33.53 35.22 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.143 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -153.94 8.2 0.35 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.556 HG21 HD22 ' A' ' 166' ' ' LEU . 55.4 m -78.71 137.16 37.65 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.372 0.606 . . . . 0.0 110.392 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.52 HG23 ' HZ1' ' A' ' 192' ' ' LYS . 30.5 m -116.42 145.02 43.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.825 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.554 ' N ' HD12 ' A' ' 190' ' ' ILE . 55.4 mp0 -55.66 -36.46 67.1 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.146 -0.621 . . . . 0.0 109.646 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.541 ' O ' ' HG2' ' A' ' 176' ' ' ARG . 89.6 m-20 -65.43 -48.29 73.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.973 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -67.25 -40.8 86.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.609 0.718 . . . . 0.0 110.158 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.835 HD22 HD11 ' A' ' 190' ' ' ILE . 65.8 tp -64.68 -41.42 96.06 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.107 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.541 ' HG2' ' O ' ' A' ' 173' ' ' ASP . 41.2 ptt85 -69.66 -40.03 76.68 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.395 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 173' ' ' ASP . 75.4 mm-40 -65.12 -37.86 88.8 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.037 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.439 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 65.2 t80 -61.72 -54.53 41.33 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.416 0.627 . . . . 0.0 110.135 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.607 ' HZ ' HD11 ' A' ' 228' ' ' ILE . 86.6 m-85 -73.58 -21.83 60.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.703 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.41 -26.54 22.86 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.222 -0.99 . . . . 0.0 110.847 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.507 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -54.91 -41.49 71.03 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 123.752 0.821 . . . . 0.0 111.072 179.211 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -69.02 -32.59 72.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.099 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 174.94 -125.34 1.08 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.306 -0.95 . . . . 0.0 112.702 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 57.1 m -117.44 143.33 46.13 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.903 HG21 ' CD2' ' A' ' 188' ' ' LEU . 15.0 p -109.8 135.07 49.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.715 0.293 . . . . 0.0 110.238 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.452 HG23 ' CB ' ' A' ' 206' ' ' SER . 0.5 OUTLIER -95.79 -47.58 6.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.928 -179.18 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.418 ' HB3' ' HB3' ' A' ' 206' ' ' SER . 59.6 t0 -136.6 132.19 34.76 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.281 0.562 . . . . 0.0 112.488 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.903 ' CD2' HG21 ' A' ' 185' ' ' VAL . 0.3 OUTLIER -116.22 129.72 56.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.58 179.278 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 11.7 tptt -137.03 116.07 12.41 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.835 HD11 HD22 ' A' ' 175' ' ' LEU . 55.1 mt -126.74 126.26 68.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.989 176.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.547 ' SD ' ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -86.03 114.95 23.31 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.52 ' HZ1' HG23 ' A' ' 171' ' ' THR . 69.5 mttt -117.84 153.35 33.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.856 0.36 . . . . 0.0 111.458 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.591 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 3.1 t0 -124.79 74.11 64.19 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.31 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.77 -28.7 83.17 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.54 2.16 . . . . 0.0 112.905 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -66.74 -58.72 4.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.057 0.456 . . . . 0.0 111.108 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.2 p -75.16 -18.6 60.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.341 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 86.29 12.17 70.87 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.802 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.591 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 88.7 mtt-85 -122.32 177.16 5.5 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-O 120.87 0.367 . . . . 0.0 111.974 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 86.0 p -139.7 160.85 38.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.37 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.546 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 39.5 mmt180 -55.47 -31.96 62.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.989 0.423 . . . . 0.0 110.081 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.474 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 92.87 6.57 63.46 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.378 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.547 ' CE1' ' SD ' ' A' ' 191' ' ' MET . 26.2 p90 -146.56 154.33 41.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.153 0.501 . . . . 0.0 111.102 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.535 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -142.88 159.2 27.34 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.88 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.578 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 90.5 m-85 -106.83 123.66 48.48 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.629 HD22 ' CE2' ' A' ' 207' ' ' PHE . 7.3 tt -115.07 131.48 56.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.394 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.498 ' N ' HD23 ' A' ' 205' ' ' LEU . 38.8 t -116.31 135.67 53.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.015 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.629 ' CE2' HD22 ' A' ' 205' ' ' LEU . 75.5 m-85 -111.92 135.49 52.48 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.29 -35.33 78.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.464 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -109.77 115.16 55.86 Favored Pre-proline 0 C--O 1.231 0.119 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.695 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -56.2 -23.08 43.33 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.519 2.146 . . . . 0.0 112.862 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.1 t -57.66 -38.32 74.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.78 0.324 . . . . 0.0 111.113 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.94 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.9 m -59.64 -36.56 76.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.595 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.805 HG13 ' SD ' ' A' ' 161' ' ' MET . 83.0 t -60.48 -42.75 92.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.921 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.407 ' O ' HG12 ' A' ' 217' ' ' VAL . 55.5 t0 -59.49 -41.45 89.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.88 0.371 . . . . 0.0 110.805 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.449 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 17.4 pt-20 -78.34 -36.41 46.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.726 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.94 HG23 ' O ' ' A' ' 212' ' ' SER . 93.8 t -63.5 -46.31 95.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 CA-C-O 120.924 0.393 . . . . 0.0 110.422 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 214' ' ' ASP . 8.0 p -62.01 -36.62 75.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -59.97 -38.7 83.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.706 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 31.4 m -87.66 142.39 27.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.918 0.389 . . . . 0.0 111.847 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 228' ' ' ILE . 60.1 tp60 -66.23 -40.89 90.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.455 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.845 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 58.2 m-70 74.55 105.73 0.07 Allowed 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.615 HG12 HG12 ' A' ' 227' ' ' VAL . 75.3 mt -112.28 108.02 24.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.5 tt -117.0 125.99 52.21 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.948 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 55.76 41.19 30.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.03 8.29 87.41 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.95 -0.643 . . . . 0.0 114.643 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.474 ' HG3' ' CB ' ' A' ' 167' ' ' ASN . 42.2 mmtm -127.2 153.76 45.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.55 0.675 . . . . 0.0 111.961 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.615 HG12 HG12 ' A' ' 222' ' ' ILE . 34.2 m -100.06 136.93 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.64 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.805 HD12 HG23 ' A' ' 163' ' ' ILE . 31.1 pt -123.75 161.85 25.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.083 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -124.95 80.3 63.79 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.119 0.485 . . . . 0.0 111.756 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.653 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 31.3 Cg_exo -63.92 76.31 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.399 2.733 . . . . 0.0 112.043 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 161' ' ' MET . 9.9 mtmt -95.5 159.42 15.01 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.117 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.458 ' HA ' ' HG2' ' A' ' 161' ' ' MET . 16.5 tpt180 -57.41 136.91 56.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.068 0.461 . . . . 0.0 111.578 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.31 145.71 55.0 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.49 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 13.9 mt -110.31 120.47 44.15 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.946 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.402 ' HG2' ' CG ' ' A' ' 238' ' ' GLU . 11.3 Cg_endo -54.97 147.76 50.78 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.04 1.827 . . . . 0.0 111.309 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.415 ' HD3' ' NE2' ' A' ' 239' ' ' GLN . 25.2 mmt180 -55.86 -36.71 67.88 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -57.68 -43.19 84.89 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.003 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.684 ' O ' HG23 ' A' ' 242' ' ' THR . 97.6 mt-10 -71.92 -39.66 69.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.084 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.415 ' NE2' ' HD3' ' A' ' 236' ' ' ARG . 27.1 mt-30 -61.18 -36.94 81.22 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.472 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -59.68 -37.31 78.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.999 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -86.41 -0.48 56.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 238' ' ' GLU . 27.3 p -87.85 162.54 16.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.081 0.467 . . . . 0.0 111.689 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -158.33 91.83 0.12 Allowed Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.767 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.584 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 77.5 tttt -79.2 132.42 36.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.764 0.316 . . . . 0.0 110.644 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.68 HD13 ' O ' ' A' ' 245' ' ' ILE . 0.0 OUTLIER -117.45 162.62 15.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.735 0.779 . . . . 0.0 112.254 -178.368 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.408 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 81.9 t80 -103.0 133.97 47.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.817 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.652 ' O ' ' HB2' ' A' ' 286' ' ' PHE . 8.2 p -128.15 135.05 63.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.351 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -123.96 12.03 8.2 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.349 -0.929 . . . . 0.0 113.694 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 313' ' ' ILE . . . -97.78 15.76 61.35 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.725 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.988 HD11 ' HA3' ' A' ' 287' ' ' GLY . 31.7 pt -120.9 155.56 24.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.489 0.662 . . . . 0.0 112.597 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.996 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -137.73 177.17 20.14 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.086 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.15 -26.96 44.39 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 121.981 1.787 . . . . 0.0 111.702 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.13 -35.1 72.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.592 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.996 HG22 ' O ' ' A' ' 251' ' ' GLY . 20.5 m -65.85 -28.1 43.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.74 127.35 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.07 -32.38 79.18 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.213 1.942 . . . . 0.0 113.126 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -61.15 -47.16 87.51 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.239 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 84.1 tt0 -66.67 -36.35 82.31 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.241 0.543 . . . . 0.0 110.944 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.72 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 31.3 t80 -59.5 -45.06 92.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.449 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.7 -40.32 92.16 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.321 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 258' ' ' GLU . 20.8 pt-20 -76.33 -30.64 57.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.08 0.467 . . . . 0.0 110.604 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.576 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 11.6 t80 -63.94 -55.56 21.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.057 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.832 ' CD2' HG21 ' A' ' 289' ' ' VAL . 4.2 m-85 -66.72 -24.66 66.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.547 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.634 ' N ' HD11 ' A' ' 269' ' ' ILE . 71.2 p -60.08 -24.78 64.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.537 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -54.89 -35.76 64.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.467 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.667 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 13.0 p90 -114.39 35.43 4.21 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.073 0.463 . . . . 0.0 111.604 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 264' ' ' SER . . . 164.31 149.03 5.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.641 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 44.5 m -59.91 -36.07 76.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.944 0.402 . . . . 0.0 110.92 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.651 HD11 ' C ' ' A' ' 263' ' ' PHE . 66.0 mt 64.82 90.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.161 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.611 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 80.5 mt -56.65 -42.47 76.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.201 178.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.451 ' OD2' ' CE ' ' A' ' 231' ' ' LYS . 61.9 t0 -168.69 100.88 0.4 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.745 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -98.73 136.72 38.37 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -143.02 155.43 44.64 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 1.073 HD23 HD11 ' A' ' 276' ' ' LEU . 30.6 tp -65.94 -35.45 80.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.176 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.657 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 86.7 mmm 105.58 -79.41 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.168 0.987 . . . . 0.0 112.234 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 1.073 HD11 HD23 ' A' ' 274' ' ' LEU . 6.5 mp 59.14 65.92 1.12 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.461 0.172 . . . . 0.0 111.017 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.71 -41.31 81.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.383 0.611 . . . . 0.0 109.598 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' A' ' 280' ' ' THR . 55.8 mttp -142.0 114.87 8.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.966 177.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.68 ' O ' HD23 ' A' ' 276' ' ' LEU . 87.8 m-20 60.59 -65.44 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.034 -179.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 278' ' ' LYS . 0.3 OUTLIER 170.94 18.7 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -58.07 -38.58 89.94 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.691 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 286' ' ' PHE . 96.1 mm-40 -60.96 -36.37 79.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.259 0.552 . . . . 0.0 110.349 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.819 ' OG ' HD21 ' A' ' 274' ' ' LEU . 36.8 t -60.58 -23.77 64.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.54 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -48.05 -33.4 7.99 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -144.6 -18.52 0.19 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 119.083 -1.532 . . . . 0.0 115.755 -178.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.652 ' HB2' ' O ' ' A' ' 247' ' ' VAL . 26.3 p90 -136.61 165.17 26.51 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.132 1.466 . . . . 0.0 113.269 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.988 ' HA3' HD11 ' A' ' 250' ' ' ILE . . . -141.62 163.57 26.84 Favored Glycine 0 CA--C 1.52 0.393 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.516 178.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.584 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -116.89 130.22 56.57 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.446 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.832 HG21 ' CD2' ' A' ' 263' ' ' PHE . 61.2 t -125.94 136.19 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.351 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 53.0 m -114.02 135.92 53.48 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.472 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 49.3 m-85 -115.76 136.35 53.14 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.611 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 21.8 t70 -59.18 -34.82 72.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.535 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 51.0 m -119.69 143.22 47.86 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.375 0.607 . . . . 0.0 111.763 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.55 -31.2 71.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.161 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 296' ' ' ALA . 53.5 p30 -60.8 -33.69 73.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.46 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.574 ' N ' ' OD1' ' A' ' 295' ' ' ASP . . . -62.16 -37.94 87.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.919 0.39 . . . . 0.0 110.65 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.593 ' O ' HG12 ' A' ' 300' ' ' VAL . 75.2 t -61.48 -42.07 92.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.031 0.443 . . . . 0.0 110.61 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -59.52 -37.17 77.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.592 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -58.35 -43.63 88.42 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.053 0.454 . . . . 0.0 111.821 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 1.008 HG23 HD11 ' A' ' 306' ' ' ILE . 1.0 OUTLIER -70.2 -34.4 58.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.456 -179.35 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 79.7 m -59.64 -47.24 86.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.333 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.19 -39.29 94.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.187 0.517 . . . . 0.0 110.419 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.1 m-20 -62.12 -34.75 76.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.772 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.675 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 23.2 tptm 65.39 -73.95 0.06 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.675 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 5.1 m-30 -108.87 134.51 51.45 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.888 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 1.008 HD11 HG23 ' A' ' 300' ' ' VAL . 14.9 mt -116.52 137.84 49.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.073 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.421 ' OD1' ' CE ' ' A' ' 312' ' ' LYS . 73.0 m-20 -75.99 87.53 2.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.68 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 7.8 t80 -97.76 -71.76 0.67 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.385 0.612 . . . . 0.0 110.655 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.629 ' HD2' HG12 ' A' ' 254' ' ' VAL . 4.6 mmpt? -96.69 -164.24 1.13 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.344 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.431 ' OD1' ' HG2' ' A' ' 311' ' ' ARG . 55.8 p30 -59.21 -21.8 60.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.702 0.287 . . . . 0.0 110.792 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.431 ' HG2' ' OD1' ' A' ' 310' ' ' ASP . 24.9 mmm180 -120.67 157.62 29.2 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.615 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.599 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 24.8 mmtm -72.5 154.02 41.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.634 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 249' ' ' GLY . 35.3 pt -117.46 148.86 19.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.118 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -106.48 130.17 54.32 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 0.628 HG12 HG23 ' A' ' 247' ' ' VAL . 81.7 mt -120.94 129.64 75.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.169 0.509 . . . . 0.0 112.231 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -128.99 153.24 47.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.545 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -63.54 144.43 57.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.73 0.3 . . . . 0.0 110.718 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.53 144.68 46.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.629 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 . . . . . 0 C--N 1.331 -0.206 0 CA-C-O 120.811 0.339 . . . . 0.0 111.501 -179.493 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.7 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.715 0.293 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.447 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 80.9 tttt -64.46 138.74 58.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.423 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.542 ' CE ' HG11 ' A' ' 216' ' ' VAL . 89.8 mtp -127.27 157.87 38.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.283 0.563 . . . . 0.0 111.909 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.535 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 1.3 t80 -103.29 129.94 50.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.882 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 21.8 mm -114.07 129.34 70.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.357 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -128.58 163.09 22.14 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.821 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.527 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 76.4 38.37 33.62 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.888 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 75.7 mt -59.52 -25.45 64.5 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.414 ' O ' ' N ' ' A' ' 169' ' ' ASP . 38.7 t-20 72.52 41.02 0.6 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.973 0.416 . . . . 0.0 110.278 -178.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.452 ' CD2' ' HD2' ' A' ' 198' ' ' ARG . 23.5 m0 29.84 38.37 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.33 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 167' ' ' ASN . 58.4 t0 -156.54 28.43 0.33 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.798 0.332 . . . . 0.0 111.462 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.513 HG22 ' CD2' ' A' ' 175' ' ' LEU . 61.0 m -121.44 141.64 50.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 111.002 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.57 ' C ' HD12 ' A' ' 190' ' ' ILE . 15.8 p -117.35 163.09 16.87 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.635 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.779 ' N ' HD12 ' A' ' 190' ' ' ILE . 96.1 mt-10 -57.82 -33.24 68.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.515 ' O ' ' HG2' ' A' ' 176' ' ' ARG . 21.8 t70 -64.02 -41.34 97.47 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.974 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -63.54 -38.79 92.49 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.6 HD12 ' HE2' ' A' ' 179' ' ' PHE . 3.7 mm? -61.41 -40.32 93.96 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 173' ' ' ASP . 0.1 OUTLIER -61.77 -37.38 84.09 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.683 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.47 -37.39 87.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.022 0.439 . . . . 0.0 110.073 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.606 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 64.0 t80 -78.86 -64.72 1.12 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.44 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.6 ' HE2' HD12 ' A' ' 175' ' ' LEU . 78.0 m-85 -68.06 -20.76 64.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.385 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -50.79 -29.04 18.21 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.615 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.837 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -58.86 -41.23 86.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.2 0.524 . . . . 0.0 110.298 179.239 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.837 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 71.3 m-85 -71.04 -33.95 70.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.882 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -172.19 -172.91 38.49 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.881 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 33.9 p -72.72 -11.81 60.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.77 0.319 . . . . 0.0 110.875 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.65 ' O ' HG12 ' A' ' 185' ' ' VAL . 1.1 t 52.2 87.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -177.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 3.3 m -56.69 -43.47 80.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.696 -176.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -150.3 140.93 22.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.244 0.545 . . . . 0.0 112.311 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.554 HD23 ' CG1' ' A' ' 185' ' ' VAL . 0.2 OUTLIER -116.31 134.4 54.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.055 179.001 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 0.3 OUTLIER -131.81 123.6 27.92 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.382 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.779 HD12 ' N ' ' A' ' 172' ' ' GLU . 2.4 mt -125.07 128.09 72.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.396 176.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.496 ' HE1' ' HA2' ' A' ' 203' ' ' GLY . 3.1 mpp? -103.77 141.98 35.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.966 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 199' ' ' SER . 1.8 pttt -131.36 177.04 7.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.047 0.451 . . . . 0.0 111.56 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 74.3 m-20 -119.27 83.08 24.5 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.751 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.6 -26.3 54.44 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.269 1.979 . . . . 0.0 112.096 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.42 -67.4 0.63 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.295 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 56.1 p -70.71 -22.41 62.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.543 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 83.61 21.34 58.24 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.024 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.596 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 16.8 tpp85 -125.43 136.61 53.58 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 121.168 0.509 . . . . 0.0 111.934 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 192' ' ' LYS . 46.8 m -63.38 151.71 40.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.72 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.564 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 26.2 mmm180 -58.38 -32.2 68.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.943 0.401 . . . . 0.0 110.628 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.46 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 95.24 0.17 63.48 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.772 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 36.5 p90 -144.13 159.7 42.18 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.988 0.423 . . . . 0.0 111.067 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.496 ' HA2' ' HE1' ' A' ' 191' ' ' MET . . . -148.1 169.25 28.83 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.556 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.569 ' HB2' ' HB3' ' A' ' 189' ' ' LYS . 96.3 m-85 -110.07 129.19 55.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.092 0.472 . . . . 0.0 110.359 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.803 HD23 ' N ' ' A' ' 206' ' ' SER . 3.6 tt -108.78 132.7 53.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.404 -177.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.803 ' N ' HD23 ' A' ' 205' ' ' LEU . 33.1 t -122.22 131.61 54.02 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.305 178.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 205' ' ' LEU . 88.4 m-85 -118.23 136.92 53.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.057 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.589 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.4 tt0 -61.66 -35.14 77.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.053 0.454 . . . . 0.0 110.304 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -109.6 119.21 48.58 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.733 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.64 -26.6 73.36 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.413 2.075 . . . . 0.0 112.839 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.0 m -58.02 -36.44 72.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.567 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.447 ' O ' HG23 ' A' ' 216' ' ' VAL . 23.5 m -58.16 -34.07 69.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.964 0.411 . . . . 0.0 110.593 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.538 HG13 ' SD ' ' A' ' 161' ' ' MET . 78.0 t -61.0 -39.51 82.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.279 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.457 ' O ' HG22 ' A' ' 217' ' ' VAL . 21.6 t70 -56.0 -42.39 76.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.743 0.306 . . . . 0.0 111.178 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 182' ' ' TYR . 96.4 mt-10 -66.9 -33.61 75.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.071 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.775 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 92.7 t -59.13 -42.85 87.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.734 -178.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 214' ' ' ASP . 20.3 m -72.79 -32.52 40.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.31 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 214' ' ' ASP . 45.0 mmtt -60.57 -34.24 73.87 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.616 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 52.7 m -99.05 138.78 35.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.836 0.35 . . . . 0.0 111.534 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 57.8 tp60 -65.91 -41.64 91.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.078 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.775 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 64.2 m-70 83.04 115.0 0.06 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 178.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.901 HD12 HG12 ' A' ' 227' ' ' VAL . 21.5 mm -117.66 109.35 27.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 175.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.5 tt -122.39 130.48 53.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.061 0.458 . . . . 0.0 111.63 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 57.8 t0 52.84 33.61 14.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.682 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 83.14 5.68 88.84 Favored Glycine 0 CA--C 1.517 0.163 0 C-N-CA 120.588 -0.815 . . . . 0.0 114.665 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.402 ' HD2' ' HB2' ' A' ' 167' ' ' ASN . 36.8 ttmt -133.32 131.96 40.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.816 0.808 . . . . 0.0 111.612 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.901 HG12 HD12 ' A' ' 222' ' ' ILE . 19.6 m -67.83 136.03 27.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.574 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 165' ' ' GLY . 35.6 pt -122.59 157.95 27.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.223 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -127.76 80.06 72.6 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.008 0.432 . . . . 0.0 111.92 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.539 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 47.7 Cg_exo -59.56 136.84 73.87 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 123.188 2.592 . . . . 0.0 111.542 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -138.46 154.54 48.85 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.715 -0.221 . . . . 0.0 110.721 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -57.57 136.97 56.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 0.0 111.319 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -72.36 146.47 47.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.605 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.771 HD12 ' HG2' ' A' ' 239' ' ' GLN . 1.2 pt -134.04 108.48 11.59 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.783 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 234' ' ' ILE . 1.6 Cg_endo -46.87 154.78 0.98 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.105 1.87 . . . . 0.0 110.884 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -51.47 -40.93 60.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.601 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 54.6 p30 -64.68 -38.74 92.01 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.215 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.601 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 96.8 mt-10 -70.48 -35.04 73.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.612 0.244 . . . . 0.0 111.181 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.771 ' HG2' HD12 ' A' ' 234' ' ' ILE . 26.6 mt-30 -59.21 -39.59 83.16 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.021 0.439 . . . . 0.0 110.0 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -62.71 -42.75 99.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.369 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -64.12 -39.65 94.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.542 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 238' ' ' GLU . 53.1 p -68.48 -38.22 80.82 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.879 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 61.54 142.41 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.016 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.543 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 6.8 tptm -131.66 131.04 42.84 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.952 HD12 HG21 ' A' ' 315' ' ' ILE . 8.4 pt -120.23 154.32 23.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.482 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.503 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 88.3 t80 -100.91 132.24 46.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.838 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.826 HG21 ' CZ ' ' A' ' 263' ' ' PHE . 20.6 t -120.4 128.46 76.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.028 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -121.65 -7.34 8.16 Favored Glycine 0 C--N 1.329 0.163 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.441 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.544 ' O ' HG22 ' A' ' 313' ' ' ILE . . . -81.25 9.56 53.66 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.17 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.743 HD11 ' HA3' ' A' ' 287' ' ' GLY . 41.3 pt -111.7 133.68 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 116.968 0.384 . . . . 0.0 111.229 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 159.18 -49.43 0.4 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.693 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.96 -33.57 89.54 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.446 2.097 . . . . 0.0 112.72 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -162.68 64.03 0.2 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.077 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.526 HG21 ' HB ' ' A' ' 250' ' ' ILE . 27.6 m -131.36 156.22 42.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.529 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.68 156.43 79.51 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.449 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.57 -40.14 86.52 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 121.521 1.481 . . . . 0.0 111.562 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.24 -42.99 99.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.289 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' A' ' 262' ' ' PHE . 97.7 mt-10 -68.04 -41.07 82.62 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.95 0.405 . . . . 0.0 111.276 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.675 ' CE1' HD13 ' A' ' 250' ' ' ILE . 82.8 t80 -65.13 -47.84 75.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.12 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 264' ' ' SER . 84.4 tt0 -64.17 -42.03 96.89 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.094 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -76.39 -30.71 57.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.022 0.439 . . . . 0.0 111.085 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.694 ' CZ ' HG21 ' A' ' 306' ' ' ILE . 5.5 t80 -61.83 -64.82 0.81 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.019 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.995 ' CB ' HD11 ' A' ' 269' ' ' ILE . 32.8 m-85 -62.64 -27.51 69.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.064 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.455 ' OG ' ' HA ' ' A' ' 268' ' ' THR . 33.3 t -56.38 -28.53 59.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.087 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -53.13 -34.7 57.92 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.803 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 14.4 p90 -116.71 54.5 0.85 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.907 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.519 ' O ' HG22 ' A' ' 268' ' ' THR . . . 153.06 -12.77 0.61 Allowed Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.775 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.567 ' O ' ' O ' ' A' ' 269' ' ' ILE . 0.5 OUTLIER 66.95 -1.84 1.29 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.995 HD11 ' CB ' ' A' ' 263' ' ' PHE . 77.4 mt 33.54 115.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.622 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 75.7 mt -60.4 -42.06 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.06 176.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -166.16 97.47 0.61 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.927 ' HB2' HG21 ' A' ' 269' ' ' ILE . . . -104.82 142.72 34.22 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -140.07 150.59 44.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.444 0.64 . . . . 0.0 112.141 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.576 ' O ' ' HB2' ' A' ' 275' ' ' MET . 43.5 tp -66.49 -37.54 85.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.713 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.576 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 91.9 mmm 90.73 111.16 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.424 0.69 . . . . 0.0 111.147 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 276' ' ' LEU . 6.2 mp -118.46 124.11 46.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.704 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -62.41 -39.06 92.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.87 0.843 . . . . 0.0 109.045 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -161.09 -106.97 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.083 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -62.34 -37.2 84.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.014 0.435 . . . . 0.0 110.054 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 1.2 t 171.66 68.82 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.75 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -93.19 -75.35 1.3 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.094 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 286' ' ' PHE . 96.0 mm-40 -57.54 -30.7 65.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.171 0.51 . . . . 0.0 110.034 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.485 ' HB2' ' CD2' ' A' ' 274' ' ' LEU . 76.5 p -64.18 163.2 13.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.465 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 284' ' ' ARG . 59.4 ttp180 69.69 6.26 5.63 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.252 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -130.92 -48.02 0.12 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.65 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 40.6 p90 -148.67 166.77 27.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.542 0.211 . . . . 0.0 111.029 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.743 ' HA3' HD11 ' A' ' 250' ' ' ILE . . . -136.72 157.06 23.5 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.263 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.543 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.9 OUTLIER -109.75 129.84 55.58 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.748 0.419 . . . . 0.0 110.552 179.47 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.508 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 48.5 t -126.16 134.22 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.801 ' O ' HG23 ' A' ' 269' ' ' ILE . 30.5 m -123.01 139.44 54.08 Favored 'General case' 0 C--O 1.23 0.063 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 242' ' ' THR . 51.0 m-85 -117.5 140.32 49.77 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.622 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 21.4 t70 -56.34 -34.86 67.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.599 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 51.1 m -119.86 142.74 48.39 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.948 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.47 -32.05 73.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.045 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -56.21 -36.5 68.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.467 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -60.06 -37.07 78.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.408 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.692 HG13 ' CG2' ' A' ' 245' ' ' ILE . 71.4 t -61.79 -44.13 98.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.037 0.446 . . . . 0.0 110.405 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -63.2 -37.48 87.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.1 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -58.38 -43.14 88.37 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.803 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 0.4 OUTLIER -73.45 -32.82 38.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.923 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 83.9 m -57.21 -44.39 83.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -60.43 -40.26 90.42 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.329 0.585 . . . . 0.0 109.812 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 305' ' ' PHE . 88.0 m-20 -60.41 -32.48 71.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.407 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.635 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 22.0 tptt 69.88 -68.2 0.21 Allowed 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.635 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.0 m-30 -115.5 149.72 37.66 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.445 178.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.694 HG21 ' CZ ' ' A' ' 262' ' ' PHE . 23.7 mm -117.23 140.18 41.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.742 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -80.28 39.74 0.46 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.961 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.62 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 6.2 t80 -48.24 -68.4 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.478 ' HD3' ' CZ ' ' A' ' 308' ' ' PHE . 16.9 mmmt -105.6 19.41 20.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.811 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 53.6 t0 69.25 9.69 7.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.732 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -109.88 2.02 19.57 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.037 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.423 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 22.6 mttm 62.2 121.55 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.017 0.437 . . . . 0.0 111.714 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 249' ' ' GLY . 31.6 pt -116.28 147.09 19.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.444 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . 0.564 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 84.7 mt-10 -103.93 132.19 50.43 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.847 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 0.952 HG21 HD12 ' A' ' 245' ' ' ILE . 63.2 mt -120.35 127.98 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.589 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -126.7 148.39 49.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.716 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -55.53 148.3 15.96 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.03 140.92 36.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.139 0.495 . . . . 0.0 111.394 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.63 -179.916 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 4.0 m . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.667 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 8.5 tptm -63.25 134.07 55.27 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.76 0.314 . . . . 0.0 110.342 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.785 ' SD ' HG13 ' A' ' 213' ' ' VAL . 89.8 mmm -123.4 147.28 47.26 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.62 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 3.4 t80 -109.56 126.05 53.17 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.823 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 3.7 mt -121.96 130.16 74.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.112 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.509 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -125.05 156.04 18.84 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.038 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.85 33.34 57.81 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.707 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.607 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 69.7 mt -58.68 -32.45 69.14 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.645 ' O ' ' N ' ' A' ' 169' ' ' ASP . 45.4 t30 110.49 31.22 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.283 0.633 . . . . 0.0 110.99 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.473 ' CG ' ' HD2' ' A' ' 198' ' ' ARG . 6.5 m0 53.04 -49.25 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.645 ' N ' ' O ' ' A' ' 167' ' ' ASN . 50.3 p30 -82.27 9.27 9.16 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 166' ' ' LEU . 85.7 m -68.99 137.81 54.02 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.203 0.525 . . . . 0.0 109.975 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 30.6 m -112.14 148.33 34.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.387 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.662 ' N ' HD12 ' A' ' 190' ' ' ILE . 55.6 mp0 -54.56 -37.51 65.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.555 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 89.5 m-20 -63.2 -40.12 96.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.946 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -61.6 -36.69 81.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.302 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.673 HD23 ' CE2' ' A' ' 179' ' ' PHE . 5.8 mt -55.34 -49.38 72.37 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.555 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -67.05 -31.94 72.8 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.482 179.073 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.43 -39.0 78.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.695 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.636 ' CE2' ' CE2' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -94.08 -55.62 3.14 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.113 179.288 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.823 ' CZ ' HD13 ' A' ' 163' ' ' ILE . 64.0 m-85 -60.72 -28.95 69.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.874 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.93 -23.28 10.86 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.169 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.82 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -54.52 -40.52 68.69 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.882 0.373 . . . . 0.0 111.14 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.82 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 55.5 m-85 -69.32 -31.67 70.29 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.243 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 166.97 -134.41 3.26 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.871 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 57.7 m -117.64 136.89 53.01 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.887 HG23 ' CE1' ' A' ' 207' ' ' PHE . 0.9 OUTLIER -95.0 127.79 46.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.613 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.746 HG23 ' N ' ' A' ' 208' ' ' GLU . 54.0 p -70.18 -35.94 74.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.397 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -148.86 145.24 27.39 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.879 HD22 HG11 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -116.45 129.06 56.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.749 178.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.565 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 7.3 tppt? -138.59 111.36 7.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 172' ' ' GLU . 82.3 mt -125.68 123.13 63.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 174.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.588 ' O ' ' O ' ' A' ' 192' ' ' LYS . 0.0 OUTLIER -59.9 -37.61 79.93 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.084 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.588 ' O ' ' O ' ' A' ' 191' ' ' MET . 26.7 tttt 49.18 149.68 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.268 0.556 . . . . 0.0 112.008 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 9.9 t0 -128.3 78.48 75.52 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.366 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.74 -24.17 61.96 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.408 2.072 . . . . 0.0 112.011 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -73.82 -72.0 0.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.572 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 48.4 p -69.03 -26.21 64.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.624 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.66 7.01 65.22 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.707 -0.759 . . . . 0.0 113.241 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 20.9 tpp180 -124.38 125.78 44.87 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-N 117.267 0.534 . . . . 0.0 111.181 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.1 t -70.27 156.99 38.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.63 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.663 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 83.8 mmt-85 -55.55 -31.75 62.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.705 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 95.78 0.49 62.28 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.675 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.663 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 42.6 p90 -142.47 154.41 44.51 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.418 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -150.45 170.66 30.36 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.666 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.62 ' CE2' ' CD1' ' A' ' 162' ' ' PHE . 89.5 m-85 -107.91 125.55 51.62 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.109 0.481 . . . . 0.0 109.963 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.669 HD11 HG21 ' A' ' 185' ' ' VAL . 16.8 tp -112.61 131.19 55.74 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.197 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.577 ' O ' HG22 ' A' ' 185' ' ' VAL . 49.1 m -120.1 140.39 51.12 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.723 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.887 ' CE1' HG23 ' A' ' 185' ' ' VAL . 78.4 m-85 -121.65 141.88 50.69 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.567 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.746 ' N ' HG23 ' A' ' 186' ' ' THR . 84.5 tt0 -64.45 -34.75 78.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.245 178.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -110.76 115.58 53.27 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.926 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 0.406 ' O ' ' HB ' ' A' ' 213' ' ' VAL . 52.5 Cg_exo -56.25 -25.78 57.83 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.582 2.188 . . . . 0.0 113.033 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.2 m -58.06 -37.42 74.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.0 110.555 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.887 ' O ' HG23 ' A' ' 216' ' ' VAL . 25.0 m -59.97 -34.76 73.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.244 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.785 HG13 ' SD ' ' A' ' 161' ' ' MET . 71.2 t -60.39 -41.0 85.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.214 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -57.4 -44.86 84.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.051 0.453 . . . . 0.0 110.487 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.58 -33.77 73.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.384 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 212' ' ' SER . 74.9 t -59.65 -40.59 82.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.692 -178.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 230' ' ' PRO . 21.3 m -88.87 -38.68 11.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -178.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -60.14 -34.73 73.95 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.495 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 32.2 m -93.37 146.28 23.86 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.438 ' NE2' ' CG2' ' A' ' 227' ' ' VAL . 54.0 tp60 -79.76 140.76 36.8 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.855 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 41.8 m-70 -125.85 139.41 53.51 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -176.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.593 HG22 ' H ' ' A' ' 225' ' ' GLY . 67.7 mt -125.52 114.61 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.347 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.434 ' HG ' ' CD2' ' A' ' 178' ' ' TYR . 1.0 OUTLIER -82.22 -50.83 8.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.04 0.448 . . . . 0.0 111.99 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -142.86 43.68 1.58 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.788 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.593 ' H ' HG22 ' A' ' 222' ' ' ILE . . . 96.17 -0.65 62.22 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.978 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.436 ' CG ' ' OD1' ' A' ' 167' ' ' ASN . 12.2 mmmm -99.36 169.49 9.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.663 0.268 . . . . 0.0 110.352 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.438 ' CG2' ' NE2' ' A' ' 220' ' ' GLN . 14.6 p -118.33 132.91 66.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.948 0.404 . . . . 0.0 110.125 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.642 HD12 ' CG2' ' A' ' 163' ' ' ILE . 35.9 pt -129.41 161.13 39.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.949 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -129.63 81.01 70.64 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.0 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.746 ' O ' HG12 ' A' ' 217' ' ' VAL . 78.1 Cg_exo -54.97 129.48 35.56 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.958 2.438 . . . . 0.0 112.782 -178.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -132.86 154.58 50.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.423 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.604 ' HD3' ' N ' ' A' ' 233' ' ' ALA . 1.5 tmt_? -63.5 135.08 56.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.902 0.382 . . . . 0.0 110.759 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.667 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -63.91 145.77 55.24 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.286 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -109.92 130.67 22.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.479 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.43 ' HG2' ' HB2' ' A' ' 238' ' ' GLU . 9.6 Cg_endo -53.45 138.84 65.87 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 121.772 1.648 . . . . 0.0 110.85 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -56.56 -40.39 75.08 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.16 -45.6 92.53 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.496 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.43 ' HB2' ' HG2' ' A' ' 235' ' ' PRO . 97.1 mt-10 -71.61 -37.32 70.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.599 0.714 . . . . 0.0 109.842 178.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -59.5 -39.48 83.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.979 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -59.51 -39.28 83.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.037 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -60.35 -35.3 75.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.54 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.528 HG21 ' CD1' ' A' ' 270' ' ' ILE . 19.3 p -84.08 162.21 20.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.991 0.424 . . . . 0.0 111.65 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -154.27 118.54 0.87 Allowed Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.13 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 18.2 ttpp -88.49 135.93 33.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.732 0.301 . . . . 0.0 111.127 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.73 HG21 HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -119.51 164.6 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.358 0.599 . . . . 0.0 111.781 -179.012 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.439 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 88.2 t80 -101.27 136.98 40.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.156 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.853 HG23 HG12 ' A' ' 315' ' ' ILE . 9.2 p -129.72 145.13 36.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.107 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.56 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -131.84 165.36 23.44 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 97.31 -2.69 61.25 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.986 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.79 HD11 ' HA3' ' A' ' 287' ' ' GLY . 43.7 pt -117.64 137.92 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-O 121.172 0.511 . . . . 0.0 111.604 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.868 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -174.18 -89.26 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.488 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.66 132.57 43.58 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.455 2.103 . . . . 0.0 112.984 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 51.17 40.17 25.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.818 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 251' ' ' GLY . 29.8 m -105.84 -35.49 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.049 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 254' ' ' VAL . 13.4 mmm180 57.39 132.63 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.76 -30.22 66.09 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.892 1.728 . . . . 0.0 112.35 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 39.0 tttm -61.28 -44.14 97.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.604 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.681 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 98.0 mt-10 -67.0 -39.87 87.22 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.164 0.506 . . . . 0.0 110.599 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.78 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 15.7 t80 -62.55 -45.49 92.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.029 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 257' ' ' LYS . 20.3 pt-20 -69.23 -41.16 77.39 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.795 0.331 . . . . 0.0 111.021 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.412 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.7 pt-20 -74.26 -29.76 61.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.288 0.566 . . . . 0.0 110.157 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.571 ' CZ ' HD11 ' A' ' 313' ' ' ILE . 5.8 t80 -60.94 -57.28 13.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.884 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.701 ' CD2' HG21 ' A' ' 289' ' ' VAL . 3.7 m-85 -65.18 -23.44 67.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.355 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.653 ' N ' HD11 ' A' ' 269' ' ' ILE . 27.2 t -53.97 -30.14 45.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.616 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -53.39 -34.75 58.92 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.105 -0.238 . . . . 0.0 111.116 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.757 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 7.4 p90 -119.0 46.02 1.96 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.21 0.529 . . . . 0.0 111.74 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.486 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 156.31 152.92 6.41 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.916 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 43.0 p -70.28 -25.53 63.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.041 0.448 . . . . 0.0 110.748 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.653 HD11 ' N ' ' A' ' 264' ' ' SER . 76.9 mt 54.55 96.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.111 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.576 HG13 ' CA ' ' A' ' 292' ' ' ASP . 79.3 mt -59.18 -40.61 81.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.207 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 50.3 p30 -169.77 156.55 6.42 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.496 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -155.07 145.32 21.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.866 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -145.45 150.71 36.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.11 0.481 . . . . 0.0 111.852 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.59 ' O ' ' HB2' ' A' ' 275' ' ' MET . 24.7 tp -66.17 -39.75 89.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.229 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.922 ' O ' HD12 ' A' ' 276' ' ' LEU . 94.8 mmm 98.2 151.85 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.495 0.718 . . . . 0.0 109.659 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.922 HD12 ' O ' ' A' ' 275' ' ' MET . 0.3 OUTLIER -162.04 84.44 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.562 0.22 . . . . 0.0 111.427 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -85.89 110.84 19.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.912 0.386 . . . . 0.0 110.621 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.635 ' O ' HG22 ' A' ' 280' ' ' THR . 40.8 mttm 55.95 30.69 16.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.91 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 51.51 43.95 29.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.135 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.635 HG22 ' O ' ' A' ' 278' ' ' LYS . 1.6 t -165.83 -41.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.717 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -55.0 -37.49 62.9 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.475 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.571 ' HG2' ' HB2' ' A' ' 275' ' ' MET . 3.4 tp-100 -109.41 132.51 54.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.747 0.308 . . . . 0.0 111.494 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 282' ' ' GLN . 27.5 p 148.89 -18.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.059 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 51.1 ttt85 -56.46 -37.97 71.03 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.226 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 250' ' ' ILE . . . 144.59 43.08 0.05 OUTLIER Glycine 0 CA--C 1.522 0.503 0 C-N-CA 119.984 -1.103 . . . . 0.0 114.147 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.49 ' CE1' ' OE1' ' A' ' 282' ' ' GLN . 15.5 p90 -140.28 167.47 22.06 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 117.483 0.641 . . . . 0.0 110.409 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.79 ' HA3' HD11 ' A' ' 250' ' ' ILE . . . -147.51 169.28 28.43 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.579 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.445 ' CE2' ' NZ ' ' A' ' 244' ' ' LYS . 0.3 OUTLIER -122.42 124.16 42.99 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 122.346 0.258 . . . . 0.0 111.053 179.429 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.78 HG23 ' CZ ' ' A' ' 259' ' ' PHE . 61.2 t -127.67 138.07 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.033 0.445 . . . . 0.0 112.142 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 44.4 m -116.04 137.09 52.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.241 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.486 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 41.7 m-85 -115.1 135.19 54.47 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.576 ' CA ' HG13 ' A' ' 270' ' ' ILE . 55.1 t0 -59.01 -35.37 73.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.652 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 30.5 t -118.35 139.31 51.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.207 0.527 . . . . 0.0 111.61 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.914 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -64.08 -31.89 73.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.02 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -57.06 -35.61 69.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.299 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.2 -37.33 77.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.705 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.914 HG12 ' O ' ' A' ' 294' ' ' ALA . 6.2 p -58.73 -38.21 70.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.005 0.431 . . . . 0.0 110.662 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -63.3 -37.43 87.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.181 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 302' ' ' GLN . 92.8 mtt-85 -58.23 -41.13 83.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.893 -178.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.757 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 2.3 p -65.12 -33.68 65.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.066 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 74.5 m -56.92 -39.75 75.06 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . 0.409 ' HB3' ' O ' ' A' ' 299' ' ' ARG . 50.6 tp60 -62.77 -35.5 80.03 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.924 177.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.756 ' ND2' HD12 ' A' ' 306' ' ' ILE . 22.9 p30 -101.2 42.76 1.1 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.008 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.638 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 18.7 tptm -16.08 -65.07 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.915 0.388 . . . . 0.0 110.432 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.638 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.1 m-30 -110.22 142.36 41.89 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.756 HD12 ' ND2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -117.01 130.23 72.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.732 179.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -73.18 71.55 1.18 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.535 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 2.9 t80 -62.47 -105.6 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.344 -177.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.46 ' HD2' ' CE1' ' A' ' 308' ' ' PHE . 12.6 mmmm -61.83 -37.17 83.46 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.054 0.454 . . . . 0.0 111.316 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 309' ' ' LYS . 60.3 t0 175.8 -25.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.791 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -111.8 159.43 18.31 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.199 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.628 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 42.4 mttp -72.99 140.48 47.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.333 0.587 . . . . 0.0 111.905 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 305' ' ' PHE . 36.3 pt -119.0 152.79 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.615 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -107.54 131.48 54.29 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.617 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 0.853 HG12 HG23 ' A' ' 247' ' ' VAL . 74.1 mt -119.85 129.71 75.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.38 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 22.9 tttm -133.08 144.37 49.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.5 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -54.1 144.99 18.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.721 0.296 . . . . 0.0 110.314 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.67 140.14 55.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 111.073 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.932 -179.851 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 51.7 t . . . . . 0 C--O 1.23 0.056 0 CA-C-O 121.005 0.431 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.864 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 6.5 tptt -135.07 142.73 46.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.584 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.794 ' SD ' HG13 ' A' ' 213' ' ' VAL . 87.0 mmm -122.21 147.01 46.72 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.58 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 1.6 t80 -108.81 125.6 52.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.036 177.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 202' ' ' PHE . 20.9 mm -118.04 129.71 74.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.613 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -127.06 162.73 21.12 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.007 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.67 36.12 38.58 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.745 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.543 HD22 HG21 ' A' ' 170' ' ' THR . 70.7 mt -59.61 -24.55 63.91 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 72.48 43.78 0.45 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.136 0.494 . . . . 0.0 110.505 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 21.1 m0 31.39 39.38 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.429 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -160.54 46.57 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.353 . . . . 0.0 111.304 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.543 HG21 HD22 ' A' ' 166' ' ' LEU . 90.4 m -123.96 139.92 53.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.019 0.438 . . . . 0.0 110.899 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 33.5 p -119.93 160.07 23.44 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.393 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.535 ' N ' HD12 ' A' ' 190' ' ' ILE . 55.8 mp0 -61.98 -30.54 71.0 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.844 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 88.8 m-20 -61.03 -42.89 99.33 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.907 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -65.93 -38.54 88.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.121 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.979 HD22 HD21 ' A' ' 205' ' ' LEU . 10.6 mt -61.87 -42.47 99.09 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.844 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -65.78 -38.82 90.06 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.893 179.329 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.45 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 84.5 tt0 -70.89 -45.01 65.09 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.134 0.492 . . . . 0.0 110.457 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.984 ' OH ' ' HB2' ' A' ' 221' ' ' HIS . 19.0 t80 -63.17 -45.14 93.2 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.28 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.606 ' CE2' HD23 ' A' ' 175' ' ' LEU . 96.0 m-85 -98.04 2.02 48.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.34 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -58.51 -28.1 61.89 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.358 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.566 ' H ' ' CD ' ' A' ' 181' ' ' LYS . 0.6 OUTLIER -56.72 -42.73 79.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.959 0.885 . . . . 0.0 110.328 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -70.99 -35.19 72.0 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 113.781 -1.554 . . . . 0.0 112.75 -177.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 177.55 -174.37 46.87 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 119.679 -1.248 . . . . 0.0 113.741 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.8 m -63.82 -28.55 69.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.042 -0.579 . . . . 0.0 111.241 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.642 ' CG1' ' O ' ' A' ' 185' ' ' VAL . 0.4 OUTLIER 64.3 87.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -176.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -54.77 -46.15 74.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.033 -176.661 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 186' ' ' THR . 90.8 m-20 -139.25 152.36 47.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.226 0.536 . . . . 0.0 112.012 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.701 HD11 ' CB ' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -125.55 129.08 49.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.505 179.452 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 22.8 tptt -132.33 119.26 20.5 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.488 0.661 . . . . 0.0 112.643 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.535 HD12 ' N ' ' A' ' 172' ' ' GLU . 1.9 mt -128.83 131.95 67.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.662 177.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.622 ' SD ' ' CE2' ' A' ' 202' ' ' PHE . 0.8 OUTLIER -88.77 127.32 35.6 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -133.24 162.74 30.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.979 0.418 . . . . 0.0 111.593 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.578 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 32.3 m-20 -124.81 84.37 58.33 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.348 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.34 -25.42 39.06 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.241 1.961 . . . . 0.0 112.362 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.88 -71.29 0.36 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.9 0.381 . . . . 0.0 111.313 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.4 p -71.8 -21.56 61.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.178 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 80.36 26.76 54.02 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.32 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.578 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 15.8 ttp180 -119.78 149.95 41.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.26 0.552 . . . . 0.0 112.372 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.8 t -108.71 148.41 30.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.593 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.626 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 59.8 mmt-85 -53.35 -29.92 36.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.758 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.514 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 97.56 2.16 58.81 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.137 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.626 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 25.6 p90 -142.96 155.35 44.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.937 0.398 . . . . 0.0 110.819 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.507 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -142.94 161.73 27.52 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.768 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.639 ' HA ' ' O ' ' A' ' 161' ' ' MET . 89.7 m-85 -111.65 130.55 55.73 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.827 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.979 HD21 HD22 ' A' ' 175' ' ' LEU . 44.8 mt -109.35 141.67 41.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.974 0.416 . . . . 0.0 111.667 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 33.1 t -127.15 131.15 50.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.346 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.583 ' CE1' HG23 ' A' ' 185' ' ' VAL . 99.1 m-85 -119.15 140.58 49.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.814 0.34 . . . . 0.0 111.562 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.501 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.3 tt0 -60.87 -34.63 74.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.089 0.471 . . . . 0.0 110.089 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.1 114.08 51.44 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.395 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.74 -26.83 58.58 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.389 2.059 . . . . 0.0 113.005 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.2 m -58.61 -36.17 73.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.775 0.321 . . . . 0.0 111.153 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.422 ' O ' HG23 ' A' ' 216' ' ' VAL . 21.9 m -58.63 -35.04 71.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.049 0.452 . . . . 0.0 110.66 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.794 HG13 ' SD ' ' A' ' 161' ' ' MET . 54.6 t -60.94 -38.67 79.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.784 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -54.2 -42.82 70.16 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.347 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -69.69 -34.34 73.8 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.71 HG12 ' HB2' ' A' ' 230' ' ' PRO . 98.3 t -60.64 -44.77 97.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.967 0.413 . . . . 0.0 111.346 -178.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.597 HG22 ' HE1' ' A' ' 161' ' ' MET . 41.9 t -76.77 -51.68 18.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 7.8 tptm -61.17 -40.5 94.14 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 220' ' ' GLN . 88.7 m -59.0 -38.27 78.81 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 219' ' ' THR . 63.7 tt0 60.69 111.7 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -177.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.984 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -139.92 167.12 22.84 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -176.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.814 HG23 ' C ' ' A' ' 226' ' ' LYS . 3.6 mp -118.0 126.05 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.207 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.757 HD12 ' CG ' ' A' ' 178' ' ' TYR . 7.5 tt -119.0 132.21 56.05 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.157 0.503 . . . . 0.0 111.744 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.516 ' HB2' HD23 ' A' ' 223' ' ' LEU . 19.5 t70 63.81 28.82 14.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.093 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 94.11 -14.3 65.58 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.542 -0.837 . . . . 0.0 115.037 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.814 ' C ' HG23 ' A' ' 222' ' ' ILE . 66.6 mttt -113.49 137.54 51.41 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 117.953 0.877 . . . . 0.0 112.338 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.809 HG12 HG12 ' A' ' 222' ' ' ILE . 33.7 m -64.77 128.27 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.282 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.613 HG22 ' O ' ' A' ' 164' ' ' GLY . 37.6 pt -124.28 155.1 31.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.045 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.1 76.69 78.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.295 0.569 . . . . 0.0 110.619 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.71 ' HB2' HG12 ' A' ' 216' ' ' VAL . 80.2 Cg_exo -53.0 128.67 29.86 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.12 2.547 . . . . 0.0 111.537 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -139.03 148.3 43.22 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.317 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.692 ' HE ' HG11 ' A' ' 213' ' ' VAL . 15.2 mmt85 -48.97 138.76 11.14 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.12 0.485 . . . . 0.0 111.523 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.864 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -75.72 146.07 40.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.98 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.84 129.1 24.8 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.417 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.04 149.15 21.8 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 121.915 1.744 . . . . 0.0 110.911 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 52.6 mmm-85 -54.62 -40.44 68.93 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.671 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -64.57 -40.32 95.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.596 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -65.51 -36.39 83.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.6 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -60.14 -37.59 80.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.991 0.424 . . . . 0.0 110.521 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -60.07 -38.62 83.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.129 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -59.68 -35.58 74.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.665 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.454 HG22 ' HA ' ' A' ' 292' ' ' ASP . 20.7 p -87.13 161.86 17.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.005 0.431 . . . . 0.0 111.666 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -142.87 113.91 0.82 Allowed Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.722 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 33.0 ttpt -85.33 140.75 30.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.96 0.409 . . . . 0.0 111.599 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 1.059 HD12 HG21 ' A' ' 315' ' ' ILE . 10.1 pt -118.36 160.52 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.488 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 315' ' ' ILE . 84.6 t80 -99.63 132.46 44.96 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 287' ' ' GLY . 14.0 p -128.55 145.34 35.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.639 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.41 166.11 19.32 Favored Glycine 0 C--O 1.226 -0.378 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.92 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 78.41 30.81 48.33 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.262 -0.971 . . . . 0.0 111.799 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.698 HD11 HG13 ' A' ' 247' ' ' VAL . 34.7 mm -55.27 -46.61 78.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 81.47 126.41 0.81 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.024 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -56.49 -29.56 78.71 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.604 2.202 . . . . 0.0 113.332 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -91.64 10.66 27.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.391 . . . . 0.0 111.388 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.67 ' HB ' ' O ' ' A' ' 250' ' ' ILE . 13.0 p -56.24 -40.9 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.524 ' N ' HG13 ' A' ' 254' ' ' VAL . 11.2 tpp85 63.59 116.08 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -176.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -50.29 -30.4 26.23 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 121.994 1.796 . . . . 0.0 112.561 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -60.51 -42.13 95.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.315 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 77.5 mm-40 -68.24 -39.66 82.21 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.049 0.452 . . . . 0.0 111.556 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.561 ' CZ ' HG22 ' A' ' 289' ' ' VAL . 40.6 t80 -62.63 -47.01 85.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.782 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.19 -42.43 93.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.694 0.283 . . . . 0.0 111.556 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -78.18 -31.16 49.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.806 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.506 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 15.1 t80 -60.66 -57.1 14.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.153 0.501 . . . . 0.0 111.698 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.708 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 16.9 m-85 -66.38 -23.8 66.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.715 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.703 ' N ' HD11 ' A' ' 269' ' ' ILE . 25.2 t -56.64 -30.51 63.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.527 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -53.55 -36.62 62.04 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.855 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 9.2 p90 -116.82 42.76 2.41 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.119 0.485 . . . . 0.0 111.51 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.546 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 156.97 148.42 5.09 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.824 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.437 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 50.1 m -59.85 -36.92 77.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.729 0.3 . . . . 0.0 111.72 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.703 HD11 ' N ' ' A' ' 264' ' ' SER . 69.9 mt 69.86 77.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.394 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.522 HG12 ' CA ' ' A' ' 292' ' ' ASP . 35.4 mm -59.84 -40.97 84.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.806 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -154.28 86.71 1.16 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.586 ' HB2' HG23 ' A' ' 269' ' ' ILE . . . -101.85 131.26 48.29 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -143.66 152.57 41.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.504 0.668 . . . . 0.0 112.712 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 1.023 HD23 HD11 ' A' ' 276' ' ' LEU . 21.1 tp -68.43 -31.57 70.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.783 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.718 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 10.3 mmm 92.86 -86.61 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.001 0.92 . . . . 0.0 112.721 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 1.023 HD11 HD23 ' A' ' 274' ' ' LEU . 5.9 mp 62.27 145.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.227 0.537 . . . . 0.0 111.268 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 51.6 p30 -113.08 -132.24 0.33 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.388 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -55.99 -32.45 63.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.51 ' OD1' HG23 ' A' ' 280' ' ' THR . 61.1 t0 -149.81 -108.0 0.07 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.736 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.51 HG23 ' OD1' ' A' ' 279' ' ' ASP . 64.4 p -108.4 20.08 19.04 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -52.44 -39.3 52.3 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 119.645 -1.264 . . . . 0.0 111.975 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.574 ' HB3' ' HA ' ' A' ' 276' ' ' LEU . 13.1 tm0? -64.98 -32.83 74.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.039 0.447 . . . . 0.0 111.424 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 48.0 p -57.2 -10.08 1.14 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.777 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -50.4 -36.95 35.16 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 121.406 -0.118 . . . . 0.0 110.908 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 151.57 26.72 0.05 OUTLIER Glycine 0 CA--C 1.524 0.601 0 C-N-CA 119.423 -1.37 . . . . 0.0 115.567 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.571 ' HA ' ' HA2' ' A' ' 248' ' ' GLY . 13.4 p90 -138.78 157.01 46.87 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.722 1.261 . . . . 0.0 111.184 178.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.742 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -148.26 166.02 29.02 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.777 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -113.52 130.03 56.43 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.629 ' HB ' HG12 ' A' ' 245' ' ' ILE . 40.8 t -125.57 133.34 69.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.849 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 52.2 m -114.79 135.38 54.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.546 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 24.5 m-85 -120.02 139.34 52.65 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.522 ' CA ' HG12 ' A' ' 270' ' ' ILE . 53.0 t0 -58.82 -36.93 75.31 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.763 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 99.8 p -123.12 147.73 46.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.406 0.622 . . . . 0.0 111.715 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.43 -30.55 70.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.439 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -55.56 -40.36 71.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.332 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.648 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -65.18 -37.58 87.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.792 0.329 . . . . 0.0 110.413 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.815 HG13 HG22 ' A' ' 245' ' ' ILE . 69.4 t -62.08 -49.07 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 CA-C-O 121.179 0.514 . . . . 0.0 109.738 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -66.68 -35.5 80.29 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.874 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.584 ' HD3' ' HB2' ' A' ' 266' ' ' TRP . 62.3 ttt-85 -56.19 -45.77 79.68 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.083 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.855 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 2.1 p -71.84 -35.35 54.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.964 0.411 . . . . 0.0 111.214 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 74.0 m -59.07 -40.74 86.12 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.701 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -57.57 -34.66 69.44 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.312 0.577 . . . . 0.0 109.843 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 305' ' ' PHE . 81.6 m-20 -83.85 4.77 27.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.686 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.706 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 30.7 tptt 44.04 -82.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.323 0.249 . . . . 0.0 110.575 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.719 ' HB3' ' HB3' ' A' ' 312' ' ' LYS . 3.1 m-30 -105.31 135.92 45.8 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.12 0.486 . . . . 0.0 110.269 178.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.694 ' CD1' HG23 ' A' ' 300' ' ' VAL . 0.9 OUTLIER -115.01 134.92 56.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.661 178.653 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -69.36 130.36 42.35 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.807 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.573 ' HE2' HG23 ' A' ' 254' ' ' VAL . 17.7 t80 -150.25 -72.56 0.17 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.89 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.46 ' HE3' ' CE2' ' A' ' 308' ' ' PHE . 4.0 mmpt? -91.96 -176.53 4.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.261 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -50.14 -30.57 11.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.911 0.386 . . . . 0.0 110.384 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -117.56 152.74 34.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.903 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.719 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 62.6 mttp -62.18 148.77 43.52 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.115 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.639 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 28.4 pt -107.81 138.63 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . 0.603 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 81.9 mt-10 -104.55 132.89 50.28 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 1.059 HG21 HD12 ' A' ' 245' ' ' ILE . 82.6 mt -119.31 128.55 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 121.394 0.616 . . . . 0.0 111.744 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -131.25 146.07 52.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.838 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -49.79 145.46 5.31 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.234 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.45 142.5 43.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.138 0.494 . . . . 0.0 111.463 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.477 179.806 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.676 ' SG ' HG21 ' A' ' 213' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 121.115 0.483 . . . . 0.0 110.039 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.792 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 6.7 tptm -117.92 135.65 53.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.639 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.925 ' SD ' HG13 ' A' ' 213' ' ' VAL . 89.0 mmm -117.72 145.19 44.62 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.628 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 3.3 t80 -110.43 130.79 55.48 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.477 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.785 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 19.9 mm -116.87 127.68 74.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.578 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.48 ' O ' ' HB ' ' A' ' 228' ' ' ILE . . . -128.81 161.52 22.42 Favored Glycine 0 CA--C 1.505 -0.562 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.518 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.418 ' C ' HG22 ' A' ' 228' ' ' ILE . . . 77.59 27.69 58.7 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.96 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.969 HD23 HG21 ' A' ' 228' ' ' ILE . 72.9 mt -86.45 140.44 29.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.636 0.255 . . . . 0.0 111.176 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -63.63 135.42 56.75 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.541 ' CE2' ' HD2' ' A' ' 198' ' ' ARG . 4.1 m-90 -53.6 143.21 20.61 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.176 -0.609 . . . . 0.0 109.906 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 168' ' ' TRP . 53.7 t0 74.21 36.53 0.66 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.742 -177.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.596 HG21 HD13 ' A' ' 166' ' ' LEU . 90.0 m -59.98 -34.67 73.62 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.17 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.508 ' C ' HD12 ' A' ' 190' ' ' ILE . 0.0 OUTLIER 59.66 127.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -178.519 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.765 ' N ' HD12 ' A' ' 190' ' ' ILE . 55.1 mp0 -58.15 -31.62 67.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.361 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.598 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.9 m-20 -55.46 -41.22 72.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.761 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 170' ' ' THR . 85.7 m-20 -64.83 -37.63 88.26 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.871 HD22 HD21 ' A' ' 205' ' ' LEU . 4.8 mt -60.51 -45.41 93.91 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.598 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -67.68 -34.84 77.71 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.363 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.29 -37.96 89.28 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.028 0.442 . . . . 0.0 109.851 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.43 ' OH ' ' HB3' ' A' ' 221' ' ' HIS . 67.3 t80 -80.58 -61.47 1.96 Allowed 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.437 0.637 . . . . 0.0 110.936 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.604 ' CE2' HD23 ' A' ' 175' ' ' LEU . 72.2 m-85 -66.04 -25.68 67.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.776 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.25 -26.11 12.82 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.241 -0.98 . . . . 0.0 110.738 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.524 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 0.1 OUTLIER -54.29 -46.05 72.67 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.511 0.724 . . . . 0.0 111.02 179.007 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -70.31 -35.33 73.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.701 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 171.36 -169.89 42.86 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.19 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 48.1 m -84.0 138.48 33.08 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 206' ' ' SER . 7.1 p -102.34 124.37 56.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.793 HG23 ' N ' ' A' ' 208' ' ' GLU . 69.4 p -69.63 -40.6 76.46 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.792 0.33 . . . . 0.0 111.136 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.501 ' OD1' ' O ' ' A' ' 186' ' ' THR . 86.3 m-20 -149.11 161.99 40.87 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.342 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' A' ' 175' ' ' LEU . 0.0 OUTLIER -138.4 144.23 40.13 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.207 -178.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 11.2 tptt -140.5 121.57 14.69 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 178.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.765 HD12 ' N ' ' A' ' 172' ' ' GLU . 11.4 mt -124.56 130.82 73.39 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.796 176.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.619 ' HB2' ' HB2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -86.2 109.12 18.69 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -121.4 148.11 44.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.733 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 198' ' ' ARG . 10.7 t0 -123.76 77.46 56.83 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -56.73 -23.25 48.71 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.678 2.252 . . . . 0.0 112.758 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.66 -74.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.53 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.1 p -69.75 -26.05 64.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.03 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.87 -2.97 67.04 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.389 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.541 ' HD2' ' CE2' ' A' ' 168' ' ' TRP . 9.8 tpp85 -129.41 137.0 50.66 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.73 -167.22 1.94 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.391 0.615 . . . . 0.0 112.48 -178.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.947 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 66.8 mmt-85 -53.52 -38.49 63.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.474 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 166' ' ' LEU . . . 81.2 18.05 70.28 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.955 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.947 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 32.2 p90 -139.52 159.81 41.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.669 0.271 . . . . 0.0 110.534 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.571 ' HA2' ' HE2' ' A' ' 191' ' ' MET . . . -142.51 160.07 27.28 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.948 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.628 ' CE2' ' CD1' ' A' ' 162' ' ' PHE . 97.5 m-85 -108.37 129.05 55.26 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.871 HD21 HD22 ' A' ' 175' ' ' LEU . 65.7 mt -108.31 142.05 39.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.939 0.399 . . . . 0.0 111.969 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.7 ' O ' HG23 ' A' ' 185' ' ' VAL . 33.8 t -125.01 128.2 48.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.314 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -117.02 138.93 51.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.95 0.405 . . . . 0.0 111.975 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.793 ' N ' HG23 ' A' ' 186' ' ' THR . 84.4 tt0 -62.81 -34.52 77.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.727 178.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.92 117.48 53.72 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.509 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.04 -21.13 33.14 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.639 2.226 . . . . 0.0 113.296 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.7 m -57.31 -39.02 74.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.617 0.246 . . . . 0.0 111.553 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.931 ' O ' HG23 ' A' ' 216' ' ' VAL . 21.2 m -60.82 -37.53 82.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.818 0.342 . . . . 0.0 110.696 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.925 HG13 ' SD ' ' A' ' 161' ' ' MET . 62.0 t -61.51 -43.81 97.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.376 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -61.47 -41.43 97.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.931 0.396 . . . . 0.0 111.045 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.462 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 21.7 pt-20 -76.76 -29.44 56.11 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 212' ' ' SER . 79.5 t -61.85 -43.89 98.03 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-O 121.027 0.442 . . . . 0.0 110.639 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 50.1 t -71.87 -45.53 64.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -60.15 -38.76 84.12 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.475 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 35.5 m -81.72 144.28 31.24 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -80.21 138.67 36.88 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.836 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 41.0 m-70 -122.34 132.16 54.25 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -176.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.86 HD12 HG12 ' A' ' 227' ' ' VAL . 29.1 mm -122.24 110.56 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.492 HD23 ' CG ' ' A' ' 224' ' ' ASP . 7.7 tt -122.4 126.72 48.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.926 0.393 . . . . 0.0 111.061 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.492 ' CG ' HD23 ' A' ' 223' ' ' LEU . 84.9 m-20 55.4 41.81 30.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.226 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 74.32 14.03 81.06 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.707 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -125.73 152.63 45.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.981 0.39 . . . . 0.0 111.721 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.86 HG12 HD12 ' A' ' 222' ' ' ILE . 27.5 m -99.89 130.64 48.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.312 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.969 HG21 HD23 ' A' ' 166' ' ' LEU . 33.6 pt -126.04 158.44 35.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.396 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.57 80.48 71.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.159 0.504 . . . . 0.0 110.786 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.558 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 61.8 Cg_exo -56.66 127.97 28.1 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 123.07 2.513 . . . . 0.0 112.096 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 8.8 mtmm -133.13 156.06 48.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.008 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -60.14 137.18 58.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.769 0.318 . . . . 0.0 110.98 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.792 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -64.34 144.52 57.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.269 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.483 HG22 ' HD2' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -122.41 137.03 27.1 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.645 179.304 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.5 ' HD2' ' OE1' ' A' ' 238' ' ' GLU . 34.8 Cg_exo -56.26 145.05 79.43 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 121.923 1.749 . . . . 0.0 110.727 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.411 ' C ' ' HD3' ' A' ' 236' ' ' ARG . 4.2 tmt_? -55.38 -40.97 71.99 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.931 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -61.72 -41.76 98.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.436 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.5 ' OE1' ' HD2' ' A' ' 235' ' ' PRO . 94.4 mt-10 -66.14 -35.25 79.99 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.906 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -59.98 -37.0 78.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.07 0.462 . . . . 0.0 110.259 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -59.79 -38.17 81.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.975 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -58.66 -37.98 77.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.193 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 19.2 p -84.8 161.98 19.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.114 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.04 161.74 24.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.809 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.482 ' HD2' ' CE2' ' A' ' 288' ' ' PHE . 7.6 ttpm? -138.7 131.99 30.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.812 0.306 . . . . 0.0 111.182 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.675 ' CG2' HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -120.9 162.52 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 121.409 0.623 . . . . 0.0 112.23 -178.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.522 ' HB3' ' O ' ' A' ' 316' ' ' LYS . 85.1 t80 -104.19 138.22 40.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.746 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.704 HG23 HG12 ' A' ' 315' ' ' ILE . 9.2 p -131.99 147.61 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.546 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -125.99 165.18 19.28 Favored Glycine 0 C--O 1.226 -0.389 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 178.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 85.59 14.66 67.56 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.586 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.666 ' CG2' HG11 ' A' ' 254' ' ' VAL . 35.8 mm -54.95 -45.7 76.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 1.015 ' O ' HG12 ' A' ' 254' ' ' VAL . . . 59.44 129.77 0.01 OUTLIER Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.961 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.93 -27.11 52.23 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.326 2.017 . . . . 0.0 113.137 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -59.25 -33.97 71.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.919 0.39 . . . . 0.0 111.427 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 1.015 HG12 ' O ' ' A' ' 251' ' ' GLY . 7.1 p -50.5 -39.55 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.443 ' N ' HG13 ' A' ' 254' ' ' VAL . 7.7 tpt180 68.11 126.65 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.445 ' HB3' ' HG ' ' A' ' 274' ' ' LEU . 8.9 Cg_endo -51.08 -26.62 19.56 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 121.904 1.736 . . . . 0.0 112.827 -177.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -62.01 -45.5 93.34 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 78.2 mm-40 -66.38 -38.41 87.48 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.701 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 40.6 t80 -60.88 -45.56 94.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.166 -178.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.49 -43.4 97.37 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.594 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -78.12 -28.52 48.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.013 0.435 . . . . 0.0 111.012 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.599 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 4.3 t80 -59.12 -58.61 7.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.918 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.702 ' CG ' HG21 ' A' ' 289' ' ' VAL . 5.8 m-85 -63.51 -23.63 67.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.218 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.685 ' N ' HD11 ' A' ' 269' ' ' ILE . 23.1 t -55.13 -29.82 58.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.842 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -52.35 -35.47 51.17 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.361 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.68 ' CZ2' ' CD2' ' A' ' 263' ' ' PHE . 9.0 p90 -116.13 41.72 2.53 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.215 0.531 . . . . 0.0 111.526 179.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.509 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 159.39 157.12 8.38 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.81 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 4.5 t -73.45 -25.19 60.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.339 . . . . 0.0 111.011 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.685 HD11 ' N ' ' A' ' 264' ' ' SER . 75.1 mt 58.11 124.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.768 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.562 HD11 ' HB2' ' A' ' 292' ' ' ASP . 25.3 mm -93.2 -74.45 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.14 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -92.09 -72.54 0.59 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.793 0.33 . . . . 0.0 111.738 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 289' ' ' VAL . . . 46.56 101.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.353 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . 0.509 ' HG3' ' HG2' ' A' ' 275' ' ' MET . 14.1 pt20 -143.17 158.22 43.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.115 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.607 ' HB3' ' CD ' ' A' ' 282' ' ' GLN . 42.6 mt -63.78 -33.98 76.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.181 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.698 ' O ' ' HB3' ' A' ' 282' ' ' GLN . 8.0 mtm 68.11 71.13 0.32 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.634 0.254 . . . . 0.0 110.96 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.542 HD23 ' HG2' ' A' ' 282' ' ' GLN . 9.7 mt -76.4 126.64 31.36 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.129 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -58.93 -38.17 78.37 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.888 0.852 . . . . 0.0 108.726 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -157.34 -101.05 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 113.993 -1.458 . . . . 0.0 108.026 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.782 ' O ' HG23 ' A' ' 280' ' ' THR . 89.5 m-20 -62.77 -39.08 93.06 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.574 178.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.5 OUTLIER 170.77 50.07 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.005 -179.729 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -56.16 -38.38 76.79 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.092 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.698 ' HB3' ' O ' ' A' ' 275' ' ' MET . 4.8 pp0? -61.81 -30.07 70.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.197 0.522 . . . . 0.0 111.632 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 52.2 p -54.55 -14.18 1.21 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.626 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -51.33 -36.64 43.7 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 121.332 -0.147 . . . . 0.0 110.775 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 157.37 23.75 0.03 OUTLIER Glycine 0 CA--C 1.526 0.721 0 C-N-CA 119.596 -1.288 . . . . 0.0 115.379 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.459 ' HA ' ' HA2' ' A' ' 248' ' ' GLY . 2.0 p90 -138.43 163.17 32.59 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.672 1.236 . . . . 0.0 111.073 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.691 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -142.17 159.83 27.11 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.525 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.496 ' CD2' ' SD ' ' A' ' 275' ' ' MET . 0.1 OUTLIER -122.41 124.17 43.02 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.702 HG21 ' CG ' ' A' ' 263' ' ' PHE . 52.4 t -125.89 136.19 61.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.083 0.468 . . . . 0.0 111.501 178.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 55.7 m -116.44 136.24 53.16 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.509 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 42.8 m-85 -114.1 136.92 52.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.355 0.598 . . . . 0.0 112.398 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.562 ' HB2' HD11 ' A' ' 270' ' ' ILE . 51.7 t0 -57.09 -36.11 70.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.638 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 50.4 m -121.97 145.2 48.35 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.337 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.912 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -65.77 -28.99 69.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.531 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -54.68 -35.62 63.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.872 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.45 -39.26 83.03 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.912 HG12 ' O ' ' A' ' 294' ' ' ALA . 7.3 p -60.0 -37.51 72.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.974 0.416 . . . . 0.0 111.331 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -61.98 -39.31 91.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.846 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -61.08 -43.83 98.29 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.649 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 0.9 OUTLIER -69.38 -34.1 60.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.32 -179.322 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 89.5 m -57.77 -45.28 86.18 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.062 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -62.23 -39.72 93.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.213 0.53 . . . . 0.0 109.883 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.6 m-20 -62.38 -33.64 75.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.123 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.638 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 22.6 tptm 68.47 -69.06 0.16 Allowed 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -177.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.638 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.4 m-30 -116.28 151.11 36.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.121 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.625 HD11 HG23 ' A' ' 300' ' ' VAL . 8.4 mm -116.53 136.35 53.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.502 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -79.93 65.12 4.98 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.599 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 3.9 t80 -65.86 -63.44 1.09 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.461 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 5.5 mmpt? -105.91 38.79 1.92 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.376 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 61.47 34.24 18.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -175.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -151.01 163.96 37.52 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 113.167 -1.833 . . . . 0.0 107.351 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 68.5 mttt -97.15 136.26 37.92 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.514 0.673 . . . . 0.0 112.711 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 305' ' ' PHE . 36.3 pt -117.62 150.95 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . 0.535 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 87.7 mt-10 -106.06 133.35 50.91 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.86 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 0.704 HG12 HG23 ' A' ' 247' ' ' VAL . 74.3 mt -122.59 129.32 75.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.227 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.522 ' O ' ' HB3' ' A' ' 246' ' ' PHE . 8.8 tptt -133.94 141.22 47.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.717 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -53.69 150.56 7.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.669 0.271 . . . . 0.0 110.332 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -49.69 142.86 7.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.948 0.404 . . . . 0.0 111.232 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.718 -179.06 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 43.5 t . . . . . 0 CA--C 1.529 0.144 0 CA-C-O 120.755 0.312 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -138.94 137.41 36.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.099 0.475 . . . . 0.0 111.198 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.827 ' SD ' HG13 ' A' ' 213' ' ' VAL . 94.6 mmm -113.56 148.07 36.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.26 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.583 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 2.9 t80 -104.06 127.79 51.64 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 203' ' ' GLY . 20.3 mm -116.71 129.1 73.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.734 0.302 . . . . 0.0 111.364 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -133.33 163.27 24.36 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 178.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.84 36.63 52.37 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.981 -1.104 . . . . 0.0 112.024 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 64.3 mt -59.36 -26.73 65.33 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 52.2 t30 69.67 40.38 1.38 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -177.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 15.4 m0 30.9 38.5 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 114.636 -1.166 . . . . 0.0 112.76 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -164.34 13.56 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.789 HG22 ' HB2' ' A' ' 175' ' ' LEU . 63.1 m -60.74 -38.17 84.24 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.569 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.1 OUTLIER 51.92 135.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.178 0.514 . . . . 0.0 111.591 -179.432 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.574 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 97.8 mt-10 -61.15 -33.77 73.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.028 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.43 ' O ' ' HG3' ' A' ' 177' ' ' GLU . 91.5 m-20 -59.37 -44.49 92.71 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.629 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 170' ' ' THR . 81.9 m-20 -77.16 -42.23 38.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.376 0.608 . . . . 0.0 110.735 178.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.789 ' HB2' HG22 ' A' ' 170' ' ' THR . 41.1 tp -66.63 -48.75 68.46 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.419 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.505 ' HG3' HG11 ' A' ' 185' ' ' VAL . 68.0 ttp85 -63.13 -44.42 95.63 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.806 0.336 . . . . 0.0 111.015 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 173' ' ' ASP . 98.3 mt-10 -67.03 -37.29 83.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.476 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.663 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 69.5 t80 -61.16 -48.21 82.64 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.1 0.476 . . . . 0.0 110.864 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -82.76 -12.06 57.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.885 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.17 -29.85 53.33 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 177.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.499 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 0.3 OUTLIER -56.48 -45.27 81.01 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.307 -0.947 . . . . 0.0 110.764 178.761 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -70.64 -33.66 71.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.331 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -173.38 -179.7 44.22 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.26 -0.971 . . . . 0.0 113.166 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 46.6 m -63.07 -31.09 72.15 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.833 HG23 ' CE1' ' A' ' 207' ' ' PHE . 1.2 t 63.95 85.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -177.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -59.22 -50.98 71.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.019 -178.005 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 206' ' ' SER . 60.7 t0 -147.49 105.87 3.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.171 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.99 ' O ' HD13 ' A' ' 188' ' ' LEU . 0.0 OUTLIER -97.93 144.44 27.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.903 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.869 ' N ' HD22 ' A' ' 188' ' ' LEU . 30.7 tptt -127.26 128.68 46.41 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.627 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.574 ' HB ' ' HG2' ' A' ' 172' ' ' GLU . 1.5 tt -117.82 -10.35 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.845 -0.162 . . . . 0.0 111.428 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.84 ' HE3' ' O ' ' A' ' 202' ' ' PHE . 17.0 mtm 51.44 150.18 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.987 0.422 . . . . 0.0 111.543 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.4 ' HG3' ' HD3' ' A' ' 194' ' ' PRO . 7.5 ptmt -134.5 163.66 29.21 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.095 0.474 . . . . 0.0 112.223 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.642 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 1.3 t70 -124.23 76.55 60.64 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.619 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.4 ' HD3' ' HG3' ' A' ' 192' ' ' LYS . 38.8 Cg_exo -58.03 -25.46 70.66 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.711 2.274 . . . . 0.0 112.98 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -68.94 -66.66 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.32 . . . . 0.0 111.588 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.0 p -71.98 -20.31 61.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.772 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 88.07 12.88 65.1 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.369 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.642 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 55.5 mtt180 -118.47 167.75 11.3 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 121.094 0.473 . . . . 0.0 112.253 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.9 t -69.71 152.19 44.95 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.254 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.897 ' HG3' ' CE1' ' A' ' 202' ' ' PHE . 15.2 tpt180 -52.68 -32.02 40.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.977 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.406 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 98.1 -4.11 60.57 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.485 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.897 ' CE1' ' HG3' ' A' ' 200' ' ' ARG . 12.1 p90 -151.41 159.45 44.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.721 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -152.71 150.43 22.22 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.274 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.666 ' HA ' ' O ' ' A' ' 161' ' ' MET . 94.8 m-85 -106.78 125.63 51.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.081 0.44 . . . . 0.0 109.82 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 161' ' ' MET . 46.6 mt -103.1 138.92 39.3 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.911 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 23.2 t -123.17 132.77 54.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.119 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.833 ' CE1' HG23 ' A' ' 185' ' ' VAL . 96.9 m-85 -117.89 140.55 49.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 111.695 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.424 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.2 tt0 -60.66 -34.12 73.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.198 0.523 . . . . 0.0 109.673 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.2 115.17 50.36 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.609 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.62 -21.76 32.81 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.665 2.244 . . . . 0.0 113.22 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.5 m -56.86 -35.7 69.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.726 0.298 . . . . 0.0 111.307 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.923 ' O ' HG23 ' A' ' 216' ' ' VAL . 32.3 m -58.49 -36.96 74.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.851 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.827 HG13 ' SD ' ' A' ' 161' ' ' MET . 63.0 t -60.83 -42.02 90.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.179 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.423 ' O ' HG12 ' A' ' 217' ' ' VAL . 94.6 m-20 -59.29 -40.64 86.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.877 0.37 . . . . 0.0 111.177 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.401 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 12.9 pt-20 -80.81 -27.38 36.59 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 212' ' ' SER . 53.1 t -62.07 -45.77 97.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 CA-C-O 120.773 0.32 . . . . 0.0 111.693 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 214' ' ' ASP . 8.3 p -60.01 -36.55 68.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -60.96 -35.87 77.89 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.753 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 29.6 m -80.66 143.27 33.19 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 93.1 mt-30 -65.97 -36.83 84.37 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.863 ' HB3' HD11 ' A' ' 228' ' ' ILE . 82.4 m-70 78.4 44.33 0.07 Allowed 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 75.4 mt -75.38 82.2 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.2 tt -82.52 -75.47 0.31 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -176.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 49.2 p30 -94.67 13.22 25.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.582 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 95.17 7.4 59.56 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.052 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.12 137.0 52.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.6 p -69.73 126.17 29.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.277 0.56 . . . . 0.0 111.773 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.863 HD11 ' HB3' ' A' ' 221' ' ' HIS . 34.5 pt -124.84 157.52 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.329 178.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.8 77.21 76.6 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.202 0.525 . . . . 0.0 112.4 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.637 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 35.0 Cg_exo -63.55 84.98 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 123.087 2.524 . . . . 0.0 111.653 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -100.73 157.13 16.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.825 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.507 ' HD3' HG11 ' A' ' 213' ' ' VAL . 37.7 tpt85 -60.27 137.04 58.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.935 0.397 . . . . 0.0 111.574 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -59.91 145.79 44.58 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.06 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 9.7 mt -109.51 124.36 34.05 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.282 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.69 143.44 57.87 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 121.802 1.668 . . . . 0.0 110.753 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 32.5 mmm180 -57.53 -39.27 76.2 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.695 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 55.2 p30 -63.88 -41.69 97.67 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.978 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.613 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 97.5 mt-10 -73.43 -37.92 65.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.558 0.694 . . . . 0.0 109.703 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -60.41 -39.98 89.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.314 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -59.52 -40.24 86.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.211 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -61.13 -35.05 76.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.148 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 292' ' ' ASP . 16.3 p -82.87 161.39 21.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.392 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -149.03 173.02 29.05 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.193 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.56 ' O ' ' HB2' ' A' ' 318' ' ' ALA . 6.9 tptm -135.01 131.7 37.41 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.728 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -121.48 162.24 20.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.348 0.594 . . . . 0.0 111.011 179.486 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -104.6 136.56 43.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.35 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.75 HG11 ' CE1' ' A' ' 259' ' ' PHE . 14.7 p -131.49 147.87 32.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.422 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -129.11 166.59 21.46 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.404 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 84.2 22.79 53.8 Favored Glycine 0 C--N 1.328 0.107 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.476 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.534 HG23 HG21 ' A' ' 254' ' ' VAL . 43.0 mm -54.97 -48.99 74.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.725 ' O ' HG22 ' A' ' 254' ' ' VAL . . . 57.88 129.64 0.01 OUTLIER Glycine 0 CA--C 1.525 0.679 0 C-N-CA 119.807 -1.187 . . . . 0.0 111.436 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . 0.5 ' HD3' ' HG3' ' A' ' 284' ' ' ARG . 52.0 Cg_exo -54.04 -24.92 34.49 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.165 1.91 . . . . 0.0 112.907 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -57.84 -36.49 72.37 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 251' ' ' GLY . 16.2 m -65.98 -36.76 78.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 62.35 153.32 0.11 Allowed Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -56.54 -31.12 85.39 Favored 'Trans proline' 0 CA--C 1.527 0.154 0 C-N-CA 122.39 2.06 . . . . 0.0 113.478 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -64.12 -49.0 73.9 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.562 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 97.8 mt-10 -66.22 -35.57 80.78 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.938 0.399 . . . . 0.0 112.029 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.75 ' CE1' HG11 ' A' ' 247' ' ' VAL . 35.5 t80 -59.62 -45.34 92.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.471 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.4 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.5 tt0 -64.73 -40.58 95.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.455 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 258' ' ' GLU . 20.5 pt-20 -75.79 -33.5 60.16 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.7 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.714 ' CE2' HD11 ' A' ' 313' ' ' ILE . 83.8 t80 -58.9 -56.78 17.84 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.652 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 18.6 m-85 -65.83 -24.61 66.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.326 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.713 ' N ' HD11 ' A' ' 269' ' ' ILE . 24.9 t -56.21 -31.14 63.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.55 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -53.99 -36.15 62.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.526 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.708 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 6.9 p90 -119.18 50.58 1.21 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.49 0.662 . . . . 0.0 111.213 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.566 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 148.86 145.85 4.21 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.634 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.444 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 41.1 m -59.74 -38.1 80.77 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.713 HD11 ' N ' ' A' ' 264' ' ' SER . 76.9 mt 70.72 84.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.533 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.619 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 66.5 mt -59.69 -38.72 77.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.836 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -131.99 -84.89 0.49 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 289' ' ' VAL . . . 61.68 113.08 0.02 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.705 0.288 . . . . 0.0 110.867 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -139.29 155.23 47.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.362 0.601 . . . . 0.0 112.07 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.557 HD21 ' CB ' ' A' ' 283' ' ' SER . 35.5 tp -65.05 -35.19 80.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.251 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.549 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 95.7 mmm 76.66 12.81 2.41 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.577 ' O ' HD23 ' A' ' 276' ' ' LEU . 0.9 OUTLIER -56.64 119.09 5.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.215 0.531 . . . . 0.0 111.334 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 279' ' ' ASP . 58.3 t0 -88.79 119.0 28.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.852 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 62.9 -75.31 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.273 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.428 ' OD1' HG23 ' A' ' 280' ' ' THR . 51.6 t0 -142.53 98.75 3.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.781 0.324 . . . . 0.0 111.648 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.428 HG23 ' OD1' ' A' ' 279' ' ' ASP . 2.8 p 44.62 50.54 8.38 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -84.48 -74.7 1.23 Allowed Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.028 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 286' ' ' PHE . 92.4 mm-40 -60.94 -32.02 71.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.243 0.544 . . . . 0.0 109.814 179.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.559 ' O ' ' HB3' ' A' ' 284' ' ' ARG . 54.1 p -63.17 168.27 4.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.45 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.559 ' HB3' ' O ' ' A' ' 283' ' ' SER . 39.1 ttt85 81.03 -41.39 0.16 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.826 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -94.94 -52.16 1.82 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.225 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 29.0 p90 -143.45 167.7 21.57 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.193 0.521 . . . . 0.0 112.209 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.744 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -137.13 158.39 24.28 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.141 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.516 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.7 OUTLIER -115.34 127.44 55.42 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.734 -0.274 . . . . 0.0 111.207 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.728 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 21.8 t -124.2 136.38 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.799 0.333 . . . . 0.0 111.69 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 33.6 m -115.68 136.22 53.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.659 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.566 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 31.5 m-85 -118.33 139.21 51.69 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.619 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 55.8 p30 -62.56 -32.22 73.15 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.663 179.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . 0.573 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 99.0 p -122.23 145.81 47.86 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.27 0.557 . . . . 0.0 111.556 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.98 -33.63 75.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.169 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -57.31 -37.39 72.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.361 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.59 82.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.914 0.387 . . . . 0.0 110.915 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.511 ' O ' HG12 ' A' ' 300' ' ' VAL . 83.3 t -62.23 -42.42 95.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.981 0.42 . . . . 0.0 110.96 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -60.94 -36.62 79.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.356 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -56.98 -43.31 81.56 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.708 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 1.3 p -69.15 -34.55 63.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.656 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 80.8 m -58.01 -45.92 86.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.473 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -62.68 -39.54 94.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.252 0.549 . . . . 0.0 110.258 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -63.36 -31.99 73.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.955 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.686 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 38.4 tptt 67.81 -75.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.686 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.9 m-30 -111.16 135.57 51.49 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.702 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.683 HD11 HG23 ' A' ' 300' ' ' VAL . 1.0 OUTLIER -118.55 137.41 52.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.192 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -79.08 112.64 16.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.965 0.412 . . . . 0.0 110.287 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.583 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 1.3 t80 -91.99 -89.22 0.19 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.809 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.503 ' HD3' ' CE1' ' A' ' 308' ' ' PHE . 0.0 OUTLIER -92.41 -74.86 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.939 0.399 . . . . 0.0 110.981 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -131.78 -15.79 3.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.259 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -122.02 157.36 31.53 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.518 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 312' ' ' LYS . 11.9 mptt -79.04 143.34 35.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.935 0.398 . . . . 0.0 111.093 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.714 HD11 ' CE2' ' A' ' 262' ' ' PHE . 29.9 pt -115.3 147.81 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . 0.561 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 84.1 mt-10 -104.78 133.3 49.83 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.651 -0.42 . . . . 0.0 109.982 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 0.69 HG12 HG23 ' A' ' 247' ' ' VAL . 73.5 mt -122.55 127.95 75.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.069 0.461 . . . . 0.0 111.253 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -126.01 155.05 42.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.725 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 70.0 ttp85 -58.87 146.12 38.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.718 0.294 . . . . 0.0 110.378 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 244' ' ' LYS . . . -55.71 145.26 24.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.076 0.465 . . . . 0.0 111.442 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.549 -179.928 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 45.8 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.959 0.409 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.764 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 62.9 tttt -129.66 141.36 50.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.574 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.853 ' SD ' HG13 ' A' ' 213' ' ' VAL . 95.1 mmm -118.08 146.38 44.15 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.536 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 6.7 t80 -106.09 127.55 53.26 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.939 HG23 HD12 ' A' ' 228' ' ' ILE . 11.1 mm -115.37 117.45 55.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.249 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 202' ' ' PHE . . . -91.54 178.86 41.53 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.813 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.887 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 26.69 80.11 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 114.387 0.515 . . . . 0.0 114.387 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.449 ' O ' ' HB ' ' A' ' 170' ' ' THR . 58.8 mt -85.76 2.13 46.81 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.881 ' O ' ' N ' ' A' ' 169' ' ' ASP . 41.7 t-20 61.04 41.39 13.96 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 16.9 m0 34.49 -55.97 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.053 0.941 . . . . 0.0 113.522 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.881 ' N ' ' O ' ' A' ' 167' ' ' ASN . 93.1 m-20 -53.21 -34.84 58.74 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 166' ' ' LEU . 55.8 m -62.95 139.43 58.75 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.189 0.518 . . . . 0.0 111.206 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 10.5 p -116.12 167.43 11.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.324 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.84 ' N ' HD12 ' A' ' 190' ' ' ILE . 21.2 pt-20 -59.85 -27.08 66.35 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 89.6 m-20 -62.07 -43.01 99.76 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.044 0.449 . . . . 0.0 110.3 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -67.05 -36.66 82.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.766 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.527 HD23 ' CE2' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -53.63 -49.82 67.04 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -179.025 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 180' ' ' GLY . 0.0 OUTLIER -65.29 -33.45 76.01 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.623 178.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -62.02 -41.36 97.99 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.255 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.444 ' OH ' ' HB3' ' A' ' 221' ' ' HIS . 64.0 t80 -75.74 -60.0 2.51 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.628 0.727 . . . . 0.0 111.003 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.527 ' CE2' HD23 ' A' ' 175' ' ' LEU . 80.8 m-85 -69.0 -21.1 64.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.652 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.95 -25.53 16.82 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.687 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.821 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -55.7 -40.72 72.78 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.0 0.428 . . . . 0.0 110.795 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.821 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 64.6 m-85 -69.96 -32.49 70.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.43 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 167.08 -133.11 2.8 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.831 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.4 m -119.93 139.06 53.02 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.77 HG21 ' HB3' ' A' ' 188' ' ' LEU . 0.8 OUTLIER -91.22 117.63 34.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.2 t -66.7 -43.77 83.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.138 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -156.28 98.34 1.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.77 ' HB3' HG21 ' A' ' 185' ' ' VAL . 0.0 OUTLIER -94.34 142.1 27.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.499 178.587 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.627 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 49.1 tptt -130.92 128.0 39.62 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.84 HD12 ' N ' ' A' ' 172' ' ' GLU . 1.4 mt -122.54 129.53 75.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.623 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.52 ' HE1' ' HA2' ' A' ' 203' ' ' GLY . 2.6 mpp? -92.6 135.08 34.39 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.404 ' HG3' ' HD3' ' A' ' 194' ' ' PRO . 26.2 pttm -131.91 168.67 17.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.163 0.506 . . . . 0.0 112.168 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 0.6 OUTLIER -125.43 85.24 58.84 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.742 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.404 ' HD3' ' HG3' ' A' ' 192' ' ' LYS . 11.9 Cg_endo -55.77 -24.57 47.28 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.305 2.003 . . . . 0.0 112.313 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -73.37 -70.66 0.35 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.372 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 55.0 p -71.49 -21.08 61.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.019 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 84.18 19.57 60.58 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.376 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.558 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 79.7 mtt180 -120.43 163.59 17.67 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.6 m -111.95 154.5 25.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.104 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.713 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 14.3 mmp_? -51.35 -29.43 15.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.476 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 98.08 -1.84 59.47 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.706 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.713 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 36.4 p90 -140.86 158.64 43.66 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.326 -0.437 . . . . 0.0 110.448 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.52 ' HA2' ' HE1' ' A' ' 191' ' ' MET . . . -142.92 161.99 27.49 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.627 ' HB2' ' HB3' ' A' ' 189' ' ' LYS . 94.8 m-85 -104.68 122.16 45.08 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.706 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 63.1 tp -109.75 126.34 53.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.813 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.594 ' O ' HG23 ' A' ' 185' ' ' VAL . 29.4 t -118.31 139.05 51.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.973 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.711 ' CE2' HG21 ' A' ' 216' ' ' VAL . 82.1 m-85 -119.4 146.51 45.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.95 0.405 . . . . 0.0 111.497 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.55 -36.12 82.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.616 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -111.07 121.81 39.62 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.363 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -56.33 -27.17 65.85 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.491 2.127 . . . . 0.0 112.923 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.0 t -58.35 -36.34 73.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.768 0.318 . . . . 0.0 110.713 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.87 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.8 m -58.83 -35.21 72.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.28 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.853 HG13 ' SD ' ' A' ' 161' ' ' MET . 82.3 t -61.47 -40.89 87.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.887 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -58.21 -43.57 87.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.783 0.325 . . . . 0.0 110.769 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.27 -34.83 75.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.132 0.492 . . . . 0.0 111.197 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.9 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 79.9 t -60.85 -43.02 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.785 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.713 HG21 ' NH2' ' A' ' 232' ' ' ARG . 25.1 m -86.52 -31.84 6.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -59.64 -35.26 74.06 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.472 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 74.4 m -100.59 147.01 26.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -78.96 139.24 38.28 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.9 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 44.0 m-70 -120.63 129.26 53.64 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -176.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 68.6 mt -122.44 115.4 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.1 tt -117.94 127.25 53.66 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.758 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 58.9 t0 52.87 36.34 21.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.959 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.06 13.86 82.9 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.731 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -126.48 156.39 40.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.994 0.397 . . . . 0.0 111.626 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.599 HG12 ' OD2' ' A' ' 229' ' ' ASP . 44.0 t -99.94 129.61 50.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.801 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.939 HD12 HG23 ' A' ' 163' ' ' ILE . 29.0 pt -109.3 -30.95 2.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.599 ' OD2' HG12 ' A' ' 227' ' ' VAL . 9.9 m-20 48.09 76.66 0.53 Allowed Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 121.246 0.546 . . . . 0.0 110.855 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.487 ' HD3' HG13 ' A' ' 228' ' ' ILE . 34.9 Cg_exo -59.8 135.58 64.58 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 123.234 2.622 . . . . 0.0 112.117 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 162' ' ' PHE . 5.5 ttpt -136.73 142.08 43.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.184 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.713 ' NH2' HG21 ' A' ' 217' ' ' VAL . 6.1 mpt_? -51.78 142.02 15.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.974 0.416 . . . . 0.0 111.355 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.764 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -68.96 143.13 54.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.21 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.553 HD12 ' HG2' ' A' ' 239' ' ' GLN . 0.1 OUTLIER -119.17 128.33 26.0 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.668 179.233 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.9 149.79 25.11 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.061 1.841 . . . . 0.0 110.858 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -53.25 -41.96 65.99 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.772 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -63.2 -40.79 98.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.971 0.415 . . . . 0.0 110.459 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -66.05 -36.94 84.58 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.649 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.553 ' HG2' HD12 ' A' ' 234' ' ' ILE . 95.2 mt-30 -60.47 -37.95 82.64 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.861 0.362 . . . . 0.0 110.568 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -60.23 -40.05 88.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.975 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -60.57 -35.12 75.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.289 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.425 HG22 HD11 ' A' ' 270' ' ' ILE . 18.3 p -83.22 162.44 21.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.521 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -155.98 108.02 0.35 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.21 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.614 ' O ' ' HB2' ' A' ' 318' ' ' ALA . 7.3 ttpm? -81.34 136.18 35.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.656 0.265 . . . . 0.0 110.935 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.67 HD13 ' O ' ' A' ' 245' ' ' ILE . 0.0 OUTLIER -119.39 162.87 17.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.498 0.666 . . . . 0.0 111.832 -179.139 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -101.72 137.07 40.52 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.066 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.854 HG11 ' CE1' ' A' ' 259' ' ' PHE . 11.7 p -131.11 145.45 35.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.934 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.648 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -130.5 164.67 22.93 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 98.1 -1.61 59.33 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.129 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.94 HD11 ' HA3' ' A' ' 287' ' ' GLY . 41.1 pt -116.62 139.49 43.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 117.192 0.496 . . . . 0.0 110.636 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.433 ' N ' HG11 ' A' ' 254' ' ' VAL . . . 177.77 -103.05 0.17 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 119.599 -1.286 . . . . 0.0 114.495 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -53.15 -25.99 31.58 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.822 2.348 . . . . 0.0 113.173 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -131.99 95.02 3.59 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.523 ' O ' ' HB2' ' A' ' 258' ' ' GLU . 0.5 OUTLIER -178.19 -46.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.152 -179.276 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 28.1 mmt180 68.37 128.02 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -177.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.38 -29.03 37.44 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.012 1.808 . . . . 0.0 112.809 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -61.72 -43.3 99.13 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.574 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 97.0 mt-10 -67.74 -35.52 78.88 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 111.368 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.893 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 19.2 t80 -59.15 -49.09 79.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.459 -178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.74 -37.7 88.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -63.71 -40.1 95.94 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.828 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.829 ' CE2' HD11 ' A' ' 313' ' ' ILE . 84.0 t80 -65.41 -55.12 19.82 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.74 ' CG ' HG21 ' A' ' 289' ' ' VAL . 9.3 m-85 -65.19 -27.24 68.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.791 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.702 ' N ' HD11 ' A' ' 269' ' ' ILE . 33.4 t -54.48 -26.97 34.46 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -50.17 -38.12 38.11 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.794 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.722 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 24.3 p90 -127.42 54.24 1.68 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.267 0.556 . . . . 0.0 111.18 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.485 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 151.48 153.28 6.14 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.432 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.402 ' HG1' ' CG ' ' A' ' 292' ' ' ASP . 32.8 p -71.43 -23.0 61.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.899 0.38 . . . . 0.0 111.14 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.702 HD11 ' N ' ' A' ' 264' ' ' SER . 77.8 mt 55.53 99.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.589 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.632 HD11 ' HA ' ' A' ' 292' ' ' ASP . 73.4 mt -58.47 -40.84 79.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.174 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -174.92 106.06 0.1 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.516 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.622 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -100.7 135.59 41.9 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.469 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -146.01 161.99 38.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.325 0.583 . . . . 0.0 112.546 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.614 ' O ' ' HB2' ' A' ' 275' ' ' MET . 56.7 mt -88.71 3.67 50.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.694 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.614 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 90.4 mtp 81.65 -49.53 0.24 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.584 0.354 . . . . 0.0 111.767 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.633 ' N ' HD22 ' A' ' 276' ' ' LEU . 1.8 mm? 47.2 56.94 6.24 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -77.65 114.48 16.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.083 0.468 . . . . 0.0 110.276 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.633 ' O ' HG22 ' A' ' 280' ' ' THR . 80.4 tttt 44.34 25.97 0.15 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.836 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 53.19 44.82 29.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.372 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.633 HG22 ' O ' ' A' ' 278' ' ' LYS . 1.7 t -171.53 -37.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.908 0.385 . . . . 0.0 111.294 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -54.42 -27.99 42.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.948 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.624 ' NE2' HD13 ' A' ' 276' ' ' LEU . 4.8 pp0? -137.07 162.79 32.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.601 0.239 . . . . 0.0 111.583 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.579 ' CB ' ' O ' ' A' ' 282' ' ' GLN . 83.2 p 121.91 -8.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 O-C-N 124.226 0.954 . . . . 0.0 110.385 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 67.6 mtt85 -57.36 -33.62 67.97 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.617 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 250' ' ' ILE . . . 158.28 35.38 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.618 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.412 ' HA ' ' HA2' ' A' ' 248' ' ' GLY . 7.5 p90 -144.36 165.18 28.65 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.524 0.662 . . . . 0.0 110.997 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.94 ' HA3' HD11 ' A' ' 250' ' ' ILE . . . -145.98 166.18 27.99 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.069 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.45 ' CE2' ' CE ' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -120.43 122.11 40.0 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 122.892 -0.181 . . . . 0.0 111.27 179.576 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.893 HG23 ' CZ ' ' A' ' 259' ' ' PHE . 57.6 t -123.84 137.67 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.049 0.452 . . . . 0.0 111.58 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 48.7 m -115.38 135.98 53.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.638 178.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.485 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 41.1 m-85 -114.95 136.94 52.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.15 0.5 . . . . 0.0 112.007 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.632 ' HA ' HD11 ' A' ' 270' ' ' ILE . 31.9 p-10 -62.38 -33.25 74.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.19 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . 0.427 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 28.6 t -123.15 140.06 53.41 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.636 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.33 -30.96 72.0 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.067 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.4 -38.18 68.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.211 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.473 ' O ' ' HD1' ' A' ' 266' ' ' TRP . . . -62.19 -37.04 83.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.907 0.384 . . . . 0.0 110.478 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.545 ' O ' HG12 ' A' ' 300' ' ' VAL . 81.3 t -61.89 -42.24 93.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.201 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.99 -36.7 77.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.147 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -57.25 -43.9 83.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.911 0.386 . . . . 0.0 112.027 -178.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.741 HG23 HD11 ' A' ' 306' ' ' ILE . 1.0 OUTLIER -69.86 -33.6 56.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.632 -179.141 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 76.8 m -57.44 -45.37 84.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.416 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -61.94 -41.42 97.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.25 0.547 . . . . 0.0 110.55 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -62.8 -32.5 73.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.433 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.682 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 10.6 tptm 67.94 -75.96 0.06 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -177.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.682 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.3 m-30 -110.52 136.1 50.16 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.741 HD11 HG23 ' A' ' 300' ' ' VAL . 1.1 mt -117.05 136.95 52.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.506 ' O ' ' OD1' ' A' ' 307' ' ' ASP . 52.4 p30 -72.83 96.94 2.15 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.146 0.498 . . . . 0.0 111.705 -178.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.656 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 6.2 t80 -102.27 -75.16 0.61 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.345 0.593 . . . . 0.0 110.375 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.456 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 10.2 mmpt? -95.14 -167.9 1.71 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.152 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -52.04 -27.72 14.71 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.836 0.35 . . . . 0.0 110.753 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 311' ' ' ARG . 60.9 mtt180 -116.67 160.48 20.67 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.414 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 71.4 mttt -71.85 147.82 46.77 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.53 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.829 HD11 ' CE2' ' A' ' 262' ' ' PHE . 28.6 pt -115.37 144.47 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . 0.596 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 83.4 mt-10 -104.29 134.52 47.38 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.059 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 0.802 HG12 HG23 ' A' ' 247' ' ' VAL . 73.5 mt -122.35 126.25 73.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.072 0.463 . . . . 0.0 111.466 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -129.96 155.42 46.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.776 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -55.46 148.42 15.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.794 0.33 . . . . 0.0 110.494 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 244' ' ' LYS . . . -56.03 145.85 24.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.995 0.426 . . . . 0.0 111.409 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.952 -179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 10.5 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.912 0.387 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 82.7 tttt -62.03 139.91 58.4 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.457 0.646 . . . . 0.0 111.74 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.818 ' SD ' HG13 ' A' ' 213' ' ' VAL . 92.7 mmm -121.08 149.13 43.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.617 -179.045 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.596 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 8.4 t80 -105.92 129.42 54.07 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.775 ' CG2' HD21 ' A' ' 166' ' ' LEU . 14.9 mm -114.76 127.51 72.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.835 -178.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 228' ' ' ILE . . . -130.09 162.25 23.07 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.908 179.216 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.473 ' C ' HG22 ' A' ' 228' ' ' ILE . . . 75.6 27.39 63.29 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 119.861 -1.161 . . . . 0.0 111.691 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.938 HD23 HG21 ' A' ' 228' ' ' ILE . 84.6 mt -85.1 140.32 31.06 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 120.802 0.335 . . . . 0.0 111.414 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.484 ' N ' ' HG1' ' A' ' 170' ' ' THR . 2.1 t-20 -63.07 136.75 57.98 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.423 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.449 ' CD2' ' HD2' ' A' ' 198' ' ' ARG . 3.9 m0 -51.9 -28.23 15.58 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.811 0.339 . . . . 0.0 110.882 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -92.4 9.04 35.89 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.564 178.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.585 ' O ' ' HB2' ' A' ' 174' ' ' ASN . 89.6 m -56.24 -37.2 69.41 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.566 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.7 OUTLIER 53.64 145.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.247 0.546 . . . . 0.0 110.794 -178.38 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.605 ' N ' HD12 ' A' ' 190' ' ' ILE . 97.3 mt-10 -61.45 -33.15 73.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.766 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.577 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 92.6 m-20 -57.38 -41.26 79.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.872 -178.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.585 ' HB2' ' O ' ' A' ' 170' ' ' THR . 83.2 m-20 -64.49 -35.71 81.83 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.768 HD12 HD11 ' A' ' 190' ' ' ILE . 2.4 mt -54.02 -51.15 64.9 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.577 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -63.58 -36.76 84.85 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.935 179.605 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -66.4 -44.8 82.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.085 0.469 . . . . 0.0 110.34 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.605 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 62.4 t80 -66.33 -47.32 73.88 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.922 179.207 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.513 ' CE2' HD23 ' A' ' 175' ' ' LEU . 86.4 m-85 -91.39 -1.77 57.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.108 -178.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -61.89 -28.86 70.94 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.486 179.012 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.442 ' CD ' ' H ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -58.19 -37.41 74.71 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.715 0.769 . . . . 0.0 110.797 -178.722 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -66.72 -30.69 70.98 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.062 -178.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 163.97 -126.64 1.55 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.195 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 57.3 m -119.23 141.46 48.89 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.53 HG21 ' CD2' ' A' ' 188' ' ' LEU . 13.8 p -106.69 128.73 61.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.586 -0.445 . . . . 0.0 109.972 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.411 HG23 ' CB ' ' A' ' 206' ' ' SER . 1.2 t -84.49 -43.49 14.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.535 -178.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -138.68 136.18 35.58 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -178.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.722 HD11 ' CB ' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -116.07 128.76 55.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.091 179.008 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 8.9 tptt -140.29 113.69 8.56 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.768 HD11 HD12 ' A' ' 175' ' ' LEU . 79.4 mt -126.77 126.62 68.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 174.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.686 ' HB2' ' HB2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -81.31 77.25 8.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.235 0.541 . . . . 0.0 110.644 -178.587 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -73.06 141.66 47.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.258 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 10.2 m-20 -92.36 100.55 3.82 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 193' ' ' ASP . 27.9 Cg_endo -62.06 -27.07 78.84 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.523 2.149 . . . . 0.0 112.796 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -75.34 -76.3 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.707 -179.484 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 57.9 p -69.99 -22.5 63.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 80.54 24.62 58.37 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.234 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.501 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 16.4 tpp85 -113.07 129.73 56.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.971 0.415 . . . . 0.0 111.395 -179.552 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.404 ' HB2' ' HA ' ' A' ' 168' ' ' TRP . 49.8 m -66.48 151.35 47.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.097 0.475 . . . . 0.0 111.288 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.8 ' HG3' ' CE1' ' A' ' 202' ' ' PHE . 17.3 tpt85 -59.55 -29.34 67.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.48 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 102.35 -9.75 56.14 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.722 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.8 ' CE1' ' HG3' ' A' ' 200' ' ' ARG . 21.0 p90 -144.24 155.3 43.81 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.448 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -144.79 164.13 27.86 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.828 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.596 ' CE2' ' CD1' ' A' ' 162' ' ' PHE . 96.5 m-85 -105.17 123.49 47.92 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.058 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.69 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 58.2 tp -108.02 125.52 51.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.442 -178.124 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.417 ' O ' HG23 ' A' ' 185' ' ' VAL . 27.3 t -118.29 134.51 54.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.671 0.272 . . . . 0.0 110.983 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.69 ' CZ ' HD21 ' A' ' 205' ' ' LEU . 88.5 m-85 -115.42 138.67 50.76 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 120.963 0.411 . . . . 0.0 112.012 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -62.04 -35.03 77.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.842 178.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.84 117.51 53.76 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.631 179.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -56.79 -22.88 47.22 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.512 2.142 . . . . 0.0 112.875 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.3 t -57.37 -36.74 71.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.407 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.931 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.0 m -58.88 -35.64 73.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.809 0.337 . . . . 0.0 110.733 179.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.818 HG13 ' SD ' ' A' ' 161' ' ' MET . 87.1 t -61.47 -42.33 93.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -59.57 -42.2 91.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.33 . . . . 0.0 111.003 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.464 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 15.2 pt-20 -74.58 -29.26 61.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.669 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 212' ' ' SER . 75.3 t -61.97 -42.95 96.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.129 0.49 . . . . 0.0 110.346 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.77 -40.31 88.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -58.61 -38.7 78.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.679 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 39.5 m -82.39 140.2 33.61 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.071 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 60.7 tp60 -66.23 -40.01 89.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.539 178.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.814 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 85.9 m-70 82.34 97.68 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 178.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 72.1 mt -115.34 109.54 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 176.232 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.411 HD12 ' CG ' ' A' ' 178' ' ' TYR . 6.9 tt -116.54 128.05 55.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.935 0.397 . . . . 0.0 111.593 -178.27 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 22.4 t70 49.02 38.41 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.405 179.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 83.46 7.44 86.37 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.526 178.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.456 ' HD3' ' HE2' ' A' ' 278' ' ' LYS . 35.4 mmtp -120.49 152.09 38.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.778 0.323 . . . . 0.0 111.398 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 41.3 t -104.93 132.8 50.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.489 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.938 HG21 HD23 ' A' ' 166' ' ' LEU . 38.8 pt -123.73 159.72 28.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.193 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -125.19 77.85 67.35 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.307 0.575 . . . . 0.0 111.081 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.59 ' HD2' ' CD2' ' A' ' 221' ' ' HIS . 50.5 Cg_exo -59.1 123.86 14.38 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.4 2.733 . . . . 0.0 111.735 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.42 ' NZ ' ' OD2' ' A' ' 271' ' ' ASP . 9.1 mtmm -134.05 153.44 51.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.793 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -56.26 138.06 51.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.042 0.449 . . . . 0.0 111.77 -179.438 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -64.03 145.13 56.43 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.591 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 2.5 mt -114.21 135.76 22.19 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.589 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.45 ' HG2' ' HB3' ' A' ' 238' ' ' GLU . 10.8 Cg_endo -55.6 139.2 82.59 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.814 1.676 . . . . 0.0 111.099 179.247 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -57.0 -41.33 78.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -61.09 -45.62 93.99 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.494 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.45 ' HB3' ' HG2' ' A' ' 235' ' ' PRO . 84.2 tt0 -70.2 -38.51 75.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.673 0.749 . . . . 0.0 109.569 178.093 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -59.53 -39.83 85.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.289 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.19 -40.88 91.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.35 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.426 ' HE3' ' HA ' ' A' ' 238' ' ' GLU . 10.5 mtmp? -61.98 -35.39 78.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.684 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.656 HG21 ' CD1' ' A' ' 270' ' ' ILE . 18.2 p -84.18 162.51 20.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.221 0.534 . . . . 0.0 111.826 -178.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -165.34 172.85 41.03 Favored Glycine 0 C--O 1.226 -0.383 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.448 179.228 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.554 ' HE2' ' CE2' ' A' ' 288' ' ' PHE . 14.0 pttm -135.99 151.36 49.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.384 0.592 . . . . 0.0 111.603 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.615 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -118.82 165.58 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 121.457 0.646 . . . . 0.0 111.916 -178.395 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.422 ' CE1' ' CD2' ' A' ' 286' ' ' PHE . 82.5 t80 -99.93 133.74 43.86 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.407 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.819 HG11 ' CE1' ' A' ' 259' ' ' PHE . 13.1 p -131.16 143.57 40.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.758 179.305 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 313' ' ' ILE . . . -126.85 169.43 18.78 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.288 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.22 15.84 56.69 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.161 -1.018 . . . . 0.0 112.456 -179.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.499 ' CG2' HG21 ' A' ' 254' ' ' VAL . 65.3 mt -110.78 131.15 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 120.961 0.41 . . . . 0.0 110.971 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.88 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -174.04 -101.73 0.15 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.324 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.79 139.34 56.99 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.273 1.982 . . . . 0.0 113.01 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 55.15 45.45 25.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 178.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 251' ' ' GLY . 15.4 m -125.39 -48.52 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.232 178.455 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.565 ' HB3' ' OE1' ' A' ' 258' ' ' GLU . 2.4 tpp85 57.09 136.51 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.214 0 CA-C-O 120.833 0.349 . . . . 0.0 110.17 -179.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.14 -26.91 53.21 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.518 2.146 . . . . 0.0 113.466 -178.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -59.8 -48.01 83.41 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.698 -179.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.565 ' OE1' ' HB3' ' A' ' 255' ' ' ARG . 58.8 mp0 -67.97 -35.56 78.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.029 0.442 . . . . 0.0 111.246 179.119 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.819 ' CE1' HG11 ' A' ' 247' ' ' VAL . 29.8 t80 -60.67 -45.31 94.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.914 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.444 ' HG2' ' HB3' ' A' ' 272' ' ' ALA . 97.1 mt-10 -65.59 -39.41 91.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.154 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.529 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.1 pt-20 -75.75 -30.51 59.21 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.742 0.306 . . . . 0.0 110.773 179.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.945 ' CE2' HD11 ' A' ' 313' ' ' ILE . 79.0 t80 -58.18 -57.48 12.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.136 0.493 . . . . 0.0 111.924 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.726 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 30.9 m-85 -68.28 -21.66 64.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.611 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.719 ' N ' HD11 ' A' ' 269' ' ' ILE . 34.0 t -55.35 -25.27 34.02 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.043 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -47.82 -38.6 16.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.705 178.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.726 ' CZ2' ' CD2' ' A' ' 263' ' ' PHE . 24.3 p90 -132.15 55.79 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.237 0.541 . . . . 0.0 111.444 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.458 ' HA3' ' CD1' ' A' ' 291' ' ' TYR . . . 151.59 145.29 4.1 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.652 179.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.414 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 52.8 m -58.68 -36.38 74.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.847 0.356 . . . . 0.0 111.133 179.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.719 HD11 ' N ' ' A' ' 264' ' ' SER . 73.8 mt 67.74 86.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.177 -178.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.656 ' CD1' HG21 ' A' ' 242' ' ' THR . 78.9 mt -55.98 -44.6 78.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.798 179.377 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.42 ' OD2' ' NZ ' ' A' ' 231' ' ' LYS . 59.5 t0 -166.89 105.02 0.58 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.703 0.287 . . . . 0.0 111.667 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.612 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -100.19 136.84 39.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.701 179.242 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -139.46 145.45 38.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.114 0.483 . . . . 0.0 111.9 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.533 ' O ' ' HB2' ' A' ' 275' ' ' MET . 23.3 tp -67.39 -38.07 84.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.351 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.567 ' O ' HD23 ' A' ' 276' ' ' LEU . 92.5 mmm 101.87 115.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.937 0.895 . . . . 0.0 109.52 -178.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.567 HD23 ' O ' ' A' ' 275' ' ' MET . 29.7 mt -123.39 140.8 52.64 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.204 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.569 ' HB3' ' HA3' ' A' ' 281' ' ' GLY . 59.4 t0 -157.66 93.72 1.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.053 177.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.456 ' HE2' ' HD3' ' A' ' 226' ' ' LYS . 11.2 mmtt 69.41 48.13 0.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.205 0.526 . . . . 0.0 110.189 -177.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 60.0 t0 67.14 -70.68 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.719 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 59.5 p -69.32 -14.13 62.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.436 -179.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . 0.569 ' HA3' ' HB3' ' A' ' 277' ' ' ASP . . . -55.12 126.48 38.91 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.866 -178.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.436 ' HB2' ' CB ' ' A' ' 275' ' ' MET . 58.2 mm-40 41.25 36.79 0.52 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.996 -0.602 . . . . 0.0 110.87 178.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 90.8 p -126.57 157.88 37.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.859 -179.441 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.466 ' HA ' ' HA2' ' A' ' 251' ' ' GLY . 72.0 ttt180 58.16 39.78 25.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.118 0.485 . . . . 0.0 109.808 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -160.46 -68.83 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.945 -179.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.485 ' HB2' ' O ' ' A' ' 247' ' ' VAL . 29.7 p90 -136.82 166.85 22.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.967 0.413 . . . . 0.0 111.462 -178.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.756 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -135.27 158.15 23.48 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.883 179.012 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.554 ' CE2' ' HE2' ' A' ' 244' ' ' LYS . 0.2 OUTLIER -115.13 127.95 55.89 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 122.254 0.222 . . . . 0.0 110.624 179.419 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.624 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 48.2 t -121.21 135.18 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.689 178.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 48.8 m -111.38 136.36 50.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.537 178.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.649 ' OH ' ' HB3' ' A' ' 263' ' ' PHE . 39.2 m-85 -116.08 138.69 51.02 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.371 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.601 ' O ' HG22 ' A' ' 242' ' ' THR . 21.7 t70 -57.82 -34.04 69.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.56 178.091 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 28.9 t -119.06 137.41 53.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.351 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.83 -29.76 70.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.1 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -56.05 -37.05 68.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.419 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.655 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -60.2 -35.84 76.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.908 0.385 . . . . 0.0 110.811 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.559 HG13 HG22 ' A' ' 245' ' ' ILE . 71.2 t -60.57 -44.3 96.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.988 0.423 . . . . 0.0 110.658 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -63.43 -37.23 86.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.071 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -58.16 -42.74 86.62 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.84 HG23 HD11 ' A' ' 306' ' ' ILE . 1.2 p -68.99 -33.7 60.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.797 0.332 . . . . 0.0 111.603 -179.405 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 72.6 m -55.2 -42.24 73.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.106 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -61.83 -37.35 84.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.085 0.469 . . . . 0.0 110.529 179.399 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.55 ' OD1' ' C ' ' A' ' 305' ' ' PHE . 0.0 OUTLIER -62.96 -35.99 81.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.654 -179.795 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.696 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 45.1 tptt 70.69 -71.86 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.696 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 32.7 m-85 -119.89 130.08 54.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.733 178.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.84 HD11 HG23 ' A' ' 300' ' ' VAL . 39.8 mt -113.11 136.42 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -78.04 95.22 4.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.0 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.708 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 4.9 t80 -87.36 -85.43 0.17 Allowed 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.991 179.451 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.561 ' HG3' HG12 ' A' ' 254' ' ' VAL . 12.1 mmmt -94.91 4.5 53.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.56 ' HB2' ' O ' ' A' ' 309' ' ' LYS . 83.5 m-20 107.68 -31.34 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.04 0.936 . . . . 0.0 110.499 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' A' ' 312' ' ' LYS . 28.9 tpt180 -57.43 -35.46 70.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.945 179.337 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.579 ' HG3' ' HB3' ' A' ' 305' ' ' PHE . 16.4 tptt 96.12 71.6 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.537 -179.349 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.945 HD11 ' CE2' ' A' ' 262' ' ' PHE . 29.9 pt -57.2 98.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.624 0.726 . . . . 0.0 110.173 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . 0.678 ' HG2' ' CE2' ' A' ' 305' ' ' PHE . 77.0 mt-10 -61.85 138.04 58.31 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 0.651 HG12 HG23 ' A' ' 247' ' ' VAL . 72.3 mt -121.93 128.54 75.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 19.4 mtpt -131.61 150.98 51.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.7 178.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -58.13 144.77 39.2 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.467 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 244' ' ' LYS . . . -65.06 143.63 57.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.972 0.415 . . . . 0.0 111.244 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 318' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.285 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 26.3 m . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.539 0.209 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 38.6 ttpt -74.36 139.25 43.97 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.168 0.509 . . . . 0.0 111.58 -179.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.734 ' SD ' HG13 ' A' ' 213' ' ' VAL . 87.3 mmm -112.52 149.32 32.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.504 -179.304 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 230' ' ' PRO . 4.6 t80 -103.08 129.19 49.83 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.751 HG21 HD21 ' A' ' 175' ' ' LEU . 17.8 mm -116.8 125.91 73.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.943 -179.517 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.533 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -120.91 155.97 16.18 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 178.404 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.57 41.53 35.6 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 119.971 -1.109 . . . . 0.0 111.8 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.727 HD22 HD11 ' A' ' 175' ' ' LEU . 75.0 mt -58.81 -28.18 65.76 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.774 ' O ' ' N ' ' A' ' 169' ' ' ASP . 52.5 t30 71.98 45.41 0.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -177.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.424 ' CZ3' ' NH2' ' A' ' 198' ' ' ARG . 10.9 m0 23.36 -62.62 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.534 1.134 . . . . 0.0 113.911 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.774 ' N ' ' O ' ' A' ' 167' ' ' ASN . 92.3 m-20 -53.91 -33.82 57.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.142 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.461 ' C ' HG23 ' A' ' 171' ' ' THR . 87.9 m -52.92 -39.31 62.69 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.593 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.626 ' C ' HD12 ' A' ' 190' ' ' ILE . 0.1 OUTLIER 55.44 166.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.073 0.464 . . . . 0.0 109.822 -177.846 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.884 ' N ' HD12 ' A' ' 190' ' ' ILE . 21.0 pt-20 -67.76 -23.0 65.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.399 -179.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.616 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.8 m-20 -58.68 -44.29 90.17 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.459 -178.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.433 ' HB2' ' CG2' ' A' ' 170' ' ' THR . 83.9 m-20 -68.11 -35.33 77.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.677 0.275 . . . . 0.0 111.542 179.27 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.898 HD12 HD11 ' A' ' 190' ' ' ILE . 1.5 mt -55.91 -44.8 78.63 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.19 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.616 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -64.37 -38.77 92.2 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.978 179.312 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.435 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 75.6 mm-40 -69.41 -42.49 75.01 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.536 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 53.8 t80 -64.96 -47.59 77.06 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.421 0.629 . . . . 0.0 111.565 179.471 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.496 ' CE2' HD23 ' A' ' 175' ' ' LEU . 82.4 m-85 -92.42 -1.04 57.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.224 -178.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -58.45 -31.16 66.08 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.205 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -41.18 90.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.543 0.687 . . . . 0.0 110.576 -179.322 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -68.34 -33.89 75.1 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.209 -178.301 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.44 -174.62 44.85 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.862 -179.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 54.5 m -63.48 -28.29 69.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.777 0.322 . . . . 0.0 111.319 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.766 HG22 HD11 ' A' ' 205' ' ' LEU . 1.2 t 64.86 82.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -176.697 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.615 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 3.1 m -56.72 -42.87 79.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.414 -176.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -148.34 144.62 27.67 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.417 ' HA ' HD13 ' A' ' 188' ' ' LEU . 0.2 OUTLIER -115.4 134.7 54.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.571 178.577 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.561 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 11.1 tptt -141.39 67.13 1.35 Allowed 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.898 HD11 HD12 ' A' ' 175' ' ' LEU . 3.3 mt -66.43 -9.93 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 121.104 0.478 . . . . 0.0 110.377 177.359 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.618 ' HE2' ' HA2' ' A' ' 203' ' ' GLY . 1.8 mpp? 74.53 -56.62 0.63 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.588 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 199' ' ' SER . 8.0 mtmp? 56.43 152.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.077 0.465 . . . . 0.0 111.597 179.392 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.682 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 0.7 OUTLIER -126.08 78.58 70.35 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.519 -179.762 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -56.51 -25.41 58.26 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 121.988 1.792 . . . . 0.0 111.706 179.442 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.77 -67.16 0.66 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.66 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.5 p -67.25 -26.83 66.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.507 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 93.14 0.77 67.66 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.818 -0.706 . . . . 0.0 113.151 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.682 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 1.5 tpt180 -127.41 125.94 41.53 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 117.162 0.481 . . . . 0.0 110.743 179.708 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 192' ' ' LYS . 42.8 m -58.11 155.46 11.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.161 0.505 . . . . 0.0 111.59 -179.404 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.553 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 40.3 mmt180 -55.68 -30.46 61.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.666 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.405 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 97.82 0.16 59.06 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.853 -178.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.692 ' C ' HD11 ' A' ' 166' ' ' LEU . 28.2 p90 -148.36 159.18 44.27 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.618 ' HA2' ' HE2' ' A' ' 191' ' ' MET . . . -147.04 163.75 28.63 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.09 -1.052 . . . . 0.0 111.548 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.561 ' HB2' ' HB3' ' A' ' 189' ' ' LYS . 99.0 m-85 -104.63 122.16 45.06 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.766 HD11 HG22 ' A' ' 185' ' ' VAL . 53.5 tp -102.77 127.1 50.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.209 -177.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 186' ' ' THR . 51.8 m -119.7 139.88 51.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.453 -179.573 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.659 ' CZ ' HD21 ' A' ' 205' ' ' LEU . 94.9 m-85 -122.6 139.68 53.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.578 178.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.615 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.5 tt0 -59.98 -33.83 72.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.924 0.392 . . . . 0.0 110.114 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 13.3 mtmm -114.51 122.91 33.19 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.008 179.383 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -56.78 -20.44 35.44 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.744 2.296 . . . . 0.0 113.023 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.9 m -56.48 -36.93 69.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.694 0.283 . . . . 0.0 111.306 -179.269 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.936 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.4 m -59.18 -35.87 74.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.798 0.333 . . . . 0.0 110.764 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.734 HG13 ' SD ' ' A' ' 161' ' ' MET . 83.2 t -61.56 -42.5 94.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.069 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.48 ' O ' HG22 ' A' ' 217' ' ' VAL . 55.4 t0 -59.58 -42.4 92.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.744 0.306 . . . . 0.0 111.091 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.453 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 14.8 pt-20 -74.38 -29.41 61.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.596 179.454 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 212' ' ' SER . 64.6 t -59.77 -42.37 88.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.064 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 214' ' ' ASP . 24.2 m -72.5 -26.95 24.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -58.63 -31.69 68.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.458 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.615 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 68.7 m -108.42 140.01 42.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.893 0.378 . . . . 0.0 111.605 -179.129 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 63.4 tt0 -65.53 -40.74 93.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.64 179.079 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.729 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 71.7 m-70 84.47 110.74 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 178.352 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 1.031 HD12 HG12 ' A' ' 227' ' ' VAL . 20.3 mm -116.66 114.05 44.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 175.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.429 HD12 ' CG ' ' A' ' 178' ' ' TYR . 5.8 tt -122.58 122.3 38.54 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.469 -178.092 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 51.5 42.39 29.36 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 178.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.07 8.26 87.95 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.562 -0.827 . . . . 0.0 113.443 178.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.416 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 35.5 mmtp -121.5 155.37 35.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.753 0.311 . . . . 0.0 111.008 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 1.031 HG12 HD12 ' A' ' 222' ' ' ILE . 32.8 m -110.5 134.94 51.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.04 0.447 . . . . 0.0 110.349 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 164' ' ' GLY . 36.5 pt -124.32 158.63 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.866 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -126.74 79.2 72.28 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 121.16 0.505 . . . . 0.0 111.175 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 162' ' ' PHE . 51.1 Cg_exo -58.98 120.87 9.01 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.739 2.293 . . . . 0.0 110.669 179.232 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -134.1 146.97 50.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.686 0.279 . . . . 0.0 111.712 -179.065 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.535 ' N ' ' HD2' ' A' ' 232' ' ' ARG . 0.0 OUTLIER -49.4 134.91 18.38 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.986 0.422 . . . . 0.0 110.989 -179.557 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -65.45 145.66 55.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.915 -179.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 1.2 mt -118.13 137.55 24.65 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.167 179.223 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.447 ' HG2' ' HB2' ' A' ' 238' ' ' GLU . 9.5 Cg_endo -54.28 141.03 72.11 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 121.8 1.666 . . . . 0.0 110.97 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -55.76 -41.76 74.45 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -178.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -60.83 -41.79 96.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.782 0.325 . . . . 0.0 111.047 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.462 ' O ' HG23 ' A' ' 242' ' ' THR . 84.5 tt0 -64.75 -36.59 84.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.601 179.394 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -60.0 -38.83 83.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.704 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -61.12 -39.42 89.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.207 0.527 . . . . 0.0 110.394 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -60.97 -31.4 70.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.347 179.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.541 HG22 ' CD1' ' A' ' 270' ' ' ILE . 10.4 p -75.31 161.44 29.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.911 -178.136 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.69 112.72 0.85 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.086 179.53 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.61 ' HE3' ' CD2' ' A' ' 288' ' ' PHE . 5.3 tptp -85.8 129.2 34.89 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -179.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.689 HG21 HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -120.84 160.71 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.474 0.654 . . . . 0.0 111.865 -179.55 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.49 ' HB2' ' HA ' ' A' ' 318' ' ' ALA . 76.2 t80 -104.31 137.45 42.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.951 179.416 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.758 HG23 HG12 ' A' ' 315' ' ' ILE . 7.2 p -128.68 147.17 33.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.644 -179.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.673 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -128.7 166.96 21.01 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.026 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 81.02 42.19 9.76 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.804 -179.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.566 ' CG2' HG11 ' A' ' 254' ' ' VAL . 27.3 mm -55.65 -36.29 41.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.849 0.357 . . . . 0.0 111.295 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 60.79 169.02 0.5 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.868 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.26 144.66 81.59 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.032 2.488 . . . . 0.0 113.674 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 55.11 42.47 30.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.936 178.245 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.623 HG23 ' HE2' ' A' ' 308' ' ' PHE . 12.5 p -63.72 -38.3 81.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.996 178.612 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.615 ' O ' ' O ' ' A' ' 254' ' ' VAL . 4.5 mpt_? 50.31 126.29 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.43 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.48 -28.28 44.13 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.077 1.852 . . . . 0.0 112.668 -178.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -61.17 -47.79 84.55 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.614 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.527 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 53.0 mp0 -69.44 -39.62 77.69 Favored 'General case' 0 C--O 1.224 -0.261 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.693 ' CE1' HG11 ' A' ' 247' ' ' VAL . 27.4 t80 -61.37 -47.25 86.68 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.21 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.531 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.5 tt0 -65.58 -43.11 90.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.736 0.303 . . . . 0.0 111.295 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.527 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.8 pt-20 -76.47 -28.86 56.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.129 0.49 . . . . 0.0 110.877 179.444 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.662 ' CZ ' ' HB2' ' A' ' 308' ' ' PHE . 11.6 t80 -61.93 -56.48 18.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.13 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.763 ' CG ' HG21 ' A' ' 289' ' ' VAL . 5.2 m-85 -67.67 -27.56 66.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.069 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.745 ' N ' HD11 ' A' ' 269' ' ' ILE . 80.1 p -56.44 -23.97 42.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.736 0.303 . . . . 0.0 111.113 -178.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -56.68 -35.94 69.01 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.275 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.677 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 19.4 p90 -111.66 48.99 0.92 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -179.648 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 133.43 150.39 6.31 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.184 178.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.4 m -70.3 131.68 44.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.782 HG23 ' O ' ' A' ' 290' ' ' THR . 74.5 mt -102.9 118.65 50.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.84 -178.73 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.683 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 72.7 mt -69.51 -39.4 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 120.289 -0.565 . . . . 0.0 112.236 179.359 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -136.38 -87.44 0.32 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.725 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . 65.14 110.42 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.709 0.29 . . . . 0.0 110.886 -178.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . 0.419 ' O ' ' NE2' ' A' ' 282' ' ' GLN . 21.6 pt20 -141.23 158.67 43.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.253 0.549 . . . . 0.0 111.853 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 1.038 HD23 HD11 ' A' ' 276' ' ' LEU . 28.6 tp -66.1 -26.86 67.66 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.09 -179.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.66 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 66.8 mmm 82.51 -80.91 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.457 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 1.038 HD11 HD23 ' A' ' 274' ' ' LEU . 5.2 mp 55.53 72.25 0.5 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.16 -178.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.483 ' HB3' ' HA3' ' A' ' 281' ' ' GLY . 60.2 t0 -79.91 113.56 18.16 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.001 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 18.6 mttt 69.76 -59.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.358 -178.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.728 ' OD1' HG23 ' A' ' 280' ' ' THR . 53.7 p30 -178.1 -31.12 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 179.133 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.728 HG23 ' OD1' ' A' ' 279' ' ' ASP . 68.2 p -109.46 10.89 25.22 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.493 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . 0.483 ' HA3' ' HB3' ' A' ' 277' ' ' ASP . . . -91.37 99.07 2.52 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.209 -0.995 . . . . 0.0 113.149 -179.525 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.693 ' HB2' ' CZ ' ' A' ' 286' ' ' PHE . 38.2 tt0 75.38 -8.1 1.65 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.89 0.476 . . . . 0.0 112.18 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 21.9 m -57.77 -38.46 75.46 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -137.79 142.59 40.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.31 178.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.05 -46.46 1.71 Allowed Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.484 -0.865 . . . . 0.0 114.399 178.591 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.693 ' CZ ' ' HB2' ' A' ' 282' ' ' GLN . 23.7 p90 -140.24 168.38 19.93 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.224 1.012 . . . . 0.0 113.076 -179.162 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.506 ' C ' HG12 ' A' ' 247' ' ' VAL . . . -138.03 174.35 21.95 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.173 179.164 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.61 ' CD2' ' HE3' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -137.17 123.33 20.44 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.294 0.547 . . . . 0.0 111.44 -179.948 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.763 HG21 ' CG ' ' A' ' 263' ' ' PHE . 56.8 t -126.44 137.6 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.008 0.432 . . . . 0.0 111.815 178.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.782 ' O ' HG23 ' A' ' 269' ' ' ILE . 32.6 m -110.73 136.45 49.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.7 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.436 ' OH ' ' O ' ' A' ' 263' ' ' PHE . 31.0 m-85 -117.96 136.1 53.72 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.683 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 55.7 t0 -59.05 -36.18 74.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.254 178.6 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 49.9 m -121.53 143.88 49.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.471 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.92 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -66.57 -28.72 68.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.389 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -56.01 -36.59 68.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.824 -179.126 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.71 91.46 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.292 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.92 HG12 ' O ' ' A' ' 294' ' ' ALA . 6.2 p -59.62 -36.96 68.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.219 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -62.18 -38.41 88.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.346 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -59.87 -43.41 94.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.894 -178.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.833 HG23 HD11 ' A' ' 306' ' ' ILE . 0.8 OUTLIER -69.4 -34.84 64.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.375 -179.334 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 80.2 m -59.33 -46.6 88.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.155 -179.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -62.49 -38.83 91.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.199 0.523 . . . . 0.0 109.965 179.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 305' ' ' PHE . 88.5 m-20 -61.55 -32.36 72.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.257 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.645 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 18.8 tptm 69.24 -69.55 0.16 Allowed 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.645 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.7 m-30 -113.95 143.0 45.43 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.758 178.063 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.833 HD11 HG23 ' A' ' 300' ' ' VAL . 6.9 mm -111.94 136.35 48.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -72.41 83.69 1.08 Allowed 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.198 -179.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.662 ' HB2' ' CZ ' ' A' ' 262' ' ' PHE . 4.9 t80 -105.9 142.84 34.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.556 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.533 ' HG2' ' CD2' ' A' ' 308' ' ' PHE . 18.8 mmmt 46.34 -135.89 0.79 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.116 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -96.74 9.77 40.74 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -178.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -151.05 165.82 32.63 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.479 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 53.0 mttt -78.86 143.46 35.94 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.76 179.159 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.673 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 33.7 pt -121.1 153.76 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.088 179.185 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . 0.604 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 84.0 mt-10 -110.16 134.98 51.65 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.414 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 0.758 HG12 HG23 ' A' ' 247' ' ' VAL . 76.7 mt -122.28 128.61 75.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.268 0.556 . . . . 0.0 112.17 -179.287 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -128.4 156.66 42.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.113 179.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -54.68 146.97 15.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.64 0.257 . . . . 0.0 110.363 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.49 ' HA ' ' HB2' ' A' ' 246' ' ' PHE . . . -54.26 -98.28 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.042 -179.273 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 318' ' ' ALA . 56.3 mm-40 . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.416 0.151 . . . . 0.0 111.351 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.531 ' HA ' HG21 ' A' ' 213' ' ' VAL . 8.2 m . . . . . 0 CA--C 1.529 0.173 0 CA-C-O 120.806 0.336 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 74.2 tttt -56.74 139.69 49.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.179 0.514 . . . . 0.0 111.896 -178.607 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.758 ' SD ' HG13 ' A' ' 213' ' ' VAL . 94.7 mmm -121.94 150.46 41.98 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.896 -178.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.711 ' CE1' ' CZ ' ' A' ' 204' ' ' PHE . 1.5 t80 -108.42 129.64 55.25 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.262 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.604 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 24.4 mm -116.83 131.04 70.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.253 -179.221 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 228' ' ' ILE . . . -130.17 166.2 22.25 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 178.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.78 32.54 59.02 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.937 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.709 HD22 HG21 ' A' ' 170' ' ' THR . 65.2 mt -59.57 -23.43 62.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -179.234 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 169' ' ' ASP . 33.3 t-20 70.3 37.29 1.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -177.549 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.542 ' CZ2' ' HD2' ' A' ' 198' ' ' ARG . 18.6 m0 37.12 17.95 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.28 -1.327 . . . . 0.0 113.829 179.453 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 167' ' ' ASN . 93.3 m-20 -139.28 10.04 2.52 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.779 ' CG2' HD13 ' A' ' 223' ' ' LEU . 95.1 m -57.24 -38.52 73.94 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.552 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.2 OUTLIER 54.78 142.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.108 0.48 . . . . 0.0 110.459 -178.344 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.6 ' CA ' HD12 ' A' ' 190' ' ' ILE . 97.2 mt-10 -61.63 -34.96 76.58 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.597 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 60.1 t0 -57.28 -42.45 81.7 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 170' ' ' THR . 82.9 m-20 -64.13 -37.8 88.76 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.022 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.956 HD22 HD21 ' A' ' 205' ' ' LEU . 11.0 mt -56.76 -50.5 72.09 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.229 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.597 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -67.46 -34.71 77.74 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.429 179.506 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -59.44 -38.91 81.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.395 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.622 ' CE2' ' CE2' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -94.69 -55.71 3.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.676 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.686 ' CE2' HD23 ' A' ' 175' ' ' LEU . 72.0 m-85 -60.62 -29.55 69.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.28 179.145 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.63 -24.13 23.62 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.904 179.073 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.804 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -55.71 -38.75 70.14 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.896 0.379 . . . . 0.0 111.483 -179.632 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.804 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 59.2 m-85 -68.1 -30.78 70.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.516 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 166.9 -129.33 1.9 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.092 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 59.7 m -117.4 141.78 47.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 206' ' ' SER . 10.5 p -104.41 125.44 59.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.736 HG23 ' N ' ' A' ' 208' ' ' GLU . 43.4 p -70.75 -35.48 72.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.605 -178.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -154.14 149.75 27.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.338 0.59 . . . . 0.0 112.253 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.503 HD22 HG21 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -118.63 130.14 55.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.476 179.689 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.549 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 35.5 tptt -128.57 118.87 23.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.211 0.529 . . . . 0.0 111.341 179.391 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.6 HD12 ' CA ' ' A' ' 172' ' ' GLU . 0.3 OUTLIER -124.44 138.48 53.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.696 177.676 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.718 ' HB2' ' HB3' ' A' ' 200' ' ' ARG . 15.1 mmt -86.29 135.08 33.68 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.901 -179.213 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -139.25 134.67 32.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.052 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 0.8 OUTLIER -123.31 78.02 53.29 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.676 -179.939 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.63 -27.9 72.32 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.252 1.968 . . . . 0.0 112.117 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -71.82 -63.01 1.22 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.083 0.468 . . . . 0.0 111.036 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 55.2 p -72.88 -18.83 61.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.512 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 79.6 28.9 50.45 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.36 -179.776 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.542 ' HD2' ' CZ2' ' A' ' 168' ' ' TRP . 7.8 ttp180 -124.91 141.81 51.88 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 121.048 0.452 . . . . 0.0 111.854 -179.399 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 191' ' ' MET . 22.6 p -84.73 8.23 17.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.649 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.813 ' HG3' ' CE1' ' A' ' 202' ' ' PHE . 11.4 tpt180 76.48 -42.64 0.44 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.065 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.548 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 96.37 4.73 59.48 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.851 -0.69 . . . . 0.0 114.219 178.311 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.813 ' CE1' ' HG3' ' A' ' 200' ' ' ARG . 36.6 p90 -149.54 159.13 44.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.257 0.551 . . . . 0.0 112.106 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -151.66 170.88 31.16 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.418 179.577 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.711 ' CZ ' ' CE1' ' A' ' 162' ' ' PHE . 78.9 m-85 -114.98 134.94 54.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.025 0.441 . . . . 0.0 112.058 -179.558 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.956 HD21 HD22 ' A' ' 175' ' ' LEU . 59.5 mt -107.73 139.65 41.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.349 179.112 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.625 ' O ' HG23 ' A' ' 185' ' ' VAL . 20.1 t -123.24 126.97 47.93 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.712 ' CE2' HG21 ' A' ' 216' ' ' VAL . 84.4 m-85 -114.64 135.18 54.43 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.736 ' N ' HG23 ' A' ' 186' ' ' THR . 84.5 tt0 -63.35 -35.56 80.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.153 178.583 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.69 117.39 54.26 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.879 179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.78 -28.09 74.65 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.58 2.187 . . . . 0.0 113.041 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 20.4 m -59.02 -39.65 82.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.796 0.331 . . . . 0.0 110.724 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.855 ' O ' HG23 ' A' ' 216' ' ' VAL . 23.8 m -61.42 -35.58 77.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.222 0.534 . . . . 0.0 110.095 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.758 HG13 ' SD ' ' A' ' 161' ' ' MET . 96.7 t -62.19 -41.74 92.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.392 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 218' ' ' LYS . 92.4 m-20 -58.62 -43.61 89.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.305 -179.345 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -70.02 -34.35 73.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.855 0.36 . . . . 0.0 111.708 178.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 212' ' ' SER . 87.0 t -60.35 -44.36 95.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.18 -178.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.611 HG11 ' NE ' ' A' ' 232' ' ' ARG . 10.4 p -80.75 -44.84 21.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.464 ' N ' HG13 ' A' ' 217' ' ' VAL . 15.0 mtpt -59.21 -34.19 71.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.713 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 27.5 m -96.46 143.65 27.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.135 0.493 . . . . 0.0 111.745 -178.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -93.3 125.28 37.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.902 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.603 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 0.0 OUTLIER -131.79 152.34 51.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.201 -179.028 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.581 HG22 ' H ' ' A' ' 225' ' ' GLY . 70.7 mt -121.91 128.41 75.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.871 179.393 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.779 HD13 ' CG2' ' A' ' 170' ' ' THR . 4.7 mt -88.1 -72.78 0.51 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -93.07 14.15 18.7 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.143 -178.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.581 ' H ' HG22 ' A' ' 222' ' ' ILE . . . 100.19 -0.32 56.0 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.987 -178.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -112.22 132.58 54.84 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 227' ' ' VAL . 34.3 m -59.01 120.05 4.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.498 -179.325 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.745 HG13 ' HD3' ' A' ' 230' ' ' PRO . 31.1 pt -97.47 -33.0 4.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.298 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 47.57 73.72 0.94 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.079 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.745 ' HD3' HG13 ' A' ' 228' ' ' ILE . 31.0 Cg_endo -60.54 135.01 58.07 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.736 2.291 . . . . 0.0 112.143 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -128.53 151.99 48.81 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.547 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.611 ' NE ' HG11 ' A' ' 217' ' ' VAL . 1.9 mpt_? -59.47 143.45 49.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.206 0.527 . . . . 0.0 112.233 -178.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -74.95 150.14 39.16 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.613 179.611 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . 0.885 HD12 ' HG2' ' A' ' 239' ' ' GLN . 0.1 OUTLIER -124.89 133.49 24.84 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.287 178.873 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.559 ' HD2' ' OE1' ' A' ' 238' ' ' GLU . 44.0 Cg_exo -54.96 145.64 61.81 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 121.775 1.65 . . . . 0.0 110.092 178.321 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 48.7 tpt85 -54.55 -40.53 68.79 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.565 -178.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.599 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 53.4 p30 -65.24 -37.31 86.84 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.371 179.414 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.599 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 93.1 mt-10 -68.29 -34.85 76.92 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.008 179.393 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.885 ' HG2' HD12 ' A' ' 234' ' ' ILE . 97.4 mt-30 -58.89 -38.62 79.28 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.045 0.45 . . . . 0.0 109.901 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -61.51 -39.08 89.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.048 178.594 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -60.05 -34.76 73.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.393 179.529 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.757 HG21 HD11 ' A' ' 270' ' ' ILE . 12.1 p -105.38 162.96 12.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.407 -178.607 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.22 168.62 25.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.519 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 289' ' ' VAL . 7.2 ttpm? -134.31 139.6 45.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.431 0.158 . . . . 0.0 110.678 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.823 HD12 HG11 ' A' ' 300' ' ' VAL . 0.1 OUTLIER -118.71 157.53 20.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 121.13 0.491 . . . . 0.0 111.465 -179.361 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -102.8 128.37 49.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.645 178.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.835 HG11 HD12 ' A' ' 313' ' ' ILE . 41.5 t -124.55 131.27 72.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.885 0.374 . . . . 0.0 111.44 179.303 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.655 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -105.45 174.19 20.94 Favored Glycine 0 C--O 1.225 -0.411 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.907 179.219 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 285' ' ' GLY . . . 82.86 16.22 70.79 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.933 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.574 ' CD1' ' CE1' ' A' ' 259' ' ' PHE . 64.0 mt -116.13 132.66 65.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.94 0.4 . . . . 0.0 111.519 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.695 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -168.02 -116.3 0.36 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.666 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.89 143.53 99.58 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.616 2.211 . . . . 0.0 113.389 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 55.34 41.81 30.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.953 178.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.738 HG12 ' HG2' ' A' ' 309' ' ' LYS . 16.6 m -118.8 -1.84 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.369 178.099 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.597 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.2 OUTLIER 37.61 111.91 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.431 0 O-C-N 123.365 0.415 . . . . 0.0 111.804 -179.851 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.19 -39.72 51.82 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.542 1.495 . . . . 0.0 111.492 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -62.6 -40.99 98.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.014 0.435 . . . . 0.0 109.959 178.23 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.511 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 85.0 tt0 -65.11 -37.47 87.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.822 179.502 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.574 ' CE1' ' CD1' ' A' ' 250' ' ' ILE . 35.1 t80 -60.51 -45.46 93.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.643 179.076 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.543 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.4 tt0 -64.1 -42.01 97.08 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.511 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.3 pt-20 -74.73 -30.23 61.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.015 0.436 . . . . 0.0 110.362 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.57 ' CE1' ' HD1' ' A' ' 308' ' ' PHE . 88.1 t80 -58.78 -46.56 87.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.885 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.757 ' HZ ' HG11 ' A' ' 247' ' ' VAL . 34.8 m-85 -88.09 -7.12 57.44 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.745 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.499 ' N ' HD11 ' A' ' 269' ' ' ILE . 81.6 p -62.6 -26.28 68.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.039 0.447 . . . . 0.0 111.107 -179.668 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -57.16 -38.41 73.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.911 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.641 ' HH2' HG21 ' A' ' 306' ' ' ILE . 11.6 m-90 -59.26 -38.35 79.89 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.342 0.591 . . . . 0.0 111.199 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 264' ' ' SER . . . 174.83 -159.77 28.51 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.069 -178.757 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 51.3 m -79.57 130.73 35.65 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.143 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.829 HG23 ' O ' ' A' ' 290' ' ' THR . 72.2 mt -106.59 118.32 54.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.757 HD11 HG21 ' A' ' 242' ' ' THR . 69.5 mt -61.17 -52.46 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 120.089 -0.645 . . . . 0.0 112.288 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 270' ' ' ILE . 72.9 m-20 -162.97 68.9 0.22 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.668 ' HB2' HG21 ' A' ' 269' ' ' ILE . . . -73.87 135.71 43.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.387 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -139.63 149.43 43.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.451 0.643 . . . . 0.0 111.969 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.569 ' O ' ' HB2' ' A' ' 275' ' ' MET . 22.6 tp -65.14 -37.91 88.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.855 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.731 ' C ' HD12 ' A' ' 276' ' ' LEU . 93.6 mmm 84.62 148.59 0.07 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.14 0.576 . . . . 0.0 109.899 -178.293 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.731 HD12 ' C ' ' A' ' 275' ' ' MET . 5.5 mp -158.57 133.34 8.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.632 0.253 . . . . 0.0 110.734 179.453 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -74.82 -134.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.129 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.41 ' O ' ' OD1' ' A' ' 279' ' ' ASP . 86.4 mttt -58.78 -37.14 75.65 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.499 ' O ' HD23 ' A' ' 276' ' ' LEU . 95.9 m-20 -140.34 -85.07 0.22 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.762 179.125 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 57.8 p -116.04 24.31 11.54 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.711 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -51.88 -41.92 52.55 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.805 -179.08 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.702 ' HG3' ' HB2' ' A' ' 275' ' ' MET . 0.9 OUTLIER -64.52 -34.74 78.94 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.972 0.415 . . . . 0.0 111.493 178.991 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 39.4 t -49.59 -15.14 0.14 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.244 -177.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -51.18 -36.87 43.36 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.098 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 249' ' ' GLY . . . 154.2 31.09 0.03 OUTLIER Glycine 0 CA--C 1.528 0.888 0 C-N-CA 118.828 -1.653 . . . . 0.0 116.636 178.419 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.441 ' O ' ' OE1' ' A' ' 282' ' ' GLN . 12.7 p90 -143.89 160.6 40.51 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.51 1.655 . . . . 0.0 111.962 178.322 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -147.2 163.34 28.68 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.952 179.286 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.442 ' CE2' ' HE3' ' A' ' 244' ' ' LYS . 1.4 m-30 -113.68 128.07 56.28 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.485 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 39.8 t -121.52 132.67 70.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.527 0.203 . . . . 0.0 110.462 177.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.829 ' O ' HG23 ' A' ' 269' ' ' ILE . 49.7 m -120.26 136.51 54.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.642 0.258 . . . . 0.0 110.42 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.555 ' CE1' HG12 ' A' ' 269' ' ' ILE . 45.7 m-85 -119.23 134.98 54.91 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.671 ' HA ' HD11 ' A' ' 270' ' ' ILE . 55.0 t0 -60.52 -34.84 74.68 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.649 178.07 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 23.3 t -117.32 140.79 49.12 Favored 'General case' 0 N--CA 1.46 0.047 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.066 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.53 -28.36 69.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.873 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 296' ' ' ALA . 53.8 p30 -59.26 -35.87 74.49 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.53 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.575 ' N ' ' OD1' ' A' ' 295' ' ' ASP . . . -64.29 -33.83 76.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.979 0.419 . . . . 0.0 110.335 179.215 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.691 HG13 ' CG2' ' A' ' 245' ' ' ILE . 72.2 t -62.55 -43.44 98.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.196 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -61.35 -42.58 98.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.751 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -64.49 -42.81 95.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.151 0.501 . . . . 0.0 112.116 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.987 HG22 HD13 ' A' ' 315' ' ' ILE . 1.4 p -66.59 -36.23 76.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.618 -178.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 75.1 m -71.3 -42.41 68.69 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -57.76 -39.46 77.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.811 0.339 . . . . 0.0 111.697 -178.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.48 ' HB2' HD11 ' A' ' 306' ' ' ILE . 89.1 m-20 -57.84 -30.85 66.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.557 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.695 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 7.4 tptt 70.13 -71.8 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.695 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.8 m-30 -111.68 138.16 48.61 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.042 0.448 . . . . 0.0 110.949 178.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.641 HG21 ' HH2' ' A' ' 266' ' ' TRP . 21.9 mm -117.97 137.33 52.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.522 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -75.51 86.35 2.62 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.996 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.57 ' HD1' ' CE1' ' A' ' 262' ' ' PHE . 5.1 t80 -110.24 129.04 55.8 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.44 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.738 ' HG2' HG12 ' A' ' 254' ' ' VAL . 0.0 OUTLIER 59.01 40.33 22.39 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.751 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 53.98 37.5 26.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.514 0.673 . . . . 0.0 109.274 -178.014 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -148.59 162.51 39.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.93 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.65 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 30.6 mttt -93.89 133.69 37.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.232 0.539 . . . . 0.0 111.509 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.835 HD12 HG11 ' A' ' 247' ' ' VAL . 32.2 pt -118.06 144.17 26.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.196 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . 0.514 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 89.1 mt-10 -101.55 142.13 33.38 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.731 -178.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 0.987 HD13 HG22 ' A' ' 300' ' ' VAL . 69.6 mt -118.71 126.51 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 121.095 0.474 . . . . 0.0 111.496 -179.514 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -137.64 137.4 38.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.846 179.34 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -48.66 144.67 4.17 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.566 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 244' ' ' LYS . . . -55.92 143.81 30.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.008 0.432 . . . . 0.0 111.259 -179.083 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.245 -179.824 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.8 p . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.918 0.389 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.545 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 5.3 tptm -67.55 138.49 56.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.031 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.688 ' O ' ' HA ' ' A' ' 204' ' ' PHE . 90.0 mtp -129.46 160.0 34.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.077 0.465 . . . . 0.0 111.906 -179.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.564 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 1.6 t80 -107.63 129.54 54.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.771 178.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.503 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 20.4 mm -118.49 130.62 73.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 121.263 -0.175 . . . . 0.0 111.205 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.525 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -128.53 158.37 21.71 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.726 178.889 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.23 36.61 34.4 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.586 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 68.3 mt -59.79 -26.03 65.4 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 169' ' ' ASP . 54.3 t30 74.11 39.88 0.48 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.93 0.395 . . . . 0.0 110.207 -178.188 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.434 ' CE2' ' HD2' ' A' ' 198' ' ' ARG . 9.6 m0 30.65 30.06 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.638 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 167' ' ' ASN . 89.6 m-20 -130.97 5.8 4.57 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 172' ' ' GLU . 23.6 m -82.73 133.76 35.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 110.348 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 172' ' ' GLU . 5.3 p -109.49 14.69 23.43 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.104 -179.409 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.71 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 95.5 mt-10 77.67 -30.28 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -177.619 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.709 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 90.1 m-20 -62.92 -41.0 99.31 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 121.114 0.483 . . . . 0.0 111.486 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.519 ' HB3' HD21 ' A' ' 223' ' ' LEU . 85.1 m-20 -61.53 -38.0 85.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.685 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.745 HD22 HD21 ' A' ' 205' ' ' LEU . 18.9 mt -62.81 -41.93 99.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -178.247 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.709 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -68.83 -42.73 76.77 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.752 179.955 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.518 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 84.2 tt0 -72.64 -44.38 61.97 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.031 0.443 . . . . 0.0 110.811 179.014 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.606 ' OH ' ' CB ' ' A' ' 221' ' ' HIS . 43.1 t80 -62.62 -44.39 96.41 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.575 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.616 ' CE2' HD23 ' A' ' 175' ' ' LEU . 95.3 m-85 -97.8 -0.27 45.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.061 -178.531 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -59.32 -29.75 66.61 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.822 178.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.575 ' H ' ' CD ' ' A' ' 181' ' ' LYS . 0.5 OUTLIER -57.34 -42.29 81.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 122.093 0.949 . . . . 0.0 110.356 -179.897 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -69.65 -34.1 73.53 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.702 -1.59 . . . . 0.0 112.492 -177.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -175.39 -173.43 41.14 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 119.46 -1.353 . . . . 0.0 114.187 -179.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.545 ' O ' HG12 ' A' ' 185' ' ' VAL . 51.7 m -61.74 -26.53 68.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.533 -0.833 . . . . 0.0 112.05 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 184' ' ' THR . 8.0 p 51.31 73.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.831 0.824 . . . . 0.0 109.427 -177.292 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.4 t -54.23 -46.36 72.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.62 -1.173 . . . . 0.0 113.275 -177.584 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -137.45 157.33 46.8 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.587 0.708 . . . . 0.0 112.849 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.718 HD11 ' HB2' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -127.32 130.87 50.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.429 179.599 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 20.0 tptt -134.26 120.58 20.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 179.676 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.71 ' HB ' ' HG2' ' A' ' 172' ' ' GLU . 1.0 OUTLIER -127.88 134.61 64.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.139 176.868 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.591 ' N ' ' SD ' ' A' ' 191' ' ' MET . 0.0 OUTLIER -92.8 135.95 33.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.456 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -127.93 150.94 49.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.608 -178.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.631 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 17.8 m-20 -119.76 78.11 22.2 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.665 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.94 -26.41 74.47 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.11 1.874 . . . . 0.0 111.701 179.176 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.29 -66.55 0.71 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.444 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.8 p -67.58 -27.51 66.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.125 179.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 90.6 6.14 68.29 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.411 179.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.631 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 6.2 ttp85 -128.82 129.48 45.68 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 117.519 0.66 . . . . 0.0 111.816 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.5 t -66.37 155.46 37.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.807 -179.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.685 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 1.1 mpt_? -53.95 -34.03 58.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.131 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.489 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 93.82 1.85 65.29 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.842 -179.103 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.685 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 33.6 p90 -139.54 156.6 46.8 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.953 0.406 . . . . 0.0 110.919 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.521 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -144.31 158.92 27.63 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.819 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.688 ' HA ' ' O ' ' A' ' 161' ' ' MET . 90.5 m-85 -108.7 130.0 55.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 117.082 0.441 . . . . 0.0 110.463 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.745 HD21 HD22 ' A' ' 175' ' ' LEU . 64.2 mt -106.68 138.06 43.55 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.861 0.362 . . . . 0.0 111.943 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 49.0 m -121.29 136.2 55.0 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -123.36 145.29 48.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.748 0.309 . . . . 0.0 111.108 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.45 -34.36 76.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.952 178.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.7 115.34 51.39 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.336 179.161 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.37 -24.34 51.43 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.643 2.228 . . . . 0.0 113.61 -179.111 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 85.4 p -60.82 -31.42 70.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.586 0.232 . . . . 0.0 111.444 -179.405 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.862 ' O ' HG23 ' A' ' 216' ' ' VAL . 19.5 m -59.68 -36.11 75.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.912 0.387 . . . . 0.0 110.771 179.528 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.529 HG13 ' SD ' ' A' ' 161' ' ' MET . 85.8 t -62.13 -41.95 93.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.435 -179.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -59.26 -41.38 88.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.66 -179.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.403 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 16.3 pt-20 -76.79 -34.55 57.97 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 212' ' ' SER . 76.4 t -62.23 -46.31 96.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.25 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 230' ' ' PRO . 13.3 p -68.24 -45.53 82.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.022 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.489 ' N ' HG13 ' A' ' 217' ' ' VAL . 27.0 mttp -61.31 -36.19 79.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.026 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.405 ' O ' ' O ' ' A' ' 220' ' ' GLN . 47.9 m -59.11 -38.78 80.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.783 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.405 ' O ' ' O ' ' A' ' 219' ' ' THR . 63.9 tt0 60.67 107.26 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -177.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.614 ' O ' HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -136.92 167.63 21.12 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -176.568 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.755 HG23 ' O ' ' A' ' 226' ' ' LYS . 3.0 mt -125.58 118.8 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.321 176.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.606 HD23 ' OD1' ' A' ' 224' ' ' ASP . 8.4 tt -91.16 -54.27 4.01 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -177.468 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.606 ' OD1' HD23 ' A' ' 223' ' ' LEU . 97.4 m-20 -101.14 16.13 26.44 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.056 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.419 ' H ' HG22 ' A' ' 222' ' ' ILE . . . 98.92 -1.86 58.06 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.568 -178.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.755 ' O ' HG23 ' A' ' 222' ' ' ILE . 32.8 mmtp -110.76 139.23 46.24 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.105 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.701 HG21 ' O ' ' A' ' 276' ' ' LEU . 16.1 m -64.29 123.99 18.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.903 -179.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 221' ' ' HIS . 34.0 pt -120.78 151.21 23.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.624 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -128.54 80.4 72.57 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 121.073 0.463 . . . . 0.0 111.502 -179.356 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.676 ' O ' HG23 ' A' ' 217' ' ' VAL . 72.4 Cg_exo -53.01 126.31 21.07 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.43 2.087 . . . . 0.0 110.583 179.208 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.479 ' HZ3' ' HB2' ' A' ' 231' ' ' LYS . 1.2 ttmm -131.9 149.52 52.42 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.725 -178.487 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 14.1 ttp-105 -64.27 133.64 53.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.281 179.24 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.545 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -56.86 145.18 30.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.85 0.357 . . . . 0.0 111.033 -179.413 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 5.1 mt -108.67 125.08 32.56 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.487 -179.412 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.54 152.16 12.85 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.077 1.851 . . . . 0.0 110.503 178.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.47 ' HD3' ' OE1' ' A' ' 239' ' ' GLN . 31.2 mmt180 -55.89 -40.26 72.74 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.148 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -63.8 -46.35 85.58 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.17 179.12 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.29 -35.2 73.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.301 0.572 . . . . 0.0 109.923 178.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.47 ' OE1' ' HD3' ' A' ' 236' ' ' ARG . 61.1 tt0 -58.25 -42.27 86.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.183 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -63.08 -40.31 97.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.327 0.584 . . . . 0.0 110.011 178.314 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 242' ' ' THR . 24.2 mttp -62.63 -34.05 76.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.384 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 291' ' ' TYR . 68.2 p -29.08 -81.26 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -178.179 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 76.71 46.28 11.59 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.96 179.204 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 7.9 ttpm? -59.73 136.21 57.92 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.675 ' CG2' HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -123.31 161.2 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.771 0.796 . . . . 0.0 112.919 -179.307 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 315' ' ' ILE . 91.8 t80 -99.2 135.92 39.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.866 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.671 HG12 ' O ' ' A' ' 287' ' ' GLY . 9.6 p -129.92 144.03 39.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.238 0.542 . . . . 0.0 111.601 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.634 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.75 171.55 18.42 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.87 16.93 58.91 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.045 -1.074 . . . . 0.0 111.994 -179.111 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.739 HG22 HG21 ' A' ' 254' ' ' VAL . 68.7 mt -110.52 129.33 65.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.961 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -169.75 -99.08 0.12 Allowed Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.135 -179.592 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . 0.542 ' O ' HG13 ' A' ' 254' ' ' VAL . 32.1 Cg_exo -60.02 136.37 68.96 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.399 2.066 . . . . 0.0 113.255 -179.238 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 51.72 43.01 30.25 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.245 178.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.961 HG22 ' O ' ' A' ' 251' ' ' GLY . 14.8 m -127.0 45.4 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 254' ' ' VAL . 0.1 OUTLIER -40.77 151.67 0.26 Allowed Pre-proline 0 N--CA 1.462 0.155 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.859 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.415 ' N ' HD11 ' A' ' 274' ' ' LEU . 11.1 Cg_endo -55.28 -28.02 60.21 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 121.982 1.788 . . . . 0.0 112.381 -178.308 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -61.44 -44.62 96.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.293 179.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.506 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 55.6 mp0 -67.43 -38.7 84.95 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.902 0.382 . . . . 0.0 111.716 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.737 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 31.6 t80 -64.72 -47.52 77.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.534 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.46 -41.55 98.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.832 0.348 . . . . 0.0 110.626 179.589 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.5 pt-20 -75.39 -28.84 59.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.424 178.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.598 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 3.7 t80 -62.57 -56.87 13.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.607 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.694 ' C ' HD11 ' A' ' 269' ' ' ILE . 7.0 m-85 -65.89 -21.42 66.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.064 -179.384 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.701 ' N ' HD11 ' A' ' 269' ' ' ILE . 67.5 p -57.87 -20.12 34.28 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.742 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -47.67 -38.43 14.94 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.059 178.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.731 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 23.5 p90 -131.17 44.0 3.01 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 264' ' ' SER . . . 161.47 150.03 5.8 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.164 179.137 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.417 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 55.7 m -59.98 -34.83 73.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.876 0.369 . . . . 0.0 111.005 179.443 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.701 HD11 ' N ' ' A' ' 264' ' ' SER . 79.0 mt 68.44 112.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.075 -178.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.606 HG22 ' HB ' ' A' ' 290' ' ' THR . 14.7 tt -61.04 -29.43 45.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.916 0.388 . . . . 0.0 110.359 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 272' ' ' ALA . 55.8 t0 -176.9 -48.53 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.533 179.433 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.849 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . 52.13 122.11 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.879 0.371 . . . . 0.0 111.755 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -141.34 155.19 45.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.394 0.616 . . . . 0.0 112.43 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.761 ' HB2' HD11 ' A' ' 276' ' ' LEU . 64.0 mt -66.41 -31.79 72.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.212 178.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.569 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 94.2 mmm 102.1 -80.8 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.643 0.777 . . . . 0.0 110.397 -178.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.761 HD11 ' HB2' ' A' ' 274' ' ' LEU . 0.1 OUTLIER 38.57 64.74 0.71 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.345 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.628 ' O ' HG22 ' A' ' 227' ' ' VAL . 57.1 t0 -56.57 -39.81 74.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.943 0.402 . . . . 0.0 110.747 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.617 ' O ' HG22 ' A' ' 280' ' ' THR . 17.2 mtpt -95.07 9.56 39.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.39 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.2 t70 60.56 42.25 14.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.143 0.497 . . . . 0.0 110.386 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 278' ' ' LYS . 0.0 OUTLIER -171.26 -67.26 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.346 179.834 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . 0.523 ' H ' HG23 ' A' ' 280' ' ' THR . . . -83.19 175.56 52.8 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.467 179.201 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 64.05 45.06 4.31 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.013 0.435 . . . . 0.0 110.88 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.521 ' OG ' HD23 ' A' ' 276' ' ' LEU . 10.3 p -167.98 -40.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.033 179.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.443 ' O ' ' HA3' ' A' ' 251' ' ' GLY . 41.2 ttm180 -55.2 -31.34 61.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.933 179.299 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -105.77 -39.18 2.23 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.746 -0.74 . . . . 0.0 114.571 -178.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -136.6 167.24 21.77 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.001 0.9 . . . . 0.0 112.828 -178.17 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.671 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -132.44 159.14 23.29 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.187 178.685 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.425 ' HB2' ' HG2' ' A' ' 275' ' ' MET . 0.1 OUTLIER -119.21 124.6 47.16 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 122.734 -0.274 . . . . 0.0 111.612 -179.502 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.849 HG13 ' HB2' ' A' ' 272' ' ' ALA . 57.4 t -128.98 135.72 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 178.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.606 ' HB ' HG22 ' A' ' 270' ' ' ILE . 26.5 m -122.4 139.9 53.31 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.358 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.615 ' O ' ' HA ' ' A' ' 242' ' ' THR . 74.5 m-85 -113.35 137.32 51.69 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 293' ' ' SER . 54.1 p30 -63.35 -30.14 71.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.295 178.55 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . 0.537 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 99.1 p -115.55 144.1 44.37 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.272 0.558 . . . . 0.0 111.362 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.942 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -69.03 -33.32 73.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.348 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -57.04 -36.9 71.03 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.79 -39.09 87.59 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.942 HG12 ' O ' ' A' ' 294' ' ' ALA . 8.7 p -59.68 -37.83 72.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.437 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -62.79 -39.03 92.97 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -179.142 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -60.56 -43.29 97.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.902 HG23 HD11 ' A' ' 306' ' ' ILE . 0.9 OUTLIER -67.71 -34.18 66.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.671 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 77.4 m -57.82 -45.88 85.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.497 -179.166 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -61.59 -40.47 94.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.205 0.526 . . . . 0.0 110.704 179.68 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -60.52 -33.25 72.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.18 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.669 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 47.8 tptt 68.52 -73.21 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -177.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.669 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.6 m-30 -114.42 144.25 43.62 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.276 178.43 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.902 HD11 HG23 ' A' ' 300' ' ' VAL . 24.4 mt -118.89 133.4 65.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.639 178.204 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -76.84 75.69 3.46 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.598 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 5.2 t80 -72.8 -52.03 16.61 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.553 0.692 . . . . 0.0 110.927 -179.196 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.466 ' HD3' ' CE1' ' A' ' 308' ' ' PHE . 23.6 mmmt -128.39 -151.78 0.49 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.191 -179.147 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -58.08 -26.48 62.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.386 179.198 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -121.29 159.69 25.48 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.109 0.481 . . . . 0.0 112.237 -178.149 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.528 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 49.2 mttt -75.78 149.04 38.03 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.167 179.508 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.634 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 36.8 pt -117.84 149.52 20.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.311 178.466 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . 0.587 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 83.0 mt-10 -110.79 132.13 54.46 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.584 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 0.573 HG12 HG23 ' A' ' 247' ' ' VAL . 79.7 mt -121.05 126.9 75.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.14 0.495 . . . . 0.0 111.685 -179.487 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -126.09 150.31 48.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.133 179.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.572 ' HA ' HG22 ' A' ' 245' ' ' ILE . 95.1 mtm-85 -55.83 144.13 28.87 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.264 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 244' ' ' LYS . . . -61.66 142.66 57.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.983 0.42 . . . . 0.0 111.34 -179.337 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.128 179.551 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.087 0.47 . . . . 0.0 109.949 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.477 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 74.9 tttt -127.01 139.1 53.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.851 -179.505 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.826 ' SD ' HG13 ' A' ' 213' ' ' VAL . 93.2 mmm -116.29 147.56 41.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.42 -178.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.574 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 2.9 t80 -104.74 130.22 52.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.446 -0.797 . . . . 0.0 108.912 178.314 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.496 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 21.8 mm -117.42 130.84 71.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.312 -179.217 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.574 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -128.5 162.81 22.12 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 178.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.46 36.43 34.05 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.14 -1.029 . . . . 0.0 111.992 -179.717 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.483 HD22 HG21 ' A' ' 170' ' ' THR . 50.7 mt -60.68 -26.12 66.86 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -178.774 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.461 ' HB2' ' HG3' ' A' ' 226' ' ' LYS . 42.0 t30 71.38 40.76 0.81 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -176.902 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 8.2 m0 31.4 41.76 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.948 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -174.84 21.89 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 179.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.522 ' O ' ' O ' ' A' ' 171' ' ' THR . 98.1 m -61.62 -38.19 86.72 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.524 ' C ' HD12 ' A' ' 190' ' ' ILE . 0.0 OUTLIER 57.82 130.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -177.657 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.944 ' N ' HD12 ' A' ' 190' ' ' ILE . 21.6 pt-20 -58.77 -29.49 66.82 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -178.29 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.533 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.1 m-20 -60.06 -40.67 90.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.71 0.29 . . . . 0.0 111.582 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 170' ' ' THR . 83.1 m-20 -64.91 -37.17 86.75 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -179.138 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.687 HD23 ' CE2' ' A' ' 179' ' ' PHE . 7.2 mt -55.8 -47.78 76.53 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.533 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -65.1 -33.03 75.06 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.068 179.269 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -62.23 -39.02 91.41 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.672 -179.189 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.827 ' CD2' HD12 ' A' ' 223' ' ' LEU . 0.0 OUTLIER -94.59 -45.91 7.18 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-O 120.723 0.297 . . . . 0.0 110.755 179.614 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.687 ' CE2' HD23 ' A' ' 175' ' ' LEU . 75.0 m-85 -72.93 -13.96 61.36 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 179.074 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.69 -26.45 24.79 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.27 -0.49 . . . . 0.0 113.564 -179.297 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.752 ' HD3' ' H ' ' A' ' 181' ' ' LYS . 0.5 OUTLIER -56.47 -41.95 77.39 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.909 0.861 . . . . 0.0 110.796 -179.719 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.762 ' OH ' HG21 ' A' ' 219' ' ' THR . 66.6 m-85 -69.72 -35.15 74.78 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.054 -1.43 . . . . 0.0 112.927 -177.345 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 174.93 -175.08 47.02 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.352 -1.404 . . . . 0.0 114.171 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.556 ' O ' HG12 ' A' ' 185' ' ' VAL . 54.1 m -63.11 -25.11 68.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.573 -0.814 . . . . 0.0 111.659 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.593 HG21 HD23 ' A' ' 188' ' ' LEU . 7.9 p 52.75 79.66 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 CA-C-O 121.962 0.887 . . . . 0.0 109.091 -177.006 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -47.19 -50.95 19.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.664 -177.175 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 206' ' ' SER . 22.9 t70 -146.02 124.52 12.42 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.593 HD23 HG21 ' A' ' 185' ' ' VAL . 0.0 OUTLIER -108.97 153.87 22.97 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.708 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.605 ' HG3' ' SD ' ' A' ' 191' ' ' MET . 11.8 tptt -138.07 125.24 21.57 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -177.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 190' ' ' ILE . . . . . 0.944 HD12 ' N ' ' A' ' 172' ' ' GLU . 5.6 mt -123.67 126.55 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.564 175.58 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . 0.605 ' SD ' ' HG3' ' A' ' 189' ' ' LYS . 2.6 mpp? -94.6 57.98 2.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.295 -179.489 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.401 ' HA ' ' OG ' ' A' ' 199' ' ' SER . 34.2 tttm -63.9 149.49 47.02 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.81 -179.033 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.526 ' HB3' ' O ' ' A' ' 198' ' ' ARG . 2.1 t0 -120.4 75.85 24.88 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.594 -179.48 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.14 -23.88 75.09 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.59 2.193 . . . . 0.0 112.767 179.608 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -68.28 -73.85 0.14 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.883 -179.041 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.7 p -68.05 -25.54 65.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.704 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 93.95 -0.23 66.76 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.591 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.526 ' O ' ' HB3' ' A' ' 193' ' ' ASP . 0.8 OUTLIER -127.29 131.9 50.42 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.71 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.442 ' OG ' ' NH1' ' A' ' 200' ' ' ARG . 13.3 t -110.5 155.37 22.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.552 0.692 . . . . 0.0 112.799 -178.009 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.651 ' NH2' HG23 ' A' ' 190' ' ' ILE . 0.5 OUTLIER -45.01 -32.21 1.58 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.731 -179.801 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.486 ' H ' ' HD3' ' A' ' 200' ' ' ARG . . . 90.11 22.17 36.33 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.59 -0.814 . . . . 0.0 114.849 178.607 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.61 ' CE2' ' HB2' ' A' ' 200' ' ' ARG . 41.5 p90 -150.83 152.66 34.06 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 117.503 0.652 . . . . 0.0 111.008 178.773 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -138.54 161.69 25.75 Favored Glycine 0 C--O 1.228 -0.265 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.355 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.575 ' HB2' ' HB3' ' A' ' 189' ' ' LYS . 85.3 m-85 -110.73 126.0 54.1 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.9 -179.836 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.609 HD21 HD22 ' A' ' 175' ' ' LEU . 53.9 mt -107.73 142.01 38.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.687 0.28 . . . . 0.0 110.8 179.811 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 187' ' ' ASP . 26.3 t -124.65 130.12 51.82 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.614 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.831 ' CE2' HG21 ' A' ' 216' ' ' VAL . 97.6 m-85 -114.76 135.75 53.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.94 0.4 . . . . 0.0 111.31 179.603 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.43 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.4 tt0 -60.23 -34.23 73.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.473 179.204 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.62 116.96 56.79 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.823 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.85 -29.5 81.7 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.515 2.143 . . . . 0.0 113.189 -179.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.7 m -59.15 -37.91 78.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.786 0.327 . . . . 0.0 110.853 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.821 ' O ' HG23 ' A' ' 216' ' ' VAL . 23.3 m -59.83 -34.42 73.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.194 0.521 . . . . 0.0 110.31 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.826 HG13 ' SD ' ' A' ' 161' ' ' MET . 78.1 t -60.38 -41.24 86.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.094 -179.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -57.82 -43.95 86.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.026 0.441 . . . . 0.0 110.754 -179.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.7 -33.36 72.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.044 178.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.831 HG21 ' CE2' ' A' ' 207' ' ' PHE . 96.8 t -60.39 -43.07 93.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.589 -178.512 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 230' ' ' PRO . 9.0 p -84.23 -49.5 16.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.121 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 218' ' ' LYS . . . . . 0.514 ' N ' HG13 ' A' ' 217' ' ' VAL . 81.4 tttt -59.93 -39.68 86.3 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.424 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.762 HG21 ' OH ' ' A' ' 182' ' ' TYR . 70.5 m -59.19 -38.89 80.94 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.329 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.408 ' O ' ' O ' ' A' ' 219' ' ' THR . 63.1 tt0 62.1 114.67 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.03 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.686 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 0.0 OUTLIER -134.2 169.03 17.79 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -176.707 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.887 ' CD1' HG13 ' A' ' 227' ' ' VAL . 16.1 mm -117.62 128.39 74.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.839 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.827 HD12 ' CD2' ' A' ' 178' ' ' TYR . 8.5 tt -117.3 126.0 52.0 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.708 179.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.414 ' CG ' HD23 ' A' ' 223' ' ' LEU . 86.9 m-20 53.53 41.89 32.02 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 178.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 90.35 -23.88 19.5 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.412 -0.899 . . . . 0.0 114.337 177.444 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.605 ' O ' HG23 ' A' ' 222' ' ' ILE . 34.7 mmtp -95.66 151.21 19.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.202 0.501 . . . . 0.0 111.405 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.887 HG13 ' CD1' ' A' ' 222' ' ' ILE . 26.3 t -92.28 128.76 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.769 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 164' ' ' GLY . 28.3 pt -125.67 154.98 34.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.253 -179.341 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.58 78.21 75.86 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.121 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 230' ' ' PRO . . . . . 0.646 ' O ' HG23 ' A' ' 217' ' ' VAL . 9.4 Cg_endo -52.28 131.59 40.51 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.636 2.224 . . . . 0.0 111.775 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 162' ' ' PHE . 5.4 ttpm? -136.21 139.73 43.01 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.731 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.446 ' HG3' ' CG1' ' A' ' 213' ' ' VAL . 0.9 OUTLIER -50.82 141.98 12.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.088 0.471 . . . . 0.0 111.743 -179.494 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -62.45 144.44 55.92 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.391 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -107.68 135.81 19.73 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 121.353 -0.139 . . . . 0.0 110.902 179.761 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.91 139.95 85.03 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 121.789 1.659 . . . . 0.0 110.623 178.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -58.52 -37.55 75.86 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -60.18 -48.29 82.36 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.711 -179.856 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -73.04 -41.33 64.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.567 0.699 . . . . 0.0 110.168 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.518 ' O ' HG23 ' A' ' 242' ' ' THR . 61.1 tt0 -60.36 -37.06 79.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.505 -179.479 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -56.25 -37.42 69.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.613 -179.368 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 242' ' ' THR . 39.8 mttm -82.62 -74.09 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.468 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 239' ' ' GLN . 33.5 p 38.62 -168.01 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.087 0.47 . . . . 0.0 112.215 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -168.08 49.75 0.23 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.353 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 15.3 tttp -72.82 128.72 36.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.76 0.314 . . . . 0.0 110.532 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.716 ' CG2' HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -125.02 162.94 26.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -179.409 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.421 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 87.4 t80 -101.45 134.15 44.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.647 -1.161 . . . . 0.0 111.181 179.566 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.754 HG11 ' CE1' ' A' ' 259' ' ' PHE . 14.0 p -127.79 136.38 60.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.687 179.006 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -125.04 4.66 8.38 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.747 -178.702 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.624 ' O ' HG22 ' A' ' 313' ' ' ILE . . . -88.14 9.16 76.0 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.744 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.996 HD11 ' HA3' ' A' ' 287' ' ' GLY . 31.9 pt -120.61 154.75 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 121.004 0.43 . . . . 0.0 111.521 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.816 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -167.51 -142.58 3.5 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.839 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.07 -19.71 34.25 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.55 2.167 . . . . 0.0 112.449 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -82.9 3.18 30.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.81 -179.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.816 HG22 ' O ' ' A' ' 251' ' ' GLY . 19.1 m -126.77 157.04 38.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.718 0.294 . . . . 0.0 110.792 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.4 ' HD2' ' HD2' ' A' ' 256' ' ' PRO . 17.0 mmt85 -111.65 154.94 43.75 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.4 ' HD2' ' HD2' ' A' ' 255' ' ' ARG . 13.8 Cg_endo -57.49 -43.01 55.23 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 121.793 1.662 . . . . 0.0 111.797 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 261' ' ' GLU . 35.3 mttp -63.14 -43.14 99.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.129 179.349 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 261' ' ' GLU . 76.3 mm-40 -66.53 -36.87 83.75 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.576 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.754 ' CE1' HG11 ' A' ' 247' ' ' VAL . 25.2 t80 -63.67 -52.37 61.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.21 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -64.11 -37.25 86.76 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 258' ' ' GLU . 72.7 tt0 -61.88 -38.03 86.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.876 -1.511 . . . . 0.0 111.968 178.213 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.779 ' CE2' HD11 ' A' ' 313' ' ' ILE . 71.6 t80 -69.61 -56.52 7.06 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -179.445 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.704 ' C ' HD11 ' A' ' 269' ' ' ILE . 18.9 m-85 -65.2 -24.08 67.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.932 -179.377 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.711 ' N ' HD11 ' A' ' 269' ' ' ILE . 86.1 p -59.48 -25.91 64.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.376 -179.312 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -57.54 -36.89 72.22 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 266' ' ' TRP . . . . . 0.75 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 11.9 p90 -115.18 39.81 2.82 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.113 0.482 . . . . 0.0 111.765 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.508 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 157.51 146.74 4.58 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.709 178.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.434 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 59.8 m -58.94 -37.49 76.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.754 0.311 . . . . 0.0 111.27 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.711 HD11 ' N ' ' A' ' 264' ' ' SER . 73.9 mt 69.3 90.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.099 -179.202 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.63 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 75.0 mt -54.97 -44.76 75.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.932 179.009 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . 0.467 ' O ' ' HB ' ' A' ' 290' ' ' THR . 54.0 t0 -156.49 146.76 21.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.824 179.079 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.402 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -154.69 141.37 18.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.348 178.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -146.61 155.83 42.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.505 0.669 . . . . 0.0 112.378 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 274' ' ' LEU . . . . . 0.631 HD23 HD22 ' A' ' 276' ' ' LEU . 27.0 tp -64.44 -33.9 76.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.426 179.382 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 275' ' ' MET . . . . . 0.585 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 72.9 mmm 69.48 80.74 0.18 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 -178.478 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.631 HD22 HD23 ' A' ' 274' ' ' LEU . 0.2 OUTLIER -119.38 126.67 51.94 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.34 179.578 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.459 ' HB2' ' HG2' ' A' ' 282' ' ' GLN . 60.0 t0 -86.63 118.71 26.22 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.128 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 278' ' ' LYS . . . . . 0.458 ' CE ' ' HE2' ' A' ' 226' ' ' LYS . 26.9 mmtp 59.22 -150.23 0.44 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.602 -0.439 . . . . 0.0 109.911 -178.358 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.2 -38.73 68.75 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.222 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 280' ' ' THR . 14.4 t -168.42 114.37 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.906 0.384 . . . . 0.0 111.448 179.282 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 277' ' ' ASP . . . -145.4 -90.91 0.11 Allowed Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.207 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.585 ' HB2' ' O ' ' A' ' 275' ' ' MET . 97.3 mm-40 -56.39 -31.26 63.69 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.934 0.494 . . . . 0.0 111.946 -179.084 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.476 ' HB2' ' CD2' ' A' ' 274' ' ' LEU . 91.8 p -72.76 -4.71 33.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.562 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -51.9 -34.64 42.25 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 250' ' ' ILE . . . -156.22 9.51 0.29 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 119.318 -1.42 . . . . 0.0 115.398 -179.094 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 16.4 p90 -145.87 164.65 31.28 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.976 1.388 . . . . 0.0 112.084 179.12 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.996 ' HA3' HD11 ' A' ' 250' ' ' ILE . . . -140.1 164.68 26.13 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.254 179.126 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.496 ' HB2' ' HG2' ' A' ' 275' ' ' MET . 0.2 OUTLIER -119.4 128.54 54.14 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.367 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.672 HG23 ' CZ ' ' A' ' 259' ' ' PHE . 44.1 t -128.31 138.27 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.813 0.34 . . . . 0.0 111.524 178.289 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 36.2 m -117.34 136.41 53.15 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 291' ' ' TYR . . . . . 0.508 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 39.7 m-85 -115.31 136.01 53.55 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.416 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.63 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 55.3 p30 -64.79 -32.93 74.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.724 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . 0.57 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 51.0 m -121.98 144.42 48.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.312 0.577 . . . . 0.0 112.237 -178.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.989 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -66.23 -32.06 73.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.075 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -56.61 -38.19 71.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.098 -179.717 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -64.42 -41.59 96.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.767 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.989 HG12 ' O ' ' A' ' 294' ' ' ALA . 9.7 p -59.83 -37.05 69.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.014 0.435 . . . . 0.0 111.479 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -61.75 -37.26 83.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.717 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -58.88 -44.13 91.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.165 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.75 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 0.7 OUTLIER -73.41 -35.87 47.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.927 0.394 . . . . 0.0 111.274 -179.642 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 79.3 m -58.53 -46.14 87.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.032 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -63.6 -40.62 97.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.225 0.536 . . . . 0.0 110.192 179.198 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.416 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.4 m-20 -64.3 -35.6 81.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.865 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.675 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 35.5 tptt 67.76 -67.37 0.19 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.168 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.675 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 17.5 m-85 -113.98 131.84 56.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.929 179.148 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 306' ' ' ILE . . . . . 0.667 HD11 HG23 ' A' ' 300' ' ' VAL . 1.3 mt -122.18 138.69 51.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.127 178.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.494 ' OD1' ' CD ' ' A' ' 312' ' ' LYS . 94.0 m-20 -73.89 119.21 17.79 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.422 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.728 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 9.4 t80 -119.75 -76.07 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.417 0.627 . . . . 0.0 109.948 178.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.522 ' CG ' HG12 ' A' ' 254' ' ' VAL . 6.4 mmpt? -97.72 -163.39 1.04 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.513 178.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -52.93 -31.31 39.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.785 0.326 . . . . 0.0 110.742 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -112.15 153.62 26.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.106 0.479 . . . . 0.0 111.351 -179.369 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.598 ' CG ' ' HB3' ' A' ' 305' ' ' PHE . 19.7 tptt -70.77 143.96 51.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.541 -179.091 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.779 HD11 ' CE2' ' A' ' 262' ' ' PHE . 26.4 pt -111.31 141.38 26.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.799 179.218 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -101.48 131.69 47.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.716 179.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 315' ' ' ILE . . . . . 0.624 HD13 ' CE2' ' A' ' 263' ' ' PHE . 72.2 mt -119.92 129.57 75.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.156 0.503 . . . . 0.0 111.421 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 30.5 tttp -131.6 141.49 49.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.162 -179.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.458 ' HA ' HG22 ' A' ' 245' ' ' ILE . 34.9 ttp180 -54.55 137.75 42.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 0.0 110.581 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.72 140.73 56.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.332 -179.269 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.191 179.089 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.422 ' HG3' ' H ' ' A' ' 158' ' ' SER . 52.3 pttt . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.313 0.102 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.69 -34.3 74.14 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.6 0.238 . . . . 0.0 111.57 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.422 ' H ' ' HG3' ' A' ' 156' ' ' LYS . 22.4 m -57.98 -35.53 71.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 110.937 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 44.0 m -89.24 4.68 47.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.168 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -72.43 138.44 47.12 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 121.573 0.701 . . . . 0.0 112.215 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.832 ' SD ' HG13 ' A' ' 213' ' ' VAL . 82.1 mmm -116.08 150.63 37.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.653 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.601 ' CE2' ' N9 ' ' B' ' 6' ' ' ' A' . 4.8 t80 -103.57 128.57 50.8 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.61 ' CG2' HD21 ' A' ' 166' ' ' LEU . 16.2 mm -115.26 127.72 72.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.702 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -132.31 163.63 23.96 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.511 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.43 29.78 59.44 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.352 -0.927 . . . . 0.0 112.269 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.946 HD23 HG21 ' A' ' 228' ' ' ILE . 76.4 mt -86.84 140.63 29.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.744 0.307 . . . . 0.0 111.164 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.51 ' HB2' ' HG3' ' A' ' 226' ' ' LYS . 22.2 t30 -66.13 133.68 51.21 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.612 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 4.1 m-90 -52.09 -38.47 57.39 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.99 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.432 ' HB3' HD22 ' A' ' 167' ' ' ASN . 48.2 t0 -62.97 -26.85 69.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.5 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 51.5 m -54.07 139.86 33.59 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.542 0.687 . . . . 0.0 111.383 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 28.5 m -119.39 151.5 38.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.7 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.791 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 98.5 mt-10 -55.33 -36.3 66.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.854 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -58.3 -43.81 88.26 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 120.602 -0.439 . . . . 0.0 109.861 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -65.45 -37.3 86.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.622 HD13 HD12 ' A' ' 188' ' ' LEU . 1.0 OUTLIER -55.43 -62.37 1.72 Allowed 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.332 178.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.481 ' O ' ' N ' ' A' ' 180' ' ' GLY . 67.2 ttp85 -57.19 -41.04 78.58 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.912 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.08 -40.23 94.35 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.742 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.551 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 62.7 t80 -61.98 -48.07 81.99 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.637 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.566 ' CD2' HD23 ' A' ' 175' ' ' LEU . 88.8 m-85 -87.93 0.0 56.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.395 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -61.2 -28.84 69.79 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.595 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.443 ' CD ' ' H ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -58.64 -38.67 78.58 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.803 0.811 . . . . 0.0 110.04 -179.049 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -67.63 -30.03 69.49 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.62 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 159.46 -132.83 3.13 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.238 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 52.8 m -119.92 139.62 52.15 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.914 HG12 ' CE1' ' A' ' 207' ' ' PHE . 3.4 m -100.81 122.8 53.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.489 -0.485 . . . . 0.0 110.502 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.3 t -73.22 -46.92 47.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.288 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -145.73 121.7 10.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.016 0.436 . . . . 0.0 111.455 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -118.6 139.69 51.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.572 179.462 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.588 ' O ' ' CA ' ' A' ' 203' ' ' GLY . 8.7 tptt -133.01 83.38 2.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.841 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.791 ' HB ' ' HG2' ' A' ' 172' ' ' GLU . 12.0 tt -60.45 -22.64 26.02 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-O 121.146 0.498 . . . . 0.0 109.77 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.635 ' HE1' ' HA2' ' A' ' 203' ' ' GLY . 0.0 OUTLIER 73.13 55.38 0.12 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.486 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.63 152.07 46.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.467 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 1.5 t0 -124.16 75.85 59.77 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.23 -25.43 80.06 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.462 2.108 . . . . 0.0 112.308 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.74 -66.52 0.6 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.806 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 70.9 p -68.65 -24.83 64.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.195 0.521 . . . . 0.0 110.281 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.59 -3.35 68.27 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.431 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.484 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 6.3 ttp180 -130.35 124.37 32.1 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.971 0.415 . . . . 0.0 111.268 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.1 m -64.41 156.14 30.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.779 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.667 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 5.4 mpt_? -57.07 -33.91 67.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.083 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.604 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 93.17 3.37 65.42 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.668 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.667 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 40.4 p90 -144.62 154.8 43.19 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.635 ' HA2' ' HE1' ' A' ' 191' ' ' MET . . . -151.18 169.11 30.84 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 119.373 -1.394 . . . . 0.0 113.273 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.85 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 98.0 m-85 -106.54 120.47 42.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.188 0.518 . . . . 0.0 109.674 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.618 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 55.3 tp -108.39 125.56 51.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.955 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 50.2 m -118.55 143.56 46.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.312 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.914 ' CE1' HG12 ' A' ' 185' ' ' VAL . 74.3 m-85 -120.81 144.33 48.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.394 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.18 -34.8 77.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.943 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -110.87 119.51 45.89 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.787 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -56.55 -22.05 41.29 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.673 2.249 . . . . 0.0 113.139 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.7 m -57.14 -37.35 71.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.577 0.227 . . . . 0.0 111.558 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.939 ' O ' HG23 ' A' ' 216' ' ' VAL . 21.6 m -59.33 -35.81 74.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.816 0.341 . . . . 0.0 110.745 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.832 HG13 ' SD ' ' A' ' 161' ' ' MET . 78.1 t -61.16 -42.3 92.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.243 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.406 ' O ' HG22 ' A' ' 217' ' ' VAL . 54.0 t0 -59.22 -41.92 89.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.869 0.366 . . . . 0.0 111.179 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.42 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 15.3 pt-20 -76.34 -29.17 57.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.82 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.939 HG23 ' O ' ' A' ' 212' ' ' SER . 77.1 t -60.05 -41.54 86.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.441 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 214' ' ' ASP . 21.9 m -72.17 -30.02 34.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -59.12 -37.67 77.75 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.704 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 43.4 m -91.86 142.27 27.75 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 63.7 tt0 -66.19 -41.68 89.9 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.666 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.798 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 79.3 m-70 81.65 111.2 0.07 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.482 HD13 ' O ' ' A' ' 221' ' ' HIS . 20.5 mm -119.24 113.38 41.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.8 tt -120.67 124.63 45.67 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.937 0.399 . . . . 0.0 111.736 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 52.67 43.0 31.77 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.47 8.35 87.63 Favored Glycine 0 CA--C 1.516 0.141 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.345 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.51 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 2.4 mmmm -120.11 164.61 15.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.68 0.276 . . . . 0.0 110.532 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.9 p -117.52 135.99 56.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.087 0.47 . . . . 0.0 110.263 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.946 HG21 HD23 ' A' ' 166' ' ' LEU . 37.4 pt -126.96 160.47 35.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.61 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -127.83 79.22 74.01 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.158 0.504 . . . . 0.0 110.744 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.559 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 52.3 Cg_exo -58.78 124.06 14.91 Favored 'Trans proline' 0 CA--C 1.528 0.185 0 C-N-CA 122.934 2.423 . . . . 0.0 111.454 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 8.9 mtmm -133.58 157.18 46.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.915 0.388 . . . . 0.0 111.454 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 35.6 tpt85 -57.6 136.06 56.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.407 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.29 144.44 56.95 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.947 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.519 ' CD1' ' C6 ' ' B' ' 6' ' ' ' A' . 11.5 mt -111.06 125.25 31.0 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.67 143.44 46.69 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 121.82 1.68 . . . . 0.0 110.707 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -57.62 -39.86 77.86 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -62.27 -46.19 89.91 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.295 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.456 ' O ' HG23 ' A' ' 242' ' ' THR . 84.4 tt0 -69.78 -38.16 76.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.578 0.704 . . . . 0.0 109.762 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.443 ' NE2' " O2'" ' B' ' 6' ' ' ' A' . 43.4 tt0 -59.27 -40.96 87.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.027 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -61.61 -40.53 95.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.896 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -61.21 -34.59 75.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.46 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.729 HG22 ' HA ' ' A' ' 292' ' ' ASP . 19.1 p -80.71 161.93 24.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.535 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -147.46 175.77 26.64 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.178 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.517 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 49.1 tptt -131.08 129.94 42.56 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.648 HD13 ' O ' ' A' ' 245' ' ' ILE . 0.0 OUTLIER -119.74 161.12 19.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.377 0.608 . . . . 0.0 111.116 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.524 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 86.6 t80 -103.96 135.99 44.45 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.451 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 287' ' ' GLY . 7.5 p -129.48 144.55 37.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.563 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.65 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -129.8 176.87 18.45 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.82 32.73 26.13 Favored Glycine 0 C--N 1.32 -0.333 0 C-N-CA 119.895 -1.145 . . . . 0.0 112.211 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 1.023 HG23 HG21 ' A' ' 254' ' ' VAL . 69.3 mt -107.86 130.89 59.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -143.0 -163.12 9.6 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.438 -0.886 . . . . 0.0 113.39 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -52.32 147.69 27.88 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.934 2.423 . . . . 0.0 112.463 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 50.1 t0 74.16 -3.7 2.47 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.672 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 1.023 HG21 HG23 ' A' ' 250' ' ' ILE . 11.3 p -60.93 -38.58 79.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.1 OUTLIER 54.56 115.25 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.403 -179.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.21 -34.42 69.27 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 121.664 1.576 . . . . 0.0 111.998 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -61.75 -43.31 99.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.682 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.519 ' HB3' ' O ' ' A' ' 254' ' ' VAL . 84.3 tt0 -65.86 -35.66 81.28 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.281 0.563 . . . . 0.0 110.548 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.63 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 13.9 t80 -58.65 -45.16 89.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.594 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.414 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.4 tt0 -65.38 -41.96 93.17 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.3 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 258' ' ' GLU . 20.3 pt-20 -73.65 -30.8 63.14 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.01 0.433 . . . . 0.0 110.506 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.511 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 8.5 t80 -61.16 -53.23 59.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.224 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.688 ' CD2' HG21 ' A' ' 289' ' ' VAL . 4.3 m-85 -70.0 -23.5 63.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.888 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.637 ' N ' HD11 ' A' ' 269' ' ' ILE . 70.8 p -58.41 -25.61 62.34 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.734 0.302 . . . . 0.0 111.541 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -55.38 -34.51 64.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.242 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.687 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 11.2 p90 -117.05 45.12 1.94 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.259 0.552 . . . . 0.0 111.434 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.504 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 152.44 147.69 4.66 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.745 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 49.8 m -59.41 -37.99 79.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 111.348 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.68 HD11 ' C ' ' A' ' 263' ' ' PHE . 70.4 mt 67.55 86.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.873 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 292' ' ' ASP . 34.0 mm -58.56 -38.94 73.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.9 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -155.98 150.34 25.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.095 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -153.2 132.38 12.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.087 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -149.93 163.04 39.13 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 275' ' ' MET . 1.6 mm? -95.83 7.77 45.4 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.643 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.887 ' O ' HD12 ' A' ' 276' ' ' LEU . 86.0 mtp 71.02 -80.28 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.14 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.887 HD12 ' O ' ' A' ' 275' ' ' MET . 0.1 OUTLIER 37.95 49.42 1.17 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 178.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.464 ' HB2' ' OP1' ' B' ' 4' ' ' ' A' . 22.0 t70 -57.28 -45.04 84.47 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.386 -0.525 . . . . 0.0 110.661 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.512 ' O ' HG23 ' A' ' 280' ' ' THR . 61.4 mttp -108.02 3.42 24.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.09 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.484 ' OD1' ' HB2' ' A' ' 276' ' ' LEU . 83.3 m-20 51.28 38.13 20.57 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 278' ' ' LYS . 63.6 p -111.17 0.18 16.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.924 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.62 -30.73 0.26 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 119.409 -1.377 . . . . 0.0 114.334 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.528 ' HB2' ' HA ' ' A' ' 276' ' ' LEU . 94.9 mt-30 -57.46 -31.15 65.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.33 0.565 . . . . 0.0 110.641 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.714 ' CB ' HD23 ' A' ' 276' ' ' LEU . 95.4 p -59.32 -26.0 64.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.393 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -127.3 154.87 44.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.315 0.578 . . . . 0.0 111.389 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.52 -50.49 0.98 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.727 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.52 ' C ' HD12 ' A' ' 250' ' ' ILE . 22.4 p90 -145.16 165.07 29.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.862 0.331 . . . . 0.0 110.748 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.682 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -137.24 163.68 25.36 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.421 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.517 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -122.4 124.96 44.85 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.278 0.231 . . . . 0.0 110.8 179.489 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.688 HG21 ' CD2' ' A' ' 263' ' ' PHE . 43.4 t -127.12 139.9 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.009 0.433 . . . . 0.0 112.032 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.422 ' OG1' ' CD ' ' A' ' 244' ' ' LYS . 34.8 m -114.69 137.87 51.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.858 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.504 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 37.8 m-85 -117.43 140.11 50.02 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.729 ' HA ' HG22 ' A' ' 242' ' ' THR . 29.2 p-10 -61.53 -33.79 74.43 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.236 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.424 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 31.1 t -124.16 139.06 54.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.423 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.82 -31.73 73.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.61 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -56.12 -37.24 69.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.97 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -60.92 -36.65 79.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.957 0.408 . . . . 0.0 110.352 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 300' ' ' VAL . 82.0 t -61.1 -40.87 87.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.143 0.497 . . . . 0.0 110.194 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -59.47 -36.61 76.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.407 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -56.84 -42.91 80.5 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.085 0.469 . . . . 0.0 111.046 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.809 HG23 HD11 ' A' ' 306' ' ' ILE . 0.3 OUTLIER -75.71 -30.22 21.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.667 179.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 80.9 m -56.43 -45.87 80.55 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -64.15 -34.31 77.76 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -100.54 70.58 1.47 Allowed 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.204 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.609 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 7.6 tptt -53.81 -43.74 69.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.239 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.609 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.9 m-85 -113.55 126.0 54.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.302 0.572 . . . . 0.0 110.899 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.809 HD11 HG23 ' A' ' 300' ' ' VAL . 25.8 mt -117.68 139.17 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.192 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -79.54 102.39 8.81 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.595 ' HE2' HG23 ' A' ' 254' ' ' VAL . 5.7 t80 -107.4 -72.57 0.72 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.385 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.528 ' HD3' ' CE2' ' A' ' 308' ' ' PHE . 3.7 mmmt -100.15 26.28 6.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.346 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 63.03 41.56 8.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.697 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 312' ' ' LYS . 94.6 mtt180 -150.78 7.86 0.56 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.151 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 311' ' ' ARG . 24.0 mmtm 56.71 138.53 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.537 0.684 . . . . 0.0 112.129 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.65 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 36.3 pt -120.81 148.01 24.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.221 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . 0.408 ' CG ' ' HE3' ' A' ' 304' ' ' LYS . 84.9 tt0 -104.32 127.35 51.96 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 0.608 HG12 HG23 ' A' ' 247' ' ' VAL . 86.8 mt -118.19 130.86 72.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.324 0.583 . . . . 0.0 112.074 -178.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -132.51 142.84 49.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.526 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 69.3 mtt85 -53.11 149.13 7.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.641 0.258 . . . . 0.0 110.378 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 244' ' ' LYS . . . -54.27 141.88 28.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.91 0.386 . . . . 0.0 111.116 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -137.17 160.29 66.43 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.313 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.45 146.58 94.58 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.711 2.274 . . . . 0.0 112.124 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.0 -34.97 70.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.789 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.396 -179.943 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.433 ' O2 ' " O4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.429 -0.67 0 C3'-C2'-O2' 111.205 -0.722 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.524 ' C5 ' ' CE1' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.945 0 C3'-C2'-O2' 111.423 -0.647 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.535 ' O2 ' ' P ' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -1.022 0 C3'-C2'-C1' 100.76 -0.823 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.612 ' C2 ' ' CZ3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.426 -0.848 0 C4'-C3'-C2' 103.749 1.049 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.867 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.75 0 C4'-C3'-C2' 103.66 0.96 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.867 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.976 0 C3'-C2'-O2' 111.004 -0.792 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.85 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.955 0 C3'-C2'-O2' 111.289 -0.693 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.937 0 C3'-C2'-O2' 111.251 -0.706 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.2 tptt . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.776 0.322 . . . . 0.0 111.324 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -111.97 154.13 25.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.27 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 93.7 p -62.3 -23.61 66.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.087 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 37.4 m -50.33 -24.29 2.88 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.502 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -56.15 141.25 41.41 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.288 0.566 . . . . 0.0 111.621 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.671 ' CG ' HG23 ' A' ' 213' ' ' VAL . 93.8 mtp -115.83 156.04 26.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.435 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.621 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 3.5 t80 -105.16 129.57 53.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.894 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.638 HG23 HD12 ' A' ' 228' ' ' ILE . 16.0 mm -116.98 131.37 69.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.478 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.679 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -134.48 164.08 24.62 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.411 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.2 25.32 66.51 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.368 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.981 HD23 HG21 ' A' ' 228' ' ' ILE . 75.6 mt -86.88 143.05 27.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.734 0.302 . . . . 0.0 110.949 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.4 ' OD1' ' N6 ' ' B' ' 4' ' ' ' A' . 39.8 t-20 -61.12 133.23 55.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.581 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 4.8 m0 -52.32 -28.18 18.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.703 0.287 . . . . 0.0 111.013 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 50.2 p30 -83.81 8.5 14.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.16 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 88.8 m -70.77 140.23 51.24 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.351 0.596 . . . . 0.0 110.164 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 173' ' ' ASP . 27.9 m -114.97 144.38 43.68 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.566 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.948 ' HB3' HD21 ' A' ' 188' ' ' LEU . 98.3 mt-10 -55.73 -35.42 66.13 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.865 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.795 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 92.1 m-20 -57.1 -40.46 77.05 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -65.15 -38.69 91.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.11 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.722 HD22 HD21 ' A' ' 205' ' ' LEU . 3.6 mt -63.22 -48.32 78.76 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.795 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -71.63 -34.11 69.52 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.033 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -62.08 -38.57 89.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.536 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 63.8 t80 -80.25 -61.86 1.85 Allowed 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.942 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.575 ' CE2' HD23 ' A' ' 175' ' ' LEU . 72.6 m-85 -66.62 -21.47 66.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.81 -1.087 . . . . 0.0 112.314 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -50.56 -27.97 13.85 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.512 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 1.7 tmtt? -55.15 -43.14 73.92 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.864 -0.668 . . . . 0.0 110.062 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.467 ' CG ' HG22 ' A' ' 216' ' ' VAL . 46.0 m-85 -71.08 -33.94 70.69 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.454 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.419 ' O ' ' HA2' ' A' ' 180' ' ' GLY . . . -177.38 179.99 47.89 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.334 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 54.1 m -62.89 -33.85 76.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.805 0.336 . . . . 0.0 111.68 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.818 HG23 ' CE1' ' A' ' 207' ' ' PHE . 0.5 OUTLIER 64.99 102.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 121.205 0.526 . . . . 0.0 109.654 -178.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.75 HG23 ' N ' ' A' ' 208' ' ' GLU . 43.9 p -67.29 -37.68 83.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.965 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 206' ' ' SER . 20.1 t70 -160.81 160.77 31.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.948 HD21 ' HB3' ' A' ' 172' ' ' GLU . 0.1 OUTLIER -158.43 144.13 16.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.055 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.518 ' CG ' ' HB2' ' A' ' 204' ' ' PHE . 0.0 OUTLIER -131.71 113.56 13.7 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.696 ' HB ' ' HG2' ' A' ' 172' ' ' GLU . 2.0 tt -93.05 11.1 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.542 ' CG ' " H1'" ' B' ' 7' ' ' ' U' . 0.0 OUTLIER 67.21 -71.09 0.1 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.763 -178.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.724 ' HA ' ' HA ' ' A' ' 199' ' ' SER . 20.0 ttmm 59.81 133.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.095 0.474 . . . . 0.0 111.261 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 88.2 m-20 -120.73 87.78 42.74 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.893 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.59 -24.71 37.83 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.342 2.028 . . . . 0.0 112.306 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -75.46 -75.63 0.17 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.402 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 62.8 p -70.36 -24.43 62.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.051 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 91.26 9.8 63.0 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.992 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 17.9 ttp85 -96.15 133.01 40.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.213 0.53 . . . . 0.0 111.827 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.724 ' HA ' ' HA ' ' A' ' 192' ' ' LYS . 75.4 m -85.83 10.22 14.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.132 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.515 ' HG3' ' CB ' ' A' ' 191' ' ' MET . 40.2 mmt180 74.94 -41.88 0.48 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.586 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 92.95 6.01 63.77 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.331 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.613 ' HB2' ' O ' ' A' ' 163' ' ' ILE . 33.9 p90 -147.37 155.48 42.01 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.441 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -154.92 166.65 32.53 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.148 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.656 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 91.1 m-85 -109.92 128.39 55.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.655 0.264 . . . . 0.0 110.416 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.722 HD21 HD22 ' A' ' 175' ' ' LEU . 63.3 mt -104.99 140.5 38.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.837 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 33.1 t -123.21 130.69 53.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.347 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.818 ' CE1' HG23 ' A' ' 185' ' ' VAL . 94.7 m-85 -117.25 138.33 51.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.001 0.429 . . . . 0.0 111.538 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.75 ' N ' HG23 ' A' ' 186' ' ' THR . 84.4 tt0 -61.48 -34.62 75.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.095 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -113.36 120.49 39.8 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.955 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.755 ' O ' HG12 ' A' ' 213' ' ' VAL . 49.6 Cg_exo -56.17 -22.29 39.46 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.537 2.158 . . . . 0.0 112.989 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.6 m -56.61 -37.91 71.33 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.688 0.28 . . . . 0.0 111.291 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.867 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.4 m -59.68 -35.69 74.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 0.0 110.284 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 210' ' ' PRO . 0.4 OUTLIER -59.48 -40.51 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.721 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -62.57 -41.88 99.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.432 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.401 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 10.1 pt-20 -77.68 -34.08 53.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.997 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 212' ' ' SER . 84.0 t -62.62 -47.09 94.57 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 CA-C-O 121.104 0.478 . . . . 0.0 110.522 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.22 -34.09 67.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -57.99 -37.43 74.23 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.685 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 38.5 m -96.0 141.73 29.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.724 0.297 . . . . 0.0 111.619 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 228' ' ' ILE . 63.6 tt0 -67.05 -41.53 86.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.765 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 47.0 m-70 77.61 122.3 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.996 HD12 HG12 ' A' ' 227' ' ' VAL . 21.0 mm -116.38 110.65 32.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 175.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.494 HD23 ' CG ' ' A' ' 224' ' ' ASP . 7.1 tt -121.77 125.91 47.64 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.228 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.494 ' CG ' HD23 ' A' ' 223' ' ' LEU . 86.7 m-20 53.92 41.56 32.0 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 76.5 12.86 83.98 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.551 -0.833 . . . . 0.0 114.162 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -126.13 156.48 40.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.482 0.641 . . . . 0.0 111.764 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.996 HG12 HD12 ' A' ' 222' ' ' ILE . 33.7 m -107.82 136.52 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.298 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.981 HG21 HD23 ' A' ' 166' ' ' LEU . 34.3 pt -126.78 162.76 30.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.012 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -129.02 79.18 75.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.046 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.732 ' HG3' ' CD2' ' A' ' 221' ' ' HIS . 9.6 Cg_endo -54.21 133.48 55.85 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.417 2.078 . . . . 0.0 111.681 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.623 ' HE2' ' H62' ' B' ' 6' ' ' ' A' . 4.3 ttpm? -137.65 147.78 45.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.619 0.247 . . . . 0.0 110.774 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -56.28 137.53 52.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 111.391 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.75 148.87 51.35 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.114 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.55 HG13 ' N6 ' ' B' ' 6' ' ' ' A' . 5.6 mt -114.27 142.84 28.68 Favored Pre-proline 0 N--CA 1.464 0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.581 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.465 ' HD2' HG22 ' A' ' 234' ' ' ILE . 37.3 Cg_exo -56.94 138.88 88.0 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 121.763 1.642 . . . . 0.0 110.732 178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -60.06 -40.4 89.32 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.608 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 56.7 p30 -64.67 -40.8 96.06 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.573 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.608 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 97.3 mt-10 -71.47 -35.93 71.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.579 0.704 . . . . 0.0 109.363 177.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.421 ' NE2' " O2'" ' B' ' 6' ' ' ' A' . 43.0 tt0 -58.42 -42.01 86.3 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.752 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -63.53 -40.09 96.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.057 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -60.06 -36.45 77.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.708 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.722 HG21 ' CD1' ' A' ' 270' ' ' ILE . 17.2 p -78.84 160.63 27.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.532 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -142.11 169.26 25.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.424 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 7.9 ttpm? -134.79 136.07 42.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.54 0.21 . . . . 0.0 110.839 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.835 HD12 HG21 ' A' ' 315' ' ' ILE . 9.6 pt -120.29 156.6 23.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.127 0.489 . . . . 0.0 111.53 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 315' ' ' ILE . 78.9 t80 -94.41 131.44 40.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.15 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.851 HG21 ' CZ ' ' A' ' 263' ' ' PHE . 25.1 t -124.47 135.9 62.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.396 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.558 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -132.57 178.32 18.16 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.71 26.35 46.44 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.037 -1.078 . . . . 0.0 112.268 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.65 HD11 ' C ' ' A' ' 286' ' ' PHE . 32.0 pt -118.44 154.79 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 121.04 0.448 . . . . 0.0 111.339 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.763 ' O ' HG12 ' A' ' 254' ' ' VAL . . . -127.43 176.01 18.02 Favored Glycine 0 C--O 1.226 -0.344 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.972 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . 0.419 ' HD3' ' HG3' ' A' ' 284' ' ' ARG . 54.1 Cg_exo -51.69 -28.61 30.3 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 121.92 1.746 . . . . 0.0 111.304 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -61.32 -30.53 70.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.177 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.763 HG12 ' O ' ' A' ' 251' ' ' GLY . 7.8 p -47.54 -38.59 6.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.819 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.0 OUTLIER 56.34 125.68 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.281 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.47 -35.8 86.28 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 121.787 1.658 . . . . 0.0 112.656 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -63.56 -47.76 80.21 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 85.0 tt0 -68.07 -37.05 80.83 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.126 0.488 . . . . 0.0 111.15 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.504 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 27.4 t80 -58.88 -45.68 89.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.061 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.426 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.4 tt0 -66.84 -40.98 88.11 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.944 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' A' ' 258' ' ' GLU . 19.5 pt-20 -70.26 -34.09 72.39 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.882 0.372 . . . . 0.0 110.491 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.603 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 83.7 t80 -60.4 -54.33 46.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.454 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.851 ' CZ ' HG21 ' A' ' 247' ' ' VAL . 26.9 m-85 -69.22 -28.39 66.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.67 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.651 ' N ' HD11 ' A' ' 269' ' ' ILE . 22.7 t -57.05 -29.67 63.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.455 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 262' ' ' PHE . 19.9 pt20 -53.26 -36.09 60.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.822 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.814 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 12.5 p90 -115.19 40.99 2.53 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.915 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 170.91 -179.01 43.08 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.465 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.518 HG23 ' HB3' ' A' ' 292' ' ' ASP . 0.0 OUTLIER -104.81 0.75 28.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.77 0.319 . . . . 0.0 110.345 179.045 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.651 HD11 ' N ' ' A' ' 264' ' ' SER . 75.5 mt 28.91 97.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.722 ' CD1' HG21 ' A' ' 242' ' ' THR . 72.5 mt -60.44 -45.47 96.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.581 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -164.83 94.02 0.66 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -99.09 136.4 39.1 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -142.16 154.52 44.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.624 0.726 . . . . 0.0 112.745 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.794 HD21 ' O ' ' A' ' 283' ' ' SER . 35.7 tp -64.68 -37.38 87.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.648 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.611 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 95.8 mmm 93.32 114.75 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.518 -178.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.415 HD22 ' OG ' ' A' ' 283' ' ' SER . 28.5 mt -111.15 141.9 44.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.421 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.681 ' HB3' ' HA3' ' A' ' 281' ' ' GLY . 59.8 t0 -144.52 88.01 1.9 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.156 0.503 . . . . 0.0 110.405 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.704 ' O ' HG22 ' A' ' 280' ' ' THR . 3.5 mtmp? 64.6 37.13 8.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.568 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.461 ' O ' ' HB ' ' A' ' 280' ' ' THR . 86.0 m-20 51.84 44.23 29.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.961 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.704 HG22 ' O ' ' A' ' 278' ' ' LYS . 1.6 t 169.66 46.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.911 0.386 . . . . 0.0 110.729 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . 0.681 ' HA3' ' HB3' ' A' ' 277' ' ' ASP . . . -136.43 -111.82 1.13 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.313 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.51 ' OE1' ' HB3' ' A' ' 275' ' ' MET . 91.9 mt-30 -56.9 -24.99 56.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.027 -0.587 . . . . 0.0 111.101 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.794 ' O ' HD21 ' A' ' 274' ' ' LEU . 16.8 m -49.52 -31.9 11.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.086 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.419 ' HG3' ' HD3' ' A' ' 252' ' ' PRO . 70.7 ttp85 -116.36 136.98 52.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.161 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.16 -57.03 0.44 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.799 -0.715 . . . . 0.0 114.071 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.65 ' C ' HD11 ' A' ' 250' ' ' ILE . 35.1 p90 -141.62 167.98 20.86 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.555 0.677 . . . . 0.0 112.02 -178.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.448 ' N ' HD11 ' A' ' 250' ' ' ILE . . . -134.45 156.02 22.21 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.238 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.515 ' HB2' ' HG2' ' A' ' 275' ' ' MET . 0.1 OUTLIER -111.97 129.85 56.05 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.709 0.29 . . . . 0.0 111.722 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.54 HG21 ' CG ' ' A' ' 263' ' ' PHE . 38.4 t -122.39 135.04 63.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 111.496 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 52.0 m -118.48 135.64 54.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.444 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 38.7 m-85 -116.87 134.99 54.08 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.633 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 54.4 t0 -59.43 -36.08 75.22 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.5 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 50.5 m -120.77 143.92 48.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.266 0.555 . . . . 0.0 111.436 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.63 -30.61 71.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.158 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -56.47 -38.9 72.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.278 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.8 88.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.074 0.464 . . . . 0.0 110.299 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.702 HG13 HG21 ' A' ' 245' ' ' ILE . 71.6 t -62.2 -42.99 97.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.707 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -60.57 -37.72 82.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.125 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -58.59 -43.81 89.62 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.814 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 0.4 OUTLIER -74.34 -34.38 36.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.953 0.406 . . . . 0.0 111.045 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 97.8 m -58.24 -44.69 88.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.193 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -62.22 -40.12 95.08 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.312 0.577 . . . . 0.0 109.91 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -63.81 -32.67 74.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.369 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.707 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 22.5 tptm 67.47 -74.89 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.629 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.707 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.5 m-30 -109.06 131.85 54.67 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.127 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.66 HD11 HG23 ' A' ' 300' ' ' VAL . 1.7 mt -121.07 138.08 52.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.48 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.414 ' OD1' ' CE ' ' A' ' 312' ' ' LYS . 86.9 m-20 -67.55 138.46 56.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.603 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 2.2 t80 -140.62 -107.98 0.15 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.209 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 310' ' ' ASP . 2.6 mmpt? -58.92 -38.54 79.18 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.834 0.35 . . . . 0.0 111.862 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 309' ' ' LYS . 58.3 t0 176.7 -29.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.227 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 88.2 mmt-85 -113.66 160.32 18.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.607 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 37.0 mmtm -66.65 140.67 57.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.092 0.472 . . . . 0.0 111.567 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.558 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 34.5 pt -110.45 133.75 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . 0.548 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 84.2 mt-10 -96.04 131.49 42.38 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.798 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 0.835 HG21 HD12 ' A' ' 245' ' ' ILE . 68.6 mt -120.3 123.92 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.068 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -130.41 154.81 47.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.983 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -56.12 151.53 12.11 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -48.29 142.98 5.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.975 0.417 . . . . 0.0 110.866 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -124.31 168.38 13.11 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.731 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.68 152.01 29.54 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.792 2.328 . . . . 0.0 111.801 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -55.86 -34.99 65.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.877 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 84.1 t60 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.293 -0.86 . . . . 0.0 110.868 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.706 0 C3'-C2'-O2' 111.206 -0.722 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.514 ' C6 ' ' CG ' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.918 0 C3'-C2'-O2' 111.286 -0.695 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.538 " H2'" ' OP2' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.951 0 C3'-C2'-O2' 111.402 -0.655 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.586 " O2'" ' HA3' ' A' ' 201' ' ' GLY . . . . . . . . 0 O5'--C5' 1.425 -0.944 0 C4'-C3'-C2' 103.861 1.161 . 0.01 2u . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.679 ' C6 ' ' HA3' ' A' ' 164' ' ' GLY . . . . . . . . 0 O5'--C5' 1.424 -0.992 0 C4'-C3'-C2' 103.658 0.958 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.626 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.892 0 C3'-C2'-O2' 111.186 -0.729 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.656 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.939 0 C4'-C3'-C2' 103.686 0.986 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.893 0 C3'-C2'-O2' 111.249 -0.707 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.6 pttp . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.642 0.258 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -58.62 -37.11 75.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.018 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 69.3 m -150.5 8.61 0.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.917 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.3 m -60.59 -26.36 66.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.835 0.35 . . . . 0.0 110.844 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.511 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 6.3 tptt -56.85 136.37 55.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.47 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.68 ' SD ' HG13 ' A' ' 213' ' ' VAL . 90.3 mtp -125.74 155.88 40.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.303 0.573 . . . . 0.0 112.016 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.596 ' CD2' ' C5 ' ' B' ' 6' ' ' ' A' . 3.1 t80 -105.22 130.88 53.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.376 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.828 HG23 HD12 ' A' ' 228' ' ' ILE . 22.4 mm -117.4 128.89 74.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.556 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.525 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -122.43 157.15 17.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.968 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.565 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 74.68 54.52 5.91 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.218 -0.992 . . . . 0.0 112.27 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.532 HD11 ' N ' ' A' ' 203' ' ' GLY . 69.4 mt -83.55 3.47 32.34 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.659 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 36.9 t30 58.27 39.95 25.12 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.842 -0.536 . . . . 0.0 110.109 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.57 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 8.8 m0 33.32 35.05 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.075 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -175.72 22.48 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.504 ' OG1' ' O ' ' A' ' 166' ' ' LEU . 95.1 m -59.84 -34.65 73.38 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 122.137 -0.352 . . . . 0.0 111.795 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.0 OUTLIER 62.33 131.23 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -178.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.63 ' N ' HD12 ' A' ' 190' ' ' ILE . 96.5 mt-10 -59.02 -34.95 72.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.633 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.638 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.9 m-20 -57.04 -40.77 77.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.886 0.374 . . . . 0.0 111.386 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 170' ' ' THR . 85.9 m-20 -63.12 -36.19 82.77 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.742 ' CB ' HD11 ' A' ' 188' ' ' LEU . 6.3 mt -59.93 -42.25 93.57 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.638 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -65.29 -38.82 91.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.016 179.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.447 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 75.8 mm-40 -70.82 -44.11 67.21 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.043 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.556 ' O ' ' HD3' ' A' ' 181' ' ' LYS . 58.4 t80 -65.28 -44.56 87.59 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.223 0.535 . . . . 0.0 111.435 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.609 ' CE2' HD23 ' A' ' 175' ' ' LEU . 88.5 m-85 -94.86 -1.82 51.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.206 -0.907 . . . . 0.0 112.452 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -61.54 -26.97 67.25 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.312 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.621 ' H ' ' CD ' ' A' ' 181' ' ' LYS . 0.8 OUTLIER -56.11 -39.76 72.69 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.032 0.92 . . . . 0.0 111.002 -179.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -67.51 -27.86 67.34 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.711 -1.586 . . . . 0.0 112.012 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 159.64 -123.15 1.2 Allowed Glycine 0 CA--C 1.507 -0.432 0 C-N-CA 120.678 -0.773 . . . . 0.0 111.674 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.492 ' O ' ' HD1' ' A' ' 207' ' ' PHE . 28.3 p -119.88 160.0 23.55 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 206' ' ' SER . 8.1 p -122.67 130.25 74.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.332 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.769 HG23 ' N ' ' A' ' 208' ' ' GLU . 50.9 p -77.12 -38.86 51.22 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -155.29 150.98 27.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.472 0.653 . . . . 0.0 112.564 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.742 HD11 ' CB ' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -122.06 130.88 53.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.454 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 9.5 tptp -136.41 120.54 17.77 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.63 HD12 ' N ' ' A' ' 172' ' ' GLU . 6.4 mt -130.28 130.63 65.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.771 176.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.541 ' SD ' ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -90.38 122.26 33.09 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.53 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.56 ' HG3' HG22 ' A' ' 190' ' ' ILE . 58.9 mttm -126.76 156.46 41.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.752 0.31 . . . . 0.0 111.496 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.649 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 7.7 t70 -122.19 80.24 44.12 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.378 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.41 -25.88 50.53 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.429 2.086 . . . . 0.0 112.57 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -72.19 -67.44 0.54 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.916 0.389 . . . . 0.0 111.235 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 61.4 p -71.63 -22.12 61.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.629 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 84.21 18.2 63.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.378 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.649 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 2.1 ttt-85 -122.98 144.24 49.38 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 120.92 0.39 . . . . 0.0 111.273 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.435 ' OG ' ' HA ' ' A' ' 168' ' ' TRP . 90.1 p -110.38 157.61 19.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.979 0.419 . . . . 0.0 111.039 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.557 ' N ' ' HD2' ' A' ' 200' ' ' ARG . 1.5 mpt_? -53.53 -32.43 50.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.502 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.435 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 94.42 -0.09 65.51 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.352 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.554 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 23.9 p90 -139.15 154.86 48.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.222 0.534 . . . . 0.0 110.873 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.532 ' N ' HD11 ' A' ' 166' ' ' LEU . . . -140.42 162.2 26.52 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.23 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.701 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 95.6 m-85 -106.21 127.46 53.24 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.979 0.418 . . . . 0.0 109.982 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.664 HD23 ' N ' ' A' ' 206' ' ' SER . 2.0 tt -107.23 128.03 54.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.807 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.664 ' N ' HD23 ' A' ' 205' ' ' LEU . 11.9 t -117.0 132.45 56.7 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.494 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 205' ' ' LEU . 72.5 m-85 -117.5 141.55 48.22 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.769 ' N ' HG23 ' A' ' 186' ' ' THR . 47.0 tp10 -63.07 -36.08 82.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.6 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.24 116.57 51.0 Favored Pre-proline 0 CA--C 1.529 0.141 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.624 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.97 -26.02 65.86 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.346 2.031 . . . . 0.0 112.584 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 21.4 m -57.98 -37.28 73.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.26 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.915 ' O ' HG23 ' A' ' 216' ' ' VAL . 23.5 m -59.08 -35.61 73.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.942 0.401 . . . . 0.0 110.399 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.68 HG13 ' SD ' ' A' ' 161' ' ' MET . 86.0 t -61.68 -42.32 93.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.022 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -59.6 -41.63 90.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.131 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.43 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 18.7 pt-20 -75.1 -31.49 61.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.818 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 212' ' ' SER . 77.7 t -60.99 -44.69 98.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.278 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 230' ' ' PRO . 21.1 m -76.23 -29.24 19.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.028 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -58.31 -33.04 69.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.667 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 88.5 m -111.53 145.49 38.99 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -76.87 145.12 38.53 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.776 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 63.7 m-70 -120.57 134.05 55.32 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -176.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.61 HD13 HG23 ' A' ' 227' ' ' VAL . 28.3 mm -119.61 113.64 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.1 tt -121.66 126.77 49.8 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.74 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 56.4 t0 52.75 37.38 23.62 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 93.47 -24.67 24.49 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.839 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.523 ' HZ2' ' N6 ' ' B' ' 4' ' ' ' A' . 30.9 mmtp -97.58 170.96 8.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.841 0.353 . . . . 0.0 111.324 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.61 HG23 HD13 ' A' ' 222' ' ' ILE . 11.7 p -120.89 139.97 46.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.927 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.828 HD12 HG23 ' A' ' 163' ' ' ILE . 36.0 pt -123.64 159.86 27.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.097 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -125.25 81.39 63.64 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.172 0.51 . . . . 0.0 110.834 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.724 ' O ' HG12 ' A' ' 217' ' ' VAL . 51.0 Cg_exo -57.83 129.05 31.47 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.966 2.444 . . . . 0.0 111.551 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.618 ' HE2' ' H62' ' B' ' 6' ' ' ' A' . 3.3 ttpm? -140.74 155.94 46.32 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.571 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.595 ' CD ' HG11 ' A' ' 213' ' ' VAL . 52.5 mmm-85 -56.08 140.11 44.85 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.515 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.35 147.43 52.58 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.886 0.374 . . . . 0.0 111.506 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.606 HD12 ' C6 ' ' B' ' 6' ' ' ' A' . 35.7 mt -118.48 125.73 27.64 Favored Pre-proline 0 C--N 1.333 -0.132 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.155 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.451 ' HG2' ' CB ' ' A' ' 238' ' ' GLU . 9.8 Cg_endo -54.3 146.13 52.16 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 121.461 1.44 . . . . 0.0 110.072 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -55.98 -40.25 73.01 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.48 -44.13 95.27 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.897 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.451 ' CB ' ' HG2' ' A' ' 235' ' ' PRO . 84.3 tt0 -67.43 -38.14 84.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.038 0.447 . . . . 0.0 110.645 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.416 ' O ' HG23 ' A' ' 242' ' ' THR . 59.8 tp60 -58.95 -40.71 85.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.998 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -60.38 -40.38 90.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.082 0.468 . . . . 0.0 110.661 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -61.52 -36.58 80.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.267 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 291' ' ' TYR . 69.5 p -31.31 -75.57 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 80.61 47.77 6.6 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.918 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 16.8 tttp -58.77 138.54 57.09 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 122.449 0.299 . . . . 0.0 110.785 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.474 HG21 HG13 ' A' ' 297' ' ' VAL . 0.2 OUTLIER -121.41 161.52 21.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.527 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 75.2 t80 -96.03 131.24 42.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.82 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.848 HG21 ' CE2' ' A' ' 263' ' ' PHE . 59.9 t -124.02 139.97 48.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.494 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.66 -174.32 13.79 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.456 ' O ' ' CG2' ' A' ' 313' ' ' ILE . . . 79.98 57.14 3.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 119.765 -1.207 . . . . 0.0 112.882 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.578 ' CG2' HG21 ' A' ' 254' ' ' VAL . 31.6 mm -104.41 129.41 56.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.919 ' O ' HG13 ' A' ' 254' ' ' VAL . . . -107.81 169.25 14.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.004 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.39 141.54 89.35 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.454 2.103 . . . . 0.0 112.622 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 55.76 42.45 29.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.254 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.919 HG13 ' O ' ' A' ' 251' ' ' GLY . 2.5 m -73.15 -35.79 48.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.675 0.274 . . . . 0.0 110.916 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.21 124.29 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.09 -28.68 51.94 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 121.867 1.711 . . . . 0.0 111.9 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -60.75 -42.94 98.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.015 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 96.7 mt-10 -66.21 -39.4 89.58 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.925 0.393 . . . . 0.0 111.128 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.699 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 37.1 t80 -64.9 -46.75 80.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.385 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.528 ' O ' HD12 ' A' ' 269' ' ' ILE . 96.8 mt-10 -64.47 -40.58 95.97 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.717 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 21.1 pt-20 -76.3 -29.71 57.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 110.391 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.722 ' HE2' HD11 ' A' ' 313' ' ' ILE . 18.3 t80 -61.53 -57.2 13.08 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.944 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.903 ' CB ' HD11 ' A' ' 269' ' ' ILE . 7.4 m-85 -67.41 -27.22 66.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.106 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 267' ' ' GLY . 34.8 m -54.53 -27.24 36.89 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -46.77 -38.21 9.74 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.348 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.72 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 19.9 p90 -126.66 42.66 3.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.09 0.471 . . . . 0.0 111.269 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 264' ' ' SER . . . 162.71 154.17 7.49 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.756 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.407 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 50.9 m -61.27 -35.6 77.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.888 0.375 . . . . 0.0 111.593 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.903 HD11 ' CB ' ' A' ' 263' ' ' PHE . 2.5 mt 69.39 80.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.633 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.618 HD11 ' HB3' ' A' ' 292' ' ' ASP . 34.4 mm -59.85 -41.75 86.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.51 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -157.86 86.48 0.91 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.559 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -105.23 130.59 53.34 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -147.39 155.82 42.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.334 0.588 . . . . 0.0 112.506 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.726 HD21 ' O ' ' A' ' 283' ' ' SER . 34.5 tp -65.08 -36.98 86.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.825 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.69 ' O ' HD23 ' A' ' 276' ' ' LEU . 95.7 mmm 81.24 119.92 0.05 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.329 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.728 HD22 ' HB2' ' A' ' 283' ' ' SER . 25.4 mt -127.03 129.03 47.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.598 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -62.24 -39.57 93.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.616 0.722 . . . . 0.0 109.599 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -161.77 -46.94 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.462 -1.244 . . . . 0.0 108.907 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.465 ' O ' HD13 ' A' ' 276' ' ' LEU . 91.9 m-20 -131.19 -79.93 0.53 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.653 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.435 ' HA ' ' HB2' ' A' ' 283' ' ' SER . 68.7 p -116.3 13.36 15.57 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.891 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -49.87 -81.54 0.05 OUTLIER Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.419 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.689 ' OE1' H5'' ' B' ' 2' ' ' ' A' . 68.8 mm-40 -83.97 6.38 22.12 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 122.781 0.433 . . . . 0.0 110.791 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.728 ' HB2' HD22 ' A' ' 276' ' ' LEU . 22.8 t -56.95 -31.57 65.13 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.233 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 20.9 ptp180 -130.27 158.17 40.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.399 0.618 . . . . 0.0 111.902 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.68 -34.79 5.39 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.048 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 18.1 p90 -155.27 164.28 39.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 117.286 0.543 . . . . 0.0 111.768 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -135.13 150.92 20.32 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.121 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.511 ' HB2' ' HG2' ' A' ' 275' ' ' MET . 0.1 OUTLIER -112.26 125.61 54.35 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.859 -0.201 . . . . 0.0 111.483 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.699 HG23 ' CZ ' ' A' ' 259' ' ' PHE . 60.5 t -130.22 137.43 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 27.8 m -119.32 137.54 53.64 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.578 ' O ' ' HA ' ' A' ' 242' ' ' THR . 43.7 m-85 -114.44 142.25 46.61 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.618 ' HB3' HD11 ' A' ' 270' ' ' ILE . 27.7 p-10 -62.63 -33.9 75.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.03 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.421 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 50.9 m -123.46 144.49 49.49 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.308 0.575 . . . . 0.0 111.719 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.4 -28.86 68.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.209 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 296' ' ' ALA . 52.4 p30 -60.27 -33.3 72.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.661 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.566 ' N ' ' OD1' ' A' ' 295' ' ' ASP . . . -61.33 -36.85 81.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.083 0.468 . . . . 0.0 110.368 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 300' ' ' VAL . 83.2 t -62.06 -42.51 95.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.089 0.471 . . . . 0.0 110.442 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -61.43 -38.09 85.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.624 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -59.39 -43.77 92.88 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.942 0.401 . . . . 0.0 111.73 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.995 HG23 HD11 ' A' ' 306' ' ' ILE . 0.7 OUTLIER -72.16 -34.91 51.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.368 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 85.5 m -59.07 -45.65 90.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.164 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -62.63 -39.17 92.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.253 0.549 . . . . 0.0 110.089 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -62.53 -32.9 73.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.744 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.655 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 7.1 tptt 69.2 -72.76 0.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.67 ' HB3' ' HB3' ' A' ' 312' ' ' LYS . 3.8 m-30 -114.76 142.62 46.28 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.576 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.995 HD11 HG23 ' A' ' 300' ' ' VAL . 6.8 mt -120.11 133.73 65.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -75.37 80.65 2.44 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.183 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.608 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 11.7 t80 -76.9 -57.68 3.71 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.775 0.798 . . . . 0.0 109.869 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.459 ' HE3' ' CE2' ' A' ' 308' ' ' PHE . 9.3 mmpt? -109.87 -165.04 0.97 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.453 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -55.2 -23.45 22.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.758 0.313 . . . . 0.0 110.478 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -118.59 159.68 23.15 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.014 0.435 . . . . 0.0 111.558 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.67 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 78.5 mttt -76.58 147.96 37.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.818 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.722 HD11 ' HE2' ' A' ' 262' ' ' PHE . 23.4 pt -118.16 151.4 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . 0.604 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 81.9 mt-10 -106.6 135.72 47.63 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.259 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 0.79 HG23 HG22 ' A' ' 247' ' ' VAL . 72.1 mt -120.51 126.91 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 120.927 0.394 . . . . 0.0 110.977 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm -128.43 154.54 45.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.147 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 40.9 ptt85 -55.47 147.91 16.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.352 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.97 139.57 58.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.143 0.497 . . . . 0.0 111.407 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -129.93 77.93 75.83 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.173 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.15 132.9 52.82 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.038 1.825 . . . . 0.0 111.959 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -61.13 -34.69 75.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.82 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.05 179.879 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.672 0 C1'-C2'-O2' 108.51 -0.697 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.689 H5'' ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.934 0 C3'-C2'-O2' 111.521 -0.613 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.427 " H2'" ' OP2' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.003 0 C3'-C2'-O2' 111.219 -0.718 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.659 ' N7 ' ' HA ' ' A' ' 167' ' ' ASN . . . . . . . . 0 O5'--C5' 1.425 -0.94 0 C4'-C3'-C2' 103.742 1.042 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.658 H5'' " H3'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.79 0 C5'-C4'-O4' 107.806 -0.996 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.618 ' H62' ' HE2' ' A' ' 231' ' ' LYS . . . . . . . . 0 O5'--C5' 1.425 -0.94 0 C1'-C2'-O2' 108.54 -0.687 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.701 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.968 0 C3'-C2'-O2' 111.182 -0.73 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -1.003 0 C3'-C2'-O2' 111.281 -0.696 . 0.0 OUTLIER '7D dist 2u wannabe' 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.553 ' HG3' ' H ' ' A' ' 158' ' ' SER . 15.0 pttm . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.407 0.146 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -60.68 -34.13 73.88 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.847 0.356 . . . . 0.0 111.516 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.553 ' H ' ' HG3' ' A' ' 156' ' ' LYS . 86.2 p -62.28 -24.23 67.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.36 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.606 ' SG ' HG21 ' A' ' 213' ' ' VAL . 0.2 OUTLIER 62.76 59.6 1.4 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.274 0.559 . . . . 0.0 110.173 -179.339 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 68.1 tttt -69.58 140.3 53.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.506 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.827 ' SD ' HG13 ' A' ' 213' ' ' VAL . 86.4 mmm -115.03 147.95 39.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.78 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.635 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 5.6 t80 -108.71 130.97 55.36 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.614 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 16.6 mm -111.65 127.82 68.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.687 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -133.85 165.34 24.28 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.795 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.453 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 75.74 28.68 60.62 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.254 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.964 HD23 HG21 ' A' ' 228' ' ' ILE . 66.1 mt -86.99 139.62 30.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.883 0.373 . . . . 0.0 110.744 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.546 ' O ' ' N ' ' A' ' 169' ' ' ASP . 30.3 t30 -65.48 136.39 56.38 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.635 ' HD1' ' HG ' ' A' ' 199' ' ' SER . 6.2 m0 -60.27 75.95 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 167' ' ' ASN . 58.4 t0 178.28 -22.31 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.656 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 88.8 m -65.07 138.53 58.38 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.182 0.515 . . . . 0.0 111.038 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.505 ' C ' HD12 ' A' ' 190' ' ' ILE . 7.4 p -115.96 166.37 12.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.923 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.7 ' N ' HD12 ' A' ' 190' ' ' ILE . 53.1 mp0 -58.34 -28.91 65.52 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.813 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.1 m-20 -58.07 -43.46 86.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.846 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -65.99 -38.41 88.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.607 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.668 HD12 HD11 ' A' ' 190' ' ' ILE . 4.7 mt -61.65 -42.71 99.27 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.813 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -66.04 -38.22 87.82 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.798 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.45 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 97.1 mt-10 -69.55 -43.43 72.96 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.124 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.485 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 56.2 t80 -67.22 -48.66 67.16 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.477 0.656 . . . . 0.0 111.603 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.663 ' CB ' HD11 ' A' ' 205' ' ' LEU . 94.9 m-85 -91.75 -1.59 57.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.128 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -57.95 -29.15 61.71 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.22 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.844 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -57.05 -40.49 76.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.19 -0.505 . . . . 0.0 110.841 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.844 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 78.1 m-85 -70.34 -34.97 73.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.122 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 178.74 -173.88 46.12 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 119.938 -1.125 . . . . 0.0 113.652 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.6 m -62.38 -30.69 71.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.13 -0.535 . . . . 0.0 111.178 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.638 ' CG1' ' O ' ' A' ' 185' ' ' VAL . 0.4 OUTLIER 67.47 89.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -177.399 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.461 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -56.13 -49.32 74.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.517 -177.073 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -142.45 137.68 30.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.28 0.562 . . . . 0.0 112.409 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.66 HD11 ' HB3' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -115.08 133.03 56.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.524 179.115 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 15.3 tptt -133.78 122.61 23.54 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.7 HD12 ' N ' ' A' ' 172' ' ' GLU . 4.7 mt -128.58 130.41 68.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.757 176.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.585 ' CE ' ' HA2' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -93.01 126.44 38.09 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.444 ' HG3' HG22 ' A' ' 190' ' ' ILE . 12.6 mtpt -126.08 152.85 45.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.972 0.415 . . . . 0.0 111.933 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.615 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 4.6 m-20 -122.72 68.87 33.62 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.885 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.9 -24.99 80.56 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.925 2.417 . . . . 0.0 113.098 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -60.98 -47.38 86.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.929 0.395 . . . . 0.0 111.265 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 55.2 p -96.83 -4.04 41.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.235 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 76.68 24.97 66.12 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.619 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.615 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 5.9 tpt180 -121.83 159.84 25.91 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.635 ' HG ' ' HD1' ' A' ' 168' ' ' TRP . 97.8 p -128.32 154.16 46.23 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.21 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.556 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 4.9 mpt_? -55.76 -35.63 66.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.362 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 166' ' ' LEU . . . 86.8 5.06 81.81 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.59 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.614 ' HB2' ' O ' ' A' ' 163' ' ' ILE . 39.6 p90 -144.93 157.31 44.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.864 0.364 . . . . 0.0 110.647 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.585 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -150.45 166.45 30.15 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.015 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.747 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 95.4 m-85 -105.92 127.19 52.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.16 0.505 . . . . 0.0 109.89 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.663 HD11 ' CB ' ' A' ' 179' ' ' PHE . 6.3 tt -108.45 130.45 55.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.942 -178.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.586 ' N ' HD23 ' A' ' 205' ' ' LEU . 54.9 m -120.84 140.3 51.95 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.724 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.648 ' CE2' HD22 ' A' ' 205' ' ' LEU . 84.9 m-85 -121.05 142.74 49.54 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.395 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.461 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.5 tt0 -63.36 -35.38 80.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.195 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.42 119.27 47.18 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.92 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -56.84 -28.21 75.83 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.609 2.206 . . . . 0.0 113.102 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.6 m -58.67 -35.42 72.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.383 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.407 ' OG ' ' CG ' ' A' ' 207' ' ' PHE . 87.2 p -61.13 -30.15 70.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.92 0.391 . . . . 0.0 110.725 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.827 HG13 ' SD ' ' A' ' 161' ' ' MET . 70.1 t -62.71 -39.2 83.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.167 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -56.38 -41.85 76.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.847 0.356 . . . . 0.0 111.238 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.42 ' HB2' ' HD2' ' A' ' 182' ' ' TYR . 97.1 mt-10 -67.36 -34.77 77.99 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.774 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 94.2 t -63.06 -45.3 99.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.073 0.463 . . . . 0.0 111.31 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 52.8 t -70.09 -43.42 79.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -59.39 -35.99 74.99 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.429 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 61.9 m -98.05 143.73 28.3 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -76.13 147.61 38.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.774 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 35.8 m-70 -126.31 132.38 51.65 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 226' ' ' LYS . 68.3 mt -122.2 115.24 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.505 HD23 ' CG ' ' A' ' 224' ' ' ASP . 7.3 tt -121.78 127.11 50.26 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.515 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.505 ' CG ' HD23 ' A' ' 223' ' ' LEU . 85.6 m-20 54.45 42.52 31.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.999 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 73.91 18.32 79.59 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.005 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 222' ' ' ILE . 0.5 OUTLIER -128.21 153.46 46.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.801 0.301 . . . . 0.0 110.893 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.13 130.34 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.983 0.42 . . . . 0.0 110.259 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.964 HG21 HD23 ' A' ' 166' ' ' LEU . 34.5 pt -127.19 159.54 37.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.796 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -128.27 79.73 73.52 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.217 0.532 . . . . 0.0 111.037 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.483 ' HB2' HG12 ' A' ' 216' ' ' VAL . 37.3 Cg_exo -60.36 126.97 21.44 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 123.176 2.584 . . . . 0.0 111.687 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 12.4 mtmm -132.7 156.55 46.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.846 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -58.92 136.46 57.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.935 0.398 . . . . 0.0 111.608 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -66.99 143.9 56.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.089 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.579 ' CG1' ' C6 ' ' B' ' 6' ' ' ' A' . 0.0 OUTLIER -114.76 124.57 30.26 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.803 179.195 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.418 ' HG2' ' CG ' ' A' ' 238' ' ' GLU . 10.4 Cg_endo -53.93 151.06 28.14 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 121.987 1.791 . . . . 0.0 110.643 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.457 ' NH2' H5'' ' B' ' 7' ' ' ' U' . 21.0 mmt180 -54.29 -37.21 64.51 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -60.25 -43.53 96.03 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.964 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.418 ' CG ' ' HG2' ' A' ' 235' ' ' PRO . 97.7 mt-10 -72.6 -38.66 67.77 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.313 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -60.86 -39.38 88.95 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.844 0.354 . . . . 0.0 110.691 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -62.69 -40.35 96.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.171 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -60.19 -38.18 82.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.811 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 25.7 p -82.55 161.46 22.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.009 0.433 . . . . 0.0 111.55 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -154.02 114.79 0.64 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.961 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.459 ' NZ ' ' CE2' ' A' ' 288' ' ' PHE . 19.8 ttpp -85.77 134.33 33.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.645 0.259 . . . . 0.0 111.134 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.698 HG21 HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -118.42 163.24 15.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.479 0.657 . . . . 0.0 111.407 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.526 ' CG ' ' C6 ' ' B' ' 2' ' ' ' A' . 91.8 t80 -103.41 137.44 41.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.765 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.847 HG11 ' CE1' ' A' ' 259' ' ' PHE . 10.8 p -131.35 146.87 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.878 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.523 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -129.83 172.09 20.15 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 84.65 28.74 31.5 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.086 -1.054 . . . . 0.0 112.508 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.528 HG23 HG11 ' A' ' 254' ' ' VAL . 68.1 mt -110.52 133.0 57.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.819 0.342 . . . . 0.0 110.575 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.4 ' O ' ' HB ' ' A' ' 254' ' ' VAL . . . -123.03 172.2 15.88 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.392 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . 0.437 ' HG3' ' NE ' ' A' ' 284' ' ' ARG . 51.6 Cg_exo -53.78 -31.06 59.88 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.054 1.836 . . . . 0.0 111.667 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -60.15 -36.58 77.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.156 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.528 HG11 HG23 ' A' ' 250' ' ' ILE . 25.5 t -58.13 -45.1 88.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.486 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 254' ' ' VAL . 2.0 mmm180 60.97 141.84 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.28 -28.31 52.04 Favored 'Trans proline' 0 CA--C 1.528 0.189 0 C-N-CA 122.033 1.822 . . . . 0.0 112.919 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -61.69 -45.96 91.74 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 97.6 mt-10 -69.05 -38.39 79.09 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.171 0.51 . . . . 0.0 111.691 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.847 ' CE1' HG11 ' A' ' 247' ' ' VAL . 20.3 t80 -61.23 -47.19 87.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.805 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.439 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.4 tt0 -65.21 -41.84 94.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.601 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.8 pt-20 -75.05 -34.09 61.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.919 0.39 . . . . 0.0 111.211 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.671 ' HE2' HD11 ' A' ' 313' ' ' ILE . 16.4 t80 -62.2 -55.0 32.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.063 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.837 ' CD2' HG21 ' A' ' 289' ' ' VAL . 4.5 m-85 -67.92 -23.62 65.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.074 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.654 ' N ' HD11 ' A' ' 269' ' ' ILE . 23.2 t -55.91 -31.38 62.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.818 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -53.64 -35.79 61.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.644 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.647 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 11.3 p90 -115.89 48.69 1.19 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.363 0.601 . . . . 0.0 111.148 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.574 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 148.39 146.18 4.29 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.671 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.425 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 45.2 m -59.41 -37.47 78.1 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.654 HD11 ' N ' ' A' ' 264' ' ' SER . 74.2 mt 69.7 83.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.417 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.509 HD11 ' CG ' ' A' ' 292' ' ' ASP . 32.1 mm -57.25 -43.59 82.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.543 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -161.63 93.1 0.9 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.576 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -103.32 134.65 46.34 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -143.63 155.47 44.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.467 0.651 . . . . 0.0 112.331 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.747 HD21 ' O ' ' A' ' 283' ' ' SER . 32.7 tp -64.3 -38.41 90.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.364 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.588 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 93.6 mmm 95.0 115.48 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.466 0.706 . . . . 0.0 110.966 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 275' ' ' MET . 29.7 mt -120.42 116.68 25.94 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.931 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -64.05 -38.98 93.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.778 0.799 . . . . 0.0 109.179 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -150.39 -49.38 0.13 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.583 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 280' ' ' THR . 35.5 p-10 -150.38 -54.32 0.15 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.874 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.4 ' N ' ' OD1' ' A' ' 279' ' ' ASP . 64.4 p -126.49 14.17 7.63 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -56.74 -80.93 0.07 OUTLIER Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.64 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.989 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 78.4 mm-40 -83.38 3.21 32.75 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.562 0.345 . . . . 0.0 110.532 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.747 ' O ' HD21 ' A' ' 274' ' ' LEU . 86.4 p -61.35 -26.31 67.73 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.619 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.437 ' NE ' ' HG3' ' A' ' 252' ' ' PRO . 98.2 mtt180 -119.38 146.4 45.37 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.145 0.497 . . . . 0.0 111.85 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.95 -43.39 1.8 Allowed Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.505 -0.77 . . . . 0.0 114.327 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 23.2 p90 -149.29 165.13 32.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.914 0.857 . . . . 0.0 112.732 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.65 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -135.12 161.13 24.56 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.752 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.459 ' CE2' ' NZ ' ' A' ' 244' ' ' LYS . 0.2 OUTLIER -118.05 126.95 53.28 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.498 0.185 . . . . 0.0 111.498 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.837 HG21 ' CD2' ' A' ' 263' ' ' PHE . 60.1 t -124.87 136.02 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.017 0.436 . . . . 0.0 111.685 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 50.4 m -114.72 134.65 54.92 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.574 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 30.4 m-85 -114.74 137.01 52.44 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.509 ' CG ' HD11 ' A' ' 270' ' ' ILE . 52.5 t0 -56.73 -36.14 69.37 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.027 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 31.0 t -122.33 139.35 53.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.498 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.913 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -64.27 -30.05 71.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.985 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -54.96 -35.08 63.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.491 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -59.09 -38.37 79.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.616 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.913 HG12 ' O ' ' A' ' 294' ' ' ALA . 7.0 p -59.2 -37.66 69.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.824 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -62.37 -37.7 86.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.305 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -58.65 -43.23 89.73 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.636 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.974 HG23 HD11 ' A' ' 306' ' ' ILE . 0.9 OUTLIER -70.58 -35.52 61.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.696 -179.127 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 75.2 m -60.28 -44.04 95.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.86 0.362 . . . . 0.0 110.579 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.69 -33.93 74.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.189 0.518 . . . . 0.0 110.175 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.623 ' O ' ' N ' ' A' ' 305' ' ' PHE . 80.6 m-20 -85.66 5.36 32.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.943 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.694 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 13.4 tptt 37.62 -81.57 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.719 0.407 . . . . 0.0 111.03 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.694 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 2.7 m-30 -108.52 143.86 36.95 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.856 0.36 . . . . 0.0 110.23 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.974 HD11 HG23 ' A' ' 300' ' ' VAL . 25.3 mt -118.0 138.04 49.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.142 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.544 ' OD1' ' O ' ' A' ' 307' ' ' ASP . 51.0 p30 -75.34 114.36 13.78 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.017 0.437 . . . . 0.0 109.951 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.538 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 1.9 t80 -106.16 -109.37 0.29 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.457 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 1.5 mmpt? -59.38 -37.24 77.45 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.933 0.397 . . . . 0.0 111.896 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -179.6 -27.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.889 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 60.5 mtp85 -112.67 153.85 27.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.989 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.475 ' HG3' ' HB3' ' A' ' 305' ' ' PHE . 2.1 tptm -72.17 139.89 48.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.975 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.671 HD11 ' HE2' ' A' ' 262' ' ' PHE . 35.9 pt -115.46 152.09 17.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.884 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -100.71 132.17 46.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.017 0.437 . . . . 0.0 110.908 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 0.675 HG12 HG23 ' A' ' 247' ' ' VAL . 74.5 mt -120.35 128.45 75.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.819 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -132.85 147.18 52.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.916 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -50.97 149.65 3.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.712 0.291 . . . . 0.0 110.435 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 244' ' ' LYS . . . -55.36 141.6 35.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.07 0.462 . . . . 0.0 111.417 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -113.51 118.17 43.85 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.992 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.33 -20.98 34.54 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.272 1.981 . . . . 0.0 112.03 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.454 ' O ' ' CG ' ' A' ' 322' ' ' HIS . 17.9 mmm180 65.27 -71.0 0.08 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.0 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . 0.454 ' CG ' ' O ' ' A' ' 321' ' ' ARG . 2.3 m80 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.749 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.695 0 C3'-C2'-O2' 111.261 -0.703 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.989 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.953 0 C3'-C2'-O2' 111.371 -0.665 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.459 " H2'" ' OP2' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.944 0 C3'-C2'-O2' 111.24 -0.71 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.577 ' C2 ' ' CZ3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.425 -0.913 0 C4'-C3'-C2' 103.69 0.99 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.992 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.85 0 C4'-C3'-C2' 103.73 1.03 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.992 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.971 0 C3'-C2'-O2' 111.242 -0.71 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.747 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.423 -1.058 0 C3'-C2'-O2' 111.304 -0.688 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.959 0 C1'-C2'-O2' 108.535 -0.688 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 42.3 tttt . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.869 0.366 . . . . 0.0 111.336 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 60.8 mp0 -61.85 -33.29 73.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.017 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.3 m -119.83 146.96 45.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.003 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 20.0 p 178.55 -26.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.322 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -64.33 139.59 58.78 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.908 0.385 . . . . 0.0 110.682 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.662 ' O ' ' HA ' ' A' ' 204' ' ' PHE . 91.2 mtp -115.61 151.1 35.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.827 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.603 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 3.5 t80 -104.88 127.44 52.71 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.714 HG23 HD12 ' A' ' 228' ' ' ILE . 13.4 mt -121.68 127.12 75.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.797 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 202' ' ' PHE . . . -117.9 149.03 18.57 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.43 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.51 36.26 39.0 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.458 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.632 HD22 HD11 ' A' ' 175' ' ' LEU . 74.5 mt -59.1 -34.33 71.88 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.682 ' O ' ' N ' ' A' ' 169' ' ' ASP . 26.4 t30 101.8 37.34 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.638 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 9.3 m0 40.91 -68.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.382 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.682 ' N ' ' O ' ' A' ' 167' ' ' ASN . 92.5 m-20 -55.37 -30.0 59.52 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.629 ' O ' ' ND2' ' A' ' 174' ' ' ASN . 86.7 m -44.39 -36.03 2.66 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.581 ' C ' HD12 ' A' ' 190' ' ' ILE . 0.0 OUTLIER 54.88 165.06 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.726 -0.609 . . . . 0.0 110.969 -179.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.732 ' N ' HD12 ' A' ' 190' ' ' ILE . 53.7 mp0 -63.49 -35.79 81.62 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 174' ' ' ASN . 54.4 p30 -61.68 -39.2 90.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.629 ' ND2' ' O ' ' A' ' 170' ' ' THR . 63.9 m-80 -64.7 -37.6 88.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.632 HD11 HD22 ' A' ' 166' ' ' LEU . 3.6 mm? -62.85 -39.9 95.81 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 120.919 0.39 . . . . 0.0 111.192 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 180' ' ' GLY . 69.9 ttp85 -56.53 -41.89 77.54 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.08 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -68.28 -43.6 77.38 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.346 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.455 ' O ' ' HD3' ' A' ' 181' ' ' LYS . 61.4 t80 -65.14 -46.38 81.18 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.87 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.627 ' CB ' HD11 ' A' ' 205' ' ' LEU . 78.3 m-85 -91.64 -3.66 56.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.072 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -60.42 -31.15 73.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.294 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.455 ' HD3' ' O ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -57.69 -41.15 81.05 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.512 0.673 . . . . 0.0 110.841 -179.136 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -67.08 -33.44 75.5 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.14 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.64 -177.2 47.11 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.91 -1.138 . . . . 0.0 113.354 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 44.2 m -61.6 -31.56 71.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.289 -0.456 . . . . 0.0 110.72 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.852 HG23 ' CE1' ' A' ' 207' ' ' PHE . 0.9 OUTLIER 65.19 95.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -178.031 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.469 ' O ' ' OD1' ' A' ' 187' ' ' ASP . 2.3 t -63.55 -45.57 89.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.084 -178.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 186' ' ' THR . 91.5 m-20 -141.65 153.86 44.99 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.475 HD23 HG11 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -129.55 129.77 44.89 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.312 178.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 19.4 tptt -136.48 116.73 13.54 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.732 HD12 ' N ' ' A' ' 172' ' ' GLU . 86.0 mt -127.64 131.0 70.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.728 174.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.503 ' SD ' ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -78.23 99.07 6.11 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.76 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 41.8 pttt -89.36 153.02 21.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.048 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 1.3 m-20 -124.72 78.77 63.85 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.251 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.77 -24.69 64.96 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.41 2.073 . . . . 0.0 112.132 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.01 -74.65 0.18 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.456 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.1 p -68.2 -27.72 66.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.578 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.38 7.88 64.84 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.696 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 0.8 OUTLIER -122.87 121.48 36.32 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 117.651 0.725 . . . . 0.0 111.313 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 56.6 m -75.64 161.06 29.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.684 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.552 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -55.45 -33.46 63.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.858 178.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.551 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 96.3 -5.24 65.21 Favored Glycine 0 CA--C 1.517 0.177 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.014 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.571 ' CD2' " H4'" ' B' ' 5' ' ' ' U' . 35.5 p90 -134.2 154.34 51.3 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.462 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -146.38 167.71 27.95 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.12 -1.038 . . . . 0.0 112.412 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.719 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 89.1 m-85 -108.59 125.83 52.27 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.677 HD21 HG22 ' A' ' 185' ' ' VAL . 7.4 tt -109.13 131.84 54.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.161 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.509 ' N ' HD23 ' A' ' 205' ' ' LEU . 22.8 t -120.71 135.86 55.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.9 0.381 . . . . 0.0 111.8 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.852 ' CE1' HG23 ' A' ' 185' ' ' VAL . 87.2 m-85 -116.69 143.65 45.39 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.681 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -60.94 -34.57 74.92 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -114.23 115.73 44.91 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.211 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.74 -23.56 41.96 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.547 2.165 . . . . 0.0 113.171 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.566 ' O ' ' OE1' ' A' ' 215' ' ' GLU . 23.3 t -57.79 -38.15 74.97 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.498 ' HA ' ' OE1' ' A' ' 215' ' ' GLU . 24.0 m -56.97 -34.37 68.01 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.911 0.386 . . . . 0.0 110.314 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.724 HG11 ' CD ' ' A' ' 232' ' ' ARG . 85.0 t -60.35 -39.26 80.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.312 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 218' ' ' LYS . 92.9 m-20 -57.37 -41.2 79.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.403 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.566 ' OE1' ' O ' ' A' ' 211' ' ' SER . 47.6 mp0 -65.44 -35.74 81.82 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.076 0.465 . . . . 0.0 111.788 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.753 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 85.5 t -59.96 -44.01 93.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.964 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 214' ' ' ASP . 22.3 m -73.24 -35.51 47.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 214' ' ' ASP . 56.0 mtmt -60.09 -30.31 69.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 79.3 m -110.98 144.76 39.57 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -78.8 145.02 34.55 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.753 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 44.2 m-70 -120.96 129.51 53.46 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.469 HG12 HG22 ' A' ' 227' ' ' VAL . 68.3 mt -121.98 113.25 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 176.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.55 ' CD1' HD13 ' A' ' 175' ' ' LEU . 6.0 tt -122.23 124.06 42.93 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.163 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 53.29 42.48 32.08 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.85 9.2 87.01 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.719 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.523 ' NZ ' ' C6 ' ' B' ' 4' ' ' ' A' . 34.3 mmtp -123.66 150.41 44.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.897 0.379 . . . . 0.0 111.32 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.469 HG22 HG12 ' A' ' 222' ' ' ILE . 40.0 t -106.24 132.83 52.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.377 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.714 HD12 HG23 ' A' ' 163' ' ' ILE . 34.7 pt -123.82 159.13 29.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.517 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.74 82.05 64.49 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.425 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.599 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 73.4 Cg_exo -55.23 130.82 42.71 Favored 'Trans proline' 0 CA--C 1.528 0.195 0 C-N-CA 122.998 2.465 . . . . 0.0 112.189 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.54 ' CE ' ' H62' ' B' ' 6' ' ' ' A' . 9.5 ttpt -139.75 144.16 37.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.579 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.724 ' CD ' HG11 ' A' ' 213' ' ' VAL . 56.1 mmm-85 -52.58 142.71 17.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.015 0.436 . . . . 0.0 111.051 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.03 143.62 52.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.654 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.633 HG22 ' HB2' ' A' ' 238' ' ' GLU . 0.3 OUTLIER -115.44 123.31 31.67 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.536 179.117 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.47 ' HD2' ' OE1' ' A' ' 238' ' ' GLU . 78.2 Cg_exo -50.36 148.7 14.08 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 121.908 1.738 . . . . 0.0 110.996 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -53.7 -39.89 65.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.592 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 54.5 p30 -64.42 -37.57 87.99 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.914 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.633 ' HB2' HG22 ' A' ' 234' ' ' ILE . 94.9 mt-10 -68.23 -36.38 79.39 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.264 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -60.01 -37.29 79.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.911 0.386 . . . . 0.0 110.342 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -60.4 -39.43 87.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.631 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -60.5 -36.21 77.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.117 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 20.6 p -89.09 162.92 15.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.445 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.27 167.3 24.75 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.907 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.558 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 6.6 tptm -133.69 133.31 41.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.796 0.298 . . . . 0.0 110.591 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.634 HD12 HG21 ' A' ' 315' ' ' ILE . 5.7 pt -123.87 157.15 30.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.345 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.523 ' CZ ' ' N7 ' ' B' ' 2' ' ' ' A' . 88.9 t80 -97.27 131.0 44.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.926 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.821 HG21 ' CZ ' ' A' ' 263' ' ' PHE . 26.7 t -123.58 137.37 57.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.883 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.494 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -127.22 173.95 18.42 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.278 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 81.35 34.75 25.17 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.062 -1.066 . . . . 0.0 111.628 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.833 HG22 HG21 ' A' ' 254' ' ' VAL . 64.2 mt -110.52 130.82 63.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.698 0.285 . . . . 0.0 110.65 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.872 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -165.12 -107.54 0.2 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.184 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . 0.472 ' O ' HG13 ' A' ' 254' ' ' VAL . 25.1 Cg_endo -62.2 137.7 67.72 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.522 2.148 . . . . 0.0 113.465 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 52.03 42.85 30.66 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.266 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 251' ' ' GLY . 18.8 m -121.68 27.17 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.439 ' HB2' ' OE1' ' A' ' 258' ' ' GLU . 3.2 mmt180 -41.62 155.91 0.22 Allowed Pre-proline 0 N--CA 1.462 0.163 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -50.93 -28.01 22.63 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.011 1.808 . . . . 0.0 112.177 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -61.81 -47.15 86.41 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.004 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.475 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 54.8 mp0 -69.76 -40.17 76.26 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.85 0.357 . . . . 0.0 111.431 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.511 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 48.8 t80 -65.05 -46.69 80.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.117 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.33 -40.87 96.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.965 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.8 pt-20 -74.55 -32.6 62.49 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.974 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.735 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 78.3 t80 -59.93 -58.41 8.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.225 0.536 . . . . 0.0 111.713 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.821 ' CZ ' HG21 ' A' ' 247' ' ' VAL . 33.0 m-85 -66.78 -24.62 66.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.828 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.711 ' N ' HD11 ' A' ' 269' ' ' ILE . 34.6 t -55.7 -24.21 33.23 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -47.01 -38.76 11.34 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.063 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.797 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 23.0 p90 -132.34 53.6 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.086 0.47 . . . . 0.0 111.574 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.526 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 153.34 148.89 5.02 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.937 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.44 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 56.7 m -59.88 -37.09 78.35 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.711 HD11 ' N ' ' A' ' 264' ' ' SER . 72.1 mt 69.74 78.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.223 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 292' ' ' ASP . 33.6 mm -59.0 -44.51 91.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.961 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 270' ' ' ILE . 75.8 m-20 -153.51 86.99 1.22 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.58 ' HB2' HG23 ' A' ' 269' ' ' ILE . . . -103.27 135.99 43.88 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -141.66 151.1 42.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.498 0.665 . . . . 0.0 112.125 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.575 ' CD2' ' HB2' ' A' ' 283' ' ' SER . 37.1 tp -67.14 -34.89 78.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.625 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.613 ' HE2' ' HB2' ' A' ' 288' ' ' PHE . 2.9 ttm 86.46 145.8 0.06 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.008 0.523 . . . . 0.0 110.624 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.581 ' CB ' ' HA ' ' A' ' 280' ' ' THR . 0.5 OUTLIER 174.41 87.18 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 120.641 0.258 . . . . 0.0 111.048 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.01 -42.16 89.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.868 0.366 . . . . 0.0 110.656 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.446 ' O ' ' OD1' ' A' ' 279' ' ' ASP . 50.5 mttt -139.51 133.88 31.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.666 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.474 ' C ' HG23 ' A' ' 280' ' ' THR . 44.1 p30 30.12 44.51 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.581 ' HA ' ' CB ' ' A' ' 276' ' ' LEU . 1.3 p 70.23 29.52 3.66 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 278' ' ' LYS . . . -66.29 -58.72 8.25 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.246 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.911 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 97.4 mm-40 -64.04 -29.85 70.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.834 0.35 . . . . 0.0 111.353 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.575 ' HB2' ' CD2' ' A' ' 274' ' ' LEU . 87.0 p -56.55 -27.82 58.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.712 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -87.3 126.9 35.13 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.02 0.438 . . . . 0.0 111.537 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.14 -37.1 3.52 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 114.989 0.755 . . . . 0.0 114.989 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.545 ' CE2' ' CE ' ' A' ' 275' ' ' MET . 12.3 p90 -147.23 162.6 38.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.415 1.107 . . . . 0.0 112.733 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.704 ' N ' HD12 ' A' ' 250' ' ' ILE . . . -143.25 163.91 27.36 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 121.102 -0.57 . . . . 0.0 113.264 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.613 ' HB2' ' HE2' ' A' ' 275' ' ' MET . 0.3 OUTLIER -113.5 132.38 55.7 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.511 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 42.6 t -123.74 136.09 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 35.8 m -118.39 136.99 53.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.509 178.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.526 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 30.7 m-85 -120.65 140.56 51.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.514 ' HB2' HD11 ' A' ' 270' ' ' ILE . 51.3 t0 -57.88 -36.28 72.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.307 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 93.7 p -125.86 149.19 48.86 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.331 0.586 . . . . 0.0 111.784 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.96 -29.68 69.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.18 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -56.16 -38.23 70.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.333 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.498 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -61.38 -37.51 83.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.055 0.455 . . . . 0.0 110.468 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.556 HG13 ' CG2' ' A' ' 245' ' ' ILE . 77.1 t -61.91 -44.62 99.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.713 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -61.82 -37.6 85.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.346 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -58.42 -43.4 88.66 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.917 HG23 HD11 ' A' ' 306' ' ' ILE . 0.5 OUTLIER -73.18 -32.04 36.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.915 0.388 . . . . 0.0 111.152 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 91.6 m -54.97 -44.55 74.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.046 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -62.76 -40.07 96.12 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.003 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.44 ' O ' ' N ' ' A' ' 305' ' ' PHE . 86.1 m-20 -63.98 -36.22 83.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.518 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.681 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 19.1 tptm 66.57 -67.84 0.15 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.792 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.681 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 20.9 m-85 -115.87 136.24 53.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.235 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.917 HD11 HG23 ' A' ' 300' ' ' VAL . 30.0 mt -121.55 137.97 53.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.965 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 307' ' ' ASP . 52.6 p30 -78.99 85.46 4.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.977 0.417 . . . . 0.0 111.199 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.735 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 4.1 t80 -79.36 -71.78 0.43 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.5 ' HE3' ' CE1' ' A' ' 308' ' ' PHE . 8.1 mmpt? -104.56 -145.56 0.38 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.151 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.493 ' OD1' ' HG3' ' A' ' 311' ' ' ARG . 54.5 p30 -81.59 2.48 29.07 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.13 0.49 . . . . 0.0 109.952 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.493 ' HG3' ' OD1' ' A' ' 310' ' ' ASP . 94.0 mtt-85 -126.24 149.16 49.27 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.588 ' HG2' ' HB3' ' A' ' 305' ' ' PHE . 11.3 tttp -80.02 137.2 36.76 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.654 HD11 ' CE2' ' A' ' 262' ' ' PHE . 21.7 pt -105.01 135.85 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.82 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . 0.417 ' HB2' ' CE2' ' A' ' 305' ' ' PHE . 84.6 tt0 -102.15 130.31 48.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.812 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 0.638 HD13 ' CE2' ' A' ' 263' ' ' PHE . 67.5 mt -119.34 128.54 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-O 121.024 0.44 . . . . 0.0 111.125 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -130.91 144.19 51.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.253 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -51.85 138.05 24.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.93 0.395 . . . . 0.0 110.424 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 244' ' ' LYS . . . -64.68 145.27 56.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.004 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . 0.444 ' HG3' ' HD2' ' A' ' 320' ' ' PRO . 58.2 tt0 -114.62 146.44 35.98 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.614 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.444 ' HD2' ' HG3' ' A' ' 319' ' ' GLU . 46.5 Cg_exo -56.47 134.18 62.71 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 121.957 1.772 . . . . 0.0 111.981 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -58.34 -37.91 76.1 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.966 0.412 . . . . 0.0 110.965 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.899 -179.898 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.671 0 C3'-C2'-O2' 111.256 -0.705 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.911 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.424 -1.001 0 C1'-C2'-O2' 108.599 -0.667 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.424 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -1.015 0 C4'-C3'-C2' 103.756 1.056 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.638 ' C2 ' ' CZ3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.425 -0.929 0 C4'-C3'-C2' 103.993 1.293 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.784 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.826 0 C5'-C4'-O4' 107.973 -0.877 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.784 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.927 0 C3'-C2'-C1' 100.832 -0.742 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.719 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.914 0 C3'-C2'-C1' 100.861 -0.71 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . 0.495 ' N3 ' " H2'" ' B' ' 8' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.944 0 C3'-C2'-O2' 111.221 -0.717 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.9 pttp . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.9 0.381 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -57.87 145.37 35.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.691 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.5 m -116.17 146.06 42.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.087 0.47 . . . . 0.0 111.038 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 20.5 m -90.01 8.9 30.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.544 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.483 ' HE3' ' HB1' ' A' ' 233' ' ' ALA . 36.6 ttpt -64.45 137.46 57.89 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.428 0.632 . . . . 0.0 111.458 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.825 ' SD ' HG13 ' A' ' 213' ' ' VAL . 85.2 mmm -117.2 151.79 36.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.215 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.581 ' CE2' ' N9 ' ' B' ' 6' ' ' ' A' . 5.9 t80 -106.13 129.31 54.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.678 ' CG2' HD21 ' A' ' 166' ' ' LEU . 12.9 mm -116.45 127.61 74.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.73 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -130.45 163.97 23.05 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.492 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 73.88 28.58 64.55 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.809 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.678 HD21 ' CG2' ' A' ' 163' ' ' ILE . 74.3 mt -86.7 142.15 28.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.782 0.325 . . . . 0.0 111.604 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -64.65 135.42 55.91 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.581 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 4.7 m0 -52.06 -31.52 30.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.688 0.28 . . . . 0.0 111.003 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -91.17 5.41 49.17 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.614 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.52 ' O ' ' O ' ' A' ' 171' ' ' THR . 86.1 m -58.04 -40.43 80.88 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.558 ' C ' HD12 ' A' ' 190' ' ' ILE . 0.1 OUTLIER 53.16 157.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.189 0.519 . . . . 0.0 110.1 -177.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.54 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 97.4 mt-10 -62.41 -26.78 68.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.704 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.685 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 93.0 m-20 -53.53 -42.85 67.87 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.464 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -68.09 -38.0 81.85 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.526 HD23 ' CE2' ' A' ' 179' ' ' PHE . 5.1 mt -59.69 -47.6 85.0 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.685 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -68.02 -37.2 81.11 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.194 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.417 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 48.5 tp10 -67.76 -45.51 74.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.866 0.365 . . . . 0.0 110.421 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.607 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 72.2 t80 -67.17 -48.28 68.44 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.767 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.535 ' CB ' HD11 ' A' ' 205' ' ' LEU . 81.3 m-85 -88.73 -4.52 58.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.185 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -58.67 -32.02 68.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.199 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -41.5 89.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.707 0.765 . . . . 0.0 109.988 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -68.55 -34.24 75.5 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.89 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -179.12 -176.84 47.21 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.247 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.521 ' O ' HG22 ' A' ' 185' ' ' VAL . 49.0 m -63.3 -30.09 71.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.518 -0.341 . . . . 0.0 111.559 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.652 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 0.6 OUTLIER 64.85 83.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 122.355 1.074 . . . . 0.0 108.478 -177.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.476 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -53.13 -47.74 68.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.723 -177.097 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 186' ' ' THR . 92.2 m-20 -138.95 156.08 47.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.213 0.53 . . . . 0.0 112.391 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -132.77 136.78 46.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.876 179.252 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.587 ' O ' ' HA2' ' A' ' 203' ' ' GLY . 7.8 tptt -142.79 66.05 1.33 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.584 0.231 . . . . 0.0 111.415 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.561 ' HA ' ' HA3' ' A' ' 203' ' ' GLY . 8.7 tt -61.82 -19.16 20.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.59 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.67 ' CE ' ' HA2' ' A' ' 203' ' ' GLY . 10.8 mtm 64.07 131.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.741 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.55 ' HG3' ' HD3' ' A' ' 194' ' ' PRO . 6.2 pttt -132.2 156.49 46.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.958 0.408 . . . . 0.0 111.805 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 10.7 t0 -125.65 74.63 69.94 Favored Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.901 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.55 ' HD3' ' HG3' ' A' ' 192' ' ' LYS . 19.9 Cg_endo -59.98 -27.67 85.43 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.616 2.211 . . . . 0.0 112.788 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -66.81 -59.12 3.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.952 0.406 . . . . 0.0 111.366 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 65.8 p -74.27 -18.43 60.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.417 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 89.7 9.19 66.66 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.134 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 25.1 mmt85 -120.95 -179.22 3.95 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.294 0.569 . . . . 0.0 111.859 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.482 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 51.0 m -119.93 152.64 37.11 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.969 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.472 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 5.9 mpt_? -51.35 -34.87 35.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.833 0.349 . . . . 0.0 110.745 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.746 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 87.81 2.57 81.32 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.419 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.651 ' O ' ' HE3' ' A' ' 191' ' ' MET . 14.8 p90 -139.37 153.74 47.71 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.67 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -145.06 155.97 26.72 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.062 -1.066 . . . . 0.0 112.413 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.691 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 97.4 m-85 -102.88 123.37 46.4 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.691 HD23 ' N ' ' A' ' 206' ' ' SER . 1.6 tt -106.37 127.81 53.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.168 -177.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.691 ' N ' HD23 ' A' ' 205' ' ' LEU . 34.5 t -115.8 133.62 55.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.765 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.606 ' CE2' HD22 ' A' ' 205' ' ' LEU . 95.7 m-85 -116.18 136.4 53.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.408 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.476 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.5 tt0 -61.54 -33.76 74.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.136 0.493 . . . . 0.0 109.75 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -110.09 120.4 44.63 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.802 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.91 -23.06 49.17 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.522 2.148 . . . . 0.0 113.073 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.1 m -57.12 -36.76 71.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.543 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.915 ' O ' HG23 ' A' ' 216' ' ' VAL . 23.0 m -58.85 -36.45 74.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.698 0.285 . . . . 0.0 110.938 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.825 HG13 ' SD ' ' A' ' 161' ' ' MET . 73.4 t -62.12 -42.88 96.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.231 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -60.11 -41.76 93.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.314 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.465 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 19.3 pt-20 -73.94 -28.51 61.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.903 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 212' ' ' SER . 70.3 t -59.89 -42.7 90.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.638 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.2 m -73.87 -27.38 22.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -58.54 -31.38 67.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.74 0.305 . . . . 0.0 111.488 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.59 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 67.3 m -108.29 142.41 38.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.818 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.409 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 14.1 pt20 -68.51 -40.71 80.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.463 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.712 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 61.0 m-70 81.97 118.52 0.05 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 72.8 mt -114.26 106.47 20.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.497 HD21 HG23 ' A' ' 170' ' ' THR . 6.9 tt -122.62 121.39 36.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.82 0.343 . . . . 0.0 110.781 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 50.14 40.31 21.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.53 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.79 11.21 84.88 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.503 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 31.6 mmtm -113.4 139.48 48.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 117.233 0.517 . . . . 0.0 111.595 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.81 ' O ' ' O ' ' A' ' 228' ' ' ILE . 17.2 m -73.61 -30.45 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.999 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.81 ' O ' ' O ' ' A' ' 227' ' ' VAL . 17.0 pt 34.42 136.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -123.7 80.87 55.22 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.171 0.51 . . . . 0.0 111.258 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.471 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 46.9 Cg_exo -59.13 126.15 20.16 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.151 2.567 . . . . 0.0 112.202 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt -134.25 153.67 51.72 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.432 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 41.8 mtm180 -56.06 145.29 26.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.995 0.426 . . . . 0.0 111.767 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.483 ' HB1' ' HE3' ' A' ' 160' ' ' LYS . . . -64.85 146.76 54.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.054 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 1.023 HG22 ' C2 ' ' B' ' 6' ' ' ' A' . 3.2 tt -108.25 137.14 19.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.318 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.452 ' HG2' ' HG3' ' A' ' 238' ' ' GLU . 13.0 Cg_endo -55.93 143.19 83.16 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.826 1.684 . . . . 0.0 110.709 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -54.53 -36.61 64.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.739 0.304 . . . . 0.0 111.25 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.31 -41.49 84.61 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 242' ' ' THR . 97.4 mt-10 -68.14 -35.88 78.8 Favored 'General case' 0 C--O 1.23 0.07 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.484 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -60.82 -36.76 79.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.045 0.45 . . . . 0.0 111.039 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -58.66 -38.86 79.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.533 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 242' ' ' THR . 75.2 mmtt -87.47 -76.9 0.36 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 238' ' ' GLU . 76.9 p 34.66 -165.68 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -162.97 55.62 0.29 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.728 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.532 ' CE ' ' CD2' ' A' ' 288' ' ' PHE . 7.9 tptt -73.7 121.17 20.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.692 0.282 . . . . 0.0 110.399 -178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.7 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -130.01 164.58 32.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.176 0.512 . . . . 0.0 110.848 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -104.91 136.57 44.16 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.316 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.85 HG11 ' CE1' ' A' ' 259' ' ' PHE . 15.0 p -130.7 144.83 36.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.719 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.643 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -130.37 170.14 21.02 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.93 21.52 35.89 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 119.889 -1.148 . . . . 0.0 112.377 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 287' ' ' GLY . 67.0 mt -106.52 128.9 60.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.874 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -166.09 -115.28 0.32 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.329 -0.938 . . . . 0.0 113.272 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.43 138.63 86.86 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.334 2.023 . . . . 0.0 113.506 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 54.02 44.45 29.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.34 -0.845 . . . . 0.0 113.215 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.874 HG22 ' O ' ' A' ' 251' ' ' GLY . 8.8 m -109.49 -54.23 5.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.443 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.477 ' N ' HG23 ' A' ' 254' ' ' VAL . 13.2 mmt180 60.85 135.98 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -54.82 -31.9 74.61 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.192 1.928 . . . . 0.0 113.418 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -60.12 -45.08 94.22 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.792 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.682 ' HA ' ' HB3' ' A' ' 261' ' ' GLU . 58.6 mp0 -68.52 -33.69 74.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.828 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.85 ' CE1' HG11 ' A' ' 247' ' ' VAL . 13.2 t80 -61.93 -52.73 62.85 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.897 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.664 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.3 tt0 -63.77 -37.14 86.24 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.682 ' HB3' ' HA ' ' A' ' 258' ' ' GLU . 81.7 tt0 -61.41 -37.74 84.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 113.824 -1.534 . . . . 0.0 111.717 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.882 ' CE2' HD11 ' A' ' 313' ' ' ILE . 84.3 t80 -68.93 -54.72 13.9 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.782 ' CB ' HD11 ' A' ' 269' ' ' ILE . 7.3 m-85 -66.04 -25.22 66.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.208 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 86.5 p -56.32 -23.06 34.59 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -52.29 -39.68 60.82 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.298 -1.319 . . . . 0.0 113.072 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.665 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 43.9 p90 -120.87 58.33 0.95 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.543 0.687 . . . . 0.0 112.268 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.422 ' HA3' ' HB1' ' A' ' 296' ' ' ALA . . . 122.32 153.9 8.98 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.012 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.7 m -72.49 132.18 43.51 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.782 HD11 ' CB ' ' A' ' 263' ' ' PHE . 74.9 mt -93.98 126.14 46.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.711 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.772 HG22 ' HB ' ' A' ' 290' ' ' THR . 10.5 tt -65.55 -36.25 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.281 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 270' ' ' ILE . 51.2 p30 171.79 73.71 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.894 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.573 ' HB2' HG21 ' A' ' 269' ' ' ILE . . . -67.76 142.53 56.21 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.408 0.147 . . . . 0.0 111.01 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -144.03 152.16 40.64 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.84 HD23 ' HG ' ' A' ' 276' ' ' LEU . 22.3 tp -65.89 -35.87 81.85 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.087 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.582 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 93.1 mmm 99.5 -13.66 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.925 0.89 . . . . 0.0 112.574 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.84 ' HG ' HD23 ' A' ' 274' ' ' LEU . 0.0 OUTLIER -64.59 50.44 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 179.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.489 ' O ' HG22 ' A' ' 227' ' ' VAL . 21.8 t70 -59.0 -40.51 85.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.075 0.464 . . . . 0.0 110.592 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 279' ' ' ASP . 37.1 mtpt -59.79 -26.92 66.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.326 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 278' ' ' LYS . 54.3 t0 80.44 38.62 0.09 Allowed 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.096 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 281' ' ' GLY . 0.1 OUTLIER -166.62 -61.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.061 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . 0.557 ' H ' HG23 ' A' ' 280' ' ' THR . . . -82.49 164.28 43.39 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.396 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.405 ' OE1' ' HB3' ' A' ' 275' ' ' MET . 48.3 mt-30 59.36 41.65 19.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.883 0.373 . . . . 0.0 110.12 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.492 ' HA ' HD21 ' A' ' 274' ' ' LEU . 29.8 t -127.45 142.14 51.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.896 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.477 ' CA ' ' HA2' ' A' ' 251' ' ' GLY . 60.6 mtm180 45.85 25.49 0.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.671 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -119.53 -62.85 0.27 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.039 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.473 ' CZ ' " C4'" ' B' ' 2' ' ' ' A' . 41.6 p90 -139.23 164.9 28.6 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.805 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -130.39 156.54 21.63 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 119.927 -1.13 . . . . 0.0 113.625 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.532 ' CD2' ' CE ' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -119.3 123.08 43.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.729 -0.236 . . . . 0.0 110.465 179.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.815 HG23 ' CZ ' ' A' ' 259' ' ' PHE . 57.4 t -123.91 137.37 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.195 0.521 . . . . 0.0 112.105 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.772 ' HB ' HG22 ' A' ' 270' ' ' ILE . 20.8 m -120.41 138.33 53.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.407 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -114.91 138.96 50.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.145 0.498 . . . . 0.0 111.776 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 293' ' ' SER . 53.0 p30 -62.42 -30.47 71.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.928 178.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.55 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 51.0 m -119.76 142.65 48.36 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 121.18 0.514 . . . . 0.0 111.3 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.6 -31.83 72.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.72 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.48 -37.12 69.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.618 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.434 ' O ' ' HD1' ' A' ' 266' ' ' TRP . . . -61.15 -38.01 84.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.416 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 79.9 t -60.99 -40.01 84.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.933 0.397 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -58.08 -36.89 73.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.937 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -56.78 -43.75 81.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.987 0.422 . . . . 0.0 111.704 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.817 HG23 HD11 ' A' ' 306' ' ' ILE . 0.3 OUTLIER -76.1 -30.07 20.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.815 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 84.9 m -55.91 -45.29 78.72 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.77 -34.76 79.1 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.08 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -102.15 79.89 1.92 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.602 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.633 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 11.9 tptt -55.74 -44.59 77.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.048 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.633 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 8.5 m-85 -117.06 126.73 53.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.514 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.817 HD11 HG23 ' A' ' 300' ' ' VAL . 2.4 mt -121.37 139.38 48.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.228 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -78.76 113.32 16.74 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.376 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.601 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 7.0 t80 -112.3 -77.28 0.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.928 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.412 ' HG3' HG12 ' A' ' 254' ' ' VAL . 6.4 mmpt? -97.41 -167.29 1.51 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.967 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -51.84 -29.78 20.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.839 0.352 . . . . 0.0 110.486 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -105.42 144.59 31.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.05 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.578 ' HE2' ' HB3' ' A' ' 305' ' ' PHE . 10.3 tptt -70.74 142.04 51.45 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.882 HD11 ' CE2' ' A' ' 262' ' ' PHE . 28.8 pt -109.64 141.2 25.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.034 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . 0.506 ' HG3' ' CE1' ' A' ' 305' ' ' PHE . 85.6 tt0 -101.59 131.82 47.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.813 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 0.781 HG12 HG23 ' A' ' 247' ' ' VAL . 71.3 mt -119.91 128.29 75.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.108 0.48 . . . . 0.0 111.766 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.415 ' HE3' ' OE2' ' A' ' 314' ' ' GLU . 38.1 mttp -127.89 156.06 43.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.83 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -60.46 148.46 37.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -53.95 137.46 39.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.19 0.519 . . . . 0.0 111.611 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -133.27 81.06 56.99 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.649 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.25 137.65 71.22 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.187 1.925 . . . . 0.0 112.002 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -59.66 -35.42 74.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.106 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 79.5 m80 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.928 -179.893 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.722 0 C3'-C2'-O2' 111.244 -0.709 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.473 " C4'" ' CZ ' ' A' ' 286' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.972 0 C3'-C2'-O2' 111.208 -0.721 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.567 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.964 0 C3'-C2'-C1' 100.855 -0.716 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.746 " O2'" ' HA3' ' A' ' 201' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.853 0 C4'-C3'-C2' 103.957 1.257 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.902 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.818 0 C4'-C3'-C2' 103.573 0.873 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 1.023 ' C2 ' HG22 ' A' ' 234' ' ' ILE . . . . . . . . 0 O5'--C5' 1.426 -0.893 0 C4'-C3'-C2' 103.547 0.847 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.691 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.423 -1.068 0 C3'-C2'-O2' 111.416 -0.65 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . 0.753 ' N3 ' " H2'" ' B' ' 8' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.423 -1.032 0 O4'-C1'-C2' 107.485 0.775 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 27.7 tptp . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.655 0.264 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 158' ' ' SER . 84.5 tt0 -104.26 136.33 44.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.975 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 157' ' ' GLU . 2.2 m 48.91 174.15 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.616 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.96 77.83 1.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.694 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.47 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 79.4 tttt -87.69 134.62 33.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.88 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.415 ' N ' ' O ' ' A' ' 205' ' ' LEU . 5.0 tpp -120.39 147.37 45.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.648 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.626 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 5.0 t80 -100.19 129.35 46.2 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.807 HG23 HD12 ' A' ' 228' ' ' ILE . 21.8 mm -116.79 128.37 74.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.792 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.673 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -130.67 165.93 22.65 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.198 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.9 27.75 62.01 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.571 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.964 HD23 HG21 ' A' ' 228' ' ' ILE . 80.9 mt -87.41 144.28 26.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.737 0.303 . . . . 0.0 111.714 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.46 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 9.4 t30 -66.92 133.77 50.68 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.587 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 5.0 m-90 -50.23 -34.77 24.1 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.298 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -63.73 -20.63 65.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.5 m -50.83 139.24 17.28 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.786 0.803 . . . . 0.0 111.89 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.515 ' C ' HD12 ' A' ' 190' ' ' ILE . 32.6 m -120.51 148.38 43.91 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.778 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.887 ' N ' HD12 ' A' ' 190' ' ' ILE . 96.2 mt-10 -56.63 -34.84 67.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.606 0.241 . . . . 0.0 110.544 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.632 ' OD1' ' N ' ' A' ' 174' ' ' ASN . 54.9 p30 -61.46 -38.04 85.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.576 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.632 ' N ' ' OD1' ' A' ' 173' ' ' ASP . 84.0 m-20 -65.56 -36.13 82.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.159 0.504 . . . . 0.0 110.526 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.543 HD12 HD11 ' A' ' 190' ' ' ILE . 0.4 OUTLIER -53.42 -48.6 68.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.273 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.544 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -64.18 -37.0 85.88 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.107 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.425 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 84.4 tt0 -65.92 -44.13 86.05 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.722 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.48 ' OH ' ' HB3' ' A' ' 221' ' ' HIS . 73.2 t80 -64.88 -46.59 81.14 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.144 0.497 . . . . 0.0 111.429 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.485 ' HE1' HG13 ' A' ' 216' ' ' VAL . 91.5 m-85 -91.18 1.67 56.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.255 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -60.73 -28.69 68.52 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.381 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.465 ' CD ' ' H ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -58.98 -38.05 78.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.705 0.764 . . . . 0.0 110.445 -179.01 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.418 ' CE2' ' HA ' ' A' ' 216' ' ' VAL . 47.9 m-85 -67.31 -29.62 69.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.526 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 153.76 -124.31 1.55 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.892 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 56.8 m -117.16 139.01 51.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.95 HG12 ' CE1' ' A' ' 207' ' ' PHE . 4.8 m -109.56 126.2 66.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.685 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.81 HG23 ' N ' ' A' ' 208' ' ' GLU . 43.9 p -75.1 -31.89 61.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.58 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.851 ' C ' HD13 ' A' ' 188' ' ' LEU . 51.5 t0 -150.6 150.01 30.63 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.851 HD13 ' C ' ' A' ' 187' ' ' ASP . 0.0 OUTLIER -141.49 81.45 1.78 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.013 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.576 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 8.4 tptp -79.41 119.43 22.43 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.887 HD12 ' N ' ' A' ' 172' ' ' GLU . 74.0 mt -127.26 112.42 28.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 174.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.634 ' HB2' ' HD3' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -61.37 -34.43 75.3 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.2 -177.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.47 ' O ' ' O ' ' A' ' 191' ' ' MET . 52.2 tttm 49.6 162.79 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.455 ' N ' ' HG2' ' A' ' 192' ' ' LYS . 5.2 t70 -112.18 100.27 48.85 Favored Pre-proline 0 N--CA 1.463 0.206 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.347 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.8 -29.15 85.0 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.325 2.016 . . . . 0.0 113.165 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -78.96 -88.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.6 p -70.79 -27.11 63.66 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 193' ' ' ASP . . . 97.66 -8.28 63.78 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.204 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 199' ' ' SER . 33.3 mtm-85 -124.65 133.38 53.25 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.242 0.544 . . . . 0.0 111.849 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.575 ' O ' ' HB3' ' A' ' 200' ' ' ARG . 36.2 t 162.22 -177.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.071 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.833 ' HG2' ' H ' ' A' ' 202' ' ' PHE . 58.2 ttp85 68.52 -95.42 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.24 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.545 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 85.11 9.53 80.06 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.386 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.833 ' H ' ' HG2' ' A' ' 200' ' ' ARG . 34.5 p90 -146.14 153.53 40.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -148.65 166.59 29.22 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 119.858 -1.163 . . . . 0.0 112.209 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.802 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 89.9 m-85 -108.75 122.53 47.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.016 0.436 . . . . 0.0 110.023 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.948 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 0.7 OUTLIER -114.75 129.55 56.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.493 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.792 ' N ' HD12 ' A' ' 205' ' ' LEU . 58.5 m -115.18 143.08 45.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.251 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.95 ' CE1' HG12 ' A' ' 185' ' ' VAL . 92.5 m-85 -117.74 138.09 52.26 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.81 ' N ' HG23 ' A' ' 186' ' ' THR . 84.5 tt0 -63.68 -35.59 81.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.892 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.17 116.34 56.93 Favored Pre-proline 0 C--N 1.333 -0.123 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.388 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.914 ' O ' HG12 ' A' ' 213' ' ' VAL . 46.4 Cg_exo -56.13 -25.01 52.71 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.241 1.96 . . . . 0.0 112.829 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.7 m -58.84 -36.25 74.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.65 0.262 . . . . 0.0 111.47 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.758 ' O ' HG23 ' A' ' 216' ' ' VAL . 89.7 p -62.53 -32.7 73.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.453 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.914 HG12 ' O ' ' A' ' 210' ' ' PRO . 3.0 p -62.66 -37.2 78.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.892 0.377 . . . . 0.0 110.754 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 218' ' ' LYS . 54.9 t0 -61.99 -42.98 99.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.589 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 212' ' ' SER . 4.5 pt-20 -74.06 -32.34 63.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.904 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.826 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 92.7 t -63.61 -44.63 98.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.073 0.463 . . . . 0.0 110.894 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 213' ' ' VAL . 59.1 t -68.02 -46.14 82.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 214' ' ' ASP . 47.0 mmtm -61.11 -34.51 75.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.403 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 49.2 m -88.37 144.03 26.65 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -79.74 141.41 36.37 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.826 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 55.2 m-70 -121.15 130.77 53.88 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -176.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.565 HG12 HG22 ' A' ' 227' ' ' VAL . 69.0 mt -123.63 112.31 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.264 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.559 HD23 ' CG ' ' A' ' 224' ' ' ASP . 6.7 tt -119.12 127.23 53.17 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.139 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.559 ' CG ' HD23 ' A' ' 223' ' ' LEU . 86.0 m-20 55.05 42.46 30.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.314 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 77.62 10.95 85.91 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.56 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 222' ' ' ILE . 6.3 mptt -126.67 153.76 44.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.976 0.388 . . . . 0.0 110.753 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.565 HG22 HG12 ' A' ' 222' ' ' ILE . 43.4 t -102.25 132.8 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.917 0.389 . . . . 0.0 110.859 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.964 HG21 HD23 ' A' ' 166' ' ' LEU . 30.8 pt -125.27 159.62 32.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.377 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -126.86 82.86 66.89 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 121.13 0.49 . . . . 0.0 110.981 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.537 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 56.0 Cg_exo -56.73 128.57 30.55 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.195 2.597 . . . . 0.0 112.15 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.682 ' HE3' ' O4 ' ' B' ' 5' ' ' ' U' . 10.2 mtmp? -133.98 157.26 46.51 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.665 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 40.1 tpt85 -58.74 135.08 57.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.987 0.423 . . . . 0.0 111.165 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -65.81 145.85 55.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.088 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.795 HG22 ' HB2' ' A' ' 238' ' ' GLU . 6.1 mt -117.96 120.46 32.57 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.561 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.545 ' HB2' ' OE1' ' A' ' 238' ' ' GLU . 34.5 Cg_exo -53.89 152.69 22.38 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 121.548 1.499 . . . . 0.0 110.634 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 52.3 mmm-85 -54.23 -35.63 62.65 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.32 -40.74 82.86 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.795 ' HB2' HG22 ' A' ' 234' ' ' ILE . 55.3 mp0 -65.85 -35.82 81.73 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.587 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -59.35 -39.81 84.38 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.598 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -64.14 -45.19 89.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.053 0.454 . . . . 0.0 110.185 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -65.09 -40.08 94.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.649 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.742 HG23 ' O ' ' A' ' 238' ' ' GLU . 24.8 p -83.69 161.42 21.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.129 -178.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.53 166.27 25.88 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.34 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.496 ' HE3' ' CE2' ' A' ' 288' ' ' PHE . 4.6 ttpt -137.45 135.61 37.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.075 0.437 . . . . 0.0 111.233 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.956 HD12 ' CG2' ' A' ' 315' ' ' ILE . 7.4 pt -120.05 159.83 20.98 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 121.176 0.512 . . . . 0.0 110.933 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.55 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 90.0 t80 -99.52 129.62 45.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.675 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.458 HG22 HD12 ' A' ' 315' ' ' ILE . 44.0 t -119.83 137.32 54.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.349 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.05 167.72 18.38 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.564 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 94.48 8.58 59.64 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.197 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.965 HG22 HG21 ' A' ' 254' ' ' VAL . 27.8 mm -56.8 -39.89 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 120.762 0.315 . . . . 0.0 110.581 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 250' ' ' ILE . . . 27.56 -145.36 0.01 OUTLIER Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.677 -0.692 . . . . 0.0 114.419 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.9 169.25 11.89 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.338 2.692 . . . . 0.0 113.533 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 60.46 43.47 13.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.313 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.965 HG21 HG22 ' A' ' 250' ' ' ILE . 26.8 m -133.8 156.88 41.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.924 0.392 . . . . 0.0 110.991 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.92 155.12 74.84 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.778 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -57.01 -40.3 85.01 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 121.532 1.488 . . . . 0.0 110.851 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.52 -42.62 98.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.773 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 262' ' ' PHE . 74.6 mm-40 -65.43 -41.34 93.64 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.491 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.478 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 43.1 t80 -66.91 -48.96 67.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.722 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -64.65 -40.89 96.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.774 0.321 . . . . 0.0 111.058 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.1 pt-20 -74.69 -30.72 61.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.892 0.377 . . . . 0.0 110.548 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.669 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 91.4 t80 -57.38 -44.65 84.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.172 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.659 ' HZ ' HD12 ' A' ' 313' ' ' ILE . 86.7 m-85 -92.7 -2.22 56.22 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 267' ' ' GLY . 47.2 t -60.09 -30.16 69.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -56.36 -39.8 73.46 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.44 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.699 ' HH2' HG21 ' A' ' 306' ' ' ILE . 17.3 m-90 -60.42 -39.23 86.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.085 0.469 . . . . 0.0 110.811 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 264' ' ' SER . . . -173.71 -172.55 39.18 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.663 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 90.7 m -58.34 -37.18 74.64 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.625 HD11 ' C ' ' A' ' 263' ' ' PHE . 49.2 mt 61.7 86.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.65 HD11 ' HB3' ' A' ' 292' ' ' ASP . 31.4 mm -55.09 -44.5 74.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -159.66 92.48 1.04 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -104.86 133.98 48.75 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -144.68 154.94 43.3 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.812 ' CD1' HG21 ' A' ' 250' ' ' ILE . 31.8 tp -66.19 -37.83 86.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.23 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.625 ' O ' HD23 ' A' ' 276' ' ' LEU . 93.2 mmm 84.21 138.08 0.06 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.199 -178.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 275' ' ' MET . 0.2 OUTLIER 173.59 89.78 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.841 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 278' ' ' LYS . 55.4 p30 -64.16 -39.86 94.92 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.688 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.615 ' N ' ' OD1' ' A' ' 277' ' ' ASP . 60.1 mttm -101.11 7.98 43.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.978 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.461 ' HA ' ' CD1' ' A' ' 276' ' ' LEU . 51.2 t0 78.94 -13.69 0.94 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.857 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 46.4 p -139.43 12.13 2.55 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -94.58 -74.63 1.25 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.761 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.983 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 80.1 mm-40 -60.1 -32.47 71.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.049 0.452 . . . . 0.0 111.232 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.697 ' OG ' HD21 ' A' ' 274' ' ' LEU . 33.1 t -61.66 -4.7 1.52 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.911 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -49.94 -38.2 35.4 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 178.91 19.17 0.03 OUTLIER Glycine 0 CA--C 1.524 0.604 0 C-N-CA 118.717 -1.706 . . . . 0.0 115.847 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.444 ' CZ ' " C4'" ' B' ' 2' ' ' ' A' . 24.9 p90 -137.93 160.53 39.07 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.755 1.278 . . . . 0.0 111.022 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -139.36 157.27 24.97 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.319 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.496 ' CE2' ' HE3' ' A' ' 244' ' ' LYS . 0.6 OUTLIER -111.13 129.18 56.01 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.582 0.353 . . . . 0.0 110.919 179.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.492 ' O ' ' HG3' ' A' ' 244' ' ' LYS . 42.3 t -122.76 133.14 69.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.712 0.292 . . . . 0.0 111.16 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 52.5 m -119.61 138.02 53.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.379 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.515 ' CE1' HG12 ' A' ' 269' ' ' ILE . 47.8 m-85 -120.45 143.42 48.5 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.65 ' HB3' HD11 ' A' ' 270' ' ' ILE . 52.9 p30 -63.56 -32.65 74.18 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.499 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.611 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 98.2 p -127.06 149.34 49.96 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 121.26 0.552 . . . . 0.0 111.806 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -68.35 -32.76 73.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.092 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -56.25 -39.6 72.83 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.658 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -63.88 -34.72 78.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.173 0.511 . . . . 0.0 110.591 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.753 HG13 ' CG2' ' A' ' 245' ' ' ILE . 78.1 t -63.14 -42.1 95.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.664 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -60.55 -42.01 95.72 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -64.33 -45.86 86.01 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.85 HG22 HG13 ' A' ' 315' ' ' ILE . 7.5 p -70.62 -40.65 77.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 95.1 m -67.69 -40.11 84.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.737 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -56.85 -39.91 75.15 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.872 0.368 . . . . 0.0 111.022 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.777 ' HB3' HD11 ' A' ' 306' ' ' ILE . 44.5 t-20 -60.2 -33.34 72.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.736 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.681 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 6.7 tptm 75.24 -62.56 0.44 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.336 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.681 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 24.4 m-85 -116.07 132.78 56.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.236 0.541 . . . . 0.0 111.994 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.777 HD11 ' HB3' ' A' ' 303' ' ' ASN . 20.7 mm -121.22 140.85 44.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.002 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -78.82 130.0 35.22 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.669 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 1.8 t80 -118.23 -127.06 0.28 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.451 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.5 ' HD3' ' CE1' ' A' ' 308' ' ' PHE . 0.0 OUTLIER -60.21 -36.05 76.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.194 0.521 . . . . 0.0 110.563 -179.091 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -177.43 -35.78 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.218 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -86.59 144.93 26.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.423 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.53 ' HE3' ' HB3' ' A' ' 305' ' ' PHE . 3.0 tptt -74.26 136.6 42.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 306' ' ' ILE . 30.8 pt -112.56 143.57 22.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.298 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -102.41 138.63 39.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 0.956 ' CG2' HD12 ' A' ' 245' ' ' ILE . 15.2 mm -112.37 127.14 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -136.53 137.02 39.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.479 0.181 . . . . 0.0 110.988 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -55.51 146.82 19.21 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 244' ' ' LYS . . . -51.37 135.49 26.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.284 0.564 . . . . 0.0 111.245 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -132.37 84.62 51.21 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.431 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.51 137.69 32.24 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 121.762 1.641 . . . . 0.0 111.696 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -58.01 -34.93 70.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.302 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 83.7 t60 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.843 -179.815 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.46 " O2'" ' N7 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.728 0 C3'-C2'-O2' 111.181 -0.731 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.983 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.952 0 C1'-C2'-O2' 108.571 -0.676 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.527 " H4'" ' HG3' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.424 -1.024 0 C3'-C2'-O2' 111.163 -0.737 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.587 ' C5 ' ' CE3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.425 -0.921 0 C4'-C3'-C2' 103.906 1.206 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.774 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.819 0 C4'-C3'-C2' 103.621 0.921 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.774 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.0 0 C4'-C3'-C2' 103.463 0.763 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.802 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.897 0 C3'-C2'-C1' 100.796 -0.782 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.937 0 O4'-C1'-C2' 107.431 0.736 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.835 0.35 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.32 -33.15 69.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.077 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.5 p -67.94 160.5 28.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.99 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.58 97.2 4.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.42 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.64 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 75.6 tttt -100.08 141.59 32.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.205 0.526 . . . . 0.0 111.829 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.506 ' N ' ' O ' ' A' ' 205' ' ' LEU . 82.4 mmm -124.02 145.86 48.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.649 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.65 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 3.6 t80 -105.5 127.52 53.06 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.672 HG22 HD21 ' A' ' 166' ' ' LEU . 18.2 mt -122.28 130.11 74.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.445 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.442 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -128.73 163.98 22.0 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.747 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.524 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 72.51 47.31 28.42 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 119.829 -1.177 . . . . 0.0 111.481 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.76 HD12 HH21 ' A' ' 200' ' ' ARG . 45.2 mt -83.63 9.67 11.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.52 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 49.4 t30 62.81 43.61 6.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.023 0.44 . . . . 0.0 110.195 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.537 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 6.0 m0 39.15 39.45 0.41 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.267 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 171' ' ' THR . 59.8 t0 -162.44 -111.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.263 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.779 HG22 ' HB2' ' A' ' 175' ' ' LEU . 77.0 m 63.26 -40.97 0.2 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.617 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.5 OUTLIER 47.74 155.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.553 0.692 . . . . 0.0 111.374 -179.296 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.528 ' N ' HD12 ' A' ' 190' ' ' ILE . 96.3 mt-10 -62.5 -31.98 72.83 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.659 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -64.0 -61.53 2.22 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.563 ' HB2' ' O ' ' A' ' 170' ' ' THR . 85.9 m-20 -62.57 -37.19 85.23 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.226 0.536 . . . . 0.0 110.016 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.779 ' HB2' HG22 ' A' ' 170' ' ' THR . 52.3 tp -61.86 -42.97 99.69 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.359 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 -61.65 -42.52 99.02 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.169 0.509 . . . . 0.0 110.173 177.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -66.82 -40.31 88.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.224 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.496 ' OH ' ' HB3' ' A' ' 221' ' ' HIS . 50.6 t80 -59.91 -45.26 93.12 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.163 0.506 . . . . 0.0 110.898 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.406 ' HB3' HD21 ' A' ' 205' ' ' LEU . 97.5 m-85 -95.46 -0.99 51.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.072 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -58.27 -30.85 64.98 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.008 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.426 ' HD3' ' O ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -58.34 -41.78 85.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.534 0.683 . . . . 0.0 110.644 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -67.39 -35.35 79.13 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.613 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -179.42 -177.19 47.61 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 119.719 -1.229 . . . . 0.0 113.483 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.52 ' C ' HG13 ' A' ' 185' ' ' VAL . 46.7 m -63.11 -30.69 71.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.029 -0.586 . . . . 0.0 110.995 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.619 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 0.6 OUTLIER 64.38 91.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.857 0.837 . . . . 0.0 108.954 -177.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.7 t -58.49 -44.48 89.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.581 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 206' ' ' SER . 89.0 m-20 -135.59 149.31 49.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.49 0.662 . . . . 0.0 112.687 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.522 ' CD1' HD23 ' A' ' 175' ' ' LEU . 0.2 OUTLIER -126.83 127.62 45.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.099 179.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.539 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 13.0 tptt -135.95 120.78 18.55 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.528 HD12 ' N ' ' A' ' 172' ' ' GLU . 0.8 OUTLIER -130.35 132.0 65.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.83 176.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.695 ' HB2' ' HD2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -99.23 156.49 16.95 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.432 -179.156 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.492 ' HG3' ' HD3' ' A' ' 194' ' ' PRO . 13.4 pttt -132.23 161.93 32.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.641 0.258 . . . . 0.0 110.881 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 1.0 OUTLIER -125.49 75.65 69.36 Favored Pre-proline 0 C--O 1.232 0.144 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.189 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.492 ' HD3' ' HG3' ' A' ' 192' ' ' LYS . 26.8 Cg_exo -61.77 -25.46 78.63 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.504 2.136 . . . . 0.0 112.019 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.45 -71.16 0.36 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.882 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 58.5 p -66.9 -28.71 68.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.072 0.463 . . . . 0.0 110.458 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 89.53 6.8 70.08 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.209 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 3.3 tpt180 -123.6 124.08 42.01 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.291 0.546 . . . . 0.0 110.632 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.472 ' HB3' ' NH1' ' A' ' 200' ' ' ARG . 54.8 m -62.31 147.9 46.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.164 0.507 . . . . 0.0 112.047 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.76 HH21 HD12 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -60.62 -35.59 76.54 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.849 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 91.89 7.59 64.26 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 114.973 0.749 . . . . 0.0 114.973 177.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.622 ' H ' ' HG2' ' A' ' 200' ' ' ARG . 36.6 p90 -141.12 153.91 45.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.23 0.538 . . . . 0.0 111.371 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.515 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -142.51 161.61 27.35 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.606 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.795 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 97.7 m-85 -105.75 124.56 49.77 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.626 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 44.2 tp -111.01 127.37 55.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.321 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' A' ' 187' ' ' ASP . 49.9 m -117.81 142.05 47.73 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.786 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.626 ' CZ ' HD21 ' A' ' 205' ' ' LEU . 93.5 m-85 -120.73 146.16 46.76 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.063 0.458 . . . . 0.0 111.707 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.72 -34.95 79.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.752 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 0.6 OUTLIER -118.54 135.91 23.85 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.934 -179.308 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.998 ' O ' HG12 ' A' ' 213' ' ' VAL . 39.6 Cg_exo -60.53 -26.36 82.66 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.846 2.364 . . . . 0.0 113.286 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 31.4 m -58.08 -38.45 76.4 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.188 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.63 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.9 m -61.41 -37.88 85.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.809 0.338 . . . . 0.0 111.069 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.998 HG12 ' O ' ' A' ' 210' ' ' PRO . 3.0 p -61.43 -35.87 69.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.466 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.431 ' O ' ' HG3' ' A' ' 218' ' ' LYS . 92.6 m-20 -60.79 -43.54 97.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.793 0.33 . . . . 0.0 111.375 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.29 -34.64 77.82 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.788 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 98.4 t -60.58 -43.47 94.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 230' ' ' PRO . 20.9 m -83.51 -37.8 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 214' ' ' ASP . 25.7 mttm -60.51 -32.77 71.77 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.405 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 48.3 m -99.49 144.91 28.04 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -76.84 145.41 38.4 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.788 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 74.2 m-70 -121.87 128.15 51.29 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -176.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 70.9 mt -128.41 89.07 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.436 ' CD1' HG23 ' A' ' 170' ' ' THR . 6.8 tt -67.36 -38.68 85.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -163.8 50.32 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.005 0.431 . . . . 0.0 111.353 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 91.28 2.44 70.82 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.661 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.611 ' HZ2' ' N6 ' ' B' ' 4' ' ' ' A' . 10.7 mmtp -116.58 152.25 34.54 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 41.6 t -105.12 131.62 53.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.132 0.491 . . . . 0.0 110.932 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.587 HD12 HG23 ' A' ' 163' ' ' ILE . 36.8 pt -123.66 159.82 28.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.113 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -126.93 79.82 72.12 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-O 121.127 0.489 . . . . 0.0 111.125 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.613 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 52.0 Cg_exo -57.93 124.02 15.02 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.649 2.233 . . . . 0.0 111.107 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.546 ' HE2' ' H62' ' B' ' 6' ' ' ' A' . 4.0 ttpm? -134.88 149.08 50.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.639 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -52.5 141.16 20.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.9 0.381 . . . . 0.0 110.769 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.64 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -64.98 148.52 51.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.982 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.651 HD12 ' C6 ' ' B' ' 6' ' ' ' A' . 65.3 mt -109.64 128.58 25.15 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.407 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.89 141.0 57.13 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 121.623 1.548 . . . . 0.0 110.802 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 57.4 mmm-85 -57.37 -39.66 76.51 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.382 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.07 -43.19 99.28 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.018 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.481 ' O ' HG23 ' A' ' 242' ' ' THR . 97.0 mt-10 -68.72 -37.25 79.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.088 0.471 . . . . 0.0 110.552 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -60.1 -40.69 90.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.92 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -60.59 -39.8 89.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.811 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -60.78 -32.7 72.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.411 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.791 HG22 HD12 ' A' ' 270' ' ' ILE . 11.3 p -77.91 161.98 27.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.129 0.49 . . . . 0.0 111.818 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -146.55 115.25 0.78 Allowed Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.86 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.472 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 46.3 tptt -82.44 130.61 35.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.519 0.2 . . . . 0.0 110.918 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.684 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -120.97 159.79 22.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.249 0.547 . . . . 0.0 110.758 179.199 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.55 ' CG ' ' C6 ' ' B' ' 2' ' ' ' A' . 91.9 t80 -103.26 137.52 41.28 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.061 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.837 HG23 HG12 ' A' ' 315' ' ' ILE . 7.2 p -130.46 143.98 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.818 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.626 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -131.92 165.47 23.44 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 94.43 13.42 53.97 Favored Glycine 0 C--N 1.321 -0.264 0 C-N-CA 119.952 -1.118 . . . . 0.0 112.333 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.833 HD11 ' CA ' ' A' ' 287' ' ' GLY . 36.4 pt -117.9 155.69 19.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.771 0.32 . . . . 0.0 110.93 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.666 ' H ' HG12 ' A' ' 254' ' ' VAL . . . 178.2 -134.69 2.46 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.292 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.67 -28.03 63.91 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.973 1.782 . . . . 0.0 111.179 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.03 -31.99 70.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.374 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.772 HG11 ' HB ' ' A' ' 250' ' ' ILE . 7.9 p -122.55 143.23 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.668 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.8 mmm-85 -102.39 163.12 18.29 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.08 -40.39 81.74 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 121.483 1.455 . . . . 0.0 112.003 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -64.37 -46.32 83.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.847 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.432 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 84.1 tt0 -65.59 -39.79 91.97 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-O 120.913 0.387 . . . . 0.0 111.881 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.643 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 26.3 t80 -61.66 -45.91 92.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.011 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -64.53 -42.17 95.91 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.478 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.432 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.7 pt-20 -74.1 -30.78 62.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.187 0.518 . . . . 0.0 110.432 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.709 ' CZ ' HG21 ' A' ' 306' ' ' ILE . 5.7 t80 -60.45 -56.53 20.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.817 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.679 ' C ' HD11 ' A' ' 269' ' ' ILE . 4.6 m-85 -64.64 -23.46 67.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.041 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.686 ' N ' HD11 ' A' ' 269' ' ' ILE . 22.7 t -55.12 -30.55 59.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.941 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -52.72 -35.33 55.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.096 -0.242 . . . . 0.0 111.398 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.665 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 7.4 p90 -117.55 45.27 1.96 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 121.16 0.505 . . . . 0.0 111.593 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.516 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 152.48 146.79 4.43 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.857 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.406 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 46.2 m -59.32 -38.21 79.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.769 0.319 . . . . 0.0 111.358 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.686 HD11 ' N ' ' A' ' 264' ' ' SER . 75.3 mt 68.0 82.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.487 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.791 HD12 HG22 ' A' ' 242' ' ' THR . 71.2 mt -58.35 -40.52 78.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.4 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 290' ' ' THR . 58.0 t0 -149.83 142.48 24.54 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.992 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.44 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -158.08 136.97 11.4 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.623 0.249 . . . . 0.0 111.046 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . 0.402 ' HG3' ' SD ' ' A' ' 275' ' ' MET . 21.7 pt20 -148.69 154.04 39.09 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.143 0.497 . . . . 0.0 112.018 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.569 ' O ' ' HB2' ' A' ' 275' ' ' MET . 31.9 tp -66.02 -37.01 84.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.859 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.569 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 92.2 mmm 86.95 126.55 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.471 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.51 ' HB3' ' OG ' ' A' ' 283' ' ' SER . 0.0 OUTLIER -154.66 138.68 16.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 111.134 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -81.7 -132.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -56.6 -35.01 67.76 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 122.115 -0.366 . . . . 0.0 110.547 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 276' ' ' LEU . 93.2 m-20 -135.58 -101.46 0.22 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.583 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 63.7 p -111.04 16.78 20.97 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -42.09 -79.85 0.05 OUTLIER Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.564 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.491 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 90.3 mm-40 -59.29 -33.16 70.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.082 0.468 . . . . 0.0 110.011 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.623 ' O ' ' HG2' ' A' ' 284' ' ' ARG . 58.8 m -64.56 171.84 3.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.529 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 283' ' ' SER . 42.2 ptt85 49.55 46.68 23.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.305 0.574 . . . . 0.0 110.398 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -167.87 -67.78 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.455 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.526 ' CD2' ' HE1' ' A' ' 246' ' ' PHE . 35.7 p90 -139.29 167.0 23.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.731 0.301 . . . . 0.0 111.212 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.833 ' CA ' HD11 ' A' ' 250' ' ' ILE . . . -133.88 164.29 24.43 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.702 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.472 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.2 OUTLIER -118.5 126.8 52.79 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.442 -0.379 . . . . 0.0 110.822 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.684 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 46.6 t -127.53 139.7 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.443 ' OG1' ' CD ' ' A' ' 244' ' ' LYS . 32.5 m -116.66 137.69 52.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.408 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.516 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 40.2 m-85 -117.95 140.49 49.66 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 293' ' ' SER . 54.0 p30 -62.1 -32.14 72.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.285 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.591 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 29.7 t -124.46 139.43 53.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.209 0.528 . . . . 0.0 111.508 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.81 -30.93 71.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.177 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -56.48 -37.66 70.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.202 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -61.31 -36.86 81.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 0.0 110.736 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.576 ' O ' HG12 ' A' ' 300' ' ' VAL . 95.0 t -61.17 -43.11 95.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.029 0.442 . . . . 0.0 110.501 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -61.77 -36.5 81.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.719 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -57.18 -42.8 81.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.826 0.346 . . . . 0.0 111.917 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.665 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 1.2 p -68.94 -33.53 59.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.397 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 76.3 m -57.49 -44.28 84.79 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.998 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.77 -38.82 89.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.232 0.539 . . . . 0.0 109.93 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.6 m-20 -61.12 -33.38 73.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.999 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.628 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 52.4 tptt 67.4 -70.4 0.12 Allowed 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -177.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.628 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.0 m-30 -115.56 148.46 39.54 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.755 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.709 HG21 ' CZ ' ' A' ' 262' ' ' PHE . 5.7 mm -115.18 137.56 48.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -78.19 46.36 0.6 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.03 0.443 . . . . 0.0 110.36 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.546 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 7.3 t80 -56.95 -65.48 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.402 ' HE2' ' C ' ' A' ' 308' ' ' PHE . 4.4 mmpt? -101.28 20.92 14.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.506 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 58.99 35.77 24.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.527 0.68 . . . . 0.0 109.293 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -139.07 0.95 1.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.614 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.441 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 98.4 mttt 64.78 123.25 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.242 0.544 . . . . 0.0 112.004 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.626 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 34.4 pt -116.46 146.46 20.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.281 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -100.71 130.78 46.79 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.785 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 0.837 HG12 HG23 ' A' ' 247' ' ' VAL . 72.3 mt -121.26 131.4 73.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.594 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 246' ' ' PHE . 8.0 tptp -131.71 144.61 51.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.643 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -57.71 144.52 37.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.936 0.398 . . . . 0.0 110.805 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.08 147.17 40.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.375 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -110.09 151.15 42.33 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.055 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.566 ' O ' ' CB ' ' A' ' 321' ' ' ARG . 20.4 Cg_endo -60.27 -24.17 76.49 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.7 2.266 . . . . 0.0 112.402 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.566 ' CB ' ' O ' ' A' ' 320' ' ' PRO . 52.5 mmm-85 111.55 125.5 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.931 0.892 . . . . 0.0 110.514 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.904 -179.845 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.43 -0.644 0 C3'-C2'-O2' 111.241 -0.71 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.55 ' C6 ' ' CG ' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.935 0 C3'-C2'-O2' 111.306 -0.688 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.503 " C3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -1.018 0 C1'-C2'-O2' 108.61 -0.663 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.611 ' N6 ' ' HZ2' ' A' ' 226' ' ' LYS . . . . . . . . 0 O5'--C5' 1.425 -0.948 0 C4'-C3'-C2' 103.906 1.206 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.988 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.89 0 C5'-C4'-O4' 108.032 -0.835 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.988 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.972 0 C3'-C2'-O2' 111.304 -0.688 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.795 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.423 -1.037 0 C3'-C2'-O2' 111.213 -0.72 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.979 0 C3'-C2'-O2' 111.16 -0.738 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.435 ' HG2' ' HG2' ' A' ' 157' ' ' GLU . 70.5 tttt . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.632 0.253 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.435 ' HG2' ' HG2' ' A' ' 156' ' ' LYS . 75.3 mm-40 60.24 -79.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.238 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 156' ' ' LYS . 10.1 t 53.74 18.51 1.55 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.574 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 14.0 m -59.45 -27.73 66.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.79 0.329 . . . . 0.0 111.029 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -56.72 143.79 35.16 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.236 0.541 . . . . 0.0 111.452 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.823 ' SD ' HG13 ' A' ' 213' ' ' VAL . 84.0 mmm -116.21 149.64 38.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.792 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.762 ' HB3' ' HG2' ' A' ' 231' ' ' LYS . 4.2 t80 -104.1 128.87 51.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.543 HG22 HD21 ' A' ' 166' ' ' LEU . 15.9 mm -113.88 127.09 71.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.674 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -131.95 166.8 23.04 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.537 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.459 ' C ' HG22 ' A' ' 228' ' ' ILE . . . 76.89 33.54 45.79 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.353 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.614 ' O ' ' C8 ' ' B' ' 4' ' ' ' A' . 61.4 mt -80.74 146.55 30.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 169' ' ' ASP . 43.8 t30 -79.85 59.48 3.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.712 0.291 . . . . 0.0 111.421 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.538 ' CG ' ' C8 ' ' B' ' 4' ' ' ' A' . 12.2 m0 28.92 37.83 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.502 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 167' ' ' ASN . 54.8 t0 -163.14 20.08 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.799 HG22 HD11 ' A' ' 190' ' ' ILE . 59.9 m -76.26 136.55 39.66 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.861 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 173' ' ' ASP . 30.8 m -114.46 144.47 43.28 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.23 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.553 ' N ' HD12 ' A' ' 190' ' ' ILE . 54.5 mp0 -56.43 -36.55 69.11 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.404 -0.519 . . . . 0.0 109.878 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.408 ' H ' HG22 ' A' ' 171' ' ' THR . 89.4 m-20 -65.65 -48.62 71.52 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.795 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -66.37 -41.7 89.06 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.584 0.706 . . . . 0.0 109.976 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.744 HD23 ' CD1' ' A' ' 188' ' ' LEU . 63.9 tp -64.19 -41.62 97.01 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.173 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -62.87 -45.23 93.51 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.267 0.556 . . . . 0.0 110.167 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -66.85 -38.13 85.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.871 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.566 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 52.4 t80 -57.9 -46.05 85.52 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.223 0.535 . . . . 0.0 110.87 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.462 ' CD2' ' HD1' ' A' ' 178' ' ' TYR . 96.1 m-85 -93.66 1.26 56.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.647 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -59.28 -28.43 64.38 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.23 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.443 ' CD ' ' H ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -58.51 -39.14 79.24 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.759 0.79 . . . . 0.0 110.503 -179.11 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -67.53 -31.81 72.16 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.045 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 161.72 -133.27 3.09 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.283 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.0 m -119.28 140.16 50.74 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.955 HG21 HD23 ' A' ' 188' ' ' LEU . 2.8 m -102.36 126.68 56.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.405 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.749 HG23 ' N ' ' A' ' 208' ' ' GLU . 51.8 p -69.92 -37.91 76.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.291 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' A' ' 186' ' ' THR . 90.9 m-20 -143.74 155.68 44.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.195 0.521 . . . . 0.0 112.029 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.955 HD23 HG21 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -133.79 126.41 30.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.567 179.335 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 15.2 tptt -134.6 119.67 18.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.345 0.593 . . . . 0.0 112.225 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.799 HD11 HG22 ' A' ' 170' ' ' THR . 0.8 OUTLIER -125.49 129.61 72.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.022 176.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.667 ' CE ' ' HA2' ' A' ' 203' ' ' GLY . 3.1 mtm -96.23 134.56 39.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.191 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -128.48 155.56 44.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.852 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.524 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 6.0 m-20 -123.21 73.15 48.35 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.509 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.72 -28.75 88.05 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.718 2.279 . . . . 0.0 113.131 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -64.86 -57.86 7.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 0.0 110.95 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 55.9 p -78.74 -15.02 58.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.224 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 80.16 24.28 59.72 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.573 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 1.9 tpt180 -124.22 175.61 6.93 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 120.687 0.279 . . . . 0.0 110.509 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.423 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 32.6 t -126.4 147.4 49.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.626 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 36.6 mmt180 -54.48 -35.07 62.69 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.23 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.609 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 90.2 3.34 72.83 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.532 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.626 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 26.3 p90 -139.8 157.5 45.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.777 0.323 . . . . 0.0 110.653 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.667 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -147.0 160.07 28.17 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.935 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.811 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 98.1 m-85 -105.6 124.27 49.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.361 0.6 . . . . 0.0 109.971 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.663 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 60.2 tp -111.51 125.73 54.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.367 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 23.9 t -118.86 136.91 53.78 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.684 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.893 ' CE1' HG12 ' A' ' 185' ' ' VAL . 68.3 m-85 -119.84 143.8 47.7 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.668 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.749 ' N ' HG23 ' A' ' 186' ' ' THR . 84.5 tt0 -63.95 -34.85 78.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.941 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.81 115.54 55.25 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.764 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.25 -21.1 34.56 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.591 2.194 . . . . 0.0 112.87 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.9 m -56.73 -36.3 69.56 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.785 0.326 . . . . 0.0 111.18 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.946 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.4 m -58.39 -35.1 71.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.935 0.398 . . . . 0.0 110.296 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.823 HG13 ' SD ' ' A' ' 161' ' ' MET . 75.1 t -60.39 -42.28 90.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.95 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.41 ' O ' HG22 ' A' ' 217' ' ' VAL . 22.0 t70 -58.98 -41.98 88.86 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.899 0.381 . . . . 0.0 110.837 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.415 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 20.3 pt-20 -76.89 -30.62 56.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.752 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.946 HG23 ' O ' ' A' ' 212' ' ' SER . 77.6 t -60.22 -41.32 86.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.418 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 214' ' ' ASP . 21.0 m -71.53 -31.99 44.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -59.93 -38.8 83.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.723 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 35.0 m -85.13 143.16 29.0 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 63.3 tt0 -66.0 -40.96 91.6 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.935 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.86 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 85.2 m-70 78.84 97.81 0.06 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 72.2 mt -117.07 107.66 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.443 ' HG ' ' CD2' ' A' ' 178' ' ' TYR . 3.6 tt -97.66 -74.13 0.59 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.401 ' OD1' HD23 ' A' ' 223' ' ' LEU . 92.6 m-20 -90.78 14.86 12.4 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 101.99 -6.78 54.38 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.226 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.406 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -99.69 -172.59 2.27 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.632 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 15.0 p -120.03 135.91 58.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.241 0.543 . . . . 0.0 111.159 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.493 HD11 ' HB3' ' A' ' 221' ' ' HIS . 36.0 pt -124.98 156.66 33.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.199 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.468 ' O ' ' O4 ' ' B' ' 5' ' ' ' U' . 25.9 t0 -127.84 78.51 75.0 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.207 0.527 . . . . 0.0 111.289 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.581 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 74.4 Cg_exo -55.39 131.21 44.89 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.844 2.363 . . . . 0.0 111.299 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.762 ' HG2' ' HB3' ' A' ' 162' ' ' PHE . 0.5 OUTLIER -136.78 170.3 16.31 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -70.82 140.09 51.11 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.125 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.58 143.8 56.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.763 0.316 . . . . 0.0 111.184 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.52 HD12 ' C6 ' ' B' ' 6' ' ' ' A' . 28.6 mt -111.44 121.91 38.94 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.015 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.51 144.14 52.76 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.836 1.691 . . . . 0.0 110.986 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -56.81 -39.11 73.56 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.486 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -61.3 -46.53 89.91 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.115 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 242' ' ' THR . 84.6 tt0 -68.85 -37.22 78.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.358 0.599 . . . . 0.0 109.737 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.411 ' NE2' " O2'" ' B' ' 6' ' ' ' A' . 47.7 tt0 -58.5 -43.46 89.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.742 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -65.14 -40.26 94.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.408 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -60.11 -37.77 81.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.218 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 238' ' ' GLU . 19.9 p -81.39 161.71 23.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.167 0.508 . . . . 0.0 111.987 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.56 163.72 25.18 Favored Glycine 0 C--N 1.332 0.338 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.424 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.651 ' C ' ' HB2' ' A' ' 318' ' ' ALA . 11.8 tttm -138.07 137.76 38.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.141 0.471 . . . . 0.0 110.719 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.701 HD13 ' O ' ' A' ' 245' ' ' ILE . 0.0 OUTLIER -123.06 164.21 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.688 0.756 . . . . 0.0 112.538 -179.245 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.559 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 86.0 t80 -105.1 138.62 41.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.565 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.638 HG12 ' O ' ' A' ' 287' ' ' GLY . 7.4 p -127.45 133.75 67.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -105.48 -4.04 40.51 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.586 -0.816 . . . . 0.0 114.178 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 313' ' ' ILE . . . -115.82 115.72 3.46 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.72 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.606 ' O ' HG21 ' A' ' 254' ' ' VAL . 24.5 mm -94.22 -78.42 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.475 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 119.21 162.29 11.96 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.075 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.69 128.25 22.85 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.143 1.896 . . . . 0.0 112.719 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 51.47 42.18 29.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.65 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.722 ' O ' ' HB3' ' A' ' 258' ' ' GLU . 6.4 t -63.91 -44.26 97.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.404 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.4 OUTLIER 61.51 134.86 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -178.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.43 -31.01 66.46 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 121.946 1.764 . . . . 0.0 112.706 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -63.99 -48.63 75.63 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.722 ' HB3' ' O ' ' A' ' 254' ' ' VAL . 42.8 tp10 -64.6 -38.15 90.0 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.044 0.45 . . . . 0.0 111.054 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.616 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 44.8 t80 -59.49 -44.19 93.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.165 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.464 ' O ' HD12 ' A' ' 269' ' ' ILE . 97.2 mt-10 -65.34 -40.58 93.84 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.557 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 264' ' ' SER . 20.6 pt-20 -77.72 -30.63 51.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.21 0.529 . . . . 0.0 110.466 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.711 ' CZ ' HG21 ' A' ' 306' ' ' ILE . 5.5 t80 -61.9 -54.87 35.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.436 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.85 ' CD2' HG21 ' A' ' 289' ' ' VAL . 4.3 m-85 -65.17 -23.82 67.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.553 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.704 ' N ' HD11 ' A' ' 269' ' ' ILE . 23.5 t -54.82 -25.47 28.66 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -46.45 -37.34 7.62 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.41 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.713 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 23.2 p90 -129.83 54.45 1.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.052 0.453 . . . . 0.0 111.472 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 264' ' ' SER . . . 149.11 146.52 4.34 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.803 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.449 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 53.1 m -59.26 -37.51 77.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.758 0.313 . . . . 0.0 111.354 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.704 HD11 ' N ' ' A' ' 264' ' ' SER . 74.8 mt 71.55 85.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.848 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.594 HD11 ' HB3' ' A' ' 292' ' ' ASP . 34.8 mm -59.36 -35.51 58.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.198 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.58 ' O ' ' HB3' ' A' ' 272' ' ' ALA . 61.6 t0 -137.97 -104.76 0.18 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.079 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.608 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . 80.36 113.93 0.06 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.934 0.397 . . . . 0.0 112.016 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -141.99 155.83 45.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.317 0.579 . . . . 0.0 111.382 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.541 ' O ' ' HB2' ' A' ' 275' ' ' MET . 22.9 tp -63.63 -36.49 83.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.421 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.569 ' HG2' ' HB2' ' A' ' 288' ' ' PHE . 95.8 mmm 76.96 123.37 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.674 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.504 ' HG ' ' HB3' ' A' ' 283' ' ' SER . 5.1 mp -128.35 125.81 39.45 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.497 ' H ' ' H ' ' A' ' 282' ' ' GLN . 55.9 t0 -62.67 -40.75 98.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.594 0.712 . . . . 0.0 109.697 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -162.12 -73.7 0.05 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.781 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.408 ' O ' HD23 ' A' ' 276' ' ' LEU . 60.8 t0 -94.56 -75.75 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.484 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 73.3 p -129.33 13.57 6.08 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.357 -0.383 . . . . 0.0 112.015 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -44.99 -91.01 0.01 OUTLIER Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.037 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.497 ' H ' ' H ' ' A' ' 277' ' ' ASP . 98.7 mt-30 -60.26 -25.65 65.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.167 -0.517 . . . . 0.0 111.599 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.51 ' O ' HD21 ' A' ' 274' ' ' LEU . 63.5 p -51.89 -27.32 12.42 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.73 0.3 . . . . 0.0 110.938 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -122.5 139.07 54.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.911 0.386 . . . . 0.0 110.557 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.63 -53.52 0.58 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.25 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.571 ' C ' HD11 ' A' ' 250' ' ' ILE . 33.3 p90 -142.56 166.27 25.13 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 117.425 0.612 . . . . 0.0 111.708 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.638 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -134.42 157.36 22.89 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.259 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.569 ' HB2' ' HG2' ' A' ' 275' ' ' MET . 0.2 OUTLIER -118.16 125.24 49.82 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.868 -0.195 . . . . 0.0 111.171 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.85 HG21 ' CD2' ' A' ' 263' ' ' PHE . 53.3 t -128.4 137.57 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.036 0.445 . . . . 0.0 112.151 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 54.8 m -117.02 136.69 52.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.311 178.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.47 ' CD1' ' HA3' ' A' ' 267' ' ' GLY . 47.5 m-85 -118.03 142.6 47.21 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 293' ' ' SER . 54.7 p30 -62.13 -31.58 72.07 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.108 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.613 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 27.6 t -124.67 139.54 53.77 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.161 0.505 . . . . 0.0 111.963 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.91 -31.58 72.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.946 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -55.46 -36.54 66.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.966 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -60.64 -34.86 74.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.649 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.589 ' O ' HG12 ' A' ' 300' ' ' VAL . 84.6 t -59.55 -43.73 91.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.148 0.499 . . . . 0.0 110.309 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -62.43 -36.36 82.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.693 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 89.7 mtt-85 -57.12 -43.91 82.8 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.002 0.429 . . . . 0.0 111.976 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.713 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 1.3 p -68.77 -32.28 54.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.356 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 76.2 m -57.13 -43.74 82.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.207 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -60.45 -41.27 93.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.218 0.532 . . . . 0.0 110.186 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.416 ' O ' ' N ' ' A' ' 305' ' ' PHE . 88.3 m-20 -61.81 -33.53 74.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.399 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.639 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 7.9 tptm 67.05 -73.5 0.08 Allowed 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -178.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.639 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.5 m-30 -115.82 147.63 40.79 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.43 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.711 HG21 ' CZ ' ' A' ' 262' ' ' PHE . 37.6 mt -119.92 129.51 75.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -59.48 -35.43 74.1 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.438 0.637 . . . . 0.0 111.005 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.529 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 1.3 t80 49.88 -124.86 2.11 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.299 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.526 ' HE3' ' CE1' ' A' ' 308' ' ' PHE . 2.0 mmpt? -59.57 -37.51 78.67 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.931 0.396 . . . . 0.0 110.997 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 309' ' ' LYS . 23.3 t70 170.35 -0.18 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.26 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -122.12 152.39 39.94 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.785 0.326 . . . . 0.0 110.2 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 79.7 mttt -77.78 129.38 35.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.078 0.466 . . . . 0.0 111.222 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 305' ' ' PHE . 26.8 pt -115.3 143.33 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.375 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . 0.571 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 85.6 mt-10 -100.91 133.25 45.67 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.471 -0.492 . . . . 0.0 109.897 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 0.631 HG12 HG23 ' A' ' 247' ' ' VAL . 82.4 mt -122.21 126.07 73.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.144 0.497 . . . . 0.0 111.898 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 322' ' ' HIS . 52.1 mttp -133.05 -170.45 2.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.456 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.545 ' O ' ' HB3' ' A' ' 246' ' ' PHE . 74.7 mtp180 -57.34 146.8 27.74 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.728 0.299 . . . . 0.0 110.623 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.876 ' O ' ' H2 ' ' B' ' 2' ' ' ' A' . . . -60.86 -23.16 64.93 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . 0.491 ' CB ' ' CD ' ' A' ' 320' ' ' PRO . 24.6 tt0 -111.61 -72.99 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.511 ' HG2' ' HB2' ' A' ' 317' ' ' ARG . 9.9 Cg_endo -54.16 138.15 71.19 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 121.769 1.646 . . . . 0.0 112.377 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.491 ' HA ' ' N6 ' ' B' ' 2' ' ' ' A' . 27.0 mmt85 -59.44 -35.27 73.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.121 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 316' ' ' LYS . 77.5 m80 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.18 -0.914 . . . . 0.0 111.078 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.43 -0.635 0 C3'-C2'-O2' 111.258 -0.704 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.876 ' H2 ' ' O ' ' A' ' 318' ' ' ALA . . . . . . . . 0 O5'--C5' 1.425 -0.949 0 C1'-C2'-O2' 108.747 -0.618 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.641 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -1.009 0 C3'-C2'-O2' 111.305 -0.688 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.641 " H4'" " H3'" ' B' ' 3' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.897 0 C4'-C3'-C2' 103.887 1.187 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.674 ' C6 ' ' HA3' ' A' ' 164' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.843 0 C5'-C4'-O4' 108.171 -0.735 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.616 ' N9 ' ' CE2' ' A' ' 162' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.926 0 C4'-C3'-C2' 103.389 0.689 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.811 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.972 0 C4'-C3'-C2' 103.541 0.841 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . 0.661 ' N3 ' " H2'" ' B' ' 8' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.896 0 C3'-C2'-O2' 111.175 -0.733 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 79.5 tttt . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.864 0.364 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.72 -33.5 68.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.008 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.4 m -57.47 -34.85 69.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.127 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.6 p -55.0 -21.73 12.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.273 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.57 ' HE2' ' HB3' ' A' ' 204' ' ' PHE . 15.4 tptm -56.27 140.06 46.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.453 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.797 ' SD ' HG13 ' A' ' 213' ' ' VAL . 86.1 mmm -118.15 150.0 40.11 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.075 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.613 ' CE2' ' N9 ' ' B' ' 6' ' ' ' A' . 4.3 t80 -106.79 130.17 54.54 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.683 ' CG2' HD21 ' A' ' 166' ' ' LEU . 17.2 mm -115.41 121.81 67.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.024 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.685 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -126.44 164.8 19.89 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.441 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.725 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 74.79 27.13 65.5 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.547 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.683 HD21 ' CG2' ' A' ' 163' ' ' ILE . 71.0 mt -87.63 142.21 28.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.901 0.381 . . . . 0.0 111.349 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.402 ' OD1' ' N6 ' ' B' ' 4' ' ' ' A' . 9.5 t30 -67.23 134.16 51.12 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.569 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 4.7 m-90 -52.15 -36.77 52.4 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.999 -0.281 . . . . 0.0 111.404 -178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -60.23 -31.47 70.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.689 0.281 . . . . 0.0 111.359 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.466 HG23 ' HB3' ' A' ' 174' ' ' ASN . 79.6 m -58.3 140.18 53.82 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.335 0.588 . . . . 0.0 111.971 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.42 ' C ' HD12 ' A' ' 190' ' ' ILE . 1.5 p -118.36 167.76 11.26 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.495 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.822 ' N ' HD12 ' A' ' 190' ' ' ILE . 96.1 mt-10 -58.91 -33.26 70.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -60.43 -41.23 93.57 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.466 ' HB3' HG23 ' A' ' 170' ' ' THR . 47.8 t-20 -61.63 -41.71 97.87 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.538 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.717 HD12 HD11 ' A' ' 190' ' ' ILE . 3.9 mt -65.56 -42.94 91.25 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.703 178.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.938 ' HG3' HG11 ' A' ' 185' ' ' VAL . 70.7 ttp85 -60.9 -44.51 97.03 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.735 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -67.86 -39.16 83.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.573 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 67.0 t80 -70.89 -62.1 1.52 Allowed 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.308 0.575 . . . . 0.0 111.41 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.538 ' CE2' HD23 ' A' ' 175' ' ' LEU . 67.4 m-85 -70.52 -24.21 62.78 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.516 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 183' ' ' GLY . . . -51.29 -27.03 14.89 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.672 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.5 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -56.2 -43.96 79.02 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.405 0.682 . . . . 0.0 110.99 178.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -71.51 -34.4 70.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.727 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 180' ' ' GLY . . . -164.62 -173.8 33.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.147 -1.025 . . . . 0.0 113.258 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.956 ' O ' HG12 ' A' ' 185' ' ' VAL . 51.0 m -59.22 -35.05 72.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.425 0.155 . . . . 0.0 110.782 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.956 HG12 ' O ' ' A' ' 184' ' ' THR . 1.0 OUTLIER 78.67 69.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 CA-C-O 122.631 1.205 . . . . 0.0 108.749 -178.231 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.67 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 5.7 m -52.34 -42.55 63.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.08 -1.418 . . . . 0.0 112.801 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.418 ' HB3' ' HB3' ' A' ' 206' ' ' SER . 54.5 t0 -148.35 141.49 25.0 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.71 HD11 ' HB3' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -121.22 131.21 54.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.562 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 8.5 tptp -136.23 121.05 18.57 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.822 HD12 ' N ' ' A' ' 172' ' ' GLU . 4.3 mt -127.05 132.45 69.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.663 176.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.574 ' HB2' ' CG ' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -92.15 125.11 36.7 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.969 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 199' ' ' SER . 4.1 mtmp? -126.7 155.04 43.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.895 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 9.1 t70 -97.22 108.8 46.48 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.693 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.69 -26.18 81.35 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.549 2.166 . . . . 0.0 112.958 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.412 ' HB3' ' OD1' ' A' ' 193' ' ' ASP . . . -74.68 -86.64 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 51.8 p -71.66 -21.52 61.8 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 193' ' ' ASP . . . 93.12 4.88 64.37 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.119 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.479 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 11.0 tpt180 -74.93 143.05 43.9 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.481 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 23.6 t -103.32 148.77 25.45 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.746 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.645 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 15.0 mmm180 -53.18 -30.6 38.26 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.761 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 95.93 -0.87 62.82 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.86 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.686 ' CD1' " H4'" ' B' ' 5' ' ' ' U' . 25.4 p90 -136.62 156.4 48.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.875 0.369 . . . . 0.0 110.299 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.563 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -142.87 162.5 27.44 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.982 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.742 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 97.8 m-85 -105.06 125.3 50.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.363 0.602 . . . . 0.0 109.521 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.658 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 46.8 tp -106.7 130.3 54.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.041 -177.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' A' ' 187' ' ' ASP . 28.0 t -124.3 135.13 53.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.883 0.373 . . . . 0.0 111.979 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.658 ' CZ ' HD21 ' A' ' 205' ' ' LEU . 95.4 m-85 -119.48 140.05 51.09 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.782 178.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.67 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.3 tt0 -60.58 -34.47 74.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.026 0.441 . . . . 0.0 110.087 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.5 119.48 49.3 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.499 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.59 -20.55 27.66 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.516 2.144 . . . . 0.0 112.801 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 85.1 p -59.97 -31.07 69.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.667 0.27 . . . . 0.0 111.234 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.932 ' O ' HG23 ' A' ' 216' ' ' VAL . 23.0 m -59.44 -36.06 75.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.603 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.797 HG13 ' SD ' ' A' ' 161' ' ' MET . 70.5 t -61.61 -43.52 97.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.305 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -59.81 -42.03 92.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.01 0.433 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.02 -31.9 61.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.77 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 212' ' ' SER . 66.0 t -60.76 -42.27 91.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 120.662 0.267 . . . . 0.0 110.983 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 24.3 m -73.15 -27.55 24.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -58.72 -35.5 72.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.659 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.694 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 57.4 m -100.13 141.52 32.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.852 0.358 . . . . 0.0 111.863 -178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 59.7 tp60 -66.09 -40.64 90.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.737 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.79 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 64.8 m-70 79.31 116.49 0.06 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 24.6 mm -116.4 107.4 22.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.2 tt -121.32 122.96 41.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.789 0.328 . . . . 0.0 110.177 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 51.73 40.17 26.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.148 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 73.64 20.32 79.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.342 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -115.21 136.23 53.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.329 0.565 . . . . 0.0 111.506 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.756 ' O ' ' O ' ' A' ' 228' ' ' ILE . 9.5 p -62.04 -35.89 71.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.096 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.756 ' O ' ' O ' ' A' ' 227' ' ' VAL . 9.0 pt 30.9 128.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.513 0.725 . . . . 0.0 112.68 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -123.29 84.56 51.94 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 121.056 0.455 . . . . 0.0 111.315 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.498 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 50.7 Cg_exo -56.05 135.34 69.31 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.912 2.408 . . . . 0.0 111.986 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.403 ' HZ3' ' H3 ' ' B' ' 5' ' ' ' U' . 9.3 ttpt -136.88 157.3 47.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.909 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -55.93 133.45 51.53 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.747 0.308 . . . . 0.0 110.852 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 160' ' ' LYS . . . -72.91 148.05 44.71 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.514 ' CD1' ' C6 ' ' B' ' 6' ' ' ' A' . 0.7 OUTLIER -122.13 125.58 26.56 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.674 178.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.444 ' HG2' ' CG ' ' A' ' 238' ' ' GLU . 9.4 Cg_endo -51.84 145.62 31.2 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 121.791 1.66 . . . . 0.0 111.14 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 236' ' ' ARG . 6.2 tmm_? -54.66 -39.25 67.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.78 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 55.3 p30 -61.42 -38.51 87.39 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.702 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.586 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 97.9 mt-10 -68.17 -34.13 75.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.995 0.426 . . . . 0.0 110.381 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -59.61 -38.28 80.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.281 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.93 -40.47 93.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.627 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -61.69 -34.94 76.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.162 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 22.4 p -83.41 162.23 21.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.572 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -146.47 112.71 0.63 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.847 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 17.5 ttpp -88.72 134.27 33.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.893 0.378 . . . . 0.0 111.194 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.686 HG21 HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -117.46 164.02 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.537 0.684 . . . . 0.0 111.43 -179.247 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.581 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 93.5 t80 -101.85 136.34 41.85 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.518 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.821 HG11 ' CE1' ' A' ' 259' ' ' PHE . 12.5 p -131.57 146.37 33.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.314 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.646 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -131.66 169.43 21.94 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 89.92 17.82 52.77 Favored Glycine 0 N--CA 1.454 -0.147 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.727 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.91 HG23 HG21 ' A' ' 254' ' ' VAL . 23.3 mm -54.96 -43.84 70.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.841 0.353 . . . . 0.0 110.792 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 50.51 174.12 0.01 OUTLIER Glycine 0 CA--C 1.521 0.451 0 CA-C-N 116.074 -0.512 . . . . 0.0 114.086 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.09 154.68 65.83 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.62 2.88 . . . . 0.0 113.616 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 57.62 41.67 25.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.919 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.91 HG21 HG23 ' A' ' 250' ' ' ILE . 2.4 p -85.79 -40.69 14.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.542 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.6 OUTLIER 60.05 118.97 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -178.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -52.92 -33.78 63.48 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 121.743 1.629 . . . . 0.0 112.426 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -61.51 -41.74 97.77 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.998 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.656 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 98.3 mt-10 -66.16 -36.15 82.36 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.627 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.821 ' CE1' HG11 ' A' ' 247' ' ' VAL . 16.5 t80 -63.86 -50.11 70.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.782 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.725 ' HG2' ' HB3' ' A' ' 272' ' ' ALA . 97.2 mt-10 -64.67 -37.03 86.18 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.605 ' HB3' ' HA ' ' A' ' 258' ' ' GLU . 78.5 tt0 -63.03 -37.9 89.04 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.646 -1.616 . . . . 0.0 111.883 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.815 ' CE2' HD11 ' A' ' 313' ' ' ILE . 86.4 t80 -67.78 -55.08 14.41 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.683 ' CE2' HD11 ' A' ' 245' ' ' ILE . 10.0 m-85 -66.45 -25.29 66.66 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.727 ' N ' HD11 ' A' ' 269' ' ' ILE . 35.1 t -55.29 -31.31 61.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.689 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -56.15 -36.48 68.33 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.291 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.664 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 9.0 p90 -117.57 51.79 1.02 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.44 0.638 . . . . 0.0 111.16 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.512 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 148.3 148.03 4.66 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.508 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.444 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 11.8 t -64.06 -35.8 81.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 110.928 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.727 HD11 ' N ' ' A' ' 264' ' ' SER . 79.3 mt 71.66 83.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.223 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.507 HG12 ' CA ' ' A' ' 292' ' ' ASP . 36.0 mm -58.98 -38.58 74.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.984 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -149.46 150.91 33.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.185 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.725 ' HB3' ' HG2' ' A' ' 260' ' ' GLU . . . -170.59 122.31 0.62 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.577 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -142.85 152.3 42.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.22 0.533 . . . . 0.0 111.861 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.81 HD11 HG21 ' A' ' 250' ' ' ILE . 29.2 tp -64.23 -37.82 88.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.901 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.524 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 91.8 mmm 101.59 102.87 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.441 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.412 ' CD2' ' HB3' ' A' ' 283' ' ' SER . 23.9 mt -108.05 139.02 43.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.521 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.605 ' HB3' ' HA3' ' A' ' 281' ' ' GLY . 59.9 t0 -145.39 93.31 2.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.092 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.855 ' O ' HG22 ' A' ' 280' ' ' THR . 40.8 mtpt 65.38 39.18 5.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.873 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.468 ' O ' ' HB ' ' A' ' 280' ' ' THR . 57.4 t0 46.31 41.75 9.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.782 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.855 HG22 ' O ' ' A' ' 278' ' ' LYS . 2.0 t 171.2 50.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.911 0.386 . . . . 0.0 110.709 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . 0.605 ' HA3' ' HB3' ' A' ' 277' ' ' ASP . . . -131.49 -112.11 1.42 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.448 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 1.023 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 78.8 mm-40 -57.9 -28.36 64.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.415 -0.392 . . . . 0.0 110.431 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.412 ' HB3' ' CD2' ' A' ' 276' ' ' LEU . 86.3 p -57.69 -22.64 47.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.215 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -52.73 -36.63 57.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.92 0.39 . . . . 0.0 110.749 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 286' ' ' PHE . . . -166.61 -176.62 37.86 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.091 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.558 ' O ' ' O ' ' A' ' 285' ' ' GLY . 3.1 p90 48.54 155.13 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.175 0.512 . . . . 0.0 112.075 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.69 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -139.25 164.41 25.9 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.153 -1.022 . . . . 0.0 113.783 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.452 ' CE2' ' NZ ' ' A' ' 244' ' ' LYS . 0.4 OUTLIER -119.73 125.6 49.04 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.669 0.388 . . . . 0.0 110.949 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.684 HG23 ' CZ ' ' A' ' 259' ' ' PHE . 48.9 t -127.45 137.07 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.003 0.43 . . . . 0.0 111.748 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 44.4 m -113.55 135.8 53.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.605 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.584 ' OH ' ' HB3' ' A' ' 263' ' ' PHE . 34.5 m-85 -117.15 137.21 52.47 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.507 ' CA ' HG12 ' A' ' 270' ' ' ILE . 50.5 t0 -58.84 -35.65 73.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.558 178.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 30.5 t -119.99 140.18 51.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.28 0.562 . . . . 0.0 111.887 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.962 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -63.66 -30.64 71.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.526 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -55.74 -35.12 65.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.029 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.26 90.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.539 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.962 HG12 ' O ' ' A' ' 294' ' ' ALA . 9.5 p -61.16 -37.14 76.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.001 0.429 . . . . 0.0 110.735 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.94 -38.18 90.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.527 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -59.16 -43.37 92.08 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.906 0.384 . . . . 0.0 111.943 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.752 HG23 HD11 ' A' ' 306' ' ' ILE . 0.9 OUTLIER -72.58 -36.68 54.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.638 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 74.5 m -59.23 -42.93 92.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.833 0.349 . . . . 0.0 110.447 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -61.78 -34.17 75.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.215 0.531 . . . . 0.0 110.013 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.65 ' O ' ' N ' ' A' ' 305' ' ' PHE . 80.6 m-20 -87.04 4.9 40.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.213 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.656 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 19.9 tptm 41.85 -80.85 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.605 0.24 . . . . 0.0 110.4 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.656 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 2.2 m-30 -107.58 141.26 39.33 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.752 HD11 HG23 ' A' ' 300' ' ' VAL . 1.0 OUTLIER -116.58 134.47 59.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.538 ' O ' ' HE1' ' A' ' 262' ' ' PHE . 89.0 m-20 -70.67 124.59 24.63 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.556 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 2.0 t80 -112.0 -109.89 0.35 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.501 ' HE2' ' OE1' ' A' ' 258' ' ' GLU . 1.2 mmmp? -60.15 -37.42 80.07 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.743 0.306 . . . . 0.0 111.386 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.406 ' CG ' ' O ' ' A' ' 309' ' ' LYS . 32.5 m-20 -177.96 -27.39 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.219 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -113.13 160.81 17.82 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.951 0.405 . . . . 0.0 110.841 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 43.9 mttt -71.67 143.63 49.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.351 0.596 . . . . 0.0 112.114 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.815 HD11 ' CE2' ' A' ' 262' ' ' PHE . 31.6 pt -118.93 147.87 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . 0.532 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 87.4 mt-10 -101.05 129.73 46.95 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.515 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 0.763 HG12 HG23 ' A' ' 247' ' ' VAL . 74.7 mt -123.31 127.61 74.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.207 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.486 ' HG2' ' HD2' ' A' ' 246' ' ' PHE . 3.4 ptpt -135.2 163.62 29.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.601 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 45.8 ptt85 -59.03 148.84 29.37 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.45 133.19 55.56 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.79 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -137.62 82.93 26.17 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.964 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.43 129.15 32.3 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 121.571 1.514 . . . . 0.0 111.474 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.412 ' HG3' " O2'" ' B' ' 2' ' ' ' A' . 25.6 mmt85 -60.88 -34.9 75.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.209 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.873 -179.891 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.449 ' N3 ' ' HA3' ' A' ' 248' ' ' GLY . . . . . . . . 0 O5'--C5' 1.428 -0.726 0 C3'-C2'-O2' 111.357 -0.67 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 1.023 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.951 0 C3'-C2'-O2' 111.199 -0.724 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.543 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.956 0 C3'-C2'-C1' 100.735 -0.85 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.761 " O2'" ' HA3' ' A' ' 201' ' ' GLY . . . . . . . . 0 O5'--C5' 1.425 -0.96 0 C4'-C3'-C2' 104.091 1.391 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.928 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.796 0 C4'-C3'-C2' 103.742 1.042 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.928 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.038 0 C3'-C2'-O2' 111.239 -0.711 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.742 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -1.011 0 C1'-C2'-O2' 108.514 -0.695 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . 0.439 ' N3 ' " C2'" ' B' ' 8' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -1.016 0 C3'-C2'-O2' 111.272 -0.699 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 60.7 mttp . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.831 0.348 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -58.02 142.97 44.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.882 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.1 m -120.86 147.72 45.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.125 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.718 ' HA ' HG21 ' A' ' 213' ' ' VAL . 7.8 p -83.99 6.28 22.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.385 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.586 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 5.3 tptm -69.56 131.6 44.94 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.825 ' SD ' HG13 ' A' ' 213' ' ' VAL . 93.3 mmm -120.67 143.57 48.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.877 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.607 ' CD2' ' C4 ' ' B' ' 6' ' ' ' A' . 2.7 t80 -108.29 125.74 52.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.921 ' HB ' HD21 ' A' ' 166' ' ' LEU . 0.3 OUTLIER -120.88 127.86 75.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.615 -179.446 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.597 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -121.49 153.34 16.7 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.318 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.464 ' C ' HG22 ' A' ' 228' ' ' ILE . . . 73.44 29.08 64.49 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.151 -1.023 . . . . 0.0 110.994 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.921 HD21 ' HB ' ' A' ' 163' ' ' ILE . 69.1 mt -59.06 -33.3 70.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.728 ' O ' ' N ' ' A' ' 169' ' ' ASP . 21.1 t30 107.63 37.19 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.977 0.511 . . . . 0.0 110.669 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.612 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 5.1 m0 45.99 -59.7 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.728 ' N ' ' O ' ' A' ' 167' ' ' ASN . 89.4 m-20 -83.4 19.73 1.48 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.627 ' OG1' ' HB3' ' A' ' 166' ' ' LEU . 57.6 m -51.88 -36.08 47.35 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.502 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.0 OUTLIER 58.26 139.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.157 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.661 ' O ' ' HD3' ' A' ' 176' ' ' ARG . 58.1 mp0 -60.39 -36.25 77.65 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -58.8 -40.9 85.42 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.596 ' HB2' ' O ' ' A' ' 170' ' ' THR . 82.8 m-20 -61.69 -36.63 81.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.695 HD23 ' CE2' ' A' ' 179' ' ' PHE . 7.0 mt -55.74 -51.31 67.79 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.661 ' HD3' ' O ' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -67.93 -30.36 69.66 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.298 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -58.42 -39.35 79.52 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.37 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.64 ' OH ' ' CG ' ' A' ' 221' ' ' HIS . 0.0 OUTLIER -96.04 -55.52 2.95 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.25 179.199 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.695 ' CE2' HD23 ' A' ' 175' ' ' LEU . 72.5 m-85 -60.14 -27.15 66.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.397 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.42 -23.58 9.35 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.199 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.827 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -54.05 -40.46 67.13 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.992 0.425 . . . . 0.0 110.714 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.827 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 53.8 m-85 -69.85 -32.21 70.48 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.275 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 164.81 -130.19 2.13 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.262 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 49.1 m -120.96 140.28 52.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.659 HG21 HD23 ' A' ' 188' ' ' LEU . 0.2 OUTLIER -92.88 120.65 42.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.257 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.5 t -71.61 -45.53 61.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.348 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -149.9 109.51 4.02 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.659 HD23 HG21 ' A' ' 185' ' ' VAL . 0.1 OUTLIER -102.65 150.16 23.71 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.341 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 204' ' ' PHE . 18.9 tptt -133.69 124.53 26.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.94 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.582 HD12 ' CA ' ' A' ' 172' ' ' GLU . 1.0 OUTLIER -123.0 134.31 66.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.582 ' HB2' ' HB2' ' A' ' 200' ' ' ARG . 10.0 mmt -86.93 135.16 33.4 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -131.79 138.75 48.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.736 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 7.4 t0 -121.72 75.7 36.56 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.594 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -60.47 -25.81 81.38 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.521 2.147 . . . . 0.0 111.998 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -71.83 -67.9 0.5 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.255 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 49.2 p -68.95 -26.98 65.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.112 0.482 . . . . 0.0 110.079 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.93 4.09 67.48 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.585 -0.734 . . . . 0.0 113.09 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.465 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 6.0 tpt180 -127.13 121.85 32.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.239 0.52 . . . . 0.0 110.329 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.574 ' HG ' ' HD1' ' A' ' 168' ' ' TRP . 66.5 p -71.91 160.56 32.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.919 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.585 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 23.9 mmm180 -58.3 -34.34 70.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.861 0.362 . . . . 0.0 110.093 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.484 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 94.39 -0.98 66.33 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.526 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.617 ' CD2' " H4'" ' B' ' 5' ' ' ' U' . 38.7 p90 -137.96 159.04 43.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.934 0.397 . . . . 0.0 110.426 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 189' ' ' LYS . . . -153.21 171.33 32.16 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.028 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.749 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 73.0 m-85 -110.2 125.3 52.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.833 0.349 . . . . 0.0 110.756 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.771 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 23.5 tp -110.1 132.18 54.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.427 ' O ' HG23 ' A' ' 185' ' ' VAL . 45.7 m -121.48 145.69 47.68 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.182 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 1.007 ' CE2' HG21 ' A' ' 216' ' ' VAL . 96.9 m-85 -121.4 147.59 45.52 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.862 0.363 . . . . 0.0 111.826 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.44 -35.7 80.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.328 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.45 119.19 53.63 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.603 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.15 -29.73 76.36 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.32 2.013 . . . . 0.0 112.636 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.3 t -59.54 -37.46 78.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 0.0 110.858 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.844 ' O ' HG23 ' A' ' 216' ' ' VAL . 24.0 m -59.25 -34.87 72.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.047 0.451 . . . . 0.0 110.5 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.825 HG13 ' SD ' ' A' ' 161' ' ' MET . 70.8 t -61.1 -42.74 94.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.211 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -59.55 -43.4 93.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.921 0.391 . . . . 0.0 111.046 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.429 ' HB3' ' CE2' ' A' ' 182' ' ' TYR . 98.4 mt-10 -69.38 -35.38 75.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.368 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 1.007 HG21 ' CE2' ' A' ' 207' ' ' PHE . 99.0 t -60.91 -46.42 96.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.899 0.38 . . . . 0.0 110.829 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 230' ' ' PRO . 14.8 p -75.44 -40.01 41.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -59.11 -36.96 76.08 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 29.9 m -96.37 144.61 26.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.156 0.503 . . . . 0.0 112.077 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -92.09 125.24 36.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.851 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.64 ' CG ' ' OH ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -130.58 155.89 45.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.177 0.513 . . . . 0.0 111.39 -178.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 226' ' ' LYS . 73.5 mt -122.12 125.76 73.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.297 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.648 HD12 HD13 ' A' ' 228' ' ' ILE . 3.8 mt -103.26 125.36 49.88 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.927 0.394 . . . . 0.0 111.607 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 52.58 41.16 31.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.29 2.18 87.06 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.897 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.763 ' O ' HG23 ' A' ' 222' ' ' ILE . 21.8 mmtt -107.18 137.96 44.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 117.3 0.55 . . . . 0.0 111.131 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 227' ' ' VAL . 10.1 p -80.49 125.08 39.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.138 0.494 . . . . 0.0 111.094 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.807 HD12 ' CG2' ' A' ' 163' ' ' ILE . 34.4 pt -126.38 156.34 36.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.95 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -131.05 83.38 60.91 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.384 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.726 ' O ' HG23 ' A' ' 217' ' ' VAL . 72.8 Cg_exo -52.76 130.73 38.53 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.606 2.204 . . . . 0.0 112.061 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.533 ' CE ' ' H62' ' B' ' 6' ' ' ' A' . 6.3 ttpt -136.72 144.29 43.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.0 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.431 ' HD2' ' N ' ' A' ' 233' ' ' ALA . 3.8 tmm_? -54.61 140.53 34.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.993 0.425 . . . . 0.0 111.188 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -59.74 149.17 31.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.184 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.991 HG22 ' C2 ' ' B' ' 6' ' ' ' A' . 3.5 tt -112.62 134.98 21.53 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.019 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.425 ' HG2' ' HB2' ' A' ' 238' ' ' GLU . 18.1 Cg_endo -59.14 144.27 99.45 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.587 1.525 . . . . 0.0 109.547 177.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.3 mmt180 -55.84 -36.57 67.66 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.745 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -60.97 -43.03 99.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.388 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.425 ' HB2' ' HG2' ' A' ' 235' ' ' PRO . 85.0 tt0 -68.43 -37.52 80.36 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.115 0.483 . . . . 0.0 110.719 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.466 ' OE1' HG21 ' A' ' 234' ' ' ILE . 57.7 tp60 -59.11 -43.58 91.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.908 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -65.46 -39.1 91.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.718 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -59.49 -39.24 83.11 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 21.1 p -90.64 161.23 15.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.178 0.513 . . . . 0.0 112.005 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.36 166.56 25.76 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.626 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.535 ' HG3' ' O ' ' A' ' 289' ' ' VAL . 39.7 ttpt -136.85 132.31 34.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.864 0.332 . . . . 0.0 111.338 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.674 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -115.74 163.76 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-O 121.282 0.563 . . . . 0.0 111.028 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.555 ' CD1' ' C5 ' ' B' ' 2' ' ' ' A' . 89.0 t80 -100.23 137.38 38.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.67 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.683 HG12 ' O ' ' A' ' 287' ' ' GLY . 7.9 p -129.78 145.39 35.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.963 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.594 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.07 166.85 18.66 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.49 15.7 56.5 Favored Glycine 0 N--CA 1.454 -0.131 0 C-N-CA 120.015 -1.088 . . . . 0.0 112.533 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.839 HG23 HG21 ' A' ' 254' ' ' VAL . 69.8 mt -110.66 131.99 60.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.516 0.198 . . . . 0.0 110.595 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.685 ' O ' HG12 ' A' ' 254' ' ' VAL . . . -167.98 -116.29 0.36 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.239 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.82 142.13 98.63 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.623 2.216 . . . . 0.0 113.294 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 54.98 43.58 29.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.351 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.839 HG21 HG23 ' A' ' 250' ' ' ILE . 7.1 p -108.31 -50.87 7.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.239 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.525 ' N ' HG13 ' A' ' 254' ' ' VAL . 7.7 mpt_? 59.07 132.01 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.224 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.5 -27.97 52.49 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.154 1.903 . . . . 0.0 112.911 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -60.72 -48.09 83.37 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.584 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 261' ' ' GLU . 61.0 mp0 -69.3 -36.98 77.58 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.669 ' CE1' HG11 ' A' ' 247' ' ' VAL . 18.6 t80 -61.8 -49.52 75.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.649 0.262 . . . . 0.0 110.679 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.826 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.4 tt0 -64.15 -37.73 88.5 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 258' ' ' GLU . 43.0 tp10 -62.62 -39.28 93.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.669 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.846 ' CE2' HD11 ' A' ' 313' ' ' ILE . 89.8 t80 -64.87 -58.52 5.95 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 1.022 ' HB2' HD11 ' A' ' 269' ' ' ILE . 33.4 m-85 -69.7 -23.24 63.4 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 260' ' ' GLU . 30.4 t -56.57 -32.33 65.1 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -54.71 -34.23 62.1 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.8 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 8.5 p90 -119.86 56.53 0.95 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.255 0.55 . . . . 0.0 112.073 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.585 ' HA3' ' CD1' ' A' ' 291' ' ' TYR . . . 160.65 -31.74 0.37 Allowed Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.786 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.574 HG22 ' O ' ' A' ' 267' ' ' GLY . 0.5 OUTLIER 85.34 2.82 0.65 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.777 0.431 . . . . 0.0 111.544 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 1.022 HD11 ' HB2' ' A' ' 263' ' ' PHE . 76.4 mt 30.13 108.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.747 HD11 ' HB3' ' A' ' 292' ' ' ASP . 32.0 mm -68.49 -36.01 72.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.486 175.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -137.45 -88.42 0.27 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.636 ' HB3' HG21 ' A' ' 269' ' ' ILE . . . 61.17 123.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.948 0.404 . . . . 0.0 111.548 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -141.37 154.92 45.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.031 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.623 ' O ' ' HB2' ' A' ' 275' ' ' MET . 20.0 tp -62.74 -37.58 87.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.259 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.775 ' HB2' ' HB3' ' A' ' 282' ' ' GLN . 93.8 mmm 93.83 176.71 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.848 0.717 . . . . 0.0 109.857 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.744 HD22 ' O ' ' A' ' 275' ' ' MET . 0.0 OUTLIER -179.43 78.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.621 0.248 . . . . 0.0 111.053 -179.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -84.37 109.66 18.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.935 0.398 . . . . 0.0 110.241 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.669 ' O ' HG22 ' A' ' 280' ' ' THR . 59.6 mttp 57.12 35.43 26.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.685 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.425 ' O ' ' HB ' ' A' ' 280' ' ' THR . 85.6 m-20 53.82 44.26 29.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.74 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.669 HG22 ' O ' ' A' ' 278' ' ' LYS . 1.7 t 174.98 35.16 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.726 0.298 . . . . 0.0 111.585 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -99.46 -73.33 1.07 Allowed Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.696 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.775 ' HB3' ' HB2' ' A' ' 275' ' ' MET . 5.0 pp0? -59.69 -30.96 69.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.43 ' N ' ' CD ' ' A' ' 282' ' ' GLN . 85.0 p -56.85 -22.96 40.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.555 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -56.52 -33.34 65.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.249 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 250' ' ' ILE . . . 144.98 28.08 0.1 OUTLIER Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.116 -1.04 . . . . 0.0 114.733 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.537 ' CE1' ' HA ' ' A' ' 282' ' ' GLN . 17.6 p90 -141.82 165.75 26.61 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.416 1.108 . . . . 0.0 112.19 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.683 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -143.98 165.65 27.27 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.774 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.431 ' HE2' ' HZ2' ' A' ' 244' ' ' LYS . 0.4 OUTLIER -116.48 127.11 54.27 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.221 0.208 . . . . 0.0 111.252 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.674 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 21.5 t -122.32 135.68 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.88 0.371 . . . . 0.0 111.924 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 52.6 m -113.84 136.02 53.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.402 178.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.585 ' CD1' ' HA3' ' A' ' 267' ' ' GLY . 31.3 m-85 -120.1 143.15 48.31 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.747 ' HB3' HD11 ' A' ' 270' ' ' ILE . 52.9 p30 -62.34 -33.97 75.74 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.329 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.65 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 50.8 m -127.04 145.18 50.81 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.147 0.499 . . . . 0.0 111.746 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.05 -30.69 71.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.933 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -56.61 -37.04 70.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.421 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.67 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -60.44 -35.46 75.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.384 . . . . 0.0 110.803 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.571 HG22 ' CG2' ' A' ' 245' ' ' ILE . 96.7 t -61.36 -44.05 97.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.155 0.502 . . . . 0.0 110.527 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.75 -36.8 84.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.129 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -57.55 -43.51 84.51 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.8 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 0.7 OUTLIER -72.2 -32.25 42.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.919 0.39 . . . . 0.0 110.973 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 81.6 m -56.29 -44.74 80.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.269 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -62.42 -40.2 95.76 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.271 0.558 . . . . 0.0 110.054 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -63.4 -34.47 77.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.419 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.675 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 15.9 tptm 66.11 -72.7 0.08 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.803 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.675 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 16.3 m-85 -111.17 127.79 55.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.334 0.588 . . . . 0.0 111.682 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.72 HD11 HG23 ' A' ' 300' ' ' VAL . 1.4 mt -118.22 138.99 47.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.584 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.425 ' OD1' ' CE ' ' A' ' 312' ' ' LYS . 73.4 m-20 -76.47 110.98 11.46 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.323 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.658 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 6.0 t80 -108.11 -70.16 0.82 Allowed 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.601 0.715 . . . . 0.0 110.063 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.474 ' HD3' ' CE2' ' A' ' 308' ' ' PHE . 0.0 OUTLIER -106.91 -158.5 0.66 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.169 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -54.88 -32.88 61.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.818 0.342 . . . . 0.0 110.789 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -113.85 153.16 29.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.012 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.425 ' CE ' ' OD1' ' A' ' 307' ' ' ASP . 18.8 mmtp -67.18 152.46 45.71 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.043 0.449 . . . . 0.0 111.008 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.846 HD11 ' CE2' ' A' ' 262' ' ' PHE . 27.7 pt -114.1 132.22 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -95.2 131.45 41.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 0.638 HD13 ' CE2' ' A' ' 263' ' ' PHE . 74.4 mt -118.76 125.26 74.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.429 0.633 . . . . 0.0 112.488 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -132.8 155.65 48.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.908 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -55.3 144.96 23.18 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.574 ' O ' ' CB ' ' A' ' 319' ' ' GLU . . . -94.67 131.62 40.27 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . 0.603 ' HB3' ' HD3' ' A' ' 320' ' ' PRO . 4.4 tm-20 106.74 -53.9 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.39 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.984 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.603 ' HD3' ' HB3' ' A' ' 319' ' ' GLU . 32.5 Cg_exo -57.24 -27.44 74.95 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 121.688 1.592 . . . . 0.0 111.71 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.57 45.03 27.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.698 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . 0.451 ' CD2' ' O ' ' A' ' 320' ' ' PRO . 93.4 m-70 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.779 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.717 0 C3'-C2'-O2' 111.215 -0.719 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.555 ' C5 ' ' CD1' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.939 0 C3'-C2'-O2' 111.362 -0.668 . 0.077 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.571 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.997 0 C3'-C2'-O2' 111.34 -0.676 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.612 ' C2 ' ' CZ3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.423 -1.042 0 C3'-C2'-O2' 110.793 -0.864 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.961 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.843 0 C4'-C3'-C2' 103.672 0.972 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.991 ' C2 ' HG22 ' A' ' 234' ' ' ILE . . . . . . . . 0 O5'--C5' 1.425 -0.917 0 C4'-C3'-C2' 103.579 0.879 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.749 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.931 0 C3'-C2'-O2' 111.312 -0.685 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.894 0 C3'-C2'-O2' 111.24 -0.71 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.695 0.284 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 60.5 mp0 -61.91 -34.04 75.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.214 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.4 p -127.65 154.11 45.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.09 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.2 p 166.64 43.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.683 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.433 ' HG2' ' CB ' ' A' ' 233' ' ' ALA . 74.5 tttt -129.99 142.13 50.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.062 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.586 ' HE2' HG11 ' A' ' 216' ' ' VAL . 87.4 mmm -118.84 148.69 42.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.451 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.594 ' CE2' ' N9 ' ' B' ' 6' ' ' ' A' . 4.2 t80 -107.03 129.05 54.86 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.958 HG23 HD12 ' A' ' 228' ' ' ILE . 7.7 mm -116.64 125.05 73.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.783 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 228' ' ' ILE . . . -125.63 158.79 20.04 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 178.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.43 33.37 53.11 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.979 -1.105 . . . . 0.0 112.194 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 83.0 mt -59.38 -18.63 40.42 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.785 ' O ' ' N ' ' A' ' 169' ' ' ASP . 58.2 t30 73.5 41.97 0.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -177.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.611 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 9.5 m0 41.32 -55.65 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.858 -1.064 . . . . 0.0 113.823 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.785 ' N ' ' O ' ' A' ' 167' ' ' ASN . 52.9 p30 -58.02 -31.2 66.74 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.521 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 86.2 m -65.56 138.11 57.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.248 0.547 . . . . 0.0 111.293 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.445 ' C ' HD12 ' A' ' 190' ' ' ILE . 9.3 p -117.64 166.93 11.82 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.345 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.928 ' N ' HD12 ' A' ' 190' ' ' ILE . 20.8 pt-20 -60.73 -25.78 66.69 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.676 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 90.6 m-20 -61.37 -43.69 98.44 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.133 0.492 . . . . 0.0 110.095 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -67.36 -37.65 83.53 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.861 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.581 HD23 ' CE2' ' A' ' 179' ' ' PHE . 3.3 mt -58.43 -43.73 88.86 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.676 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -67.02 -36.72 82.75 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.295 179.202 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.433 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 48.6 tp10 -64.56 -40.91 96.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.065 0.46 . . . . 0.0 110.411 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 59.4 t80 -74.93 -61.68 1.8 Allowed 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.604 0.716 . . . . 0.0 111.111 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.88 ' HZ ' HD11 ' A' ' 228' ' ' ILE . 80.1 m-85 -70.68 -15.7 62.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.514 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.71 -27.76 20.67 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.243 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.828 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -57.5 -41.93 81.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.107 0.479 . . . . 0.0 110.431 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.828 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 68.6 m-85 -70.39 -35.56 73.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.841 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -177.09 -176.65 45.39 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.464 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.521 ' C ' HG13 ' A' ' 185' ' ' VAL . 44.2 m -64.53 -30.75 71.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.123 -0.538 . . . . 0.0 111.476 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.631 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 0.6 OUTLIER 65.54 90.14 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 121.854 0.835 . . . . 0.0 108.91 -177.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.0 t -59.23 -44.02 92.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.915 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -139.72 136.26 34.01 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.464 HD23 ' CG2' ' A' ' 185' ' ' VAL . 0.3 OUTLIER -117.58 133.04 56.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.316 178.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.567 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 9.1 tptp -134.01 120.95 20.91 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.928 HD12 ' N ' ' A' ' 172' ' ' GLU . 0.4 OUTLIER -128.24 134.08 65.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.361 176.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.543 ' CE ' ' HA2' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -90.47 140.03 30.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.746 -179.078 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -133.31 168.48 18.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.919 0.39 . . . . 0.0 111.377 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 7.4 m-20 -117.7 93.92 44.77 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.383 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.53 -24.64 29.46 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.335 2.024 . . . . 0.0 112.693 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -75.55 -83.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.673 0.273 . . . . 0.0 111.449 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 63.2 p -71.77 -24.13 61.7 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.443 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 92.47 7.15 63.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.772 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 4.2 tpt180 -82.22 154.25 25.52 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.946 0.403 . . . . 0.0 110.781 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 28.3 t -105.69 146.84 29.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.718 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.648 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 34.2 mmt180 -54.33 -30.89 52.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.894 0.378 . . . . 0.0 110.296 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.577 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 97.25 -2.02 60.96 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.237 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.648 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 39.7 p90 -139.4 155.57 47.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.058 0.456 . . . . 0.0 110.387 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.543 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -148.31 169.28 28.97 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.664 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.785 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 95.9 m-85 -107.84 125.76 51.83 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.083 0.468 . . . . 0.0 109.945 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.627 HD22 ' CE2' ' A' ' 207' ' ' PHE . 6.0 tt -108.42 128.56 54.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.577 -178.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.547 ' N ' HD23 ' A' ' 205' ' ' LEU . 49.9 m -120.34 142.53 49.05 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.331 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.649 ' CE2' HG21 ' A' ' 216' ' ' VAL . 84.8 m-85 -119.14 141.21 49.02 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.712 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.06 -35.51 80.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.166 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -108.17 117.37 55.04 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.756 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.885 ' O ' HG12 ' A' ' 213' ' ' VAL . 45.5 Cg_exo -56.74 -26.38 65.6 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.563 2.175 . . . . 0.0 113.276 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 85.7 p -61.78 -32.35 72.61 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.325 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.62 ' O ' HG23 ' A' ' 216' ' ' VAL . 24.7 m -60.31 -35.5 75.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.809 0.338 . . . . 0.0 110.706 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.885 HG12 ' O ' ' A' ' 210' ' ' PRO . 2.6 p -58.85 -35.34 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.981 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.454 ' O ' HG22 ' A' ' 217' ' ' VAL . 20.4 t70 -59.06 -44.63 91.86 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.008 0.432 . . . . 0.0 110.73 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -68.25 -33.07 73.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.58 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.945 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 99.0 t -58.97 -40.68 81.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.261 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 214' ' ' ASP . 24.2 m -77.73 -29.85 16.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.16 -0.616 . . . . 0.0 112.062 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -60.15 -38.78 84.17 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.779 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 60.4 m -91.48 146.59 23.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.761 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.498 ' HG2' HG21 ' A' ' 227' ' ' VAL . 63.4 tt0 -67.13 -42.0 85.19 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.529 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.945 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 57.8 m-70 74.95 96.04 0.07 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 72.3 mt -113.53 115.81 50.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.492 HD23 ' CG ' ' A' ' 224' ' ' ASP . 6.6 tt -123.77 126.07 45.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.008 0.433 . . . . 0.0 111.148 -178.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.492 ' CG ' HD23 ' A' ' 223' ' ' LEU . 86.6 m-20 54.63 42.45 31.25 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 91.0 -30.95 5.88 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.612 -0.804 . . . . 0.0 114.33 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -103.13 155.82 18.14 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 221' ' ' HIS . 11.9 p -102.81 124.48 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.958 HD12 HG23 ' A' ' 163' ' ' ILE . 17.8 pt -84.94 -26.9 6.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -177.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 23.7 t70 52.37 70.58 1.81 Allowed Pre-proline 0 C--N 1.318 -0.802 0 CA-C-O 121.532 0.682 . . . . 0.0 110.802 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.677 ' HD2' ' CD2' ' A' ' 221' ' ' HIS . 43.6 Cg_exo -58.83 136.39 73.32 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.942 3.095 . . . . 0.0 112.122 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.406 ' N ' ' HE3' ' A' ' 161' ' ' MET . 14.1 ttpt -138.35 150.11 46.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.351 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -48.35 147.17 2.45 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.802 0.334 . . . . 0.0 110.789 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.433 ' CB ' ' HG2' ' A' ' 160' ' ' LYS . . . -98.0 145.0 26.94 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.209 0.528 . . . . 0.0 112.199 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.853 HD11 ' OD2' ' A' ' 271' ' ' ASP . 0.7 OUTLIER -110.9 126.22 29.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.13 179.3 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.561 ' HB2' ' OE1' ' A' ' 238' ' ' GLU . 36.8 Cg_exo -54.49 152.54 26.29 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.492 1.462 . . . . 0.0 110.549 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -52.32 -37.83 56.96 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -57.88 -43.57 86.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.886 ' O ' HG23 ' A' ' 242' ' ' THR . 58.9 mp0 -67.9 -36.99 81.17 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.705 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -59.98 -38.15 81.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.988 0.423 . . . . 0.0 110.732 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -61.2 -37.21 82.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.543 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -88.44 4.26 47.07 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.886 HG23 ' O ' ' A' ' 238' ' ' GLU . 16.7 p -121.33 160.86 23.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.052 0.453 . . . . 0.0 112.021 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.27 167.52 25.18 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.606 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.575 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 78.2 tttt -136.57 137.21 39.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.209 0.505 . . . . 0.0 110.905 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.62 HD12 ' CG2' ' A' ' 315' ' ' ILE . 7.1 pt -120.31 157.54 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.39 0.614 . . . . 0.0 112.126 -178.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.521 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 81.0 t80 -94.78 130.34 41.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.96 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.981 HG21 ' CZ ' ' A' ' 263' ' ' PHE . 57.2 t -124.6 133.17 70.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.643 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.701 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -119.98 166.96 13.51 Favored Glycine 0 C--O 1.225 -0.445 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.746 ' O ' HG22 ' A' ' 313' ' ' ILE . . . 94.54 13.36 53.98 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.132 -1.033 . . . . 0.0 112.103 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.556 HG23 HG11 ' A' ' 254' ' ' VAL . 67.4 mt -108.84 130.61 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 120.812 0.339 . . . . 0.0 110.491 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.827 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -165.27 -119.11 0.46 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.544 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.38 144.08 96.77 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 122.313 2.009 . . . . 0.0 113.137 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 57.34 45.68 19.67 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.827 HG22 ' O ' ' A' ' 251' ' ' GLY . 16.1 m -118.33 -50.89 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.388 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.521 ' N ' HG23 ' A' ' 254' ' ' VAL . 9.8 mmt180 62.83 130.25 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.195 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.68 -28.62 47.6 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 121.98 1.787 . . . . 0.0 112.194 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 12.7 tptp -60.6 -44.14 96.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.142 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.578 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 79.3 mm-40 -66.91 -39.77 87.48 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.84 0.352 . . . . 0.0 111.085 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.599 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 30.5 t80 -63.25 -48.01 80.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.537 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.427 ' O ' ' CD1' ' A' ' 269' ' ' ILE . 84.3 tt0 -64.46 -42.74 95.76 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.36 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.406 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.9 pt-20 -76.7 -28.85 56.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.83 0.348 . . . . 0.0 110.81 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.874 ' CE2' HD11 ' A' ' 313' ' ' ILE . 12.8 t80 -60.66 -55.59 31.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.169 0.509 . . . . 0.0 111.39 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.981 ' CZ ' HG21 ' A' ' 247' ' ' VAL . 10.4 m-85 -69.64 -22.45 63.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.994 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.707 ' N ' HD11 ' A' ' 269' ' ' ILE . 27.8 t -57.22 -30.94 65.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.892 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -54.04 -36.11 62.71 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.754 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 7.3 p90 -117.76 41.36 2.88 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.763 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.496 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 159.92 147.93 5.07 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.985 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.423 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 52.5 m -59.52 -36.85 76.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 0.0 111.285 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.707 HD11 ' N ' ' A' ' 264' ' ' SER . 69.8 mt 68.81 78.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.395 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.545 ' O ' ' OD1' ' A' ' 271' ' ' ASP . 32.1 mm -58.91 -45.59 91.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.449 -0.5 . . . . 0.0 112.094 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.853 ' OD2' HD11 ' A' ' 234' ' ' ILE . 83.4 m-20 -151.26 90.7 1.61 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.583 ' HB2' HG23 ' A' ' 269' ' ' ILE . . . -106.03 132.62 51.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.528 0.204 . . . . 0.0 110.506 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -145.61 151.61 38.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.285 0.564 . . . . 0.0 111.885 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.59 ' O ' ' HB2' ' A' ' 275' ' ' MET . 26.3 tp -66.05 -36.57 83.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.713 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.59 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 96.0 mmm 84.13 114.28 0.05 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.513 -178.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 276' ' ' LEU . 5.1 mp -122.39 138.58 54.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.744 0.306 . . . . 0.0 111.418 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.469 ' HB2' ' HA3' ' A' ' 281' ' ' GLY . 85.0 m-20 -129.4 100.39 5.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.084 0.469 . . . . 0.0 110.679 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.738 ' O ' HG22 ' A' ' 280' ' ' THR . 94.3 mttt 63.48 35.99 11.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.17 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.429 ' O ' ' HB ' ' A' ' 280' ' ' THR . 85.8 m-20 51.45 43.82 29.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.75 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 278' ' ' LYS . 0.9 OUTLIER 169.86 47.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.041 0.448 . . . . 0.0 110.753 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' A' ' 277' ' ' ASP . . . -139.53 -105.38 0.64 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.135 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.448 ' OE1' ' HB3' ' A' ' 275' ' ' MET . 96.5 mt-30 -56.85 -27.04 59.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.209 -0.496 . . . . 0.0 111.525 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.561 ' O ' HD21 ' A' ' 274' ' ' LEU . 83.3 p -53.18 -24.63 11.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.95 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -118.58 136.89 53.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.652 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 105.96 -57.95 0.46 Allowed Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.573 -0.823 . . . . 0.0 114.242 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.461 ' CZ ' " O4'" ' B' ' 2' ' ' ' A' . 32.5 p90 -140.72 166.77 23.84 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.757 0.779 . . . . 0.0 112.652 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -135.93 154.83 22.04 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.461 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.575 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -110.22 129.89 55.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.747 0.308 . . . . 0.0 111.711 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.67 HG21 ' CD2' ' A' ' 263' ' ' PHE . 55.1 t -124.48 134.84 65.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.978 0.418 . . . . 0.0 111.901 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 63.0 m -115.48 135.75 53.79 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.496 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 38.9 m-85 -117.04 139.51 50.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.511 ' CA ' HG12 ' A' ' 270' ' ' ILE . 51.1 t0 -58.22 -36.53 73.28 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.421 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 49.1 m -123.66 144.2 49.78 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.318 0.58 . . . . 0.0 112.053 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.92 -30.61 71.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.693 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -56.26 -37.53 69.91 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.005 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -61.21 -36.65 80.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.011 0.434 . . . . 0.0 110.403 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.583 HG13 HG21 ' A' ' 245' ' ' ILE . 75.1 t -61.74 -42.82 95.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.234 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -61.5 -37.68 84.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.53 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -59.06 -44.09 91.8 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.965 HG23 HD11 ' A' ' 306' ' ' ILE . 0.8 OUTLIER -71.9 -33.04 46.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.175 -179.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 89.0 m -57.88 -45.6 86.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.142 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -61.09 -41.46 96.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.254 0.549 . . . . 0.0 110.018 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -61.91 -33.05 73.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.211 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.648 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 31.8 tptt 68.16 -74.21 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -178.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.648 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.0 m-30 -113.31 141.55 46.88 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.424 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.965 HD11 HG23 ' A' ' 300' ' ' VAL . 34.6 mt -116.98 136.65 53.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -75.09 79.82 2.25 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.367 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.531 ' CD2' HD13 ' A' ' 313' ' ' ILE . 9.1 t80 -83.17 -105.7 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.978 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 310' ' ' ASP . 4.2 mmpt? -60.71 -34.96 75.17 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 309' ' ' LYS . 52.2 p30 137.78 0.17 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.997 0.919 . . . . 0.0 111.142 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 312' ' ' LYS . 73.3 mtt85 -98.18 4.44 48.96 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.451 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 95.1 mttt 65.04 54.07 1.29 Allowed 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.109 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.874 HD11 ' CE2' ' A' ' 262' ' ' PHE . 20.3 pt -50.14 99.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.777 0.799 . . . . 0.0 110.784 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . 0.567 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 92.4 mt-10 -60.91 139.53 57.97 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.19 -178.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 0.772 HG23 HG22 ' A' ' 247' ' ' VAL . 63.2 mt -121.65 128.14 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.009 0.433 . . . . 0.0 111.065 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -133.85 142.78 47.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.112 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 21.7 ttp-105 -50.8 146.74 5.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.699 0.285 . . . . 0.0 110.624 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.23 143.51 27.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.402 . . . . 0.0 111.131 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -99.43 123.88 46.66 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.358 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -55.77 -21.35 32.15 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.54 2.16 . . . . 0.0 112.129 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.478 ' NH1' ' C4 ' ' B' ' 3' ' ' ' U' . 0.0 OUTLIER 76.92 0.72 3.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.092 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 68.6 m80 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.767 179.744 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.735 0 C3'-C2'-O2' 111.235 -0.712 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.521 ' C5 ' ' CE1' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.957 0 C3'-C2'-O2' 111.273 -0.699 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.478 ' C4 ' ' NH1' ' A' ' 321' ' ' ARG . . . . . . . . 0 O5'--C5' 1.423 -1.052 0 C3'-C2'-O2' 111.488 -0.625 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.713 ' N7 ' ' HA ' ' A' ' 167' ' ' ASN . . . . . . . . 0 O5'--C5' 1.426 -0.905 0 C4'-C3'-C2' 103.706 1.006 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.589 " H4'" ' CD1' ' A' ' 202' ' ' PHE . . . . . . . . 0 O5'--C5' 1.428 -0.756 0 C4'-C3'-C2' 103.67 0.97 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.594 ' N9 ' ' CE2' ' A' ' 162' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -1.008 0 C4'-C3'-C2' 103.567 0.867 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.785 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -1.027 0 C3'-C2'-O2' 111.128 -0.749 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . 0.498 H5'' " O2'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.96 0 C3'-C2'-O2' 111.143 -0.744 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 26.1 pttm . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.65 0.262 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -108.97 148.59 30.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.776 0.322 . . . . 0.0 110.909 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 86.5 p -62.71 -29.1 70.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.26 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.5 p 34.69 35.01 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.881 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.484 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 21.8 tttt -96.2 137.5 35.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.499 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.64 ' HE2' ' HB ' ' A' ' 216' ' ' VAL . 8.5 tpp -114.36 145.4 41.87 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.637 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 6.8 t80 -102.85 131.85 49.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.925 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.112 HG22 HD11 ' A' ' 166' ' ' LEU . 17.5 mm -116.63 132.37 66.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.354 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.604 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -123.59 156.64 17.9 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.294 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.405 ' HA2' " H5'" ' B' ' 4' ' ' ' A' . . . 76.31 34.95 44.2 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.407 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 1.112 HD11 HG22 ' A' ' 163' ' ' ILE . 4.4 mp -92.62 141.75 28.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.638 0.256 . . . . 0.0 110.732 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.56 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 0.6 OUTLIER -60.16 135.44 57.72 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.198 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.626 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 4.3 m0 -53.91 -33.66 57.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.794 0.331 . . . . 0.0 110.754 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -93.22 9.72 34.91 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.422 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 1.131 HG21 HD21 ' A' ' 223' ' ' LEU . 98.5 m -56.98 -40.54 76.72 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.49 HG23 ' C ' ' A' ' 170' ' ' THR . 0.1 OUTLIER 54.32 162.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -177.322 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.532 ' O ' ' HD3' ' A' ' 176' ' ' ARG . 57.2 mp0 -62.73 -28.56 70.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.113 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.575 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 92.6 m-20 -55.47 -43.44 75.53 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -67.46 -36.95 82.17 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 1.009 HD22 HD21 ' A' ' 205' ' ' LEU . 6.1 mt -56.38 -48.39 76.97 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.575 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -68.42 -30.36 69.24 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.333 179.15 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -56.89 -39.4 74.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.577 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.792 ' HD2' HD12 ' A' ' 223' ' ' LEU . 0.0 OUTLIER -96.37 -59.47 1.82 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.967 0.413 . . . . 0.0 110.092 178.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.635 ' CE2' HD23 ' A' ' 175' ' ' LEU . 70.9 m-85 -59.87 -31.95 70.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.544 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -50.13 -25.37 7.75 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.11 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.825 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -56.41 -41.19 75.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.775 0.321 . . . . 0.0 111.487 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.825 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 69.8 m-85 -70.56 -35.74 73.25 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -174.66 -177.54 43.87 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.475 -1.345 . . . . 0.0 114.195 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 61.1 m -62.73 -34.38 77.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.699 -0.75 . . . . 0.0 111.867 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.848 HG23 ' CE1' ' A' ' 207' ' ' PHE . 0.5 OUTLIER 67.15 106.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.76 HG23 ' N ' ' A' ' 208' ' ' GLU . 43.3 p -64.78 -36.79 85.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.983 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -154.01 150.65 28.49 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.473 HD23 HG11 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -118.47 133.66 55.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.348 179.188 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 10.5 tptt -133.48 119.09 19.13 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 172' ' ' GLU . 0.8 OUTLIER -128.58 137.66 56.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.034 177.506 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.566 ' HB2' ' HB2' ' A' ' 200' ' ' ARG . 0.3 OUTLIER -96.19 127.53 42.28 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.857 -179.525 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -131.95 155.52 47.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.983 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.601 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 15.2 t0 -120.55 80.82 31.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.442 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.09 -24.85 42.49 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.52 2.147 . . . . 0.0 112.642 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.79 -70.52 0.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.867 0.365 . . . . 0.0 111.111 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 49.4 p -73.08 -20.56 60.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.812 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 84.87 19.72 59.06 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.53 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.601 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 8.3 tpt180 -115.6 151.92 34.05 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 120.756 0.312 . . . . 0.0 110.466 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.546 ' O ' ' CD1' ' A' ' 168' ' ' TRP . 49.1 m -117.34 153.4 33.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.904 0.383 . . . . 0.0 110.809 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.653 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 30.5 mmt180 -54.34 -34.5 61.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 110.961 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.522 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 90.71 5.61 68.59 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.231 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.962 ' HA ' HD13 ' A' ' 166' ' ' LEU . 22.5 p90 -140.36 158.92 43.29 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.881 0.372 . . . . 0.0 110.641 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.456 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -143.02 162.9 27.47 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.402 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.637 ' CE1' ' CD1' ' A' ' 162' ' ' PHE . 95.8 m-85 -109.68 129.59 55.59 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.867 0.365 . . . . 0.0 110.199 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 1.009 HD21 HD22 ' A' ' 175' ' ' LEU . 61.1 mt -104.54 141.21 36.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.778 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 186' ' ' THR . 18.0 t -127.94 128.37 44.98 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.848 ' CE1' HG23 ' A' ' 185' ' ' VAL . 98.1 m-85 -120.41 143.08 48.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.14 0.495 . . . . 0.0 112.073 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.76 ' N ' HG23 ' A' ' 186' ' ' THR . 47.3 tp10 -62.14 -34.37 76.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.063 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -110.83 116.23 52.29 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.4 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.7 -30.59 76.31 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.454 2.103 . . . . 0.0 113.064 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.418 ' O ' ' OD1' ' A' ' 214' ' ' ASP . 25.6 m -59.39 -35.51 74.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.626 0.25 . . . . 0.0 110.926 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.821 ' O ' HG23 ' A' ' 216' ' ' VAL . 24.8 m -57.01 -34.61 68.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.131 0.491 . . . . 0.0 109.898 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.51 HG11 ' CD ' ' A' ' 232' ' ' ARG . 83.5 t -63.49 -38.4 82.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.678 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.695 ' OD1' ' N ' ' A' ' 215' ' ' GLU . 36.4 p30 -60.35 -39.4 87.0 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.746 -178.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.695 ' N ' ' OD1' ' A' ' 214' ' ' ASP . 97.8 mt-10 -70.95 -35.52 72.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.527 0.68 . . . . 0.0 110.714 177.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 212' ' ' SER . 93.9 t -60.44 -36.88 72.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.528 -178.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 230' ' ' PRO . 6.5 p -87.21 -54.22 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.493 ' N ' HG13 ' A' ' 217' ' ' VAL . 26.2 mttt -60.44 -36.74 78.93 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.424 ' HB ' ' CE1' ' A' ' 221' ' ' HIS . 62.0 m -58.26 -37.75 75.58 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 63.86 110.56 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -177.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.723 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 0.0 OUTLIER -137.98 175.13 9.86 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -176.037 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.861 HG23 ' O ' ' A' ' 226' ' ' LYS . 17.8 mm -115.36 120.25 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.75 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 1.131 HD21 HG21 ' A' ' 170' ' ' THR . 18.8 tp -69.64 -43.81 71.89 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.644 -0.423 . . . . 0.0 112.017 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -177.36 69.68 0.02 OUTLIER 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.741 0.305 . . . . 0.0 111.774 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 95.21 -8.09 69.54 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.467 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.861 ' O ' HG23 ' A' ' 222' ' ' ILE . 76.2 mttt -124.08 157.76 33.81 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 117.036 0.418 . . . . 0.0 111.584 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.91 HG21 ' OD2' ' A' ' 279' ' ' ASP . 44.3 t -93.88 126.95 46.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.165 0.507 . . . . 0.0 110.26 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.63 HD13 ' HB2' ' A' ' 223' ' ' LEU . 31.6 pt -126.87 155.98 37.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.048 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 8.7 p30 -132.15 81.57 61.15 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 121.191 0.519 . . . . 0.0 110.421 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.771 ' O ' HG23 ' A' ' 217' ' ' VAL . 92.8 Cg_exo -47.51 127.02 13.05 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.72 2.28 . . . . 0.0 111.345 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.454 ' HE2' ' H62' ' B' ' 6' ' ' ' A' . 5.6 ttpt -132.45 144.96 50.83 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.684 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.51 ' CD ' HG11 ' A' ' 213' ' ' VAL . 57.3 mmm-85 -50.06 143.1 8.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.202 0.525 . . . . 0.0 111.269 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -68.62 150.08 48.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.787 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.57 HD12 ' C6 ' ' B' ' 6' ' ' ' A' . 34.4 mt -117.44 140.4 27.32 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.935 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.475 ' HD2' ' OE1' ' A' ' 238' ' ' GLU . 45.0 Cg_exo -55.26 139.84 81.27 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 121.758 1.639 . . . . 0.0 111.229 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.449 ' O ' ' HD3' ' A' ' 236' ' ' ARG . 3.2 tmt_? -56.83 -41.12 77.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.728 0.299 . . . . 0.0 111.123 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -60.01 -39.35 85.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.368 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.503 ' O ' HG23 ' A' ' 242' ' ' THR . 94.8 mt-10 -63.66 -32.62 74.16 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.701 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.501 ' OE1' " H2'" ' B' ' 6' ' ' ' A' . 98.9 mm-40 -58.24 -38.52 77.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.998 0.428 . . . . 0.0 110.213 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -61.06 -42.33 98.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.223 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -63.15 -36.0 82.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.461 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 238' ' ' GLU . 21.0 p -83.26 161.44 21.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.155 0.502 . . . . 0.0 111.897 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.94 169.99 25.07 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.609 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.539 ' CE ' ' CD2' ' A' ' 288' ' ' PHE . 46.9 tptt -134.71 130.36 36.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.861 0.331 . . . . 0.0 110.706 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.656 HD12 HG21 ' A' ' 315' ' ' ILE . 5.5 pt -123.5 154.84 29.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 121.11 0.481 . . . . 0.0 110.65 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.556 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 92.9 t80 -97.28 133.37 42.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.651 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.752 HG21 ' CZ ' ' A' ' 263' ' ' PHE . 21.4 t -121.42 139.36 48.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.032 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.595 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -129.02 171.93 19.77 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.18 36.9 16.56 Favored Glycine 0 C--N 1.323 -0.181 0 C-N-CA 120.071 -1.061 . . . . 0.0 111.901 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.866 HG22 HG21 ' A' ' 254' ' ' VAL . 69.8 mt -111.66 132.32 60.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.598 0.237 . . . . 0.0 110.81 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.862 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -158.16 -119.59 0.57 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.246 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.63 140.58 95.45 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.38 2.053 . . . . 0.0 113.482 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 54.15 44.06 29.74 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.402 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.866 HG21 HG22 ' A' ' 250' ' ' ILE . 22.4 m -121.04 27.77 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.529 ' HG3' ' HD2' ' A' ' 256' ' ' PRO . 0.2 OUTLIER -39.96 155.12 0.18 Allowed Pre-proline 0 N--CA 1.465 0.304 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.529 ' HD2' ' HG3' ' A' ' 255' ' ' ARG . 7.5 Cg_endo -50.19 -29.47 22.77 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.051 1.834 . . . . 0.0 112.128 -178.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -62.05 -45.72 92.31 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.036 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -68.29 -42.11 79.97 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.101 0.477 . . . . 0.0 111.066 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.468 ' CZ ' ' CG2' ' A' ' 289' ' ' VAL . 35.3 t80 -66.13 -47.2 74.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.294 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.733 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.4 tt0 -64.9 -41.37 95.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.333 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -75.01 -31.98 61.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.613 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.685 ' CE2' HD11 ' A' ' 313' ' ' ILE . 83.4 t80 -59.51 -55.61 32.42 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.818 ' CB ' HD11 ' A' ' 269' ' ' ILE . 25.3 m-85 -66.85 -30.65 70.88 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.537 ' HA ' HG13 ' A' ' 269' ' ' ILE . 16.5 m -56.01 -27.43 52.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.758 0.313 . . . . 0.0 111.194 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -51.89 -38.04 54.66 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.745 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 19.9 p90 -110.84 48.08 0.94 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.586 0.708 . . . . 0.0 111.954 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 133.28 149.08 6.04 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.313 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 53.4 m -69.76 131.85 45.18 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.818 HD11 ' CB ' ' A' ' 263' ' ' PHE . 49.6 mt -94.44 135.92 27.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.005 0.431 . . . . 0.0 111.395 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' A' ' 292' ' ' ASP . 27.3 mm -92.38 -75.09 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.49 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 272' ' ' ALA . 90.4 m-20 -93.0 -75.51 0.49 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.489 ' HB3' HG21 ' A' ' 269' ' ' ILE . . . 42.79 108.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -140.64 157.73 45.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.222 0.534 . . . . 0.0 111.68 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.573 ' O ' ' HB2' ' A' ' 275' ' ' MET . 25.9 tp -62.17 -37.39 85.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.537 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.709 ' O ' HD23 ' A' ' 276' ' ' LEU . 84.9 mtp 86.27 128.26 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.95 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 275' ' ' MET . 31.9 mt -130.14 120.9 25.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.853 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.444 ' O ' ' HG3' ' A' ' 278' ' ' LYS . 55.1 t0 -61.0 -41.75 97.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.213 0.53 . . . . 0.0 110.192 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.542 ' O ' HG22 ' A' ' 280' ' ' THR . 98.8 mttt -165.28 59.09 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.975 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.91 ' OD2' HG21 ' A' ' 227' ' ' VAL . 83.7 m-20 58.17 44.62 18.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.739 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 278' ' ' LYS . 1.5 t -178.66 -34.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.401 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 276' ' ' LEU . . . -83.39 178.48 52.71 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.436 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.491 ' NE2' " O3'" ' B' ' 2' ' ' ' A' . 98.1 mt-30 42.9 21.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.483 ' O ' HD21 ' A' ' 274' ' ' LEU . 94.0 p -80.54 -30.82 37.1 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -134.36 154.04 51.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.362 0.601 . . . . 0.0 112.463 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.13 -40.94 2.27 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.041 -0.981 . . . . 0.0 114.422 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.664 ' C ' HD12 ' A' ' 250' ' ' ILE . 12.4 p90 -149.0 165.55 31.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.792 0.796 . . . . 0.0 111.556 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.788 ' N ' HD12 ' A' ' 250' ' ' ILE . . . -138.99 153.79 22.94 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.975 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.539 ' CD2' ' CE ' ' A' ' 244' ' ' LYS . 0.3 OUTLIER -109.59 127.38 54.47 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.594 0.358 . . . . 0.0 110.364 179.255 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.556 HG21 ' CG ' ' A' ' 263' ' ' PHE . 38.5 t -125.32 135.45 63.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.453 ' OG1' ' CD ' ' A' ' 244' ' ' LYS . 47.5 m -120.27 136.52 54.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.313 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.407 ' OH ' ' O ' ' A' ' 263' ' ' PHE . 40.5 m-85 -116.21 138.4 51.32 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.617 ' HB2' HD11 ' A' ' 270' ' ' ILE . 51.4 t0 -57.3 -36.35 70.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.507 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 50.6 m -122.37 145.04 48.64 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.247 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.83 -27.84 68.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.649 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -55.56 -38.42 69.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.626 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.44 -37.38 85.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.977 0.417 . . . . 0.0 110.901 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.566 HG13 ' CG2' ' A' ' 245' ' ' ILE . 73.1 t -62.71 -43.66 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.258 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -61.58 -38.66 88.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.29 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -59.51 -43.32 93.41 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.895 HG23 HD11 ' A' ' 306' ' ' ILE . 1.2 p -70.92 -33.04 50.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.466 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 81.6 m -57.5 -45.63 84.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.278 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -61.76 -42.2 98.68 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.207 0.527 . . . . 0.0 110.364 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.9 m-20 -63.04 -35.25 79.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.607 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.677 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 16.2 tptm 67.58 -67.79 0.17 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.677 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 16.1 m-85 -114.97 133.35 56.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.166 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.895 HD11 HG23 ' A' ' 300' ' ' VAL . 14.8 mt -121.45 140.17 46.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.92 178.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.54 ' OD1' ' O ' ' A' ' 307' ' ' ASP . 50.7 p30 -77.1 110.21 11.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.224 0.535 . . . . 0.0 110.884 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.637 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 7.9 t80 -110.21 -79.65 0.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.543 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.463 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 6.7 mmpt? -97.89 -162.4 0.95 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.505 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -52.76 -28.97 24.7 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.759 0.314 . . . . 0.0 110.456 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -109.99 152.66 25.61 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.534 ' HG2' ' HB3' ' A' ' 305' ' ' PHE . 14.2 tttp -75.29 139.99 42.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.527 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.685 HD11 ' CE2' ' A' ' 262' ' ' PHE . 27.4 pt -105.49 136.63 38.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.236 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . 0.434 ' HB2' ' CE2' ' A' ' 305' ' ' PHE . 84.5 tt0 -101.25 131.32 47.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.651 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 0.683 HD13 ' CE2' ' A' ' 263' ' ' PHE . 66.0 mt -119.48 127.51 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-O 121.052 0.454 . . . . 0.0 111.2 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -131.34 144.7 51.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.482 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -49.62 146.19 4.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.017 0.437 . . . . 0.0 111.065 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.32 147.36 36.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.632 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . 0.401 ' HG2' ' HD2' ' A' ' 320' ' ' PRO . 0.3 OUTLIER -115.01 152.68 46.81 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.938 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.401 ' HD2' ' HG2' ' A' ' 319' ' ' GLU . 31.3 Cg_exo -59.29 -26.19 80.97 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.512 2.141 . . . . 0.0 112.341 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 32.9 mmm180 35.23 53.22 0.71 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.857 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.962 179.941 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.724 0 C3'-C2'-O2' 111.318 -0.684 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.556 ' C5 ' ' CE1' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.974 0 C3'-C2'-O2' 111.454 -0.637 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.593 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.968 0 C3'-C2'-O2' 111.333 -0.678 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.626 ' C2 ' ' CZ3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.425 -0.94 0 C4'-C3'-C2' 103.876 1.176 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.897 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.788 0 C4'-C3'-C2' 103.709 1.009 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.897 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.895 0 C3'-C2'-O2' 111.265 -0.702 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.63 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.912 0 O4'-C1'-N19 109.482 1.282 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . 0.571 ' P ' " O2'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.427 -0.788 0 O4'-C1'-C2' 107.474 0.767 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 52.6 tttp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.864 0.364 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 57.09 22.09 7.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.166 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.6 m -120.14 147.58 44.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.698 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.4 m 47.62 25.3 0.64 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.23 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 205' ' ' LEU . 37.6 ttpt -89.49 136.59 32.94 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.099 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.805 ' SD ' HG13 ' A' ' 213' ' ' VAL . 29.0 mtm -124.86 164.14 20.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.147 0.499 . . . . 0.0 111.239 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.602 ' CD2' ' C4 ' ' B' ' 6' ' ' ' A' . 1.8 t80 -98.49 130.01 45.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.302 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.805 HG23 HD12 ' A' ' 228' ' ' ILE . 47.0 mt -119.28 127.73 75.84 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.67 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.705 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.645 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -127.27 165.63 20.35 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.73 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.13 34.71 40.66 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.962 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.556 HD22 HG21 ' A' ' 170' ' ' THR . 73.9 mt -59.25 -22.89 61.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.542 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 51.8 t30 75.59 39.61 0.33 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.198 0.523 . . . . 0.0 109.751 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.559 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 20.4 m0 33.53 35.22 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.143 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -153.94 8.2 0.35 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.556 HG21 HD22 ' A' ' 166' ' ' LEU . 55.4 m -78.71 137.16 37.65 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.372 0.606 . . . . 0.0 110.392 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.52 HG23 ' HZ1' ' A' ' 192' ' ' LYS . 30.5 m -116.42 145.02 43.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.825 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.554 ' N ' HD12 ' A' ' 190' ' ' ILE . 55.4 mp0 -55.66 -36.46 67.1 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.146 -0.621 . . . . 0.0 109.646 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.541 ' O ' ' HG2' ' A' ' 176' ' ' ARG . 89.6 m-20 -65.43 -48.29 73.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.973 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -67.25 -40.8 86.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.609 0.718 . . . . 0.0 110.158 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.835 HD22 HD11 ' A' ' 190' ' ' ILE . 65.8 tp -64.68 -41.42 96.06 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.107 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.541 ' HG2' ' O ' ' A' ' 173' ' ' ASP . 41.2 ptt85 -69.66 -40.03 76.68 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.395 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 173' ' ' ASP . 75.4 mm-40 -65.12 -37.86 88.8 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.037 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.439 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 65.2 t80 -61.72 -54.53 41.33 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.416 0.627 . . . . 0.0 110.135 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.607 ' HZ ' HD11 ' A' ' 228' ' ' ILE . 86.6 m-85 -73.58 -21.83 60.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.703 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.41 -26.54 22.86 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.222 -0.99 . . . . 0.0 110.847 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.507 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -54.91 -41.49 71.03 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 123.752 0.821 . . . . 0.0 111.072 179.211 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -69.02 -32.59 72.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.099 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 174.94 -125.34 1.08 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.306 -0.95 . . . . 0.0 112.702 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 57.1 m -117.44 143.33 46.13 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.903 HG21 ' CD2' ' A' ' 188' ' ' LEU . 15.0 p -109.8 135.07 49.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.715 0.293 . . . . 0.0 110.238 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.452 HG23 ' CB ' ' A' ' 206' ' ' SER . 0.5 OUTLIER -95.79 -47.58 6.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.928 -179.18 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.418 ' HB3' ' HB3' ' A' ' 206' ' ' SER . 59.6 t0 -136.6 132.19 34.76 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.281 0.562 . . . . 0.0 112.488 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.903 ' CD2' HG21 ' A' ' 185' ' ' VAL . 0.3 OUTLIER -116.22 129.72 56.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.58 179.278 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 11.7 tptt -137.03 116.07 12.41 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.835 HD11 HD22 ' A' ' 175' ' ' LEU . 55.1 mt -126.74 126.26 68.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.989 176.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.547 ' SD ' ' CE1' ' A' ' 202' ' ' PHE . 0.0 OUTLIER -86.03 114.95 23.31 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.52 ' HZ1' HG23 ' A' ' 171' ' ' THR . 69.5 mttt -117.84 153.35 33.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.856 0.36 . . . . 0.0 111.458 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.591 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 3.1 t0 -124.79 74.11 64.19 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.31 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.77 -28.7 83.17 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.54 2.16 . . . . 0.0 112.905 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -66.74 -58.72 4.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.057 0.456 . . . . 0.0 111.108 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.2 p -75.16 -18.6 60.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.341 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 86.29 12.17 70.87 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.802 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.591 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 88.7 mtt-85 -122.32 177.16 5.5 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-O 120.87 0.367 . . . . 0.0 111.974 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 86.0 p -139.7 160.85 38.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.37 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.546 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 39.5 mmt180 -55.47 -31.96 62.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.989 0.423 . . . . 0.0 110.081 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.474 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 92.87 6.57 63.46 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.378 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.547 ' CE1' ' SD ' ' A' ' 191' ' ' MET . 26.2 p90 -146.56 154.33 41.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.153 0.501 . . . . 0.0 111.102 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.535 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -142.88 159.2 27.34 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.88 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.744 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 90.5 m-85 -106.83 123.66 48.48 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.629 HD22 ' CE2' ' A' ' 207' ' ' PHE . 7.3 tt -115.07 131.48 56.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.394 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.498 ' N ' HD23 ' A' ' 205' ' ' LEU . 38.8 t -116.31 135.67 53.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.015 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.629 ' CE2' HD22 ' A' ' 205' ' ' LEU . 75.5 m-85 -111.92 135.49 52.48 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.29 -35.33 78.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.464 178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -109.77 115.16 55.86 Favored Pre-proline 0 C--O 1.231 0.119 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.695 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -56.2 -23.08 43.33 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.519 2.146 . . . . 0.0 112.862 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.1 t -57.66 -38.32 74.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.78 0.324 . . . . 0.0 111.113 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.94 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.9 m -59.64 -36.56 76.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.595 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.805 HG13 ' SD ' ' A' ' 161' ' ' MET . 83.0 t -60.48 -42.75 92.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.921 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.407 ' O ' HG12 ' A' ' 217' ' ' VAL . 55.5 t0 -59.49 -41.45 89.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.88 0.371 . . . . 0.0 110.805 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.449 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 17.4 pt-20 -78.34 -36.41 46.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.726 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.94 HG23 ' O ' ' A' ' 212' ' ' SER . 93.8 t -63.5 -46.31 95.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 CA-C-O 120.924 0.393 . . . . 0.0 110.422 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 214' ' ' ASP . 8.0 p -62.01 -36.62 75.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -59.97 -38.7 83.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.706 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 31.4 m -87.66 142.39 27.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.918 0.389 . . . . 0.0 111.847 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 228' ' ' ILE . 60.1 tp60 -66.23 -40.89 90.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.455 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.845 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 58.2 m-70 74.55 105.73 0.07 Allowed 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.615 HG12 HG12 ' A' ' 227' ' ' VAL . 75.3 mt -112.28 108.02 24.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.5 tt -117.0 125.99 52.21 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.948 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 55.76 41.19 30.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.03 8.29 87.41 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.95 -0.643 . . . . 0.0 114.643 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.474 ' HG3' ' CB ' ' A' ' 167' ' ' ASN . 42.2 mmtm -127.2 153.76 45.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.55 0.675 . . . . 0.0 111.961 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.615 HG12 HG12 ' A' ' 222' ' ' ILE . 34.2 m -100.06 136.93 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.64 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.805 HD12 HG23 ' A' ' 163' ' ' ILE . 31.1 pt -123.75 161.85 25.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.083 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -124.95 80.3 63.79 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.119 0.485 . . . . 0.0 111.756 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.653 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 31.3 Cg_exo -63.92 76.31 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.399 2.733 . . . . 0.0 112.043 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 161' ' ' MET . 9.9 mtmt -95.5 159.42 15.01 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.117 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.458 ' HA ' ' HG2' ' A' ' 161' ' ' MET . 16.5 tpt180 -57.41 136.91 56.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.068 0.461 . . . . 0.0 111.578 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.31 145.71 55.0 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.49 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.542 HD12 ' C5 ' ' B' ' 6' ' ' ' A' . 13.9 mt -110.31 120.47 44.15 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.946 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.402 ' HG2' ' CG ' ' A' ' 238' ' ' GLU . 11.3 Cg_endo -54.97 147.76 50.78 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.04 1.827 . . . . 0.0 111.309 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.415 ' HD3' ' NE2' ' A' ' 239' ' ' GLN . 25.2 mmt180 -55.86 -36.71 67.88 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -57.68 -43.19 84.89 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.003 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.684 ' O ' HG23 ' A' ' 242' ' ' THR . 97.6 mt-10 -71.92 -39.66 69.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.084 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.415 ' NE2' ' HD3' ' A' ' 236' ' ' ARG . 27.1 mt-30 -61.18 -36.94 81.22 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.472 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -59.68 -37.31 78.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.999 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -86.41 -0.48 56.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 238' ' ' GLU . 27.3 p -87.85 162.54 16.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.081 0.467 . . . . 0.0 111.689 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -158.33 91.83 0.12 Allowed Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.767 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.584 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 77.5 tttt -79.2 132.42 36.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.764 0.316 . . . . 0.0 110.644 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.68 HD13 ' O ' ' A' ' 245' ' ' ILE . 0.0 OUTLIER -117.45 162.62 15.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.735 0.779 . . . . 0.0 112.254 -178.368 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.427 ' CG ' ' C6 ' ' B' ' 2' ' ' ' A' . 81.9 t80 -103.0 133.97 47.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.817 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.652 ' O ' ' HB2' ' A' ' 286' ' ' PHE . 8.2 p -128.15 135.05 63.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.351 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -123.96 12.03 8.2 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.349 -0.929 . . . . 0.0 113.694 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 313' ' ' ILE . . . -97.78 15.76 61.35 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.725 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.988 HD11 ' HA3' ' A' ' 287' ' ' GLY . 31.7 pt -120.9 155.56 24.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.489 0.662 . . . . 0.0 112.597 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.996 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -137.73 177.17 20.14 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.086 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.15 -26.96 44.39 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 121.981 1.787 . . . . 0.0 111.702 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.13 -35.1 72.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.592 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.996 HG22 ' O ' ' A' ' 251' ' ' GLY . 20.5 m -65.85 -28.1 43.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.74 127.35 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.07 -32.38 79.18 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.213 1.942 . . . . 0.0 113.126 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -61.15 -47.16 87.51 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.239 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 84.1 tt0 -66.67 -36.35 82.31 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.241 0.543 . . . . 0.0 110.944 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.72 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 31.3 t80 -59.5 -45.06 92.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.449 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.7 -40.32 92.16 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.321 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 258' ' ' GLU . 20.8 pt-20 -76.33 -30.64 57.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.08 0.467 . . . . 0.0 110.604 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.576 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 11.6 t80 -63.94 -55.56 21.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.057 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.832 ' CD2' HG21 ' A' ' 289' ' ' VAL . 4.2 m-85 -66.72 -24.66 66.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.547 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.634 ' N ' HD11 ' A' ' 269' ' ' ILE . 71.2 p -60.08 -24.78 64.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.537 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -54.89 -35.76 64.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.467 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.667 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 13.0 p90 -114.39 35.43 4.21 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.073 0.463 . . . . 0.0 111.604 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 264' ' ' SER . . . 164.31 149.03 5.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.641 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 44.5 m -59.91 -36.07 76.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.944 0.402 . . . . 0.0 110.92 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.651 HD11 ' C ' ' A' ' 263' ' ' PHE . 66.0 mt 64.82 90.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.161 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.611 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 80.5 mt -56.65 -42.47 76.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.201 178.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.451 ' OD2' ' CE ' ' A' ' 231' ' ' LYS . 61.9 t0 -168.69 100.88 0.4 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.745 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -98.73 136.72 38.37 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -143.02 155.43 44.64 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 1.073 HD23 HD11 ' A' ' 276' ' ' LEU . 30.6 tp -65.94 -35.45 80.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.176 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.657 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 86.7 mmm 105.58 -79.41 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.168 0.987 . . . . 0.0 112.234 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 1.073 HD11 HD23 ' A' ' 274' ' ' LEU . 6.5 mp 59.14 65.92 1.12 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.461 0.172 . . . . 0.0 111.017 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.424 ' HA ' ' OP2' ' B' ' 4' ' ' ' A' . 22.0 t70 -57.71 -41.31 81.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.383 0.611 . . . . 0.0 109.598 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' A' ' 280' ' ' THR . 55.8 mttp -142.0 114.87 8.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.966 177.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.68 ' O ' HD23 ' A' ' 276' ' ' LEU . 87.8 m-20 60.59 -65.44 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.034 -179.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 278' ' ' LYS . 0.3 OUTLIER 170.94 18.7 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -58.07 -38.58 89.94 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.691 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.918 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 96.1 mm-40 -60.96 -36.37 79.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.259 0.552 . . . . 0.0 110.349 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.819 ' OG ' HD21 ' A' ' 274' ' ' LEU . 36.8 t -60.58 -23.77 64.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.54 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -48.05 -33.4 7.99 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -144.6 -18.52 0.19 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 119.083 -1.532 . . . . 0.0 115.755 -178.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.652 ' HB2' ' O ' ' A' ' 247' ' ' VAL . 26.3 p90 -136.61 165.17 26.51 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.132 1.466 . . . . 0.0 113.269 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.988 ' HA3' HD11 ' A' ' 250' ' ' ILE . . . -141.62 163.57 26.84 Favored Glycine 0 CA--C 1.52 0.393 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.516 178.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.584 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -116.89 130.22 56.57 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.446 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.832 HG21 ' CD2' ' A' ' 263' ' ' PHE . 61.2 t -125.94 136.19 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.351 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 53.0 m -114.02 135.92 53.48 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.472 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 49.3 m-85 -115.76 136.35 53.14 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.611 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 21.8 t70 -59.18 -34.82 72.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.535 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 51.0 m -119.69 143.22 47.86 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.375 0.607 . . . . 0.0 111.763 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -66.55 -31.2 71.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.161 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.574 ' OD1' ' N ' ' A' ' 296' ' ' ALA . 53.5 p30 -60.8 -33.69 73.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.46 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.574 ' N ' ' OD1' ' A' ' 295' ' ' ASP . . . -62.16 -37.94 87.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.919 0.39 . . . . 0.0 110.65 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.593 ' O ' HG12 ' A' ' 300' ' ' VAL . 75.2 t -61.48 -42.07 92.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.031 0.443 . . . . 0.0 110.61 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -59.52 -37.17 77.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.592 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -58.35 -43.63 88.42 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.053 0.454 . . . . 0.0 111.821 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 1.008 HG23 HD11 ' A' ' 306' ' ' ILE . 1.0 OUTLIER -70.2 -34.4 58.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.456 -179.35 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 79.7 m -59.64 -47.24 86.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.333 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.19 -39.29 94.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.187 0.517 . . . . 0.0 110.419 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.1 m-20 -62.12 -34.75 76.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.772 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.675 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 23.2 tptm 65.39 -73.95 0.06 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.675 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 5.1 m-30 -108.87 134.51 51.45 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.888 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 1.008 HD11 HG23 ' A' ' 300' ' ' VAL . 14.9 mt -116.52 137.84 49.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.073 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.421 ' OD1' ' CE ' ' A' ' 312' ' ' LYS . 73.0 m-20 -75.99 87.53 2.93 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.68 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 7.8 t80 -97.76 -71.76 0.67 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.385 0.612 . . . . 0.0 110.655 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.629 ' HD2' HG12 ' A' ' 254' ' ' VAL . 4.6 mmpt? -96.69 -164.24 1.13 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.344 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.431 ' OD1' ' HG2' ' A' ' 311' ' ' ARG . 55.8 p30 -59.21 -21.8 60.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.702 0.287 . . . . 0.0 110.792 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.431 ' HG2' ' OD1' ' A' ' 310' ' ' ASP . 24.9 mmm180 -120.67 157.62 29.2 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.615 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.599 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 24.8 mmtm -72.5 154.02 41.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 0.0 110.634 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 249' ' ' GLY . 35.3 pt -117.46 148.86 19.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.118 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -106.48 130.17 54.32 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 0.628 HG12 HG23 ' A' ' 247' ' ' VAL . 81.7 mt -120.94 129.64 75.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.169 0.509 . . . . 0.0 112.231 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -128.99 153.24 47.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.545 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -63.54 144.43 57.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.73 0.3 . . . . 0.0 110.718 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.53 144.68 46.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.629 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -122.73 159.65 52.38 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.811 0.339 . . . . 0.0 111.501 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.76 -23.01 64.51 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.842 2.362 . . . . 0.0 112.68 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 41.05 97.26 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.969 0.414 . . . . 0.0 111.74 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 84.5 t60 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.034 179.875 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.43 -0.643 0 C3'-C2'-O2' 111.273 -0.699 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.918 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.921 0 C3'-C2'-O2' 111.307 -0.687 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.515 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.423 -1.084 0 C3'-C2'-O2' 111.3 -0.69 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.563 " H3'" " C5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.895 0 C4'-C3'-C2' 103.903 1.203 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.563 " C5'" " H3'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.782 0 C3'-C2'-O2' 110.927 -0.818 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.602 ' C4 ' ' CD2' ' A' ' 162' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.925 0 C3'-C2'-C1' 100.899 -0.668 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.744 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.984 0 C4'-C3'-C2' 103.614 0.914 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . 0.714 ' N3 ' " H2'" ' B' ' 8' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.998 0 C3'-C2'-O2' 111.203 -0.723 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.762 0.315 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -61.69 -32.35 72.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.792 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.9 m -57.38 -33.65 68.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.971 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.7 m -56.26 -33.49 65.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.721 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.447 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 80.9 tttt -64.46 138.74 58.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.423 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.542 ' CE ' HG11 ' A' ' 216' ' ' VAL . 89.8 mtp -127.27 157.87 38.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.283 0.563 . . . . 0.0 111.909 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.568 ' CE2' ' N9 ' ' B' ' 6' ' ' ' A' . 1.3 t80 -103.29 129.94 50.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.882 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 21.8 mm -114.07 129.34 70.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.357 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.544 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -128.58 163.09 22.14 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.821 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.527 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 76.4 38.37 33.62 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.888 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 75.7 mt -59.52 -25.45 64.5 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.596 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 38.7 t-20 72.52 41.02 0.6 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.973 0.416 . . . . 0.0 110.278 -178.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.58 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 23.5 m0 29.84 38.37 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.33 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 167' ' ' ASN . 58.4 t0 -156.54 28.43 0.33 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.798 0.332 . . . . 0.0 111.462 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.513 HG22 ' CD2' ' A' ' 175' ' ' LEU . 61.0 m -121.44 141.64 50.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 111.002 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.57 ' C ' HD12 ' A' ' 190' ' ' ILE . 15.8 p -117.35 163.09 16.87 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.635 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.779 ' N ' HD12 ' A' ' 190' ' ' ILE . 96.1 mt-10 -57.82 -33.24 68.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.515 ' O ' ' HG2' ' A' ' 176' ' ' ARG . 21.8 t70 -64.02 -41.34 97.47 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.974 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -63.54 -38.79 92.49 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.6 HD12 ' HE2' ' A' ' 179' ' ' PHE . 3.7 mm? -61.41 -40.32 93.96 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 173' ' ' ASP . 0.1 OUTLIER -61.77 -37.38 84.09 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.683 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.47 -37.39 87.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.022 0.439 . . . . 0.0 110.073 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.606 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 64.0 t80 -78.86 -64.72 1.12 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.44 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.6 ' HE2' HD12 ' A' ' 175' ' ' LEU . 78.0 m-85 -68.06 -20.76 64.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.385 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -50.79 -29.04 18.21 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.615 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.837 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -58.86 -41.23 86.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.2 0.524 . . . . 0.0 110.298 179.239 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.837 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 71.3 m-85 -71.04 -33.95 70.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.882 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -172.19 -172.91 38.49 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.881 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 33.9 p -72.72 -11.81 60.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.77 0.319 . . . . 0.0 110.875 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 185' ' ' VAL . 1.1 t 52.2 87.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -177.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.589 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 3.3 m -56.69 -43.47 80.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.696 -176.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -150.3 140.93 22.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.244 0.545 . . . . 0.0 112.311 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.554 HD23 ' CG1' ' A' ' 185' ' ' VAL . 0.2 OUTLIER -116.31 134.4 54.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.055 179.001 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 0.3 OUTLIER -131.81 123.6 27.92 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.382 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.779 HD12 ' N ' ' A' ' 172' ' ' GLU . 2.4 mt -125.07 128.09 72.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.396 176.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.832 ' HG2' " H1'" ' B' ' 7' ' ' ' U' . 3.1 mpp? -103.77 141.98 35.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.966 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 199' ' ' SER . 1.8 pttt -131.36 177.04 7.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.047 0.451 . . . . 0.0 111.56 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 74.3 m-20 -119.27 83.08 24.5 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.751 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.6 -26.3 54.44 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.269 1.979 . . . . 0.0 112.096 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.42 -67.4 0.63 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.295 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 56.1 p -70.71 -22.41 62.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.543 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 83.61 21.34 58.24 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.024 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.596 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 16.8 tpp85 -125.43 136.61 53.58 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 121.168 0.509 . . . . 0.0 111.934 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 192' ' ' LYS . 46.8 m -63.38 151.71 40.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.72 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.564 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 26.2 mmm180 -58.38 -32.2 68.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.943 0.401 . . . . 0.0 110.628 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.619 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 95.24 0.17 63.48 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.772 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 36.5 p90 -144.13 159.7 42.18 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.988 0.423 . . . . 0.0 111.067 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.461 ' HA2' ' HE1' ' A' ' 191' ' ' MET . . . -148.1 169.25 28.83 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.556 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.74 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 96.3 m-85 -110.07 129.19 55.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.092 0.472 . . . . 0.0 110.359 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.803 HD23 ' N ' ' A' ' 206' ' ' SER . 3.6 tt -108.78 132.7 53.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.404 -177.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.803 ' N ' HD23 ' A' ' 205' ' ' LEU . 33.1 t -122.22 131.61 54.02 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.305 178.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 205' ' ' LEU . 88.4 m-85 -118.23 136.92 53.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.057 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.589 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.4 tt0 -61.66 -35.14 77.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.053 0.454 . . . . 0.0 110.304 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -109.6 119.21 48.58 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.733 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.64 -26.6 73.36 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.413 2.075 . . . . 0.0 112.839 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.0 m -58.02 -36.44 72.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.567 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.447 ' O ' HG23 ' A' ' 216' ' ' VAL . 23.5 m -58.16 -34.07 69.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.964 0.411 . . . . 0.0 110.593 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.538 HG13 ' SD ' ' A' ' 161' ' ' MET . 78.0 t -61.0 -39.51 82.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.279 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.457 ' O ' HG22 ' A' ' 217' ' ' VAL . 21.6 t70 -56.0 -42.39 76.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.743 0.306 . . . . 0.0 111.178 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 182' ' ' TYR . 96.4 mt-10 -66.9 -33.61 75.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.071 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.775 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 92.7 t -59.13 -42.85 87.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.734 -178.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 214' ' ' ASP . 20.3 m -72.79 -32.52 40.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.31 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 214' ' ' ASP . 45.0 mmtt -60.57 -34.24 73.87 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.616 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 52.7 m -99.05 138.78 35.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.836 0.35 . . . . 0.0 111.534 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 57.8 tp60 -65.91 -41.64 91.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.078 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.775 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 64.2 m-70 83.04 115.0 0.06 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 178.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.901 HD12 HG12 ' A' ' 227' ' ' VAL . 21.5 mm -117.66 109.35 27.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 175.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.5 tt -122.39 130.48 53.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.061 0.458 . . . . 0.0 111.63 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 57.8 t0 52.84 33.61 14.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.682 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 83.14 5.68 88.84 Favored Glycine 0 CA--C 1.517 0.163 0 C-N-CA 120.588 -0.815 . . . . 0.0 114.665 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.437 ' NZ ' ' C6 ' ' B' ' 4' ' ' ' A' . 36.8 ttmt -133.32 131.96 40.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.816 0.808 . . . . 0.0 111.612 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.901 HG12 HD12 ' A' ' 222' ' ' ILE . 19.6 m -67.83 136.03 27.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.574 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 165' ' ' GLY . 35.6 pt -122.59 157.95 27.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.223 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.577 ' O ' ' O4 ' ' B' ' 5' ' ' ' U' . 1.1 m-20 -127.76 80.06 72.6 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.008 0.432 . . . . 0.0 111.92 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.539 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 47.7 Cg_exo -59.56 136.84 73.87 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 123.188 2.592 . . . . 0.0 111.542 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.65 ' HE2' ' H62' ' B' ' 6' ' ' ' A' . 7.2 ttpm? -138.46 154.54 48.85 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.715 -0.221 . . . . 0.0 110.721 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -57.57 136.97 56.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 0.0 111.319 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -72.36 146.47 47.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.605 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.771 HD12 ' HG2' ' A' ' 239' ' ' GLN . 1.2 pt -134.04 108.48 11.59 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.783 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 234' ' ' ILE . 1.6 Cg_endo -46.87 154.78 0.98 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.105 1.87 . . . . 0.0 110.884 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -51.47 -40.93 60.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.601 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 54.6 p30 -64.68 -38.74 92.01 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.215 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.601 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 96.8 mt-10 -70.48 -35.04 73.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.612 0.244 . . . . 0.0 111.181 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.771 ' HG2' HD12 ' A' ' 234' ' ' ILE . 26.6 mt-30 -59.21 -39.59 83.16 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.021 0.439 . . . . 0.0 110.0 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -62.71 -42.75 99.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.369 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -64.12 -39.65 94.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.542 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 238' ' ' GLU . 53.1 p -68.48 -38.22 80.82 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.879 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 61.54 142.41 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.016 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.543 ' HE2' ' CD2' ' A' ' 288' ' ' PHE . 6.8 tptm -131.66 131.04 42.84 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.952 HD12 HG21 ' A' ' 315' ' ' ILE . 8.4 pt -120.23 154.32 23.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.482 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.551 ' CZ ' ' N7 ' ' B' ' 2' ' ' ' A' . 88.3 t80 -100.91 132.24 46.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.838 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.826 HG21 ' CZ ' ' A' ' 263' ' ' PHE . 20.6 t -120.4 128.46 76.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.028 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -121.65 -7.34 8.16 Favored Glycine 0 C--N 1.329 0.163 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.441 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.544 ' O ' HG22 ' A' ' 313' ' ' ILE . . . -81.25 9.56 53.66 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.495 -0.86 . . . . 0.0 113.17 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.743 HD11 ' HA3' ' A' ' 287' ' ' GLY . 41.3 pt -111.7 133.68 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 116.968 0.384 . . . . 0.0 111.229 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 159.18 -49.43 0.4 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.693 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.96 -33.57 89.54 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.446 2.097 . . . . 0.0 112.72 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -162.68 64.03 0.2 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.077 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.526 HG21 ' HB ' ' A' ' 250' ' ' ILE . 27.6 m -131.36 156.22 42.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.529 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.68 156.43 79.51 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.449 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.57 -40.14 86.52 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 121.521 1.481 . . . . 0.0 111.562 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.24 -42.99 99.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.289 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' A' ' 262' ' ' PHE . 97.7 mt-10 -68.04 -41.07 82.62 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.95 0.405 . . . . 0.0 111.276 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.675 ' CE1' HD13 ' A' ' 250' ' ' ILE . 82.8 t80 -65.13 -47.84 75.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.12 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 264' ' ' SER . 84.4 tt0 -64.17 -42.03 96.89 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.094 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -76.39 -30.71 57.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.022 0.439 . . . . 0.0 111.085 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.694 ' CZ ' HG21 ' A' ' 306' ' ' ILE . 5.5 t80 -61.83 -64.82 0.81 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.019 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.995 ' CB ' HD11 ' A' ' 269' ' ' ILE . 32.8 m-85 -62.64 -27.51 69.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.064 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.455 ' OG ' ' HA ' ' A' ' 268' ' ' THR . 33.3 t -56.38 -28.53 59.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.087 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -53.13 -34.7 57.92 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.803 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 14.4 p90 -116.71 54.5 0.85 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.907 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.519 ' O ' HG22 ' A' ' 268' ' ' THR . . . 153.06 -12.77 0.61 Allowed Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.775 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.567 ' O ' ' O ' ' A' ' 269' ' ' ILE . 0.5 OUTLIER 66.95 -1.84 1.29 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.995 HD11 ' CB ' ' A' ' 263' ' ' PHE . 77.4 mt 33.54 115.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.622 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 75.7 mt -60.4 -42.06 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.06 176.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -166.16 97.47 0.61 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.927 ' HB2' HG21 ' A' ' 269' ' ' ILE . . . -104.82 142.72 34.22 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -140.07 150.59 44.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.444 0.64 . . . . 0.0 112.141 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.576 ' O ' ' HB2' ' A' ' 275' ' ' MET . 43.5 tp -66.49 -37.54 85.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.713 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.576 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 91.9 mmm 90.73 111.16 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.424 0.69 . . . . 0.0 111.147 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 276' ' ' LEU . 6.2 mp -118.46 124.11 46.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.704 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -62.41 -39.06 92.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.87 0.843 . . . . 0.0 109.045 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -161.09 -106.97 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.083 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -62.34 -37.2 84.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.014 0.435 . . . . 0.0 110.054 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 1.2 t 171.66 68.82 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.75 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -93.19 -75.35 1.3 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.094 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.785 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 96.0 mm-40 -57.54 -30.7 65.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.171 0.51 . . . . 0.0 110.034 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.485 ' HB2' ' CD2' ' A' ' 274' ' ' LEU . 76.5 p -64.18 163.2 13.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.465 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.425 ' O ' ' HG2' ' A' ' 284' ' ' ARG . 59.4 ttp180 69.69 6.26 5.63 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.252 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -130.92 -48.02 0.12 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.65 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 40.6 p90 -148.67 166.77 27.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.542 0.211 . . . . 0.0 111.029 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.743 ' HA3' HD11 ' A' ' 250' ' ' ILE . . . -136.72 157.06 23.5 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.263 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.543 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.9 OUTLIER -109.75 129.84 55.58 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.748 0.419 . . . . 0.0 110.552 179.47 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.508 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 48.5 t -126.16 134.22 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.801 ' O ' HG23 ' A' ' 269' ' ' ILE . 30.5 m -123.01 139.44 54.08 Favored 'General case' 0 C--O 1.23 0.063 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 242' ' ' THR . 51.0 m-85 -117.5 140.32 49.77 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.622 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 21.4 t70 -56.34 -34.86 67.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.599 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 51.1 m -119.86 142.74 48.39 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.948 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.47 -32.05 73.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.045 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -56.21 -36.5 68.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.467 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -60.06 -37.07 78.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.408 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.692 HG13 ' CG2' ' A' ' 245' ' ' ILE . 71.4 t -61.79 -44.13 98.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.037 0.446 . . . . 0.0 110.405 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -63.2 -37.48 87.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.1 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -58.38 -43.14 88.37 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.803 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 0.4 OUTLIER -73.45 -32.82 38.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.923 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 83.9 m -57.21 -44.39 83.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -60.43 -40.26 90.42 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.329 0.585 . . . . 0.0 109.812 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 305' ' ' PHE . 88.0 m-20 -60.41 -32.48 71.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.407 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.635 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 22.0 tptt 69.88 -68.2 0.21 Allowed 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.635 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.0 m-30 -115.5 149.72 37.66 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.445 178.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.694 HG21 ' CZ ' ' A' ' 262' ' ' PHE . 23.7 mm -117.23 140.18 41.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.742 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -80.28 39.74 0.46 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.961 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.62 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 6.2 t80 -48.24 -68.4 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.478 ' HD3' ' CZ ' ' A' ' 308' ' ' PHE . 16.9 mmmt -105.6 19.41 20.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.811 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 53.6 t0 69.25 9.69 7.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.732 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -109.88 2.02 19.57 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.037 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.423 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 22.6 mttm 62.2 121.55 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.017 0.437 . . . . 0.0 111.714 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 249' ' ' GLY . 31.6 pt -116.28 147.09 19.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.444 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . 0.564 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 84.7 mt-10 -103.93 132.19 50.43 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.847 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 0.952 HG21 HD12 ' A' ' 245' ' ' ILE . 63.2 mt -120.35 127.98 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.589 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -126.7 148.39 49.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.716 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -55.53 148.3 15.96 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.03 140.92 36.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.139 0.495 . . . . 0.0 111.394 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -117.39 111.03 40.3 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.63 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -49.99 102.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.906 1.737 . . . . 0.0 111.885 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -57.97 -38.1 75.42 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.15 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 85.1 t60 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.873 -179.759 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.676 0 C3'-C2'-O2' 111.178 -0.732 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.785 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.967 0 O4'-C1'-C2' 107.474 0.767 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.786 ' O2 ' " H3'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.023 0 C3'-C2'-O2' 111.36 -0.669 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.619 " O2'" ' HA3' ' A' ' 201' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.882 0 C4'-C3'-C2' 104.05 1.35 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.797 " O2'" ' P ' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.883 0 C3'-C2'-C1' 100.321 -1.31 OUTLIER-EPSILON 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.797 ' P ' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.957 0 C4'-C3'-C2' 103.464 0.764 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.832 " H1'" ' HG2' ' A' ' 191' ' ' MET . . . . . . . . 0 O5'--C5' 1.425 -0.92 0 C1'-C2'-O2' 108.509 -0.697 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . 0.481 ' N7 ' " H2'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.983 0 C3'-C2'-O2' 111.219 -0.718 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 65.2 mttp . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.636 0.255 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.603 ' HG3' ' H ' ' A' ' 159' ' ' CYS . 43.7 tp10 -101.55 138.54 38.41 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.786 0.327 . . . . 0.0 110.543 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 53.7 p -80.31 -2.52 45.64 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.198 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.603 ' H ' ' HG3' ' A' ' 157' ' ' GLU . 4.0 m -85.07 13.45 6.14 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.667 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 8.5 tptm -63.25 134.07 55.27 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.76 0.314 . . . . 0.0 110.342 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.785 ' SD ' HG13 ' A' ' 213' ' ' VAL . 89.8 mmm -123.4 147.28 47.26 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.62 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 3.4 t80 -109.56 126.05 53.17 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.823 HD13 ' CZ ' ' A' ' 179' ' ' PHE . 3.7 mt -121.96 130.16 74.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.112 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.509 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -125.05 156.04 18.84 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.038 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.85 33.34 57.81 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.707 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.607 ' O ' ' CB ' ' A' ' 167' ' ' ASN . 69.7 mt -58.68 -32.45 69.14 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.645 ' O ' ' N ' ' A' ' 169' ' ' ASP . 45.4 t30 110.49 31.22 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.283 0.633 . . . . 0.0 110.99 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.571 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 6.5 m0 53.04 -49.25 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.645 ' N ' ' O ' ' A' ' 167' ' ' ASN . 50.3 p30 -82.27 9.27 9.16 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 166' ' ' LEU . 85.7 m -68.99 137.81 54.02 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.203 0.525 . . . . 0.0 109.975 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 30.6 m -112.14 148.33 34.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.387 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.662 ' N ' HD12 ' A' ' 190' ' ' ILE . 55.6 mp0 -54.56 -37.51 65.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.555 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 89.5 m-20 -63.2 -40.12 96.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.946 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -61.6 -36.69 81.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.302 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.673 HD23 ' CE2' ' A' ' 179' ' ' PHE . 5.8 mt -55.34 -49.38 72.37 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.555 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -67.05 -31.94 72.8 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.482 179.073 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.43 -39.0 78.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.695 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.636 ' CE2' ' CE2' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -94.08 -55.62 3.14 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.113 179.288 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.823 ' CZ ' HD13 ' A' ' 163' ' ' ILE . 64.0 m-85 -60.72 -28.95 69.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.874 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.93 -23.28 10.86 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.169 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.82 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -54.52 -40.52 68.69 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.882 0.373 . . . . 0.0 111.14 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.82 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 55.5 m-85 -69.32 -31.67 70.29 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.243 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 166.97 -134.41 3.26 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.871 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 57.7 m -117.64 136.89 53.01 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.887 HG23 ' CE1' ' A' ' 207' ' ' PHE . 0.9 OUTLIER -95.0 127.79 46.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.613 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.746 HG23 ' N ' ' A' ' 208' ' ' GLU . 54.0 p -70.18 -35.94 74.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.397 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -148.86 145.24 27.39 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.879 HD22 HG11 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -116.45 129.06 56.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.749 178.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.565 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 7.3 tppt? -138.59 111.36 7.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 172' ' ' GLU . 82.3 mt -125.68 123.13 63.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 174.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.588 ' O ' ' O ' ' A' ' 192' ' ' LYS . 0.0 OUTLIER -59.9 -37.61 79.93 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.084 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.588 ' O ' ' O ' ' A' ' 191' ' ' MET . 26.7 tttt 49.18 149.68 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.268 0.556 . . . . 0.0 112.008 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 9.9 t0 -128.3 78.48 75.52 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.366 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.74 -24.17 61.96 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.408 2.072 . . . . 0.0 112.011 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -73.82 -72.0 0.29 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.572 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 48.4 p -69.03 -26.21 64.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.624 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.66 7.01 65.22 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.707 -0.759 . . . . 0.0 113.241 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 20.9 tpp180 -124.38 125.78 44.87 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-N 117.267 0.534 . . . . 0.0 111.181 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.1 t -70.27 156.99 38.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.63 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.663 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 83.8 mmt-85 -55.55 -31.75 62.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.705 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.442 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 95.78 0.49 62.28 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.675 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.663 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 42.6 p90 -142.47 154.41 44.51 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.418 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -150.45 170.66 30.36 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.666 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.848 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 89.5 m-85 -107.91 125.55 51.62 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.109 0.481 . . . . 0.0 109.963 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.669 HD11 HG21 ' A' ' 185' ' ' VAL . 16.8 tp -112.61 131.19 55.74 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.197 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.577 ' O ' HG22 ' A' ' 185' ' ' VAL . 49.1 m -120.1 140.39 51.12 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.723 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.887 ' CE1' HG23 ' A' ' 185' ' ' VAL . 78.4 m-85 -121.65 141.88 50.69 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.567 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.746 ' N ' HG23 ' A' ' 186' ' ' THR . 84.5 tt0 -64.45 -34.75 78.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.245 178.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -110.76 115.58 53.27 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.926 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.406 ' O ' ' HB ' ' A' ' 213' ' ' VAL . 52.5 Cg_exo -56.25 -25.78 57.83 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.582 2.188 . . . . 0.0 113.033 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.2 m -58.06 -37.42 74.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.0 110.555 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.887 ' O ' HG23 ' A' ' 216' ' ' VAL . 25.0 m -59.97 -34.76 73.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.244 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.785 HG13 ' SD ' ' A' ' 161' ' ' MET . 71.2 t -60.39 -41.0 85.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.214 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -57.4 -44.86 84.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.051 0.453 . . . . 0.0 110.487 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.58 -33.77 73.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.384 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 212' ' ' SER . 74.9 t -59.65 -40.59 82.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.692 -178.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 230' ' ' PRO . 21.3 m -88.87 -38.68 11.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -178.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -60.14 -34.73 73.95 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.495 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 32.2 m -93.37 146.28 23.86 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.438 ' NE2' ' CG2' ' A' ' 227' ' ' VAL . 54.0 tp60 -79.76 140.76 36.8 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.855 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 41.8 m-70 -125.85 139.41 53.51 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -176.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.593 HG22 ' H ' ' A' ' 225' ' ' GLY . 67.7 mt -125.52 114.61 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.347 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.434 ' HG ' ' CD2' ' A' ' 178' ' ' TYR . 1.0 OUTLIER -82.22 -50.83 8.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.04 0.448 . . . . 0.0 111.99 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -142.86 43.68 1.58 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.788 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.593 ' H ' HG22 ' A' ' 222' ' ' ILE . . . 96.17 -0.65 62.22 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.978 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.436 ' CG ' ' OD1' ' A' ' 167' ' ' ASN . 12.2 mmmm -99.36 169.49 9.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.663 0.268 . . . . 0.0 110.352 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.438 ' CG2' ' NE2' ' A' ' 220' ' ' GLN . 14.6 p -118.33 132.91 66.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.948 0.404 . . . . 0.0 110.125 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.642 HD12 ' CG2' ' A' ' 163' ' ' ILE . 35.9 pt -129.41 161.13 39.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.949 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -129.63 81.01 70.64 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.0 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.746 ' O ' HG12 ' A' ' 217' ' ' VAL . 78.1 Cg_exo -54.97 129.48 35.56 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.958 2.438 . . . . 0.0 112.782 -178.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.409 ' HE2' ' O4 ' ' B' ' 5' ' ' ' U' . 9.8 mtmm -132.86 154.58 50.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.423 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.604 ' HD3' ' N ' ' A' ' 233' ' ' ALA . 1.5 tmt_? -63.5 135.08 56.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.902 0.382 . . . . 0.0 110.759 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.667 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -63.91 145.77 55.24 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.286 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.505 ' CD1' ' C6 ' ' B' ' 6' ' ' ' A' . 0.8 OUTLIER -109.92 130.67 22.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.479 179.498 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.43 ' HG2' ' HB2' ' A' ' 238' ' ' GLU . 9.6 Cg_endo -53.45 138.84 65.87 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 121.772 1.648 . . . . 0.0 110.85 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -56.56 -40.39 75.08 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.16 -45.6 92.53 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.496 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.43 ' HB2' ' HG2' ' A' ' 235' ' ' PRO . 97.1 mt-10 -71.61 -37.32 70.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.599 0.714 . . . . 0.0 109.842 178.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.438 ' NE2' " O2'" ' B' ' 6' ' ' ' A' . 45.3 tt0 -59.5 -39.48 83.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.979 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -59.51 -39.28 83.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.037 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -60.35 -35.3 75.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.54 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.528 HG21 ' CD1' ' A' ' 270' ' ' ILE . 19.3 p -84.08 162.21 20.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.991 0.424 . . . . 0.0 111.65 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -154.27 118.54 0.87 Allowed Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.13 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 18.2 ttpp -88.49 135.93 33.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.732 0.301 . . . . 0.0 111.127 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.73 HG21 HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -119.51 164.6 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.358 0.599 . . . . 0.0 111.781 -179.012 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.54 ' CZ ' ' N7 ' ' B' ' 2' ' ' ' A' . 88.2 t80 -101.27 136.98 40.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.156 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.853 HG23 HG12 ' A' ' 315' ' ' ILE . 9.2 p -129.72 145.13 36.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.107 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.56 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -131.84 165.36 23.44 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 97.31 -2.69 61.25 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.986 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.79 HD11 ' HA3' ' A' ' 287' ' ' GLY . 43.7 pt -117.64 137.92 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-O 121.172 0.511 . . . . 0.0 111.604 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.868 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -174.18 -89.26 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.488 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.66 132.57 43.58 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.455 2.103 . . . . 0.0 112.984 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 51.17 40.17 25.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.818 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 251' ' ' GLY . 29.8 m -105.84 -35.49 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.049 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 254' ' ' VAL . 13.4 mmm180 57.39 132.63 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.76 -30.22 66.09 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.892 1.728 . . . . 0.0 112.35 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 260' ' ' GLU . 39.0 tttm -61.28 -44.14 97.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.604 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.681 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 98.0 mt-10 -67.0 -39.87 87.22 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.164 0.506 . . . . 0.0 110.599 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.78 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 15.7 t80 -62.55 -45.49 92.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.029 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 257' ' ' LYS . 20.3 pt-20 -69.23 -41.16 77.39 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.795 0.331 . . . . 0.0 111.021 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.412 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.7 pt-20 -74.26 -29.76 61.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.288 0.566 . . . . 0.0 110.157 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.571 ' CZ ' HD11 ' A' ' 313' ' ' ILE . 5.8 t80 -60.94 -57.28 13.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.884 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.701 ' CD2' HG21 ' A' ' 289' ' ' VAL . 3.7 m-85 -65.18 -23.44 67.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.355 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.653 ' N ' HD11 ' A' ' 269' ' ' ILE . 27.2 t -53.97 -30.14 45.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.616 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -53.39 -34.75 58.92 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.105 -0.238 . . . . 0.0 111.116 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.757 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 7.4 p90 -119.0 46.02 1.96 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.21 0.529 . . . . 0.0 111.74 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.486 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 156.31 152.92 6.41 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.916 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 43.0 p -70.28 -25.53 63.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.041 0.448 . . . . 0.0 110.748 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.653 HD11 ' N ' ' A' ' 264' ' ' SER . 76.9 mt 54.55 96.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.111 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.576 HG13 ' CA ' ' A' ' 292' ' ' ASP . 79.3 mt -59.18 -40.61 81.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.207 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 50.3 p30 -169.77 156.55 6.42 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.496 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -155.07 145.32 21.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.866 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -145.45 150.71 36.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.11 0.481 . . . . 0.0 111.852 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.59 ' O ' ' HB2' ' A' ' 275' ' ' MET . 24.7 tp -66.17 -39.75 89.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.229 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.922 ' O ' HD12 ' A' ' 276' ' ' LEU . 94.8 mmm 98.2 151.85 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.495 0.718 . . . . 0.0 109.659 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.922 HD12 ' O ' ' A' ' 275' ' ' MET . 0.3 OUTLIER -162.04 84.44 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.562 0.22 . . . . 0.0 111.427 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -85.89 110.84 19.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.912 0.386 . . . . 0.0 110.621 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.635 ' O ' HG22 ' A' ' 280' ' ' THR . 40.8 mttm 55.95 30.69 16.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.91 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 51.51 43.95 29.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.135 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.635 HG22 ' O ' ' A' ' 278' ' ' LYS . 1.6 t -165.83 -41.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.717 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -55.0 -37.49 62.9 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.475 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.571 ' HG2' ' HB2' ' A' ' 275' ' ' MET . 3.4 tp-100 -109.41 132.51 54.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.747 0.308 . . . . 0.0 111.494 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 282' ' ' GLN . 27.5 p 148.89 -18.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.059 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 51.1 ttt85 -56.46 -37.97 71.03 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.226 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 250' ' ' ILE . . . 144.59 43.08 0.05 OUTLIER Glycine 0 CA--C 1.522 0.503 0 C-N-CA 119.984 -1.103 . . . . 0.0 114.147 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.521 ' CE1' " H4'" ' B' ' 2' ' ' ' A' . 15.5 p90 -140.28 167.47 22.06 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 117.483 0.641 . . . . 0.0 110.409 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.79 ' HA3' HD11 ' A' ' 250' ' ' ILE . . . -147.51 169.28 28.43 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.579 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.445 ' CE2' ' NZ ' ' A' ' 244' ' ' LYS . 0.3 OUTLIER -122.42 124.16 42.99 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 122.346 0.258 . . . . 0.0 111.053 179.429 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.78 HG23 ' CZ ' ' A' ' 259' ' ' PHE . 61.2 t -127.67 138.07 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.033 0.445 . . . . 0.0 112.142 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 44.4 m -116.04 137.09 52.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.241 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.486 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 41.7 m-85 -115.1 135.19 54.47 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.576 ' CA ' HG13 ' A' ' 270' ' ' ILE . 55.1 t0 -59.01 -35.37 73.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.652 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 30.5 t -118.35 139.31 51.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.207 0.527 . . . . 0.0 111.61 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.914 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -64.08 -31.89 73.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.02 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -57.06 -35.61 69.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.299 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.2 -37.33 77.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.705 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.914 HG12 ' O ' ' A' ' 294' ' ' ALA . 6.2 p -58.73 -38.21 70.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.005 0.431 . . . . 0.0 110.662 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -63.3 -37.43 87.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.181 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 302' ' ' GLN . 92.8 mtt-85 -58.23 -41.13 83.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.893 -178.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.757 ' HB ' ' NE1' ' A' ' 266' ' ' TRP . 2.3 p -65.12 -33.68 65.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.066 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 74.5 m -56.92 -39.75 75.06 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . 0.409 ' HB3' ' O ' ' A' ' 299' ' ' ARG . 50.6 tp60 -62.77 -35.5 80.03 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.924 177.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.756 ' ND2' HD12 ' A' ' 306' ' ' ILE . 22.9 p30 -101.2 42.76 1.1 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.008 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.638 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 18.7 tptm -16.08 -65.07 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.915 0.388 . . . . 0.0 110.432 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.638 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 4.1 m-30 -110.22 142.36 41.89 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.756 HD12 ' ND2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -117.01 130.23 72.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.732 179.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -73.18 71.55 1.18 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.535 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 2.9 t80 -62.47 -105.6 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.344 -177.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.46 ' HD2' ' CE1' ' A' ' 308' ' ' PHE . 12.6 mmmm -61.83 -37.17 83.46 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.054 0.454 . . . . 0.0 111.316 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 309' ' ' LYS . 60.3 t0 175.8 -25.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.791 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -111.8 159.43 18.31 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.199 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.628 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 42.4 mttp -72.99 140.48 47.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.333 0.587 . . . . 0.0 111.905 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 305' ' ' PHE . 36.3 pt -119.0 152.79 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.615 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -107.54 131.48 54.29 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.617 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 0.853 HG12 HG23 ' A' ' 247' ' ' VAL . 74.1 mt -119.85 129.71 75.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.38 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 22.9 tttm -133.08 144.37 49.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.5 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -54.1 144.99 18.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.721 0.296 . . . . 0.0 110.314 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.67 140.14 55.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 111.073 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -87.46 143.3 33.94 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.932 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.64 -19.86 47.57 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.472 2.114 . . . . 0.0 111.763 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.506 ' HD3' ' C5 ' ' B' ' 3' ' ' ' U' . 1.9 ttt-85 41.63 92.98 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.687 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 54.5 p-80 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.909 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.754 0 C3'-C2'-O2' 111.243 -0.709 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.54 ' N7 ' ' CZ ' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.989 0 C3'-C2'-O2' 111.382 -0.661 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.559 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.423 -1.036 0 C3'-C2'-O2' 111.227 -0.715 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.584 " H3'" " C5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.909 0 C4'-C3'-C2' 103.782 1.082 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.902 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.857 0 C3'-C2'-O2' 110.962 -0.806 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.902 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.005 0 C3'-C2'-O2' 111.122 -0.751 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.848 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.987 0 C4'-C3'-C2' 103.694 0.994 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . 0.622 ' N3 ' " H2'" ' B' ' 8' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.954 0 C3'-C2'-O2' 111.257 -0.704 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 97.0 mttt . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.822 0.344 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 60.1 mp0 -61.48 -33.87 74.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.575 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.7 p 28.89 94.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.651 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 51.7 t -124.85 92.63 3.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.214 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.864 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 6.5 tptt -135.07 142.73 46.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.584 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.794 ' SD ' HG13 ' A' ' 213' ' ' VAL . 87.0 mmm -122.21 147.01 46.72 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.619 ' CE2' ' N9 ' ' B' ' 6' ' ' ' A' . 1.6 t80 -108.81 125.6 52.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.036 177.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 202' ' ' PHE . 20.9 mm -118.04 129.71 74.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.613 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -127.06 162.73 21.12 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.007 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.67 36.12 38.58 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.745 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.543 HD22 HG21 ' A' ' 170' ' ' THR . 70.7 mt -59.61 -24.55 63.91 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.563 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 42.2 t-20 72.48 43.78 0.45 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.136 0.494 . . . . 0.0 110.505 -178.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.572 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 21.1 m0 31.39 39.38 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.429 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -160.54 46.57 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.353 . . . . 0.0 111.304 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.543 HG21 HD22 ' A' ' 166' ' ' LEU . 90.4 m -123.96 139.92 53.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.019 0.438 . . . . 0.0 110.899 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 33.5 p -119.93 160.07 23.44 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.393 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.535 ' N ' HD12 ' A' ' 190' ' ' ILE . 55.8 mp0 -61.98 -30.54 71.0 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.844 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 88.8 m-20 -61.03 -42.89 99.33 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.907 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -65.93 -38.54 88.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.121 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.979 HD22 HD21 ' A' ' 205' ' ' LEU . 10.6 mt -61.87 -42.47 99.09 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.844 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -65.78 -38.82 90.06 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.893 179.329 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.45 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 84.5 tt0 -70.89 -45.01 65.09 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.134 0.492 . . . . 0.0 110.457 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.984 ' OH ' ' HB2' ' A' ' 221' ' ' HIS . 19.0 t80 -63.17 -45.14 93.2 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.28 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.606 ' CE2' HD23 ' A' ' 175' ' ' LEU . 96.0 m-85 -98.04 2.02 48.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.34 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -58.51 -28.1 61.89 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.358 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.566 ' H ' ' CD ' ' A' ' 181' ' ' LYS . 0.6 OUTLIER -56.72 -42.73 79.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.959 0.885 . . . . 0.0 110.328 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -70.99 -35.19 72.0 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 113.781 -1.554 . . . . 0.0 112.75 -177.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 177.55 -174.37 46.87 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 119.679 -1.248 . . . . 0.0 113.741 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.8 m -63.82 -28.55 69.93 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.042 -0.579 . . . . 0.0 111.241 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.642 ' CG1' ' O ' ' A' ' 185' ' ' VAL . 0.4 OUTLIER 64.3 87.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -176.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -54.77 -46.15 74.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.033 -176.661 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 186' ' ' THR . 90.8 m-20 -139.25 152.36 47.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.226 0.536 . . . . 0.0 112.012 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.701 HD11 ' CB ' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -125.55 129.08 49.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.505 179.452 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.491 ' HE2' ' C2 ' ' B' ' 7' ' ' ' U' . 22.8 tptt -132.33 119.26 20.5 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.488 0.661 . . . . 0.0 112.643 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.535 HD12 ' N ' ' A' ' 172' ' ' GLU . 1.9 mt -128.83 131.95 67.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.662 177.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.622 ' SD ' ' CE2' ' A' ' 202' ' ' PHE . 0.8 OUTLIER -88.77 127.32 35.6 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -133.24 162.74 30.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.979 0.418 . . . . 0.0 111.593 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.578 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 32.3 m-20 -124.81 84.37 58.33 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.348 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.34 -25.42 39.06 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.241 1.961 . . . . 0.0 112.362 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.88 -71.29 0.36 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.9 0.381 . . . . 0.0 111.313 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.4 p -71.8 -21.56 61.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.178 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 80.36 26.76 54.02 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.32 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.578 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 15.8 ttp180 -119.78 149.95 41.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.26 0.552 . . . . 0.0 112.372 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.8 t -108.71 148.41 30.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.593 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.626 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 59.8 mmt-85 -53.35 -29.92 36.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.758 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.59 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 97.56 2.16 58.81 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.137 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.626 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 25.6 p90 -142.96 155.35 44.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.937 0.398 . . . . 0.0 110.819 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.507 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -142.94 161.73 27.52 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.768 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.672 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 89.7 m-85 -111.65 130.55 55.73 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.827 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.979 HD21 HD22 ' A' ' 175' ' ' LEU . 44.8 mt -109.35 141.67 41.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.974 0.416 . . . . 0.0 111.667 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 33.1 t -127.15 131.15 50.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.346 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.583 ' CE1' HG23 ' A' ' 185' ' ' VAL . 99.1 m-85 -119.15 140.58 49.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.814 0.34 . . . . 0.0 111.562 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.501 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.3 tt0 -60.87 -34.63 74.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.089 0.471 . . . . 0.0 110.089 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.1 114.08 51.44 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.395 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.74 -26.83 58.58 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.389 2.059 . . . . 0.0 113.005 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.2 m -58.61 -36.17 73.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.775 0.321 . . . . 0.0 111.153 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.422 ' O ' HG23 ' A' ' 216' ' ' VAL . 21.9 m -58.63 -35.04 71.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.049 0.452 . . . . 0.0 110.66 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.794 HG13 ' SD ' ' A' ' 161' ' ' MET . 54.6 t -60.94 -38.67 79.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.784 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -54.2 -42.82 70.16 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.347 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -69.69 -34.34 73.8 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.71 HG12 ' HB2' ' A' ' 230' ' ' PRO . 98.3 t -60.64 -44.77 97.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.967 0.413 . . . . 0.0 111.346 -178.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.597 HG22 ' HE1' ' A' ' 161' ' ' MET . 41.9 t -76.77 -51.68 18.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 7.8 tptm -61.17 -40.5 94.14 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 220' ' ' GLN . 88.7 m -59.0 -38.27 78.81 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 219' ' ' THR . 63.7 tt0 60.69 111.7 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -177.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.984 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 0.0 OUTLIER -139.92 167.12 22.84 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -176.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.814 HG23 ' C ' ' A' ' 226' ' ' LYS . 3.6 mp -118.0 126.05 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.207 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.757 HD12 ' CG ' ' A' ' 178' ' ' TYR . 7.5 tt -119.0 132.21 56.05 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.157 0.503 . . . . 0.0 111.744 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.516 ' HB2' HD23 ' A' ' 223' ' ' LEU . 19.5 t70 63.81 28.82 14.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.093 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 94.11 -14.3 65.58 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.542 -0.837 . . . . 0.0 115.037 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.814 ' C ' HG23 ' A' ' 222' ' ' ILE . 66.6 mttt -113.49 137.54 51.41 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 117.953 0.877 . . . . 0.0 112.338 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.809 HG12 HG12 ' A' ' 222' ' ' ILE . 33.7 m -64.77 128.27 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.282 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.613 HG22 ' O ' ' A' ' 164' ' ' GLY . 37.6 pt -124.28 155.1 31.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.045 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.1 76.69 78.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.295 0.569 . . . . 0.0 110.619 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.71 ' HB2' HG12 ' A' ' 216' ' ' VAL . 80.2 Cg_exo -53.0 128.67 29.86 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.12 2.547 . . . . 0.0 111.537 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -139.03 148.3 43.22 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.317 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.692 ' HE ' HG11 ' A' ' 213' ' ' VAL . 15.2 mmt85 -48.97 138.76 11.14 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.12 0.485 . . . . 0.0 111.523 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.864 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -75.72 146.07 40.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.98 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.515 ' CG1' ' C6 ' ' B' ' 6' ' ' ' A' . 0.0 OUTLIER -112.84 129.1 24.8 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.417 179.286 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.04 149.15 21.8 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 121.915 1.744 . . . . 0.0 110.911 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 52.6 mmm-85 -54.62 -40.44 68.93 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.671 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -64.57 -40.32 95.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.596 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -65.51 -36.39 83.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.6 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -60.14 -37.59 80.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.991 0.424 . . . . 0.0 110.521 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -60.07 -38.62 83.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.129 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -59.68 -35.58 74.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.665 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.454 HG22 ' HA ' ' A' ' 292' ' ' ASP . 20.7 p -87.13 161.86 17.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.005 0.431 . . . . 0.0 111.666 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -142.87 113.91 0.82 Allowed Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.722 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 33.0 ttpt -85.33 140.75 30.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.96 0.409 . . . . 0.0 111.599 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 1.059 HD12 HG21 ' A' ' 315' ' ' ILE . 10.1 pt -118.36 160.52 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.488 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.544 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 84.6 t80 -99.63 132.46 44.96 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 287' ' ' GLY . 14.0 p -128.55 145.34 35.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.639 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.41 166.11 19.32 Favored Glycine 0 C--O 1.226 -0.378 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.92 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 78.41 30.81 48.33 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.262 -0.971 . . . . 0.0 111.799 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.698 HD11 HG13 ' A' ' 247' ' ' VAL . 34.7 mm -55.27 -46.61 78.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 81.47 126.41 0.81 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.024 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -56.49 -29.56 78.71 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.604 2.202 . . . . 0.0 113.332 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -91.64 10.66 27.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.391 . . . . 0.0 111.388 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.67 ' HB ' ' O ' ' A' ' 250' ' ' ILE . 13.0 p -56.24 -40.9 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.524 ' N ' HG13 ' A' ' 254' ' ' VAL . 11.2 tpp85 63.59 116.08 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -176.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -50.29 -30.4 26.23 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 121.994 1.796 . . . . 0.0 112.561 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -60.51 -42.13 95.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.315 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 77.5 mm-40 -68.24 -39.66 82.21 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.049 0.452 . . . . 0.0 111.556 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.561 ' CZ ' HG22 ' A' ' 289' ' ' VAL . 40.6 t80 -62.63 -47.01 85.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.782 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.19 -42.43 93.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.694 0.283 . . . . 0.0 111.556 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -78.18 -31.16 49.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.806 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.506 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 15.1 t80 -60.66 -57.1 14.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.153 0.501 . . . . 0.0 111.698 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.708 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 16.9 m-85 -66.38 -23.8 66.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.715 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.703 ' N ' HD11 ' A' ' 269' ' ' ILE . 25.2 t -56.64 -30.51 63.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.527 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -53.55 -36.62 62.04 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.855 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 9.2 p90 -116.82 42.76 2.41 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.119 0.485 . . . . 0.0 111.51 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.546 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 156.97 148.42 5.09 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.824 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.437 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 50.1 m -59.85 -36.92 77.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.729 0.3 . . . . 0.0 111.72 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.703 HD11 ' N ' ' A' ' 264' ' ' SER . 69.9 mt 69.86 77.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.394 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.522 HG12 ' CA ' ' A' ' 292' ' ' ASP . 35.4 mm -59.84 -40.97 84.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.806 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -154.28 86.71 1.16 Allowed 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.586 ' HB2' HG23 ' A' ' 269' ' ' ILE . . . -101.85 131.26 48.29 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -143.66 152.57 41.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.504 0.668 . . . . 0.0 112.712 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 1.023 HD23 HD11 ' A' ' 276' ' ' LEU . 21.1 tp -68.43 -31.57 70.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.783 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.718 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 10.3 mmm 92.86 -86.61 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.001 0.92 . . . . 0.0 112.721 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 1.023 HD11 HD23 ' A' ' 274' ' ' LEU . 5.9 mp 62.27 145.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.227 0.537 . . . . 0.0 111.268 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.432 ' HA ' ' OP1' ' B' ' 4' ' ' ' A' . 51.6 p30 -113.08 -132.24 0.33 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.388 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -55.99 -32.45 63.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.51 ' OD1' HG23 ' A' ' 280' ' ' THR . 61.1 t0 -149.81 -108.0 0.07 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.736 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.51 HG23 ' OD1' ' A' ' 279' ' ' ASP . 64.4 p -108.4 20.08 19.04 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -52.44 -39.3 52.3 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 119.645 -1.264 . . . . 0.0 111.975 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.574 ' HB3' ' HA ' ' A' ' 276' ' ' LEU . 13.1 tm0? -64.98 -32.83 74.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.039 0.447 . . . . 0.0 111.424 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 48.0 p -57.2 -10.08 1.14 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.777 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -50.4 -36.95 35.16 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 121.406 -0.118 . . . . 0.0 110.908 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 151.57 26.72 0.05 OUTLIER Glycine 0 CA--C 1.524 0.601 0 C-N-CA 119.423 -1.37 . . . . 0.0 115.567 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.571 ' HA ' ' HA2' ' A' ' 248' ' ' GLY . 13.4 p90 -138.78 157.01 46.87 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.722 1.261 . . . . 0.0 111.184 178.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.742 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -148.26 166.02 29.02 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.777 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -113.52 130.03 56.43 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.629 ' HB ' HG12 ' A' ' 245' ' ' ILE . 40.8 t -125.57 133.34 69.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.849 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 52.2 m -114.79 135.38 54.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.546 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 24.5 m-85 -120.02 139.34 52.65 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.522 ' CA ' HG12 ' A' ' 270' ' ' ILE . 53.0 t0 -58.82 -36.93 75.31 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.763 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 99.8 p -123.12 147.73 46.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.406 0.622 . . . . 0.0 111.715 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.43 -30.55 70.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.439 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -55.56 -40.36 71.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.332 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.648 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -65.18 -37.58 87.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.792 0.329 . . . . 0.0 110.413 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.815 HG13 HG22 ' A' ' 245' ' ' ILE . 69.4 t -62.08 -49.07 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 CA-C-O 121.179 0.514 . . . . 0.0 109.738 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -66.68 -35.5 80.29 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.874 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.584 ' HD3' ' HB2' ' A' ' 266' ' ' TRP . 62.3 ttt-85 -56.19 -45.77 79.68 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.083 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.855 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 2.1 p -71.84 -35.35 54.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.964 0.411 . . . . 0.0 111.214 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 74.0 m -59.07 -40.74 86.12 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.701 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -57.57 -34.66 69.44 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.312 0.577 . . . . 0.0 109.843 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.596 ' O ' ' N ' ' A' ' 305' ' ' PHE . 81.6 m-20 -83.85 4.77 27.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.686 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.706 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 30.7 tptt 44.04 -82.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.323 0.249 . . . . 0.0 110.575 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.719 ' HB3' ' HB3' ' A' ' 312' ' ' LYS . 3.1 m-30 -105.31 135.92 45.8 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.12 0.486 . . . . 0.0 110.269 178.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.694 ' CD1' HG23 ' A' ' 300' ' ' VAL . 0.9 OUTLIER -115.01 134.92 56.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.661 178.653 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -69.36 130.36 42.35 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.807 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.573 ' HE2' HG23 ' A' ' 254' ' ' VAL . 17.7 t80 -150.25 -72.56 0.17 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.89 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.46 ' HE3' ' CE2' ' A' ' 308' ' ' PHE . 4.0 mmpt? -91.96 -176.53 4.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.261 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -50.14 -30.57 11.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.911 0.386 . . . . 0.0 110.384 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -117.56 152.74 34.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.903 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.719 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 62.6 mttp -62.18 148.77 43.52 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.115 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.639 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 28.4 pt -107.81 138.63 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . 0.603 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 81.9 mt-10 -104.55 132.89 50.28 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 1.059 HG21 HD12 ' A' ' 245' ' ' ILE . 82.6 mt -119.31 128.55 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 121.394 0.616 . . . . 0.0 111.744 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -131.25 146.07 52.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.838 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -49.79 145.46 5.31 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.844 -0.343 . . . . 0.0 110.234 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.45 142.5 43.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.138 0.494 . . . . 0.0 111.463 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -126.83 82.18 67.99 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.477 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.416 ' HA ' ' O4 ' ' B' ' 3' ' ' ' U' . 77.8 Cg_exo -50.57 143.27 28.69 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.231 1.954 . . . . 0.0 111.969 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.434 ' NH2' H5'' ' B' ' 3' ' ' ' U' . 20.5 mmt85 -56.74 -34.98 68.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.824 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.839 179.974 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.739 0 C3'-C2'-O2' 111.167 -0.736 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.544 ' C5 ' ' CE1' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.962 0 C1'-C2'-O2' 108.463 -0.712 . 0.51 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.496 " C3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.998 0 C4'-C3'-C2' 103.614 0.914 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.59 " O2'" ' HA3' ' A' ' 201' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.883 0 C4'-C3'-C2' 103.923 1.223 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.56 " H1'" ' CE2' ' A' ' 162' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.89 0 O4'-C1'-N19 109.123 0.923 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.63 ' N1 ' ' HA ' ' A' ' 233' ' ' ALA . . . . . . . . 0 O5'--C5' 1.423 -1.067 0 C3'-C2'-O2' 111.311 -0.686 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.672 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -1.03 0 C3'-C2'-O2' 111.226 -0.715 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.96 0 C3'-C2'-O2' 111.236 -0.712 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 48.3 tttp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.766 0.317 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 158' ' ' SER . 75.8 mm-40 -111.12 154.6 24.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 157' ' ' GLU . 3.9 m 90.39 93.47 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.003 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.676 ' SG ' HG21 ' A' ' 213' ' ' VAL . 0.0 OUTLIER -135.74 109.01 7.78 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.115 0.483 . . . . 0.0 110.039 179.16 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.792 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 6.7 tptm -117.92 135.65 53.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.639 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.925 ' SD ' HG13 ' A' ' 213' ' ' VAL . 89.0 mmm -117.72 145.19 44.62 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.628 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 3.3 t80 -110.43 130.79 55.48 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.477 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.785 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 19.9 mm -116.87 127.68 74.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.578 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.678 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -128.81 161.52 22.42 Favored Glycine 0 CA--C 1.505 -0.562 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.518 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.45 ' HA2' " C5'" ' B' ' 4' ' ' ' A' . . . 77.59 27.69 58.7 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.96 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.969 HD23 HG21 ' A' ' 228' ' ' ILE . 72.9 mt -86.45 140.44 29.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.636 0.255 . . . . 0.0 111.176 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.486 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 18.2 t30 -63.63 135.42 56.75 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.576 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 4.1 m-90 -53.6 143.21 20.61 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.176 -0.609 . . . . 0.0 109.906 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 168' ' ' TRP . 53.7 t0 74.21 36.53 0.66 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.742 -177.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.596 HG21 HD13 ' A' ' 166' ' ' LEU . 90.0 m -59.98 -34.67 73.62 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.17 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.508 ' C ' HD12 ' A' ' 190' ' ' ILE . 0.0 OUTLIER 59.66 127.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -178.519 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.765 ' N ' HD12 ' A' ' 190' ' ' ILE . 55.1 mp0 -58.15 -31.62 67.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.361 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.598 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.9 m-20 -55.46 -41.22 72.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.761 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 170' ' ' THR . 85.7 m-20 -64.83 -37.63 88.26 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.871 HD22 HD21 ' A' ' 205' ' ' LEU . 4.8 mt -60.51 -45.41 93.91 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.598 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -67.68 -34.84 77.71 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.363 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.29 -37.96 89.28 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.028 0.442 . . . . 0.0 109.851 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.43 ' OH ' ' HB3' ' A' ' 221' ' ' HIS . 67.3 t80 -80.58 -61.47 1.96 Allowed 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.437 0.637 . . . . 0.0 110.936 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.604 ' CE2' HD23 ' A' ' 175' ' ' LEU . 72.2 m-85 -66.04 -25.68 67.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.776 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.25 -26.11 12.82 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.241 -0.98 . . . . 0.0 110.738 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.524 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 0.1 OUTLIER -54.29 -46.05 72.67 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.511 0.724 . . . . 0.0 111.02 179.007 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -70.31 -35.33 73.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.701 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 171.36 -169.89 42.86 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.19 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 48.1 m -84.0 138.48 33.08 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 206' ' ' SER . 7.1 p -102.34 124.37 56.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.793 HG23 ' N ' ' A' ' 208' ' ' GLU . 69.4 p -69.63 -40.6 76.46 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.792 0.33 . . . . 0.0 111.136 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.501 ' OD1' ' O ' ' A' ' 186' ' ' THR . 86.3 m-20 -149.11 161.99 40.87 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.342 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' A' ' 175' ' ' LEU . 0.0 OUTLIER -138.4 144.23 40.13 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.207 -178.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 11.2 tptt -140.5 121.57 14.69 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 178.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.765 HD12 ' N ' ' A' ' 172' ' ' GLU . 11.4 mt -124.56 130.82 73.39 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.796 176.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.619 ' HB2' ' HB2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -86.2 109.12 18.69 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -121.4 148.11 44.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.733 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 198' ' ' ARG . 10.7 t0 -123.76 77.46 56.83 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -56.73 -23.25 48.71 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.678 2.252 . . . . 0.0 112.758 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.66 -74.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.53 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.1 p -69.75 -26.05 64.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.03 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.87 -2.97 67.04 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.389 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.541 ' HD2' ' CE2' ' A' ' 168' ' ' TRP . 9.8 tpp85 -129.41 137.0 50.66 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.73 -167.22 1.94 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.391 0.615 . . . . 0.0 112.48 -178.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.947 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 66.8 mmt-85 -53.52 -38.49 63.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.474 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.474 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 81.2 18.05 70.28 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.955 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.947 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 32.2 p90 -139.52 159.81 41.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.669 0.271 . . . . 0.0 110.534 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.571 ' HA2' ' HE2' ' A' ' 191' ' ' MET . . . -142.51 160.07 27.28 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.948 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.69 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 97.5 m-85 -108.37 129.05 55.26 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.871 HD21 HD22 ' A' ' 175' ' ' LEU . 65.7 mt -108.31 142.05 39.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.939 0.399 . . . . 0.0 111.969 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.7 ' O ' HG23 ' A' ' 185' ' ' VAL . 33.8 t -125.01 128.2 48.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.314 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -117.02 138.93 51.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.95 0.405 . . . . 0.0 111.975 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.793 ' N ' HG23 ' A' ' 186' ' ' THR . 84.4 tt0 -62.81 -34.52 77.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.727 178.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.92 117.48 53.72 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.509 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.04 -21.13 33.14 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.639 2.226 . . . . 0.0 113.296 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.7 m -57.31 -39.02 74.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.617 0.246 . . . . 0.0 111.553 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.931 ' O ' HG23 ' A' ' 216' ' ' VAL . 21.2 m -60.82 -37.53 82.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.818 0.342 . . . . 0.0 110.696 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.925 HG13 ' SD ' ' A' ' 161' ' ' MET . 62.0 t -61.51 -43.81 97.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.376 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -61.47 -41.43 97.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.931 0.396 . . . . 0.0 111.045 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.462 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 21.7 pt-20 -76.76 -29.44 56.11 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 212' ' ' SER . 79.5 t -61.85 -43.89 98.03 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-O 121.027 0.442 . . . . 0.0 110.639 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 50.1 t -71.87 -45.53 64.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -60.15 -38.76 84.12 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.475 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 35.5 m -81.72 144.28 31.24 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -80.21 138.67 36.88 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.836 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 41.0 m-70 -122.34 132.16 54.25 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -176.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.86 HD12 HG12 ' A' ' 227' ' ' VAL . 29.1 mm -122.24 110.56 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.492 HD23 ' CG ' ' A' ' 224' ' ' ASP . 7.7 tt -122.4 126.72 48.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.926 0.393 . . . . 0.0 111.061 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.492 ' CG ' HD23 ' A' ' 223' ' ' LEU . 84.9 m-20 55.4 41.81 30.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.226 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 74.32 14.03 81.06 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.707 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.444 ' NZ ' ' N6 ' ' B' ' 4' ' ' ' A' . 35.8 mmtp -125.73 152.63 45.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.981 0.39 . . . . 0.0 111.721 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.86 HG12 HD12 ' A' ' 222' ' ' ILE . 27.5 m -99.89 130.64 48.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.312 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.969 HG21 HD23 ' A' ' 166' ' ' LEU . 33.6 pt -126.04 158.44 35.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.396 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.57 80.48 71.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.159 0.504 . . . . 0.0 110.786 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.558 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 61.8 Cg_exo -56.66 127.97 28.1 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 123.07 2.513 . . . . 0.0 112.096 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.4 ' HE2' ' O4 ' ' B' ' 5' ' ' ' U' . 8.8 mtmm -133.13 156.06 48.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.008 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -60.14 137.18 58.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.769 0.318 . . . . 0.0 110.98 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.792 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -64.34 144.52 57.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.269 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.619 HD11 ' N6 ' ' B' ' 6' ' ' ' A' . 0.1 OUTLIER -122.41 137.03 27.1 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.645 179.304 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.5 ' HD2' ' OE1' ' A' ' 238' ' ' GLU . 34.8 Cg_exo -56.26 145.05 79.43 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 121.923 1.749 . . . . 0.0 110.727 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.411 ' C ' ' HD3' ' A' ' 236' ' ' ARG . 4.2 tmt_? -55.38 -40.97 71.99 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.931 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -61.72 -41.76 98.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.436 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.5 ' OE1' ' HD2' ' A' ' 235' ' ' PRO . 94.4 mt-10 -66.14 -35.25 79.99 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.906 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -59.98 -37.0 78.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.07 0.462 . . . . 0.0 110.259 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -59.79 -38.17 81.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.975 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -58.66 -37.98 77.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.193 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 19.2 p -84.8 161.98 19.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.114 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.04 161.74 24.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.809 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.482 ' HD2' ' CE2' ' A' ' 288' ' ' PHE . 7.6 ttpm? -138.7 131.99 30.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.812 0.306 . . . . 0.0 111.182 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.675 ' CG2' HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -120.9 162.52 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 121.409 0.623 . . . . 0.0 112.23 -178.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.539 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 85.1 t80 -104.19 138.22 40.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.746 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.704 HG23 HG12 ' A' ' 315' ' ' ILE . 9.2 p -131.99 147.61 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.546 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -125.99 165.18 19.28 Favored Glycine 0 C--O 1.226 -0.389 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 178.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 85.59 14.66 67.56 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.586 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.666 ' CG2' HG11 ' A' ' 254' ' ' VAL . 35.8 mm -54.95 -45.7 76.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 1.015 ' O ' HG12 ' A' ' 254' ' ' VAL . . . 59.44 129.77 0.01 OUTLIER Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.961 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.93 -27.11 52.23 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.326 2.017 . . . . 0.0 113.137 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -59.25 -33.97 71.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.919 0.39 . . . . 0.0 111.427 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 1.015 HG12 ' O ' ' A' ' 251' ' ' GLY . 7.1 p -50.5 -39.55 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.443 ' N ' HG13 ' A' ' 254' ' ' VAL . 7.7 tpt180 68.11 126.65 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.445 ' HB3' ' HG ' ' A' ' 274' ' ' LEU . 8.9 Cg_endo -51.08 -26.62 19.56 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 121.904 1.736 . . . . 0.0 112.827 -177.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -62.01 -45.5 93.34 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 78.2 mm-40 -66.38 -38.41 87.48 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.701 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 40.6 t80 -60.88 -45.56 94.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.166 -178.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.49 -43.4 97.37 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.594 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -78.12 -28.52 48.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.013 0.435 . . . . 0.0 111.012 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.599 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 4.3 t80 -59.12 -58.61 7.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.918 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.702 ' CG ' HG21 ' A' ' 289' ' ' VAL . 5.8 m-85 -63.51 -23.63 67.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.218 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.685 ' N ' HD11 ' A' ' 269' ' ' ILE . 23.1 t -55.13 -29.82 58.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.842 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -52.35 -35.47 51.17 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.361 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.68 ' CZ2' ' CD2' ' A' ' 263' ' ' PHE . 9.0 p90 -116.13 41.72 2.53 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.215 0.531 . . . . 0.0 111.526 179.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.509 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 159.39 157.12 8.38 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.81 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 4.5 t -73.45 -25.19 60.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.339 . . . . 0.0 111.011 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.685 HD11 ' N ' ' A' ' 264' ' ' SER . 75.1 mt 58.11 124.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.768 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.562 HD11 ' HB2' ' A' ' 292' ' ' ASP . 25.3 mm -93.2 -74.45 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.14 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -92.09 -72.54 0.59 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.793 0.33 . . . . 0.0 111.738 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 289' ' ' VAL . . . 46.56 101.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.353 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . 0.509 ' HG3' ' HG2' ' A' ' 275' ' ' MET . 14.1 pt20 -143.17 158.22 43.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.115 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.607 ' HB3' ' CD ' ' A' ' 282' ' ' GLN . 42.6 mt -63.78 -33.98 76.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.181 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.698 ' O ' ' HB3' ' A' ' 282' ' ' GLN . 8.0 mtm 68.11 71.13 0.32 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.634 0.254 . . . . 0.0 110.96 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.542 HD23 ' HG2' ' A' ' 282' ' ' GLN . 9.7 mt -76.4 126.64 31.36 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.129 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -58.93 -38.17 78.37 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.888 0.852 . . . . 0.0 108.726 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -157.34 -101.05 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 113.993 -1.458 . . . . 0.0 108.026 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.782 ' O ' HG23 ' A' ' 280' ' ' THR . 89.5 m-20 -62.77 -39.08 93.06 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.574 178.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.5 OUTLIER 170.77 50.07 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.005 -179.729 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -56.16 -38.38 76.79 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.092 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.698 ' HB3' ' O ' ' A' ' 275' ' ' MET . 4.8 pp0? -61.81 -30.07 70.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.197 0.522 . . . . 0.0 111.632 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 52.2 p -54.55 -14.18 1.21 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.626 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -51.33 -36.64 43.7 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 121.332 -0.147 . . . . 0.0 110.775 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 157.37 23.75 0.03 OUTLIER Glycine 0 CA--C 1.526 0.721 0 C-N-CA 119.596 -1.288 . . . . 0.0 115.379 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.517 ' CE1' " H4'" ' B' ' 2' ' ' ' A' . 2.0 p90 -138.43 163.17 32.59 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 118.672 1.236 . . . . 0.0 111.073 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.691 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -142.17 159.83 27.11 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.525 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.496 ' CD2' ' SD ' ' A' ' 275' ' ' MET . 0.1 OUTLIER -122.41 124.17 43.02 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.702 HG21 ' CG ' ' A' ' 263' ' ' PHE . 52.4 t -125.89 136.19 61.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.083 0.468 . . . . 0.0 111.501 178.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 55.7 m -116.44 136.24 53.16 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.509 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 42.8 m-85 -114.1 136.92 52.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.355 0.598 . . . . 0.0 112.398 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.562 ' HB2' HD11 ' A' ' 270' ' ' ILE . 51.7 t0 -57.09 -36.11 70.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.638 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 50.4 m -121.97 145.2 48.35 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.337 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.912 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -65.77 -28.99 69.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.531 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -54.68 -35.62 63.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.872 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -59.45 -39.26 83.03 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.912 HG12 ' O ' ' A' ' 294' ' ' ALA . 7.3 p -60.0 -37.51 72.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.974 0.416 . . . . 0.0 111.331 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -61.98 -39.31 91.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.846 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -61.08 -43.83 98.29 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.649 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 0.9 OUTLIER -69.38 -34.1 60.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.32 -179.322 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 89.5 m -57.77 -45.28 86.18 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.062 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -62.23 -39.72 93.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.213 0.53 . . . . 0.0 109.883 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.6 m-20 -62.38 -33.64 75.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.123 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.638 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 22.6 tptm 68.47 -69.06 0.16 Allowed 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -177.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.638 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.4 m-30 -116.28 151.11 36.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.121 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.625 HD11 HG23 ' A' ' 300' ' ' VAL . 8.4 mm -116.53 136.35 53.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.502 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -79.93 65.12 4.98 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.599 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 3.9 t80 -65.86 -63.44 1.09 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.461 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 5.5 mmpt? -105.91 38.79 1.92 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.376 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 61.47 34.24 18.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -175.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -151.01 163.96 37.52 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 113.167 -1.833 . . . . 0.0 107.351 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 68.5 mttt -97.15 136.26 37.92 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.514 0.673 . . . . 0.0 112.711 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 305' ' ' PHE . 36.3 pt -117.62 150.95 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . 0.535 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 87.7 mt-10 -106.06 133.35 50.91 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.86 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 0.704 HG12 HG23 ' A' ' 247' ' ' VAL . 74.3 mt -122.59 129.32 75.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.227 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.522 ' O ' ' HB3' ' A' ' 246' ' ' PHE . 8.8 tptt -133.94 141.22 47.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.717 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -53.69 150.56 7.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.669 0.271 . . . . 0.0 110.332 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -49.69 142.86 7.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.948 0.404 . . . . 0.0 111.232 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -96.61 149.82 36.26 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.718 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 321' ' ' ARG . 36.7 Cg_exo -59.66 -18.77 49.69 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.952 2.435 . . . . 0.0 112.439 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 320' ' ' PRO . 51.0 mmm-85 70.27 -61.03 0.47 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.964 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.884 179.857 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.758 0 C3'-C2'-O2' 111.285 -0.695 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.539 ' C5 ' ' CE1' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.869 0 C3'-C2'-O2' 111.231 -0.714 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.585 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.423 -1.047 0 C1'-C2'-O2' 108.294 -0.769 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.585 " H4'" " H3'" ' B' ' 3' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.9 0 C4'-C3'-C2' 103.861 1.161 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.954 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.791 0 C4'-C3'-C2' 103.758 1.058 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.954 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.999 0 C3'-C2'-O2' 111.247 -0.708 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.69 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.996 0 C1'-C2'-O2' 108.524 -0.692 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . 0.513 ' P ' " O2'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.01 0 C3'-C2'-O2' 111.308 -0.687 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.928 0.394 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -62.05 -31.27 71.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.058 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 86.6 p -60.13 -26.49 66.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.39 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 43.5 t -133.66 95.76 3.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.755 0.312 . . . . 0.0 111.246 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -138.94 137.41 36.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.099 0.475 . . . . 0.0 111.198 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.827 ' SD ' HG13 ' A' ' 213' ' ' VAL . 94.6 mmm -113.56 148.07 36.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.26 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.626 ' CE2' ' N9 ' ' B' ' 6' ' ' ' A' . 2.9 t80 -104.06 127.79 51.64 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 203' ' ' GLY . 20.3 mm -116.71 129.1 73.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.734 0.302 . . . . 0.0 111.364 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.561 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -133.33 163.27 24.36 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 178.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.84 36.63 52.37 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.981 -1.104 . . . . 0.0 112.024 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 64.3 mt -59.36 -26.73 65.33 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.66 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 52.2 t30 69.67 40.38 1.38 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -177.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.63 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 15.4 m0 30.9 38.5 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 114.636 -1.166 . . . . 0.0 112.76 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -164.34 13.56 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.789 HG22 ' HB2' ' A' ' 175' ' ' LEU . 63.1 m -60.74 -38.17 84.24 Favored 'General case' 0 C--O 1.226 -0.138 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.569 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.1 OUTLIER 51.92 135.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.178 0.514 . . . . 0.0 111.591 -179.432 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.574 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 97.8 mt-10 -61.15 -33.77 73.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.028 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.43 ' O ' ' HG3' ' A' ' 177' ' ' GLU . 91.5 m-20 -59.37 -44.49 92.71 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.629 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 170' ' ' THR . 81.9 m-20 -77.16 -42.23 38.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.376 0.608 . . . . 0.0 110.735 178.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.789 ' HB2' HG22 ' A' ' 170' ' ' THR . 41.1 tp -66.63 -48.75 68.46 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.419 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.505 ' HG3' HG11 ' A' ' 185' ' ' VAL . 68.0 ttp85 -63.13 -44.42 95.63 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.806 0.336 . . . . 0.0 111.015 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 173' ' ' ASP . 98.3 mt-10 -67.03 -37.29 83.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.476 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.663 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 69.5 t80 -61.16 -48.21 82.64 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.1 0.476 . . . . 0.0 110.864 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -82.76 -12.06 57.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.885 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.17 -29.85 53.33 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 177.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.499 ' C ' ' CD ' ' A' ' 181' ' ' LYS . 0.3 OUTLIER -56.48 -45.27 81.01 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.307 -0.947 . . . . 0.0 110.764 178.761 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -70.64 -33.66 71.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.331 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -173.38 -179.7 44.22 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.26 -0.971 . . . . 0.0 113.166 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 46.6 m -63.07 -31.09 72.15 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.833 HG23 ' CE1' ' A' ' 207' ' ' PHE . 1.2 t 63.95 85.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -177.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -59.22 -50.98 71.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.019 -178.005 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 206' ' ' SER . 60.7 t0 -147.49 105.87 3.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.171 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.99 HD13 ' O ' ' A' ' 188' ' ' LEU . 0.0 OUTLIER -97.93 144.44 27.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.903 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.869 ' N ' HD22 ' A' ' 188' ' ' LEU . 30.7 tptt -127.26 128.68 46.41 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.627 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.574 ' HB ' ' HG2' ' A' ' 172' ' ' GLU . 1.5 tt -117.82 -10.35 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.845 -0.162 . . . . 0.0 111.428 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.84 ' HE3' ' O ' ' A' ' 202' ' ' PHE . 17.0 mtm 51.44 150.18 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.987 0.422 . . . . 0.0 111.543 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.4 ' HG3' ' HD3' ' A' ' 194' ' ' PRO . 7.5 ptmt -134.5 163.66 29.21 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.095 0.474 . . . . 0.0 112.223 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.642 ' CB ' ' O ' ' A' ' 198' ' ' ARG . 1.3 t70 -124.23 76.55 60.64 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.619 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.4 ' HD3' ' HG3' ' A' ' 192' ' ' LYS . 38.8 Cg_exo -58.03 -25.46 70.66 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.711 2.274 . . . . 0.0 112.98 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -68.94 -66.66 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.32 . . . . 0.0 111.588 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.0 p -71.98 -20.31 61.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.772 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 88.07 12.88 65.1 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.369 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.642 ' O ' ' CB ' ' A' ' 193' ' ' ASP . 55.5 mtt180 -118.47 167.75 11.3 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-O 121.094 0.473 . . . . 0.0 112.253 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.9 t -69.71 152.19 44.95 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.254 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.897 ' HG3' ' CE1' ' A' ' 202' ' ' PHE . 15.2 tpt180 -52.68 -32.02 40.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.977 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.481 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 98.1 -4.11 60.57 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.485 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.897 ' CE1' ' HG3' ' A' ' 200' ' ' ARG . 12.1 p90 -151.41 159.45 44.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.721 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -152.71 150.43 22.22 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.274 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.717 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 94.8 m-85 -106.78 125.63 51.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.081 0.44 . . . . 0.0 109.82 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 161' ' ' MET . 46.6 mt -103.1 138.92 39.3 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.911 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 23.2 t -123.17 132.77 54.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.119 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.833 ' CE1' HG23 ' A' ' 185' ' ' VAL . 96.9 m-85 -117.89 140.55 49.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 111.695 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.424 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.2 tt0 -60.66 -34.12 73.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.198 0.523 . . . . 0.0 109.673 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.2 115.17 50.36 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.609 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.62 -21.76 32.81 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.665 2.244 . . . . 0.0 113.22 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.5 m -56.86 -35.7 69.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.726 0.298 . . . . 0.0 111.307 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.923 ' O ' HG23 ' A' ' 216' ' ' VAL . 32.3 m -58.49 -36.96 74.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.851 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.827 HG13 ' SD ' ' A' ' 161' ' ' MET . 63.0 t -60.83 -42.02 90.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.179 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.423 ' O ' HG12 ' A' ' 217' ' ' VAL . 94.6 m-20 -59.29 -40.64 86.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.877 0.37 . . . . 0.0 111.177 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.401 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 12.9 pt-20 -80.81 -27.38 36.59 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 212' ' ' SER . 53.1 t -62.07 -45.77 97.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 CA-C-O 120.773 0.32 . . . . 0.0 111.693 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 214' ' ' ASP . 8.3 p -60.01 -36.55 68.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -60.96 -35.87 77.89 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.753 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 29.6 m -80.66 143.27 33.19 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 93.1 mt-30 -65.97 -36.83 84.37 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.863 ' HB3' HD11 ' A' ' 228' ' ' ILE . 82.4 m-70 78.4 44.33 0.07 Allowed 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 75.4 mt -75.38 82.2 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.2 tt -82.52 -75.47 0.31 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -176.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 49.2 p30 -94.67 13.22 25.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.582 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 95.17 7.4 59.56 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.052 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.12 137.0 52.59 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.6 p -69.73 126.17 29.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.277 0.56 . . . . 0.0 111.773 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.863 HD11 ' HB3' ' A' ' 221' ' ' HIS . 34.5 pt -124.84 157.52 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.329 178.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.446 ' O ' ' O4 ' ' B' ' 5' ' ' ' U' . 0.3 OUTLIER -127.8 77.21 76.6 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.202 0.525 . . . . 0.0 112.4 -179.096 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.637 ' HG2' ' CD2' ' A' ' 221' ' ' HIS . 35.0 Cg_exo -63.55 84.98 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 123.087 2.524 . . . . 0.0 111.653 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -100.73 157.13 16.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.825 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.507 ' HD3' HG11 ' A' ' 213' ' ' VAL . 37.7 tpt85 -60.27 137.04 58.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.935 0.397 . . . . 0.0 111.574 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.521 ' HA ' ' N1 ' ' B' ' 6' ' ' ' A' . . . -59.91 145.79 44.58 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.06 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.555 HG13 ' N6 ' ' B' ' 6' ' ' ' A' . 9.7 mt -109.51 124.36 34.05 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.282 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.69 143.44 57.87 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 121.802 1.668 . . . . 0.0 110.753 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 32.5 mmm180 -57.53 -39.27 76.2 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.695 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 55.2 p30 -63.88 -41.69 97.67 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.978 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.613 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 97.5 mt-10 -73.43 -37.92 65.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.558 0.694 . . . . 0.0 109.703 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.563 ' NE2' " O2'" ' B' ' 6' ' ' ' A' . 61.1 tt0 -60.41 -39.98 89.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.314 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -59.52 -40.24 86.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.211 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -61.13 -35.05 76.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.148 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 292' ' ' ASP . 16.3 p -82.87 161.39 21.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.392 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -149.03 173.02 29.05 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.193 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.56 ' O ' ' HB2' ' A' ' 318' ' ' ALA . 6.9 tptm -135.01 131.7 37.41 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.476 -0.194 . . . . 0.0 110.476 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.728 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -121.48 162.24 20.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.348 0.594 . . . . 0.0 111.011 179.486 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -104.6 136.56 43.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.35 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.75 HG11 ' CE1' ' A' ' 259' ' ' PHE . 14.7 p -131.49 147.87 32.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.422 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -129.11 166.59 21.46 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.404 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 84.2 22.79 53.8 Favored Glycine 0 C--N 1.328 0.107 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.476 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.534 HG23 HG21 ' A' ' 254' ' ' VAL . 43.0 mm -54.97 -48.99 74.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.725 ' O ' HG22 ' A' ' 254' ' ' VAL . . . 57.88 129.64 0.01 OUTLIER Glycine 0 CA--C 1.525 0.679 0 C-N-CA 119.807 -1.187 . . . . 0.0 111.436 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . 0.5 ' HD3' ' HG3' ' A' ' 284' ' ' ARG . 52.0 Cg_exo -54.04 -24.92 34.49 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.165 1.91 . . . . 0.0 112.907 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -57.84 -36.49 72.37 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 251' ' ' GLY . 16.2 m -65.98 -36.76 78.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 62.35 153.32 0.11 Allowed Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -56.54 -31.12 85.39 Favored 'Trans proline' 0 CA--C 1.527 0.154 0 C-N-CA 122.39 2.06 . . . . 0.0 113.478 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -64.12 -49.0 73.9 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.562 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 97.8 mt-10 -66.22 -35.57 80.78 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.938 0.399 . . . . 0.0 112.029 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.75 ' CE1' HG11 ' A' ' 247' ' ' VAL . 35.5 t80 -59.62 -45.34 92.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.471 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.4 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.5 tt0 -64.73 -40.58 95.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.455 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 258' ' ' GLU . 20.5 pt-20 -75.79 -33.5 60.16 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.7 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.714 ' CE2' HD11 ' A' ' 313' ' ' ILE . 83.8 t80 -58.9 -56.78 17.84 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.652 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 18.6 m-85 -65.83 -24.61 66.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.326 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.713 ' N ' HD11 ' A' ' 269' ' ' ILE . 24.9 t -56.21 -31.14 63.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.55 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -53.99 -36.15 62.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.526 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.708 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 6.9 p90 -119.18 50.58 1.21 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.49 0.662 . . . . 0.0 111.213 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.566 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 148.86 145.85 4.21 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.634 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.444 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 41.1 m -59.74 -38.1 80.77 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.713 HD11 ' N ' ' A' ' 264' ' ' SER . 76.9 mt 70.72 84.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.533 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.619 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 66.5 mt -59.69 -38.72 77.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.836 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -131.99 -84.89 0.49 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 289' ' ' VAL . . . 61.68 113.08 0.02 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.705 0.288 . . . . 0.0 110.867 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -139.29 155.23 47.88 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.362 0.601 . . . . 0.0 112.07 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.557 HD21 ' CB ' ' A' ' 283' ' ' SER . 35.5 tp -65.05 -35.19 80.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.251 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.549 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 95.7 mmm 76.66 12.81 2.41 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.577 ' O ' HD23 ' A' ' 276' ' ' LEU . 0.9 OUTLIER -56.64 119.09 5.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.215 0.531 . . . . 0.0 111.334 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 279' ' ' ASP . 58.3 t0 -88.79 119.0 28.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.852 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 62.9 -75.31 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.273 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.428 ' OD1' HG23 ' A' ' 280' ' ' THR . 51.6 t0 -142.53 98.75 3.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.781 0.324 . . . . 0.0 111.648 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.428 HG23 ' OD1' ' A' ' 279' ' ' ASP . 2.8 p 44.62 50.54 8.38 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -84.48 -74.7 1.23 Allowed Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.028 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.94 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 92.4 mm-40 -60.94 -32.02 71.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.243 0.544 . . . . 0.0 109.814 179.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.559 ' O ' ' HB3' ' A' ' 284' ' ' ARG . 54.1 p -63.17 168.27 4.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.45 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.559 ' HB3' ' O ' ' A' ' 283' ' ' SER . 39.1 ttt85 81.03 -41.39 0.16 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.826 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -94.94 -52.16 1.82 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.225 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.513 ' CZ ' " O4'" ' B' ' 2' ' ' ' A' . 29.0 p90 -143.45 167.7 21.57 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.193 0.521 . . . . 0.0 112.209 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.744 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -137.13 158.39 24.28 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.141 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.516 ' CD2' ' HE2' ' A' ' 244' ' ' LYS . 0.7 OUTLIER -115.34 127.44 55.42 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.734 -0.274 . . . . 0.0 111.207 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.728 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 21.8 t -124.2 136.38 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.799 0.333 . . . . 0.0 111.69 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 33.6 m -115.68 136.22 53.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.659 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.566 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 31.5 m-85 -118.33 139.21 51.69 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.619 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 55.8 p30 -62.56 -32.22 73.15 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.663 179.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.573 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 99.0 p -122.23 145.81 47.86 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.27 0.557 . . . . 0.0 111.556 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.98 -33.63 75.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.169 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -57.31 -37.39 72.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.361 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.59 82.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.914 0.387 . . . . 0.0 110.915 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.511 ' O ' HG12 ' A' ' 300' ' ' VAL . 83.3 t -62.23 -42.42 95.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.981 0.42 . . . . 0.0 110.96 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -60.94 -36.62 79.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.356 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -56.98 -43.31 81.56 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.708 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 1.3 p -69.15 -34.55 63.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.656 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 80.8 m -58.01 -45.92 86.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.473 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -62.68 -39.54 94.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.252 0.549 . . . . 0.0 110.258 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -63.36 -31.99 73.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.955 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.686 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 38.4 tptt 67.81 -75.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.686 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.9 m-30 -111.16 135.57 51.49 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.702 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.683 HD11 HG23 ' A' ' 300' ' ' VAL . 1.0 OUTLIER -118.55 137.41 52.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.192 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -79.08 112.64 16.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.965 0.412 . . . . 0.0 110.287 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.583 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 1.3 t80 -91.99 -89.22 0.19 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.809 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.503 ' HD3' ' CE1' ' A' ' 308' ' ' PHE . 0.0 OUTLIER -92.41 -74.86 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.939 0.399 . . . . 0.0 110.981 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -131.78 -15.79 3.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.259 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -122.02 157.36 31.53 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.518 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 312' ' ' LYS . 11.9 mptt -79.04 143.34 35.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.935 0.398 . . . . 0.0 111.093 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.714 HD11 ' CE2' ' A' ' 262' ' ' PHE . 29.9 pt -115.3 147.81 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . 0.561 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 84.1 mt-10 -104.78 133.3 49.83 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.651 -0.42 . . . . 0.0 109.982 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 0.69 HG12 HG23 ' A' ' 247' ' ' VAL . 73.5 mt -122.55 127.95 75.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.069 0.461 . . . . 0.0 111.253 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -126.01 155.05 42.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.725 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 70.0 ttp85 -58.87 146.12 38.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.718 0.294 . . . . 0.0 110.378 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 244' ' ' LYS . . . -55.71 145.26 24.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.076 0.465 . . . . 0.0 111.442 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -124.24 86.19 54.67 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.549 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.447 ' HA ' ' O4 ' ' B' ' 3' ' ' ' U' . 72.8 Cg_exo -49.37 142.02 23.52 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.353 2.035 . . . . 0.0 112.261 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -57.86 -35.29 70.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.19 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 77.6 m80 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.842 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.698 0 C3'-C2'-O2' 111.247 -0.708 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.94 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.946 0 C3'-C2'-O2' 111.284 -0.695 . 0.211 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.465 " H2'" ' OP2' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.027 0 C3'-C2'-O2' 111.254 -0.705 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.66 ' N7 ' ' HA ' ' A' ' 167' ' ' ASN . . . . . . . . 0 O5'--C5' 1.425 -0.927 0 C4'-C3'-C2' 103.786 1.086 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.561 ' C6 ' ' HA3' ' A' ' 164' ' ' GLY . . . . . . . . 0 O5'--C5' 1.425 -0.932 0 N19-C1'-C2' 114.789 0.868 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.626 ' N9 ' ' CE2' ' A' ' 162' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.968 0 C4'-C3'-C2' 103.737 1.037 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.717 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.954 0 C4'-C3'-C2' 103.421 0.721 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . 0.457 ' P ' " O2'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.922 0 C3'-C2'-O2' 111.326 -0.681 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.7 tttt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.794 0.33 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -103.46 138.89 39.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.652 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 87.9 p -127.75 154.62 45.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.945 0.403 . . . . 0.0 111.222 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 45.8 t -175.12 61.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.457 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.764 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 62.9 tttt -129.66 141.36 50.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.574 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.853 ' SD ' HG13 ' A' ' 213' ' ' VAL . 95.1 mmm -118.08 146.38 44.15 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.635 ' CE2' ' C8 ' ' B' ' 6' ' ' ' A' . 6.7 t80 -106.09 127.55 53.26 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.939 HG23 HD12 ' A' ' 228' ' ' ILE . 11.1 mm -115.37 117.45 55.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.249 -179.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 202' ' ' PHE . . . -91.54 178.86 41.53 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.813 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.887 ' O ' HG22 ' A' ' 228' ' ' ILE . . . 26.69 80.11 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 114.387 0.515 . . . . 0.0 114.387 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.449 ' O ' ' HB ' ' A' ' 170' ' ' THR . 58.8 mt -85.76 2.13 46.81 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.881 ' O ' ' N ' ' A' ' 169' ' ' ASP . 41.7 t-20 61.04 41.39 13.96 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.573 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 16.9 m0 34.49 -55.97 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.053 0.941 . . . . 0.0 113.522 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.881 ' N ' ' O ' ' A' ' 167' ' ' ASN . 93.1 m-20 -53.21 -34.84 58.74 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 166' ' ' LEU . 55.8 m -62.95 139.43 58.75 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.189 0.518 . . . . 0.0 111.206 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 10.5 p -116.12 167.43 11.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.324 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.84 ' N ' HD12 ' A' ' 190' ' ' ILE . 21.2 pt-20 -59.85 -27.08 66.35 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 89.6 m-20 -62.07 -43.01 99.76 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.044 0.449 . . . . 0.0 110.3 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -67.05 -36.66 82.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.766 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.527 HD23 ' CE2' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -53.63 -49.82 67.04 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -179.025 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 180' ' ' GLY . 0.0 OUTLIER -65.29 -33.45 76.01 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.623 178.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -62.02 -41.36 97.99 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.255 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.444 ' OH ' ' HB3' ' A' ' 221' ' ' HIS . 64.0 t80 -75.74 -60.0 2.51 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.628 0.727 . . . . 0.0 111.003 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.527 ' CE2' HD23 ' A' ' 175' ' ' LEU . 80.8 m-85 -69.0 -21.1 64.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.652 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -51.95 -25.53 16.82 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.687 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.821 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -55.7 -40.72 72.78 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.0 0.428 . . . . 0.0 110.795 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.821 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 64.6 m-85 -69.96 -32.49 70.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.43 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 167.08 -133.11 2.8 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.831 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.4 m -119.93 139.06 53.02 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.77 HG21 ' HB3' ' A' ' 188' ' ' LEU . 0.8 OUTLIER -91.22 117.63 34.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.2 t -66.7 -43.77 83.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.138 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -156.28 98.34 1.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.77 ' HB3' HG21 ' A' ' 185' ' ' VAL . 0.0 OUTLIER -94.34 142.1 27.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.499 178.587 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.627 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 49.1 tptt -130.92 128.0 39.62 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.84 HD12 ' N ' ' A' ' 172' ' ' GLU . 1.4 mt -122.54 129.53 75.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.623 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.58 ' HG2' " H1'" ' B' ' 7' ' ' ' U' . 2.6 mpp? -92.6 135.08 34.39 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.404 ' HG3' ' HD3' ' A' ' 194' ' ' PRO . 26.2 pttm -131.91 168.67 17.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.163 0.506 . . . . 0.0 112.168 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 0.6 OUTLIER -125.43 85.24 58.84 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.742 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.404 ' HD3' ' HG3' ' A' ' 192' ' ' LYS . 11.9 Cg_endo -55.77 -24.57 47.28 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.305 2.003 . . . . 0.0 112.313 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -73.37 -70.66 0.35 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.372 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 55.0 p -71.49 -21.08 61.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.019 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 84.18 19.57 60.58 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.376 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.558 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 79.7 mtt180 -120.43 163.59 17.67 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.6 m -111.95 154.5 25.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.104 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.713 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 14.3 mmp_? -51.35 -29.43 15.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.476 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.537 ' HA3' " C2'" ' B' ' 4' ' ' ' A' . . . 98.08 -1.84 59.47 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.706 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.713 ' CE1' ' HB3' ' A' ' 200' ' ' ARG . 36.4 p90 -140.86 158.64 43.66 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.326 -0.437 . . . . 0.0 110.448 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.52 ' HA2' ' HE1' ' A' ' 191' ' ' MET . . . -142.92 161.99 27.49 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.674 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 94.8 m-85 -104.68 122.16 45.08 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.706 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 63.1 tp -109.75 126.34 53.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.813 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.594 ' O ' HG23 ' A' ' 185' ' ' VAL . 29.4 t -118.31 139.05 51.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.973 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.711 ' CE2' HG21 ' A' ' 216' ' ' VAL . 82.1 m-85 -119.4 146.51 45.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.95 0.405 . . . . 0.0 111.497 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.55 -36.12 82.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.616 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -111.07 121.81 39.62 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.363 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -56.33 -27.17 65.85 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.491 2.127 . . . . 0.0 112.923 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.0 t -58.35 -36.34 73.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.768 0.318 . . . . 0.0 110.713 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.87 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.8 m -58.83 -35.21 72.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.28 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.853 HG13 ' SD ' ' A' ' 161' ' ' MET . 82.3 t -61.47 -40.89 87.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.887 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -58.21 -43.57 87.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.783 0.325 . . . . 0.0 110.769 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.27 -34.83 75.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.132 0.492 . . . . 0.0 111.197 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.9 ' O ' ' NE2' ' A' ' 221' ' ' HIS . 79.9 t -60.85 -43.02 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.785 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.713 HG21 ' NH2' ' A' ' 232' ' ' ARG . 25.1 m -86.52 -31.84 6.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -59.64 -35.26 74.06 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.472 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 74.4 m -100.59 147.01 26.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -78.96 139.24 38.28 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.9 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 44.0 m-70 -120.63 129.26 53.64 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -176.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 68.6 mt -122.44 115.4 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 7.1 tt -117.94 127.25 53.66 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.758 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 58.9 t0 52.87 36.34 21.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.959 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.06 13.86 82.9 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.731 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -126.48 156.39 40.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.994 0.397 . . . . 0.0 111.626 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.599 HG12 ' OD2' ' A' ' 229' ' ' ASP . 44.0 t -99.94 129.61 50.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.801 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.939 HD12 HG23 ' A' ' 163' ' ' ILE . 29.0 pt -109.3 -30.95 2.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.599 ' OD2' HG12 ' A' ' 227' ' ' VAL . 9.9 m-20 48.09 76.66 0.53 Allowed Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 121.246 0.546 . . . . 0.0 110.855 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.487 ' HD3' HG13 ' A' ' 228' ' ' ILE . 34.9 Cg_exo -59.8 135.58 64.58 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 123.234 2.622 . . . . 0.0 112.117 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.591 ' HE2' ' H62' ' B' ' 6' ' ' ' A' . 5.5 ttpt -136.73 142.08 43.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.184 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.713 ' NH2' HG21 ' A' ' 217' ' ' VAL . 6.1 mpt_? -51.78 142.02 15.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.974 0.416 . . . . 0.0 111.355 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.764 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -68.96 143.13 54.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.21 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.553 HD12 ' HG2' ' A' ' 239' ' ' GLN . 0.1 OUTLIER -119.17 128.33 26.0 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.668 179.233 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.9 149.79 25.11 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.061 1.841 . . . . 0.0 110.858 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -53.25 -41.96 65.99 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.772 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -63.2 -40.79 98.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.971 0.415 . . . . 0.0 110.459 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -66.05 -36.94 84.58 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.649 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.553 ' HG2' HD12 ' A' ' 234' ' ' ILE . 95.2 mt-30 -60.47 -37.95 82.64 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.861 0.362 . . . . 0.0 110.568 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -60.23 -40.05 88.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.975 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -60.57 -35.12 75.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.289 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.425 HG22 HD11 ' A' ' 270' ' ' ILE . 18.3 p -83.22 162.44 21.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.521 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -155.98 108.02 0.35 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.21 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.614 ' O ' ' HB2' ' A' ' 318' ' ' ALA . 7.3 ttpm? -81.34 136.18 35.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.656 0.265 . . . . 0.0 110.935 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.67 HD13 ' O ' ' A' ' 245' ' ' ILE . 0.0 OUTLIER -119.39 162.87 17.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.498 0.666 . . . . 0.0 111.832 -179.139 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.515 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 91.2 t80 -101.72 137.07 40.52 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.066 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.854 HG11 ' CE1' ' A' ' 259' ' ' PHE . 11.7 p -131.11 145.45 35.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.934 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.648 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -130.5 164.67 22.93 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 98.1 -1.61 59.33 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.129 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.94 HD11 ' HA3' ' A' ' 287' ' ' GLY . 41.1 pt -116.62 139.49 43.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 117.192 0.496 . . . . 0.0 110.636 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.433 ' N ' HG11 ' A' ' 254' ' ' VAL . . . 177.77 -103.05 0.17 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 119.599 -1.286 . . . . 0.0 114.495 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -53.15 -25.99 31.58 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.822 2.348 . . . . 0.0 113.173 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -131.99 95.02 3.59 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.523 ' O ' ' HB2' ' A' ' 258' ' ' GLU . 0.5 OUTLIER -178.19 -46.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.152 -179.276 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 28.1 mmt180 68.37 128.02 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -177.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.38 -29.03 37.44 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.012 1.808 . . . . 0.0 112.809 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -61.72 -43.3 99.13 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.574 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 97.0 mt-10 -67.74 -35.52 78.88 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 111.368 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.893 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 19.2 t80 -59.15 -49.09 79.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.459 -178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.74 -37.7 88.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -63.71 -40.1 95.94 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.828 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.829 ' CE2' HD11 ' A' ' 313' ' ' ILE . 84.0 t80 -65.41 -55.12 19.82 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.74 ' CG ' HG21 ' A' ' 289' ' ' VAL . 9.3 m-85 -65.19 -27.24 68.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.791 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.702 ' N ' HD11 ' A' ' 269' ' ' ILE . 33.4 t -54.48 -26.97 34.46 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -50.17 -38.12 38.11 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.794 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.722 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 24.3 p90 -127.42 54.24 1.68 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.267 0.556 . . . . 0.0 111.18 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.485 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 151.48 153.28 6.14 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.432 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.402 ' HG1' ' CG ' ' A' ' 292' ' ' ASP . 32.8 p -71.43 -23.0 61.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.899 0.38 . . . . 0.0 111.14 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.702 HD11 ' N ' ' A' ' 264' ' ' SER . 77.8 mt 55.53 99.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.589 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.632 HD11 ' HA ' ' A' ' 292' ' ' ASP . 73.4 mt -58.47 -40.84 79.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.174 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -174.92 106.06 0.1 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.516 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.622 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -100.7 135.59 41.9 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.469 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -146.01 161.99 38.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.325 0.583 . . . . 0.0 112.546 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.614 ' O ' ' HB2' ' A' ' 275' ' ' MET . 56.7 mt -88.71 3.67 50.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.694 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.614 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 90.4 mtp 81.65 -49.53 0.24 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.584 0.354 . . . . 0.0 111.767 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.633 HD22 ' N ' ' A' ' 276' ' ' LEU . 1.8 mm? 47.2 56.94 6.24 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.403 ' OD2' ' HE2' ' A' ' 275' ' ' MET . 88.6 m-20 -77.65 114.48 16.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.083 0.468 . . . . 0.0 110.276 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.633 ' O ' HG22 ' A' ' 280' ' ' THR . 80.4 tttt 44.34 25.97 0.15 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.836 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 53.19 44.82 29.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.372 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.633 HG22 ' O ' ' A' ' 278' ' ' LYS . 1.7 t -171.53 -37.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.908 0.385 . . . . 0.0 111.294 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -54.42 -27.99 42.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.948 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.624 ' NE2' HD13 ' A' ' 276' ' ' LEU . 4.8 pp0? -137.07 162.79 32.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.601 0.239 . . . . 0.0 111.583 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.579 ' CB ' ' O ' ' A' ' 282' ' ' GLN . 83.2 p 121.91 -8.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 O-C-N 124.226 0.954 . . . . 0.0 110.385 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 67.6 mtt85 -57.36 -33.62 67.97 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.617 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 250' ' ' ILE . . . 158.28 35.38 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.618 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.465 ' CE1' " H5'" ' B' ' 2' ' ' ' A' . 7.5 p90 -144.36 165.18 28.65 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.524 0.662 . . . . 0.0 110.997 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.94 ' HA3' HD11 ' A' ' 250' ' ' ILE . . . -145.98 166.18 27.99 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.069 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.45 ' CE2' ' CE ' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -120.43 122.11 40.0 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 122.892 -0.181 . . . . 0.0 111.27 179.576 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.893 HG23 ' CZ ' ' A' ' 259' ' ' PHE . 57.6 t -123.84 137.67 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.049 0.452 . . . . 0.0 111.58 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 48.7 m -115.38 135.98 53.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.638 178.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.485 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 41.1 m-85 -114.95 136.94 52.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.15 0.5 . . . . 0.0 112.007 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.632 ' HA ' HD11 ' A' ' 270' ' ' ILE . 31.9 p-10 -62.38 -33.25 74.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.19 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.427 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 28.6 t -123.15 140.06 53.41 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.636 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.33 -30.96 72.0 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.067 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.4 -38.18 68.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.211 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.473 ' O ' ' HD1' ' A' ' 266' ' ' TRP . . . -62.19 -37.04 83.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.907 0.384 . . . . 0.0 110.478 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.545 ' O ' HG12 ' A' ' 300' ' ' VAL . 81.3 t -61.89 -42.24 93.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.201 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.99 -36.7 77.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.147 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -57.25 -43.9 83.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.911 0.386 . . . . 0.0 112.027 -178.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.741 HG23 HD11 ' A' ' 306' ' ' ILE . 1.0 OUTLIER -69.86 -33.6 56.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.632 -179.141 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 76.8 m -57.44 -45.37 84.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.416 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -61.94 -41.42 97.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.25 0.547 . . . . 0.0 110.55 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -62.8 -32.5 73.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.433 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.682 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 10.6 tptm 67.94 -75.96 0.06 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -177.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.682 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.3 m-30 -110.52 136.1 50.16 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.741 HD11 HG23 ' A' ' 300' ' ' VAL . 1.1 mt -117.05 136.95 52.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.506 ' OD1' ' O ' ' A' ' 307' ' ' ASP . 52.4 p30 -72.83 96.94 2.15 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.146 0.498 . . . . 0.0 111.705 -178.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.656 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 6.2 t80 -102.27 -75.16 0.61 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.345 0.593 . . . . 0.0 110.375 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.456 ' HE3' ' CZ ' ' A' ' 308' ' ' PHE . 10.2 mmpt? -95.14 -167.9 1.71 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.152 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -52.04 -27.72 14.71 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.836 0.35 . . . . 0.0 110.753 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 311' ' ' ARG . 60.9 mtt180 -116.67 160.48 20.67 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.414 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 71.4 mttt -71.85 147.82 46.77 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.53 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.829 HD11 ' CE2' ' A' ' 262' ' ' PHE . 28.6 pt -115.37 144.47 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . 0.596 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 83.4 mt-10 -104.29 134.52 47.38 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.059 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 0.802 HG12 HG23 ' A' ' 247' ' ' VAL . 73.5 mt -122.35 126.25 73.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.072 0.463 . . . . 0.0 111.466 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -129.96 155.42 46.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.776 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -55.46 148.42 15.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.794 0.33 . . . . 0.0 110.494 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 244' ' ' LYS . . . -56.03 145.85 24.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.995 0.426 . . . . 0.0 111.409 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.1 101.49 53.91 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.952 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.53 ' O ' ' HB2' ' A' ' 321' ' ' ARG . 53.0 Cg_exo -54.96 -20.26 22.44 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.517 2.145 . . . . 0.0 112.354 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.53 ' HB2' ' O ' ' A' ' 320' ' ' PRO . 50.2 mmm-85 93.44 -0.0 0.09 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.282 0.633 . . . . 0.0 111.169 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.107 179.753 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.657 0 C3'-C2'-O2' 111.256 -0.705 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.515 ' C5 ' ' CE1' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.98 0 C3'-C2'-O2' 111.313 -0.685 . 0.01 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.695 " O2'" " H3'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.01 0 C3'-C2'-O2' 111.292 -0.692 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.573 ' C2 ' ' CZ3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.424 -0.984 0 O4'-C1'-C2' 107.773 0.981 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.695 " H3'" " O2'" ' B' ' 3' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.427 -0.832 0 C5'-C4'-O4' 107.741 -1.042 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.649 ' OP2' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.861 0 C3'-C2'-O2' 111.297 -0.691 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.674 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -1.026 0 C4'-C3'-C2' 103.444 0.744 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . 0.714 ' N3 ' " H2'" ' B' ' 8' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -1.017 0 C3'-C2'-O2' 111.204 -0.723 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 52.2 tttp . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.722 0.296 . . . . 0.0 111.392 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -59.47 -33.62 71.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.321 -179.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.5 m -56.89 -36.06 69.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.94 0.4 . . . . 0.0 110.785 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 10.5 m -60.1 -29.42 68.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.421 179.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 82.7 tttt -62.03 139.91 58.4 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.457 0.646 . . . . 0.0 111.74 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.818 ' SD ' HG13 ' A' ' 213' ' ' VAL . 92.7 mmm -121.08 149.13 43.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.617 -179.045 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.596 ' CD1' ' CE2' ' A' ' 204' ' ' PHE . 8.4 t80 -105.92 129.42 54.07 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.775 ' CG2' HD21 ' A' ' 166' ' ' LEU . 14.9 mm -114.76 127.51 72.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.835 -178.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.743 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -130.09 162.25 23.07 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.908 179.216 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.538 ' HA2' " H5'" ' B' ' 4' ' ' ' A' . . . 75.6 27.39 63.29 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 119.861 -1.161 . . . . 0.0 111.691 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.938 HD23 HG21 ' A' ' 228' ' ' ILE . 84.6 mt -85.1 140.32 31.06 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 120.802 0.335 . . . . 0.0 111.414 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.484 ' N ' ' HG1' ' A' ' 170' ' ' THR . 2.1 t-20 -63.07 136.75 57.98 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.423 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.61 ' CZ3' ' C2 ' ' B' ' 4' ' ' ' A' . 3.9 m0 -51.9 -28.23 15.58 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.811 0.339 . . . . 0.0 110.882 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -92.4 9.04 35.89 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.564 178.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.585 ' O ' ' HB2' ' A' ' 174' ' ' ASN . 89.6 m -56.24 -37.2 69.41 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.566 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.7 OUTLIER 53.64 145.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.247 0.546 . . . . 0.0 110.794 -178.38 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.605 ' N ' HD12 ' A' ' 190' ' ' ILE . 97.3 mt-10 -61.45 -33.15 73.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.766 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.577 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 92.6 m-20 -57.38 -41.26 79.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.872 -178.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.585 ' HB2' ' O ' ' A' ' 170' ' ' THR . 83.2 m-20 -64.49 -35.71 81.83 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.768 HD12 HD11 ' A' ' 190' ' ' ILE . 2.4 mt -54.02 -51.15 64.9 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.577 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -63.58 -36.76 84.85 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.935 179.605 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -66.4 -44.8 82.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.085 0.469 . . . . 0.0 110.34 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.605 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 62.4 t80 -66.33 -47.32 73.88 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.922 179.207 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.513 ' CE2' HD23 ' A' ' 175' ' ' LEU . 86.4 m-85 -91.39 -1.77 57.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.108 -178.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -61.89 -28.86 70.94 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.486 179.012 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.442 ' CD ' ' H ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -58.19 -37.41 74.71 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.715 0.769 . . . . 0.0 110.797 -178.722 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -66.72 -30.69 70.98 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.062 -178.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 163.97 -126.64 1.55 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.195 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 57.3 m -119.23 141.46 48.89 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.53 HG21 ' CD2' ' A' ' 188' ' ' LEU . 13.8 p -106.69 128.73 61.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.586 -0.445 . . . . 0.0 109.972 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.411 HG23 ' CB ' ' A' ' 206' ' ' SER . 1.2 t -84.49 -43.49 14.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.535 -178.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -138.68 136.18 35.58 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -178.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.722 HD11 ' CB ' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -116.07 128.76 55.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.091 179.008 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 8.9 tptt -140.29 113.69 8.56 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.768 HD11 HD12 ' A' ' 175' ' ' LEU . 79.4 mt -126.77 126.62 68.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 174.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.686 ' HB2' ' HB2' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -81.31 77.25 8.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.235 0.541 . . . . 0.0 110.644 -178.587 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -73.06 141.66 47.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.258 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 10.2 m-20 -92.36 100.55 3.82 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 193' ' ' ASP . 27.9 Cg_endo -62.06 -27.07 78.84 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.523 2.149 . . . . 0.0 112.796 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -75.34 -76.3 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.707 -179.484 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 57.9 p -69.99 -22.5 63.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.144 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 80.54 24.62 58.37 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.234 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.501 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 16.4 tpp85 -113.07 129.73 56.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.971 0.415 . . . . 0.0 111.395 -179.552 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.404 ' HB2' ' HA ' ' A' ' 168' ' ' TRP . 49.8 m -66.48 151.35 47.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.097 0.475 . . . . 0.0 111.288 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.8 ' HG3' ' CE1' ' A' ' 202' ' ' PHE . 17.3 tpt85 -59.55 -29.34 67.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.48 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.673 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 102.35 -9.75 56.14 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.722 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.8 ' CE1' ' HG3' ' A' ' 200' ' ' ARG . 21.0 p90 -144.24 155.3 43.81 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.448 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -144.79 164.13 27.86 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.828 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.74 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 96.5 m-85 -105.17 123.49 47.92 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.058 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.69 HD21 ' CZ ' ' A' ' 207' ' ' PHE . 58.2 tp -108.02 125.52 51.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.442 -178.124 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.417 ' O ' HG23 ' A' ' 185' ' ' VAL . 27.3 t -118.29 134.51 54.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.671 0.272 . . . . 0.0 110.983 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.69 ' CZ ' HD21 ' A' ' 205' ' ' LEU . 88.5 m-85 -115.42 138.67 50.76 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 120.963 0.411 . . . . 0.0 112.012 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -62.04 -35.03 77.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.842 178.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.84 117.51 53.76 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.631 179.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -56.79 -22.88 47.22 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.512 2.142 . . . . 0.0 112.875 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.3 t -57.37 -36.74 71.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.407 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.931 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.0 m -58.88 -35.64 73.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.809 0.337 . . . . 0.0 110.733 179.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.818 HG13 ' SD ' ' A' ' 161' ' ' MET . 87.1 t -61.47 -42.33 93.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -59.57 -42.2 91.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.33 . . . . 0.0 111.003 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.464 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 15.2 pt-20 -74.58 -29.26 61.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.669 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 212' ' ' SER . 75.3 t -61.97 -42.95 96.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.129 0.49 . . . . 0.0 110.346 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.77 -40.31 88.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -58.61 -38.7 78.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.679 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 39.5 m -82.39 140.2 33.61 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.071 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 60.7 tp60 -66.23 -40.01 89.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.539 178.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.814 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 85.9 m-70 82.34 97.68 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 178.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 72.1 mt -115.34 109.54 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 176.232 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.411 HD12 ' CG ' ' A' ' 178' ' ' TYR . 6.9 tt -116.54 128.05 55.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.935 0.397 . . . . 0.0 111.593 -178.27 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 22.4 t70 49.02 38.41 12.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.405 179.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 83.46 7.44 86.37 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.526 178.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.456 ' HD3' ' HE2' ' A' ' 278' ' ' LYS . 35.4 mmtp -120.49 152.09 38.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.778 0.323 . . . . 0.0 111.398 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 41.3 t -104.93 132.8 50.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.489 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.938 HG21 HD23 ' A' ' 166' ' ' LEU . 38.8 pt -123.73 159.72 28.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.193 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -125.19 77.85 67.35 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.307 0.575 . . . . 0.0 111.081 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.59 ' HD2' ' CD2' ' A' ' 221' ' ' HIS . 50.5 Cg_exo -59.1 123.86 14.38 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.4 2.733 . . . . 0.0 111.735 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.42 ' NZ ' ' OD2' ' A' ' 271' ' ' ASP . 9.1 mtmm -134.05 153.44 51.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.793 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -56.26 138.06 51.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.042 0.449 . . . . 0.0 111.77 -179.438 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -64.03 145.13 56.43 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.591 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.506 ' CD1' ' C6 ' ' B' ' 6' ' ' ' A' . 2.5 mt -114.21 135.76 22.19 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.589 179.279 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.45 ' HG2' ' HB3' ' A' ' 238' ' ' GLU . 10.8 Cg_endo -55.6 139.2 82.59 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.814 1.676 . . . . 0.0 111.099 179.247 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -57.0 -41.33 78.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -61.09 -45.62 93.99 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.494 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.45 ' HB3' ' HG2' ' A' ' 235' ' ' PRO . 84.2 tt0 -70.2 -38.51 75.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.673 0.749 . . . . 0.0 109.569 178.093 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.437 ' NE2' " O2'" ' B' ' 6' ' ' ' A' . 45.2 tt0 -59.53 -39.83 85.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.289 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.19 -40.88 91.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.35 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.426 ' HE3' ' HA ' ' A' ' 238' ' ' GLU . 10.5 mtmp? -61.98 -35.39 78.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.684 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.656 HG21 ' CD1' ' A' ' 270' ' ' ILE . 18.2 p -84.18 162.51 20.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.221 0.534 . . . . 0.0 111.826 -178.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -165.34 172.85 41.03 Favored Glycine 0 C--O 1.226 -0.383 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.448 179.228 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.554 ' HE2' ' CE2' ' A' ' 288' ' ' PHE . 14.0 pttm -135.99 151.36 49.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.384 0.592 . . . . 0.0 111.603 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.615 ' CD1' ' HB ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -118.82 165.58 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 121.457 0.646 . . . . 0.0 111.916 -178.395 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.462 ' CE1' ' C5 ' ' B' ' 2' ' ' ' A' . 82.5 t80 -99.93 133.74 43.86 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.407 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.819 HG11 ' CE1' ' A' ' 259' ' ' PHE . 13.1 p -131.16 143.57 40.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.758 179.305 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 313' ' ' ILE . . . -126.85 169.43 18.78 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.288 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.22 15.84 56.69 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.161 -1.018 . . . . 0.0 112.456 -179.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.499 ' CG2' HG21 ' A' ' 254' ' ' VAL . 65.3 mt -110.78 131.15 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 120.961 0.41 . . . . 0.0 110.971 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.88 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -174.04 -101.73 0.15 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.324 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.79 139.34 56.99 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.273 1.982 . . . . 0.0 113.01 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 55.15 45.45 25.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 178.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 251' ' ' GLY . 15.4 m -125.39 -48.52 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.232 178.455 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.565 ' HB3' ' OE1' ' A' ' 258' ' ' GLU . 2.4 tpp85 57.09 136.51 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.214 0 CA-C-O 120.833 0.349 . . . . 0.0 110.17 -179.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.14 -26.91 53.21 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.518 2.146 . . . . 0.0 113.466 -178.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -59.8 -48.01 83.41 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.698 -179.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.565 ' OE1' ' HB3' ' A' ' 255' ' ' ARG . 58.8 mp0 -67.97 -35.56 78.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.029 0.442 . . . . 0.0 111.246 179.119 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.819 ' CE1' HG11 ' A' ' 247' ' ' VAL . 29.8 t80 -60.67 -45.31 94.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.914 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.444 ' HG2' ' HB3' ' A' ' 272' ' ' ALA . 97.1 mt-10 -65.59 -39.41 91.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.154 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.529 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.1 pt-20 -75.75 -30.51 59.21 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.742 0.306 . . . . 0.0 110.773 179.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.945 ' CE2' HD11 ' A' ' 313' ' ' ILE . 79.0 t80 -58.18 -57.48 12.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.136 0.493 . . . . 0.0 111.924 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.726 ' CD2' ' CZ2' ' A' ' 266' ' ' TRP . 30.9 m-85 -68.28 -21.66 64.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.611 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.719 ' N ' HD11 ' A' ' 269' ' ' ILE . 34.0 t -55.35 -25.27 34.02 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.043 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -47.82 -38.6 16.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.705 178.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.726 ' CZ2' ' CD2' ' A' ' 263' ' ' PHE . 24.3 p90 -132.15 55.79 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.237 0.541 . . . . 0.0 111.444 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.458 ' HA3' ' CD1' ' A' ' 291' ' ' TYR . . . 151.59 145.29 4.1 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.652 179.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.414 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 52.8 m -58.68 -36.38 74.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.847 0.356 . . . . 0.0 111.133 179.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.719 HD11 ' N ' ' A' ' 264' ' ' SER . 73.8 mt 67.74 86.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.177 -178.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.656 ' CD1' HG21 ' A' ' 242' ' ' THR . 78.9 mt -55.98 -44.6 78.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.798 179.377 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.42 ' OD2' ' NZ ' ' A' ' 231' ' ' LYS . 59.5 t0 -166.89 105.02 0.58 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.703 0.287 . . . . 0.0 111.667 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.612 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -100.19 136.84 39.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.701 179.242 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -139.46 145.45 38.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.114 0.483 . . . . 0.0 111.9 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.533 ' O ' ' HB2' ' A' ' 275' ' ' MET . 23.3 tp -67.39 -38.07 84.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.351 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.567 ' O ' HD23 ' A' ' 276' ' ' LEU . 92.5 mmm 101.87 115.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.937 0.895 . . . . 0.0 109.52 -178.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.567 HD23 ' O ' ' A' ' 275' ' ' MET . 29.7 mt -123.39 140.8 52.64 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.204 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.569 ' HB3' ' HA3' ' A' ' 281' ' ' GLY . 59.4 t0 -157.66 93.72 1.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.053 177.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.456 ' HE2' ' HD3' ' A' ' 226' ' ' LYS . 11.2 mmtt 69.41 48.13 0.65 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.205 0.526 . . . . 0.0 110.189 -177.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 60.0 t0 67.14 -70.68 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.719 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 59.5 p -69.32 -14.13 62.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.436 -179.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . 0.569 ' HA3' ' HB3' ' A' ' 277' ' ' ASP . . . -55.12 126.48 38.91 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.866 -178.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.971 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 58.2 mm-40 41.25 36.79 0.52 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.996 -0.602 . . . . 0.0 110.87 178.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 90.8 p -126.57 157.88 37.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.859 -179.441 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.466 ' HA ' ' HA2' ' A' ' 251' ' ' GLY . 72.0 ttt180 58.16 39.78 25.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.118 0.485 . . . . 0.0 109.808 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -160.46 -68.83 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.945 -179.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.517 ' CE1' " C4'" ' B' ' 2' ' ' ' A' . 29.7 p90 -136.82 166.85 22.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.967 0.413 . . . . 0.0 111.462 -178.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.756 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -135.27 158.15 23.48 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.883 179.012 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.554 ' CE2' ' HE2' ' A' ' 244' ' ' LYS . 0.2 OUTLIER -115.13 127.95 55.89 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 122.254 0.222 . . . . 0.0 110.624 179.419 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.624 ' CG2' ' CZ ' ' A' ' 259' ' ' PHE . 48.2 t -121.21 135.18 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.689 178.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 269' ' ' ILE . 48.8 m -111.38 136.36 50.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.537 178.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.649 ' OH ' ' HB3' ' A' ' 263' ' ' PHE . 39.2 m-85 -116.08 138.69 51.02 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.371 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.601 ' O ' HG22 ' A' ' 242' ' ' THR . 21.7 t70 -57.82 -34.04 69.25 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.56 178.091 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 28.9 t -119.06 137.41 53.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.351 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -64.83 -29.76 70.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.1 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -56.05 -37.05 68.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.419 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.655 ' HB1' ' O ' ' A' ' 266' ' ' TRP . . . -60.2 -35.84 76.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.908 0.385 . . . . 0.0 110.811 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.559 HG13 HG22 ' A' ' 245' ' ' ILE . 71.2 t -60.57 -44.3 96.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.988 0.423 . . . . 0.0 110.658 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -63.43 -37.23 86.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.071 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -58.16 -42.74 86.62 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.84 HG23 HD11 ' A' ' 306' ' ' ILE . 1.2 p -68.99 -33.7 60.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.797 0.332 . . . . 0.0 111.603 -179.405 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 72.6 m -55.2 -42.24 73.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.106 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -61.83 -37.35 84.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.085 0.469 . . . . 0.0 110.529 179.399 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.55 ' OD1' ' C ' ' A' ' 305' ' ' PHE . 0.0 OUTLIER -62.96 -35.99 81.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.654 -179.795 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.696 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 45.1 tptt 70.69 -71.86 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.696 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 32.7 m-85 -119.89 130.08 54.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.733 178.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.84 HD11 HG23 ' A' ' 300' ' ' VAL . 39.8 mt -113.11 136.42 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -78.04 95.22 4.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.0 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.708 ' CD1' ' CD1' ' A' ' 262' ' ' PHE . 4.9 t80 -87.36 -85.43 0.17 Allowed 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.991 179.451 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.561 ' HG3' HG12 ' A' ' 254' ' ' VAL . 12.1 mmmt -94.91 4.5 53.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.56 ' HB2' ' O ' ' A' ' 309' ' ' LYS . 83.5 m-20 107.68 -31.34 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.04 0.936 . . . . 0.0 110.499 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' A' ' 312' ' ' LYS . 28.9 tpt180 -57.43 -35.46 70.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.945 179.337 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.579 ' HG3' ' HB3' ' A' ' 305' ' ' PHE . 16.4 tptt 96.12 71.6 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.537 -179.349 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.945 HD11 ' CE2' ' A' ' 262' ' ' PHE . 29.9 pt -57.2 98.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.624 0.726 . . . . 0.0 110.173 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . 0.678 ' HG2' ' CE2' ' A' ' 305' ' ' PHE . 77.0 mt-10 -61.85 138.04 58.31 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 0.651 HG12 HG23 ' A' ' 247' ' ' VAL . 72.3 mt -121.93 128.54 75.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 19.4 mtpt -131.61 150.98 51.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.7 178.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -58.13 144.77 39.2 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.467 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 244' ' ' LYS . . . -65.06 143.63 57.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.972 0.415 . . . . 0.0 111.244 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . 0.43 ' O ' ' C2 ' ' B' ' 2' ' ' ' A' . 0.9 OUTLIER 177.52 137.32 0.22 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.285 -179.85 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -55.98 126.75 23.43 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 121.541 1.494 . . . . 0.0 111.026 179.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.428 ' CB ' " O2'" ' B' ' 2' ' ' ' A' . 38.1 tpt85 -58.84 -37.82 77.32 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 120.931 0.396 . . . . 0.0 111.103 -179.387 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 77.1 m80 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.938 -179.861 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.692 0 C3'-C2'-O2' 111.214 -0.719 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.971 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.942 0 C3'-C2'-O2' 110.883 -0.834 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.55 " H3'" " H4'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.423 -1.068 0 C3'-C2'-O2' 111.349 -0.673 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.673 " O2'" ' HA3' ' A' ' 201' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.888 0 C4'-C3'-C2' 104.034 1.334 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.743 ' C6 ' ' HA3' ' A' ' 164' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.783 0 O4'-C1'-N19 109.166 0.966 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.602 " O5'" " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.001 0 C4'-C3'-C2' 103.646 0.946 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.74 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.963 0 C3'-C2'-O2' 111.101 -0.758 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . 0.412 ' OP1' ' NH2' ' A' ' 200' ' ' ARG . . . . . . . . 0 O5'--C5' 1.425 -0.968 0 C3'-C2'-O2' 111.242 -0.71 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.864 0.364 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 60.4 mp0 -61.84 -34.22 75.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.0 t -126.09 142.27 51.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.103 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 26.3 m -86.64 0.35 54.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.041 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 38.6 ttpt -74.36 139.25 43.97 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.168 0.509 . . . . 0.0 111.58 -179.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.734 ' SD ' HG13 ' A' ' 213' ' ' VAL . 87.3 mmm -112.52 149.32 32.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.504 -179.304 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.58 ' CE2' ' N9 ' ' B' ' 6' ' ' ' A' . 4.6 t80 -103.08 129.19 49.83 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.751 HG21 HD21 ' A' ' 175' ' ' LEU . 17.8 mm -116.8 125.91 73.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.943 -179.517 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.574 ' HA3' ' C6 ' ' B' ' 5' ' ' ' U' . . . -120.91 155.97 16.18 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 178.404 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.57 41.53 35.6 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 119.971 -1.109 . . . . 0.0 111.8 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.727 HD22 HD11 ' A' ' 175' ' ' LEU . 75.0 mt -58.81 -28.18 65.76 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.774 ' O ' ' N ' ' A' ' 169' ' ' ASP . 52.5 t30 71.98 45.41 0.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -177.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.655 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 10.9 m0 23.36 -62.62 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.534 1.134 . . . . 0.0 113.911 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.774 ' N ' ' O ' ' A' ' 167' ' ' ASN . 92.3 m-20 -53.91 -33.82 57.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.142 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.461 ' C ' HG23 ' A' ' 171' ' ' THR . 87.9 m -52.92 -39.31 62.69 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.593 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.626 ' C ' HD12 ' A' ' 190' ' ' ILE . 0.1 OUTLIER 55.44 166.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.073 0.464 . . . . 0.0 109.822 -177.846 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.884 ' N ' HD12 ' A' ' 190' ' ' ILE . 21.0 pt-20 -67.76 -23.0 65.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.399 -179.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.616 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.8 m-20 -58.68 -44.29 90.17 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.459 -178.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.433 ' HB2' ' CG2' ' A' ' 170' ' ' THR . 83.9 m-20 -68.11 -35.33 77.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.677 0.275 . . . . 0.0 111.542 179.27 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.898 HD12 HD11 ' A' ' 190' ' ' ILE . 1.5 mt -55.91 -44.8 78.63 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.19 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.616 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -64.37 -38.77 92.2 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.978 179.312 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.435 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 75.6 mm-40 -69.41 -42.49 75.01 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.536 ' OH ' ' HA ' ' A' ' 221' ' ' HIS . 53.8 t80 -64.96 -47.59 77.06 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.421 0.629 . . . . 0.0 111.565 179.471 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.496 ' CE2' HD23 ' A' ' 175' ' ' LEU . 82.4 m-85 -92.42 -1.04 57.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.224 -178.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 176' ' ' ARG . . . -58.45 -31.16 66.08 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.205 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -41.18 90.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.543 0.687 . . . . 0.0 110.576 -179.322 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -68.34 -33.89 75.1 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.209 -178.301 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.44 -174.62 44.85 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.862 -179.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 54.5 m -63.48 -28.29 69.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.777 0.322 . . . . 0.0 111.319 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.766 HG22 HD11 ' A' ' 205' ' ' LEU . 1.2 t 64.86 82.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -176.697 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.615 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 3.1 m -56.72 -42.87 79.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.414 -176.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -148.34 144.62 27.67 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.417 ' HA ' HD13 ' A' ' 188' ' ' LEU . 0.2 OUTLIER -115.4 134.7 54.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.571 178.577 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.561 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 11.1 tptt -141.39 67.13 1.35 Allowed 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.898 HD11 HD12 ' A' ' 175' ' ' LEU . 3.3 mt -66.43 -9.93 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 121.104 0.478 . . . . 0.0 110.377 177.359 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.618 ' HE2' ' HA2' ' A' ' 203' ' ' GLY . 1.8 mpp? 74.53 -56.62 0.63 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.588 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 199' ' ' SER . 8.0 mtmp? 56.43 152.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.077 0.465 . . . . 0.0 111.597 179.392 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.682 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 0.7 OUTLIER -126.08 78.58 70.35 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.519 -179.762 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -56.51 -25.41 58.26 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 121.988 1.792 . . . . 0.0 111.706 179.442 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.77 -67.16 0.66 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.66 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.5 p -67.25 -26.83 66.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.507 179.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 93.14 0.77 67.66 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.818 -0.706 . . . . 0.0 113.151 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.682 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 1.5 tpt180 -127.41 125.94 41.53 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 117.162 0.481 . . . . 0.0 110.743 179.708 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 192' ' ' LYS . 42.8 m -58.11 155.46 11.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.161 0.505 . . . . 0.0 111.59 -179.404 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.553 ' HB3' ' CE1' ' A' ' 202' ' ' PHE . 40.3 mmt180 -55.68 -30.46 61.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.666 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.671 ' HA3' " O2'" ' B' ' 4' ' ' ' A' . . . 97.82 0.16 59.06 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.853 -178.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.692 ' C ' HD11 ' A' ' 166' ' ' LEU . 28.2 p90 -148.36 159.18 44.27 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.618 ' HA2' ' HE2' ' A' ' 191' ' ' MET . . . -147.04 163.75 28.63 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.09 -1.052 . . . . 0.0 111.548 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.742 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 99.0 m-85 -104.63 122.16 45.06 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.766 HD11 HG22 ' A' ' 185' ' ' VAL . 53.5 tp -102.77 127.1 50.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.209 -177.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 186' ' ' THR . 51.8 m -119.7 139.88 51.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.453 -179.573 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.659 ' CZ ' HD21 ' A' ' 205' ' ' LEU . 94.9 m-85 -122.6 139.68 53.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.578 178.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.615 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.5 tt0 -59.98 -33.83 72.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.924 0.392 . . . . 0.0 110.114 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 13.3 mtmm -114.51 122.91 33.19 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.008 179.383 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -56.78 -20.44 35.44 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.744 2.296 . . . . 0.0 113.023 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.9 m -56.48 -36.93 69.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.694 0.283 . . . . 0.0 111.306 -179.269 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.936 ' O ' HG23 ' A' ' 216' ' ' VAL . 22.4 m -59.18 -35.87 74.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.798 0.333 . . . . 0.0 110.764 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.734 HG13 ' SD ' ' A' ' 161' ' ' MET . 83.2 t -61.56 -42.5 94.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.069 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.48 ' O ' HG22 ' A' ' 217' ' ' VAL . 55.4 t0 -59.58 -42.4 92.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.744 0.306 . . . . 0.0 111.091 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.453 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 14.8 pt-20 -74.38 -29.41 61.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.596 179.454 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 212' ' ' SER . 64.6 t -59.77 -42.37 88.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.064 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 214' ' ' ASP . 24.2 m -72.5 -26.95 24.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -58.63 -31.69 68.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.458 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.615 ' O ' ' CD2' ' A' ' 221' ' ' HIS . 68.7 m -108.42 140.01 42.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.893 0.378 . . . . 0.0 111.605 -179.129 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 63.4 tt0 -65.53 -40.74 93.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.64 179.079 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.729 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 71.7 m-70 84.47 110.74 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 178.352 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 1.031 HD12 HG12 ' A' ' 227' ' ' VAL . 20.3 mm -116.66 114.05 44.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 175.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.429 HD12 ' CG ' ' A' ' 178' ' ' TYR . 5.8 tt -122.58 122.3 38.54 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.469 -178.092 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 51.5 42.39 29.36 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 178.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 79.07 8.26 87.95 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.562 -0.827 . . . . 0.0 113.443 178.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.416 ' HG3' ' HB2' ' A' ' 167' ' ' ASN . 35.5 mmtp -121.5 155.37 35.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.753 0.311 . . . . 0.0 111.008 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 1.031 HG12 HD12 ' A' ' 222' ' ' ILE . 32.8 m -110.5 134.94 51.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.04 0.447 . . . . 0.0 110.349 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 164' ' ' GLY . 36.5 pt -124.32 158.63 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.866 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -126.74 79.2 72.28 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 121.16 0.505 . . . . 0.0 111.175 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 162' ' ' PHE . 51.1 Cg_exo -58.98 120.87 9.01 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.739 2.293 . . . . 0.0 110.669 179.232 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.537 ' HD3' ' O4 ' ' B' ' 5' ' ' ' U' . 28.7 mtpt -134.1 146.97 50.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.686 0.279 . . . . 0.0 111.712 -179.065 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.535 ' N ' ' HD2' ' A' ' 232' ' ' ARG . 0.0 OUTLIER -49.4 134.91 18.38 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.986 0.422 . . . . 0.0 110.989 -179.557 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.447 ' HA ' ' N1 ' ' B' ' 6' ' ' ' A' . . . -65.45 145.66 55.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.915 -179.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.501 HD11 ' N6 ' ' B' ' 6' ' ' ' A' . 1.2 mt -118.13 137.55 24.65 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.167 179.223 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.447 ' HG2' ' HB2' ' A' ' 238' ' ' GLU . 9.5 Cg_endo -54.28 141.03 72.11 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 121.8 1.666 . . . . 0.0 110.97 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -55.76 -41.76 74.45 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -178.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -60.83 -41.79 96.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.782 0.325 . . . . 0.0 111.047 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.462 ' O ' HG23 ' A' ' 242' ' ' THR . 84.5 tt0 -64.75 -36.59 84.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.601 179.394 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.408 ' NE2' ' N3 ' ' B' ' 6' ' ' ' A' . 94.8 mt-30 -60.0 -38.83 83.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.704 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -61.12 -39.42 89.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.207 0.527 . . . . 0.0 110.394 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -60.97 -31.4 70.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.347 179.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.541 HG22 ' CD1' ' A' ' 270' ' ' ILE . 10.4 p -75.31 161.44 29.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.911 -178.136 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.69 112.72 0.85 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.086 179.53 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.61 ' HE3' ' CD2' ' A' ' 288' ' ' PHE . 5.3 tptp -85.8 129.2 34.89 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -179.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.689 HG21 HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -120.84 160.71 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.474 0.654 . . . . 0.0 111.865 -179.55 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.491 ' CE1' ' C4 ' ' B' ' 2' ' ' ' A' . 76.2 t80 -104.31 137.45 42.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.951 179.416 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.758 HG23 HG12 ' A' ' 315' ' ' ILE . 7.2 p -128.68 147.17 33.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.644 -179.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.673 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -128.7 166.96 21.01 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.026 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 81.02 42.19 9.76 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.804 -179.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.566 ' CG2' HG11 ' A' ' 254' ' ' VAL . 27.3 mm -55.65 -36.29 41.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.849 0.357 . . . . 0.0 111.295 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 60.79 169.02 0.5 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.868 179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.26 144.66 81.59 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.032 2.488 . . . . 0.0 113.674 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 55.11 42.47 30.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.936 178.245 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.623 HG23 ' HE2' ' A' ' 308' ' ' PHE . 12.5 p -63.72 -38.3 81.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.996 178.612 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.615 ' O ' ' O ' ' A' ' 254' ' ' VAL . 4.5 mpt_? 50.31 126.29 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.43 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.48 -28.28 44.13 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.077 1.852 . . . . 0.0 112.668 -178.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -61.17 -47.79 84.55 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.614 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.527 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 53.0 mp0 -69.44 -39.62 77.69 Favored 'General case' 0 C--O 1.224 -0.261 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.693 ' CE1' HG11 ' A' ' 247' ' ' VAL . 27.4 t80 -61.37 -47.25 86.68 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.21 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.531 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.5 tt0 -65.58 -43.11 90.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.736 0.303 . . . . 0.0 111.295 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.527 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.8 pt-20 -76.47 -28.86 56.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.129 0.49 . . . . 0.0 110.877 179.444 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.662 ' CZ ' ' HB2' ' A' ' 308' ' ' PHE . 11.6 t80 -61.93 -56.48 18.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.683 . . . . 0.0 112.13 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.763 ' CG ' HG21 ' A' ' 289' ' ' VAL . 5.2 m-85 -67.67 -27.56 66.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.069 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.745 ' N ' HD11 ' A' ' 269' ' ' ILE . 80.1 p -56.44 -23.97 42.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.736 0.303 . . . . 0.0 111.113 -178.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -56.68 -35.94 69.01 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.275 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.677 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 19.4 p90 -111.66 48.99 0.92 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -179.648 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 133.43 150.39 6.31 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.184 178.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 50.4 m -70.3 131.68 44.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.782 HG23 ' O ' ' A' ' 290' ' ' THR . 74.5 mt -102.9 118.65 50.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.84 -178.73 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.683 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 72.7 mt -69.51 -39.4 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 120.289 -0.565 . . . . 0.0 112.236 179.359 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -136.38 -87.44 0.32 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.725 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . 65.14 110.42 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.709 0.29 . . . . 0.0 110.886 -178.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . 0.419 ' O ' ' NE2' ' A' ' 282' ' ' GLN . 21.6 pt20 -141.23 158.67 43.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.253 0.549 . . . . 0.0 111.853 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 1.038 HD23 HD11 ' A' ' 276' ' ' LEU . 28.6 tp -66.1 -26.86 67.66 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.09 -179.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.818 ' HE1' " O3'" ' B' ' 3' ' ' ' U' . 66.8 mmm 82.51 -80.91 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.457 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 1.038 HD11 HD23 ' A' ' 274' ' ' LEU . 5.2 mp 55.53 72.25 0.5 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.16 -178.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.483 ' HB3' ' HA3' ' A' ' 281' ' ' GLY . 60.2 t0 -79.91 113.56 18.16 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.001 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 18.6 mttt 69.76 -59.55 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.358 -178.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.728 ' OD1' HG23 ' A' ' 280' ' ' THR . 53.7 p30 -178.1 -31.12 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 179.133 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.728 HG23 ' OD1' ' A' ' 279' ' ' ASP . 68.2 p -109.46 10.89 25.22 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.493 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . 0.483 ' HA3' ' HB3' ' A' ' 277' ' ' ASP . . . -91.37 99.07 2.52 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.209 -0.995 . . . . 0.0 113.149 -179.525 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.693 ' HB2' ' CZ ' ' A' ' 286' ' ' PHE . 38.2 tt0 75.38 -8.1 1.65 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.89 0.476 . . . . 0.0 112.18 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 21.9 m -57.77 -38.46 75.46 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -137.79 142.59 40.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.31 178.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.05 -46.46 1.71 Allowed Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.484 -0.865 . . . . 0.0 114.399 178.591 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.693 ' CZ ' ' HB2' ' A' ' 282' ' ' GLN . 23.7 p90 -140.24 168.38 19.93 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.224 1.012 . . . . 0.0 113.076 -179.162 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.506 ' C ' HG12 ' A' ' 247' ' ' VAL . . . -138.03 174.35 21.95 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.173 179.164 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.61 ' CD2' ' HE3' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -137.17 123.33 20.44 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.294 0.547 . . . . 0.0 111.44 -179.948 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.763 HG21 ' CG ' ' A' ' 263' ' ' PHE . 56.8 t -126.44 137.6 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.008 0.432 . . . . 0.0 111.815 178.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.782 ' O ' HG23 ' A' ' 269' ' ' ILE . 32.6 m -110.73 136.45 49.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.7 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.436 ' OH ' ' O ' ' A' ' 263' ' ' PHE . 31.0 m-85 -117.96 136.1 53.72 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.683 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 55.7 t0 -59.05 -36.18 74.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.254 178.6 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 49.9 m -121.53 143.88 49.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.471 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.92 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -66.57 -28.72 68.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.389 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -56.01 -36.59 68.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.824 -179.126 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.71 91.46 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.292 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.92 HG12 ' O ' ' A' ' 294' ' ' ALA . 6.2 p -59.62 -36.96 68.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.219 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -62.18 -38.41 88.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.346 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -59.87 -43.41 94.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.894 -178.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.833 HG23 HD11 ' A' ' 306' ' ' ILE . 0.8 OUTLIER -69.4 -34.84 64.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.375 -179.334 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 80.2 m -59.33 -46.6 88.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.155 -179.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -62.49 -38.83 91.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.199 0.523 . . . . 0.0 109.965 179.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 305' ' ' PHE . 88.5 m-20 -61.55 -32.36 72.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.257 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.645 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 18.8 tptm 69.24 -69.55 0.16 Allowed 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.645 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.7 m-30 -113.95 143.0 45.43 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.758 178.063 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.833 HD11 HG23 ' A' ' 300' ' ' VAL . 6.9 mm -111.94 136.35 48.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -72.41 83.69 1.08 Allowed 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.198 -179.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.662 ' HB2' ' CZ ' ' A' ' 262' ' ' PHE . 4.9 t80 -105.9 142.84 34.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.556 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.533 ' HG2' ' CD2' ' A' ' 308' ' ' PHE . 18.8 mmmt 46.34 -135.89 0.79 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.116 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -96.74 9.77 40.74 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -178.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -151.05 165.82 32.63 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.479 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 53.0 mttt -78.86 143.46 35.94 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.76 179.159 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.673 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 33.7 pt -121.1 153.76 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.088 179.185 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . 0.604 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 84.0 mt-10 -110.16 134.98 51.65 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.414 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 0.758 HG12 HG23 ' A' ' 247' ' ' VAL . 76.7 mt -122.28 128.61 75.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.268 0.556 . . . . 0.0 112.17 -179.287 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -128.4 156.66 42.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.113 179.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -54.68 146.97 15.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.64 0.257 . . . . 0.0 110.363 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.57 ' O ' ' N1 ' ' B' ' 2' ' ' ' A' . . . -54.26 -98.28 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.042 -179.273 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 318' ' ' ALA . 56.3 mm-40 69.38 102.4 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.416 0.151 . . . . 0.0 111.351 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 319' ' ' GLU . 18.7 Cg_endo -58.97 143.66 99.6 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.232 1.954 . . . . 0.0 111.842 179.481 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -58.08 -34.88 70.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.052 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 77.4 m80 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.916 179.973 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.697 0 C3'-C2'-O2' 111.206 -0.722 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.57 ' N1 ' ' O ' ' A' ' 318' ' ' ALA . . . . . . . . 0 O5'--C5' 1.425 -0.939 0 C1'-C2'-O2' 108.559 -0.68 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.818 " O3'" ' HE1' ' A' ' 275' ' ' MET . . . . . . . . 0 O5'--C5' 1.423 -1.043 0 C1'-C2'-O2' 108.379 -0.74 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.685 ' N7 ' ' HA ' ' A' ' 167' ' ' ASN . . . . . . . . 0 O5'--C5' 1.426 -0.875 0 C4'-C3'-C2' 103.801 1.101 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.702 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.729 0 C5'-C4'-O4' 107.771 -1.021 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.702 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.916 0 C3'-C2'-O2' 111.08 -0.766 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.742 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.89 0 C4'-C3'-C2' 103.543 0.843 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . 0.774 " H3'" ' N3 ' ' B' ' 8' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.997 0 O4'-C1'-C2' 107.384 0.703 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.4 tttt . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.89 0.376 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.447 ' OE2' ' HG2' ' A' ' 232' ' ' ARG . 47.9 tp10 -105.81 145.29 31.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.906 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.2 m -116.71 144.69 44.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.109 0.481 . . . . 0.0 111.292 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.531 ' HA ' HG21 ' A' ' 213' ' ' VAL . 8.2 m -65.29 -29.75 70.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.56 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 74.2 tttt -56.74 139.69 49.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.179 0.514 . . . . 0.0 111.896 -178.607 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.758 ' SD ' HG13 ' A' ' 213' ' ' VAL . 94.7 mmm -121.94 150.46 41.98 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.896 -178.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.711 ' CE1' ' CZ ' ' A' ' 204' ' ' PHE . 1.5 t80 -108.42 129.64 55.25 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.262 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.604 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 24.4 mm -116.83 131.04 70.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.253 -179.221 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 228' ' ' ILE . . . -130.17 166.2 22.25 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 178.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.78 32.54 59.02 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.937 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.709 HD22 HG21 ' A' ' 170' ' ' THR . 65.2 mt -59.57 -23.43 62.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -179.234 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.587 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 33.3 t-20 70.3 37.29 1.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -177.549 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.625 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 18.6 m0 37.12 17.95 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.28 -1.327 . . . . 0.0 113.829 179.453 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 167' ' ' ASN . 93.3 m-20 -139.28 10.04 2.52 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.779 ' CG2' HD13 ' A' ' 223' ' ' LEU . 95.1 m -57.24 -38.52 73.94 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.552 ' O ' ' O ' ' A' ' 170' ' ' THR . 0.2 OUTLIER 54.78 142.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.108 0.48 . . . . 0.0 110.459 -178.344 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.6 ' CA ' HD12 ' A' ' 190' ' ' ILE . 97.2 mt-10 -61.63 -34.96 76.58 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.597 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 60.1 t0 -57.28 -42.45 81.7 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 170' ' ' THR . 82.9 m-20 -64.13 -37.8 88.76 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.022 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.956 HD22 HD21 ' A' ' 205' ' ' LEU . 11.0 mt -56.76 -50.5 72.09 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.229 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.597 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -67.46 -34.71 77.74 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.429 179.506 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -59.44 -38.91 81.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.395 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.622 ' CE2' ' CE2' ' A' ' 179' ' ' PHE . 0.0 OUTLIER -94.69 -55.71 3.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.676 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.686 ' CE2' HD23 ' A' ' 175' ' ' LEU . 72.0 m-85 -60.62 -29.55 69.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.28 179.145 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.63 -24.13 23.62 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.904 179.073 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.804 ' HG3' ' CD1' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -55.71 -38.75 70.14 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.896 0.379 . . . . 0.0 111.483 -179.632 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.804 ' CD1' ' HG3' ' A' ' 181' ' ' LYS . 59.2 m-85 -68.1 -30.78 70.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.516 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 166.9 -129.33 1.9 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.092 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 59.7 m -117.4 141.78 47.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 206' ' ' SER . 10.5 p -104.41 125.44 59.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.736 HG23 ' N ' ' A' ' 208' ' ' GLU . 43.4 p -70.75 -35.48 72.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.605 -178.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -154.14 149.75 27.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.338 0.59 . . . . 0.0 112.253 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.503 HD22 HG21 ' A' ' 185' ' ' VAL . 0.2 OUTLIER -118.63 130.14 55.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.476 179.689 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.549 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 35.5 tptt -128.57 118.87 23.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.211 0.529 . . . . 0.0 111.341 179.391 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.6 HD12 ' CA ' ' A' ' 172' ' ' GLU . 0.3 OUTLIER -124.44 138.48 53.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.696 177.676 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.718 ' HB2' ' HB3' ' A' ' 200' ' ' ARG . 15.1 mmt -86.29 135.08 33.68 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.901 -179.213 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -139.25 134.67 32.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.052 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 0.8 OUTLIER -123.31 78.02 53.29 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.676 -179.939 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.63 -27.9 72.32 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.252 1.968 . . . . 0.0 112.117 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -71.82 -63.01 1.22 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.083 0.468 . . . . 0.0 111.036 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 55.2 p -72.88 -18.83 61.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.512 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 193' ' ' ASP . . . 79.6 28.9 50.45 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.36 -179.776 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.542 ' HD2' ' CZ2' ' A' ' 168' ' ' TRP . 7.8 ttp180 -124.91 141.81 51.88 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 121.048 0.452 . . . . 0.0 111.854 -179.399 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 191' ' ' MET . 22.6 p -84.73 8.23 17.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.649 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.813 ' HG3' ' CE1' ' A' ' 202' ' ' PHE . 11.4 tpt180 76.48 -42.64 0.44 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.065 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.548 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 96.37 4.73 59.48 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.851 -0.69 . . . . 0.0 114.219 178.311 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.813 ' CE1' ' HG3' ' A' ' 200' ' ' ARG . 36.6 p90 -149.54 159.13 44.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.257 0.551 . . . . 0.0 112.106 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -151.66 170.88 31.16 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.418 179.577 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.745 ' CE1' ' C6 ' ' B' ' 7' ' ' ' U' . 78.9 m-85 -114.98 134.94 54.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.025 0.441 . . . . 0.0 112.058 -179.558 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.956 HD21 HD22 ' A' ' 175' ' ' LEU . 59.5 mt -107.73 139.65 41.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.349 179.112 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.625 ' O ' HG23 ' A' ' 185' ' ' VAL . 20.1 t -123.24 126.97 47.93 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.712 ' CE2' HG21 ' A' ' 216' ' ' VAL . 84.4 m-85 -114.64 135.18 54.43 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.736 ' N ' HG23 ' A' ' 186' ' ' THR . 84.5 tt0 -63.35 -35.56 80.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.153 178.583 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.69 117.39 54.26 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.879 179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.78 -28.09 74.65 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.58 2.187 . . . . 0.0 113.041 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 20.4 m -59.02 -39.65 82.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.796 0.331 . . . . 0.0 110.724 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.855 ' O ' HG23 ' A' ' 216' ' ' VAL . 23.8 m -61.42 -35.58 77.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.222 0.534 . . . . 0.0 110.095 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.758 HG13 ' SD ' ' A' ' 161' ' ' MET . 96.7 t -62.19 -41.74 92.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.392 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 218' ' ' LYS . 92.4 m-20 -58.62 -43.61 89.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.305 -179.345 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -70.02 -34.35 73.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.855 0.36 . . . . 0.0 111.708 178.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 212' ' ' SER . 87.0 t -60.35 -44.36 95.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.18 -178.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.611 HG11 ' NE ' ' A' ' 232' ' ' ARG . 10.4 p -80.75 -44.84 21.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.464 ' N ' HG13 ' A' ' 217' ' ' VAL . 15.0 mtpt -59.21 -34.19 71.88 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.713 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 27.5 m -96.46 143.65 27.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.135 0.493 . . . . 0.0 111.745 -178.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -93.3 125.28 37.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.902 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.603 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 0.0 OUTLIER -131.79 152.34 51.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.201 -179.028 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.581 HG22 ' H ' ' A' ' 225' ' ' GLY . 70.7 mt -121.91 128.41 75.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.871 179.393 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.779 HD13 ' CG2' ' A' ' 170' ' ' THR . 4.7 mt -88.1 -72.78 0.51 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -93.07 14.15 18.7 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.143 -178.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.581 ' H ' HG22 ' A' ' 222' ' ' ILE . . . 100.19 -0.32 56.0 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.987 -178.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -112.22 132.58 54.84 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 227' ' ' VAL . 34.3 m -59.01 120.05 4.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.498 -179.325 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.745 HG13 ' HD3' ' A' ' 230' ' ' PRO . 31.1 pt -97.47 -33.0 4.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.298 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 47.57 73.72 0.94 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.079 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.745 ' HD3' HG13 ' A' ' 228' ' ' ILE . 31.0 Cg_endo -60.54 135.01 58.07 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.736 2.291 . . . . 0.0 112.143 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.425 ' HE2' ' O4 ' ' B' ' 5' ' ' ' U' . 16.3 mtmm -128.53 151.99 48.81 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.547 179.047 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.611 ' NE ' HG11 ' A' ' 217' ' ' VAL . 1.9 mpt_? -59.47 143.45 49.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.206 0.527 . . . . 0.0 112.233 -178.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -74.95 150.14 39.16 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.613 179.611 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.885 HD12 ' HG2' ' A' ' 239' ' ' GLN . 0.1 OUTLIER -124.89 133.49 24.84 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.287 178.873 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.559 ' HD2' ' OE1' ' A' ' 238' ' ' GLU . 44.0 Cg_exo -54.96 145.64 61.81 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 121.775 1.65 . . . . 0.0 110.092 178.321 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 48.7 tpt85 -54.55 -40.53 68.79 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.565 -178.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.599 ' OD1' ' N ' ' A' ' 238' ' ' GLU . 53.4 p30 -65.24 -37.31 86.84 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.371 179.414 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.599 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 93.1 mt-10 -68.29 -34.85 76.92 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.008 179.393 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.885 ' HG2' HD12 ' A' ' 234' ' ' ILE . 97.4 mt-30 -58.89 -38.62 79.28 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.045 0.45 . . . . 0.0 109.901 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -61.51 -39.08 89.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.048 178.594 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -60.05 -34.76 73.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.393 179.529 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.757 HG21 HD11 ' A' ' 270' ' ' ILE . 12.1 p -105.38 162.96 12.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.407 -178.607 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.22 168.62 25.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.519 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 289' ' ' VAL . 7.2 ttpm? -134.31 139.6 45.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.431 0.158 . . . . 0.0 110.678 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.823 HD12 HG11 ' A' ' 300' ' ' VAL . 0.1 OUTLIER -118.71 157.53 20.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 121.13 0.491 . . . . 0.0 111.465 -179.361 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.555 ' CE1' ' C4 ' ' B' ' 2' ' ' ' A' . 88.1 t80 -102.8 128.37 49.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.645 178.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.835 HG11 HD12 ' A' ' 313' ' ' ILE . 41.5 t -124.55 131.27 72.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.885 0.374 . . . . 0.0 111.44 179.303 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.655 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -105.45 174.19 20.94 Favored Glycine 0 C--O 1.225 -0.411 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.907 179.219 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 285' ' ' GLY . . . 82.86 16.22 70.79 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.933 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.574 ' CD1' ' CE1' ' A' ' 259' ' ' PHE . 64.0 mt -116.13 132.66 65.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.94 0.4 . . . . 0.0 111.519 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.695 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -168.02 -116.3 0.36 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.666 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.89 143.53 99.58 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.616 2.211 . . . . 0.0 113.389 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 55.34 41.81 30.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.953 178.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.738 HG12 ' HG2' ' A' ' 309' ' ' LYS . 16.6 m -118.8 -1.84 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.369 178.099 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.597 ' O ' ' O ' ' A' ' 254' ' ' VAL . 0.2 OUTLIER 37.61 111.91 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.431 0 O-C-N 123.365 0.415 . . . . 0.0 111.804 -179.851 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.19 -39.72 51.82 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 121.542 1.495 . . . . 0.0 111.492 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -62.6 -40.99 98.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.014 0.435 . . . . 0.0 109.959 178.23 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.511 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 85.0 tt0 -65.11 -37.47 87.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.822 179.502 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.574 ' CE1' ' CD1' ' A' ' 250' ' ' ILE . 35.1 t80 -60.51 -45.46 93.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.643 179.076 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.543 ' O ' HD12 ' A' ' 269' ' ' ILE . 84.4 tt0 -64.1 -42.01 97.08 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.511 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.3 pt-20 -74.73 -30.23 61.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.015 0.436 . . . . 0.0 110.362 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.57 ' CE1' ' HD1' ' A' ' 308' ' ' PHE . 88.1 t80 -58.78 -46.56 87.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.885 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.757 ' HZ ' HG11 ' A' ' 247' ' ' VAL . 34.8 m-85 -88.09 -7.12 57.44 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.745 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.499 ' N ' HD11 ' A' ' 269' ' ' ILE . 81.6 p -62.6 -26.28 68.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.039 0.447 . . . . 0.0 111.107 -179.668 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -57.16 -38.41 73.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.911 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.641 ' HH2' HG21 ' A' ' 306' ' ' ILE . 11.6 m-90 -59.26 -38.35 79.89 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.342 0.591 . . . . 0.0 111.199 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 264' ' ' SER . . . 174.83 -159.77 28.51 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.069 -178.757 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 51.3 m -79.57 130.73 35.65 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.143 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.829 HG23 ' O ' ' A' ' 290' ' ' THR . 72.2 mt -106.59 118.32 54.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.757 HD11 HG21 ' A' ' 242' ' ' THR . 69.5 mt -61.17 -52.46 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 120.089 -0.645 . . . . 0.0 112.288 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 270' ' ' ILE . 72.9 m-20 -162.97 68.9 0.22 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.668 ' HB2' HG21 ' A' ' 269' ' ' ILE . . . -73.87 135.71 43.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.387 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -139.63 149.43 43.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.451 0.643 . . . . 0.0 111.969 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.569 ' O ' ' HB2' ' A' ' 275' ' ' MET . 22.6 tp -65.14 -37.91 88.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.855 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.731 ' C ' HD12 ' A' ' 276' ' ' LEU . 93.6 mmm 84.62 148.59 0.07 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.14 0.576 . . . . 0.0 109.899 -178.293 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.731 HD12 ' C ' ' A' ' 275' ' ' MET . 5.5 mp -158.57 133.34 8.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.632 0.253 . . . . 0.0 110.734 179.453 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -74.82 -134.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.129 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.41 ' O ' ' OD1' ' A' ' 279' ' ' ASP . 86.4 mttt -58.78 -37.14 75.65 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.499 ' O ' HD23 ' A' ' 276' ' ' LEU . 95.9 m-20 -140.34 -85.07 0.22 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.762 179.125 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 57.8 p -116.04 24.31 11.54 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.711 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -51.88 -41.92 52.55 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.805 -179.08 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.702 ' HG3' ' HB2' ' A' ' 275' ' ' MET . 0.9 OUTLIER -64.52 -34.74 78.94 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.972 0.415 . . . . 0.0 111.493 178.991 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 39.4 t -49.59 -15.14 0.14 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.244 -177.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.409 ' NH2' ' OP1' ' B' ' 2' ' ' ' A' . 59.2 ttp180 -51.18 -36.87 43.36 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.098 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 249' ' ' GLY . . . 154.2 31.09 0.03 OUTLIER Glycine 0 CA--C 1.528 0.888 0 C-N-CA 118.828 -1.653 . . . . 0.0 116.636 178.419 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.503 ' CE1' " H4'" ' B' ' 2' ' ' ' A' . 12.7 p90 -143.89 160.6 40.51 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.51 1.655 . . . . 0.0 111.962 178.322 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -147.2 163.34 28.68 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.952 179.286 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.442 ' CE2' ' HE3' ' A' ' 244' ' ' LYS . 1.4 m-30 -113.68 128.07 56.28 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.485 ' HB ' ' CD1' ' A' ' 245' ' ' ILE . 39.8 t -121.52 132.67 70.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.527 0.203 . . . . 0.0 110.462 177.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.829 ' O ' HG23 ' A' ' 269' ' ' ILE . 49.7 m -120.26 136.51 54.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.642 0.258 . . . . 0.0 110.42 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.555 ' CE1' HG12 ' A' ' 269' ' ' ILE . 45.7 m-85 -119.23 134.98 54.91 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.671 ' HA ' HD11 ' A' ' 270' ' ' ILE . 55.0 t0 -60.52 -34.84 74.68 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.649 178.07 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 23.3 t -117.32 140.79 49.12 Favored 'General case' 0 N--CA 1.46 0.047 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.066 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.53 -28.36 69.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.873 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.575 ' OD1' ' N ' ' A' ' 296' ' ' ALA . 53.8 p30 -59.26 -35.87 74.49 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.53 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.575 ' N ' ' OD1' ' A' ' 295' ' ' ASP . . . -64.29 -33.83 76.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.979 0.419 . . . . 0.0 110.335 179.215 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.691 HG13 ' CG2' ' A' ' 245' ' ' ILE . 72.2 t -62.55 -43.44 98.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.196 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -61.35 -42.58 98.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.751 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -64.49 -42.81 95.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.151 0.501 . . . . 0.0 112.116 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.987 HG22 HD13 ' A' ' 315' ' ' ILE . 1.4 p -66.59 -36.23 76.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.618 -178.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 75.1 m -71.3 -42.41 68.69 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -57.76 -39.46 77.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.811 0.339 . . . . 0.0 111.697 -178.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.48 ' HB2' HD11 ' A' ' 306' ' ' ILE . 89.1 m-20 -57.84 -30.85 66.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.557 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.695 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 7.4 tptt 70.13 -71.8 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.695 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.8 m-30 -111.68 138.16 48.61 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.042 0.448 . . . . 0.0 110.949 178.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.641 HG21 ' HH2' ' A' ' 266' ' ' TRP . 21.9 mm -117.97 137.33 52.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.522 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -75.51 86.35 2.62 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.996 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.57 ' HD1' ' CE1' ' A' ' 262' ' ' PHE . 5.1 t80 -110.24 129.04 55.8 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.44 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.738 ' HG2' HG12 ' A' ' 254' ' ' VAL . 0.0 OUTLIER 59.01 40.33 22.39 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.751 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 53.98 37.5 26.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.514 0.673 . . . . 0.0 109.274 -178.014 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -148.59 162.51 39.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.93 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.65 ' HD3' ' HD2' ' A' ' 305' ' ' PHE . 30.6 mttt -93.89 133.69 37.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.232 0.539 . . . . 0.0 111.509 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.835 HD12 HG11 ' A' ' 247' ' ' VAL . 32.2 pt -118.06 144.17 26.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.196 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . 0.514 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 89.1 mt-10 -101.55 142.13 33.38 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.731 -178.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 0.987 HD13 HG22 ' A' ' 300' ' ' VAL . 69.6 mt -118.71 126.51 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 121.095 0.474 . . . . 0.0 111.496 -179.514 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -137.64 137.4 38.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.846 179.34 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -48.66 144.67 4.17 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.566 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 244' ' ' LYS . . . -55.92 143.81 30.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.008 0.432 . . . . 0.0 111.259 -179.083 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . 0.429 ' HG3' ' CD ' ' A' ' 320' ' ' PRO . 1.9 tt0 -123.65 143.69 42.45 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.245 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.429 ' CD ' ' HG3' ' A' ' 319' ' ' GLU . 13.7 Cg_endo -56.53 139.61 87.9 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.119 1.879 . . . . 0.0 111.59 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 46.5 tpt85 -57.01 -37.63 71.96 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.881 0.372 . . . . 0.0 110.998 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 83.7 t60 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.864 179.913 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.455 " O3'" ' H8 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.728 0 C3'-C2'-O2' 111.246 -0.708 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.555 ' C4 ' ' CE1' ' A' ' 246' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.917 0 C3'-C2'-O2' 111.195 -0.726 . 0.0 OUTLIER '7D dist 0b' 0.0 . . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.532 ' H6 ' " O2'" ' B' ' 2' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.99 0 C1'-C2'-O2' 108.453 -0.716 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.625 ' C5 ' ' CE3' ' A' ' 168' ' ' TRP . . . . . . . . 0 O5'--C5' 1.426 -0.861 0 C4'-C3'-C2' 103.792 1.092 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.806 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.787 0 C4'-C3'-C2' 103.709 1.009 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.806 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.031 0 C4'-C3'-C2' 103.637 0.937 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.745 ' C6 ' ' CE1' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.421 -1.16 0 C5'-C4'-O4' 107.003 -1.569 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.97 0 C3'-C2'-O2' 111.284 -0.695 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 88.3 mttt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.9 0.381 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 61.31 19.23 9.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.258 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 24.0 m -57.97 -36.02 71.99 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.831 0.348 . . . . 0.0 110.883 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.8 p -60.78 -30.84 70.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.714 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.545 ' HB3' ' HB3' ' A' ' 233' ' ' ALA . 5.3 tptm -67.55 138.49 56.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.031 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.688 ' O ' ' HA ' ' A' ' 204' ' ' PHE . 90.0 mtp -129.46 160.0 34.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.077 0.465 . . . . 0.0 111.906 -179.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.564 ' CD1' ' CE1' ' A' ' 204' ' ' PHE . 1.6 t80 -107.63 129.54 54.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.771 178.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.503 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 20.4 mm -118.49 130.62 73.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 121.263 -0.175 . . . . 0.0 111.205 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.525 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -128.53 158.37 21.71 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.726 178.889 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 77.23 36.61 34.4 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.586 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 201' ' ' GLY . 68.3 mt -59.79 -26.03 65.4 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.738 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 54.3 t30 74.11 39.88 0.48 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.93 0.395 . . . . 0.0 110.207 -178.188 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.648 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 9.6 m0 30.65 30.06 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.638 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 167' ' ' ASN . 89.6 m-20 -130.97 5.8 4.57 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 172' ' ' GLU . 23.6 m -82.73 133.76 35.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 110.348 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 172' ' ' GLU . 5.3 p -109.49 14.69 23.43 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.104 -179.409 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.71 ' HG2' ' HB ' ' A' ' 190' ' ' ILE . 95.5 mt-10 77.67 -30.28 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -177.619 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.709 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 90.1 m-20 -62.92 -41.0 99.31 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 121.114 0.483 . . . . 0.0 111.486 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.519 ' HB3' HD21 ' A' ' 223' ' ' LEU . 85.1 m-20 -61.53 -38.0 85.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.685 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.745 HD22 HD21 ' A' ' 205' ' ' LEU . 18.9 mt -62.81 -41.93 99.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -178.247 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.709 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -68.83 -42.73 76.77 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.752 179.955 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.518 ' N ' ' HG2' ' A' ' 176' ' ' ARG . 84.2 tt0 -72.64 -44.38 61.97 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.031 0.443 . . . . 0.0 110.811 179.014 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.606 ' OH ' ' CB ' ' A' ' 221' ' ' HIS . 43.1 t80 -62.62 -44.39 96.41 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.575 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.616 ' CE2' HD23 ' A' ' 175' ' ' LEU . 95.3 m-85 -97.8 -0.27 45.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.061 -178.531 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -59.32 -29.75 66.61 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.822 178.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.575 ' H ' ' CD ' ' A' ' 181' ' ' LYS . 0.5 OUTLIER -57.34 -42.29 81.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 122.093 0.949 . . . . 0.0 110.356 -179.897 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -69.65 -34.1 73.53 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.702 -1.59 . . . . 0.0 112.492 -177.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -175.39 -173.43 41.14 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 119.46 -1.353 . . . . 0.0 114.187 -179.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.545 ' O ' HG12 ' A' ' 185' ' ' VAL . 51.7 m -61.74 -26.53 68.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.533 -0.833 . . . . 0.0 112.05 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 184' ' ' THR . 8.0 p 51.31 73.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.831 0.824 . . . . 0.0 109.427 -177.292 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.4 t -54.23 -46.36 72.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.62 -1.173 . . . . 0.0 113.275 -177.584 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -137.45 157.33 46.8 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.587 0.708 . . . . 0.0 112.849 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.718 HD11 ' HB2' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -127.32 130.87 50.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.429 179.599 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 204' ' ' PHE . 20.0 tptt -134.26 120.58 20.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 179.676 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.71 ' HB ' ' HG2' ' A' ' 172' ' ' GLU . 1.0 OUTLIER -127.88 134.61 64.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.139 176.868 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.591 ' N ' ' SD ' ' A' ' 191' ' ' MET . 0.0 OUTLIER -92.8 135.95 33.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.456 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -127.93 150.94 49.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.608 -178.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.631 ' HB2' ' O ' ' A' ' 198' ' ' ARG . 17.8 m-20 -119.76 78.11 22.2 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.665 -179.666 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.94 -26.41 74.47 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.11 1.874 . . . . 0.0 111.701 179.176 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -74.29 -66.55 0.71 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.444 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.8 p -67.58 -27.51 66.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.125 179.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 90.6 6.14 68.29 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.411 179.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.631 ' O ' ' HB2' ' A' ' 193' ' ' ASP . 6.2 ttp85 -128.82 129.48 45.68 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 117.519 0.66 . . . . 0.0 111.816 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.5 t -66.37 155.46 37.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.807 -179.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.685 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 1.1 mpt_? -53.95 -34.03 58.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.131 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.489 ' O ' ' HG ' ' A' ' 166' ' ' LEU . . . 93.82 1.85 65.29 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.842 -179.103 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.685 ' CE2' ' HB3' ' A' ' 200' ' ' ARG . 33.6 p90 -139.54 156.6 46.8 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.953 0.406 . . . . 0.0 110.919 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.521 ' HA2' ' CE ' ' A' ' 191' ' ' MET . . . -144.31 158.92 27.63 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.819 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.688 ' HA ' ' O ' ' A' ' 161' ' ' MET . 90.5 m-85 -108.7 130.0 55.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 117.082 0.441 . . . . 0.0 110.463 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.745 HD21 HD22 ' A' ' 175' ' ' LEU . 64.2 mt -106.68 138.06 43.55 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.861 0.362 . . . . 0.0 111.943 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 49.0 m -121.29 136.2 55.0 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -123.36 145.29 48.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.748 0.309 . . . . 0.0 111.108 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.45 -34.36 76.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.952 178.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.7 115.34 51.39 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.336 179.161 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.37 -24.34 51.43 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.643 2.228 . . . . 0.0 113.61 -179.111 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 85.4 p -60.82 -31.42 70.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.586 0.232 . . . . 0.0 111.444 -179.405 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.862 ' O ' HG23 ' A' ' 216' ' ' VAL . 19.5 m -59.68 -36.11 75.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.912 0.387 . . . . 0.0 110.771 179.528 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.529 HG13 ' SD ' ' A' ' 161' ' ' MET . 85.8 t -62.13 -41.95 93.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.435 -179.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -59.26 -41.38 88.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.66 -179.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.403 ' OE2' ' HA ' ' A' ' 212' ' ' SER . 16.3 pt-20 -76.79 -34.55 57.97 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 212' ' ' SER . 76.4 t -62.23 -46.31 96.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.25 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 230' ' ' PRO . 13.3 p -68.24 -45.53 82.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.022 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.489 ' N ' HG13 ' A' ' 217' ' ' VAL . 27.0 mttp -61.31 -36.19 79.43 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.026 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.405 ' O ' ' O ' ' A' ' 220' ' ' GLN . 47.9 m -59.11 -38.78 80.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.783 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.405 ' O ' ' O ' ' A' ' 219' ' ' THR . 63.9 tt0 60.67 107.26 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -177.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.614 ' O ' HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -136.92 167.63 21.12 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -176.568 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.755 HG23 ' O ' ' A' ' 226' ' ' LYS . 3.0 mt -125.58 118.8 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.321 176.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.606 HD23 ' OD1' ' A' ' 224' ' ' ASP . 8.4 tt -91.16 -54.27 4.01 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -177.468 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.606 ' OD1' HD23 ' A' ' 223' ' ' LEU . 97.4 m-20 -101.14 16.13 26.44 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.056 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.419 ' H ' HG22 ' A' ' 222' ' ' ILE . . . 98.92 -1.86 58.06 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.568 -178.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.755 ' O ' HG23 ' A' ' 222' ' ' ILE . 32.8 mmtp -110.76 139.23 46.24 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.105 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.701 HG21 ' O ' ' A' ' 276' ' ' LEU . 16.1 m -64.29 123.99 18.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.903 -179.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 221' ' ' HIS . 34.0 pt -120.78 151.21 23.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.624 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -128.54 80.4 72.57 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 121.073 0.463 . . . . 0.0 111.502 -179.356 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.676 ' O ' HG23 ' A' ' 217' ' ' VAL . 72.4 Cg_exo -53.01 126.31 21.07 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.43 2.087 . . . . 0.0 110.583 179.208 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.551 ' HD2' ' H62' ' B' ' 6' ' ' ' A' . 1.2 ttmm -131.9 149.52 52.42 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.725 -178.487 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 14.1 ttp-105 -64.27 133.64 53.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.281 179.24 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.545 ' HB3' ' HB3' ' A' ' 160' ' ' LYS . . . -56.86 145.18 30.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.85 0.357 . . . . 0.0 111.033 -179.413 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.522 HD12 ' C5 ' ' B' ' 6' ' ' ' A' . 5.1 mt -108.67 125.08 32.56 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.487 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.54 152.16 12.85 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.077 1.851 . . . . 0.0 110.503 178.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.47 ' HD3' ' OE1' ' A' ' 239' ' ' GLN . 31.2 mmt180 -55.89 -40.26 72.74 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.148 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -63.8 -46.35 85.58 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.17 179.12 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.29 -35.2 73.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.301 0.572 . . . . 0.0 109.923 178.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.47 ' OE1' ' HD3' ' A' ' 236' ' ' ARG . 61.1 tt0 -58.25 -42.27 86.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.183 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -63.08 -40.31 97.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.327 0.584 . . . . 0.0 110.011 178.314 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 242' ' ' THR . 24.2 mttp -62.63 -34.05 76.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.384 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 291' ' ' TYR . 68.2 p -29.08 -81.26 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -178.179 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 76.71 46.28 11.59 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.96 179.204 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 7.9 ttpm? -59.73 136.21 57.92 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.675 ' CG2' HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -123.31 161.2 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.771 0.796 . . . . 0.0 112.919 -179.307 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.505 ' CD1' ' C5 ' ' B' ' 2' ' ' ' A' . 91.8 t80 -99.2 135.92 39.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.866 179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.671 HG12 ' O ' ' A' ' 287' ' ' GLY . 9.6 p -129.92 144.03 39.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.238 0.542 . . . . 0.0 111.601 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.634 ' O ' ' HB ' ' A' ' 313' ' ' ILE . . . -126.75 171.55 18.42 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.87 16.93 58.91 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.045 -1.074 . . . . 0.0 111.994 -179.111 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.739 HG22 HG21 ' A' ' 254' ' ' VAL . 68.7 mt -110.52 129.33 65.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.961 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -169.75 -99.08 0.12 Allowed Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.135 -179.592 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . 0.542 ' O ' HG13 ' A' ' 254' ' ' VAL . 32.1 Cg_exo -60.02 136.37 68.96 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.399 2.066 . . . . 0.0 113.255 -179.238 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 51.72 43.01 30.25 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.245 178.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.961 HG22 ' O ' ' A' ' 251' ' ' GLY . 14.8 m -127.0 45.4 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 254' ' ' VAL . 0.1 OUTLIER -40.77 151.67 0.26 Allowed Pre-proline 0 N--CA 1.462 0.155 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.859 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.415 ' N ' HD11 ' A' ' 274' ' ' LEU . 11.1 Cg_endo -55.28 -28.02 60.21 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 121.982 1.788 . . . . 0.0 112.381 -178.308 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -61.44 -44.62 96.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.293 179.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.506 ' HA ' ' HG2' ' A' ' 261' ' ' GLU . 55.6 mp0 -67.43 -38.7 84.95 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.902 0.382 . . . . 0.0 111.716 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.737 ' CZ ' HG23 ' A' ' 289' ' ' VAL . 31.6 t80 -64.72 -47.52 77.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.534 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.46 -41.55 98.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.832 0.348 . . . . 0.0 110.626 179.589 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 258' ' ' GLU . 20.5 pt-20 -75.39 -28.84 59.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.424 178.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.598 ' HB2' ' CE1' ' A' ' 308' ' ' PHE . 3.7 t80 -62.57 -56.87 13.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.607 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.694 ' C ' HD11 ' A' ' 269' ' ' ILE . 7.0 m-85 -65.89 -21.42 66.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.064 -179.384 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.701 ' N ' HD11 ' A' ' 269' ' ' ILE . 67.5 p -57.87 -20.12 34.28 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.742 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -47.67 -38.43 14.94 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.059 178.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.731 ' NE1' ' HB ' ' A' ' 300' ' ' VAL . 23.5 p90 -131.17 44.0 3.01 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 264' ' ' SER . . . 161.47 150.03 5.8 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.164 179.137 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.417 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 55.7 m -59.98 -34.83 73.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.876 0.369 . . . . 0.0 111.005 179.443 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.701 HD11 ' N ' ' A' ' 264' ' ' SER . 79.0 mt 68.44 112.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.075 -178.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.606 HG22 ' HB ' ' A' ' 290' ' ' THR . 14.7 tt -61.04 -29.43 45.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.916 0.388 . . . . 0.0 110.359 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 272' ' ' ALA . 55.8 t0 -176.9 -48.53 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.533 179.433 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.849 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . 52.13 122.11 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.879 0.371 . . . . 0.0 111.755 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -141.34 155.19 45.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.394 0.616 . . . . 0.0 112.43 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.761 ' HB2' HD11 ' A' ' 276' ' ' LEU . 64.0 mt -66.41 -31.79 72.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.212 178.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.569 ' HB2' ' O ' ' A' ' 274' ' ' LEU . 94.2 mmm 102.1 -80.8 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.643 0.777 . . . . 0.0 110.397 -178.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.761 HD11 ' HB2' ' A' ' 274' ' ' LEU . 0.1 OUTLIER 38.57 64.74 0.71 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.345 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.628 ' O ' HG22 ' A' ' 227' ' ' VAL . 57.1 t0 -56.57 -39.81 74.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.943 0.402 . . . . 0.0 110.747 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.617 ' O ' HG22 ' A' ' 280' ' ' THR . 17.2 mtpt -95.07 9.56 39.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.39 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 22.2 t70 60.56 42.25 14.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.143 0.497 . . . . 0.0 110.386 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 278' ' ' LYS . 0.0 OUTLIER -171.26 -67.26 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.346 179.834 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . 0.523 ' H ' HG23 ' A' ' 280' ' ' THR . . . -83.19 175.56 52.8 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.467 179.201 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.897 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 94.0 mm-40 64.05 45.06 4.31 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.013 0.435 . . . . 0.0 110.88 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.521 ' OG ' HD23 ' A' ' 276' ' ' LEU . 10.3 p -167.98 -40.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.033 179.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.443 ' O ' ' HA3' ' A' ' 251' ' ' GLY . 41.2 ttm180 -55.2 -31.34 61.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.933 179.299 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -105.77 -39.18 2.23 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.746 -0.74 . . . . 0.0 114.571 -178.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.491 ' CE1' " C4'" ' B' ' 2' ' ' ' A' . 27.3 p90 -136.6 167.24 21.77 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.001 0.9 . . . . 0.0 112.828 -178.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.671 ' O ' HG12 ' A' ' 247' ' ' VAL . . . -132.44 159.14 23.29 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.187 178.685 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.425 ' HB2' ' HG2' ' A' ' 275' ' ' MET . 0.1 OUTLIER -119.21 124.6 47.16 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 122.734 -0.274 . . . . 0.0 111.612 -179.502 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.849 HG13 ' HB2' ' A' ' 272' ' ' ALA . 57.4 t -128.98 135.72 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 178.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.606 ' HB ' HG22 ' A' ' 270' ' ' ILE . 26.5 m -122.4 139.9 53.31 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.358 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.615 ' O ' ' HA ' ' A' ' 242' ' ' THR . 74.5 m-85 -113.35 137.32 51.69 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 293' ' ' SER . 54.1 p30 -63.35 -30.14 71.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.295 178.55 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.537 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 99.1 p -115.55 144.1 44.37 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.272 0.558 . . . . 0.0 111.362 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.942 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -69.03 -33.32 73.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.348 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -57.04 -36.9 71.03 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -60.79 -39.09 87.59 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.942 HG12 ' O ' ' A' ' 294' ' ' ALA . 8.7 p -59.68 -37.83 72.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.437 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -62.79 -39.03 92.97 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -179.142 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -60.56 -43.29 97.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.902 HG23 HD11 ' A' ' 306' ' ' ILE . 0.9 OUTLIER -67.71 -34.18 66.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.671 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 77.4 m -57.82 -45.88 85.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.497 -179.166 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -61.59 -40.47 94.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.205 0.526 . . . . 0.0 110.704 179.68 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -60.52 -33.25 72.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.18 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.669 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 47.8 tptt 68.52 -73.21 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -177.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.669 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 3.6 m-30 -114.42 144.25 43.62 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.276 178.43 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.902 HD11 HG23 ' A' ' 300' ' ' VAL . 24.4 mt -118.89 133.4 65.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.639 178.204 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -76.84 75.69 3.46 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.598 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 5.2 t80 -72.8 -52.03 16.61 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.553 0.692 . . . . 0.0 110.927 -179.196 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.466 ' HD3' ' CE1' ' A' ' 308' ' ' PHE . 23.6 mmmt -128.39 -151.78 0.49 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.191 -179.147 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -58.08 -26.48 62.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.386 179.198 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -121.29 159.69 25.48 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.109 0.481 . . . . 0.0 112.237 -178.149 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.528 ' HB3' ' HB3' ' A' ' 305' ' ' PHE . 49.2 mttt -75.78 149.04 38.03 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.167 179.508 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.634 ' HB ' ' O ' ' A' ' 248' ' ' GLY . 36.8 pt -117.84 149.52 20.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.311 178.466 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . 0.587 ' HG2' ' CE1' ' A' ' 305' ' ' PHE . 83.0 mt-10 -110.79 132.13 54.46 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.584 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 0.573 HG12 HG23 ' A' ' 247' ' ' VAL . 79.7 mt -121.05 126.9 75.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.14 0.495 . . . . 0.0 111.685 -179.487 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -126.09 150.31 48.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.133 179.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.572 ' HA ' HG22 ' A' ' 245' ' ' ILE . 95.1 mtm-85 -55.83 144.13 28.87 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.264 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 244' ' ' LYS . . . -61.66 142.66 57.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.983 0.42 . . . . 0.0 111.34 -179.337 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -109.62 136.94 20.25 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.128 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.38 130.98 42.99 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 121.823 1.682 . . . . 0.0 111.438 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 44.6 tpt85 -58.52 -37.72 76.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 84.0 t60 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.925 -179.96 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.756 0 C3'-C2'-O2' 111.229 -0.714 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.897 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.425 -0.947 0 C3'-C2'-O2' 111.331 -0.679 . 0.18 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.606 ' O2 ' " H3'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.983 0 C1'-C2'-O2' 108.572 -0.676 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.738 ' N7 ' ' HA ' ' A' ' 167' ' ' ASN . . . . . . . . 0 O5'--C5' 1.427 -0.829 0 C4'-C3'-C2' 103.998 1.298 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.758 " O2'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.429 -0.662 0 O4'-C1'-N19 109.036 0.836 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.758 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.939 0 C4'-C3'-O3' 113.176 0.991 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.634 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.985 0 C4'-C3'-C2' 103.461 0.761 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . 0.406 ' OP2' ' HG3' ' A' ' 200' ' ' ARG . . . . . . . . 0 O5'--C5' 1.425 -0.95 0 C3'-C2'-O2' 111.262 -0.703 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.991 0.424 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -61.6 -32.34 72.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.791 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.1 t -116.2 145.22 43.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.956 -179.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.67 91.27 3.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.949 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.477 ' CE ' ' HB3' ' A' ' 204' ' ' PHE . 74.9 tttt -127.01 139.1 53.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.851 -179.505 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.826 ' SD ' HG13 ' A' ' 213' ' ' VAL . 93.2 mmm -116.29 147.56 41.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.42 -178.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.682 ' CE2' ' C8 ' ' B' ' 6' ' ' ' A' . 2.9 t80 -104.74 130.22 52.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.446 -0.797 . . . . 0.0 108.912 178.314 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.496 ' O ' ' HB2' ' A' ' 202' ' ' PHE . 21.8 mm -117.42 130.84 71.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.312 -179.217 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.574 ' O ' HG22 ' A' ' 228' ' ' ILE . . . -128.5 162.81 22.12 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 178.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.412 ' HA2' H5'' ' B' ' 4' ' ' ' A' . . . 77.46 36.43 34.05 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.14 -1.029 . . . . 0.0 111.992 -179.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.483 HD22 HG21 ' A' ' 170' ' ' THR . 50.7 mt -60.68 -26.12 66.86 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -178.774 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.75 ' HA ' ' N7 ' ' B' ' 4' ' ' ' A' . 42.0 t30 71.38 40.76 0.81 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -176.902 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.603 ' CE3' ' C5 ' ' B' ' 4' ' ' ' A' . 8.2 m0 31.4 41.76 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.948 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -174.84 21.89 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 179.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.522 ' O ' ' O ' ' A' ' 171' ' ' THR . 98.1 m -61.62 -38.19 86.72 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.524 ' C ' HD12 ' A' ' 190' ' ' ILE . 0.0 OUTLIER 57.82 130.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -177.657 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.944 ' N ' HD12 ' A' ' 190' ' ' ILE . 21.6 pt-20 -58.77 -29.49 66.82 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -178.29 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.533 ' HA ' ' HD3' ' A' ' 176' ' ' ARG . 91.1 m-20 -60.06 -40.67 90.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.71 0.29 . . . . 0.0 111.582 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 170' ' ' THR . 83.1 m-20 -64.91 -37.17 86.75 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -179.138 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.687 HD23 ' CE2' ' A' ' 179' ' ' PHE . 7.2 mt -55.8 -47.78 76.53 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.533 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER -65.1 -33.03 75.06 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.068 179.269 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -62.23 -39.02 91.41 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.672 -179.189 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.827 ' CD2' HD12 ' A' ' 223' ' ' LEU . 0.0 OUTLIER -94.59 -45.91 7.18 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-O 120.723 0.297 . . . . 0.0 110.755 179.614 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.687 ' CE2' HD23 ' A' ' 175' ' ' LEU . 75.0 m-85 -72.93 -13.96 61.36 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 179.074 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -52.69 -26.45 24.79 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.27 -0.49 . . . . 0.0 113.564 -179.297 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.752 ' HD3' ' H ' ' A' ' 181' ' ' LYS . 0.5 OUTLIER -56.47 -41.95 77.39 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.909 0.861 . . . . 0.0 110.796 -179.719 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.762 ' OH ' HG21 ' A' ' 219' ' ' THR . 66.6 m-85 -69.72 -35.15 74.78 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.054 -1.43 . . . . 0.0 112.927 -177.345 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 174.93 -175.08 47.02 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.352 -1.404 . . . . 0.0 114.171 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.556 ' O ' HG12 ' A' ' 185' ' ' VAL . 54.1 m -63.11 -25.11 68.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.573 -0.814 . . . . 0.0 111.659 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.593 HG21 HD23 ' A' ' 188' ' ' LEU . 7.9 p 52.75 79.66 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 CA-C-O 121.962 0.887 . . . . 0.0 109.091 -177.006 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 208' ' ' GLU . 0.2 OUTLIER -47.19 -50.95 19.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.664 -177.175 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 206' ' ' SER . 22.9 t70 -146.02 124.52 12.42 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.593 HD23 HG21 ' A' ' 185' ' ' VAL . 0.0 OUTLIER -108.97 153.87 22.97 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.708 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.605 ' HG3' ' SD ' ' A' ' 191' ' ' MET . 11.8 tptt -138.07 125.24 21.57 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -177.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . 0.944 HD12 ' N ' ' A' ' 172' ' ' GLU . 5.6 mt -123.67 126.55 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.564 175.58 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . 0.605 ' SD ' ' HG3' ' A' ' 189' ' ' LYS . 2.6 mpp? -94.6 57.98 2.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.295 -179.489 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.401 ' HA ' ' OG ' ' A' ' 199' ' ' SER . 34.2 tttm -63.9 149.49 47.02 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.81 -179.033 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.526 ' HB3' ' O ' ' A' ' 198' ' ' ARG . 2.1 t0 -120.4 75.85 24.88 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.594 -179.48 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.14 -23.88 75.09 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.59 2.193 . . . . 0.0 112.767 179.608 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -68.28 -73.85 0.14 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.883 -179.041 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.7 p -68.05 -25.54 65.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.704 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 93.95 -0.23 66.76 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.591 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.526 ' O ' ' HB3' ' A' ' 193' ' ' ASP . 0.8 OUTLIER -127.29 131.9 50.42 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.71 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.442 ' OG ' ' NH1' ' A' ' 200' ' ' ARG . 13.3 t -110.5 155.37 22.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.552 0.692 . . . . 0.0 112.799 -178.009 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.651 ' NH2' HG23 ' A' ' 190' ' ' ILE . 0.5 OUTLIER -45.01 -32.21 1.58 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.731 -179.801 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.628 ' HA3' " H2'" ' B' ' 4' ' ' ' A' . . . 90.11 22.17 36.33 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.59 -0.814 . . . . 0.0 114.849 178.607 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.61 ' CE2' ' HB2' ' A' ' 200' ' ' ARG . 41.5 p90 -150.83 152.66 34.06 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 117.503 0.652 . . . . 0.0 111.008 178.773 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -138.54 161.69 25.75 Favored Glycine 0 C--O 1.228 -0.265 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.355 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.713 ' CE2' ' C6 ' ' B' ' 7' ' ' ' U' . 85.3 m-85 -110.73 126.0 54.1 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.9 -179.836 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.609 HD21 HD22 ' A' ' 175' ' ' LEU . 53.9 mt -107.73 142.01 38.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.687 0.28 . . . . 0.0 110.8 179.811 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 187' ' ' ASP . 26.3 t -124.65 130.12 51.82 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.614 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.831 ' CE2' HG21 ' A' ' 216' ' ' VAL . 97.6 m-85 -114.76 135.75 53.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.94 0.4 . . . . 0.0 111.31 179.603 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.43 ' N ' ' OG1' ' A' ' 186' ' ' THR . 84.4 tt0 -60.23 -34.23 73.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.473 179.204 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.62 116.96 56.79 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.823 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.85 -29.5 81.7 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.515 2.143 . . . . 0.0 113.189 -179.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 22.7 m -59.15 -37.91 78.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.786 0.327 . . . . 0.0 110.853 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.821 ' O ' HG23 ' A' ' 216' ' ' VAL . 23.3 m -59.83 -34.42 73.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.194 0.521 . . . . 0.0 110.31 179.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.826 HG13 ' SD ' ' A' ' 161' ' ' MET . 78.1 t -60.38 -41.24 86.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.094 -179.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -57.82 -43.95 86.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.026 0.441 . . . . 0.0 110.754 -179.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.7 -33.36 72.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.044 178.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.831 HG21 ' CE2' ' A' ' 207' ' ' PHE . 96.8 t -60.39 -43.07 93.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.589 -178.512 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 230' ' ' PRO . 9.0 p -84.23 -49.5 16.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.121 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.514 ' N ' HG13 ' A' ' 217' ' ' VAL . 81.4 tttt -59.93 -39.68 86.3 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.424 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.762 HG21 ' OH ' ' A' ' 182' ' ' TYR . 70.5 m -59.19 -38.89 80.94 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.329 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.408 ' O ' ' O ' ' A' ' 219' ' ' THR . 63.1 tt0 62.1 114.67 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.03 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.686 ' NE2' ' O ' ' A' ' 216' ' ' VAL . 0.0 OUTLIER -134.2 169.03 17.79 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -176.707 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.887 ' CD1' HG13 ' A' ' 227' ' ' VAL . 16.1 mm -117.62 128.39 74.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.839 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.827 HD12 ' CD2' ' A' ' 178' ' ' TYR . 8.5 tt -117.3 126.0 52.0 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.708 179.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.414 ' CG ' HD23 ' A' ' 223' ' ' LEU . 86.9 m-20 53.53 41.89 32.02 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 178.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 90.35 -23.88 19.5 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.412 -0.899 . . . . 0.0 114.337 177.444 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.605 ' O ' HG23 ' A' ' 222' ' ' ILE . 34.7 mmtp -95.66 151.21 19.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.202 0.501 . . . . 0.0 111.405 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.887 HG13 ' CD1' ' A' ' 222' ' ' ILE . 26.3 t -92.28 128.76 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.769 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 164' ' ' GLY . 28.3 pt -125.67 154.98 34.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.253 -179.341 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -129.58 78.21 75.86 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.121 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 230' ' ' PRO . . . . . 0.646 ' O ' HG23 ' A' ' 217' ' ' VAL . 9.4 Cg_endo -52.28 131.59 40.51 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.636 2.224 . . . . 0.0 111.775 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 162' ' ' PHE . 5.4 ttpm? -136.21 139.73 43.01 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.731 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.446 ' HG3' ' CG1' ' A' ' 213' ' ' VAL . 0.9 OUTLIER -50.82 141.98 12.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.088 0.471 . . . . 0.0 111.743 -179.494 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.531 ' HA ' ' N1 ' ' B' ' 6' ' ' ' A' . . . -62.45 144.44 55.92 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.391 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.581 HG13 ' N6 ' ' B' ' 6' ' ' ' A' . 0.4 OUTLIER -107.68 135.81 19.73 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 121.353 -0.139 . . . . 0.0 110.902 179.761 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.91 139.95 85.03 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 121.789 1.659 . . . . 0.0 110.623 178.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -58.52 -37.55 75.86 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -60.18 -48.29 82.36 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.711 -179.856 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -73.04 -41.33 64.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.567 0.699 . . . . 0.0 110.168 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.518 ' O ' HG23 ' A' ' 242' ' ' THR . 61.1 tt0 -60.36 -37.06 79.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.505 -179.479 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -56.25 -37.42 69.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.613 -179.368 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 242' ' ' THR . 39.8 mttm -82.62 -74.09 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.468 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 239' ' ' GLN . 33.5 p 38.62 -168.01 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.087 0.47 . . . . 0.0 112.215 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -168.08 49.75 0.23 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.353 -179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 15.3 tttp -72.82 128.72 36.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.76 0.314 . . . . 0.0 110.532 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.716 ' CG2' HG23 ' A' ' 297' ' ' VAL . 0.0 OUTLIER -125.02 162.94 26.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -179.409 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.421 ' HE1' ' CD2' ' A' ' 286' ' ' PHE . 87.4 t80 -101.45 134.15 44.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.647 -1.161 . . . . 0.0 111.181 179.566 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.754 HG11 ' CE1' ' A' ' 259' ' ' PHE . 14.0 p -127.79 136.38 60.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.687 179.006 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -125.04 4.66 8.38 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.747 -178.702 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.624 ' O ' HG22 ' A' ' 313' ' ' ILE . . . -88.14 9.16 76.0 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.744 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.996 HD11 ' HA3' ' A' ' 287' ' ' GLY . 31.9 pt -120.61 154.75 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 121.004 0.43 . . . . 0.0 111.521 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.816 ' O ' HG22 ' A' ' 254' ' ' VAL . . . -167.51 -142.58 3.5 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.839 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.07 -19.71 34.25 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.55 2.167 . . . . 0.0 112.449 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -82.9 3.18 30.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.81 -179.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.816 HG22 ' O ' ' A' ' 251' ' ' GLY . 19.1 m -126.77 157.04 38.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.718 0.294 . . . . 0.0 110.792 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.4 ' HD2' ' HD2' ' A' ' 256' ' ' PRO . 17.0 mmt85 -111.65 154.94 43.75 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.4 ' HD2' ' HD2' ' A' ' 255' ' ' ARG . 13.8 Cg_endo -57.49 -43.01 55.23 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 121.793 1.662 . . . . 0.0 111.797 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 261' ' ' GLU . 35.3 mttp -63.14 -43.14 99.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.129 179.349 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 261' ' ' GLU . 76.3 mm-40 -66.53 -36.87 83.75 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.576 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.754 ' CE1' HG11 ' A' ' 247' ' ' VAL . 25.2 t80 -63.67 -52.37 61.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.21 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -64.11 -37.25 86.76 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 258' ' ' GLU . 72.7 tt0 -61.88 -38.03 86.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 113.876 -1.511 . . . . 0.0 111.968 178.213 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.779 ' CE2' HD11 ' A' ' 313' ' ' ILE . 71.6 t80 -69.61 -56.52 7.06 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -179.445 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.704 ' C ' HD11 ' A' ' 269' ' ' ILE . 18.9 m-85 -65.2 -24.08 67.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.932 -179.377 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.711 ' N ' HD11 ' A' ' 269' ' ' ILE . 86.1 p -59.48 -25.91 64.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.376 -179.312 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 265' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -57.54 -36.89 72.22 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 266' ' ' TRP . . . . . 0.75 ' CZ2' HG21 ' A' ' 300' ' ' VAL . 11.9 p90 -115.18 39.81 2.82 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.113 0.482 . . . . 0.0 111.765 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.508 ' HA3' ' CE1' ' A' ' 291' ' ' TYR . . . 157.51 146.74 4.58 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.709 178.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.434 ' O ' ' HB ' ' A' ' 269' ' ' ILE . 59.8 m -58.94 -37.49 76.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.754 0.311 . . . . 0.0 111.27 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.711 HD11 ' N ' ' A' ' 264' ' ' SER . 73.9 mt 69.3 90.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.099 -179.202 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.63 ' CD1' ' HA ' ' A' ' 292' ' ' ASP . 75.0 mt -54.97 -44.76 75.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.932 179.009 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . 0.467 ' O ' ' HB ' ' A' ' 290' ' ' THR . 54.0 t0 -156.49 146.76 21.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.824 179.079 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.402 ' HB2' HG13 ' A' ' 289' ' ' VAL . . . -154.69 141.37 18.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.348 178.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -146.61 155.83 42.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.505 0.669 . . . . 0.0 112.378 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . 0.631 HD23 HD22 ' A' ' 276' ' ' LEU . 27.0 tp -64.44 -33.9 76.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.426 179.382 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 275' ' ' MET . . . . . 0.585 ' O ' ' HB2' ' A' ' 282' ' ' GLN . 72.9 mmm 69.48 80.74 0.18 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 -178.478 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.631 HD22 HD23 ' A' ' 274' ' ' LEU . 0.2 OUTLIER -119.38 126.67 51.94 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.34 179.578 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.459 ' HB2' ' HG2' ' A' ' 282' ' ' GLN . 60.0 t0 -86.63 118.71 26.22 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.128 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 278' ' ' LYS . . . . . 0.458 ' CE ' ' HE2' ' A' ' 226' ' ' LYS . 26.9 mmtp 59.22 -150.23 0.44 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.602 -0.439 . . . . 0.0 109.911 -178.358 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.2 -38.73 68.75 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.222 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 280' ' ' THR . 14.4 t -168.42 114.37 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.906 0.384 . . . . 0.0 111.448 179.282 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 277' ' ' ASP . . . -145.4 -90.91 0.11 Allowed Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.207 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.948 ' OE1' " H4'" ' B' ' 2' ' ' ' A' . 97.3 mm-40 -56.39 -31.26 63.69 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.934 0.494 . . . . 0.0 111.946 -179.084 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.476 ' HB2' ' CD2' ' A' ' 274' ' ' LEU . 91.8 p -72.76 -4.71 33.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.562 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -51.9 -34.64 42.25 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 250' ' ' ILE . . . -156.22 9.51 0.29 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 119.318 -1.42 . . . . 0.0 115.398 -179.094 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 282' ' ' GLN . 16.4 p90 -145.87 164.65 31.28 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.976 1.388 . . . . 0.0 112.084 179.12 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.996 ' HA3' HD11 ' A' ' 250' ' ' ILE . . . -140.1 164.68 26.13 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.254 179.126 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.496 ' HB2' ' HG2' ' A' ' 275' ' ' MET . 0.2 OUTLIER -119.4 128.54 54.14 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.367 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.672 HG23 ' CZ ' ' A' ' 259' ' ' PHE . 44.1 t -128.31 138.27 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.813 0.34 . . . . 0.0 111.524 178.289 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 244' ' ' LYS . 36.2 m -117.34 136.41 53.15 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.508 ' CE1' ' HA3' ' A' ' 267' ' ' GLY . 39.7 m-85 -115.31 136.01 53.55 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.416 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.63 ' HA ' ' CD1' ' A' ' 270' ' ' ILE . 55.3 p30 -64.79 -32.93 74.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.724 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.57 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 51.0 m -121.98 144.42 48.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.312 0.577 . . . . 0.0 112.237 -178.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.989 ' O ' HG12 ' A' ' 297' ' ' VAL . . . -66.23 -32.06 73.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.075 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -56.61 -38.19 71.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.098 -179.717 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -64.42 -41.59 96.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.767 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.989 HG12 ' O ' ' A' ' 294' ' ' ALA . 9.7 p -59.83 -37.05 69.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.014 0.435 . . . . 0.0 111.479 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 298' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -61.75 -37.26 83.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.717 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -58.88 -44.13 91.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.165 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.75 HG21 ' CZ2' ' A' ' 266' ' ' TRP . 0.7 OUTLIER -73.41 -35.87 47.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.927 0.394 . . . . 0.0 111.274 -179.642 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 301' ' ' CYS . . . . . . . . . . . . . 79.3 m -58.53 -46.14 87.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.032 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 302' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -63.6 -40.62 97.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.225 0.536 . . . . 0.0 110.192 179.198 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.416 ' O ' ' N ' ' A' ' 305' ' ' PHE . 87.4 m-20 -64.3 -35.6 81.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.865 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.675 ' HG3' ' CD1' ' A' ' 305' ' ' PHE . 35.5 tptt 67.76 -67.37 0.19 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.168 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.675 ' CD1' ' HG3' ' A' ' 304' ' ' LYS . 17.5 m-85 -113.98 131.84 56.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.929 179.148 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 306' ' ' ILE . . . . . 0.667 HD11 HG23 ' A' ' 300' ' ' VAL . 1.3 mt -122.18 138.69 51.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.127 178.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.494 ' OD1' ' CD ' ' A' ' 312' ' ' LYS . 94.0 m-20 -73.89 119.21 17.79 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.422 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.728 ' CE1' ' HB2' ' A' ' 262' ' ' PHE . 9.4 t80 -119.75 -76.07 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.417 0.627 . . . . 0.0 109.948 178.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.522 ' CG ' HG12 ' A' ' 254' ' ' VAL . 6.4 mmpt? -97.72 -163.39 1.04 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.513 178.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -52.93 -31.31 39.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.785 0.326 . . . . 0.0 110.742 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -112.15 153.62 26.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.106 0.479 . . . . 0.0 111.351 -179.369 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.598 ' CG ' ' HB3' ' A' ' 305' ' ' PHE . 19.7 tptt -70.77 143.96 51.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.541 -179.091 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.779 HD11 ' CE2' ' A' ' 262' ' ' PHE . 26.4 pt -111.31 141.38 26.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.799 179.218 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 314' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -101.48 131.69 47.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.716 179.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 315' ' ' ILE . . . . . 0.624 HD13 ' CE2' ' A' ' 263' ' ' PHE . 72.2 mt -119.92 129.57 75.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.156 0.503 . . . . 0.0 111.421 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 30.5 tttp -131.6 141.49 49.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.162 -179.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.458 ' HA ' HG22 ' A' ' 245' ' ' ILE . 34.9 ttp180 -54.55 137.75 42.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 0.0 110.581 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.72 140.73 56.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.332 -179.269 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -75.42 152.5 85.66 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.191 179.089 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.7 -23.83 42.94 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.25 1.967 . . . . 0.0 111.712 179.685 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.485 ' HG3' ' O4 ' ' B' ' 3' ' ' ' U' . 31.6 mmm180 38.09 40.58 0.32 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.482 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 322' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.895 -179.683 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.725 0 C3'-C2'-O2' 111.32 -0.683 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.948 " H4'" ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 O5'--C5' 1.424 -1.008 0 C3'-C2'-O2' 111.274 -0.698 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.521 ' O2 ' " H3'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.028 0 C3'-C2'-O2' 111.117 -0.753 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.753 " H3'" H5'' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.998 0 O4'-C1'-C2' 107.771 0.979 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.753 H5'' " H3'" ' B' ' 4' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.731 0 C4'-C3'-C2' 103.548 0.848 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.682 ' C8 ' ' CE2' ' A' ' 162' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.961 0 C4'-C3'-C2' 103.574 0.874 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.713 ' C6 ' ' CE2' ' A' ' 204' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -1.0 0 C3'-C2'-O2' 111.341 -0.675 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 8' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.984 0 C3'-C2'-O2' 111.26 -0.703 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 stop_ save_